N Unused Total %Cov %Cov(50) %Cov(95) Accessions Names Used Annotation Contrib Conf Sequence Modifications Cleavages dMass Prec MW Prec m/z Theor MW Theor m/z Theor z Sc Spectrum Specific Time PrecursorSignal PrecursorElution 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AARLEALKENGGAR cleaved L-A@N-term; missed R-L@3; missed K-E@8 0.215480998158455 1455.01086425781 486.0109 1454.79541015625 485.939056396484 3 18 1.1.1.2756.6 1 25.9927 17642.69 25.8398 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AEYHAKATEHLSTLSEK acrolein addition +94(K)@6 cleaved L-A@N-term; missed K-A@6 0.241723001003265 2008.23193359375 670.4179 2007.99011230469 670.337341308594 3 19 1.1.1.3173.5 1 36.0127 1486.569 36.0416 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AHVDALRTHLAPYSDELR missed R-T@7 0.16864800453186 2063.22338867188 1032.619 2063.05493164063 1032.53466796875 2 25 1.1.1.3110.5 1 34.5011 2986.219 34.5543 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AHVDALRTHLAPYSDELRQR Dehydrated(S)@14 missed R-T@7; missed R-Q@18 0.301358014345169 2329.50537109375 583.3836 2329.20385742188 583.308288574219 4 21 1.1.1.3078.6 1 33.7283 4464.945 33.7607 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.397614985704422 3897.48095703125 780.5035 3897.08349609375 780.423950195313 5 22 1.1.1.3672.2 1 48.2016 9981.84 48.1585 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AKPALEDLRQGLLPVLESFK missed R-Q@9 0.24702200293541 2223.509765625 742.1772 2223.2626953125 742.094848632813 3 23 1.1.1.3983.4 1 55.7691 18553.25 55.813 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.256220996379852 3591.21508789063 1198.079 3590.9599609375 1197.99389648438 3 27 1.1.1.4727.11 1 74.5146 1933.542 74.4955 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed R-Q@9; missed K-V@20; missed K-K@32 0.333180993795395 3719.38818359375 930.8543 3719.05493164063 930.77099609375 4 26 1.1.1.4664.15 1 72.9169 8710.157 73.0339 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLN cleaved N-T@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.389037996530533 3946.57104492188 790.3215 3946.18188476563 790.24365234375 5 14 1.1.1.4770.13 1 75.5594 1906.521 75.5711 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.327212005853653 4047.55493164063 1012.896 4047.22973632813 1012.81469726563 4 23 1.1.1.4733.9 1 74.6531 4472.79 74.8348 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.316486001014709 4175.6025390625 1044.908 4175.2880859375 1044.82934570313 4 18 1.1.1.4789.21 1 76.0616 1085.946 75.9349 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AKVQPYLDDFQK Carbamidomethyl@N-term missed K-V@2 0.165985003113747 1507.93310546875 754.9738 1507.76708984375 754.890808105469 2 20 1.1.1.3021.12 1 32.3625 649.0872 32.3435 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AKVQPYLDDFQKK missed K-V@2; missed K-K@12 0.224125996232033 1579.06469726563 527.3622 1578.84057617188 527.287475585938 3 19 1.1.1.2888.6 1 29.1522 2749.264 29.2138 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR missed K-V@2; missed K-K@12; missed K-W@13 0.382454007863998 2843.77758789063 569.7628 2843.39526367188 569.686340332031 5 21 1.1.1.3754.4 1 50.143 23193.47 50.2122 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AKVQPYLDDFQKKWQEEMELYRQK missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22 0.319808006286621 3099.86865234375 775.9744 3099.548828125 775.894470214844 4 19 1.1.1.3719.14 1 49.2582 5208.046 49.3454 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AKVQPYLDDFQKKWQEEMELYRQKVEPLR missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22; missed K-V@24 0.350744992494583 3694.24853515625 924.5694 3693.89770507813 924.481689453125 4 23 1.1.1.3770.16 1 50.562 851.1752 50.5453 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 AKVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22; missed K-V@24; missed R-A@29 0.408340007066727 4548.73046875 910.7534 4548.322265625 910.671752929688 5 28 1.1.1.3815.8 1 51.6705 7010.923 51.7118 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 ARAHVDALRTHLAPYSDELRQR missed R-A@2; missed R-T@9; missed R-Q@20 0.305644005537033 2574.65844726563 644.6719 2574.35278320313 644.595458984375 4 23 1.1.1.2961.10 1 30.9166 4904.896 30.8276 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 ARLEALKENGGAR cleaved A-A@N-term; missed R-L@2; missed K-E@7 0.213532000780106 1383.97180175781 462.3312 1383.75830078125 462.260040283203 3 17 1.1.1.2747.6 1 25.7794 8275.659 25.8159 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 ATEHLSTLSEK Dehydrated(T)@7 0.150894999504089 1196.75463867188 599.3846 1196.60375976563 599.309143066406 2 19 1.1.1.2695.5 1 24.5397 6126.045 24.5765 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 ATEHLSTLSEKAK cleaved K-P@C-term; missed K-A@11 0.213440999388695 1413.95983886719 472.3272 1413.74633789063 472.256072998047 3 19 1.1.1.2611.8 1 22.5248 1223.803 22.5365 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 ATEHLSTLSEKAKPALEDLR missed K-A@11 0.296371012926102 2208.47143554688 553.1251 2208.17504882813 553.051025390625 4 23 1.1.1.3096.7 1 34.1609 5117.113 34.1925 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFK missed K-A@11; missed R-Q@20 0.342754989862442 3420.20922851563 856.0596 3419.86645507813 855.973876953125 4 27 1.1.1.3940.6 1 54.7415 1185.729 54.7591 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed K-A@11; missed R-Q@20; missed K-V@31 0.409557998180389 4787.97314453125 958.6019 4787.5634765625 958.52001953125 5 20 1.1.1.4649.18 1 72.5226 8710.146 72.5035 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43 0.464179009199142 4916.123046875 820.3611 4915.65869140625 820.28369140625 6 33 1.1.1.4561.4 1 70.2225 1614.434 70.2851 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLN cleaved N-T@C-term; missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.476958006620407 5143.2626953125 858.2177 5142.78564453125 858.138244628906 6 17 1.1.1.4664.11 1 72.9136 811.6836 72.927 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.413118988275528 5244.2490234375 1049.857 5243.83349609375 1049.77392578125 5 24 1.1.1.4690.17 1 73.5958 1483.093 73.6536 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 -0.478065997362137 5371.4140625 768.3521 5371.89208984375 768.42041015625 7 17 1.1.1.4768.8 1 75.504 599.7152 75.5199 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 DEPPQSPWDR cleaved Q-D@N-term 0.155869007110596 1225.69226074219 613.8534 1225.53637695313 613.775451660156 2 16 1.1.1.2953.11 1 30.7249 73240.41 30.4674 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 DEPPQSPWDRVK cleaved Q-D@N-term; missed R-V@10 0.160705000162125 1452.86047363281 727.4375 1452.69970703125 727.357177734375 2 19 1.1.1.2966.11 1 31.0381 12240 31.0432 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.254328995943069 2669.62451171875 890.8821 2669.3701171875 890.797302246094 3 28 1.1.1.4155.3 1 59.9872 91016.72 60.2192 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGR cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.264066994190216 3084.8154296875 1029.279 3084.55151367188 1029.19116210938 3 22 1.1.1.4252.15 1 62.3595 6034.971 62.5432 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.333788990974426 4466.53466796875 1117.641 4466.203125 1117.55798339844 4 24 1.1.1.4370.15 1 65.4081 107153.7 65.5895 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27; missed K-Q@40 0.43402299284935 5063.00341796875 1013.608 5062.5673828125 1013.52081298828 5 28 1.1.1.4430.10 1 66.8852 9080.329 66.7942 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 DLATVYVDVLK 0.161354005336761 1234.84228515625 618.4284 1234.68090820313 618.347717285156 2 18 1.1.1.3790.3 1 51.0577 36416.11 50.9995 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 DLATVYVDVLKDSGR missed K-D@11 0.168772995471954 1650.03125 826.0229 1649.86242675781 825.9384765625 2 20 1.1.1.3800.6 1 51.3011 4790.637 51.3913 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@11; missed R-D@15 0.253264993429184 3031.76611328125 1011.596 3031.51391601563 1011.51190185547 3 35 1.1.1.4043.3 1 57.2688 79970.9 57.2098 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK missed K-D@11; missed R-D@15; missed K-Q@28 0.335372000932693 3628.2138671875 908.0607 3627.87841796875 907.976867675781 4 25 1.1.1.4065.8 1 57.8281 1512.147 57.8398 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK missed K-D@11; missed R-D@15; missed K-Q@28; missed K-L@33 0.437440007925034 5222.08349609375 1045.424 5221.64599609375 1045.33642578125 5 23 1.1.1.4436.5 1 67.0439 958.0847 66.9518 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.164890006184578 1815.00842285156 908.5115 1814.84350585938 908.429016113281 2 24 1.1.1.3408.9 1 41.6669 3917.682 41.7207 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 DSGRDYVSQFEGSALGKQLNLK missed R-D@4; missed K-Q@17 0.246021002531052 2411.4541015625 804.8253 2411.2080078125 804.743286132813 3 28 1.1.1.3650.17 1 47.6454 20298.39 47.7047 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK missed R-D@4; missed K-Q@17; missed K-L@22 0.401540994644165 4005.37719726563 802.0827 4004.9755859375 802.002380371094 5 36 1.1.1.4048.9 1 57.3923 12203.01 57.4333 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 DYVSQFEGSALGK 0.160522997379303 1399.82250976563 700.9185 1399.66198730469 700.838256835938 2 22 1.1.1.3498.16 1 43.8784 3764.118 43.7379 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 DYVSQFEGSALGKQLNLK missed K-Q@13 0.170316994190216 1996.19689941406 999.1057 1996.02661132813 999.020568847656 2 26 1.1.1.3735.21 1 49.6719 5024.719 49.6251 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 DYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK missed K-Q@13; missed K-L@18 0.335298001766205 3590.12939453125 898.5396 3589.7939453125 898.455810546875 4 27 1.1.1.4222.4 1 61.6123 1394.365 61.6554 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 EPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved D-E@N-term; missed R-V@9; missed K-D@11; missed K-D@22; missed R-D@26 0.418397009372711 4351.59423828125 871.3262 4351.17626953125 871.242492675781 5 23 1.1.1.4353.4 1 64.9521 2298.485 64.9421 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 EQLGPVTQEFWDNLEK 0.17417399585247 1932.10070800781 967.0576 1931.92651367188 966.970520019531 2 25 1.1.1.3837.16 1 52.2338 12177.79 52.243 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 EQLGPVTQEFWDNLEKETEGLR missed K-E@16 0.248780995607376 2617.51489257813 873.5122 2617.26611328125 873.429260253906 3 20 1.1.1.4052.13 1 57.5004 10683.69 57.5644 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 EQLGPVTQEFWDNLEKETEGLRQEMSK reduced acrolein addition +96(K)@16; Dethiomethyl(M)@25 missed K-E@16; missed R-Q@22 0.250988990068436 3268.83984375 818.2172 3268.5888671875 818.154479980469 4 20 1.1.1.3866.5 1 52.9384 1894.52 52.957 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 EQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK missed K-E@16; missed R-Q@22; missed K-D@27 0.410820990800858 3934.30493164063 787.8683 3933.89428710938 787.7861328125 5 22 1.1.1.4372.2 1 65.4493 5155.503 65.3662 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 EQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK missed K-E@16; missed R-Q@22; missed K-D@27; missed K-A@33 0.481795012950897 4133.50830078125 689.9253 4133.0263671875 689.844970703125 6 20 1.1.1.4336.3 1 64.503 3829.518 64.4184 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 ETEGLRQEMSK Glu->pyro-Glu@N-term missed R-Q@6 0.16245299577713 1288.77062988281 645.3926 1288.60815429688 645.311340332031 2 18 1.1.1.2789.7 1 26.7936 784.3757 26.7987 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 ETEGLRQEMSKDLEEVK Glu->pyro-Glu@N-term; Oxidation(M)@9 missed R-Q@6; missed K-D@11 0.240084007382393 2018.20275878906 673.7415 2017.96264648438 673.661499023438 3 25 1.1.1.2969.8 1 31.1099 755.0214 31.115 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 ETEGLRQEMSKDLEEVKAK missed R-Q@6; missed K-D@11; missed K-A@17 0.239024996757507 2219.34936523438 740.7904 2219.1103515625 740.710754394531 3 26 1.1.1.3181.7 1 36.1989 5107.992 36.1611 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 KVQPYLDDFQKKWQEEMELYR acrolein addition +112(K)@1; reduced acrolein addition +96(K)@12; Dethiomethyl(M)@17 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 0.254229992628098 2932.71899414063 734.187 2932.46459960938 734.123474121094 4 22 1.1.1.3494.17 1 43.7792 2988.572 43.9612 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 KWQEEMELYR Oxidation(M)@6 missed K-W@1 0.163354992866516 1426.81848144531 714.4165 1426.65515136719 714.334838867188 2 16 1.1.1.2817.11 1 27.461 3293.546 27.4422 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 KWQEEMELYRQK Dioxidation(W)@2; Oxidation(M)@6 missed K-W@1; missed R-Q@10 0.220960006117821 1715.01940917969 572.6804 1714.79846191406 572.606750488281 3 18 1.1.1.2694.7 1 24.5208 1660.391 24.5284 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 KWQEEMELYRQKVEPLR missed K-W@1; missed R-Q@10; missed K-V@12 0.30773401260376 2261.47045898438 566.3749 2261.16259765625 566.297973632813 4 18 1.1.1.3311.3 1 39.3021 1232.474 39.3699 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 KWQEEMELYRQKVEPLRAELQEGAR missed K-W@1; missed R-Q@10; missed K-V@12; missed R-A@17 0.323289006948471 3115.91064453125 779.9849 3115.58740234375 779.904113769531 4 18 1.1.1.3555.8 1 45.2659 1804.604 45.2776 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LAARLEALKENGGAR Ammonia-loss(N)@11 missed R-L@4; missed K-E@9 0.168568998575211 1551.021484375 776.518 1550.85290527344 776.433715820313 2 17 1.1.1.2811.9 1 27.3146 661.655 27.2754 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LAARLEALKENGGARLAEYHAKATEHLSTLSEK Deamidated(N)@11 missed R-L@4; missed K-E@9; missed R-L@15; missed K-A@22 0.459511011838913 3578.3447265625 597.3981 3577.88525390625 597.321472167969 6 19 1.1.1.3224.5 1 37.2315 1390.211 37.2639 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LAEYHAKATEHLSTLSEK missed K-A@7 0.163038998842239 2027.19543457031 1014.605 2027.03234863281 1014.5234375 2 32 1.1.1.2712.9 1 24.9516 4383.606 24.9831 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38 -0.519957005977631 5599.4619140625 934.2509 5599.98193359375 934.337585449219 6 21 1.1.1.4505.10 1 68.7924 668.8059 68.753 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38; missed K-K@50; missed K-L@51 -0.503319025039673 6183.80810546875 1031.642 6184.31005859375 1031.7255859375 6 17 1.1.1.4603.16 1 71.3078 681.0218 71.0234 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LATVYVDVLKDSGRDYVSQFEGSALGK cleaved D-L@N-term; missed K-D@10; missed R-D@14 0.319685012102127 2916.806640625 730.2089 2916.48681640625 730.129028320313 4 23 1.1.1.3783.10 1 50.8861 2125.734 50.8748 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LEALKENGGAR Formyl(K)@5 missed K-E@5 0.15565299987793 1184.77062988281 593.3926 1184.61499023438 593.314758300781 2 19 1.1.1.2711.9 1 24.9252 1943.152 24.9353 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LHELQEKLSPLGEEMR missed K-L@7 0.231020003557205 1908.20849609375 637.0768 1907.9775390625 636.999755859375 3 25 1.1.1.3189.8 1 36.3932 7622.044 36.4966 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LHELQEKLSPLGEEMRDR missed K-L@7; missed R-D@16 0.167981997132301 2179.2734375 1090.644 2179.10546875 1090.56005859375 2 23 1.1.1.3104.8 1 34.3564 5628.306 34.3374 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term cleaved V-L@N-term; missed K-D@2; missed R-D@6 0.102338999509811 2113.14526367188 1057.58 2113.0439453125 1057.529296875 2 18 1.1.1.3359.13 1 40.4714 4808.233 40.5975 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LKLLDNWDSVTSTFSK cleaved N-L@N-term; missed K-L@2 0.177781999111176 1853.13488769531 927.5747 1852.95703125 927.48583984375 2 19 1.1.1.3770.17 1 50.5628 680.2344 50.5453 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 0.162676006555557 1627.93566894531 814.9751 1627.77294921875 814.893737792969 2 20 1.1.1.3404.17 1 41.5657 4113.332 41.7693 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LLDNWDSVTSTFSKLR missed K-L@14 0.173586994409561 1881.13684082031 941.5757 1880.96325683594 941.488891601563 2 19 1.1.1.3800.8 1 51.3028 10501.48 51.3913 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSK missed K-L@14; missed R-E@16; missed K-E@32; missed R-Q@38 0.468167006969452 5083.95556640625 848.3332 5083.4873046875 848.255187988281 6 16 1.1.1.4726.11 1 74.4821 2215.358 74.6648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LNLKLLDNWDSVTSTFSK Acetyl@N-term; HPNE addition +172(K)@4 cleaved Q-L@N-term; missed K-L@4 0.223725005984306 2294.42822265625 765.8167 2294.20458984375 765.742126464844 3 26 1.1.1.4323.7 1 64.1682 7367.836 64.185 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LREQLGPVTQEFW Trp->Hydroxykynurenin(W)@13 cleaved W-D@C-term; missed R-E@2 0.168589994311333 1621.97863769531 811.9966 1621.81005859375 811.912292480469 2 20 1.1.1.3625.18 1 47.0009 757.1614 46.9313 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LREQLGPVTQEFWDNLEK missed R-E@2 0.203830003738403 2201.3154296875 734.7791 2201.11157226563 734.711181640625 3 21 1.1.1.3406.11 1 41.6165 815.5399 41.6477 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR Oxidation(W)@13 missed R-E@2; missed K-E@18 0.326795995235443 2902.77294921875 726.7005 2902.44604492188 726.618774414063 4 22 1.1.1.3629.13 1 47.101 776.748 47.1392 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQ cleaved Q-E@C-term; missed R-E@2; missed K-E@18; missed R-Q@24 0.32123801112175 3014.8310546875 754.715 3014.509765625 754.634704589844 4 28 1.1.1.4018.8 1 56.636 571.5278 56.6027 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK missed R-E@2; missed K-E@18; missed R-Q@24 0.313562005758286 3490.03344726563 873.5156 3489.7197265625 873.437255859375 4 23 1.1.1.3755.18 1 50.1794 1861.573 50.2375 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Dioxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.396358013153076 4251.46044921875 851.2994 4251.06396484375 851.220092773438 5 32 1.1.1.3866.7 1 52.9418 4134.339 52.9818 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Dioxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.411314994096756 4450.607421875 891.1288 4450.1962890625 891.046508789063 5 23 1.1.1.3822.9 1 51.8514 2023.751 51.892 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 LSPLGEEMRDR missed R-D@9 0.156819999217987 1301.79663085938 651.9056 1301.63977050781 651.8271484375 2 19 1.1.1.2870.6 1 28.7272 51013.98 28.5644 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 PLRAELQEGAR cleaved E-P@N-term; missed R-A@3 0.155086994171143 1238.82824707031 620.4214 1238.67309570313 620.343872070313 2 18 1.1.1.2911.9 1 29.712 8064.037 29.7679 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 PPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Lys-add@N-term; acrolein addition +112(K)@10 cleaved E-P@N-term; missed R-V@8; missed K-D@10; missed K-D@21; missed R-D@25 0.285887002944946 4462.56689453125 893.5206 4462.28076171875 893.463439941406 5 26 1.1.1.3967.4 1 55.3993 3782.074 55.3453 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 PYLDDFQKKWQEEMELYR cleaved Q-P@N-term; missed K-K@8; missed K-W@9 0.244148999452591 2417.38037109375 806.8007 2417.13623046875 806.719360351563 3 27 1.1.1.3795.11 1 51.1874 2596.093 51.1247 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@1; hexanoyl addition +98(K)@13 cleaved Q-Q@N-term; missed R-V@11; missed K-D@13; missed K-D@24; missed R-D@28 0.407483994960785 4693.7265625 1174.439 4693.31884765625 1174.3369140625 4 22 1.1.1.4384.4 1 65.7592 7625.664 65.8405 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QEMSKDLEEVK Gln->pyro-Glu@N-term; Oxidation(M)@3 missed K-D@5 0.156131997704506 1333.76330566406 667.8889 1333.60717773438 667.810852050781 2 18 1.1.1.2708.14 1 24.8585 5465.644 24.7679 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QEMSKDLEEVKAK Gln->pyro-Glu@N-term missed K-D@5; missed K-A@11 0.165087997913361 1516.90942382813 759.462 1516.74426269531 759.379455566406 2 22 1.1.1.2906.8 1 29.591 1885.699 29.5745 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QGLLPVLESFKVSFLSALEEYTK missed K-V@11 0.245845004916191 2597.64501953125 866.889 2597.39916992188 866.807006835938 3 21 1.1.1.4761.10 1 75.3329 4346.73 75.0787 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QGLLPVLESFKVSFLSALEEYTKK missed K-V@11; missed K-K@23 0.251834005117416 2725.74609375 909.5893 2725.494140625 909.50537109375 3 22 1.1.1.4662.8 1 72.8633 2109.867 72.8203 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QGLLPVLESFKVSFLSALEEYTKKLN HPNE addition +172(K)@23; reduced acrolein addition +58(K)@24 cleaved N-T@C-term; missed K-V@11; missed K-K@23; missed K-L@24 0.267453998327255 3183.04052734375 796.7674 3182.77294921875 796.700561523438 4 17 1.1.1.4703.10 1 73.922 2492.25 73.9116 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed K-V@11; missed K-K@23; missed K-L@24 0.31640899181366 3053.9853515625 764.5036 3053.6689453125 764.424499511719 4 19 1.1.1.4764.4 1 75.4053 2376.188 75.2256 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QGLLPVLESFKVSFLSALEEYTKKLNTQ Gln->pyro-Glu@N-term missed K-V@11; missed K-K@23; missed K-L@24 0.324663996696472 3165.02563476563 792.2637 3164.70092773438 792.182495117188 4 25 1.1.1.4814.8 1 76.6947 2528.065 76.7048 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9 0.240034997463226 2163.33935546875 722.1204 2163.09936523438 722.040405273438 3 23 1.1.1.3296.6 1 38.9509 1047.627 38.9395 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term missed K-L@2; missed K-L@9; missed R-D@18 0.242759004235268 2418.47534179688 807.1657 2418.232421875 807.084777832031 3 25 1.1.1.3410.4 1 41.7089 6126.301 41.5496 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QKLHELQEKLSPLGEEMRDRAR missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 0.245282992720604 2662.642578125 888.5548 2662.39721679688 888.473022460938 3 20 1.1.1.3112.6 1 34.5492 1775.746 34.6268 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.164768993854523 1706.07592773438 854.0452 1705.9111328125 853.962829589844 2 24 1.1.1.3040.6 1 32.8165 18549.37 32.8009 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.175318002700806 2208.3173828125 1105.166 2208.142578125 1105.07861328125 2 17 1.1.1.3816.19 1 51.7051 1161.954 51.7378 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR Gln->pyro-Glu@N-term missed K-L@5; missed K-L@19 0.253129005432129 2460.55444335938 821.1921 2460.30126953125 821.107727050781 3 28 1.1.1.4243.2 1 62.1369 5002.808 62.1751 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QLNLKLLDNWDSVTSTFSKLREQLGPVTQEFWDNLEK missed K-L@5; missed K-L@19; missed R-E@21 0.341874003410339 4391.5869140625 1098.904 4391.24365234375 1098.81823730469 4 15 1.1.1.4585.18 1 70.8362 287.7249 70.8412 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QLNLKLLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSK missed K-L@5; missed K-L@19; missed R-E@21; missed K-E@37; missed R-Q@43 0.482477009296417 5680.33447265625 947.7297 5679.85205078125 947.649291992188 6 20 1.1.1.4744.14 1 74.9253 751.9905 74.9321 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 QQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Hex(S)@8 cleaved W-Q@N-term; missed R-V@12; missed K-D@14; missed K-D@25; missed R-D@29 0.40506899356842 4884.77783203125 977.9629 4884.373046875 977.881896972656 5 25 1.1.1.4377.4 1 65.5753 5649.986 65.5655 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 RHFWQQDEPPQSPWDR cleaved A-R@N-term; missed R-H@1 0.238335996866226 2108.19970703125 703.7405 2107.96118164063 703.661010742188 3 22 1.1.1.3200.8 1 36.6567 1469.963 36.5924 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 RHFWQQDEPPQSPWDRVKDLATVYVDVLK cleaved A-R@N-term; missed R-H@1; missed R-V@16; missed K-D@18 0.390615999698639 3552.185546875 711.4444 3551.794921875 711.366271972656 5 23 1.1.1.4035.4 1 57.0638 8498.026 57.1083 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 RHFWQQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved A-R@N-term; missed R-H@1; missed R-V@16; missed K-D@18; missed K-D@29; missed R-D@33 0.491742998361588 5349.11962890625 892.5272 5348.6279296875 892.445251464844 6 26 1.1.1.4283.15 1 63.1402 2907.593 63.1004 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 SGRDYVSQFEGSALGK cleaved D-S@N-term; missed R-D@3 0.168518006801605 1699.98510742188 850.9998 1699.81652832031 850.915588378906 2 24 1.1.1.3272.6 1 38.3844 943.2516 38.3895 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 SKLREQLGPVTQEFWDNLEKETEGLRQEMSK hexanoyl addition +98(K)@2 cleaved F-S@N-term; missed K-L@2; missed R-E@4; missed K-E@20; missed R-Q@26 -0.804271996021271 3802.11572265625 761.4304 3802.919921875 761.591247558594 5 22 1.1.1.4055.6 1 57.5729 11373.28 57.7411 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 SQARHFWQQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved G-S@N-term; missed R-H@4; missed R-V@19; missed K-D@21; missed K-D@32; missed R-D@36 -2.19420003890991 5632.5615234375 939.7675 5634.755859375 940.133239746094 6 25 1.1.1.4399.6 1 66.1025 1428.103 66.1109 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 TEHLSTLSEK cleaved A-T@N-term 0.147659003734589 1143.72485351563 572.8697 1143.5771484375 572.795837402344 2 17 1.1.1.2649.9 1 23.4347 18187.61 23.1859 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 THLAPYSDELR 0.156660005450249 1300.7978515625 651.4062 1300.64111328125 651.327880859375 2 17 1.1.1.2835.12 1 27.8866 17384.24 27.8712 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.161644995212555 1584.96252441406 793.4885 1584.80090332031 793.40771484375 2 22 1.1.1.2763.9 1 26.1707 56772.6 26.0318 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 THLAPYSDELRQRLAARLEALKENGGAR missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.387275010347366 3135.05688476563 628.0187 3134.66967773438 627.941223144531 5 19 1.1.1.3616.12 1 46.7656 52841.68 46.5003 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 VEPLRAELQEGAR missed R-A@5 0.162121996283531 1466.9462890625 734.4804 1466.7841796875 734.399353027344 2 22 1.1.1.2901.9 1 29.4732 112744.5 29.6955 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 VKDLATVYVDVLK missed K-D@2 0.164602994918823 1462.00891113281 732.0117 1461.84423828125 731.929443359375 2 23 1.1.1.3630.19 1 47.1325 1438.074 47.2183 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 VKDLATVYVDVLKDSGR missed K-D@2; missed K-D@13 0.173975005745888 1877.19982910156 939.6072 1877.02587890625 939.520202636719 2 17 1.1.1.3655.21 1 47.7767 2516.932 47.6031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.254195004701614 3258.93212890625 1087.318 3258.67724609375 1087.23303222656 3 19 1.1.1.3767.18 1 50.4863 1075.092 50.4686 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30 0.331174999475479 3855.373046875 964.8505 3855.04174804688 964.767761230469 4 38 1.1.1.3980.7 1 55.7071 8179.773 55.7639 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30; missed K-L@35 0.493593007326126 5449.302734375 909.2244 5448.80908203125 909.142150878906 6 27 1.1.1.4300.14 1 63.5787 7280.105 63.6158 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 VQPYLDDFQKK missed K-K@10 0.158522993326187 1379.86706542969 690.9408 1379.70849609375 690.861511230469 2 18 1.1.1.2990.10 1 31.6112 18177.41 31.57 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 VQPYLDDFQKKWQEEMELYR missed K-K@10; missed K-W@11 0.248687997460365 2644.51196289063 882.5112 2644.26318359375 882.428344726563 3 22 1.1.1.3805.5 1 51.4344 123629.1 51.1732 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 VQPYLDDFQKKWQEEMELYRQK missed K-K@10; missed K-W@11; missed R-Q@20 0.251641988754272 2900.66845703125 967.8967 2900.41674804688 967.812866210938 3 21 1.1.1.3751.18 1 50.0797 23754.04 49.9884 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLR missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.255356997251511 3495.02026367188 1166.014 3494.765625 1165.92919921875 3 20 1.1.1.3810.18 1 51.5546 4349.893 51.5128 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.325037002563477 4349.5146484375 1088.386 4349.1904296875 1088.30480957031 4 24 1.1.1.3864.7 1 52.903 17102.33 52.6395 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 VSFLSALEEYTK 0.162975996732712 1385.87084960938 693.9427 1385.70788574219 693.861206054688 2 21 1.1.1.3930.2 1 54.4991 22289.7 54.735 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 2 99.0000009536743 VSFLSALEEYTKKLNTQ missed K-K@12; missed K-L@13 0.240636005997658 1970.27673339844 657.7662 1970.03601074219 657.685974121094 3 21 1.1.1.4043.2 1 57.2646 46133.92 57.3555 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 1.79588079452515 99.0000009536743 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38; missed K-K@50; missed K-L@51 -0.505118012428284 6055.74609375 866.1139 6056.25146484375 866.18603515625 7 13 1.1.1.4593.13 1 71.0395 414.5669 70.9974 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 1.60206043720245 99.0000009536743 WQEEMELYR Oxidation(M)@5 0.15870800614357 1298.71887207031 650.3667 1298.56018066406 650.287353515625 2 15 1.1.1.2983.10 1 31.4435 18662.42 31.3067 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 1.55284202098846 99.0000009536743 YVSQFEGSALGK cleaved D-Y@N-term 0.158047005534172 1284.79309082031 643.4038 1284.63500976563 643.324768066406 2 16 1.1.1.2997.17 1 31.7784 7654.483 31.8594 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 1.45593166351318 98.4799981117249 VQPYLDDFQK 0.156683996319771 1251.77026367188 626.8924 1251.61352539063 626.814025878906 2 16 1.1.1.3198.5 1 36.6113 94192.29 36.3529 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 1.44369733333588 98.4799981117249 VSFLSALEEYTKKLNT cleaved T-Q@C-term; missed K-K@12; missed K-L@13 0.240008994936943 1842.21752929688 615.0798 1841.9775390625 614.999755859375 3 17 1.1.1.4047.3 1 57.3613 5001.845 57.4073 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 1.36653172969818 98.5000014305115 AHVDALRTHLAPYSDELRQRLAARLEALK missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24 0.391826003789902 3313.20849609375 663.649 3312.81665039063 663.570617675781 5 16 1.1.1.3693.3 1 48.6216 2267.426 48.6151 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 1.29242980480194 97.5799977779388 LAARLEALK missed R-L@4 0.147706001996994 983.760498046875 492.8875 983.61279296875 492.813659667969 2 15 1.1.1.2836.8 1 27.9113 21196.86 27.8473 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 1.26760601997375 96.9299972057343 AKPALEDLR 0.148772001266479 1011.72009277344 506.8673 1011.5712890625 506.792938232422 2 13 1.1.1.2732.3 1 25.4221 16405.79 25.2216 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 1.25963723659515 99.0000009536743 PVLESFKVSFLSALEEYTKK cleaved L-P@N-term; missed K-V@7; missed K-K@19 0.241457998752594 2314.48754882813 772.5031 2314.24609375 772.422607421875 3 20 1.1.1.4679.9 1 73.3018 252.7707 73.2648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 1.21467018127441 97.3800003528595 DLEEVKAK missed K-A@6 0.146442994475365 930.648681640625 466.3316 930.502197265625 466.258392333984 2 12 1.1.1.2611.7 1 22.5231 644.3798 22.4881 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 1.18708670139313 97.460001707077 VSFLSALEEYTKK missed K-K@12 0.166645005345345 1513.96948242188 757.992 1513.80285644531 757.90869140625 2 15 1.1.1.3817.10 1 51.7235 1864.292 51.7634 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 1.15490198135376 99.0000009536743 LREQLGPVTQEFWD cleaved D-N@C-term; missed R-E@2 0.168464004993439 1717.015625 859.5151 1716.84716796875 859.430847167969 2 20 1.1.1.3696.14 1 48.701 1279.84 48.6876 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 1.05061006546021 99.0000009536743 ALGKQLNLKLLDNWDSVTSTFSK Deamidated(Q)@5 cleaved S-A@N-term; missed K-Q@4; missed K-L@9 0.0338853001594543 2578.39819335938 860.4733 2578.3642578125 860.462036132813 3 20 1.1.1.3899.4 1 53.7522 5285.245 53.6965 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.970616221427917 95.0600028038025 QGLLPVLESFK 0.160426005721092 1229.86242675781 615.9385 1229.70202636719 615.858276367188 2 16 1.1.1.3878.2 1 53.2322 6679.532 53.3743 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.962573409080505 99.0000009536743 LLDNWDSVTSTFSKLREQLGPVTQEFWDNLEK Dioxidation(W)@27 missed K-L@14; missed R-E@16 0.35360398888588 3827.22265625 957.8129 3826.86889648438 957.724548339844 4 20 1.1.1.4420.5 1 66.6321 808.3127 66.5331 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.931814193725586 99.0000009536743 EHLSTLSEK cleaved T-E@N-term 0.145777001976967 1042.67529296875 522.3449 1042.52954101563 522.272033691406 2 15 1.1.1.2628.6 1 22.9329 13318.63 23.0661 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.906578242778778 99.0000009536743 AEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ ONE addition +154(K)@17 cleaved L-A@N-term; missed K-A@6; missed K-A@17; missed R-Q@26; missed K-V@37; missed K-K@49; missed K-L@50 0.558073997497559 6225.88330078125 890.4192 6225.3251953125 890.339477539063 7 21 1.1.1.4603.14 1 71.3045 826.2817 71.3389 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.716698825359344 89.8899972438812 LSPLGEEMR 0.15132899582386 1030.6630859375 516.3388 1030.51171875 516.263122558594 2 14 1.1.1.2996.3 1 31.7458 52817.77 31.642 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.698970019817352 99.0000009536743 KDLATVYVDVLKDSGRDYVSQFEGSALGK hexanoyl addition +98(K)@1 cleaved V-K@N-term; missed K-D@1; missed K-D@12; missed R-D@16 0.2933149933815 3257.97534179688 815.5011 3257.68188476563 815.427795410156 4 19 1.1.1.4046.10 1 57.3413 1211.763 57.3555 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.623423099517822 98.8200008869171 SPLGEEMRDR cleaved L-S@N-term; missed R-D@8 0.154091998934746 1188.70983886719 595.3622 1188.5556640625 595.28515625 2 15 1.1.1.2852.8 1 28.2932 1323.029 28.1814 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.58335953950882 99.0000009536743 PYSDELRQR cleaved A-P@N-term; missed R-Q@7 0.152595996856689 1162.72570800781 582.3701 1162.57312011719 582.293823242188 2 15 1.1.1.2745.3 1 25.7392 1735.096 25.792 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.560667335987091 99.0000009536743 QEGARQKLHELQEKLSPLGEEMRDR acrolein addition +38(K)@7 cleaved L-Q@N-term; missed R-Q@5; missed K-L@7; missed K-L@14; missed R-D@23 0.300038993358612 3014.83569335938 754.7162 3014.53564453125 754.641174316406 4 16 1.1.1.3396.16 1 41.3679 2700.78 41.3523 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.528708279132843 99.0000009536743 PPQSPWDRVK cleaved E-P@N-term; missed R-V@8 0.154191002249718 1208.78442382813 605.3995 1208.63024902344 605.322387695313 2 15 1.1.1.2957.9 1 30.82 2452.191 31.0432 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.493494987487793 99.0000009536743 LREQLGPVTQEF cleaved F-W@C-term; missed R-E@2 0.162171006202698 1415.90307617188 708.9588 1415.74084472656 708.877685546875 2 18 1.1.1.3418.7 1 41.9059 715.0563 41.7937 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.490797460079193 99.0000009536743 LRQGLLPVLESFKVSFLSALEEYTKKLNTQ cleaved D-L@N-term; missed R-Q@2; missed K-V@13; missed K-K@25; missed K-L@26 0.328759998083115 3451.24145507813 863.8176 3450.91259765625 863.735412597656 4 23 1.1.1.4659.13 1 72.7823 1334.959 72.794 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.477555751800537 99.0000009536743 EALKENGGAR Deamidated(N)@6 cleaved L-E@N-term; missed K-E@4 0.145024999976158 1044.6650390625 523.3398 1044.52001953125 523.267272949219 2 16 1.1.1.2627.8 1 22.9123 12808.2 22.8267 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.413412719964981 99.0000009536743 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTK cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21 0.396582990884781 3719.45141601563 744.8976 3719.05493164063 744.818237304688 5 22 1.1.1.4657.9 1 72.7257 23522.98 72.9799 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.402304798364639 99.0000009536743 NWDSVTSTFSK cleaved D-N@N-term 0.159301996231079 1270.74230957031 636.3784 1270.5830078125 636.298767089844 2 16 1.1.1.3292.5 1 38.8628 1592.742 38.9156 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.402304798364639 99.0000009536743 PLGEEMRDR cleaved S-P@N-term; missed R-D@7 0.151940003037453 1101.67565917969 551.8451 1101.52368164063 551.769104003906 2 15 1.1.1.2846.5 1 28.1525 6606.971 28.2292 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.346787512302399 99.0000009536743 PYLDDFQKKWQEEMELYRQK cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18 0.318866014480591 2673.60864257813 669.4094 2673.28979492188 669.329711914063 4 18 1.1.1.3752.9 1 50.0972 1182.948 50.0873 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.338187336921692 98.2800006866455 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLN acrolein addition +56(K)@30; reduced acrolein addition +58(K)@31 cleaved K-P@N-term; cleaved N-T@C-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.319258987903595 3861.43725585938 966.3666 3861.11791992188 966.286743164063 4 18 1.1.1.4714.6 1 74.1897 6575.353 74.2031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.298432022333145 98.1899976730347 EGLRQEMSK cleaved T-E@N-term; missed R-Q@4 0.148775994777679 1076.67724609375 539.3459 1076.52844238281 539.271484375 2 15 1.1.1.2619.4 1 22.7219 312.2606 22.7073 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.28819277882576 97.4900007247925 AKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ ONE addition +154(K)@2; acrolein addition +76(K)@15 cleaved H-A@N-term; missed K-A@2; missed K-A@13; missed R-Q@22; missed K-V@33; missed K-K@45; missed K-L@46 -0.495216995477676 5800.65966796875 829.6729 5801.15478515625 829.74365234375 7 17 1.1.1.4695.6 1 73.7135 379.8102 73.7057 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.24412514269352 95.9999978542328 SALEEYTKKLNTQ cleaved L-S@N-term; missed K-K@8; missed K-L@9 0.166908994317055 1523.95007324219 762.9823 1523.78308105469 762.898864746094 2 15 1.1.1.4735.5 1 74.6984 485.0705 74.6648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.224753752350807 99.0000009536743 PYLDDFQKK cleaved Q-P@N-term; missed K-K@8 0.156120002269745 1152.73767089844 577.3761 1152.58154296875 577.298034667969 2 15 1.1.1.2990.8 1 31.6079 2938.828 31.594 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.202040359377861 94.9100017547607 LAPYSDELRQR cleaved H-L@N-term; missed R-Q@9 0.162765994668007 1346.85705566406 674.4358 1346.69421386719 674.354431152344 2 13 1.1.1.2756.9 1 25.9977 795.7868 26.1038 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.175874173641205 99.0000009536743 EPPQSPWDRVKDLATVYVDVLK cleaved D-E@N-term; missed R-V@9; missed K-D@11 0.260093003511429 2554.60327148438 852.5417 2554.34301757813 852.455017089844 3 17 1.1.1.4082.9 1 58.2044 1102.263 58.1949 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.173277482390404 99.0000009536743 PVLESFKVSFLSALEEYTKKLNTQ cleaved L-P@N-term; missed K-V@7; missed K-K@19; missed K-L@20 -6.94997978210449 2763.529296875 922.1837 2770.47924804688 924.500366210938 3 25 1.1.1.4758.8 1 75.2639 7752.191 75.1768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.172630727291107 99.0000009536743 PPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQ reduced acrolein addition +58(K)@21; reduced acrolein addition +58(K)@38 cleaved E-P@N-term; cleaved Q-L@C-term; missed R-V@8; missed K-D@10; missed K-D@21; missed R-D@25; missed K-Q@38 0.40515598654747 4466.68115234375 745.4541 4466.27587890625 745.386596679688 6 17 1.1.1.4375.2 1 65.5277 102931.7 65.6136 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.171984925866127 98.7800002098084 KVQPYLDDFQKKWQEEMELYRQK acrolein addition +112(K)@1 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12; missed R-Q@21 0.395909011363983 3140.9599609375 629.1993 3140.56420898438 629.1201171875 5 17 1.1.1.3724.6 1 49.379 2759.27 49.4478 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.168130233883858 99.0000009536743 PYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR HPNE addition +172(K)@8; acrolein addition +56(K)@9; Oxidation(M)@14 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18; missed K-V@20; missed R-A@25 -0.474678009748459 4365.7197265625 624.6815 4366.1943359375 624.749328613281 7 20 1.1.1.3768.5 1 50.5013 20445 50.3918 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.148130401968956 99.0000009536743 GKQLNLKLLDNWDSVTSTFSK Carbamyl@N-term cleaved L-G@N-term; missed K-Q@2; missed K-L@7 0.277613013982773 2436.54248046875 813.1881 2436.26489257813 813.095581054688 3 21 1.1.1.3897.7 1 53.7039 692.7721 53.6723 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.143875554203987 95.8400011062622 DRVKDLATVYVDVLKDSGRDYVSQFEGSALGK acrolein addition +38(K)@4; MDA adduct +62(K)@15 cleaved W-D@N-term; missed R-V@2; missed K-D@4; missed K-D@15; missed R-D@19 0.0958174988627434 3629.93310546875 1210.985 3629.83666992188 1210.95275878906 3 14 1.1.1.3361.14 1 40.5199 2048.029 40.5975 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.140861704945564 98.5300004482269 ARQKLHELQEKLSPLGEEMRDR MDA adduct +54(K)@4 cleaved G-A@N-term; missed R-Q@2; missed K-L@4; missed K-L@11; missed R-D@20 0.209450006484985 2716.61743164063 906.5464 2716.40795898438 906.4765625 3 15 1.1.1.3401.11 1 41.4935 2824.864 41.3771 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.125518172979355 99.0000009536743 KAKVQPYLDDFQKKWQEEMELYR acrolein addition +56(K)@1; reduced acrolein addition +96(K)@3 cleaved V-K@N-term; missed K-A@1; missed K-V@3; missed K-K@13; missed K-W@14 0.277810007333755 3123.85180664063 781.9702 3123.57397460938 781.900756835938 4 18 1.1.1.3755.14 1 50.176 1386.732 50.2122 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.118615336716175 32.5100004673004 LHELQEK 0.141317993402481 895.61767578125 448.8161 895.476318359375 448.745452880859 2 11 1.1.1.2497.4 1 20.2807 314.635 20.2612 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.11294562369585 80.9000015258789 LAARLEALKENGGARLAEYHAK Deamidated(N)@11 missed R-L@4; missed K-E@9; missed R-L@15 0.364051997661591 2381.6455078125 477.3364 2381.28149414063 477.263580322266 5 12 1.1.1.3000.4 1 31.8427 5459.427 31.8837 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.11294562369585 33.7000012397766 QKVEPLRAELQEGARQK missed K-V@2; missed R-A@7; missed R-Q@15 0.284458011388779 1979.37573242188 495.8512 1979.09118652344 495.780090332031 4 12 1.1.1.2709.3 1 24.8691 2038.641 24.8636 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.107905395328999 98.2900023460388 KVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR acrolein addition +112(K)@1 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12; missed R-Q@21; missed K-V@23; missed R-A@28 0.426349997520447 4589.76416015625 918.9601 4589.337890625 918.874816894531 5 17 1.1.1.3820.13 1 51.8034 961.2267 51.7891 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.107348963618279 97.2400009632111 LLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +96(K)@9 cleaved G-L@N-term; missed K-V@9; missed K-K@21; missed K-L@22 0.252036988735199 3092.95703125 774.2465 3092.70483398438 774.183532714844 4 16 1.1.1.4567.4 1 70.366 1292.176 70.358 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.103473782539368 83.2199990749359 QEMSKDLEEVKAKVQPYLDDFQKKWQEEMELYR ONE addition +154(K)@5; ONE addition +154(K)@11; acrolein addition +112(K)@13 missed K-D@5; missed K-A@11; missed K-V@13; missed K-K@23; missed K-W@24 0.506636023521423 4580.78125 764.4708 4580.2744140625 764.386413574219 6 13 1.1.1.3758.13 1 50.2512 658.0186 50.263 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.102922990918159 82.9599976539612 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKK reduced HNE(H)@5; HPNE addition +172(K)@7; reduced HNE(H)@11; reduced acrolein addition +96(K)@18 missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38; missed K-K@50 0.444590002298355 6312.9501953125 902.8573 6312.50537109375 902.793762207031 7 14 1.1.1.4802.13 1 76.4007 390.8901 76.3833 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0803989768028259 97.6000010967255 LREQLGPVTQ cleaved Q-E@C-term; missed R-E@2 0.157820999622345 1139.78771972656 570.9011 1139.6298828125 570.822204589844 2 13 1.1.1.2845.8 1 28.1236 431.2278 28.1814 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0736575573682785 97.6000010967255 LRQGLLPVLESFKVSFLSALEEYTK cleaved D-L@N-term; missed R-Q@2; missed K-V@13 0.318347007036209 2866.90283203125 717.733 2866.58447265625 717.653381347656 4 17 1.1.1.4620.10 1 71.7467 285.1649 71.761 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0726296380162239 99.0000009536743 KATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +96(K)@1; reduced HNE(H)@5; MDA adduct +62(K)@12; reduced acrolein addition +96(K)@14 cleaved A-K@N-term; missed K-A@1; missed K-A@12; missed R-Q@21; missed K-V@32; missed K-K@44; missed K-L@45 0.409276992082596 5912.65771484375 986.4502 5912.248046875 986.381958007813 6 20 1.1.1.4684.14 1 73.4371 2747.196 73.3433 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0726296380162239 96.969997882843 KPALEDLRQGLLPVLESFKVSFLSALEEYTKK acrolein addition +112(K)@1 cleaved A-K@N-term; missed R-Q@8; missed K-V@19; missed K-K@31 0.402996003627777 3760.47314453125 753.1019 3760.0703125 753.021301269531 5 19 1.1.1.4688.5 1 73.531 1506.474 73.498 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0675262287259102 99.0000009536743 AELQEGARQKLHELQEKLSPLGEEMRDR reduced acrolein addition +58(K)@10; Delta:H(4)C(2)(H)@12 missed R-Q@8; missed K-L@10; missed K-L@17; missed R-D@26 0.291644006967545 3376.04858398438 845.0194 3375.7568359375 844.946472167969 4 19 1.1.1.3984.11 1 55.7996 998.5772 55.7883 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0649968460202217 98.3500003814697 LESFKVSFLSALEEYTKKLNTQ acrolein addition +112(K)@5 cleaved V-L@N-term; missed K-V@5; missed K-K@17; missed K-L@18 0.341838985681534 2686.75244140625 672.6954 2686.41064453125 672.609924316406 4 19 1.1.1.4673.6 1 73.145 1882.655 73.0072 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0634862631559372 98.0099976062775 AKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK ONE addition +154(K)@2; reduced HNE(H)@6; MDA adduct +54(K)@13; acrolein addition +94(K)@15 cleaved H-A@N-term; missed K-A@2; missed K-A@13; missed R-Q@22; missed K-V@33 -0.587478995323181 5446.390625 908.7391 5446.97802734375 908.836975097656 6 18 1.1.1.4787.17 1 76.0055 5254.512 75.8564 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0624821111559868 96.6600000858307 AHVDALR Delta:H(2)C(2)(H)@2 0.138577997684479 806.578491210938 404.2965 806.439880371094 404.227233886719 2 11 1.1.1.2676.2 1 24.0773 1746.196 24.0493 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.057991947978735 50.2900004386902 VSFLSALEEYTKKLN HPNE addition +172(K)@12; hexanoyl addition +98(K)@13 cleaved N-T@C-term; missed K-K@12; missed K-L@13 0.190943002700806 2011.30383300781 671.4419 2011.11291503906 671.378234863281 3 13 1.1.1.4055.2 1 57.5695 924.7064 57.5905 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.057991947978735 92.2999978065491 WDSVTSTFSK cleaved N-W@N-term 0.153644993901253 1156.69372558594 579.3541 1156.5400390625 579.277282714844 2 13 1.1.1.3091.4 1 34.0393 1761.852 34.0485 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0560111254453659 98.5000014305115 STLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +38(K)@8; Deamidated(Q)@16 cleaved L-S@N-term; missed K-A@6; missed R-Q@15; missed K-V@26; missed K-K@38; missed K-L@39 0.413506001234055 4860.03466796875 973.0142 4859.62109375 972.931518554688 5 19 1.1.1.4742.4 1 74.869 2658.527 74.9077 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0555173270404339 99.0000009536743 RVKDLATVYVDVLKDSGRDYVSQFEGSALGK Formyl@N-term; reduced acrolein addition +96(K)@3 cleaved D-R@N-term; missed R-V@1; missed K-D@3; missed K-D@14; missed R-D@18 0.301019996404648 3539.1318359375 885.7902 3538.83081054688 885.714965820313 4 22 1.1.1.3871.12 1 53.0682 1589.593 53.1052 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0535477325320244 91.8699979782104 LGEEMRDR cleaved P-L@N-term; missed R-D@6 0.151725992560387 1004.62268066406 503.3186 1004.47094726563 503.242736816406 2 12 1.1.1.2852.7 1 28.2907 1362.527 28.2529 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0535477325320244 97.1099972724915 LLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLR Dioxidation(W)@27 missed K-L@14; missed R-E@16; missed K-E@32 0.389697998762131 4512.59814453125 903.5269 4512.20849609375 903.448974609375 5 17 1.1.1.4594.16 1 71.0691 245.6024 71.0495 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0530567318201065 40.9099996089935 QKVEPLR Gln->pyro-Glu@N-term missed K-V@2 0.140119001269341 851.626647949219 426.8206 851.486511230469 426.750518798828 2 10 1.1.1.2550.2 1 21.1341 368.4173 21.2275 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0510982386767864 78.7599980831146 AARLEALK cleaved L-A@N-term; missed R-L@3 0.145344004034996 870.674072265625 436.3443 870.528686523438 436.271636962891 2 11 1.1.1.2836.5 1 27.9038 9159.207 27.8473 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0496351458132267 86.8300020694733 HELQEKLSPLGEEMRDR acrolein addition +112(K)@6 cleaved L-H@N-term; missed K-L@6; missed R-D@15 0.30103000998497 2178.375 545.601 2178.07397460938 545.525756835938 4 13 1.1.1.3684.2 1 48.4233 2902.809 48.4945 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0472075566649437 98.6999988555908 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ hexanoyl addition +98(K)@1; MDA adduct +54(K)@3 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21; missed K-K@33; missed K-L@34 0.275000989437103 4455.74267578125 1114.943 4455.466796875 1114.8740234375 4 19 1.1.1.4728.6 1 74.5388 4086.821 74.374 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0438315682113171 99.0000009536743 EHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKK reduced HNE(H)@2; MDA adduct +54(K)@9; Deamidated(Q)@19 cleaved T-E@N-term; missed K-A@9; missed R-Q@18; missed K-V@29; missed K-K@41 0.457280993461609 4957.15625 827.2 4956.69921875 827.123779296875 6 21 1.1.1.4593.12 1 71.0378 1176.301 71.2334 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0419141501188278 98.6299991607666 VKDLATVYVDVLKD cleaved D-S@C-term; missed K-D@2; missed K-D@13 0.164637997746468 1577.03588867188 789.5252 1576.87121582031 789.44287109375 2 13 1.1.1.3636.17 1 47.2885 142.4637 47.1918 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0395292229950428 93.0800020694733 HAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +94(K)@3; acrolein addition +56(K)@14; MDA adduct +54(K)@16 cleaved Y-H@N-term; missed K-A@3; missed K-A@14; missed R-Q@23; missed K-V@34 0.429232001304626 5328.263671875 1066.66 5327.83349609375 1066.57397460938 5 16 1.1.1.4646.12 1 72.4412 948.2375 72.5035 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0390538051724434 97.6999998092651 PYLDDFQKKWQEEMELYRQKVEPLR HPNE addition +172(K)@8; reduced acrolein addition +96(K)@9 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18; missed K-V@20 0.445257008075714 3536.25146484375 590.3825 3535.80615234375 590.308288574219 6 17 1.1.1.3816.6 1 51.6942 2831.036 51.8152 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0376306623220444 98.8200008869171 EKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK MDA adduct +54(K)@2 cleaved S-E@N-term; missed K-A@2; missed R-Q@11; missed K-V@22 0.382806003093719 3902.49096679688 976.63 3902.10815429688 976.534301757813 4 19 1.1.1.4706.9 1 74.0016 665.1427 74.0092 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0338582694530487 92.7100002765656 KVQPYLDDFQK acrolein addition +112(K)@1 cleaved A-K@N-term; missed K-V@1 0.234834000468254 1491.99572753906 498.3392 1491.76098632813 498.260925292969 3 13 1.1.1.3073.10 1 33.6068 2046.704 33.5449 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0329202637076378 90.4500007629395 KLHELQEKLSPLGEEMRDR ONE addition +154(K)@1 cleaved Q-K@N-term; missed K-L@1; missed K-L@8; missed R-D@17 0.185417994856834 2461.4853515625 821.5024 2461.2998046875 821.440551757813 3 14 1.1.1.3578.10 1 45.8263 552.9203 45.8073 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0324520207941532 96.9799995422363 RHFWQQDEPPQSPWDRVKDLATVYVDVLKDSGR cleaved A-R@N-term; missed R-H@1; missed R-V@16; missed K-D@18; missed K-D@29 0.478709995746613 3967.45532226563 662.2498 3966.9765625 662.170043945313 6 16 1.1.1.4049.2 1 57.4124 559.7681 57.4333 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0315170511603355 88.4599983692169 VSQFEGSALGKQLNLKLLDNWDSVTSTFSK MDA adduct +54(K)@11; acrolein addition +38(K)@16 cleaved Y-V@N-term; missed K-Q@11; missed K-L@16 0.0971831977367401 3403.826171875 1135.616 3403.72998046875 1135.583984375 3 14 1.1.1.3705.5 1 48.9235 1950.632 48.9529 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.031050318852067 92.4399971961975 EYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +96(K)@5; acrolein addition +76(K)@16; MDA adduct +54(K)@18 cleaved A-E@N-term; missed K-A@5; missed K-A@16; missed R-Q@25; missed K-V@36; missed K-K@48; missed K-L@49 -0.391568005084991 6225.896484375 890.4211 6226.2880859375 890.476989746094 7 16 1.1.1.4579.13 1 70.6754 755.2719 70.6872 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0305840894579887 65.7500028610229 HAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced HNE(H)@1; MDA adduct +54(K)@34 cleaved Y-H@N-term; missed K-A@3; missed K-A@14; missed R-Q@23; missed K-V@34; missed K-K@46; missed K-L@47 0.269717991352081 5920.49365234375 846.7921 5920.22412109375 846.753601074219 7 13 1.1.1.4696.6 1 73.7393 232.5935 73.7057 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0301183573901653 92.7699983119965 KPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT acrolein addition +112(K)@1 cleaved A-K@N-term; cleaved T-Q@C-term; missed R-Q@8; missed K-V@19; missed K-K@31; missed K-L@32 0.407036989927292 4088.65185546875 818.7377 4088.24487304688 818.65625 5 19 1.1.1.4761.7 1 75.3304 1063.258 75.3471 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0301183573901653 96.8299984931946 TEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced HNE(H)@3 cleaved A-T@N-term; missed K-A@10; missed R-Q@19; missed K-V@30; missed K-K@42; missed K-L@43 -0.581506013870239 5458.40380859375 910.7413 5458.9853515625 910.838195800781 6 17 1.1.1.4792.16 1 76.1368 9526.109 76.0139 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0277971606701612 88.2799983024597 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKL ONE addition +154(K)@43; MDA adduct +62(K)@44 cleaved L-N@C-term; missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.427561014890671 5245.28515625 875.2215 5244.85791015625 875.150207519531 6 17 1.1.1.4662.7 1 72.8616 355.5946 72.8734 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0264103766530752 89.9800002574921 YSDELRQR cleaved P-Y@N-term; missed R-Q@6 0.147864997386932 1065.66821289063 533.8414 1065.52026367188 533.767456054688 2 12 1.1.1.2744.5 1 25.7087 6216.647 25.792 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0259490963071585 98.6800014972687 ALKENGGAR Deamidated(N)@5 cleaved E-A@N-term; missed K-E@3 0.142879992723465 915.620300292969 458.8174 915.477416992188 458.745971679688 2 15 1.1.1.2622.3 1 22.7843 18427.79 22.8267 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0250280071049929 87.7699971199036 GGARLAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK reduced HNE(H)@15; ONE addition +154(K)@22; reduced acrolein addition +58(K)@24 cleaved N-G@N-term; missed R-L@4; missed K-A@11; missed K-A@22; missed R-Q@31; missed K-V@42 0.358312994241714 6311.79296875 902.692 6311.43505859375 902.640808105469 7 15 1.1.1.4710.10 1 74.093 613.8431 73.8871 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0241088643670082 71.0600018501282 SEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKK reduced acrolein addition +58(K)@3 cleaved L-S@N-term; missed K-A@3; missed R-Q@12; missed K-V@23; missed K-K@35 0.362868010997772 4121.62939453125 825.3331 4121.2666015625 825.260559082031 5 13 1.1.1.4682.13 1 73.3839 669.4847 73.3433 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0227337870746851 17.5500005483627 ENGGARLAEYHAKATEHLSTLSEK hexanoyl addition +98(K)@13 missed R-L@6; missed K-A@13 0.273492008447647 2709.64575195313 678.4187 2709.37231445313 678.350341796875 4 12 1.1.1.3258.8 1 38.0472 0 -1 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0195421073585749 79.1999995708466 QKLHELQEKLSPLGEEMRD cleaved D-R@C-term; missed K-L@2; missed K-L@9; missed R-D@18 0.296555995941162 2279.45458984375 570.8709 2279.15795898438 570.796752929688 4 12 1.1.1.3186.7 1 36.3171 2390.733 36.3049 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0186344906687737 66.8500006198883 PALEDLRQGLLPVLESFKVSFLSALEEYTKKL cleaved K-P@N-term; cleaved L-N@C-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.313078999519348 3633.32006835938 909.3373 3633.0068359375 909.259033203125 4 12 1.1.1.4764.7 1 75.4128 3335.661 75.5199 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0177287664264441 95.8100020885468 YHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced HNE(H)@2; acrolein addition +38(K)@4; reduced HNE(H)@8 cleaved E-Y@N-term; missed K-A@4; missed K-A@15; missed R-Q@24; missed K-V@35; missed K-K@47; missed K-L@48 0.469976991415024 6225.89306640625 890.4206 6225.42333984375 890.353454589844 7 17 1.1.1.4617.9 1 71.6733 688.0779 71.6548 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0141246430575848 85.1100027561188 DLEEVKAKVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR missed K-A@6; missed K-V@8; missed K-K@18; missed K-W@19; missed R-Q@28; missed K-V@30; missed R-A@35 -10.9462995529175 5250.73583984375 876.1299 5261.68212890625 877.954284667969 6 14 1.1.1.3976.10 1 55.6038 1426.054 55.6172 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0141246430575848 88.3899986743927 GARQKLHELQEKLSPLGEEMRDR acrolein addition +56(K)@5 cleaved E-G@N-term; missed R-Q@3; missed K-L@5; missed K-L@12; missed R-D@21 0.28151398897171 2775.7265625 694.9389 2775.44506835938 694.868530273438 4 13 1.1.1.3405.8 1 41.5886 314.127 41.5496 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0123337358236313 99.0000009536743 SEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Delta:H(4)C(2)@N-term; acrolein addition +56(K)@3 cleaved L-S@N-term; missed K-A@3; missed R-Q@12; missed K-V@23; missed K-K@35; missed K-L@36 0.0762033984065056 4603.5908203125 1151.905 4603.51513671875 1151.88610839844 4 27 1.1.1.4734.14 1 74.6825 23503.19 74.7135 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0118871601298451 94.2300021648407 DSGRDYVSQFEGSALGKQL acrolein addition +56(K)@17; Deamidated(Q)@18 cleaved L-N@C-term; missed R-D@4; missed K-Q@17 0.227641999721527 2113.22412109375 705.4153 2112.99633789063 705.339416503906 3 14 1.1.1.3379.8 1 40.9537 35142.36 40.7677 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0118871601298451 83.8500022888184 KLHELQEKLSPLGEEMR acrolein addition +56(K)@1; reduced HNE(H)@3 cleaved Q-K@N-term; missed K-L@1; missed K-L@8 0.176000997424126 2250.4052734375 751.1424 2250.22924804688 751.083740234375 3 13 1.1.1.3754.12 1 50.1496 681.6541 50.1622 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0114410435780883 89.5399987697601 FSKLREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK acrolein addition +56(K)@3 cleaved T-F@N-term; missed K-L@3; missed R-E@5; missed K-E@21; missed R-Q@27; missed K-D@32; missed K-A@38 0.438647001981735 4820.87158203125 804.4859 4820.43310546875 804.412780761719 6 15 1.1.1.4269.10 1 62.7849 1476.111 62.7991 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0114410435780883 93.1100010871887 HLSTLSEK cleaved E-H@N-term 0.14112900197506 913.628051757813 457.8213 913.486877441406 457.750732421875 2 12 1.1.1.2638.6 1 23.1758 443.0094 23.114 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0114410435780883 99.0000009536743 SEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Dehydrated(S)@1 cleaved L-S@N-term; missed K-A@3; missed R-Q@12; missed K-V@23 0.264654994010925 3917.38354492188 784.484 3917.11889648438 784.431091308594 5 22 1.1.1.4709.5 1 74.0703 780.9556 74.0092 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.010550182312727 75.4599988460541 EYHAKATEHLSTLSEK reduced HNE(H)@3; acrolein addition +76(K)@5 cleaved A-E@N-term; missed K-A@5 0.278582006692886 2077.35180664063 520.3452 2077.0732421875 520.275573730469 4 12 1.1.1.3280.6 1 38.5675 2368.903 38.557 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0101054366677999 95.6700026988983 EPLRAELQEGARQKLHELQEKLSPLGEEMRDR HPNE addition +172(K)@14 cleaved V-E@N-term; missed R-A@4; missed R-Q@12; missed K-L@14; missed K-L@21; missed R-D@30 -0.555113017559052 3956.51904296875 660.4271 3957.07421875 660.519653320313 6 16 1.1.1.4051.3 1 57.4659 1747.297 57.486 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.0101054366677999 94.9199974536896 KDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK MDA adduct +62(K)@12; reduced acrolein addition +96(K)@34 cleaved V-K@N-term; missed K-D@1; missed K-D@12; missed R-D@16; missed K-Q@29; missed K-L@34 -0.49602198600769 5507.31787109375 918.8936 5507.81396484375 918.976257324219 6 16 1.1.1.4303.10 1 63.6535 633.0315 63.5896 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00921730790287256 91.8200016021729 VKAKVQPYLDDFQKKWQEEMELYRQKVEPLR acrolein addition +112(K)@2; HPNE addition +172(K)@4; hexanoyl addition +98(K)@14; MDA adduct +62(K)@15 cleaved E-V@N-term; missed K-A@2; missed K-V@4; missed K-K@14; missed K-W@15; missed R-Q@24; missed K-V@26 0.406536996364594 4365.71875 624.6814 4365.3125 624.623291015625 7 15 1.1.1.3771.4 1 50.5777 27767.37 50.597 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00833099242299795 79.1299998760223 LATVYVDVLK cleaved D-L@N-term 0.155338004231453 1119.80932617188 560.9119 1119.65393066406 560.834228515625 2 11 1.1.1.3524.3 1 44.5055 1117.711 44.4999 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00833099242299795 97.2400009632111 VKAKVQPYLDDFQKKWQEEMELYR MDA adduct +54(K)@4 cleaved E-V@N-term; missed K-A@2; missed K-V@4; missed K-K@14; missed K-W@15 -0.647140026092529 3123.92211914063 625.7917 3124.56909179688 625.921142578125 5 17 1.1.1.3757.7 1 50.2208 478.617 50.2375 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00788851175457239 85.9899997711182 DSGRDYVSQFEGSALGKQLNLKLLDNW ONE addition +154(K)@17; hexanoyl addition +98(K)@22; Deamidated(N)@26 cleaved W-D@C-term; missed R-D@4; missed K-Q@17; missed K-L@22 0.115654997527599 3305.79809570313 1102.94 3305.68188476563 1102.90124511719 3 13 1.1.1.3367.7 1 40.6655 1943.805 40.5249 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00788851175457239 97.8200018405914 EKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT reduced acrolein addition +58(K)@2; acrolein addition +112(K)@4; Deamidated(Q)@12 cleaved S-E@N-term; cleaved T-Q@C-term; missed K-A@2; missed R-Q@11; missed K-V@22; missed K-K@34; missed K-L@35 0.0962096005678177 4475.54248046875 1119.893 4475.4453125 1119.86865234375 4 18 1.1.1.4735.11 1 74.7085 1648.201 74.7135 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00656376918777823 64.2199993133545 PPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNL acrolein addition +56(K)@21 cleaved E-P@N-term; cleaved L-K@C-term; missed R-V@8; missed K-D@10; missed K-D@21; missed R-D@25; missed K-Q@38 0.25347301363945 4746.6826171875 1187.678 4746.42919921875 1187.61462402344 4 12 1.1.1.4378.7 1 65.6086 2133.951 65.6136 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00612308504059911 90.4799997806549 PLRAELQEGARQKL Deamidated(Q)@12; reduced acrolein addition +96(K)@13 cleaved E-P@N-term; cleaved L-H@C-term; missed R-A@3; missed R-Q@11; missed K-L@13 0.199424996972084 1705.15173339844 569.3912 1704.95227050781 569.32470703125 3 14 1.1.1.3006.15 1 31.9963 4965.161 32.029 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00524305552244186 92.2500014305115 FEGSALGKQLNLKLLDNWDSVTSTFSK acrolein addition +112(K)@8; Deamidated(Q)@9; acrolein addition +38(K)@13 cleaved Q-F@N-term; missed K-Q@8; missed K-L@13 0.0666263997554779 3148.66430664063 1050.562 3148.59692382813 1050.53955078125 3 15 1.1.1.3696.20 1 48.706 12675.66 48.7119 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00524305552244186 99.0000009536743 GSQARHFWQQDEPPQSPWDRVKDLATVYVDVLK cleaved T-G@N-term; missed R-H@5; missed R-V@20; missed K-D@22 -11.1956996917725 3883.74853515625 971.9444 3894.94409179688 974.743347167969 4 19 1.1.1.4176.8 1 60.5028 17487.1 60.4369 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00392634514719248 79.4900000095367 LKLLDNWDSVTSTFSKLR acrolein addition +38(K)@2; Deamidated(N)@6 cleaved N-L@N-term; missed K-L@2; missed K-L@16 0.198189005255699 2161.34008789063 721.454 2161.14184570313 721.387939453125 3 13 1.1.1.3804.2 1 51.3969 999.8028 51.4154 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00392634514719248 61.4799976348877 RVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK MDA adduct +62(K)@14 cleaved D-R@N-term; missed R-V@1; missed K-D@3; missed K-D@14; missed R-D@18; missed K-Q@31 0.485017001628876 4073.6435546875 679.9479 4073.15869140625 679.867065429688 6 12 1.1.1.3982.6 1 55.7463 963.0725 55.7639 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00348832807503641 94.7300016880035 ALEDLRQGLLPVLESFKVSFLSALEEYTK cleaved P-A@N-term; missed R-Q@6; missed K-V@17 -11.0581998825073 3283.71704101563 821.9365 3294.77514648438 824.701049804688 4 16 1.1.1.4717.4 1 74.2617 2174.54 74.3003 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00348832807503641 74.0000009536743 KPALEDLRQGLLPVLESFKVSFLSALEEYTKKLN acrolein addition +112(K)@1; HPNE addition +172(K)@31; hexanoyl addition +98(K)@32 cleaved A-K@N-term; cleaved N-T@C-term; missed R-Q@8; missed K-V@19; missed K-K@31; missed K-L@32 0.419725000858307 4257.80029296875 710.6406 4257.38037109375 710.570678710938 6 17 1.1.1.4770.8 1 75.5552 1177.346 75.5711 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00348832807503641 73.9300012588501 LKENGGAR Deamidated(N)@4 cleaved A-L@N-term; missed K-E@2 0.140138000249863 844.580444335938 423.2975 844.440307617188 423.227416992188 2 9 1.1.1.2625.6 1 22.861 1185.474 22.8267 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00348832807503641 72.9399979114532 LLDNWDSVTSTFSKLREQLG cleaved G-P@C-term; missed K-L@14; missed R-E@16 0.250384002923965 2308.42041015625 770.4807 2308.169921875 770.397277832031 3 12 1.1.1.4048.8 1 57.3914 657.8282 57.4073 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00348832807503641 99.0000009536743 LTLAVLFLTGSQARHFWQQDEPPQSPWDRVKDLATVYVDVLK cleaved V-L@N-term; missed R-H@14; missed R-V@29; missed K-D@31 -11.8649997711182 4854.6845703125 971.9442 4866.5498046875 974.317199707031 5 19 1.1.1.4183.6 1 60.6753 17249.7 60.4616 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00348832807503641 95.4100012779236 PVLESFKVSFLSALEEYTK cleaved L-P@N-term; missed K-V@7 -9.18787002563477 2176.96313476563 726.6617 2186.15112304688 729.724304199219 3 19 1.1.1.4705.2 1 73.9657 782.4429 73.9362 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00305075151845813 60.2400004863739 DSGRDYVSQFEGSALGKQLNLKLLDNWDSV ONE addition +154(K)@17; reduced acrolein addition +96(K)@22 cleaved V-T@C-term; missed R-D@4; missed K-Q@17; missed K-L@22 0.124288000166416 3603.93505859375 1202.319 3603.80981445313 1202.27722167969 3 12 1.1.1.3370.6 1 40.7386 670.9917 40.7437 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00305075151845813 90.9200012683868 PLRAELQEGARQKLHELQEKLSPLGEEMRDR Deamidated(Q)@7; acrolein addition +56(K)@13; HPNE addition +172(K)@20 cleaved E-P@N-term; missed R-A@3; missed R-Q@11; missed K-L@13; missed K-L@20; missed R-D@29 -0.490536987781525 3884.55126953125 555.9432 3885.04174804688 556.013244628906 7 15 1.1.1.3734.12 1 49.6384 1301.892 49.6769 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00261361571028829 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKL HPNE addition +172(K)@32; HPNE addition +172(K)@33; Amidated@C-term cleaved L-N@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.30986100435257 4175.6845703125 836.1442 4175.375 836.082275390625 5 25 1.1.1.4742.3 1 74.8665 142627.7 74.8833 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00261361571028829 99.0000009536743 EHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Methyl(E)@1; reduced HNE(H)@2 cleaved T-E@N-term; missed K-A@9; missed R-Q@18; missed K-V@29 0.40837100148201 4788.03369140625 799.0129 4787.625 798.94482421875 6 32 1.1.1.4643.12 1 72.358 16257.05 72.5035 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00261361571028829 99.0000009536743 HLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK ONE addition +154(K)@8; HPNE addition +172(K)@10; Oxidation(P)@11 cleaved E-H@N-term; missed K-A@8; missed R-Q@17; missed K-V@28 0.353518009185791 4828.994140625 966.8061 4828.640625 966.735412597656 5 32 1.1.1.4658.17 1 72.7607 7923.354 72.7408 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00261361571028829 99.0000009536743 HLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ ONE addition +154(K)@8; HPNE addition +172(K)@10; Oxidation(P)@11 cleaved E-H@N-term; missed K-A@8; missed R-Q@17; missed K-V@28; missed K-K@40; missed K-L@41 0.427516013383865 5413.396484375 903.24 5412.96875 903.168762207031 6 27 1.1.1.4699.14 1 73.8228 31984.53 73.7823 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00261361571028829 99.0000009536743 LHELQEKLSPLGEEMRDRAR Dimethyl(R)@18; Deamidated(R)@20 missed K-L@7; missed R-D@16; missed R-A@18 0.243553996086121 2435.50268554688 812.8415 2435.25903320313 812.760314941406 3 19 1.1.1.2993.9 1 31.6825 1007.824 31.6901 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00261361571028829 37.9599988460541 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAKVQPY acrolein addition +38(K)@18; ONE addition +154(K)@29; ONE addition +154(K)@35; acrolein addition +38(K)@37 cleaved Y-L@C-term; missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35; missed K-V@37 0.116274997591972 5273.79833984375 1055.767 5273.6845703125 1055.744140625 5 11 1.1.1.4014.14 1 56.5453 897.4248 56.5046 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00261361571028829 87.3799979686737 NWDSVTSTFSKLR MDA adduct +54(K)@11 cleaved D-N@N-term; missed K-L@11 0.160338997840881 1593.93908691406 797.9768 1593.77868652344 797.896606445313 2 15 1.1.1.3991.6 1 55.9701 12525.44 55.813 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00261361571028829 80.5499970912933 QLNLKLLDNWD cleaved D-S@C-term; missed K-L@5 0.161051005125046 1370.88049316406 686.4475 1370.71936035156 686.367004394531 2 12 1.1.1.3808.3 1 51.4927 1319.004 51.5622 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00261361571028829 74.5299994945526 YLDDFQKKWQEEMELYRQKVEPLRAELQEGAR HPNE addition +172(K)@7; HPNE addition +172(K)@8 cleaved P-Y@N-term; missed K-K@7; missed K-W@8; missed R-Q@17; missed K-V@19; missed R-A@24 -0.521287977695465 4368.708984375 625.1086 4369.23046875 625.183044433594 7 13 1.1.1.3721.7 1 49.3032 1202.815 49.3454 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00217691925354302 75.3400027751923 DYVSQFEGSALGKQL acrolein addition +56(K)@13; Deamidated(Q)@14 cleaved L-N@C-term; missed K-Q@13 0.155966997146606 1697.97082519531 849.9927 1697.81481933594 849.914672851563 2 12 1.1.1.3484.11 1 43.5329 4979.298 43.2671 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00217691925354302 99.0000009536743 EHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Methyl(E)@1; reduced HNE(H)@2 cleaved T-E@N-term; missed K-A@9; missed R-Q@18; missed K-V@29; missed K-K@41; missed K-L@42 0.420980989933014 5372.37451171875 896.403 5371.95361328125 896.332824707031 6 33 1.1.1.4665.13 1 72.942 25877.01 73.0339 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00217691925354302 98.089998960495 QKLHELQEK Lys->Allysine(K)@2 missed K-L@2 0.15344500541687 1150.75170898438 576.3831 1150.59826660156 576.306396484375 2 15 1.1.1.2656.12 1 23.6082 663.2361 23.591 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00217691925354302 96.9099998474121 QRLAARLEALKENGGAR Methyl(Q)@1; reduced acrolein addition +58(K)@11 missed R-L@2; missed R-L@6; missed K-E@11 0.164366006851196 1924.26098632813 642.4276 1924.0966796875 642.372802734375 3 15 1.1.1.3260.7 1 38.095 1284.603 38.1026 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00217691925354302 99.0000009536743 WQEEMELYRQK Methyl+Deamidated(Q)@2; Oxidation(M)@5 missed R-Q@9 0.129648000001907 1569.84301757813 785.9288 1569.71337890625 785.863952636719 2 17 1.1.1.3194.7 1 36.5155 1148.18 36.5445 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00174066168256104 37.5 EHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT reduced HNE(H)@2; acrolein addition +56(K)@9 cleaved T-E@N-term; cleaved T-Q@C-term; missed K-A@9; missed R-Q@18; missed K-V@29; missed K-K@41; missed K-L@42 0.424071997404099 5286.32958984375 882.0622 5285.9052734375 881.991516113281 6 12 1.1.1.4768.13 1 75.5082 408.2669 75.4945 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00174066168256104 99.0000009536743 EKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +58(K)@2; acrolein addition +112(K)@4; Deamidated(R)@11 cleaved S-E@N-term; missed K-A@2; missed R-Q@11; missed K-V@22; missed K-K@34; missed K-L@35 0.0874368026852608 4603.5908203125 1151.905 4603.50390625 1151.88330078125 4 22 1.1.1.4727.10 1 74.5129 23491.86 74.7135 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00174066168256104 84.4799995422363 FEGSALGKQLNLKLLDNWDSVTSTFSKLR ONE addition +154(K)@8; Deamidated(N)@11; MDA adduct +62(K)@13 cleaved Q-F@N-term; missed K-Q@8; missed K-L@13; missed K-L@27 0.35614201426506 3484.18505859375 697.8443 3483.82885742188 697.773071289063 5 14 1.1.1.3809.6 1 51.5199 1537.378 51.5128 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00174066168256104 57.6600015163422 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEE HPNE addition +172(K)@18; reduced acrolein addition +96(K)@29 cleaved E-V@C-term; missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.502617001533508 4244.5859375 708.4383 4244.08349609375 708.354553222656 6 12 1.1.1.4317.3 1 64.0111 966.8223 63.9282 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00174066168256104 95.6099987030029 SFKVSFLSALEEYTKKLNTQ cleaved E-S@N-term; missed K-V@3; missed K-K@15; missed K-L@16 2.87463998794556 2335.10620117188 779.376 2332.2314453125 778.417785644531 3 16 1.1.1.4611.7 1 71.5126 353.3695 71.4963 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00174066168256104 74.9300003051758 TEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLN acrolein addition +56(K)@10; acrolein addition +56(K)@12; HPNE addition +172(K)@42; hexanoyl addition +98(K)@43 cleaved A-T@N-term; cleaved N-T@C-term; missed K-A@10; missed R-Q@19; missed K-V@30; missed K-K@42; missed K-L@43 0.503067970275879 5454.4873046875 780.2197 5453.98388671875 780.147888183594 7 14 1.1.1.4702.7 1 73.8949 2788.375 73.8871 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00174066168256104 93.9599990844727 VLESFKVSFLSALEEYTKKLNTQ cleaved P-V@N-term; missed K-V@6; missed K-K@18; missed K-L@19 -5.93091011047363 2667.49560546875 890.1725 2673.42651367188 892.149475097656 3 17 1.1.1.4740.8 1 74.8215 51688.27 74.6648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00174066168256104 83.6399972438812 YHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKK reduced acrolein addition +58(K)@4; acrolein addition +56(K)@15; reduced acrolein addition +58(K)@17; acrolein addition +112(K)@35 cleaved E-Y@N-term; missed K-A@4; missed K-A@15; missed R-Q@24; missed K-V@35; missed K-K@47 0.459109008312225 5699.53466796875 950.9297 5699.0751953125 950.853149414063 6 15 1.1.1.4678.19 1 73.2845 2269.467 73.0072 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00130484171677381 72.3999977111816 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQL acrolein addition +38(K)@40; Deamidated(Q)@41 cleaved Q-D@N-term; cleaved L-N@C-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27; missed K-Q@40 0.32820001244545 4746.6748046875 1187.676 4746.34521484375 1187.59362792969 4 13 1.1.1.4392.5 1 65.9525 1929.792 65.961 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00130484171677381 77.3999989032745 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVT MDA adduct +54(K)@17; Deamidated(N)@20; acrolein addition +94(K)@22 cleaved T-S@C-term; missed R-D@4; missed K-Q@17; missed K-L@22 0.197059005498886 3603.93505859375 1202.319 3603.73681640625 1202.2529296875 3 13 1.1.1.3370.6 1 40.7386 670.9917 40.7437 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00130484171677381 94.4800019264221 KENGGARLAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ cleaved L-K@N-term; missed K-E@1; missed R-L@7; missed K-A@14; missed K-A@25; missed R-Q@34; missed K-V@45; missed K-K@57; missed K-L@58 -11.940899848938 6884.728515625 1148.462 6896.671875 1150.45251464844 6 20 1.1.1.4740.13 1 74.8298 4782.722 74.9077 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00130484171677381 99.0000009536743 LREQLGPVTQEFWDN Methyl(D)@14 cleaved N-L@C-term; missed R-E@2 0.125876992940903 1845.03161621094 923.5231 1844.90576171875 923.460144042969 2 15 1.1.1.3644.19 1 47.4957 108.6717 47.477 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00130484171677381 74.5400011539459 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKA acrolein addition +76(K)@29; acrolein addition +94(K)@35 cleaved A-K@C-term; missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 -0.542591989040375 4443.64697265625 889.7367 4444.189453125 889.84521484375 5 13 1.1.1.4264.12 1 62.6583 1228.468 62.5432 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.00130484171677381 80.0300002098084 PVLESFKVSFLSALEEYTKKLNT cleaved L-P@N-term; cleaved T-Q@C-term; missed K-V@7; missed K-K@19; missed K-L@20 -1.89232003688812 2640.5283203125 881.1834 2642.42065429688 881.814208984375 3 13 1.1.1.4761.11 1 75.3337 560.1521 75.2983 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000869458774104714 92.0899987220764 ALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ cleaved P-A@N-term; missed R-Q@6; missed K-V@17; missed K-K@29; missed K-L@30 -12.890700340271 3866.21264648438 774.2498 3879.10327148438 776.827941894531 5 16 1.1.1.4574.5 1 70.5452 1707.205 70.6364 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000869458774104714 98.6400008201599 DLRQGLLPVLESFKVSFLSALEEYTKKLNTQ cleaved E-D@N-term; missed R-Q@3; missed K-V@14; missed K-K@26; missed K-L@27 -9.2701997756958 3556.66943359375 890.1746 3565.93969726563 892.4921875 4 19 1.1.1.4754.10 1 75.1667 9236.44 75.1523 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000869458774104714 90.9699976444244 EDLRQGLLPVLESFKVSFLSALEEYTK cleaved L-E@N-term; missed R-Q@4; missed K-V@15 -3.04196000099182 3107.61206054688 777.9103 3110.65405273438 778.670776367188 4 17 1.1.1.4708.4 1 74.0385 970.0678 74.0092 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000869458774104714 76.1300027370453 HFWQQDEPPQSPWDRVKDLATVYVDVLKDSGR missed R-V@15; missed K-D@17; missed K-D@28 -11.8468999862671 3799.02856445313 760.813 3810.87548828125 763.182373046875 5 13 1.1.1.4351.2 1 64.8975 335.5397 64.8374 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000869458774104714 52.2800028324127 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAKVQPYLD acrolein addition +94(K)@18; acrolein addition +112(K)@29 cleaved D-D@C-term; missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35; missed K-V@37 -0.471224009990692 5323.1884765625 888.2054 5323.65966796875 888.283935546875 6 12 1.1.1.4319.10 1 64.0678 156.6764 64.0053 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000869458774104714 46.5000003576279 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAKVQPYLDDF acrolein addition +56(K)@18; MDA adduct +54(K)@29; acrolein addition +94(K)@37 cleaved F-Q@C-term; missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35; missed K-V@37 0.598483979701996 5584.337890625 931.7303 5583.73974609375 931.630554199219 6 12 1.1.1.4059.6 0 57.6735 949.0243 57.6662 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000869458774104714 99.0000009536743 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HexNAc(S)@16; acrolein addition +38(K)@18; Deamidated(N)@33 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.474373996257782 4217.7607421875 703.9674 4218.2353515625 704.046447753906 6 23 1.1.1.4703.4 1 73.917 1648.967 73.9116 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000869458774104714 32.260000705719 QRLAARLEALKENGGARLAEYHAKATEHLSTLSEKAKP acrolein addition +56(K)@11; reduced HNE(H)@28; acrolein addition +38(K)@35; hexanoyl addition +98(K)@37 cleaved P-A@C-term; missed R-L@2; missed R-L@6; missed K-E@11; missed R-L@17; missed K-A@24; missed K-A@35 0.169585004448891 4507.6611328125 902.5395 4507.49169921875 902.505554199219 5 11 1.1.1.4424.4 1 66.7251 7896.951 66.6892 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 63.0599975585938 AELQEGAR Delta:H(2)C(2)@N-term 0.145198002457619 898.596069335938 450.3053 898.450866699219 450.232696533203 2 11 1.1.1.2600.3 1 22.2512 1229.099 22.3178 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 87.8199994564056 AHVDALRTHLAPYSDELRQRL Phospho(S)@14 cleaved L-A@C-term; missed R-T@7; missed R-Q@18; missed R-L@20 0.336210995912552 2540.60107421875 509.1275 2540.26489257813 509.060272216797 5 14 1.1.1.3009.7 1 32.0642 2079.824 32.029 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 89.1099989414215 DLEEVKAKVQPYLDDFQK Methyl(K)@6; reduced acrolein addition +58(K)@8 missed K-A@6; missed K-V@8 0.198084995150566 2236.36083984375 746.4609 2236.16259765625 746.394836425781 3 15 1.1.1.4016.4 1 56.5834 277.8381 56.578 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 73.7200021743774 DSGRDYVSQFEGSALGKQLNLKLLDNWD hexanoyl addition +98(K)@17; MDA adduct +62(K)@22 cleaved D-S@C-term; missed R-D@4; missed K-Q@17; missed K-L@22 0.369762003421783 3328.01098632813 833.01 3327.64111328125 832.917541503906 4 13 1.1.1.3855.7 1 52.6765 3189.619 52.737 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 64.7499978542328 DYVSQFEGSALGKQLNLKLLDNW Deamidated(N)@16; acrolein addition +38(K)@18; Deamidated(N)@22 cleaved W-D@C-term; missed K-Q@13; missed K-L@18 0.182116001844406 2677.509765625 893.5105 2677.32763671875 893.449768066406 3 12 1.1.1.3471.19 1 43.2103 2271.146 43.0677 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 90.5600011348724 EDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ cleaved L-E@N-term; missed R-Q@4; missed K-V@15; missed K-K@27; missed K-L@28 -9.22144031524658 3685.7607421875 738.1594 3694.98217773438 740.003723144531 5 16 1.1.1.4724.3 1 74.4293 1029.307 74.4955 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 89.4699990749359 EMSKDLEEVK Glu->pyro-Glu@N-term; Oxidation(M)@2 cleaved Q-E@N-term; missed K-D@4 0.137933999300003 1204.70251464844 603.3585 1204.56457519531 603.28955078125 2 12 1.1.1.2689.9 1 24.3983 2972.729 24.5284 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 99.0000009536743 HLSTLSEKAKPALEDLRQGLLPVLESFK Oxidation(H)@1; ONE addition +154(K)@8; HPNE addition +172(K)@10 cleaved E-H@N-term; missed K-A@8; missed R-Q@17 0.344806998968124 3461.2880859375 693.2649 3460.943359375 693.195922851563 5 19 1.1.1.3985.5 1 55.8193 1942.719 55.8624 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 53.8399994373322 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTKK hexanoyl addition +98(K)@1; hexanoyl addition +98(K)@3; MDA adduct +62(K)@21 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21; missed K-K@33 0.318839997053146 4105.630859375 822.1334 4105.31201171875 822.069641113281 5 13 1.1.1.4671.14 1 73.0994 368.0475 73.2135 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 89.2499983310699 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLN hexanoyl addition +98(K)@3; acrolein addition +56(K)@33; HPNE addition +172(K)@34; Deamidated(N)@36 cleaved E-K@N-term; cleaved N-T@C-term; missed K-A@1; missed R-Q@10; missed K-V@21; missed K-K@33; missed K-L@34 0.450331002473831 4401.92041015625 734.6607 4401.47021484375 734.585632324219 6 16 1.1.1.4754.3 1 75.1567 540.0507 75.2012 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 69.1500008106232 KLREQLGPVTQEFWDNLEKETEGLRQEMSK acrolein addition +112(K)@1 cleaved S-K@N-term; missed K-L@1; missed R-E@3; missed K-E@19; missed R-Q@25 -0.610700011253357 3729.25659179688 746.8586 3729.8671875 746.980712890625 5 13 1.1.1.4061.9 1 57.726 1169.67 57.7411 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 99.0000009536743 KPALEDLRQGLLPVLESFKVSFLSALEEYTK hexanoyl addition +98(K)@1; Methyl(D)@6 cleaved A-K@N-term; missed R-Q@8; missed K-V@19 0.303200989961624 3632.31494140625 909.086 3632.01171875 909.010192871094 4 28 1.1.1.4713.4 1 74.1671 3718.069 74.2273 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 99.0000009536743 KPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ hexanoyl addition +98(K)@1; Methyl(E)@5 cleaved A-K@N-term; missed R-Q@8; missed K-V@19; missed K-K@31; missed K-L@32 0.366272985935211 4216.7060546875 844.3485 4216.33984375 844.275268554688 5 29 1.1.1.4741.9 1 74.8473 10728.02 74.6892 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 72.8600025177002 LAEYHAK Delta:H(2)C(2)@N-term 0.141120001673698 856.58544921875 429.3 856.444274902344 429.229431152344 2 11 1.1.1.2629.5 1 22.952 4368.027 22.9704 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 99.0000009536743 LDNWDSVTSTFSK Methyl(N)@3 cleaved L-L@N-term 0.185843005776405 1512.8955078125 757.455 1512.70959472656 757.362121582031 2 18 1.1.1.3176.5 1 36.0843 1328.981 36.0894 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 97.4799990653992 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAKVQP acrolein addition +94(K)@18; Dethiomethyl(M)@27; hexanoyl addition +98(K)@29; reduced acrolein addition +96(K)@37 cleaved P-Y@C-term; missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35; missed K-V@37 0.198789000511169 4966.75927734375 828.8005 4966.560546875 828.767333984375 6 18 1.1.1.3780.13 1 50.8133 1620.831 50.8497 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 56.3199996948242 LSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK MDA adduct +54(K)@4; Deamidated(Q)@14 cleaved T-L@N-term; missed K-A@4; missed R-Q@13; missed K-V@24 0.365705996751785 4103.57470703125 1026.901 4103.2080078125 1026.80932617188 4 13 1.1.1.4716.21 1 74.2467 1069.456 74.2273 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 98.5700011253357 LSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +112(K)@4; acrolein addition +112(K)@6; Oxidation(P)@7; Deamidated(Q)@14 cleaved T-L@N-term; missed K-A@4; missed R-Q@13; missed K-V@24; missed K-K@36; missed K-L@37 0.183503001928329 4873.80908203125 975.7691 4873.62548828125 975.732421875 5 20 1.1.1.4737.6 1 74.7535 1562.481 74.6892 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 88.7799978256226 LSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Carbamidomethyl@N-term; MDA adduct +62(K)@7; acrolein addition +38(K)@9 cleaved H-L@N-term; missed K-A@7; missed R-Q@16; missed K-V@27 -0.542479991912842 4505.8876953125 902.1848 4506.43017578125 902.293334960938 5 16 1.1.1.4712.11 1 74.1414 841.6353 73.8871 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 99.0000009536743 PALEDLRQGLLPVLESFKVSFLSALEEYTK Octanoyl(S)@16; ONE addition +154(K)@18 cleaved K-P@N-term; missed R-Q@7; missed K-V@18 0.175224006175995 3672.20703125 919.059 3672.03173828125 919.015197753906 4 21 1.1.1.4710.11 1 74.0946 615.1614 74.1303 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 99.0000009536743 PALEDLRQGLLPVLESFKVSFLSALEEYTKK acrolein addition +38(K)@18; HexNAc(S)@20 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30 -0.537919998168945 3760.47998046875 753.1033 3761.01782226563 753.210876464844 5 21 1.1.1.4702.6 1 73.894 4629.47 73.8606 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 96.3500022888184 PQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Dioxidation(W)@5; acrolein addition +76(K)@9; acrolein addition +112(K)@20; ONE addition +154(K)@37 cleaved P-P@N-term; missed R-V@7; missed K-D@9; missed K-D@20; missed R-D@24; missed K-Q@37; missed K-L@42 -0.490207999944687 6688.8955078125 956.5638 6689.3857421875 956.6337890625 7 18 1.1.1.4549.11 1 69.9193 612.5514 69.9294 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 92.4799978733063 QKVEPLRAELQEGARQKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Deamidated(Q)@16; acrolein addition +76(K)@17; Delta:H(2)C(2)(H)@19 missed K-V@2; missed R-A@7; missed R-Q@15; missed K-L@17; missed K-L@24; missed R-D@33 0.498748987913132 4226.689453125 705.4555 4226.1904296875 705.372375488281 6 16 1.1.1.4049.3 1 57.4133 3106.522 57.4333 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 95.5799996852875 QLNLKLLDNWDSVTSTFSKL Phospho(S)@12 cleaved L-R@C-term; missed K-L@5; missed K-L@19 0.261141002178192 2401.4541015625 801.492 2401.19311523438 801.404968261719 3 16 1.1.1.3845.5 1 52.4249 1159.508 52.4184 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 51.3300001621246 STLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK reduced acrolein addition +58(K)@6; acrolein addition +94(K)@8; Deamidated(Q)@16; HPNE addition +172(K)@26 cleaved L-S@N-term; missed K-A@6; missed R-Q@15; missed K-V@26 0.474934011697769 4561.94580078125 761.3316 4561.47119140625 761.25244140625 6 13 1.1.1.4701.10 1 73.8729 201.0643 73.8871 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 52.810001373291 TEHLSTLSEKAKPALEDLRQGLLPVLESFK reduced HNE(H)@3 cleaved A-T@N-term; missed K-A@10; missed R-Q@19 -0.649017989635468 3506.31103515625 702.2695 3506.9599609375 702.399291992188 5 12 1.1.1.4341.3 1 64.6342 449.2092 64.6543 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 42.4699991941452 TLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +38(K)@7; hexanoyl addition +98(K)@25 cleaved S-T@N-term; missed K-A@5; missed R-Q@14; missed K-V@25; missed K-K@37; missed K-L@38 0.401170998811722 4870.07958984375 812.6872 4869.67822265625 812.620361328125 6 13 1.1.1.4693.13 1 73.668 489.6274 73.6797 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 81.6999971866608 VDALRTHLAPYSDELRQR cleaved H-V@N-term; missed R-T@5; missed R-Q@16 -3.11050009727478 2136.00805664063 535.0093 2139.11840820313 535.786926269531 4 13 1.1.1.2981.5 1 31.3907 1449.296 31.3785 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 96.4600026607513 VKAKVQPYLDDFQKKWQEEMELYRQK reduced acrolein addition +58(K)@2; acrolein addition +112(K)@4; reduced acrolein addition +96(K)@15; Dethiomethyl(M)@20 cleaved E-V@N-term; missed K-A@2; missed K-V@4; missed K-K@14; missed K-W@15; missed R-Q@24 0.210127994418144 3545.07080078125 710.0214 3544.86059570313 709.979370117188 5 17 1.1.1.3465.13 1 43.056 1813.516 43.0677 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0.000434511806815863 70.7799971103668 VLTLAVLFLTGSQARHFWQQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved A-V@N-term; missed R-H@15; missed R-V@30; missed K-D@32; missed K-D@43; missed R-D@47 -1.10557997226715 6761.34423828125 1127.898 6762.451171875 1128.08239746094 6 16 1.1.1.4388.4 1 65.8594 1206.161 65.8405 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AARLEALKENGGAR cleaved L-A@N-term; missed R-L@3; missed K-E@8 0.215480998158455 1455.01086425781 486.0109 1454.79541015625 485.939056396484 3 18 1.1.1.2749.4 1 25.8231 17642.69 25.8398 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AARLEALKENGGAR cleaved L-A@N-term; missed R-L@3; missed K-E@8 0.215755999088287 1455.01110839844 486.011 1454.79541015625 485.939056396484 3 19 1.1.1.2763.6 1 26.1632 16827.21 26.1758 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AARLEALKENGGAR Deamidated(N)@10 cleaved L-A@N-term; missed R-L@3; missed K-E@8 0.21849499642849 1455.99792480469 486.3399 1455.77941894531 486.267059326172 3 17 1.1.1.2797.4 1 26.9743 15985.98 27.1322 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AARLEALKENGGAR Deamidated(N)@10 cleaved L-A@N-term; missed R-L@3; missed K-E@8 0.21849499642849 1455.99792480469 486.3399 1455.77941894531 486.267059326172 3 17 1.1.1.2804.3 1 27.136 15985.98 27.1322 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AARLEALKENGGAR Deamidated(N)@10 cleaved L-A@N-term; missed R-L@3; missed K-E@8 0.21849499642849 1455.99792480469 486.3399 1455.77941894531 486.267059326172 3 16 1.1.1.2811.4 1 27.3063 15985.98 27.1322 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AARLEALKENGGAR Deamidated(N)@10 cleaved L-A@N-term; missed R-L@3; missed K-E@8 0.21849499642849 1455.99792480469 486.3399 1455.77941894531 486.267059326172 3 16 1.1.1.2818.5 1 27.4748 5111.176 27.4183 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9199993610382 AARLEALKENGGAR ONE addition +154(K)@8 cleaved L-A@N-term; missed R-L@3; missed K-E@8 0.286101013422012 1609.18090820313 403.3025 1608.89477539063 403.23095703125 4 13 1.1.1.2817.2 1 27.4459 42212.47 27.5376 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9199993610382 AARLEALKENGGAR ONE addition +154(K)@8 cleaved L-A@N-term; missed R-L@3; missed K-E@8 0.286101013422012 1609.18090820313 403.3025 1608.89477539063 403.23095703125 4 13 1.1.1.2824.2 1 27.6128 42212.47 27.5376 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 AARLEALKENGGAR ONE addition +154(K)@8; Deamidated(N)@10 cleaved L-A@N-term; missed R-L@3; missed K-E@8 0.285362005233765 1610.16418457031 403.5483 1609.87878417969 403.476959228516 4 13 1.1.1.2833.2 1 27.8305 20301.88 27.8951 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.7300004959106 AARLEALKENGGAR cleaved L-A@N-term; missed R-L@3; missed K-E@8 0.217860996723175 1455.01318359375 486.0117 1454.79541015625 485.939056396484 3 12 1.1.1.2752.4 1 25.8967 17642.69 25.8398 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 44.1599994897842 AELQEGAR 0.141073003411293 872.576293945313 437.2954 872.435180664063 437.224884033203 2 12 1.1.1.2572.2 1 21.6126 1558.108 21.4938 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 43.5799986124039 AELQEGAR 0.141073003411293 872.576293945313 437.2954 872.435180664063 437.224884033203 2 12 1.1.1.2527.2 1 20.7719 2660.403 20.777 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 43.5799986124039 AELQEGAR 0.140827998518944 872.576049804688 437.2953 872.435180664063 437.224884033203 2 12 1.1.1.2549.2 1 21.1159 2305.401 20.945 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 43.5799986124039 AELQEGAR 0.140827998518944 872.576049804688 437.2953 872.435180664063 437.224884033203 2 12 1.1.1.2556.3 1 21.2789 2062.073 21.0329 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.4699991941452 AELQEGAR 0.141073003411293 872.576293945313 437.2954 872.435180664063 437.224884033203 2 13 1.1.1.2478.2 1 19.9123 8332.637 20.0943 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.4699991941452 AELQEGAR 0.141256004571915 872.576477050781 437.2955 872.435180664063 437.224884033203 2 13 1.1.1.2487.2 1 20.0892 11666.4 20.1998 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.4699991941452 AELQEGAR 0.141256004571915 872.576477050781 437.2955 872.435180664063 437.224884033203 2 13 1.1.1.2496.2 1 20.2561 11666.4 20.1998 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.4699991941452 AELQEGAR 0.140644997358322 872.575866699219 437.2952 872.435180664063 437.224884033203 2 13 1.1.1.2516.2 1 20.594 5525.758 20.3906 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.4699991941452 AELQEGAR 0.140827998518944 872.576049804688 437.2953 872.435180664063 437.224884033203 2 13 1.1.1.2541.2 1 20.9399 2305.401 20.945 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.4699991941452 AELQEGAR 0.141073003411293 872.576293945313 437.2954 872.435180664063 437.224884033203 2 13 1.1.1.2563.2 1 21.4533 1558.108 21.4938 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 32.8000009059906 AELQEGAR 0.141073003411293 872.576293945313 437.2954 872.435180664063 437.224884033203 2 12 1.1.1.2508.2 1 20.4257 8961.793 20.2858 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 30.6800007820129 AELQEGAR 0.143270000815392 872.578491210938 437.2965 872.435180664063 437.224884033203 2 9 1.1.1.2604.5 1 22.3501 1062.297 22.3924 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 26.6699999570847 AELQEGAR 0.140644997358322 872.575866699219 437.2952 872.435180664063 437.224884033203 2 11 1.1.1.2597.3 1 22.1726 1168.134 22.1131 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.6900029182434 AELQEGARQKLHELQEKLSPLGEEMRDR reduced acrolein addition +58(K)@10; Methyl(L)@11 missed R-Q@8; missed K-L@10; missed K-L@17; missed R-D@26 0.352508008480072 3362.09375 673.426 3361.7412109375 673.355529785156 5 16 1.1.1.3881.3 1 53.3069 1470.454 53.2765 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AEYHAKATEHLSTLSEK ONE addition +154(K)@6 cleaved L-A@N-term; missed K-A@6 0.178728997707367 2068.22534179688 1035.12 2068.04760742188 1035.03112792969 2 18 1.1.1.2722.9 1 25.1928 1986.026 25.2692 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AEYHAKATEHLSTLSEK acrolein addition +94(K)@6 cleaved L-A@N-term; missed K-A@6 0.236046999692917 2008.22619628906 670.416 2007.99011230469 670.337341308594 3 16 1.1.1.3273.6 1 38.4084 634.4684 38.4374 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.4900007247925 AEYHAKATEHLSTLSEK acrolein addition +94(K)@6 cleaved L-A@N-term; missed K-A@6 0.298716992139816 2008.28894042969 503.0795 2007.99011230469 503.004821777344 4 14 1.1.1.3175.3 1 36.0479 2394.076 36.0416 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.0300018787384 AEYHAKATEHLSTLSEK ONE addition +154(K)@6 cleaved L-A@N-term; missed K-A@6 0.298453003168106 2068.34619140625 518.0938 2068.04760742188 518.019226074219 4 14 1.1.1.2730.5 1 25.3763 41566.78 25.2454 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.5100028514862 AEYHAKATEHLSTLSEK ONE addition +154(K)@6 cleaved L-A@N-term; missed K-A@6 0.298453003168106 2068.34619140625 518.0938 2068.04760742188 518.019226074219 4 13 1.1.1.2721.4 1 25.1599 41566.78 25.2454 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 58.7700009346008 AEYHAKATEHLSTLSEK ONE addition +154(K)@6 cleaved L-A@N-term; missed K-A@6 0.238224998116493 2068.28588867188 690.4359 2068.04760742188 690.356506347656 3 20 1.1.1.2722.8 1 25.1903 7366.772 25.2454 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.9699985980988 AEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Carbamidomethyl@N-term; MDA adduct +62(K)@6; HPNE addition +172(K)@19 cleaved L-A@N-term; missed K-A@6; missed K-A@17; missed R-Q@26; missed K-V@37 -0.550967991352081 5777.49365234375 963.9229 5778.044921875 964.014770507813 6 13 1.1.1.4651.17 1 72.5745 193.5116 72.5829 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.0100002288818 AEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ ONE addition +154(K)@6 cleaved L-A@N-term; missed K-A@6; missed K-A@17; missed R-Q@26; missed K-V@37; missed K-K@49; missed K-L@50 0.552519023418427 6225.8779296875 890.4184 6225.3251953125 890.339477539063 7 15 1.1.1.4596.6 1 71.1149 539.8462 71.1284 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.5299980640411 AEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ ONE addition +154(K)@6 cleaved L-A@N-term; missed K-A@6; missed K-A@17; missed R-Q@26; missed K-V@37; missed K-K@49; missed K-L@50 0.566618978977203 6225.89208984375 890.4204 6225.3251953125 890.339477539063 7 15 1.1.1.4572.10 1 70.4991 591.735 70.4581 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.5299980640411 AEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ ONE addition +154(K)@6 cleaved L-A@N-term; missed K-A@6; missed K-A@17; missed R-Q@26; missed K-V@37; missed K-K@49; missed K-L@50 0.571317970752716 6225.896484375 890.4211 6225.3251953125 890.339477539063 7 15 1.1.1.4588.7 1 70.9036 755.2719 70.6872 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 58.7700009346008 AHVDALRTHLA Dehydrated(T)@8 cleaved A-P@C-term; missed R-T@7 0.154798999428749 1184.79626464844 593.4054 1184.64147949219 593.328002929688 2 13 1.1.1.3016.10 1 32.2387 1851.522 32.2713 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 34.4099998474121 AHVDALRTHLA Dehydrated(T)@8 cleaved A-P@C-term; missed R-T@7 0.161024004220963 1184.80249023438 593.4085 1184.64147949219 593.328002929688 2 13 1.1.1.3035.4 1 32.6954 924.4748 32.7287 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELR missed R-T@7 0.235406994819641 2063.29028320313 688.7707 2063.05493164063 688.692199707031 3 22 1.1.1.3108.12 1 34.4529 18015.47 34.5543 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELR missed R-T@7 0.235406994819641 2063.29028320313 688.7707 2063.05493164063 688.692199707031 3 27 1.1.1.3115.11 1 34.62 18015.47 34.5543 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELR missed R-T@7 0.293743014335632 2063.3486328125 516.8444 2063.05493164063 516.77099609375 4 17 1.1.1.3107.7 1 34.4204 67938.86 34.5543 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELR missed R-T@7 0.293743014335632 2063.3486328125 516.8444 2063.05493164063 516.77099609375 4 17 1.1.1.3120.2 1 34.7424 67938.86 34.5543 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.0000026226044 AHVDALRTHLAPYSDELR missed R-T@7 0.348264992237091 2063.40307617188 413.6879 2063.05493164063 413.618255615234 5 14 1.1.1.3113.3 1 34.565 19343.05 34.5543 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR Carbamidomethyl(H)@9 missed R-T@7; missed R-Q@18 0.237970992922783 2404.47387695313 802.4986 2404.23608398438 802.419250488281 3 20 1.1.1.3008.11 1 32.0482 948.8516 32.0776 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.304464995861053 2347.51904296875 587.887 2347.21459960938 587.810913085938 4 20 1.1.1.3011.12 1 32.1137 178856.6 32.2953 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.241490006446838 2347.4560546875 783.4926 2347.21459960938 783.412109375 3 28 1.1.1.3011.17 1 32.1196 26215.3 32.2953 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.241490006446838 2347.4560546875 783.4926 2347.21459960938 783.412109375 3 28 1.1.1.3018.14 1 32.2869 26418.77 32.2953 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.241672992706299 2347.45629882813 783.4927 2347.21459960938 783.412109375 3 26 1.1.1.3025.12 1 32.4589 23772.41 32.4399 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.242038995027542 2347.45654296875 783.4928 2347.21459960938 783.412109375 3 27 1.1.1.3032.6 1 32.6273 17180.7 32.7527 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.242038995027542 2347.45654296875 783.4928 2347.21459960938 783.412109375 3 25 1.1.1.3039.8 1 32.7957 17180.7 32.7527 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.242038995027542 2347.45654296875 783.4928 2347.21459960938 783.412109375 3 27 1.1.1.3046.12 1 32.9641 17180.7 32.7527 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.241672992706299 2347.45629882813 783.4927 2347.21459960938 783.412109375 3 23 1.1.1.3053.10 1 33.1322 14774.34 32.873 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.303977012634277 2347.5185546875 587.8869 2347.21459960938 587.810913085938 4 21 1.1.1.3060.7 1 33.2951 80493.66 33.0413 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.241124004125595 2347.45556640625 783.4925 2347.21459960938 783.412109375 3 25 1.1.1.3060.8 1 33.2976 10515.31 33.0413 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR Carbamidomethyl@N-term missed R-T@7; missed R-Q@18 0.305705994367599 2404.54174804688 602.1427 2404.23608398438 602.066284179688 4 18 1.1.1.3072.4 1 33.5787 8354.57 33.6409 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR Carbamidomethyl@N-term missed R-T@7; missed R-Q@18 0.359129011631012 2404.59521484375 481.9263 2404.23608398438 481.854461669922 5 18 1.1.1.3073.9 1 33.6051 18698.58 33.6409 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR Trimethyl(R)@7; Delta:H(4)C(2)(H)@9 missed R-T@7; missed R-Q@18 0.266497999429703 2417.55932617188 605.3971 2417.29272460938 605.330444335938 4 21 1.1.1.3089.5 1 33.9955 1744.727 33.8326 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR Delta:H(2)C(2)(H)@2 missed R-T@7; missed R-Q@18 0.311520010232925 2373.54174804688 594.3927 2373.23022460938 594.314819335938 4 17 1.1.1.3260.4 1 38.0874 1804.002 38.0786 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR Dehydrated(S)@14 missed R-T@7; missed R-Q@18 0.355605006217957 2329.5595703125 466.9192 2329.20385742188 466.848083496094 5 17 1.1.1.3081.6 1 33.7986 8562.647 33.7607 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR Carbamidomethyl(H)@9 missed R-T@7; missed R-Q@18 0.357145994901657 2404.59301757813 481.9259 2404.23608398438 481.854461669922 5 17 1.1.1.3006.10 1 31.9905 20153.65 32.0776 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.241490006446838 2347.4560546875 783.4926 2347.21459960938 783.412109375 3 19 1.1.1.3067.10 1 33.4663 5006.137 33.2093 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.304464995861053 2347.51904296875 587.887 2347.21459960938 587.810913085938 4 19 1.1.1.3018.10 1 32.2811 180962.5 32.2953 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.304464995861053 2347.51904296875 587.887 2347.21459960938 587.810913085938 4 19 1.1.1.3025.9 1 32.4538 180962.5 32.2953 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.303977012634277 2347.5185546875 587.8869 2347.21459960938 587.810913085938 4 19 1.1.1.3039.7 1 32.7932 95239 32.7527 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.303487986326218 2347.51806640625 587.8868 2347.21459960938 587.810913085938 4 19 1.1.1.3046.10 1 32.9608 95031.97 32.9452 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.303487986326218 2347.51806640625 587.8868 2347.21459960938 587.810913085938 4 19 1.1.1.3053.8 1 33.1272 95031.97 32.9452 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.358040988445282 2347.57250976563 470.5218 2347.21459960938 470.4501953125 5 19 1.1.1.3067.6 1 33.4596 92216.78 33.2093 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.357582986354828 2347.57202148438 470.5217 2347.21459960938 470.4501953125 5 19 1.1.1.3074.5 1 33.6283 8653.813 33.6169 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.356667011976242 2347.5712890625 470.5215 2347.21459960938 470.4501953125 5 19 1.1.1.3087.7 1 33.9409 3344.705 33.9766 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.360024005174637 2347.57446289063 470.5222 2347.21459960938 470.4501953125 5 18 1.1.1.3011.4 1 32.1071 294597.8 32.2713 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.303487986326218 2347.51806640625 587.8868 2347.21459960938 587.810913085938 4 18 1.1.1.3067.9 1 33.4646 51964.98 33.2093 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.303977012634277 2347.5185546875 587.8869 2347.21459960938 587.810913085938 4 18 1.1.1.3032.5 1 32.6239 95239 32.7527 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.177415996789932 2347.39135742188 1174.703 2347.21459960938 1174.61450195313 2 17 1.1.1.3036.8 1 32.7236 3303.401 32.6806 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.360024005174637 2347.57446289063 470.5222 2347.21459960938 470.4501953125 5 17 1.1.1.3018.5 1 32.2769 294597.8 32.2713 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.360024005174637 2347.57446289063 470.5222 2347.21459960938 470.4501953125 5 17 1.1.1.3025.6 1 32.4488 294597.8 32.2713 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.360635012388229 2347.5751953125 470.5223 2347.21459960938 470.4501953125 5 17 1.1.1.3032.4 1 32.6206 255706.4 32.3676 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.303977012634277 2347.5185546875 587.8869 2347.21459960938 587.810913085938 4 17 1.1.1.3037.15 1 32.7443 95239 32.7527 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.358651012182236 2347.5732421875 470.5219 2347.21459960938 470.4501953125 5 17 1.1.1.3053.6 1 33.1239 146790.6 32.9692 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.298361986875534 2347.51293945313 587.8855 2347.21459960938 587.810913085938 4 17 1.1.1.3074.8 1 33.6358 5057.342 33.6169 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQR Oxidation(Y)@13 missed R-T@7; missed R-Q@18 0.31223601102829 2363.52172851563 591.8877 2363.20947265625 591.809631347656 4 16 1.1.1.2983.9 1 31.4419 816.7764 31.4743 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.989999294281 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.300069987773895 2347.5146484375 587.8859 2347.21459960938 587.810913085938 4 16 1.1.1.2950.9 1 30.6493 1709.283 30.6353 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.989999294281 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.359566003084183 2347.57397460938 470.5221 2347.21459960938 470.4501953125 5 16 1.1.1.3039.6 1 32.7907 144858.1 32.8249 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.989999294281 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.358651012182236 2347.5732421875 470.5219 2347.21459960938 470.4501953125 5 16 1.1.1.3046.7 1 32.9558 146790.6 32.9692 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.989999294281 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.359566003084183 2347.57397460938 470.5221 2347.21459960938 470.4501953125 5 16 1.1.1.3060.5 1 33.2901 127016.5 33.0413 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.9099979400635 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.304464995861053 2347.51904296875 587.887 2347.21459960938 587.810913085938 4 16 1.1.1.3030.14 1 32.5775 174775.1 32.3194 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8100011348724 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.360024005174637 2347.57446289063 470.5222 2347.21459960938 470.4501953125 5 15 1.1.1.3017.5 1 32.2587 294597.8 32.2713 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5399980545044 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.170579999685287 2347.38525390625 1174.7 2347.21459960938 1174.61450195313 2 13 1.1.1.3043.9 1 32.892 3005.162 32.8009 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.729998588562 AHVDALRTHLAPYSDELRQR Palmitoyl(S)@14 missed R-T@7; missed R-Q@18 0.37178298830986 2585.81591796875 518.1705 2585.44409179688 518.096130371094 5 17 1.1.1.4572.3 1 70.4891 4786.08 70.6364 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.0000026226044 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.360024005174637 2347.57446289063 470.5222 2347.21459960938 470.4501953125 5 14 1.1.1.3025.5 1 32.4472 294597.8 32.2713 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1099998950958 AHVDALRTHLAPYSDELRQR Carbamidomethyl(H)@9 missed R-T@7; missed R-Q@18 -0.666872024536133 2403.56909179688 481.7211 2404.23608398438 481.854461669922 5 14 1.1.1.3095.6 1 34.1319 1018.906 34.0485 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.5100016593933 AHVDALRTHLAPYSDELRQR Palmitoyl(S)@14 missed R-T@7; missed R-Q@18 0.37178298830986 2585.81591796875 518.1705 2585.44409179688 518.096130371094 5 16 1.1.1.4579.5 1 70.6688 4786.08 70.6364 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.7800004482269 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.173754006624222 2347.38745117188 1174.701 2347.21459960938 1174.61450195313 2 12 1.1.1.3026.11 1 32.4829 3823.718 32.488 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.7599980831146 AHVDALRTHLAPYSDELRQR Carbamidomethyl(H)@9 missed R-T@7; missed R-Q@18 0.359129011631012 2404.59521484375 481.9263 2404.23608398438 481.854461669922 5 13 1.1.1.2992.6 1 31.656 4080.428 31.5461 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.6300020217896 AHVDALRTHLAPYSDELRQR Oxidation(H)@2; Dehydrated(D)@4; Deamidated(R)@7 missed R-T@7; missed R-Q@18 0.318765997886658 2346.50170898438 587.6327 2346.18286132813 587.552978515625 4 15 1.1.1.3324.2 1 39.6145 449.9142 39.6337 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.410001039505 AHVDALRTHLAPYSDELRQR Deamidated(R)@18 missed R-T@7; missed R-Q@18 0.320448994636536 2348.51904296875 588.137 2348.19848632813 588.056884765625 4 12 1.1.1.3047.6 1 32.9832 35822.14 32.9212 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.8299970626831 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.360024005174637 2347.57446289063 470.5222 2347.21459960938 470.4501953125 5 13 1.1.1.3017.6 1 32.2612 294597.8 32.2713 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.8299970626831 AHVDALRTHLAPYSDELRQR missed R-T@7; missed R-Q@18 0.358651012182236 2347.5732421875 470.5219 2347.21459960938 470.4501953125 5 13 1.1.1.3051.5 1 33.0776 146790.6 32.9692 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.92999958992 AHVDALRTHLAPYSDELRQR Palmitoyl(S)@14 missed R-T@7; missed R-Q@18 0.312348008155823 2585.75659179688 647.4464 2585.44409179688 647.368347167969 4 14 1.1.1.4579.7 1 70.6704 3464.284 70.6617 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 55.6999981403351 AHVDALRTHLAPYSDELRQR Palmitoyl(S)@14 missed R-T@7; missed R-Q@18 0.37178298830986 2585.81591796875 518.1705 2585.44409179688 518.096130371094 5 14 1.1.1.4586.4 1 70.8478 4786.08 70.6364 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Deamidated(N)@31 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.404199987649918 3898.4716796875 780.7016 3898.0673828125 780.620788574219 5 24 1.1.1.3651.18 1 47.6715 10544.34 47.8336 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 1.38821995258331 3898.4716796875 780.7016 3897.08349609375 780.423950195313 5 21 1.1.1.3658.15 1 47.8492 10544.34 47.8336 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.457782000303268 3897.54125976563 650.5975 3897.08349609375 650.521179199219 6 23 1.1.1.3664.10 1 47.9993 35295.05 48.0381 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.398835003376007 3897.48217773438 780.5037 3897.08349609375 780.423950195313 5 23 1.1.1.3665.3 1 48.0326 12989.86 47.9879 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.4566830098629 3897.5400390625 650.5973 3897.08349609375 650.521179199219 6 22 1.1.1.3671.5 1 48.1676 30774.01 48.1585 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Deamidated(N)@31 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.384057998657227 3898.45141601563 780.6976 3898.0673828125 780.620788574219 5 20 1.1.1.3682.5 1 48.3875 4814.128 48.4169 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.517278015613556 3897.6005859375 557.8074 3897.08349609375 557.733459472656 7 17 1.1.1.3664.4 1 47.9943 40376.73 48.0622 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Deamidated(N)@31 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.449351996183395 3898.51684570313 650.7601 3898.0673828125 650.685180664063 6 17 1.1.1.3682.2 1 48.3749 14150.13 48.4169 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1199989318848 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Dehydrated(S)@14 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.515574991703033 3879.58837890625 555.2342 3879.07275390625 555.160522460938 7 17 1.1.1.3680.3 1 48.3479 3167.711 48.3926 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8699991703033 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Deamidated(N)@31 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.471691012382507 3898.5390625 650.7638 3898.0673828125 650.685180664063 6 16 1.1.1.3650.10 1 47.6396 26079.93 47.7818 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.6899988651276 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Deamidated(N)@31 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.535153985023499 3898.6025390625 557.9505 3898.0673828125 557.8740234375 7 14 1.1.1.3653.7 1 47.7134 28686.89 47.7818 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.7199997901917 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Ammonia-loss(N)@31 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.529178977012634 3880.5859375 555.3767 3880.05688476563 555.301086425781 7 15 1.1.1.3689.4 1 48.5286 2465.414 48.4945 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1900012493134 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Dehydrated(E)@16; Deamidated(N)@31 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.472001999616623 3880.52880859375 647.7621 3880.05688476563 647.683410644531 6 15 1.1.1.3664.9 1 47.9985 1102.515 47.9879 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.9199991226196 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.33305299282074 3897.41650390625 975.3614 3897.08349609375 975.278137207031 4 14 1.1.1.3661.16 1 47.9298 2110.788 47.9879 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 77.2800028324127 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Deamidated(Q)@19 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.471691012382507 3898.5390625 650.7638 3898.0673828125 650.685180664063 6 12 1.1.1.3657.10 1 47.8194 26079.93 47.7818 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.1299986839294 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Deamidated(N)@31 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.471691012382507 3898.5390625 650.7638 3898.0673828125 650.685180664063 6 12 1.1.1.3650.11 1 47.6404 26079.93 47.7818 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.8599994182587 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Deamidated(N)@31 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 -0.550769984722137 3897.5166015625 650.5934 3898.0673828125 650.685180664063 6 12 1.1.1.3759.8 1 50.2726 735.1077 50.2886 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 62.279999256134 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Deamidated(N)@31 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 0.33780699968338 3898.4052734375 975.6086 3898.0673828125 975.524108886719 4 11 1.1.1.3653.21 1 47.7251 1771.628 47.8078 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.2400004863739 AHVDALRTHLAPYSDELRQRLAARLEALKENGGAR Carbamyl(R)@24 missed R-T@7; missed R-Q@18; missed R-L@20; missed R-L@24; missed K-E@29 -0.533016979694366 3939.55615234375 657.6 3940.08911132813 657.688781738281 6 13 1.1.1.3689.5 1 48.5311 1285.781 48.5187 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.5400009155273 AKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK ONE addition +154(K)@2; HPNE addition +172(K)@13; HPNE addition +172(K)@15 cleaved H-A@N-term; missed K-A@2; missed K-A@13; missed R-Q@22; missed K-V@33 0.466670006513596 5485.48193359375 784.6475 5485.01513671875 784.580871582031 7 16 1.1.1.4701.14 1 73.8762 696.4315 73.8606 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.92999792099 AKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Carbamidomethyl@N-term; reduced acrolein addition +96(K)@2; acrolein addition +56(K)@13; acrolein addition +112(K)@15 cleaved H-A@N-term; missed K-A@2; missed K-A@13; missed R-Q@22; missed K-V@33 0.286484986543655 5308.138671875 1062.635 5307.853515625 1062.57800292969 5 16 1.1.1.4775.18 1 75.692 770.1401 75.6996 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.6099991798401 AKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK ONE addition +154(K)@2; acrolein addition +112(K)@13; acrolein addition +112(K)@15; MDA adduct +62(K)@33 cleaved H-A@N-term; missed K-A@2; missed K-A@13; missed R-Q@22; missed K-V@33 -0.453298002481461 5426.46240234375 776.2162 5426.91552734375 776.280944824219 7 14 1.1.1.4701.11 1 73.8737 363.5302 73.808 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.9000005722046 AKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK HPNE addition +172(K)@2; reduced HNE(H)@6; acrolein addition +56(K)@13; reduced acrolein addition +96(K)@15 cleaved H-A@N-term; missed K-A@2; missed K-A@13; missed R-Q@22; missed K-V@33 0.44412899017334 5469.46435546875 782.3593 5469.02001953125 782.295837402344 7 14 1.1.1.4701.13 1 73.8754 1130.689 73.8606 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 77.9999971389771 AKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ ONE addition +154(K)@2; acrolein addition +94(K)@15; Deamidated(Q)@23; reduced acrolein addition +58(K)@33 cleaved H-A@N-term; missed K-A@2; missed K-A@13; missed R-Q@22; missed K-V@33; missed K-K@45; missed K-L@46 0.324551999568939 5878.515625 980.7599 5878.19091796875 980.705810546875 6 14 1.1.1.4775.15 1 75.6895 1020.77 75.6738 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.3900008201599 AKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +94(K)@15 cleaved H-A@N-term; missed K-A@2; missed K-A@13; missed R-Q@22; missed K-V@33; missed K-K@45; missed K-L@46 0.451642990112305 5665.517578125 945.2602 5665.06591796875 945.184936523438 6 13 1.1.1.4693.18 1 73.6721 267.5084 73.6536 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.92999958992 AKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ ONE addition +154(K)@2; acrolein addition +76(K)@15; reduced acrolein addition +58(K)@33 cleaved H-A@N-term; missed K-A@2; missed K-A@13; missed R-Q@22; missed K-V@33; missed K-K@45; missed K-L@46 -0.614094972610474 5858.58251953125 977.4377 5859.19677734375 977.5400390625 6 13 1.1.1.4781.18 1 75.8488 773.5314 75.8564 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 35.6799989938736 AKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ ONE addition +154(K)@2; acrolein addition +94(K)@13; acrolein addition +94(K)@15 cleaved H-A@N-term; missed K-A@2; missed K-A@13; missed R-Q@22; missed K-V@33; missed K-K@45; missed K-L@46 -0.547755002975464 5912.6591796875 986.4505 5913.20703125 986.541809082031 6 12 1.1.1.4678.20 1 73.2854 2682.041 73.1363 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8100011348724 AKPALEDLR 0.148772001266479 1011.72009277344 506.8673 1011.5712890625 506.792938232422 2 14 1.1.1.2724.3 1 25.2286 16405.79 25.2216 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.4100022315979 AKPALEDLR 2.08913993835449 1013.66046142578 507.8375 1011.5712890625 506.792938232422 2 13 1.1.1.2717.4 1 25.0636 129260.3 24.9831 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFK missed R-Q@9 0.24702200293541 2223.509765625 742.1772 2223.2626953125 742.094848632813 3 22 1.1.1.3990.5 1 55.9444 18553.25 55.813 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFK missed R-Q@9 0.305357992649078 2223.56811523438 556.8993 2223.2626953125 556.822937011719 4 18 1.1.1.3976.3 1 55.5971 17078.23 55.7883 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9499995708466 AKPALEDLRQGLLPVLESFK missed R-Q@9 0.246472999453545 2223.50927734375 742.177 2223.2626953125 742.094848632813 3 17 1.1.1.3975.3 1 55.5778 18169.75 55.813 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.3100016117096 AKPALEDLRQGLLPVLESFK missed R-Q@9 0.305357992649078 2223.56811523438 556.8993 2223.2626953125 556.822937011719 4 17 1.1.1.3983.2 1 55.7674 19006.93 55.8875 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.3100016117096 AKPALEDLRQGLLPVLESFK missed R-Q@9 0.305357992649078 2223.56811523438 556.8993 2223.2626953125 556.822937011719 4 17 1.1.1.3990.2 1 55.9419 19006.93 55.8875 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4199988842011 AKPALEDLRQGLLPVLESFK missed R-Q@9 0.177089005708694 2223.439453125 1112.727 2223.2626953125 1112.638671875 2 14 1.1.1.3982.21 1 55.7588 3295.93 55.813 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4199988842011 AKPALEDLRQGLLPVLESFK missed R-Q@9 0.177089005708694 2223.439453125 1112.727 2223.2626953125 1112.638671875 2 16 1.1.1.3989.16 1 55.929 3295.93 55.813 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.5100014209747 AKPALEDLRQGLLPVLESFK Arg-add@N-term; MDA adduct +62(K)@2 missed R-Q@9 0.325803995132446 2441.70532226563 611.4336 2441.37939453125 611.352172851563 4 14 1.1.1.3982.3 1 55.7438 1647.588 55.7639 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 52.5499999523163 AKPALEDLRQGLLPVLESFK Arg-add@N-term; MDA adduct +62(K)@2 missed R-Q@9 0.325803995132446 2441.70532226563 611.4336 2441.37939453125 611.352172851563 4 12 1.1.1.3991.3 1 55.9676 1647.588 55.7639 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.389129012823105 3591.34912109375 719.2771 3590.9599609375 719.199279785156 5 19 1.1.1.4590.3 1 70.954 1824.724 71.1544 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.389129012823105 3591.34912109375 719.2771 3590.9599609375 719.199279785156 5 28 1.1.1.4597.2 1 71.1369 1849.31 71.1544 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.330487996339798 3591.29052734375 898.8299 3590.9599609375 898.747253417969 4 16 1.1.1.4602.11 1 71.2753 1457.079 71.1544 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.39614799618721 3591.35620117188 719.2785 3590.9599609375 719.199279785156 5 19 1.1.1.4604.8 1 71.323 1675 71.1025 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.336102992296219 3591.29614257813 898.8313 3590.9599609375 898.747253417969 4 16 1.1.1.4698.14 1 73.7971 106021.5 73.9362 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.391265988349915 3591.35131835938 719.2775 3590.9599609375 719.199279785156 5 26 1.1.1.4699.4 1 73.8145 155710.5 73.9362 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.259882986545563 3591.22143554688 1198.081 3590.9599609375 1197.99389648438 3 26 1.1.1.4700.21 1 73.8556 17121.68 74.0092 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.44862499833107 3591.40869140625 599.5754 3590.9599609375 599.500610351563 6 18 1.1.1.4703.3 1 73.9162 7993.852 73.9362 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.336102992296219 3591.29614257813 898.8313 3590.9599609375 898.747253417969 4 24 1.1.1.4705.4 1 73.9707 106021.5 73.9362 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK MDA adduct +54(K)@20 missed R-Q@9; missed K-V@20 0.239601001143456 3645.21020507813 912.3098 3644.97045898438 912.249938964844 4 18 1.1.1.4705.5 1 73.9732 950.9104 73.9362 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.391265988349915 3591.35131835938 719.2775 3590.9599609375 719.199279785156 5 24 1.1.1.4706.2 1 73.9891 155710.5 73.9362 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.259882986545563 3591.22143554688 1198.081 3590.9599609375 1197.99389648438 3 38 1.1.1.4707.12 1 74.0284 17121.68 74.0092 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.390044987201691 3591.35009765625 719.2773 3590.9599609375 719.199279785156 5 14 1.1.1.4708.3 1 74.0377 168644 74.2031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.335370987653732 3591.29541015625 898.8311 3590.9599609375 898.747253417969 4 17 1.1.1.4708.8 1 74.0444 127631.1 74.2031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.448258996009827 3591.408203125 599.5753 3590.9599609375 599.500610351563 6 20 1.1.1.4710.2 1 74.0855 9239.197 74.2031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK hexanoyl addition +98(K)@20 missed R-Q@9; missed K-V@20 0.229002997279167 3689.26220703125 923.3228 3689.033203125 923.265563964844 4 14 1.1.1.4710.12 1 74.0963 219.3379 74.082 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +38(K)@20 missed R-Q@9; missed K-V@20 0.322393000125885 3629.29809570313 726.8669 3628.9755859375 726.802429199219 5 16 1.1.1.4712.4 1 74.1356 1195.718 74.1064 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.390044987201691 3591.35009765625 719.2773 3590.9599609375 719.199279785156 5 23 1.1.1.4713.2 1 74.1604 168644 74.2031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.335370987653732 3591.29541015625 898.8311 3590.9599609375 898.747253417969 4 24 1.1.1.4713.3 1 74.1638 127631.1 74.2031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.390044987201691 3591.35009765625 719.2773 3590.9599609375 719.199279785156 5 15 1.1.1.4716.3 1 74.2317 168644 74.2031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.448258996009827 3591.408203125 599.5753 3590.9599609375 599.500610351563 6 17 1.1.1.4717.2 1 74.2567 9239.197 74.2031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK MDA adduct +54(K)@20 missed R-Q@9; missed K-V@20 0.303124994039536 3645.27368164063 730.062 3644.97045898438 730.001403808594 5 22 1.1.1.4718.3 1 74.2867 1758.178 74.082 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.390044987201691 3591.35009765625 719.2773 3590.9599609375 719.199279785156 5 25 1.1.1.4720.6 1 74.3314 168644 74.2031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.335370987653732 3591.29541015625 898.8311 3590.9599609375 898.747253417969 4 26 1.1.1.4720.14 1 74.3381 127631.1 74.2031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.265742987394333 3591.22729492188 1198.083 3590.9599609375 1197.99389648438 3 21 1.1.1.4720.21 1 74.3439 22425.38 74.2273 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK HPNE addition +172(K)@2; hexanoyl addition +98(K)@20 missed R-Q@9; missed K-V@20 0.294106990098953 3861.43725585938 966.3666 3861.14306640625 966.293029785156 4 14 1.1.1.4722.21 1 74.3935 6575.353 74.2031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.386687994003296 3591.3466796875 719.2766 3590.9599609375 719.199279785156 5 25 1.1.1.4727.3 1 74.5013 16160.76 74.5438 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.321211010217667 3591.28125 898.8276 3590.9599609375 898.747253417969 4 21 1.1.1.4727.8 1 74.5096 10602.45 74.4955 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.386687994003296 3591.3466796875 719.2766 3590.9599609375 719.199279785156 5 24 1.1.1.4734.3 1 74.6691 16160.76 74.5438 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.321211010217667 3591.28125 898.8276 3590.9599609375 898.747253417969 4 18 1.1.1.4734.11 1 74.6775 10602.45 74.4955 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.327802002429962 3591.28784179688 898.8292 3590.9599609375 898.747253417969 4 20 1.1.1.4739.7 1 74.8032 4732.283 74.8107 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.387603014707565 3591.34765625 719.2768 3590.9599609375 719.199279785156 5 23 1.1.1.4741.3 1 74.839 6981.799 74.7864 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.327802002429962 3591.28784179688 898.8292 3590.9599609375 898.747253417969 4 15 1.1.1.4743.6 1 74.8942 4732.283 74.8107 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.328534990549088 3591.28857421875 898.8294 3590.9599609375 898.747253417969 4 20 1.1.1.4747.8 1 74.9977 3185.134 75.1279 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.387603014707565 3591.34765625 719.2768 3590.9599609375 719.199279785156 5 19 1.1.1.4748.4 1 75.0102 7208.276 74.7618 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.388518989086151 3591.34838867188 719.277 3590.9599609375 719.199279785156 5 24 1.1.1.4755.2 1 75.1811 4685.298 75.1768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.328534990549088 3591.28857421875 898.8294 3590.9599609375 898.747253417969 4 17 1.1.1.4764.6 1 75.4103 3058.325 75.4945 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.329023003578186 3591.2890625 898.8295 3590.9599609375 898.747253417969 4 15 1.1.1.4780.18 1 75.8225 1231.166 75.8564 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.388213992118835 3591.34814453125 719.2769 3590.9599609375 719.199279785156 5 15 1.1.1.4785.13 1 75.9492 1221.328 75.8564 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK reduced acrolein addition +58(K)@2 missed R-Q@9; missed K-V@20 0.304735988378525 3649.306640625 913.3339 3649.001953125 913.257751464844 4 18 1.1.1.4793.18 1 76.1647 297.0762 76.146 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.386078000068665 3591.34594726563 719.2765 3590.9599609375 719.199279785156 5 14 1.1.1.4795.14 1 76.2145 546.7281 76.1723 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 0.330487996339798 3591.29052734375 898.8299 3590.9599609375 898.747253417969 4 13 1.1.1.4592.14 1 71.0124 1457.079 71.1544 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK HPNE addition +172(K)@2; hexanoyl addition +98(K)@20 missed R-Q@9; missed K-V@20 0.293862998485565 3861.43701171875 966.3665 3861.14306640625 966.293029785156 4 13 1.1.1.4700.16 1 73.8514 5614.928 73.985 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Carbamidomethyl(K)@20 missed R-Q@9; missed K-V@20 0.393117010593414 3648.37451171875 730.6822 3647.9814453125 730.603576660156 5 24 1.1.1.4696.2 1 73.7352 6530.415 73.808 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Dehydrated(S)@18; reduced acrolein addition +58(K)@20; Dehydrated(S)@22 missed R-Q@9; missed K-V@20 0.354478001594543 3613.33520507813 723.6743 3612.98071289063 723.603393554688 5 25 1.1.1.4709.3 1 74.0652 2758.787 74.1788 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Cation:Na(E)@17 missed R-Q@9; missed K-V@20 0.328278988599777 3613.27026367188 904.3248 3612.94189453125 904.242736816406 4 23 1.1.1.4711.3 1 74.1252 2524.85 74.1064 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +56(K)@20; Ser->LacticAcid(S)@22 missed R-Q@9; missed K-V@20 0.403171986341476 3632.37841796875 727.483 3631.97534179688 727.40234375 5 23 1.1.1.4768.5 1 75.5015 7896.625 75.5199 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Ser->LacticAcid(S)@18; acrolein addition +56(K)@20 missed R-Q@9; missed K-V@20 0.339585989713669 3632.31494140625 909.086 3631.97534179688 909.001098632813 4 28 1.1.1.4768.17 1 75.5115 5748.674 75.5199 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 -0.66780298948288 3590.29223632813 898.5803 3590.9599609375 898.747253417969 4 20 1.1.1.4757.5 1 75.238 1796.178 75.2256 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Formyl@N-term; reduced acrolein addition +58(K)@2 missed R-Q@9; missed K-V@20 0.330574005842209 3677.32739257813 920.3391 3676.99682617188 920.256469726563 4 21 1.1.1.4805.8 1 76.4803 388.825 76.4602 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Dehydrated(S)@18; reduced acrolein addition +58(K)@20 missed R-Q@9; missed K-V@20 -0.694112002849579 3630.29711914063 727.0667 3630.9912109375 727.205505371094 5 21 1.1.1.4701.8 1 73.8712 1164.701 73.9116 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Cation:Na(E)@17 missed R-Q@9; missed K-V@20 0.393269002437592 3613.33520507813 723.6743 3612.94189453125 723.595642089844 5 21 1.1.1.4716.4 1 74.2326 2758.787 74.1788 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +56(K)@20; Ser->LacticAcid(S)@22 missed R-Q@9; missed K-V@20 0.403171986341476 3632.37841796875 727.483 3631.97534179688 727.40234375 5 21 1.1.1.4761.4 1 75.3278 7900.312 75.5199 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +56(K)@20; Ser->LacticAcid(S)@22 missed R-Q@9; missed K-V@20 0.403171986341476 3632.37841796875 727.483 3631.97534179688 727.40234375 5 21 1.1.1.4775.4 1 75.6804 7896.625 75.5199 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2299983501434 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Lys->Allysine(K)@2 missed R-Q@9; missed K-V@20 0.336488008499146 3590.26489257813 898.5735 3589.92846679688 898.489379882813 4 19 1.1.1.4789.18 1 76.0591 1231.7 76.1723 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.0599999427795 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Delta:H(2)C(2)(K)@2 missed R-Q@9; missed K-V@20 0.387883991003037 3617.36352539063 724.48 3616.9755859375 724.402404785156 5 18 1.1.1.4774.4 1 75.6545 2461.454 75.7254 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.5499987602234 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Glucuronyl(S)@18; acrolein addition +94(K)@20 missed R-Q@9; missed K-V@20 0.470205992460251 3861.50415039063 773.3081 3861.03393554688 773.214050292969 5 19 1.1.1.4712.5 1 74.1364 2003.275 74.2031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1800029277802 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 -1.47396004199982 3589.48608398438 898.3788 3590.9599609375 898.747253417969 4 19 1.1.1.4771.13 1 75.5849 1287.516 75.5711 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.0399975776672 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Carbamidomethyl(K)@20 missed R-Q@9; missed K-V@20 0.327823013067245 3648.30932617188 913.0846 3647.9814453125 913.002624511719 4 17 1.1.1.4697.16 1 73.7731 4490.148 73.808 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.0399975776672 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK HexNAc(S)@18; reduced acrolein addition +96(K)@20 missed R-Q@9; missed K-V@20 -0.557144999504089 3889.53979492188 778.9152 3890.09692382813 779.026672363281 5 19 1.1.1.4716.10 1 74.2376 834.9814 74.2273 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8999981880188 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Deamidated(R)@9; reduced acrolein addition +96(K)@20 missed R-Q@9; missed K-V@20 0.28302401304245 3688.28442382813 738.6642 3688.00146484375 738.607604980469 5 17 1.1.1.4698.6 1 73.7904 1254.513 73.808 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8999981880188 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Glycerophospho(S)@18; acrolein addition +94(K)@20 missed R-Q@9; missed K-V@20 -0.476280003786087 3838.52856445313 768.713 3839.0048828125 768.808288574219 5 18 1.1.1.4714.3 1 74.1847 1250.924 74.2031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2700009346008 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Decanoyl(S)@18; MDA adduct +62(K)@20 missed R-Q@9; missed K-V@20 0.411725014448166 3807.52319335938 762.5119 3807.111328125 762.429565429688 5 19 1.1.1.4714.2 1 74.183 981.0685 74.1788 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.0900008678436 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Cation:Na(E)@17 missed R-Q@9; missed K-V@20 0.392048001289368 3613.333984375 723.6741 3612.94189453125 723.595642089844 5 17 1.1.1.4702.5 1 73.8932 3394.231 73.9362 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.6099996566772 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK MDA adduct +54(K)@20 missed R-Q@9; missed K-V@20 -0.705785989761353 3644.2646484375 729.8602 3644.97045898438 730.001403808594 5 16 1.1.1.4703.7 1 73.9195 1538.571 73.9362 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.6099996566772 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Phospho(S)@18; ONE addition +154(K)@20 missed R-Q@9; missed K-V@20 0.486321985721588 3825.51196289063 766.1097 3825.02563476563 766.012390136719 5 17 1.1.1.4716.8 1 74.2359 577.8002 74.2273 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.8199996948242 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Deamidated(Q)@10 missed R-Q@9; missed K-V@20 -0.593971014022827 3591.35009765625 719.2773 3591.94409179688 719.396057128906 5 16 1.1.1.4712.2 1 74.1339 168644 74.2031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.9099986553192 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Decanoyl(S)@18; acrolein addition +94(K)@20 missed R-Q@9; missed K-V@20 0.340846002101898 3839.478515625 960.8769 3839.1376953125 960.791687011719 4 17 1.1.1.4713.5 1 74.1705 960.0439 74.2273 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.5499985218048 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Deamidated(Q)@10 missed R-Q@9; missed K-V@20 0.40761598944664 3592.3515625 719.4776 3591.94409179688 719.396057128906 5 15 1.1.1.4703.5 1 73.9178 75848.88 73.9362 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.5499985218048 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Hex(S)@18; acrolein addition +56(K)@20 missed R-Q@9; missed K-V@20 0.502534985542297 3809.54150390625 762.9156 3809.0390625 762.815063476563 5 17 1.1.1.4706.3 1 73.9908 1865.813 74.0092 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.4800007343292 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 -0.677812993526459 3590.2822265625 898.5778 3590.9599609375 898.747253417969 4 15 1.1.1.4750.15 1 75.0686 1687.242 75.0787 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.0299985408783 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Carbamyl@N-term; acrolein addition +38(K)@2 missed R-Q@9; missed K-V@20 0.225528001785278 3672.20703125 919.059 3671.9814453125 919.002624511719 4 15 1.1.1.4712.15 1 74.1447 615.1614 74.1303 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.6099972724915 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +56(K)@2; HPNE addition +172(K)@20 missed R-Q@9; missed K-V@20 -0.558919012546539 3818.537109375 764.7147 3819.09619140625 764.826477050781 5 14 1.1.1.4716.7 1 74.2351 1715.477 74.2031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.3000004291534 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Palmitoyl(S)@18; MDA adduct +54(K)@20 missed R-Q@9; missed K-V@20 0.275559991598129 3883.47583007813 971.8762 3883.2001953125 971.807312011719 4 16 1.1.1.4701.21 1 73.882 624.4421 74.0092 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.6099991798401 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Carbamidomethyl(E)@17; HPNE addition +172(K)@20 missed R-Q@9; missed K-V@20 -0.539763987064362 3819.55151367188 764.9176 3820.09130859375 765.025573730469 5 15 1.1.1.4700.7 1 73.8439 535.3467 73.9116 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.6099991798401 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK HPNE addition +172(K)@2; Carbamyl(R)@9; reduced acrolein addition +96(K)@20 missed R-Q@9; missed K-V@20 0.410008996725082 3902.54321289063 781.5159 3902.13330078125 781.433898925781 5 15 1.1.1.4712.6 1 74.1372 664.1946 74.1788 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.9000005722046 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Cation:K(E)@17; HexNAc(S)@18; ONE addition +154(K)@20 missed R-Q@9; missed K-V@20 0.291115999221802 3986.3857421875 798.2844 3986.0947265625 798.226196289063 5 16 1.1.1.4765.5 1 75.43 1243.972 75.5199 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.1699986457825 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Hex(S)@18 missed R-Q@9; missed K-V@20 0.391665011644363 3753.40454101563 751.6882 3753.0126953125 751.60986328125 5 15 1.1.1.4693.9 1 73.6646 837.8215 73.6536 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.4599997997284 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Methyl(E)@17 missed R-Q@9; missed K-V@20 0.370061010122299 3605.345703125 722.0764 3604.9755859375 722.002380371094 5 14 1.1.1.4703.6 1 73.9187 769.3868 73.8871 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.4599997997284 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK HPNE addition +172(K)@2; MDA adduct +54(K)@20 missed R-Q@9; missed K-V@20 -0.552241981029511 3816.5283203125 764.3129 3817.08056640625 764.423400878906 5 13 1.1.1.4716.6 1 74.2342 1278.291 74.2273 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.5599999427795 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed R-Q@9; missed K-V@20 -0.695146977901459 3590.26489257813 898.5735 3590.9599609375 898.747253417969 4 13 1.1.1.4796.19 1 76.2449 1231.7 76.1723 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 51.9599974155426 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Formyl@N-term; reduced acrolein addition +58(K)@2 missed R-Q@9; missed K-V@20 0.330574005842209 3677.32739257813 920.3391 3676.99682617188 920.256469726563 4 13 1.1.1.4804.8 1 76.4526 388.825 76.4602 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 50.6900012493134 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK Cation:Na(E)@17 missed R-Q@9; missed K-V@20 0.392657995223999 3613.33447265625 723.6742 3612.94189453125 723.595642089844 5 13 1.1.1.4712.3 1 74.1347 2678.561 74.1064 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 45.6299990415573 AKPALEDLRQGLLPVLESFKVSFLSALEEYTK MDA adduct +54(K)@20 missed R-Q@9; missed K-V@20 -0.703954994678497 3644.2666015625 729.8606 3644.97045898438 730.001403808594 5 12 1.1.1.4710.6 1 74.0888 1334.641 74.1064 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed R-Q@9; missed K-V@20; missed K-K@32 0.451319009065628 3719.50634765625 620.925 3719.05493164063 620.849792480469 6 18 1.1.1.4663.6 1 72.8826 17847.37 73.0591 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed R-Q@9; missed K-V@20; missed K-K@32 0.3907850086689 3719.44580078125 744.8964 3719.05493164063 744.818237304688 5 23 1.1.1.4664.7 1 72.9102 31636.29 73.0591 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK HPNE addition +172(K)@2; hexanoyl addition +98(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32 0.420552998781204 3989.65869140625 665.9504 3989.23803710938 665.880310058594 6 14 1.1.1.4667.6 1 72.9897 957.4576 73.1363 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed R-Q@9; missed K-V@20; missed K-K@32 0.451319009065628 3719.50634765625 620.925 3719.05493164063 620.849792480469 6 21 1.1.1.4670.6 1 73.0671 17847.37 73.0591 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed R-Q@9; missed K-V@20; missed K-K@32 0.3907850086689 3719.44580078125 744.8964 3719.05493164063 744.818237304688 5 25 1.1.1.4671.6 1 73.0927 31636.29 73.0591 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed R-Q@9; missed K-V@20; missed K-K@32 0.334645986557007 3719.3896484375 930.8547 3719.05493164063 930.77099609375 4 29 1.1.1.4671.15 1 73.1002 10729.95 73.1363 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed R-Q@9; missed K-V@20; missed K-K@32 0.452416986227036 3719.50732421875 620.9252 3719.05493164063 620.849792480469 6 21 1.1.1.4677.4 1 73.2455 14892.11 73.2648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK HPNE addition +172(K)@2; hexanoyl addition +98(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32 0.420552998781204 3989.65869140625 665.9504 3989.23803710938 665.880310058594 6 14 1.1.1.4678.10 1 73.277 711.9448 73.2648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed R-Q@9; missed K-V@20; missed K-K@32 0.3907850086689 3719.44580078125 744.8964 3719.05493164063 744.818237304688 5 26 1.1.1.4678.12 1 73.2787 27170.74 73.2913 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK HPNE addition +172(K)@2; hexanoyl addition +98(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32 0.352023988962173 3989.59008789063 798.9253 3989.23803710938 798.854858398438 5 14 1.1.1.4678.14 1 73.2804 9767.553 73.3433 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed R-Q@9; missed K-V@20; missed K-K@32 0.334645986557007 3719.3896484375 930.8547 3719.05493164063 930.77099609375 4 25 1.1.1.4678.18 1 73.2837 12039.68 73.3689 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed R-Q@9; missed K-V@20; missed K-K@32 0.451319009065628 3719.50634765625 620.925 3719.05493164063 620.849792480469 6 18 1.1.1.4684.3 1 73.427 22781.08 73.4215 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed R-Q@9; missed K-V@20; missed K-K@32 0.391090005636215 3719.44604492188 744.8965 3719.05493164063 744.818237304688 5 16 1.1.1.4685.9 1 73.4576 40031.21 73.4215 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed R-Q@9; missed K-V@20; missed K-K@32 0.391090005636215 3719.44604492188 744.8965 3719.05493164063 744.818237304688 5 25 1.1.1.4685.10 1 73.4585 40031.21 73.4215 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed R-Q@9; missed K-V@20; missed K-K@32 0.334645986557007 3719.3896484375 930.8547 3719.05493164063 930.77099609375 4 27 1.1.1.4685.19 1 73.466 12039.68 73.3689 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed R-Q@9; missed K-V@20; missed K-K@32 0.451319009065628 3719.50634765625 620.925 3719.05493164063 620.849792480469 6 24 1.1.1.4691.3 1 73.6073 22781.08 73.4215 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed R-Q@9; missed K-V@20; missed K-K@32 0.391090005636215 3719.44604492188 744.8965 3719.05493164063 744.818237304688 5 25 1.1.1.4692.5 1 73.6352 40031.21 73.4215 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed R-Q@9; missed K-V@20; missed K-K@32 0.333180993795395 3719.38818359375 930.8543 3719.05493164063 930.77099609375 4 16 1.1.1.4694.16 1 73.6965 10141.46 73.4215 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK HPNE addition +172(K)@2; hexanoyl addition +98(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32 0.352634012699127 3989.59057617188 798.9254 3989.23803710938 798.854858398438 5 13 1.1.1.4664.10 1 72.9127 9269.278 73.1626 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK HPNE addition +172(K)@2; hexanoyl addition +98(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32 0.352023988962173 3989.59008789063 798.9253 3989.23803710938 798.854858398438 5 13 1.1.1.4666.8 1 72.964 9199.094 73.1363 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK Arg-add@N-term; hexanoyl addition +98(K)@2; Oxidation(P)@3 missed R-Q@9; missed K-V@20; missed K-K@32 0.365943014621735 3989.59008789063 798.9253 3989.22412109375 798.852111816406 5 24 1.1.1.4685.16 1 73.4635 9767.553 73.3433 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK Carbamidomethyl(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32 0.398129999637604 3776.474609375 756.3022 3776.07641601563 756.222534179688 5 21 1.1.1.4662.5 1 72.8583 1298.599 72.794 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.869998216629 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK Arg-add@N-term; hexanoyl addition +98(K)@2; Oxidation(P)@3 missed R-Q@9; missed K-V@20; missed K-K@32 0.365943014621735 3989.59008789063 798.9253 3989.22412109375 798.852111816406 5 19 1.1.1.4671.11 1 73.0969 9199.094 73.1363 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.5499987602234 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK Arg-add@N-term; GlyGly(K)@2 missed R-Q@9; missed K-V@20; missed K-K@32 0.329522997140884 3989.52856445313 998.3894 3989.19897460938 998.307006835938 4 19 1.1.1.4678.21 1 73.2862 3954.974 73.3433 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.7499971389771 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK reduced acrolein addition +58(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32 -0.567840993404388 3776.52905273438 630.4288 3777.09692382813 630.5234375 6 16 1.1.1.4659.5 1 72.7756 645.4616 72.794 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.1700010299683 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK Deamidated(Q)@10 missed R-Q@9; missed K-V@20; missed K-K@32 0.406219989061356 3720.44506835938 745.0963 3720.0390625 745.015075683594 5 15 1.1.1.4683.9 1 73.4065 20898 73.3956 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 65.1899993419647 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK Carbamidomethyl@N-term; HPNE addition +172(K)@2; hexanoyl addition +98(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32 0.185112997889519 4046.44458007813 810.2962 4046.25952148438 810.259155273438 5 13 1.1.1.4679.11 1 73.3035 409.4447 73.3433 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.92999958992 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK Carbamidomethyl@N-term; reduced acrolein addition +96(K)@2; reduced acrolein addition +96(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32 0.459309011697769 3968.65063476563 794.7374 3968.19140625 794.645568847656 5 13 1.1.1.4682.11 1 73.3822 175.854 73.3433 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 49.4300007820129 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK reduced acrolein addition +58(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32 -0.622271001338959 3776.474609375 756.3022 3777.09692382813 756.426635742188 5 12 1.1.1.4663.7 1 72.8834 1298.599 72.794 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 45.6299990415573 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK Formyl@N-term; HPNE addition +172(K)@2; reduced acrolein addition +96(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32 0.37526199221611 4015.59252929688 804.1258 4015.21728515625 804.050720214844 5 13 1.1.1.4672.15 1 73.1262 120.9569 73.0591 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 44.3599998950958 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKK acrolein addition +56(K)@20; Ser->LacticAcid(S)@22 missed R-Q@9; missed K-V@20; missed K-K@32 0.470670998096466 3760.541015625 627.7641 3760.0703125 627.685668945313 6 16 1.1.1.4700.2 1 73.8397 2930.119 73.8606 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8999981880188 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKL ONE addition +154(K)@32; MDA adduct +62(K)@33 cleaved L-N@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.413601994514465 4048.66772460938 675.7852 4048.25415039063 675.71630859375 6 20 1.1.1.4719.5 1 74.3061 4382.422 74.3003 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.5400009155273 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKL reduced acrolein addition +96(K)@33 cleaved L-N@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.434495985507965 3928.63110351563 655.7791 3928.19653320313 655.706726074219 6 21 1.1.1.4778.5 1 75.7592 1940.203 75.7776 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.2299988269806 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKL reduced acrolein addition +96(K)@33 cleaved L-N@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.373656988143921 3928.57006835938 786.7213 3928.19653320313 786.646606445313 5 22 1.1.1.4778.12 1 75.765 4150.479 75.7776 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 59.35999751091 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKL reduced acrolein addition +58(K)@20; Delta:H(2)C(2)(K)@32; HPNE addition +172(K)@33 cleaved L-N@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.405239999294281 4088.71166992188 682.4592 4088.30639648438 682.391662597656 6 14 1.1.1.4777.11 1 75.7381 1996.245 75.6738 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLN HPNE addition +172(K)@32; reduced acrolein addition +58(K)@33 cleaved N-T@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.341904014348984 4176.67578125 836.3424 4176.333984375 836.274047851563 5 20 1.1.1.4707.2 1 74.0126 82332.73 73.9116 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLN HPNE addition +172(K)@32; hexanoyl addition +98(K)@33 cleaved N-T@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.349665999412537 4216.71484375 844.3502 4216.365234375 844.2802734375 5 21 1.1.1.4762.4 1 75.3597 47079.64 75.5457 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLN HPNE addition +172(K)@32; hexanoyl addition +98(K)@33 cleaved N-T@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.349665999412537 4216.71484375 844.3502 4216.365234375 844.2802734375 5 24 1.1.1.4769.14 1 75.5348 47274.82 75.5457 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLN HPNE addition +172(K)@32; hexanoyl addition +98(K)@33 cleaved N-T@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.41355699300766 4216.77880859375 703.8037 4216.365234375 703.734802246094 6 25 1.1.1.4770.6 1 75.5535 28081.26 75.5457 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLN HPNE addition +172(K)@32; hexanoyl addition +98(K)@33 cleaved N-T@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.41355699300766 4216.77880859375 703.8037 4216.365234375 703.734802246094 6 20 1.1.1.4771.3 1 75.5765 28081.26 75.5457 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLN HPNE addition +172(K)@32; acrolein addition +56(K)@33; Deamidated(N)@35 cleaved N-T@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.447315990924835 4175.74951171875 696.9655 4175.30224609375 696.890991210938 6 21 1.1.1.4782.8 1 75.8666 3686.337 75.9088 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLN HPNE addition +172(K)@32; reduced acrolein addition +58(K)@33; Amidated@C-term cleaved N-T@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.335319012403488 4175.68505859375 836.1443 4175.349609375 836.077209472656 5 23 1.1.1.4721.2 1 74.3597 198518.4 74.4468 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLN Carbamidomethyl(K)@20; HPNE addition +172(K)@32; acrolein addition +56(K)@33; Deamidated(N)@35 cleaved N-T@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.437204986810684 4232.7607421875 706.4674 4232.32373046875 706.39453125 6 20 1.1.1.4716.2 1 74.2309 17880.28 74.3245 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLN HPNE addition +172(K)@32; reduced acrolein addition +58(K)@33; Amidated@C-term cleaved N-T@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.400063991546631 4175.75 696.9656 4175.349609375 696.89892578125 6 20 1.1.1.4798.12 1 76.2915 1263.331 76.2516 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.1500029563904 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLN Delta:H(2)C(2)(K)@2; HPNE addition +172(K)@32; reduced acrolein addition +58(K)@33; Amidated@C-term cleaved N-T@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.395278006792068 4201.7607421875 701.3007 4201.365234375 701.23486328125 6 20 1.1.1.4784.7 1 75.9181 7294.404 75.8301 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.5499987602234 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLN HPNE addition +172(K)@32; reduced acrolein addition +58(K)@33; Amidated@C-term cleaved N-T@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.381752997636795 4175.7314453125 696.9625 4175.349609375 696.89892578125 6 18 1.1.1.4697.6 1 73.7647 2702.058 73.8606 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.0800001621246 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLN ONE addition +154(K)@32; reduced acrolein addition +96(K)@33; Deamidated(N)@35 cleaved N-T@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.345234006643295 4197.66796875 840.5409 4197.32275390625 840.471862792969 5 16 1.1.1.4735.7 1 74.7018 1948.211 74.6892 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.0299985408783 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLN Dehydrated(T)@31; MDA adduct +62(K)@32; hexanoyl addition +98(K)@33 cleaved N-T@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.451521009206772 4088.71166992188 682.4592 4088.26025390625 682.383972167969 6 16 1.1.1.4770.5 1 75.5527 1996.245 75.6738 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.6099991798401 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLN ONE addition +154(K)@32; reduced acrolein addition +58(K)@33 cleaved N-T@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -0.656625986099243 4157.66650390625 832.5406 4158.3232421875 832.671936035156 5 14 1.1.1.4770.15 1 75.561 696.1954 75.5966 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 62.9100024700165 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLN Arg-add@N-term; HPNE addition +172(K)@2; HPNE addition +172(K)@32; reduced acrolein addition +58(K)@33 cleaved N-T@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.288197010755539 4504.8330078125 901.9739 4504.544921875 901.916259765625 5 15 1.1.1.4703.13 1 73.9245 1088.432 73.9362 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 45.6299990415573 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLN acrolein addition +56(K)@32; HPNE addition +172(K)@33; Deamidated(N)@35 cleaved N-T@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.44768300652504 4175.75 696.9656 4175.30224609375 696.890991210938 6 12 1.1.1.4791.12 1 76.1071 1618.643 76.0932 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.399403989315033 4047.62890625 810.5331 4047.22973632813 810.453186035156 5 15 1.1.1.4659.10 1 72.7798 930.2183 72.7674 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.390554010868073 4047.6201171875 810.5313 4047.22973632813 810.453186035156 5 20 1.1.1.4726.8 1 74.4796 18306.35 74.6892 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT acrolein addition +56(K)@32; acrolein addition +94(K)@33 cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.37099701166153 4197.66845703125 840.541 4197.2978515625 840.466796875 5 21 1.1.1.4728.4 1 74.5321 2128.723 74.471 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.46060898900032 4047.69018554688 675.6223 4047.22973632813 675.545532226563 6 21 1.1.1.4730.2 1 74.5714 14363.26 74.8107 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.38994300365448 4047.61962890625 810.5312 4047.22973632813 810.453186035156 5 23 1.1.1.4733.4 1 74.6456 18613.65 74.6892 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.460974991321564 4047.69067382813 675.6224 4047.22973632813 675.545532226563 6 17 1.1.1.4737.2 1 74.7426 15931.91 74.8833 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.389638006687164 4047.619140625 810.5311 4047.22973632813 810.453186035156 5 23 1.1.1.4740.4 1 74.8156 22503.71 74.8833 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.328188985586166 4047.55883789063 1012.897 4047.22973632813 1012.81469726563 4 26 1.1.1.4740.10 1 74.8248 4843.333 74.8833 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.460974991321564 4047.69067382813 675.6224 4047.22973632813 675.545532226563 6 16 1.1.1.4744.2 1 74.9112 15931.91 74.8833 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.389638006687164 4047.619140625 810.5311 4047.22973632813 810.453186035156 5 20 1.1.1.4747.3 1 74.9868 22503.71 74.8833 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.328188985586166 4047.55883789063 1012.897 4047.22973632813 1012.81469726563 4 29 1.1.1.4747.9 1 75.0002 4843.333 74.8833 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.454017013311386 4047.68359375 675.6212 4047.22973632813 675.545532226563 6 20 1.1.1.4751.3 1 75.0833 21760.77 75.2012 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.38994300365448 4047.61962890625 810.5312 4047.22973632813 810.453186035156 5 21 1.1.1.4754.6 1 75.16 35645.06 75.2012 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.328188985586166 4047.55883789063 1012.897 4047.22973632813 1012.81469726563 4 32 1.1.1.4754.12 1 75.17 6950.138 75.1768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.454017013311386 4047.68359375 675.6212 4047.22973632813 675.545532226563 6 20 1.1.1.4758.2 1 75.2539 21760.77 75.2012 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.38841700553894 4047.61791992188 810.5309 4047.22973632813 810.453186035156 5 23 1.1.1.4761.6 1 75.3295 31428.16 75.2983 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.32770100235939 4047.55883789063 1012.897 4047.22973632813 1012.81469726563 4 25 1.1.1.4761.19 1 75.3404 6196.875 75.3226 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.454017013311386 4047.68359375 675.6212 4047.22973632813 675.545532226563 6 18 1.1.1.4765.2 1 75.425 22444.12 75.1768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.38841700553894 4047.61791992188 810.5309 4047.22973632813 810.453186035156 5 21 1.1.1.4768.10 1 75.5057 31428.16 75.2983 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.447791010141373 4047.67749023438 675.6202 4047.22973632813 675.545532226563 6 14 1.1.1.4772.8 1 75.6065 15373.46 75.3471 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT Carbamidomethyl(K)@20; acrolein addition +56(K)@32; reduced acrolein addition +58(K)@33; Methyl(N)@35 cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.440254002809525 4232.77490234375 706.4698 4232.3349609375 706.396423339844 6 27 1.1.1.4709.2 1 74.0627 8605.396 73.9606 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT acrolein addition +56(K)@32; reduced acrolein addition +58(K)@33; Methyl(N)@35 cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.437182009220123 4175.75048828125 696.9657 4175.3134765625 696.892822265625 6 24 1.1.1.4718.2 1 74.2825 129434.7 74.471 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT acrolein addition +56(K)@32; reduced acrolein addition +58(K)@33; Methyl(N)@35 cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.436448991298676 4175.75 696.9656 4175.3134765625 696.892822265625 6 26 1.1.1.4725.2 1 74.4575 140894.2 74.5438 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT acrolein addition +56(K)@32; reduced acrolein addition +58(K)@33; Methyl(N)@35 cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.436448991298676 4175.75 696.9656 4175.3134765625 696.892822265625 6 28 1.1.1.4732.3 1 74.6256 140894.2 74.5438 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT acrolein addition +56(K)@32; reduced acrolein addition +58(K)@33; Methyl(N)@35 cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.43791401386261 4175.75146484375 696.9658 4175.3134765625 696.892822265625 6 26 1.1.1.4739.3 1 74.7931 149418.2 74.6648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT acrolein addition +56(K)@32; reduced acrolein addition +58(K)@33; Methyl(N)@35 cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.436448991298676 4175.75 696.9656 4175.3134765625 696.892822265625 6 25 1.1.1.4746.3 1 74.9643 96168.52 74.8833 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT acrolein addition +56(K)@32; reduced acrolein addition +58(K)@33; Methyl(N)@35 cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.436082988977432 4175.74951171875 696.9655 4175.3134765625 696.892822265625 6 26 1.1.1.4753.3 1 75.1339 121874.5 75.1768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT acrolein addition +56(K)@32; reduced acrolein addition +58(K)@33; Methyl(N)@35 cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.436082988977432 4175.74951171875 696.9655 4175.3134765625 696.892822265625 6 26 1.1.1.4760.2 1 75.3025 121874.5 75.1768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT reduced acrolein addition +58(K)@33; Ammonia-loss(N)@35 cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.402153998613358 4088.64697265625 818.7367 4088.24487304688 818.65625 5 23 1.1.1.4771.9 1 75.5815 4056.231 75.6738 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT acrolein addition +56(K)@32; reduced acrolein addition +58(K)@33; Methyl(N)@35 cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.436082988977432 4175.74951171875 696.9655 4175.3134765625 696.892822265625 6 21 1.1.1.4767.3 1 75.4744 100774.4 75.2256 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.470002412796 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT acrolein addition +56(K)@32; acrolein addition +94(K)@33 cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -0.549732029438019 4196.748046875 700.4653 4197.2978515625 700.556884765625 6 18 1.1.1.4728.2 1 74.5254 936.6702 74.471 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.470002412796 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT Delta:H(2)C(2)(K)@2 cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.392360001802444 4073.6376953125 815.7348 4073.24536132813 815.656311035156 5 19 1.1.1.4782.13 1 75.8708 1865.137 75.8826 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2299983501434 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT Deamidated(N)@35 cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.398970007896423 4048.61254882813 810.7298 4048.21362304688 810.650024414063 5 21 1.1.1.4719.7 1 74.3077 8100.39 74.3003 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.1500029563904 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT acrolein addition +56(K)@32; reduced acrolein addition +58(K)@33; Methyl(N)@35 cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.437182009220123 4175.75048828125 696.9657 4175.3134765625 696.892822265625 6 19 1.1.1.4658.7 1 72.7507 4544.571 72.6356 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.5299980640411 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT Arg-add@N-term; hexanoyl addition +98(K)@2; Oxidation(P)@3 cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.367237001657486 4317.76611328125 864.5605 4317.39892578125 864.487060546875 5 17 1.1.1.4740.6 1 74.8181 3787.427 74.8591 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.9700014591217 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT Deamidated(N)@35 cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.398970007896423 4048.61254882813 810.7298 4048.21362304688 810.650024414063 5 14 1.1.1.4712.8 1 74.1389 8100.39 74.3003 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.9700014591217 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT Deamidated(N)@35 cleaved T-Q@C-term; missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.334407985210419 4048.546875 1013.144 4048.21362304688 1013.06066894531 4 14 1.1.1.4716.20 1 74.2459 1721.994 74.3003 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.403569996356964 4175.69189453125 836.1456 4175.2880859375 836.06494140625 5 17 1.1.1.4649.12 1 72.5176 7636.096 72.6356 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.462334007024765 4175.75048828125 696.9657 4175.2880859375 696.888671875 6 20 1.1.1.4651.4 1 72.5637 4544.571 72.6356 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.334553003311157 4175.62255859375 1044.913 4175.2880859375 1044.82934570313 4 26 1.1.1.4652.18 1 72.6016 1386.516 72.6356 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.403569996356964 4175.69189453125 836.1456 4175.2880859375 836.06494140625 5 19 1.1.1.4656.6 1 72.7017 7636.096 72.6356 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.396856009960175 4175.68505859375 836.1443 4175.2880859375 836.06494140625 5 20 1.1.1.4714.4 1 74.1863 176606.4 74.4226 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.325275003910065 4175.61474609375 1044.911 4175.2880859375 1044.82934570313 4 19 1.1.1.4714.11 1 74.198 42391.63 74.374 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.325275003910065 4175.61474609375 1044.911 4175.2880859375 1044.82934570313 4 36 1.1.1.4721.3 1 74.3681 58073.39 74.4955 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.396856009960175 4175.68505859375 836.1443 4175.2880859375 836.06494140625 5 16 1.1.1.4722.15 1 74.3885 198518.4 74.4468 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.396856009960175 4175.68505859375 836.1443 4175.2880859375 836.06494140625 5 20 1.1.1.4728.3 1 74.5287 221061.3 74.568 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.325275003910065 4175.61474609375 1044.911 4175.2880859375 1044.82934570313 4 35 1.1.1.4728.5 1 74.5354 58073.39 74.4955 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.461600989103317 4175.75 696.9656 4175.2880859375 696.888671875 6 22 1.1.1.4730.4 1 74.5731 140894.2 74.5438 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.396856009960175 4175.68505859375 836.1443 4175.2880859375 836.06494140625 5 21 1.1.1.4735.6 1 74.7001 250264.8 74.6648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.325275003910065 4175.61474609375 1044.911 4175.2880859375 1044.82934570313 4 36 1.1.1.4735.9 1 74.7051 54141.83 74.6648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.463066011667252 4175.75146484375 696.9658 4175.2880859375 696.888671875 6 18 1.1.1.4738.2 1 74.7693 149418.2 74.6648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.325275003910065 4175.61474609375 1044.911 4175.2880859375 1044.82934570313 4 34 1.1.1.4742.6 1 74.8748 54141.83 74.6648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.395330011844635 4175.68359375 836.144 4175.2880859375 836.06494140625 5 17 1.1.1.4747.4 1 74.9885 177252.4 74.7376 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.395940989255905 4175.68408203125 836.1441 4175.2880859375 836.06494140625 5 18 1.1.1.4749.8 1 75.0381 194599.5 75.1768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.324786990880966 4175.61474609375 1044.911 4175.2880859375 1044.82934570313 4 34 1.1.1.4749.16 1 75.0456 41293.68 75.1768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.461234986782074 4175.74951171875 696.9655 4175.2880859375 696.888671875 6 20 1.1.1.4750.5 1 75.0603 121874.5 75.1768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.395940989255905 4175.68408203125 836.1441 4175.2880859375 836.06494140625 5 14 1.1.1.4755.3 1 75.1836 194599.5 75.1768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.395940989255905 4175.68408203125 836.1441 4175.2880859375 836.06494140625 5 21 1.1.1.4756.7 1 75.2138 194599.5 75.1768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.324786990880966 4175.61474609375 1044.911 4175.2880859375 1044.82934570313 4 34 1.1.1.4756.8 1 75.2155 41293.68 75.1768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.395940989255905 4175.68408203125 836.1441 4175.2880859375 836.06494140625 5 20 1.1.1.4763.10 1 75.3842 194599.5 75.1768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.324786990880966 4175.61474609375 1044.911 4175.2880859375 1044.82934570313 4 36 1.1.1.4763.12 1 75.3875 41293.68 75.1768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.395330011844635 4175.68359375 836.144 4175.2880859375 836.06494140625 5 24 1.1.1.4770.16 1 75.5619 134418.3 75.2983 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.332111001014709 4175.61865234375 1044.912 4175.2880859375 1044.82934570313 4 29 1.1.1.4770.20 1 75.5652 24706.24 75.2983 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.461234986782074 4175.74951171875 696.9655 4175.2880859375 696.888671875 6 23 1.1.1.4774.3 1 75.6537 40572.22 75.3959 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.395025014877319 4175.68310546875 836.1439 4175.2880859375 836.06494140625 5 20 1.1.1.4777.16 1 75.7422 42092.78 75.4945 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.395330011844635 4175.68359375 836.144 4175.2880859375 836.06494140625 5 22 1.1.1.4784.11 1 75.9215 7481.27 75.9088 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +58(K)@33 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.359447002410889 4233.689453125 847.7452 4233.330078125 847.673278808594 5 14 1.1.1.4784.12 1 75.9223 1941.584 75.8564 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.461234986782074 4175.74951171875 696.9655 4175.2880859375 696.888671875 6 19 1.1.1.4789.9 1 76.0516 3686.337 75.9088 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.393498986959457 4175.681640625 836.1436 4175.2880859375 836.06494140625 5 19 1.1.1.4791.16 1 76.1105 5289.108 76.1723 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +58(K)@33 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.367686986923218 4233.69775390625 847.7468 4233.330078125 847.673278808594 5 18 1.1.1.4794.14 1 76.1879 3398.665 76.1989 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.318928003311157 4175.60693359375 1044.909 4175.2880859375 1044.82934570313 4 20 1.1.1.4797.16 1 76.2711 1419.789 76.1723 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.393498986959457 4175.681640625 836.1436 4175.2880859375 836.06494140625 5 18 1.1.1.4798.17 1 76.2956 5289.108 76.1723 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.396551012992859 4175.6845703125 836.1442 4175.2880859375 836.06494140625 5 20 1.1.1.4805.7 1 76.4778 1660.096 76.4091 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.331622987985611 4175.61865234375 1044.912 4175.2880859375 1044.82934570313 4 13 1.1.1.4774.18 1 75.6662 11093.26 75.3959 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Deamidated(N)@35 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.33686500787735 4176.61083984375 1045.16 4176.27197265625 1045.07531738281 4 32 1.1.1.4700.18 1 73.853 16135.13 73.9116 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.395350992679596 4232.705078125 847.5483 4232.3095703125 847.46923828125 5 21 1.1.1.4705.3 1 73.9682 11670.24 73.9606 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Deamidated(N)@35 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.33686500787735 4176.61083984375 1045.16 4176.27197265625 1045.07531738281 4 32 1.1.1.4707.11 1 74.0268 16135.13 73.9116 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.341408997774124 4232.65087890625 1059.17 4232.3095703125 1059.08471679688 4 31 1.1.1.4709.7 1 74.0769 3136.67 73.985 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.395350992679596 4232.705078125 847.5483 4232.3095703125 847.46923828125 5 23 1.1.1.4712.9 1 74.1397 11670.24 73.9606 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Deamidated(N)@35 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.339307010173798 4176.61083984375 1045.16 4176.27197265625 1045.07531738281 4 27 1.1.1.4715.5 1 74.2223 24877.08 74.374 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Acetyl(S)@18 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -0.534071028232574 4216.7646484375 703.8014 4217.298828125 703.890380859375 6 23 1.1.1.4741.2 1 74.8382 7551.837 74.6648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Glucuronyl(S)@18; acrolein addition +94(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.527540981769562 4445.8896484375 741.9889 4445.3623046875 741.900939941406 6 23 1.1.1.4741.5 1 74.8407 4397.915 74.8833 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Trimethyl(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -0.562766015529633 4216.7724609375 703.8027 4217.3349609375 703.896484375 6 22 1.1.1.4748.3 1 75.0094 6995.402 75.1768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +58(K)@33; Ammonia-loss(N)@35 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.335839003324509 4216.638671875 1055.167 4216.3037109375 1055.08312988281 4 29 1.1.1.4769.19 1 75.539 8010.26 75.5457 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carboxyethyl(K)@32 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.334419995546341 4247.642578125 1062.918 4247.30908203125 1062.83459472656 4 30 1.1.1.4784.20 1 75.929 1003.885 75.9088 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Formyl(K)@33 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.336219996213913 4203.61865234375 1051.912 4203.283203125 1051.82800292969 4 24 1.1.1.4787.20 1 76.008 1833.1 76.0139 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Methyl(K)@32; reduced acrolein addition +58(K)@33 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.297545999288559 4247.642578125 1062.918 4247.345703125 1062.84375 4 27 1.1.1.4799.19 1 76.3255 1894.572 76.3568 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.465406000614166 4232.77490234375 706.4698 4232.3095703125 706.392211914063 6 21 1.1.1.4702.3 1 73.8915 8605.396 73.9606 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +58(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -0.678991973400116 4232.65087890625 1059.17 4233.330078125 1059.33984375 4 21 1.1.1.4702.14 1 73.9066 3136.67 73.985 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Acetyl(S)@18 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -0.534071028232574 4216.7646484375 703.8014 4217.298828125 703.890380859375 6 22 1.1.1.4733.2 1 74.6439 7551.837 74.6648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -5.15367984771729 4170.13427734375 835.0342 4175.2880859375 836.06494140625 5 21 1.1.1.4748.9 1 75.0161 3422.444 75.0295 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +58(K)@33 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -0.716588973999023 4232.61474609375 1059.161 4233.330078125 1059.33984375 4 21 1.1.1.4794.18 1 76.1913 746.3503 76.1989 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Deamidated(N)@35 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.40344101190567 4176.67578125 836.3424 4176.27197265625 836.26171875 5 22 1.1.1.4706.4 1 73.9925 82332.73 73.9116 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Acetyl(S)@18 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -0.526746988296509 4216.77197265625 703.8026 4217.298828125 703.890380859375 6 22 1.1.1.4719.6 1 74.3069 4011.177 74.374 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Acetyl(S)@18 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -0.534071028232574 4216.7646484375 703.8014 4217.298828125 703.890380859375 6 21 1.1.1.4726.4 1 74.4763 7445.042 74.6648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Acetyl(S)@18 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -0.534071028232574 4216.7646484375 703.8014 4217.298828125 703.890380859375 6 21 1.1.1.4730.5 1 74.5739 7551.837 74.6648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Delta:H(2)C(2)(K)@2 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.391642987728119 4201.6953125 841.3464 4201.3037109375 841.26806640625 5 20 1.1.1.4778.13 1 75.7659 20943.32 75.8301 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Arg-add@N-term; hexanoyl addition +98(K)@2; Oxidation(P)@3 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.368351995944977 4445.82568359375 890.1724 4445.45751953125 890.098754882813 5 21 1.1.1.4726.14 1 74.4846 43534.14 74.5197 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +56(K)@33; Deamidated(N)@35 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.341901004314423 4232.638671875 1059.167 4232.29833984375 1059.08190917969 4 19 1.1.1.4717.6 1 74.2675 4152.593 74.3245 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Glucuronyl(S)@18; acrolein addition +94(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.526808977127075 4445.88916015625 741.9888 4445.3623046875 741.900939941406 6 21 1.1.1.4734.6 1 74.6716 7212.453 74.6648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.470002412796 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Deamidated(N)@35 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.40344101190567 4176.67578125 836.3424 4176.27197265625 836.26171875 5 18 1.1.1.4699.11 1 73.8203 82332.73 73.9116 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.470002412796 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Deamidated(N)@35 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.46305900812149 4176.7353515625 697.1298 4176.27197265625 697.052673339844 6 22 1.1.1.4704.2 1 73.9406 53639.04 73.9116 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.470002412796 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl(E)@17 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.451124012470245 4232.7607421875 706.4674 4232.3095703125 706.392211914063 6 19 1.1.1.4723.2 1 74.4058 17880.28 74.3245 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.470002412796 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +56(K)@33; Deamidated(N)@35 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.341901004314423 4232.638671875 1059.167 4232.29833984375 1059.08190917969 4 18 1.1.1.4724.8 1 74.4418 4152.593 74.3245 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.470002412796 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Formyl@N-term; reduced acrolein addition +58(K)@2 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.400115996599197 4261.72509765625 853.3523 4261.3251953125 853.272277832031 5 19 1.1.1.4803.8 1 76.4214 2833.684 76.4853 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2299983501434 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Glucuronyl(S)@18; acrolein addition +94(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.52827399969101 4445.890625 741.989 4445.3623046875 741.900939941406 6 20 1.1.1.4727.4 1 74.5029 5716.423 74.5197 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2299983501434 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Deamidated(Q)@10; Methyl(T)@31; reduced acrolein addition +58(K)@32 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -0.621968984603882 4247.70751953125 850.5488 4248.32958984375 850.673217773438 5 20 1.1.1.4782.16 1 75.8733 3947.36 75.9088 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.1500029563904 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Glucuronyl(S)@18; acrolein addition +94(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.52863997220993 4445.890625 741.9891 4445.3623046875 741.900939941406 6 20 1.1.1.4722.7 1 74.3818 5729.729 74.5438 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.1500029563904 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Deamidated(N)@35 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -0.58807498216629 4175.68408203125 836.1441 4176.27197265625 836.26171875 5 18 1.1.1.4754.7 1 75.1617 194599.5 75.1768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.869998216629 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ PyridoxalPhosphate(K)@33 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.363427996635437 3946.6376953125 658.7802 3946.27416992188 658.719665527344 6 19 1.1.1.4719.4 1 74.3052 6468.541 74.3245 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.6599991321564 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +56(K)@33; Deamidated(N)@35 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.403228014707565 4232.70166015625 847.5476 4232.29833984375 847.466979980469 5 17 1.1.1.4731.3 1 74.6054 14746.69 74.349 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.5499987602234 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Trimethyl(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -0.556540012359619 4216.77880859375 703.8037 4217.3349609375 703.896484375 6 18 1.1.1.4763.4 1 75.3767 28081.26 75.5457 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1800029277802 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +56(K)@33; Deamidated(N)@35 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.404143005609512 4232.70263671875 847.5478 4232.29833984375 847.466979980469 5 22 1.1.1.4719.12 1 74.3127 24681.93 74.3245 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1800029277802 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +56(K)@2; Oxidation(P)@14 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.399652987718582 4247.708984375 850.5491 4247.30908203125 850.469116210938 5 17 1.1.1.4798.18 1 76.2965 6132.286 76.3306 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.0399975776672 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl(E)@17; HexNAc(S)@18; acrolein addition +94(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.324393004179001 4529.75537109375 755.9665 4529.4306640625 755.912414550781 6 19 1.1.1.4774.7 1 75.657 3580.101 75.5199 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8999981880188 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.448193997144699 4232.7578125 706.4669 4232.3095703125 706.392211914063 6 17 1.1.1.4738.3 1 74.7751 2959.02 74.6407 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8999981880188 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Ser->LacticAcid(S)@18; acrolein addition +56(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.475093990564346 4216.77880859375 703.8037 4216.3037109375 703.724548339844 6 18 1.1.1.4778.6 1 75.76 28081.26 75.5457 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.8199996948242 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Trimethyl(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -0.563131988048553 4216.77197265625 703.8026 4217.3349609375 703.896484375 6 17 1.1.1.4720.5 1 74.3306 4011.177 74.374 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.8199996948242 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HexNAc(S)@18; acrolein addition +76(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.518652975559235 4454.91748046875 743.4935 4454.39892578125 743.407104492188 6 17 1.1.1.4727.5 1 74.5046 884.6472 74.471 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.8199996948242 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HexNAc(S)@18; acrolein addition +38(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -0.464598000049591 4415.91845703125 736.9937 4416.38330078125 737.071166992188 6 17 1.1.1.4758.3 1 75.2556 364.2935 75.2256 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.8199996948242 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Glucuronyl(S)@18; acrolein addition +94(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.397318989038467 4445.7587890625 1112.447 4445.3623046875 1112.34777832031 4 18 1.1.1.4760.9 1 75.3175 811.2341 75.2983 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.8199996948242 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Trimethyl(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -0.556540012359619 4216.77880859375 703.8037 4217.3349609375 703.896484375 6 17 1.1.1.4777.13 1 75.7397 28081.26 75.5457 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.5400009155273 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Deamidated(N)@35 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.46305900812149 4176.7353515625 697.1298 4176.27197265625 697.052673339844 6 17 1.1.1.4711.2 1 74.1168 53639.04 73.9116 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.5400009155273 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Formyl@N-term; reduced acrolein addition +58(K)@2; Deamidated(Q)@10 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.362098008394241 4262.6708984375 1066.675 4262.30908203125 1066.58447265625 4 17 1.1.1.4803.13 1 76.4297 448.493 76.4602 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9300010204315 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl(K)@33 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.451124012470245 4232.7607421875 706.4674 4232.3095703125 706.392211914063 6 16 1.1.1.4724.2 1 74.4268 17880.28 74.3245 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9300010204315 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl(E)@17; HexNAc(S)@18; acrolein addition +94(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.332816004753113 4529.763671875 755.9679 4529.4306640625 755.912414550781 6 18 1.1.1.4760.4 1 75.3059 3485.805 75.3226 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9300010204315 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl(E)@17; HexNAc(S)@18; acrolein addition +94(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.324393004179001 4529.75537109375 755.9665 4529.4306640625 755.912414550781 6 18 1.1.1.4767.7 1 75.4777 3580.101 75.5199 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9300010204315 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +56(K)@20; Ser->LacticAcid(S)@22 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.335839003324509 4216.638671875 1055.167 4216.3037109375 1055.08312988281 4 17 1.1.1.4776.19 1 75.7187 8010.26 75.5457 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.5999999046326 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Hex(S)@18 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.464807987213135 4337.8056640625 723.9749 4337.3408203125 723.8974609375 6 17 1.1.1.4700.5 1 73.8422 2827.82 73.8606 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.9099986553192 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Hex(S)@18; acrolein addition +56(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -0.429448992013931 4392.93798828125 733.1636 4393.3671875 733.235168457031 6 17 1.1.1.4730.6 1 74.5748 1277.362 74.4955 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.5499985218048 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +58(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -0.570010006427765 4232.76025390625 706.4673 4233.330078125 706.562316894531 6 15 1.1.1.4731.2 1 74.5996 11176.43 74.349 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.5499985218048 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Hex(S)@18; reduced acrolein addition +58(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -0.473785012960434 4394.9091796875 733.4921 4395.3828125 733.571105957031 6 17 1.1.1.4743.2 1 74.8876 496.1374 74.7864 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.5499985218048 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +56(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -0.583899974822998 4230.73046875 706.129 4231.314453125 706.226318359375 6 15 1.1.1.4761.3 1 75.327 941.8262 75.3471 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.4800007343292 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Glucuronyl(S)@18; acrolein addition +94(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.390971004962921 4445.7548828125 1112.446 4445.3623046875 1112.34777832031 4 19 1.1.1.4740.12 1 74.8281 11791.36 74.6648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.5299980640411 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl@N-term; ONE addition +154(K)@2; Oxidation(P)@3 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.458528012037277 4402.8623046875 881.5798 4402.40380859375 881.488037109375 5 16 1.1.1.4726.13 1 74.4838 1070.509 74.4955 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.5299980640411 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +56(K)@20; Phosphopantetheine(S)@22 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -0.608415007591248 4570.7919921875 762.8059 4571.400390625 762.907287597656 6 18 1.1.1.4773.9 1 75.633 5958.213 75.5711 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.0299985408783 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Arg-add@N-term; MDA adduct +62(K)@2 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -0.530879020690918 4392.8740234375 879.5821 4393.40478515625 879.688293457031 5 16 1.1.1.4722.18 1 74.391 661.1453 74.3985 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.0299985408783 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Formyl(K)@32; acrolein addition +38(K)@33 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.343030989170074 4241.642578125 1061.418 4241.298828125 1061.33190917969 4 14 1.1.1.4794.19 1 76.1921 503.818 76.146 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.5100016593933 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Dehydrated(S)@22 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.39258998632431 4157.67041015625 832.5413 4157.27783203125 832.462829589844 5 15 1.1.1.4702.8 1 73.8965 2096.29 73.8337 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.5100016593933 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamyl@N-term; acrolein addition +56(K)@2; HPNE addition +172(K)@20; Deamidated(N)@35 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -0.596930027008057 4446.8173828125 890.3707 4447.4140625 890.490112304688 5 17 1.1.1.4704.3 1 73.9431 3011.67 73.9116 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.5100016593933 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Hex(S)@18; acrolein addition +56(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -0.430913001298904 4392.9365234375 733.1633 4393.3671875 733.235168457031 6 16 1.1.1.4722.4 1 74.3793 922.1741 74.374 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.5100016593933 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Deamidated(N)@35 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.411985993385315 4176.68408203125 836.3441 4176.27197265625 836.26171875 5 15 1.1.1.4744.5 1 74.9137 146168.8 74.6648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.5100016593933 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl(E)@17; Oxidation(F)@19; HPNE addition +172(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.366968989372253 4420.78125 885.1636 4420.41455078125 885.090209960938 5 17 1.1.1.4750.14 1 75.0678 1194.445 75.1034 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.6099972724915 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +56(K)@33; Deamidated(N)@35 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.404143005609512 4232.70263671875 847.5478 4232.29833984375 847.466979980469 5 14 1.1.1.4723.3 1 74.4116 24681.93 74.3245 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.6099972724915 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl(E)@28 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.45881399512291 4232.7685546875 706.4687 4232.3095703125 706.392211914063 6 15 1.1.1.4747.2 1 74.9852 1484.992 74.9077 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.6099991798401 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ MDA adduct +54(K)@2; Methyl(E)@17; acrolein addition +94(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.389324009418488 4337.74560546875 868.5564 4337.3564453125 868.478515625 5 15 1.1.1.4700.12 1 73.848 3952.334 73.8606 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.6099991798401 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Arg-add@N-term; GlyGly(K)@2 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.320885002613068 4445.7548828125 1112.446 4445.43212890625 1112.36535644531 4 23 1.1.1.4733.11 1 74.6564 11791.36 74.6648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.6099991798401 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Lys-add@N-term; hexanoyl addition +98(K)@2; acrolein addition +94(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.364780992269516 4495.86279296875 900.1799 4495.498046875 900.10693359375 5 15 1.1.1.4761.15 1 75.337 786.1343 75.2983 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.8299977779388 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Acetyl@N-term missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.344496011734009 4217.642578125 1055.418 4217.298828125 1055.33190917969 4 14 1.1.1.4792.19 1 76.1393 1973.882 76.0405 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 77.1499991416931 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Deamidated(N)@35 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.410459995269775 4176.6826171875 836.3438 4176.27197265625 836.26171875 5 13 1.1.1.4726.10 1 74.4813 130201.3 74.5438 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 76.2799978256226 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Cation:Na(E)@29 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.397944003343582 4197.66796875 840.5409 4197.27001953125 840.461303710938 5 14 1.1.1.4758.5 1 75.2589 1547.88 75.1768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.4599997997284 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Deamidated(N)@35 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.468919008970261 4176.7412109375 697.1308 4176.27197265625 697.052673339844 6 17 1.1.1.4752.3 1 75.1094 77359.54 75.1768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 65.1899993419647 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ GlnGlnGlnThrGlyGly(K)@2; reduced acrolein addition +96(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 -0.532540023326874 4870.07958984375 812.6872 4870.61181640625 812.775939941406 6 14 1.1.1.4693.13 1 73.668 489.6274 73.6797 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 62.9100024700165 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Deamidated(Q)@10; Deamidated(N)@35 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.485024988651276 4177.7412109375 697.2975 4177.25634765625 697.216674804688 6 13 1.1.1.4701.3 1 73.867 29069.93 73.9116 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.92999958992 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl@N-term; HPNE addition +172(K)@2; MDA adduct +62(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.413432985544205 4466.8486328125 894.377 4466.43505859375 894.294311523438 5 13 1.1.1.4729.3 1 74.5529 965.8395 74.5438 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 51.9599974155426 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +56(K)@32; Deamidated(N)@35 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.403228014707565 4232.70166015625 847.5476 4232.29833984375 847.466979980469 5 12 1.1.1.4744.8 1 74.9162 1604.484 74.9569 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 48.1599986553192 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ hexanoyl addition +98(K)@2; Dicarbamidomethyl(D)@7; Deamidated(Q)@10; acrolein addition +76(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.432929009199142 4464.8525390625 893.9778 4464.41943359375 893.891174316406 5 14 1.1.1.4776.12 1 75.7128 712.7571 75.5457 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 46.8899995088577 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +112(K)@2; Deamidated(Q)@10 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.405454993247986 4288.72998046875 858.7533 4288.32470703125 858.672180175781 5 12 1.1.1.4791.18 1 76.1121 509.6316 76.0932 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 44.3599998950958 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Arg-add@N-term; hexanoyl addition +98(K)@2 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.345504999160767 4429.80810546875 886.9689 4429.46240234375 886.899780273438 5 13 1.1.1.4744.10 1 74.9187 1086.775 74.9077 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 41.839998960495 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Acetyl@N-term missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.401977986097336 4217.70068359375 844.5474 4217.298828125 844.467041015625 5 17 1.1.1.4790.13 1 76.0815 7666.902 76.0405 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.3500000238419 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Methyl(K)@32; reduced acrolein addition +58(K)@33 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.432285010814667 4247.77783203125 708.9703 4247.345703125 708.898254394531 6 13 1.1.1.4800.19 1 76.3501 743.6859 76.3568 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 36.8900001049042 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Arg-add@N-term; MDA adduct +62(K)@2; acrolein addition +112(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.43121799826622 4505.888671875 902.185 4505.45751953125 902.098754882813 5 13 1.1.1.4726.17 1 74.4871 1512.339 74.4955 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 30.9700012207031 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HPNE addition +172(K)@2; Oxidation(P)@14; hexanoyl addition +98(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.443001002073288 4461.9091796875 744.6588 4461.46630859375 744.5849609375 6 12 1.1.1.4748.6 1 75.0119 2316.19 75.0295 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 21.4499995112419 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Dehydrated(S)@18 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.45678499341011 4157.734375 693.963 4157.27783203125 693.886901855469 6 12 1.1.1.4699.3 1 73.8136 1346.734 73.8337 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 20.4999998211861 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ GlyGly(K)@20 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.472873002290726 4289.80419921875 715.9746 4289.3310546875 715.895812988281 6 12 1.1.1.4792.12 1 76.1335 395.9724 76.146 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 20.4999998211861 AKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Dehydrated(T)@31; MDA adduct +54(K)@33 missed R-Q@9; missed K-V@20; missed K-K@32; missed K-L@33 0.410039991140366 4211.6982421875 843.3469 4211.2880859375 843.264892578125 5 12 1.1.1.4803.7 1 76.4197 257.3239 76.4348 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQK missed K-V@2 0.159617006778717 1450.9052734375 726.4599 1450.74560546875 726.380065917969 2 20 1.1.1.3019.11 1 32.3077 3815.141 32.3676 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.6700007915497 AKVQPYLDDFQK missed K-V@2 0.222165003418922 1450.9677734375 484.6632 1450.74560546875 484.589141845703 3 15 1.1.1.3020.7 1 32.3359 10297.18 32.3676 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.9900012016296 AKVQPYLDDFQK Carboxyethyl(K)@2 missed K-V@2 0.168639004230499 1522.93542480469 762.475 1522.76672363281 762.390686035156 2 14 1.1.1.3532.14 1 44.7077 294.3247 44.6939 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.5100028514862 AKVQPYLDDFQK Carbamidomethyl@N-term missed K-V@2 0.224412992596626 1507.99145507813 503.6711 1507.76708984375 503.596313476563 3 13 1.1.1.3022.9 1 32.3783 2506.887 32.3676 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.0499970912933 AKVQPYLDDFQK Formyl@N-term; reduced acrolein addition +58(K)@2 missed K-V@2 0.163487002253532 1536.94592285156 769.4802 1536.78234863281 769.398498535156 2 12 1.1.1.3685.5 1 48.4499 848.7392 48.4409 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKK Carbamidomethyl@N-term missed K-V@2; missed K-K@12 0.225001007318497 1636.08703613281 546.3696 1635.86206054688 546.294616699219 3 15 1.1.1.2891.10 1 29.2294 631.5458 29.1897 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Dioxidation(W)@14; Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.247712001204491 2891.62768554688 964.8832 2891.3798828125 964.800598144531 3 22 1.1.1.3474.14 1 43.2852 895.0714 43.3662 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Carbamidomethyl@N-term; reduced acrolein addition +96(K)@13; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.244909003376961 2948.7158203125 738.1862 2948.47094726563 738.125 4 21 1.1.1.3475.7 1 43.3032 32297.37 43.0677 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR reduced acrolein addition +96(K)@13; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.310182005167007 2891.75952148438 579.3592 2891.44946289063 579.297180175781 5 21 1.1.1.3479.9 1 43.4006 4188.124 43.3662 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Dioxidation(W)@14; Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.313800007104874 2891.69384765625 723.9307 2891.3798828125 723.852294921875 4 27 1.1.1.3479.14 1 43.4056 7637.251 43.4405 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Carbamidomethyl@N-term; reduced acrolein addition +96(K)@13; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.245152994990349 2948.71606445313 738.1863 2948.47094726563 738.125 4 21 1.1.1.3482.13 1 43.4786 1531.534 43.4654 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR reduced acrolein addition +96(K)@13; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.309572011232376 2891.75903320313 579.3591 2891.44946289063 579.297180175781 5 20 1.1.1.3486.6 1 43.5739 4443.591 43.4405 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR reduced acrolein addition +96(K)@13; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.24439999461174 2891.69384765625 723.9307 2891.44946289063 723.86962890625 4 23 1.1.1.3486.10 1 43.5806 7637.251 43.4405 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR reduced acrolein addition +96(K)@13; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.244644001126289 2891.69409179688 723.9308 2891.44946289063 723.86962890625 4 23 1.1.1.3493.8 1 43.7526 6600.621 43.5151 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.31632399559021 2859.70654296875 715.9339 2859.39013671875 715.854797363281 4 22 1.1.1.3641.14 1 47.4151 11030.55 47.5024 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.320719003677368 2859.7109375 715.935 2859.39013671875 715.854797363281 4 24 1.1.1.3656.18 1 47.8002 4620.123 47.7562 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Carbamyl@N-term; acrolein addition +38(K)@2; Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.297302007675171 2940.708984375 736.1845 2940.41162109375 736.110168457031 4 21 1.1.1.3709.7 1 49.0135 11805.83 49.0253 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Carbamidomethyl@N-term missed K-V@2; missed K-K@12; missed K-W@13 0.323711007833481 2900.74047851563 726.1924 2900.41674804688 726.111450195313 4 25 1.1.1.3758.9 1 50.2479 82428.06 49.9884 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Carbamidomethyl@N-term missed K-V@2; missed K-K@12; missed K-W@13 0.251825004816055 2900.66845703125 967.8968 2900.41674804688 967.812866210938 3 20 1.1.1.3758.17 1 50.2545 24034.17 49.9884 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Carbamyl@N-term; acrolein addition +38(K)@2 missed K-V@2; missed K-K@12; missed K-W@13 0.294658005237579 2924.71142578125 732.1851 2924.41674804688 732.111450195313 4 21 1.1.1.3801.4 1 51.3262 6722.824 51.2701 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Carbamyl@N-term; acrolein addition +56(K)@2; Oxidation(W)@14; Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.296216994524002 2974.71337890625 744.6856 2974.4169921875 744.611572265625 4 19 1.1.1.3317.6 1 39.4607 1808.739 39.5138 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Formyl@N-term; reduced acrolein addition +58(K)@2 missed K-V@2; missed K-K@12; missed K-W@13 0.253782004117966 2929.68579101563 977.5692 2929.43212890625 977.484619140625 3 19 1.1.1.4019.11 1 56.6633 638.2178 56.6271 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Formyl@N-term; reduced acrolein addition +58(K)@2 missed K-V@2; missed K-K@12; missed K-W@13 0.32328799366951 2929.75537109375 733.4461 2929.43212890625 733.365295410156 4 19 1.1.1.4016.3 1 56.5826 1972.956 56.6271 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Carbamyl@N-term; acrolein addition +56(K)@2; reduced acrolein addition +96(K)@13; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.227507993578911 2990.708984375 748.6845 2990.4814453125 748.627624511719 4 20 1.1.1.3559.2 1 45.3604 9181.409 45.446 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Carbamyl@N-term; acrolein addition +56(K)@2; reduced acrolein addition +96(K)@13; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.227507993578911 2990.708984375 748.6845 2990.4814453125 748.627624511719 4 20 1.1.1.3566.3 1 45.5277 9181.409 45.446 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.31632399559021 2859.70654296875 715.9339 2859.39013671875 715.854797363281 4 18 1.1.1.3649.20 1 47.6226 11030.55 47.5024 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Formyl@N-term; reduced acrolein addition +58(K)@2; reduced acrolein addition +96(K)@13; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.257912993431091 2977.744140625 745.4433 2977.48608398438 745.378845214844 4 20 1.1.1.3761.15 1 50.3302 1297.902 50.3663 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Carbamyl@N-term; acrolein addition +38(K)@2 missed K-V@2; missed K-K@12; missed K-W@13 0.294901996850967 2924.71166992188 732.1852 2924.41674804688 732.111450195313 4 19 1.1.1.3794.5 1 51.1548 7178.836 51.1247 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Carbamyl@N-term; acrolein addition +38(K)@2 missed K-V@2; missed K-K@12; missed K-W@13 0.299053013324738 2924.7158203125 732.1862 2924.41674804688 732.111450195313 4 19 1.1.1.3808.7 1 51.496 6938.495 51.246 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Carbamyl@N-term; acrolein addition +56(K)@2; Dioxidation(W)@14; Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.296420007944107 2990.70849609375 748.6844 2990.412109375 748.610290527344 4 20 1.1.1.3552.3 1 45.1921 9008.527 45.3738 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Carbamyl@N-term; acrolein addition +56(K)@2; Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.299432992935181 2958.7216796875 740.6877 2958.42211914063 740.612854003906 4 19 1.1.1.3706.6 1 48.9402 2001.991 49.0253 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR hexanoyl addition +98(K)@2; Deamidated(Q)@4 missed K-V@2; missed K-K@12; missed K-W@13 0.272368997335434 2942.72485351563 736.6885 2942.45239257813 736.620361328125 4 18 1.1.1.3795.8 1 51.1824 2040.848 51.1489 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.254325985908508 2859.64453125 954.2221 2859.39013671875 954.137329101563 3 17 1.1.1.3656.21 1 47.8027 954.3249 47.7301 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Dioxidation(W)@14 missed K-V@2; missed K-K@12; missed K-W@13 0.315795004367828 2875.70092773438 719.9325 2875.38500976563 719.853576660156 4 18 1.1.1.3659.16 1 47.8765 1215.322 47.9879 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Carbamidomethyl@N-term missed K-V@2; missed K-K@12; missed K-W@13 0.383390009403229 2900.80004882813 581.1673 2900.41674804688 581.090637207031 5 18 1.1.1.3758.5 1 50.2445 95567.06 49.9884 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Carbamyl@N-term; acrolein addition +56(K)@2; reduced acrolein addition +96(K)@13; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.227507993578911 2990.708984375 748.6845 2990.4814453125 748.627624511719 4 19 1.1.1.3573.4 1 45.7014 9134.73 45.446 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.378444999456406 2859.7685546875 572.961 2859.39013671875 572.885314941406 5 17 1.1.1.3642.10 1 47.4373 5670.558 47.5024 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Carbamyl@N-term; acrolein addition +38(K)@2; Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.298034012317657 2940.70971679688 736.1847 2940.41162109375 736.110168457031 4 18 1.1.1.3695.6 1 48.6708 6990.976 48.7361 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYR Carbamyl@N-term; acrolein addition +38(K)@2; Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.298523008823395 2940.71020507813 736.1848 2940.41162109375 736.110168457031 4 18 1.1.1.3702.3 1 48.8414 7792.42 48.8324 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.989999294281 AKVQPYLDDFQKKWQEEMELYR missed K-V@2; missed K-K@12; missed K-W@13 0.323689997196198 2843.71899414063 711.937 2843.39526367188 711.856079101563 4 16 1.1.1.3753.5 1 50.1186 52456.47 50.2122 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 AKVQPYLDDFQKKWQEEMELYR Dehydrated(D)@9; Deamidated(Q)@11; reduced acrolein addition +58(K)@12 missed K-V@2; missed K-K@12; missed K-W@13 0.329614996910095 2884.740234375 722.1923 2884.41064453125 722.109924316406 4 18 1.1.1.3765.6 1 50.4254 20604.4 50.3143 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.7100005149841 AKVQPYLDDFQKKWQEEMELYR hexanoyl addition +98(K)@2; Deamidated(Q)@4; Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.280627995729446 2958.72802734375 740.6893 2958.447265625 740.619140625 4 17 1.1.1.3696.7 1 48.6951 1635.101 48.8084 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6800014972687 AKVQPYLDDFQKKWQEEMELYR missed K-V@2; missed K-K@12; missed K-W@13 0.323689997196198 2843.71899414063 711.937 2843.39526367188 711.856079101563 4 16 1.1.1.3761.12 1 50.3277 52456.47 50.2122 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.5499978065491 AKVQPYLDDFQKKWQEEMELYR reduced acrolein addition +96(K)@13; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.30926701426506 2891.75854492188 579.359 2891.44946289063 579.297180175781 5 17 1.1.1.3493.4 1 43.7459 4091.282 43.5151 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.5499978065491 AKVQPYLDDFQKKWQEEMELYR Acetyl@N-term missed K-V@2; missed K-K@12; missed K-W@13 0.325087994337082 2885.73095703125 722.44 2885.40576171875 722.358703613281 4 17 1.1.1.3865.2 1 52.9124 760.0615 52.957 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.3799993991852 AKVQPYLDDFQKKWQEEMELYR Carbamyl@N-term; acrolein addition +38(K)@2; Dioxidation(W)@14 missed K-V@2; missed K-K@12; missed K-W@13 0.301654994487762 2956.70825195313 740.1843 2956.40649414063 740.10888671875 4 18 1.1.1.3730.12 1 49.5362 5398.942 49.4478 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.199999332428 AKVQPYLDDFQKKWQEEMELYR Dioxidation(W)@14; Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.253387987613678 2891.63330078125 964.8851 2891.3798828125 964.800598144531 3 17 1.1.1.3483.17 1 43.5101 866.3831 43.4405 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.5899994373322 AKVQPYLDDFQKKWQEEMELYR hexanoyl addition +98(K)@2; Deamidated(Q)@4; Dioxidation(W)@14; Dioxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.279527008533478 3006.71166992188 752.6852 3006.43212890625 752.615295410156 4 18 1.1.1.3617.15 1 46.794 894.3666 46.8296 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.5899994373322 AKVQPYLDDFQKKWQEEMELYR Carbamyl@N-term; acrolein addition +38(K)@2 missed K-V@2; missed K-K@12; missed K-W@13 0.294901996850967 2924.71166992188 732.1852 2924.41674804688 732.111450195313 4 17 1.1.1.3787.5 1 50.981 7178.836 51.1247 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.3599970340729 AKVQPYLDDFQKKWQEEMELYR Formyl(K)@2; Deamidated(Q)@4; Dehydrated(Y)@6 missed K-V@2; missed K-K@12; missed K-W@13 0.344826996326447 2854.70849609375 714.6844 2854.36352539063 714.598205566406 4 19 1.1.1.3795.6 1 51.1799 1019.407 51.0975 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1199989318848 AKVQPYLDDFQKKWQEEMELYR hexanoyl addition +98(K)@2; Deamidated(Q)@4; Oxidation(W)@14 missed K-V@2; missed K-K@12; missed K-W@13 0.267444998025894 2958.71484375 740.686 2958.447265625 740.619140625 4 17 1.1.1.3496.10 1 43.8256 712.5669 43.8867 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.6000020503998 AKVQPYLDDFQKKWQEEMELYR reduced acrolein addition +96(K)@13; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.310182005167007 2891.75952148438 579.3592 2891.44946289063 579.297180175781 5 16 1.1.1.3472.11 1 43.2288 4188.124 43.3662 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.6000020503998 AKVQPYLDDFQKKWQEEMELYR reduced acrolein addition +96(K)@13; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.244644001126289 2891.69409179688 723.9308 2891.44946289063 723.86962890625 4 16 1.1.1.3472.16 1 43.233 7620.703 43.4157 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.3199973106384 AKVQPYLDDFQKKWQEEMELYR Delta:H(2)C(2)(K)@2 missed K-V@2; missed K-K@12; missed K-W@13 0.313654989004135 2869.724609375 718.4384 2869.41088867188 718.359985351563 4 16 1.1.1.3838.3 1 52.2483 345.0582 52.243 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.0300028324127 AKVQPYLDDFQKKWQEEMELYR Delta:H(2)C(2)(K)@12; acrolein addition +38(K)@13; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.351839005947113 2859.77490234375 572.9623 2859.42309570313 572.891906738281 5 17 1.1.1.3660.10 1 47.897 2242.689 47.7562 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.0300028324127 AKVQPYLDDFQKKWQEEMELYR acrolein addition +76(K)@2; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 -0.72425901889801 2870.69897460938 718.682 2871.42309570313 718.863098144531 4 17 1.1.1.3710.4 1 49.0326 2397.161 49.0253 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.0300028324127 AKVQPYLDDFQKKWQEEMELYR Carbamyl@N-term; acrolein addition +38(K)@2; Dioxidation(W)@14 missed K-V@2; missed K-K@12; missed K-W@13 0.301654994487762 2956.70825195313 740.1843 2956.40649414063 740.10888671875 4 17 1.1.1.3723.12 1 49.358 5398.942 49.4478 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.7499990463257 AKVQPYLDDFQKKWQEEMELYR Carbamidomethyl@N-term; reduced acrolein addition +96(K)@13; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.310813009738922 2948.78173828125 590.7636 2948.47094726563 590.701477050781 5 16 1.1.1.3486.7 1 43.5756 992.8722 43.5151 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.4000005722046 AKVQPYLDDFQKKWQEEMELYR hexanoyl addition +98(K)@2; Dioxidation(W)@14 missed K-V@2; missed K-K@12; missed K-W@13 0.269484996795654 2973.72778320313 744.4392 2973.45825195313 744.371826171875 4 15 1.1.1.3724.11 1 49.3832 647.8301 49.4478 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.6600029468536 AKVQPYLDDFQKKWQEEMELYR Hex(K)@2 missed K-V@2; missed K-K@12; missed K-W@13 0.321648001670837 3005.76977539063 752.4497 3005.44799804688 752.369323730469 4 16 1.1.1.3753.8 1 50.1236 693.4759 50.137 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.0400023460388 AKVQPYLDDFQKKWQEEMELYR hexanoyl addition +98(K)@2; Dioxidation(W)@14; Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.276524007320404 2989.72973632813 748.4397 2989.453125 748.370544433594 4 15 1.1.1.3457.19 1 42.8628 1473.336 42.7711 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.1499977111816 AKVQPYLDDFQKKWQEEMELYR reduced acrolein addition +58(K)@2; Deamidated(Q)@4; Oxidation(P)@5; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.28575798869133 2870.69848632813 718.6819 2870.41259765625 718.610473632813 4 16 1.1.1.3696.5 1 48.6935 2094.77 48.8324 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.1499977111816 AKVQPYLDDFQKKWQEEMELYR reduced acrolein addition +58(K)@2; Deamidated(Q)@4; Oxidation(P)@5; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.28575798869133 2870.69848632813 718.6819 2870.41259765625 718.610473632813 4 16 1.1.1.3703.4 1 48.8614 2094.77 48.8324 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.7000014781952 AKVQPYLDDFQKKWQEEMELYR HPNE addition +172(K)@2 missed K-V@2; missed K-K@12; missed K-W@13 0.0704352036118507 3015.57568359375 754.9012 3015.50512695313 754.883544921875 4 14 1.1.1.3799.5 1 51.2793 1202.508 51.2701 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.580001115799 AKVQPYLDDFQKKWQEEMELYR Carbamyl@N-term; acrolein addition +56(K)@2; Oxidation(W)@14; Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.29865899682045 2974.7158203125 744.6862 2974.4169921875 744.611572265625 4 15 1.1.1.3433.6 1 42.2699 871.9098 42.1844 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.1999986171722 AKVQPYLDDFQKKWQEEMELYR hexanoyl addition +98(K)@2; Deamidated(Q)@4; Dioxidation(W)@14; Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.21433499455452 2990.65161132813 997.8911 2990.43725585938 997.819641113281 3 14 1.1.1.3567.8 1 45.5592 763.7177 45.5428 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.4900000095367 AKVQPYLDDFQKKWQEEMELYR Tyr->Dha(Y)@6; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.244169995188713 2701.59423828125 676.4058 2701.35009765625 676.344787597656 4 15 1.1.1.3537.5 1 44.831 3754.088 44.6204 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.4900000095367 AKVQPYLDDFQKKWQEEMELYR Tyr->Dha(Y)@6; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.243193000555038 2701.59326171875 676.4056 2701.35009765625 676.344787597656 4 15 1.1.1.3544.5 1 45.0007 7463.733 45.0853 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.4900000095367 AKVQPYLDDFQKKWQEEMELYR Tyr->Dha(Y)@6; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.312211006879807 2701.662109375 541.3397 2701.35009765625 541.277282714844 5 15 1.1.1.3546.3 1 45.0412 7337.891 45.0853 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.4900000095367 AKVQPYLDDFQKKWQEEMELYR Tyr->Dha(Y)@6; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.243193000555038 2701.59326171875 676.4056 2701.35009765625 676.344787597656 4 15 1.1.1.3553.9 1 45.2178 7463.733 45.0853 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.7699997425079 AKVQPYLDDFQKKWQEEMELYR Carbamidomethyl@N-term; Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.253004014492035 2916.66455078125 973.2288 2916.41162109375 973.144470214844 3 12 1.1.1.3645.21 1 47.523 3572.17 47.426 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.0499970912933 AKVQPYLDDFQKKWQEEMELYR hexanoyl addition +98(K)@2; Deamidated(Q)@4; Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.274280995130539 2958.7216796875 740.6877 2958.447265625 740.619140625 4 12 1.1.1.3714.8 1 49.1299 2001.991 49.0253 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 53.82000207901 AKVQPYLDDFQKKWQEEMELYR Tyr->Dha(Y)@6; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.307022988796234 2701.65698242188 541.3387 2701.35009765625 541.277282714844 5 14 1.1.1.3528.5 1 44.6054 3590.312 44.6447 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.2100007534027 AKVQPYLDDFQKKWQEEMELYR Acetyl@N-term; acrolein addition +38(K)@2; Oxidation(W)@14 missed K-V@2; missed K-K@12; missed K-W@13 0.306223005056381 2939.72265625 735.9379 2939.41625976563 735.861389160156 4 13 1.1.1.3728.12 1 49.4859 446.548 49.4731 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 23.6699998378754 AKVQPYLDDFQKKWQEEMELYR hexanoyl addition +98(K)@2; Deamidated(Q)@4; Trp->Kynurenin(W)@14; Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13 0.278144985437393 2962.72045898438 741.6874 2962.44213867188 741.617858886719 4 12 1.1.1.3606.16 1 46.5164 993.7696 46.6261 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 16.4100006222725 AKVQPYLDDFQKKWQEEMELYR missed K-V@2; missed K-K@12; missed K-W@13 0.382454007863998 2843.77758789063 569.7628 2843.39526367188 569.686340332031 5 13 1.1.1.3761.4 1 50.321 23193.47 50.2122 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYRQK missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22 0.387971013784409 3099.93676757813 620.9946 3099.548828125 620.917053222656 5 18 1.1.1.3726.13 1 49.436 10242.9 49.3199 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYRQK Carbamidomethyl@N-term missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22 0.386770993471146 3156.95703125 632.3987 3156.5703125 632.321350097656 5 19 1.1.1.3723.8 1 49.3547 1592.028 49.3199 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYRQK missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22 0.387971013784409 3099.93676757813 620.9946 3099.548828125 620.917053222656 5 17 1.1.1.3719.9 1 49.254 10242.9 49.3199 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYRQK Carbamyl@N-term; acrolein addition +56(K)@2; reduced acrolein addition +96(K)@13; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22 0.226798996329308 3246.86181640625 812.7227 3246.63500976563 812.666015625 4 19 1.1.1.3464.18 1 43.0352 2188.759 43.0677 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYRQK Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22 0.387928992509842 3115.931640625 624.1936 3115.54370117188 624.116027832031 5 17 1.1.1.3611.14 1 46.6404 1274.429 46.6513 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYRQK Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22 0.390980988740921 3115.9345703125 624.1942 3115.54370117188 624.116027832031 5 17 1.1.1.3623.13 1 46.9454 1248.228 46.9827 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.7100005149841 AKVQPYLDDFQKKWQEEMELYRQK Acetyl@N-term; acrolein addition +38(K)@2; Deamidated(Q)@4 missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22 0.312750995159149 3180.87182617188 796.2252 3180.55908203125 796.147033691406 4 18 1.1.1.3748.6 1 50.0006 886.9866 49.9632 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.5499978065491 AKVQPYLDDFQKKWQEEMELYRQK reduced acrolein addition +96(K)@13; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22 0.320277005434036 3147.92309570313 630.5919 3147.60302734375 630.527893066406 5 17 1.1.1.3418.4 1 41.8992 1023.3 42.0383 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.5899994373322 AKVQPYLDDFQKKWQEEMELYRQK Carbamyl@N-term; acrolein addition +38(K)@2 missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22 0.363822013139725 3180.93408203125 637.1941 3180.5703125 637.121337890625 5 17 1.1.1.3752.6 1 50.0947 6485.391 49.9884 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1199989318848 AKVQPYLDDFQKKWQEEMELYRQK acrolein addition +112(K)@2; Deamidated(Q)@4 missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22 0.3143689930439 3212.89965820313 804.2322 3212.58520507813 804.153564453125 4 16 1.1.1.3748.7 1 50.0031 439.8468 50.038 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.6000020503998 AKVQPYLDDFQKKWQEEMELYRQK Carbamidomethyl@N-term missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22 0.320317000150681 3156.890625 790.2299 3156.5703125 790.149841308594 4 16 1.1.1.3722.18 1 49.3379 882.8889 49.3199 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.0300028324127 AKVQPYLDDFQKKWQEEMELYRQK Carbamyl@N-term; acrolein addition +56(K)@2; reduced acrolein addition +96(K)@13; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22 0.291543990373611 3246.92651367188 650.3926 3246.63500976563 650.334289550781 5 17 1.1.1.3463.9 1 43.0029 7075.934 43.0925 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.0300028324127 AKVQPYLDDFQKKWQEEMELYRQK Carbamyl@N-term; acrolein addition +38(K)@2 missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22 0.363822013139725 3180.93408203125 637.1941 3180.5703125 637.121337890625 5 16 1.1.1.3745.8 1 49.921 6485.391 49.9884 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.4200029373169 AKVQPYLDDFQKKWQEEMELYRQK Carbamyl@N-term; acrolein addition +38(K)@2; Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22 0.372325003147125 3196.9375 640.3948 3196.56518554688 640.3203125 5 16 1.1.1.3649.15 1 47.6184 1958.847 47.6538 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2100026607513 AKVQPYLDDFQKKWQEEMELYRQK hexanoyl addition +98(K)@2; Deamidated(Q)@4 missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22 0.348735004663467 3198.95458984375 640.7982 3198.60595703125 640.728454589844 5 14 1.1.1.3747.10 1 49.9742 907.9647 49.9632 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.2300009727478 AKVQPYLDDFQKKWQEEMELYRQK hexanoyl addition +98(K)@2; Deamidated(Q)@4; reduced acrolein addition +96(K)@13; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22 0.26639199256897 3246.92651367188 650.3926 3246.66015625 650.339294433594 5 15 1.1.1.3470.11 1 43.1786 7075.934 43.0925 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.2300009727478 AKVQPYLDDFQKKWQEEMELYRQK Delta:H(4)C(2)@N-term; MDA adduct +54(K)@2; Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22 -0.649906992912292 3196.935546875 640.3944 3197.58544921875 640.5244140625 5 16 1.1.1.3641.9 1 47.4109 1415.913 47.426 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1900012493134 AKVQPYLDDFQKKWQEEMELYRQK reduced acrolein addition +96(K)@13; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22 0.320277005434036 3147.92309570313 630.5919 3147.60302734375 630.527893066406 5 14 1.1.1.3425.3 1 42.067 1023.3 42.0383 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.1100008487701 AKVQPYLDDFQKKWQEEMELYRQK ONE addition +154(K)@2; Deamidated(Q)@4; Oxidation(P)@5 missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22 0.125286996364594 3270.75244140625 818.6954 3270.62719726563 818.6640625 4 14 1.1.1.3749.16 1 50.0288 777.1398 50.0873 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.5499973297119 AKVQPYLDDFQKKWQEEMELYRQK hexanoyl addition +98(K)@2; Deamidated(Q)@4 missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22 0.282159000635147 3198.88818359375 800.7293 3198.60595703125 800.658752441406 4 13 1.1.1.3753.10 1 50.1269 835.2576 50.0873 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.580001115799 AKVQPYLDDFQKKWQEEMELYRQK Carbamidomethyl@N-term missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22 0.447364985942841 3157.017578125 527.1769 3156.5703125 527.102294921875 6 13 1.1.1.3721.5 1 49.3015 358.6318 49.3199 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.7699997425079 AKVQPYLDDFQKKWQEEMELYRQK HPNE addition +172(K)@2 missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22 -0.849170982837677 3270.8095703125 655.1692 3271.65869140625 655.339050292969 5 13 1.1.1.3754.7 1 50.1455 626.2382 50.1123 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.1299986839294 AKVQPYLDDFQKKWQEEMELYRQK Carbamyl@N-term; acrolein addition +56(K)@2; reduced acrolein addition +96(K)@13; Dethiomethyl(M)@18 missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22 0.226798996329308 3246.86181640625 812.7227 3246.63500976563 812.666015625 4 14 1.1.1.3471.18 1 43.2095 2188.759 43.0677 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.1299986839294 AKVQPYLDDFQKKWQEEMELYRQK hexanoyl addition +98(K)@2; Dehydrated(D)@9 missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22 0.256718993186951 3179.8681640625 795.9743 3179.611328125 795.910095214844 4 13 1.1.1.3749.14 1 50.0271 684.5841 50.1123 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYRQKVEPLR Deamidated(Q)@11 missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22; missed K-V@24 -0.519527971744537 3694.3623046875 616.7343 3694.8818359375 616.820922851563 6 24 1.1.1.3769.5 1 50.5269 8035.83 50.5453 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYRQKVEPLR Carbamidomethyl@N-term missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22; missed K-V@24 0.402449011802673 3751.32153320313 751.2716 3750.91918945313 751.191101074219 5 20 1.1.1.3770.12 1 50.5587 855.9557 50.5453 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYRQKVEPLR missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22; missed K-V@24 0.40242800116539 3694.30004882813 739.8673 3693.89770507813 739.786804199219 5 25 1.1.1.3772.5 1 50.6044 5359.829 50.5453 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22; missed K-V@24; missed R-A@29 0.47699099779129 4548.79931640625 759.1405 4548.322265625 759.060974121094 6 20 1.1.1.3820.7 1 51.7984 15916.3 51.7118 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 AKVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22; missed K-V@24; missed R-A@29 0.47699099779129 4548.79931640625 759.1405 4548.322265625 759.060974121094 6 18 1.1.1.3813.9 1 51.6215 15916.3 51.7118 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1900012493134 AKVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR acrolein addition +38(K)@12; acrolein addition +76(K)@13; Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22; missed K-V@24; missed R-A@29 -0.519048988819122 4677.84521484375 669.2709 4678.3642578125 669.345031738281 7 14 1.1.1.3709.5 1 49.0102 683.6489 48.9286 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.0499970912933 AKVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Acetyl@N-term; acrolein addition +38(K)@2; Deamidated(Q)@11; Oxidation(M)@18 missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22; missed K-V@24; missed R-A@29 0.474898010492325 4645.80224609375 775.3077 4645.32763671875 775.228515625 6 14 1.1.1.3765.13 1 50.4312 454.8402 50.3918 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 52.700001001358 AKVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Carbamidomethyl@N-term missed K-V@2; missed K-K@12; missed K-W@13; missed R-Q@22; missed K-V@24; missed R-A@29 0.410802006721497 4605.75439453125 922.1582 4605.34375 922.076049804688 5 12 1.1.1.3815.9 1 51.6713 1232.282 51.6864 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.5100016593933 ALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ cleaved P-A@N-term; missed R-Q@6; missed K-V@17; missed K-K@29; missed K-L@30 -12.9000997543335 3866.203125 774.2479 3879.10327148438 776.827941894531 5 15 1.1.1.4595.8 1 71.0875 762.8638 70.9974 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.9700014591217 ALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ cleaved P-A@N-term; missed R-Q@6; missed K-V@17; missed K-K@29; missed K-L@30 -12.890700340271 3866.21264648438 774.2498 3879.10327148438 776.827941894531 5 15 1.1.1.4581.5 1 70.7198 1707.205 70.6364 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.8299970626831 ALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ cleaved P-A@N-term; missed R-Q@6; missed K-V@17; missed K-K@29; missed K-L@30 -12.8902997970581 3866.212890625 774.2499 3879.10327148438 776.827941894531 5 15 1.1.1.4588.3 1 70.8986 1748.466 70.6364 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 51.9599974155426 ALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ cleaved P-A@N-term; missed R-Q@6; missed K-V@17; missed K-K@29; missed K-L@30 -12.8998003005981 3866.20361328125 774.248 3879.10327148438 776.827941894531 5 13 1.1.1.4603.13 1 71.3028 670.3998 71.0234 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.710000038147 ALGKQLNLKLLDNWDSVTSTFSK Deamidated(Q)@5 cleaved S-A@N-term; missed K-Q@4; missed K-L@9 0.0338853001594543 2578.39819335938 860.4733 2578.3642578125 860.462036132813 3 14 1.1.1.3892.12 1 53.5863 5285.245 53.6965 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.4100022315979 ALKENGGAR cleaved E-A@N-term; missed K-E@3 0.144290000200272 914.6376953125 458.3261 914.493408203125 458.253967285156 2 11 1.1.1.2602.8 1 22.3043 13230.6 22.3685 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1099998950958 ALKENGGAR cleaved E-A@N-term; missed K-E@3 0.144290000200272 914.6376953125 458.3261 914.493408203125 458.253967285156 2 11 1.1.1.2609.6 1 22.473 13230.6 22.3685 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ARAHVDALRTHLAPYSDELRQR missed R-A@2; missed R-T@9; missed R-Q@20 0.362760007381439 2574.71557617188 515.9504 2574.35278320313 515.877807617188 5 22 1.1.1.2954.9 1 30.7439 19629.78 30.8276 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ARAHVDALRTHLAPYSDELRQR missed R-A@2; missed R-T@9; missed R-Q@20 0.362760007381439 2574.71557617188 515.9504 2574.35278320313 515.877807617188 5 20 1.1.1.2961.7 1 30.9116 19629.78 30.8276 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ARAHVDALRTHLAPYSDELRQR missed R-A@2; missed R-T@9; missed R-Q@20 0.362760007381439 2574.71557617188 515.9504 2574.35278320313 515.877807617188 5 21 1.1.1.2969.6 1 31.1049 18971.97 30.8515 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ARAHVDALRTHLAPYSDELRQR missed R-A@2; missed R-T@9; missed R-Q@20 0.414198994636536 2574.76684570313 430.1351 2574.35278320313 430.066070556641 6 18 1.1.1.2959.5 1 30.8587 10026.05 30.8276 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 23.0399996042252 ARAHVDALRTHLAPYSDELRQRLAARLEALKENGGAR missed R-A@2; missed R-T@9; missed R-Q@20; missed R-L@22; missed R-L@26; missed K-E@31 -4.37722015380859 4119.84423828125 687.648 4124.2216796875 688.377563476563 6 12 1.1.1.3605.15 1 46.4902 735.8447 46.5003 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ARLEALKENGGAR cleaved A-A@N-term; missed R-L@2; missed K-E@7 0.213807001709938 1383.97204589844 462.3313 1383.75830078125 462.260040283203 3 17 1.1.1.2754.5 1 25.9447 7866.398 25.9357 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ARLEALKENGGAR Deamidated(N)@9 cleaved A-A@N-term; missed R-L@2; missed K-E@7 0.213524997234344 1384.95581054688 462.6592 1384.74230957031 462.588043212891 3 17 1.1.1.2792.6 1 26.86 7069.042 27.0369 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ARLEALKENGGAR cleaved A-A@N-term; missed R-L@2; missed K-E@7 0.214081004261971 1383.97229003906 462.3314 1383.75830078125 462.260040283203 3 16 1.1.1.2761.5 1 26.1127 7990.03 25.8638 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ARLEALKENGGAR cleaved A-A@N-term; missed R-L@2; missed K-E@7 0.211426004767418 1383.9697265625 462.3305 1383.75830078125 462.260040283203 3 14 1.1.1.2613.5 1 22.5776 186.562 22.5611 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ARLEALKENGGAR Deamidated(N)@9 cleaved A-A@N-term; missed R-L@2; missed K-E@7 0.214074999094009 1384.95629882813 462.6594 1384.74230957031 462.588043212891 3 16 1.1.1.2799.4 1 27.0252 8574.381 27.1561 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ARLEALKENGGAR Deamidated(N)@9 cleaved A-A@N-term; missed R-L@2; missed K-E@7 0.214074999094009 1384.95629882813 462.6594 1384.74230957031 462.588043212891 3 15 1.1.1.2806.5 1 27.1954 8574.381 27.1561 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.4100022315979 ARQKLHELQEKLSPLGEEMRDR MDA adduct +54(K)@4 cleaved G-A@N-term; missed R-Q@2; missed K-L@4; missed K-L@11; missed R-D@20 0.277368009090424 2716.68530273438 680.1786 2716.40795898438 680.109252929688 4 14 1.1.1.3389.6 1 41.1919 12467.43 41.23 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.4100022315979 ARQKLHELQEKLSPLGEEMRDR MDA adduct +54(K)@4 cleaved G-A@N-term; missed R-Q@2; missed K-L@4; missed K-L@11; missed R-D@20 0.214576005935669 2716.62255859375 906.5481 2716.40795898438 906.4765625 3 14 1.1.1.3394.9 1 41.3194 3484.912 41.23 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.4100022315979 ARQKLHELQEKLSPLGEEMRDR MDA adduct +54(K)@4 cleaved G-A@N-term; missed R-Q@2; missed K-L@4; missed K-L@11; missed R-D@20 0.281762987375259 2716.68969726563 680.1797 2716.40795898438 680.109252929688 4 14 1.1.1.3397.15 1 41.3917 10800.39 41.3523 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.4100022315979 ARQKLHELQEKLSPLGEEMRDR MDA adduct +54(K)@4 cleaved G-A@N-term; missed R-Q@2; missed K-L@4; missed K-L@11; missed R-D@20 0.281762987375259 2716.68969726563 680.1797 2716.40795898438 680.109252929688 4 14 1.1.1.3404.15 1 41.5641 10800.39 41.3523 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.410001039505 ARQKLHELQEKLSPLGEEMRDR MDA adduct +54(K)@4 cleaved G-A@N-term; missed R-Q@2; missed K-L@4; missed K-L@11; missed R-D@20 0.345591992139816 2716.75341796875 544.358 2716.40795898438 544.288879394531 5 12 1.1.1.3404.8 1 41.5582 3570.552 41.3523 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 53.2599985599518 ARQKLHELQEKLSPLGEEMRDR Dehydrated(E)@7 cleaved G-A@N-term; missed R-Q@2; missed K-L@4; missed K-L@11; missed R-D@20 0.363682985305786 2644.75048828125 662.1949 2644.38671875 662.103942871094 4 13 1.1.1.3835.6 1 52.1749 2939.312 52.1924 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK Delta:H(2)C(2)@N-term 0.154954001307487 1240.78491210938 621.3997 1240.6298828125 621.322265625 2 18 1.1.1.2699.16 1 24.6431 4141.743 24.6482 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK Dehydrated(S)@6 0.154558002948761 1196.75830078125 599.3864 1196.60375976563 599.309143066406 2 19 1.1.1.2713.15 1 24.9781 1276.19 24.9592 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.156200006604195 1214.7705078125 608.3925 1214.6142578125 608.314392089844 2 19 1.1.1.2788.4 1 26.7698 1285.24 26.751 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK -0.875050008296967 1213.7392578125 607.8769 1214.6142578125 608.314392089844 2 17 1.1.1.2811.8 1 27.3129 1623.062 27.4422 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 1.15973997116089 1215.77404785156 608.8943 1214.6142578125 608.314392089844 2 19 1.1.1.3054.5 1 33.1529 335.9132 33.2572 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK -0.874440014362335 1213.73986816406 607.8772 1214.6142578125 608.314392089844 2 17 1.1.1.2828.9 1 27.718 1052.703 27.7996 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK Formyl@N-term 0.157500997185707 1242.76672363281 622.3906 1242.60925292969 622.311889648438 2 18 1.1.1.2836.9 1 27.9139 1685.656 27.8473 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK Formyl@N-term 0.157500997185707 1242.76672363281 622.3906 1242.60925292969 622.311889648438 2 18 1.1.1.2829.9 1 27.7444 1685.656 27.8473 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.151804998517036 1214.76611328125 608.3903 1214.6142578125 608.314392089844 2 19 1.1.1.2683.8 1 24.2549 3292.087 24.241 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.15302599966526 1214.76733398438 608.3909 1214.6142578125 608.314392089844 2 19 1.1.1.2727.7 1 25.3093 1413.67 25.2931 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.155956000089645 1214.77026367188 608.3924 1214.6142578125 608.314392089844 2 19 1.1.1.2735.5 1 25.5015 958.4329 25.5065 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.15302599966526 1214.76733398438 608.3909 1214.6142578125 608.314392089844 2 19 1.1.1.2743.8 1 25.689 1653.038 25.649 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.155344992876053 1214.76965332031 608.3921 1214.6142578125 608.314392089844 2 19 1.1.1.2750.8 1 25.8562 1781.543 25.7681 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.155956000089645 1214.77026367188 608.3924 1214.6142578125 608.314392089844 2 19 1.1.1.2760.10 1 26.0937 1990.139 26.1278 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.149363994598389 1214.763671875 608.3891 1214.6142578125 608.314392089844 2 19 1.1.1.2629.15 1 22.9603 496985.7 23.0422 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.149363994598389 1214.763671875 608.3891 1214.6142578125 608.314392089844 2 19 1.1.1.2655.7 1 23.5834 143418.6 23.3292 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.149974003434181 1214.76428222656 608.3894 1214.6142578125 608.314392089844 2 19 1.1.1.2676.8 1 24.0874 3588.91 24.0974 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.153147995471954 1214.76745605469 608.391 1214.6142578125 608.314392089844 2 19 1.1.1.2704.7 1 24.7578 3012.44 24.8396 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.153513997793198 1214.76782226563 608.3912 1214.6142578125 608.314392089844 2 19 1.1.1.2718.10 1 25.0941 1579.696 25.1265 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.149363994598389 1214.763671875 608.3891 1214.6142578125 608.314392089844 2 19 1.1.1.2636.13 1 23.1279 496985.7 23.0422 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.149729996919632 1214.76403808594 608.3893 1214.6142578125 608.314392089844 2 19 1.1.1.2647.7 1 23.3931 414113.2 23.138 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.149729996919632 1214.76403808594 608.3893 1214.6142578125 608.314392089844 2 19 1.1.1.2662.8 1 23.7507 46948.09 23.4957 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.149363994598389 1214.763671875 608.3891 1214.6142578125 608.314392089844 2 19 1.1.1.2636.12 1 23.1263 496985.7 23.0422 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.152781993150711 1214.76708984375 608.3908 1214.6142578125 608.314392089844 2 19 1.1.1.2690.13 1 24.424 5516.904 24.5284 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.152416005730629 1214.76672363281 608.3906 1214.6142578125 608.314392089844 2 18 1.1.1.2781.11 1 26.5993 1247.14 26.5838 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.153513997793198 1214.76782226563 608.3912 1214.6142578125 608.314392089844 2 19 1.1.1.2899.5 1 29.4218 1479.643 29.3821 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.153147995471954 1214.76745605469 608.391 1214.6142578125 608.314392089844 2 18 1.1.1.2711.10 1 24.9269 3012.44 24.8396 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.206419005990028 1214.82067871094 405.9475 1214.6142578125 405.878692626953 3 18 1.1.1.2753.4 1 25.919 5862.031 25.8878 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.156200006604195 1214.7705078125 608.3925 1214.6142578125 608.314392089844 2 18 1.1.1.2851.7 1 28.2717 1130.475 28.2053 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.155956000089645 1214.77026367188 608.3924 1214.6142578125 608.314392089844 2 18 1.1.1.2891.11 1 29.2311 1429.82 29.1175 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.152538001537323 1214.76684570313 608.3907 1214.6142578125 608.314392089844 2 17 1.1.1.2587.7 1 21.9416 869.8533 22.0022 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.158763006329536 1214.77307128906 608.3938 1214.6142578125 608.314392089844 2 18 1.1.1.2876.14 1 28.8718 1424.426 28.8287 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.149608001112938 1214.76391601563 608.3892 1214.6142578125 608.314392089844 2 18 1.1.1.2644.4 1 23.3242 471071 23.0661 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.149363994598389 1214.763671875 608.3891 1214.6142578125 608.314392089844 2 17 1.1.1.2629.14 1 22.9595 496985.7 23.0422 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.161570996046066 1214.77587890625 608.3952 1214.6142578125 608.314392089844 2 17 1.1.1.3061.4 1 33.3241 391.929 33.3052 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.156322002410889 1214.77062988281 608.3926 1214.6142578125 608.314392089844 2 17 1.1.1.2804.9 1 27.146 1190.677 27.2038 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK Amidated@C-term 0.211460992693901 1213.84167480469 405.6212 1213.63024902344 405.550689697266 3 16 1.1.1.2625.3 1 22.856 9759.897 22.8506 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK Carbamidomethyl(E)@3 0.207385003566742 1271.84313964844 424.955 1271.6357421875 424.885864257813 3 16 1.1.1.2634.6 1 23.0767 22717.14 22.9224 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK Carbamidomethyl(E)@3 0.206836000084877 1271.84252929688 424.9548 1271.6357421875 424.885864257813 3 16 1.1.1.2641.5 1 23.2459 4102.226 22.9943 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK Delta:H(2)C(2)@N-term 0.208865001797676 1240.83874511719 414.6202 1240.6298828125 414.550598144531 3 16 1.1.1.2699.3 1 24.6281 16944.85 24.6243 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK Delta:H(2)C(2)@N-term 0.209140002727509 1240.83911132813 414.6203 1240.6298828125 414.550598144531 3 16 1.1.1.2706.2 1 24.7981 2232.915 24.8157 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK Amidated@C-term 0.211460992693901 1213.84167480469 405.6212 1213.63024902344 405.550689697266 3 16 1.1.1.2624.2 1 22.8313 9759.897 22.8506 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK -0.875050008296967 1213.7392578125 607.8769 1214.6142578125 608.314392089844 2 16 1.1.1.2818.9 1 27.4815 1623.062 27.4422 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.2066929936409 1214.82092285156 405.9476 1214.6142578125 405.878692626953 3 17 1.1.1.2789.2 1 26.7794 4804.93 26.5838 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.15302599966526 1214.76733398438 608.3909 1214.6142578125 608.314392089844 2 17 1.1.1.2869.11 1 28.6998 1354.801 28.6842 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.209347993135452 1214.82360839844 405.9485 1214.6142578125 405.878692626953 3 17 1.1.1.2968.2 1 31.0709 2823.293 31.0671 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.208799004554749 1214.82312011719 405.9483 1214.6142578125 405.878692626953 3 17 1.1.1.2633.4 1 23.0494 1210293 23.0422 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.209074005484581 1214.82336425781 405.9484 1214.6142578125 405.878692626953 3 17 1.1.1.2647.4 1 23.3856 1109412 23.138 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.2066929936409 1214.82092285156 405.9476 1214.6142578125 405.878692626953 3 17 1.1.1.2697.2 1 24.5803 20671.19 24.5765 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK Carbamidomethyl(H)@4 0.207385003566742 1271.84313964844 424.955 1271.6357421875 424.885864257813 3 16 1.1.1.2627.6 1 22.909 22717.14 22.9224 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK Carbamidomethyl(H)@4 0.152680993080139 1271.78845214844 636.9015 1271.6357421875 636.825134277344 2 17 1.1.1.2634.10 1 23.0833 1520.051 23.0422 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.2066929936409 1214.82092285156 405.9476 1214.6142578125 405.878692626953 3 16 1.1.1.2781.2 1 26.5868 4804.93 26.5838 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.159373998641968 1214.77368164063 608.3941 1214.6142578125 608.314392089844 2 16 1.1.1.3036.6 1 32.7186 389.1743 32.7527 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.208799004554749 1214.82312011719 405.9483 1214.6142578125 405.878692626953 3 16 1.1.1.2640.3 1 23.217 1210293 23.0422 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.208799004554749 1214.82312011719 405.9483 1214.6142578125 405.878692626953 3 16 1.1.1.2655.3 1 23.5734 535015.1 23.3292 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.209713995456696 1214.82397460938 405.9486 1214.6142578125 405.878692626953 3 16 1.1.1.2662.3 1 23.7399 202582.8 23.5195 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.209074005484581 1214.82336425781 405.9484 1214.6142578125 405.878692626953 3 16 1.1.1.2669.4 1 23.908 82743.96 23.8064 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.206419005990028 1214.82067871094 405.9475 1214.6142578125 405.878692626953 3 16 1.1.1.2676.3 1 24.079 19247.63 24.265 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.206419005990028 1214.82067871094 405.9475 1214.6142578125 405.878692626953 3 16 1.1.1.2683.2 1 24.2449 19186.98 24.217 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.206052005290985 1214.8203125 405.9474 1214.6142578125 405.878692626953 3 16 1.1.1.2690.2 1 24.4114 19161.76 24.4084 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.206052005290985 1214.8203125 405.9474 1214.6142578125 405.878692626953 3 16 1.1.1.2704.2 1 24.7478 20732.48 24.5045 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.206967994570732 1214.8212890625 405.9477 1214.6142578125 405.878692626953 3 16 1.1.1.2711.2 1 24.9144 12387.2 24.6723 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.209074005484581 1214.82336425781 405.9484 1214.6142578125 405.878692626953 3 16 1.1.1.2735.2 1 25.489 5758.131 25.3881 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.2066929936409 1214.82092285156 405.9476 1214.6142578125 405.878692626953 3 16 1.1.1.2743.2 1 25.6765 5524.63 25.7442 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.206419005990028 1214.82067871094 405.9475 1214.6142578125 405.878692626953 3 16 1.1.1.2752.2 1 25.8917 5862.031 25.8878 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.206967994570732 1214.8212890625 405.9477 1214.6142578125 405.878692626953 3 16 1.1.1.2797.3 1 26.9718 3755.363 26.9415 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.206967994570732 1214.8212890625 405.9477 1214.6142578125 405.878692626953 3 16 1.1.1.2805.3 1 27.1598 4323.041 27.1799 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.2066929936409 1214.82092285156 405.9476 1214.6142578125 405.878692626953 3 16 1.1.1.2814.2 1 27.376 4318.495 27.5138 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.2066929936409 1214.82092285156 405.9476 1214.6142578125 405.878692626953 3 16 1.1.1.2821.2 1 27.5413 4318.495 27.5138 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.206419005990028 1214.82067871094 405.9475 1214.6142578125 405.878692626953 3 16 1.1.1.2844.2 1 28.0906 3321.75 27.9429 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.2066929936409 1214.82092285156 405.9476 1214.6142578125 405.878692626953 3 16 1.1.1.2870.2 1 28.7139 2987.748 28.8287 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.158518999814987 1214.77282714844 608.3937 1214.6142578125 608.314392089844 2 16 1.1.1.2966.9 1 31.0348 803.0962 31.0193 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEK 0.206967994570732 1214.8212890625 405.9477 1214.6142578125 405.878692626953 3 16 1.1.1.2983.2 1 31.4302 3021.433 31.3307 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.989999294281 ATEHLSTLSEK acrolein addition +56(K)@11 0.215330004692078 1270.85583496094 424.6259 1270.64050292969 424.554107666016 3 15 1.1.1.2669.8 1 23.9113 620.0078 23.903 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.989999294281 ATEHLSTLSEK 0.155956000089645 1214.77026367188 608.3924 1214.6142578125 608.314392089844 2 16 1.1.1.2859.12 1 28.4618 996.9566 28.4925 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8300025463104 ATEHLSTLSEK 0.156565994024277 1214.77087402344 608.3927 1214.6142578125 608.314392089844 2 15 1.1.1.3072.5 1 33.5812 594.905 33.6409 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6000001430511 ATEHLSTLSEK Dehydrated(E)@10 0.156755000352859 1196.76049804688 599.3875 1196.60375976563 599.309143066406 2 16 1.1.1.2927.11 1 30.0927 48170.16 30.0337 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2699990272522 ATEHLSTLSEK Carbamidomethyl(S)@6 0.20949099957943 1271.84521484375 424.9557 1271.6357421875 424.885864257813 3 15 1.1.1.2653.6 1 23.5349 1758.002 23.5671 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2699990272522 ATEHLSTLSEK Carboxy(E)@3; Delta:H(2)C(2)(H)@4 0.190271005034447 1284.81005859375 643.4123 1284.61975097656 643.317138671875 2 17 1.1.1.2664.14 1 23.7981 2268.848 23.8064 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.1500029563904 ATEHLSTLSEK 0.2066929936409 1214.82092285156 405.9476 1214.6142578125 405.878692626953 3 15 1.1.1.2719.2 1 25.1056 7847.01 25.0787 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.1500029563904 ATEHLSTLSEK 0.206419005990028 1214.82067871094 405.9475 1214.6142578125 405.878692626953 3 15 1.1.1.2727.2 1 25.2968 5393.359 25.2931 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.1500029563904 ATEHLSTLSEK 0.206419005990028 1214.82067871094 405.9475 1214.6142578125 405.878692626953 3 15 1.1.1.2828.2 1 27.7072 4808.465 27.6567 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.1500029563904 ATEHLSTLSEK 0.206419005990028 1214.82067871094 405.9475 1214.6142578125 405.878692626953 3 15 1.1.1.2836.3 1 27.9005 4846.91 27.6567 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.1500029563904 ATEHLSTLSEK 0.213009998202324 1214.82727050781 405.9497 1214.6142578125 405.878692626953 3 15 1.1.1.2880.2 1 28.9531 2667.045 28.9491 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.1500029563904 ATEHLSTLSEK 0.212368994951248 1214.82666015625 405.9495 1214.6142578125 405.878692626953 3 15 1.1.1.2907.2 1 29.6026 2745.316 29.5504 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.1500029563904 ATEHLSTLSEK 0.213284999132156 1214.82751464844 405.9498 1214.6142578125 405.878692626953 3 15 1.1.1.2935.2 1 30.2791 3232.828 30.251 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.1500029563904 ATEHLSTLSEK 0.213009998202324 1214.82727050781 405.9497 1214.6142578125 405.878692626953 3 14 1.1.1.2975.2 1 31.2378 3029.63 31.2587 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.089998960495 ATEHLSTLSEK Cation:Na(E)@10 0.14886499941349 1236.7451171875 619.3798 1236.59619140625 619.305419921875 2 15 1.1.1.2634.7 1 23.0783 2470.029 23.0422 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.8500008583069 ATEHLSTLSEK 0.20550300180912 1214.81982421875 405.9472 1214.6142578125 405.878692626953 3 14 1.1.1.2587.3 1 21.9316 1114.669 22.0022 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.4900007247925 ATEHLSTLSEK 0.253612011671066 1214.86791992188 608.4412 1214.6142578125 608.314392089844 2 13 1.1.1.3199.6 1 36.6303 505.7768 36.6404 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.0300018787384 ATEHLSTLSEK Carbamidomethyl(H)@4 0.152680993080139 1271.78845214844 636.9015 1271.6357421875 636.825134277344 2 18 1.1.1.2627.11 1 22.9173 7658.403 22.9464 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.0300018787384 ATEHLSTLSEK -8.85441970825195 1205.75988769531 603.8872 1214.6142578125 608.314392089844 2 13 1.1.1.3255.8 1 37.9754 3301.817 38.0069 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8100011348724 ATEHLSTLSEK 0.206052005290985 1214.8203125 405.9474 1214.6142578125 405.878692626953 3 14 1.1.1.2767.2 1 26.2507 7186.015 26.1278 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8100011348724 ATEHLSTLSEK 0.15217199921608 1214.76647949219 608.3905 1214.6142578125 608.314392089844 2 15 1.1.1.2856.6 1 28.3865 966.1037 28.3966 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5399980545044 ATEHLSTLSEK 0.136791005730629 1214.75109863281 608.3828 1214.6142578125 608.314392089844 2 15 1.1.1.2915.7 1 29.8044 3146.185 29.9852 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2700009346008 ATEHLSTLSEK Amidated@C-term 0.211460992693901 1213.84167480469 405.6212 1213.63024902344 405.550689697266 3 15 1.1.1.2623.3 1 22.8115 9759.897 22.8506 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2700009346008 ATEHLSTLSEK Oxidation(H)@4 0.149689003825188 1230.75891113281 616.3867 1230.60925292969 616.311889648438 2 14 1.1.1.2733.5 1 25.4508 553.3051 25.4592 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.990002155304 ATEHLSTLSEK -0.871631979942322 1213.74267578125 607.8786 1214.6142578125 608.314392089844 2 15 1.1.1.2946.10 1 30.5531 1096.473 30.5872 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.990002155304 ATEHLSTLSEK 3.22344994544983 1217.83776855469 406.9532 1214.6142578125 405.878692626953 3 14 1.1.1.3113.2 1 34.5608 21896.79 34.5302 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.6099987030029 ATEHLSTLSEK 0.206052005290985 1214.8203125 405.9474 1214.6142578125 405.878692626953 3 14 1.1.1.2760.4 1 26.0845 7186.015 26.1278 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.389997959137 ATEHLSTLSEK -0.875050008296967 1213.7392578125 607.8769 1214.6142578125 608.314392089844 2 15 1.1.1.2843.7 1 28.081 1078.287 27.9907 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.2400028705597 ATEHLSTLSEK 0.209074005484581 1214.82336425781 405.9484 1214.6142578125 405.878692626953 3 14 1.1.1.2647.3 1 23.3831 1109412 23.138 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.2400028705597 ATEHLSTLSEK 0.212643995881081 1214.82690429688 405.9496 1214.6142578125 405.878692626953 3 14 1.1.1.3142.2 1 35.2563 1255.971 35.2764 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.4100022315979 ATEHLSTLSEK Cation:Na(E)@10 0.14886499941349 1236.7451171875 619.3798 1236.59619140625 619.305419921875 2 14 1.1.1.2641.7 1 23.2525 2470.029 23.0422 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.4100022315979 ATEHLSTLSEK 0.206967994570732 1214.8212890625 405.9477 1214.6142578125 405.878692626953 3 14 1.1.1.2861.2 1 28.4963 2770.262 28.4925 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.0599977970123 ATEHLSTLSEK Carbamidomethyl(H)@4 0.208941996097565 1271.8447265625 424.9555 1271.6357421875 424.885864257813 3 14 1.1.1.2662.6 1 23.7457 634.4213 23.7583 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.6900019645691 ATEHLSTLSEK 1.1525399684906 1215.76684570313 608.8907 1214.6142578125 608.314392089844 2 15 1.1.1.2636.14 1 23.1296 170944.8 23.0422 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9199993610382 ATEHLSTLSEK -0.093325100839138 1214.52099609375 405.8476 1214.6142578125 405.878692626953 3 13 1.1.1.2774.2 1 26.4194 11700.59 26.4403 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9000020027161 ATEHLSTLSEK 0.160594001412392 1214.77490234375 608.3947 1214.6142578125 608.314392089844 2 13 1.1.1.3097.5 1 34.1808 717.1849 34.1685 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.3099994659424 ATEHLSTLSEK 0.206419005990028 1214.82067871094 405.9475 1214.6142578125 405.878692626953 3 13 1.1.1.2713.2 1 24.9622 10893.63 24.8157 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.3099994659424 ATEHLSTLSEK 0.158397004008293 1214.77270507813 608.3936 1214.6142578125 608.314392089844 2 13 1.1.1.3044.12 1 32.9144 414.1739 32.8971 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.0799970626831 ATEHLSTLSEK -0.648243010044098 1213.96606445313 607.9903 1214.6142578125 608.314392089844 2 14 1.1.1.3117.4 1 34.67 3460.756 34.6026 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.0000026226044 ATEHLSTLSEK 0.16193699836731 1214.77624511719 608.3954 1214.6142578125 608.314392089844 2 13 1.1.1.3241.7 1 37.6338 450.2458 37.5514 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 ATEHLSTLSEK Amidated@C-term 0.199420005083084 1213.82971191406 607.9221 1213.63024902344 607.822387695313 2 17 1.1.1.2622.7 0 22.791 16398.72 22.6835 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 ATEHLSTLSEK Formyl@N-term 0.155059993267059 1242.76428222656 622.3894 1242.60925292969 622.311889648438 2 13 1.1.1.2832.8 1 27.8183 1666.12 27.8234 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 ATEHLSTLSEK -0.874440014362335 1213.73986816406 607.8772 1214.6142578125 608.314392089844 2 14 1.1.1.2835.11 1 27.885 1052.703 27.7996 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 ATEHLSTLSEK -0.871631979942322 1213.74267578125 607.8786 1214.6142578125 608.314392089844 2 13 1.1.1.2953.10 1 30.7232 1096.473 30.5872 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.7000014781952 ATEHLSTLSEK Palmitoyl(S)@9 0.224983006715775 1453.06896972656 485.3636 1452.84399414063 485.288604736328 3 16 1.1.1.4813.2 1 76.663 2236.479 76.6806 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.4900023937225 ATEHLSTLSEK 0.156200006604195 1214.7705078125 608.3925 1214.6142578125 608.314392089844 2 13 1.1.1.2997.14 1 31.7759 823.1157 31.7384 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.5299990177155 ATEHLSTLSEK 1.21167004108429 1215.82592773438 406.2826 1214.6142578125 405.878692626953 3 13 1.1.1.2656.3 1 23.5948 74638.71 23.5195 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.7800006866455 ATEHLSTLSEK 0.213926002383232 1214.82824707031 405.95 1214.6142578125 405.878692626953 3 13 1.1.1.3086.2 1 33.9085 1715.6 33.8326 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.5900008678436 ATEHLSTLSEK 1.21139001846313 1215.82568359375 406.2825 1214.6142578125 405.878692626953 3 13 1.1.1.2628.3 1 22.9279 434782.2 23.0661 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.569997549057 ATEHLSTLSEK 0.212643995881081 1214.82690429688 405.9496 1214.6142578125 405.878692626953 3 13 1.1.1.3132.2 1 35.0172 987.3731 35.0124 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.370001077652 ATEHLSTLSEK 0.156200006604195 1214.7705078125 608.3925 1214.6142578125 608.314392089844 2 11 1.1.1.3011.15 1 32.1162 614.3737 32.0533 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.0999989509583 ATEHLSTLSEK 0.209074005484581 1214.82336425781 405.9484 1214.6142578125 405.878692626953 3 13 1.1.1.2729.2 1 25.3459 5758.131 25.3881 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.0999989509583 ATEHLSTLSEK 0.206967994570732 1214.8212890625 405.9477 1214.6142578125 405.878692626953 3 13 1.1.1.2796.2 1 26.9519 3755.363 26.9415 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.0999989509583 ATEHLSTLSEK 0.213284999132156 1214.82751464844 405.9498 1214.6142578125 405.878692626953 3 13 1.1.1.2928.2 1 30.1101 3560.356 30.1544 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.7800004482269 ATEHLSTLSEK 0.209074005484581 1214.82336425781 405.9484 1214.6142578125 405.878692626953 3 13 1.1.1.2656.2 1 23.594 444297.2 23.3531 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.7800004482269 ATEHLSTLSEK 0.209074005484581 1214.82336425781 405.9484 1214.6142578125 405.878692626953 3 13 1.1.1.2675.3 1 24.0551 82449.45 23.8064 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.7599980831146 ATEHLSTLSEK Delta:H(2)C(2)@N-term; Delta:H(2)C(2)(H)@4 0.158103004097939 1266.8037109375 634.4091 1266.64562988281 634.330078125 2 14 1.1.1.2910.12 1 29.6883 1217 29.671 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.7599980831146 ATEHLSTLSEK -0.853213012218475 1213.76110839844 405.5943 1214.6142578125 405.878692626953 3 12 1.1.1.2956.2 1 30.7851 21367.4 30.6353 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.7599980831146 ATEHLSTLSEK 2.65156006813049 1217.26586914063 609.6402 1214.6142578125 608.314392089844 2 13 1.1.1.3206.6 1 36.7981 57874.8 36.8082 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 77.8599977493286 ATEHLSTLSEK Formyl(K)@11 0.208970993757248 1242.81811523438 415.28 1242.60925292969 415.210327148438 3 12 1.1.1.2674.4 1 24.03 3607.978 24.0003 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 76.9200026988983 ATEHLSTLSEK Delta:H(2)C(2)@N-term; Delta:H(2)C(2)(H)@4 0.159324005246162 1266.80493164063 634.4097 1266.64562988281 634.330078125 2 13 1.1.1.2848.7 1 28.2002 450.3508 28.2053 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 76.9200026988983 ATEHLSTLSEK Dehydrated(S)@9 0.156755000352859 1196.76049804688 599.3875 1196.60375976563 599.309143066406 2 12 1.1.1.2920.11 1 29.9235 48170.16 30.0337 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.5100028514862 ATEHLSTLSEK 0.155956000089645 1214.77026367188 608.3924 1214.6142578125 608.314392089844 2 10 1.1.1.3004.11 1 31.9428 680.3186 31.9562 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.410001039505 ATEHLSTLSEK 2.15570998191834 1216.77001953125 609.3923 1214.6142578125 608.314392089844 2 13 1.1.1.2629.16 1 22.9611 43417.81 22.9943 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.410001039505 ATEHLSTLSEK Delta:H(2)C(2)@N-term; Delta:H(2)C(2)(H)@4 0.158103004097939 1266.8037109375 634.4091 1266.64562988281 634.330078125 2 13 1.1.1.2918.13 1 29.8818 1217 29.671 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.2400004863739 ATEHLSTLSEK 1.21139001846313 1215.82568359375 406.2825 1214.6142578125 405.878692626953 3 12 1.1.1.2640.4 1 23.2195 434782.2 23.0661 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.2400004863739 ATEHLSTLSEK 1.21167004108429 1215.82592773438 406.2826 1214.6142578125 405.878692626953 3 12 1.1.1.2647.5 1 23.3881 397963 23.138 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.2400004863739 ATEHLSTLSEK Dehydrated(S)@9; Carbamidomethyl(E)@10; ONE addition +154(K)@11 0.125742003321648 1407.85034179688 470.2907 1407.724609375 470.248809814453 3 13 1.1.1.2673.10 1 24.0107 1327.149 24.025 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.2400004863739 ATEHLSTLSEK Dehydrated(S)@9; Carbamidomethyl(E)@10; ONE addition +154(K)@11 0.122079998254776 1407.8466796875 470.2895 1407.724609375 470.248809814453 3 13 1.1.1.2693.4 1 24.4902 3013.815 24.5284 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.2400004863739 ATEHLSTLSEK -0.875050008296967 1213.7392578125 607.8769 1214.6142578125 608.314392089844 2 12 1.1.1.2918.10 1 29.8768 6377.231 30.082 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 58.7700009346008 ATEHLSTLSEK -0.874805986881256 1213.73950195313 607.877 1214.6142578125 608.314392089844 2 12 1.1.1.2939.7 1 30.382 7328.724 30.1303 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 58.7700009346008 ATEHLSTLSEK Dehydrated(T)@2; ONE addition +154(K)@11 0.154908999800682 1350.85803222656 676.4363 1350.703125 676.358825683594 2 11 1.1.1.3033.7 1 32.6465 0 -1 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 57.260000705719 ATEHLSTLSEK Dehydrated(E)@10; ONE addition +154(K)@11 0.0740988031029701 1350.77722167969 676.3959 1350.703125 676.358825683594 2 11 1.1.1.2688.6 1 24.3794 231.4012 24.4084 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 52.5099992752075 ATEHLSTLSEK -0.875050008296967 1213.7392578125 607.8769 1214.6142578125 608.314392089844 2 12 1.1.1.2932.8 1 30.2192 7184.923 30.1303 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 47.4299997091293 ATEHLSTLSEK Ser->LacticAcid(S)@9; acrolein addition +56(K)@11 0.165664002299309 1255.79528808594 628.9049 1255.62963867188 628.822082519531 2 10 1.1.1.2672.17 1 23.9919 244.9606 23.9759 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 43.5799986124039 ATEHLSTLSEK 0.213926002383232 1214.82824707031 405.95 1214.6142578125 405.878692626953 3 12 1.1.1.3079.2 1 33.7406 1715.6 33.8326 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.4699991941452 ATEHLSTLSEK 0.172923997044563 1214.78723144531 608.4009 1214.6142578125 608.314392089844 2 12 1.1.1.3018.12 1 32.2836 1362.022 32.2472 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 37.6899987459183 ATEHLSTLSEK 0.206419005990028 1214.82067871094 405.9475 1214.6142578125 405.878692626953 3 12 1.1.1.2685.2 1 24.2927 19727.12 24.3128 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 37.6899987459183 ATEHLSTLSEK 0.2066929936409 1214.82092285156 405.9476 1214.6142578125 405.878692626953 3 12 1.1.1.2700.4 1 24.653 20671.19 24.5765 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 37.6899987459183 ATEHLSTLSEK 0.20550300180912 1214.81982421875 405.9472 1214.6142578125 405.878692626953 3 12 1.1.1.2737.2 1 25.5356 5146.87 25.6252 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 34.4099998474121 ATEHLSTLSEK Carbamidomethyl(S)@9; Cation:K(E)@10; hexanoyl addition +98(K)@11 0.128393992781639 1407.79321289063 704.9039 1407.66479492188 704.839660644531 2 9 1.1.1.2673.21 1 24.0199 217.7235 24.025 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 34.0200006961823 ATEHLSTLSEK 0.161815002560616 1214.77612304688 608.3953 1214.6142578125 608.314392089844 2 11 1.1.1.3327.3 1 39.6906 364.2372 39.7057 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 30.2100002765656 ATEHLSTLSEK 0.206419005990028 1214.82067871094 405.9475 1214.6142578125 405.878692626953 3 11 1.1.1.2836.2 1 27.8988 4846.91 27.6567 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 15.9899994730949 ATEHLSTLSEK Delta:H(2)C(2)@N-term; Delta:H(2)C(2)(H)@4 0.158103004097939 1266.8037109375 634.4091 1266.64562988281 634.330078125 2 12 1.1.1.2903.7 1 29.5164 1217 29.671 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.9600007534027 ATEHLSTLSEKA Dehydrated(E)@10 cleaved A-K@C-term; missed K-A@11 0.155040994286537 1267.7958984375 634.9052 1267.64086914063 634.827697753906 2 12 1.1.1.2668.13 1 23.8962 227.6563 23.8788 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 72.0600008964539 ATEHLSTLSEKAK Hypusine(K)@11 cleaved K-P@C-term; missed K-A@11 0.255988985300064 1501.07080078125 501.3642 1500.81481933594 501.278869628906 3 14 1.1.1.4782.4 1 75.8633 2137.461 75.8301 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 65.1899993419647 ATEHLSTLSEKAK Hypusine(K)@11 cleaved K-P@C-term; missed K-A@11 0.255988985300064 1501.07080078125 501.3642 1500.81481933594 501.278869628906 3 14 1.1.1.4781.4 1 75.8371 2137.461 75.8301 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 44.3599998950958 ATEHLSTLSEKAK Hypusine(K)@13 cleaved K-P@C-term; missed K-A@11 0.255988985300064 1501.07080078125 501.3642 1500.81481933594 501.278869628906 3 13 1.1.1.4780.4 1 75.8108 2137.461 75.8301 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 57.5500011444092 ATEHLSTLSEKAKP Methyl(K)@13 cleaved P-A@C-term; missed K-A@11 0.253333985805511 1525.06811523438 509.3633 1524.81481933594 509.278869628906 3 13 1.1.1.4782.5 1 75.8641 1401.045 75.9088 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.7599980831146 ATEHLSTLSEKAKPALED Delta:H(2)C(2)(K)@11; MDA adduct +62(K)@13 cleaved D-L@C-term; missed K-A@11 0.30376198887825 2027.32495117188 507.8385 2027.02111816406 507.762573242188 4 14 1.1.1.3023.8 1 32.4024 2833.177 32.4399 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLR Formyl(K)@11; reduced acrolein addition +58(K)@13 missed K-A@11 0.243431001901627 2294.45532226563 765.8257 2294.21166992188 765.744567871094 3 21 1.1.1.3688.2 1 48.4995 852.8813 48.5187 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLR Ser->LacticAcid(S)@9; acrolein addition +56(K)@11 missed K-A@11 0.308155000209808 2249.49853515625 563.3819 2249.1904296875 563.304870605469 4 18 1.1.1.3167.6 1 35.8611 2207.232 35.9462 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLR Carboxyethyl(K)@11 missed K-A@11 0.308445006608963 2280.50463867188 571.1334 2280.19604492188 571.056335449219 4 20 1.1.1.3613.9 1 46.6866 1346.711 46.727 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLR missed K-A@11 0.355654001235962 2208.53076171875 442.7134 2208.17504882813 442.642272949219 5 17 1.1.1.3096.4 1 34.1534 3418.833 34.1925 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.4200029373169 ATEHLSTLSEKAKPALEDLR Carbamidomethyl(K)@11 missed K-A@11 0.123296000063419 2265.31982421875 567.3372 2265.19653320313 567.306396484375 4 15 1.1.1.3510.4 1 44.1656 1259.358 44.2828 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.0400004386902 ATEHLSTLSEKAKPALEDLR Carboxyethyl(K)@11 missed K-A@11 0.244004994630814 2280.44018554688 761.154 2280.19604492188 761.072631835938 3 13 1.1.1.3613.19 1 46.695 739.8818 46.727 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.6000008583069 ATEHLSTLSEKAKPALEDLR Formyl(K)@11; reduced acrolein addition +58(K)@13 missed K-A@11 -0.687184989452362 2293.52465820313 574.3884 2294.21166992188 574.560241699219 4 16 1.1.1.3687.2 1 48.4811 746.4352 48.4945 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFK missed K-A@11; missed R-Q@20 0.389250993728638 3420.25561523438 685.0584 3419.86645507813 684.980590820313 5 21 1.1.1.3941.5 1 54.7652 2942.78 54.7591 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.430002450943 ATEHLSTLSEKAKPALEDLRQGLLPVLESFK Ser->LacticAcid(S)@9; acrolein addition +56(K)@13 missed K-A@11; missed R-Q@20 0.339646011590958 3461.22143554688 866.3126 3460.8818359375 866.227722167969 4 16 1.1.1.3985.7 1 55.8226 1026.472 55.8624 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.710000038147 ATEHLSTLSEKAKPALEDLRQGLLPVLESFK reduced acrolein addition +58(K)@13; Methyl(D)@18 missed K-A@11; missed R-Q@20 0.368784010410309 3492.29272460938 699.4658 3491.923828125 699.39208984375 5 15 1.1.1.4293.4 1 63.388 350.3139 63.3038 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed K-A@11; missed R-Q@20; missed K-V@31 0.409557998180389 4787.97314453125 958.6019 4787.5634765625 958.52001953125 5 31 1.1.1.4644.5 1 72.3851 8710.146 72.5035 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK HPNE addition +172(K)@13; hexanoyl addition +98(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31 0.357674986124039 5058.103515625 1012.628 5057.74658203125 1012.556640625 5 17 1.1.1.4645.21 1 72.4189 4411.305 72.5035 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +56(K)@11 missed K-A@11; missed R-Q@20; missed K-V@31 0.450895994901657 4844.041015625 808.3474 4843.58984375 808.272277832031 6 16 1.1.1.4651.9 1 72.5678 1411.082 72.4768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK HPNE addition +172(K)@11; hexanoyl addition +98(K)@13 missed K-A@11; missed R-Q@20; missed K-V@31 0.431086003780365 5058.177734375 844.0369 5057.74658203125 843.965087890625 6 23 1.1.1.4651.11 1 72.5695 2392.137 72.5035 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed K-A@11; missed R-Q@20; missed K-V@31 0.409557998180389 4787.97314453125 958.6019 4787.5634765625 958.52001953125 5 31 1.1.1.4651.16 1 72.5737 8710.146 72.5035 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed K-A@11; missed R-Q@20; missed K-V@31 0.469909012317657 4788.03369140625 799.0129 4787.5634765625 798.9345703125 6 17 1.1.1.4657.12 1 72.7282 16257.05 72.5035 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK reduced acrolein addition +58(K)@11 missed K-A@11; missed R-Q@20; missed K-V@31 0.368182003498077 4845.9736328125 970.202 4845.60546875 970.12841796875 5 22 1.1.1.4768.20 1 75.514 1192.43 75.5457 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK reduced acrolein addition +58(K)@11 missed K-A@11; missed R-Q@20; missed K-V@31 0.432559996843338 4846.0380859375 808.6803 4845.60546875 808.608215332031 6 25 1.1.1.4769.11 1 75.5323 1006.564 75.5199 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Glucuronyl(S)@29; acrolein addition +94(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31 0.540243029594421 5058.177734375 844.0369 5057.6376953125 843.946899414063 6 26 1.1.1.4644.3 1 72.3801 2392.137 72.5035 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Carbamidomethyl(K)@11 missed K-A@11; missed R-Q@20; missed K-V@31 0.470050990581512 4845.05517578125 808.5165 4844.5849609375 808.438110351563 6 28 1.1.1.4648.12 1 72.4909 2682.482 72.4768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Carbamidomethyl(T)@7 missed K-A@11; missed R-Q@20; missed K-V@31 0.402864992618561 4844.98779296875 970.0049 4844.5849609375 969.92431640625 5 23 1.1.1.4648.20 1 72.4976 1630.829 72.4496 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Ser->LacticAcid(S)@9; acrolein addition +56(K)@13 missed K-A@11; missed R-Q@20; missed K-V@31 0.415055990219116 4828.994140625 966.8061 4828.5791015625 966.723083496094 5 26 1.1.1.4651.18 1 72.5753 7923.354 72.7408 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Dehydrated(T)@7 missed K-A@11; missed R-Q@20; missed K-V@31 0.465092986822128 4770.01806640625 796.0103 4769.55322265625 795.932800292969 6 26 1.1.1.4660.7 1 72.8036 1414.602 72.7674 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Methyl(E)@10; reduced acrolein addition +58(K)@11 missed K-A@11; missed R-Q@20; missed K-V@31 0.426310002803802 4860.04736328125 811.0152 4859.62109375 810.944152832031 6 27 1.1.1.4775.9 1 75.6845 2072.698 75.6996 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Dehydrated(T)@7; Methyl(E)@10; acrolein addition +76(K)@11 missed K-A@11; missed R-Q@20; missed K-V@31 0.390078991651535 4859.990234375 973.0053 4859.60009765625 972.927307128906 5 32 1.1.1.4776.16 1 75.7162 2297.237 75.6996 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Delta:H(4)C(2)(K)@11; reduced acrolein addition +58(K)@13 missed K-A@11; missed R-Q@20; missed K-V@31 0.427749991416931 4874.064453125 813.3514 4873.63671875 813.280090332031 6 26 1.1.1.4781.10 1 75.8421 1629.317 75.8826 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Carbamidomethyl(S)@9 missed K-A@11; missed R-Q@20; missed K-V@31 0.470050990581512 4845.05517578125 808.5165 4844.5849609375 808.438110351563 6 21 1.1.1.4641.11 1 72.3042 2682.482 72.4768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.470002412796 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK ONE addition +154(K)@13; Ser->LacticAcid(S)@29; HPNE addition +172(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31 0.440185010433197 5099.2021484375 850.8743 5098.76220703125 850.800964355469 6 20 1.1.1.4657.14 1 72.7298 1651.268 72.6882 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.1500029563904 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Dehydrated(T)@7 missed K-A@11; missed R-Q@20; missed K-V@31 0.412616014480591 4769.9658203125 955.0004 4769.55322265625 954.917907714844 5 17 1.1.1.4655.18 1 72.6806 851.6871 72.7674 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.869998216629 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Carbamidomethyl(E)@17 missed K-A@11; missed R-Q@20; missed K-V@31 0.402864992618561 4844.98779296875 970.0049 4844.5849609375 969.92431640625 5 18 1.1.1.4641.15 1 72.3076 1630.829 72.4496 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.6599991321564 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Formyl(K)@11; reduced acrolein addition +58(K)@13 missed K-A@11; missed R-Q@20; missed K-V@31 0.405494004487991 4874.005859375 975.8085 4873.6005859375 975.727355957031 5 18 1.1.1.4785.19 1 75.9543 1736.692 75.8826 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.8499977588654 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK ONE addition +154(K)@11; MDA adduct +62(K)@13; reduced acrolein addition +96(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31 -0.533935010433197 5099.2021484375 850.8743 5099.736328125 850.963317871094 6 16 1.1.1.4650.17 1 72.5482 1651.268 72.6882 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.0299985408783 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK reduced acrolein addition +58(K)@11; ONE addition +154(K)@13; Deamidated(Q)@21; hexanoyl addition +98(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31 0.374462991952896 5099.138671875 1020.835 5098.76220703125 1020.75970458984 5 15 1.1.1.4653.21 1 72.6305 1572.262 72.7408 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.6099972724915 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK HPNE addition +172(K)@11; HPNE addition +172(K)@13; reduced acrolein addition +58(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31 0.386500000953674 5190.2119140625 866.0426 5189.82568359375 865.978210449219 6 14 1.1.1.4648.17 1 72.4951 622.7555 72.5035 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.6099991798401 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK HPNE addition +172(K)@11; MDA adduct +54(K)@13; hexanoyl addition +98(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31 -0.634898006916046 5111.12255859375 852.861 5111.75732421875 852.966857910156 6 14 1.1.1.4651.12 1 72.5703 137.7836 72.5829 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 62.9100024700165 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK HPNE addition +172(K)@11; acrolein addition +94(K)@13; MDA adduct +62(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31 -0.597867012023926 5115.1337890625 1024.034 5115.73095703125 1024.15356445313 5 13 1.1.1.4647.18 1 72.4693 815.7671 72.3968 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 61.7399990558624 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK ONE addition +154(K)@11; MDA adduct +62(K)@13; reduced acrolein addition +96(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31 -0.599655985832214 5099.138671875 1020.835 5099.736328125 1020.95452880859 5 13 1.1.1.4660.17 1 72.8119 1572.262 72.7408 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 48.1599986553192 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Dehydrated(T)@7 missed K-A@11; missed R-Q@20; missed K-V@31 0.536185026168823 4770.08935546875 682.4486 4769.55322265625 682.372009277344 7 13 1.1.1.4655.7 1 72.6715 372.6195 72.7674 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 46.8899995088577 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK MDA adduct +62(K)@11; acrolein addition +94(K)@13; HPNE addition +172(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31 -0.53788298368454 5115.193359375 853.5395 5115.73095703125 853.629150390625 6 12 1.1.1.4646.8 1 72.4345 717.8174 72.424 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 41.839998960495 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK reduced HNE(H)@4; PyridoxalPhosphate(K)@11; acrolein addition +112(K)@13 missed K-A@11; missed R-Q@20; missed K-V@31 0.38654899597168 4829.119140625 690.8815 4828.73291015625 690.826232910156 7 22 1.1.1.4656.5 1 72.6992 3827.817 72.7408 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.3500000238419 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK HPNE addition +172(K)@11; HPNE addition +172(K)@13; Deamidated(Q)@21; hexanoyl addition +98(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31 0.393034994602203 5231.23388671875 872.8796 5230.8408203125 872.814086914063 6 12 1.1.1.4657.15 1 72.7307 307.979 72.6882 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.3500000238419 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Delta:H(2)C(2)(K)@11; MDA adduct +62(K)@13 missed K-A@11; missed R-Q@20; missed K-V@31 -0.556007027626038 4875.0390625 976.0151 4875.59521484375 976.126281738281 5 13 1.1.1.4781.17 1 75.848 992.0544 75.8826 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43 0.464179009199142 4916.123046875 820.3611 4915.65869140625 820.28369140625 6 22 1.1.1.4568.8 1 70.3919 1614.434 70.2851 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43 0.527032017707825 4916.185546875 703.3195 4915.65869140625 703.244201660156 7 21 1.1.1.4572.6 1 70.4924 1748.379 70.3337 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKK missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43 0.53942197561264 4916.1982421875 703.3213 4915.65869140625 703.244201660156 7 18 1.1.1.4579.8 1 70.6713 454.782 70.5603 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKK Methyl(E)@10; reduced acrolein addition +58(K)@11 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43 0.437426000833511 4988.15380859375 832.3662 4987.71630859375 832.293334960938 6 21 1.1.1.4761.8 1 75.3312 728.0597 75.4204 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.5499987602234 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKK Trimethyl(K)@11 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43 -0.553963005542755 4957.15185546875 827.1992 4957.70556640625 827.291564941406 6 18 1.1.1.4697.12 1 73.7697 479.1971 73.7823 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.2699987888336 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKK Acetyl(S)@9 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43 -0.515745997428894 4957.1533203125 827.1995 4957.66943359375 827.285461425781 6 17 1.1.1.4615.6 1 71.6134 1186.232 71.3389 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.92999792099 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKK Formyl(K)@11 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43 0.478542000055313 4944.13232421875 825.0293 4943.65380859375 824.949523925781 6 16 1.1.1.4697.11 1 73.7689 311.9303 73.7823 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 45.6299990415573 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKK Dehydrated(E)@10; reduced acrolein addition +58(K)@11; Deamidated(Q)@21 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43 0.471446007490158 4957.1455078125 827.1982 4956.673828125 827.11962890625 6 23 1.1.1.4607.7 1 71.4056 1187.23 71.3389 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 41.839998960495 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKK reduced HNE(H)@4; PyridoxalPhosphate(K)@11; acrolein addition +112(K)@13 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43 0.327549010515213 4957.1552734375 827.1998 4956.82763671875 827.145263671875 6 23 1.1.1.4600.10 1 71.225 1213.676 71.2595 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.5299980640411 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLN Deamidated(Q)@21; ONE addition +154(K)@43; acrolein addition +76(K)@44 cleaved N-T@C-term; missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 -0.472039997577667 5373.42822265625 768.6399 5373.900390625 768.707336425781 7 15 1.1.1.4692.7 1 73.6369 15353.53 73.6273 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.6099972724915 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLN HPNE addition +172(K)@43; hexanoyl addition +98(K)@44 cleaved N-T@C-term; missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 -0.535022020339966 5412.43359375 774.2121 5412.96875 774.288513183594 7 14 1.1.1.4674.9 1 73.1731 668.6191 73.0339 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 62.9100024700165 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLN Dehydrated(T)@7; HPNE addition +172(K)@43; reduced acrolein addition +58(K)@44 cleaved N-T@C-term; missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.507710993289948 5355.4345703125 893.5797 5354.9267578125 893.4951171875 6 14 1.1.1.4688.12 1 73.5368 753.1733 73.5238 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 44.3599998950958 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLN HPNE addition +172(K)@13; hexanoyl addition +98(K)@31; ONE addition +154(K)@43; acrolein addition +76(K)@44 cleaved N-T@C-term; missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 -0.525321006774902 5642.57421875 807.0893 5643.099609375 807.164367675781 7 12 1.1.1.4666.10 1 72.9657 2913.71 73.1103 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 20.4999998211861 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLN Acetyl(S)@9; HPNE addition +172(K)@43; hexanoyl addition +98(K)@44 cleaved N-T@C-term; missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.369709998369217 5455.34912109375 910.2321 5454.9794921875 910.170471191406 6 13 1.1.1.4771.15 1 75.5865 1057.256 75.6738 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.470905989408493 5244.30419921875 875.058 5243.83349609375 874.9794921875 6 18 1.1.1.4673.14 1 73.1516 453.5244 73.1363 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.533758997917175 5244.3671875 750.2026 5243.83349609375 750.126342773438 7 15 1.1.1.4674.7 1 73.1714 515.6042 73.1363 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.533758997917175 5244.3671875 750.2026 5243.83349609375 750.126342773438 7 17 1.1.1.4676.7 1 73.2271 515.6042 73.1363 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.474568009376526 5244.30810546875 875.0586 5243.83349609375 874.9794921875 6 17 1.1.1.4680.10 1 73.3291 3008.933 73.5238 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.541022002696991 5244.37451171875 750.2036 5243.83349609375 750.126342773438 7 22 1.1.1.4685.11 1 73.4593 5757.136 73.6536 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.473468989133835 5244.306640625 875.0584 5243.83349609375 874.9794921875 6 22 1.1.1.4687.15 1 73.5138 7315.438 73.6536 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT HPNE addition +172(K)@13; hexanoyl addition +98(K)@31 cleaved T-Q@C-term; missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.429520010948181 5514.44580078125 920.0816 5514.0166015625 920.010009765625 6 18 1.1.1.4688.14 1 73.5385 964.6268 73.498 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.541022002696991 5244.37451171875 750.2036 5243.83349609375 750.126342773438 7 28 1.1.1.4693.8 1 73.6638 5737.828 73.6536 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.473468989133835 5244.306640625 875.0584 5243.83349609375 874.9794921875 6 27 1.1.1.4694.9 1 73.6906 7315.438 73.6536 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.541022002696991 5244.37451171875 750.2036 5243.83349609375 750.126342773438 7 13 1.1.1.4700.6 1 73.843 5737.828 73.6536 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT Ser->LacticAcid(S)@9; acrolein addition +56(K)@11 cleaved T-Q@C-term; missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.489158987998962 5285.337890625 881.8969 5284.8486328125 881.815368652344 6 26 1.1.1.4699.13 1 73.822 4481.785 73.808 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT Methyl(E)@10; reduced acrolein addition +58(K)@11 cleaved T-Q@C-term; missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.434630990028381 5316.32568359375 887.0615 5315.890625 886.989074707031 6 20 1.1.1.4782.17 1 75.8742 1427.423 75.8826 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.6099991798401 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT Formyl(K)@11; reduced acrolein addition +58(K)@13 cleaved T-Q@C-term; missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.473554998636246 5330.34375 889.3979 5329.8701171875 889.318969726563 6 15 1.1.1.4787.16 1 76.0046 794.2575 76.0405 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 58.1499993801117 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT Dehydrated(T)@7; reduced acrolein addition +58(K)@13; Deamidated(Q)@21 cleaved T-Q@C-term; missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.554575979709625 5285.4033203125 756.0649 5284.8486328125 755.985656738281 7 14 1.1.1.4701.9 1 73.872 3609.74 73.8337 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 45.6299990415573 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT Deamidated(Q)@21 cleaved T-Q@C-term; missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.546508014202118 5245.36376953125 750.345 5244.8173828125 750.266906738281 7 12 1.1.1.4667.9 1 72.9922 347.3488 72.9537 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 34.4799995422363 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT Ser->LacticAcid(S)@9; acrolein addition +56(K)@13 cleaved T-Q@C-term; missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.429906994104385 5285.2783203125 1058.063 5284.8486328125 1057.97705078125 5 13 1.1.1.4695.20 1 73.7252 872.1587 73.8337 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.408129990100861 5372.298828125 1075.467 5371.89208984375 1075.38562011719 5 23 1.1.1.4663.20 1 72.8943 5577.916 73.0072 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.538352012634277 5372.43017578125 768.4973 5371.89208984375 768.42041015625 7 29 1.1.1.4664.8 1 72.911 25747.73 73.0339 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.482519000768662 5372.37451171875 896.403 5371.89208984375 896.322570800781 6 30 1.1.1.4666.14 1 72.969 25877.01 73.0339 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HPNE addition +172(K)@11; hexanoyl addition +98(K)@13 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.370894998311996 5642.443359375 1129.496 5642.0751953125 1129.42224121094 5 20 1.1.1.4666.21 1 72.9749 4200.797 73.1103 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ hexanoyl addition +98(K)@11; HPNE addition +172(K)@13 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.499103009700775 5642.57421875 807.0893 5642.0751953125 807.018005371094 7 17 1.1.1.4667.11 1 72.9938 2913.71 73.1103 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HPNE addition +172(K)@11; hexanoyl addition +98(K)@13 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.438935995101929 5642.51416015625 941.4263 5642.0751953125 941.353088378906 6 20 1.1.1.4667.17 1 72.9988 11977.13 73.0339 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HPNE addition +172(K)@13; hexanoyl addition +98(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.499103009700775 5642.57421875 807.0893 5642.0751953125 807.018005371094 7 22 1.1.1.4669.5 1 73.0441 2913.71 73.1103 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.408129990100861 5372.298828125 1075.467 5371.89208984375 1075.38562011719 5 31 1.1.1.4670.18 1 73.0771 5577.916 73.0072 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HPNE addition +172(K)@11; hexanoyl addition +98(K)@13 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.370894998311996 5642.443359375 1129.496 5642.0751953125 1129.42224121094 5 25 1.1.1.4673.21 1 73.1575 4200.797 73.1103 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HPNE addition +172(K)@11; hexanoyl addition +98(K)@13 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.438935995101929 5642.51416015625 941.4263 5642.0751953125 941.353088378906 6 22 1.1.1.4674.17 1 73.1797 11977.13 73.0339 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.408740013837814 5372.298828125 1075.467 5371.89208984375 1075.38562011719 5 33 1.1.1.4677.19 1 73.258 3210.304 73.2913 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.473363012075424 5372.365234375 896.4015 5371.89208984375 896.322570800781 6 32 1.1.1.4680.11 1 73.3299 14159.73 73.2913 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HPNE addition +172(K)@13; hexanoyl addition +98(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.367843002080917 5642.443359375 1129.496 5642.0751953125 1129.42224121094 5 19 1.1.1.4680.21 1 73.3383 3984.292 73.3689 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.54604297876358 5372.43798828125 768.4984 5371.89208984375 768.42041015625 7 27 1.1.1.4681.6 1 73.3514 27119.66 73.4215 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HPNE addition +172(K)@11; hexanoyl addition +98(K)@13 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.501239001750946 5642.576171875 807.0896 5642.0751953125 807.018005371094 7 23 1.1.1.4684.6 1 73.4295 2817.164 73.3956 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.409960985183716 5372.3037109375 1075.468 5371.89208984375 1075.38562011719 5 43 1.1.1.4684.17 1 73.4421 5803.045 73.4215 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ MDA adduct +54(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.461198002099991 5426.36376953125 776.2021 5425.90234375 776.13623046875 7 14 1.1.1.4685.15 1 73.4627 436.7874 73.4215 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.482519000768662 5372.37451171875 896.403 5371.89208984375 896.322570800781 6 35 1.1.1.4687.17 1 73.5154 26880.89 73.4215 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HPNE addition +172(K)@11; hexanoyl addition +98(K)@13 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.367843002080917 5642.443359375 1129.496 5642.0751953125 1129.42224121094 5 18 1.1.1.4687.21 1 73.5188 3984.292 73.3689 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HPNE addition +172(K)@13; hexanoyl addition +98(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.437471002340317 5642.5126953125 941.426 5642.0751953125 941.353088378906 6 20 1.1.1.4688.15 1 73.5393 11659.07 73.4215 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.409960985183716 5372.3037109375 1075.468 5371.89208984375 1075.38562011719 5 38 1.1.1.4691.20 1 73.6215 5700.666 73.6273 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HPNE addition +172(K)@11; hexanoyl addition +98(K)@13 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.501239001750946 5642.576171875 807.0896 5642.0751953125 807.018005371094 7 22 1.1.1.4692.11 1 73.6402 2877.672 73.3689 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ hexanoyl addition +98(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.507058024406433 5470.47216796875 782.5033 5469.96484375 782.430847167969 7 14 1.1.1.4693.11 1 73.6663 699.743 73.6797 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +56(K)@11 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.445928007364273 5428.3642578125 905.7346 5427.91796875 905.660278320313 6 15 1.1.1.4693.14 1 73.6688 1094.319 73.6536 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.546469986438751 5372.4384765625 768.4985 5371.89208984375 768.42041015625 7 29 1.1.1.4694.4 1 73.6864 25631.35 73.6273 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.482519000768662 5372.37451171875 896.403 5371.89208984375 896.322570800781 6 33 1.1.1.4694.11 1 73.6923 26500.01 73.6273 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.546469986438751 5372.4384765625 768.4985 5371.89208984375 768.42041015625 7 32 1.1.1.4695.4 1 73.7119 25631.35 73.6273 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ hexanoyl addition +98(K)@11; HPNE addition +172(K)@13 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.437471002340317 5642.5126953125 941.426 5642.0751953125 941.353088378906 6 19 1.1.1.4695.14 1 73.7202 10287.09 73.4471 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.482519000768662 5372.37451171875 896.403 5371.89208984375 896.322570800781 6 18 1.1.1.4701.16 1 73.8779 28221.49 73.6009 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.482519000768662 5372.37451171875 896.403 5371.89208984375 896.322570800781 6 20 1.1.1.4701.17 1 73.8787 28221.49 73.6009 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.54604297876358 5372.43798828125 768.4984 5371.89208984375 768.42041015625 7 16 1.1.1.4703.8 1 73.9203 21709.81 73.6536 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +58(K)@11 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.433452010154724 5430.3671875 906.0685 5429.93359375 905.996215820313 6 14 1.1.1.4774.12 1 75.6612 3662.817 75.6996 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +58(K)@11 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.433452010154724 5430.3671875 906.0685 5429.93359375 905.996215820313 6 27 1.1.1.4775.13 1 75.6879 3662.817 75.6996 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +58(K)@11 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.506253004074097 5430.43994140625 776.7844 5429.93359375 776.712097167969 7 19 1.1.1.4778.11 1 75.7642 1439.259 75.6996 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HPNE addition +172(K)@11; HPNE addition +172(K)@13; reduced acrolein addition +96(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.310326009988785 5812.4794921875 831.3615 5812.16943359375 831.317199707031 7 19 1.1.1.4788.14 1 76.0296 658.3664 76.0139 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Deamidated(N)@46 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.477750986814499 5373.353515625 896.5662 5372.8759765625 896.486572265625 6 27 1.1.1.4658.11 1 72.754 3756.638 72.7674 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl(K)@11 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.536724984645844 5429.4501953125 776.643 5428.91357421875 776.566345214844 7 24 1.1.1.4663.8 1 72.8842 6452.485 72.9537 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl(K)@11 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.472407013177872 5429.3857421875 905.9049 5428.91357421875 905.826171875 6 28 1.1.1.4665.16 1 72.9445 8450.798 72.9537 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl(K)@11 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.404489010572433 5429.318359375 1086.871 5428.91357421875 1086.78991699219 5 24 1.1.1.4665.21 1 72.9487 1720.997 72.9799 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl(K)@11 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.536724984645844 5429.4501953125 776.643 5428.91357421875 776.566345214844 7 25 1.1.1.4670.8 1 73.0687 6452.485 72.9537 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl(K)@11 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.472407013177872 5429.3857421875 905.9049 5428.91357421875 905.826171875 6 26 1.1.1.4672.18 1 73.1287 8450.798 72.9537 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Glucuronyl(S)@29; acrolein addition +94(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.60825902223587 5642.57421875 807.0893 5641.9658203125 807.002380371094 7 27 1.1.1.4677.7 1 73.248 2913.71 73.1103 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl(S)@6 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.470575988292694 5429.3837890625 905.9046 5428.91357421875 905.826171875 6 23 1.1.1.4679.13 1 73.3068 1160.261 73.2648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Glucuronyl(S)@29; acrolein addition +94(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.54662698507309 5642.5126953125 941.426 5641.9658203125 941.334899902344 6 26 1.1.1.4681.11 1 73.3555 11659.07 73.4215 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Ser->LacticAcid(S)@9; acrolein addition +56(K)@11 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.489053010940552 5413.396484375 903.24 5412.9072265625 903.158508300781 6 29 1.1.1.4689.11 1 73.5618 32744.37 73.7823 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl(S)@9 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.523479998111725 5429.43701171875 776.6411 5428.91357421875 776.566345214844 7 22 1.1.1.4694.5 1 73.6873 1041.392 73.6536 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Dehydrated(T)@7 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.474406003952026 5354.35595703125 893.3999 5353.88134765625 893.320861816406 6 29 1.1.1.4695.10 1 73.7169 4002.826 73.7823 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Ser->LacticAcid(S)@9; acrolein addition +56(K)@13 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.489053010940552 5413.396484375 903.24 5412.9072265625 903.158508300781 6 32 1.1.1.4696.7 1 73.741 31984.53 73.7823 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Dehydrated(S)@9 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.545620977878571 5354.4267578125 765.9254 5353.88134765625 765.847473144531 7 27 1.1.1.4699.8 1 73.8178 3166.635 73.7823 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Ser->LacticAcid(S)@9; acrolein addition +56(K)@13 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.426140010356903 5413.33349609375 1083.674 5412.9072265625 1083.58874511719 5 26 1.1.1.4699.21 1 73.8287 7317.078 73.7823 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Trimethyl(K)@11 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.435934990644455 5414.375 903.4031 5413.93896484375 903.330444335938 6 23 1.1.1.4761.16 1 75.3379 3343.502 75.4697 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Delta:H(4)C(2)(K)@11 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.432664006948471 5400.35595703125 901.0666 5399.92333984375 900.994506835938 6 24 1.1.1.4763.11 1 75.3858 2365.53 75.4451 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Delta:H(4)C(2)(K)@11 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.499788999557495 5400.4228515625 772.4963 5399.92333984375 772.424865722656 7 29 1.1.1.4766.9 1 75.4564 1090.791 75.4451 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Lys->Allysine(K)@11 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.467521995306015 5371.32763671875 896.2286 5370.8603515625 896.150634765625 6 22 1.1.1.4767.13 1 75.4878 1392.615 75.5457 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Trimethyl(K)@11 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.435934990644455 5414.375 903.4031 5413.93896484375 903.330444335938 6 24 1.1.1.4768.16 1 75.5107 3343.502 75.4697 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carboxyethyl(K)@11 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.473473995923996 5444.38671875 908.405 5443.9130859375 908.326110839844 6 35 1.1.1.4781.14 1 75.8455 14476.14 75.8564 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Methyl(E)@10; reduced acrolein addition +58(K)@11 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.497438997030258 5444.44677734375 778.7854 5443.94921875 778.71435546875 7 31 1.1.1.4782.10 1 75.8683 5740.807 75.8564 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Delta:H(4)C(2)(K)@11; reduced acrolein addition +58(K)@13 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.438894987106323 5458.40380859375 910.7413 5457.96484375 910.668151855469 6 31 1.1.1.4785.18 1 75.9534 9526.109 76.0139 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +58(K)@11; Formyl(K)@13 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.415051996707916 5458.34375 1092.676 5457.9287109375 1092.59301757813 5 25 1.1.1.4785.20 1 75.9551 2275.466 76.0139 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Delta:H(4)C(2)(K)@11; reduced acrolein addition +58(K)@13 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.500587999820709 5458.4658203125 780.7881 5457.96484375 780.716552734375 7 29 1.1.1.4786.17 1 75.9791 3701.599 76.0139 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HexNAc(S)@9; acrolein addition +112(K)@11; acrolein addition +112(K)@13 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 -0.625127017498016 5798.451171875 829.3574 5799.076171875 829.446716308594 7 22 1.1.1.4782.15 1 75.8725 936.8329 75.8564 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HPNE addition +172(K)@11; HPNE addition +172(K)@13; GlycerylPE(E)@17 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 -0.497767001390457 5912.6591796875 986.4505 5913.1572265625 986.533447265625 6 21 1.1.1.4670.14 1 73.0737 2682.041 73.1363 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Deamidated(N)@46 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.53999400138855 5373.416015625 768.6381 5372.8759765625 768.560974121094 7 19 1.1.1.4652.3 1 72.5891 2993.379 72.7674 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Trimethyl(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 -0.556863009929657 5413.3818359375 903.2376 5413.93896484375 903.330444335938 6 20 1.1.1.4667.16 1 72.998 2396.071 72.927 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carboxyethyl(K)@11 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.400550007820129 5444.3134765625 1089.87 5443.9130859375 1089.78991699219 5 20 1.1.1.4778.20 1 75.7717 3169.118 75.8564 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.3900010585785 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ MDA adduct +62(K)@11; ONE addition +154(K)@13; acrolein addition +112(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 -0.465411007404327 5699.59375 815.235 5700.0595703125 815.301452636719 7 18 1.1.1.4676.8 1 73.2288 758.6635 73.0339 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2299983501434 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl(T)@7 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 -0.535039007663727 5428.37841796875 905.737 5428.91357421875 905.826171875 6 19 1.1.1.4686.6 1 73.4829 1068.867 73.4215 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.1500029563904 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Trimethyl(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 -0.542581021785736 5413.396484375 903.24 5413.93896484375 903.330444335938 6 19 1.1.1.4703.14 1 73.9253 31984.53 73.7823 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.869998216629 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Dehydrated(T)@7 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.545620977878571 5354.4267578125 765.9254 5353.88134765625 765.847473144531 7 18 1.1.1.4692.6 1 73.636 3166.635 73.7823 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.5499987602234 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl(S)@6 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.535871028900146 5429.44921875 776.6429 5428.91357421875 776.566345214844 7 18 1.1.1.4678.13 1 73.2795 5156.246 73.0072 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8999981880188 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Dehydrated(E)@10; reduced acrolein addition +58(K)@13; Deamidated(Q)@21 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.550625026226044 5413.4580078125 774.3584 5412.9072265625 774.279724121094 7 21 1.1.1.4700.9 1 73.8455 31212.58 73.7823 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.9100008010864 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Ser->LacticAcid(S)@29; acrolein addition +38(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.460067003965378 5395.35693359375 900.2334 5394.896484375 900.15673828125 6 18 1.1.1.4666.15 1 72.9699 303.1856 72.9537 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.8499977588654 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ hexanoyl addition +98(K)@11; reduced acrolein addition +58(K)@13; ONE addition +154(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.446575999259949 5682.552734375 948.0994 5682.1064453125 948.025024414063 6 16 1.1.1.4697.20 1 73.7764 1133.473 73.6797 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.8499977588654 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Deamidated(N)@46 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.500455975532532 5373.37646484375 896.57 5372.8759765625 896.486572265625 6 16 1.1.1.4701.18 1 73.8795 17877.59 73.6273 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.6099996566772 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Ser->Oxoalanine(S)@33; Deamidated(N)@46 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 -0.552423000335693 5370.30859375 1075.069 5370.8603515625 1075.17932128906 5 18 1.1.1.4656.9 1 72.7092 358.0748 72.6882 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.6099996566772 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Dehydrated(T)@7; reduced acrolein addition +58(K)@11; reduced acrolein addition +58(K)@13 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.434134006500244 5470.3994140625 912.7405 5469.96484375 912.668151855469 6 17 1.1.1.4665.17 1 72.9453 743.4191 72.9537 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.8199996948242 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Phosphopantetheine(S)@29; MDA adduct +62(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.543672978878021 5774.537109375 963.4301 5773.9931640625 963.339477539063 6 18 1.1.1.4683.19 1 73.4165 338.1959 73.3689 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.5400009155273 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ hexanoyl addition +98(K)@11; reduced acrolein addition +58(K)@13; Deamidated(Q)@21; ONE addition +154(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.440344005823135 5683.53076171875 948.2624 5683.09033203125 948.189025878906 6 16 1.1.1.4699.19 1 73.827 1924.467 73.6797 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9300010204315 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Deamidated(Q)@21; Deamidated(N)@46 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 -0.491982012987137 5373.3681640625 896.5686 5373.85986328125 896.650573730469 6 16 1.1.1.4674.14 1 73.1772 17263.5 73.0339 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.2699987888336 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Delta:H(2)C(2)(K)@11; acrolein addition +56(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 -0.502583980560303 5453.43115234375 909.9125 5453.93359375 909.996215820313 6 18 1.1.1.4702.11 1 73.9016 2357.497 73.8871 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.1700010299683 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Dehydrated(T)@7; reduced acrolein addition +58(K)@11; Deamidated(Q)@21; Deamidated(N)@46 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.554401993751526 5414.44580078125 774.4995 5413.89111328125 774.420288085938 7 17 1.1.1.4664.9 1 72.9119 2036.325 72.9001 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.92999792099 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Deamidated(N)@46 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.477750986814499 5373.353515625 896.5662 5372.8759765625 896.486572265625 6 15 1.1.1.4651.14 1 72.572 3707.379 72.7674 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.92999792099 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ MDA adduct +62(K)@11; HPNE addition +172(K)@13; acrolein addition +94(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 -0.525273025035858 5699.5341796875 950.9296 5700.0595703125 951.017150878906 6 15 1.1.1.4664.16 1 72.9177 2644.58 72.9799 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.92999792099 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ MDA adduct +62(K)@11; HPNE addition +172(K)@13; acrolein addition +94(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 -0.536991000175476 5699.5224609375 950.9277 5700.0595703125 951.017150878906 6 15 1.1.1.4686.8 1 73.4862 671.2871 73.4215 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.92999792099 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl(E)@10 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.533734023571014 5429.447265625 776.6426 5428.91357421875 776.566345214844 7 16 1.1.1.4687.11 1 73.5104 1128.88 73.3956 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.92999792099 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Dehydrated(T)@7 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.422479003667831 5354.3037109375 1071.868 5353.88134765625 1071.78356933594 5 16 1.1.1.4693.21 1 73.6746 776.9146 73.7823 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.5100016593933 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Dehydrated(E)@10; Deamidated(Q)@21 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.506259977817535 5355.37158203125 893.5692 5354.865234375 893.48486328125 6 16 1.1.1.4695.11 1 73.7177 2393.637 73.6797 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.6099972724915 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Dehydrated(T)@7 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.513225018978119 5354.39453125 893.4064 5353.88134765625 893.320861816406 6 15 1.1.1.4667.15 1 72.9972 679.5839 72.9537 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.6099972724915 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HPNE addition +172(K)@11; HPNE addition +172(K)@13; reduced acrolein addition +58(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.394715011119843 5774.54833984375 963.432 5774.15380859375 963.3662109375 6 14 1.1.1.4668.13 1 73.0221 620.5689 72.9799 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.6099972724915 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamyl(R)@20; acrolein addition +38(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.318062990903854 5453.23388671875 1091.654 5452.91357421875 1091.58996582031 5 14 1.1.1.4670.19 1 73.0779 151.3464 73.0591 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.6099972724915 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ ONE addition +154(K)@11; hexanoyl addition +98(K)@13; acrolein addition +76(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.488988012075424 5700.5849609375 815.3765 5700.095703125 815.306640625 7 14 1.1.1.4680.8 1 73.3274 532.8862 73.0591 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.6099972724915 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HPNE addition +172(K)@11; reduced acrolein addition +58(K)@13; ONE addition +154(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.407476991415024 5756.55078125 960.4324 5756.14306640625 960.364440917969 6 14 1.1.1.4688.16 1 73.541 258.6721 73.5494 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.6099972724915 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +38(K)@11; acrolein addition +76(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 -0.519876003265381 5485.4189453125 915.2438 5485.93896484375 915.330444335938 6 14 1.1.1.4781.15 1 75.8463 983.1086 75.9349 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.6099991798401 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HPNE addition +172(K)@11; hexanoyl addition +98(K)@13; Deamidated(N)@46 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.460168987512589 5643.51904296875 941.5938 5643.05908203125 941.51708984375 6 14 1.1.1.4660.13 1 72.8086 6597.481 73.0072 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.9000005722046 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 -1.88467001914978 5370.00732421875 896.0085 5371.89208984375 896.322570800781 6 14 1.1.1.4715.3 1 74.214 2364.631 74.2031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.9000005722046 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ ONE addition +154(K)@11; hexanoyl addition +98(K)@13; Deamidated(Q)@21; hexanoyl addition +98(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.3992780148983 5723.52099609375 954.9274 5723.12158203125 954.860900878906 6 14 1.1.1.4781.16 1 75.8471 408.3244 75.8301 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.4099977016449 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Dehydrated(S)@9; reduced acrolein addition +58(K)@13; Deamidated(Q)@21 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.54934298992157 5413.45654296875 774.3582 5412.9072265625 774.279724121094 7 15 1.1.1.4683.11 1 73.4081 12789.85 73.6536 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.8299977779388 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 -1.83010005950928 5370.06201171875 896.0176 5371.89208984375 896.322570800781 6 14 1.1.1.4708.7 1 74.0427 1970.428 73.9606 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 76.2799978256226 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ MDA adduct +62(K)@11; MDA adduct +62(K)@13; acrolein addition +38(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.4809789955616 5534.419921875 923.4106 5533.93896484375 923.330444335938 6 13 1.1.1.4664.13 1 72.9152 719.2031 72.927 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 76.2799978256226 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +58(K)@13 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 -0.549825012683868 5429.3837890625 905.9046 5429.93359375 905.996215820313 6 13 1.1.1.4678.17 1 73.2829 1160.261 73.2648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 76.2799978256226 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +58(K)@11; HPNE addition +172(K)@13; acrolein addition +94(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.380030989646912 5696.4658203125 950.4182 5696.08544921875 950.354858398438 6 13 1.1.1.4683.18 1 73.4148 308.4141 73.3956 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 73.5199987888336 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Delta:H(2)C(2)(K)@11; acrolein addition +56(K)@13 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.481424987316132 5454.4150390625 910.0765 5453.93359375 909.996215820313 6 14 1.1.1.4697.15 1 73.7722 3392.006 73.8871 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 65.1899993419647 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HPNE addition +172(K)@13; Deamidated(Q)@21; ONE addition +154(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.398627996444702 5699.48388671875 1140.904 5699.08544921875 1140.82434082031 5 12 1.1.1.4664.21 1 72.9219 747.1415 72.9799 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 65.1899993419647 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HPNE addition +172(K)@11; HPNE addition +172(K)@13; reduced acrolein addition +58(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.396912008523941 5774.55078125 963.4324 5774.15380859375 963.3662109375 6 12 1.1.1.4690.12 1 73.5883 301.8877 73.6273 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 65.1899993419647 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Dehydrated(T)@7; acrolein addition +38(K)@11; MDA adduct +62(K)@13 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.574501991271973 5454.4873046875 780.2197 5453.91259765625 780.137634277344 7 14 1.1.1.4694.7 1 73.6889 2803.279 73.8871 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 62.9100024700165 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HPNE addition +172(K)@13; Deamidated(Q)@21; ONE addition +154(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.448846995830536 5699.5341796875 950.9296 5699.08544921875 950.854797363281 6 13 1.1.1.4663.16 1 72.8909 2644.58 72.9799 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 61.7399990558624 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ ONE addition +154(K)@11; reduced acrolein addition +58(K)@13; Deamidated(Q)@21; hexanoyl addition +98(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.440344005823135 5683.53076171875 948.2624 5683.09033203125 948.189025878906 6 13 1.1.1.4692.17 1 73.6452 1924.467 73.6797 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 59.35999751091 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Oxidation(P)@25 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.454766988754272 5388.341796875 899.0642 5387.88671875 898.988403320313 6 13 1.1.1.4665.14 1 72.9428 264.1321 72.9537 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 51.9599974155426 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +58(K)@11; MDA adduct +54(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 -0.553566992282867 5483.390625 784.3488 5483.9443359375 784.427917480469 7 12 1.1.1.4665.9 1 72.9386 194.7745 72.9537 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 51.9599974155426 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HPNE addition +172(K)@11; reduced acrolein addition +96(K)@13; hexanoyl addition +98(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.393139004707336 5738.52587890625 957.4282 5738.13232421875 957.362670898438 6 12 1.1.1.4783.15 1 75.8988 397.5702 75.8564 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 48.1599986553192 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ hexanoyl addition +98(K)@31; ONE addition +154(K)@43; reduced acrolein addition +58(K)@44 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.419476002454758 5682.52587890625 948.0949 5682.1064453125 948.025024414063 6 12 1.1.1.4674.18 1 73.1806 351.736 73.1626 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 48.1599986553192 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +38(K)@13; acrolein addition +76(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 -0.519876003265381 5485.4189453125 915.2438 5485.93896484375 915.330444335938 6 12 1.1.1.4788.18 1 76.0329 983.1086 75.9349 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 46.8899995088577 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +58(K)@11; hexanoyl addition +98(K)@13; acrolein addition +76(K)@31; acrolein addition +38(K)@43 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.480497986078262 5642.5341796875 807.0836 5642.0537109375 807.014953613281 7 11 1.1.1.4652.4 1 72.5899 208.7096 72.6356 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 46.8899995088577 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +58(K)@11; acrolein addition +112(K)@13; acrolein addition +112(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.468728989362717 5654.50732421875 943.4252 5654.03857421875 943.347045898438 6 12 1.1.1.4681.12 1 73.3564 217.5229 73.4215 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 45.6299990415573 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HPNE addition +172(K)@13; hexanoyl addition +98(K)@31; Deamidated(N)@46 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.43197101354599 5643.4912109375 941.5891 5643.05908203125 941.51708984375 6 12 1.1.1.4653.18 1 72.628 808.509 72.6882 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 45.6299990415573 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Dehydrated(T)@7; reduced acrolein addition +58(K)@13; Deamidated(Q)@21; Deamidated(N)@46 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.486849009990692 5414.3779296875 903.4036 5413.89111328125 903.322509765625 6 14 1.1.1.4659.15 1 72.7839 2747.511 72.9001 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 41.839998960495 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 -11.9729995727539 5359.9189453125 894.3271 5371.89208984375 896.322570800781 6 12 1.1.1.4722.19 1 74.3918 43947.24 74.1303 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 41.839998960495 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +58(K)@11; Formyl(K)@13 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.475279986858368 5458.40380859375 910.7413 5457.9287109375 910.662048339844 6 13 1.1.1.4794.17 1 76.1904 9526.109 76.0139 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 40.5900001525879 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Trimethyl(K)@13 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 -0.495535999536514 5413.443359375 774.3563 5413.93896484375 774.427124023438 7 13 1.1.1.4771.7 1 75.5798 1341.778 75.4697 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.3500000238419 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ ONE addition +154(K)@11; reduced acrolein addition +58(K)@13; Deamidated(Q)@21; hexanoyl addition +98(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.440344005823135 5683.53076171875 948.2624 5683.09033203125 948.189025878906 6 12 1.1.1.4683.17 1 73.4131 601.4332 73.4215 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.3500000238419 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Dehydrated(T)@7; MDA adduct +54(K)@13; acrolein addition +38(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 -0.524586975574493 5445.3828125 908.5711 5445.90771484375 908.658508300781 6 13 1.1.1.4776.13 1 75.7137 9004.049 75.8564 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 32.1200013160706 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 -3.22902989387512 5368.6630859375 895.7844 5371.89208984375 896.322570800781 6 12 1.1.1.4761.14 1 75.3362 596.8944 75.274 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 22.4199995398521 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Dehydrated(E)@10; Deamidated(Q)@21; reduced acrolein addition +58(K)@31 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.550625026226044 5413.4580078125 774.3584 5412.9072265625 774.279724121094 7 13 1.1.1.4691.8 1 73.6114 31212.58 73.7823 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 15.2999997138977 ATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ MDA adduct +54(K)@13; Deamidated(Q)@21; Oxidation(P)@25 missed K-A@11; missed R-Q@20; missed K-V@31; missed K-K@43; missed K-L@44 0.459210008382797 5443.3408203125 908.2307 5442.88134765625 908.154174804688 6 12 1.1.1.4790.14 1 76.0823 1922.531 75.9349 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.3299975395203 ATVYVDVLKDSGRDYVSQFEGSALGK Lys-add@N-term; acrolein addition +76(K)@9 cleaved L-A@N-term; missed K-D@9; missed R-D@13 0.121919997036457 3007.65209960938 1003.558 3007.52905273438 1003.51696777344 3 14 1.1.1.3380.11 1 40.9772 3793.885 40.7194 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.3100011348724 ATVYVDVLKDSGRDYVSQFEGSALGK Lys-add@N-term; acrolein addition +76(K)@9 cleaved L-A@N-term; missed K-D@9; missed R-D@13 0.123934999108315 3007.65209960938 1003.558 3007.52905273438 1003.51696777344 3 14 1.1.1.3359.12 1 40.4698 3822.635 40.5249 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.3100011348724 ATVYVDVLKDSGRDYVSQFEGSALGK Lys-add@N-term; acrolein addition +76(K)@9 cleaved L-A@N-term; missed K-D@9; missed R-D@13 0.123934999108315 3007.65209960938 1003.558 3007.52905273438 1003.51696777344 3 14 1.1.1.3366.18 1 40.6387 3822.635 40.5249 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.3100011348724 ATVYVDVLKDSGRDYVSQFEGSALGK Lys-add@N-term; acrolein addition +76(K)@9 cleaved L-A@N-term; missed K-D@9; missed R-D@13 0.122836001217365 3007.65209960938 1003.558 3007.52905273438 1003.51696777344 3 14 1.1.1.3373.10 1 40.8075 3809.291 40.7194 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 36.0300004482269 ATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK HPNE addition +172(K)@26; acrolein addition +56(K)@31; Dioxidation(W)@36 cleaved L-A@N-term; missed K-D@9; missed R-D@13; missed K-Q@26; missed K-L@31 0.476094990968704 5254.13720703125 876.6968 5253.6611328125 876.617431640625 6 12 1.1.1.4332.6 1 64.4008 509.7997 64.4973 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 25.3600001335144 DALRTHLAPYSDELRQRLAAR cleaved V-D@N-term; missed R-T@4; missed R-Q@15; missed R-L@17 -5.70969009399414 2445.59985351563 612.4072 2451.3095703125 613.834655761719 4 12 1.1.1.3343.4 1 40.0737 2876.168 40.1146 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR cleaved Q-D@N-term 0.155625000596046 1225.69201660156 613.8533 1225.53637695313 613.775451660156 2 16 1.1.1.2906.7 1 29.5885 135937.7 29.8162 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR cleaved Q-D@N-term 0.156234994530678 1225.69262695313 613.8536 1225.53637695313 613.775451660156 2 16 1.1.1.2967.9 1 31.062 23921.69 30.8036 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR cleaved Q-D@N-term 0.154037997126579 1225.6904296875 613.8525 1225.53637695313 613.775451660156 2 15 1.1.1.2982.13 1 31.4196 17683.04 31.1868 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR cleaved Q-D@N-term 0.154282003641129 1225.69067382813 613.8526 1225.53637695313 613.775451660156 2 15 1.1.1.2989.10 1 31.5889 12947.81 31.3307 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR cleaved Q-D@N-term 0.156234994530678 1225.69262695313 613.8536 1225.53637695313 613.775451660156 2 15 1.1.1.2936.12 1 30.3149 96316.14 30.2992 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR cleaved Q-D@N-term 0.156234994530678 1225.69262695313 613.8536 1225.53637695313 613.775451660156 2 15 1.1.1.2975.12 1 31.2519 20152.17 30.9953 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR cleaved Q-D@N-term 0.156234994530678 1225.69262695313 613.8536 1225.53637695313 613.775451660156 2 15 1.1.1.2946.11 1 30.5548 96182.95 30.2992 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR cleaved Q-D@N-term 0.155869007110596 1225.69226074219 613.8534 1225.53637695313 613.775451660156 2 15 1.1.1.2960.6 1 30.891 38523.6 30.6353 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDR cleaved Q-D@N-term 0.155869007110596 1225.69226074219 613.8534 1225.53637695313 613.775451660156 2 15 1.1.1.2915.8 1 29.8061 165514.7 29.8645 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.990002155304 DEPPQSPWDR cleaved Q-D@N-term 0.158309996128082 1225.69470214844 613.8546 1225.53637695313 613.775451660156 2 13 1.1.1.2996.7 1 31.7575 7529.117 31.4982 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.4100022315979 DEPPQSPWDR cleaved Q-D@N-term 0.21060399711132 1225.74694824219 409.5896 1225.53637695313 409.519409179688 3 13 1.1.1.2953.2 1 30.7107 11607.39 30.4674 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.6900019645691 DEPPQSPWDR cleaved Q-D@N-term 0.21060399711132 1225.74694824219 409.5896 1225.53637695313 409.519409179688 3 13 1.1.1.2939.2 1 30.3745 14000.35 30.3954 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.6900019645691 DEPPQSPWDR cleaved Q-D@N-term 0.213350996375084 1225.74975585938 409.5905 1225.53637695313 409.519409179688 3 13 1.1.1.2968.3 1 31.0726 3042.643 30.9714 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.3099985122681 DEPPQSPWDR cleaved Q-D@N-term 0.210328996181488 1225.74670410156 409.5895 1225.53637695313 409.519409179688 3 13 1.1.1.2910.2 1 29.6742 15065.73 29.8645 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9199993610382 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.152245998382568 1257.67846679688 629.8465 1257.52624511719 629.770385742188 2 14 1.1.1.2702.6 1 24.7151 420.4809 24.6482 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9199993610382 DEPPQSPWDR cleaved Q-D@N-term 0.156234994530678 1225.69262695313 613.8536 1225.53637695313 613.775451660156 2 13 1.1.1.2899.6 1 29.4251 38995.51 29.6469 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9199993610382 DEPPQSPWDR cleaved Q-D@N-term 0.155869007110596 1225.69226074219 613.8534 1225.53637695313 613.775451660156 2 13 1.1.1.2910.11 1 29.6867 164316.4 29.8645 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9199993610382 DEPPQSPWDR cleaved Q-D@N-term 0.210328996181488 1225.74670410156 409.5895 1225.53637695313 409.519409179688 3 13 1.1.1.2917.2 1 29.8443 15170.09 29.8645 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9199993610382 DEPPQSPWDR cleaved Q-D@N-term 0.21060399711132 1225.74694824219 409.5896 1225.53637695313 409.519409179688 3 13 1.1.1.2946.3 1 30.5431 14000.35 30.3954 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9199993610382 DEPPQSPWDR cleaved Q-D@N-term 0.21060399711132 1225.74694824219 409.5896 1225.53637695313 409.519409179688 3 13 1.1.1.2975.3 1 31.2386 2914.502 31.2108 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.1899983882904 DEPPQSPWDR Oxidation(P)@7 cleaved Q-D@N-term 0.154361993074417 1241.68566894531 621.8501 1241.53125 621.772888183594 2 12 1.1.1.2681.6 1 24.2119 253.9231 24.1453 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.1899983882904 DEPPQSPWDR cleaved Q-D@N-term 0.155869007110596 1225.69226074219 613.8534 1225.53637695313 613.775451660156 2 12 1.1.1.2927.14 1 30.0977 168770 29.8403 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.154442995786667 1257.6806640625 629.8476 1257.52624511719 629.770385742188 2 11 1.1.1.2602.13 1 22.3127 609.443 22.4881 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.149072006344795 1257.67529296875 629.8449 1257.52624511719 629.770385742188 2 14 1.1.1.2657.12 1 23.632 1047.027 23.591 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 DEPPQSPWDR Oxidation(P)@7 cleaved Q-D@N-term 0.205649003386497 1241.73693847656 414.9196 1241.53125 414.851043701172 3 12 1.1.1.2667.3 1 23.8588 988.0931 23.903 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term 0.153142005205154 1229.68444824219 615.8495 1229.53125 615.772888183594 2 13 1.1.1.2714.11 1 24.997 1855.658 24.9592 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.154442995786667 1257.6806640625 629.8476 1257.52624511719 629.770385742188 2 14 1.1.1.2760.12 1 26.097 36643.08 26.1278 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term 0.158147007226944 1229.689453125 615.852 1229.53125 615.772888183594 2 13 1.1.1.2792.8 1 26.865 1723.188 26.7034 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 DEPPQSPWDR Deamidated(Q)@5 cleaved Q-D@N-term 0.234584003686905 1226.75500488281 409.9256 1226.52038574219 409.847412109375 3 13 1.1.1.2976.2 1 31.2635 1294.254 31.2348 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2300000190735 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term 0.153385996818542 1229.68469238281 615.8496 1229.53125 615.772888183594 2 13 1.1.1.2721.7 1 25.1691 2151.687 25.1265 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.7300004959106 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.154442995786667 1257.6806640625 629.8476 1257.52624511719 629.770385742188 2 14 1.1.1.2767.20 1 26.2665 36643.08 26.1278 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.7300004959106 DEPPQSPWDR Oxidation(W)@8 cleaved Q-D@N-term 0.158147007226944 1241.689453125 621.852 1241.53125 621.772888183594 2 13 1.1.1.2801.7 1 27.0728 1123.764 26.9415 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.6699974536896 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term 0.210776001214981 1229.74206542969 410.9213 1229.53125 410.851043701172 3 13 1.1.1.2785.3 1 26.6899 2578.56 26.6795 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.6699974536896 DEPPQSPWDR cleaved Q-D@N-term 0.155869007110596 1225.69226074219 613.8534 1225.53637695313 613.775451660156 2 12 1.1.1.2918.11 1 29.8785 165514.7 29.8645 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1099998950958 DEPPQSPWDR Oxidation(W)@8 cleaved Q-D@N-term 0.212606996297836 1241.74389648438 414.9219 1241.53125 414.851043701172 3 12 1.1.1.2598.3 1 22.1995 304.7159 22.0632 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1099998950958 DEPPQSPWDR Oxidation(P)@7 cleaved Q-D@N-term 0.154361993074417 1241.68566894531 621.8501 1241.53125 621.772888183594 2 13 1.1.1.2776.14 1 26.4815 911.9147 26.4883 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.5299990177155 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.210032999515533 1257.73620605469 420.2527 1257.52624511719 420.182678222656 3 9 1.1.1.2615.4 1 22.6165 179.8483 22.5365 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.5299990177155 DEPPQSPWDR Oxidation(W)@8 cleaved Q-D@N-term 0.158147007226944 1241.689453125 621.852 1241.53125 621.772888183594 2 12 1.1.1.2719.11 1 25.1197 460.9206 25.1026 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.3100011348724 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.209482997655869 1257.73571777344 420.2525 1257.52624511719 420.182678222656 3 11 1.1.1.2746.5 1 25.7513 3329.538 25.9838 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.8599989414215 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.154199004173279 1257.68041992188 629.8475 1257.52624511719 629.770385742188 2 13 1.1.1.2682.9 1 24.2334 496.7265 24.1931 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.7599980831146 DEPPQSPWDR Oxidation(W)@8 cleaved Q-D@N-term 0.210501000285149 1241.74182128906 414.9212 1241.53125 414.851043701172 3 12 1.1.1.2589.2 1 21.9837 339.4786 21.8967 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.7599980831146 DEPPQSPWDR Oxidation(W)@8 cleaved Q-D@N-term 0.151310995221138 1241.6826171875 621.8486 1241.53125 621.772888183594 2 11 1.1.1.2663.10 1 23.7755 506.7515 23.8306 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.7599980831146 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.151635006070137 1257.67785644531 629.8462 1257.52624511719 629.770385742188 2 13 1.1.1.2668.12 1 23.8946 1143.603 23.8788 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.7599980831146 DEPPQSPWDR Trp->Hydroxykynurenin(W)@8 cleaved Q-D@N-term 0.152856007218361 1245.67907714844 623.8468 1245.52624511719 623.770385742188 2 13 1.1.1.2695.6 1 24.5422 1266.668 24.5765 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.7599980831146 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.15480899810791 1257.68103027344 629.8478 1257.52624511719 629.770385742188 2 13 1.1.1.2787.5 1 26.746 12006.93 26.6556 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 77.8599977493286 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.149072006344795 1257.67529296875 629.8449 1257.52624511719 629.770385742188 2 12 1.1.1.2649.14 1 23.4431 1047.027 23.591 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 75.9599983692169 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.154687002301216 1257.68090820313 629.8477 1257.52624511719 629.770385742188 2 14 1.1.1.2780.5 1 26.5754 18832.24 26.3199 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.9599993228912 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term 0.156803995370865 1229.68811035156 615.8513 1229.53125 615.772888183594 2 12 1.1.1.2807.5 1 27.2226 667.901 27.2277 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 73.9300012588501 DEPPQSPWDR Oxidation(W)@8 cleaved Q-D@N-term 0.156803995370865 1241.68811035156 621.8513 1241.53125 621.772888183594 2 11 1.1.1.2767.19 1 26.2648 942.9097 26.2238 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 73.9300012588501 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term 0.159366995096207 1229.69067382813 615.8526 1229.53125 615.772888183594 2 12 1.1.1.2781.12 1 26.601 1770.899 26.6317 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 73.9300012588501 DEPPQSPWDR Deamidated(Q)@5 cleaved Q-D@N-term 0.233118996024132 1226.75354003906 409.9251 1226.52038574219 409.847412109375 3 12 1.1.1.2958.3 1 30.8406 1733.677 30.8036 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 72.8600025177002 DEPPQSPWDR Oxidation(W)@8 cleaved Q-D@N-term 0.151921004056931 1241.68322753906 621.8489 1241.53125 621.772888183594 2 11 1.1.1.2597.6 1 22.1826 331.6738 22.1131 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 72.8600025177002 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term 0.155582994222641 1229.68688964844 615.8507 1229.53125 615.772888183594 2 12 1.1.1.2773.8 1 26.4112 2843.537 26.3681 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.6300020217896 DEPPQSPWDR Oxidation(W)@8 cleaved Q-D@N-term 0.151310995221138 1241.6826171875 621.8486 1241.53125 621.772888183594 2 10 1.1.1.2621.8 1 22.7712 236.1156 22.7311 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.6300020217896 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.154687002301216 1257.68090820313 629.8477 1257.52624511719 629.770385742188 2 13 1.1.1.2753.9 1 25.9307 36783.91 26.1038 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.6300020217896 DEPPQSPWDR Oxidation(P)@7 cleaved Q-D@N-term 0.154606997966766 1241.68591308594 621.8502 1241.53125 621.772888183594 2 12 1.1.1.2783.5 1 26.6471 1301.016 26.6556 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.6300020217896 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term 0.155582994222641 1229.68688964844 615.8507 1229.53125 615.772888183594 2 12 1.1.1.2799.6 1 27.0319 1077.577 27.0131 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.6300020217896 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.214609995484352 1257.74084472656 420.2542 1257.52624511719 420.182678222656 3 12 1.1.1.2820.6 1 27.5225 903.2451 27.5138 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.4599986076355 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term 0.208945006132126 1229.740234375 410.9207 1229.53125 410.851043701172 3 13 1.1.1.2766.2 1 26.2293 2180.871 26.1758 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.4599986076355 DEPPQSPWDR Oxidation(P)@7 cleaved Q-D@N-term 0.158390998840332 1241.68969726563 621.8521 1241.53125 621.772888183594 2 12 1.1.1.2810.6 1 27.2942 848.1429 27.2515 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.410001039505 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.210032999515533 1257.73620605469 420.2527 1257.52624511719 420.182678222656 3 11 1.1.1.2614.3 1 22.5979 179.8483 22.5365 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.410001039505 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.154442995786667 1257.6806640625 629.8476 1257.52624511719 629.770385742188 2 12 1.1.1.2616.6 1 22.6512 617.1384 22.4881 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.410001039505 DEPPQSPWDR Oxidation(P)@7 cleaved Q-D@N-term 0.158512994647026 1241.68981933594 621.8522 1241.53125 621.772888183594 2 12 1.1.1.2727.8 1 25.3118 651.8002 25.3406 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.410001039505 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term 0.155217006802559 1229.6865234375 615.8505 1229.53125 615.772888183594 2 12 1.1.1.2729.6 1 25.3593 1198.567 25.3406 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.410001039505 DEPPQSPWDR Oxidation(P)@7 cleaved Q-D@N-term 0.15497300028801 1241.68627929688 621.8504 1241.53125 621.772888183594 2 12 1.1.1.2751.7 1 25.8802 1395.064 26.0558 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.410001039505 DEPPQSPWDR Oxidation(W)@8 cleaved Q-D@N-term 0.15497300028801 1241.68627929688 621.8504 1241.53125 621.772888183594 2 12 1.1.1.2758.9 1 26.0507 1410.933 26.0558 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.0599975585938 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.152612000703812 1257.67883300781 629.8467 1257.52624511719 629.770385742188 2 11 1.1.1.2692.13 1 24.4705 412.3867 24.4084 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.0599975585938 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.210399001836777 1257.73657226563 420.2528 1257.52624511719 420.182678222656 3 12 1.1.1.2760.5 1 26.0854 5309.224 26.0798 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.0599975585938 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.210948005318642 1257.73718261719 420.253 1257.52624511719 420.182678222656 3 12 1.1.1.2773.3 1 26.3986 2583.839 26.3681 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.0599975585938 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.210673004388809 1257.73681640625 420.2529 1257.52624511719 420.182678222656 3 12 1.1.1.2787.2 1 26.7335 2335.532 26.7034 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.0599975585938 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.209482997655869 1257.73571777344 420.2525 1257.52624511719 420.182678222656 3 12 1.1.1.2794.3 1 26.9026 1782.494 26.8701 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.0599975585938 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.155296996235847 1257.68151855469 629.848 1257.52624511719 629.770385742188 2 12 1.1.1.2808.7 1 27.244 4906.948 27.2038 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.2400004863739 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.155053004622459 1257.68127441406 629.8479 1257.52624511719 629.770385742188 2 12 1.1.1.2738.6 1 25.5693 5465.501 25.792 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.2400004863739 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.154687002301216 1257.68090820313 629.8477 1257.52624511719 629.770385742188 2 12 1.1.1.2746.11 1 25.7613 21757.05 25.9838 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.2400004863739 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.155296996235847 1257.68151855469 629.848 1257.52624511719 629.770385742188 2 12 1.1.1.2794.5 1 26.9093 11854.17 26.6795 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.2400004863739 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.155419006943703 1257.681640625 629.8481 1257.52624511719 629.770385742188 2 12 1.1.1.2801.8 1 27.0745 5136.15 27.0846 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.2400004863739 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.215159997344017 1257.74133300781 420.2544 1257.52624511719 420.182678222656 3 12 1.1.1.2811.3 1 27.3046 963.3939 27.1561 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.2400004863739 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.157495006918907 1257.68371582031 629.8491 1257.52624511719 629.770385742188 2 12 1.1.1.2822.6 1 27.5768 3126.399 27.466 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.2400004863739 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.154442995786667 1257.6806640625 629.8476 1257.52624511719 629.770385742188 2 12 1.1.1.2829.10 1 27.7469 2017.345 27.7281 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.2400004863739 DEPPQSPWDR Amidated@C-term cleaved Q-D@N-term 0.152702003717422 1224.705078125 613.3598 1224.55236816406 613.283447265625 2 12 1.1.1.2892.8 1 29.2568 852.5736 29.2618 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 58.7700009346008 DEPPQSPWDR Oxidation(W)@8 cleaved Q-D@N-term 0.212606996297836 1241.74389648438 414.9219 1241.53125 414.851043701172 3 11 1.1.1.2613.3 1 22.571 204.147 22.5611 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 58.7700009346008 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.154199004173279 1257.68041992188 629.8475 1257.52624511719 629.770385742188 2 11 1.1.1.2689.10 1 24.4 496.7265 24.1931 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 52.5099992752075 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.157495006918907 1257.68371582031 629.8491 1257.52624511719 629.770385742188 2 11 1.1.1.2642.12 1 23.2765 528.7565 23.2576 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 52.5099992752075 DEPPQSPWDR Trp->Hydroxykynurenin(W)@8 cleaved Q-D@N-term 0.152856007218361 1245.67907714844 623.8468 1245.52624511719 623.770385742188 2 12 1.1.1.2704.8 1 24.7603 1266.668 24.5765 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 52.5099992752075 DEPPQSPWDR Trp->Kynurenin(W)@8 cleaved Q-D@N-term 0.15472899377346 1229.68603515625 615.8503 1229.53125 615.772888183594 2 12 1.1.1.2740.5 0 25.6168 579.4014 25.6015 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 52.5099992752075 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.210399001836777 1257.73657226563 420.2528 1257.52624511719 420.182678222656 3 12 1.1.1.2753.5 1 25.9206 5309.224 26.0798 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 49.1600006818771 DEPPQSPWDR Trioxidation(W)@8 cleaved Q-D@N-term 0.156110003590584 1273.67724609375 637.8459 1273.52111816406 637.767822265625 2 9 1.1.1.2611.12 1 22.5314 223.7996 22.5122 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 47.4299997091293 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.155296996235847 1257.68151855469 629.848 1257.52624511719 629.770385742188 2 12 1.1.1.2815.5 1 27.4133 4906.948 27.2038 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 45.660001039505 DEPPQSPWDR Dioxidation(W)@8 cleaved Q-D@N-term 0.152245998382568 1257.67846679688 629.8465 1257.52624511719 629.770385742188 2 12 1.1.1.2700.18 1 24.6655 420.4809 24.6482 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 36.3599985837936 DEPPQSPWDR Trioxidation(W)@8 cleaved Q-D@N-term 0.153302997350693 1273.67443847656 637.8445 1273.52111816406 637.767822265625 2 10 1.1.1.2664.13 1 23.7964 448.4331 23.8788 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVK cleaved Q-D@N-term; missed R-V@10 0.161559000611305 1452.861328125 727.4379 1452.69970703125 727.357177734375 2 19 1.1.1.2959.12 1 30.8704 12662.64 30.8994 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVK cleaved Q-D@N-term; missed R-V@10 0.160705000162125 1452.86047363281 727.4375 1452.69970703125 727.357177734375 2 19 1.1.1.2973.11 1 31.2057 12240 31.0432 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVK cleaved Q-D@N-term; missed R-V@10 0.160949006676674 1452.86071777344 727.4376 1452.69970703125 727.357177734375 2 19 1.1.1.2980.10 1 31.3735 9487.852 31.115 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVK cleaved Q-D@N-term; missed R-V@10 0.161925002932549 1452.86169433594 727.4381 1452.69970703125 727.357177734375 2 17 1.1.1.2994.8 1 31.7092 3173.038 31.4503 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVK cleaved Q-D@N-term; missed R-V@10 0.161559000611305 1452.861328125 727.4379 1452.69970703125 727.357177734375 2 16 1.1.1.2951.6 1 30.6783 12012.1 30.8994 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10 0.162818998098373 1484.85241699219 743.4335 1484.68957519531 743.35205078125 2 16 1.1.1.2762.9 1 26.1442 3373.954 26.1518 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10 0.163063004612923 1484.85266113281 743.4336 1484.68957519531 743.35205078125 2 14 1.1.1.2776.15 1 26.4832 1473.141 26.2476 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.5100028514862 DEPPQSPWDRVK cleaved Q-D@N-term; missed R-V@10 0.16448900103569 1452.8642578125 727.4394 1452.69970703125 727.357177734375 2 13 1.1.1.3001.8 1 31.8761 1870.197 31.642 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.2999975681305 DEPPQSPWDRVK cleaved Q-D@N-term; missed R-V@10 0.160949006676674 1452.86071777344 727.4376 1452.69970703125 727.357177734375 2 12 1.1.1.2987.10 1 31.541 5378.626 31.2827 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 77.8599977493286 DEPPQSPWDRVK cleaved Q-D@N-term; missed R-V@10 0.219224005937576 1452.9189453125 485.3136 1452.69970703125 485.240509033203 3 12 1.1.1.2994.6 1 31.7042 17379.05 31.4503 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 73.9300012588501 DEPPQSPWDRVK cleaved Q-D@N-term; missed R-V@10 0.219499006867409 1452.91918945313 485.3137 1452.69970703125 485.240509033203 3 12 1.1.1.2959.10 1 30.8671 75907.22 30.9714 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.0599975585938 DEPPQSPWDRVK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10 0.159888997673988 1484.84948730469 743.432 1484.68957519531 743.35205078125 2 12 1.1.1.2769.16 1 26.3115 1392.341 26.2957 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.2400004863739 DEPPQSPWDRVK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10 0.222589999437332 1484.912109375 495.978 1484.68957519531 495.90380859375 3 12 1.1.1.2785.5 1 26.6983 2981.396 26.6795 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 40.1699990034103 DEPPQSPWDRVK Oxidation(W)@8 cleaved Q-D@N-term; missed R-V@10 0.224797993898392 1468.91943359375 490.6471 1468.69470214844 490.572174072266 3 12 1.1.1.2830.5 1 27.764 769.6965 27.7757 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.262569010257721 2669.63256835938 890.8848 2669.3701171875 890.797302246094 3 23 1.1.1.3985.8 1 55.8243 738.3652 55.8378 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.253024995326996 2701.61303710938 901.5449 2701.35986328125 901.460571289063 3 27 1.1.1.3997.10 1 56.1235 17589.1 56.0378 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.252658993005753 2701.61254882813 901.5448 2701.35986328125 901.460571289063 3 24 1.1.1.4004.7 1 56.2965 18003.22 56.0378 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.247348994016647 2701.60717773438 901.543 2701.35986328125 901.460571289063 3 22 1.1.1.4011.9 1 56.465 7498.361 56.3816 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.250380992889404 2673.61547851563 892.2124 2673.36499023438 892.128967285156 3 24 1.1.1.4037.13 1 57.122 11175.56 57.1337 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.254694998264313 2669.62475585938 890.8822 2669.3701171875 890.797302246094 3 22 1.1.1.4148.3 1 59.8252 19837.22 60.0489 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.254694998264313 2669.62475585938 890.8822 2669.3701171875 890.797302246094 3 32 1.1.1.4162.4 1 60.1542 90777.57 60.195 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.254694998264313 2669.62475585938 890.8822 2669.3701171875 890.797302246094 3 30 1.1.1.4169.3 1 60.3222 90777.57 60.195 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.255061000585556 2669.62524414063 890.8823 2669.3701171875 890.797302246094 3 28 1.1.1.4176.4 1 60.4936 90615.41 60.4126 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.255061000585556 2669.62524414063 890.8823 2669.3701171875 890.797302246094 3 29 1.1.1.4183.3 1 60.6653 88937.3 60.4126 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.255061000585556 2669.62524414063 890.8823 2669.3701171875 890.797302246094 3 30 1.1.1.4190.3 1 60.8391 61739.32 60.5841 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.254694998264313 2669.62475585938 890.8822 2669.3701171875 890.797302246094 3 27 1.1.1.4197.3 1 61.0085 33216.96 60.7538 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.255243986845016 2669.62524414063 890.8824 2669.3701171875 890.797302246094 3 26 1.1.1.4204.3 1 61.1812 14470.98 60.9297 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.254694998264313 2669.62475585938 890.8822 2669.3701171875 890.797302246094 3 26 1.1.1.4211.2 1 61.3437 6226.443 61.0986 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.261287003755569 2669.63134765625 890.8844 2669.3701171875 890.797302246094 3 23 1.1.1.4219.2 1 61.5392 2143.03 61.388 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.256159991025925 2669.62622070313 890.8827 2669.3701171875 890.797302246094 3 25 1.1.1.4229.3 1 61.784 3650.73 61.8518 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.256159991025925 2669.62622070313 890.8827 2669.3701171875 890.797302246094 3 21 1.1.1.4236.6 1 61.9592 3650.73 61.8518 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK Delta:H(4)C(2)(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.220037996768951 2697.62133789063 900.2144 2697.4013671875 900.141052246094 3 24 1.1.1.4368.7 1 65.3527 906.6769 65.4181 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.253024995326996 2701.61303710938 901.5449 2701.35986328125 901.460571289063 3 21 1.1.1.3985.9 1 55.826 17568.35 56.0626 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.250014990568161 2673.61499023438 892.2123 2673.36499023438 892.128967285156 3 21 1.1.1.4015.3 1 56.5596 3529.02 56.6767 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.320782989263535 2669.69091796875 668.43 2669.3701171875 668.349792480469 4 20 1.1.1.4204.2 1 61.1771 13768.21 60.9297 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK Delta:H(2)C(2)@N-term cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.254121005535126 2695.63989257813 899.5539 2695.3857421875 899.469177246094 3 21 1.1.1.4248.6 1 62.2636 1137.867 62.4183 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.250014990568161 2673.61499023438 892.2123 2673.36499023438 892.128967285156 3 20 1.1.1.4022.11 1 56.7387 3529.02 56.6767 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.321271002292633 2669.69140625 668.4301 2669.3701171875 668.349792480469 4 20 1.1.1.4183.2 1 60.662 81842.2 60.4126 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.320295006036758 2669.6904296875 668.4299 2669.3701171875 668.349792480469 4 19 1.1.1.4148.2 1 59.8169 32216.59 60.0489 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.320782989263535 2669.69091796875 668.43 2669.3701171875 668.349792480469 4 19 1.1.1.4190.2 1 60.8366 48852.88 60.5841 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.321271002292633 2669.69140625 668.4301 2669.3701171875 668.349792480469 4 19 1.1.1.4155.2 1 59.983 122041.3 60.2192 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.261835992336273 2669.6318359375 890.8846 2669.3701171875 890.797302246094 3 18 1.1.1.4244.6 1 62.1575 1308.229 62.1751 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.321271002292633 2669.69140625 668.4301 2669.3701171875 668.349792480469 4 18 1.1.1.4162.2 1 60.1508 120375 60.195 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.322492003440857 2669.69262695313 668.4304 2669.3701171875 668.349792480469 4 18 1.1.1.4212.2 1 61.3702 2158.322 61.388 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK Formyl@N-term cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.256424009799957 2697.62133789063 900.2144 2697.36499023438 900.128967285156 3 19 1.1.1.4298.8 1 63.5211 1119.491 63.5634 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK acrolein addition +56(K)@12; Oxidation(D)@13 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.257185995578766 2741.6484375 914.8901 2741.39111328125 914.804321289063 3 30 1.1.1.4536.4 1 69.5724 2058.506 69.6915 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK reduced acrolein addition +58(K)@12; Methyl(D)@13 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.220800995826721 2741.6484375 914.8901 2741.42749023438 914.816467285156 3 30 1.1.1.4543.4 1 69.7601 2058.506 69.6915 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK Dimethyl(R)@10; reduced acrolein addition +58(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.214367002248764 2755.65771484375 919.5598 2755.443359375 919.488342285156 3 31 1.1.1.4632.5 1 72.0709 10491.23 72.1319 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK Dimethyl(R)@10; reduced acrolein addition +58(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.214367002248764 2755.65771484375 919.5598 2755.443359375 919.488342285156 3 31 1.1.1.4639.6 1 72.251 10491.23 72.1319 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK Oxidation(P)@7 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.253127992153168 2685.6181640625 896.2133 2685.36499023438 896.128967285156 3 19 1.1.1.3768.16 1 50.5105 3684.393 50.5713 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.320782989263535 2669.69091796875 668.43 2669.3701171875 668.349792480469 4 17 1.1.1.4176.2 1 60.4903 85068.87 60.3883 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK Carbamidomethyl@N-term; Deamidated(Q)@5 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.258675992488861 2727.63427734375 910.2187 2727.37548828125 910.132446289063 3 18 1.1.1.4315.13 1 63.9678 1628.266 63.7985 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK Dimethyl(R)@10; reduced acrolein addition +58(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.214550003409386 2755.65771484375 919.5599 2755.443359375 919.488342285156 3 21 1.1.1.4625.14 1 71.8871 9663.222 72.1319 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.320295006036758 2669.6904296875 668.4299 2669.3701171875 668.349792480469 4 17 1.1.1.4248.3 1 62.2553 1631.481 62.2477 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8900005817413 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 1.59484004974365 2670.96484375 891.3289 2669.3701171875 890.797302246094 3 18 1.1.1.4403.2 1 66.1939 1656.695 66.1109 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.089998960495 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.321271002292633 2669.69140625 668.4301 2669.3701171875 668.349792480469 4 16 1.1.1.4169.2 1 60.3197 120375 60.195 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.089998960495 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.320782989263535 2669.69091796875 668.43 2669.3701171875 668.349792480469 4 16 1.1.1.4197.2 1 61.006 27930.1 60.7538 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.089998960495 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.321271002292633 2669.69140625 668.4301 2669.3701171875 668.349792480469 4 16 1.1.1.4222.2 1 61.6098 3843.382 61.8518 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.089998960495 DEPPQSPWDRVKDLATVYVDVLK Trp->Hydroxykynurenin(W)@8; hexanoyl addition +98(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.222584992647171 2787.65576171875 930.2258 2787.43310546875 930.151611328125 3 17 1.1.1.4397.4 1 66.0477 1528.284 66.135 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.8799998760223 DEPPQSPWDRVKDLATVYVDVLK Trp->Hydroxykynurenin(W)@8; hexanoyl addition +98(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.222584992647171 2787.65576171875 930.2258 2787.43310546875 930.151611328125 3 17 1.1.1.4404.4 1 66.2195 1528.284 66.135 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1199989318848 DEPPQSPWDRVKDLATVYVDVLK Dioxidation(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.318991005420685 2701.67895507813 676.427 2701.35986328125 676.347229003906 4 18 1.1.1.4004.3 1 56.2898 28803.5 56.0378 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.1899995803833 DEPPQSPWDRVKDLATVYVDVLK Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.315126001834869 2673.68017578125 669.4273 2673.36499023438 669.348510742188 4 16 1.1.1.4037.4 1 57.1145 15535.73 57.1337 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.4900026321411 DEPPQSPWDRVKDLATVYVDVLK Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.315126001834869 2673.68017578125 669.4273 2673.36499023438 669.348510742188 4 16 1.1.1.4015.2 1 56.5579 4691.574 56.6767 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.4900026321411 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.322003990411758 2669.69213867188 668.4303 2669.3701171875 668.349792480469 4 15 1.1.1.4229.2 1 61.7823 3787.295 61.8518 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.7200000286102 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.314435005187988 2669.6845703125 668.4284 2669.3701171875 668.349792480469 4 16 1.1.1.4255.4 1 62.4243 1256.718 62.4675 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.5400009155273 DEPPQSPWDRVKDLATVYVDVLK Oxidation(R)@10; acrolein addition +56(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.25755301117897 2741.64868164063 914.8902 2741.39111328125 914.804321289063 3 17 1.1.1.4529.6 1 69.3963 1825.249 69.5875 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.6900029182434 DEPPQSPWDRVKDLATVYVDVLK acrolein addition +38(K)@12; Dehydrated(D)@13 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.301292985677719 2689.67651367188 673.4264 2689.37524414063 673.35107421875 4 16 1.1.1.3981.2 1 55.7191 1247.633 55.7393 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.8500006198883 DEPPQSPWDRVKDLATVYVDVLK Dioxidation(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.318991005420685 2701.67895507813 676.427 2701.35986328125 676.347229003906 4 17 1.1.1.3990.3 1 55.9427 28405.55 56.0626 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.3299996852875 DEPPQSPWDRVKDLATVYVDVLK Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.315126001834869 2673.68017578125 669.4273 2673.36499023438 669.348510742188 4 15 1.1.1.4022.4 1 56.7329 4691.574 56.6767 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.0299985408783 DEPPQSPWDRVKDLATVYVDVLK Carbamidomethyl@N-term cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.326662987470627 2726.71826171875 682.6868 2726.3916015625 682.605163574219 4 14 1.1.1.4481.7 1 68.1691 358.373 68.1065 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.5100016593933 DEPPQSPWDRVKDLATVYVDVLK Carbamidomethyl@N-term cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.332522004842758 2726.72412109375 682.6883 2726.3916015625 682.605163574219 4 15 1.1.1.4496.3 1 68.5486 260.1908 68.5662 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.5100016593933 DEPPQSPWDRVKDLATVYVDVLK Carbamidomethyl@N-term cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.32422199845314 2726.7158203125 682.6862 2726.3916015625 682.605163574219 4 15 1.1.1.4547.6 1 69.8593 372.2885 69.8761 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.710000038147 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.323224008083344 2669.693359375 668.4306 2669.3701171875 668.349792480469 4 14 1.1.1.4290.5 1 63.3113 840.9349 63.2262 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.2600028514862 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.322735995054245 2669.69287109375 668.4305 2669.3701171875 668.349792480469 4 14 1.1.1.3985.4 1 55.8185 708.4958 55.8378 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.2600028514862 DEPPQSPWDRVKDLATVYVDVLK Dioxidation(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.318991005420685 2701.67895507813 676.427 2701.35986328125 676.347229003906 4 16 1.1.1.3997.4 1 56.1177 28405.55 56.0626 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.2600028514862 DEPPQSPWDRVKDLATVYVDVLK Dioxidation(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.317037999629974 2701.67700195313 676.4265 2701.35986328125 676.347229003906 4 16 1.1.1.4011.4 1 56.4608 12696.51 56.3571 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.4899971485138 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.314435005187988 2669.6845703125 668.4284 2669.3701171875 668.349792480469 4 13 1.1.1.4262.5 1 62.6012 1256.718 62.4675 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.9999992847443 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.255977004766464 2669.6259765625 890.8826 2669.3701171875 890.797302246094 3 13 1.1.1.4285.13 1 63.189 782.049 63.2521 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.5100014209747 DEPPQSPWDRVKDLATVYVDVLK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.318257987499237 2701.67822265625 676.4268 2701.35986328125 676.347229003906 4 14 1.1.1.4026.6 1 56.8366 1348.931 56.7266 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.5100014209747 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.322003990411758 2669.69213867188 668.4303 2669.3701171875 668.349792480469 4 13 1.1.1.4236.3 1 61.9567 3787.295 61.8518 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.0100028514862 DEPPQSPWDRVKDLATVYVDVLK Delta:H(2)C(2)@N-term cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.318805009126663 2695.70458984375 674.9334 2695.3857421875 674.853698730469 4 14 1.1.1.4254.3 1 62.3982 936.9351 62.4183 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.8299977779388 DEPPQSPWDRVKDLATVYVDVLK Carbamidomethyl@N-term cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.330080986022949 2726.7216796875 682.6877 2726.3916015625 682.605163574219 4 14 1.1.1.4464.3 1 67.7292 584.6061 67.7966 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 76.3999998569489 DEPPQSPWDRVKDLATVYVDVLK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.253024995326996 2701.61303710938 901.5449 2701.35986328125 901.460571289063 3 13 1.1.1.4025.14 1 56.8178 924.3882 56.7521 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 75.3400027751923 DEPPQSPWDRVKDLATVYVDVLK FormaldehydeAdduct(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.338849008083344 2681.708984375 671.4345 2681.3701171875 671.349792480469 4 12 1.1.1.4431.2 1 66.9043 102.7343 66.9518 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.2799997329712 DEPPQSPWDRVKDLATVYVDVLK Oxidation(P)@7 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.311464011669159 2685.67651367188 672.4264 2685.36499023438 672.348510742188 4 13 1.1.1.4085.2 1 58.2724 1326.01 58.2686 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 72.1300005912781 DEPPQSPWDRVKDLATVYVDVLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.322492003440857 2669.69262695313 668.4304 2669.3701171875 668.349792480469 4 11 1.1.1.4318.3 1 64.0365 509.9272 64.185 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 61.2100005149841 DEPPQSPWDRVKDLATVYVDVLK Amidated@C-term cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.259463012218475 2668.6455078125 890.5558 2668.38598632813 890.469299316406 3 13 1.1.1.4359.5 1 65.1118 1568.045 64.9955 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 59.35999751091 DEPPQSPWDRVKDLATVYVDVLK Dimethyl(R)@10; reduced acrolein addition +58(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.281309008598328 2755.724609375 689.9384 2755.443359375 689.868103027344 4 14 1.1.1.4634.10 1 72.1177 1041.674 72.1594 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 53.6199986934662 DEPPQSPWDRVKDLATVYVDVLK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.318257987499237 2701.67822265625 676.4268 2701.35986328125 676.347229003906 4 12 1.1.1.4019.5 1 56.6583 1348.931 56.7266 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 45.6299990415573 DEPPQSPWDRVKDLATVYVDVLK Dioxidation(W)@8; MDA adduct +54(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.286772012710571 2755.6572265625 919.5597 2755.37036132813 919.464111328125 3 13 1.1.1.4646.9 1 72.4362 10059.79 72.1594 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.7899985313416 DEPPQSPWDRVKDLATVYVDVLK Oxidation(P)@7 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.30511599779129 2685.67016601563 672.4248 2685.36499023438 672.348510742188 4 12 1.1.1.3788.3 1 51.0041 1768.756 51.0728 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.3500000238419 DEPPQSPWDRVKDLATVYVDVLK Dimethyl(R)@10; acrolein addition +56(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.186926007270813 2753.61450195313 918.8788 2753.42749023438 918.816467285156 3 13 1.1.1.4464.5 1 67.7342 324.1923 67.6977 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 37.2299998998642 DEPPQSPWDRVKDLATVYVDVLK reduced acrolein addition +58(K)@12; Methyl(D)@13 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.221166998147964 2741.64868164063 914.8902 2741.42749023438 914.816467285156 3 12 1.1.1.4320.4 1 64.0889 4524.125 64.2885 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 33.6400002241135 DEPPQSPWDRVKDLATVYVDVLK Oxidation(P)@7 cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.314637988805771 2685.6796875 672.4272 2685.36499023438 672.348510742188 4 12 1.1.1.3766.9 1 50.4536 5865.33 50.5713 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 33.4199994802475 DEPPQSPWDRVKDLATVYVDVLK Amidated@C-term cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.326526999473572 2668.71264648438 668.1854 2668.38598632813 668.103820800781 4 12 1.1.1.4352.3 1 64.9245 1888.832 64.9689 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 30.9700012207031 DEPPQSPWDRVKDLATVYVDVLK Carbamidomethyl@N-term cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.316897004842758 2726.70849609375 682.6844 2726.3916015625 682.605163574219 4 12 1.1.1.4456.2 1 67.5304 322.0948 67.5497 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 28.7099987268448 DEPPQSPWDRVKDLATVYVDVLK Carbamidomethyl@N-term cleaved Q-D@N-term; missed R-V@10; missed K-D@12 0.266739994287491 2726.658203125 909.8934 2726.3916015625 909.804443359375 3 12 1.1.1.4466.5 1 67.7815 482.7683 67.7223 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGR Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.255804985761642 3116.79809570313 1039.94 3116.54150390625 1039.85437011719 3 22 1.1.1.4036.16 1 57.099 1499.691 57.1083 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGR cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.325760006904602 3084.87744140625 772.2266 3084.55151367188 772.145202636719 4 21 1.1.1.4248.5 1 62.2603 12743.9 62.4922 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGR cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.326981008052826 3084.87866210938 772.2269 3084.55151367188 772.145202636719 4 21 1.1.1.4262.8 1 62.6037 22545.45 62.6452 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGR cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.265166014432907 3084.818359375 1029.28 3084.55151367188 1029.19116210938 3 32 1.1.1.4262.18 1 62.612 7166.798 62.6196 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGR cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.265166014432907 3084.818359375 1029.28 3084.55151367188 1029.19116210938 3 24 1.1.1.4269.20 1 62.7932 7166.798 62.6196 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGR cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.326981008052826 3084.87866210938 772.2269 3084.55151367188 772.145202636719 4 20 1.1.1.4269.7 1 62.7824 22545.45 62.6452 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGR cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.326981008052826 3084.87866210938 772.2269 3084.55151367188 772.145202636719 4 19 1.1.1.4255.6 1 62.4277 21862.85 62.6196 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGR Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.323724001646042 3116.865234375 780.2236 3116.54150390625 780.142639160156 4 19 1.1.1.4034.9 1 57.0424 4994.73 57.1083 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGR cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.331620007753372 3084.88330078125 772.2281 3084.55151367188 772.145202636719 4 17 1.1.1.4293.5 1 63.3888 694.3021 63.2521 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6199975013733 DEPPQSPWDRVKDLATVYVDVLKDSGR cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.327224999666214 3084.87890625 772.227 3084.55151367188 772.145202636719 4 16 1.1.1.4276.9 1 62.9606 19631.94 62.6963 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.1000006198883 DEPPQSPWDRVKDLATVYVDVLKDSGR Dimethyl(R)@10; reduced acrolein addition +58(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.286531001329422 3170.91137695313 793.7351 3170.62475585938 793.663452148438 4 19 1.1.1.4650.12 1 72.544 1297.58 72.5035 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.869998216629 DEPPQSPWDRVKDLATVYVDVLKDSGR Dimethyl(R)@10; reduced acrolein addition +58(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.286531001329422 3170.91137695313 793.7351 3170.62475585938 793.663452148438 4 17 1.1.1.4651.6 1 72.5653 1297.58 72.5035 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.0399975776672 DEPPQSPWDRVKDLATVYVDVLKDSGR Dimethyl(R)@10; reduced acrolein addition +58(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.286531001329422 3170.91137695313 793.7351 3170.62475585938 793.663452148438 4 18 1.1.1.4647.8 1 72.4609 1297.58 72.5035 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8999981880188 DEPPQSPWDRVKDLATVYVDVLKDSGR Dimethyl(R)@10; reduced acrolein addition +58(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.286531001329422 3170.91137695313 793.7351 3170.62475585938 793.663452148438 4 18 1.1.1.4649.9 1 72.5151 1297.58 72.5035 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.5999999046326 DEPPQSPWDRVKDLATVYVDVLKDSGR Dimethyl(R)@10; reduced acrolein addition +58(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.286531001329422 3170.91137695313 793.7351 3170.62475585938 793.663452148438 4 17 1.1.1.4648.10 1 72.4892 1297.58 72.5035 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.1700019836426 DEPPQSPWDRVKDLATVYVDVLKDSGR cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.326981008052826 3084.87866210938 772.2269 3084.55151367188 772.145202636719 4 14 1.1.1.4271.7 1 62.8337 22545.45 62.6452 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.8999998569489 DEPPQSPWDRVKDLATVYVDVLKDSGR cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.330886989831924 3084.88256835938 772.2279 3084.55151367188 772.145202636719 4 14 1.1.1.4286.6 1 63.2086 1615.031 62.9506 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.710000038147 DEPPQSPWDRVKDLATVYVDVLKDSGR cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.396120011806488 3084.94775390625 617.9968 3084.55151367188 617.917602539063 5 14 1.1.1.4253.2 1 62.3754 15805.41 62.6196 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.710000038147 DEPPQSPWDRVKDLATVYVDVLKDSGR cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.395509988069534 3084.94702148438 617.9967 3084.55151367188 617.917602539063 5 14 1.1.1.4269.3 1 62.779 17017.76 62.6708 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.5100014209747 DEPPQSPWDRVKDLATVYVDVLKDSGR cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.395509988069534 3084.94702148438 617.9967 3084.55151367188 617.917602539063 5 13 1.1.1.4252.2 1 62.3487 14941 62.594 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.5100014209747 DEPPQSPWDRVKDLATVYVDVLKDSGR cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.396120011806488 3084.94775390625 617.9968 3084.55151367188 617.917602539063 5 13 1.1.1.4254.2 1 62.3974 16106.27 62.594 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.1699986457825 DEPPQSPWDRVKDLATVYVDVLKDSGR Dimethyl(R)@10; reduced acrolein addition +58(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.286531001329422 3170.91137695313 793.7351 3170.62475585938 793.663452148438 4 14 1.1.1.4646.5 1 72.4312 1297.58 72.5035 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 75.3400027751923 DEPPQSPWDRVKDLATVYVDVLKDSGR cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.395509988069534 3084.94702148438 617.9967 3084.55151367188 617.917602539063 5 13 1.1.1.4255.3 1 62.4227 16863.74 62.6196 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.1499972343445 DEPPQSPWDRVKDLATVYVDVLKDSGR cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.395509988069534 3084.94702148438 617.9967 3084.55151367188 617.917602539063 5 12 1.1.1.4262.3 1 62.5995 17017.76 62.6708 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 37.2299998998642 DEPPQSPWDRVKDLATVYVDVLKDSGR Deamidated(Q)@5; Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23 0.275573998689651 3117.80029296875 1040.274 3117.525390625 1040.18249511719 3 12 1.1.1.4036.17 1 57.0999 865.4052 57.1083 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(P)@7 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.398736000061035 4482.5966796875 897.5266 4482.19775390625 897.446838378906 5 22 1.1.1.4005.7 1 56.3207 6411.33 56.4066 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(D)@13 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.398736000061035 4482.5966796875 897.5266 4482.19775390625 897.446838378906 5 24 1.1.1.4012.8 1 56.4969 6411.33 56.4066 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(R)@10 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.596441984176636 4481.6015625 897.3276 4482.19775390625 897.446838378906 5 24 1.1.1.4035.12 1 57.0705 2695.018 57.0575 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@5; Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.569145977497101 4498.60791015625 900.7288 4499.1767578125 900.842651367188 5 23 1.1.1.4247.2 1 62.2268 21827.67 62.4675 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.344448000192642 4498.53857421875 1125.642 4498.19287109375 1125.55554199219 4 23 1.1.1.4249.7 1 62.2887 9208.566 62.5178 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.416395008563995 4498.609375 900.7291 4498.19287109375 900.645874023438 5 24 1.1.1.4254.8 1 62.4024 28619.6 62.4922 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.416395008563995 4498.609375 900.7291 4498.19287109375 900.645874023438 5 27 1.1.1.4255.8 1 62.431 28619.6 62.4922 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.416395008563995 4498.609375 900.7291 4498.19287109375 900.645874023438 5 26 1.1.1.4256.7 1 62.4507 28619.6 62.4922 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.343959987163544 4498.53466796875 1125.641 4498.19287109375 1125.55554199219 4 32 1.1.1.4256.15 1 62.4574 9287.81 62.5178 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.416395008563995 4498.609375 900.7291 4498.19287109375 900.645874023438 5 28 1.1.1.4263.12 1 62.6326 28619.6 62.4922 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.343959987163544 4498.53466796875 1125.641 4498.19287109375 1125.55554199219 4 25 1.1.1.4263.20 1 62.6393 9287.81 62.5178 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.416700005531311 4498.609375 900.7292 4498.19287109375 900.645874023438 5 24 1.1.1.4270.14 1 62.8141 24614.98 62.5432 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.420587003231049 4470.61865234375 895.131 4470.19775390625 895.046875 5 26 1.1.1.4290.12 1 63.3172 13419.47 63.3556 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.420587003231049 4470.61865234375 895.131 4470.19775390625 895.046875 5 23 1.1.1.4297.11 1 63.498 13419.47 63.3556 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.418004006147385 4466.62109375 894.3315 4466.203125 894.247863769531 5 23 1.1.1.4328.8 1 64.3023 3183.329 64.314 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK reduced acrolein addition +58(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.598408997058868 4523.646484375 905.7366 4524.2451171875 905.856262207031 5 22 1.1.1.4366.3 1 65.2976 5834.128 65.3662 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.414952009916306 4466.6181640625 894.3309 4466.203125 894.247863769531 5 32 1.1.1.4369.4 1 65.3812 168840.6 65.6136 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.333788990974426 4466.53466796875 1117.641 4466.203125 1117.55798339844 4 41 1.1.1.4370.16 1 65.4089 107153.7 65.5895 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.416173011064529 4466.619140625 894.3311 4466.203125 894.247863769531 5 30 1.1.1.4376.3 1 65.5545 172004.6 65.6136 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.333788990974426 4466.53466796875 1117.641 4466.203125 1117.55798339844 4 31 1.1.1.4379.4 1 65.6326 109200.7 65.6136 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.416173011064529 4466.619140625 894.3311 4466.203125 894.247863769531 5 28 1.1.1.4383.2 1 65.7307 172004.6 65.6136 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.416478008031845 4466.61962890625 894.3312 4466.203125 894.247863769531 5 29 1.1.1.4390.2 1 65.8948 168363.7 65.6385 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.346484005451202 4466.55078125 1117.645 4466.203125 1117.55798339844 4 41 1.1.1.4390.5 1 65.9074 102293.6 65.7201 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.415562987327576 4466.61865234375 894.331 4466.203125 894.247863769531 5 23 1.1.1.4398.2 1 66.07 105019.9 66.1109 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.340137004852295 4466.54248046875 1117.643 4466.203125 1117.55798339844 4 40 1.1.1.4398.3 1 66.0758 85656.17 65.8405 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.415562987327576 4466.61865234375 894.331 4466.203125 894.247863769531 5 27 1.1.1.4405.5 1 66.2429 105019.9 66.1109 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.345995992422104 4466.55078125 1117.645 4466.203125 1117.55798339844 4 41 1.1.1.4405.7 1 66.2479 44296.85 66.1109 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.414952009916306 4466.6181640625 894.3309 4466.203125 894.247863769531 5 27 1.1.1.4412.3 1 66.4111 75394.98 66.1591 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.339648008346558 4466.54248046875 1117.643 4466.203125 1117.55798339844 4 21 1.1.1.4412.7 1 66.4211 32545.78 66.1591 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.436619997024536 4466.6396484375 894.3352 4466.203125 894.247863769531 5 21 1.1.1.4419.5 1 66.5971 2124.815 66.507 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.424717992544174 4466.6279296875 894.3328 4466.203125 894.247863769531 5 25 1.1.1.4426.4 1 66.7774 1920.508 66.7419 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Delta:H(2)C(2)@N-term cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.428050011396408 4492.646484375 899.5366 4492.21875 899.450988769531 5 25 1.1.1.4427.6 1 66.803 3356.661 66.8468 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Delta:H(2)C(2)@N-term cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.428050011396408 4492.646484375 899.5366 4492.21875 899.450988769531 5 25 1.1.1.4434.6 1 66.991 3356.661 66.8468 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.487976014614105 4498.6806640625 750.7874 4498.19287109375 750.706115722656 6 21 1.1.1.4263.7 1 62.6284 20429.19 62.5178 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.419672012329102 4470.61767578125 895.1308 4470.19775390625 895.046875 5 21 1.1.1.4283.16 1 63.141 4063.978 63.0504 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.415562987327576 4466.61865234375 894.331 4466.203125 894.247863769531 5 20 1.1.1.4222.3 1 61.6106 1576.099 61.5817 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.418004006147385 4466.62109375 894.3315 4466.203125 894.247863769531 5 20 1.1.1.4335.8 1 64.4814 3183.329 64.314 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.470236986875534 4466.67333984375 745.4528 4466.203125 745.374450683594 6 20 1.1.1.4368.3 1 65.3461 93793.2 65.5895 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Delta:H(2)C(2)@N-term cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.428355008363724 4492.64697265625 899.5367 4492.21875 899.450988769531 5 21 1.1.1.4420.4 1 66.6279 3400.134 66.8468 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(P)@7 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.58728700876236 4481.61083984375 897.3294 4482.19775390625 897.446838378906 5 21 1.1.1.4334.4 1 64.4539 2130.848 64.4706 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(R)@27 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.567843019962311 4466.619140625 894.3311 4467.18701171875 894.444702148438 5 21 1.1.1.4388.3 1 65.8535 173540.8 65.5895 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@5 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.506088018417358 4466.68115234375 745.4541 4467.18701171875 745.538452148438 6 20 1.1.1.4382.2 1 65.7053 102931.7 65.6136 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.487976014614105 4498.6806640625 750.7874 4498.19287109375 750.706115722656 6 20 1.1.1.4256.4 1 62.4482 20429.19 62.5178 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.428297013044357 4498.62109375 900.7315 4498.19287109375 900.645874023438 5 20 1.1.1.4278.14 1 63.0146 1115.634 63.0255 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK MDA adduct +62(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.403391987085342 4528.6220703125 906.7317 4528.21875 906.651000976563 5 19 1.1.1.4338.8 1 64.5605 2231.214 64.4706 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.426243990659714 4466.62939453125 894.3331 4466.203125 894.247863769531 5 19 1.1.1.4342.7 1 64.6636 2269.782 64.6283 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.427159011363983 4466.63037109375 894.3333 4466.203125 894.247863769531 5 19 1.1.1.4433.7 1 66.9613 1364.727 66.9518 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trp->Kynurenin(W)@8; acrolein addition +38(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.582428991794586 4507.63134765625 902.5335 4508.21337890625 902.650024414063 5 20 1.1.1.4371.7 1 65.4263 5053.843 65.5895 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@5; FormaldehydeAdduct(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.426542013883591 4479.61376953125 896.93 4479.18701171875 896.844665527344 5 20 1.1.1.4285.14 1 63.1898 3134.857 63.1753 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.419672012329102 4470.61767578125 895.1308 4470.19775390625 895.046875 5 19 1.1.1.4276.14 1 62.9648 4063.978 63.0504 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.48496600985527 4470.68310546875 746.1211 4470.19775390625 746.040283203125 6 19 1.1.1.4292.4 1 63.3624 8332.108 63.3556 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK MDA adduct +54(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.321929007768631 4520.53564453125 905.1144 4520.21337890625 905.049987792969 5 18 1.1.1.4390.3 1 65.899 1128.698 65.7924 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.396030992269516 4466.59912109375 894.3271 4466.203125 894.247863769531 5 22 1.1.1.4442.2 1 67.1882 1587.568 67.1582 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK reduced acrolein addition +58(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.369608998298645 4524.6142578125 905.9302 4524.2451171875 905.856262207031 5 22 1.1.1.4466.4 1 67.7798 2485.725 67.7223 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.424717992544174 4466.6279296875 894.3328 4466.203125 894.247863769531 5 24 1.1.1.4491.3 1 68.4141 1243.109 68.4308 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.407018005847931 4466.60986328125 894.3293 4466.203125 894.247863769531 5 24 1.1.1.4522.5 1 69.2223 1231.531 69.113 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.414952009916306 4466.6181640625 894.3309 4466.203125 894.247863769531 5 21 1.1.1.4529.5 1 69.3937 846.6556 69.3316 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.396030992269516 4466.59912109375 894.3271 4466.203125 894.247863769531 5 22 1.1.1.4598.9 1 71.1721 596.66 71.1025 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@8; acrolein addition +56(K)@23; Oxidation(D)@24 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.395693004131317 4570.60986328125 915.1292 4570.2138671875 915.050048828125 5 26 1.1.1.4615.9 1 71.6184 512.4635 71.6285 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Delta:H(4)C(2)(K)@23 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.36216801404953 4494.5966796875 899.9266 4494.234375 899.854125976563 5 31 1.1.1.4636.9 1 72.1701 1145.18 72.2115 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trimethyl(K)@23 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.306858003139496 4508.5546875 1128.146 4508.25 1128.06982421875 4 29 1.1.1.4643.15 1 72.3605 564.3044 72.3706 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trimethyl(K)@23 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.374532997608185 4508.62451171875 902.7322 4508.25 902.657287597656 5 29 1.1.1.4647.11 1 72.4634 1463.782 72.3706 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(P)@7; acrolein addition +56(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.40310001373291 4538.62744140625 908.7327 4538.22412109375 908.652099609375 5 24 1.1.1.4653.16 1 72.6263 2246.826 72.6882 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK reduced acrolein addition +58(K)@23; Methyl(D)@24 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.366104006767273 4538.62646484375 908.7326 4538.2607421875 908.659362792969 5 32 1.1.1.4759.4 1 75.2866 2501.092 75.3226 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK reduced acrolein addition +58(K)@23; Dimethyl(R)@27 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.35649698972702 4552.6328125 911.5338 4552.2763671875 911.462524414063 5 24 1.1.1.4774.14 1 75.6629 2183.28 75.6738 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK MDA adduct +62(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.403391987085342 4528.6220703125 906.7317 4528.21875 906.651000976563 5 18 1.1.1.4331.10 1 64.3782 2231.214 64.4706 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.424717992544174 4466.6279296875 894.3328 4466.203125 894.247863769531 5 18 1.1.1.4362.6 1 65.1888 84889.7 65.443 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.479025989770889 4466.68212890625 745.4543 4466.203125 745.374450683594 6 18 1.1.1.4411.3 1 66.3848 55616.86 66.135 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(P)@7; Deamidated(R)@10; reduced acrolein addition +58(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.597054004669189 4540.626953125 909.1326 4541.2236328125 909.252014160156 5 20 1.1.1.4360.2 1 65.1368 306.1223 65.1269 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(P)@7 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.598882973194122 4481.59912109375 897.3271 4482.19775390625 897.446838378906 5 19 1.1.1.4381.4 1 65.6747 833.7039 65.6864 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dimethyl(R)@10; reduced acrolein addition +58(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.365042001008987 4552.64111328125 911.5355 4552.2763671875 911.462524414063 5 22 1.1.1.4692.16 1 73.6444 983.6575 73.6536 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.405187010765076 4466.6083984375 894.3289 4466.203125 894.247863769531 5 20 1.1.1.4449.9 1 67.3619 1529.111 67.3034 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.403661012649536 4466.6064453125 894.3286 4466.203125 894.247863769531 5 20 1.1.1.4456.5 1 67.5379 1477.501 67.5497 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK MDA adduct +62(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.400339990854263 4528.619140625 906.7311 4528.21875 906.651000976563 5 17 1.1.1.4288.10 1 63.2639 1515.897 63.2781 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.480857014656067 4466.68408203125 745.4546 4466.203125 745.374450683594 6 17 1.1.1.4329.4 1 64.3212 1813.931 64.314 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK acrolein addition +56(K)@23 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.711468994617462 4521.5185546875 1131.387 4522.22900390625 1131.56457519531 4 18 1.1.1.4375.3 1 65.5361 443.0304 65.5171 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.479025989770889 4466.68212890625 745.4543 4466.203125 745.374450683594 6 17 1.1.1.4397.2 1 66.0427 66558.13 66.1109 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.42502298951149 4466.6279296875 894.3329 4466.203125 894.247863769531 5 19 1.1.1.4471.8 1 67.9085 1530.395 67.9497 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.9000022411346 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK reduced acrolein addition +58(K)@23; Methyl(D)@24 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.312894999980927 4538.57470703125 1135.651 4538.2607421875 1135.57238769531 4 20 1.1.1.4761.21 1 75.342 672.9146 75.3471 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8900005817413 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Acetyl@N-term cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.560455977916718 4507.6533203125 902.5379 4508.21337890625 902.650024414063 5 18 1.1.1.4363.4 1 65.2161 1148.532 65.2593 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.7600028514862 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@5 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.502426028251648 4466.6845703125 745.4547 4467.18701171875 745.538452148438 6 17 1.1.1.4361.2 1 65.16 31798.46 65.4181 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.7600028514862 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@5; Deamidated(R)@10; acrolein addition +38(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.380380988121033 4506.56689453125 1127.649 4506.1865234375 1127.55395507813 4 18 1.1.1.4373.4 1 65.4869 1017.63 65.5171 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.7600028514862 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK MDA adduct +54(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.695527017116547 4519.51806640625 904.9109 4520.21337890625 905.049987792969 5 17 1.1.1.4399.5 1 66.0992 1009.38 66.0868 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.7600028514862 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@5 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.491073995828629 4466.69580078125 745.4566 4467.18701171875 745.538452148438 6 17 1.1.1.4432.3 1 66.9317 1115.866 66.7419 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2299983501434 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.418004006147385 4466.62109375 894.3315 4466.203125 894.247863769531 5 18 1.1.1.4481.11 1 68.1757 1240.52 68.1065 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2299983501434 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trp->Kynurenin(W)@8; acrolein addition +38(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.413664996623993 4508.62744140625 902.7327 4508.21337890625 902.650024414063 5 19 1.1.1.4551.6 1 69.9691 1211.551 70.0352 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.089998960495 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.481750011444092 4498.6748046875 750.7864 4498.19287109375 750.706115722656 6 17 1.1.1.4249.2 1 62.2762 20244.3 62.5178 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.089998960495 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.413567990064621 4470.611328125 895.1296 4470.19775390625 895.046875 5 17 1.1.1.4269.12 1 62.7866 3727.793 63.0255 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.089998960495 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(P)@7 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.486063987016678 4482.68408203125 748.1213 4482.19775390625 748.040283203125 6 17 1.1.1.4352.4 1 64.927 1204.226 64.9689 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.089998960495 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.479025989770889 4466.68212890625 745.4543 4466.203125 745.374450683594 6 16 1.1.1.4404.2 1 66.2128 66558.13 66.1109 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.8799998760223 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK acrolein addition +38(K)@12; Dehydrated(T)@16 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.372940987348557 4486.5810546875 898.3235 4486.2080078125 898.248901367188 5 17 1.1.1.4386.2 1 65.803 739.2142 65.7444 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.8799998760223 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.478659987449646 4466.681640625 745.4542 4466.203125 745.374450683594 6 16 1.1.1.4389.2 1 65.87 101802.3 65.6136 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.8799998760223 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.492942005395889 4466.69580078125 745.4566 4466.203125 745.374450683594 6 16 1.1.1.4425.2 1 66.7481 1115.866 66.7419 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.869998216629 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(P)@7; acrolein addition +56(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.331701993942261 4538.5546875 1135.646 4538.22412109375 1135.56335449219 4 17 1.1.1.4652.20 1 72.6033 986.5511 72.7142 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.5499987602234 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.490377992391586 4466.693359375 745.4562 4466.203125 745.374450683594 6 17 1.1.1.4476.3 1 68.0366 906.7454 67.9236 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.5499987602234 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.424717992544174 4466.6279296875 894.3328 4466.203125 894.247863769531 5 17 1.1.1.4500.11 1 68.6657 1243.109 68.4308 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.5499987602234 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(P)@7; acrolein addition +56(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.40310001373291 4538.62744140625 908.7327 4538.22412109375 908.652099609375 5 18 1.1.1.4654.13 1 72.6504 2246.826 72.6882 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8999981880188 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@5 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.490341007709503 4466.69677734375 745.4567 4467.18701171875 745.538452148438 6 17 1.1.1.4491.2 1 68.4115 737.2721 68.4051 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8999981880188 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trp->Hydroxykynurenin(W)@8; hexanoyl addition +98(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.364042997360229 4584.6298828125 917.9333 4584.26611328125 917.860473632813 5 18 1.1.1.4569.8 1 70.4227 564.8251 70.4581 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5200006961823 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@5; Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.496039986610413 4498.6806640625 750.7874 4499.1767578125 750.8701171875 6 17 1.1.1.4270.4 1 62.8057 18302.84 62.5432 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.4900026321411 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(D)@13 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.46409198641777 4482.662109375 748.1176 4482.19775390625 748.040283203125 6 17 1.1.1.4008.4 1 56.3873 3451.546 56.4066 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.6099996566772 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK reduced acrolein addition +58(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.369608998298645 4524.6142578125 905.9302 4524.2451171875 905.856262207031 5 16 1.1.1.4459.4 1 67.6067 2485.725 67.7223 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.6099996566772 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.41373199224472 4466.61669921875 894.3306 4466.203125 894.247863769531 5 16 1.1.1.4463.5 1 67.7097 1579.376 67.6977 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.6099996566772 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.417088985443115 4466.6201171875 894.3313 4466.203125 894.247863769531 5 16 1.1.1.4538.7 1 69.6344 674.2239 69.4819 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.0999984741211 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term; Oxidation(P)@4 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.570785999298096 4538.6484375 908.737 4539.21923828125 908.851135253906 5 18 1.1.1.4491.4 1 68.4166 2710.859 68.1598 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.9300000667572 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(P)@7 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.332527011632919 4482.53076171875 1121.64 4482.19775390625 1121.55676269531 4 16 1.1.1.4035.19 1 57.0763 1141.398 57.0575 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.5400009155273 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@8; MDA adduct +54(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.438728004693985 4552.64208984375 911.5357 4552.20361328125 911.447937011719 5 17 1.1.1.4712.13 1 74.1431 1283.822 74.2273 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.0999994277954 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Cation:Na(D)@28 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.398645013570786 4488.58349609375 898.724 4488.18505859375 898.644287109375 5 17 1.1.1.4379.2 1 65.621 1136.933 65.6136 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.0999994277954 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.333788990974426 4466.53466796875 1117.641 4466.203125 1117.55798339844 4 15 1.1.1.4419.9 1 66.6037 4250.359 66.3283 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.6900029182434 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.482688009738922 4466.685546875 745.4549 4466.203125 745.374450683594 6 15 1.1.1.4343.3 1 64.6867 1324.759 64.6016 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.8500006198883 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK reduced acrolein addition +58(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.379373997449875 4524.6240234375 905.9321 4524.2451171875 905.856262207031 5 15 1.1.1.4287.9 1 63.237 577.8939 63.2521 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.92999792099 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.491842985153198 4466.69482421875 745.4564 4466.203125 745.374450683594 6 15 1.1.1.4484.4 1 68.2474 576.0623 68.2642 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.92999792099 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(P)@7; MDA adduct +62(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.432646989822388 4544.64599609375 909.9365 4544.21337890625 909.849975585938 5 16 1.1.1.4509.11 1 68.9011 370.0146 68.8599 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.92999792099 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.41312101483345 4466.6162109375 894.3305 4466.203125 894.247863769531 5 15 1.1.1.4615.8 1 71.6167 458.5608 71.5226 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.4800007343292 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK reduced acrolein addition +58(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.317802995443344 4524.5625 1132.148 4524.2451171875 1132.06848144531 4 15 1.1.1.4468.9 1 67.8416 528.576 67.8721 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.5999987125397 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@5; acrolein addition +56(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.49516299366951 4523.70849609375 754.9587 4523.21337890625 754.876159667969 6 15 1.1.1.4364.2 1 65.2393 3111.977 65.3929 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.9700014591217 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Delta:H(4)C(2)@N-term; reduced acrolein addition +58(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.387014001607895 4552.6630859375 911.5399 4552.2763671875 911.462524414063 5 18 1.1.1.4495.5 1 68.5273 486.6964 68.593 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.710000038147 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.486063987016678 4470.68408203125 746.1213 4470.19775390625 746.040283203125 6 15 1.1.1.4278.4 1 63.0062 2591.501 63.0255 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.710000038147 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trp->Kynurenin(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.48496600985527 4470.68310546875 746.1211 4470.19775390625 746.040283203125 6 15 1.1.1.4285.4 1 63.1815 8332.108 63.3556 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.2600028514862 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trp->Kynurenin(W)@8; acrolein addition +38(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.524336993694305 4507.689453125 752.2888 4508.21337890625 752.376220703125 6 15 1.1.1.4406.2 1 66.2629 1672.263 66.1109 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.6099972724915 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trimethyl(K)@23 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.374532997608185 4508.62451171875 902.7322 4508.25 902.657287597656 5 16 1.1.1.4650.18 1 72.549 1463.782 72.3706 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.3000004291534 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trp->Hydroxykynurenin(W)@8; hexanoyl addition +98(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.364042997360229 4584.6298828125 917.9333 4584.26611328125 917.860473632813 5 15 1.1.1.4577.18 1 70.6289 512.2828 70.6112 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.6099991798401 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.481588989496231 4466.6845703125 745.4547 4466.203125 745.374450683594 6 14 1.1.1.4454.5 1 67.4821 1041.872 67.4013 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.6099991798401 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.472434014081955 4466.67529296875 745.4532 4466.203125 745.374450683594 6 14 1.1.1.4462.3 1 67.6776 719.6838 67.7223 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.6099991798401 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.490377992391586 4466.693359375 745.4562 4466.203125 745.374450683594 6 14 1.1.1.4469.7 1 67.8554 906.7454 67.9236 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.6099991798401 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.491842985153198 4466.69482421875 745.4564 4466.203125 745.374450683594 6 14 1.1.1.4505.4 1 68.7874 515.5882 68.7259 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.6099991798401 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.52512401342392 4465.677734375 745.2869 4466.203125 745.374450683594 6 14 1.1.1.4541.2 1 69.6995 216.4817 69.6645 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.6099991798401 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.415562987327576 4466.61865234375 894.331 4466.203125 894.247863769531 5 14 1.1.1.4547.8 1 69.8627 798.5925 69.9561 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.6099991798401 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.395116001367569 4466.59814453125 894.3269 4466.203125 894.247863769531 5 14 1.1.1.4630.9 1 72.0163 498.2151 72.0264 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.9000005722046 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK reduced acrolein addition +58(K)@12; acrolein addition +56(K)@23 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.379465997219086 4580.650390625 917.1374 4580.27099609375 917.0615234375 5 14 1.1.1.4471.10 1 67.9119 246.9053 67.8721 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.5100014209747 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK MDA adduct +54(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.684845983982086 4519.52880859375 904.913 4520.21337890625 905.049987792969 5 14 1.1.1.4371.8 1 65.4271 1448.333 65.6136 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.0100028514862 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK MDA adduct +62(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.47350800037384 4528.6923828125 755.7893 4528.21875 755.710388183594 6 13 1.1.1.4333.7 1 64.4281 1347.596 64.4706 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.0100028514862 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.482688009738922 4466.685546875 745.4549 4466.203125 745.374450683594 6 13 1.1.1.4336.4 1 64.5038 1324.759 64.6016 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.0100028514862 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(D)@13 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.575384974479675 4481.62255859375 897.3318 4482.19775390625 897.446838378906 5 15 1.1.1.4350.7 1 64.8728 1079.004 64.9689 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.0100028514862 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trp->Kynurenin(W)@8; acrolein addition +38(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.491378009319305 4507.72216796875 752.2943 4508.21337890625 752.376220703125 6 14 1.1.1.4361.3 1 65.1616 1013.438 65.2329 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.0100028514862 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK reduced acrolein addition +58(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.536472022533417 4523.70849609375 754.9587 4524.2451171875 755.048095703125 6 13 1.1.1.4371.3 1 65.423 3111.977 65.3929 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.0100028514862 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trp->Kynurenin(W)@8; acrolein addition +38(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.519209980964661 4507.6943359375 752.2897 4508.21337890625 752.376220703125 6 14 1.1.1.4384.2 1 65.7509 2822.2 65.6136 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.0100028514862 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trp->Kynurenin(W)@8; acrolein addition +38(K)@23 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.552522003650665 4507.6611328125 902.5395 4508.21337890625 902.650024414063 5 14 1.1.1.4424.4 1 66.7251 7896.951 66.6892 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.9900004863739 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.586023986339569 4465.6171875 894.1307 4466.203125 894.247863769531 5 13 1.1.1.4349.5 1 64.8487 1281.596 64.5755 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.4799993038177 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@8; acrolein addition +76(K)@12; HPNE addition +172(K)@23 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.349200010299683 4746.6826171875 1187.678 4746.333984375 1187.5908203125 4 14 1.1.1.4385.6 1 65.784 2132.698 65.8644 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 73.2100009918213 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.477926999330521 4466.68115234375 745.4541 4466.203125 745.374450683594 6 16 1.1.1.4375.2 1 65.5277 102931.7 65.6136 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 72.1300005912781 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(D)@13 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.473612993955612 4482.67138671875 748.1192 4482.19775390625 748.040283203125 6 14 1.1.1.4032.11 1 56.9935 2362.787 57.0575 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 72.1300005912781 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trp->Kynurenin(W)@8; Deamidated(Q)@32 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.552747011184692 4470.62939453125 895.1331 4471.18212890625 895.24365234375 5 14 1.1.1.4399.4 1 66.0967 4636.404 66.1109 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.5200026035309 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK acrolein addition +56(K)@12; Oxidation(D)@13 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.331701993942261 4538.5546875 1135.646 4538.22412109375 1135.56335449219 4 14 1.1.1.4660.19 1 72.8152 986.5511 72.7142 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.4700012207031 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.472434014081955 4466.67529296875 745.4532 4466.203125 745.374450683594 6 13 1.1.1.4440.4 1 67.139 963.512 67.1825 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.4700012207031 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.395116001367569 4466.59814453125 894.3269 4466.203125 894.247863769531 5 13 1.1.1.4570.14 1 70.448 548.4647 70.4328 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.7799999713898 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.41312101483345 4466.6162109375 894.3305 4466.203125 894.247863769531 5 12 1.1.1.4054.10 1 57.5502 879.1894 57.5384 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.7799999713898 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(P)@7 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.513324975967407 4481.6845703125 747.9547 4482.19775390625 748.040283203125 6 13 1.1.1.4338.5 1 64.5571 1404.154 64.4706 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.3900008201599 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.396946996450424 4466.60009765625 894.3273 4466.203125 894.247863769531 5 13 1.1.1.4585.12 1 70.8287 534.2319 70.8412 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.2399997711182 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.424717992544174 4466.6279296875 894.3328 4466.203125 894.247863769531 5 12 1.1.1.4429.12 1 66.8605 1920.508 66.7419 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 66.2999987602234 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.405187010765076 4466.6083984375 894.3289 4466.203125 894.247863769531 5 13 1.1.1.4607.8 1 71.4073 486.8344 71.3129 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 65.1899993419647 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.494040995836258 4466.697265625 745.4568 4466.203125 745.374450683594 6 13 1.1.1.4498.3 1 68.6012 607.9633 68.5392 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 65.1899993419647 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(P)@7; acrolein addition +56(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.40310001373291 4538.62744140625 908.7327 4538.22412109375 908.652099609375 5 14 1.1.1.4661.15 1 72.8371 2246.826 72.6882 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 65.039998292923 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.500587999820709 4465.70263671875 745.291 4466.203125 745.374450683594 6 12 1.1.1.4350.2 1 64.8687 487.874 64.7851 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.9500021934509 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.47222900390625 4498.6650390625 750.7848 4498.19287109375 750.706115722656 6 13 1.1.1.4277.2 1 62.9796 805.7933 63.0006 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 61.760002374649 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trp->Kynurenin(W)@8; acrolein addition +38(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.524336993694305 4507.689453125 752.2888 4508.21337890625 752.376220703125 6 13 1.1.1.4396.2 1 66.0219 1672.263 66.1109 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.6599986553192 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Trp->Kynurenin(W)@8; acrolein addition +38(K)@23 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.551910996437073 4507.66162109375 902.5396 4508.21337890625 902.650024414063 5 13 1.1.1.4417.4 1 66.5411 7258.649 66.5856 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.3099980354309 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK MDA adduct +54(K)@23 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.633467018604279 4519.580078125 754.2706 4520.21337890625 754.376220703125 6 12 1.1.1.4400.2 1 66.1166 797.5818 66.135 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 51.9599974155426 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(P)@7; acrolein addition +56(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 -0.576514005661011 4537.6474609375 908.5368 4538.22412109375 908.652099609375 5 14 1.1.1.4468.5 1 67.8316 1596.406 68.0798 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 46.2399989366531 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.485617995262146 4466.6884765625 745.4554 4466.203125 745.374450683594 6 15 1.1.1.4418.3 1 66.5746 1153.777 66.5595 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 45.210000872612 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@5; Deamidated(R)@10 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.431174010038376 4468.60205078125 894.7277 4468.1708984375 894.641479492188 5 13 1.1.1.4314.8 1 63.9376 1729.436 63.7985 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 44.1900014877319 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@5; Deamidated(R)@10; acrolein addition +38(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.500959992408752 4506.6875 752.1219 4506.1865234375 752.038391113281 6 13 1.1.1.4385.2 1 65.7732 1827.611 65.7201 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.3500000238419 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK acrolein addition +56(K)@12; MDA adduct +62(K)@23 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.393106997013092 4584.63818359375 917.9349 4584.2451171875 917.856262207031 5 12 1.1.1.4657.16 1 72.7315 318.9264 72.8734 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 27.0599991083145 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Delta:H(2)C(2)(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27 0.352806985378265 4492.57080078125 1124.15 4492.21875 1124.06188964844 4 12 1.1.1.4432.11 1 66.9434 915.3683 66.8206 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27; missed K-Q@40 0.508351027965546 5063.076171875 844.8533 5062.5673828125 844.7685546875 6 22 1.1.1.4416.2 1 66.5148 14387.06 66.7681 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27; missed K-Q@40 0.43402299284935 5063.00341796875 1013.608 5062.5673828125 1013.52081298828 5 32 1.1.1.4416.5 1 66.5248 8182.173 66.7681 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27; missed K-Q@40 0.508351027965546 5063.076171875 844.8533 5062.5673828125 844.7685546875 6 22 1.1.1.4423.2 1 66.696 14454.43 66.7419 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27; missed K-Q@40 0.43402299284935 5063.00341796875 1013.608 5062.5673828125 1013.52081298828 5 34 1.1.1.4423.6 1 66.7027 9080.329 66.7942 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK Deamidated(Q)@5 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27; missed K-Q@40 -0.475665003061295 5063.076171875 844.8533 5063.5517578125 844.932556152344 6 23 1.1.1.4430.5 1 66.881 14454.43 66.7419 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK Ammonia-loss(N)@43; reduced acrolein addition +58(K)@45 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27; missed K-Q@40 0.449591010808945 5104.03369140625 1021.814 5103.5830078125 1021.72387695313 5 21 1.1.1.4424.6 1 66.7293 2270.385 66.8468 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK reduced acrolein addition +58(K)@40; Ammonia-loss(N)@43 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27; missed K-Q@40 0.449591010808945 5104.03369140625 1021.814 5103.5830078125 1021.72387695313 5 20 1.1.1.4431.9 1 66.9151 2270.385 66.8468 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK reduced acrolein addition +58(K)@40; Methyl(Q)@41 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27; missed K-Q@40 0.386700987815857 5135.013671875 1028.01 5134.625 1027.93225097656 5 26 1.1.1.4554.9 1 70.054 1374.142 70.0093 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK reduced acrolein addition +58(K)@40; Dimethyl(N)@43 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27; missed K-Q@40 0.377398997545242 5149.0185546875 1030.811 5148.640625 1030.73547363281 5 23 1.1.1.4597.5 1 71.1494 881.812 71.1544 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27; missed K-Q@40 0.50798499584198 5063.07568359375 844.8532 5062.5673828125 844.7685546875 6 19 1.1.1.4437.5 1 67.067 14045.49 66.7942 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.089998960495 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK reduced acrolein addition +58(K)@40; Ammonia-loss(N)@43 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27; missed K-Q@40 0.515251994132996 5104.09814453125 851.6903 5103.5830078125 851.604431152344 6 18 1.1.1.4429.10 1 66.8588 4465.548 66.873 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.869998216629 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK reduced acrolein addition +58(K)@40; Ammonia-loss(N)@43 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27; missed K-Q@40 0.515251994132996 5104.09814453125 851.6903 5103.5830078125 851.604431152344 6 19 1.1.1.4436.4 1 67.0414 4478.378 66.873 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.1899995803833 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK Dioxidation(K)@12 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27; missed K-Q@40 0.418680995702744 5094.978515625 1020.003 5094.5576171875 1019.91876220703 5 18 1.1.1.4294.18 1 63.4256 1330.454 63.4072 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.92999792099 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK reduced acrolein addition +58(K)@40; Methyl(Q)@41 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27; missed K-Q@40 0.411725997924805 5135.03857421875 1028.015 5134.625 1027.93225097656 5 17 1.1.1.4553.8 1 70.0276 1374.142 70.0093 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.3000004291534 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK reduced acrolein addition +58(K)@40; Methyl(Q)@41 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27; missed K-Q@40 0.457062005996704 5135.08203125 856.8543 5134.625 856.778137207031 6 16 1.1.1.4549.8 1 69.9143 1428.163 70.0093 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.0100028514862 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK Dioxidation(W)@8 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27; missed K-Q@40 0.489834994077683 5095.04736328125 850.1818 5094.5576171875 850.100158691406 6 14 1.1.1.4293.11 1 63.3938 3137.525 63.4332 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.9500021934509 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27; missed K-Q@40 0.517506003379822 5063.0849609375 844.8548 5062.5673828125 844.7685546875 6 12 1.1.1.4409.4 1 66.3339 9606.811 66.5856 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 46.8899995088577 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK Trimethyl(K)@40 cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27; missed K-Q@40 0.402148991823196 5105.0185546875 1022.011 5104.61474609375 1021.93017578125 5 14 1.1.1.4485.9 1 68.2857 232.6289 68.2642 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 41.839998960495 DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK cleaved Q-D@N-term; missed R-V@10; missed K-D@12; missed K-D@23; missed R-D@27; missed K-Q@40 0.43402299284935 5063.00341796875 1013.608 5062.5673828125 1013.52081298828 5 12 1.1.1.4437.7 1 67.0703 9078.113 66.7942 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 36.7000013589859 DLATVYVDVLK 0.161354005336761 1234.84228515625 618.4284 1234.68090820313 618.347717285156 2 12 1.1.1.3783.5 1 50.8819 36416.11 50.9995 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLKDSGR missed K-D@11 0.168772995471954 1650.03125 826.0229 1649.86242675781 825.9384765625 2 21 1.1.1.3807.3 1 51.4705 4790.637 51.3913 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLKDSGR missed K-D@11 0.229977995157242 1650.09240722656 551.0381 1649.86242675781 550.96142578125 3 16 1.1.1.3800.2 1 51.2978 5613.926 51.3671 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@11; missed R-D@15 0.32252699136734 3031.83642578125 758.9664 3031.51391601563 758.8857421875 4 26 1.1.1.4036.7 1 57.0915 104538.8 57.2098 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@11; missed R-D@15 0.253264993429184 3031.76611328125 1011.596 3031.51391601563 1011.51190185547 3 30 1.1.1.4036.14 1 57.0974 79970.9 57.2098 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@11; missed R-D@15 0.32252699136734 3031.83642578125 758.9664 3031.51391601563 758.8857421875 4 27 1.1.1.4045.5 1 57.3125 104538.8 57.2098 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGK reduced acrolein addition +58(K)@11; Dehydrated(S)@13; Deamidated(R)@15 missed K-D@11; missed R-D@15 0.270787000656128 3072.80029296875 1025.274 3072.52905273438 1025.18371582031 3 27 1.1.1.4047.18 1 57.3738 3939.942 57.3814 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGK Amino(Y)@6; Delta:H(2)C(2)(K)@11 missed K-D@11; missed R-D@15 0.324541985988617 3072.86499023438 769.2235 3072.54028320313 769.142395019531 4 22 1.1.1.4047.6 1 57.3638 5738.3 57.3814 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGK Carboxyethyl(K)@11 missed K-D@11; missed R-D@15 0.269490003585815 3103.80517578125 1035.609 3103.53491210938 1035.51892089844 3 38 1.1.1.4470.13 1 67.8893 702.7277 67.9497 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGK reduced acrolein addition +58(K)@11; Methyl(D)@16 missed K-D@11; missed R-D@15 0.294308990240097 3103.86572265625 776.9737 3103.5712890625 776.900146484375 4 22 1.1.1.4477.4 1 68.0681 596.587 67.9758 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGK Carboxyethyl(K)@11 missed K-D@11; missed R-D@15 0.269490003585815 3103.80517578125 1035.609 3103.53491210938 1035.51892089844 3 39 1.1.1.4477.6 1 68.0748 702.7277 67.9497 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGK reduced acrolein addition +58(K)@11; Dimethyl(R)@15 missed K-D@11; missed R-D@15 0.289889007806778 3117.876953125 780.4765 3117.5869140625 780.404052734375 4 23 1.1.1.4554.4 1 70.0448 696.6689 70.1887 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGK reduced acrolein addition +58(K)@11; Methyl(D)@12; Methyl(S)@13 missed K-D@11; missed R-D@15 0.218796998262405 3117.80615234375 1040.276 3117.5869140625 1040.20300292969 3 41 1.1.1.4559.6 1 70.1836 857.8533 70.1646 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGK reduced acrolein addition +58(K)@11; Dimethyl(R)@15 missed K-D@11; missed R-D@15 0.289889007806778 3117.876953125 780.4765 3117.5869140625 780.404052734375 4 28 1.1.1.4563.2 1 70.2676 696.6689 70.1887 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGK Carbamidomethyl(K)@11 missed K-D@11; missed R-D@15 0.327185988426209 3088.86254882813 773.2229 3088.53540039063 773.14111328125 4 18 1.1.1.4035.7 1 57.0663 1416.29 57.1083 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGK Carboxyethyl(K)@11 missed K-D@11; missed R-D@15 0.330695003271103 3103.86572265625 776.9737 3103.53491210938 776.890991210938 4 20 1.1.1.4470.5 1 67.8793 596.587 67.9758 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGK reduced acrolein addition +58(K)@11; Dimethyl(R)@15 missed K-D@11; missed R-D@15 0.218796998262405 3117.80615234375 1040.276 3117.5869140625 1040.20300292969 3 21 1.1.1.4567.8 1 70.3726 857.8533 70.1646 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@11; missed R-D@15 0.321061998605728 3031.8349609375 758.966 3031.51391601563 758.8857421875 4 18 1.1.1.3977.8 1 55.6257 726.9683 55.6172 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.8799998760223 DLATVYVDVLKDSGRDYVSQFEGSALGK Cation:Na(D)@8 missed K-D@11; missed R-D@15 0.327398985624313 3053.8232421875 764.4631 3053.49584960938 764.381225585938 4 17 1.1.1.4039.10 1 57.1703 1023.112 57.1846 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.8799998760223 DLATVYVDVLKDSGRDYVSQFEGSALGK Trimethyl(K)@11 missed K-D@11; missed R-D@15 0.297794014215469 3073.85864257813 769.4719 3073.56079101563 769.3974609375 4 16 1.1.1.4327.3 1 64.2684 437.8581 64.3404 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1199989318848 DLATVYVDVLKDSGRDYVSQFEGSALGK Delta:H(2)C(2)@N-term missed K-D@11; missed R-D@15 0.25653600692749 3057.78515625 1020.269 3057.52954101563 1020.18377685547 3 16 1.1.1.4037.18 1 57.1262 619.6885 57.1337 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.4900026321411 DLATVYVDVLKDSGRDYVSQFEGSALGK Delta:H(2)C(2)@N-term missed K-D@11; missed R-D@15 0.316642999649048 3057.84619140625 765.4688 3057.52954101563 765.3896484375 4 16 1.1.1.4036.8 1 57.0924 564.6758 57.1337 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.3300008773804 DLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@20 missed K-D@11; missed R-D@15 0.34095299243927 3032.8388671875 759.217 3032.49780273438 759.131713867188 4 15 1.1.1.4040.5 1 57.1914 56460.35 57.2098 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.2799997329712 DLATVYVDVLKDSGRDYVSQFEGSALGK Delta:H(2)C(2)@N-term missed K-D@11; missed R-D@15 0.249944001436234 3057.779296875 1020.267 3057.52954101563 1020.18377685547 3 13 1.1.1.4045.16 1 57.3217 504.797 57.3063 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.0500011444092 DLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@11; missed R-D@15 3.02913999557495 3034.54418945313 1012.522 3031.51391601563 1011.51190185547 3 12 1.1.1.3373.11 1 40.8092 1144.885 40.8159 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.7799999713898 DLATVYVDVLKDSGRDYVSQFEGSALGK Dicarbamidomethyl(D)@8; ONE addition +154(K)@11 missed K-D@11; missed R-D@15 0.436859011650085 3300.09301757813 661.0259 3299.65625 660.9384765625 5 13 1.1.1.3891.4 1 53.5547 6010.334 53.6965 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 43.979999423027 DLATVYVDVLKDSGRDYVSQFEGSALGK MDA adduct +54(K)@11 missed K-D@11; missed R-D@15 0.231639996170998 3085.75610351563 772.4463 3085.5244140625 772.388366699219 4 13 1.1.1.4039.11 1 57.1711 542.0433 57.1846 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK Carboxyethyl(K)@28 missed K-D@11; missed R-D@15; missed K-Q@28 0.338413000106812 3700.23803710938 926.0668 3699.89965820313 925.982177734375 4 28 1.1.1.4289.11 1 63.2903 1366.574 63.3556 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK missed K-D@11; missed R-D@15; missed K-Q@28; missed K-L@33 0.437440007925034 5222.08349609375 1045.424 5221.64599609375 1045.33642578125 5 18 1.1.1.4429.16 1 66.8663 964.7206 66.9518 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.089998960495 DLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Dioxidation(W)@38 missed K-D@11; missed R-D@15; missed K-Q@28; missed K-L@33 -0.564230978488922 5253.0732421875 1051.622 5253.6357421875 1051.734375 5 17 1.1.1.4336.13 1 64.5147 457.0731 64.4706 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.6400017738342 DLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Deamidated(Q)@20; Dioxidation(W)@38 missed K-D@11; missed R-D@15; missed K-Q@28; missed K-L@33 -0.553982973098755 5254.0634765625 1051.82 5254.61962890625 1051.93127441406 5 17 1.1.1.4334.7 1 64.4589 577.0667 64.4706 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4199988842011 DLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK missed K-D@11; missed R-D@15; missed K-Q@28; missed K-L@33 0.506578981876373 5222.15234375 871.366 5221.64599609375 871.281616210938 6 16 1.1.1.4433.6 1 66.9604 1082.911 66.9518 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.1499972343445 DLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK HPNE addition +172(K)@28; Deamidated(Q)@29; hexanoyl addition +98(K)@33; acrolein addition +76(K)@47 missed K-D@11; missed R-D@15; missed K-Q@28; missed K-L@33 0.525560975074768 5569.3701171875 929.2356 5568.84423828125 929.148010253906 6 12 1.1.1.4331.14 0 64.3815 481.961 64.3404 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8100011348724 DLEEVKAK missed K-A@6 0.146016001701355 930.648254394531 466.3314 930.502197265625 466.258392333984 2 11 1.1.1.2604.7 1 22.3518 11321.39 22.0881 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2700009346008 DLEEVKAK Delta:H(2)C(2)@N-term missed K-A@6 0.146356999874115 956.664245605469 479.3394 956.517883300781 479.266204833984 2 12 1.1.1.2703.5 1 24.7314 1963.333 24.6482 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.370001077652 DLEEVKAK reduced acrolein addition +58(K)@6 missed K-A@6 0.115382000803947 988.659484863281 495.337 988.544067382813 495.279327392578 2 12 1.1.1.2921.6 1 29.951 637.2926 29.9369 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 72.3999977111816 DLEEVKAK missed K-A@6 0.146016001701355 930.648254394531 466.3314 930.502197265625 466.258392333984 2 12 1.1.1.2589.4 1 21.9904 11845.87 22.0881 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.5100028514862 DLEEVKAK missed K-A@6 0.146016001701355 930.648254394531 466.3314 930.502197265625 466.258392333984 2 12 1.1.1.2597.4 1 22.1759 11845.87 22.0881 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 50.8499979972839 DLEEVKAK Formyl(K)@6 missed K-A@6 0.143898993730545 958.641052246094 480.3278 958.497131347656 480.255828857422 2 12 1.1.1.2711.5 1 24.9185 1603.442 24.9592 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 43.5799986124039 DLEEVKAK missed K-A@6 0.144428998231888 930.646667480469 466.3306 930.502197265625 466.258392333984 2 11 1.1.1.2618.9 1 22.6998 421.243 22.7073 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.1500029563904 DLRQGLLPVLESFKVSFLSALEEYTKKLNTQ cleaved E-D@N-term; missed R-Q@3; missed K-V@14; missed K-K@26; missed K-L@27 -9.27898979187012 3556.66064453125 890.1724 3565.93969726563 892.4921875 4 18 1.1.1.4719.13 1 74.3144 41831.16 74.5197 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.5699985027313 DNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLR MDA adduct +62(K)@12; Oxidation(P)@19; Trp->Kynurenin(W)@25 cleaved L-D@N-term; missed K-L@12; missed R-E@14; missed K-E@30 -0.060376800596714 4335.99560546875 723.6732 4336.05615234375 723.683288574219 6 15 1.1.1.3861.3 1 52.8166 2123.944 52.7615 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.7499990463257 DRVKDLATVYVDVLKDSGRDYVSQFEGSALGK acrolein addition +38(K)@4; MDA adduct +62(K)@15 cleaved W-D@N-term; missed R-V@2; missed K-D@4; missed K-D@15; missed R-D@19 0.091422900557518 3629.92724609375 1210.983 3629.83666992188 1210.95275878906 3 14 1.1.1.3368.17 1 40.6899 3159.666 40.695 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.3099985122681 DRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(R)@2; hexanoyl addition +98(K)@4 cleaved W-D@N-term; missed R-V@2; missed K-D@4; missed K-D@15; missed R-D@19 0.159705996513367 3629.02221679688 908.2628 3628.86254882813 908.222900390625 4 16 1.1.1.3888.14 1 53.4873 487.364 53.5234 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.710000038147 DRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(R)@2; hexanoyl addition +98(K)@4 cleaved W-D@N-term; missed R-V@2; missed K-D@4; missed K-D@15; missed R-D@19 0.152870997786522 3629.01538085938 908.2611 3628.86254882813 908.222900390625 4 15 1.1.1.3881.7 1 53.3136 691.7971 53.3497 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 75.3400027751923 DRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Delta:H(2)C(2)@N-term cleaved W-D@N-term; missed R-V@2; missed K-D@4; missed K-D@15; missed R-D@19 0.333072990179062 3556.15405273438 890.0458 3555.82104492188 889.962524414063 4 14 1.1.1.3875.9 1 53.1639 747.4642 53.13 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.165500998497009 1815.00903320313 908.5118 1814.84350585938 908.429016113281 2 21 1.1.1.3342.9 1 40.0588 2383.878 40.187 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.165500998497009 1815.00903320313 908.5118 1814.84350585938 908.429016113281 2 24 1.1.1.3343.8 1 40.0829 2383.878 40.187 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.165500998497009 1815.00903320313 908.5118 1814.84350585938 908.429016113281 2 24 1.1.1.3350.5 1 40.251 2383.878 40.187 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.167942002415657 1815.01147460938 908.513 1814.84350585938 908.429016113281 2 26 1.1.1.3357.6 1 40.4199 179842 40.5975 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.234640002250671 1815.078125 606.0333 1814.84350585938 605.955139160156 3 21 1.1.1.3358.5 1 40.4357 113803.5 40.5733 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.234640002250671 1815.078125 606.0333 1814.84350585938 605.955139160156 3 20 1.1.1.3365.4 1 40.6026 113803.5 40.5733 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.167942002415657 1815.01147460938 908.513 1814.84350585938 908.429016113281 2 27 1.1.1.3365.15 1 40.6168 182893.4 40.5975 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK Cation:Na(E)@11 missed R-D@4 0.233958005905151 1837.05944824219 613.3604 1836.82543945313 613.282409667969 3 18 1.1.1.3368.9 1 40.6799 771.3373 40.7437 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.168185994029045 1815.01171875 908.5131 1814.84350585938 908.429016113281 2 28 1.1.1.3372.7 1 40.7842 213335.1 40.7194 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.235189005732536 1815.07873535156 606.0335 1814.84350585938 605.955139160156 3 21 1.1.1.3375.4 1 40.8475 143652.7 40.7677 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK Cation:Na(E)@11 missed R-D@4 0.233591005206108 1837.05908203125 613.3603 1836.82543945313 613.282409667969 3 20 1.1.1.3375.5 1 40.8491 762.7374 40.8885 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.167942002415657 1815.01147460938 908.513 1814.84350585938 908.429016113281 2 28 1.1.1.3380.9 1 40.9738 211080.3 40.7194 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.234823003411293 1815.07836914063 606.0334 1814.84350585938 605.955139160156 3 21 1.1.1.3382.5 1 41.0223 142182.7 40.7677 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.167942002415657 1815.01147460938 908.513 1814.84350585938 908.429016113281 2 28 1.1.1.3387.17 1 41.1477 157843.2 40.8885 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.167942002415657 1815.01147460938 908.513 1814.84350585938 908.429016113281 2 24 1.1.1.3394.10 1 41.3211 62336.8 41.0584 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.168185994029045 1815.01171875 908.5131 1814.84350585938 908.429016113281 2 24 1.1.1.3401.12 1 41.4951 9340.613 41.23 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.233724996447563 1815.07727050781 606.033 1814.84350585938 605.955139160156 3 20 1.1.1.3413.11 1 41.7803 7502.684 41.7207 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.164890006184578 1815.00842285156 908.5115 1814.84350585938 908.429016113281 2 23 1.1.1.3417.7 1 41.8814 3894.938 41.7207 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.162327006459236 1815.005859375 908.5102 1814.84350585938 908.429016113281 2 20 1.1.1.3425.10 1 42.0787 580.0576 42.0383 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK Delta:H(2)C(2)@N-term missed R-D@4 0.165231004357338 1841.0244140625 921.5195 1840.85913085938 921.436828613281 2 22 1.1.1.3429.6 1 42.1793 3659.836 42.2825 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK Delta:H(2)C(2)@N-term missed R-D@4 0.165231004357338 1841.0244140625 921.5195 1840.85913085938 921.436828613281 2 26 1.1.1.3436.13 1 42.3503 3659.836 42.2825 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK Delta:H(2)C(2)@N-term missed R-D@4 0.227474004030228 1841.08666992188 614.7028 1840.85913085938 614.627014160156 3 22 1.1.1.3437.6 1 42.3695 3989.99 42.2825 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK Delta:H(2)C(2)@N-term missed R-D@4 0.165475994348526 1841.02465820313 921.5196 1840.85913085938 921.436828613281 2 25 1.1.1.3467.13 1 43.1106 4037.772 43.0925 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK Formyl@N-term missed R-D@4 0.165824994444847 1843.00427246094 922.5094 1842.83837890625 922.426513671875 2 18 1.1.1.3482.18 1 43.4828 1320.724 43.5396 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK Delta:H(2)C(2)@N-term missed R-D@4 0.227474004030228 1841.08666992188 614.7028 1840.85913085938 614.627014160156 3 20 1.1.1.3430.6 1 42.1997 3989.99 42.2825 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK Delta:H(2)C(2)@N-term missed R-D@4 0.233333006501198 1841.09252929688 614.7048 1840.85913085938 614.627014160156 3 20 1.1.1.3467.7 1 43.1006 4360.755 43.0925 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK Cation:Na(E)@11 missed R-D@4 0.234141007065773 1837.0595703125 613.3605 1836.82543945313 613.282409667969 3 17 1.1.1.3361.9 1 40.5115 590.3318 40.5733 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.233724996447563 1815.07727050781 606.033 1814.84350585938 605.955139160156 3 18 1.1.1.3420.6 1 41.9551 7563.354 41.7207 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.22859799861908 1815.07214355469 606.0313 1814.84350585938 605.955139160156 3 18 1.1.1.3443.8 1 42.5108 1019.476 42.477 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.229696005582809 1815.0732421875 606.0317 1814.84350585938 605.955139160156 3 17 1.1.1.3500.5 1 43.9182 567.0509 43.9366 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK Dehydrated(S)@2 missed R-D@4 0.167765006422997 1797.00073242188 899.5076 1796.83288574219 899.423767089844 2 15 1.1.1.3311.13 1 39.3171 633.799 39.2743 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.229696005582809 1815.0732421875 606.0317 1814.84350585938 605.955139160156 3 19 1.1.1.3184.8 1 36.2708 3342.572 36.3049 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.235189005732536 1815.07873535156 606.0335 1814.84350585938 605.955139160156 3 19 1.1.1.3366.6 1 40.6287 143652.7 40.7677 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.235189005732536 1815.07873535156 606.0335 1814.84350585938 605.955139160156 3 19 1.1.1.3376.5 1 40.8701 143652.7 40.7677 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.233724996447563 1815.07727050781 606.033 1814.84350585938 605.955139160156 3 17 1.1.1.3427.4 1 42.119 2273.866 41.867 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.22859799861908 1815.07214355469 606.0313 1814.84350585938 605.955139160156 3 17 1.1.1.3436.7 1 42.3403 1019.476 42.477 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.228230997920036 1815.07177734375 606.0312 1814.84350585938 605.955139160156 3 17 1.1.1.3453.11 1 42.7627 626.6546 42.7465 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK Nitro(Y)@6 missed R-D@4 0.168459996581078 1859.9970703125 931.0058 1859.82861328125 930.921569824219 2 18 1.1.1.3499.19 1 43.9051 443.1728 43.9118 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.234273999929428 1815.07775878906 606.0332 1814.84350585938 605.955139160156 3 18 1.1.1.3345.3 1 40.1253 2471.366 40.2112 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.235189005732536 1815.07873535156 606.0335 1814.84350585938 605.955139160156 3 18 1.1.1.3383.8 1 41.0426 136232.9 40.7918 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.233724996447563 1815.07727050781 606.033 1814.84350585938 605.955139160156 3 17 1.1.1.3415.9 1 41.8292 7502.684 41.7207 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK Cation:Na(E)@11 missed R-D@4 0.233591005206108 1837.05908203125 613.3603 1836.82543945313 613.282409667969 3 16 1.1.1.3382.6 1 41.0257 762.7374 40.8885 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.229513004422188 1815.07299804688 606.0316 1814.84350585938 605.955139160156 3 16 1.1.1.3492.9 1 43.7245 597.8142 43.7133 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.234640002250671 1815.078125 606.0333 1814.84350585938 605.955139160156 3 15 1.1.1.3624.14 1 46.9718 594.5186 46.9055 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.233724996447563 1815.07727050781 606.033 1814.84350585938 605.955139160156 3 16 1.1.1.3631.15 1 47.1556 578.6163 47.0865 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK Delta:H(2)C(2)@N-term missed R-D@4 0.13544599711895 1840.99462890625 921.5046 1840.85913085938 921.436828613281 2 17 1.1.1.3460.20 1 42.9385 509.8422 42.9187 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGK missed R-D@4 0.234273999929428 1815.07775878906 606.0332 1814.84350585938 605.955139160156 3 16 1.1.1.3461.10 1 42.9542 540.9393 43.0179 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.989999294281 DSGRDYVSQFEGSALGK missed R-D@4 0.293404012918472 1815.13696289063 454.7915 1814.84350585938 454.718139648438 4 16 1.1.1.3375.2 1 40.8441 2206.238 40.84 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.989999294281 DSGRDYVSQFEGSALGK missed R-D@4 0.293404012918472 1815.13696289063 454.7915 1814.84350585938 454.718139648438 4 16 1.1.1.3382.3 1 41.0173 2206.238 40.84 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.989999294281 DSGRDYVSQFEGSALGK missed R-D@4 0.230063006281853 1815.07360839844 606.0318 1814.84350585938 605.955139160156 3 16 1.1.1.3645.14 1 47.5172 463.214 47.553 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 DSGRDYVSQFEGSALGK Formyl@N-term missed R-D@4 0.23105899989605 1843.06945800781 615.3638 1842.83837890625 615.286743164063 3 17 1.1.1.3486.9 1 43.5789 846.6807 43.5396 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1000015735626 DSGRDYVSQFEGSALGK missed R-D@4 0.233724996447563 1815.07727050781 606.033 1814.84350585938 605.955139160156 3 15 1.1.1.3603.13 1 46.4381 712.0471 46.3739 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8699991703033 DSGRDYVSQFEGSALGK Delta:H(2)C(2)@N-term missed R-D@4 0.165475994348526 1841.02465820313 921.5196 1840.85913085938 921.436828613281 2 16 1.1.1.3474.13 1 43.2835 4037.772 43.0925 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8100011348724 DSGRDYVSQFEGSALGK missed R-D@4 0.298530995845795 1815.14208984375 454.7928 1814.84350585938 454.718139648438 4 15 1.1.1.3368.4 1 40.6757 2199.445 40.695 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.0400004386902 DSGRDYVSQFEGSALGK Acetyl@N-term missed R-D@4 0.1667769998312 1857.02087402344 929.5177 1856.85412597656 929.434326171875 2 13 1.1.1.3444.14 1 42.5452 261.0651 42.5015 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.0400004386902 DSGRDYVSQFEGSALGK Deamidated(Q)@9 missed R-D@4 0.19471600651741 1816.02221679688 606.348 1815.82751464844 606.283142089844 3 14 1.1.1.3529.10 1 44.6313 16301.11 44.7911 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9199993610382 DSGRDYVSQFEGSALGK Deamidated(Q)@9 missed R-D@4 0.252027988433838 1816.07958984375 606.3671 1815.82751464844 606.283142089844 3 13 1.1.1.3366.7 1 40.6296 65753.72 40.7437 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2300000190735 DSGRDYVSQFEGSALGK Didehydro(Y)@6 missed R-D@4 0.239609003067017 1813.06750488281 605.3631 1812.82788085938 605.283203125 3 14 1.1.1.3191.5 1 36.4403 485.6798 36.3768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.7000014781952 DSGRDYVSQFEGSALGK missed R-D@4 0.1613499969244 1815.0048828125 908.5097 1814.84350585938 908.429016113281 2 11 1.1.1.3489.18 1 43.6559 213.4051 43.6385 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.7000014781952 DSGRDYVSQFEGSALGK missed R-D@4 0.229696005582809 1815.0732421875 606.0317 1814.84350585938 605.955139160156 3 14 1.1.1.3610.7 1 46.611 844.0068 46.5512 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.7000014781952 DSGRDYVSQFEGSALGK missed R-D@4 0.23335799574852 1815.07690429688 606.0329 1814.84350585938 605.955139160156 3 14 1.1.1.3617.7 1 46.7873 606.5969 46.7782 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.7000014781952 DSGRDYVSQFEGSALGK missed R-D@4 0.234273999929428 1815.07775878906 606.0332 1814.84350585938 605.955139160156 3 14 1.1.1.3638.9 1 47.3343 516.4317 47.3228 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.7000014781952 DSGRDYVSQFEGSALGK missed R-D@4 0.233724996447563 1815.07727050781 606.033 1814.84350585938 605.955139160156 3 14 1.1.1.3662.9 1 47.9474 409.5558 47.9113 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.7199997901917 DSGRDYVSQFEGSALGK missed R-D@4 -0.18265700340271 1814.66088867188 605.8942 1814.84350585938 605.955139160156 3 14 1.1.1.3509.10 1 44.1467 564.567 44.1353 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1900012493134 DSGRDYVSQFEGSALGK Formyl@N-term missed R-D@4 0.165824994444847 1843.00427246094 922.5094 1842.83837890625 922.426513671875 2 11 1.1.1.3489.19 1 43.6568 1320.724 43.5396 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1900012493134 DSGRDYVSQFEGSALGK Deamidated(Q)@9 missed R-D@4 0.198194995522499 1816.02575683594 606.3492 1815.82751464844 606.283142089844 3 13 1.1.1.3596.10 1 46.2581 5062.774 46.0015 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 77.2800028324127 DSGRDYVSQFEGSALGK Delta:H(2)C(2)@N-term missed R-D@4 0.233333006501198 1841.09252929688 614.7048 1840.85913085938 614.627014160156 3 13 1.1.1.3464.8 1 43.0268 4360.755 43.0925 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.6800005435944 DSGRDYVSQFEGSALGK missed R-D@4 0.229147002100945 1815.07263183594 606.0315 1814.84350585938 605.955139160156 3 13 1.1.1.3737.5 1 49.7099 288.0405 49.7283 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 65.8399999141693 DSGRDYVSQFEGSALGK missed R-D@4 0.299019008874893 1815.142578125 454.7929 1814.84350585938 454.718139648438 4 13 1.1.1.3360.4 1 40.4839 2145.625 40.7194 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.2400004863739 DSGRDYVSQFEGSALGK missed R-D@4 -3.81693005561829 1811.02661132813 604.6828 1814.84350585938 605.955139160156 3 12 1.1.1.3500.4 1 43.9173 516.6775 43.9366 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.6600024700165 DSGRDYVSQFEGSALGK missed R-D@4 0.239583998918533 1815.08312988281 606.035 1814.84350585938 605.955139160156 3 13 1.1.1.3653.9 1 47.7151 437.0181 47.6791 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 36.7000013589859 DSGRDYVSQFEGSALGK missed R-D@4 0.158908993005753 1815.00244140625 908.5085 1814.84350585938 908.429016113281 2 10 1.1.1.3499.18 1 43.9042 206.9544 43.9118 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 34.0200006961823 DSGRDYVSQFEGSALGK hexanoyl addition +98(K)@17 missed R-D@4 0.0643815994262695 1912.98107910156 957.4978 1912.91662597656 957.465637207031 2 12 1.1.1.3375.9 1 40.8566 1022.384 40.7194 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLK Carbamidomethyl(K)@17 missed R-D@4; missed K-Q@17 0.251473993062973 2468.48095703125 823.8343 2468.2294921875 823.75048828125 3 21 1.1.1.3648.17 1 47.5948 2334.819 47.6538 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLK missed R-D@4; missed K-Q@17 0.31284099817276 2411.52099609375 603.8875 2411.2080078125 603.809326171875 4 21 1.1.1.3650.8 1 47.6379 26467.52 47.7047 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLK reduced acrolein addition +58(K)@17; Ammonia-loss(N)@20 missed R-D@4; missed K-Q@17 0.323159992694855 2452.54663085938 614.1439 2452.22338867188 614.063110351563 4 22 1.1.1.3657.8 1 47.8177 7792.354 47.9113 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLK missed R-D@4; missed K-Q@17 0.246021002531052 2411.4541015625 804.8253 2411.2080078125 804.743286132813 3 27 1.1.1.3657.20 1 47.8277 20298.39 47.7047 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLK Dehydrated(S)@13; reduced acrolein addition +58(K)@17; Deamidated(Q)@18 missed R-D@4; missed K-Q@17 0.259330987930298 2452.48266601563 818.5015 2452.22338867188 818.415100097656 3 24 1.1.1.3664.16 1 48.0043 6473.071 47.9366 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLK Formyl(K)@17 missed R-D@4; missed K-Q@17 0.251044988632202 2439.4541015625 814.1586 2439.203125 814.074951171875 3 27 1.1.1.3726.18 1 49.4402 1006.174 49.4731 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLK Trimethyl(K)@17 missed R-D@4; missed K-Q@17 0.209508001804352 2453.46459960938 818.8288 2453.25512695313 818.758972167969 3 30 1.1.1.3734.19 1 49.6442 1929.131 49.6251 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLK reduced acrolein addition +58(K)@17 missed R-D@4; missed K-Q@17 0.210869997739792 2469.4609375 824.1609 2469.25 824.090576171875 3 23 1.1.1.3764.17 1 50.4089 5007.348 50.4939 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLK Carboxyethyl(K)@17 missed R-D@4; missed K-Q@17 0.244117006659508 2483.47338867188 828.8317 2483.22924804688 828.750366210938 3 26 1.1.1.3794.6 1 51.1556 7088.187 51.246 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLK Carboxyethyl(K)@17 missed R-D@4; missed K-Q@17 0.244117006659508 2483.47338867188 828.8317 2483.22924804688 828.750366210938 3 27 1.1.1.3801.6 1 51.3295 7088.187 51.246 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLK reduced acrolein addition +58(K)@17; Ammonia-loss(N)@20 missed R-D@4; missed K-Q@17 0.259330987930298 2452.48266601563 818.5015 2452.22338867188 818.415100097656 3 20 1.1.1.3656.19 1 47.801 6473.071 47.9366 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLK Trimethyl(K)@17 missed R-D@4; missed K-Q@17 0.275411993265152 2453.53051757813 614.3899 2453.25512695313 614.321044921875 4 20 1.1.1.3733.11 1 49.6117 792.9902 49.6251 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLK reduced acrolein addition +58(K)@17; Ammonia-loss(N)@20 missed R-D@4; missed K-Q@17 0.323159992694855 2452.54663085938 614.1439 2452.22338867188 614.063110351563 4 18 1.1.1.3664.8 1 47.9977 7792.354 47.9113 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6800014972687 DSGRDYVSQFEGSALGKQLNLK missed R-D@4; missed K-Q@17 0.371574014425278 2411.57958984375 483.3232 2411.2080078125 483.248901367188 5 16 1.1.1.3653.4 1 47.7109 867.9837 47.7047 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1599996089935 DSGRDYVSQFEGSALGKQLNLK missed R-D@4; missed K-Q@17 0.159594997763634 2411.36767578125 804.7965 2411.2080078125 804.743286132813 3 15 1.1.1.3379.9 1 40.9562 20717.08 40.7918 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.0499992370605 DSGRDYVSQFEGSALGKQLNLK missed R-D@4; missed K-Q@17 0.159045994281769 2411.3671875 804.7963 2411.2080078125 804.743286132813 3 15 1.1.1.3358.12 1 40.4474 19640.21 40.5733 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.0499992370605 DSGRDYVSQFEGSALGKQLNLK missed R-D@4; missed K-Q@17 0.159045994281769 2411.3671875 804.7963 2411.2080078125 804.743286132813 3 15 1.1.1.3365.10 1 40.6084 19640.21 40.5733 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.0499992370605 DSGRDYVSQFEGSALGKQLNLK missed R-D@4; missed K-Q@17 0.15922899544239 2411.36743164063 804.7964 2411.2080078125 804.743286132813 3 15 1.1.1.3386.10 1 41.1249 17382.62 40.8642 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.6000020503998 DSGRDYVSQFEGSALGKQLNLK Formyl(K)@17 missed R-D@4; missed K-Q@17 0.251044988632202 2439.4541015625 814.1586 2439.203125 814.074951171875 3 16 1.1.1.3730.16 1 49.5395 1006.174 49.4731 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.1399981975555 DSGRDYVSQFEGSALGKQLNLK reduced acrolein addition +58(K)@17 missed R-D@4; missed K-Q@17 0.277323991060257 2469.52734375 618.3891 2469.25 618.319763183594 4 15 1.1.1.3766.5 1 50.4502 973.9315 50.4686 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.3099994659424 DSGRDYVSQFEGSALGKQLNLK missed R-D@4; missed K-Q@17 0.159594997763634 2411.36767578125 804.7965 2411.2080078125 804.743286132813 3 14 1.1.1.3372.6 1 40.7817 20717.08 40.7918 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.7000014781952 DSGRDYVSQFEGSALGKQLNLK missed R-D@4; missed K-Q@17 0.31284099817276 2411.52099609375 603.8875 2411.2080078125 603.809326171875 4 14 1.1.1.3658.8 1 47.8434 26467.52 47.7047 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1900012493134 DSGRDYVSQFEGSALGKQLNLK Deamidated(N)@20 missed R-D@4; missed K-Q@17 0.250775009393692 2412.44287109375 805.1549 2412.19213867188 805.0712890625 3 10 1.1.1.3624.18 1 46.9751 370.7879 47.0085 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1900012493134 DSGRDYVSQFEGSALGKQLNLK Delta:H(2)C(2)@N-term missed R-D@4; missed K-Q@17 0.244165003299713 2437.46801757813 813.4966 2437.2236328125 813.415222167969 3 14 1.1.1.3716.15 1 49.1845 286.8635 49.1701 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1900012493134 DSGRDYVSQFEGSALGKQLNLK Trimethyl(K)@17 missed R-D@4; missed K-Q@17 0.209508001804352 2453.46459960938 818.8288 2453.25512695313 818.758972167969 3 14 1.1.1.3736.16 1 49.6933 1929.131 49.6251 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1900012493134 DSGRDYVSQFEGSALGKQLNLK Carboxyethyl(K)@17 missed R-D@4; missed K-Q@17 0.174916997551918 2483.4033203125 1242.709 2483.22924804688 1242.62194824219 2 14 1.1.1.3796.7 1 51.2167 3276.253 51.246 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.9199991226196 DSGRDYVSQFEGSALGKQLNLK missed R-D@4; missed K-Q@17 0.176026999950409 2411.38330078125 1206.699 2411.2080078125 1206.611328125 2 11 1.1.1.3651.21 1 47.674 1909.379 47.7047 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.4900000095367 DSGRDYVSQFEGSALGKQLNLK Amidated@C-term missed R-D@4; missed K-Q@17 0.199701994657516 2410.423828125 804.4819 2410.22412109375 804.415283203125 3 13 1.1.1.3740.18 1 49.7984 270.3561 49.78 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.7400023937225 DSGRDYVSQFEGSALGKQLNLK Trimethyl(K)@17 missed R-D@4; missed K-Q@17 0.287131011486053 2453.54223632813 614.3928 2453.25512695313 614.321044921875 4 13 1.1.1.3638.10 1 47.3351 194.6111 47.3228 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.6300020217896 DSGRDYVSQFEGSALGKQLNLK acrolein addition +38(K)@17; Hex(N)@20; hexanoyl addition +98(K)@22 missed R-D@4; missed K-Q@17 0.162183001637459 2709.51196289063 904.1779 2709.34985351563 904.123840332031 3 13 1.1.1.3387.15 1 41.146 6310.542 40.8885 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.0499970912933 DSGRDYVSQFEGSALGKQLNLK Deamidated(Q)@9; Formyl(K)@17; acrolein addition +56(K)@22 missed R-D@4; missed K-Q@17 0.24099799990654 2496.45434570313 833.1587 2496.21313476563 833.078369140625 3 13 1.1.1.3761.16 1 50.3311 395.7627 50.3663 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.410001039505 DSGRDYVSQFEGSALGKQLNLK acrolein addition +112(K)@17; Methyl(L)@21; HPNE addition +172(K)@22 missed R-D@4; missed K-Q@17 0.125431001186371 2709.51147460938 904.1778 2709.38623046875 904.135986328125 3 13 1.1.1.3359.10 1 40.4664 8225.521 40.5492 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.410001039505 DSGRDYVSQFEGSALGKQLNLK Hydroxymethyl(N)@20 missed R-D@4; missed K-Q@17 0.00108108995482326 2441.2197265625 814.7472 2441.21875 814.746826171875 3 13 1.1.1.3365.12 1 40.6117 668.7768 40.695 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.410001039505 DSGRDYVSQFEGSALGKQLNLK HPNE addition +172(K)@17; Methyl(N)@20; acrolein addition +112(K)@22 missed R-D@4; missed K-Q@17 0.125064998865128 2709.51123046875 904.1777 2709.38623046875 904.135986328125 3 13 1.1.1.3366.16 1 40.6371 8345.681 40.7194 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.5000002384186 DSGRDYVSQFEGSALGKQLNLKLL Oxidation(N)@20; acrolein addition +56(K)@22 cleaved L-D@C-term; missed R-D@4; missed K-Q@17; missed K-L@22 0.114197999238968 2709.51147460938 904.1778 2709.3974609375 904.139709472656 3 15 1.1.1.3380.7 1 40.9705 8351.411 40.7194 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 72.0399975776672 DSGRDYVSQFEGSALGKQLNLKLL MDA adduct +54(K)@22 cleaved L-D@C-term; missed R-D@4; missed K-Q@17; missed K-L@22 0.26256600022316 2691.6494140625 673.9196 2691.38671875 673.85400390625 4 12 1.1.1.3653.16 1 47.7209 2273.831 47.7047 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.6599986553192 DSGRDYVSQFEGSALGKQLNLKLLDNW ONE addition +154(K)@17; hexanoyl addition +98(K)@22; Deamidated(N)@26 cleaved W-D@C-term; missed R-D@4; missed K-Q@17; missed K-L@22 0.115654997527599 3305.79809570313 1102.94 3305.68188476563 1102.90124511719 3 13 1.1.1.3360.10 1 40.4956 1943.805 40.5249 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 61.6699993610382 DSGRDYVSQFEGSALGKQLNLKLLDNW ONE addition +154(K)@17; hexanoyl addition +98(K)@22; Deamidated(N)@26 cleaved W-D@C-term; missed R-D@4; missed K-Q@17; missed K-L@22 0.116020999848843 3305.79809570313 1102.94 3305.68188476563 1102.90124511719 3 12 1.1.1.3375.10 1 40.8591 1494.538 40.8159 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.3900015354156 DSGRDYVSQFEGSALGKQLNLKLLDNW hexanoyl addition +98(K)@17; Deamidated(N)@20; HPNE addition +172(K)@22; Trp->Kynurenin(W)@27 cleaved W-D@C-term; missed R-D@4; missed K-Q@17; missed K-L@22 0.3298279941082 3328.01733398438 833.0116 3327.6875 832.929138183594 4 13 1.1.1.3868.4 1 52.9893 1930.614 53.0061 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Dioxidation(W)@27 missed R-D@4; missed K-Q@17; missed K-L@22 0.405730992555618 4037.37109375 808.4815 4036.96533203125 808.400390625 5 32 1.1.1.3989.6 1 55.9199 2588.976 55.9877 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Dioxidation(W)@27 missed R-D@4; missed K-Q@17; missed K-L@22 0.405730992555618 4037.37109375 808.4815 4036.96533203125 808.400390625 5 24 1.1.1.3996.5 1 56.094 2588.976 55.9877 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Trp->Kynurenin(W)@27 missed R-D@4; missed K-Q@17; missed K-L@22 0.408091992139816 4009.37866210938 802.883 4008.97045898438 802.801391601563 5 22 1.1.1.4020.5 1 56.6833 690.523 56.6519 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK reduced acrolein addition +58(K)@17; Ammonia-loss(N)@20 missed R-D@4; missed K-Q@17; missed K-L@22 0.412227004766464 4046.40307617188 810.2879 4045.99096679688 810.205444335938 5 28 1.1.1.4052.8 1 57.4962 2641.852 57.486 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Trimethyl(K)@17 missed R-D@4; missed K-Q@17; missed K-L@22 0.301625996828079 4047.32299804688 1012.838 4047.0224609375 1012.76293945313 4 38 1.1.1.4230.6 1 61.8218 548.1746 61.827 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK reduced acrolein addition +58(K)@17 missed R-D@4; missed K-Q@17; missed K-L@22 0.313059002161026 4063.3310546875 1016.84 4063.01733398438 1016.76165771484 4 38 1.1.1.4267.12 1 62.7347 1338.942 62.7473 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Carboxyethyl(K)@17 missed R-D@4; missed K-Q@17; missed K-L@22 0.345268994569778 4077.34301757813 1020.343 4076.99682617188 1020.25646972656 4 47 1.1.1.4301.17 1 63.6074 6242.771 63.6678 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK reduced acrolein addition +58(K)@17; Methyl(Q)@18 missed R-D@4; missed K-Q@17; missed K-L@22 0.375887006521225 4077.40893554688 816.4891 4077.033203125 816.413879394531 5 29 1.1.1.4303.5 1 63.6494 908.8354 63.6678 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Methyl(N)@20; reduced acrolein addition +58(K)@22 missed R-D@4; missed K-Q@17; missed K-L@22 0.308883994817734 4077.34301757813 1020.343 4077.033203125 1020.26556396484 4 23 1.1.1.4308.14 1 63.7875 6242.771 63.6678 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK reduced acrolein addition +58(K)@17; Dimethyl(N)@20 missed R-D@4; missed K-Q@17; missed K-L@22 0.311055988073349 4091.35888671875 1023.847 4091.048828125 1023.76947021484 4 34 1.1.1.4341.15 1 64.6443 2382.52 64.7067 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Dioxidation(W)@27 missed R-D@4; missed K-Q@17; missed K-L@22 0.334576994180679 4037.298828125 1010.332 4036.96533203125 1010.24865722656 4 20 1.1.1.3996.12 1 56.0999 2685.377 56.0126 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK acrolein addition +56(K)@17; MDA adduct +62(K)@22 missed R-D@4; missed K-Q@17; missed K-L@22 0.332834005355835 4123.3505859375 1031.845 4123.017578125 1031.76159667969 4 19 1.1.1.4234.12 1 61.9136 721.9459 61.9515 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Formyl(K)@17; reduced acrolein addition +58(K)@22 missed R-D@4; missed K-Q@17; missed K-L@22 0.427383989095688 4091.43969726563 819.2952 4091.01245117188 819.209777832031 5 19 1.1.1.4343.6 1 64.6892 290.5683 64.7067 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Carboxyethyl(K)@22 missed R-D@4; missed K-Q@17; missed K-L@22 0.35698801279068 4077.35498046875 1020.346 4076.99682617188 1020.25646972656 4 41 1.1.1.4435.2 1 67.0124 485.4023 67.03 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK acrolein addition +56(K)@17; Oxidation(D)@25; Deamidated(N)@26 missed R-D@4; missed K-Q@17; missed K-L@22 -0.638746976852417 4077.34301757813 1020.343 4077.98071289063 1020.50244140625 4 20 1.1.1.4300.20 1 63.5837 6242.771 63.6678 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK missed R-D@4; missed K-Q@17; missed K-L@22 2.75921988487244 4007.73486328125 1002.941 4004.9755859375 1002.25115966797 4 18 1.1.1.4019.14 1 56.6658 558.4514 56.6519 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Formyl(K)@17; reduced acrolein addition +58(K)@22; Dioxidation(W)@27 missed R-D@4; missed K-Q@17; missed K-L@22 0.359320998191834 4123.36279296875 1031.848 4123.00244140625 1031.7578125 4 18 1.1.1.4333.16 1 64.4356 274.0193 64.4448 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.089998960495 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK acrolein addition +56(K)@17; Oxidation(N)@20; Dioxidation(W)@27 missed R-D@4; missed K-Q@17; missed K-L@22 0.345185995101929 4109.33056640625 1028.34 4108.986328125 1028.25390625 4 18 1.1.1.4283.21 1 63.1452 265.6686 63.1502 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.5000016689301 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Dioxidation(W)@27 missed R-D@4; missed K-Q@17; missed K-L@22 0.334576994180679 4037.298828125 1010.332 4036.96533203125 1010.24865722656 4 13 1.1.1.3987.14 1 55.8766 2685.377 56.0126 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.4199979305267 DSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK acrolein addition +56(K)@17; Deamidated(N)@20 missed R-D@4; missed K-Q@17; missed K-L@22 0.41584700345993 4062.40161132813 813.4876 4061.98583984375 813.404418945313 5 12 1.1.1.4051.9 1 57.471 1621.095 57.4073 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 57.260000705719 DSVTSTFSK cleaved W-D@N-term 0.143298000097275 970.604064941406 486.3093 970.460754394531 486.237640380859 2 11 1.1.1.2722.5 1 25.1828 2285.714 25.1742 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 65.3199970722198 DSVTSTFSKLREQLGPVTQEFWDNLEKETEGLR Oxidation(P)@16 cleaved W-D@N-term; missed K-L@9; missed R-E@11; missed K-E@27 0.560810029506683 3855.45703125 772.0987 3854.89624023438 771.986511230469 5 13 1.1.1.4026.9 1 56.8391 337.8316 56.8542 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK Deamidated(Q)@5 0.180048003792763 1400.82604980469 701.4203 1400.64599609375 701.330261230469 2 20 1.1.1.3472.15 1 43.2322 41079.45 43.2919 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK 0.161865994334221 1399.82385253906 700.9192 1399.66198730469 700.838256835938 2 22 1.1.1.3477.11 1 43.3528 122576.2 43.2919 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK 0.161865994334221 1399.82385253906 700.9192 1399.66198730469 700.838256835938 2 22 1.1.1.3484.9 1 43.5295 124597.2 43.2671 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK Deamidated(Q)@5 0.180048003792763 1400.82604980469 701.4203 1400.64599609375 701.330261230469 2 20 1.1.1.3484.10 1 43.5312 41748.4 43.2671 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK 0.161743998527527 1399.82373046875 700.9191 1399.66198730469 700.838256835938 2 20 1.1.1.3491.17 1 43.7049 45914.71 43.4405 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK 0.162720993161201 1399.82470703125 700.9196 1399.66198730469 700.838256835938 2 19 1.1.1.3505.12 1 44.048 1635.081 44.0605 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK 0.162720993161201 1399.82470703125 700.9196 1399.66198730469 700.838256835938 2 17 1.1.1.3512.10 1 44.2205 1635.081 44.0605 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK 0.165040001273155 1399.82702636719 700.9208 1399.66198730469 700.838256835938 2 20 1.1.1.3558.3 1 45.333 774.3135 45.3257 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK Delta:H(2)C(2)@N-term 0.164893001317978 1425.84252929688 713.9285 1425.67761230469 713.846069335938 2 20 1.1.1.3658.12 1 47.8467 2171.145 47.7818 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK 0.222156003117561 1399.88415527344 467.6353 1399.66198730469 467.561248779297 3 17 1.1.1.3477.4 1 43.3469 15426.01 43.2919 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK Delta:H(2)C(2)@N-term 0.165014997124672 1425.84265136719 713.9286 1425.67761230469 713.846069335938 2 17 1.1.1.3643.10 1 47.4627 1555.933 47.4515 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK 0.161743998527527 1399.82373046875 700.9191 1399.66198730469 700.838256835938 2 14 1.1.1.3464.15 1 43.0327 111058.9 43.2671 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK 0.222156003117561 1399.88415527344 467.6353 1399.66198730469 467.561248779297 3 16 1.1.1.3470.5 1 43.1736 15426.01 43.2919 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGK Delta:H(2)C(2)@N-term 0.165014997124672 1425.84265136719 713.9286 1425.67761230469 713.846069335938 2 15 1.1.1.3644.10 1 47.4882 1555.933 47.4515 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 DYVSQFEGSALGK Delta:H(2)C(2)@N-term 0.164893001317978 1425.84252929688 713.9285 1425.67761230469 713.846069335938 2 17 1.1.1.3651.16 1 47.6698 2171.145 47.7818 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 DYVSQFEGSALGK Delta:H(2)C(2)@N-term 0.164893001317978 1425.84252929688 713.9285 1425.67761230469 713.846069335938 2 15 1.1.1.3659.15 1 47.8757 2171.145 47.7818 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.7000014781952 DYVSQFEGSALGK 0.221789002418518 1399.8837890625 467.6352 1399.66198730469 467.561248779297 3 14 1.1.1.3484.4 1 43.5212 15887.81 43.2671 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 58.1499993801117 DYVSQFEGSALGK Cation:Na(E)@7 0.226234003901482 1421.8701171875 474.964 1421.64392089844 474.888580322266 3 12 1.1.1.3476.4 1 43.3246 686.6905 43.2671 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 47.5499987602234 DYVSQFEGSALGKQ HPNE addition +172(K)@13; Methyl(Q)@14 cleaved Q-L@C-term; missed K-Q@13 0.120272003114223 1713.96643066406 857.9905 1713.84619140625 857.930358886719 2 11 1.1.1.3474.10 1 43.2785 280.1754 43.2919 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 71.6099977493286 DYVSQFEGSALGKQL Hypusine(K)@13 cleaved L-N@C-term; missed K-Q@13 -0.045405101031065 1727.82763671875 864.9211 1727.873046875 864.943786621094 2 11 1.1.1.3474.11 1 43.2802 213.0158 43.2919 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGKQLNLK missed K-Q@13 0.237380996346474 1996.26391601563 666.4286 1996.02661132813 666.349487304688 3 21 1.1.1.3733.13 1 49.6134 10852.29 49.6251 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1199989318848 DYVSQFEGSALGKQLNLK reduced acrolein addition +58(K)@13; Ammonia-loss(N)@16 missed K-Q@13 0.186006993055344 2037.22741699219 1019.621 2037.04187011719 1019.52819824219 2 16 1.1.1.3741.21 1 49.8268 1740.657 49.78 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.3199973106384 DYVSQFEGSALGKQLNLK Ammonia-loss(N)@16; reduced acrolein addition +58(K)@18 missed K-Q@13 0.250142008066177 2037.2919921875 680.1046 2037.04187011719 680.021240234375 3 16 1.1.1.3738.8 1 49.7384 4210.7 49.806 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1900012493134 DYVSQFEGSALGKQLNLK acrolein addition +56(K)@13; Deamidated(Q)@14 missed K-Q@13 0.248574003577232 2053.28540039063 685.4357 2053.03686523438 685.352844238281 3 13 1.1.1.3730.11 1 49.5354 548.3528 49.5742 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1900012493134 DYVSQFEGSALGKQLNLK acrolein addition +56(K)@13; Deamidated(N)@16 missed K-Q@13 0.180105999112129 2053.21728515625 1027.616 2053.03686523438 1027.52563476563 2 11 1.1.1.3732.21 1 49.5944 168.3359 49.5742 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.5300028324127 DYVSQFEGSALGKQLNLK missed K-Q@13 0.237380996346474 1996.26391601563 666.4286 1996.02661132813 666.349487304688 3 13 1.1.1.3731.13 1 49.5624 10852.29 49.6251 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.7699997425079 DYVSQFEGSALGKQLNLK missed K-Q@13 -0.593917012214661 1995.4326171875 666.1515 1996.02661132813 666.349487304688 3 14 1.1.1.3763.11 1 50.3783 1085.223 50.4686 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 44.6099996566772 DYVSQFEGSALGKQLNLK reduced acrolein addition +58(K)@13; Ammonia-loss(N)@16 missed K-Q@13 0.316596001386642 2037.35852050781 510.3469 2037.04187011719 510.267730712891 4 10 1.1.1.3741.4 1 49.8126 139.5399 49.806 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 DYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Dioxidation(W)@23 missed K-Q@13; missed K-L@18 0.338633000850677 3622.12255859375 906.5379 3621.78393554688 906.453247070313 4 25 1.1.1.4045.10 1 57.3167 1334.358 57.3309 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4199988842011 DYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK reduced acrolein addition +58(K)@18 missed K-Q@13; missed K-L@18 0.230152994394302 3648.0654296875 1217.029 3647.8359375 1216.95263671875 3 17 1.1.1.4357.18 1 65.0691 141.0073 65.0479 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EALKENGGAR cleaved L-E@N-term; missed K-E@4 0.149305000901222 1043.68530273438 522.8499 1043.53601074219 522.775268554688 2 14 1.1.1.2609.8 1 22.4764 8207.434 22.3685 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8900005817413 EALKENGGAR Deamidated(N)@6 cleaved L-E@N-term; missed K-E@4 0.145024999976158 1044.6650390625 523.3398 1044.52001953125 523.267272949219 2 15 1.1.1.2620.6 1 22.7449 12808.2 22.8267 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.8999972343445 EALKENGGAR cleaved L-E@N-term; missed K-E@4 0.149305000901222 1043.68530273438 522.8499 1043.53601074219 522.775268554688 2 13 1.1.1.2602.11 1 22.3093 8207.434 22.3685 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.8999972343445 EALKENGGAR ONE addition +154(K)@4 cleaved L-E@N-term; missed K-E@4 0.163328006863594 1197.79870605469 599.9066 1197.63537597656 599.824951171875 2 15 1.1.1.2620.8 1 22.7499 3576.267 22.7788 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 EALKENGGAR ONE addition +154(K)@4; Deamidated(N)@6 cleaved L-E@N-term; missed K-E@4 0.166494995355606 1198.78588867188 600.4002 1198.61938476563 600.316955566406 2 14 1.1.1.2654.7 1 23.5571 3411.474 23.5433 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.6300020217896 EALKENGGAR Glu->pyro-Glu@N-term cleaved L-E@N-term; missed K-E@4 0.148883000016212 1025.67431640625 513.8444 1025.525390625 513.769958496094 2 10 1.1.1.2603.5 1 22.332 656.9664 22.3685 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.0599975585938 EALKENGGAR Glu->pyro-Glu@N-term; Deamidated(N)@6 cleaved L-E@N-term; missed K-E@4 0.149364992976189 1026.65881347656 514.3367 1026.50939941406 514.261962890625 2 10 1.1.1.2622.4 1 22.786 956.3748 22.8267 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.5200026035309 EDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ cleaved L-E@N-term; missed R-Q@4; missed K-V@15; missed K-K@27; missed K-L@28 -10.1155996322632 3684.86645507813 737.9806 3694.98217773438 740.003723144531 5 14 1.1.1.4750.7 1 75.062 1891.321 75.1523 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.92999958992 EDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ cleaved L-E@N-term; missed R-Q@4; missed K-V@15; missed K-K@27; missed K-L@28 -1.70098996162415 3693.28125 739.6635 3694.98217773438 740.003723144531 5 14 1.1.1.4722.6 1 74.3809 551.7974 74.374 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 65.7100021839142 EGLRQEMSKDLEEVKAKVQPYLDDFQKKWQEEMELYR cleaved T-E@N-term; missed R-Q@4; missed K-D@9; missed K-A@15; missed K-V@17; missed K-K@27; missed K-W@28 -3.30012011528015 4611.97265625 769.6694 4615.2724609375 770.219421386719 6 17 1.1.1.3799.6 1 51.281 490.8582 51.2701 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EHLSTLSEK cleaved T-E@N-term 0.145777001976967 1042.67529296875 522.3449 1042.52954101563 522.272033691406 2 15 1.1.1.2642.9 1 23.2714 13318.63 23.0661 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EHLSTLSEK cleaved T-E@N-term 0.145777001976967 1042.67529296875 522.3449 1042.52954101563 522.272033691406 2 15 1.1.1.2635.3 1 23.1006 13318.63 23.0661 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.089998960495 EHLSTLSEK cleaved T-E@N-term 0.145898997783661 1042.67541503906 522.345 1042.52954101563 522.272033691406 2 13 1.1.1.2649.8 1 23.4331 11111.31 23.1859 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.4900007247925 EHLSTLSEK Glu->pyro-Glu@N-term cleaved T-E@N-term 0.146697998046875 1024.66564941406 513.3401 1024.51892089844 513.266723632813 2 13 1.1.1.2637.4 1 23.1477 1100.184 23.0901 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.6900019645691 EHLSTLSEK Glu->pyro-Glu@N-term cleaved T-E@N-term 0.146697998046875 1024.66564941406 513.3401 1024.51892089844 513.266723632813 2 11 1.1.1.2629.9 1 22.9553 1100.184 23.0901 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9199993610382 EHLSTLSEK cleaved T-E@N-term 0.149195000529289 1042.6787109375 522.3466 1042.52954101563 522.272033691406 2 12 1.1.1.2657.8 1 23.6253 2060.102 23.5433 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 EHLSTLSEK Glu->pyro-Glu@N-term cleaved T-E@N-term 0.147309005260468 1024.66625976563 513.3404 1024.51892089844 513.266723632813 2 11 1.1.1.2728.7 1 25.333 497.6588 25.2454 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1099998950958 EHLSTLSEK cleaved T-E@N-term 0.15395599603653 1042.68347167969 522.349 1042.52954101563 522.272033691406 2 10 1.1.1.2679.7 1 24.1616 286.8088 24.217 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Methyl(E)@1; reduced HNE(H)@2 cleaved T-E@N-term; missed K-A@9; missed R-Q@18; missed K-V@29 0.40837100148201 4788.03369140625 799.0129 4787.625 798.94482421875 6 37 1.1.1.4650.13 1 72.5449 16257.05 72.5035 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 41.839998960495 EHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK ONE addition +154(K)@11 cleaved T-E@N-term; missed K-A@9; missed R-Q@18; missed K-V@29 0.439940005540848 4770.01806640625 796.0103 4769.578125 795.93701171875 6 12 1.1.1.4660.6 1 72.8027 1414.602 72.7674 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 28.7099987268448 EHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK ONE addition +154(K)@9; reduced acrolein addition +58(K)@11; Deamidated(Q)@19 cleaved T-E@N-term; missed K-A@9; missed R-Q@18; missed K-V@29 0.457150995731354 4829.0615234375 805.8508 4828.60400390625 805.774658203125 6 24 1.1.1.4651.8 1 72.567 12233.8 72.7408 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 17.790000140667 EHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT ONE addition +154(K)@9; reduced acrolein addition +58(K)@11; Deamidated(Q)@19 cleaved T-E@N-term; cleaved T-Q@C-term; missed K-A@9; missed R-Q@18; missed K-V@29; missed K-K@41; missed K-L@42 0.529424011707306 5285.4033203125 756.0649 5284.8740234375 755.9892578125 7 12 1.1.1.4698.8 1 73.7921 3609.74 73.8337 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Methyl(E)@1; reduced HNE(H)@2 cleaved T-E@N-term; missed K-A@9; missed R-Q@18; missed K-V@29; missed K-K@41; missed K-L@42 0.476814985275269 5372.43017578125 768.4973 5371.95361328125 768.42919921875 7 31 1.1.1.4669.3 1 73.0407 25747.73 73.0339 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Methyl(E)@1; reduced HNE(H)@2 cleaved T-E@N-term; missed K-A@9; missed R-Q@18; missed K-V@29; missed K-K@41; missed K-L@42 0.476814985275269 5372.43017578125 768.4973 5371.95361328125 768.42919921875 7 32 1.1.1.4671.8 1 73.0944 25747.73 73.0339 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Methyl(E)@1; reduced HNE(H)@2 cleaved T-E@N-term; missed K-A@9; missed R-Q@18; missed K-V@29; missed K-K@41; missed K-L@42 0.420980989933014 5372.37451171875 896.403 5371.95361328125 896.332824707031 6 37 1.1.1.4673.15 1 73.1525 25877.01 73.0339 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Methyl(E)@1; reduced HNE(H)@2 cleaved T-E@N-term; missed K-A@9; missed R-Q@18; missed K-V@29; missed K-K@41; missed K-L@42 0.484504997730255 5372.43798828125 768.4984 5371.95361328125 768.42919921875 7 32 1.1.1.4688.6 1 73.5318 27119.66 73.4215 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.869998216629 EHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ ONE addition +154(K)@9; reduced acrolein addition +58(K)@11; Deamidated(Q)@19 cleaved T-E@N-term; missed K-A@9; missed R-Q@18; missed K-V@29; missed K-K@41; missed K-L@42 0.46280300617218 5413.39501953125 903.2398 5412.9326171875 903.162658691406 6 18 1.1.1.4682.17 1 73.3872 9434.201 73.6273 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 30.9700012207031 EHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ hexanoyl addition +98(K)@9; MDA adduct +62(K)@11; MDA adduct +54(K)@29 cleaved T-E@N-term; missed K-A@9; missed R-Q@18; missed K-V@29; missed K-K@41; missed K-L@42 -0.448646992444992 5413.4580078125 774.3584 5413.90673828125 774.422485351563 7 12 1.1.1.4691.8 1 73.6114 31212.58 73.7823 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.7900018692017 EKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK HPNE addition +172(K)@2 cleaved S-E@N-term; missed K-A@2; missed R-Q@11; missed K-V@22 0.292948007583618 4020.4990234375 1006.132 4020.20751953125 1006.05914306641 4 19 1.1.1.4706.10 1 74.0041 557.0729 74.0092 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2299983501434 EKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Glu->pyro-Glu@N-term; MDA adduct +62(K)@2 cleaved S-E@N-term; missed K-A@2; missed R-Q@11; missed K-V@22 0.350199997425079 3892.45288085938 974.1205 3892.1025390625 974.032958984375 4 19 1.1.1.4714.7 1 74.1913 780.9251 74.2273 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1800029277802 EKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +112(K)@4; Oxidation(P)@5 cleaved S-E@N-term; missed K-A@2; missed R-Q@11; missed K-V@22 0.331133991479874 3976.47607421875 995.1263 3976.14477539063 995.043518066406 4 18 1.1.1.4712.19 1 74.1497 1084.303 74.0335 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.5100016593933 EKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Carbamidomethyl@N-term; MDA adduct +54(K)@4 cleaved S-E@N-term; missed K-A@2; missed R-Q@11; missed K-V@22 0.355728000402451 3959.4853515625 990.8786 3959.12963867188 990.789672851563 4 16 1.1.1.4707.8 1 74.0217 384.8079 74.0092 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.9699983596802 EKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK reduced acrolein addition +58(K)@2; acrolein addition +112(K)@4 cleaved S-E@N-term; missed K-A@2; missed R-Q@11; missed K-V@22 0.0510299988090992 4018.24291992188 1005.568 4018.19189453125 1005.55523681641 4 14 1.1.1.4739.8 1 74.8057 1052.727 74.7618 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.3000004291534 EKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Glu->pyro-Glu@N-term; reduced acrolein addition +58(K)@4 cleaved S-E@N-term; missed K-A@2; missed R-Q@11; missed K-V@22 0.333261996507645 3888.46215820313 973.1228 3888.12890625 973.039489746094 4 15 1.1.1.4712.18 1 74.1481 916.101 74.2031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 61.7399990558624 EKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +56(K)@4 cleaved S-E@N-term; missed K-A@2; missed R-Q@11; missed K-V@22 -0.615998029708862 3903.5078125 976.8842 3904.12377929688 977.038208007813 4 14 1.1.1.4714.8 1 74.193 834.3756 74.1788 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 23.929999768734 EKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLN hexanoyl addition +98(K)@4; HPNE addition +172(K)@34; hexanoyl addition +98(K)@35 cleaved S-E@N-term; cleaved N-T@C-term; missed K-A@2; missed R-Q@11; missed K-V@22; missed K-K@34; missed K-L@35 0.335783004760742 4571.91162109375 915.3896 4571.57568359375 915.322448730469 5 12 1.1.1.4771.16 1 75.5874 308.021 75.5711 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.470002412796 EKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +112(K)@2; reduced acrolein addition +58(K)@4; Deamidated(Q)@12 cleaved S-E@N-term; missed K-A@2; missed R-Q@11; missed K-V@22; missed K-K@34; missed K-L@35 0.0874368026852608 4603.5908203125 1151.905 4603.50390625 1151.88330078125 4 19 1.1.1.4741.13 1 74.854 23503.19 74.7135 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2299983501434 EKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Glu->pyro-Glu@N-term; Oxidation(D)@9 cleaved S-E@N-term; missed K-A@2; missed R-Q@11; missed K-V@22; missed K-K@34; missed K-L@35 0.449510991573334 4430.859375 887.1792 4430.41015625 887.089294433594 5 21 1.1.1.4732.6 1 74.6356 1514.372 74.4955 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.5499987602234 EKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Glu->pyro-Glu@N-term; reduced acrolein addition +58(K)@4 cleaved S-E@N-term; missed K-A@2; missed R-Q@11; missed K-V@22; missed K-K@34; missed K-L@35 0.391696006059647 4472.8486328125 895.577 4472.45703125 895.498657226563 5 18 1.1.1.4723.4 1 74.4175 994.0897 74.3985 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.5499987602234 EKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ hexanoyl addition +98(K)@2; reduced acrolein addition +58(K)@4; Deamidated(Q)@12 cleaved S-E@N-term; missed K-A@2; missed R-Q@11; missed K-V@22; missed K-K@34; missed K-L@35 0.295217007398605 4589.81884765625 1148.462 4589.52490234375 1148.38842773438 4 18 1.1.1.4762.6 1 75.3664 3883.387 75.1523 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.8199996948242 EKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ hexanoyl addition +98(K)@2; reduced acrolein addition +58(K)@4; Deamidated(Q)@12 cleaved S-E@N-term; missed K-A@2; missed R-Q@11; missed K-V@22; missed K-K@34; missed K-L@35 0.294728994369507 4589.81884765625 1148.462 4589.52490234375 1148.38842773438 4 17 1.1.1.4754.13 1 75.1717 4917.198 75.0295 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.3000004291534 EKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +58(K)@2; acrolein addition +112(K)@4; Deamidated(Q)@12 cleaved S-E@N-term; missed K-A@2; missed R-Q@11; missed K-V@22; missed K-K@34; missed K-L@35 0.139682993292809 4603.642578125 1151.918 4603.50390625 1151.88330078125 4 15 1.1.1.4756.10 1 75.2205 666.9208 75.1768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 51.9599974155426 EKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +56(K)@2; reduced acrolein addition +58(K)@4 cleaved S-E@N-term; missed K-A@2; missed R-Q@11; missed K-V@22; missed K-K@34; missed K-L@35 0.435422003269196 4546.92919921875 910.3931 4546.49365234375 910.306030273438 5 13 1.1.1.4726.18 1 74.4879 805.8074 74.471 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 45.6299990415573 EKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +96(K)@4; Deamidated(Q)@12 cleaved S-E@N-term; missed K-A@2; missed R-Q@11; missed K-V@22; missed K-K@34; missed K-L@35 0.29899400472641 4529.76611328125 755.9683 4529.46728515625 755.918518066406 6 13 1.1.1.4781.7 1 75.8396 1065.845 75.9088 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 36.8900001049042 EKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ cleaved S-E@N-term; missed K-A@2; missed R-Q@11; missed K-V@22; missed K-K@34; missed K-L@35 -0.563026010990143 4431.86279296875 887.3798 4432.42578125 887.492431640625 5 16 1.1.1.4739.6 1 74.8007 1153.501 74.6892 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 40.4000014066696 ELYRQKVEPLRAELQEGAR cleaved M-E@N-term; missed R-Q@4; missed K-V@6; missed R-A@11 -9.26667022705078 2274.96215820313 569.7478 2284.22875976563 572.064453125 4 12 1.1.1.3817.3 1 51.7177 1004.237 51.7118 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 51.6799986362457 EMRDRARAHVDALRTHLAPYSDELRQR cleaved E-E@N-term; missed R-D@3; missed R-A@5; missed R-A@7; missed R-T@14; missed R-Q@25 -1.09204995632172 3260.57299804688 816.1505 3261.6650390625 816.423522949219 4 12 1.1.1.3024.8 1 32.4323 1268.522 32.3194 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.4899981021881 EMSKDLEEVKAK Glu->pyro-Glu@N-term; Oxidation(M)@2 cleaved Q-E@N-term; missed K-D@4; missed K-A@10 0.212509006261826 1403.9091796875 468.977 1403.69665527344 468.906158447266 3 11 1.1.1.2663.4 1 23.7655 459.65 23.7344 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EPPQSPWDRVKDLATVYVDVLK Oxidation(P)@3; MDA adduct +54(K)@11 cleaved D-E@N-term; missed R-V@9; missed K-D@11 0.255102008581162 2624.60375976563 875.8752 2624.3486328125 875.790161132813 3 18 1.1.1.4322.11 1 64.146 3932.225 64.0053 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.8799998760223 EPPQSPWDRVKDLATVYVDVLK Oxidation(P)@6; MDA adduct +54(K)@11 cleaved D-E@N-term; missed R-V@9; missed K-D@11 0.255102008581162 2624.60375976563 875.8752 2624.3486328125 875.790161132813 3 17 1.1.1.4315.10 1 63.9652 3932.225 64.0053 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.9999992847443 EPPQSPWDRVKDLATVYVDVLK Deamidated(Q)@4; Deamidated(R)@9; ONE addition +154(K)@11 cleaved D-E@N-term; missed R-V@9; missed K-D@11 0.242302998900414 2710.65283203125 904.5582 2710.41064453125 904.477478027344 3 16 1.1.1.4186.2 1 60.7357 1833.262 60.7293 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.3300018310547 EPPQSPWDRVKDLATVYVDVLK cleaved D-E@N-term; missed R-V@9; missed K-D@11 0.30817499756813 2554.6513671875 639.6701 2554.34301757813 639.593078613281 4 12 1.1.1.4082.2 1 58.1985 1765.522 58.1949 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.2399997711182 EPPQSPWDRVKDLATVYVDVLK Deamidated(Q)@4; Deamidated(R)@9; ONE addition +154(K)@11 cleaved D-E@N-term; missed R-V@9; missed K-D@11 0.241387993097305 2710.65185546875 904.5579 2710.41064453125 904.477478027344 3 14 1.1.1.4179.3 1 60.5674 2261.641 60.5841 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.9500021934509 EPPQSPWDRVKDLATVYVDVLK Deamidated(Q)@4; Deamidated(R)@9; ONE addition +154(K)@11 cleaved D-E@N-term; missed R-V@9; missed K-D@11 0.24065600335598 2710.65112304688 904.5577 2710.41064453125 904.477478027344 3 15 1.1.1.4193.2 1 60.9128 1459.08 60.9054 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term; MDA adduct +54(K)@11 cleaved D-E@N-term; missed R-V@9; missed K-D@11; missed K-D@22; missed R-D@26 0.358657985925674 4462.56689453125 893.5206 4462.2080078125 893.448913574219 5 23 1.1.1.3959.2 1 55.2038 3782.074 55.3453 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@4; Deamidated(R)@9; ONE addition +154(K)@11 cleaved D-E@N-term; missed R-V@9; missed K-D@11; missed K-D@22; missed R-D@26 0.387668013572693 4507.63134765625 902.5335 4507.24365234375 902.455993652344 5 23 1.1.1.4372.4 1 65.4559 5053.843 65.5895 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@4; Deamidated(R)@9; ONE addition +154(K)@11 cleaved D-E@N-term; missed R-V@9; missed K-D@11; missed K-D@22; missed R-D@26 0.387668013572693 4507.63134765625 902.5335 4507.24365234375 902.455993652344 5 29 1.1.1.4379.3 1 65.6268 5053.843 65.5895 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@4; Deamidated(R)@9; ONE addition +154(K)@11 cleaved D-E@N-term; missed R-V@9; missed K-D@11; missed K-D@22; missed R-D@26 0.387668013572693 4507.63134765625 902.5335 4507.24365234375 902.455993652344 5 29 1.1.1.4380.2 1 65.6457 5053.843 65.5895 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@4; Deamidated(R)@9; ONE addition +154(K)@11 cleaved D-E@N-term; missed R-V@9; missed K-D@11; missed K-D@22; missed R-D@26 0.386752992868423 4507.63037109375 902.5333 4507.24365234375 902.455993652344 5 30 1.1.1.4387.3 1 65.8295 3416.616 65.7924 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@4; Deamidated(R)@9; ONE addition +154(K)@11 cleaved D-E@N-term; missed R-V@9; missed K-D@11; missed K-D@22; missed R-D@26 0.388583987951279 4507.6318359375 902.5337 4507.24365234375 902.455993652344 5 31 1.1.1.4395.2 1 66.0012 3381.899 65.8405 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@4; Deamidated(R)@9; ONE addition +154(K)@11 cleaved D-E@N-term; missed R-V@9; missed K-D@11; missed K-D@22; missed R-D@26 0.394991993904114 4507.638671875 902.535 4507.24365234375 902.455993652344 5 30 1.1.1.4402.2 1 66.1648 2746.743 66.1109 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(P)@6; MDA adduct +54(K)@11 cleaved D-E@N-term; missed R-V@9; missed K-D@11; missed K-D@22; missed R-D@26 0.414137989282608 4421.595703125 885.3264 4421.181640625 885.243591308594 5 25 1.1.1.4467.7 1 67.8048 6624.422 67.8721 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(P)@6; MDA adduct +54(K)@11 cleaved D-E@N-term; missed R-V@9; missed K-D@11; missed K-D@22; missed R-D@26 0.414137989282608 4421.595703125 885.3264 4421.181640625 885.243591308594 5 23 1.1.1.4474.6 1 67.9843 6624.422 67.8721 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@4; Deamidated(R)@9; ONE addition +154(K)@11 cleaved D-E@N-term; missed R-V@9; missed K-D@11; missed K-D@22; missed R-D@26 0.320665001869202 4507.5625 1127.898 4507.24365234375 1127.81811523438 4 19 1.1.1.4381.6 1 65.6814 1803.994 65.5655 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term; reduced acrolein addition +58(K)@11 cleaved D-E@N-term; missed R-V@9; missed K-D@11; missed K-D@22; missed R-D@26 0.449232012033463 4466.6884765625 745.4554 4466.2392578125 745.380493164063 6 18 1.1.1.4418.3 1 66.5746 1153.777 66.5595 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 EPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(P)@6; MDA adduct +54(K)@11 cleaved D-E@N-term; missed R-V@9; missed K-D@11; missed K-D@22; missed R-D@26 0.412918001413345 4421.59423828125 885.3262 4421.181640625 885.243591308594 5 20 1.1.1.4460.9 1 67.6332 6132.579 67.8721 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.5499987602234 EPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(P)@6; MDA adduct +54(K)@11 cleaved D-E@N-term; missed R-V@9; missed K-D@11; missed K-D@22; missed R-D@26 0.341580986976624 4421.5224609375 1106.388 4421.181640625 1106.30261230469 4 18 1.1.1.4467.16 1 67.8132 1806.516 67.8721 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.8500006198883 EPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@4; Deamidated(R)@9; ONE addition +154(K)@11 cleaved D-E@N-term; missed R-V@9; missed K-D@11; missed K-D@22; missed R-D@26 0.418491005897522 4507.662109375 902.5397 4507.24365234375 902.455993652344 5 17 1.1.1.4410.7 1 66.3663 6862.165 66.5595 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.1700019836426 EPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved D-E@N-term; missed R-V@9; missed K-D@11; missed K-D@22; missed R-D@26 0.418397009372711 4351.59423828125 871.3262 4351.17626953125 871.242492675781 5 15 1.1.1.4346.5 1 64.7667 2298.485 64.9421 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.2600028514862 EPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK hexanoyl addition +98(K)@11; reduced acrolein addition +58(K)@22 cleaved D-E@N-term; missed R-V@9; missed K-D@11; missed K-D@22; missed R-D@26 0.272558003664017 4507.5625 1127.898 4507.291015625 1127.830078125 4 16 1.1.1.4388.4 1 65.8594 1206.161 65.8405 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.809999704361 EPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved D-E@N-term; missed R-V@9; missed K-D@11; missed K-D@22; missed R-D@26 0.48717001080513 4351.6630859375 726.2845 4351.17626953125 726.203308105469 6 14 1.1.1.4355.4 1 65.0063 1323.082 64.9421 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.4099998474121 EPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK hexanoyl addition +98(K)@11; reduced acrolein addition +58(K)@22 cleaved D-E@N-term; missed R-V@9; missed K-D@11; missed K-D@22; missed R-D@26 0.414986997842789 4507.7060546875 752.2916 4507.291015625 752.222473144531 6 14 1.1.1.4391.2 1 65.9193 1604.581 65.9369 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.9399993419647 EPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK reduced acrolein addition +58(K)@11; hexanoyl addition +98(K)@22 cleaved D-E@N-term; missed R-V@9; missed K-D@11; missed K-D@22; missed R-D@26 0.40326800942421 4507.6943359375 752.2897 4507.291015625 752.222473144531 6 14 1.1.1.4376.2 1 65.5487 2822.2 65.6136 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.1499972343445 EPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK MDA adduct +62(K)@11; acrolein addition +94(K)@22 cleaved D-E@N-term; missed R-V@9; missed K-D@11; missed K-D@22; missed R-D@26 0.4651780128479 4507.69873046875 752.2904 4507.2333984375 752.212890625 6 12 1.1.1.4368.4 1 65.3477 2566.553 65.5171 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 52.0099997520447 EPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK acrolein addition +112(K)@11 cleaved D-E@N-term; missed R-V@9; missed K-D@11; missed K-D@22; missed R-D@26 -0.586866021156311 4462.6416015625 744.7809 4463.228515625 744.878723144531 6 12 1.1.1.3967.3 1 55.3977 2943 55.3453 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.3500000238419 EPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK acrolein addition +112(K)@11; Oxidation(D)@12 cleaved D-E@N-term; missed R-V@9; missed K-D@11; missed K-D@22; missed R-D@26 0.391683012247086 4479.615234375 896.9303 4479.2236328125 896.851989746094 5 14 1.1.1.4471.9 1 67.9102 540.2525 67.8467 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEK Dioxidation(W)@11 0.172869995236397 1964.08923339844 983.0519 1963.91638183594 982.965454101563 2 23 1.1.1.3732.20 1 49.5935 3973.565 49.7026 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEK Dioxidation(W)@11 0.238408997654915 1964.15478515625 655.7255 1963.91638183594 655.646057128906 3 21 1.1.1.3735.13 1 49.6652 1355.877 49.7283 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEK Trp->Kynurenin(W)@11 0.23997600376606 1936.16137695313 646.3944 1935.92138671875 646.314392089844 3 22 1.1.1.3754.6 1 50.1446 879.5201 50.1622 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEK 0.240079000592232 1932.16662597656 645.0628 1931.92651367188 644.982788085938 3 22 1.1.1.3837.4 1 52.2238 3215.997 52.243 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEK 0.17417399585247 1932.10070800781 967.0576 1931.92651367188 966.970520019531 2 18 1.1.1.3836.12 1 52.2053 12177.79 52.243 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1199989318848 EQLGPVTQEFWDNLEK Dioxidation(W)@11 0.172869995236397 1964.08923339844 983.0519 1963.91638183594 982.965454101563 2 15 1.1.1.3742.21 1 49.8527 3973.565 49.7026 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLR Dioxidation(W)@11 missed K-E@16 0.246745005249977 2649.50268554688 884.1748 2649.255859375 884.092529296875 3 22 1.1.1.3924.3 1 54.3607 2415.756 54.3981 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLR Trp->Kynurenin(W)@11 missed K-E@16 0.25288999080658 2621.51391601563 874.8452 2621.26098632813 874.760925292969 3 19 1.1.1.3952.5 1 55.0379 348.4558 55.0284 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.8799998760223 EQLGPVTQEFWDNLEKETEGLR Glu->pyro-Glu@N-term missed K-E@16 0.265570998191834 2599.52099609375 867.5143 2599.25537109375 867.42578125 3 14 1.1.1.4337.7 1 64.5323 242.6711 64.6016 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.0100028514862 EQLGPVTQEFWDNLEKETEGLR Glu->pyro-Glu@N-term; Oxidation(P)@5 missed K-E@16 -0.591477990150452 2614.65893554688 654.672 2615.25024414063 654.819885253906 4 14 1.1.1.4053.3 1 57.5183 905.7427 57.5384 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLRQEMSK Trp->Kynurenin(W)@11; Oxidation(M)@25 missed K-E@16; missed R-Q@22 0.326290011405945 3240.85083007813 811.22 3240.5244140625 811.138427734375 4 21 1.1.1.3870.10 1 53.0418 1770.675 53.056 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(W)@11 missed K-E@16; missed R-Q@22 0.324093014001846 3252.8486328125 814.2194 3252.5244140625 814.138427734375 4 26 1.1.1.4028.8 1 56.8896 10494.58 56.9564 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@25 missed K-E@16; missed R-Q@22 0.325843989849091 3236.85546875 810.2211 3236.52954101563 810.1396484375 4 21 1.1.1.4030.12 1 56.9438 12839.09 57.0069 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLRQEMSK Trp->Kynurenin(W)@11 missed K-E@16; missed R-Q@22 0.328040987253189 3224.85766601563 807.2217 3224.52954101563 807.1396484375 4 25 1.1.1.4041.2 1 57.2155 2498.2 57.2098 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLRQEMSK missed K-E@16; missed R-Q@22 0.255158990621567 3220.79028320313 1074.604 3220.53466796875 1074.51879882813 3 25 1.1.1.4187.4 1 60.7686 2656.395 60.9539 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLRQEMSK missed K-E@16; missed R-Q@22 0.327838003635406 3220.86254882813 806.2229 3220.53466796875 806.140930175781 4 25 1.1.1.4189.2 1 60.8102 3387.664 61.002 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLRQEMSK missed K-E@16; missed R-Q@22 0.328327000141144 3220.86303710938 806.223 3220.53466796875 806.140930175781 4 22 1.1.1.4196.2 1 60.9819 3301.897 60.9539 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLRQEMSK missed K-E@16; missed R-Q@22 0.261384010314941 3220.79614257813 1074.606 3220.53466796875 1074.51879882813 3 23 1.1.1.4196.7 1 60.9919 3140.68 61.0745 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLRQEMSK missed K-E@16; missed R-Q@22 0.330523997545242 3220.865234375 806.2236 3220.53466796875 806.140930175781 4 25 1.1.1.4203.3 1 61.1523 4619.756 61.0986 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLRQEMSK missed K-E@16; missed R-Q@22 0.261384010314941 3220.79614257813 1074.606 3220.53466796875 1074.51879882813 3 20 1.1.1.4203.8 1 61.1631 3140.68 61.0745 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLRQEMSK missed K-E@16; missed R-Q@22 0.261018007993698 3220.79614257813 1074.606 3220.53466796875 1074.51879882813 3 23 1.1.1.4210.7 1 61.3345 2828.278 61.3156 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLRQEMSK missed K-E@16; missed R-Q@22 0.262849003076553 3220.79614257813 1074.606 3220.53466796875 1074.51879882813 3 21 1.1.1.4217.8 1 61.5019 2905.521 61.4612 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLRQEMSK missed K-E@16; missed R-Q@22 0.329791009426117 3220.86450195313 806.2234 3220.53466796875 806.140930175781 4 26 1.1.1.4224.3 1 61.6597 3533.052 61.6797 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLRQEMSK Glu->pyro-Glu@N-term missed K-E@16; missed R-Q@22 0.261694997549057 3202.78735351563 1068.603 3202.52416992188 1068.51525878906 3 29 1.1.1.4396.4 1 66.0336 824.7441 66.0387 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(W)@11; Oxidation(M)@25 missed K-E@16; missed R-Q@22 0.321853995323181 3268.84130859375 818.2176 3268.51928710938 818.137145996094 4 20 1.1.1.3859.2 1 52.7666 2202.919 52.7863 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLRQEMSK missed K-E@16; missed R-Q@22 0.329546988010406 3220.8642578125 806.2233 3220.53466796875 806.140930175781 4 19 1.1.1.4210.2 1 61.3203 5392.373 61.3156 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLRQEMSK missed K-E@16; missed R-Q@22 0.329546988010406 3220.8642578125 806.2233 3220.53466796875 806.140930175781 4 18 1.1.1.4217.2 1 61.4894 4665.646 61.4612 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4199988842011 EQLGPVTQEFWDNLEKETEGLRQEMSK missed K-E@16; missed R-Q@22 0.261018007993698 3220.79614257813 1074.606 3220.53466796875 1074.51879882813 3 17 1.1.1.4224.16 1 61.6705 1738.825 61.7042 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.5200023651123 EQLGPVTQEFWDNLEKETEGLRQEMSK missed K-E@16; missed R-Q@22 0.329791009426117 3220.86450195313 806.2234 3220.53466796875 806.140930175781 4 15 1.1.1.4231.7 1 61.835 3533.052 61.6797 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.7899985313416 EQLGPVTQEFWDNLEKETEGLRQEMSK Deamidated(Q)@8; reduced acrolein addition +96(K)@16; Dethiomethyl(M)@25 missed K-E@16; missed R-Q@22 0.274053990840912 3269.84692382813 818.469 3269.57275390625 818.400451660156 4 12 1.1.1.3852.2 1 52.5949 1594.293 52.6152 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK missed K-E@16; missed R-Q@22; missed K-D@27 0.410820990800858 3934.30493164063 787.8683 3933.89428710938 787.7861328125 5 22 1.1.1.4365.3 1 65.2676 5155.503 65.3662 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Oxidation(M)@25 missed K-E@16; missed R-Q@22; missed K-D@27 0.404370009899139 3950.29345703125 791.066 3949.88916015625 790.985107421875 5 20 1.1.1.4037.8 1 57.1178 1439.204 57.1337 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Glu->pyro-Glu@N-term missed K-E@16; missed R-Q@22; missed K-D@27 0.340893000364304 3916.224609375 980.0634 3915.88354492188 979.978210449219 4 26 1.1.1.4561.6 1 70.2283 999.3346 70.2609 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4199988842011 EQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK missed K-E@16; missed R-Q@22; missed K-D@27 0.343511998653412 3934.23779296875 984.5667 3933.89428710938 984.480834960938 4 16 1.1.1.4365.6 1 65.2734 3383.677 65.3662 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 EQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK missed K-E@16; missed R-Q@22; missed K-D@27; missed K-A@33 0.481795012950897 4133.50830078125 689.9253 4133.0263671875 689.844970703125 6 18 1.1.1.4329.3 1 64.3203 3829.518 64.4184 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4199988842011 EQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK missed K-E@16; missed R-Q@22; missed K-D@27; missed K-A@33 0.415706992149353 4133.44189453125 827.6957 4133.0263671875 827.612548828125 5 17 1.1.1.4330.7 1 64.3496 2310.535 64.4184 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4199988842011 EQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK missed K-E@16; missed R-Q@22; missed K-D@27; missed K-A@33 0.415706992149353 4133.44189453125 827.6957 4133.0263671875 827.612548828125 5 16 1.1.1.4337.5 1 64.5307 2310.535 64.4184 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.5200023651123 EQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK missed K-E@16; missed R-Q@22; missed K-D@27; missed K-A@33 0.347909986972809 4133.37451171875 1034.351 4133.0263671875 1034.26379394531 4 15 1.1.1.4332.12 1 64.4083 554.7614 64.4184 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.9999997615814 ESFKVSFLSALEEYTKKLNTQ Carbamidomethyl@N-term; Oxidation(F)@3; HPNE addition +172(K)@4 cleaved L-E@N-term; missed K-V@4; missed K-K@16; missed K-L@17 0.362019002437592 2706.76245117188 677.6979 2706.400390625 677.607360839844 4 15 1.1.1.4698.5 1 73.7896 2202.141 73.7823 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ETEGLRQEMSK missed R-Q@6 0.153963997960091 1306.77270507813 654.3936 1306.61877441406 654.316650390625 2 18 1.1.1.2623.6 1 22.8215 6754.876 22.7073 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ETEGLRQEMSK Glu->pyro-Glu@N-term; Oxidation(M)@9 missed R-Q@6 0.155576005578041 1304.75866699219 653.3866 1304.60302734375 653.308837890625 2 16 1.1.1.2614.5 1 22.6063 810.2667 22.6358 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8900005817413 ETEGLRQEMSK Glu->pyro-Glu@N-term missed R-Q@6 0.158668994903564 1288.76684570313 645.3907 1288.60815429688 645.311340332031 2 15 1.1.1.2797.7 1 26.9818 886.8928 26.8939 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.990002155304 ETEGLRQEMSK Oxidation(M)@9 missed R-Q@6 0.210915997624397 1322.82458496094 441.9488 1322.61364746094 441.878479003906 3 13 1.1.1.2454.2 1 19.6042 1514.026 19.6968 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.4100022315979 ETEGLRQEMSK Oxidation(M)@9 missed R-Q@6 0.210640996694565 1322.82421875 441.9487 1322.61364746094 441.878479003906 3 13 1.1.1.2480.2 1 19.9653 1574.631 19.7768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.3099994659424 ETEGLRQEMSK missed R-Q@6 0.153720006346703 1306.7724609375 654.3935 1306.61877441406 654.316650390625 2 14 1.1.1.2630.5 1 22.9859 4493.41 22.7311 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 ETEGLRQEMSK Oxidation(M)@9 missed R-Q@6 0.211281999945641 1322.82495117188 441.9489 1322.61364746094 441.878479003906 3 12 1.1.1.2436.2 1 19.4329 322.8229 19.51 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 ETEGLRQEMSK Oxidation(M)@9 missed R-Q@6 0.210640996694565 1322.82421875 441.9487 1322.61364746094 441.878479003906 3 12 1.1.1.2489.2 1 20.139 712.6951 19.9174 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2300000190735 ETEGLRQEMSK Oxidation(M)@9 missed R-Q@6 0.210365995764732 1322.82397460938 441.9486 1322.61364746094 441.878479003906 3 12 1.1.1.2469.2 1 19.7718 1817.919 19.745 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 36.1000001430511 ETEGLRQEMSK missed R-Q@6 0.208362996578217 1306.82702636719 436.6163 1306.61877441406 436.546844482422 3 12 1.1.1.2616.4 1 22.6454 39601.27 22.7073 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 34.6799999475479 ETEGLRQEMSK missed R-Q@6 0.208362996578217 1306.82702636719 436.6163 1306.61877441406 436.546844482422 3 12 1.1.1.2623.5 1 22.8182 39601.27 22.7073 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ETEGLRQEMSKDLEEVK Oxidation(M)@9 missed R-Q@6; missed K-D@11 0.230434998869896 2036.20361328125 679.7418 2035.97314453125 679.6650390625 3 25 1.1.1.2726.2 1 25.2879 1847.2 25.2931 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ETEGLRQEMSKDLEEVK missed R-Q@6; missed K-D@11 0.235663995146751 2020.21398925781 674.4119 2019.97827148438 674.333374023438 3 24 1.1.1.3203.5 1 36.7313 14440.15 36.9524 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ETEGLRQEMSKDLEEVK missed R-Q@6; missed K-D@11 0.236213997006416 2020.21447753906 674.4121 2019.97827148438 674.333374023438 3 26 1.1.1.3212.7 1 36.9472 17138.98 37.0003 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ETEGLRQEMSKDLEEVK missed R-Q@6; missed K-D@11 0.236213997006416 2020.21447753906 674.4121 2019.97827148438 674.333374023438 3 23 1.1.1.3219.9 1 37.1151 17138.98 37.0003 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ETEGLRQEMSKDLEEVK Glu->pyro-Glu@N-term missed R-Q@6; missed K-D@11 0.237074002623558 2002.20483398438 668.4089 2001.9677734375 668.329833984375 3 25 1.1.1.3468.9 1 43.1272 2366.637 43.0428 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ETEGLRQEMSKDLEEVK Oxidation(M)@9 missed R-Q@6; missed K-D@11 0.168863996863365 2036.14147949219 1019.078 2035.97314453125 1018.99389648438 2 17 1.1.1.2740.6 1 25.6201 501.5018 25.6252 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ETEGLRQEMSKDLEEVK missed R-Q@6; missed K-D@11 0.171103000640869 2020.1494140625 1011.082 2019.97827148438 1010.99639892578 2 17 1.1.1.3210.7 1 36.8993 976.7087 36.9764 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8900005817413 ETEGLRQEMSKDLEEVK Glu->pyro-Glu@N-term; Oxidation(M)@9 missed R-Q@6; missed K-D@11 0.245394006371498 2018.2080078125 673.7433 2017.96264648438 673.661499023438 3 15 1.1.1.2947.11 1 30.5805 748.5181 30.5872 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1099998950958 ETEGLRQEMSKDLEEVK Oxidation(M)@9 missed R-Q@6; missed K-D@11 0.288100004196167 2036.26135253906 510.0726 2035.97314453125 510.000579833984 4 12 1.1.1.2727.4 1 25.3018 4191.785 25.2692 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1099998950958 ETEGLRQEMSKDLEEVK Oxidation(M)@9 missed R-Q@6; missed K-D@11 0.291274011135101 2036.26452636719 510.0734 2035.97314453125 510.000579833984 4 12 1.1.1.2737.4 1 25.5423 5059.57 25.6015 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.1299986839294 ETEGLRQEMSKDLEEVK Glu->pyro-Glu@N-term missed R-Q@6; missed K-D@11 0.237074002623558 2002.20483398438 668.4089 2001.9677734375 668.329833984375 3 11 1.1.1.3461.12 1 42.9558 2366.637 43.0428 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 34.6799999475479 ETEGLRQEMSKDLEEVK missed R-Q@6; missed K-D@11 0.171103000640869 2020.1494140625 1011.082 2019.97827148438 1010.99639892578 2 11 1.1.1.3218.8 1 37.0912 976.7087 36.9764 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 25.0800013542175 ETEGLRQEMSKDLEEVK missed R-Q@6; missed K-D@11 0.297419011592865 2020.27575683594 506.0762 2019.97827148438 506.001861572266 4 12 1.1.1.3219.5 1 37.1051 18972.8 36.9764 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 21.3599994778633 ETEGLRQEMSKDLEEVK missed R-Q@6; missed K-D@11 0.297419011592865 2020.27575683594 506.0762 2019.97827148438 506.001861572266 4 12 1.1.1.3205.7 1 36.7766 18164.73 36.9524 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 ETEGLRQEMSKDLEEVKAK Oxidation(M)@9 missed R-Q@6; missed K-D@11; missed K-A@17 0.232879996299744 2235.33813476563 746.12 2235.10522460938 746.042358398438 3 20 1.1.1.2701.14 1 24.6913 773.1818 24.6723 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.470002412796 ETEGLRQEMSKDLEEVKAK Glu->pyro-Glu@N-term missed R-Q@6; missed K-D@11; missed K-A@17 0.239885002374649 2201.33959960938 734.7872 2201.09985351563 734.707214355469 3 16 1.1.1.3419.9 1 41.9305 732.2031 41.9159 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.199999332428 ETEGLRQEMSKDLEEVKAK Glu->pyro-Glu@N-term missed R-Q@6; missed K-D@11; missed K-A@17 0.297610998153687 2201.3974609375 551.3566 2201.09985351563 551.2822265625 4 16 1.1.1.3423.10 1 42.0241 522.8906 42.0138 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.0000026226044 ETEGLRQEMSKDLEEVKAK missed R-Q@6; missed K-D@11; missed K-A@17 0.300962001085281 2219.41137695313 555.8601 2219.1103515625 555.784851074219 4 14 1.1.1.3174.4 1 36.0249 24385.36 36.1372 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.1100008487701 ETEGLRQEMSKDLEEVKAK Delta:H(4)C(2)(K)@17; reduced acrolein addition +58(K)@19 missed R-Q@6; missed K-D@11; missed K-A@17 0.271254003047943 2305.45483398438 577.371 2305.18359375 577.303161621094 4 14 1.1.1.3733.8 1 49.6092 220.4042 49.651 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.1100008487701 ETEGLRQEMSKDLEEVKAK Formyl(K)@17; reduced acrolein addition +58(K)@19 missed R-Q@6; missed K-D@11; missed K-A@17 0.248265996575356 2305.3955078125 769.4724 2305.14721679688 769.3896484375 3 14 1.1.1.3733.16 1 49.6159 534.7605 49.6251 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 25.0800013542175 ETEGLRQEMSKDLEEVKAK missed R-Q@6; missed K-D@11; missed K-A@17 0.300962001085281 2219.41137695313 555.8601 2219.1103515625 555.784851074219 4 12 1.1.1.3183.4 1 36.2477 24385.36 36.1372 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.7199997901917 FEGSALGKQLNLKLLDNWDSVTSTFSK MDA adduct +54(K)@8; HPNE addition +172(K)@13 cleaved Q-F@N-term; missed K-Q@8; missed K-L@13 0.139936000108719 3223.80517578125 1075.609 3223.66528320313 1075.56237792969 3 14 1.1.1.3703.15 1 48.8739 10436.66 48.8324 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1900012493134 FEGSALGKQLNLKLLDNWDSVTSTFSK acrolein addition +56(K)@8; Deamidated(N)@11; acrolein addition +94(K)@13 cleaved Q-F@N-term; missed K-Q@8; missed K-L@13 0.0666263997554779 3148.66430664063 1050.562 3148.59692382813 1050.53955078125 3 14 1.1.1.3703.14 1 48.8722 12675.66 48.7119 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1900012493134 FEGSALGKQLNLKLLDNWDSVTSTFSK MDA adduct +54(K)@8; HPNE addition +172(K)@13 cleaved Q-F@N-term; missed K-Q@8; missed K-L@13 0.139936000108719 3223.80517578125 1075.609 3223.66528320313 1075.56237792969 3 14 1.1.1.3710.9 1 49.0443 10436.66 48.8324 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.1999986171722 FEGSALGKQLNLKLLDNWDSVTSTFSK MDA adduct +54(K)@8; HPNE addition +172(K)@13 cleaved Q-F@N-term; missed K-Q@8; missed K-L@13 0.139936000108719 3223.80517578125 1075.609 3223.66528320313 1075.56237792969 3 13 1.1.1.3696.21 1 48.7068 10436.66 48.8324 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.0599987506866 FEGSALGKQLNLKLLDNWDSVTSTFSK HPNE addition +172(K)@8; MDA adduct +54(K)@13 cleaved Q-F@N-term; missed K-Q@8; missed K-L@13 0.183319002389908 3223.8486328125 806.9694 3223.66528320313 806.923583984375 4 12 1.1.1.4048.10 1 57.3931 639.0021 57.3814 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 58.7499976158142 FLTGSQARHFWQQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(R)@8; reduced HNE(H)@9; reduced acrolein addition +58(K)@25 cleaved L-F@N-term; missed R-H@8; missed R-V@23; missed K-D@25; missed K-D@36; missed R-D@40 0.0511374995112419 6270.18505859375 896.748 6270.1337890625 896.740661621094 7 13 1.1.1.4377.2 1 65.5703 620.8459 65.5655 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.3899998664856 GARLAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK cleaved G-G@N-term; missed R-L@3; missed K-A@10; missed K-A@21; missed R-Q@30; missed K-V@41 -6.3739800453186 5877.767578125 980.6352 5884.1416015625 981.697509765625 6 18 1.1.1.4714.9 1 74.1947 646.722 74.2273 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.6099991798401 GGARLAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK cleaved N-G@N-term; missed R-L@4; missed K-A@11; missed K-A@22; missed R-Q@31; missed K-V@42 1.10712003707886 5942.27001953125 991.3856 5941.1630859375 991.201110839844 6 13 1.1.1.4716.16 1 74.2426 533.2279 74.2273 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 26.5300005674362 GGARLAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK cleaved N-G@N-term; missed R-L@4; missed K-A@11; missed K-A@22; missed R-Q@31; missed K-V@42 -1.93499994277954 5939.22802734375 990.8786 5941.1630859375 991.201110839844 6 14 1.1.1.4707.8 1 74.0217 384.8079 74.0092 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8900005817413 GKQLNLKLLDNWDSVTSTFSK Carbamidomethyl@N-term; acrolein addition +38(K)@2 cleaved L-G@N-term; missed K-Q@2; missed K-L@7 0.244604006409645 2488.54077148438 830.5209 2488.29614257813 830.439331054688 3 17 1.1.1.3896.4 1 53.6847 1238.919 53.6723 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8900005817413 GKQLNLKLLDNWDSVTSTFSK Carbamyl@N-term; Deamidated(N)@5 cleaved L-G@N-term; missed K-Q@2; missed K-L@7 0.306719988584518 2437.5556640625 813.5258 2437.2490234375 813.423583984375 3 18 1.1.1.3904.4 1 53.8707 1291.39 53.8172 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 61.2100005149841 GKQLNLKLLDNWDSVTSTFSK Acetyl@N-term; MDA adduct +62(K)@2; acrolein addition +38(K)@7 cleaved L-G@N-term; missed K-Q@2; missed K-L@7 0.287155002355576 2535.58813476563 846.2033 2535.30102539063 846.107604980469 3 13 1.1.1.3893.11 1 53.6101 515.8908 53.648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 24.0299999713898 GSQARHFWQQDEPPQSPWDRVKDLATVYVDVLK cleaved T-G@N-term; missed R-H@5; missed R-V@20; missed K-D@22 -11.1949996948242 3883.74926757813 971.9446 3894.94409179688 974.743347167969 4 11 1.1.1.4190.7 1 60.8492 11757.29 60.5841 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.6400005817413 HAKATEHLSTLSEK cleaved Y-H@N-term; missed K-A@3 4.1995701789856 1555.0048828125 519.3422 1550.80529785156 517.9423828125 3 12 1.1.1.2937.10 1 30.334 754.2564 30.3474 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.5599999427795 HAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK reduced acrolein addition +58(K)@3; reduced HNE(H)@7; MDA adduct +62(K)@14; acrolein addition +38(K)@16 cleaved Y-H@N-term; missed K-A@3; missed K-A@14; missed R-Q@23; missed K-V@34 -0.48225000500679 5439.47607421875 778.0753 5439.95849609375 778.144226074219 7 13 1.1.1.4701.12 1 73.8745 385.0806 73.8606 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.3500000238419 HAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK reduced acrolein addition +58(K)@3; reduced HNE(H)@7; reduced acrolein addition +58(K)@34 cleaved Y-H@N-term; missed K-A@3; missed K-A@14; missed R-Q@23; missed K-V@34 -0.519730985164642 5397.44921875 772.0715 5397.96923828125 772.145690917969 7 12 1.1.1.4700.8 1 73.8447 883.9467 73.8606 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.0599992275238 HELQEKLSPLGEEMRDR ONE addition +154(K)@6 cleaved L-H@N-term; missed K-L@6; missed R-D@15 0.300467014312744 2220.42138671875 556.1126 2220.12084960938 556.037475585938 4 12 1.1.1.3189.5 1 36.3856 15897.34 36.1372 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.0599975585938 HELQEKLSPLGEEMRDR acrolein addition +112(K)@6; Amidated@C-term cleaved L-H@N-term; missed K-L@6; missed R-D@15 0.332652986049652 2177.42260742188 545.3629 2177.08984375 545.279724121094 4 13 1.1.1.3095.8 1 34.1369 1045.562 34.1685 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 49.3699997663498 HFWQQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Arg-add@N-term missed R-V@15; missed K-D@17; missed K-D@28; missed R-D@32 0.491742998361588 5349.11962890625 892.5272 5348.6279296875 892.445251464844 6 25 1.1.1.4283.15 1 63.1402 2907.593 63.1004 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 HLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK ONE addition +154(K)@8; HPNE addition +172(K)@10; Oxidation(P)@11 cleaved E-H@N-term; missed K-A@8; missed R-Q@17; missed K-V@28 0.42076501250267 4829.0615234375 805.8508 4828.640625 805.780700683594 6 26 1.1.1.4651.8 1 72.567 12233.8 72.7408 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 HLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK ONE addition +154(K)@8; HPNE addition +172(K)@10; Oxidation(P)@11 cleaved E-H@N-term; missed K-A@8; missed R-Q@17; missed K-V@28 0.42076501250267 4829.0615234375 805.8508 4828.640625 805.780700683594 6 34 1.1.1.4658.10 1 72.7532 12233.8 72.7408 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.8299970626831 HLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK ONE addition +154(K)@8; HPNE addition +172(K)@10; Oxidation(P)@11 cleaved E-H@N-term; missed K-A@8; missed R-Q@17; missed K-V@28 0.478796005249023 4829.119140625 690.8815 4828.640625 690.813049316406 7 23 1.1.1.4656.5 1 72.6992 3827.817 72.7408 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.1199975013733 HLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKK ONE addition +154(K)@8; HPNE addition +172(K)@10; Oxidation(P)@11 cleaved E-H@N-term; missed K-A@8; missed R-Q@17; missed K-V@28; missed K-K@40 0.489728987216949 4957.22509765625 709.1823 4956.7353515625 709.112365722656 7 16 1.1.1.4603.9 1 71.2978 1077.204 71.2334 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.2299988269806 HLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKK ONE addition +154(K)@8; HPNE addition +172(K)@10; Oxidation(P)@11 cleaved E-H@N-term; missed K-A@8; missed R-Q@17; missed K-V@28; missed K-K@40 0.419795989990234 4957.1552734375 827.1998 4956.7353515625 827.1298828125 6 24 1.1.1.4600.10 1 71.225 1213.676 71.2595 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.9699983596802 HLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKK ONE addition +154(K)@8; HPNE addition +172(K)@10; Oxidation(P)@11 cleaved E-H@N-term; missed K-A@8; missed R-Q@17; missed K-V@28; missed K-K@40 0.409909009933472 4957.1455078125 827.1982 4956.7353515625 827.1298828125 6 24 1.1.1.4607.7 1 71.4056 1187.23 71.3389 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 24.9500006437302 HLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT ONE addition +154(K)@8; acrolein addition +112(K)@10; acrolein addition +76(K)@28 cleaved E-H@N-term; cleaved T-Q@C-term; missed K-A@8; missed R-Q@17; missed K-V@28; missed K-K@40; missed K-L@41 0.389499008655548 5285.2783203125 1058.063 5284.88916015625 1057.98510742188 5 12 1.1.1.4695.20 1 73.7252 872.1587 73.8337 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.5499987602234 HLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ ONE addition +154(K)@8; HPNE addition +172(K)@10; Oxidation(P)@11 cleaved E-H@N-term; missed K-A@8; missed R-Q@17; missed K-V@28; missed K-K@40; missed K-L@41 0.364601999521255 5413.33349609375 1083.674 5412.96875 1083.60107421875 5 32 1.1.1.4692.21 1 73.6485 7317.078 73.7823 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9300010204315 HLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ ONE addition +154(K)@8; HPNE addition +172(K)@10; Oxidation(P)@11 cleaved E-H@N-term; missed K-A@8; missed R-Q@17; missed K-V@28; missed K-K@40; missed K-L@41 0.489086985588074 5413.4580078125 774.3584 5412.96875 774.288513183594 7 27 1.1.1.4690.6 1 73.5833 30965.27 73.7823 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.1700010299683 HLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ ONE addition +154(K)@8; HPNE addition +172(K)@10; Oxidation(P)@11 cleaved E-H@N-term; missed K-A@8; missed R-Q@17; missed K-V@28; missed K-K@40; missed K-L@41 0.489086985588074 5413.4580078125 774.3584 5412.96875 774.288513183594 7 25 1.1.1.4698.9 1 73.7929 31212.58 73.7823 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.9500013589859 HVDALRTHLAPYSDELRQR Deamidated(R)@6; reduced HNE(H)@8 cleaved A-H@N-term; missed R-T@6; missed R-Q@17 0.278885006904602 2435.57104492188 609.9 2435.2919921875 609.830322265625 4 12 1.1.1.3087.9 1 33.9442 2367.739 33.8087 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 36.3599985837936 HVDALRTHLAPYSDELRQR reduced HNE(H)@1; Deamidated(R)@6 cleaved A-H@N-term; missed R-T@6; missed R-Q@17 0.33603098988533 2435.62817382813 488.1329 2435.2919921875 488.065704345703 5 12 1.1.1.3080.9 1 33.7763 4323.102 33.8087 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +76(K)@1; acrolein addition +76(K)@3 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21 0.315746992826462 3871.43334960938 968.8656 3871.11743164063 968.786682128906 4 22 1.1.1.4715.4 1 74.2181 5535.183 74.2273 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1800029277802 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTK cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21 0.3907850086689 3719.44580078125 744.8964 3719.05493164063 744.818237304688 5 17 1.1.1.4660.4 1 72.8011 30629.52 73.0339 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8999981880188 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTK hexanoyl addition +98(K)@3 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21 0.415154010057449 3817.54321289063 764.5159 3817.12817382813 764.432922363281 5 17 1.1.1.4709.4 1 74.0678 763.3066 74.0092 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.5400009155273 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Carbamidomethyl@N-term; reduced acrolein addition +96(K)@3 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21 0.367837011814117 3872.50170898438 775.5076 3872.13403320313 775.43408203125 5 17 1.1.1.4716.9 1 74.2367 1103.369 74.2273 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.92999792099 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +76(K)@1; acrolein addition +76(K)@3 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21 0.315746992826462 3871.43334960938 968.8656 3871.11743164063 968.786682128906 4 16 1.1.1.4708.11 1 74.0494 5495.342 74.2273 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.9700014591217 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTK MDA adduct +54(K)@1; acrolein addition +112(K)@3 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21 0.338057994842529 3885.4560546875 972.3713 3885.11791992188 972.286743164063 4 15 1.1.1.4708.13 1 74.0527 795.6254 74.0335 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.5200026035309 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTK cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21 0.334645986557007 3719.3896484375 930.8547 3719.05493164063 930.77099609375 4 13 1.1.1.4657.17 1 72.7323 5984.104 72.9799 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.5200026035309 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTK hexanoyl addition +98(K)@1; MDA adduct +62(K)@3; hexanoyl addition +98(K)@21 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21 0.264463007450104 3977.4814453125 995.3776 3977.21704101563 995.3115234375 4 13 1.1.1.4716.17 1 74.2434 1151.767 74.2031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.92999958992 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTK HPNE addition +172(K)@1; acrolein addition +112(K)@3 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21 0.314850002527237 4003.53100585938 1001.89 4003.21728515625 1001.81158447266 4 13 1.1.1.4707.10 1 74.0251 774.3915 74.0092 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 51.9599974155426 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTK MDA adduct +62(K)@1; reduced acrolein addition +58(K)@3 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21 0.374787002801895 3839.4873046875 960.8791 3839.11254882813 960.785400390625 4 13 1.1.1.4706.7 1 73.9975 867.3706 74.0092 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 50.6900012493134 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTK HPNE addition +172(K)@1; acrolein addition +56(K)@3 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21 -0.617994010448456 3946.57299804688 790.3219 3947.19116210938 790.445495605469 5 13 1.1.1.4716.11 1 74.2384 10604.14 74.3245 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 45.6299990415573 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +112(K)@3; Deamidated(Q)@11; ONE addition +154(K)@21 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21 0.194962993264198 3986.3857421875 798.2844 3986.19067382813 798.245422363281 5 13 1.1.1.4772.13 1 75.6106 1243.972 75.5199 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 35.6799989938736 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTK HPNE addition +172(K)@1; acrolein addition +112(K)@3 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21 0.313874006271362 4003.53100585938 1001.89 4003.21728515625 1001.81158447266 4 12 1.1.1.4716.18 1 74.2442 698.2001 74.2273 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 41.839998960495 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTKK reduced acrolein addition +96(K)@3; reduced acrolein addition +58(K)@21 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21; missed K-K@33 0.381195992231369 4001.63037109375 801.3334 4001.24926757813 801.257141113281 5 12 1.1.1.4677.6 1 73.2472 191.2879 73.2135 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 51.9599974155426 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLN HPNE addition +172(K)@1; MDA adduct +54(K)@3; HPNE addition +172(K)@33; hexanoyl addition +98(K)@34 cleaved E-K@N-term; cleaved N-T@C-term; missed K-A@1; missed R-Q@10; missed K-V@21; missed K-K@33; missed K-L@34 0.211267992854118 4570.7919921875 762.8059 4570.58056640625 762.770690917969 6 14 1.1.1.4766.8 1 75.4547 5958.213 75.5711 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 20.9800004959106 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT HPNE addition +172(K)@1; acrolein addition +56(K)@3; reduced acrolein addition +58(K)@21 cleaved E-K@N-term; cleaved T-Q@C-term; missed K-A@1; missed R-Q@10; missed K-V@21; missed K-K@33; missed K-L@34 0.406616002321243 4461.9091796875 744.6588 4461.50244140625 744.591064453125 6 12 1.1.1.4750.8 1 75.0628 2316.19 75.0295 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.0599999427795 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +58(K)@1; acrolein addition +94(K)@3 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21; missed K-K@33; missed K-L@34 0.275000989437103 4455.74267578125 1114.943 4455.466796875 1114.8740234375 4 20 1.1.1.4720.20 1 74.3431 4086.821 74.374 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.0599999427795 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ hexanoyl addition +98(K)@1; MDA adduct +54(K)@3 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21; missed K-K@33; missed K-L@34 0.389672994613647 4455.8564453125 892.1786 4455.466796875 892.100646972656 5 20 1.1.1.4755.6 1 75.1911 891.3297 75.1523 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.869998216629 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HPNE addition +172(K)@3; Deamidated(Q)@11 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21; missed K-K@33; missed K-L@34 0.356920003890991 4476.833984375 896.3741 4476.47705078125 896.302673339844 5 18 1.1.1.4752.6 1 75.1153 1879.814 75.1768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8999981880188 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl@N-term; reduced acrolein addition +96(K)@3 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21; missed K-K@33; missed K-L@34 0.367628991603851 4456.82958984375 892.3732 4456.4619140625 892.299682617188 5 18 1.1.1.4747.7 1 74.9952 1706.579 75.0052 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2700009346008 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +56(K)@1; MDA adduct +62(K)@3 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21; missed K-K@33; missed K-L@34 0.34859099984169 4421.7734375 885.362 4421.4248046875 885.292297363281 5 17 1.1.1.4758.7 1 75.2623 1986.488 75.1523 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7099974155426 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +112(K)@3; Oxidation(P)@4 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21; missed K-K@33; missed K-L@34 0.432222992181778 4431.86279296875 887.3798 4431.4306640625 887.293395996094 5 18 1.1.1.4739.6 1 74.8007 1153.501 74.6892 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.6099996566772 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ ONE addition +154(K)@3; Deamidated(Q)@11 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21; missed K-K@33; missed K-L@34 0.355704993009567 4458.822265625 892.7717 4458.466796875 892.700561523438 5 17 1.1.1.4740.9 1 74.8231 3073.024 74.7618 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.1700010299683 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ MDA adduct +54(K)@1; MDA adduct +54(K)@3 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21; missed K-K@33; missed K-L@34 0.543506979942322 4411.94775390625 736.3319 4411.404296875 736.241333007813 6 16 1.1.1.4722.5 1 74.3801 721.0216 74.471 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.0299985408783 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HPNE addition +172(K)@3 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21; missed K-K@33; missed K-L@34 0.106499999761581 4475.599609375 896.1272 4475.4931640625 896.105895996094 5 15 1.1.1.4741.10 1 74.849 3867.433 74.7376 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.9700014591217 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +58(K)@1; acrolein addition +94(K)@3 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21; missed K-K@33; missed K-L@34 0.358850002288818 4455.82568359375 892.1724 4455.466796875 892.100646972656 5 16 1.1.1.4719.14 1 74.3161 11153.61 74.374 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.9700014591217 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +58(K)@1; acrolein addition +94(K)@3 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21; missed K-K@33; missed K-L@34 0.351830989122391 4455.81884765625 892.171 4455.466796875 892.100646972656 5 15 1.1.1.4733.8 1 74.6514 1876.097 74.6648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.6099972724915 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ MDA adduct +54(K)@1; acrolein addition +112(K)@3 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21; missed K-K@33; missed K-L@34 -0.531316995620728 4468.9150390625 745.8264 4469.4462890625 745.914978027344 6 15 1.1.1.4722.8 1 74.3826 756.1802 74.3985 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.3000004291534 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +56(K)@1; reduced acrolein addition +96(K)@3 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21; missed K-K@33; missed K-L@34 0.358850002288818 4455.82568359375 892.1724 4455.466796875 892.100646972656 5 15 1.1.1.4726.15 1 74.4854 11153.61 74.374 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 77.9999971389771 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +56(K)@1; MDA adduct +62(K)@3 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21; missed K-K@33; missed K-L@34 0.429875999689102 4421.85498046875 737.9831 4421.4248046875 737.911437988281 6 14 1.1.1.4743.3 1 74.8892 1587.39 74.8833 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 59.35999751091 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ ONE addition +154(K)@1; hexanoyl addition +98(K)@3 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21; missed K-K@33; missed K-L@34 0.209719002246857 4555.765625 760.3015 4555.5556640625 760.266540527344 6 13 1.1.1.4781.8 1 75.8405 1772.123 75.8564 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.92999958992 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ hexanoyl addition +98(K)@1; reduced acrolein addition +58(K)@3 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21; missed K-K@33; missed K-L@34 0.258837014436722 4459.7587890625 1115.947 4459.498046875 1115.8818359375 4 13 1.1.1.4737.7 1 74.7568 1191.57 74.7618 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.4600009918213 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +56(K)@1; MDA adduct +62(K)@3 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21; missed K-K@33; missed K-L@34 0.433537989854813 4421.8583984375 737.9837 4421.4248046875 737.911437988281 6 13 1.1.1.4761.5 1 75.3287 1222.317 75.274 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 41.839998960495 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ ONE addition +154(K)@1; reduced acrolein addition +58(K)@3; Deamidated(Q)@11 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21; missed K-K@33; missed K-L@34 0.366207987070084 4516.87451171875 904.3822 4516.50830078125 904.308959960938 5 13 1.1.1.4749.10 1 75.0397 702.6577 75.1523 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 30.9700012207031 KAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HPNE addition +172(K)@3; MDA adduct +54(K)@21 cleaved E-K@N-term; missed K-A@1; missed R-Q@10; missed K-V@21; missed K-K@33; missed K-L@34 0.262609004974365 4529.76611328125 755.9683 4529.50390625 755.924560546875 6 12 1.1.1.4781.7 1 75.8396 1065.845 75.9088 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.2300007343292 KAKVQPYLDDFQKK acrolein addition +76(K)@1; Deamidated(Q)@5; Oxidation(P)@6; HPNE addition +172(K)@13 cleaved V-K@N-term; missed K-A@1; missed K-V@3; missed K-K@13 0.167740002274513 1972.22351074219 658.4151 1972.05578613281 658.359191894531 3 14 1.1.1.3226.4 1 37.2786 2316.116 37.3118 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KAKVQPYLDDFQKKWQEEMELYR acrolein addition +76(K)@1; acrolein addition +94(K)@3; reduced acrolein addition +96(K)@14; Dethiomethyl(M)@19 cleaved V-K@N-term; missed K-A@1; missed K-V@3; missed K-K@13; missed K-W@14 0.224221006035805 3189.841796875 798.4677 3189.61743164063 798.411682128906 4 19 1.1.1.3477.16 1 43.357 513.978 43.3662 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.6000020503998 KAKVQPYLDDFQKKWQEEMELYR Carbamyl(K)@3 cleaved V-K@N-term; missed K-A@1; missed K-V@3; missed K-K@13; missed K-W@14 0.0940072014927864 3014.59008789063 754.6548 3014.49609375 754.631286621094 4 19 1.1.1.3793.3 1 51.1306 1409.386 51.1247 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.4200029373169 KAKVQPYLDDFQKKWQEEMELYR Carbamyl@N-term cleaved V-K@N-term; missed K-A@1; missed K-V@3; missed K-K@13; missed K-W@14 0.0852181985974312 3014.58129882813 754.6526 3014.49609375 754.631286621094 4 18 1.1.1.3800.5 1 51.3003 1370.979 51.2701 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1900012493134 KAKVQPYLDDFQKKWQEEMELYR acrolein addition +76(K)@1; Delta:H(2)C(2)(K)@3; Deamidated(Q)@5 cleaved V-K@N-term; missed K-A@1; missed K-V@3; missed K-K@13; missed K-W@14 0.12720499932766 3074.6484375 769.6694 3074.52124023438 769.637573242188 4 18 1.1.1.3799.6 1 51.281 490.8582 51.2701 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.2399985790253 KATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK cleaved A-K@N-term; missed K-A@1; missed K-A@12; missed R-Q@21; missed K-V@32 1.21809995174408 4916.876953125 984.3826 4915.65869140625 984.139038085938 5 16 1.1.1.4707.7 1 74.0201 496.0942 74.0092 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 76.2799978256226 KATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK reduced HNE(H)@5; HPNE addition +172(K)@12; acrolein addition +112(K)@14; acrolein addition +56(K)@32 cleaved A-K@N-term; missed K-A@1; missed K-A@12; missed R-Q@21; missed K-V@32 0.419934988021851 5414.39794921875 903.4069 5413.97802734375 903.3369140625 6 14 1.1.1.4704.4 1 73.9456 22384.12 73.7823 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.1700010299683 KATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ ONE addition +154(K)@1; reduced HNE(H)@5; MDA adduct +62(K)@12; acrolein addition +38(K)@14 cleaved A-K@N-term; missed K-A@1; missed K-A@12; missed R-Q@21; missed K-V@32; missed K-K@44; missed K-L@45 0.411107987165451 5912.6591796875 986.4505 5912.248046875 986.381958007813 6 16 1.1.1.4677.15 1 73.2547 2682.041 73.1363 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 55.4700016975403 KDSGRDYVSQFEGSALGK Cation:Na(D)@6 cleaved L-K@N-term; missed K-D@1; missed R-D@5 0.197466000914574 1965.11791992188 656.0466 1964.92041015625 655.980773925781 3 12 1.1.1.3596.14 1 46.2614 752.6166 46.1971 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.5399985313416 KLHELQEKLSPLGEEMRDR acrolein addition +56(K)@1; reduced HNE(H)@3 cleaved Q-K@N-term; missed K-L@1; missed K-L@8; missed R-D@17 0.256307989358902 2521.61376953125 631.4107 2521.357421875 631.346618652344 4 13 1.1.1.3662.11 1 47.949 11482.06 47.8336 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.8999996185303 KLHELQEKLSPLGEEMRDR acrolein addition +56(K)@1; reduced HNE(H)@3 cleaved Q-K@N-term; missed K-L@1; missed K-L@8; missed R-D@17 0.308784991502762 2521.66625976563 505.3405 2521.357421875 505.278747558594 5 13 1.1.1.3655.5 1 47.7634 6814.181 47.8336 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.8599994182587 KLHELQEKLSPLGEEMRDR acrolein addition +56(K)@1; reduced HNE(H)@3 cleaved Q-K@N-term; missed K-L@1; missed K-L@8; missed R-D@17 0.246298000216484 2521.60375976563 631.4082 2521.357421875 631.346618652344 4 12 1.1.1.3698.2 1 48.7426 9874.142 48.6151 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 66.1899983882904 KLHELQEKLSPLGEEMRDR acrolein addition +94(K)@1; reduced acrolein addition +58(K)@8 cleaved Q-K@N-term; missed K-L@1; missed K-L@8; missed R-D@17 0.344442993402481 2459.62866210938 492.933 2459.2841796875 492.864135742188 5 12 1.1.1.3436.5 1 42.3369 4647.22 42.4039 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 16.5199995040894 KLLDNWDSVTSTFSK acrolein addition +76(K)@1; Deamidated(N)@5; Trp->Kynurenin(W)@6 cleaved L-K@N-term; missed K-L@1 0.310074001550674 1821.193359375 608.0717 1820.88330078125 607.968383789063 3 11 1.1.1.4623.14 1 71.8299 772.8045 71.734 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.5499987602234 KPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +112(K)@1 cleaved A-K@N-term; missed R-Q@8; missed K-V@19 0.39767798781395 3632.373046875 727.4819 3631.97534179688 727.40234375 5 21 1.1.1.4716.5 1 74.2334 4823.833 74.2273 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.3100006580353 KPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +112(K)@1 cleaved A-K@N-term; missed R-Q@8; missed K-V@19 0.339585989713669 3632.31494140625 909.086 3631.97534179688 909.001098632813 4 19 1.1.1.4720.15 1 74.3389 3718.069 74.2273 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.8199996948242 KPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +112(K)@1 cleaved A-K@N-term; missed R-Q@8; missed K-V@19 0.340319007635117 3632.31567382813 909.0862 3631.97534179688 909.001098632813 4 23 1.1.1.4706.5 1 73.9941 1251.061 73.985 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.5400009155273 KPALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +112(K)@1 cleaved A-K@N-term; missed R-Q@8; missed K-V@19 0.339585989713669 3632.31494140625 909.086 3631.97534179688 909.001098632813 4 20 1.1.1.4714.5 1 74.188 3718.069 74.2273 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2700009346008 KPALEDLRQGLLPVLESFKVSFLSALEEYTKK acrolein addition +112(K)@1 cleaved A-K@N-term; missed R-Q@8; missed K-V@19; missed K-K@31 0.469938009977341 3760.54028320313 627.764 3760.0703125 627.685668945313 6 17 1.1.1.4691.4 1 73.6081 1735.462 73.6273 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.6099996566772 KPALEDLRQGLLPVLESFKVSFLSALEEYTKK acrolein addition +112(K)@1 cleaved A-K@N-term; missed R-Q@8; missed K-V@19; missed K-K@31 0.402996003627777 3760.47314453125 753.1019 3760.0703125 753.021301269531 5 16 1.1.1.4681.5 1 73.3505 1506.474 73.498 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.8199996948242 KPALEDLRQGLLPVLESFKVSFLSALEEYTKK acrolein addition +112(K)@1 cleaved A-K@N-term; missed R-Q@8; missed K-V@19; missed K-K@31 0.461515992879868 3760.53173828125 627.7626 3760.0703125 627.685668945313 6 16 1.1.1.4682.4 1 73.3764 710.0506 73.4215 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 KPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ hexanoyl addition +98(K)@1; Methyl(D)@6 cleaved A-K@N-term; missed R-Q@8; missed K-V@19; missed K-K@31; missed K-L@32 0.366272985935211 4216.7060546875 844.3485 4216.33984375 844.275268554688 5 25 1.1.1.4734.9 1 74.6741 10728.02 74.6892 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.6599991321564 KPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +112(K)@1 cleaved A-K@N-term; missed R-Q@8; missed K-V@19; missed K-K@31; missed K-L@32 0.400523006916046 4216.7041015625 844.3481 4216.3037109375 844.268005371094 5 26 1.1.1.4748.10 1 75.0177 8493.865 74.7618 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.6599991321564 KPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +112(K)@1 cleaved A-K@N-term; missed R-Q@8; missed K-V@19; missed K-K@31; missed K-L@32 0.404184997081757 4216.70751953125 844.3488 4216.3037109375 844.268005371094 5 25 1.1.1.4755.4 1 75.1861 8668.885 75.1768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8999981880188 KPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +112(K)@1 cleaved A-K@N-term; missed R-Q@8; missed K-V@19; missed K-K@31; missed K-L@32 0.333397001028061 4216.638671875 1055.167 4216.3037109375 1055.08312988281 4 18 1.1.1.4755.7 1 75.1936 1041.231 75.2012 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.5400009155273 KPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +112(K)@1 cleaved A-K@N-term; missed R-Q@8; missed K-V@19; missed K-K@31; missed K-L@32 0.468869000673294 4216.7724609375 703.8027 4216.3037109375 703.724548339844 6 21 1.1.1.4756.3 1 75.2072 6995.402 75.1768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.0299985408783 KPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +112(K)@1 cleaved A-K@N-term; missed R-Q@8; missed K-V@19; missed K-K@31; missed K-L@32 0.400523006916046 4216.7041015625 844.3481 4216.3037109375 844.268005371094 5 19 1.1.1.4727.7 1 74.5079 6856.135 74.5438 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.0299985408783 KPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +112(K)@1 cleaved A-K@N-term; missed R-Q@8; missed K-V@19; missed K-K@31; missed K-L@32 0.475093990564346 4216.77880859375 703.8037 4216.3037109375 703.724548339844 6 18 1.1.1.4764.2 1 75.4003 28081.26 75.5457 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 76.2799978256226 KPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +112(K)@1; Deamidated(N)@34 cleaved A-K@N-term; missed R-Q@8; missed K-V@19; missed K-K@31; missed K-L@32 0.42145100235939 4217.708984375 844.5491 4217.28759765625 844.464782714844 5 14 1.1.1.4702.9 1 73.8982 2077.629 73.9362 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 65.1899993419647 KPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +112(K)@1 cleaved A-K@N-term; missed R-Q@8; missed K-V@19; missed K-K@31; missed K-L@32 0.333397001028061 4216.638671875 1055.167 4216.3037109375 1055.08312988281 4 13 1.1.1.4749.17 1 75.0472 1041.231 75.2012 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 44.3599998950958 KPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ hexanoyl addition +98(K)@1 cleaved A-K@N-term; missed R-Q@8; missed K-V@19; missed K-K@31; missed K-L@32 0.306802004575729 4202.630859375 1051.665 4202.32421875 1051.58837890625 4 12 1.1.1.4778.18 1 75.77 2266.029 75.8301 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 20.4999998211861 KPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +56(K)@1; Deamidated(Q)@9; acrolein addition +38(K)@19 cleaved A-K@N-term; missed R-Q@8; missed K-V@19; missed K-K@31; missed K-L@32 0.441341012716293 4199.71826171875 700.9603 4199.27685546875 700.886779785156 6 12 1.1.1.4701.5 1 73.8687 746.4695 73.9116 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.4799973964691 KVQPYLDDFQK acrolein addition +112(K)@1 cleaved A-K@N-term; missed K-V@1 0.234834000468254 1491.99572753906 498.3392 1491.76098632813 498.260925292969 3 12 1.1.1.3066.10 1 33.4407 2046.704 33.5449 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.7599980831146 KVQPYLDDFQK acrolein addition +112(K)@1 cleaved A-K@N-term; missed K-V@1 0.235749006271362 1491.99670410156 498.3395 1491.76098632813 498.260925292969 3 12 1.1.1.3080.10 1 33.778 872.7485 33.7847 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KVQPYLDDFQKKWQEEMELYR acrolein addition +112(K)@1; Dioxidation(W)@13; Oxidation(M)@17 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 0.32363098859787 2932.71899414063 734.187 2932.39526367188 734.106079101563 4 23 1.1.1.3501.15 1 43.9544 3023.413 43.9612 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KVQPYLDDFQKKWQEEMELYR acrolein addition +112(K)@1; reduced acrolein addition +96(K)@12; Dethiomethyl(M)@17 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 0.31903600692749 2932.78369140625 587.564 2932.46459960938 587.500244140625 5 20 1.1.1.3499.11 1 43.8984 2950.119 43.9366 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KVQPYLDDFQKKWQEEMELYR acrolein addition +112(K)@1 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 0.329614996910095 2884.740234375 722.1923 2884.41064453125 722.109924316406 4 24 1.1.1.3757.10 1 50.2233 20604.4 50.3143 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KVQPYLDDFQKKWQEEMELYR acrolein addition +112(K)@1; reduced acrolein addition +96(K)@12; Dethiomethyl(M)@17 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 0.31903600692749 2932.78369140625 587.564 2932.46459960938 587.500244140625 5 19 1.1.1.3498.9 1 43.8717 2950.119 43.9366 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KVQPYLDDFQKKWQEEMELYR acrolein addition +112(K)@1; Oxidation(M)@17 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 0.33543199300766 2900.74096679688 726.1925 2900.40551757813 726.108642578125 4 20 1.1.1.3648.14 1 47.5923 2164.85 47.6538 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 KVQPYLDDFQKKWQEEMELYR acrolein addition +112(K)@1 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 0.262611001729965 2884.67309570313 962.565 2884.41064453125 962.477478027344 3 23 1.1.1.3760.16 1 50.305 3782.307 50.3143 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8699991703033 KVQPYLDDFQKKWQEEMELYR acrolein addition +112(K)@1; Oxidation(M)@17 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 0.323469996452332 2900.72900390625 726.1895 2900.40551757813 726.108642578125 4 19 1.1.1.3662.17 1 47.9541 1473.695 48.0136 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.6000020503998 KVQPYLDDFQKKWQEEMELYR acrolein addition +112(K)@1; reduced acrolein addition +96(K)@12; Dethiomethyl(M)@17 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 0.323309004306793 2932.7880859375 587.5649 2932.46459960938 587.500244140625 5 17 1.1.1.3506.8 1 44.0694 2950.119 43.9366 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.6000020503998 KVQPYLDDFQKKWQEEMELYR acrolein addition +112(K)@1 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 0.390087008476257 2884.80053710938 577.9674 2884.41064453125 577.889404296875 5 20 1.1.1.3758.4 1 50.2437 13931.92 50.3143 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.7499990463257 KVQPYLDDFQKKWQEEMELYR acrolein addition +112(K)@1; Oxidation(M)@17 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 0.390046000480652 2900.79541015625 581.1664 2900.40551757813 581.08837890625 5 16 1.1.1.3651.10 1 47.6648 1652.918 47.6538 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.4000005722046 KVQPYLDDFQKKWQEEMELYR acrolein addition +112(K)@1; reduced acrolein addition +96(K)@12; Dethiomethyl(M)@17 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 0.31903600692749 2932.78369140625 587.564 2932.46459960938 587.500244140625 5 16 1.1.1.3491.9 1 43.6982 2834.945 43.9366 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.7199997901917 KVQPYLDDFQKKWQEEMELYR acrolein addition +112(K)@1; Oxidation(M)@17 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 0.33543199300766 2900.74096679688 726.1925 2900.40551757813 726.108642578125 4 17 1.1.1.3655.16 1 47.7725 2164.85 47.6538 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 19.9399992823601 KVQPYLDDFQKKWQEEMELYR acrolein addition +112(K)@1; reduced acrolein addition +96(K)@12; Dethiomethyl(M)@17 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12 0.254229992628098 2932.71899414063 734.187 2932.46459960938 734.123474121094 4 12 1.1.1.3508.14 1 44.1253 3023.413 43.9612 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.7199997901917 KVQPYLDDFQKKWQEEMELYRQK acrolein addition +112(K)@1 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12; missed R-Q@21 0.335498005151749 3140.89965820313 786.2322 3140.56420898438 786.148315429688 4 14 1.1.1.3724.14 1 49.3857 946.4255 49.4478 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.7199997901917 KVQPYLDDFQKKWQEEMELYRQK acrolein addition +112(K)@1 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12; missed R-Q@21 0.395909011363983 3140.9599609375 629.1993 3140.56420898438 629.1201171875 5 14 1.1.1.3731.12 1 49.5616 2759.27 49.4478 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.8699970245361 KVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR acrolein addition +112(K)@1 cleaved A-K@N-term; missed K-V@1; missed K-K@11; missed K-W@12; missed R-Q@21; missed K-V@23; missed R-A@28 0.495611011981964 4589.83349609375 765.9795 4589.337890625 765.896911621094 6 15 1.1.1.3816.10 1 51.6976 3200.574 51.7891 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KWQEEMELYR Dioxidation(W)@2; Oxidation(M)@6 missed K-W@1 0.159976005554199 1458.80493164063 730.4097 1458.64489746094 730.329711914063 2 17 1.1.1.2772.9 1 26.3871 5874.629 26.5121 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KWQEEMELYR Dioxidation(W)@2; Oxidation(M)@6 missed K-W@1 0.159976005554199 1458.80493164063 730.4097 1458.64489746094 730.329711914063 2 17 1.1.1.2779.7 1 26.5524 5874.629 26.5121 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KWQEEMELYR Oxidation(M)@6 missed K-W@1 0.163354992866516 1426.81848144531 714.4165 1426.65515136719 714.334838867188 2 16 1.1.1.2824.8 1 27.6278 3293.546 27.4422 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KWQEEMELYR Trp->Kynurenin(W)@2; Oxidation(M)@6 missed K-W@1 0.164045006036758 1430.81408691406 716.4143 1430.65002441406 716.332275390625 2 16 1.1.1.2783.6 1 26.6505 679.9881 26.6795 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KWQEEMELYR missed K-W@1 0.160099998116493 1410.8203125 706.4174 1410.66015625 706.337341308594 2 17 1.1.1.3106.3 1 34.4046 7547.862 34.6268 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KWQEEMELYR missed K-W@1 0.161320999264717 1410.82153320313 706.418 1410.66015625 706.337341308594 2 17 1.1.1.3125.8 1 34.8607 6317.583 34.796 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KWQEEMELYR missed K-W@1 0.161320999264717 1410.82153320313 706.418 1410.66015625 706.337341308594 2 17 1.1.1.3132.7 1 35.0313 6319.044 34.796 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KWQEEMELYR missed K-W@1 0.160221993923187 1410.82043457031 706.4175 1410.66015625 706.337341308594 2 17 1.1.1.3114.9 1 34.5941 7973.935 34.6268 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.7500011920929 KWQEEMELYR Dioxidation(W)@2 missed K-W@1 0.163191005587578 1442.81323242188 722.4139 1442.65002441406 722.332275390625 2 14 1.1.1.2998.10 1 31.8042 709.9968 31.8352 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5399980545044 KWQEEMELYR missed K-W@1 0.161442995071411 1410.82165527344 706.4181 1410.66015625 706.337341308594 2 14 1.1.1.3155.6 1 35.5825 684.7541 35.5876 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.4100022315979 KWQEEMELYR Oxidation(M)@6 missed K-W@1 0.216105997562408 1426.87121582031 476.631 1426.65515136719 476.558990478516 3 13 1.1.1.2824.6 1 27.6228 14367.32 27.4422 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 KWQEEMELYR Trp->Kynurenin(W)@2; Oxidation(M)@6 missed K-W@1 0.217194005846977 1430.8671875 477.963 1430.65002441406 477.890625 3 13 1.1.1.2783.2 1 26.6371 2101.542 26.6556 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2300000190735 KWQEEMELYR Dioxidation(W)@2; Oxidation(M)@6 missed K-W@1 0.215259999036789 1458.86022949219 487.294 1458.64489746094 487.222259521484 3 13 1.1.1.2772.5 1 26.3771 15532.79 26.4883 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2300000190735 KWQEEMELYR Oxidation(M)@6 missed K-W@1 0.216105997562408 1426.87121582031 476.631 1426.65515136719 476.558990478516 3 12 1.1.1.2810.4 1 27.2875 14367.32 27.4422 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.7300004959106 KWQEEMELYR Dioxidation(W)@2; Oxidation(M)@6 missed K-W@1 0.215534999966621 1458.86047363281 487.2941 1458.64489746094 487.222259521484 3 13 1.1.1.2786.5 1 26.7121 15811.09 26.4643 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.7599980831146 KWQEEMELYR Dioxidation(W)@2 missed K-W@1 0.218658998608589 1442.86865234375 481.9635 1442.65002441406 481.890625 3 12 1.1.1.2999.10 1 31.8218 2797.63 31.811 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.4099996089935 KWQEEMELYR missed K-W@1 0.218863993883133 1410.87902832031 471.3003 1410.66015625 471.227325439453 3 13 1.1.1.3110.4 1 34.4969 11948.42 34.6268 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.4099996089935 KWQEEMELYR missed K-W@1 0.219778999686241 1410.88000488281 471.3006 1410.66015625 471.227325439453 3 13 1.1.1.3155.4 1 35.5758 1522.87 35.6114 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 72.3999977111816 KWQEEMELYR missed K-W@1 0.219504997134209 1410.87963867188 471.3005 1410.66015625 471.227325439453 3 13 1.1.1.3132.6 1 35.028 10249.74 34.7718 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.6300020217896 KWQEEMELYR Dioxidation(W)@2; Oxidation(M)@6 missed K-W@1 0.215259999036789 1458.86022949219 487.294 1458.64489746094 487.222259521484 3 12 1.1.1.2779.4 1 26.5449 15532.79 26.4883 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 34.6799999475479 KWQEEMELYR missed K-W@1 0.218863993883133 1410.87902832031 471.3003 1410.66015625 471.227325439453 3 12 1.1.1.3111.4 1 34.5151 11948.42 34.6268 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 34.0200006961823 KWQEEMELYR missed K-W@1 0.218863993883133 1410.87902832031 471.3003 1410.66015625 471.227325439453 3 12 1.1.1.3108.5 1 34.4412 11774.27 34.6268 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 33.390000462532 KWQEEMELYR missed K-W@1 0.218863993883133 1410.87902832031 471.3003 1410.66015625 471.227325439453 3 12 1.1.1.3118.7 1 34.6916 11948.42 34.6268 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 32.8000009059906 KWQEEMELYR missed K-W@1 0.218863993883133 1410.87902832031 471.3003 1410.66015625 471.227325439453 3 12 1.1.1.3125.7 1 34.8582 12164.51 34.6026 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KWQEEMELYRQK Oxidation(M)@6 missed K-W@1; missed R-Q@10 0.220249995589256 1683.02893066406 562.0169 1682.80859375 561.943481445313 3 16 1.1.1.2707.5 1 24.8278 1229.773 24.8396 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 KWQEEMELYRQK missed K-W@1; missed R-Q@10 0.226028993725777 1667.03979492188 556.6872 1666.81372070313 556.611877441406 3 18 1.1.1.2948.5 1 30.5987 3152.947 30.6593 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.0499992370605 KWQEEMELYRQK missed K-W@1; missed R-Q@10 0.226028993725777 1667.03979492188 556.6872 1666.81372070313 556.611877441406 3 15 1.1.1.2955.3 1 30.7745 3152.947 30.6593 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 32.8000009059906 KWQEEMELYRQK missed K-W@1; missed R-Q@10 0.28192400932312 1667.095703125 417.7812 1666.81372070313 417.710693359375 4 12 1.1.1.2952.3 1 30.6908 3182.884 30.6593 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.6099987030029 LAARLEALK missed R-L@4 0.147706001996994 983.760498046875 492.8875 983.61279296875 492.813659667969 2 14 1.1.1.2829.5 1 27.7369 21196.86 27.8473 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.220375999808311 1568.09985351563 523.7072 1567.87939453125 523.633728027344 3 21 1.1.1.2743.3 1 25.6781 240952.4 25.8398 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.16057400405407 1568.0400390625 785.0273 1567.87939453125 784.947021484375 2 25 1.1.1.2743.9 1 25.6915 40867.29 25.8159 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.220375999808311 1568.09985351563 523.7072 1567.87939453125 523.633728027344 3 21 1.1.1.2750.4 1 25.847 240952.4 25.8398 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.16057400405407 1568.0400390625 785.0273 1567.87939453125 784.947021484375 2 27 1.1.1.2750.9 1 25.8587 40867.29 25.8159 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.220375999808311 1568.09985351563 523.7072 1567.87939453125 523.633728027344 3 23 1.1.1.2757.6 1 26.0184 240952.4 25.8398 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.16057400405407 1568.0400390625 785.0273 1567.87939453125 784.947021484375 2 27 1.1.1.2757.9 1 26.0243 40867.29 25.8159 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.220559000968933 1568.09997558594 523.7073 1567.87939453125 523.633728027344 3 22 1.1.1.2764.4 1 26.188 241727.5 26.1758 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.160818994045258 1568.04028320313 785.0274 1567.87939453125 784.947021484375 2 27 1.1.1.2764.6 1 26.1947 33880.82 26.1758 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.220559000968933 1568.09997558594 523.7073 1567.87939453125 523.633728027344 3 22 1.1.1.2771.4 1 26.363 241727.5 26.1758 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Deamidated(N)@11 missed R-L@4; missed K-E@9 0.220917999744415 1569.08435058594 524.0354 1568.86340332031 523.961730957031 3 19 1.1.1.2790.3 1 26.8091 172469.2 27.0369 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Deamidated(N)@11 missed R-L@4; missed K-E@9 0.16117799282074 1569.02465820313 785.5196 1568.86340332031 785.439025878906 2 25 1.1.1.2790.5 1 26.8174 22779.65 27.0369 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Deamidated(N)@11 missed R-L@4; missed K-E@9 0.220917999744415 1569.08435058594 524.0354 1568.86340332031 523.961730957031 3 20 1.1.1.2797.5 1 26.9768 192374.7 27.1084 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Deamidated(N)@11 missed R-L@4; missed K-E@9 0.161788001656532 1569.02526855469 785.5199 1568.86340332031 785.439025878906 2 26 1.1.1.2797.8 1 26.9843 27617.01 27.1322 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Deamidated(N)@11 missed R-L@4; missed K-E@9 0.220917999744415 1569.08435058594 524.0354 1568.86340332031 523.961730957031 3 17 1.1.1.2804.5 1 27.1393 192374.7 27.1084 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Deamidated(N)@11 missed R-L@4; missed K-E@9 0.220917999744415 1569.08435058594 524.0354 1568.86340332031 523.961730957031 3 20 1.1.1.2804.6 1 27.141 192374.7 27.1084 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Deamidated(N)@11 missed R-L@4; missed K-E@9 0.161788001656532 1569.02526855469 785.5199 1568.86340332031 785.439025878906 2 26 1.1.1.2804.11 1 27.1493 27617.01 27.1322 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Deamidated(N)@11 missed R-L@4; missed K-E@9 0.220917999744415 1569.08435058594 524.0354 1568.86340332031 523.961730957031 3 19 1.1.1.2811.5 1 27.3079 192374.7 27.1084 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Deamidated(N)@11 missed R-L@4; missed K-E@9 0.161788001656532 1569.02526855469 785.5199 1568.86340332031 785.439025878906 2 24 1.1.1.2811.10 1 27.3163 27617.01 27.1322 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Ammonia-loss(N)@11 missed R-L@4; missed K-E@9 0.218299001455307 1551.07116699219 518.031 1550.85290527344 517.958251953125 3 21 1.1.1.2815.4 1 27.4091 7921.933 27.3707 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Deamidated(N)@11 missed R-L@4; missed K-E@9 0.218171998858452 1569.08166503906 524.0345 1568.86340332031 523.961730957031 3 18 1.1.1.2816.4 1 27.4329 80829.41 27.3707 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Deamidated(N)@11 missed R-L@4; missed K-E@9 0.218171998858452 1569.08166503906 524.0345 1568.86340332031 523.961730957031 3 20 1.1.1.2818.6 1 27.4765 80829.41 27.3707 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Deamidated(N)@11 missed R-L@4; missed K-E@9 0.161421999335289 1569.02490234375 785.5197 1568.86340332031 785.439025878906 2 22 1.1.1.2818.10 1 27.4832 15879.12 27.2277 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Deamidated(N)@11 missed R-L@4; missed K-E@9 0.218538001179695 1569.08203125 524.0346 1568.86340332031 523.961730957031 3 21 1.1.1.2825.4 1 27.6416 76739.48 27.3945 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Deamidated(N)@11 missed R-L@4; missed K-E@9 0.21798799932003 1569.08142089844 524.0344 1568.86340332031 523.961730957031 3 17 1.1.1.2827.6 1 27.6959 47741.42 27.4422 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Delta:H(2)C(2)@N-term missed R-L@4; missed K-E@9 0.224562004208565 1594.11962890625 532.3805 1593.89514160156 532.3056640625 3 18 1.1.1.3038.10 1 32.7717 2243.886 32.8971 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Delta:H(2)C(2)@N-term missed R-L@4; missed K-E@9 0.224562004208565 1594.11962890625 532.3805 1593.89514160156 532.3056640625 3 19 1.1.1.3045.7 1 32.9351 2243.886 32.8971 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Delta:H(2)C(2)@N-term missed R-L@4; missed K-E@9 0.225843995809555 1594.12097167969 532.3809 1593.89514160156 532.3056640625 3 20 1.1.1.3052.7 1 33.1058 2228.385 32.9692 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Formyl(K)@9 missed R-L@4; missed K-E@9 0.230160996317863 1596.1044921875 533.0421 1595.87438964844 532.965393066406 3 21 1.1.1.3058.8 1 33.2522 1324.344 33.0894 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Delta:H(2)C(2)@N-term; Deamidated(N)@11 missed R-L@4; missed K-E@9 0.226019993424416 1595.10510253906 532.709 1594.87915039063 532.633666992188 3 20 1.1.1.3093.5 1 34.0814 3925.321 34.2166 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Trimethyl(K)@9 missed R-L@4; missed K-E@9 0.18605999648571 1610.11242675781 537.7114 1609.92639160156 537.6494140625 3 23 1.1.1.3096.6 1 34.1584 10084.29 34.1925 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Delta:H(2)C(2)@N-term; Deamidated(N)@11 missed R-L@4; missed K-E@9 0.226019993424416 1595.10510253906 532.709 1594.87915039063 532.633666992188 3 19 1.1.1.3100.10 1 34.2507 3925.321 34.2166 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Trimethyl(K)@9 missed R-L@4; missed K-E@9 0.124610997736454 1610.05102539063 806.0328 1609.92639160156 805.970458984375 2 18 1.1.1.3100.16 1 34.2599 1560.545 34.2166 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Delta:H(2)C(2)@N-term missed R-L@4; missed K-E@9 0.224562004208565 1594.11962890625 532.3805 1593.89514160156 532.3056640625 3 23 1.1.1.3118.8 1 34.6941 4356.057 34.6992 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Delta:H(2)C(2)@N-term; Deamidated(N)@11 missed R-L@4; missed K-E@9 0.227851003408432 1595.10693359375 532.7096 1594.87915039063 532.633666992188 3 21 1.1.1.3136.8 1 35.1248 2907.252 35.1566 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR reduced acrolein addition +58(K)@9 missed R-L@4; missed K-E@9 0.1978590041399 1626.119140625 543.047 1625.92126464844 542.981018066406 3 21 1.1.1.3258.5 1 38.0397 2487.673 38.1026 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Carboxyethyl(K)@9 missed R-L@4; missed K-E@9 0.165324002504349 1640.06591796875 821.0402 1639.90051269531 820.957580566406 2 20 1.1.1.3383.13 1 41.0467 6282.69 41.0341 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Carboxyethyl(K)@9 missed R-L@4; missed K-E@9 0.229459002614021 1640.13000488281 547.7173 1639.90051269531 547.640808105469 3 22 1.1.1.3384.5 1 41.0677 7668.394 41.0584 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Carboxyethyl(K)@9 missed R-L@4; missed K-E@9 0.229459002614021 1640.13000488281 547.7173 1639.90051269531 547.640808105469 3 19 1.1.1.3391.3 1 41.2362 7668.394 41.0584 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR reduced acrolein addition +58(K)@9; Dimethyl(N)@11 missed R-L@4; missed K-E@9 0.12805899977684 1654.08068847656 828.0476 1653.95263671875 827.983581542969 2 21 1.1.1.3517.7 1 44.3476 11469.7 44.4516 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Deamidated(N)@11 missed R-L@4; missed K-E@9 0.220917999744415 1569.08435058594 524.0354 1568.86340332031 523.961730957031 3 17 1.1.1.2796.3 1 26.9603 192374.7 27.1084 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Ammonia-loss(N)@11 missed R-L@4; missed K-E@9 0.222510993480682 1551.07543945313 518.0324 1550.85290527344 517.958251953125 3 19 1.1.1.2808.5 1 27.239 7965.032 27.2754 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Lys->Allysine(K)@9 missed R-L@4; missed K-E@9 0.225337997078896 1567.07312011719 523.365 1566.84777832031 523.289855957031 3 19 1.1.1.3097.4 1 34.1783 1821.381 34.2166 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Carboxyethyl(K)@9 missed R-L@4; missed K-E@9 0.229459002614021 1640.13000488281 547.7173 1639.90051269531 547.640808105469 3 18 1.1.1.3377.4 1 40.9076 7668.394 41.0584 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR missed R-L@4; missed K-E@9 -0.783224999904633 1567.09619140625 523.3727 1567.87939453125 523.633728027344 3 13 1.1.1.3007.10 1 32.0148 277.2177 31.932 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR MDA adduct +62(K)@9; Cation:Na(E)@10 missed R-L@4; missed K-E@9 0.213075995445251 1652.09008789063 551.704 1651.87707519531 551.632934570313 3 17 1.1.1.3233.4 1 37.4413 1606.891 37.5035 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR reduced acrolein addition +58(K)@9 missed R-L@4; missed K-E@9 0.131161004304886 1626.05249023438 814.0335 1625.92126464844 813.967956542969 2 19 1.1.1.3258.9 1 38.0497 1204.588 38.0786 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR reduced acrolein addition +58(K)@9; Dimethyl(N)@11 missed R-L@4; missed K-E@9 0.194147005677223 1654.14672851563 552.3895 1653.95263671875 552.324829101563 3 20 1.1.1.3517.2 1 44.3351 26578.15 44.4275 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR reduced acrolein addition +58(K)@9 missed R-L@4; missed K-E@9 0.131161004304886 1626.05249023438 814.0335 1625.92126464844 813.967956542969 2 18 1.1.1.3265.6 1 38.2136 1204.588 38.0786 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR reduced acrolein addition +58(K)@9; Dimethyl(N)@11 missed R-L@4; missed K-E@9 0.12805899977684 1654.08068847656 828.0476 1653.95263671875 827.983581542969 2 20 1.1.1.3524.6 1 44.5105 11469.7 44.4516 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR reduced acrolein addition +58(K)@9; Dimethyl(N)@11 missed R-L@4; missed K-E@9 0.194147005677223 1654.14672851563 552.3895 1653.95263671875 552.324829101563 3 19 1.1.1.3524.2 1 44.5039 26578.15 44.4275 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.225502997636795 1568.10498046875 523.7089 1567.87939453125 523.633728027344 3 17 1.1.1.2778.5 1 26.5243 1166.119 26.5838 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.221474006772041 1568.10095214844 523.7076 1567.87939453125 523.633728027344 3 17 1.1.1.2786.7 1 26.7155 1666.863 26.7749 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR missed R-L@4; missed K-E@9 -0.800620019435883 1567.07885742188 523.3669 1567.87939453125 523.633728027344 3 16 1.1.1.3088.7 1 33.969 432.4267 33.9766 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Palmitoyl(K)@9 missed R-L@4; missed K-E@9 0.246080994606018 1806.35522460938 603.1257 1806.10913085938 603.043640136719 3 21 1.1.1.4805.4 1 76.4702 534.7136 76.4853 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR MDA adduct +54(K)@9 missed R-L@4; missed K-E@9 0.10928600281477 1621.99926757813 541.6737 1621.89001464844 541.637268066406 3 16 1.1.1.2799.5 1 27.0285 855.9282 26.9893 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAARLEALKENGGAR Delta:H(2)C(2)@N-term; Deamidated(N)@11 missed R-L@4; missed K-E@9 0.219978004693985 1595.09912109375 532.707 1594.87915039063 532.633666992188 3 16 1.1.1.3086.9 1 33.9202 3502.311 34.1445 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8900005817413 LAARLEALKENGGAR Carbamidomethyl(K)@9 missed R-L@4; missed K-E@9 0.223813995718956 1625.12475585938 542.7155 1624.90087890625 542.640930175781 3 15 1.1.1.2743.5 1 25.6815 1520.667 25.7681 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.4799990653992 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.220559000968933 1568.09997558594 523.7073 1567.87939453125 523.633728027344 3 15 1.1.1.2768.6 1 26.279 241727.5 26.1758 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8100011348724 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.220559000968933 1568.09997558594 523.7073 1567.87939453125 523.633728027344 3 15 1.1.1.2894.7 1 29.2982 429.0133 29.2859 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2700009346008 LAARLEALKENGGAR Deamidated(R)@4 missed R-L@4; missed K-E@9 0.236298993229866 1569.09973144531 524.0405 1568.86340332031 523.961730957031 3 14 1.1.1.2748.9 1 25.8042 82482.62 25.8398 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2700009346008 LAARLEALKENGGAR Deamidated(R)@4 missed R-L@4; missed K-E@9 0.236298993229866 1569.09973144531 524.0405 1568.86340332031 523.961730957031 3 14 1.1.1.2755.8 1 25.9737 82482.62 25.8398 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.990002155304 LAARLEALKENGGAR missed R-L@4; missed K-E@9 -0.823325991630554 1567.05615234375 523.3593 1567.87939453125 523.633728027344 3 14 1.1.1.3069.3 1 33.51 0 -1 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.4200029373169 LAARLEALKENGGAR Cation:Na(E)@6 missed R-L@4; missed K-E@9 0.233792006969452 1590.09521484375 531.039 1589.861328125 530.961059570313 3 15 1.1.1.3466.6 1 43.0841 531.1317 43.0428 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.0900018215179 LAARLEALKENGGAR Acetyl@N-term; Arg->GluSA(R)@4 missed R-L@4; missed K-E@9 0.237120002508163 1567.07373046875 523.3652 1566.83654785156 523.2861328125 3 17 1.1.1.3521.2 1 44.4332 4772.098 44.5239 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.4100022315979 LAARLEALKENGGAR Deamidated(N)@11 missed R-L@4; missed K-E@9 0.235383003950119 1569.09887695313 524.0402 1568.86340332031 523.961730957031 3 13 1.1.1.2763.7 1 26.1657 84943.71 26.1758 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.4100022315979 LAARLEALKENGGAR acrolein addition +38(K)@9; Deamidated(N)@11 missed R-L@4; missed K-E@9 0.204950004816055 1607.08410644531 402.7783 1606.87915039063 402.72705078125 4 13 1.1.1.2795.2 1 26.9365 914.0305 27.1084 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9199993610382 LAARLEALKENGGAR Cation:Na(E)@6; Deamidated(N)@11 missed R-L@4; missed K-E@9 0.229207992553711 1591.07458496094 531.3655 1590.84545898438 531.2890625 3 14 1.1.1.2805.10 1 27.1715 1432.114 27.1799 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.5100028514862 LAARLEALKENGGAR missed R-L@4; missed K-E@9 -0.783774971961975 1567.095703125 523.3725 1567.87939453125 523.633728027344 3 14 1.1.1.3000.6 1 31.846 315.3388 31.7868 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.4600005149841 LAARLEALKENGGAR Acetyl@N-term; Arg->GluSA(R)@4 missed R-L@4; missed K-E@9 0.237120002508163 1567.07373046875 523.3652 1566.83654785156 523.2861328125 3 16 1.1.1.3528.4 1 44.6037 4772.098 44.5239 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.3099994659424 LAARLEALKENGGAR MDA adduct +54(K)@9 missed R-L@4; missed K-E@9 0.159261003136635 1622.04931640625 406.5196 1621.89001464844 406.479766845703 4 14 1.1.1.2800.2 1 27.0431 4420.059 27.1322 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.3099994659424 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.220925003290176 1568.10034179688 523.7074 1567.87939453125 523.633728027344 3 14 1.1.1.2872.7 1 28.7688 565.2719 28.7324 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 LAARLEALKENGGAR Deamidated(R)@4; Deamidated(N)@11 missed R-L@4; missed K-E@9 0.233546003699303 1570.0810546875 524.3676 1569.84741210938 524.289794921875 3 14 1.1.1.2793.5 1 26.8814 65826.5 27.1084 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 LAARLEALKENGGAR missed R-L@4; missed K-E@9 -0.868368983268738 1567.01110839844 523.3443 1567.87939453125 523.633728027344 3 13 1.1.1.2848.5 1 28.1935 538.6469 28.2292 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2300000190735 LAARLEALKENGGAR missed R-L@4; missed K-E@9 2.11662006378174 1569.99609375 524.3393 1567.87939453125 523.633728027344 3 13 1.1.1.2978.5 1 31.3181 667.1183 31.3546 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.7199997901917 LAARLEALKENGGAR Carboxyethyl(K)@9; Deamidated(N)@11 missed R-L@4; missed K-E@9 0.234944999217987 1641.11950683594 548.0471 1640.88464355469 547.968811035156 3 15 1.1.1.3442.9 1 42.4864 1090.31 42.5015 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.5299990177155 LAARLEALKENGGAR Cation:Na(E)@10; Deamidated(N)@11 missed R-L@4; missed K-E@9 0.224996000528336 1591.07043457031 531.3641 1590.84545898438 531.2890625 3 13 1.1.1.2791.7 1 26.8346 1099.181 27.0131 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.5299990177155 LAARLEALKENGGAR Deamidated(N)@11 missed R-L@4; missed K-E@9 0.220917999744415 1569.08435058594 524.0354 1568.86340332031 523.961730957031 3 12 1.1.1.2812.7 1 27.3368 193798.1 27.1084 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.5900008678436 LAARLEALKENGGAR Deamidated(R)@4; Deamidated(N)@11 missed R-L@4; missed K-E@9 0.236292004585266 1570.08374023438 524.3685 1569.84741210938 524.289794921875 3 13 1.1.1.2804.7 1 27.1427 67499.3 27.1084 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.1999986171722 LAARLEALKENGGAR Hypusine(K)@9 missed R-L@4; missed K-E@9 0.1180389970541 1655.06591796875 828.5402 1654.94787597656 828.481201171875 2 12 1.1.1.3531.15 1 44.6838 624.4429 44.767 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.7599980831146 LAARLEALKENGGAR Cation:Na(E)@10; Deamidated(N)@11 missed R-L@4; missed K-E@9 0.229207992553711 1591.07458496094 531.3655 1590.84545898438 531.2890625 3 13 1.1.1.2798.5 1 27.0047 1354.242 27.0846 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.4099996089935 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.225502997636795 1568.10498046875 523.7089 1567.87939453125 523.633728027344 3 13 1.1.1.2781.6 1 26.5909 1166.119 26.5838 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 73.9700019359589 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.220375999808311 1568.09985351563 523.7072 1567.87939453125 523.633728027344 3 13 1.1.1.2750.5 1 25.8487 240952.4 25.8398 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 72.3999977111816 LAARLEALKENGGAR reduced acrolein addition +58(K)@9 missed R-L@4; missed K-E@9 0.239166006445885 1626.16052246094 407.5474 1625.92126464844 407.487609863281 4 13 1.1.1.2808.3 1 27.2339 1677.316 27.2277 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 72.3999977111816 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.226967006921768 1568.1064453125 523.7094 1567.87939453125 523.633728027344 3 13 1.1.1.2887.5 1 29.1265 527.6134 29.1656 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 71.7599987983704 LAARLEALKENGGAR missed R-L@4; missed K-E@9 -0.868368983268738 1567.01110839844 523.3443 1567.87939453125 523.633728027344 3 12 1.1.1.2855.7 1 28.3625 538.6469 28.2292 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.8000004291534 LAARLEALKENGGAR reduced acrolein addition +58(K)@9 missed R-L@4; missed K-E@9 0.185956999659538 1626.10729980469 543.043 1625.92126464844 542.981018066406 3 13 1.1.1.2793.6 1 26.8839 659.8926 26.8463 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.2400004863739 LAARLEALKENGGAR Dehydrated(E)@10 missed R-L@4; missed K-E@9 0.167233005166054 1550.0361328125 776.0253 1549.86889648438 775.941711425781 2 10 1.1.1.3012.18 1 32.144 624.2252 32.2231 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.2400004863739 LAARLEALKENGGAR Methyl(L)@8; reduced acrolein addition +58(K)@9 missed R-L@4; missed K-E@9 0.128938004374504 1640.06591796875 821.0402 1639.93701171875 820.975769042969 2 11 1.1.1.3390.19 1 41.2233 6282.69 41.0341 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 50.8499979972839 LAARLEALKENGGAR Dehydrated(E)@10 missed R-L@4; missed K-E@9 0.22434900701046 1550.09326171875 517.705 1549.86889648438 517.630249023438 3 12 1.1.1.3012.9 1 32.1356 1870.281 32.1991 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 44.6099996566772 LAARLEALKENGGAR missed R-L@4; missed K-E@9 2.63498997688293 1570.51440429688 524.5121 1567.87939453125 523.633728027344 3 9 1.1.1.3729.2 1 49.5025 912.1345 49.4731 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 43.5799986124039 LAARLEALKENGGAR hexanoyl addition +98(K)@9 missed R-L@4; missed K-E@9 0.0576243996620178 1666.01025390625 834.0124 1665.95263671875 833.983581542969 2 11 1.1.1.2747.8 1 25.7844 1235.583 25.8398 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 32.8000009059906 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.234475001692772 1568.11389160156 523.7119 1567.87939453125 523.633728027344 3 12 1.1.1.2985.8 1 31.4881 501.8238 31.5221 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 31.1699986457825 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.226601004600525 1568.10607910156 523.7093 1567.87939453125 523.633728027344 3 12 1.1.1.2914.5 1 29.7836 426.5761 29.7437 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 30.6800007820129 LAARLEALKENGGAR missed R-L@4; missed K-E@9 0.216346994042397 1568.09582519531 523.7059 1567.87939453125 523.633728027344 3 12 1.1.1.2863.6 1 28.5542 648.3906 28.5403 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.0599975585938 LAEYHAK Delta:H(2)C(2)@N-term 0.13934999704361 856.583679199219 429.2991 856.444274902344 429.229431152344 2 11 1.1.1.2642.7 1 23.2681 2228.769 23.3292 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 24.6399998664856 LAEYHAK 0.144380003213882 830.573059082031 416.2938 830.428649902344 416.221588134766 2 9 1.1.1.2638.4 1 23.1708 511.7495 23.138 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK missed K-A@7 0.228577002882957 2027.26098632813 676.7609 2027.03234863281 676.684753417969 3 31 1.1.1.2711.11 1 24.9285 28359.98 24.9831 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK Carbamidomethyl(K)@7 missed K-A@7 0.228354007005692 2084.2822265625 695.768 2084.05395507813 695.69189453125 3 30 1.1.1.2711.12 1 24.9302 3088.404 24.9592 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK Carbamidomethyl(K)@7 missed K-A@7 0.163058996200562 2084.21728515625 1043.116 2084.05395507813 1043.0341796875 2 26 1.1.1.2712.10 1 24.9541 569.4807 24.9592 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK missed K-A@7 0.228577002882957 2027.26098632813 676.7609 2027.03234863281 676.684753417969 3 31 1.1.1.2718.12 1 25.0975 28359.98 24.9831 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK Amino(Y)@4; Delta:H(2)C(2)(H)@5 missed K-A@7 0.22699099779129 2068.28588867188 690.4359 2068.05883789063 690.360229492188 3 23 1.1.1.2722.8 1 25.1903 7366.772 25.2454 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK Delta:H(2)C(2)@N-term missed K-A@7 0.295188993215561 2053.34326171875 514.3431 2053.04809570313 514.269287109375 4 21 1.1.1.2920.9 1 29.9218 2681.245 29.9127 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK Delta:H(2)C(2)@N-term missed K-A@7 0.233678996562958 2053.28173828125 685.4345 2053.04809570313 685.356628417969 3 26 1.1.1.2920.15 1 29.9285 781.0082 29.9127 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK Formyl(K)@7 missed K-A@7 0.237995997071266 2055.26538085938 686.0957 2055.02734375 686.016357421875 3 29 1.1.1.2933.4 1 30.2459 3358.756 30.2751 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK Trimethyl(K)@7 missed K-A@7 0.256321012973785 2069.33569335938 518.3412 2069.07934570313 518.277099609375 4 20 1.1.1.2946.9 1 30.5514 9442.377 30.5872 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK Carboxyethyl(K)@7 missed K-A@7 0.234730005264282 2099.28833007813 700.77 2099.05346679688 700.691772460938 3 28 1.1.1.3156.5 1 35.603 2077.828 35.5399 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK Delta:H(4)C(2)(H)@5; reduced acrolein addition +58(K)@7 missed K-A@7 0.200699999928474 2113.30615234375 705.4427 2113.10546875 705.375793457031 3 25 1.1.1.3252.6 1 37.9028 3899.559 38.0069 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK Delta:H(4)C(2)(H)@5; reduced acrolein addition +58(K)@7 missed K-A@7 0.200699999928474 2113.30615234375 705.4427 2113.10546875 705.375793457031 3 25 1.1.1.3259.8 1 38.0735 3899.559 38.0069 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK MDA adduct +54(K)@7; Methyl(T)@9; Dehydrated(E)@10 missed K-A@7 0.239354997873306 2077.28735351563 693.4364 2077.04809570313 693.356628417969 3 24 1.1.1.3278.6 1 38.5246 1109.931 38.533 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK Delta:H(4)C(2)(K)@7 missed K-A@7 0.256101995706558 2055.31982421875 514.8372 2055.06372070313 514.773193359375 4 18 1.1.1.2934.6 1 30.265 11395.32 30.2992 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK Methyl(H)@5; reduced acrolein addition +58(K)@7 missed K-A@7 0.26138100028038 2099.35131835938 525.8451 2099.08984375 525.779724121094 4 18 1.1.1.3149.4 1 35.4391 7161.58 35.5399 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK Methyl(H)@5; reduced acrolein addition +58(K)@7 missed K-A@7 0.262602001428604 2099.3525390625 525.8454 2099.08984375 525.779724121094 4 17 1.1.1.3142.6 1 35.2638 5816.055 35.4921 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK Trimethyl(K)@7 missed K-A@7 0.256321012973785 2069.33569335938 518.3412 2069.07934570313 518.277099609375 4 17 1.1.1.2953.8 1 30.7199 9442.377 30.5872 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK Delta:H(4)C(2)(H)@5; reduced acrolein addition +58(K)@7 missed K-A@7 0.264530003070831 2113.3701171875 529.3498 2113.10546875 529.283630371094 4 17 1.1.1.3259.4 1 38.0635 7352.215 38.0069 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK Palmitoyl(K)@7 missed K-A@7 0.248056992888451 2265.51000976563 756.1773 2265.26196289063 756.094604492188 3 26 1.1.1.4603.10 1 71.2986 948.4855 71.3129 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK Methyl(H)@5; reduced acrolein addition +58(K)@7 missed K-A@7 0.26138100028038 2099.35131835938 525.8451 2099.08984375 525.779724121094 4 17 1.1.1.3156.4 1 35.5997 7161.58 35.5399 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEK missed K-A@7 0.288500010967255 2027.32092285156 507.8375 2027.03234863281 507.765380859375 4 17 1.1.1.2711.6 1 24.9202 129260.3 24.9831 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8900005817413 LAEYHAKATEHLSTLSEK Delta:H(4)C(2)(H)@5; acrolein addition +38(K)@7 missed K-A@7 0.258273988962173 2093.33764648438 524.3417 2093.07934570313 524.277099609375 4 16 1.1.1.3007.11 1 32.0156 3127.429 32.0533 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8999981880188 LAEYHAKATEHLSTLSEK Palmitoyl(K)@7 missed K-A@7 0.306515008211136 2265.56860351563 567.3994 2265.26196289063 567.322814941406 4 18 1.1.1.4602.7 1 71.2687 2346.64 71.3389 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.7899978160858 LAEYHAKATEHLSTLSEK Carbamidomethyl(K)@7 missed K-A@7 0.289130985736847 2084.34301757813 522.093 2084.05395507813 522.020751953125 4 15 1.1.1.2717.5 1 25.0661 15216.07 24.9592 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.7899978160858 LAEYHAKATEHLSTLSEK reduced acrolein addition +58(K)@7; Delta:H(4)C(2)(H)@11 missed K-A@7 0.264530003070831 2113.3701171875 529.3498 2113.10546875 529.283630371094 4 15 1.1.1.3252.5 1 37.8994 7352.215 38.0069 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9300010204315 LAEYHAKATEHLSTLSEK Palmitoyl(K)@7 missed K-A@7 0.306515008211136 2265.56860351563 567.3994 2265.26196289063 567.322814941406 4 17 1.1.1.4600.6 1 71.2184 2346.64 71.3389 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9000020027161 LAEYHAKATEHLSTLSEK hexanoyl addition +98(K)@7 missed K-A@7 0.130753993988037 2125.236328125 709.4194 2125.10546875 709.375793457031 3 14 1.1.1.2714.14 1 25.002 524.4468 24.9592 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.1700010299683 LAEYHAKATEHLSTLSEK reduced HNE(H)@5; Trimethyl(A)@6; MDA adduct +62(K)@7 missed K-A@7 0.286823004484177 2289.51245117188 764.1781 2289.2255859375 764.08251953125 3 17 1.1.1.4501.6 1 68.6859 432.7722 68.6724 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.0000026226044 LAEYHAKATEHLSTLSEK missed K-A@7 0.288500010967255 2027.32092285156 507.8375 2027.03234863281 507.765380859375 4 14 1.1.1.2719.8 1 25.1147 129260.3 24.9831 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.5100016593933 LAEYHAKATEHLSTLSEK Dehydrated(Y)@4; reduced HNE(H)@5; hexanoyl addition +98(K)@7 missed K-A@7 0.284442007541656 2265.51000976563 756.1773 2265.2255859375 756.08251953125 3 15 1.1.1.4596.3 1 71.1099 941.4597 71.3129 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.6099972724915 LAEYHAKATEHLSTLSEK reduced HNE(H)@5; Trimethyl(A)@6; MDA adduct +62(K)@7 missed K-A@7 0.291399985551834 2289.51708984375 764.1796 2289.2255859375 764.08251953125 3 16 1.1.1.4494.3 1 68.4946 478.9045 68.5662 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.0900022983551 LAEYHAKATEHLSTLSEK Delta:H(2)C(2)@N-term missed K-A@7 0.300559997558594 2053.3486328125 514.3444 2053.04809570313 514.269287109375 4 13 1.1.1.2957.8 1 30.8175 859.3236 30.8036 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.4099977016449 LAEYHAKATEHLSTLSEK Palmitoyl(K)@7 missed K-A@7 0.306515008211136 2265.56860351563 567.3994 2265.26196289063 567.322814941406 4 15 1.1.1.4601.5 1 71.2411 2346.64 71.3389 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.4099977016449 LAEYHAKATEHLSTLSEK Palmitoyl(K)@7 missed K-A@7 0.306515008211136 2265.56860351563 567.3994 2265.26196289063 567.322814941406 4 15 1.1.1.4603.7 1 71.2961 2346.64 71.3389 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.4599986076355 LAEYHAKATEHLSTLSEK Hex(Y)@4 missed K-A@7 0.290975004434586 2189.37622070313 548.3513 2189.08520507813 548.278564453125 4 13 1.1.1.2712.7 1 24.9474 6019.258 24.9592 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.410001039505 LAEYHAKATEHLSTLSEK Carbamidomethyl(K)@7 missed K-A@7 0.339715987443924 2084.3935546875 417.886 2084.05395507813 417.818054199219 5 12 1.1.1.2713.3 1 24.963 8556.594 24.9592 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 55.6999981403351 LAEYHAKATEHLSTLSEK Palmitoyl(K)@7 missed K-A@7 0.306515008211136 2265.56860351563 567.3994 2265.26196289063 567.322814941406 4 14 1.1.1.4610.5 1 71.4796 2346.64 71.3389 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 51.9599974155426 LAEYHAKATEHLSTLSEK Dehydrated(Y)@4; reduced HNE(H)@5; hexanoyl addition +98(K)@7 missed K-A@7 0.284442007541656 2265.51000976563 756.1773 2265.2255859375 756.08251953125 3 13 1.1.1.4611.5 1 71.5076 948.4855 71.3129 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 20.4999998211861 LAEYHAKATEHLSTLSEK reduced HNE(H)@5; acrolein addition +76(K)@7; Delta:H(4)C(2)(H)@11 missed K-A@7 0.352910995483398 2289.57861328125 573.4019 2289.2255859375 573.313659667969 4 12 1.1.1.4494.2 1 68.4921 930.3463 68.593 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38 0.564990997314453 5600.546875 801.0854 5599.98193359375 801.004699707031 7 23 1.1.1.4498.4 1 68.6029 912.4226 68.593 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38 0.502503991127014 5600.484375 934.4213 5599.98193359375 934.337585449219 6 20 1.1.1.4501.8 1 68.6892 733.6434 68.5662 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38 0.566272974014282 5600.5478515625 801.0856 5599.98193359375 801.004699707031 7 20 1.1.1.4505.6 1 68.7891 1259.825 68.8067 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38 0.499940991401672 5600.48193359375 934.4209 5599.98193359375 934.337585449219 6 24 1.1.1.4508.4 1 68.8673 964.6623 68.8067 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Deamidated(Q)@28 missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38 -0.481510996818542 5600.484375 934.4213 5600.9658203125 934.501586914063 6 19 1.1.1.4492.4 1 68.442 733.6434 68.5662 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 33.2899987697601 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Carbamidomethyl@N-term; acrolein addition +94(K)@7; Delta:H(2)C(2)(H)@11 missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38 0.433046996593475 5777.49365234375 963.9229 5777.060546875 963.850708007813 6 13 1.1.1.4651.17 1 72.5745 193.5116 72.5829 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38; missed K-K@50; missed K-L@51 0.542383015155792 6184.8525390625 884.5576 6184.31005859375 884.480163574219 7 31 1.1.1.4564.3 1 70.296 4417.138 70.358 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38; missed K-K@50; missed K-L@51 0.471534997224808 6184.7802734375 1031.804 6184.31005859375 1031.7255859375 6 31 1.1.1.4566.9 1 70.3529 1536.905 70.358 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38; missed K-K@50; missed K-L@51 0.542383015155792 6184.8525390625 884.5576 6184.31005859375 884.480163574219 7 34 1.1.1.4571.13 1 70.4735 6011.648 70.4581 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38; missed K-K@50; missed K-L@51 0.475928992033005 6184.78662109375 1031.805 6184.31005859375 1031.7255859375 6 26 1.1.1.4573.17 1 70.5265 2248.025 70.4581 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38; missed K-K@50; missed K-L@51 0.552636981010437 6184.86279296875 884.5591 6184.31005859375 884.480163574219 7 35 1.1.1.4579.12 1 70.6746 6179.636 70.6872 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38; missed K-K@50; missed K-L@51 0.486182987689972 6184.79833984375 1031.807 6184.31005859375 1031.7255859375 6 30 1.1.1.4580.12 1 70.706 2310.262 70.7127 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38; missed K-K@50; missed K-L@51 0.552636981010437 6184.86279296875 884.5591 6184.31005859375 884.480163574219 7 23 1.1.1.4586.11 1 70.8536 6179.636 70.6872 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38; missed K-K@50; missed K-L@51 0.486182987689972 6184.79833984375 1031.807 6184.31005859375 1031.7255859375 6 30 1.1.1.4587.7 1 70.8878 2310.262 70.7127 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38; missed K-K@50; missed K-L@51 0.55349200963974 6184.86328125 884.5592 6184.31005859375 884.480163574219 7 29 1.1.1.4593.14 1 71.0411 4993.431 70.7899 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38; missed K-K@50; missed K-L@51 0.486182987689972 6184.79833984375 1031.807 6184.31005859375 1031.7255859375 6 29 1.1.1.4594.17 1 71.0707 1032.521 70.9974 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38; missed K-K@50; missed K-L@51 0.55349200963974 6184.86328125 884.5592 6184.31005859375 884.480163574219 7 25 1.1.1.4601.10 1 71.2478 2582.102 70.9707 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38; missed K-K@50; missed K-L@51 0.48691600561142 6184.79833984375 1031.807 6184.31005859375 1031.7255859375 6 16 1.1.1.4601.13 1 71.2528 529.4467 71.2334 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Trimethyl(K)@20 missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38; missed K-K@50; missed K-L@51 -0.473560988903046 6225.88330078125 890.4192 6226.35693359375 890.48681640625 7 20 1.1.1.4610.9 1 71.4863 838.5371 71.4702 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.6099996566772 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +56(K)@7; HPNE addition +172(K)@18; MDA adduct +54(K)@20 missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38; missed K-K@50; missed K-L@51 -0.453767001628876 6466.0029296875 924.722 6466.45654296875 924.786804199219 7 16 1.1.1.4569.9 1 70.4252 616.5044 70.4581 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.0100002288818 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Trimethyl(K)@20 missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38; missed K-K@50; missed K-L@51 -0.46458899974823 6225.892578125 890.4205 6226.35693359375 890.48681640625 7 16 1.1.1.4624.7 1 71.8549 592.3462 71.7869 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.6099991798401 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ MDA adduct +54(K)@7; reduced HNE(H)@11; hexanoyl addition +98(K)@20; acrolein addition +76(K)@38 missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38; missed K-K@50; missed K-L@51 0.471172988414764 6571.02685546875 939.7254 6570.5556640625 939.658081054688 7 14 1.1.1.4568.11 1 70.3961 653.6501 70.4836 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 77.9999971389771 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ hexanoyl addition +98(K)@7; reduced HNE(H)@11; MDA adduct +62(K)@18; reduced acrolein addition +58(K)@20 missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38; missed K-K@50; missed K-L@51 -0.625761985778809 6559.94873046875 1094.332 6560.5712890625 1094.43579101563 6 18 1.1.1.4740.11 0 74.8265 7337.119 74.6407 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 75.3799974918365 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +94(K)@7; reduced HNE(H)@11; MDA adduct +62(K)@18; MDA adduct +62(K)@20 missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38; missed K-K@50; missed K-L@51 -0.48769399523735 6560.0263671875 938.1539 6560.513671875 938.223510742188 7 17 1.1.1.4737.5 0 74.7501 7977.587 74.6407 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 61.7399990558624 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ hexanoyl addition +98(K)@7; reduced HNE(H)@11; MDA adduct +62(K)@18; reduced acrolein addition +58(K)@20 missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38; missed K-K@50; missed K-L@51 -0.625761985778809 6559.94873046875 1094.332 6560.5712890625 1094.43579101563 6 17 1.1.1.4733.10 0 74.6548 7337.119 74.6407 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 46.8899995088577 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced HNE(H)@11; HPNE addition +172(K)@18; acrolein addition +56(K)@20 missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38; missed K-K@50; missed K-L@51 0.446626007556915 6571.0234375 939.7249 6570.57666015625 939.6611328125 7 12 1.1.1.4588.9 1 70.907 502.9474 70.7383 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 45.6299990415573 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ hexanoyl addition +98(K)@7; reduced HNE(H)@11; MDA adduct +62(K)@18; reduced acrolein addition +58(K)@20 missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38; missed K-K@50; missed K-L@51 -0.545208990573883 6560.0263671875 938.1539 6560.5712890625 938.231750488281 7 17 1.1.1.4729.4 0 74.5562 7977.587 74.6407 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 45.6299990415573 LAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +112(K)@7; hexanoyl addition +98(K)@18; acrolein addition +38(K)@20 missed K-A@7; missed K-A@18; missed R-Q@27; missed K-V@38; missed K-K@50; missed K-L@51 -0.556428015232086 6431.896484375 1072.99 6432.451171875 1073.08251953125 6 16 1.1.1.4743.8 0 74.8976 1952.428 74.9077 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 LAPYSDELRQR cleaved H-L@N-term; missed R-Q@9 0.159958004951477 1346.85424804688 674.4344 1346.69421386719 674.354431152344 2 12 1.1.1.2748.12 1 25.8092 768.6874 25.9118 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 15.6399995088577 LDDFQKKWQEEMELYRQK Formyl@N-term; acrolein addition +56(K)@7 cleaved Y-L@N-term; missed K-K@6; missed K-W@7; missed R-Q@16 0.385753005743027 2497.58056640625 625.4024 2497.19482421875 625.305969238281 4 12 1.1.1.3749.5 1 50.0196 273.1966 50.038 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LEALKENGGAR Carboxyethyl(K)@5 missed K-E@5 0.156537994742393 1228.79772949219 615.4061 1228.64111328125 615.327880859375 2 17 1.1.1.3005.10 1 31.9687 4473.78 32.029 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LEALKENGGAR Deamidated(N)@7 missed K-E@5 0.151416003704071 1157.75549316406 579.885 1157.60400390625 579.809326171875 2 19 1.1.1.2643.5 1 23.297 2620.737 23.3054 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LEALKENGGAR missed K-E@5 0.152033001184464 1156.77209472656 579.3933 1156.61999511719 579.317321777344 2 18 1.1.1.2609.10 1 22.4797 51938.3 22.3685 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LEALKENGGAR Deamidated(N)@7 missed K-E@5 0.151416003704071 1157.75549316406 579.885 1157.60400390625 579.809326171875 2 18 1.1.1.2651.7 1 23.4906 2370.132 23.4481 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LEALKENGGAR Deamidated(N)@7 missed K-E@5 0.148852005600929 1157.7529296875 579.8837 1157.60400390625 579.809326171875 2 18 1.1.1.2622.5 1 22.7876 119751 22.8267 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LEALKENGGAR missed K-E@5 0.152033001184464 1156.77209472656 579.3933 1156.61999511719 579.317321777344 2 17 1.1.1.2602.12 1 22.311 51938.3 22.3685 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LEALKENGGAR Carboxyethyl(K)@5; Deamidated(N)@7 missed K-E@5 0.156286999583244 1229.78149414063 615.898 1229.62512207031 615.819885253906 2 16 1.1.1.3044.13 1 32.9161 585.8685 32.8971 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.989999294281 LEALKENGGAR Deamidated(N)@7 missed K-E@5 0.148363992571831 1157.75244140625 579.8835 1157.60400390625 579.809326171875 2 16 1.1.1.2636.10 1 23.1238 69083.99 22.8745 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6000001430511 LEALKENGGAR Delta:H(2)C(2)@N-term missed K-E@5 0.151519000530243 1182.78723144531 592.4009 1182.6357421875 592.325134277344 2 15 1.1.1.2715.7 1 25.0234 1116.743 25.0548 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.5300004482269 LEALKENGGAR missed K-E@5 0.152033001184464 1156.77209472656 579.3933 1156.61999511719 579.317321777344 2 15 1.1.1.2616.5 1 22.6479 41035.49 22.3924 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.089998960495 LEALKENGGAR missed K-E@5 1.13322997093201 1157.75329589844 579.8839 1156.61999511719 579.317321777344 2 13 1.1.1.2734.5 1 25.4745 359.8464 25.5777 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8100011348724 LEALKENGGAR Deamidated(N)@7 missed K-E@5 0.151416003704071 1157.75549316406 579.885 1157.60400390625 579.809326171875 2 15 1.1.1.2658.4 1 23.6534 2370.132 23.4481 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5399980545044 LEALKENGGAR Deamidated(N)@7 missed K-E@5 0.154345005750656 1157.75842285156 579.8865 1157.60400390625 579.809326171875 2 13 1.1.1.2683.7 1 24.2532 526.9671 24.217 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.9399998188019 LEALKENGGAR missed K-E@5 0.154840007424355 1156.77490234375 579.3947 1156.61999511719 579.317321777344 2 13 1.1.1.2690.11 1 24.4206 305.8747 24.3845 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.9399998188019 LEALKENGGAR Deamidated(N)@7 missed K-E@5 0.159838005900383 1157.76391601563 579.8892 1157.60400390625 579.809326171875 2 14 1.1.1.2753.7 1 25.9257 414.5367 25.9118 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.6099987030029 LEALKENGGAR Deamidated(N)@7 missed K-E@5 0.148852005600929 1157.7529296875 579.8837 1157.60400390625 579.809326171875 2 15 1.1.1.2629.11 1 22.957 119751 22.8267 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.2400028705597 LEALKENGGAR Deamidated(N)@7 missed K-E@5 0.150804996490479 1157.7548828125 579.8847 1157.60400390625 579.809326171875 2 14 1.1.1.2665.7 1 23.8205 1382.858 23.8306 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.1899983882904 LEALKENGGAR acrolein addition +56(K)@5; Hydroxymethyl(N)@7 missed K-E@5 0.155659005045891 1242.8125 622.4135 1242.65686035156 622.335693359375 2 15 1.1.1.3197.3 1 36.5873 3542.194 36.6883 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 LEALKENGGAR Delta:H(2)C(2)@N-term; Deamidated(N)@7 missed K-E@5 0.156762003898621 1183.77648925781 592.8955 1183.61975097656 592.817138671875 2 13 1.1.1.2744.6 1 25.712 463.1353 25.792 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 LEALKENGGAR acrolein addition +56(K)@5; Hydroxymethyl(N)@7 missed K-E@5 0.155659005045891 1242.8125 622.4135 1242.65686035156 622.335693359375 2 15 1.1.1.3204.2 1 36.7468 3542.194 36.6883 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2700006961823 LEALKENGGAR Deamidated(N)@7 missed K-E@5 0.153979003429413 1157.75805664063 579.8863 1157.60400390625 579.809326171875 2 11 1.1.1.2769.13 1 26.3081 773.8741 26.3681 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1099998950958 LEALKENGGAR Carbamidomethyl(K)@5 missed K-E@5 0.20508000254631 1213.84655761719 405.6228 1213.64147949219 405.554443359375 3 11 1.1.1.2609.2 1 22.4672 1459.742 22.4163 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1099998950958 LEALKENGGAR Methyl(L)@4; reduced acrolein addition +58(K)@5 missed K-E@5 0.120153002440929 1228.79772949219 615.4061 1228.67749023438 615.346069335938 2 12 1.1.1.3012.15 1 32.1406 4473.78 32.029 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.5299990177155 LEALKENGGAR Ammonia-loss(N)@7 missed K-E@5 0.149773001670837 1139.74328613281 570.8789 1139.59350585938 570.804016113281 2 12 1.1.1.2626.14 1 22.8918 4887.634 22.9224 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.0999989509583 LEALKENGGAR missed K-E@5 0.148003995418549 1156.76806640625 579.3913 1156.61999511719 579.317321777344 2 13 1.1.1.2672.11 1 23.9869 618.1307 23.903 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.0999989509583 LEALKENGGAR missed K-E@5 0.152642995119095 1156.77270507813 579.3936 1156.61999511719 579.317321777344 2 13 1.1.1.2699.15 1 24.6414 413.7466 24.6243 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.7800004482269 LEALKENGGAR missed K-E@5 0.162408992648125 1156.78247070313 579.3985 1156.61999511719 579.317321777344 2 12 1.1.1.2780.4 1 26.5721 431.487 26.344 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.7599980831146 LEALKENGGAR Formyl@N-term missed K-E@5 0.180922001600266 1184.7958984375 593.4052 1184.61499023438 593.314758300781 2 12 1.1.1.3009.10 1 32.0692 1778.625 32.2953 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 72.8600025177002 LEALKENGGAR reduced acrolein addition +58(K)@5; Dimethyl(N)@7 missed K-E@5 0.119029000401497 1242.81225585938 622.4134 1242.69323730469 622.353881835938 2 13 1.1.1.3211.7 1 36.9183 3680.575 36.6643 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 71.7599987983704 LEALKENGGAR Lys->Allysine(K)@5 missed K-E@5 0.15327200293541 1155.74169921875 578.8781 1155.58837890625 578.801452636719 2 12 1.1.1.2713.13 1 24.9747 752.8613 24.9831 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.1700029373169 LEALKENGGAR missed K-E@5 0.156183004379272 1156.77624511719 579.3954 1156.61999511719 579.317321777344 2 11 1.1.1.2774.11 1 26.4286 417.9035 26.3922 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 62.5 LEALKENGGAR missed K-E@5 0.157038003206253 1156.77709960938 579.3958 1156.61999511719 579.317321777344 2 12 1.1.1.2766.5 1 26.2393 461.8237 26.3199 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.2400004863739 LEALKENGGAR reduced acrolein addition +58(K)@5; Ammonia-loss(N)@7 missed K-E@5 0.216416001319885 1197.85180664063 400.2912 1197.63537597656 400.219055175781 3 12 1.1.1.2620.2 1 22.7348 25050.98 22.7549 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 55.9599995613098 LEALKENGGAR missed K-E@5 0.145563006401062 1156.765625 579.3901 1156.61999511719 579.317321777344 2 12 1.1.1.2743.6 1 25.684 274.445 25.8159 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 55.7099997997284 LEALKENGGAR Trimethyl(K)@5 missed K-E@5 0.176023006439209 1198.84301757813 400.6216 1198.6669921875 400.562927246094 3 12 1.1.1.2652.2 1 23.5019 27886.57 23.5433 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 50.8499979972839 LEALKENGGAR Hypusine(K)@5 missed K-E@5 0.118165001273155 1243.806640625 622.9106 1243.6884765625 622.851501464844 2 12 1.1.1.3249.5 1 37.8342 774.5797 37.8393 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 43.5799986124039 LEALKENGGAR Deamidated(N)@7 missed K-E@5 0.157030999660492 1157.76110839844 579.8878 1157.60400390625 579.809326171875 2 10 1.1.1.2781.8 1 26.5943 343.0202 26.5599 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 40.1699990034103 LEALKENGGAR reduced acrolein addition +58(K)@5; Dimethyl(N)@7 missed K-E@5 0.116832002997398 1242.81005859375 622.4123 1242.69323730469 622.353881835938 2 12 1.1.1.3219.6 1 37.1076 546.0679 37.0962 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 34.6799999475479 LEALKENGGAR Deamidated(N)@7 missed K-E@5 0.154834002256393 1157.75891113281 579.8867 1157.60400390625 579.809326171875 2 11 1.1.1.2724.5 1 25.2336 333.1517 25.2931 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 19.5299997925758 LEALKENGGAR acrolein addition +56(K)@5; Deamidated(N)@7 missed K-E@5 0.161211997270584 1213.79150390625 607.903 1213.63024902344 607.822387695313 2 10 1.1.1.2605.4 1 22.3807 150.8893 22.4163 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 19.1200003027916 LEDLRQGLLPVLESFKVSFLSALEEYTK cleaved A-L@N-term; missed R-Q@5; missed K-V@16 -5.73441982269287 3218.00366210938 805.5082 3223.73803710938 806.941772460938 4 13 1.1.1.4649.10 1 72.5159 957.3455 72.344 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 18.2300001382828 LEDLRQGLLPVLESFKVSFLSALEEYTKKLNT cleaved A-L@N-term; cleaved T-Q@C-term; missed R-Q@5; missed K-V@16; missed K-K@28; missed K-L@29 -11.9254999160767 3668.08227539063 734.6237 3680.00756835938 737.0087890625 5 12 1.1.1.4767.5 1 75.4761 912.7908 75.3715 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 41.2099987268448 LEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ cleaved A-L@N-term; missed R-Q@5; missed K-V@16; missed K-K@28; missed K-L@29 1.75730001926422 3809.82348632813 762.972 3808.06616210938 762.620544433594 5 13 1.1.1.4780.15 1 75.82 4691.602 75.5711 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 26.5300005674362 LEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ cleaved A-L@N-term; missed R-Q@5; missed K-V@16; missed K-K@28; missed K-L@29 0.926916003227234 3808.9931640625 762.8059 3808.06616210938 762.620544433594 5 15 1.1.1.4773.9 1 75.633 5958.213 75.5711 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.0599999427795 LESFKVSFLSALEEYTKKLNTQ acrolein addition +112(K)@5 cleaved V-L@N-term; missed K-V@5; missed K-K@17; missed K-L@18 0.335491001605988 2686.74609375 672.6938 2686.41064453125 672.609924316406 4 17 1.1.1.4688.3 1 73.5293 1941.954 73.4215 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.869998216629 LESFKVSFLSALEEYTKKLNTQ acrolein addition +112(K)@5 cleaved V-L@N-term; missed K-V@5; missed K-K@17; missed K-L@18 0.341838985681534 2686.75244140625 672.6954 2686.41064453125 672.609924316406 4 17 1.1.1.4666.4 1 72.9607 1882.655 73.0072 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.2699987888336 LESFKVSFLSALEEYTKKLNTQ acrolein addition +112(K)@5 cleaved V-L@N-term; missed K-V@5; missed K-K@17; missed K-L@18 -0.163776993751526 2686.24682617188 672.569 2686.41064453125 672.609924316406 4 15 1.1.1.4695.2 1 73.7102 1678.282 73.6273 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.5100016593933 LESFKVSFLSALEEYTKKLNTQ acrolein addition +112(K)@5 cleaved V-L@N-term; missed K-V@5; missed K-K@17; missed K-L@18 0.335491001605988 2686.74609375 672.6938 2686.41064453125 672.609924316406 4 14 1.1.1.4681.2 1 73.348 1941.954 73.4215 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 77.8599977493286 LGEEMRDR cleaved P-L@N-term; missed R-D@6 0.149101004004478 1004.62005615234 503.3173 1004.47094726563 503.242736816406 2 11 1.1.1.2859.10 1 28.4584 1508.955 28.4446 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 30.2100002765656 LHELQEK 0.141317993402481 895.61767578125 448.8161 895.476318359375 448.745452880859 2 11 1.1.1.2488.3 1 20.1142 308.741 20.2358 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMR Oxidation(M)@15 missed K-L@7 0.23183299601078 1924.20422363281 642.4087 1923.97241210938 642.331420898438 3 24 1.1.1.3003.12 1 31.922 2625.538 31.9078 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMR missed K-L@7 0.231020003557205 1908.20849609375 637.0768 1907.9775390625 636.999755859375 3 26 1.1.1.3196.5 1 36.56 7622.044 36.4966 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMR missed K-L@7 0.231020003557205 1908.20849609375 637.0768 1907.9775390625 636.999755859375 3 24 1.1.1.3203.4 1 36.7271 7752.691 36.4966 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMR missed K-L@7 0.291004002094269 1908.2685546875 478.0744 1907.9775390625 478.001647949219 4 18 1.1.1.3196.3 1 36.5533 8912.504 36.4727 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.989999294281 LHELQEKLSPLGEEMR missed K-L@7 0.291004002094269 1908.2685546875 478.0744 1907.9775390625 478.001647949219 4 16 1.1.1.3189.2 1 36.3806 8912.504 36.4727 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMRDR Oxidation(M)@15 missed K-L@7; missed R-D@16 0.23683600127697 2195.33740234375 732.7864 2195.1005859375 732.707458496094 3 18 1.1.1.2920.16 1 29.9301 12088.95 30.0337 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMRDR Oxidation(M)@15 missed K-L@7; missed R-D@16 0.23683600127697 2195.33740234375 732.7864 2195.1005859375 732.707458496094 3 19 1.1.1.2927.15 1 30.0994 12088.95 30.0337 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMRDR Carbamidomethyl(K)@7 missed K-L@7; missed R-D@16 0.301155000925064 2236.42822265625 560.1143 2236.126953125 560.039001464844 4 19 1.1.1.3098.9 1 34.209 1481.72 34.2166 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMRDR missed K-L@7; missed R-D@16 0.234375 2179.33984375 727.4539 2179.10546875 727.375793457031 3 22 1.1.1.3099.4 1 34.2356 36639.11 34.3133 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMRDR missed K-L@7; missed R-D@16 0.234375 2179.33984375 727.4539 2179.10546875 727.375793457031 3 22 1.1.1.3109.10 1 34.4753 36639.11 34.3133 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMRDR missed K-L@7; missed R-D@16 0.300646007061005 2179.40625 545.8588 2179.10546875 545.78369140625 4 21 1.1.1.3144.7 1 35.3193 1759.176 35.3004 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMRDR Oxidation(M)@15 missed K-L@7; missed R-D@16 0.299138993024826 2195.39965820313 549.8572 2195.1005859375 549.782409667969 4 16 1.1.1.3095.9 1 34.1394 1794.16 34.1925 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMRDR missed K-L@7; missed R-D@16 0.298204004764557 2179.40380859375 545.8582 2179.10546875 545.78369140625 4 20 1.1.1.3102.6 1 34.3048 140173.3 34.3133 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMRDR missed K-L@7; missed R-D@16 0.298204004764557 2179.40380859375 545.8582 2179.10546875 545.78369140625 4 20 1.1.1.3109.8 1 34.4719 140173.3 34.3133 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMRDR missed K-L@7; missed R-D@16 0.300157010555267 2179.40576171875 545.8587 2179.10546875 545.78369140625 4 19 1.1.1.3131.5 1 35.004 2039.09 34.8923 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMRDR Methyl(E)@6; reduced acrolein addition +58(K)@7 missed K-L@7; missed R-D@16 0.211283996701241 2251.37426757813 751.4654 2251.1630859375 751.394958496094 3 18 1.1.1.3680.5 1 48.3545 1806.625 48.3629 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMRDR Oxidation(M)@15 missed K-L@7; missed R-D@16 0.292791992425919 2195.39331054688 549.8556 2195.1005859375 549.782409667969 4 15 1.1.1.2920.10 1 29.9226 51980.92 30.0579 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMRDR missed K-L@7; missed R-D@16 0.299668997526169 2179.4052734375 545.8586 2179.10546875 545.78369140625 4 18 1.1.1.3154.3 1 35.5586 1559.003 35.5876 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMRDR Oxidation(M)@15 missed K-L@7; missed R-D@16 0.292791992425919 2195.39331054688 549.8556 2195.1005859375 549.782409667969 4 15 1.1.1.2927.8 1 30.0902 51980.92 30.0579 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.089998960495 LHELQEKLSPLGEEMRDR Oxidation(M)@15 missed K-L@7; missed R-D@16 0.292791992425919 2195.39331054688 549.8556 2195.1005859375 549.782409667969 4 14 1.1.1.2935.8 1 30.2916 52936.12 30.0337 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.8999972343445 LHELQEKLSPLGEEMRDR missed K-L@7; missed R-D@16 -5.7027702331543 2173.40283203125 544.358 2179.10546875 545.78369140625 4 15 1.1.1.3390.6 1 41.2124 4464.07 41.23 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.8999972343445 LHELQEKLSPLGEEMRDR missed K-L@7; missed R-D@16 -5.7027702331543 2173.40283203125 544.358 2179.10546875 545.78369140625 4 15 1.1.1.3397.9 1 41.3867 3570.552 41.3523 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8699991703033 LHELQEKLSPLGEEMRDR Oxidation(H)@2; Deamidated(Q)@5; Dehydrated(E)@6 missed K-L@7; missed R-D@16 0.246478006243706 2178.3203125 727.1141 2178.07397460938 727.031921386719 3 18 1.1.1.3687.3 1 48.4895 1036.374 48.4945 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8100011348724 LHELQEKLSPLGEEMRDR missed K-L@7; missed R-D@16 0.353610992431641 2179.45922851563 436.8991 2179.10546875 436.828399658203 5 15 1.1.1.3104.3 1 34.3439 51250.16 34.3374 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.6900019645691 LHELQEKLSPLGEEMRDR Oxidation(M)@15 missed K-L@7; missed R-D@16 0.348075985908508 2195.44848632813 440.097 2195.1005859375 440.027374267578 5 13 1.1.1.2927.3 1 30.086 21701.34 30.0579 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.0000026226044 LHELQEKLSPLGEEMRDR missed K-L@7; missed R-D@16 0.354068994522095 2179.45971679688 436.8992 2179.10546875 436.828399658203 5 14 1.1.1.3118.5 1 34.6866 26539.07 34.4339 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2300000190735 LHELQEKLSPLGEEMRDR missed K-L@7; missed R-D@16 1.37304997444153 2180.478515625 437.103 2179.10546875 436.828399658203 5 14 1.1.1.3154.2 1 35.5503 903.021 35.5637 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.5299990177155 LHELQEKLSPLGEEMRDR Oxidation(M)@15 missed K-L@7; missed R-D@16 0.348075985908508 2195.44848632813 440.097 2195.1005859375 440.027374267578 5 12 1.1.1.2920.5 1 29.9185 21701.34 30.0579 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.0499970912933 LHELQEKLSPLGEEMRDR Dimethyl(R)@16; Amidated@C-term missed K-L@7; missed R-D@16 0.20210500061512 2206.35498046875 736.4589 2206.15283203125 736.391540527344 3 14 1.1.1.3445.6 1 42.5664 219.5307 42.5503 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.1700029373169 LHELQEKLSPLGEEMRDR missed K-L@7; missed R-D@16 0.353610992431641 2179.45922851563 436.8991 2179.10546875 436.828399658203 5 13 1.1.1.3098.4 1 34.1998 51250.16 34.3374 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.0599975585938 LHELQEKLSPLGEEMRDR missed K-L@7; missed R-D@16 -0.759365022182465 2178.34619140625 436.6765 2179.10546875 436.828399658203 5 12 1.1.1.3147.2 1 35.3913 722.7031 35.3724 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 25.3800004720688 LHELQEKLSPLGEEMRDR missed K-L@7; missed R-D@16 0.349032998085022 2179.45458984375 436.8982 2179.10546875 436.828399658203 5 12 1.1.1.3133.7 1 35.0504 1034.748 35.0364 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 25.0800013542175 LHELQEKLSPLGEEMRDR missed K-L@7; missed R-D@16 0.353610992431641 2179.45922851563 436.8991 2179.10546875 436.828399658203 5 12 1.1.1.3111.3 1 34.5126 51250.16 34.3374 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMRDRAR Dimethyl(R)@18; Deamidated(R)@20 missed K-L@7; missed R-D@16; missed R-A@18 0.304087996482849 2435.56323242188 609.8981 2435.25903320313 609.822021484375 4 18 1.1.1.2997.15 1 31.7767 10110.38 31.6901 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMRDRAR missed K-L@7; missed R-D@16; missed R-A@18 0.302801996469498 2406.54663085938 602.6439 2406.24389648438 602.568237304688 4 18 1.1.1.3079.6 1 33.7506 12404.48 33.7127 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LHELQEKLSPLGEEMRDRAR missed K-L@7; missed R-D@16; missed R-A@18 0.246540993452072 2406.490234375 803.1707 2406.24389648438 803.088562011719 3 16 1.1.1.3079.8 1 33.7556 775.8267 33.7367 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2699990272522 LHELQEKLSPLGEEMRDRAR Oxidation(M)@15 missed K-L@7; missed R-D@16; missed R-A@18 0.299829989671707 2422.53857421875 606.6419 2422.23876953125 606.566955566406 4 14 1.1.1.2830.6 1 27.7673 815.6711 27.7043 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2700009346008 LHELQEKLSPLGEEMRDRAR Dimethyl(R)@18; Deamidated(R)@20 missed K-L@7; missed R-D@16; missed R-A@18 0.360042989253998 2435.619140625 488.1311 2435.25903320313 488.05908203125 5 16 1.1.1.2997.9 1 31.7717 17838.52 31.6901 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.6300020217896 LHELQEKLSPLGEEMRDRAR Dimethyl(R)@18; Deamidated(R)@20 missed K-L@7; missed R-D@16; missed R-A@18 0.360042989253998 2435.619140625 488.1311 2435.25903320313 488.05908203125 5 14 1.1.1.2990.6 1 31.6045 17838.52 31.6901 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 25.0800013542175 LHELQEKLSPLGEEMRDRAR missed K-L@7; missed R-D@16; missed R-A@18 0.357414990663528 2406.60107421875 482.3275 2406.24389648438 482.256042480469 5 12 1.1.1.3080.8 1 33.7746 26878.62 33.6888 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term cleaved V-L@N-term; missed K-D@2; missed R-D@6 0.106734000146389 2113.1513671875 1057.583 2113.0439453125 1057.529296875 2 16 1.1.1.3373.12 1 40.8108 5638.019 40.7437 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term cleaved V-L@N-term; missed K-D@2; missed R-D@6 0.106734000146389 2113.1513671875 1057.583 2113.0439453125 1057.529296875 2 16 1.1.1.3380.13 1 40.9805 5700.614 40.7194 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term cleaved V-L@N-term; missed K-D@2; missed R-D@6 0.180022999644279 2113.22412109375 705.4153 2113.0439453125 705.355285644531 3 16 1.1.1.3365.8 1 40.6059 30063.65 40.5975 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.7899978160858 LKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term cleaved V-L@N-term; missed K-D@2; missed R-D@6 0.180022999644279 2113.22412109375 705.4153 2113.0439453125 705.355285644531 3 15 1.1.1.3358.10 1 40.444 30063.65 40.5975 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.7899978160858 LKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term cleaved V-L@N-term; missed K-D@2; missed R-D@6 0.176727995276451 2113.220703125 705.4142 2113.0439453125 705.355285644531 3 15 1.1.1.3386.8 1 41.1216 29437.94 40.8642 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 LKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term cleaved V-L@N-term; missed K-D@2; missed R-D@6 0.180022999644279 2113.22412109375 705.4153 2113.0439453125 705.355285644531 3 14 1.1.1.3372.5 1 40.7792 35142.36 40.7677 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 LKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term cleaved V-L@N-term; missed K-D@2; missed R-D@6 0.103803999722004 2113.1474609375 1057.581 2113.0439453125 1057.529296875 2 12 1.1.1.3387.20 1 41.151 3886.893 40.8885 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.6800019741058 LKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term cleaved V-L@N-term; missed K-D@2; missed R-D@6 0.180756002664566 2113.22485351563 705.4155 2113.0439453125 705.355285644531 3 14 1.1.1.3415.14 1 41.8375 998.6212 41.7207 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.5900008678436 LKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term cleaved V-L@N-term; missed K-D@2; missed R-D@6 0.106734000146389 2113.1513671875 1057.583 2113.0439453125 1057.529296875 2 13 1.1.1.3366.19 1 40.6396 5638.019 40.7437 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.7599980831146 LKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term cleaved V-L@N-term; missed K-D@2; missed R-D@6 0.181305006146431 2113.22534179688 705.4157 2113.0439453125 705.355285644531 3 13 1.1.1.3401.8 1 41.4885 1500.162 41.23 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.7599980831146 LKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term cleaved V-L@N-term; missed K-D@2; missed R-D@6 0.180756002664566 2113.22485351563 705.4155 2113.0439453125 705.355285644531 3 13 1.1.1.3408.8 1 41.6644 1000.583 41.7207 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.410001039505 LKDSGRDYVSQFEGSALGK acrolein addition +56(K)@2; Deamidated(Q)@11 cleaved V-L@N-term; missed K-D@2; missed R-D@6 0.116990000009537 2113.1494140625 1057.582 2113.03271484375 1057.52368164063 2 12 1.1.1.3360.9 1 40.4931 5040.435 40.695 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 58.7700009346008 LKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term cleaved V-L@N-term; missed K-D@2; missed R-D@6 0.179839998483658 2113.22387695313 705.4152 2113.0439453125 705.355285644531 3 12 1.1.1.3393.6 1 41.2934 12808.64 41.0341 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.2300009727478 LKLLDNWDSVTSTFSK Carbamidomethyl@N-term; Dioxidation(W)@7 cleaved N-L@N-term; missed K-L@2 0.118637003004551 1942.08703613281 972.0508 1941.96838378906 971.991455078125 2 15 1.1.1.3562.10 1 45.4375 436.1241 45.4219 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.1100008487701 LKLLDNWDSVTSTFSK Formyl@N-term cleaved N-L@N-term; missed K-L@2 0.149663999676704 1881.10168457031 941.5581 1880.95202636719 941.483276367188 2 14 1.1.1.3703.12 1 48.8689 459.1164 48.8806 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.970002412796 LKLLDNWDSVTSTFSK Carbamidomethyl@N-term cleaved N-L@N-term; missed K-L@2 0.115547001361847 1910.09411621094 956.0543 1909.978515625 955.996520996094 2 13 1.1.1.3705.4 1 48.9194 1223.079 48.8564 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.1999986171722 LKLLDNWDSVTSTFSK Carbamidomethyl@N-term cleaved N-L@N-term; missed K-L@2 0.111518003046513 1910.09008789063 956.0523 1909.978515625 955.996520996094 2 13 1.1.1.3696.19 1 48.7052 873.2406 48.7119 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.4900000095367 LKLLDNWDSVTSTFSK Carbamidomethyl@N-term; Dioxidation(W)@7 cleaved N-L@N-term; missed K-L@2 0.117049999535084 1942.08544921875 972.05 1941.96838378906 971.991455078125 2 14 1.1.1.3571.9 1 45.6577 564.804 45.6148 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.860000371933 LKLLDNWDSVTSTFSK acrolein addition +56(K)@2; Oxidation(W)@7 cleaved N-L@N-term; missed K-L@2 0.244421005249023 1925.22265625 963.6186 1924.97814941406 963.496398925781 2 13 1.1.1.3412.12 1 41.7642 759.4063 41.5987 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 0.163041993975639 1627.93603515625 814.9753 1627.77294921875 814.893737792969 2 21 1.1.1.3411.10 1 41.7382 4724.129 41.8426 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.164342999458313 1643.93225097656 822.9734 1643.76782226563 822.891235351563 2 19 1.1.1.3412.11 1 41.7626 1704.374 41.867 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 0.163286000490189 1627.93627929688 814.9754 1627.77294921875 814.893737792969 2 23 1.1.1.3418.9 1 41.9109 4704.324 41.8426 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.164342999458313 1643.93225097656 822.9734 1643.76782226563 822.891235351563 2 22 1.1.1.3419.11 1 41.9338 1706.628 41.867 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.165319994091988 1643.93322753906 822.9739 1643.76782226563 822.891235351563 2 16 1.1.1.3451.15 1 42.7119 432.7197 42.7465 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 0.16389599442482 1615.93688964844 808.9757 1615.77294921875 808.893737792969 2 22 1.1.1.3455.10 1 42.8135 4223.572 42.9436 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.164709001779556 1643.9326171875 822.9736 1643.76782226563 822.891235351563 2 17 1.1.1.3460.17 1 42.9352 2501.896 43.0428 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.164709001779556 1643.9326171875 822.9736 1643.76782226563 822.891235351563 2 21 1.1.1.3461.16 1 42.9592 2501.896 43.0428 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 0.16389599442482 1615.93688964844 808.9757 1615.77294921875 808.893737792969 2 24 1.1.1.3462.15 1 42.9847 4223.572 42.9436 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.164709001779556 1643.9326171875 822.9736 1643.76782226563 822.891235351563 2 19 1.1.1.3468.17 1 43.1339 2501.896 43.0428 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 0.16389599442482 1615.93688964844 808.9757 1615.77294921875 808.893737792969 2 19 1.1.1.3469.9 1 43.1595 4223.572 42.9436 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.165319994091988 1643.93322753906 822.9739 1643.76782226563 822.891235351563 2 22 1.1.1.3496.12 1 43.8289 2373.7 43.7876 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trp->Hydroxykynurenin(W)@5 0.164709001779556 1631.9326171875 816.9736 1631.76782226563 816.891235351563 2 24 1.1.1.3497.14 1 43.8536 10906.1 43.8867 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trp->Hydroxykynurenin(W)@5 0.164709001779556 1631.9326171875 816.9736 1631.76782226563 816.891235351563 2 20 1.1.1.3504.17 1 44.0272 10906.1 43.8867 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Deamidated(N)@4; FormaldehydeAdduct(W)@5 0.175771996378899 1624.93786621094 813.4762 1624.76208496094 813.388305664063 2 20 1.1.1.3517.5 1 44.3426 2907.396 44.3312 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 0.166460007429123 1627.939453125 814.977 1627.77294921875 814.893737792969 2 24 1.1.1.3517.6 1 44.3451 2918.087 44.3069 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.168005004525185 1643.93591308594 822.9752 1643.76782226563 822.891235351563 2 22 1.1.1.3518.8 1 44.3693 3566.272 44.4035 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 0.165482997894287 1627.9384765625 814.9765 1627.77294921875 814.893737792969 2 20 1.1.1.3524.5 1 44.5089 1199.478 44.6447 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.165808007121086 1643.93371582031 822.9741 1643.76782226563 822.891235351563 2 22 1.1.1.3525.5 1 44.5363 2416.981 44.6204 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.165808007121086 1643.93371582031 822.9741 1643.76782226563 822.891235351563 2 21 1.1.1.3532.15 1 44.7085 2416.982 44.6204 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.167394995689392 1643.93530273438 822.9749 1643.76782226563 822.891235351563 2 24 1.1.1.3547.5 1 45.0736 59352.93 45.3017 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.167394995689392 1643.93530273438 822.9749 1643.76782226563 822.891235351563 2 25 1.1.1.3554.8 1 45.2402 98122.46 45.3978 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.167394995689392 1643.93530273438 822.9749 1643.76782226563 822.891235351563 2 25 1.1.1.3561.7 1 45.4102 98122.46 45.3978 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.167517006397247 1643.93542480469 822.975 1643.76782226563 822.891235351563 2 25 1.1.1.3568.7 1 45.5832 92155.54 45.5668 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.167517006397247 1643.93542480469 822.975 1643.76782226563 822.891235351563 2 25 1.1.1.3575.8 1 45.7511 92155.54 45.5668 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.169552996754646 1611.94763183594 806.9811 1611.77807617188 806.896301269531 2 22 1.1.1.3579.4 1 45.8404 5626.198 45.9525 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.168127000331879 1643.93603515625 822.9753 1643.76782226563 822.891235351563 2 21 1.1.1.3582.12 1 45.9157 56763.17 45.6628 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.169552996754646 1611.94763183594 806.9811 1611.77807617188 806.896301269531 2 25 1.1.1.3587.6 1 46.0416 5626.198 45.9525 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.168614998459816 1643.9365234375 822.9755 1643.76782226563 822.891235351563 2 25 1.1.1.3589.10 1 46.0938 3282.823 46.0746 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.168981999158859 1643.93688964844 822.9757 1643.76782226563 822.891235351563 2 21 1.1.1.3596.18 1 46.2648 3706.398 46.1971 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 0.168900996446609 1627.94189453125 814.9782 1627.77294921875 814.893737792969 2 23 1.1.1.3602.19 1 46.4178 2714.305 46.5257 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.168577000498772 1611.94665527344 806.9806 1611.77807617188 806.896301269531 2 24 1.1.1.3603.19 1 46.4431 17232.8 46.5257 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.169591993093491 1643.9375 822.976 1643.76782226563 822.891235351563 2 21 1.1.1.3603.20 1 46.444 2692.166 46.3483 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 0.169266998767853 1627.94226074219 814.9784 1627.77294921875 814.893737792969 2 24 1.1.1.3609.20 1 46.5953 2862.838 46.6513 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.168577000498772 1611.94665527344 806.9806 1611.77807617188 806.896301269531 2 25 1.1.1.3610.12 1 46.6194 17232.8 46.5257 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 0.169266998767853 1627.94226074219 814.9784 1627.77294921875 814.893737792969 2 19 1.1.1.3611.21 1 46.6462 2862.838 46.6513 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Deamidated(N)@4; Dioxidation(W)@5 0.169707000255585 1644.92163085938 823.4681 1644.751953125 823.383239746094 2 22 1.1.1.3614.16 1 46.7178 9902.536 46.727 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.168577000498772 1611.94665527344 806.9806 1611.77807617188 806.896301269531 2 22 1.1.1.3617.18 1 46.7965 17623.4 46.5257 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 0.166703999042511 1627.93969726563 814.9771 1627.77294921875 814.893737792969 2 21 1.1.1.3617.19 1 46.7973 2659.161 46.7782 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 0.171097993850708 1615.94409179688 808.9793 1615.77294921875 808.893737792969 2 25 1.1.1.3619.16 1 46.8458 20640.15 46.7782 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 0.169512003660202 1627.94250488281 814.9785 1627.77294921875 814.893737792969 2 25 1.1.1.3624.19 1 46.976 7777.114 47.0606 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 0.171097993850708 1615.94409179688 808.9793 1615.77294921875 808.893737792969 2 25 1.1.1.3626.18 1 47.027 15039.75 46.9055 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 0.169512003660202 1627.94250488281 814.9785 1627.77294921875 814.893737792969 2 23 1.1.1.3633.19 1 47.2115 7777.114 47.0606 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5; Dehydrated(S)@7 0.167705997824669 1625.92504882813 813.9698 1625.75732421875 813.885925292969 2 24 1.1.1.3645.19 1 47.5213 1616.618 47.477 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.168821007013321 1611.94689941406 806.9807 1611.77807617188 806.896301269531 2 24 1.1.1.3650.18 1 47.6463 7663.119 47.7562 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.168821007013321 1611.94689941406 806.9807 1611.77807617188 806.896301269531 2 24 1.1.1.3658.17 1 47.8509 7663.119 47.7562 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Deamidated(N)@4; Trp->Kynurenin(W)@5 0.165232002735138 1616.92224121094 809.4684 1616.75695800781 809.3857421875 2 22 1.1.1.3667.7 1 48.0763 2023.899 48.1585 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.166134998202324 1611.94421386719 806.9794 1611.77807617188 806.896301269531 2 25 1.1.1.3680.6 1 48.3579 16770.41 48.3091 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dehydrated(S)@7 0.164980992674828 1593.93249511719 797.9735 1593.76745605469 797.890991210938 2 21 1.1.1.3688.4 1 48.5045 2374.454 48.5429 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.169186994433403 1611.947265625 806.9809 1611.77807617188 806.896301269531 2 25 1.1.1.3694.7 1 48.6533 548248.9 48.8324 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Cation:Na(D)@6 0.166856005787849 1633.92687988281 817.9707 1633.76000976563 817.887268066406 2 23 1.1.1.3701.5 1 48.8207 1286.632 48.8564 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.169186994433403 1611.947265625 806.9809 1611.77807617188 806.896301269531 2 25 1.1.1.3702.4 1 48.8447 549020.9 48.8324 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Deamidated(N)@4 0.187002003192902 1612.94909667969 807.4818 1612.76208496094 807.388305664063 2 23 1.1.1.3702.5 1 48.8481 214499 48.8324 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.169186994433403 1611.947265625 806.9809 1611.77807617188 806.896301269531 2 25 1.1.1.3709.8 1 49.0152 549020.9 48.8324 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.169431000947952 1611.94750976563 806.981 1611.77807617188 806.896301269531 2 25 1.1.1.3716.14 1 49.1836 434432.9 48.9286 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.169431000947952 1611.94750976563 806.981 1611.77807617188 806.896301269531 2 25 1.1.1.3723.15 1 49.3605 81902.09 49.2438 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.169552996754646 1611.94763183594 806.9811 1611.77807617188 806.896301269531 2 24 1.1.1.3730.15 1 49.5387 72405.3 49.2691 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dehydrated(S)@7 0.16559100151062 1593.93310546875 797.9738 1593.76745605469 797.890991210938 2 21 1.1.1.3735.20 1 49.671 1796.378 49.7283 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.169797003269196 1611.94787597656 806.9812 1611.77807617188 806.896301269531 2 21 1.1.1.3737.12 1 49.7158 9531.059 49.4478 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.168943002820015 1611.94702148438 806.9808 1611.77807617188 806.896301269531 2 24 1.1.1.3744.18 1 49.9026 3324.462 49.9101 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.168943002820015 1611.94702148438 806.9808 1611.77807617188 806.896301269531 2 19 1.1.1.3752.15 1 50.1022 9375.699 50.2886 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.168943002820015 1611.94702148438 806.9808 1611.77807617188 806.896301269531 2 24 1.1.1.3759.13 1 50.2768 9359.64 50.2886 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Deamidated(N)@4 0.168569996953011 1612.9306640625 807.4726 1612.76208496094 807.388305664063 2 24 1.1.1.3773.10 1 50.6346 11559.88 50.6749 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.172361001372337 1611.95043945313 806.9825 1611.77807617188 806.896301269531 2 19 1.1.1.3855.5 1 52.6731 1010.057 52.7615 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.170040994882584 1611.94812011719 806.9813 1611.77807617188 806.896301269531 2 22 1.1.1.3862.3 1 52.8416 1010.057 52.7615 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.169552996754646 1611.94763183594 806.9811 1611.77807617188 806.896301269531 2 21 1.1.1.3883.3 1 53.3542 963.5526 53.3253 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Delta:H(2)C(2)@N-term 0.169771999120712 1637.96350097656 819.989 1637.79370117188 819.904113769531 2 22 1.1.1.3911.4 1 54.0404 6499.466 54.0597 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.174557998776436 1611.95263671875 806.9836 1611.77807617188 806.896301269531 2 20 1.1.1.3985.6 1 55.821 666.6461 55.7639 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.169797003269196 1611.94787597656 806.9812 1611.77807617188 806.896301269531 2 18 1.1.1.3594.16 1 46.2137 5801.294 45.9525 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.169552996754646 1611.94763183594 806.9811 1611.77807617188 806.896301269531 2 18 1.1.1.3580.7 1 45.8695 5626.198 45.9525 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Delta:H(2)C(2)@N-term 0.169284000992775 1637.96301269531 819.9888 1637.79370117188 819.904113769531 2 20 1.1.1.3897.8 1 53.7056 22737.18 53.8172 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.177975997328758 1611.9560546875 806.9853 1611.77807617188 806.896301269531 2 13 1.1.1.4479.4 1 68.1239 79.7058 68.1065 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.161779999732971 1643.9296875 822.9721 1643.76782226563 822.891235351563 2 19 1.1.1.3540.6 1 44.8981 3928.218 45.1334 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.22825600206852 1612.00634765625 538.3427 1611.77807617188 538.2666015625 3 18 1.1.1.3702.2 1 48.838 51371.65 48.8324 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.166134998202324 1611.94421386719 806.9794 1611.77807617188 806.896301269531 2 17 1.1.1.3671.6 1 48.1701 16772.52 48.3091 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.22825600206852 1612.00634765625 538.3427 1611.77807617188 538.2666015625 3 18 1.1.1.3709.2 1 49.0052 51371.65 48.8324 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.227889001369476 1612.00598144531 538.3426 1611.77807617188 538.2666015625 3 17 1.1.1.3610.5 1 46.6077 2536.056 46.5257 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.169431000947952 1611.94750976563 806.981 1611.77807617188 806.896301269531 2 15 1.1.1.3633.16 1 47.209 703.7742 47.4005 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dehydrated(D)@3 0.168521001935005 1593.93603515625 797.9753 1593.76745605469 797.890991210938 2 19 1.1.1.3771.13 1 50.5853 3795.899 50.5713 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.169552996754646 1611.94763183594 806.9811 1611.77807617188 806.896301269531 2 17 1.1.1.3780.12 1 50.8124 1630.803 50.7756 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.166622996330261 1611.94470214844 806.9796 1611.77807617188 806.896301269531 2 17 1.1.1.3815.6 1 51.6688 1227.457 51.5375 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Delta:H(2)C(2)@N-term 0.169284000992775 1637.96301269531 819.9888 1637.79370117188 819.904113769531 2 21 1.1.1.3904.5 1 53.8715 22737.18 53.8172 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Delta:H(2)C(2)@N-term 0.169771999120712 1637.96350097656 819.989 1637.79370117188 819.904113769531 2 18 1.1.1.3918.4 1 54.215 6499.466 54.0597 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 0.228701993823051 1628.00170898438 543.6745 1627.77294921875 543.598266601563 3 16 1.1.1.3409.8 1 41.6813 987.6457 41.8426 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Quinone(W)@5 0.170959994196892 1641.92321777344 821.9689 1641.75219726563 821.883361816406 2 19 1.1.1.3424.5 1 42.0509 279.9646 42.0627 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 0.165482997894287 1627.9384765625 814.9765 1627.77294921875 814.893737792969 2 18 1.1.1.3426.7 1 42.1014 4612.468 41.8426 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 0.162431001663208 1627.93542480469 814.975 1627.77294921875 814.893737792969 2 18 1.1.1.3463.16 1 43.0095 386.6086 43.0428 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 0.169023007154465 1615.94201660156 808.9783 1615.77294921875 808.893737792969 2 18 1.1.1.3512.16 1 44.2255 1052.616 44.1849 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 0.171097993850708 1615.94409179688 808.9793 1615.77294921875 808.893737792969 2 19 1.1.1.3633.17 1 47.2099 12944.48 46.9313 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.168981999158859 1643.93688964844 822.9757 1643.76782226563 822.891235351563 2 15 1.1.1.3633.20 1 47.2124 722.7654 47.2444 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 0.172318994998932 1615.9453125 808.9799 1615.77294921875 808.893737792969 2 18 1.1.1.3642.21 1 47.4465 581.6973 47.3751 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.165564000606537 1643.93347167969 822.974 1643.76782226563 822.891235351563 2 17 1.1.1.3643.18 1 47.4694 685.1449 47.4515 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 0.171097993850708 1627.94409179688 814.9793 1627.77294921875 814.893737792969 2 18 1.1.1.3696.12 1 48.6993 894.937 48.7119 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.172848999500275 1611.95092773438 806.9827 1611.77807617188 806.896301269531 2 19 1.1.1.3897.6 1 53.7031 1076.687 53.6723 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.16601300239563 1611.94409179688 806.9793 1611.77807617188 806.896301269531 2 18 1.1.1.4011.7 1 56.4634 473.9886 56.529 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.22825600206852 1612.00634765625 538.3427 1611.77807617188 538.2666015625 3 17 1.1.1.3695.4 1 48.6683 51371.65 48.8324 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.22825600206852 1612.00634765625 538.3427 1611.77807617188 538.2666015625 3 17 1.1.1.3716.3 1 49.1745 38897.41 48.9286 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.22825600206852 1612.00634765625 538.3427 1611.77807617188 538.2666015625 3 17 1.1.1.3723.6 1 49.353 13809.55 49.0974 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.165196999907494 1643.93310546875 822.9738 1643.76782226563 822.891235351563 2 15 1.1.1.3475.10 1 43.3082 2460.005 43.0428 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.173336997628212 1611.95141601563 806.983 1611.77807617188 806.896301269531 2 16 1.1.1.3946.5 1 54.8874 574.9743 54.9058 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.163733005523682 1643.931640625 822.9731 1643.76782226563 822.891235351563 2 15 1.1.1.3442.18 1 42.4939 447.2832 42.4039 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 0.165482997894287 1627.9384765625 814.9765 1627.77294921875 814.893737792969 2 17 1.1.1.3531.14 1 44.683 1199.478 44.6447 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 0.166703999042511 1627.93969726563 814.9771 1627.77294921875 814.893737792969 2 18 1.1.1.3538.8 1 44.8475 1441.939 44.767 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 0.230533003807068 1616.00354003906 539.6751 1615.77294921875 539.598266601563 3 18 1.1.1.3612.8 1 46.6605 17220.3 46.7782 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.165035992860794 1611.94311523438 806.9788 1611.77807617188 806.896301269531 2 18 1.1.1.3922.3 1 54.3072 645.0054 54.4943 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 0.162431001663208 1627.93542480469 814.975 1627.77294921875 814.893737792969 2 18 1.1.1.3444.11 1 42.5402 342.1767 42.5015 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 0.162919998168945 1627.93591308594 814.9752 1627.77294921875 814.893737792969 2 17 1.1.1.3485.11 1 43.5542 324.148 43.4405 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 0.166460007429123 1627.939453125 814.977 1627.77294921875 814.893737792969 2 16 1.1.1.3595.19 1 46.2403 1927.703 46.4751 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.167760998010635 1643.93566894531 822.9751 1643.76782226563 822.891235351563 2 17 1.1.1.3671.7 1 48.1726 494.047 48.1585 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 0.170243993401527 1627.94323730469 814.9789 1627.77294921875 814.893737792969 2 16 1.1.1.3703.7 1 48.8639 864.0602 48.8564 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.172848999500275 1611.95092773438 806.9827 1611.77807617188 806.896301269531 2 18 1.1.1.3890.4 1 53.5296 1076.687 53.6723 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK 0.169552996754646 1611.94763183594 806.9811 1611.77807617188 806.896301269531 2 14 1.1.1.3953.6 1 55.0598 573.0129 55.1264 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Methyl(D)@6 0.13034300506115 1625.92407226563 813.9693 1625.79370117188 813.904113769531 2 15 1.1.1.3409.11 1 41.6863 865.9763 41.8426 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Oxidation(W)@5 0.163286000490189 1627.93627929688 814.9754 1627.77294921875 814.893737792969 2 17 1.1.1.3425.8 1 42.0754 4880.047 41.8181 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 0.228153005242348 1616.00109863281 539.6743 1615.77294921875 539.598266601563 3 17 1.1.1.3626.11 1 47.0212 17565.02 46.7782 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.169348001480103 1643.93725585938 822.9759 1643.76782226563 822.891235351563 2 16 1.1.1.3626.19 1 47.0279 1025.141 46.9055 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Formyl(K)@14 0.164873003959656 1639.93786621094 820.9762 1639.77294921875 820.893737792969 2 17 1.1.1.3758.14 1 50.252 614.6536 50.263 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Quinone(W)@5 0.171204000711441 1641.92346191406 821.969 1641.75219726563 821.883361816406 2 15 1.1.1.3503.16 1 44.0016 802.0093 44.0605 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Dioxidation(W)@5 0.16202400624752 1643.92993164063 822.9722 1643.76782226563 822.891235351563 2 16 1.1.1.3511.18 1 44.2021 1700.278 44.0605 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSK Deamidated(N)@4 0.185537993907928 1612.94763183594 807.4811 1612.76208496094 807.388305664063 2 16 1.1.1.3765.14 1 50.432 3724.568 50.2886 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8699972629547 LLDNWDSVTSTFSK 0.173336997628212 1611.95141601563 806.983 1611.77807617188 806.896301269531 2 15 1.1.1.3977.11 1 55.6282 610.3484 55.5687 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 LLDNWDSVTSTFSK Oxidation(W)@5 0.162309005856514 1627.93530273438 814.9749 1627.77294921875 814.893737792969 2 15 1.1.1.3455.11 1 42.8152 416.9777 42.7711 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 LLDNWDSVTSTFSK Dioxidation(W)@5 0.229698002338409 1643.99755859375 549.0065 1643.76782226563 548.929931640625 3 17 1.1.1.3568.3 1 45.5732 12097.68 45.5668 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.5499978065491 LLDNWDSVTSTFSK Dioxidation(W)@5 0.229698002338409 1643.99755859375 549.0065 1643.76782226563 548.929931640625 3 17 1.1.1.3575.5 1 45.7435 12097.68 45.5668 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.5499978065491 LLDNWDSVTSTFSK Dioxidation(W)@5; Dehydrated(S)@7 0.167705997824669 1625.92504882813 813.9698 1625.75732421875 813.885925292969 2 18 1.1.1.3638.18 1 47.3418 1616.618 47.477 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.5499978065491 LLDNWDSVTSTFSK Deamidated(N)@4 0.23667199909687 1612.99877929688 538.6735 1612.76208496094 538.594604492188 3 16 1.1.1.3774.3 1 50.6548 976.5597 50.6488 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2900023460388 LLDNWDSVTSTFSK 0.166989997029305 1611.94506835938 806.9798 1611.77807617188 806.896301269531 2 15 1.1.1.3846.7 1 52.4514 794.8703 52.3929 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.7699995040894 LLDNWDSVTSTFSK 0.168943002820015 1611.94702148438 806.9808 1611.77807617188 806.896301269531 2 15 1.1.1.3831.5 1 52.0747 1252.033 51.9932 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.5899994373322 LLDNWDSVTSTFSK Trp->Hydroxykynurenin(W)@5 0.166905999183655 1631.93481445313 816.9747 1631.76782226563 816.891235351563 2 16 1.1.1.3490.18 1 43.6808 12219.5 43.9118 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.5899994373322 LLDNWDSVTSTFSK Hydroxymethyl(N)@4; Trp->Kynurenin(W)@5 0.1389269977808 1645.92248535156 823.9685 1645.78356933594 823.899047851563 2 16 1.1.1.3637.21 1 47.3178 1154.779 47.2444 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.3599970340729 LLDNWDSVTSTFSK Oxidation(W)@5 0.166460007429123 1627.939453125 814.977 1627.77294921875 814.893737792969 2 16 1.1.1.3509.15 1 44.1551 2918.087 44.3069 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1199989318848 LLDNWDSVTSTFSK Oxidation(D)@3; Ammonia-loss(N)@4; Trp->Kynurenin(W)@5 0.207859992980957 1614.94921875 808.4819 1614.74133300781 808.3779296875 2 20 1.1.1.3697.5 1 48.7244 14622.11 48.7361 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8699991703033 LLDNWDSVTSTFSK Deamidated(N)@4; Dioxidation(W)@5 0.169707000255585 1644.92163085938 823.4681 1644.751953125 823.383239746094 2 16 1.1.1.3610.13 1 46.621 9902.536 46.727 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8699991703033 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 0.230533003807068 1616.00354003906 539.6751 1615.77294921875 539.598266601563 3 16 1.1.1.3619.6 1 46.8374 17220.3 46.7782 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8699991703033 LLDNWDSVTSTFSK Dioxidation(W)@5 0.168614998459816 1643.9365234375 822.9755 1643.76782226563 822.891235351563 2 13 1.1.1.3650.20 1 47.6479 502.0887 47.6538 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8699991703033 LLDNWDSVTSTFSK Deamidated(N)@4 0.168569996953011 1612.9306640625 807.4726 1612.76208496094 807.388305664063 2 15 1.1.1.3772.13 1 50.6111 11559.88 50.6749 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.7899978160858 LLDNWDSVTSTFSK Deamidated(N)@4; FormaldehydeAdduct(W)@5 0.239051997661591 1625.00109863281 542.6743 1624.76208496094 542.594604492188 3 15 1.1.1.2992.8 1 31.661 1629.278 31.642 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.6000020503998 LLDNWDSVTSTFSK Oxidation(W)@5 0.162309005856514 1627.93530273438 814.9749 1627.77294921875 814.893737792969 2 12 1.1.1.3447.21 1 42.6189 416.9777 42.7711 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.6000020503998 LLDNWDSVTSTFSK Quinone(W)@5 0.168762996792793 1641.92102050781 821.9678 1641.75219726563 821.883361816406 2 16 1.1.1.3510.13 1 44.1781 802.0093 44.0605 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.6000020503998 LLDNWDSVTSTFSK Dioxidation(W)@5 0.229698002338409 1643.99755859375 549.0065 1643.76782226563 548.929931640625 3 16 1.1.1.3561.2 1 45.4018 12444.76 45.3978 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.6000020503998 LLDNWDSVTSTFSK Cation:Na(D)@6 0.228488996624947 1633.98852539063 545.6701 1633.76000976563 545.593933105469 3 17 1.1.1.3710.2 1 49.0293 2898.553 48.8564 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.6000020503998 LLDNWDSVTSTFSK -0.772952020168304 1611.00512695313 806.5098 1611.77807617188 806.896301269531 2 15 1.1.1.3766.14 1 50.4577 2131.73 50.4686 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.3199973106384 LLDNWDSVTSTFSK Oxidation(W)@5; Cation:K(D)@6 0.252007007598877 1665.98083496094 556.3342 1665.72888183594 556.250244140625 3 17 1.1.1.3564.2 1 45.4755 1455.318 45.5188 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.3199973106384 LLDNWDSVTSTFSK Deamidated(N)@4; Dioxidation(W)@5 0.176908999681473 1644.92883300781 823.4717 1644.751953125 823.383239746094 2 14 1.1.1.3601.18 1 46.3919 3813.696 46.2471 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2400019168854 LLDNWDSVTSTFSK 0.169552996754646 1611.94763183594 806.9811 1611.77807617188 806.896301269531 2 14 1.1.1.3595.18 1 46.2395 5166.467 45.9771 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2400019168854 LLDNWDSVTSTFSK 0.227889001369476 1612.00598144531 538.3426 1611.77807617188 538.2666015625 3 15 1.1.1.3603.10 1 46.4356 2536.056 46.5257 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.0300028324127 LLDNWDSVTSTFSK Quinone(W)@5 0.17059400677681 1641.9228515625 821.9687 1641.75219726563 821.883361816406 2 16 1.1.1.3431.6 1 42.2256 359.6146 42.234 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.0300028324127 LLDNWDSVTSTFSK Cation:Na(D)@6 0.169663995504379 1633.9296875 817.9721 1633.76000976563 817.887268066406 2 17 1.1.1.3710.6 1 49.0368 1271.006 48.9286 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 LLDNWDSVTSTFSK Dioxidation(W)@5 0.229698002338409 1643.99755859375 549.0065 1643.76782226563 548.929931640625 3 15 1.1.1.3554.2 1 45.2327 12444.76 45.3978 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 LLDNWDSVTSTFSK Dioxidation(W)@5; Cation:Na(D)@6 0.231030002236366 1665.98083496094 556.3342 1665.74987792969 556.257202148438 3 17 1.1.1.3571.2 1 45.6426 1455.318 45.5188 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 0.169512003660202 1615.94250488281 808.9785 1615.77294921875 808.893737792969 2 12 1.1.1.3599.14 1 46.3374 428.2699 46.1971 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 LLDNWDSVTSTFSK Oxidation(W)@5 0.226687997579575 1627.99963378906 543.6738 1627.77294921875 543.598266601563 3 15 1.1.1.3604.8 1 46.4592 1179.323 46.5257 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 LLDNWDSVTSTFSK Oxidation(W)@5 0.233280003070831 1628.00622558594 543.676 1627.77294921875 543.598266601563 3 15 1.1.1.3628.11 1 47.0731 1055.402 47.0606 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 LLDNWDSVTSTFSK Ammonia-loss(N)@4; Dioxidation(W)@5 0.195896998047829 1626.93725585938 814.4759 1626.74133300781 814.3779296875 2 15 1.1.1.3693.7 1 48.6316 451.4336 48.6392 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 LLDNWDSVTSTFSK Ammonia-loss(N)@4 0.170344993472099 1594.921875 798.4682 1594.75146484375 798.383056640625 2 15 1.1.1.3745.18 1 49.9294 1057.474 49.9884 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 LLDNWDSVTSTFSK Delta:H(2)C(2)@N-term; Dioxidation(W)@5 0.168467998504639 1669.95202636719 835.9833 1669.78356933594 835.899047851563 2 16 1.1.1.3778.12 1 50.7631 5091.908 50.8497 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.4200029373169 LLDNWDSVTSTFSK Deamidated(N)@4; FormaldehydeAdduct(W)@5 0.175771996378899 1624.93786621094 813.4762 1624.76208496094 813.388305664063 2 15 1.1.1.3510.12 1 44.1765 2907.396 44.3312 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.0900018215179 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 0.171830996870995 1615.94482421875 808.9797 1615.77294921875 808.893737792969 2 13 1.1.1.3589.8 1 46.0888 392.9342 46.0746 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.0900018215179 LLDNWDSVTSTFSK -0.84936797618866 1610.9287109375 806.4716 1611.77807617188 806.896301269531 2 15 1.1.1.3626.17 1 47.0262 347.1724 46.9827 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.0900018215179 LLDNWDSVTSTFSK Dioxidation(W)@5 0.180944994091988 1643.94885253906 822.9817 1643.76782226563 822.891235351563 2 14 1.1.1.3760.11 1 50.3008 471.4454 50.137 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.0400004386902 LLDNWDSVTSTFSK Dioxidation(W)@5 0.165319994091988 1643.93322753906 822.9739 1643.76782226563 822.891235351563 2 13 1.1.1.3489.15 1 43.6534 2373.7 43.7876 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.0400004386902 LLDNWDSVTSTFSK Methyl(D)@6 0.131319999694824 1625.92504882813 813.9698 1625.79370117188 813.904113769531 2 13 1.1.1.3652.17 1 47.6963 1616.618 47.477 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4199988842011 LLDNWDSVTSTFSK 0.166622996330261 1611.94470214844 806.9796 1611.77807617188 806.896301269531 2 16 1.1.1.3869.11 1 53.0176 1479.236 53.0061 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4199988842011 LLDNWDSVTSTFSK 0.172970995306969 1611.95104980469 806.9828 1611.77807617188 806.896301269531 2 14 1.1.1.3876.3 1 53.1849 1096.674 53.1544 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4199988842011 LLDNWDSVTSTFSK 0.173336997628212 1611.95141601563 806.983 1611.77807617188 806.896301269531 2 13 1.1.1.3945.5 1 54.8628 574.9743 54.9058 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4199988842011 LLDNWDSVTSTFSK 0.172970995306969 1611.95104980469 806.9828 1611.77807617188 806.896301269531 2 14 1.1.1.3995.3 1 56.0675 431.0741 56.1616 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4199988842011 LLDNWDSVTSTFSK 0.171384006738663 1611.94946289063 806.982 1611.77807617188 806.896301269531 2 14 1.1.1.4003.4 1 56.2648 391.8112 56.2596 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.2699978351593 LLDNWDSVTSTFSK Deamidated(N)@4; Methyl(D)@6 0.150478005409241 1626.92822265625 814.4714 1626.77770996094 814.396118164063 2 15 1.1.1.3589.9 1 46.0913 197.0771 46.0989 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9199993610382 LLDNWDSVTSTFSK Deamidated(N)@4; Methyl(D)@6 0.24049200117588 1627.01818847656 543.3467 1626.77770996094 543.266540527344 3 15 1.1.1.3206.5 1 36.7956 4848.786 36.8804 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.8699970245361 LLDNWDSVTSTFSK Trioxidation(W)@5 0.16881799697876 1659.931640625 830.9731 1659.76281738281 830.888671875 2 14 1.1.1.3413.15 1 41.787 262.5074 41.7693 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.8699970245361 LLDNWDSVTSTFSK Quinone(W)@5 0.168029993772507 1641.92028808594 821.9674 1641.75219726563 821.883361816406 2 15 1.1.1.3438.9 1 42.3963 288.8426 42.4039 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.8699970245361 LLDNWDSVTSTFSK Dioxidation(W)@5; Cation:Na(D)@6 0.226086005568504 1665.97595214844 556.3326 1665.74987792969 556.257202148438 3 13 1.1.1.3555.2 1 45.2567 1304.041 45.446 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.4600005149841 LLDNWDSVTSTFSK Acetyl@N-term; Methyl(D)@3 0.141995996236801 1667.9462890625 834.9804 1667.80432128906 834.909423828125 2 16 1.1.1.3456.10 1 42.8381 924.1731 42.8942 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.0400023460388 LLDNWDSVTSTFSK Oxidation(W)@5 0.226321995258331 1627.99926757813 543.6737 1627.77294921875 543.598266601563 3 13 1.1.1.3621.7 1 46.8888 1162.02 46.6764 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.6000008583069 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 0.230533003807068 1616.00354003906 539.6751 1615.77294921875 539.598266601563 3 14 1.1.1.3619.7 1 46.8383 17220.3 46.7782 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.7000014781952 LLDNWDSVTSTFSK 0.22825600206852 1612.00634765625 538.3427 1611.77807617188 538.2666015625 3 14 1.1.1.3730.7 1 49.532 7046.086 49.2691 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.2300009727478 LLDNWDSVTSTFSK Oxidation(W)@5 0.226321995258331 1627.99926757813 543.6737 1627.77294921875 543.598266601563 3 14 1.1.1.3613.8 1 46.6858 1162.02 46.6764 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.7199997901917 LLDNWDSVTSTFSK Cation:Na(D)@6 0.228488996624947 1633.98852539063 545.6701 1633.76000976563 545.593933105469 3 15 1.1.1.3696.2 1 48.691 2898.553 48.8564 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.7199997901917 LLDNWDSVTSTFSK Cation:Na(D)@6 0.228488996624947 1633.98852539063 545.6701 1633.76000976563 545.593933105469 3 15 1.1.1.3703.2 1 48.8597 2898.553 48.8564 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.4700000286102 LLDNWDSVTSTFSK -0.824464976787567 1610.95361328125 806.4841 1611.77807617188 806.896301269531 2 12 1.1.1.3992.3 1 55.9924 171.1269 55.9877 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1900012493134 LLDNWDSVTSTFSK Deamidated(N)@4 0.177358999848366 1612.939453125 807.477 1612.76208496094 807.388305664063 2 11 1.1.1.3630.20 1 47.1333 172.1738 47.1128 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1900012493134 LLDNWDSVTSTFSK Oxidation(W)@5; Dehydrated(D)@6 0.174826994538307 1609.93725585938 805.9759 1609.76245117188 805.888488769531 2 14 1.1.1.3764.15 1 50.4073 1608.08 50.4686 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.5299990177155 LLDNWDSVTSTFSK Deamidated(N)@4; Methyl(D)@6 0.24049200117588 1627.01818847656 543.3467 1626.77770996094 543.266540527344 3 14 1.1.1.3213.6 1 36.9663 4848.786 36.8804 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.1100008487701 LLDNWDSVTSTFSK Deamidated(N)@4; Quinone(W)@5 0.178398996591568 1642.91467285156 822.4646 1642.73620605469 822.375427246094 2 14 1.1.1.3448.17 1 42.6417 171.6894 42.6239 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.1100008487701 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 0.168534994125366 1615.94152832031 808.978 1615.77294921875 808.893737792969 2 11 1.1.1.3505.15 1 44.0505 1045.62 44.1104 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.1100008487701 LLDNWDSVTSTFSK Deamidated(N)@4; FormaldehydeAdduct(W)@5 0.242897003889084 1625.00500488281 542.6756 1624.76208496094 542.594604492188 3 14 1.1.1.3518.2 1 44.3593 2537.677 44.3069 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.5499973297119 LLDNWDSVTSTFSK Delta:H(2)C(2)@N-term; Trp->Kynurenin(W)@5 0.168022006750107 1641.95666503906 821.9856 1641.78857421875 821.901611328125 2 14 1.1.1.3815.7 1 51.6697 557.4656 51.7378 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.970002412796 LLDNWDSVTSTFSK Dioxidation(W)@5 0.229148998856544 1643.9970703125 549.0063 1643.76782226563 548.929931640625 3 13 1.1.1.3589.4 1 46.0821 663.5128 46.0746 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.3799998760223 LLDNWDSVTSTFSK Dioxidation(W)@5 0.229148998856544 1643.9970703125 549.0063 1643.76782226563 548.929931640625 3 13 1.1.1.3582.7 1 45.9115 8240.624 45.6628 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.5399985313416 LLDNWDSVTSTFSK Oxidation(W)@5 0.162919998168945 1627.93591308594 814.9752 1627.77294921875 814.893737792969 2 10 1.1.1.3477.17 1 43.3578 324.148 43.4405 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.2399973869324 LLDNWDSVTSTFSK Carbamidomethyl@N-term; Deamidated(N)@4 0.231321007013321 1670.01489257813 557.6789 1669.78356933594 557.601806640625 3 13 1.1.1.3780.4 1 50.8058 903.0285 50.825 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.9999992847443 LLDNWDSVTSTFSK -0.827395021915436 1610.95068359375 806.4826 1611.77807617188 806.896301269531 2 14 1.1.1.3982.9 1 55.7488 280.6207 55.7393 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.9000005722046 LLDNWDSVTSTFSK -0.0563990995287895 1611.7216796875 806.8681 1611.77807617188 806.896301269531 2 11 1.1.1.4471.5 1 67.9052 179.5056 67.9236 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.8899998664856 LLDNWDSVTSTFSK Deamidated(N)@4; Dioxidation(W)@5 0.238481000065804 1644.99035644531 549.3374 1644.751953125 549.257934570313 3 13 1.1.1.3596.6 1 46.2548 811.7857 46.2724 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.1999986171722 LLDNWDSVTSTFSK Dioxidation(W)@5 0.169348001480103 1643.93725585938 822.9759 1643.76782226563 822.891235351563 2 12 1.1.1.3658.19 1 47.8525 694.5356 47.9879 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.4900000095367 LLDNWDSVTSTFSK Deamidated(N)@4 0.184927001595497 1612.94702148438 807.4808 1612.76208496094 807.388305664063 2 11 1.1.1.3724.16 1 49.3873 53235.65 49.1215 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.449999332428 LLDNWDSVTSTFSK 0.232649996876717 1612.0107421875 538.3442 1611.77807617188 538.2666015625 3 12 1.1.1.3588.8 1 46.0586 471.1718 45.9771 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.449999332428 LLDNWDSVTSTFSK 0.233932003378868 1612.01196289063 538.3446 1611.77807617188 538.2666015625 3 13 1.1.1.3760.2 1 50.2933 565.2648 50.3143 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.7699997425079 LLDNWDSVTSTFSK Oxidation(W)@5 0.162431001663208 1627.93542480469 814.975 1627.77294921875 814.893737792969 2 11 1.1.1.3462.16 1 42.9864 354.2725 42.9436 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.7699997425079 LLDNWDSVTSTFSK Cation:Cu[I](D)@6 0.24924199283123 1673.94909667969 837.9818 1673.69982910156 837.857177734375 2 14 1.1.1.3606.18 1 46.5181 4327.924 46.5762 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.7699997425079 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5 0.231083005666733 1616.00402832031 539.6753 1615.77294921875 539.598266601563 3 11 1.1.1.3643.7 1 47.4602 323.034 47.4515 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.030002117157 LLDNWDSVTSTFSK Carbamidomethyl(D)@6 0.237736999988556 1669.03723144531 557.353 1668.79956054688 557.273803710938 3 12 1.1.1.3612.9 1 46.6614 313.4272 46.7017 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 76.5100002288818 LLDNWDSVTSTFSK Carbamidomethyl(S)@7; Dehydrated(T)@11; ONE addition +154(K)@14 0.0889374017715454 1804.97729492188 903.4959 1804.88830566406 903.451416015625 2 14 1.1.1.3695.13 1 48.6825 842.3455 48.6634 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.1299986839294 LLDNWDSVTSTFSK Methyl(D)@6 0.134128004312515 1625.92785644531 813.9712 1625.79370117188 813.904113769531 2 9 1.1.1.3494.19 1 43.7808 222.8494 43.7876 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.6300020217896 LLDNWDSVTSTFSK Nitro(W)@5 0.267163991928101 1657.0302734375 553.3507 1656.76318359375 553.261657714844 3 13 1.1.1.3171.4 1 35.9649 1020.494 35.97 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.9599981307983 LLDNWDSVTSTFSK 0.165768995881081 1611.94384765625 806.9792 1611.77807617188 806.896301269531 2 12 1.1.1.4018.9 1 56.6368 411.4057 56.6519 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.0499970912933 LLDNWDSVTSTFSK Cation:Na(D)@6 0.228121995925903 1633.98815917969 545.67 1633.76000976563 545.593933105469 3 13 1.1.1.3719.7 1 49.2524 578.0535 49.2691 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.1299993991852 LLDNWDSVTSTFSK Deamidated(N)@4; Oxidation(W)@5 0.18928000330925 1628.9462890625 815.4804 1628.75695800781 815.3857421875 2 12 1.1.1.3606.17 1 46.5173 1171.445 46.5257 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.2400004863739 LLDNWDSVTSTFSK Deamidated(N)@4; Methyl(D)@6 0.146328002214432 1626.92407226563 814.4693 1626.77770996094 814.396118164063 2 10 1.1.1.3400.16 1 41.4664 308.227 41.5002 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.2400004863739 LLDNWDSVTSTFSK Deamidated(N)@4; Dioxidation(W)@5 0.234268993139267 1644.98620605469 549.336 1644.751953125 549.257934570313 3 12 1.1.1.3611.11 1 46.6378 1058.104 46.727 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 58.1499993801117 LLDNWDSVTSTFSK Trp->Kynurenin(W)@5; Dehydrated(D)@6 0.164817005395889 1597.92724609375 799.9709 1597.76245117188 799.888488769531 2 11 1.1.1.3447.20 1 42.618 578.7271 42.6485 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 58.1499993801117 LLDNWDSVTSTFSK Deamidated(N)@4; Dioxidation(W)@5 0.234268993139267 1644.98620605469 549.336 1644.751953125 549.257934570313 3 11 1.1.1.3618.10 1 46.8154 1058.104 46.727 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 44.6099996566772 LLDNWDSVTSTFSK Methyl(D)@6 0.138155996799469 1625.93188476563 813.9732 1625.79370117188 813.904113769531 2 9 1.1.1.3503.15 1 44.0007 313.1145 44.0605 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 43.979999423027 LLDNWDSVTSTFSK 0.169186994433403 1611.947265625 806.9809 1611.77807617188 806.896301269531 2 12 1.1.1.4026.11 1 56.8408 541.7983 56.8542 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 43.41000020504 LLDNWDSVTSTFSK Carbamidomethyl(S)@10; Dehydrated(T)@11; ONE addition +154(K)@14 0.0861297994852066 1804.97448730469 903.4945 1804.88830566406 903.451416015625 2 13 1.1.1.3703.11 1 48.8672 841.2778 48.8564 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.2100007534027 LLDNWDSVTSTFSK Delta:H(2)C(2)@N-term; Trp->Kynurenin(W)@5 0.168022006750107 1641.95666503906 821.9856 1641.78857421875 821.901611328125 2 12 1.1.1.3816.15 1 51.7018 557.4656 51.7378 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 36.1099988222122 LLDNWDSVTSTFSK Deamidated(N)@4; Methyl(D)@6 0.138148993253708 1626.91589355469 814.4652 1626.77770996094 814.396118164063 2 11 1.1.1.3706.7 1 48.9427 401.9682 48.9286 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 33.6400002241135 LLDNWDSVTSTFSK Ser->LacticAcid(S)@13; acrolein addition +56(K)@14 0.176697999238968 1652.97009277344 827.4923 1652.79333496094 827.403930664063 2 10 1.1.1.3737.15 1 49.7183 364.0773 49.78 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 23.6000001430511 LLDNWDSVTSTFSK Oxidation(D)@3; Ammonia-loss(N)@4 0.17799399793148 1610.92443847656 806.4695 1610.74645996094 806.380493164063 2 13 1.1.1.4309.6 1 63.8067 433.8892 63.9795 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSKLR Dioxidation(W)@5 missed K-L@14 0.238126993179321 1913.19116210938 638.7377 1912.95300292969 638.658325195313 3 21 1.1.1.3729.5 1 49.505 13223.09 49.4221 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSKLR Carbamidomethyl(K)@14 missed K-L@14 0.242503002285957 1938.22717285156 647.083 1937.98474121094 647.002197265625 3 22 1.1.1.3799.3 1 51.276 1331.907 51.2701 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSKLR missed K-L@14 0.236683994531631 1881.19995117188 628.0739 1880.96325683594 627.994995117188 3 20 1.1.1.3800.3 1 51.2986 52028.07 51.4154 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSKLR missed K-L@14 0.236683994531631 1881.19995117188 628.0739 1880.96325683594 627.994995117188 3 22 1.1.1.3807.2 1 51.468 52028.07 51.4154 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSKLR missed K-L@14 0.173586994409561 1881.13684082031 941.5757 1880.96325683594 941.488891601563 2 25 1.1.1.3807.5 1 51.4755 10501.48 51.3913 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSKLR Dioxidation(W)@5 missed K-L@14 0.238126993179321 1913.19116210938 638.7377 1912.95300292969 638.658325195313 3 19 1.1.1.3722.8 1 49.3295 13223.09 49.4221 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.9499986171722 LLDNWDSVTSTFSKLR Delta:H(2)C(2)@N-term missed K-L@14 0.243067994713783 1907.22192382813 636.7479 1906.97888183594 636.666931152344 3 17 1.1.1.4054.2 1 57.5435 1406.433 57.5905 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.3599970340729 LLDNWDSVTSTFSKLR Deamidated(N)@4; Dioxidation(W)@5 missed K-L@14 0.238486006855965 1914.17553710938 639.0658 1913.93701171875 638.986328125 3 17 1.1.1.3768.8 1 50.5038 656.0196 50.4939 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.6000020503998 LLDNWDSVTSTFSKLR Trp->Kynurenin(W)@5 missed K-L@14 0.29839700460434 1885.25659179688 472.3214 1884.95812988281 472.246826171875 4 13 1.1.1.3757.3 1 50.2175 448.166 50.263 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.8500027656555 LLDNWDSVTSTFSKLR acrolein addition +56(K)@14; Oxidation(R)@16 missed K-L@14 0.171745002269745 1953.15612792969 977.5853 1952.984375 977.499450683594 2 15 1.1.1.4059.10 1 57.6769 1395.176 57.6911 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.0400004386902 LLDNWDSVTSTFSKLR Ser->LacticAcid(S)@13; acrolein addition +56(K)@14 missed K-L@14 0.250176995992661 1922.22875976563 641.7502 1921.978515625 641.666809082031 3 16 1.1.1.3814.3 1 51.6416 10183.1 51.7378 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.9399976730347 LLDNWDSVTSTFSKLR missed K-L@14 0.236135005950928 1881.19934082031 628.0737 1880.96325683594 627.994995117188 3 14 1.1.1.3768.6 1 50.5021 2218.023 50.6228 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2100026607513 LLDNWDSVTSTFSKLR Dioxidation(W)@5; Carbamidomethyl(K)@14 missed K-L@14 0.243212997913361 1970.2177734375 657.7465 1969.97448730469 657.665466308594 3 15 1.1.1.3722.9 1 49.3304 880.2988 49.2943 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 58.1499993801117 LLDNWDSVTSTFSKLR Ser->LacticAcid(S)@13; acrolein addition +56(K)@14 missed K-L@14 0.250176995992661 1922.22875976563 641.7502 1921.978515625 641.666809082031 3 13 1.1.1.3821.4 1 51.8217 10183.1 51.7378 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.2100007534027 LLDNWDSVTSTFSKLR MDA adduct +54(K)@14; Arg->GluSA(R)@16 missed K-L@14 0.163720995187759 1892.08410644531 947.0493 1891.92041015625 946.967468261719 2 12 1.1.1.3696.17 1 48.7035 954.5903 48.8564 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.17999792099 LLDNWDSVTSTFSKLREQL Arg->GluSA(R)@16 cleaved L-G@C-term; missed K-L@14; missed R-E@16 0.289269000291824 2208.38427734375 737.1354 2208.09497070313 737.038940429688 3 17 1.1.1.3863.4 1 52.8644 2097.254 52.7863 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSKLREQLGPVTQEFWDNLEK missed K-L@14; missed R-E@16 0.334643989801407 3795.2138671875 949.8107 3794.87915039063 949.72705078125 4 20 1.1.1.4512.14 1 68.9805 4258.113 69.2099 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSKLREQLGPVTQEFWDNLEK missed K-L@14; missed R-E@16 0.334156006574631 3795.21337890625 949.8106 3794.87915039063 949.72705078125 4 37 1.1.1.4519.6 1 69.1489 4277.057 69.2099 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSKLREQLGPVTQEFWDNLEK missed K-L@14; missed R-E@16 0.334156006574631 3795.21337890625 949.8106 3794.87915039063 949.72705078125 4 34 1.1.1.4526.4 1 69.3163 4277.057 69.2099 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSKLREQLGPVTQEFWDNLEK missed K-L@14; missed R-E@16 0.333422988653183 3795.21264648438 949.8104 3794.87915039063 949.72705078125 4 25 1.1.1.4533.6 1 69.4956 3417.839 69.2342 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSKLREQLGPVTQEFWDNLEK Dioxidation(W)@27 missed K-L@14; missed R-E@16 0.33822301030159 3827.20727539063 957.8091 3826.86889648438 957.724548339844 4 20 1.1.1.4412.5 1 66.4161 904.521 66.3781 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.8799998760223 LLDNWDSVTSTFSKLREQLGPVTQEFWDNLEK Dioxidation(W)@27 missed K-L@14; missed R-E@16 0.35360398888588 3827.22265625 957.8129 3826.86889648438 957.724548339844 4 16 1.1.1.4419.7 1 66.6004 808.3127 66.5331 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.1499972343445 LLDNWDSVTSTFSKLREQLGPVTQEFWDNLEK Deamidated(N)@4; Dioxidation(W)@5 missed K-L@14; missed R-E@16 -0.645792007446289 3827.20727539063 957.8091 3827.85302734375 957.970520019531 4 13 1.1.1.4405.6 1 66.2454 904.521 66.3781 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 51.4800012111664 LLDNWDSVTSTFSKLREQLGPVTQEFWDNLEK Deamidated(N)@4; Dioxidation(W)@27 missed K-L@14; missed R-E@16 0.368611991405487 3828.2216796875 958.0627 3827.85302734375 957.970520019531 4 12 1.1.1.4412.6 1 66.4186 458.3797 66.4803 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@41 missed K-L@14; missed R-E@16; missed K-E@32; missed R-Q@38 0.402952998876572 5099.8837890625 1020.984 5099.482421875 1020.90374755859 5 23 1.1.1.4626.13 1 71.913 2008.541 71.9998 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(W)@27 missed K-L@14; missed R-E@16; missed K-E@32; missed R-Q@38 0.470524996519089 5115.94775390625 853.6652 5115.47705078125 853.586791992188 6 20 1.1.1.4632.4 1 72.0676 1426.354 72.1852 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@41 missed K-L@14; missed R-E@16; missed K-E@32; missed R-Q@38 0.47154301404953 5099.95361328125 850.9996 5099.482421875 850.920959472656 6 19 1.1.1.4633.11 1 72.094 2410.239 71.9738 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.470002412796 LLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@41 missed K-L@14; missed R-E@16; missed K-E@32; missed R-Q@38 0.47154301404953 5099.95361328125 850.9996 5099.482421875 850.920959472656 6 18 1.1.1.4626.11 1 71.9096 2410.239 71.9738 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.1500029563904 LLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSK missed K-L@14; missed R-E@16; missed K-E@32; missed R-Q@38 -3.06100988388062 5080.42626953125 847.745 5083.4873046875 848.255187988281 6 18 1.1.1.4736.3 1 74.7225 2842.327 74.6648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.8499977588654 LLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@41 missed K-L@14; missed R-E@16; missed K-E@32; missed R-Q@38 0.47154301404953 5099.95361328125 850.9996 5099.482421875 850.920959472656 6 16 1.1.1.4624.5 1 71.8515 2410.239 71.9738 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.5100016593933 LLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(W)@27 missed K-L@14; missed R-E@16; missed K-E@32; missed R-Q@38 0.470524996519089 5115.94775390625 853.6652 5115.47705078125 853.586791992188 6 15 1.1.1.4639.5 1 72.2494 1426.354 72.1852 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.6099972724915 LLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@41 missed K-L@14; missed R-E@16; missed K-E@32; missed R-Q@38 0.402952998876572 5099.8837890625 1020.984 5099.482421875 1020.90374755859 5 14 1.1.1.4633.14 1 72.099 2008.541 71.9998 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.1699986457825 LLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(W)@27 missed K-L@14; missed R-E@16; missed K-E@32; missed R-Q@38 0.401385009288788 5115.87841796875 1024.183 5115.47705078125 1024.10266113281 5 14 1.1.1.4640.10 1 72.284 1148.066 72.1852 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 59.35999751091 LLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(W)@27 missed K-L@14; missed R-E@16; missed K-E@32; missed R-Q@38 0.401385009288788 5115.87841796875 1024.183 5115.47705078125 1024.10266113281 5 13 1.1.1.4633.15 1 72.1007 1148.066 72.1852 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.92999958992 LLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSK reduced acrolein addition +96(K)@14; Dethiomethyl(M)@41 missed K-L@14; missed R-E@16; missed K-E@32; missed R-Q@38 0.422446012496948 5131.9638671875 856.3346 5131.54150390625 856.26416015625 6 13 1.1.1.4534.2 1 69.5178 1121.808 69.4819 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 48.1599986553192 LLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@41 missed K-L@14; missed R-E@16; missed K-E@32; missed R-Q@38 0.473008006811142 5099.955078125 850.9998 5099.482421875 850.920959472656 6 12 1.1.1.4619.6 1 71.7206 2200.736 71.9738 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 32.1200013160706 LLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSK MDA adduct +62(K)@14; Carbamyl(R)@16; Dethiomethyl(M)@41 missed K-L@14; missed R-E@16; missed K-E@32; missed R-Q@38 0.551012992858887 5141.056640625 735.4439 5140.50537109375 735.365173339844 7 14 1.1.1.4557.7 1 70.1274 408.1081 70.0616 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 55.0800025463104 LLPVLESFKVSFLSALEEYTK cleaved G-L@N-term; missed K-V@9 1.18349003791809 2413.50268554688 805.5082 2412.3193359375 805.113708496094 3 13 1.1.1.4649.10 1 72.5159 957.3455 72.344 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.7900011539459 LPVLESFKVSFLSALEEYTKK cleaved L-L@N-term; missed K-V@8; missed K-K@20 -1.80489003658295 2425.52514648438 809.5157 2427.330078125 810.117309570313 3 14 1.1.1.4675.7 1 73.2034 157.2392 73.1363 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 46.5499997138977 LQEGARQKLHELQEKLSPLGEEMRDR cleaved E-L@N-term; missed R-Q@6; missed K-L@8; missed K-L@15; missed R-D@24 -12.9284000396729 3076.67553710938 616.3424 3089.60400390625 618.928100585938 5 12 1.1.1.3338.5 1 39.9618 3785.029 39.9463 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEF cleaved F-W@C-term; missed R-E@2 0.161926999688148 1415.90283203125 708.9587 1415.74084472656 708.877685546875 2 15 1.1.1.3411.8 1 41.7349 718.3422 41.7937 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.6000020503998 LREQLGPVTQEFW Trp->Hydroxykynurenin(W)@13 cleaved W-D@C-term; missed R-E@2 0.168589994311333 1621.97863769531 811.9966 1621.81005859375 811.912292480469 2 15 1.1.1.3618.20 1 46.8237 757.1614 46.9313 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Oxidation(W)@13 missed R-E@2 0.236686006188393 2217.34326171875 740.1217 2217.10668945313 740.042785644531 3 22 1.1.1.3457.18 1 42.862 1308.371 42.8203 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK missed R-E@2 0.241915002465248 2201.353515625 734.7918 2201.11157226563 734.711181640625 3 24 1.1.1.3628.17 1 47.0781 734.0605 47.0865 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Trp->Hydroxykynurenin(W)@13 missed R-E@2 0.24592199921608 2221.34741210938 741.4564 2221.1015625 741.374450683594 3 27 1.1.1.3679.3 1 48.3279 1210.693 48.315 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Dioxidation(W)@13 missed R-E@2 0.240795001387596 2233.34228515625 745.4547 2233.1015625 745.374450683594 3 26 1.1.1.3680.4 1 48.3512 49224.23 48.465 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Dioxidation(W)@13 missed R-E@2 0.173485994338989 2233.275390625 1117.645 2233.1015625 1117.55798339844 2 25 1.1.1.3683.4 1 48.4118 8530.301 48.465 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Dioxidation(W)@13 missed R-E@2 0.305418014526367 2233.40698242188 559.359 2233.1015625 559.282653808594 4 23 1.1.1.3684.3 1 48.4275 1316.634 48.4409 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Dioxidation(W)@13 missed R-E@2 0.173485994338989 2233.275390625 1117.645 2233.1015625 1117.55798339844 2 19 1.1.1.3691.9 1 48.5859 8530.301 48.465 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Dioxidation(W)@13 missed R-E@2 0.240795001387596 2233.34228515625 745.4547 2233.1015625 745.374450683594 3 26 1.1.1.3692.4 1 48.6 49229.31 48.465 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Dioxidation(W)@13 missed R-E@2 0.240795001387596 2233.34228515625 745.4547 2233.1015625 745.374450683594 3 25 1.1.1.3693.5 1 48.6266 49229.31 48.465 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Dioxidation(W)@13 missed R-E@2 0.240795001387596 2233.34228515625 745.4547 2233.1015625 745.374450683594 3 24 1.1.1.3694.4 1 48.6466 49229.31 48.465 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Trp->Kynurenin(W)@13 missed R-E@2 0.172306999564171 2205.279296875 1103.647 2205.10668945313 1103.560546875 2 20 1.1.1.3711.5 1 49.0684 1524.432 49.1458 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Trp->Kynurenin(W)@13 missed R-E@2 0.302774012088776 2205.40942382813 552.3596 2205.10668945313 552.283935546875 4 22 1.1.1.3714.3 1 49.1257 2156.137 49.1701 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Trp->Kynurenin(W)@13 missed R-E@2 0.241447001695633 2205.34814453125 736.1233 2205.10668945313 736.042785644531 3 23 1.1.1.3716.11 1 49.1811 8120.272 49.1458 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Oxidation(W)@13 missed R-E@2 0.240530997514725 2217.34716796875 740.123 2217.10668945313 740.042785644531 3 21 1.1.1.3765.10 1 50.4287 956.2017 50.4174 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK missed R-E@2 0.241915002465248 2201.353515625 734.7918 2201.11157226563 734.711181640625 3 28 1.1.1.3777.6 1 50.733 70266.88 50.8497 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK missed R-E@2 0.175277993083 2201.28735351563 1101.651 2201.11157226563 1101.56311035156 2 21 1.1.1.3777.16 1 50.7413 28225.55 50.8748 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK missed R-E@2 0.305988997220993 2201.41772460938 551.3617 2201.11157226563 551.285217285156 4 22 1.1.1.3780.3 1 50.8049 2920.749 50.8748 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Deamidated(Q)@10 missed R-E@2 0.260769009590149 2202.3564453125 735.1261 2202.095703125 735.039184570313 3 19 1.1.1.3781.8 1 50.8338 39895.62 50.8497 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK missed R-E@2 0.175277993083 2201.28735351563 1101.651 2201.11157226563 1101.56311035156 2 26 1.1.1.3784.19 1 50.9191 28225.55 50.8748 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK missed R-E@2 0.241915002465248 2201.353515625 734.7918 2201.11157226563 734.711181640625 3 20 1.1.1.3786.4 1 50.9557 70266.88 50.8497 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Oxidation(W)@13 missed R-E@2 0.244193002581596 2217.35083007813 740.1242 2217.10668945313 740.042785644531 3 19 1.1.1.3738.14 1 49.7434 558.7667 49.7283 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Oxidation(W)@13 missed R-E@2 0.245291993021965 2217.35180664063 740.1246 2217.10668945313 740.042785644531 3 18 1.1.1.3625.17 1 47.0001 453.5374 47.0865 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK Deamidated(Q)@10; Amidated@C-term missed R-E@2 0.258029013872147 2201.36962890625 734.7972 2201.11157226563 734.711181640625 3 19 1.1.1.3821.9 1 51.8258 581.2883 51.841 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEK FormaldehydeAdduct(W)@13; Deamidated(N)@15 missed R-E@2 0.255457997322083 2214.35107421875 739.1243 2214.095703125 739.039184570313 3 18 1.1.1.3682.3 1 48.3791 799.1715 48.3629 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.989999294281 LREQLGPVTQEFWDNLEK MDA adduct +62(K)@18 missed R-E@2 0.229256004095078 2263.35668945313 755.4595 2263.12744140625 755.383056640625 3 16 1.1.1.3823.7 1 51.8752 1306.053 51.892 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8699991703033 LREQLGPVTQEFWDNLEK Deamidated(Q)@10; Deamidated(N)@15 missed R-E@2 0.262593001127243 2203.34228515625 735.4547 2203.07983398438 735.3671875 3 16 1.1.1.3732.14 1 49.5885 1065.211 49.651 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 LREQLGPVTQEFWDNLEK Oxidation(W)@13 missed R-E@2 0.244743004441261 2217.35131835938 740.1244 2217.10668945313 740.042785644531 3 15 1.1.1.3632.19 1 47.1851 470.6273 47.1392 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.1100008487701 LREQLGPVTQEFWDNLEK Quinone(W)@13; Deamidated(N)@15 missed R-E@2 0.277983009815216 2232.34790039063 745.1232 2232.06982421875 745.030578613281 3 15 1.1.1.3736.11 1 49.6892 292.8429 49.7026 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 73.2999980449677 LREQLGPVTQEFWDNLEK Oxidation(W)@13 missed R-E@2 0.245291993021965 2217.35180664063 740.1246 2217.10668945313 740.042785644531 3 12 1.1.1.3616.17 1 46.7698 416.4227 46.8041 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR Dioxidation(W)@13 missed R-E@2; missed K-E@18 0.319429993629456 2918.76049804688 730.6974 2918.44091796875 730.617553710938 4 26 1.1.1.3835.7 1 52.1757 11561.32 52.243 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR Dioxidation(W)@13 missed R-E@2; missed K-E@18 0.319429993629456 2918.76049804688 730.6974 2918.44091796875 730.617553710938 4 20 1.1.1.3838.4 1 52.2492 11561.32 52.243 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR Dioxidation(W)@13 missed R-E@2; missed K-E@18 0.319429993629456 2918.76049804688 730.6974 2918.44091796875 730.617553710938 4 28 1.1.1.3842.5 1 52.3493 11561.32 52.243 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR Trp->Kynurenin(W)@13 missed R-E@2; missed K-E@18 0.31971600651741 2890.76586914063 723.6987 2890.44604492188 723.618774414063 4 28 1.1.1.3869.3 1 53.0109 8432.151 53.031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR Trp->Kynurenin(W)@13 missed R-E@2; missed K-E@18 0.247401997447014 2890.69360351563 964.5718 2890.44604492188 964.489318847656 3 29 1.1.1.3869.15 1 53.0209 3454.78 53.031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR missed R-E@2; missed K-E@18 0.320977985858917 2886.77221679688 722.7003 2886.451171875 722.620056152344 4 27 1.1.1.4019.6 1 56.6591 50873.86 56.8287 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR missed R-E@2; missed K-E@18 0.381327986717224 2886.83251953125 578.3738 2886.451171875 578.297485351563 5 23 1.1.1.4024.4 1 56.7837 910.5633 56.8542 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR missed R-E@2; missed K-E@18 0.251715987920761 2886.70288085938 963.2416 2886.451171875 963.157653808594 3 32 1.1.1.4025.16 1 56.8194 22038.24 56.8287 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR missed R-E@2; missed K-E@18 0.320977985858917 2886.77221679688 722.7003 2886.451171875 722.620056152344 4 29 1.1.1.4031.4 1 56.9623 50873.86 56.8287 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR Dioxidation(W)@13 missed R-E@2; missed K-E@18 -0.694242000579834 2917.74682617188 730.444 2918.44091796875 730.617553710938 4 19 1.1.1.3854.7 1 52.6472 697.881 52.6152 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLR missed R-E@2; missed K-E@18 0.251715987920761 2886.70288085938 963.2416 2886.451171875 963.157653808594 3 18 1.1.1.4032.16 1 56.9977 22038.24 56.8287 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8900005817413 LREQLGPVTQEFWDNLEKETEGLR Palmitoyl(T)@9 missed R-E@2; missed K-E@18 0.219730004668236 3124.90063476563 782.2324 3124.68090820313 782.177490234375 4 18 1.1.1.4029.7 1 56.9139 548.5051 56.8542 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 LREQLGPVTQEFWDNLEKETEGLR Methyl(D)@14 missed R-E@2; missed K-E@18 0.275543004274368 2900.74243164063 726.1929 2900.466796875 726.123962402344 4 16 1.1.1.3714.7 1 49.1291 334.6671 49.1215 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 76.3999998569489 LREQLGPVTQEFWDNLEKETEGLRQ Oxidation(W)@13; acrolein addition +56(K)@18 cleaved Q-E@C-term; missed R-E@2; missed K-E@18; missed R-Q@24 0.35284298658371 3086.8837890625 772.7282 3086.53100585938 772.640014648438 4 13 1.1.1.4271.8 1 62.8345 5257.308 62.6452 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24 0.328657001256943 3506.04345703125 877.5181 3505.71484375 877.435974121094 4 20 1.1.1.3724.20 1 49.3907 1505.882 49.4478 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24 0.391754001379013 3506.1064453125 702.2286 3505.71484375 702.150207519531 5 26 1.1.1.3727.11 1 49.4597 1647.757 49.4478 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK missed R-E@2; missed K-E@18; missed R-Q@24 0.370737999677658 3490.09057617188 699.0254 3489.7197265625 698.951232910156 5 27 1.1.1.3756.11 1 50.1987 2509.726 50.2375 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24 0.328657001256943 3506.04345703125 877.5181 3505.71484375 877.435974121094 4 23 1.1.1.3762.16 1 50.357 1776.889 50.4174 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.391059994697571 3538.095703125 708.6264 3537.70458984375 708.548217773438 5 24 1.1.1.3806.5 1 51.4456 40652.47 51.6116 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.332235991954803 3538.03686523438 885.5165 3537.70458984375 885.433410644531 4 22 1.1.1.3806.8 1 51.4506 25284.11 51.5869 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK reduced acrolein addition +96(K)@18; Dethiomethyl(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.32166001200676 3538.095703125 708.6264 3537.77392578125 708.562072753906 5 24 1.1.1.3813.7 1 51.6198 40652.47 51.6116 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.332235991954803 3538.03686523438 885.5165 3537.70458984375 885.433410644531 4 27 1.1.1.3813.12 1 51.624 25284.11 51.5869 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK FormaldehydeAdduct(W)@13; acrolein addition +56(K)@18; Dethiomethyl(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.366815000772476 3510.109375 703.0292 3509.74267578125 702.955810546875 5 23 1.1.1.3817.7 1 51.721 8116.572 51.8665 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Trp->Kynurenin(W)@13; Arg->Orn(R)@24; reduced acrolein addition +58(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24 0.374677985906601 3510.109375 703.0292 3509.73486328125 702.954223632813 5 27 1.1.1.3824.5 1 51.8991 8116.572 51.8665 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Trp->Kynurenin(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.333254009485245 3510.04296875 878.518 3509.70971679688 878.434692382813 4 24 1.1.1.3824.12 1 51.9049 5712.564 51.8665 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.328657001256943 3506.04345703125 877.5181 3505.71484375 877.435974121094 4 26 1.1.1.3936.3 1 54.646 26328.66 54.7591 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.391449004411697 3506.10620117188 702.2285 3505.71484375 702.150207519531 5 26 1.1.1.3937.3 1 54.6683 34527.82 54.7591 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.26366800069809 3505.97924804688 1169.667 3505.71484375 1169.57885742188 3 23 1.1.1.3940.12 1 54.7474 2039.623 54.7591 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.392363995313644 3506.10717773438 702.2287 3505.71484375 702.150207519531 5 25 1.1.1.3944.5 1 54.8416 29510.41 54.8812 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.328900992870331 3506.04370117188 877.5182 3505.71484375 877.435974121094 4 30 1.1.1.3944.7 1 54.8449 21605.1 54.8812 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.391449004411697 3506.10620117188 702.2285 3505.71484375 702.150207519531 5 24 1.1.1.3951.2 1 55.0075 36012.77 54.7591 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.328900992870331 3506.04370117188 877.5182 3505.71484375 877.435974121094 4 27 1.1.1.3951.5 1 55.01 21605.1 54.8812 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.390837997198105 3506.10546875 702.2284 3505.71484375 702.150207519531 5 25 1.1.1.3958.2 1 55.1796 16954.49 55.0284 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.32694798707962 3506.04174804688 877.5177 3505.71484375 877.435974121094 4 27 1.1.1.3958.3 1 55.1813 13006.27 55.0529 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.390228003263474 3506.10498046875 702.2283 3505.71484375 702.150207519531 5 25 1.1.1.3965.4 1 55.3543 14350.42 55.102 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.32694798707962 3506.04174804688 877.5177 3505.71484375 877.435974121094 4 25 1.1.1.3965.5 1 55.3568 10775.57 55.102 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.321332991123199 3506.0361328125 877.5163 3505.71484375 877.435974121094 4 21 1.1.1.3972.3 1 55.5277 4161.599 55.2726 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24 0.330323994159698 3522.0400390625 881.5173 3521.70971679688 881.434692382813 4 24 1.1.1.3981.5 1 55.7242 16431.35 55.9628 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24 0.393543004989624 3522.10327148438 705.4279 3521.70971679688 705.349182128906 5 21 1.1.1.3982.7 1 55.7472 22199.68 55.9628 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24 0.392933011054993 3522.1025390625 705.4278 3521.70971679688 705.349182128906 5 28 1.1.1.3989.4 1 55.9182 31287.4 56.0626 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24 0.330323994159698 3522.0400390625 881.5173 3521.70971679688 881.434692382813 4 30 1.1.1.3989.7 1 55.9207 25253.67 56.0378 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24 0.392933011054993 3522.1025390625 705.4278 3521.70971679688 705.349182128906 5 26 1.1.1.3996.3 1 56.0924 31287.4 56.0626 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24 0.330323994159698 3522.0400390625 881.5173 3521.70971679688 881.434692382813 4 31 1.1.1.3996.6 1 56.0949 25253.67 56.0378 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24 0.330323994159698 3522.0400390625 881.5173 3521.70971679688 881.434692382813 4 21 1.1.1.4003.6 1 56.2665 25897.22 56.0126 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Trp->Kynurenin(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24 0.389800995588303 3494.1044921875 699.8282 3493.71484375 699.750244140625 5 28 1.1.1.4005.4 1 56.3157 15614.75 56.431 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Trp->Kynurenin(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24 0.324995011091232 3494.03979492188 874.5172 3493.71484375 874.435974121094 4 28 1.1.1.4005.6 1 56.319 12033.88 56.431 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Trp->Kynurenin(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24 0.389800995588303 3494.1044921875 699.8282 3493.71484375 699.750244140625 5 28 1.1.1.4012.5 1 56.4893 15614.75 56.431 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Trp->Kynurenin(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24 0.324995011091232 3494.03979492188 874.5172 3493.71484375 874.435974121094 4 32 1.1.1.4012.7 1 56.4943 12033.88 56.431 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Trp->Kynurenin(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24 0.324995011091232 3494.03979492188 874.5172 3493.71484375 874.435974121094 4 21 1.1.1.4019.10 1 56.6624 12317.58 56.431 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24 0.390837997198105 3506.10546875 702.2284 3505.71484375 702.150207519531 5 26 1.1.1.4047.4 1 57.3621 2520.697 57.3814 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK missed R-E@2; missed K-E@18; missed R-Q@24 0.397899001836777 3490.11767578125 699.0308 3489.7197265625 698.951232910156 5 28 1.1.1.4054.4 1 57.5452 151128.3 57.7411 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK missed R-E@2; missed K-E@18; missed R-Q@24 0.255163997411728 3489.97436523438 1164.332 3489.7197265625 1164.24719238281 3 24 1.1.1.4055.20 1 57.5845 17059.07 57.7411 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Deamidated(Q)@25 missed R-E@2; missed K-E@18; missed R-Q@24 0.412418991327286 3491.1162109375 699.2305 3490.70385742188 699.148071289063 5 22 1.1.1.4057.2 1 57.6202 82206.88 57.7411 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK missed R-E@2; missed K-E@18; missed R-Q@24 0.331140011548996 3490.05102539063 873.52 3489.7197265625 873.437255859375 4 31 1.1.1.4059.5 1 57.6727 118040.6 57.7411 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK missed R-E@2; missed K-E@18; missed R-Q@24 0.397899001836777 3490.11767578125 699.0308 3489.7197265625 698.951232910156 5 28 1.1.1.4061.4 1 57.7219 150935.6 57.7411 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK missed R-E@2; missed K-E@18; missed R-Q@24 0.255163997411728 3489.97436523438 1164.332 3489.7197265625 1164.24719238281 3 28 1.1.1.4062.15 1 57.7574 17059.07 57.7411 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK missed R-E@2; missed K-E@18; missed R-Q@24 0.397899001836777 3490.11767578125 699.0308 3489.7197265625 698.951232910156 5 30 1.1.1.4068.4 1 57.8956 150935.6 57.7411 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK missed R-E@2; missed K-E@18; missed R-Q@24 0.331140011548996 3490.05102539063 873.52 3489.7197265625 873.437255859375 4 24 1.1.1.4068.11 1 57.9014 118040.6 57.7411 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Acetyl@N-term; Arg->GluSA(R)@2 missed R-E@2; missed K-E@18; missed R-Q@24 0.362289011478424 3489.03930664063 873.2671 3488.67700195313 873.176513671875 4 28 1.1.1.4434.5 1 66.9894 814.9539 66.978 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Deamidated(Q)@10; FormaldehydeAdduct(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24 0.416202992200851 3503.1201171875 701.6313 3502.70385742188 701.548034667969 5 21 1.1.1.4001.2 1 56.2143 916.4918 56.2352 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Trp->Hydroxykynurenin(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24 0.325197011232376 3510.03491210938 878.516 3509.70971679688 878.434692382813 4 20 1.1.1.4001.4 1 56.216 838.9064 56.1616 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Carbamidomethyl(E)@17 missed R-E@2; missed K-E@18; missed R-Q@24 0.396699011325836 3547.13793945313 710.4349 3546.7412109375 710.355529785156 5 19 1.1.1.4052.5 1 57.4937 1449.08 57.5121 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Dehydrated(D)@14; Methyl(E)@17 missed R-E@2; missed K-E@18; missed R-Q@24 0.353201985359192 3486.078125 698.2229 3485.72485351563 698.152282714844 5 21 1.1.1.3584.7 1 45.9651 1601.1 45.9525 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24 0.390837997198105 3506.10546875 702.2284 3505.71484375 702.150207519531 5 19 1.1.1.3761.11 1 50.3269 2190.85 50.4174 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Trp->Kynurenin(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24 0.39682000875473 3494.11157226563 699.8296 3493.71484375 699.750244140625 5 18 1.1.1.4020.2 1 56.6808 2200.972 56.7266 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.322512000799179 3522.0322265625 881.5153 3521.70971679688 881.434692382813 4 18 1.1.1.4010.5 1 56.4404 556.5895 56.3816 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Delta:H(2)C(2)@N-term missed R-E@2; missed K-E@18; missed R-Q@24 0.32940599322319 3516.06494140625 880.0235 3515.73559570313 879.941162109375 4 18 1.1.1.4315.11 1 63.9661 674.2266 63.9795 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Ammonia-loss(N)@15; reduced acrolein addition +58(K)@18 missed R-E@2; missed K-E@18; missed R-Q@24 0.340481996536255 3531.07568359375 883.7762 3530.73510742188 883.691040039063 4 18 1.1.1.4053.10 1 57.5242 2051.117 57.5644 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Delta:H(2)C(2)@N-term missed R-E@2; missed K-E@18; missed R-Q@24 0.394517004489899 3516.1298828125 704.2333 3515.73559570313 704.154357910156 5 18 1.1.1.4317.2 1 64.0102 732.9395 63.9795 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSK Trp->Kynurenin(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24 -0.683550000190735 3493.03125 874.2651 3493.71484375 874.435974121094 4 18 1.1.1.4026.13 1 56.8425 1136.463 56.7521 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.8799998760223 LREQLGPVTQEFWDNLEKETEGLRQEMSK Bromo(W)@13; HPNE addition +172(K)@18 missed R-E@2; missed K-E@18; missed R-Q@24 0.494323998689651 3740.23461914063 749.0542 3739.740234375 748.955322265625 5 17 1.1.1.3994.4 1 56.0434 2298.854 56.0378 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.8799998760223 LREQLGPVTQEFWDNLEKETEGLRQEMSK Trp->Kynurenin(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24 0.324995011091232 3494.03979492188 874.5172 3493.71484375 874.435974121094 4 16 1.1.1.4014.7 1 56.5369 12033.88 56.431 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8299984931946 LREQLGPVTQEFWDNLEKETEGLRQEMSK Trimethyl(K)@18 missed R-E@2; missed K-E@18; missed R-Q@24 -0.623660981655121 3531.14306640625 707.2359 3531.76684570313 707.360656738281 5 17 1.1.1.4052.4 1 57.4929 3344.325 57.5384 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5200006961823 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.25670999288559 3505.96997070313 1169.664 3505.71484375 1169.57885742188 3 15 1.1.1.3947.10 1 54.9204 1922.649 54.8812 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.4900026321411 LREQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24 0.253127992153168 3521.96313476563 1174.995 3521.70971679688 1174.91052246094 3 14 1.1.1.3996.16 1 56.1032 2152.708 56.0626 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.4900026321411 LREQLGPVTQEFWDNLEKETEGLRQEMSK Trioxidation(W)@13; Deamidated(N)@15; HPNE addition +172(K)@18 missed R-E@2; missed K-E@18; missed R-Q@24 0.459636986255646 3711.25805664063 743.2589 3710.79858398438 743.1669921875 5 17 1.1.1.4009.3 1 56.4126 933.4867 56.431 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.4900026321411 LREQLGPVTQEFWDNLEKETEGLRQEMSK acrolein addition +38(K)@18; HPNE addition +172(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24 0.412685006856918 3700.25805664063 741.0589 3699.84545898438 740.976379394531 5 15 1.1.1.4064.4 1 57.797 799.8679 57.7658 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4199988842011 LREQLGPVTQEFWDNLEKETEGLRQEMSK missed R-E@2; missed K-E@18; missed R-Q@24 0.397899001836777 3490.11767578125 699.0308 3489.7197265625 698.951232910156 5 17 1.1.1.4061.3 1 57.721 150935.6 57.7411 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.0400023460388 LREQLGPVTQEFWDNLEKETEGLRQEMSK Trp->Kynurenin(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.333254009485245 3510.04296875 878.518 3509.70971679688 878.434692382813 4 15 1.1.1.3817.15 1 51.7277 5712.564 51.8665 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.8500006198883 LREQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24 0.253127992153168 3521.96313476563 1174.995 3521.70971679688 1174.91052246094 3 14 1.1.1.3988.16 1 55.9033 2152.708 56.0626 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.1499977111816 LREQLGPVTQEFWDNLEKETEGLRQEMSK MDA adduct +62(K)@18; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.313982993364334 3568.04443359375 893.0184 3567.73046875 892.939880371094 4 14 1.1.1.3784.14 1 50.9149 386.7116 50.9003 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.6000018119812 LREQLGPVTQEFWDNLEKETEGLRQEMSK Bromo(W)@13; HPNE addition +172(K)@18 missed R-E@2; missed K-E@18; missed R-Q@24 0.494323998689651 3740.23461914063 749.0542 3739.740234375 748.955322265625 5 16 1.1.1.3987.5 1 55.8691 2298.854 56.0378 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.1700019836426 LREQLGPVTQEFWDNLEKETEGLRQEMSK Didehydroretinylidene(K)@18 missed R-E@2; missed K-E@18; missed R-Q@24 0.345840007066727 3754.25341796875 751.858 3753.90771484375 751.788818359375 5 16 1.1.1.4061.10 1 57.7269 991.7756 57.7411 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.2600028514862 LREQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24 0.392933011054993 3522.1025390625 705.4278 3521.70971679688 705.349182128906 5 14 1.1.1.3997.6 1 56.1194 31287.4 56.0626 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.2600028514862 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24 0.337689995765686 3506.05249023438 877.5204 3505.71484375 877.435974121094 4 14 1.1.1.4034.12 1 57.0449 905.8277 57.083 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.3500008583069 LREQLGPVTQEFWDNLEKETEGLRQEMSK Hex(N)@15; acrolein addition +76(K)@18 missed R-E@2; missed K-E@18; missed R-Q@24 -0.556402981281281 3727.24755859375 746.4568 3727.80395507813 746.568054199219 5 15 1.1.1.4060.5 1 57.6975 907.9864 57.716 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.580001115799 LREQLGPVTQEFWDNLEKETEGLRQEMSK reduced acrolein addition +58(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24 -0.624617993831635 3547.13696289063 710.4347 3547.76171875 710.559631347656 5 13 1.1.1.3846.4 1 52.4489 5705.864 52.3429 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.5100014209747 LREQLGPVTQEFWDNLEKETEGLRQEMSK Delta:H(2)C(2)@N-term missed R-E@2; missed K-E@18; missed R-Q@24 0.32940599322319 3516.06494140625 880.0235 3515.73559570313 879.941162109375 4 14 1.1.1.4314.6 1 63.9359 674.2266 63.9795 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.510002374649 LREQLGPVTQEFWDNLEKETEGLRQEMSK FormaldehydeAdduct(W)@13; Deamidated(N)@15 missed R-E@2; missed K-E@18; missed R-Q@24 0.352984011173248 3503.05688476563 876.7715 3502.70385742188 876.683227539063 4 14 1.1.1.4003.5 1 56.2656 626.461 56.2352 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.510002374649 LREQLGPVTQEFWDNLEKETEGLRQEMSK missed R-E@2; missed K-E@18; missed R-Q@24 -0.680579006671906 3489.03930664063 873.2671 3489.7197265625 873.437255859375 4 13 1.1.1.4427.5 1 66.8022 814.9539 66.978 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.0100028514862 LREQLGPVTQEFWDNLEKETEGLRQEMSK Deamidated(Q)@10; Dioxidation(W)@13; Deamidated(N)@15 missed R-E@2; missed K-E@18; missed R-Q@24 0.364733994007111 3524.04248046875 882.0179 3523.677734375 881.926696777344 4 14 1.1.1.3995.5 1 56.0692 5594.488 56.0626 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.4900000095367 LREQLGPVTQEFWDNLEKETEGLRQEMSK Dehydrated(D)@14; Methyl(E)@19 missed R-E@2; missed K-E@18; missed R-Q@24 0.303593009710312 3486.02856445313 872.5144 3485.72485351563 872.4384765625 4 15 1.1.1.3582.13 1 45.9165 989.6935 45.9525 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 77.9600024223328 LREQLGPVTQEFWDNLEKETEGLRQEMSK Bromo(W)@13; ONE addition +154(K)@18 missed R-E@2; missed K-E@18; missed R-Q@24 0.519353985786438 3722.2490234375 745.4571 3721.72973632813 745.353210449219 5 14 1.1.1.3993.5 1 56.0193 632.4204 56.0626 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.9599981307983 LREQLGPVTQEFWDNLEKETEGLRQEMSK MDA adduct +62(K)@18 missed R-E@2; missed K-E@18; missed R-Q@24 0.383285999298096 3552.11865234375 711.431 3551.73559570313 711.354370117188 5 14 1.1.1.4028.6 1 56.888 2453.267 56.9564 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 66.1899983882904 LREQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.260167002677917 3537.96508789063 1180.329 3537.70458984375 1180.2421875 3 12 1.1.1.3813.17 1 51.6281 1947.917 51.6116 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.9199998378754 LREQLGPVTQEFWDNLEKETEGLRQEMSK dHex(N)@15; reduced acrolein addition +96(K)@18; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.397911995649338 3748.22802734375 750.6529 3747.830078125 750.573303222656 5 14 1.1.1.3811.6 1 51.5694 992.8646 51.5869 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.2100007534027 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 0.330812007188797 3522.04052734375 881.5174 3521.70971679688 881.434692382813 4 11 1.1.1.3581.15 1 45.8939 447.4774 45.904 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.7899985313416 LREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(R)@24 missed R-E@2; missed K-E@18; missed R-Q@24 0.304486989974976 3506.01928710938 877.5121 3505.71484375 877.435974121094 4 12 1.1.1.3635.19 1 47.264 351.899 47.2444 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 25.5400002002716 LREQLGPVTQEFWDNLEKETEGLRQEMSK MDA adduct +62(K)@18 missed R-E@2; missed K-E@18; missed R-Q@24 0.318174988031387 3552.0537109375 889.0207 3551.73559570313 888.941162109375 4 13 1.1.1.4031.7 1 56.9648 1857.286 56.9564 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 15.0299996137619 LREQLGPVTQEFWDNLEKETEGLRQEMSK Trp->Kynurenin(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24 -0.612438023090363 3509.09716796875 702.8267 3509.70971679688 702.94921875 5 12 1.1.1.3633.15 1 47.2082 377.9791 47.2183 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK reduced acrolein addition +96(K)@18; Dethiomethyl(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.397745996713638 4251.53125 709.5958 4251.1337890625 709.529541015625 6 22 1.1.1.3867.7 1 52.965 3830.453 52.9818 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Oxidation(K)@18 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.402240008115768 4219.4765625 844.9026 4219.07421875 844.822143554688 5 23 1.1.1.3995.4 1 56.0684 3107.016 56.2352 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.402240008115768 4219.4765625 844.9026 4219.07421875 844.822143554688 5 30 1.1.1.4002.4 1 56.2453 3107.016 56.2352 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.470281004905701 4219.54443359375 704.2647 4219.07421875 704.186340332031 6 25 1.1.1.4004.4 1 56.2915 2567.471 56.2352 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.392778992652893 4219.46728515625 844.9007 4219.07421875 844.822143554688 5 27 1.1.1.4009.4 1 56.4142 3520.039 56.3571 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.393694996833801 4219.4677734375 844.9009 4219.07421875 844.822143554688 5 30 1.1.1.4016.8 1 56.5867 5192.146 56.5537 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.470281004905701 4219.54443359375 704.2647 4219.07421875 704.186340332031 6 23 1.1.1.4018.7 1 56.6352 3965.542 56.5537 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.414182990789413 4203.49365234375 841.706 4203.07958984375 841.623168945313 5 27 1.1.1.4312.6 1 63.8843 25581.29 64.0312 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.476792007684708 4203.55615234375 701.6 4203.07958984375 701.5205078125 6 23 1.1.1.4319.5 1 64.0636 17704.18 64.0312 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.414182990789413 4203.49365234375 841.706 4203.07958984375 841.623168945313 5 31 1.1.1.4319.9 1 64.067 25581.29 64.0312 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.340710014104843 4203.4189453125 1051.862 4203.07958984375 1051.77709960938 4 24 1.1.1.4319.18 1 64.0745 3395.823 64.0565 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.476792007684708 4203.55615234375 701.6 4203.07958984375 701.5205078125 6 26 1.1.1.4326.4 1 64.2438 17704.18 64.0312 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.414182990789413 4203.49365234375 841.706 4203.07958984375 841.623168945313 5 35 1.1.1.4326.9 1 64.2479 25581.29 64.0312 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Deamidated(N)@15; reduced acrolein addition +58(K)@18; Dehydrated(E)@21 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.423952996730804 4244.5185546875 849.911 4244.0947265625 849.826232910156 5 21 1.1.1.4311.11 1 63.8625 1211.233 63.9282 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.470281004905701 4219.54443359375 704.2647 4219.07421875 704.186340332031 6 19 1.1.1.4011.6 1 56.4625 3965.542 56.5537 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.476792007684708 4203.55615234375 701.6 4203.07958984375 701.5205078125 6 19 1.1.1.4312.4 1 63.8826 17704.18 64.0312 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.8500027656555 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK HPNE addition +172(K)@18; acrolein addition +56(K)@29; PyridoxalPhosphate(K)@35 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.310588002204895 4202.51220703125 841.5097 4202.20166015625 841.447570800781 5 17 1.1.1.4333.9 1 64.4298 1107.159 64.4448 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.4900026321411 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK HPNE addition +172(K)@18; Dethiomethyl(M)@27; reduced acrolein addition +58(K)@29; reduced acrolein addition +58(K)@35 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.385928004980087 4443.65576171875 889.7384 4443.26953125 889.661193847656 5 16 1.1.1.4304.11 1 63.6807 2253.84 63.6158 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.710000038147 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK acrolein addition +94(K)@18; Oxidation(M)@27; acrolein addition +112(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 -0.485830008983612 4424.6826171875 738.4544 4425.16845703125 738.535400390625 6 14 1.1.1.4317.4 1 64.0119 308.2221 64.0312 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.0100028514862 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK acrolein addition +112(K)@18; Oxidation(M)@27; acrolein addition +112(K)@35 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.476458013057709 4443.65576171875 889.7384 4443.17919921875 889.643127441406 5 13 1.1.1.4296.7 1 63.4679 2253.84 63.6158 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.0100028514862 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK acrolein addition +112(K)@18; Oxidation(M)@27; acrolein addition +112(K)@35 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.60307902097702 4443.7822265625 635.8333 4443.17919921875 635.747131347656 7 13 1.1.1.4307.3 1 63.7521 5342.852 63.6158 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 76.3999998569489 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Deamidated(N)@15; ONE addition +154(K)@18; Deamidated(Q)@25; hexanoyl addition +98(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.508212983608246 4457.72802734375 743.962 4457.22021484375 743.877258300781 6 13 1.1.1.4317.5 1 64.0127 405.1845 64.1073 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.9199998378754 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Deamidated(N)@15; hexanoyl addition +98(K)@18; acrolein addition +94(K)@29; MDA adduct +54(K)@35 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.418525993824005 4450.607421875 891.1288 4450.18896484375 891.045104980469 5 12 1.1.1.3824.13 1 51.9058 2023.751 51.892 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.1499972343445 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Trp->Kynurenin(W)@13; acrolein addition +38(K)@29; HPNE addition +172(K)@35 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 0.522298991680145 4417.72216796875 737.2943 4417.19970703125 737.207275390625 6 12 1.1.1.4323.5 1 64.1665 467.7592 64.0312 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 35.3100001811981 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK reduced acrolein addition +58(K)@18; Carbamidomethyl(S)@28; HPNE addition +172(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 -0.548043012619019 4489.70458984375 749.2914 4490.25244140625 749.382751464844 6 13 1.1.1.4057.5 0 57.6227 448.8871 57.6911 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 31.5699994564056 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVK Delta:H(2)C(2)@N-term; MDA adduct +62(K)@18; MDA adduct +62(K)@29; acrolein addition +38(K)@35 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29 -0.333353012800217 4390.80859375 879.169 4391.14208984375 879.235656738281 5 12 1.1.1.4270.11 1 62.8116 337.165 62.7991 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Dioxidation(W)@13; Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.411926001310349 4450.60791015625 891.1289 4450.1962890625 891.046508789063 5 22 1.1.1.3813.13 1 51.6248 2101.015 51.6617 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK reduced acrolein addition +96(K)@18; Dethiomethyl(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.402020990848541 4450.66748046875 742.7852 4450.265625 742.718200683594 6 23 1.1.1.3817.9 1 51.7227 4827.928 51.6617 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK reduced acrolein addition +96(K)@18; Dethiomethyl(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.404951006174088 4450.67041015625 742.7857 4450.265625 742.718200683594 6 22 1.1.1.3824.6 1 51.8999 4947.511 51.892 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.403768986463547 4418.6103515625 884.7293 4418.20654296875 884.648559570313 5 29 1.1.1.3931.4 1 54.5373 3129.353 54.5665 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.403158992528915 4418.609375 884.7292 4418.20654296875 884.648559570313 5 30 1.1.1.3963.4 1 55.3055 3236.48 55.4178 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.466865986585617 4418.67333984375 737.4528 4418.20654296875 737.375 6 21 1.1.1.3967.2 1 55.3968 6512.599 55.4419 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.403158992528915 4418.609375 884.7292 4418.20654296875 884.648559570313 5 28 1.1.1.3970.3 1 55.4749 3236.48 55.4178 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Dioxidation(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.411662012338638 4434.61279296875 887.9299 4434.201171875 887.847534179688 5 27 1.1.1.4053.12 1 57.5258 6079.675 57.5384 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Dioxidation(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.477932989597321 4434.67919921875 740.1205 4434.201171875 740.040832519531 6 25 1.1.1.4054.6 1 57.5468 12561.48 57.5384 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Dioxidation(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.411662012338638 4434.61279296875 887.9299 4434.201171875 887.847534179688 5 25 1.1.1.4060.7 1 57.6992 6079.675 57.5384 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Trp->Kynurenin(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.409750014543533 4406.6162109375 882.3305 4406.20654296875 882.24853515625 5 26 1.1.1.4066.12 1 57.8522 2194.856 57.8648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.420289993286133 4402.6318359375 881.5336 4402.21142578125 881.449584960938 5 24 1.1.1.4260.9 1 62.5534 24216.74 62.7991 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.420289993286133 4402.6318359375 881.5336 4402.21142578125 881.449584960938 5 33 1.1.1.4267.8 1 62.7314 24734.04 62.7991 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.486561000347137 4402.6982421875 734.7903 4402.21142578125 734.709167480469 6 25 1.1.1.4269.5 1 62.7807 37084.46 62.7991 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.343887001276016 4402.5546875 1101.646 4402.21142578125 1101.56018066406 4 24 1.1.1.4269.21 1 62.7941 2865.36 62.7991 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.420289993286133 4402.6318359375 881.5336 4402.21142578125 881.449584960938 5 36 1.1.1.4274.11 1 62.9125 24734.04 62.7991 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.486561000347137 4402.6982421875 734.7903 4402.21142578125 734.709167480469 6 23 1.1.1.4276.7 1 62.959 28080.49 63.0752 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.419068992137909 4402.63037109375 881.5334 4402.21142578125 881.449584960938 5 32 1.1.1.4281.6 1 63.0828 15875.91 63.0752 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.486561000347137 4402.6982421875 734.7903 4402.21142578125 734.709167480469 6 22 1.1.1.4283.6 1 63.1326 28080.49 63.0752 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.344375997781754 4402.5546875 1101.646 4402.21142578125 1101.56018066406 4 20 1.1.1.4284.14 1 63.1644 1660.736 63.1251 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.419068992137909 4402.63037109375 881.5334 4402.21142578125 881.449584960938 5 33 1.1.1.4288.7 1 63.2614 15875.91 63.0752 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.487293004989624 4402.69873046875 734.7904 4402.21142578125 734.709167480469 6 27 1.1.1.4290.7 1 63.313 28318.16 63.0504 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK HPNE addition +172(K)@29; hexanoyl addition +98(K)@35; PyridoxalPhosphate(K)@37 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.340043991804123 4443.720703125 741.6274 4443.38037109375 741.570678710938 6 23 1.1.1.4296.3 1 63.4646 5928.432 63.6158 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK PyridoxalPhosphate(K)@29; HPNE addition +172(K)@35; hexanoyl addition +98(K)@37 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.340043991804123 4443.720703125 741.6274 4443.38037109375 741.570678710938 6 22 1.1.1.4303.3 1 63.6477 5928.432 63.6158 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.467965006828308 4418.67431640625 737.453 4418.20654296875 737.375 6 20 1.1.1.3960.2 1 55.2316 6378.985 55.4178 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Dioxidation(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.477932989597321 4434.67919921875 740.1205 4434.201171875 740.040832519531 6 19 1.1.1.4061.7 1 57.7244 12561.48 57.5384 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 -1.40345001220703 4400.80810546875 734.4753 4402.21142578125 734.709167480469 6 20 1.1.1.4262.6 1 62.602 21076.28 62.4922 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK ONE addition +154(K)@18; Octanoyl(T)@20 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.450563013553619 4682.86572265625 781.4849 4682.41552734375 781.409851074219 6 20 1.1.1.4271.9 1 62.8353 847.8168 62.7991 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Deamidated(N)@15; ONE addition +154(K)@18; acrolein addition +94(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 -0.442532002925873 4650.89404296875 776.1563 4651.3369140625 776.230041503906 6 18 1.1.1.4274.4 1 62.9066 1345.919 62.7991 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Dioxidation(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.477932989597321 4434.67919921875 740.1205 4434.201171875 740.040832519531 6 18 1.1.1.4060.4 1 57.6967 12561.48 57.5384 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Carbamidomethyl(E)@11; reduced acrolein addition +58(K)@18; Oxidation(M)@27; acrolein addition +112(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 -0.455776989459991 4644.8662109375 775.1517 4645.322265625 775.227661132813 6 19 1.1.1.4270.6 1 62.8074 421.5392 62.7991 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK ONE addition +154(K)@18; MDA adduct +62(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 -0.482107013463974 4617.84423828125 770.648 4618.32666015625 770.728332519531 6 17 1.1.1.4268.10 1 62.7588 532.6283 62.773 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.480702012777328 4402.6923828125 734.7893 4402.21142578125 734.709167480469 6 18 1.1.1.4261.6 1 62.5764 36947.6 62.7991 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.542334020137787 4402.75390625 629.9721 4402.21142578125 629.894653320313 7 19 1.1.1.4268.4 1 62.7538 35996.98 62.7991 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.540198028087616 4402.75146484375 629.9718 4402.21142578125 629.894653320313 7 19 1.1.1.4278.2 1 63.0046 27069.76 63.0504 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Ammonia-loss(N)@15; reduced acrolein addition +58(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.493827998638153 4443.720703125 741.6274 4443.2265625 741.545104980469 6 18 1.1.1.4258.7 1 62.501 2129.661 62.5432 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Deamidated(N)@15; ONE addition +154(K)@18; acrolein addition +76(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 -0.475180000066757 4632.85107421875 773.1491 4633.326171875 773.228332519531 6 17 1.1.1.4279.5 1 63.032 1101.729 63.0504 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK MDA adduct +54(K)@18; Oxidation(M)@27; HPNE addition +172(K)@29; acrolein addition +38(K)@35 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.495135992765427 4682.837890625 781.4802 4682.3427734375 781.397705078125 6 17 1.1.1.4264.7 1 62.6541 475.6807 62.6452 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6199975013733 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Dioxidation(W)@13; ONE addition +154(K)@18; acrolein addition +94(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.49916398525238 4682.841796875 781.4809 4682.3427734375 781.397705078125 6 17 1.1.1.4278.7 1 63.0088 539.3336 63.0504 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.089998960495 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Deamidated(N)@15; ONE addition +154(K)@18; acrolein addition +94(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 -0.442532002925873 4650.89404296875 776.1563 4651.3369140625 776.230041503906 6 16 1.1.1.4263.9 1 62.6301 1345.919 62.7991 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.089998960495 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK MDA adduct +62(K)@18; Oxidation(M)@27; ONE addition +154(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 -0.48056098818779 4633.8408203125 773.3141 4634.3212890625 773.394165039063 6 16 1.1.1.4278.6 1 63.0079 1089.559 62.9757 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.089998960495 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Deamidated(N)@15; ONE addition +154(K)@18; acrolein addition +94(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 -0.458644986152649 4650.8779296875 776.1536 4651.3369140625 776.230041503906 6 16 1.1.1.4285.7 1 63.184 938.7598 63.1753 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.089998960495 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Delta:H(2)C(2)@N-term missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.497155994176865 4428.72412109375 739.128 4428.22705078125 739.045104980469 6 17 1.1.1.4366.2 1 65.2943 334.7861 65.2593 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.8799998760223 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Dioxidation(W)@13; HPNE addition +172(K)@18; Oxidation(M)@27; acrolein addition +94(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 -0.553556978702545 4715.79443359375 786.973 4716.34814453125 787.065307617188 6 17 1.1.1.4272.7 1 62.8594 370.1444 62.7991 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.8799998760223 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Deamidated(N)@15; ONE addition +154(K)@18; acrolein addition +94(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.539646029472351 4651.87646484375 776.32 4651.3369140625 776.230041503906 6 16 1.1.1.4276.10 1 62.9615 1163.629 63.1502 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.8799998760223 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Deamidated(N)@15; ONE addition +154(K)@18; acrolein addition +76(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.51249098777771 4633.8388671875 773.3137 4633.326171875 773.228332519531 6 16 1.1.1.4286.7 1 63.2095 798.0223 63.2007 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK reduced acrolein addition +96(K)@18; Dethiomethyl(M)@27 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.465362995862961 4450.73095703125 636.826 4450.265625 636.759521484375 7 16 1.1.1.3813.6 1 51.619 5295.868 51.6617 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.6800003051758 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Acetyl@N-term; Arg->GluSA(R)@2 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.492686003446579 4401.6611328125 734.6175 4401.16845703125 734.535400390625 6 18 1.1.1.4504.6 1 68.7667 735.0246 68.8333 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4199988842011 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK reduced acrolein addition +58(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 -0.540288984775543 4459.712890625 744.2928 4460.25341796875 744.3828125 6 16 1.1.1.4256.3 1 62.4474 829.0056 62.4922 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4199988842011 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.542334020137787 4402.75390625 629.9721 4402.21142578125 629.894653320313 7 17 1.1.1.4265.3 1 62.6762 35996.98 62.7991 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4199988842011 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.353165000677109 4402.5625 1101.648 4402.21142578125 1101.56018066406 4 15 1.1.1.4276.20 1 62.9698 1483.882 62.9757 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4199988842011 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.540198028087616 4402.75146484375 629.9718 4402.21142578125 629.894653320313 7 17 1.1.1.4287.5 1 63.2336 27069.76 63.0504 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.6900029182434 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Deamidated(N)@15; ONE addition +154(K)@18; MDA adduct +62(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 -0.446224987506866 4618.8642578125 770.818 4619.310546875 770.892333984375 6 15 1.1.1.4286.5 1 63.2078 425.9916 63.0752 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.8500006198883 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Deamidated(Q)@10; ONE addition +154(K)@18; acrolein addition +94(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 -0.458644986152649 4650.8779296875 776.1536 4651.3369140625 776.230041503906 6 15 1.1.1.4283.10 1 63.136 938.7598 63.1753 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.8500006198883 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Deamidated(N)@15; ONE addition +154(K)@18; Dioxidation(M)@27; acrolein addition +94(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 -0.485583990812302 4682.8408203125 781.4808 4683.32666015625 781.561706542969 6 16 1.1.1.4285.8 1 63.1848 698.5989 63.2007 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.7499978542328 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Trp->Kynurenin(W)@13; acrolein addition +38(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 -0.501420974731445 4443.720703125 741.6274 4444.22216796875 741.7109375 6 15 1.1.1.4268.7 1 62.7563 2129.661 62.5432 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.7199997901917 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Deamidated(Q)@10; acrolein addition +56(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.47120401263237 4459.69287109375 744.2894 4459.2216796875 744.210876464844 6 14 1.1.1.3784.10 1 50.9116 916.445 50.9258 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.4700000286102 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Trp->Kynurenin(W)@13; hexanoyl addition +98(K)@18; acrolein addition +112(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 -0.490027010440826 4615.841796875 770.3143 4616.33203125 770.395935058594 6 15 1.1.1.4281.3 1 63.0803 310.9905 63.0504 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.4700000286102 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK PyridoxalPhosphate(K)@18; hexanoyl addition +98(K)@29; HPNE addition +172(K)@37 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.401675999164581 4443.7822265625 635.8333 4443.38037109375 635.775939941406 7 16 1.1.1.4304.2 1 63.6732 5342.852 63.6158 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.2600028514862 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Trp->Kynurenin(W)@13 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.471626996994019 4406.67822265625 735.4536 4406.20654296875 735.375 6 14 1.1.1.4064.3 1 57.7953 4835.281 57.8648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.2600028514862 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Deamidated(N)@15; ONE addition +154(K)@18; MDA adduct +62(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.522037029266357 4619.83251953125 770.9794 4619.310546875 770.892333984375 6 14 1.1.1.4279.4 1 63.0312 374.1251 63.0006 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.5100014209747 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK ONE addition +154(K)@18; reduced acrolein addition +58(K)@29; acrolein addition +94(K)@35; acrolein addition +112(K)@37 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.356137990951538 4820.80322265625 965.1679 4820.44677734375 965.0966796875 5 13 1.1.1.4284.11 1 63.1619 699.5231 63.1004 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.8099985122681 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK MDA adduct +62(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.478478997945786 4464.70556640625 745.1249 4464.22705078125 745.045104980469 6 15 1.1.1.4308.5 1 63.78 757.3591 63.7463 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.0100028514862 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Deamidated(Q)@4; Deamidated(N)@15 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.578940987586975 4404.75830078125 630.2585 4404.1796875 630.17578125 7 13 1.1.1.4286.3 1 63.2061 8161.438 63.1251 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 77.4399995803833 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Trp->Kynurenin(W)@13; ONE addition +154(K)@18; ONE addition +154(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.3924959897995 4714.7978515625 786.8069 4714.4052734375 786.741455078125 6 13 1.1.1.4267.3 1 62.7272 348.2413 62.7991 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.9599981307983 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK reduced acrolein addition +58(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 -0.537725985050201 4459.7158203125 744.2932 4460.25341796875 744.3828125 6 14 1.1.1.4263.6 1 62.6276 764.4931 62.6196 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.4199979305267 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Deamidated(N)@15; ONE addition +154(K)@18; HPNE addition +172(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.49720099568367 4729.90185546875 789.3243 4729.40478515625 789.241394042969 6 12 1.1.1.4274.5 1 62.9074 280.1505 62.825 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.7799999713898 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Deamidated(N)@15; ONE addition +154(K)@18; MDA adduct +54(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 -0.479469001293182 4610.826171875 769.4783 4611.3056640625 769.558166503906 6 12 1.1.1.4278.5 1 63.0071 132.2705 63.0255 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.7799999713898 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK acrolein addition +94(K)@18; reduced acrolein addition +58(K)@29; HPNE addition +172(K)@35; acrolein addition +94(K)@37 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 -0.584914982318878 4819.8623046875 804.3176 4820.44677734375 804.415100097656 6 12 1.1.1.4278.11 1 63.0121 1139.4 63.0255 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.7799999713898 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK acrolein addition +76(K)@18; acrolein addition +76(K)@29; HPNE addition +172(K)@35; acrolein addition +94(K)@37 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 -0.565617024898529 4819.8603515625 804.3173 4820.42578125 804.41162109375 6 12 1.1.1.4283.12 1 63.1376 1240.645 63.1251 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.7799999713898 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Deamidated(N)@15; ONE addition +154(K)@18; acrolein addition +76(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.522011995315552 4633.84814453125 773.3153 4633.326171875 773.228332519531 6 12 1.1.1.4288.5 1 63.2597 1026.092 63.0006 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.7799999713898 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Deamidated(N)@15 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 -0.502582013607025 4402.69287109375 734.7894 4403.1953125 734.873168945313 6 11 1.1.1.4356.3 1 65.0278 146.3034 64.9689 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 66.1400020122528 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Dioxidation(W)@13; reduced acrolein addition +96(K)@18; Oxidation(M)@27; acrolein addition +112(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 -0.449557989835739 4657.8564453125 777.3167 4658.30615234375 777.391662597656 6 13 1.1.1.4269.8 1 62.7832 342.4396 62.773 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 57.940000295639 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Oxidation(W)@13; acrolein addition +94(K)@18; Oxidation(M)@27; ONE addition +154(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 -0.533537983894348 4681.80908203125 937.3691 4682.3427734375 937.475769042969 5 13 1.1.1.4266.10 1 62.7076 732.9602 62.7991 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 52.0099997520447 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Trp->Hydroxykynurenin(W)@13; MDA adduct +62(K)@37 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.367312014102936 4484.58447265625 748.438 4484.216796875 748.376770019531 6 11 1.1.1.4261.7 1 62.5772 334.0999 62.5178 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 51.4800012111664 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Dioxidation(W)@13; acrolein addition +76(K)@18; HPNE addition +172(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.459504008293152 4682.80224609375 937.5677 4682.3427734375 937.475769042969 5 12 1.1.1.4282.7 1 63.1134 529.1975 63.1004 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 49.3699997663498 LREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK Dioxidation(W)@13; reduced acrolein addition +96(K)@18; acrolein addition +112(K)@29 missed R-E@2; missed K-E@18; missed R-Q@24; missed K-D@29; missed K-A@35 0.565132021903992 4642.87646484375 774.82 4642.31103515625 774.725830078125 6 12 1.1.1.4265.7 1 62.6795 268.2852 62.6708 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 41.839998960495 LRQGLLPVLESFKVSFLSALEEYTK cleaved D-L@N-term; missed R-Q@2; missed K-V@13 -1.68824005126953 2864.89624023438 717.2313 2866.58447265625 717.653381347656 4 12 1.1.1.4620.9 1 71.7459 187.4961 71.761 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 62.9100024700165 LSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HPNE addition +172(K)@4; MDA adduct +54(K)@6; MDA adduct +62(K)@24 cleaved T-L@N-term; missed K-A@4; missed R-Q@13; missed K-V@24; missed K-K@36; missed K-L@37 -0.0417793989181519 4920.63623046875 985.1345 4920.67822265625 985.142883300781 5 13 1.1.1.4685.20 1 73.4668 976.3171 73.498 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 34.4799995422363 LSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Carbamidomethyl@N-term; acrolein addition +112(K)@4; reduced acrolein addition +58(K)@6 cleaved T-L@N-term; missed K-A@4; missed R-Q@13; missed K-V@24; missed K-K@36; missed K-L@37 0.293760001659393 4859.95068359375 1215.995 4859.65771484375 1215.92163085938 4 13 1.1.1.4743.11 1 74.9026 1279.922 74.8833 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.7800004482269 LSPLGEEMR 0.15132899582386 1030.6630859375 516.3388 1030.51171875 516.263122558594 2 14 1.1.1.2989.7 1 31.5822 52817.77 31.642 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.4699991941452 LSPLGEEMR 0.153160005807877 1030.66491699219 516.3397 1030.51171875 516.263122558594 2 11 1.1.1.2982.10 1 31.4146 51743.38 31.642 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 17.6499992609024 LSPLGEEMR 0.150962993502617 1030.66271972656 516.3386 1030.51171875 516.263122558594 2 11 1.1.1.3010.6 1 32.0885 13244.51 31.8352 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LSPLGEEMRDR missed R-D@9 0.156452998518944 1301.79626464844 651.9054 1301.63977050781 651.8271484375 2 18 1.1.1.2849.4 1 28.2199 47831.86 28.2768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LSPLGEEMRDR Delta:H(2)C(2)@N-term missed R-D@9 0.16143299639225 1327.81689453125 664.9157 1327.65539550781 664.835021972656 2 16 1.1.1.3186.9 1 36.3213 2213.559 36.4008 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LSPLGEEMRDR missed R-D@9 0.156698003411293 1301.79650878906 651.9055 1301.63977050781 651.8271484375 2 18 1.1.1.2863.8 1 28.5592 51333.02 28.5403 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LSPLGEEMRDR missed R-D@9 0.156452998518944 1301.79626464844 651.9054 1301.63977050781 651.8271484375 2 18 1.1.1.2856.7 1 28.389 50429.99 28.4206 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 LSPLGEEMRDR missed R-D@9 0.157429993152618 1301.79724121094 651.9059 1301.63977050781 651.8271484375 2 17 1.1.1.2884.10 1 29.0643 25715.59 28.8046 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8900005817413 LSPLGEEMRDR Oxidation(M)@8 missed R-D@9 0.153116002678871 1317.78784179688 659.9012 1317.63464355469 659.824645996094 2 16 1.1.1.2696.8 1 24.5712 106136.9 24.5284 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.5300004482269 LSPLGEEMRDR missed R-D@9 0.156819999217987 1301.79663085938 651.9056 1301.63977050781 651.8271484375 2 16 1.1.1.2840.8 1 28.0095 42216.07 28.2053 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.4799990653992 LSPLGEEMRDR missed R-D@9 0.156819999217987 1301.79663085938 651.9056 1301.63977050781 651.8271484375 2 16 1.1.1.2877.8 1 28.8958 49028.53 28.6362 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.990002155304 LSPLGEEMRDR Amidated@C-term missed R-D@9 0.155849993228912 1300.81164550781 651.4131 1300.65576171875 651.335144042969 2 14 1.1.1.2816.5 1 27.4371 807.9171 27.4422 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.6099987030029 LSPLGEEMRDR missed R-D@9 0.159627005457878 1301.79943847656 651.907 1301.63977050781 651.8271484375 2 15 1.1.1.2891.12 1 29.2328 6438.03 28.9732 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.3099994659424 LSPLGEEMRDR missed R-D@9 0.21543100476265 1301.85522460938 434.959 1301.63977050781 434.88720703125 3 14 1.1.1.2870.3 1 28.7172 190281.9 28.5644 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 LSPLGEEMRDR Delta:H(2)C(2)@N-term missed R-D@9 0.16143299639225 1327.81689453125 664.9157 1327.65539550781 664.835021972656 2 13 1.1.1.3193.8 1 36.489 2213.559 36.4008 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.370001077652 LSPLGEEMRDR missed R-D@9 0.159627005457878 1301.79943847656 651.907 1301.63977050781 651.8271484375 2 14 1.1.1.2898.9 1 29.3986 2849.451 29.1416 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 72.3999977111816 LSPLGEEMRDR missed R-D@9 0.212959006428719 1301.85278320313 434.9582 1301.63977050781 434.88720703125 3 13 1.1.1.2849.2 1 28.2116 175836.7 28.2292 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 72.3999977111816 LSPLGEEMRDR missed R-D@9 0.213324993848801 1301.85314941406 434.9583 1301.63977050781 434.88720703125 3 13 1.1.1.2856.4 1 28.3815 188857.4 28.5644 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 32.8000009059906 LSPLGEEMRDR missed R-D@9 0.212959006428719 1301.85278320313 434.9582 1301.63977050781 434.88720703125 3 12 1.1.1.2842.4 1 28.0454 174223 28.2292 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 32.2299987077713 LSPLGEEMRDR missed R-D@9 0.215705007314682 1301.85546875 434.9591 1301.63977050781 434.88720703125 3 12 1.1.1.2891.8 1 29.2261 17866.95 28.9732 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 30.6800007820129 LSPLGEEMRDR missed R-D@9 0.21543100476265 1301.85522460938 434.959 1301.63977050781 434.88720703125 3 12 1.1.1.2863.3 1 28.5467 190281.9 28.5644 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 26.6699999570847 LSPLGEEMRDR missed R-D@9 0.215705007314682 1301.85546875 434.9591 1301.63977050781 434.88720703125 3 12 1.1.1.2884.7 1 29.0577 65619.24 28.8046 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.5600023269653 LSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK MDA adduct +54(K)@7; acrolein addition +112(K)@9; acrolein addition +38(K)@27 cleaved H-L@N-term; missed K-A@7; missed R-Q@16; missed K-V@27 0.190429002046585 4553.646484375 911.7366 4553.4560546875 911.698486328125 5 13 1.1.1.4698.16 1 73.7988 842.1762 73.7823 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.9799976348877 LSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +38(K)@9; Dioxidation(R)@16 cleaved H-L@N-term; missed K-A@7; missed R-Q@16; missed K-V@27; missed K-K@39; missed K-L@40 0.390094995498657 5004.103515625 1001.828 5003.7109375 1001.74951171875 5 21 1.1.1.4742.5 1 74.8715 3226.245 74.9077 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 LSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Delta:H(2)C(2)(K)@7; reduced acrolein addition +58(K)@9 cleaved H-L@N-term; missed K-A@7; missed R-Q@16; missed K-V@27; missed K-K@39; missed K-L@40 0.111864000558853 5017.87353515625 1004.582 5017.76318359375 1004.55987548828 5 20 1.1.1.4736.4 1 74.7259 3306.458 74.7618 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6100018024445 LSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Methyl(E)@6; acrolein addition +56(K)@7 cleaved H-L@N-term; missed K-A@7; missed R-Q@16; missed K-V@27; missed K-K@39; missed K-L@40 0.352183997631073 5004.0986328125 1001.827 5003.74755859375 1001.75677490234 5 20 1.1.1.4749.15 1 75.0439 4344.662 75.0295 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.219997882843 LTGSQARHFWQQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved F-L@N-term; missed R-H@7; missed R-V@22; missed K-D@24; missed K-D@35; missed R-D@39 -2.31176996231079 5903.59716796875 984.9401 5905.90869140625 985.325439453125 6 14 1.1.1.4386.3 1 65.8113 1230.134 65.8644 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.8799998760223 LTLAVLFLTGSQARHFWQQDEPPQSPWDRVKDLATVYVDVLK cleaved V-L@N-term; missed R-H@14; missed R-V@29; missed K-D@31 -11.8641004562378 4854.685546875 971.9444 4866.5498046875 974.317199707031 5 17 1.1.1.4169.7 1 60.3322 17487.1 60.4369 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.2199990749359 NLKLLDNWDSVTSTFSK Arg-add@N-term; acrolein addition +94(K)@3 cleaved L-N@N-term; missed K-L@3 0.237470999360085 2217.38037109375 740.1341 2217.14306640625 740.054931640625 3 12 1.1.1.4338.4 1 64.5563 465.9078 64.4448 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 77.1799981594086 NLKLLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSK reduced acrolein addition +58(K)@3; Dioxidation(W)@8; acrolein addition +56(K)@17 cleaved L-N@N-term; missed K-L@3; missed K-L@17; missed R-E@19; missed K-E@35; missed R-Q@41 -0.429127991199493 5584.337890625 931.7303 5584.76708984375 931.801818847656 6 14 1.1.1.4059.6 0 57.6735 949.0243 57.6662 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.4899971485138 NWDSVTSTFSKLR MDA adduct +54(K)@11 cleaved D-N@N-term; missed K-L@11 0.160338997840881 1593.93908691406 797.9768 1593.77868652344 797.896606445313 2 15 1.1.1.3984.6 1 55.7954 12525.44 55.813 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.6099991798401 PALEDLRQGLLPVLESFKVSFLSALEEYTK Octanoyl(S)@16; ONE addition +154(K)@18 cleaved K-P@N-term; missed R-Q@7; missed K-V@18 0.207938998937607 3672.23974609375 919.0672 3672.03173828125 919.015197753906 4 15 1.1.1.4702.12 1 73.9032 780.5257 73.9116 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 45.6299990415573 PALEDLRQGLLPVLESFKVSFLSALEEYTK dHex(S)@16; reduced acrolein addition +58(K)@18 cleaved K-P@N-term; missed R-Q@7; missed K-V@18 0.353269994258881 3596.28100585938 900.0775 3595.927734375 899.989196777344 4 14 1.1.1.4708.9 1 74.046 2124.594 74.0578 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 28.7099987268448 PALEDLRQGLLPVLESFKVSFLSALEEYTK acrolein addition +112(K)@18 cleaved K-P@N-term; missed R-Q@7; missed K-V@18 -0.777683019638062 3503.1025390625 701.6278 3503.88037109375 701.783325195313 5 12 1.1.1.4509.9 1 68.8978 851.8674 68.8599 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.869998216629 PALEDLRQGLLPVLESFKVSFLSALEEYTKK Hex(S)@16; acrolein addition +38(K)@18 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30 -0.485078006982803 3719.50634765625 620.925 3719.99145507813 621.005859375 6 19 1.1.1.4685.5 1 73.4543 22781.08 73.4215 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8999981880188 PALEDLRQGLLPVLESFKVSFLSALEEYTKK Oxidation(Y)@28; acrolein addition +112(K)@30 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30 0.339055985212326 3648.30932617188 913.0846 3647.97021484375 912.999816894531 4 17 1.1.1.4705.6 1 73.9765 4490.148 73.808 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9300010204315 PALEDLRQGLLPVLESFKVSFLSALEEYTKK acrolein addition +38(K)@18; HexNAc(S)@20 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30 -0.476958990097046 3760.541015625 627.7641 3761.01782226563 627.843566894531 6 17 1.1.1.4700.2 1 73.8397 2930.119 73.8606 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.6099991798401 PALEDLRQGLLPVLESFKVSFLSALEEYTKK MDA adduct +54(K)@30; Amidated@C-term cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30 0.330309987068176 3573.27978515625 894.3272 3572.94946289063 894.24462890625 4 15 1.1.1.4702.10 1 73.8999 70308.02 74.0335 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.4599997997284 PALEDLRQGLLPVLESFKVSFLSALEEYTKK acrolein addition +56(K)@18; ONE addition +154(K)@30; ONE addition +154(K)@31 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30 0.311084985733032 3884.458984375 972.122 3884.14794921875 972.044250488281 4 13 1.1.1.4716.15 1 74.2417 751.6979 74.2031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 45.6299990415573 PALEDLRQGLLPVLESFKVSFLSALEEYTKK acrolein addition +112(K)@18; Dioxidation(Y)@28; reduced acrolein addition +96(K)@31 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30 0.450614988803864 3760.47314453125 753.1019 3760.02270507813 753.011779785156 5 14 1.1.1.4695.3 1 73.711 2795.13 73.6273 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 45.6299990415573 PALEDLRQGLLPVLESFKVSFLSALEEYTKK HPNE addition +172(K)@18; acrolein addition +112(K)@30; acrolein addition +112(K)@31 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30 0.286830991506577 3916.42456054688 980.1134 3916.1376953125 980.041687011719 4 12 1.1.1.4707.6 1 74.0184 373.6385 74.0092 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.3100006580353 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLN acrolein addition +56(K)@30; reduced acrolein addition +58(K)@31 cleaved K-P@N-term; cleaved N-T@C-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.319014996290207 3861.43701171875 966.3665 3861.11791992188 966.286743164063 4 17 1.1.1.4707.4 1 74.0151 5614.928 73.985 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.8499977588654 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLN acrolein addition +56(K)@30; reduced acrolein addition +58(K)@31 cleaved K-P@N-term; cleaved N-T@C-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.319014996290207 3861.43701171875 966.3665 3861.11791992188 966.286743164063 4 17 1.1.1.4706.8 1 73.9991 5614.928 73.985 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.3000004291534 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLN acrolein addition +56(K)@30; reduced acrolein addition +58(K)@31 cleaved K-P@N-term; cleaved N-T@C-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.301681011915207 3861.41967773438 966.3622 3861.11791992188 966.286743164063 4 17 1.1.1.4729.5 1 74.5595 2044.601 74.5197 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.9000005722046 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLN MDA adduct +62(K)@30; MDA adduct +62(K)@31; Deamidated(N)@33 cleaved K-P@N-term; cleaved N-T@C-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.379835993051529 3872.44506835938 969.1185 3872.06518554688 969.023559570313 4 14 1.1.1.4704.6 1 73.9506 1979.091 74.1788 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT Hydroxyheme(E)@15 cleaved K-P@N-term; cleaved T-Q@C-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.421487987041473 4461.837890625 893.3748 4462.25927734375 893.459106445313 5 21 1.1.1.4752.5 1 75.1128 4935.492 75.1523 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.9300012588501 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT Hydroxyheme(E)@15 cleaved K-P@N-term; cleaved T-Q@C-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.421487987041473 4461.837890625 893.3748 4462.25927734375 893.459106445313 5 21 1.1.1.4759.3 1 75.2832 4935.492 75.1523 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.8499977588654 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT Hydroxyheme(E)@15 cleaved K-P@N-term; cleaved T-Q@C-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.421182990074158 4461.837890625 893.3749 4462.25927734375 893.459106445313 5 18 1.1.1.4766.10 1 75.458 3300.927 75.3226 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.92999958992 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT acrolein addition +112(K)@18; Carbamidomethyl(S)@20; reduced acrolein addition +58(K)@30 cleaved K-P@N-term; cleaved T-Q@C-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.420787990093231 4075.63403320313 816.1341 4075.21337890625 816.049926757813 5 14 1.1.1.4789.15 1 76.0566 629.4771 76.0667 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 48.1599986553192 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT acrolein addition +76(K)@18; MDA adduct +62(K)@30; MDA adduct +62(K)@31 cleaved K-P@N-term; cleaved T-Q@C-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.27606999874115 4048.43627929688 810.6945 4048.16015625 810.639282226563 5 12 1.1.1.4673.11 1 73.1491 300.685 73.1103 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 48.1599986553192 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT Hydroxyheme(E)@15 cleaved K-P@N-term; cleaved T-Q@C-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.349967986345291 4461.9091796875 744.6588 4462.25927734375 744.717163085938 6 14 1.1.1.4766.6 1 75.4522 1304.104 75.3226 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Hydroxyheme(E)@15 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.427087008953094 4589.890625 918.9854 4590.31787109375 919.07080078125 5 23 1.1.1.4738.4 1 74.7809 24206.12 74.9077 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Hydroxyheme(E)@15 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.425256013870239 4589.892578125 918.9858 4590.31787109375 919.07080078125 5 25 1.1.1.4759.5 1 75.2899 25918.44 75.1523 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Hydroxyheme(E)@15 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.427087008953094 4589.890625 918.9854 4590.31787109375 919.07080078125 5 22 1.1.1.4745.4 1 74.9512 24206.12 74.9077 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Hydroxyheme(E)@15 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.427697002887726 4589.89013671875 918.9853 4590.31787109375 919.07080078125 5 22 1.1.1.4731.4 1 74.6113 15407.21 74.8348 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Hydroxyheme(E)@26 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.426782011985779 4589.89111328125 918.9855 4590.31787109375 919.07080078125 5 22 1.1.1.4752.8 1 75.1203 26812.67 75.0787 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ GlnGlnGlnThrGlyGly(K)@18 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.458211988210678 4575.880859375 916.1834 4575.42236328125 916.091796875 5 21 1.1.1.4744.13 1 74.9237 722.7542 74.8348 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +38(K)@18; HexNAc(S)@20 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.53642600774765 4216.71484375 844.3502 4217.2509765625 844.45751953125 5 21 1.1.1.4776.11 1 75.712 47274.82 75.5457 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Hydroxyheme(E)@15 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.362159013748169 4589.95556640625 765.9999 4590.31787109375 766.060241699219 6 21 1.1.1.4760.6 1 75.31 13293.32 75.1279 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Hydroxyheme(E)@15 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.363990008831024 4589.95361328125 765.9996 4590.31787109375 766.060241699219 6 21 1.1.1.4739.5 1 74.7982 16135.6 74.8833 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.9000022411346 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Hydroxyheme(E)@15 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.63393497467041 4590.95166015625 766.1659 4590.31787109375 766.060241699219 6 21 1.1.1.4725.3 1 74.4658 1749.289 74.4955 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.9000022411346 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Hydroxyheme(E)@15 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.362159013748169 4589.95556640625 765.9999 4590.31787109375 766.060241699219 6 21 1.1.1.4746.6 1 74.9727 16250.48 75.0295 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Hydroxyheme(E)@15 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.426171004772186 4589.8916015625 918.9856 4590.31787109375 919.07080078125 5 21 1.1.1.4766.12 1 75.4614 21062.27 75.2012 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.470002412796 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Hydroxyheme(E)@15 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.365087985992432 4589.95263671875 765.9994 4590.31787109375 766.060241699219 6 20 1.1.1.4732.4 1 74.6289 13119.8 74.8591 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.470002412796 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Triiodothyronine(Y)@28 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.0462191998958588 4445.826171875 890.1725 4445.8720703125 890.181701660156 5 20 1.1.1.4733.7 1 74.6498 51688.27 74.6648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.470002412796 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Hydroxyheme(E)@15 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.362159013748169 4589.95556640625 765.9999 4590.31787109375 766.060241699219 6 21 1.1.1.4753.6 1 75.1398 13293.32 75.1279 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.470002412796 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.34553599357605 3976.50170898438 995.1327 3976.15600585938 995.046325683594 4 18 1.1.1.4787.19 1 76.0071 632.4892 76.0405 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.1500029563904 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ ONE addition +154(K)@30; hexanoyl addition +98(K)@31; Deamidated(N)@33 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.389402002096176 4229.7021484375 846.9477 4229.3125 846.869812011719 5 18 1.1.1.4767.12 1 75.4861 1355.637 75.4945 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.1500029563904 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HexNAc(S)@16; acrolein addition +38(K)@18 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.449597001075745 4217.70068359375 844.5474 4217.2509765625 844.45751953125 5 19 1.1.1.4790.13 1 76.0815 7666.902 76.0405 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.1500029563904 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HexNAc(S)@16; acrolein addition +38(K)@18 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.449597001075745 4217.70068359375 844.5474 4217.2509765625 844.45751953125 5 19 1.1.1.4791.17 1 76.1113 7666.902 76.0405 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.0599999427795 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Triiodothyronine(Y)@28 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.0477451011538506 4445.82470703125 890.1722 4445.8720703125 890.181701660156 5 20 1.1.1.4747.6 1 74.9927 38776.28 74.7376 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8999981880188 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HexNAc(S)@16; acrolein addition +38(K)@18 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.485718995332718 4216.765625 703.8015 4217.2509765625 703.882446289063 6 18 1.1.1.4785.11 1 75.9476 11686.92 75.6738 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.7499971389771 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +38(K)@18; HexNAc(S)@20 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.53642600774765 4216.71484375 844.3502 4217.2509765625 844.45751953125 5 18 1.1.1.4783.13 1 75.8971 31044.3 75.6224 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.6000020503998 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HexNAc(S)@16; acrolein addition +38(K)@18 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.547106981277466 4216.7041015625 844.3481 4217.2509765625 844.45751953125 5 18 1.1.1.4724.5 1 74.4343 6856.135 74.5438 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2700009346008 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ FMN(S)@16 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.313481986522675 4413.9365234375 736.6634 4414.25 736.715637207031 6 18 1.1.1.4741.4 1 74.8398 605.1868 74.8591 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.8499977588654 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Hydroxyheme(E)@15 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.423729985952377 4589.89404296875 918.9861 4590.31787109375 919.07080078125 5 21 1.1.1.4724.6 1 74.4368 3505.573 74.4955 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.6099996566772 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ FMN(S)@16; hexanoyl addition +98(K)@18 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.490211009979248 4511.8330078125 903.3739 4512.3232421875 903.471923828125 5 18 1.1.1.4718.4 1 74.2909 1267.411 74.3245 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.8199996948242 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Hydroxyheme(E)@15; Deamidated(N)@33 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.338728010654449 4590.962890625 766.1678 4591.3017578125 766.224243164063 6 18 1.1.1.4767.9 1 75.4811 5985.22 75.2256 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.5400009155273 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ FMN(S)@16; reduced acrolein addition +58(K)@18 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.425036013126373 4471.8671875 895.3807 4472.2919921875 895.465698242188 5 18 1.1.1.4753.7 1 75.1423 857.4792 75.1523 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.3599977493286 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Hydroxyheme(E)@15; hexanoyl addition +98(K)@18 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.442389994859695 4687.94873046875 938.597 4688.39111328125 938.685485839844 5 20 1.1.1.4722.20 1 74.3926 2447.134 74.374 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.6099972724915 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Hydroxyheme(E)@15 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.362159013748169 4589.95556640625 765.9999 4590.31787109375 766.060241699219 6 16 1.1.1.4770.11 1 75.5577 5713.111 75.2983 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.9000005722046 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +112(K)@18; acrolein addition +76(K)@30; acrolein addition +94(K)@31 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.558696985244751 4257.72314453125 852.5519 4258.28173828125 852.663635253906 5 14 1.1.1.4778.14 1 75.7667 1648.214 75.8301 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.9000005722046 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ ONE addition +154(K)@30; acrolein addition +112(K)@31 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.60786098241806 4241.7001953125 849.3473 4242.30810546875 849.468872070313 5 14 1.1.1.4795.18 1 76.2178 1850.285 76.146 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.8299977779388 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +38(K)@18; HexNAc(S)@23 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.478760987520218 4216.7724609375 703.8027 4217.2509765625 703.882446289063 6 15 1.1.1.4749.3 1 75.0339 6995.402 75.1768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 73.5199987888336 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HPNE addition +172(K)@18; Acetyl(S)@20 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.412391006946564 4190.68896484375 839.1451 4190.27685546875 839.062622070313 5 15 1.1.1.4722.16 1 74.3893 948.2664 74.3245 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.5200026035309 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Hydroxyheme(E)@15; hexanoyl addition +98(K)@18 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.377218008041382 4688.013671875 782.3429 4688.39111328125 782.40576171875 6 15 1.1.1.4722.13 1 74.3868 1457.197 74.3985 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.4700012207031 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +112(K)@18; acrolein addition +56(K)@30; acrolein addition +112(K)@31 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.4324049949646 4256.7197265625 852.3512 4256.287109375 852.264709472656 5 13 1.1.1.4787.13 1 76.0021 1277.993 75.8301 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.3900008201599 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HPNE addition +172(K)@18; reduced acrolein addition +58(K)@30; acrolein addition +112(K)@31 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.358141988515854 4318.71826171875 864.751 4318.3603515625 864.679321289063 5 13 1.1.1.4775.12 1 75.687 621.8558 75.7254 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 62.9100024700165 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ HPNE addition +172(K)@30; MDA adduct +54(K)@31 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.581139028072357 4201.6953125 841.3464 4202.27685546875 841.462585449219 5 13 1.1.1.4785.16 1 75.9517 20943.32 75.8301 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.92999958992 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 2.95637989044189 3979.11254882813 995.7854 3976.15600585938 995.046325683594 4 13 1.1.1.4676.10 1 73.2321 344.7722 73.1363 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 45.6299990415573 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ MDA adduct +62(K)@18; hexanoyl addition +98(K)@30; reduced acrolein addition +96(K)@31 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.396762996912003 4232.69921875 847.5471 4232.30224609375 847.4677734375 5 12 1.1.1.4768.11 1 75.5065 1254.86 75.5199 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 41.839998960495 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +38(K)@30; acrolein addition +76(K)@31 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.549511015415192 4089.65356445313 818.938 4090.203125 819.047912597656 5 12 1.1.1.4791.14 1 76.1088 728.5109 76.1197 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 36.8900001049042 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ reduced acrolein addition +58(K)@18; MDA adduct +62(K)@30; MDA adduct +62(K)@31 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 -0.622160017490387 4157.60693359375 1040.409 4158.2294921875 1040.56457519531 4 12 1.1.1.4700.17 1 73.8522 296.1886 73.8337 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 36.8900001049042 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +94(K)@18; acrolein addition +112(K)@30; Deamidated(N)@33 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.537171006202698 4183.771484375 837.7616 4183.234375 837.654174804688 5 12 1.1.1.4760.7 1 75.3125 760.8376 75.2983 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 19.5800006389618 PALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +112(K)@18; HPNE addition +172(K)@31; HexNAc(N)@33 cleaved K-P@N-term; missed R-Q@7; missed K-V@18; missed K-K@30; missed K-L@31 0.546389997005463 4463.9443359375 744.998 4463.39794921875 744.906921386719 6 13 1.1.1.4726.6 1 74.4779 654.34 74.5197 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9199993610382 PLGEEMRDR cleaved S-P@N-term; missed R-D@7 0.151940003037453 1101.67565917969 551.8451 1101.52368164063 551.769104003906 2 13 1.1.1.2853.12 1 28.3196 6606.971 28.2292 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 PLGEEMRDR cleaved S-P@N-term; missed R-D@7 0.152184993028641 1101.67590332031 551.8452 1101.52368164063 551.769104003906 2 13 1.1.1.2860.10 1 28.4874 6684.002 28.5883 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.4799973964691 PLGEEMRDR cleaved S-P@N-term; missed R-D@7 0.151695996522903 1101.67541503906 551.845 1101.52368164063 551.769104003906 2 12 1.1.1.2839.7 1 27.9806 6153.604 28.2053 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.410001039505 PLGEEMRDR cleaved S-P@N-term; missed R-D@7 0.152184993028641 1101.67590332031 551.8452 1101.52368164063 551.769104003906 2 12 1.1.1.2867.7 1 28.65 6684.002 28.5883 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PLRAELQEGAR cleaved E-P@N-term; missed R-A@3 0.155331000685692 1238.82849121094 620.4215 1238.67309570313 620.343872070313 2 19 1.1.1.2904.8 1 29.5454 7959.879 29.7196 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PLRAELQEGAR cleaved E-P@N-term; missed R-A@3 0.152279004454613 1238.82543945313 620.42 1238.67309570313 620.343872070313 2 16 1.1.1.2770.5 1 26.3289 1010.825 26.3199 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PLRAELQEGAR cleaved E-P@N-term; missed R-A@3 0.155086994171143 1238.82824707031 620.4214 1238.67309570313 620.343872070313 2 17 1.1.1.2918.12 1 29.8801 8064.037 29.7679 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8900005817413 PLRAELQEGAR cleaved E-P@N-term; missed R-A@3 0.159115001559258 1238.83227539063 620.4234 1238.67309570313 620.343872070313 2 14 1.1.1.2778.6 1 26.5276 360.9884 26.536 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2699990272522 PLRAELQEGAR cleaved E-P@N-term; missed R-A@3 0.155452996492386 1238.82861328125 620.4216 1238.67309570313 620.343872070313 2 15 1.1.1.2897.9 1 29.377 6319.506 29.5986 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2700009346008 PLRAELQEGAR cleaved E-P@N-term; missed R-A@3 0.212659999728203 1238.8857421875 413.9692 1238.67309570313 413.898315429688 3 10 1.1.1.2689.3 1 24.3883 544.4693 24.3606 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 33.6400002241135 PLRAELQEGARQKLHELQEKLSPLGEEMRDR ONE addition +154(K)@13; reduced HNE(H)@15; HPNE addition +172(K)@20; Oxidation(M)@28 cleaved E-P@N-term; missed R-A@3; missed R-Q@11; missed K-L@13; missed K-L@20; missed R-D@29 0.459881007671356 4156.71630859375 594.8239 4156.25634765625 594.758239746094 7 12 1.1.1.3635.13 1 47.259 1066.622 47.2183 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.2699999809265 PPQSPWDRVK cleaved E-P@N-term; missed R-V@8 0.156387999653816 1208.78662109375 605.4006 1208.63024902344 605.322387695313 2 14 1.1.1.2964.11 1 30.9886 2443.326 31.0193 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.7499990463257 PPQSPWDRVK cleaved E-P@N-term; missed R-V@8 0.156387999653816 1208.78662109375 605.4006 1208.63024902344 605.322387695313 2 13 1.1.1.2973.9 1 31.2024 2443.326 31.0193 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6899971961975 PPQSPWDRVKDLATVYVDVLK Hex(R)@8; ONE addition +154(K)@10 cleaved E-P@N-term; missed R-V@8; missed K-D@10 0.196015000343323 2741.64868164063 914.8902 2741.45263671875 914.824829101563 3 18 1.1.1.4327.7 1 64.2717 4612.517 64.314 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.8500001430511 PPQSPWDRVKDLATVYVDVLK Lys-add@N-term; acrolein addition +112(K)@10 cleaved E-P@N-term; missed R-V@8; missed K-D@10 0.202886998653412 2665.65087890625 667.42 2665.44799804688 667.369262695313 4 14 1.1.1.3751.10 1 50.0731 4142.28 50.0132 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Hex(R)@8; ONE addition +154(K)@10 cleaved E-P@N-term; missed R-V@8; missed K-D@10; missed K-D@21; missed R-D@25 0.362008988857269 4538.6474609375 908.7368 4538.28564453125 908.664428710938 5 23 1.1.1.4475.5 1 68.0127 4770.545 68.1065 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Hex(R)@8; ONE addition +154(K)@10 cleaved E-P@N-term; missed R-V@8; missed K-D@10; missed K-D@21; missed R-D@25 0.362008988857269 4538.6474609375 908.7368 4538.28564453125 908.664428710938 5 25 1.1.1.4482.3 1 68.2002 4770.545 68.1065 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.5499987602234 PPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Hex(R)@8; ONE addition +154(K)@10 cleaved E-P@N-term; missed R-V@8; missed K-D@10; missed K-D@21; missed R-D@25 0.287254989147186 4538.57470703125 1135.651 4538.28564453125 1135.57873535156 4 19 1.1.1.4478.9 1 68.1014 1184.124 68.1065 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.7499971389771 PPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK HPNE addition +172(K)@10; Dicarbamidomethyl(D)@11 cleaved E-P@N-term; missed R-V@8; missed K-D@10; missed K-D@21; missed R-D@25 0.340283989906311 4508.62646484375 902.7326 4508.2861328125 902.66455078125 5 18 1.1.1.4460.11 1 67.6349 1274.756 67.5497 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.6000018119812 PPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(R)@8; HPNE addition +172(K)@10; acrolein addition +112(K)@21 cleaved E-P@N-term; missed R-V@8; missed K-D@10; missed K-D@21; missed R-D@25 0.303811013698578 4507.58251953125 1127.903 4507.27978515625 1127.82727050781 4 16 1.1.1.4417.9 1 66.5495 2465.512 66.6631 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.6000018119812 PPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Dioxidation(W)@6; Deamidated(R)@8; hexanoyl addition +98(K)@10; ONE addition +154(K)@21 cleaved E-P@N-term; missed R-V@8; missed K-D@10; missed K-D@21; missed R-D@25 0.303811013698578 4507.58251953125 1127.903 4507.27978515625 1127.82727050781 4 17 1.1.1.4424.8 1 66.7343 2465.512 66.6631 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.1700019836426 PPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK HPNE addition +172(K)@21; GlyGly(S)@23 cleaved E-P@N-term; missed R-V@8; missed K-D@10; missed K-D@21; missed R-D@25 -0.563781976699829 4507.72265625 752.2944 4508.2861328125 752.388366699219 6 17 1.1.1.4413.2 1 66.4361 5032.877 66.5856 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.2600028514862 PPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(P)@5; ONE addition +154(K)@10 cleaved E-P@N-term; missed R-V@8; missed K-D@10; missed K-D@21; missed R-D@25 0.401241987943649 4392.62890625 879.5331 4392.2275390625 879.452819824219 5 15 1.1.1.4349.4 1 64.847 613.6547 64.9421 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.8800003528595 PPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK HPNE addition +172(K)@21; GlyGly(S)@23 cleaved E-P@N-term; missed R-V@8; missed K-D@10; missed K-D@21; missed R-D@25 -0.564881026744843 4507.7216796875 752.2942 4508.2861328125 752.388366699219 6 16 1.1.1.4420.3 1 66.6237 5126.645 66.6121 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 65.5900001525879 PPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK HPNE addition +172(K)@10; hexanoyl addition +98(K)@21 cleaved E-P@N-term; missed R-V@8; missed K-D@10; missed K-D@21; missed R-D@25 0.392430007457733 4492.708984375 749.7921 4492.31640625 749.726684570313 6 12 1.1.1.4422.3 1 66.6758 1264.625 66.8468 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.1499972343445 PPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@3; HPNE addition +172(K)@10; acrolein addition +112(K)@21 cleaved E-P@N-term; missed R-V@8; missed K-D@10; missed K-D@21; missed R-D@25 0.409375011920929 4507.689453125 752.2888 4507.27978515625 752.220581054688 6 13 1.1.1.4406.2 1 66.2629 1672.263 66.1109 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 53.6199986934662 PPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK acrolein addition +94(K)@21; HexNAc(S)@29 cleaved E-P@N-term; missed R-V@8; missed K-D@10; missed K-D@21; missed R-D@25 0.334917992353439 4519.58984375 754.2722 4519.2548828125 754.216369628906 6 13 1.1.1.4387.2 1 65.8237 916.6171 65.8165 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 50.9500026702881 PPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK acrolein addition +94(K)@21; HexNAc(S)@29 cleaved E-P@N-term; missed R-V@8; missed K-D@10; missed K-D@21; missed R-D@25 0.337114989757538 4519.591796875 754.2726 4519.2548828125 754.216369628906 6 13 1.1.1.4378.2 1 65.5944 1059.932 65.5412 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 46.8899995088577 PPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK HexNAc(S)@4; MDA adduct +54(K)@10 cleaved E-P@N-term; missed R-V@8; missed K-D@10; missed K-D@21; missed R-D@25 0.391683012247086 4479.615234375 896.9303 4479.2236328125 896.851989746094 5 14 1.1.1.4471.9 1 67.9102 540.2525 67.8467 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 44.1900014877319 PPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@3; HPNE addition +172(K)@10; acrolein addition +112(K)@21 cleaved E-P@N-term; missed R-V@8; missed K-D@10; missed K-D@21; missed R-D@25 0.442333996295929 4507.72216796875 752.2943 4507.27978515625 752.220581054688 6 12 1.1.1.4361.3 1 65.1616 1013.438 65.2329 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 33.4199994802475 PPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK HPNE addition +172(K)@10; acrolein addition +112(K)@21; Deamidated(R)@25 cleaved E-P@N-term; missed R-V@8; missed K-D@10; missed K-D@21; missed R-D@25 0.409375011920929 4507.689453125 752.2888 4507.27978515625 752.220581054688 6 12 1.1.1.4399.3 1 66.0942 1672.263 66.1109 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 30.6499987840652 PPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(R)@8; HPNE addition +172(K)@10; acrolein addition +112(K)@21 cleaved E-P@N-term; missed R-V@8; missed K-D@10; missed K-D@21; missed R-D@25 0.3817999958992 4507.66162109375 902.5396 4507.27978515625 902.463256835938 5 12 1.1.1.4417.4 1 66.5411 7258.649 66.5856 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.9500021934509 PPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNL acrolein addition +56(K)@21 cleaved E-P@N-term; cleaved L-K@C-term; missed R-V@8; missed K-D@10; missed K-D@21; missed R-D@25; missed K-Q@38 0.246149003505707 4746.6748046875 1187.676 4746.42919921875 1187.61462402344 4 12 1.1.1.4400.5 1 66.1266 1046.142 66.135 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK HPNE addition +172(K)@21; Oxidation(R)@25; Carbamidomethyl(D)@26 cleaved E-P@N-term; missed R-V@8; missed K-D@10; missed K-D@21; missed R-D@25; missed K-Q@38 -0.486559003591537 5063.1376953125 724.3127 5063.62451171875 724.382202148438 7 20 1.1.1.4422.2 1 66.6716 7765.759 66.7419 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.7200000286102 PPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK HPNE addition +172(K)@21; acrolein addition +112(K)@38; Deamidated(Q)@39 cleaved E-P@N-term; missed R-V@8; missed K-D@10; missed K-D@21; missed R-D@25; missed K-Q@38 0.452982008457184 5104.09765625 851.6902 5103.64453125 851.614685058594 6 16 1.1.1.4422.4 1 66.68 4374.326 66.8468 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 17.3600003123283 PPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK reduced acrolein addition +96(K)@21; Phospho(S)@34; ONE addition +154(K)@38 cleaved E-P@N-term; missed R-V@8; missed K-D@10; missed K-D@21; missed R-D@25; missed K-Q@38 0.448680996894836 5149.06982421875 859.1856 5148.62109375 859.11083984375 6 13 1.1.1.4599.12 1 71.1976 783.129 71.1805 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 61.760002374649 PQSPWDRVKDLATVYVDVLK GlnThrGlyGly(K)@9 cleaved P-P@N-term; missed R-V@7; missed K-D@9 0.268020987510681 2671.6650390625 668.9235 2671.39697265625 668.856506347656 4 13 1.1.1.4048.2 1 57.3864 2891.601 57.4073 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.5100028514862 PQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK ONE addition +154(K)@9; HPNE addition +172(K)@20; Carbamidomethyl(D)@21 cleaved P-P@N-term; missed R-V@7; missed K-D@9; missed K-D@20; missed R-D@24 -0.590032994747162 4507.7216796875 752.2942 4508.3115234375 752.392517089844 6 14 1.1.1.4427.4 1 66.8014 5537.332 66.7161 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.4800016880035 PQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term; HPNE addition +172(K)@9; ONE addition +154(K)@20 cleaved P-P@N-term; missed R-V@7; missed K-D@9; missed K-D@20; missed R-D@24 0.312994986772537 4508.62451171875 902.7322 4508.3115234375 902.669555664063 5 14 1.1.1.4638.8 1 72.2279 1463.782 72.3706 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 51.9599974155426 PQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK acrolein addition +112(K)@9 cleaved P-P@N-term; missed R-V@7; missed K-D@9; missed K-D@20; missed R-D@24 -0.618021011352539 4236.51513671875 848.3103 4237.13330078125 848.433898925781 5 13 1.1.1.4449.8 1 67.3611 643.614 67.3279 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.92999792099 PQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK hexanoyl addition +98(K)@9; acrolein addition +76(K)@20; acrolein addition +112(K)@37; acrolein addition +56(K)@42 cleaved P-P@N-term; missed R-V@7; missed K-D@9; missed K-D@20; missed R-D@24; missed K-Q@37; missed K-L@42 -0.502821028232574 6656.89306640625 951.992 6657.39599609375 952.063842773438 7 16 1.1.1.4647.15 1 72.4668 909.2838 72.5035 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.8299970626831 PQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK HPNE addition +172(K)@20; acrolein addition +94(K)@37; acrolein addition +76(K)@42; Dioxidation(W)@47 cleaved P-P@N-term; missed R-V@7; missed K-D@9; missed K-D@20; missed R-D@24; missed K-Q@37; missed K-L@42 -0.493625998497009 6688.89208984375 956.5633 6689.3857421875 956.6337890625 7 16 1.1.1.4589.5 1 70.9323 809.8391 70.9707 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.6099991798401 PQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK acrolein addition +112(K)@9; HPNE addition +172(K)@20; acrolein addition +56(K)@37; Deamidated(N)@40 cleaved P-P@N-term; missed R-V@7; missed K-D@9; missed K-D@20; missed R-D@24; missed K-Q@37; missed K-L@42 0.496576011180878 6656.8818359375 951.9904 6656.38525390625 951.919494628906 7 15 1.1.1.4655.16 1 72.679 1071.081 72.6092 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 45.6299990415573 PQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK acrolein addition +76(K)@9; acrolein addition +112(K)@20; ONE addition +154(K)@37; Dioxidation(W)@47 cleaved P-P@N-term; missed R-V@7; missed K-D@9; missed K-D@20; missed R-D@24; missed K-Q@37; missed K-L@42 -0.56538999080658 6688.82275390625 1115.811 6689.3857421875 1115.90490722656 6 14 1.1.1.4589.7 1 70.9389 647.7654 70.944 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 19.5800006389618 PQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK HPNE addition +172(K)@9; acrolein addition +112(K)@20; reduced acrolein addition +58(K)@42 cleaved P-P@N-term; missed R-V@7; missed K-D@9; missed K-D@20; missed R-D@24; missed K-Q@37; missed K-L@42 -0.575694024562836 6656.84228515625 1110.481 6657.4169921875 1110.57678222656 6 11 1.1.1.4655.19 1 72.6815 708.4802 72.6092 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 16.9400006532669 PQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK reduced acrolein addition +96(K)@9; acrolein addition +112(K)@20; acrolein addition +38(K)@37; reduced acrolein addition +96(K)@42 cleaved P-P@N-term; missed R-V@7; missed K-D@9; missed K-D@20; missed R-D@24; missed K-Q@37; missed K-L@42 0.505052983760834 6657.90087890625 952.136 6657.39599609375 952.063842773438 7 12 1.1.1.4662.10 1 72.8666 663.8033 72.8734 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.6099991798401 PVLESFKVSFLSALEEYTKK cleaved L-P@N-term; missed K-V@7; missed K-K@19 0.239994004368782 2314.48608398438 772.5026 2314.24609375 772.422607421875 3 13 1.1.1.4672.14 1 73.1253 230.5016 73.1626 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.92999958992 PVLESFKVSFLSALEEYTKK cleaved L-P@N-term; missed K-V@7; missed K-K@19 0.253176987171173 2314.49926757813 772.507 2314.24609375 772.422607421875 3 12 1.1.1.4688.7 1 73.5326 335.8665 73.3956 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PVLESFKVSFLSALEEYTKKLNTQ cleaved L-P@N-term; missed K-V@7; missed K-K@19; missed K-L@20 3.81571006774902 2774.294921875 925.7723 2770.47924804688 924.500366210938 3 22 1.1.1.4773.17 1 75.6396 4704.577 75.648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PVLESFKVSFLSALEEYTKKLNTQ cleaved L-P@N-term; missed K-V@7; missed K-K@19; missed K-L@20 0.221163004636765 2770.70043945313 924.5741 2770.47924804688 924.500366210938 3 21 1.1.1.4751.18 1 75.0958 649.5057 75.1279 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.470002412796 PVLESFKVSFLSALEEYTKKLNTQ cleaved L-P@N-term; missed K-V@7; missed K-K@19; missed K-L@20 4.43021011352539 2774.90942382813 925.9771 2770.47924804688 924.500366210938 3 19 1.1.1.4734.13 1 74.6808 1108.68 74.6648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.470002412796 PVLESFKVSFLSALEEYTKKLNTQ cleaved L-P@N-term; missed K-V@7; missed K-K@19; missed K-L@20 -6.94997978210449 2763.529296875 922.1837 2770.47924804688 924.500366210938 3 18 1.1.1.4750.16 1 75.0695 7752.191 75.1768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.470002412796 PVLESFKVSFLSALEEYTKKLNTQ cleaved L-P@N-term; missed K-V@7; missed K-K@19; missed K-L@20 -6.94997978210449 2763.529296875 922.1837 2770.47924804688 924.500366210938 3 18 1.1.1.4751.17 1 75.095 7752.191 75.1768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.869998216629 PVLESFKVSFLSALEEYTKKLNTQ cleaved L-P@N-term; missed K-V@7; missed K-K@19; missed K-L@20 -6.94997978210449 2763.529296875 922.1837 2770.47924804688 924.500366210938 3 20 1.1.1.4765.8 1 75.435 7920.882 75.1768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1800029277802 PVLESFKVSFLSALEEYTKKLNTQ cleaved L-P@N-term; missed K-V@7; missed K-K@19; missed K-L@20 -6.94997978210449 2763.529296875 922.1837 2770.47924804688 924.500366210938 3 17 1.1.1.4753.9 1 75.1473 7752.191 75.1768 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 45.6299990415573 PVLESFKVSFLSALEEYTKKLNTQ Delta:H(2)C(2)@N-term; reduced acrolein addition +58(K)@7 cleaved L-P@N-term; missed K-V@7; missed K-K@19; missed K-L@20 0.220410004258156 2854.75732421875 952.593 2854.53686523438 952.51953125 3 13 1.1.1.4696.8 1 73.7427 180.802 73.7561 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.0100026130676 PWDRVKDLATVYVDVLK cleaved S-P@N-term; missed R-V@4; missed K-D@6 -3.35145998001099 2012.7529296875 671.9249 2016.10437011719 673.042053222656 3 14 1.1.1.4063.2 1 57.7697 1273.114 57.8154 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.7799999713898 PWDRVKDLATVYVDVLK cleaved S-P@N-term; missed R-V@4; missed K-D@6 -4.096519947052 2012.00793457031 671.6766 2016.10437011719 673.042053222656 3 12 1.1.1.4030.5 1 56.938 3185.006 57.0069 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PYLDDFQKKWQEEMELYR Oxidation(M)@14 cleaved Q-P@N-term; missed K-K@8; missed K-W@9 0.243680000305176 2433.37475585938 812.1322 2433.13110351563 812.050964355469 3 25 1.1.1.3697.6 1 48.7277 1292.568 48.7602 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PYLDDFQKKWQEEMELYR Oxidation(M)@14 cleaved Q-P@N-term; missed K-K@8; missed K-W@9 0.248256996273994 2433.37939453125 812.1337 2433.13110351563 812.050964355469 3 26 1.1.1.3707.5 1 48.9685 1389.266 49.0012 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PYLDDFQKKWQEEMELYR cleaved Q-P@N-term; missed K-K@8; missed K-W@9 -6.84313011169434 2410.29296875 804.4383 2417.13623046875 806.719360351563 3 20 1.1.1.3755.17 1 50.1785 829.4993 50.2122 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PYLDDFQKKWQEEMELYR cleaved Q-P@N-term; missed K-K@8; missed K-W@9 0.244148999452591 2417.38037109375 806.8007 2417.13623046875 806.719360351563 3 23 1.1.1.3788.8 1 51.0083 2596.093 51.1247 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 PYLDDFQKKWQEEMELYR cleaved Q-P@N-term; missed K-K@8; missed K-W@9 0.248908996582031 2417.38500976563 806.8023 2417.13623046875 806.719360351563 3 24 1.1.1.3802.9 1 51.357 2370.819 51.2701 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.0300028324127 PYLDDFQKKWQEEMELYR Trp->Kynurenin(W)@10; Oxidation(M)@14 cleaved Q-P@N-term; missed K-K@8; missed K-W@9 0.25254899263382 2437.37866210938 813.4668 2437.1259765625 813.382629394531 3 16 1.1.1.3608.14 1 46.5695 262.072 46.5762 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1900012493134 PYLDDFQKKWQEEMELYR acrolein addition +112(K)@8; acrolein addition +112(K)@9; Oxidation(W)@10 cleaved Q-P@N-term; missed K-K@8; missed K-W@9 0.337720990180969 2657.57373046875 665.4007 2657.23583984375 665.316284179688 4 15 1.1.1.3732.12 1 49.5869 1417.227 49.4731 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.2599999904633 PYLDDFQKKWQEEMELYR HPNE addition +172(K)@8; reduced acrolein addition +96(K)@9 cleaved Q-P@N-term; missed K-K@8; missed K-W@9 0.238310992717743 2685.5419921875 896.1879 2685.3037109375 896.108520507813 3 12 1.1.1.3814.16 1 51.6524 5484.473 51.7118 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 38.5699987411499 PYLDDFQKKWQEEMELYR HPNE addition +172(K)@8; reduced acrolein addition +58(K)@9; Oxidation(M)@14 cleaved Q-P@N-term; missed K-K@8; missed K-W@9 0.238049998879433 2663.52099609375 888.8476 2663.28295898438 888.768249511719 3 11 1.1.1.3600.21 1 46.3688 772.1393 46.5003 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 26.1599987745285 PYLDDFQKKWQEEMELYR acrolein addition +112(K)@9; Dethiomethyl(M)@14 cleaved Q-P@N-term; missed K-K@8; missed K-W@9 0.185690999031067 2481.37084960938 828.1309 2481.18530273438 828.069030761719 3 11 1.1.1.3617.20 1 46.7982 284.4555 46.8041 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 16.2499994039536 PYLDDFQKKWQEEMELYR Deamidated(Q)@7; HPNE addition +172(K)@8; reduced acrolein addition +58(K)@9; Oxidation(M)@14 cleaved Q-P@N-term; missed K-K@8; missed K-W@9 0.360697001218796 2664.62768554688 533.9328 2664.26684570313 533.860656738281 5 12 1.1.1.3608.6 1 46.5587 5678.539 46.6261 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.4200029373169 PYLDDFQKKWQEEMELYRQK cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18 0.316424995660782 2673.60620117188 669.4088 2673.28979492188 669.329711914063 4 15 1.1.1.3745.10 1 49.9227 1406.438 49.9884 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 57.0900022983551 PYLDDFQKKWQEEMELYRQK HPNE addition +172(K)@8; reduced acrolein addition +96(K)@9 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18 0.368923008441925 2941.826171875 589.3725 2941.45727539063 589.298706054688 5 12 1.1.1.3742.7 1 49.841 1792.055 49.8578 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 43.41000020504 PYLDDFQKKWQEEMELYRQKVEPLR acrolein addition +94(K)@8; ONE addition +154(K)@9 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18; missed K-V@20 -0.5640509724617 3515.2158203125 586.8766 3515.78002929688 586.970581054688 6 12 1.1.1.3645.12 1 47.5155 802.225 47.4515 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 PYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR HPNE addition +172(K)@8; acrolein addition +56(K)@9; Oxidation(M)@14 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18; missed K-V@20; missed R-A@25 -0.529412984848022 4365.6650390625 728.6181 4366.1943359375 728.706359863281 6 18 1.1.1.3760.6 1 50.2967 34861.29 50.3918 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.199999332428 PYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR MDA adduct +54(K)@8; MDA adduct +62(K)@9; Oxidation(M)@14; reduced acrolein addition +96(K)@20 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18; missed K-V@20; missed R-A@25 -0.486627995967865 4349.6552734375 725.9498 4350.14208984375 726.030944824219 6 18 1.1.1.3858.4 1 52.7422 86646.13 52.7127 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.0300028324127 PYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR HPNE addition +172(K)@8; reduced acrolein addition +96(K)@9 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18; missed K-V@20; missed R-A@25 0.468014985322952 4390.69873046875 732.7904 4390.23095703125 732.71240234375 6 16 1.1.1.3834.4 1 52.1481 4024.932 52.1924 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 PYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR HPNE addition +172(K)@8; acrolein addition +56(K)@9; Oxidation(W)@10 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18; missed K-V@20; missed R-A@25 -0.535273015499115 4365.6591796875 728.6171 4366.1943359375 728.706359863281 6 17 1.1.1.3782.5 1 50.8564 48785.84 50.597 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1900012493134 PYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR MDA adduct +54(K)@8; HPNE addition +172(K)@9; Oxidation(M)@14; reduced acrolein addition +58(K)@20 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18; missed K-V@20; missed R-A@25 0.523216009140015 4422.74365234375 632.8278 4422.220703125 632.753051757813 7 15 1.1.1.3768.7 1 50.503 1305.491 50.4939 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 77.2800028324127 PYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR HPNE addition +172(K)@8; reduced acrolein addition +96(K)@9 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18; missed K-V@20; missed R-A@25 0.525556981563568 4390.75634765625 628.2582 4390.23095703125 628.18310546875 7 13 1.1.1.3836.3 1 52.1977 2018.476 52.1924 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 75.0800013542175 PYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR hexanoyl addition +98(K)@8; acrolein addition +76(K)@9; acrolein addition +94(K)@20 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18; missed K-V@20; missed R-A@25 0.473031014204025 4390.6826171875 732.7877 4390.20947265625 732.708862304688 6 13 1.1.1.3881.4 1 53.3086 4995.802 53.3743 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.1499972343445 PYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR hexanoyl addition +98(K)@8; reduced acrolein addition +58(K)@9; acrolein addition +112(K)@20 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18; missed K-V@20; missed R-A@25 0.451900988817215 4390.6826171875 732.7877 4390.23095703125 732.71240234375 6 12 1.1.1.3890.2 1 53.528 4995.802 53.3743 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 44.6099996566772 PYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR HPNE addition +172(K)@8; reduced acrolein addition +96(K)@9 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18; missed K-V@20; missed R-A@25 0.449337989091873 4390.68017578125 732.7873 4390.23095703125 732.71240234375 6 12 1.1.1.3867.9 1 52.9667 14028.04 53.031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 44.1900014877319 PYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Deamidated(Q)@7; HPNE addition +172(K)@9; reduced acrolein addition +96(K)@20 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18; missed K-V@20; missed R-A@25 0.389773994684219 4391.6044921875 879.3282 4391.21484375 879.250244140625 5 12 1.1.1.4016.9 1 56.5876 3380.021 56.6767 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 40.1699990034103 PYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR HPNE addition +172(K)@8; hexanoyl addition +98(K)@9; MDA adduct +62(K)@20 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18; missed K-V@20; missed R-A@25 -0.63755202293396 4453.62451171875 891.7322 4454.26220703125 891.859680175781 5 12 1.1.1.4030.13 1 56.9447 623.4102 56.9307 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 32.3900014162064 PYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR acrolein addition +38(K)@8; hexanoyl addition +98(K)@9; acrolein addition +112(K)@20 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18; missed K-V@20; missed R-A@25 -0.55374401807785 4369.65087890625 729.2824 4370.20458984375 729.374694824219 6 12 1.1.1.3722.16 1 49.3362 3484.044 49.3706 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 19.9399992823601 PYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR hexanoyl addition +98(K)@8; hexanoyl addition +98(K)@9; Oxidation(M)@14; acrolein addition +112(K)@20 cleaved Q-P@N-term; missed K-K@8; missed K-W@9; missed R-Q@18; missed K-V@20; missed R-A@25 0.316141992807388 4446.5732421875 890.3219 4446.2568359375 890.258666992188 5 12 1.1.1.3842.7 1 52.351 648.5859 52.3429 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.6999998092651 PYSDELRQR cleaved A-P@N-term; missed R-Q@7 0.155159994959831 1162.72827148438 582.3714 1162.57312011719 582.293823242188 2 13 1.1.1.3019.8 1 32.3035 3099.475 32.2953 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.3099985122681 PYSDELRQR cleaved A-P@N-term; missed R-Q@7 0.155159994959831 1162.72827148438 582.3714 1162.57312011719 582.293823242188 2 13 1.1.1.3033.6 1 32.644 1678.223 32.8009 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9199993610382 PYSDELRQR cleaved A-P@N-term; missed R-Q@7 0.155159994959831 1162.72827148438 582.3714 1162.57312011719 582.293823242188 2 13 1.1.1.2759.4 1 26.0705 1983.496 26.0078 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9199993610382 PYSDELRQR cleaved A-P@N-term; missed R-Q@7 0.154916003346443 1162.72802734375 582.3713 1162.57312011719 582.293823242188 2 13 1.1.1.3048.6 1 33.0122 1593.63 32.9692 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9199993610382 PYSDELRQR cleaved A-P@N-term; missed R-Q@7 0.154916003346443 1162.72802734375 582.3713 1162.57312011719 582.293823242188 2 13 1.1.1.3055.7 1 33.1803 1593.63 32.9692 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 PYSDELRQR cleaved A-P@N-term; missed R-Q@7 0.154304996132851 1162.72741699219 582.371 1162.57312011719 582.293823242188 2 12 1.1.1.3040.4 1 32.8107 1663.008 32.8489 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.7300004959106 PYSDELRQR cleaved A-P@N-term; missed R-Q@7 0.151008993387222 1162.72412109375 582.3693 1162.57312011719 582.293823242188 2 12 1.1.1.2752.6 1 25.9017 1773.155 25.8878 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@1; hexanoyl addition +98(K)@13 cleaved Q-Q@N-term; missed R-V@11; missed K-D@13; missed K-D@24; missed R-D@28 0.485778987407684 4693.8046875 939.7682 4693.31884765625 939.671020507813 5 24 1.1.1.4391.3 1 65.9235 3249.148 65.7444 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Gln->pyro-Glu@N-term; Oxidation(W)@9; ONE addition +154(K)@13 cleaved Q-Q@N-term; missed R-V@11; missed K-D@13; missed K-D@24; missed R-D@28 -0.57922899723053 4746.75 950.3573 4747.32958984375 950.47314453125 5 22 1.1.1.4385.4 1 65.7782 2289.197 65.8165 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@1; hexanoyl addition +98(K)@13 cleaved Q-Q@N-term; missed R-V@11; missed K-D@13; missed K-D@24; missed R-D@28 0.481200993061066 4693.7998046875 939.7673 4693.31884765625 939.671020507813 5 21 1.1.1.4371.11 1 65.4296 2739.465 65.6136 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term; reduced acrolein addition +96(K)@13 cleaved Q-Q@N-term; missed R-V@11; missed K-D@13; missed K-D@24; missed R-D@28 -0.592598974704742 4746.748046875 950.3569 4747.3408203125 950.475402832031 5 21 1.1.1.4377.3 1 65.5728 2535.106 65.6136 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@1; hexanoyl addition +98(K)@13 cleaved Q-Q@N-term; missed R-V@11; missed K-D@13; missed K-D@24; missed R-D@28 0.413343012332916 4693.73046875 1174.44 4693.31884765625 1174.3369140625 4 20 1.1.1.4377.5 1 65.5778 6796.334 65.6136 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6199975013733 QDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term; reduced acrolein addition +96(K)@13 cleaved Q-Q@N-term; missed R-V@11; missed K-D@13; missed K-D@24; missed R-D@28 -0.582527995109558 4746.7578125 950.3589 4747.3408203125 950.475402832031 5 18 1.1.1.4400.3 1 66.12 2047.664 65.913 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.089998960495 QDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@6; hexanoyl addition +98(K)@13 cleaved Q-Q@N-term; missed R-V@11; missed K-D@13; missed K-D@24; missed R-D@28 0.41431999206543 4693.73486328125 1174.441 4693.31884765625 1174.3369140625 4 17 1.1.1.4398.4 1 66.0817 7352.371 65.8405 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.4900026321411 QDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term; reduced acrolein addition +96(K)@13 cleaved Q-Q@N-term; missed R-V@11; missed K-D@13; missed K-D@24; missed R-D@28 -0.582527995109558 4746.7578125 950.3589 4747.3408203125 950.475402832031 5 17 1.1.1.4392.3 1 65.9459 2027.293 65.913 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.6900029182434 QDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@1; hexanoyl addition +98(K)@13 cleaved Q-Q@N-term; missed R-V@11; missed K-D@13; missed K-D@24; missed R-D@28 0.411877989768982 4693.73046875 1174.44 4693.31884765625 1174.3369140625 4 16 1.1.1.4405.8 1 66.2504 5073.119 65.9906 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.4100022315979 QEGARQKLHELQEKLSPLGEEMRDR acrolein addition +38(K)@7 cleaved L-Q@N-term; missed R-Q@5; missed K-L@7; missed K-L@14; missed R-D@23 0.298819005489349 3014.83447265625 754.7159 3014.53564453125 754.641174316406 4 14 1.1.1.3389.8 1 41.1952 3158.896 41.23 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2300000190735 QEGARQKLHELQEKLSPLGEEMRDR acrolein addition +38(K)@7 cleaved L-Q@N-term; missed R-Q@5; missed K-L@7; missed K-L@14; missed R-D@23 0.232180997729301 3014.76806640625 1005.93 3014.53564453125 1005.85247802734 3 13 1.1.1.3392.8 1 41.2739 744.568 41.23 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.410001039505 QEGARQKLHELQEKLSPLGEEMRDR acrolein addition +38(K)@7 cleaved L-Q@N-term; missed R-Q@5; missed K-L@7; missed K-L@14; missed R-D@23 0.367592006921768 3014.90307617188 603.9879 3014.53564453125 603.914367675781 5 12 1.1.1.3392.5 1 41.2664 1329.996 41.23 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QEMSKDLEEVK Oxidation(M)@3 missed K-D@5 0.157536998391151 1350.79125976563 676.4029 1350.63366699219 676.324096679688 2 17 1.1.1.2605.6 1 22.3873 1663.478 22.3685 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QEMSKDLEEVK Gln->pyro-Glu@N-term; Oxidation(M)@3 missed K-D@5 0.156131997704506 1333.76330566406 667.8889 1333.60717773438 667.810852050781 2 18 1.1.1.2701.13 1 24.6896 5465.644 24.7679 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QEMSKDLEEVK missed K-D@5 0.152817994356155 1334.79162597656 668.4031 1334.63879394531 668.32666015625 2 18 1.1.1.2698.16 1 24.6175 11705.31 24.6243 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QEMSKDLEEVK Gln->pyro-Glu@N-term missed K-D@5 0.159835994243622 1317.77209472656 659.8933 1317.61218261719 659.813415527344 2 18 1.1.1.2984.10 1 31.4675 15100.64 31.618 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QEMSKDLEEVK Gln->pyro-Glu@N-term missed K-D@5 0.160201996564865 1317.7724609375 659.8935 1317.61218261719 659.813415527344 2 17 1.1.1.3005.11 1 31.9704 5477.857 31.7142 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QEMSKDLEEVK Gln->pyro-Glu@N-term missed K-D@5 0.159835994243622 1317.77209472656 659.8933 1317.61218261719 659.813415527344 2 18 1.1.1.2991.5 1 31.6302 15100.64 31.618 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QEMSKDLEEVK Gln->pyro-Glu@N-term missed K-D@5 0.159835994243622 1317.77209472656 659.8933 1317.61218261719 659.813415527344 2 18 1.1.1.2998.8 1 31.8009 15100.64 31.618 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2700009346008 QEMSKDLEEVK Oxidation(M)@3 missed K-D@5 0.211753994226456 1350.84545898438 451.2891 1350.63366699219 451.218505859375 3 13 1.1.1.2602.7 1 22.3027 11486.12 22.3685 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.4099996089935 QEMSKDLEEVK missed K-D@5 0.215792998671532 1334.85461425781 445.9588 1334.63879394531 445.886871337891 3 13 1.1.1.2699.8 1 24.6323 51670.01 24.6243 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QEMSKDLEEVKAK Gln->pyro-Glu@N-term; Oxidation(M)@3 missed K-D@5; missed K-A@11 0.220361992716789 1532.95959472656 511.9938 1532.7392578125 511.920349121094 3 19 1.1.1.2669.17 1 23.9188 6913.11 23.9516 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QEMSKDLEEVKAK missed K-D@5; missed K-A@11 0.214759007096291 1533.98559570313 512.3358 1533.77087402344 512.264221191406 3 19 1.1.1.2676.7 1 24.0857 11869.23 24.1213 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QEMSKDLEEVKAK Gln->pyro-Glu@N-term missed K-D@5; missed K-A@11 0.218632996082306 1516.962890625 506.6616 1516.74426269531 506.588714599609 3 19 1.1.1.2907.7 1 29.6127 6649.388 29.5745 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QEMSKDLEEVKAK Gln->pyro-Glu@N-term missed K-D@5; missed K-A@11 0.218632996082306 1516.962890625 506.6616 1516.74426269531 506.588714599609 3 18 1.1.1.2900.8 1 29.4492 6649.388 29.5745 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2699990272522 QEMSKDLEEVKAK Gln->pyro-Glu@N-term; Oxidation(M)@3 missed K-D@5; missed K-A@11 0.215874999761581 1532.955078125 511.9923 1532.7392578125 511.920349121094 3 14 1.1.1.2586.2 1 21.9178 112.462 21.8704 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5399980545044 QEMSKDLEEVKAK missed K-D@5; missed K-A@11 0.159169003367424 1533.93005371094 767.9723 1533.77087402344 767.892700195313 2 13 1.1.1.2676.10 1 24.0924 599.3671 24.0974 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9199993610382 QEMSKDLEEVKAK Gln->pyro-Glu@N-term; Oxidation(M)@3 missed K-D@5; missed K-A@11 0.1632149964571 1532.90246582031 767.4585 1532.7392578125 767.376892089844 2 10 1.1.1.2672.20 1 23.9944 422.7294 23.9759 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.6300020217896 QEMSKDLEEVKAK Gln->pyro-Glu@N-term; Oxidation(M)@3; Carbamidomethyl(K)@11 missed K-D@5; missed K-A@11 0.231948003172874 1589.99267578125 531.0048 1589.7607421875 530.927490234375 3 10 1.1.1.2670.15 1 23.9415 289.666 23.9516 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.8999996185303 QEMSKDLEEVKAKVQPYLDDFQKKWQEEMELYR ONE addition +154(K)@5; MDA adduct +54(K)@11; acrolein addition +38(K)@13 missed K-D@5; missed K-A@11; missed K-V@13; missed K-K@23; missed K-W@24 0.519804000854492 4406.6689453125 735.4521 4406.14892578125 735.365478515625 6 13 1.1.1.3802.6 1 51.352 1478.335 51.2701 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 16.2499994039536 QEMSKDLEEVKAKVQPYLDDFQKKWQEEMELYR Oxidation(M)@3; MDA adduct +62(K)@5; ONE addition +154(K)@13; Trioxidation(W)@25 missed K-D@5; missed K-A@11; missed K-V@13; missed K-K@23; missed K-W@24 0.569509029388428 4440.6875 741.1219 4440.1181640625 741.026977539063 6 13 1.1.1.3726.15 1 49.4377 1006.223 49.4478 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 76.8999993801117 QEMSKDLEEVKAKVQPYLDDFQKKWQEEMELYRQK HexNAc(S)@4; ONE addition +154(K)@5; ONE addition +154(K)@13 missed K-D@5; missed K-A@11; missed K-V@13; missed K-K@23; missed K-W@24; missed R-Q@33 -0.555073022842407 4926.89990234375 822.1573 4927.455078125 822.249816894531 6 14 1.1.1.3750.5 1 50.0541 372.4284 50.0625 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 48.5799998044968 QEMSKDLEEVKAKVQPYLDDFQKKWQEEMELYRQK acrolein addition +94(K)@5; acrolein addition +38(K)@23; GlnThrGlyGly(K)@35 missed K-D@5; missed K-A@11; missed K-V@13; missed K-K@23; missed K-W@24; missed R-Q@33 0.255021005868912 4891.638671875 979.335 4891.3837890625 979.283996582031 5 12 1.1.1.3868.6 1 52.9926 61952.39 52.7615 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4199988842011 QGLLPVLESFK 0.160426005721092 1229.86242675781 615.9385 1229.70202636719 615.858276367188 2 15 1.1.1.3885.2 1 53.4027 6679.532 53.3743 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4199988842011 QGLLPVLESFK Gln->pyro-Glu@N-term 0.162805005908012 1212.83825683594 607.4264 1212.67541503906 607.344970703125 2 11 1.1.1.4231.5 1 61.8333 566.4427 61.8024 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.8099985122681 QGLLPVLESFK Gln->pyro-Glu@N-term 0.162805005908012 1212.83825683594 607.4264 1212.67541503906 607.344970703125 2 9 1.1.1.4224.2 1 61.6588 566.4427 61.8024 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.9400012493134 QGLLPVLESFK Gln->pyro-Glu@N-term 0.162805005908012 1212.83825683594 607.4264 1212.67541503906 607.344970703125 2 8 1.1.1.4238.2 1 62.0065 566.4427 61.8024 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTK missed K-V@11 0.249506995081902 2597.64868164063 866.8902 2597.39916992188 866.807006835938 3 20 1.1.1.4726.12 1 74.4829 5647.018 74.6648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTK missed K-V@11 0.249872997403145 2597.64916992188 866.8903 2597.39916992188 866.807006835938 3 27 1.1.1.4733.6 1 74.6481 5873.932 74.6892 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTK missed K-V@11 0.250055998563766 2597.6494140625 866.8904 2597.39916992188 866.807006835938 3 25 1.1.1.4740.7 1 74.8198 3909.445 74.8833 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTK missed K-V@11 0.249140992760658 2597.6484375 866.8901 2597.39916992188 866.807006835938 3 22 1.1.1.4747.5 1 74.9902 4189.955 75.1034 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTK missed K-V@11 0.311138987541199 2597.71044921875 650.4349 2597.39916992188 650.357116699219 4 22 1.1.1.4752.2 1 75.1078 979.7634 75.0787 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTK missed K-V@11 0.249140992760658 2597.6484375 866.8901 2597.39916992188 866.807006835938 3 24 1.1.1.4754.9 1 75.165 4189.955 75.1034 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTK Gln->pyro-Glu@N-term missed K-V@11 0.245966002345085 2580.61865234375 861.2135 2580.37280273438 861.131530761719 3 35 1.1.1.4823.3 1 76.9166 1887.209 76.9217 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.1500029563904 QGLLPVLESFKVSFLSALEEYTK Delta:H(2)C(2)@N-term missed K-V@11 0.252777993679047 2623.66772460938 875.5632 2623.41479492188 875.478881835938 3 18 1.1.1.4803.10 1 76.4247 397.9225 76.4348 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 48.1599986553192 QGLLPVLESFKVSFLSALEEYTK Gln->pyro-Glu@N-term; Oxidation(P)@5 missed K-V@11 0.283948987722397 2596.65161132813 866.5578 2596.36767578125 866.463134765625 3 12 1.1.1.4771.12 1 75.584 423.0887 75.5457 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 30.9700012207031 QGLLPVLESFKVSFLSALEEYTK Gln->pyro-Glu@N-term; Formyl(K)@11 missed K-V@11 -0.236619994044304 2608.13110351563 870.3843 2608.36767578125 870.463134765625 3 12 1.1.1.4654.11 1 72.6487 87.2563 72.6621 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTKK missed K-V@11; missed K-K@23 0.315542012453079 2725.80981445313 682.4597 2725.494140625 682.380859375 4 24 1.1.1.4662.4 1 72.8566 10058.91 72.8203 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTKK Gln->pyro-Glu@N-term missed K-V@11; missed K-K@23 0.254334986209869 2708.72192382813 903.9146 2708.4677734375 903.829833984375 3 30 1.1.1.4803.12 1 76.428 1658.112 76.4348 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.3500000238419 QGLLPVLESFKVSFLSALEEYTKK Gln->pyro-Glu@N-term; NeuGc(S)@9; ONE addition +154(K)@11 missed K-V@11; missed K-K@23 0.171423003077507 3169.82885742188 793.4645 3169.65747070313 793.421630859375 4 13 1.1.1.4684.5 1 73.4287 1219.309 73.5238 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTKKLN HPNE addition +172(K)@23; hexanoyl addition +98(K)@24 cleaved N-T@C-term; missed K-V@11; missed K-K@23; missed K-L@24 0.27131000161171 3223.07568359375 806.7762 3222.80419921875 806.708374023438 4 18 1.1.1.4767.10 1 75.4828 2423.12 75.6738 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTKKLN HPNE addition +172(K)@23; hexanoyl addition +98(K)@24 cleaved N-T@C-term; missed K-V@11; missed K-K@23; missed K-L@24 0.271798014640808 3223.076171875 806.7763 3222.80419921875 806.708374023438 4 16 1.1.1.4774.9 1 75.6587 2431.344 75.6738 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed K-V@11; missed K-K@23; missed K-L@24 0.318850010633469 3053.98779296875 764.5042 3053.6689453125 764.424499511719 4 16 1.1.1.4743.4 1 74.8909 1224.198 74.9321 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed K-V@11; missed K-K@23; missed K-L@24 0.31640899181366 3053.9853515625 764.5036 3053.6689453125 764.424499511719 4 16 1.1.1.4750.11 1 75.0653 2376.188 75.2256 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTKKLNT cleaved T-Q@C-term; missed K-V@11; missed K-K@23; missed K-L@24 0.31640899181366 3053.9853515625 764.5036 3053.6689453125 764.424499511719 4 21 1.1.1.4757.4 1 75.2355 2376.188 75.2256 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-V@11; missed K-K@23; missed K-L@24 0.316181004047394 3182.04370117188 796.5182 3181.7275390625 796.439147949219 4 14 1.1.1.4639.3 1 72.246 214.5693 72.238 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-V@11; missed K-K@23; missed K-L@24 0.255708009004593 3181.98217773438 1061.668 3181.7275390625 1061.58312988281 3 18 1.1.1.4735.10 1 74.7068 2630.75 74.7618 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-V@11; missed K-K@23; missed K-L@24 0.31691300868988 3182.04443359375 796.5184 3181.7275390625 796.439147949219 4 16 1.1.1.4737.4 1 74.7476 19390.46 74.7864 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-V@11; missed K-K@23; missed K-L@24 0.255708009004593 3181.98217773438 1061.668 3181.7275390625 1061.58312988281 3 22 1.1.1.4742.7 1 74.8782 2630.75 74.7618 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-V@11; missed K-K@23; missed K-L@24 0.31691300868988 3182.04443359375 796.5184 3181.7275390625 796.439147949219 4 19 1.1.1.4745.3 1 74.9453 19390.46 74.7864 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-V@11; missed K-K@23; missed K-L@24 0.26230001449585 3181.9912109375 1061.671 3181.7275390625 1061.58312988281 3 16 1.1.1.4749.18 1 75.0489 2341.505 75.1523 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-V@11; missed K-K@23; missed K-L@24 0.31691300868988 3182.04443359375 796.5184 3181.7275390625 796.439147949219 4 18 1.1.1.4754.5 1 75.1583 14306.66 75.1279 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-V@11; missed K-K@23; missed K-L@24 0.26230001449585 3181.9912109375 1061.671 3181.7275390625 1061.58312988281 3 22 1.1.1.4756.9 1 75.218 2341.505 75.1523 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-V@11; missed K-K@23; missed K-L@24 0.31691300868988 3182.04443359375 796.5184 3181.7275390625 796.439147949219 4 20 1.1.1.4762.3 1 75.3564 14478.13 75.1279 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTKKLNTQ missed K-V@11; missed K-K@23; missed K-L@24 0.262665987014771 3181.9912109375 1061.671 3181.7275390625 1061.58312988281 3 20 1.1.1.4763.13 1 75.3892 2464.835 75.1279 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTKKLNTQ Deamidated(N)@26 missed K-V@11; missed K-K@23; missed K-L@24 0.328990995883942 3183.04052734375 796.7674 3182.71142578125 796.685119628906 4 22 1.1.1.4710.7 1 74.0896 2492.25 73.9116 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTKKLNTQ Gln->pyro-Glu@N-term missed K-V@11; missed K-K@23; missed K-L@24 0.254913985729218 3164.95727539063 1055.993 3164.70092773438 1055.90759277344 3 28 1.1.1.4814.10 1 76.698 4134.501 76.7048 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QGLLPVLESFKVSFLSALEEYTKKLNTQ Delta:H(2)C(2)@N-term missed K-V@11; missed K-K@23; missed K-L@24 0.327385991811752 3208.07055664063 803.0249 3207.7431640625 802.943054199219 4 20 1.1.1.4801.19 1 76.3766 1189.312 76.3833 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.0300018787384 QKLHELQEK Trimethyl(K)@2 missed K-L@2 0.120025999844074 1193.796875 597.9057 1193.67687988281 597.845703125 2 15 1.1.1.2659.4 1 23.6748 723.1235 23.6865 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.7899978160858 QKLHELQEK Deamidated(Q)@1; MDA adduct +54(K)@2 missed K-L@2 0.153963997960091 1206.77844238281 604.3965 1206.62451171875 604.319519042969 2 13 1.1.1.3202.5 1 36.7006 2055.43 36.9283 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7799971103668 QKLHELQEK Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2 missed K-L@2 0.120044998824596 1192.76525878906 597.3899 1192.64514160156 597.329895019531 2 14 1.1.1.3029.7 1 32.5526 672.1669 32.5601 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.3099985122681 QKLHELQEK Carboxyethyl(K)@2 missed K-L@2 0.155613005161285 1223.806640625 612.9106 1223.65100097656 612.832763671875 2 15 1.1.1.2800.5 1 27.0557 2021.29 27.1322 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.3099994659424 QKLHELQEK Gln->pyro-Glu@N-term missed K-L@2 0.148969992995262 1134.75231933594 568.3834 1134.60327148438 568.308959960938 2 14 1.1.1.2599.2 1 22.2252 106.5975 22.2129 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.6800022125244 QKLHELQEK Gln->pyro-Glu@N-term missed K-L@2 0.149092003703117 1134.75244140625 568.3835 1134.60327148438 568.308959960938 2 14 1.1.1.2654.6 1 23.5546 66226.7 23.4481 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.6800022125244 QKLHELQEK Gln->pyro-Glu@N-term missed K-L@2 0.148359999060631 1134.75170898438 568.3831 1134.60327148438 568.308959960938 2 14 1.1.1.2668.8 1 23.8879 1971.16 23.6388 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.0000026226044 QKLHELQEK Gln->pyro-Glu@N-term missed K-L@2 0.149092003703117 1134.75244140625 568.3835 1134.60327148438 568.308959960938 2 14 1.1.1.2661.8 1 23.7268 54404.42 23.4719 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 QKLHELQEK Gln->pyro-Glu@N-term; Carbamidomethyl(K)@2 missed K-L@2 0.154239997267723 1191.77905273438 596.8968 1191.62475585938 596.819641113281 2 13 1.1.1.2649.10 1 23.4364 548.52 23.4007 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2300000190735 QKLHELQEK Methyl+Deamidated(Q)@1; MDA adduct +54(K)@2 missed K-L@2 0.156379997730255 1220.79650878906 611.4055 1220.64013671875 611.327331542969 2 14 1.1.1.3407.2 1 41.6342 1251.257 41.5987 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.6500000953674 QKLHELQEK Gln->pyro-Glu@N-term missed K-L@2 0.149092003703117 1134.75244140625 568.3835 1134.60327148438 568.308959960938 2 14 1.1.1.2646.8 1 23.3668 66226.7 23.4481 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.7999970912933 QKLHELQEK missed K-L@2 0.151230007410049 1151.78112792969 576.8978 1151.6298828125 576.822204589844 2 15 1.1.1.2483.2 1 20.0244 600.3016 19.9704 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.7999970912933 QKLHELQEK Gln->pyro-Glu@N-term missed K-L@2 0.149335995316505 1134.75268554688 568.3836 1134.60327148438 568.308959960938 2 14 1.1.1.2639.6 1 23.1997 55622.19 23.4244 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.0799977779388 QKLHELQEK Methyl+Deamidated(Q)@1; MDA adduct +54(K)@2 missed K-L@2 0.156136006116867 1220.79626464844 611.4054 1220.64013671875 611.327331542969 2 14 1.1.1.3422.2 1 41.997 1122.656 41.7449 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.7000002861023 QKLHELQEK missed K-L@2 0.151230007410049 1151.78112792969 576.8978 1151.6298828125 576.822204589844 2 14 1.1.1.2472.2 1 19.8502 593.363 19.9704 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.7000002861023 QKLHELQEK reduced acrolein addition +58(K)@2 missed K-L@2 0.118153996765614 1209.78991699219 605.9022 1209.67175292969 605.843139648438 2 14 1.1.1.2703.7 1 24.7364 689.1359 24.744 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.0999989509583 QKLHELQEK Gln->pyro-Glu@N-term missed K-L@2 0.146284997463226 1134.74963378906 568.3821 1134.60327148438 568.308959960938 2 11 1.1.1.2690.10 1 24.419 365.8468 24.4564 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.7800004482269 QKLHELQEK Gln->pyro-Glu@N-term missed K-L@2 0.148726001381874 1134.75207519531 568.3833 1134.60327148438 568.308959960938 2 10 1.1.1.2709.9 1 24.8791 215.9038 24.8396 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.7599980831146 QKLHELQEK Carboxyethyl(K)@2 missed K-L@2 0.207144007086754 1223.85815429688 408.96 1223.65100097656 408.890930175781 3 13 1.1.1.2802.4 1 27.1033 6881.521 27.1322 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.030002117157 QKLHELQEK Methyl+Deamidated(Q)@1; MDA adduct +54(K)@2 missed K-L@2 0.156136006116867 1220.79626464844 611.4054 1220.64013671875 611.327331542969 2 14 1.1.1.3414.4 1 41.8063 1113.407 41.7449 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.6300020217896 QKLHELQEK Gln->pyro-Glu@N-term; Formyl(K)@2 missed K-L@2 0.150027006864548 1162.74829101563 582.3814 1162.59826660156 582.306396484375 2 13 1.1.1.2831.5 1 27.7945 569.7269 27.7996 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.2400004863739 QKLHELQEK Formyl@N-term; reduced acrolein addition +58(K)@2 missed K-L@2 0.158639997243881 1237.82531738281 619.9199 1237.66662597656 619.840576171875 2 13 1.1.1.2961.9 1 30.915 905.7742 30.8994 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 52.5099992752075 QKLHELQEK Gln->pyro-Glu@N-term; Carbamidomethyl(H)@4 missed K-L@2 0.153018996119499 1191.77783203125 596.8962 1191.62475585938 596.819641113281 2 11 1.1.1.2626.15 1 22.8935 242.8392 22.8745 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMR missed K-L@2; missed K-L@9 0.236171007156372 2164.3671875 722.463 2164.13110351563 722.38427734375 3 27 1.1.1.3161.3 1 35.7259 15076.82 35.8267 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMR missed K-L@2; missed K-L@9 0.170571997761726 2164.30126953125 1083.158 2164.13110351563 1083.07275390625 2 25 1.1.1.3163.3 1 35.7738 1285.278 35.8267 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMR missed K-L@2; missed K-L@9 0.236171007156372 2164.3671875 722.463 2164.13110351563 722.38427734375 3 25 1.1.1.3174.8 1 36.034 15076.82 35.8267 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2 missed K-L@2; missed K-L@9 0.313798993825912 2205.46020507813 552.3723 2205.14624023438 552.293884277344 4 22 1.1.1.3199.5 1 36.6278 2704.968 36.6643 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@9 missed K-L@2; missed K-L@9 0.310135990381241 2205.45654296875 552.3714 2205.14624023438 552.293884277344 4 18 1.1.1.3224.4 1 37.2282 2421.541 37.3118 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9 0.243330001831055 2163.3427734375 722.1215 2163.09936523438 722.040405273438 3 25 1.1.1.3287.6 1 38.7432 1196.367 38.7483 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term missed K-L@2; missed K-L@9 0.236109003424644 2147.34057617188 716.7875 2147.1044921875 716.708801269531 3 22 1.1.1.3445.5 1 42.5631 6186.467 42.6974 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term missed K-L@2; missed K-L@9 0.304881989955902 2147.40942382813 537.8596 2147.1044921875 537.783386230469 4 24 1.1.1.3447.10 1 42.6097 6468.427 42.6974 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term missed K-L@2; missed K-L@9 0.167579993605614 2147.27124023438 1074.643 2147.1044921875 1074.5595703125 2 18 1.1.1.3448.18 1 42.6434 1024.616 42.6974 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term missed K-L@2; missed K-L@9 0.304881989955902 2147.40942382813 537.8596 2147.1044921875 537.783386230469 4 22 1.1.1.3454.8 1 42.7798 6468.427 42.6974 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term missed K-L@2; missed K-L@9 0.236109003424644 2147.34057617188 716.7875 2147.1044921875 716.708801269531 3 21 1.1.1.3454.15 1 42.7857 6186.467 42.6974 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMR Deamidated(Q)@1; MDA adduct +54(K)@2 missed K-L@2; missed K-L@9 0.243177995085716 2219.36889648438 740.7969 2219.12573242188 740.7158203125 3 23 1.1.1.3839.6 1 52.2756 1020.64 52.2932 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMR Oxidation(M)@17 missed K-L@2; missed K-L@9 0.294892996549606 2180.4208984375 546.1125 2180.1259765625 546.038757324219 4 16 1.1.1.2988.7 1 31.5583 21088.92 31.5221 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMR missed K-L@2; missed K-L@9 0.296155005693436 2164.42724609375 542.1141 2164.13110351563 542.0400390625 4 20 1.1.1.3167.5 1 35.8594 70851.95 35.8028 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term missed K-L@2; missed K-L@9 0.304881989955902 2147.40942382813 537.8596 2147.1044921875 537.783386230469 4 17 1.1.1.3445.3 1 42.5581 6468.427 42.6974 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMR Formyl@N-term; reduced acrolein addition +58(K)@2 missed K-L@2; missed K-L@9 0.243031993508339 2250.41088867188 751.1442 2250.16772460938 751.063232421875 3 18 1.1.1.3714.11 1 49.1324 893.5438 49.0974 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2; Oxidation(M)@17 missed K-L@2; missed K-L@9 0.31351301074028 2221.45483398438 556.371 2221.14135742188 556.292602539063 4 15 1.1.1.3011.8 1 32.1104 693.1974 32.1263 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.989999294281 QKLHELQEKLSPLGEEMR missed K-L@2; missed K-L@9 0.296155005693436 2164.42724609375 542.1141 2164.13110351563 542.0400390625 4 16 1.1.1.3160.6 1 35.697 70851.95 35.8028 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.989999294281 QKLHELQEKLSPLGEEMR missed K-L@2; missed K-L@9 0.296155005693436 2164.42724609375 542.1141 2164.13110351563 542.0400390625 4 16 1.1.1.3174.3 1 36.0232 71746.02 35.8028 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.5499978065491 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term; Trimethyl(K)@2 missed K-L@2; missed K-L@9 0.200328007340431 2189.35180664063 730.7912 2189.1513671875 730.724426269531 3 17 1.1.1.3738.12 1 49.7417 424.505 49.7543 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.8999972343445 QKLHELQEKLSPLGEEMR Deamidated(Q)@1; acrolein addition +56(K)@2 missed K-L@2; missed K-L@9 0.307164996862412 2221.44848632813 556.3694 2221.14135742188 556.292602539063 4 14 1.1.1.3159.5 1 35.6781 1421.87 35.6832 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1199989318848 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term; Methyl(E)@8; reduced acrolein addition +58(K)@9 missed K-L@2; missed K-L@9 0.201115995645523 2219.36303710938 740.795 2219.162109375 740.727966308594 3 17 1.1.1.3825.6 1 51.9254 500.711 51.9429 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.0300018787384 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@9 missed K-L@2; missed K-L@9 0.310135990381241 2205.45654296875 552.3714 2205.14624023438 552.293884277344 4 14 1.1.1.3232.4 1 37.4148 2421.541 37.3118 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.6900019645691 QKLHELQEKLSPLGEEMR Oxidation(M)@17 missed K-L@2; missed K-L@9 0.294892996549606 2180.4208984375 546.1125 2180.1259765625 546.038757324219 4 13 1.1.1.2981.6 1 31.394 21088.92 31.5221 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.9199991226196 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term missed K-L@2; missed K-L@9 0.304881989955902 2147.40942382813 537.8596 2147.1044921875 537.783386230469 4 14 1.1.1.3461.6 1 42.9508 6503.083 42.6974 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.4900000095367 QKLHELQEKLSPLGEEMR acrolein addition +94(K)@2; Deamidated(Q)@7; Methyl(E)@8; HPNE addition +172(K)@9 missed K-L@2; missed K-L@9 0.276028007268906 2445.55859375 612.3969 2445.28247070313 612.327880859375 4 14 1.1.1.3448.10 1 42.6342 1383.157 42.6974 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.7400023937225 QKLHELQEKLSPLGEEMR Methyl(Q)@1; reduced acrolein addition +58(K)@2 missed K-L@2; missed K-L@9 0.272819995880127 2236.46142578125 560.1226 2236.1884765625 560.054443359375 4 13 1.1.1.3637.7 1 47.3061 2471.403 47.3494 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.410001039505 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term; acrolein addition +56(K)@9; Methyl(L)@10 missed K-L@2; missed K-L@9 0.20100599527359 2217.34741210938 555.3441 2217.14624023438 555.293884277344 4 13 1.1.1.3164.6 1 35.7944 540.9655 35.7789 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 19.9399992823601 QKLHELQEKLSPLGEEMR Gln->pyro-Glu@N-term; Deamidated(Q)@7; Dehydrated(E)@8; reduced acrolein addition +58(K)@9 missed K-L@2; missed K-L@9 0.251798987388611 2188.37158203125 730.4645 2188.11987304688 730.380554199219 3 12 1.1.1.3502.18 1 43.9785 630.1568 43.986 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.2377749979496 2451.49169921875 818.1712 2451.25390625 818.091918945313 3 18 1.1.1.2918.14 1 29.8835 17293.58 29.9852 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.238141000270844 2451.4921875 818.1713 2451.25390625 818.091918945313 3 20 1.1.1.2925.9 1 30.0527 19245.65 30.0579 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Oxidation(R)@18 missed K-L@2; missed K-L@9; missed R-D@18 0.238141000270844 2451.4921875 818.1713 2451.25390625 818.091918945313 3 18 1.1.1.2932.9 1 30.2217 18393.95 30.1544 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Deamidated(Q)@1; acrolein addition +56(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.315097004175186 2492.58447265625 624.1534 2492.26928710938 624.074584960938 4 18 1.1.1.3105.8 1 34.3755 16673.19 34.2408 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR missed K-L@2; missed K-L@9; missed R-D@18 0.239159002900124 2435.49829101563 812.84 2435.25903320313 812.760314941406 3 25 1.1.1.3107.12 1 34.4287 38923.55 34.3856 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR missed K-L@2; missed K-L@9; missed R-D@18 0.304087996482849 2435.56323242188 609.8981 2435.25903320313 609.822021484375 4 20 1.1.1.3108.10 1 34.4496 216691.3 34.5543 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR missed K-L@2; missed K-L@9; missed R-D@18 0.304087996482849 2435.56323242188 609.8981 2435.25903320313 609.822021484375 4 21 1.1.1.3115.10 1 34.6183 216691.3 34.5543 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR missed K-L@2; missed K-L@9; missed R-D@18 0.238426998257637 2435.49755859375 812.8398 2435.25903320313 812.760314941406 3 26 1.1.1.3115.12 1 34.6217 41914.25 34.5061 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR missed K-L@2; missed K-L@9; missed R-D@18 0.304087996482849 2435.56323242188 609.8981 2435.25903320313 609.822021484375 4 20 1.1.1.3122.7 1 34.7883 217411.3 34.5302 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR missed K-L@2; missed K-L@9; missed R-D@18 0.238426998257637 2435.49755859375 812.8398 2435.25903320313 812.760314941406 3 25 1.1.1.3122.8 1 34.7908 42052.82 34.5302 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR missed K-L@2; missed K-L@9; missed R-D@18 0.239709004759789 2435.49877929688 812.8402 2435.25903320313 812.760314941406 3 22 1.1.1.3129.12 1 34.9593 23857.01 34.6992 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR missed K-L@2; missed K-L@9; missed R-D@18 0.303110986948013 2435.56225585938 609.8978 2435.25903320313 609.822021484375 4 20 1.1.1.3136.9 1 35.1273 91319.78 34.8682 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Deamidated(Q)@1; acrolein addition +56(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.319492012262344 2492.5888671875 624.1545 2492.26928710938 624.074584960938 4 17 1.1.1.3142.7 1 35.2663 4912.352 35.3004 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.374695986509323 2476.64916992188 496.3371 2476.2744140625 496.262145996094 5 21 1.1.1.3160.5 1 35.6945 29329.58 35.8267 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.314161986112595 2476.58862304688 620.1544 2476.2744140625 620.075866699219 4 20 1.1.1.3160.8 1 35.702 17628.69 35.8506 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.251188009977341 2476.52563476563 826.5158 2476.2744140625 826.432067871094 3 23 1.1.1.3166.7 1 35.843 1549.059 35.8506 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.374695986509323 2476.64916992188 496.3371 2476.2744140625 496.262145996094 5 18 1.1.1.3167.4 1 35.8578 29329.58 35.8267 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.314161986112595 2476.58862304688 620.1544 2476.2744140625 620.075866699219 4 20 1.1.1.3167.9 1 35.8669 17628.69 35.8506 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.314161986112595 2476.58862304688 620.1544 2476.2744140625 620.075866699219 4 21 1.1.1.3174.6 1 36.029 17628.69 35.8506 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR reduced acrolein addition +58(K)@9; Deamidated(R)@18; Dehydrated(D)@19 missed K-L@2; missed K-L@9; missed R-D@18 0.251736998558044 2476.52612304688 826.516 2476.2744140625 826.432067871094 3 19 1.1.1.3181.8 1 36.2014 2446.815 36.1851 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(R)@18 missed K-L@2; missed K-L@9; missed R-D@18 0.238995000720024 2434.46655273438 812.4961 2434.2275390625 812.416442871094 3 24 1.1.1.3206.8 1 36.8031 6038.854 36.8322 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(R)@18 missed K-L@2; missed K-L@9; missed R-D@18 0.238995000720024 2434.46655273438 812.4961 2434.2275390625 812.416442871094 3 21 1.1.1.3214.9 1 36.9952 6038.854 36.8322 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term missed K-L@2; missed K-L@9; missed R-D@18 0.243309006094933 2418.47583007813 807.1659 2418.232421875 807.084777832031 3 28 1.1.1.3389.10 1 41.1985 12671.59 41.23 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term missed K-L@2; missed K-L@9; missed R-D@18 0.308663994073868 2418.54125976563 605.6426 2418.232421875 605.5654296875 4 21 1.1.1.3390.11 1 41.2166 55821.33 41.23 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Deamidated(R)@18 missed K-L@2; missed K-L@9; missed R-D@18 0.323428004980087 2419.5400390625 605.8923 2419.21655273438 605.811401367188 4 19 1.1.1.3390.12 1 41.2174 38001.11 41.23 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term missed K-L@2; missed K-L@9; missed R-D@18 0.243309006094933 2418.47583007813 807.1659 2418.232421875 807.084777832031 3 22 1.1.1.3396.19 1 41.3704 10689.47 41.3771 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term missed K-L@2; missed K-L@9; missed R-D@18 0.308663994073868 2418.54125976563 605.6426 2418.232421875 605.5654296875 4 21 1.1.1.3398.9 1 41.4112 46427.99 41.3523 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term missed K-L@2; missed K-L@9; missed R-D@18 0.308663994073868 2418.54125976563 605.6426 2418.232421875 605.5654296875 4 21 1.1.1.3398.10 1 41.4121 46427.99 41.3523 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term missed K-L@2; missed K-L@9; missed R-D@18 0.243309006094933 2418.47583007813 807.1659 2418.232421875 807.084777832031 3 27 1.1.1.3403.13 1 41.5412 10689.47 41.3771 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Carboxyethyl(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.312743008136749 2507.59301757813 627.9055 2507.2802734375 627.827331542969 4 21 1.1.1.3587.5 1 46.0383 22332.93 46.1723 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Trimethyl(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.270990997552872 2460.55053710938 616.1449 2460.27954101563 616.0771484375 4 23 1.1.1.3675.2 1 48.2742 3239.903 48.3091 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Carboxyethyl(K)@9 missed K-L@2; missed K-L@9; missed R-D@18 0.247997000813484 2490.50170898438 831.1745 2490.25366210938 831.091857910156 3 22 1.1.1.3776.10 1 50.7113 3161.166 50.7506 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Deamidated(Q)@1; MDA adduct +54(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.308530986309052 2490.56225585938 623.6478 2490.25366210938 623.570678710938 4 20 1.1.1.3785.2 1 50.9295 15120.47 50.9258 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Deamidated(Q)@1; MDA adduct +54(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.247997000813484 2490.50170898438 831.1745 2490.25366210938 831.091857910156 3 23 1.1.1.3785.7 1 50.9337 3428.71 50.9258 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR reduced acrolein addition +58(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.217740997672081 2493.51879882813 832.1802 2493.30102539063 832.107604980469 3 17 1.1.1.3489.17 1 43.6551 495.7473 43.7379 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.310703009366989 2492.580078125 624.1523 2492.26928710938 624.074584960938 4 16 1.1.1.2964.12 1 30.9903 2423.88 30.9714 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(R)@18 missed K-L@2; missed K-L@9; missed R-D@18 0.363236010074615 2434.59057617188 487.9254 2434.2275390625 487.852752685547 5 17 1.1.1.3200.6 1 36.6517 31529.25 36.8082 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(R)@18 missed K-L@2; missed K-L@9; missed R-D@18 0.304228007793427 2434.53173828125 609.6402 2434.2275390625 609.564147949219 4 17 1.1.1.3207.7 1 36.8246 57874.8 36.8082 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(R)@18 missed K-L@2; missed K-L@9; missed R-D@18 0.304228007793427 2434.53173828125 609.6402 2434.2275390625 609.564147949219 4 17 1.1.1.3214.7 1 36.9902 57874.8 36.8082 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Carbamidomethyl(H)@4 missed K-L@2; missed K-L@9; missed R-D@18 0.309172987937927 2475.56323242188 619.8981 2475.25390625 619.82080078125 4 17 1.1.1.3391.5 1 41.2396 3146.951 41.1806 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Deamidated(Q)@7; acrolein addition +56(K)@9 missed K-L@2; missed K-L@9; missed R-D@18 0.248458996415138 2475.4912109375 826.171 2475.24267578125 826.088195800781 3 16 1.1.1.3386.11 1 41.1266 485.1276 41.1806 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term missed K-L@2; missed K-L@9; missed R-D@18 0.308663994073868 2418.54125976563 605.6426 2418.232421875 605.5654296875 4 19 1.1.1.3406.9 1 41.6132 44992.48 41.3523 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Formyl@N-term; reduced acrolein addition +58(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.317844986915588 2521.61376953125 631.4107 2521.2958984375 631.331237792969 4 19 1.1.1.3655.10 1 47.7675 11482.06 47.8336 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Carboxyethyl(K)@9 missed K-L@2; missed K-L@9; missed R-D@18 0.313657999038696 2490.5673828125 623.6491 2490.25366210938 623.570678710938 4 20 1.1.1.3778.4 1 50.7564 6602.396 50.7506 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR missed K-L@2; missed K-L@9; missed R-D@18 0.303355008363724 2435.5625 609.8979 2435.25903320313 609.822021484375 4 18 1.1.1.3143.11 1 35.2937 37989.62 35.0364 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR missed K-L@2; missed K-L@9; missed R-D@18 0.3038429915905 2435.56298828125 609.898 2435.25903320313 609.822021484375 4 18 1.1.1.3151.7 1 35.487 2477.353 35.4682 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR missed K-L@2; missed K-L@9; missed R-D@18 0.3038429915905 2435.56298828125 609.898 2435.25903320313 609.822021484375 4 18 1.1.1.3129.10 1 34.9559 145199.8 34.6992 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term missed K-L@2; missed K-L@9; missed R-D@18 0.368618011474609 2418.60107421875 484.7275 2418.232421875 484.653778076172 5 18 1.1.1.3396.7 1 41.3603 22657.3 41.3523 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Delta:H(4)C(2)(K)@9 missed K-L@2; missed K-L@9; missed R-D@18 0.20736999809742 2446.47119140625 816.4977 2446.26391601563 816.428527832031 3 19 1.1.1.3652.18 1 47.6971 501.8165 47.7301 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Deamidated(Q)@1; acrolein addition +56(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.315097004175186 2492.58447265625 624.1534 2492.26928710938 624.074584960938 4 15 1.1.1.3096.8 1 34.1634 16673.19 34.2408 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.300002008676529 2476.57446289063 620.1509 2476.2744140625 620.075866699219 4 15 1.1.1.3398.12 1 41.4146 1083.515 41.4509 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR missed K-L@2; missed K-L@9; missed R-D@18 0.303110986948013 2435.56225585938 609.8978 2435.25903320313 609.822021484375 4 17 1.1.1.3158.7 1 35.6542 2307.351 35.5876 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR missed K-L@2; missed K-L@9; missed R-D@18 0.303110986948013 2435.56225585938 609.8978 2435.25903320313 609.822021484375 4 17 1.1.1.3100.12 1 34.2532 201134.2 34.482 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term missed K-L@2; missed K-L@9; missed R-D@18 0.163060992956161 2418.39526367188 1210.205 2418.232421875 1210.12353515625 2 17 1.1.1.3389.11 1 41.2002 1750.655 41.23 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term missed K-L@2; missed K-L@9; missed R-D@18 0.373501002788544 2418.60595703125 484.7285 2418.232421875 484.653778076172 5 17 1.1.1.3389.4 1 41.1885 26320.62 41.23 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term missed K-L@2; missed K-L@9; missed R-D@18 0.368618011474609 2418.60107421875 484.7275 2418.232421875 484.653778076172 5 17 1.1.1.3403.5 1 41.5311 23032.94 41.279 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR reduced acrolein addition +58(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.271255999803543 2493.572265625 624.4003 2493.30102539063 624.33251953125 4 16 1.1.1.3487.13 1 43.602 3172.04 43.7379 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR reduced acrolein addition +58(K)@9 missed K-L@2; missed K-L@9; missed R-D@18 0.278335988521576 2493.57934570313 624.4021 2493.30102539063 624.33251953125 4 16 1.1.1.3531.12 1 44.6813 1096.367 44.6691 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(R)@18 missed K-L@2; missed K-L@9; missed R-D@18 0.304228007793427 2434.53173828125 609.6402 2434.2275390625 609.564147949219 4 16 1.1.1.3199.7 1 36.6328 57287.97 36.8082 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.371755003929138 2492.64111328125 499.5355 2492.26928710938 499.461151123047 5 15 1.1.1.2957.7 1 30.8158 4923.808 30.8755 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(R)@18 missed K-L@2; missed K-L@9; missed R-D@18 0.363236010074615 2434.59057617188 487.9254 2434.2275390625 487.852752685547 5 16 1.1.1.3215.5 1 37.0158 31529.25 36.8082 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(R)@18 missed K-L@2; missed K-L@9; missed R-D@18 0.304228007793427 2434.53173828125 609.6402 2434.2275390625 609.564147949219 4 16 1.1.1.3222.6 1 37.1869 29214.59 36.9283 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8900005817413 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.371755003929138 2492.64111328125 499.5355 2492.26928710938 499.461151123047 5 15 1.1.1.2966.8 1 31.0331 4923.808 30.8755 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2699990272522 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@9 missed K-L@2; missed K-L@9; missed R-D@18 0.314895004034042 2476.58935546875 620.1546 2476.2744140625 620.075866699219 4 14 1.1.1.3185.8 1 36.2948 26715.9 36.1851 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2699990272522 QKLHELQEKLSPLGEEMRDR Acetyl@N-term missed K-L@2; missed K-L@9; missed R-D@18 0.30450901389122 2477.57421875 620.4008 2477.26977539063 620.32470703125 4 15 1.1.1.3405.7 1 41.5869 2182.128 41.5741 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.3599970340729 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Formyl(K)@9 missed K-L@2; missed K-L@9; missed R-D@18 0.312285006046295 2446.53979492188 612.6422 2446.2275390625 612.564147949219 4 17 1.1.1.3653.11 1 47.7167 998.5299 47.7301 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.3599970340729 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Formyl(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.307889997959137 2446.53540039063 612.6411 2446.2275390625 612.564147949219 4 17 1.1.1.3663.8 1 47.972 1788.478 48.0136 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8100011348724 QKLHELQEKLSPLGEEMRDR hexanoyl addition +98(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.20431099832058 2533.53662109375 634.3914 2533.33227539063 634.34033203125 4 15 1.1.1.3101.14 1 34.2807 3387.096 34.4339 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8100011348724 QKLHELQEKLSPLGEEMRDR hexanoyl addition +98(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.139321997761726 2533.4716796875 845.4978 2533.33227539063 845.451354980469 3 15 1.1.1.3123.6 1 34.81 1540.172 34.6268 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.7899978160858 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(R)@18 missed K-L@2; missed K-L@9; missed R-D@18 0.363236010074615 2434.59057617188 487.9254 2434.2275390625 487.852752685547 5 15 1.1.1.3207.5 1 36.8196 31529.25 36.8082 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.7899978160858 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.324735999107361 2434.55224609375 609.6453 2434.2275390625 609.564147949219 4 14 1.1.1.3236.4 1 37.5156 1074.577 37.5274 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.6000020503998 QKLHELQEKLSPLGEEMRDR acrolein addition +56(K)@2; Oxidation(H)@4 missed K-L@2; missed K-L@9; missed R-D@18 0.371385008096695 2507.65161132813 502.5376 2507.2802734375 502.463317871094 5 16 1.1.1.3588.6 1 46.057 15018.45 46.1723 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.6000020503998 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Trimethyl(K)@9 missed K-L@2; missed K-L@9; missed R-D@18 0.274165004491806 2460.5537109375 616.1457 2460.27954101563 616.0771484375 4 17 1.1.1.3663.9 1 47.9728 997.9723 47.8857 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.3199973106384 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@9 missed K-L@2; missed K-L@9; missed R-D@18 0.197721004486084 2476.47216796875 826.498 2476.2744140625 826.432067871094 3 16 1.1.1.3746.15 1 49.9531 1014.97 49.9632 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2700009346008 QKLHELQEKLSPLGEEMRDR Oxidation(P)@12 missed K-L@2; missed K-L@9; missed R-D@18 0.303802013397217 2451.55786132813 613.8967 2451.25390625 613.82080078125 4 14 1.1.1.2929.12 1 30.146 93106.78 30.1544 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.0900018215179 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.272902995347977 2476.54736328125 620.1441 2476.2744140625 620.075866699219 4 14 1.1.1.3753.4 1 50.1177 4256.021 50.0873 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.0400004386902 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Trimethyl(K)@9; Oxidation(R)@18 missed K-L@2; missed K-L@9; missed R-D@18 0.273391008377075 2476.5478515625 620.1442 2476.2744140625 620.075866699219 4 17 1.1.1.3504.9 1 44.0205 698.399 44.0356 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.0400004386902 QKLHELQEKLSPLGEEMRDR Methyl(E)@8; reduced acrolein addition +58(K)@9 missed K-L@2; missed K-L@9; missed R-D@18 0.213321998715401 2507.53002929688 836.8506 2507.31665039063 836.779479980469 3 15 1.1.1.3630.21 1 47.1342 2880.013 47.0865 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.0400004386902 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Delta:H(2)C(2)(K)@9 missed K-L@2; missed K-L@9; missed R-D@18 0.212705001235008 2444.4609375 815.8276 2444.24829101563 815.756652832031 3 15 1.1.1.3788.10 1 51.0099 903.487 50.9995 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.5100028514862 QKLHELQEKLSPLGEEMRDR MDA adduct +54(K)@2; Lys->Allysine(K)@9 missed K-L@2; missed K-L@9; missed R-D@18 0.238487005233765 2488.4765625 623.1264 2488.23803710938 623.066772460938 4 14 1.1.1.3103.4 1 34.3323 1781.246 34.3856 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.4600005149841 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Delta:H(2)C(2)(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.371491998434067 2444.61962890625 489.9312 2444.24829101563 489.856903076172 5 15 1.1.1.3603.7 1 46.4331 2204.307 46.4499 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.6800022125244 QKLHELQEKLSPLGEEMRDR missed K-L@2; missed K-L@9; missed R-D@18 0.303355008363724 2435.5625 609.8979 2435.25903320313 609.822021484375 4 14 1.1.1.3167.8 1 35.8644 1809.463 35.8506 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.0000026226044 QKLHELQEKLSPLGEEMRDR hexanoyl addition +98(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.203090995550156 2533.53540039063 634.3911 2533.33227539063 634.34033203125 4 14 1.1.1.3130.5 1 34.98 2765.742 34.7477 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 QKLHELQEKLSPLGEEMRDR Methyl(Q)@1; acrolein addition +94(K)@2; MDA adduct +54(K)@9 missed K-L@2; missed K-L@9; missed R-D@18 0.291671991348267 2597.61889648438 650.412 2597.3271484375 650.339050292969 4 14 1.1.1.3100.14 1 34.2565 4038.183 34.2649 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 QKLHELQEKLSPLGEEMRDR Trimethyl(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.27564999461174 2493.57666015625 624.4014 2493.30102539063 624.33251953125 4 14 1.1.1.3219.7 1 37.1101 1667.608 37.1201 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.7300004959106 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@9 missed K-L@2; missed K-L@9; missed R-D@18 0.374695986509323 2476.64916992188 496.3371 2476.2744140625 496.262145996094 5 12 1.1.1.3192.5 1 36.4576 31827.31 36.209 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.7300004959106 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(P)@12 missed K-L@2; missed K-L@9; missed R-D@18 0.304960012435913 2434.53247070313 609.6404 2434.2275390625 609.564147949219 4 13 1.1.1.3229.7 1 37.3522 4494.419 37.0962 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.4900023937225 QKLHELQEKLSPLGEEMRDR hexanoyl addition +98(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.203090995550156 2533.53540039063 634.3911 2533.33227539063 634.34033203125 4 14 1.1.1.3123.5 1 34.8075 4311.543 34.5543 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.7199997901917 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@9 missed K-L@2; missed K-L@9; missed R-D@18 0.272902995347977 2476.54736328125 620.1441 2476.2744140625 620.075866699219 4 13 1.1.1.3746.5 1 49.9447 4256.021 50.0873 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1900012493134 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2; Carboxyethyl(K)@9 missed K-L@2; missed K-L@9; missed R-D@18 0.330630987882614 2548.62622070313 638.1638 2548.29565429688 638.081176757813 4 15 1.1.1.3650.9 1 47.6387 473.0166 47.6538 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1900012493134 QKLHELQEKLSPLGEEMRDR Deamidated(Q)@1; Methyl(H)@4; MDA adduct +54(K)@9 missed K-L@2; missed K-L@9; missed R-D@18 0.3143649995327 2504.58374023438 627.1532 2504.26928710938 627.074584960938 4 15 1.1.1.3826.5 1 51.9495 3614.896 51.9932 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1900012493134 QKLHELQEKLSPLGEEMRDR Methyl+Deamidated(Q)@1; MDA adduct +54(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.3143649995327 2504.58374023438 627.1532 2504.26928710938 627.074584960938 4 15 1.1.1.3845.4 1 52.424 6916.297 52.3677 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1099998950958 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@9 missed K-L@2; missed K-L@9; missed R-D@18 0.374695986509323 2476.64916992188 496.3371 2476.2744140625 496.262145996094 5 12 1.1.1.3185.4 1 36.2881 34221.2 36.1851 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.1100008487701 QKLHELQEKLSPLGEEMRDR Trimethyl(K)@9 missed K-L@2; missed K-L@9; missed R-D@18 0.269344002008438 2477.57543945313 620.4011 2477.30615234375 620.333801269531 4 14 1.1.1.3427.6 1 42.1232 2355.128 42.0383 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.1100008487701 QKLHELQEKLSPLGEEMRDR Methyl(Q)@1; reduced acrolein addition +58(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.213321998715401 2507.53002929688 836.8506 2507.31665039063 836.779479980469 3 17 1.1.1.3594.17 1 46.2153 4249.738 46.1723 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.2999975681305 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; MDA adduct +54(K)@2; Oxidation(H)@4 missed K-L@2; missed K-L@9; missed R-D@18 0.247765004634857 2488.48583984375 623.1287 2488.23803710938 623.066772460938 4 13 1.1.1.3114.7 1 34.5908 2099.552 34.6026 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.3100011348724 QKLHELQEKLSPLGEEMRDR Formyl@N-term missed K-L@2; missed K-L@9; missed R-D@18 0.311614006757736 2463.56567382813 616.8987 2463.25390625 616.82080078125 4 13 1.1.1.3383.10 1 41.0442 1682.382 41.0341 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.2399973869324 QKLHELQEKLSPLGEEMRDR Methyl(E)@8; reduced acrolein addition +58(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.27607199549675 2523.58764648438 631.9042 2523.3115234375 631.835144042969 4 14 1.1.1.3456.8 1 42.8347 1917.826 42.7957 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.0900022983551 QKLHELQEKLSPLGEEMRDR Carbamyl@N-term; MDA adduct +62(K)@2; Dethiomethyl(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.306014001369476 2492.58325195313 624.1531 2492.27709960938 624.076599121094 4 14 1.1.1.2804.10 1 27.1477 2470.442 27.1322 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.0900022983551 QKLHELQEKLSPLGEEMRDR Deamidated(Q)@1; acrolein addition +56(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.371755003929138 2492.64111328125 499.5355 2492.26928710938 499.461151123047 5 12 1.1.1.3096.5 1 34.1559 19631.83 34.2408 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.0900022983551 QKLHELQEKLSPLGEEMRDR Deamidated(Q)@1; acrolein addition +56(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.373281002044678 2492.642578125 499.5358 2492.26928710938 499.461151123047 5 12 1.1.1.3139.5 1 35.1995 5991.252 35.3004 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.580001115799 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Trimethyl(K)@9 missed K-L@2; missed K-L@9; missed R-D@18 -0.709721982479095 2459.56982421875 615.8997 2460.27954101563 616.0771484375 4 15 1.1.1.3464.9 1 43.0277 4356.245 42.9436 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.580001115799 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Formyl(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.241924002766609 2446.46948242188 816.4971 2446.2275390625 816.416442871094 3 12 1.1.1.3664.15 1 48.0035 213.7897 47.9879 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.4799973964691 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; MDA adduct +54(K)@2; Oxidation(H)@4 missed K-L@2; missed K-L@9; missed R-D@18 0.302103012800217 2488.5400390625 498.7153 2488.23803710938 498.654876708984 5 13 1.1.1.3115.8 1 34.615 2401.466 34.5543 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.4900000095367 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Deamidated(Q)@7; Dehydrated(E)@8; reduced acrolein addition +58(K)@9 missed K-L@2; missed K-L@9; missed R-D@18 0.320692002773285 2459.56860351563 615.8994 2459.24780273438 615.819213867188 4 14 1.1.1.3457.10 1 42.8553 2176.244 42.8203 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.7699997425079 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Delta:H(2)C(2)(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.306686013936996 2444.55493164063 612.146 2444.24829101563 612.0693359375 4 13 1.1.1.3601.12 1 46.3869 3013.656 46.4499 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.7599980831146 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Deamidated(Q)@7; acrolein addition +38(K)@9 missed K-L@2; missed K-L@9; missed R-D@18 0.314613997936249 2457.546875 615.394 2457.23217773438 615.315307617188 4 12 1.1.1.3104.6 1 34.3514 653.7272 34.3133 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.9599993228912 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@9; Oxidation(R)@18 missed K-L@2; missed K-L@9; missed R-D@18 0.371297985315323 2492.640625 499.5354 2492.26928710938 499.461151123047 5 13 1.1.1.2982.9 1 31.4129 9440.002 31.3546 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.7400023937225 QKLHELQEKLSPLGEEMRDR Acetyl@N-term; Dehydrated(E)@5 missed K-L@2; missed K-L@9; missed R-D@18 0.308481991291046 2459.56762695313 615.8992 2459.25903320313 615.822021484375 4 14 1.1.1.3436.8 1 42.3419 4114.068 42.4039 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.6300020217896 QKLHELQEKLSPLGEEMRDR MDA adduct +54(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 -0.731056988239288 2488.53857421875 498.715 2489.26977539063 498.861206054688 5 12 1.1.1.3122.6 1 34.7858 1498.04 34.7718 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.4599986076355 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Deamidated(Q)@7; Deamidated(R)@18 missed K-L@2; missed K-L@9; missed R-D@18 0.348201006650925 2420.548828125 606.1445 2420.20068359375 606.057434082031 4 13 1.1.1.3390.13 1 41.2183 15588.19 41.23 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.0499970912933 QKLHELQEKLSPLGEEMRDR Carboxyethyl(K)@9 missed K-L@2; missed K-L@9; missed R-D@18 0.317869991064072 2507.59814453125 627.9068 2507.2802734375 627.827331542969 4 13 1.1.1.3623.14 1 46.9462 11471.16 47.0606 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.0499970912933 QKLHELQEKLSPLGEEMRDR acrolein addition +56(K)@9; Methyl(S)@11; Oxidation(P)@12 missed K-L@2; missed K-L@9; missed R-D@18 0.25279501080513 2521.54858398438 841.5235 2521.2958984375 841.439208984375 3 14 1.1.1.3696.13 1 48.7002 2431.466 48.6151 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.5100028514862 QKLHELQEKLSPLGEEMRDR missed K-L@2; missed K-L@9; missed R-D@18 0.360042989253998 2435.619140625 488.1311 2435.25903320313 488.05908203125 5 13 1.1.1.3136.6 1 35.1198 102694.3 34.8682 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.410001039505 QKLHELQEKLSPLGEEMRDR Methyl(Q)@1; acrolein addition +94(K)@2; MDA adduct +54(K)@9 missed K-L@2; missed K-L@9; missed R-D@18 0.349458992481232 2597.67651367188 520.5426 2597.3271484375 520.472717285156 5 13 1.1.1.3100.8 1 34.249 5227.633 34.2649 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 62.5 QKLHELQEKLSPLGEEMRDR missed K-L@2; missed K-L@9; missed R-D@18 0.360958993434906 2435.6201171875 488.1313 2435.25903320313 488.05908203125 5 13 1.1.1.3115.7 1 34.6133 221250.3 34.5302 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 62.279999256134 QKLHELQEKLSPLGEEMRDR Methyl+Deamidated(Q)@1; MDA adduct +54(K)@2; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.317496985197067 2520.58178710938 631.1527 2520.26416015625 631.073364257813 4 14 1.1.1.3781.3 1 50.8296 1958.434 50.8497 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.2400004863739 QKLHELQEKLSPLGEEMRDR Carbamidomethyl(K)@9; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.30333399772644 2508.57885742188 628.152 2508.275390625 628.076171875 4 12 1.1.1.2916.8 1 29.8327 4151.377 29.8403 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.2400004863739 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; MDA adduct +54(K)@9; Decanoyl(S)@11 missed K-L@2; missed K-L@9; missed R-D@18 0.118524000048637 2626.49731445313 876.5064 2626.37890625 876.466918945313 3 13 1.1.1.3391.11 1 41.2496 813.0524 41.23 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 59.1799974441528 QKLHELQEKLSPLGEEMRDR hexanoyl addition +98(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.20431099832058 2533.53662109375 634.3914 2533.33227539063 634.34033203125 4 13 1.1.1.3109.9 1 34.4736 3517.111 34.482 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 59.1799974441528 QKLHELQEKLSPLGEEMRDR hexanoyl addition +98(K)@9 missed K-L@2; missed K-L@9; missed R-D@18 0.203090995550156 2533.53540039063 634.3911 2533.33227539063 634.34033203125 4 13 1.1.1.3116.7 1 34.6409 4333.651 34.5543 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 57.0900022983551 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Carboxy(E)@8; acrolein addition +38(K)@9 missed K-L@2; missed K-L@9; missed R-D@18 0.355186998844147 2500.59326171875 626.1556 2500.23803710938 626.066772460938 4 13 1.1.1.3491.13 1 43.7016 358.1173 43.6635 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 53.82000207901 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; acrolein addition +56(K)@9; Dioxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.318987011909485 2506.56762695313 627.6492 2506.24853515625 627.569396972656 4 12 1.1.1.3694.3 1 48.645 1036.774 48.6634 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 52.5099992752075 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@9; Oxidation(R)@18 missed K-L@2; missed K-L@9; missed R-D@18 0.371297985315323 2492.640625 499.5354 2492.26928710938 499.461151123047 5 12 1.1.1.2981.4 1 31.3882 9440.002 31.3546 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 52.5099992752075 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(R)@18 missed K-L@2; missed K-L@9; missed R-D@18 0.363236010074615 2434.59057617188 487.9254 2434.2275390625 487.852752685547 5 12 1.1.1.3214.6 1 36.9877 31529.25 36.8082 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 50.8499979972839 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2; Oxidation(R)@18 missed K-L@2; missed K-L@9; missed R-D@18 0.371297985315323 2492.640625 499.5354 2492.26928710938 499.461151123047 5 12 1.1.1.2973.8 1 31.2007 9440.002 31.3546 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 50.8499979972839 QKLHELQEKLSPLGEEMRDR Formyl@N-term; Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 -0.664745986461639 2478.58422851563 620.6533 2479.2490234375 620.819519042969 4 13 1.1.1.3192.9 1 36.4651 1793.602 36.4248 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 49.2900013923645 QKLHELQEKLSPLGEEMRDR Carboxyethyl(K)@9 missed K-L@2; missed K-L@9; missed R-D@18 0.317869991064072 2507.59814453125 627.9068 2507.2802734375 627.827331542969 4 12 1.1.1.3630.11 1 47.1258 11471.16 47.0606 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.2100007534027 QKLHELQEKLSPLGEEMRDR Delta:H(4)C(2)(H)@4; reduced acrolein addition +58(K)@9 missed K-L@2; missed K-L@9; missed R-D@18 0.271450012922287 2521.60375976563 631.4082 2521.33227539063 631.34033203125 4 12 1.1.1.3691.4 1 48.5742 9874.142 48.6151 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 38.5699987411499 QKLHELQEKLSPLGEEMRDR Methyl(E)@8; reduced acrolein addition +58(K)@9 missed K-L@2; missed K-L@9; missed R-D@18 0.213321998715401 2507.53002929688 836.8506 2507.31665039063 836.779479980469 3 12 1.1.1.3623.21 1 46.9521 2880.013 47.0865 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 36.3599985837936 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; acrolein addition +94(K)@9; Dethiomethyl(M)@17; Dimethyl(R)@18 missed K-L@2; missed K-L@9; missed R-D@18 0.335841000080109 2492.63818359375 499.5349 2492.30224609375 499.467742919922 5 13 1.1.1.2804.4 1 27.1377 5350.485 27.1322 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 34.4099998474121 QKLHELQEKLSPLGEEMRDR Carbamyl@N-term; MDA adduct +62(K)@2; Dethiomethyl(M)@17 missed K-L@2; missed K-L@9; missed R-D@18 0.303328990936279 2492.58056640625 624.1524 2492.27709960938 624.076599121094 4 12 1.1.1.2976.6 1 31.2743 6799.517 31.3546 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 25.3800004720688 QKLHELQEKLSPLGEEMRDR missed K-L@2; missed K-L@9; missed R-D@18 0.361568987369537 2435.62060546875 488.1314 2435.25903320313 488.05908203125 5 12 1.1.1.3122.5 1 34.7833 221981.1 34.5302 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 25.220000743866 QKLHELQEKLSPLGEEMRDR reduced acrolein addition +58(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.333162993192673 2493.63403320313 499.7341 2493.30102539063 499.66748046875 5 13 1.1.1.3491.7 1 43.6966 1676.825 43.7379 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 20.1800003647804 QKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Oxidation(P)@12; Deamidated(R)@18 missed K-L@2; missed K-L@9; missed R-D@18 0.352683007717133 2435.56420898438 609.8983 2435.21142578125 609.810119628906 4 12 1.1.1.3185.7 1 36.2931 1165.663 36.3049 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 16.4100006222725 QKLHELQEKLSPLGEEMRDR MDA adduct +62(K)@2 missed K-L@2; missed K-L@9; missed R-D@18 0.31529301404953 2497.59008789063 625.4048 2497.27465820313 625.325988769531 4 13 1.1.1.3706.4 1 48.9361 521.6447 48.9047 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDRAR Gln->pyro-Glu@N-term missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 0.372269004583359 2645.74291992188 530.1559 2645.37084960938 530.081420898438 5 18 1.1.1.3371.6 1 40.7593 4219.749 40.7437 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKLHELQEKLSPLGEEMRDRAR Gln->pyro-Glu@N-term missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 0.311307996511459 2645.68212890625 662.4278 2645.37084960938 662.349975585938 4 17 1.1.1.3356.6 1 40.3908 1145.284 40.4765 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.989999294281 QKLHELQEKLSPLGEEMRDRAR missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 0.306488007307053 2662.70385742188 666.6832 2662.39721679688 666.606628417969 4 16 1.1.1.3114.8 1 34.5925 9812.307 34.5784 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.8999972343445 QKLHELQEKLSPLGEEMRDRAR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2 missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 0.438912004232407 2703.8515625 451.6492 2703.41259765625 451.576049804688 6 14 1.1.1.3156.2 1 35.593 2203.627 35.6832 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5399980545044 QKLHELQEKLSPLGEEMRDRAR Gln->pyro-Glu@N-term missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 0.372269004583359 2645.74291992188 530.1559 2645.37084960938 530.081420898438 5 15 1.1.1.3364.6 1 40.5825 4219.749 40.7437 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5399980545044 QKLHELQEKLSPLGEEMRDRAR Gln->pyro-Glu@N-term missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 0.311307996511459 2645.68212890625 662.4278 2645.37084960938 662.349975585938 4 15 1.1.1.3371.7 1 40.7627 1922.016 40.7437 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2599992752075 QKLHELQEKLSPLGEEMRDRAR Gln->pyro-Glu@N-term missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 0.317656010389328 2645.6884765625 662.4294 2645.37084960938 662.349975585938 4 15 1.1.1.3364.8 1 40.5858 919.6822 40.5975 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.6900019645691 QKLHELQEKLSPLGEEMRDRAR Oxidation(M)@17 missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 0.309132009744644 2678.70141601563 670.6826 2678.39233398438 670.605346679688 4 13 1.1.1.2855.9 1 28.3675 1292.953 28.3726 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.0000026226044 QKLHELQEKLSPLGEEMRDRAR missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 0.306488007307053 2662.70385742188 666.6832 2662.39721679688 666.606628417969 4 14 1.1.1.3106.2 1 34.3963 9661.968 34.5784 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.7000002861023 QKLHELQEKLSPLGEEMRDRAR Gln->pyro-Glu@N-term missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 0.313749998807907 2645.6845703125 662.4284 2645.37084960938 662.349975585938 4 14 1.1.1.3379.7 1 40.9512 1589.952 40.8642 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 66.6599988937378 QKLHELQEKLSPLGEEMRDRAR Gln->pyro-Glu@N-term; Nicotinyl(K)@9 missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 -0.566724002361298 2748.81762695313 550.7708 2749.38452148438 550.884155273438 5 14 1.1.1.3656.8 1 47.7919 1765.261 47.8078 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 26.3399988412857 QKLHELQEKLSPLGEEMRDRAR missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 0.366288989782333 2662.763671875 533.56 2662.39721679688 533.486755371094 5 12 1.1.1.3107.8 1 34.422 33738.84 34.6026 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 25.0800013542175 QKLHELQEKLSPLGEEMRDRAR missed K-L@2; missed K-L@9; missed R-D@18; missed R-A@20 0.306488007307053 2662.70385742188 666.6832 2662.39721679688 666.606628417969 4 12 1.1.1.3121.11 1 34.7667 9812.307 34.5784 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.2300028800964 QKVEPLRAELQ Dehydrated(E)@9 cleaved Q-E@C-term; missed K-V@2; missed R-A@7 0.155387997627258 1291.88024902344 646.9474 1291.72485351563 646.869689941406 2 14 1.1.1.2768.9 1 26.284 3740.148 26.3199 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.410001039505 QKVEPLRAELQ Dehydrated(E)@9 cleaved Q-E@C-term; missed K-V@2; missed R-A@7 0.155387997627258 1291.88024902344 646.9474 1291.72485351563 646.869689941406 2 13 1.1.1.2775.4 1 26.4551 3740.148 26.3199 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 0.163733005523682 1723.10144042969 862.558 1722.93762207031 862.476135253906 2 24 1.1.1.2766.6 1 26.2426 130243.6 26.3199 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 0.163733005523682 1723.10144042969 862.558 1722.93762207031 862.476135253906 2 25 1.1.1.2779.8 1 26.5549 139707.7 26.2957 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 0.163610994815826 1723.10131835938 862.5579 1722.93762207031 862.476135253906 2 24 1.1.1.2786.10 1 26.7221 36060.04 26.4643 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2 missed K-V@2; missed R-A@7 0.234280005097389 1764.18725585938 589.0697 1763.95300292969 588.991638183594 3 22 1.1.1.2805.11 1 27.1732 21633.69 27.2277 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2 missed K-V@2; missed R-A@7 0.234280005097389 1764.18725585938 589.0697 1763.95300292969 588.991638183594 3 23 1.1.1.2812.9 1 27.3418 21633.69 27.2277 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.22859899699688 1706.13977050781 569.7205 1705.9111328125 569.644348144531 3 21 1.1.1.3026.4 1 32.4712 96417.86 32.6566 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.16745500266552 1706.07861328125 854.0466 1705.9111328125 853.962829589844 2 21 1.1.1.3026.9 1 32.4796 17400.6 32.7046 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.22859899699688 1706.13977050781 569.7205 1705.9111328125 569.644348144531 3 21 1.1.1.3033.4 1 32.6398 113864.9 32.8249 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.167088001966476 1706.07824707031 854.0464 1705.9111328125 853.962829589844 2 24 1.1.1.3033.8 1 32.649 18303.28 32.7046 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.22859899699688 1706.13977050781 569.7205 1705.9111328125 569.644348144531 3 21 1.1.1.3043.5 1 32.882 115038.4 32.8249 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.22859899699688 1706.13977050781 569.7205 1705.9111328125 569.644348144531 3 21 1.1.1.3050.5 1 33.0536 116538 32.8009 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.16745500266552 1706.07861328125 854.0466 1705.9111328125 853.962829589844 2 24 1.1.1.3050.6 1 33.0569 18638.04 32.8009 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.22859899699688 1706.13977050781 569.7205 1705.9111328125 569.644348144531 3 22 1.1.1.3057.7 1 33.2257 94632.67 32.9692 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.164768993854523 1706.07592773438 854.0452 1705.9111328125 853.962829589844 2 22 1.1.1.3057.8 1 33.2282 12678.79 32.9692 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.228231996297836 1706.13940429688 569.7204 1705.9111328125 569.644348144531 3 22 1.1.1.3064.7 1 33.396 56873.3 33.1373 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.172460004687309 1706.08361816406 854.0491 1705.9111328125 853.962829589844 2 20 1.1.1.3075.7 1 33.6598 1112.872 33.6409 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.227682992815971 1706.13879394531 569.7202 1705.9111328125 569.644348144531 3 21 1.1.1.3078.5 1 33.725 18374.67 33.7127 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.227682992815971 1706.13879394531 569.7202 1705.9111328125 569.644348144531 3 20 1.1.1.3085.5 1 33.8895 32778.91 33.8806 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Acetyl@N-term; Dehydrated(E)@4 missed K-V@2; missed R-A@7 0.227561995387077 1747.16528320313 583.3957 1746.93762207031 583.31982421875 3 21 1.1.1.3094.7 1 34.1129 37099.85 34.1925 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Acetyl@N-term; Dehydrated(E)@4 missed K-V@2; missed R-A@7 0.227561995387077 1747.16528320313 583.3957 1746.93762207031 583.31982421875 3 21 1.1.1.3101.13 1 34.279 37099.85 34.1925 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR reduced acrolein addition +58(K)@2 missed K-V@2; missed R-A@7 0.195524007081985 1781.17504882813 594.7323 1780.9794921875 594.667114257813 3 20 1.1.1.3188.3 1 36.3659 2039.067 36.4008 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Carboxyethyl(K)@2 missed K-V@2; missed R-A@7 0.22767299413681 1795.1865234375 599.4028 1794.95886230469 599.326904296875 3 19 1.1.1.3305.6 1 39.1736 6451.923 39.083 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2 missed K-V@2; missed R-A@7 0.289869993925095 1764.24291992188 442.068 1763.95300292969 441.995513916016 4 16 1.1.1.2805.5 1 27.1632 44202.97 27.2515 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.167698994278908 1706.07885742188 854.0467 1705.9111328125 853.962829589844 2 18 1.1.1.3067.11 1 33.468 1238.848 33.473 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.168064996600151 1706.07922363281 854.0469 1705.9111328125 853.962829589844 2 19 1.1.1.3085.9 1 33.8996 2044.218 33.8806 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.227682992815971 1706.13879394531 569.7202 1705.9111328125 569.644348144531 3 20 1.1.1.3093.7 1 34.0864 32778.91 33.8806 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Carboxyethyl(K)@2 missed K-V@2; missed R-A@7 0.22767299413681 1795.1865234375 599.4028 1794.95886230469 599.326904296875 3 17 1.1.1.3298.3 1 39.0062 6451.923 39.083 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.228231996297836 1706.13940429688 569.7204 1705.9111328125 569.644348144531 3 19 1.1.1.3071.7 1 33.5638 17926.16 33.521 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.227317005395889 1706.13842773438 569.7201 1705.9111328125 569.644348144531 3 18 1.1.1.3101.12 1 34.2773 3776.964 34.0246 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.229514002799988 1706.140625 569.7208 1705.9111328125 569.644348144531 3 19 1.1.1.2780.3 1 26.5687 1525.109 26.6077 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 0.224815994501114 1723.16247558594 575.3948 1722.93762207031 575.31982421875 3 17 1.1.1.2772.7 1 26.3821 447958.9 26.3199 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 0.222251996397972 1723.15991210938 575.3939 1722.93762207031 575.31982421875 3 17 1.1.1.2779.6 1 26.5499 169158.7 26.6077 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 0.222251996397972 1723.15991210938 575.3939 1722.93762207031 575.31982421875 3 17 1.1.1.2786.8 1 26.7171 169158.7 26.6077 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2 missed K-V@2; missed R-A@7 0.178445994853973 1764.13146972656 883.073 1763.95300292969 882.983764648438 2 17 1.1.1.2806.6 1 27.1987 1899.569 27.2277 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 0.227013006806374 1723.16467285156 575.3955 1722.93762207031 575.31982421875 3 16 1.1.1.2800.4 1 27.0515 2257.84 27.0607 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 0.229943007230759 1723.16760253906 575.3965 1722.93762207031 575.31982421875 3 16 1.1.1.2807.4 1 27.2184 2229.4 27.1084 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QKVEPLRAELQEGAR Lys->Allysine(K)@2 missed K-V@2; missed R-A@7 0.227763995528221 1722.1337890625 575.0519 1721.90600585938 574.975952148438 3 16 1.1.1.3001.7 1 31.8736 2584.083 31.932 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.989999294281 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.227682992815971 1706.13879394531 569.7202 1705.9111328125 569.644348144531 3 16 1.1.1.2767.14 1 26.2607 3698.606 26.3199 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8900005817413 QKVEPLRAELQEGAR Delta:H(2)C(2)(K)@2 missed K-V@2; missed R-A@7 0.224974006414413 1749.17834472656 584.0667 1748.95336914063 583.99169921875 3 15 1.1.1.2980.8 1 31.3684 3802.792 31.4024 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6000001430511 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2 missed K-V@2; missed R-A@7 0.289869993925095 1764.24291992188 442.068 1763.95300292969 441.995513916016 4 14 1.1.1.2812.4 1 27.3301 44202.97 27.2515 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2900023460388 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 0.222434997558594 1723.16015625 575.394 1722.93762207031 575.31982421875 3 15 1.1.1.2793.7 1 26.8864 159832 26.6317 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.1500029563904 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 0.221885994076729 1723.15954589844 575.3938 1722.93762207031 575.31982421875 3 15 1.1.1.2824.7 1 27.6253 1528.478 27.5614 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.1100022792816 QKVEPLRAELQEGAR Deamidated(Q)@1; MDA adduct +54(K)@2 missed K-V@2; missed R-A@7 0.23658299446106 1778.16882324219 593.7302 1777.93225097656 593.6513671875 3 13 1.1.1.3615.12 1 46.7401 483.8783 46.7782 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.089998960495 QKVEPLRAELQEGAR Deamidated(Q)@1; acrolein addition +56(K)@2 missed K-V@2; missed R-A@7 0.289339989423752 1780.2373046875 446.0666 1779.94787597656 445.994262695313 4 14 1.1.1.2767.11 1 26.2582 7331.335 26.2957 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.089998960495 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term; Formyl(K)@2 missed K-V@2; missed R-A@7 0.165825992822647 1734.07189941406 868.0432 1733.90600585938 867.960327148438 2 14 1.1.1.3369.12 1 40.7127 395.5476 40.7194 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.8500008583069 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 0.224815994501114 1723.16247558594 575.3948 1722.93762207031 575.31982421875 3 15 1.1.1.2765.6 1 26.2154 447958.9 26.3199 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.7899978160858 QKVEPLRAELQEGAR Delta:H(2)C(2)(K)@2 missed K-V@2; missed R-A@7 0.231748998165131 1749.18505859375 584.069 1748.95336914063 583.99169921875 3 14 1.1.1.2991.4 1 31.6277 3046.202 31.7384 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.4100022315979 QKVEPLRAELQEGAR Deamidated(Q)@1; acrolein addition +56(K)@2 missed K-V@2; missed R-A@7 0.238938003778458 1780.18688964844 594.4029 1779.94787597656 594.3232421875 3 13 1.1.1.2767.17 1 26.2632 4207.372 26.3199 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.4100022315979 QKVEPLRAELQEGAR Trimethyl(K)@2 missed K-V@2; missed R-A@7 0.193795993924141 1765.17846679688 589.4001 1764.98461914063 589.335510253906 3 14 1.1.1.3065.5 1 33.4134 965.6432 33.4252 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9199993610382 QKVEPLRAELQEGAR Deamidated(Q)@1; acrolein addition +56(K)@2 missed K-V@2; missed R-A@7 0.176696002483368 1780.12463378906 891.0696 1779.94787597656 890.981262207031 2 13 1.1.1.2770.10 1 26.3389 971.4221 26.3199 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9199993610382 QKVEPLRAELQEGAR Deamidated(Q)@1; acrolein addition +56(K)@2 missed K-V@2; missed R-A@7 0.291781008243561 1780.23974609375 446.0672 1779.94787597656 445.994262695313 4 13 1.1.1.2782.6 1 26.6215 2517.784 26.5599 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.3099994659424 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 0.277963995933533 1723.21569824219 431.8112 1722.93762207031 431.74169921875 4 14 1.1.1.2779.2 1 26.5398 176033.4 26.5121 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.3099994659424 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 0.279673010110855 1723.21740722656 431.8116 1722.93762207031 431.74169921875 4 14 1.1.1.2793.3 1 26.8763 158224.6 26.6317 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.3099994659424 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 0.279184997081757 1723.21691894531 431.8115 1722.93762207031 431.74169921875 4 14 1.1.1.2817.5 1 27.4509 2933.059 27.4422 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.6499972343445 QKVEPLRAELQEGAR Carbamidomethyl@N-term missed K-V@2; missed R-A@7 0.278106987476349 1780.2373046875 446.0666 1779.95910644531 445.9970703125 4 13 1.1.1.2774.8 1 26.4244 7331.335 26.2957 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.0000026226044 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.284615993499756 1706.19580078125 427.5562 1705.9111328125 427.485046386719 4 14 1.1.1.3036.3 1 32.7111 2235.489 32.8009 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.7300004959106 QKVEPLRAELQEGAR Delta:H(2)C(2)(K)@2 missed K-V@2; missed R-A@7 0.285140991210938 1749.23852539063 438.3169 1748.95336914063 438.24560546875 4 13 1.1.1.2994.4 1 31.6992 4524.305 31.7626 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.1999986171722 QKVEPLRAELQEGAR Formyl@N-term; reduced acrolein addition +58(K)@2 missed K-V@2; missed R-A@7 0.228746995329857 1809.20324707031 604.075 1808.97448730469 603.998779296875 3 13 1.1.1.3442.13 1 42.4898 3322.488 42.5503 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.7800004482269 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 0.222434997558594 1723.16015625 575.394 1722.93762207031 575.31982421875 3 13 1.1.1.2817.8 1 27.456 1451.619 27.466 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 76.9800007343292 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 0.278818011283875 1723.21655273438 431.8114 1722.93762207031 431.74169921875 4 13 1.1.1.2832.5 1 27.8108 1952.034 27.8234 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.6800005435944 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@2 missed K-V@2; missed R-A@7 0.131205007433891 1764.08422851563 883.0494 1763.95300292969 882.983764648438 2 13 1.1.1.3512.21 1 44.2297 800.1166 44.1849 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.410001039505 QKVEPLRAELQEGAR Dehydrated(E)@4 missed K-V@2; missed R-A@7 0.229521006345749 1705.15661621094 569.3928 1704.92712402344 569.316345214844 3 12 1.1.1.2817.7 1 27.4543 0 -1 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.410001039505 QKVEPLRAELQEGAR Delta:H(2)C(2)(K)@2 missed K-V@2; missed R-A@7 0.285995006561279 1749.23937988281 438.3171 1748.95336914063 438.24560546875 4 12 1.1.1.2982.7 1 31.4096 5674.043 31.4024 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.8299970626831 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.287301003932953 1706.19848632813 427.5569 1705.9111328125 427.485046386719 4 13 1.1.1.3029.3 1 32.5426 1610.279 32.6083 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.2400004863739 QKVEPLRAELQEGAR Lys->Allysine(K)@2 missed K-V@2; missed R-A@7 0.235636994242668 1722.14172363281 575.0545 1721.90600585938 574.975952148438 3 12 1.1.1.3067.8 1 33.463 532.7927 33.4491 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 32.8000009059906 QKVEPLRAELQEGAR hexanoyl addition +98(K)@2 missed K-V@2; missed R-A@7 0.115456998348236 1821.12634277344 608.0494 1821.01086425781 608.010864257813 3 12 1.1.1.2774.15 1 26.4353 1451.39 26.3199 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 32.2299987077713 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 0.278452008962631 1723.21618652344 431.8113 1722.93762207031 431.74169921875 4 12 1.1.1.2800.3 1 27.0473 32769.95 26.7987 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 31.1699986457825 QKVEPLRAELQEGAR missed K-V@2; missed R-A@7 0.277963995933533 1723.21569824219 431.8112 1722.93762207031 431.74169921875 4 12 1.1.1.2786.3 1 26.7088 176033.4 26.5121 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 23.929999768734 QKVEPLRAELQEGAR Gln->pyro-Glu@N-term missed K-V@2; missed R-A@7 0.280952990055084 1706.19213867188 427.5553 1705.9111328125 427.485046386719 4 12 1.1.1.3057.2 1 33.2132 1721.03 32.9692 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.9500021934509 QKVEPLRAELQEGARQKLHELQEKLSPLGEEMRDR Gln->pyro-Glu@N-term; Deamidated(Q)@16; MDA adduct +62(K)@17; Delta:H(2)C(2)(H)@19 missed K-V@2; missed R-A@7; missed R-Q@15; missed K-L@17; missed K-L@24; missed R-D@33 0.495844006538391 4212.6708984375 703.1191 4212.1748046875 703.036437988281 6 13 1.1.1.4021.2 1 56.7056 2322.631 56.7521 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 0.241811007261276 2240.37426757813 747.7987 2240.13256835938 747.718078613281 3 21 1.1.1.3746.12 1 49.9506 1240.002 49.9632 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 0.24693800508976 2240.37939453125 747.8004 2240.13256835938 747.718078613281 3 23 1.1.1.3764.8 1 50.4014 7848.682 50.6488 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 0.24693800508976 2240.37939453125 747.8004 2240.13256835938 747.718078613281 3 20 1.1.1.3771.9 1 50.5819 7449.088 50.6488 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Trp->Kynurenin(W)@10 missed K-L@5 0.173812001943588 2212.31127929688 1107.163 2212.13745117188 1107.07604980469 2 21 1.1.1.3774.21 1 50.6698 1342.725 50.6488 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Trp->Kynurenin(W)@10 missed K-L@5 0.239534005522728 2212.37719726563 738.4663 2212.13745117188 738.386474609375 3 22 1.1.1.3775.12 1 50.6879 4627.29 50.6488 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Trp->Hydroxykynurenin(W)@10 missed K-L@5 0.2447409927845 2228.37719726563 743.7997 2228.13256835938 743.718078613281 3 25 1.1.1.3776.7 1 50.7088 6734.391 50.7506 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Trp->Hydroxykynurenin(W)@10 missed K-L@5 0.175478994846344 2228.30737304688 1115.161 2228.13256835938 1115.07348632813 2 21 1.1.1.3776.18 1 50.7179 2088.991 50.7255 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Deamidated(N)@9; FormaldehydeAdduct(W)@10 missed K-L@5 0.189106002449989 2221.3154296875 1111.665 2221.12670898438 1111.57055664063 2 20 1.1.1.3789.16 1 51.0393 1236.954 51.0728 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 0.245106995105743 2240.37768554688 747.7998 2240.13256835938 747.718078613281 3 32 1.1.1.3795.9 1 51.1841 121511.4 51.246 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Carbamidomethyl(K)@5; Dioxidation(W)@10 missed K-L@5 0.241587996482849 2297.3955078125 766.8058 2297.15405273438 766.725280761719 3 22 1.1.1.3795.10 1 51.1857 2418.832 51.246 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 0.174259006977081 2240.30737304688 1121.161 2240.13256835938 1121.07348632813 2 30 1.1.1.3795.14 1 51.1924 56273.88 51.2701 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 0.245106995105743 2240.37768554688 747.7998 2240.13256835938 747.718078613281 3 30 1.1.1.3802.7 1 51.3537 121511.4 51.246 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@5; Dioxidation(W)@10 missed K-L@5 0.256951987743378 2281.40478515625 761.4755 2281.14770507813 761.389892578125 3 22 1.1.1.3802.8 1 51.3553 6790.666 51.4882 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 0.174259006977081 2240.30737304688 1121.161 2240.13256835938 1121.07348632813 2 28 1.1.1.3802.12 1 51.362 56273.88 51.2701 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Oxidation(W)@10 missed K-L@5 0.239167004823685 2224.37670898438 742.4662 2224.13745117188 742.386474609375 3 22 1.1.1.3803.3 1 51.3745 3229.446 51.5128 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@5; Dioxidation(W)@10 missed K-L@5 0.256951987743378 2281.40478515625 761.4755 2281.14770507813 761.389892578125 3 25 1.1.1.3809.11 1 51.5241 6790.666 51.4882 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.243480995297432 2208.38623046875 737.136 2208.142578125 737.054809570313 3 24 1.1.1.3818.7 1 51.7467 4097.68 51.7378 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Deamidated(N)@9; Dioxidation(W)@10 missed K-L@5 0.178036004304886 2241.29541015625 1121.655 2241.11645507813 1121.56555175781 2 24 1.1.1.3821.16 1 51.8317 2977.615 51.841 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Deamidated(N)@9; Dioxidation(W)@10 missed K-L@5 0.248395994305611 2241.36499023438 748.1289 2241.11645507813 748.046081542969 3 22 1.1.1.3825.7 1 51.9262 8610.297 51.841 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.242383003234863 2208.38500976563 737.1356 2208.142578125 737.054809570313 3 20 1.1.1.3826.8 1 51.952 8225.075 51.8665 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Trp->Kynurenin(W)@10 missed K-L@5 0.24099799990654 2212.37866210938 738.4668 2212.13745117188 738.386474609375 3 27 1.1.1.3827.3 1 51.9731 21362.85 52.0434 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Trp->Kynurenin(W)@10 missed K-L@5 0.172103002667427 2212.30932617188 1107.162 2212.13745117188 1107.07604980469 2 23 1.1.1.3827.19 1 51.9864 11612.19 52.0434 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Trp->Kynurenin(W)@10 missed K-L@5 0.172103002667427 2212.30932617188 1107.162 2212.13745117188 1107.07604980469 2 20 1.1.1.3833.14 1 52.1317 11612.19 52.0434 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Trp->Kynurenin(W)@10 missed K-L@5 0.24099799990654 2212.37866210938 738.4668 2212.13745117188 738.386474609375 3 19 1.1.1.3834.7 1 52.1506 21362.85 52.0434 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@5; Trp->Kynurenin(W)@10 missed K-L@5 0.254307985305786 2253.4072265625 752.143 2253.15283203125 752.058227539063 3 20 1.1.1.3836.6 1 52.2002 1238.213 52.243 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.24201700091362 2208.384765625 737.1355 2208.142578125 737.054809570313 3 28 1.1.1.3841.7 1 52.3262 12489.83 52.2932 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.241466999053955 2208.38403320313 737.1353 2208.142578125 737.054809570313 3 27 1.1.1.3848.2 1 52.4971 9738.491 52.5172 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Deamidated(N)@3; Dioxidation(W)@10 missed K-L@5 0.252608001232147 2241.369140625 748.1303 2241.11645507813 748.046081542969 3 22 1.1.1.3887.6 1 53.4557 1325.426 53.4733 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.175073996186256 2208.3173828125 1105.166 2208.142578125 1105.07861328125 2 25 1.1.1.3890.18 1 53.5413 179810.3 53.6723 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.242566004395485 2208.38525390625 737.1357 2208.142578125 737.054809570313 3 22 1.1.1.3892.6 1 53.5813 195342 53.745 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.242566004395485 2208.38525390625 737.1357 2208.142578125 737.054809570313 3 27 1.1.1.3892.7 1 53.5821 195342 53.745 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Carbamidomethyl(K)@5 missed K-L@5 0.174363002181053 2265.33935546875 1133.677 2265.1640625 1133.58935546875 2 24 1.1.1.3892.21 1 53.5938 2025.54 53.648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.307006001472473 2208.44970703125 553.1197 2208.142578125 553.04296875 4 20 1.1.1.3893.2 1 53.6026 8111.019 53.6723 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Deamidated(N)@9 missed K-L@5 0.259954005479813 2209.38671875 737.4695 2209.12670898438 737.3828125 3 21 1.1.1.3895.3 1 53.6588 113274.8 53.6965 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.175073996186256 2208.3173828125 1105.166 2208.142578125 1105.07861328125 2 28 1.1.1.3897.13 1 53.7139 179810.3 53.6723 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Deamidated(N)@3; acrolein addition +56(K)@5 missed K-L@5 0.253942012786865 2265.40673828125 756.1429 2265.15283203125 756.058227539063 3 24 1.1.1.3898.5 1 53.7266 5681.972 53.648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.242566004395485 2208.38525390625 737.1357 2208.142578125 737.054809570313 3 28 1.1.1.3900.4 1 53.7764 195342 53.745 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@5 missed K-L@5 0.254045009613037 2249.412109375 750.8113 2249.15795898438 750.726623535156 3 23 1.1.1.3900.5 1 53.778 13850.98 53.9629 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.175073996186256 2208.3173828125 1105.166 2208.142578125 1105.07861328125 2 29 1.1.1.3904.13 1 53.8782 179810.3 53.6723 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@5 missed K-L@5 0.25441101193428 2249.41235351563 750.8114 2249.15795898438 750.726623535156 3 26 1.1.1.3907.4 1 53.9459 16172.07 54.0354 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@5 missed K-L@5 0.1856379956007 2249.34326171875 1125.679 2249.15795898438 1125.58630371094 2 21 1.1.1.3907.10 1 53.9559 5757.09 53.9871 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.242566004395485 2208.38525390625 737.1357 2208.142578125 737.054809570313 3 26 1.1.1.3911.3 1 54.0396 163775.3 53.7931 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.175073996186256 2208.3173828125 1105.166 2208.142578125 1105.07861328125 2 25 1.1.1.3911.18 1 54.0521 139538.9 53.7931 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@5 missed K-L@5 0.25441101193428 2249.41235351563 750.8114 2249.15795898438 750.726623535156 3 26 1.1.1.3914.2 1 54.1121 16172.07 54.0354 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.170923992991447 2208.31323242188 1105.164 2208.142578125 1105.07861328125 2 22 1.1.1.3914.6 1 54.1221 4305.982 54.1326 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.242932006716728 2208.38549804688 737.1358 2208.142578125 737.054809570313 3 27 1.1.1.3918.3 1 54.2125 7771.932 54.1568 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.175073996186256 2208.3173828125 1105.166 2208.142578125 1105.07861328125 2 21 1.1.1.3921.4 1 54.2896 3995.858 54.3981 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.175073996186256 2208.3173828125 1105.166 2208.142578125 1105.07861328125 2 23 1.1.1.3922.8 1 54.3181 3995.858 54.3981 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.24201700091362 2208.384765625 737.1355 2208.142578125 737.054809570313 3 27 1.1.1.3925.3 1 54.383 9304.024 54.3741 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.24201700091362 2208.384765625 737.1355 2208.142578125 737.054809570313 3 19 1.1.1.3932.3 1 54.553 9304.024 54.3741 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Oxidation(W)@10; Methylthio(D)@11 missed K-L@5 0.262189000844955 2270.38745117188 757.8031 2270.12524414063 757.715698242188 3 25 1.1.1.3932.4 1 54.5572 1872.034 54.5184 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.174342006444931 2208.3173828125 1105.166 2208.142578125 1105.07861328125 2 23 1.1.1.3936.7 1 54.6577 2295.867 54.6867 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.240551993250847 2208.38330078125 737.135 2208.142578125 737.054809570313 3 27 1.1.1.3939.2 1 54.7165 5896.778 54.6867 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.174342006444931 2208.3173828125 1105.166 2208.142578125 1105.07861328125 2 19 1.1.1.3943.5 1 54.8241 2295.867 54.6867 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.242566004395485 2208.38525390625 737.1357 2208.142578125 737.054809570313 3 24 1.1.1.3946.4 1 54.8866 4276.591 54.9058 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.174585998058319 2208.3173828125 1105.166 2208.142578125 1105.07861328125 2 21 1.1.1.3950.4 1 54.9989 1955.254 54.9058 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.242566004395485 2208.38525390625 737.1357 2208.142578125 737.054809570313 3 22 1.1.1.3953.5 1 55.0589 4276.591 54.9058 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Deamidated(N)@9 missed K-L@5 0.241459995508194 2209.3681640625 737.4633 2209.12670898438 737.3828125 3 22 1.1.1.3975.2 1 55.5745 5920.386 55.6172 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.175318002700806 2208.3173828125 1105.166 2208.142578125 1105.07861328125 2 20 1.1.1.3975.6 1 55.5878 944.0884 55.6172 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.162623003125191 2208.30541992188 1105.16 2208.142578125 1105.07861328125 2 22 1.1.1.4004.9 1 56.3007 609.5725 56.2596 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.236340001225471 2208.37890625 737.1336 2208.142578125 737.054809570313 3 23 1.1.1.4010.2 1 56.4354 1761.414 56.3816 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.241100996732712 2208.3837890625 737.1352 2208.142578125 737.054809570313 3 21 1.1.1.4017.3 1 56.6103 1318.306 56.5537 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Deamidated(N)@3 missed K-L@5 0.246221005916595 2209.37280273438 737.4649 2209.12670898438 737.3828125 3 21 1.1.1.4032.9 1 56.9918 5634.804 57.0069 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Dioxidation(W)@10 missed K-L@5 0.243030995130539 2223.34887695313 742.1236 2223.10595703125 742.042602539063 3 28 1.1.1.4032.10 1 56.9927 12441.29 57.1083 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Dioxidation(W)@10 missed K-L@5 0.174685001373291 2223.28125 1112.648 2223.10595703125 1112.56018066406 2 28 1.1.1.4036.19 1 57.1015 29747.44 57.1337 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Dioxidation(W)@10 missed K-L@5 0.243030995130539 2223.34887695313 742.1236 2223.10595703125 742.042602539063 3 29 1.1.1.4039.6 1 57.167 12441.29 57.1083 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Dioxidation(W)@10 missed K-L@5 0.174685001373291 2223.28125 1112.648 2223.10595703125 1112.56018066406 2 26 1.1.1.4044.2 1 57.3011 29747.44 57.1337 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK reduced acrolein addition +58(K)@5; Methyl(L)@6; Dioxidation(W)@10 missed K-L@5 0.212494999170303 2312.40258789063 771.8081 2312.18994140625 771.737243652344 3 24 1.1.1.4056.7 1 57.5996 2011.501 57.6411 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Carboxyethyl(K)@5; Dioxidation(W)@10 missed K-L@5 0.170952007174492 2312.32543945313 1157.17 2312.15356445313 1157.08410644531 2 24 1.1.1.4056.20 1 57.6104 3013.116 57.6411 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Trp->Kynurenin(W)@10 missed K-L@5 0.172528997063637 2195.28344726563 1098.649 2195.11108398438 1098.56274414063 2 25 1.1.1.4057.17 1 57.6327 8122.473 57.6911 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Trp->Kynurenin(W)@10 missed K-L@5 0.244598001241684 2195.35571289063 732.7925 2195.11108398438 732.7109375 3 25 1.1.1.4061.6 1 57.7235 7170.337 57.6911 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Delta:H(2)C(2)@N-term missed K-L@5 0.243823006749153 2234.40209960938 745.808 2234.158203125 745.726684570313 3 26 1.1.1.4063.7 1 57.7738 4990.795 57.7906 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 0.175744995474815 2191.29125976563 1096.653 2191.1162109375 1096.56530761719 2 23 1.1.1.4065.10 1 57.8314 2893.294 57.8648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 0.245983004570007 2191.36206054688 731.4613 2191.1162109375 731.379333496094 3 21 1.1.1.4066.4 1 57.8455 1450.515 57.8648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Delta:H(2)C(2)@N-term missed K-L@5 0.241441994905472 2234.39965820313 745.8072 2234.158203125 745.726684570313 3 25 1.1.1.4070.3 1 57.9456 4353.71 57.9883 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Delta:H(2)C(2)@N-term missed K-L@5 0.170899003744125 2234.32934570313 1118.172 2234.158203125 1118.08642578125 2 21 1.1.1.4070.9 1 57.9564 1334.115 58.0129 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 0.176721006631851 2191.29345703125 1096.654 2191.1162109375 1096.56530761719 2 21 1.1.1.4075.8 1 58.0786 1391.914 58.1404 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Acetyl@N-term missed K-L@5 0.182331994175911 2250.33544921875 1126.175 2250.1533203125 1126.08386230469 2 24 1.1.1.4081.6 1 58.1864 1838.874 58.1949 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Acetyl@N-term missed K-L@5 0.250129014253616 2250.4033203125 751.1417 2250.1533203125 751.058349609375 3 25 1.1.1.4082.6 1 58.2019 1460.105 58.1949 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Dimethyl(N)@3; reduced acrolein addition +58(K)@5; Dioxidation(W)@10 missed K-L@5 0.143329992890358 2326.34936523438 1164.182 2326.20556640625 1164.11010742188 2 22 1.1.1.4096.4 1 58.5561 1315.019 58.5612 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 0.171838000416756 2191.28735351563 1096.651 2191.1162109375 1096.56530761719 2 28 1.1.1.4124.9 1 59.2484 48396.13 59.3339 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 0.243784993886948 2191.35986328125 731.4606 2191.1162109375 731.379333496094 3 28 1.1.1.4125.2 1 59.2626 20776.93 59.3098 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Cation:Na(D)@11 missed K-L@5 0.249878004193306 2213.34790039063 738.7899 2213.09814453125 738.706604003906 3 25 1.1.1.4129.3 1 59.3646 1155.856 59.3339 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 0.171838000416756 2191.28735351563 1096.651 2191.1162109375 1096.56530761719 2 28 1.1.1.4131.7 1 59.4238 48396.13 59.3339 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 0.243784993886948 2191.35986328125 731.4606 2191.1162109375 731.379333496094 3 27 1.1.1.4132.2 1 59.4363 20776.93 59.3098 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 0.168908998370171 2191.28540039063 1096.65 2191.1162109375 1096.56530761719 2 28 1.1.1.4138.6 1 59.5904 48977.84 59.3339 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 0.244700998067856 2191.36083984375 731.4609 2191.1162109375 731.379333496094 3 26 1.1.1.4139.2 1 59.6069 18962.09 59.3581 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 0.175744995474815 2191.29125976563 1096.653 2191.1162109375 1096.56530761719 2 26 1.1.1.4146.6 1 59.7719 25203.34 59.528 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 0.244151994585991 2191.3603515625 731.4607 2191.1162109375 731.379333496094 3 24 1.1.1.4147.4 1 59.7869 11306.38 59.5522 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 0.177941992878914 2191.29345703125 1096.654 2191.1162109375 1096.56530761719 2 29 1.1.1.4153.7 1 59.9424 6841.864 59.8792 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 0.246531993150711 2191.36254882813 731.4615 2191.1162109375 731.379333496094 3 24 1.1.1.4154.4 1 59.9573 4566.236 59.7089 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 0.251293003559113 2191.36743164063 731.4631 2191.1162109375 731.379333496094 3 26 1.1.1.4161.3 1 60.1283 2235.143 60.0489 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 0.181848004460335 2191.29736328125 1096.656 2191.1162109375 1096.56530761719 2 29 1.1.1.4161.8 1 60.1367 4663.07 60.1468 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 0.184288993477821 2191.29931640625 1096.657 2191.1162109375 1096.56530761719 2 19 1.1.1.4168.6 1 60.3073 4663.07 60.1468 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 0.177453994750977 2191.29345703125 1096.654 2191.1162109375 1096.56530761719 2 21 1.1.1.4175.14 1 60.4752 3107.22 60.4126 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Carboxyethyl(K)@5 missed K-L@5 0.25128298997879 2280.4150390625 761.1456 2280.16381835938 761.061889648438 3 22 1.1.1.4225.2 1 61.6833 3959.803 61.8765 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK reduced acrolein addition +58(K)@5; Methyl(L)@6 missed K-L@5 0.146855995059013 2280.34741210938 1141.181 2280.2001953125 1141.10729980469 2 24 1.1.1.4229.8 1 61.7948 5802.528 61.9013 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Carboxyethyl(K)@5 missed K-L@5 0.25128298997879 2280.4150390625 761.1456 2280.16381835938 761.061889648438 3 22 1.1.1.4232.2 1 61.8556 3972.194 61.8765 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Carboxyethyl(K)@5 missed K-L@5 0.183241993188858 2280.34741210938 1141.181 2280.16381835938 1141.08911132813 2 25 1.1.1.4237.19 1 61.9952 5802.528 61.9013 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Carboxyethyl(K)@5 missed K-L@5 0.25128298997879 2280.4150390625 761.1456 2280.16381835938 761.061889648438 3 24 1.1.1.4239.5 1 62.0349 3972.194 61.8765 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Carbamidomethyl@N-term missed K-L@5 0.242708995938301 2265.40673828125 756.1429 2265.1640625 756.061950683594 3 20 1.1.1.3891.5 1 53.5556 5681.972 53.648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Carbamidomethyl(K)@5 missed K-L@5 0.174363002181053 2265.33935546875 1133.677 2265.1640625 1133.58935546875 2 20 1.1.1.3899.8 1 53.7614 2025.54 53.648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Cation:Na(D)@11 missed K-L@5 0.245545998215675 2230.3701171875 744.464 2230.12451171875 744.382141113281 3 21 1.1.1.3903.3 1 53.8505 2933.205 53.6723 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@5 missed K-L@5 0.1856379956007 2249.34326171875 1125.679 2249.15795898438 1125.58630371094 2 19 1.1.1.3914.7 1 54.1246 5757.09 53.9871 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Deamidated(N)@3 missed K-L@5 0.246770992875099 2209.37353515625 737.4651 2209.12670898438 737.3828125 3 20 1.1.1.3989.5 1 55.919 4355.9 55.6661 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Oxidation(W)@10 missed K-L@5 0.173567995429039 2224.31127929688 1113.163 2224.13745117188 1113.07604980469 2 18 1.1.1.3784.20 1 50.9199 1050.542 50.9258 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Dimethyl(N)@3; reduced acrolein addition +58(K)@5 missed K-L@5 0.147563993930817 2294.36328125 1148.189 2294.2158203125 1148.115234375 2 21 1.1.1.4323.21 1 64.1799 7501.664 64.1594 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.175806999206543 2208.3193359375 1105.167 2208.142578125 1105.07861328125 2 18 1.1.1.3824.19 1 51.9108 2423.635 51.8665 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Oxidation(W)@10 missed K-L@5 0.239167004823685 2224.37670898438 742.4662 2224.13745117188 742.386474609375 3 19 1.1.1.3784.9 1 50.9108 3593.571 50.9258 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Deamidated(N)@9; Dioxidation(W)@10 missed K-L@5 0.261700987815857 2224.3515625 742.4578 2224.08984375 742.37060546875 3 19 1.1.1.4039.7 1 57.1678 7115.26 57.1337 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Dioxidation(W)@10 missed K-L@5 0.169801995158195 2223.275390625 1112.645 2223.10595703125 1112.56018066406 2 18 1.1.1.4003.16 1 56.2773 345.6471 56.2596 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 0.172082006931305 2191.28735351563 1096.651 2191.1162109375 1096.56530761719 2 18 1.1.1.4038.16 1 57.1502 1350.135 57.1846 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 0.176232993602753 2191.29125976563 1096.653 2191.1162109375 1096.56530761719 2 18 1.1.1.4045.17 1 57.3225 1301.386 57.3555 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Carboxyethyl(K)@5 missed K-L@5 0.180068001151085 2280.34326171875 1141.179 2280.16381835938 1141.08911132813 2 20 1.1.1.4244.19 1 62.1684 5884.808 61.9013 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 0.247080996632576 2191.36328125 731.4617 2191.1162109375 731.379333496094 3 18 1.1.1.4046.4 1 57.3363 330.8286 57.3309 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Deamidated(N)@9 missed K-L@5 0.241459995508194 2209.3681640625 737.4633 2209.12670898438 737.3828125 3 18 1.1.1.3982.8 1 55.748 5920.386 55.6172 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK reduced acrolein addition +58(K)@5; Dioxidation(W)@10 missed K-L@5 0.143623992800713 2298.3173828125 1150.166 2298.17431640625 1150.09448242188 2 15 1.1.1.4022.20 1 56.7462 712.2184 56.8542 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Delta:H(2)C(2)@N-term; Dioxidation(W)@10 missed K-L@5 0.259180992841721 2266.4072265625 756.4764 2266.14819335938 756.390014648438 3 19 1.1.1.3942.3 1 54.7895 769.2164 54.7591 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Deamidated(N)@9 missed K-L@5 0.241459995508194 2209.3681640625 737.4633 2209.12670898438 737.3828125 3 17 1.1.1.3977.7 1 55.6249 5920.386 55.6172 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 0.251659005880356 2191.36767578125 731.4632 2191.1162109375 731.379333496094 3 17 1.1.1.4037.7 1 57.117 524.7792 57.2098 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Ammonia-loss(N)@3; reduced acrolein addition +58(K)@5; Dioxidation(W)@10 missed K-L@5 0.255425006151199 2264.37670898438 755.7995 2264.12133789063 755.71435546875 3 20 1.1.1.4046.7 1 57.3388 937.9345 57.3555 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Formyl@N-term; reduced acrolein addition +58(K)@5 missed K-L@5 0.248877003788948 2294.42822265625 765.8167 2294.17944335938 765.733764648438 3 19 1.1.1.4330.5 1 64.3479 7367.836 64.185 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 0.241445004940033 2240.3740234375 747.7986 2240.13256835938 747.718078613281 3 18 1.1.1.3788.6 1 51.0066 4072.755 50.9003 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Deamidated(N)@9; FormaldehydeAdduct(W)@10 missed K-L@5 0.257573992013931 2221.38427734375 741.4687 2221.12670898438 741.3828125 3 19 1.1.1.3789.6 1 51.0309 2703.651 51.0485 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Oxidation(W)@10 missed K-L@5 0.239167004823685 2224.37670898438 742.4662 2224.13745117188 742.386474609375 3 18 1.1.1.3810.8 1 51.5462 3229.446 51.5128 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Deamidated(N)@9; Dioxidation(W)@10 missed K-L@5 0.248395994305611 2241.36499023438 748.1289 2241.11645507813 748.046081542969 3 19 1.1.1.3818.9 1 51.7483 8610.297 51.841 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Deamidated(N)@9; Dioxidation(W)@10 missed K-L@5 0.247481003403664 2241.36401367188 748.1286 2241.11645507813 748.046081542969 3 19 1.1.1.3832.4 1 52.0987 2995.239 52.1924 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Deamidated(N)@3; MDA adduct +54(K)@5; Dioxidation(W)@10 missed K-L@5 0.256141990423203 2295.38330078125 766.135 2295.126953125 766.049621582031 3 16 1.1.1.4357.3 1 65.0541 164.2294 65.0742 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@5 missed K-L@5 0.143888995051384 2249.30126953125 1125.658 2249.15795898438 1125.58630371094 2 19 1.1.1.4487.15 1 68.3361 194.5579 68.3176 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Deamidated(N)@3; MDA adduct +54(K)@5 missed K-L@5 0.253601014614105 2263.39086914063 755.4709 2263.13720703125 755.386352539063 3 22 1.1.1.4546.3 1 69.833 1093.834 69.9561 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Carboxyethyl(K)@5 missed K-L@5 0.253601014614105 2263.39086914063 755.4709 2263.13720703125 755.386352539063 3 25 1.1.1.4553.6 1 70.0226 1093.834 69.9561 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Deamidated(N)@3; MDA adduct +54(K)@5 missed K-L@5 0.181959003210068 2263.3193359375 1132.667 2263.13720703125 1132.57592773438 2 20 1.1.1.4554.10 1 70.0565 622.9785 69.9561 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Methyl+Deamidated(Q)@1; MDA adduct +54(K)@5 missed K-L@5 0.244421005249023 2277.39721679688 760.1397 2277.15283203125 760.058227539063 3 22 1.1.1.4641.10 1 72.3034 1057.827 72.2115 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Oxidation(W)@10 missed K-L@5 0.169173002243042 2224.30737304688 1113.161 2224.13745117188 1113.07604980469 2 17 1.1.1.3829.18 1 52.0359 1126.018 52.0186 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Oxidation(W)@10 missed K-L@5 0.177717998623848 2224.3154296875 1113.165 2224.13745117188 1113.07604980469 2 16 1.1.1.3808.17 1 51.5044 1095.167 51.4882 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.174830004572868 2208.3173828125 1105.166 2208.142578125 1105.07861328125 2 19 1.1.1.3982.20 1 55.758 959.8954 55.7883 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Dioxidation(W)@10 missed K-L@5 0.174928992986679 2223.28125 1112.648 2223.10595703125 1112.56018066406 2 17 1.1.1.3971.7 1 55.5045 621.056 55.4904 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Carboxyethyl(K)@5 missed K-L@5 0.180555999279022 2280.34326171875 1141.179 2280.16381835938 1141.08911132813 2 18 1.1.1.4222.11 1 61.624 4757.805 61.8518 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Deamidated(N)@3 missed K-L@5 0.251652002334595 2192.35180664063 731.7912 2192.10009765625 731.707336425781 3 17 1.1.1.4265.4 1 62.677 723.0731 62.6196 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 0.250743001699448 2191.36694335938 731.4629 2191.1162109375 731.379333496094 3 14 1.1.1.4283.5 1 63.1318 159.8631 63.1753 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.242383003234863 2208.38500976563 737.1356 2208.142578125 737.054809570313 3 19 1.1.1.3885.6 1 53.4061 128823 53.648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.307006001472473 2208.44970703125 553.1197 2208.142578125 553.04296875 4 19 1.1.1.3904.2 1 53.869 8111.019 53.6723 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.237804993987083 2208.38037109375 737.1341 2208.142578125 737.054809570313 3 19 1.1.1.4025.6 1 56.8111 1819.333 56.8801 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.175562992691994 2208.3173828125 1105.166 2208.142578125 1105.07861328125 2 16 1.1.1.3852.9 1 52.6066 4236.714 52.5172 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.175073996186256 2208.3173828125 1105.166 2208.142578125 1105.07861328125 2 18 1.1.1.3929.7 1 54.4842 3995.858 54.3981 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.240734994411469 2208.38330078125 737.1351 2208.142578125 737.054809570313 3 19 1.1.1.4003.3 1 56.2639 1584.837 56.1616 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Deamidated(N)@9; FormaldehydeAdduct(W)@10 missed K-L@5 0.244389995932579 2221.37109375 741.4643 2221.12670898438 741.3828125 3 18 1.1.1.3514.4 1 44.2711 662.4789 44.2588 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Oxidation(W)@10 missed K-L@5 0.169173002243042 2224.30737304688 1113.161 2224.13745117188 1113.07604980469 2 17 1.1.1.3828.16 1 52.0094 1126.018 52.0186 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Dimethyl(N)@3; reduced acrolein addition +58(K)@5 missed K-L@5 0.144572004675865 2277.33325195313 1139.674 2277.18920898438 1139.60192871094 2 19 1.1.1.4634.19 1 72.1252 600.042 72.2644 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Hydroxymethyl(N)@3; acrolein addition +56(K)@5 missed K-L@5 0.18095700442791 2277.33325195313 1139.674 2277.15283203125 1139.58374023438 2 19 1.1.1.4641.20 1 72.3117 600.042 72.2644 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.240734994411469 2208.38330078125 737.1351 2208.142578125 737.054809570313 3 18 1.1.1.3996.4 1 56.0932 1584.837 56.1616 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 0.241445004940033 2240.3740234375 747.7986 2240.13256835938 747.718078613281 3 17 1.1.1.3781.11 1 50.8363 4072.755 50.9003 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Deamidated(N)@9; Dioxidation(W)@10 missed K-L@5 0.17315299808979 2241.28930664063 1121.652 2241.11645507813 1121.56555175781 2 16 1.1.1.3833.15 1 52.1325 923.1627 52.1674 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 0.245106995105743 2240.37768554688 747.7998 2240.13256835938 747.718078613281 3 16 1.1.1.3809.9 1 51.5224 116008 51.2701 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Delta:H(2)C(2)(K)@5 missed K-L@5 0.248704001307487 2217.38037109375 740.1341 2217.1318359375 740.051208496094 3 17 1.1.1.4331.4 1 64.3732 465.9078 64.4448 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8900005817413 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 0.180627003312111 2191.29736328125 1096.656 2191.1162109375 1096.56530761719 2 15 1.1.1.4182.4 1 60.6446 3225.372 60.3883 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8900005817413 QLNLKLLDNWDSVTSTFSK Formyl@N-term; reduced acrolein addition +58(K)@5 missed K-L@5 0.248877003788948 2294.42822265625 765.8167 2294.17944335938 765.733764648438 3 17 1.1.1.4324.7 1 64.1943 7367.836 64.185 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8699972629547 QLNLKLLDNWDSVTSTFSK MDA adduct +54(K)@5 missed K-L@5 0.155279994010925 2262.30859375 755.1101 2262.1533203125 755.058349609375 3 17 1.1.1.3895.4 1 53.663 1548.698 53.6723 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 QLNLKLLDNWDSVTSTFSK Oxidation(W)@10 missed K-L@5 0.23861800134182 2224.37622070313 742.466 2224.13745117188 742.386474609375 3 17 1.1.1.3829.2 1 52.0225 3731.135 51.9932 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 QLNLKLLDNWDSVTSTFSK Deamidated(N)@3; MDA adduct +54(K)@5 missed K-L@5 0.181959003210068 2263.3193359375 1132.667 2263.13720703125 1132.57592773438 2 18 1.1.1.4547.13 1 69.871 622.9785 69.9561 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Dimethyl(N)@3; reduced acrolein addition +58(K)@5 missed K-L@5 0.208035007119179 2277.39721679688 760.1397 2277.18920898438 760.070373535156 3 20 1.1.1.4634.12 1 72.1193 1057.827 72.2115 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.089998960495 QLNLKLLDNWDSVTSTFSK Delta:H(2)C(2)@N-term missed K-L@5 0.170654997229576 2234.32934570313 1118.172 2234.158203125 1118.08642578125 2 16 1.1.1.4062.14 1 57.7557 2139.651 57.8154 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.089998960495 QLNLKLLDNWDSVTSTFSK Methyl(L)@4; acrolein addition +94(K)@5 missed K-L@5 0.2117840051651 2316.41186523438 773.1446 2316.2001953125 773.073974609375 3 17 1.1.1.4321.4 1 64.1137 559.0115 64.185 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.089998960495 QLNLKLLDNWDSVTSTFSK Formyl@N-term; reduced acrolein addition +58(K)@5 missed K-L@5 0.184193000197411 2294.36328125 1148.189 2294.17944335938 1148.09704589844 2 15 1.1.1.4330.20 1 64.3605 7571.163 64.185 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.8799998760223 QLNLKLLDNWDSVTSTFSK missed K-L@5 5.10256004333496 2213.24536132813 1107.63 2208.142578125 1105.07861328125 2 15 1.1.1.3903.5 1 53.8572 2359.599 53.8656 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.8799998760223 QLNLKLLDNWDSVTSTFSK Formyl@N-term; reduced acrolein addition +58(K)@5 missed K-L@5 0.248877003788948 2294.42822265625 765.8167 2294.17944335938 765.733764648438 3 16 1.1.1.4316.6 1 63.9878 7350.649 64.185 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.8799998760223 QLNLKLLDNWDSVTSTFSK Deamidated(N)@3; MDA adduct +54(K)@5; Dioxidation(W)@10 missed K-L@5 0.189444005489349 2295.3173828125 1148.666 2295.126953125 1148.57080078125 2 14 1.1.1.4357.14 1 65.0633 151.4934 65.0214 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.6400017738342 QLNLKLLDNWDSVTSTFSK Formyl@N-term; reduced acrolein addition +58(K)@5 missed K-L@5 0.183948993682861 2294.36328125 1148.189 2294.17944335938 1148.09704589844 2 15 1.1.1.4316.20 1 63.9995 7501.664 64.1594 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.5899994373322 QLNLKLLDNWDSVTSTFSK Methyl(N)@9 missed K-L@5 0.209398999810219 2222.36767578125 741.7965 2222.158203125 741.726684570313 3 17 1.1.1.3754.11 1 50.1488 3994.298 50.137 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.3900020122528 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Dioxidation(W)@10 missed K-L@5 0.174685001373291 2223.28125 1112.648 2223.10595703125 1112.56018066406 2 14 1.1.1.4029.19 1 56.9239 29943.97 57.1337 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1199989318848 QLNLKLLDNWDSVTSTFSK Methyl(K)@5; Dehydrated(D)@8 missed K-L@5 0.207877993583679 2204.35571289063 735.7925 2204.14770507813 735.723205566406 3 18 1.1.1.3753.7 1 50.1219 7789.537 50.137 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1199989318848 QLNLKLLDNWDSVTSTFSK Methyl(L)@7; Dehydrated(D)@8 missed K-L@5 0.207877993583679 2204.35571289063 735.7925 2204.14770507813 735.723205566406 3 18 1.1.1.3755.12 1 50.1744 7789.537 50.137 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8699991703033 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@5; Trp->Hydroxykynurenin(W)@10 missed K-L@5 0.260248005390167 2269.40795898438 757.4766 2269.14770507813 757.389892578125 3 17 1.1.1.3782.8 1 50.8589 538.0458 50.8497 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8699991703033 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 0.178408995270729 2240.31127929688 1121.163 2240.13256835938 1121.07348632813 2 12 1.1.1.3814.19 1 51.6549 288.8542 51.5622 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8699991703033 QLNLKLLDNWDSVTSTFSK Trp->Kynurenin(W)@10 missed K-L@5 0.30281400680542 2212.4404296875 554.1174 2212.13745117188 554.041687011719 4 16 1.1.1.3826.3 1 51.9478 9028.363 52.0434 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8699991703033 QLNLKLLDNWDSVTSTFSK Trp->Kynurenin(W)@10 missed K-L@5 0.30281400680542 2212.4404296875 554.1174 2212.13745117188 554.041687011719 4 16 1.1.1.3833.2 1 52.1217 9028.363 52.0434 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.6000020503998 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 0.173281997442245 2240.30541992188 1121.16 2240.13256835938 1121.07348632813 2 14 1.1.1.3771.16 1 50.5878 2162.568 50.6488 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5200006961823 QLNLKLLDNWDSVTSTFSK Methyl(L)@4; reduced acrolein addition +58(K)@5 missed K-L@5 0.139776006340981 2280.33935546875 1141.177 2280.2001953125 1141.10729980469 2 15 1.1.1.4252.20 1 62.3637 524.0775 62.3451 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.4900026321411 QLNLKLLDNWDSVTSTFSK Formyl@N-term; Dioxidation(W)@10 missed K-L@5 0.177879005670547 2268.30541992188 1135.16 2268.12744140625 1135.07092285156 2 14 1.1.1.3953.17 1 55.0689 411.1454 55.0529 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.0900018215179 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@5; Dioxidation(W)@10 missed K-L@5 0.188971996307373 2281.33740234375 1141.676 2281.14770507813 1141.58117675781 2 12 1.1.1.3809.21 1 51.5324 1402.988 51.4882 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.3300008773804 QLNLKLLDNWDSVTSTFSK Cation:Na(D)@11 missed K-L@5 0.245545998215675 2230.3701171875 744.464 2230.12451171875 744.382141113281 3 16 1.1.1.3894.4 1 53.6312 2933.205 53.6723 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.3300008773804 QLNLKLLDNWDSVTSTFSK Cation:Na(D)@11 missed K-L@5 0.309192001819611 2230.43383789063 558.6157 2230.12451171875 558.538452148438 4 16 1.1.1.3899.2 1 53.7489 1803.081 53.6965 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4199988842011 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.176051005721092 2208.3193359375 1105.167 2208.142578125 1105.07861328125 2 14 1.1.1.3958.8 1 55.1896 594.041 55.1754 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4199988842011 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.165065005421638 2208.30737304688 1105.161 2208.142578125 1105.07861328125 2 16 1.1.1.3997.14 1 56.1302 792.4435 56.1369 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.0400023460388 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Dioxidation(W)@10 missed K-L@5 -0.672143995761871 2222.43383789063 556.6157 2223.10595703125 556.783752441406 4 15 1.1.1.3756.3 1 50.1921 308.4964 50.1869 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.0400023460388 QLNLKLLDNWDSVTSTFSK Trp->Kynurenin(W)@10 missed K-L@5 0.239534005522728 2212.37719726563 738.4663 2212.13745117188 738.386474609375 3 14 1.1.1.3773.7 1 50.6321 4627.29 50.6488 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.6899988651276 QLNLKLLDNWDSVTSTFSK Trp->Kynurenin(W)@10 missed K-L@5 0.185043007135391 2212.3232421875 1107.169 2212.13745117188 1107.07604980469 2 13 1.1.1.3787.17 1 50.9911 569.935 50.9749 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.7499978542328 QLNLKLLDNWDSVTSTFSK missed K-L@5 -0.852024972438812 2207.29125976563 1104.653 2208.142578125 1105.07861328125 2 15 1.1.1.4049.18 1 57.4258 1171.958 57.5644 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.7000014781952 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.174342006444931 2208.3173828125 1105.166 2208.142578125 1105.07861328125 2 13 1.1.1.3842.12 1 52.3551 4675.751 52.2932 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.2300009727478 QLNLKLLDNWDSVTSTFSK Methyl(K)@5; Dehydrated(D)@8 missed K-L@5 0.207877993583679 2204.35571289063 735.7925 2204.14770507813 735.723205566406 3 16 1.1.1.3754.10 1 50.148 7789.537 50.137 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.7199997901917 QLNLKLLDNWDSVTSTFSK Methyl(D)@11 missed K-L@5 0.140870004892349 2222.29931640625 1112.157 2222.158203125 1112.08642578125 2 12 1.1.1.3758.20 1 50.2571 1028.242 50.137 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1900012493134 QLNLKLLDNWDSVTSTFSK missed K-L@5 -3.85934996604919 2204.28344726563 1103.149 2208.142578125 1105.07861328125 2 14 1.1.1.3703.16 1 48.8755 708.8289 48.8564 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1900012493134 QLNLKLLDNWDSVTSTFSK Deamidated(N)@9; Trp->Kynurenin(W)@10 missed K-L@5 0.307812005281448 2213.42944335938 554.3646 2213.12158203125 554.287658691406 4 14 1.1.1.3849.2 1 52.5216 590.8494 52.5417 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.0400002002716 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; MDA adduct +54(K)@5; Oxidation(N)@9 missed K-L@5 0.238232001662254 2261.35986328125 566.3472 2261.12158203125 566.287658691406 4 15 1.1.1.3893.3 1 53.6035 1948.051 53.6965 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.0400002002716 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; MDA adduct +54(K)@5; Oxidation(N)@9 missed K-L@5 0.242870002985001 2261.36450195313 566.3484 2261.12158203125 566.287658691406 4 15 1.1.1.3900.2 1 53.773 1719.23 53.769 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.710000038147 QLNLKLLDNWDSVTSTFSK Dehydrated(D)@11 missed K-L@5 0.247821003198624 2190.3798828125 731.1339 2190.13208007813 731.051330566406 3 14 1.1.1.3876.2 1 53.1833 830.9566 53.1544 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.710000038147 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Dioxidation(W)@10 missed K-L@5 0.25475001335144 2223.36059570313 742.1275 2223.10595703125 742.042602539063 3 14 1.1.1.3894.3 1 53.6296 886.9892 53.745 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.710000038147 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 0.25110998749733 2191.3671875 731.463 2191.1162109375 731.379333496094 3 11 1.1.1.4290.6 1 63.3122 141.0408 63.2781 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.710000038147 QLNLKLLDNWDSVTSTFSK Methyl(Q)@1; Deamidated(N)@3; MDA adduct +54(K)@5; Dioxidation(W)@10 missed K-L@5 0.174037992954254 2309.3173828125 1155.666 2309.14282226563 1155.57861328125 2 16 1.1.1.4428.10 1 66.8417 112.897 66.8206 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.5499973297119 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Deamidated(N)@9; Dioxidation(W)@10 missed K-L@5 0.354095011949539 2224.44409179688 557.1183 2224.08984375 557.02978515625 4 14 1.1.1.3809.3 1 51.5174 492.5792 51.5375 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.2600028514862 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Deamidated(N)@9 missed K-L@5 0.252018004655838 2192.35205078125 731.7913 2192.10009765625 731.707336425781 3 11 1.1.1.4330.3 1 64.3463 220.1879 64.4448 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.170001745224 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Deamidated(N)@9; FormaldehydeAdduct(W)@10 missed K-L@5 0.255497008562088 2204.35571289063 735.7925 2204.10009765625 735.707336425781 3 14 1.1.1.3756.13 1 50.2004 7789.537 50.137 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.9399993419647 QLNLKLLDNWDSVTSTFSK Carboxyethyl(K)@5 missed K-L@5 0.18104499578476 2280.34545898438 1141.18 2280.16381835938 1141.08911132813 2 14 1.1.1.4256.17 1 62.4591 476.2399 62.4427 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.8999996185303 QLNLKLLDNWDSVTSTFSK Oxidation(W)@10 missed K-L@5 0.237335994839668 2224.375 742.4656 2224.13745117188 742.386474609375 3 13 1.1.1.3765.11 1 50.4295 820.0838 50.5197 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.9000005722046 QLNLKLLDNWDSVTSTFSK Palmitoyl(S)@12 missed K-L@5 0.255820006132126 2446.62817382813 816.55 2446.37231445313 816.464721679688 3 13 1.1.1.4871.21 1 77.9701 157.8066 77.9752 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.5100014209747 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Oxidation(W)@10 missed K-L@5 0.174482002854347 2207.28540039063 1104.65 2207.11108398438 1104.56274414063 2 12 1.1.1.4028.18 1 56.898 746.6319 56.9307 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.5100014209747 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Ammonia-loss(N)@9; Oxidation(W)@10 missed K-L@5 0.295623004436493 2190.38012695313 731.134 2190.08447265625 731.035461425781 3 15 1.1.1.4118.2 1 59.0898 2427.571 59.2068 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.5100014209747 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term missed K-L@5 0.251293003559113 2191.36743164063 731.4631 2191.1162109375 731.379333496094 3 10 1.1.1.4298.4 1 63.5178 124.5675 63.5114 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.8099985122681 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.171167999505997 2208.31323242188 1105.164 2208.142578125 1105.07861328125 2 14 1.1.1.3967.11 1 55.411 432.9756 55.3694 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.8099985122681 QLNLKLLDNWDSVTSTFSK acrolein addition +56(K)@5 missed K-L@5 0.141779005527496 2264.31127929688 1133.163 2264.1689453125 1133.09167480469 2 13 1.1.1.4046.18 1 57.348 1588.473 57.3814 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.510002374649 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Trp->Kynurenin(W)@10 missed K-L@5 0.171307995915413 2195.28125 1098.648 2195.11108398438 1098.56274414063 2 11 1.1.1.3977.18 1 55.6341 369.5872 55.5929 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.0100028514862 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@5; FormaldehydeAdduct(W)@10 missed K-L@5 0.149124994874001 2261.30712890625 754.7763 2261.15795898438 754.726623535156 3 13 1.1.1.3892.8 1 53.583 1715.443 53.6965 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.0100028514862 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; hexanoyl addition +98(K)@5; Trp->Hydroxykynurenin(W)@10 missed K-L@5 0.236211001873016 2309.41528320313 770.8124 2309.17919921875 770.733642578125 3 12 1.1.1.4428.2 1 66.8267 99.6632 66.8206 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.4900000095367 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Deamidated(N)@3; acrolein addition +38(K)@5 missed K-L@5 0.216117992997169 2230.33129882813 1116.173 2230.11572265625 1116.06518554688 2 12 1.1.1.3709.10 1 49.0202 2153.554 48.8564 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 77.2800028324127 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Deamidated(N)@3; acrolein addition +38(K)@5 missed K-L@5 0.216117992997169 2230.33129882813 1116.173 2230.11572265625 1116.06518554688 2 12 1.1.1.3700.7 1 48.8033 2153.554 48.8564 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 76.5100002288818 QLNLKLLDNWDSVTSTFSK Trioxidation(W)@10 missed K-L@5 0.246469005942345 2256.37377929688 753.1319 2256.12744140625 753.049743652344 3 13 1.1.1.3772.8 1 50.6069 386.6748 50.597 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.6800005435944 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.241650000214577 2208.38427734375 737.1354 2208.142578125 737.054809570313 3 13 1.1.1.3855.3 1 52.6698 2097.254 52.7863 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.2799997329712 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 0.241262003779411 2240.37377929688 747.7985 2240.13256835938 747.718078613281 3 12 1.1.1.3869.8 1 53.0151 787.7047 53.0061 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.9599981307983 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.174830004572868 2208.3173828125 1105.166 2208.142578125 1105.07861328125 2 13 1.1.1.3989.15 1 55.9274 959.8954 55.7883 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.9599981307983 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.166041001677513 2208.30932617188 1105.162 2208.142578125 1105.07861328125 2 12 1.1.1.4015.10 1 56.5713 380.0476 56.5537 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.9599981307983 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.237804993987083 2208.38037109375 737.1341 2208.142578125 737.054809570313 3 14 1.1.1.4027.4 1 56.8608 1819.333 56.8801 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.9599981307983 QLNLKLLDNWDSVTSTFSK missed K-L@5 0.224987998604774 2208.36767578125 737.1298 2208.142578125 737.054809570313 3 13 1.1.1.4039.5 1 57.1661 1537.885 57.1337 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.8700020313263 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Oxidation(W)@10 missed K-L@5 0.179609000682831 2207.29125976563 1104.653 2207.11108398438 1104.56274414063 2 12 1.1.1.4056.19 1 57.6096 1171.958 57.5644 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.0499970912933 QLNLKLLDNWDSVTSTFSK Oxidation(W)@10 missed K-L@5 0.23861800134182 2224.37622070313 742.466 2224.13745117188 742.386474609375 3 12 1.1.1.3836.5 1 52.1994 3731.135 51.9932 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.2400004863739 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Dioxidation(W)@10 missed K-L@5 0.260975003242493 2223.36694335938 742.1296 2223.10595703125 742.042602539063 3 12 1.1.1.3774.9 1 50.6598 911.4943 50.5453 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 54.1499972343445 QLNLKLLDNWDSVTSTFSK Dehydrated(D)@8 missed K-L@5 0.17025800049305 2190.30126953125 1096.158 2190.13208007813 1096.07336425781 2 11 1.1.1.4117.5 1 59.0773 7684.042 59.2068 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 52.700001001358 QLNLKLLDNWDSVTSTFSK Carbamidomethyl@N-term; HPNE addition +172(K)@5 missed K-L@5 0.193859994411469 2437.46801757813 813.4966 2437.27416992188 813.431945800781 3 12 1.1.1.3716.15 1 49.1845 286.8635 49.1701 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 47.2799986600876 QLNLKLLDNWDSVTSTFSK Gln->pyro-Glu@N-term; Trp->Hydroxykynurenin(W)@10 missed K-L@5 0.29228600859642 2211.39819335938 738.14 2211.10595703125 738.042602539063 3 13 1.1.1.3893.6 1 53.606 21414.16 53.6723 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 46.2399989366531 QLNLKLLDNWDSVTSTFSK Dioxidation(W)@10 missed K-L@5 0.0409579984843731 2240.17333984375 1121.094 2240.13256835938 1121.07348632813 2 10 1.1.1.3904.14 1 53.8799 665.0303 53.9629 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR missed K-L@5; missed K-L@19 0.313481003046036 2477.64135742188 620.4176 2477.32788085938 620.339233398438 4 21 1.1.1.4012.3 1 56.486 19118.87 56.7266 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR missed K-L@5; missed K-L@19 0.246233999729156 2477.57397460938 826.8653 2477.32788085938 826.783203125 3 21 1.1.1.4016.6 1 56.5851 12866.87 56.7521 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR missed K-L@5; missed K-L@19 0.313968986272812 2477.64184570313 620.4177 2477.32788085938 620.339233398438 4 20 1.1.1.4019.3 1 56.6566 23874.93 56.7521 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR missed K-L@5; missed K-L@19 0.246233999729156 2477.57397460938 826.8653 2477.32788085938 826.783203125 3 23 1.1.1.4021.6 1 56.7098 12866.87 56.7521 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR missed K-L@5; missed K-L@19 0.246233999729156 2477.57397460938 826.8653 2477.32788085938 826.783203125 3 24 1.1.1.4024.7 1 56.7862 12866.87 56.7521 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR missed K-L@5; missed K-L@19 0.313968986272812 2477.64184570313 620.4177 2477.32788085938 620.339233398438 4 22 1.1.1.4026.2 1 56.8333 23874.93 56.7521 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR Gln->pyro-Glu@N-term missed K-L@5; missed K-L@19 0.253129005432129 2460.55444335938 821.1921 2460.30126953125 821.107727050781 3 28 1.1.1.4250.2 1 62.302 5002.808 62.1751 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR Gln->pyro-Glu@N-term; Dioxidation(W)@10 missed K-L@5; missed K-L@19 0.249445006251335 2492.54052734375 831.8541 2492.291015625 831.77099609375 3 20 1.1.1.4059.4 1 57.6719 1445.73 57.6911 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR Dimethyl(N)@3; reduced acrolein addition +58(K)@5 missed K-L@5; missed K-L@19 0.213596001267433 2563.61450195313 855.5455 2563.40087890625 855.474243164063 3 22 1.1.1.4374.2 1 65.4995 848.1855 65.5171 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@5 missed K-L@5; missed K-L@19 0.258628010749817 2518.60180664063 840.5412 2518.34301757813 840.455017089844 3 17 1.1.1.4026.12 1 56.8416 2786.569 56.9307 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR Ser->LacticAcid(S)@18; acrolein addition +56(K)@19 missed K-L@5; missed K-L@19 0.258628010749817 2518.60180664063 840.5412 2518.34301757813 840.455017089844 3 20 1.1.1.4033.12 1 57.0197 2786.569 56.9307 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@5 missed K-L@5; missed K-L@19 0.32379999756813 2518.6669921875 630.674 2518.34301757813 630.593078613281 4 17 1.1.1.4026.3 1 56.8341 5733.044 56.9307 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR Gln->pyro-Glu@N-term missed K-L@5; missed K-L@19 0.253129005432129 2460.55444335938 821.1921 2460.30126953125 821.107727050781 3 16 1.1.1.4236.4 1 61.9575 4737.667 62.1507 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QLNLKLLDNWDSVTSTFSKLR Gln->pyro-Glu@N-term missed K-L@5; missed K-L@19 0.253129005432129 2460.55444335938 821.1921 2460.30126953125 821.107727050781 3 16 1.1.1.4258.10 1 62.5035 3320.378 62.2477 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.9199995994568 QLNLKLLDNWDSVTSTFSKLR Dioxidation(W)@10 missed K-L@5; missed K-L@19 0.308026999235153 2509.62573242188 628.4137 2509.31762695313 628.336669921875 4 17 1.1.1.3846.2 1 52.4472 5197.716 52.4929 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.4900026321411 QLNLKLLDNWDSVTSTFSKLR reduced acrolein addition +58(K)@19; Dimethyl(R)@21 missed K-L@5; missed K-L@19 0.218539997935295 2563.61962890625 855.5471 2563.40087890625 855.474243164063 3 16 1.1.1.4306.8 1 63.7304 460.1222 63.7463 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.5199975967407 QLNLKLLDNWDSVTSTFSKLR Carboxyethyl(K)@5 missed K-L@5; missed K-L@19 0.25238698720932 2549.60131835938 850.8744 2549.34887695313 850.790283203125 3 16 1.1.1.4325.8 1 64.2208 832.6806 64.133 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.8500006198883 QLNLKLLDNWDSVTSTFSKLR Deamidated(N)@9 missed K-L@5; missed K-L@19 0.266552001237869 2478.57836914063 827.2001 2478.31176757813 827.111206054688 3 14 1.1.1.4025.11 1 56.8153 6025.393 56.7521 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.710000038147 QLNLKLLDNWDSVTSTFSKLR Gln->pyro-Glu@N-term; Deamidated(N)@9; Carbamidomethyl(D)@11 missed K-L@5; missed K-L@19 0.360186010599136 2518.6669921875 630.674 2518.306640625 630.583984375 4 15 1.1.1.4034.4 1 57.0382 5733.044 56.9307 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.9599981307983 QLNLKLLDNWDSVTSTFSKLR missed K-L@5; missed K-L@19 0.245866999030113 2477.57373046875 826.8652 2477.32788085938 826.783203125 3 14 1.1.1.4014.4 1 56.5344 12648.77 56.7521 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.9400012493134 QLNLKLLDNWDSVTSTFSKLR missed K-L@5; missed K-L@19 0.315434008836746 2477.64331054688 620.4181 2477.32788085938 620.339233398438 4 13 1.1.1.3891.2 1 53.5531 316.8235 53.5489 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.3099980354309 QLNLKLLDNWDSVTSTFSKLR Gln->pyro-Glu@N-term; Ser->LacticAcid(S)@18; acrolein addition +56(K)@19 missed K-L@5; missed K-L@19 0.267172008752823 2501.58374023438 834.8685 2501.31665039063 834.779479980469 3 13 1.1.1.4257.7 1 62.4755 864.4786 62.5685 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8699972629547 QLNLKLLDNWDSVTSTFSKLREQLGPVTQEFWDNLEK Gln->pyro-Glu@N-term; Oxidation(W)@10; Deamidated(Q)@23 missed K-L@5; missed K-L@19; missed R-E@21 0.450819998979568 4391.64697265625 879.3367 4391.1962890625 879.246520996094 5 20 1.1.1.4585.11 1 70.8278 866.8608 70.8412 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.9000022411346 QLNLKLLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSK Oxidation(M)@46 missed K-L@5; missed K-L@19; missed R-E@21; missed K-E@37; missed R-Q@43 0.477797001600266 5696.32470703125 950.3947 5695.8466796875 950.315063476563 6 19 1.1.1.4656.8 1 72.7067 896.9106 72.6356 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 51.9599974155426 QLNLKLLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSK reduced acrolein addition +96(K)@37; Dethiomethyl(M)@46 missed K-L@5; missed K-L@19; missed R-E@21; missed K-E@37; missed R-Q@43 -0.49965900182724 5727.40625 819.2082 5727.90625 819.279541015625 7 13 1.1.1.4597.4 1 71.1452 192.0764 71.1025 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 15.2999997138977 QLNLKLLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSK Dioxidation(W)@32; Oxidation(M)@46 missed K-L@5; missed K-L@19; missed R-E@21; missed K-E@37; missed R-Q@43 0.484183013439178 5728.32080078125 955.7274 5727.83642578125 955.646728515625 6 12 1.1.1.4598.10 1 71.1737 406.0761 71.1025 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Hex(S)@8 cleaved W-Q@N-term; missed R-V@12; missed K-D@14; missed K-D@25; missed R-D@29 0.40506899356842 4884.77783203125 977.9629 4884.373046875 977.881896972656 5 21 1.1.1.4384.3 1 65.755 5649.986 65.5655 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 QQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Hex(S)@8 cleaved W-Q@N-term; missed R-V@12; missed K-D@14; missed K-D@25; missed R-D@29 0.405984997749329 4884.77880859375 977.9631 4884.373046875 977.881896972656 5 20 1.1.1.4391.4 1 65.9277 3230.454 65.8165 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.1700019836426 QQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Hex(S)@8 cleaved W-Q@N-term; missed R-V@12; missed K-D@14; missed K-D@25; missed R-D@29 0.337639003992081 4884.7109375 1222.185 4884.373046875 1222.1005859375 4 17 1.1.1.4377.6 1 65.5811 2705.233 65.5895 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.8800003528595 QQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Hex(R)@12 cleaved W-Q@N-term; missed R-V@12; missed K-D@14; missed K-D@25; missed R-D@29 0.40506899356842 4884.77783203125 977.9629 4884.373046875 977.881896972656 5 16 1.1.1.4370.12 1 65.4056 5649.986 65.5655 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 77.4399995803833 QQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Hex(R)@12 cleaved W-Q@N-term; missed R-V@12; missed K-D@14; missed K-D@25; missed R-D@29 0.337639003992081 4884.7109375 1222.185 4884.373046875 1222.1005859375 4 15 1.1.1.4384.5 1 65.7634 2705.233 65.5895 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.6900019645691 QRLAARLEALKENGGAR Methyl(Q)@1; reduced acrolein addition +58(K)@11; Methyl(E)@12 missed R-L@2; missed R-L@6; missed K-E@11 0.165257006883621 1938.27758789063 647.0998 1938.1123046875 647.044677734375 3 16 1.1.1.3385.7 1 41.0997 2235.044 41.0584 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1099998950958 QRLAARLEALKENGGAR Methyl(Q)@1; reduced acrolein addition +58(K)@11; Methyl(E)@12 missed R-L@2; missed R-L@6; missed K-E@11 0.165257006883621 1938.27758789063 647.0998 1938.1123046875 647.044677734375 3 15 1.1.1.3378.7 1 40.9294 2235.044 41.0584 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.7599980831146 QRLAARLEALKENGGAR Acetyl@N-term; Deamidated(N)@13 missed R-L@2; missed R-L@6; missed K-E@11 0.255620986223221 1895.28930664063 632.7704 1895.03369140625 632.685180664063 3 13 1.1.1.2798.6 1 27.008 1270.329 27.1084 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 38.9400005340576 QSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK Oxidation(P)@3; MDA adduct +54(K)@8; ONE addition +154(K)@19 cleaved P-Q@N-term; missed R-V@6; missed K-D@8; missed K-D@19; missed R-D@23 0.386341005563736 4252.51904296875 851.5111 4252.1328125 851.433837890625 5 12 1.1.1.4034.11 1 57.0441 876.8283 57.0575 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.4200012683868 QSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK ONE addition +154(K)@19; HPNE addition +172(K)@36; acrolein addition +112(K)@41; Dioxidation(W)@46 cleaved P-Q@N-term; missed R-V@6; missed K-D@8; missed K-D@19; missed R-D@23; missed K-Q@36; missed K-L@41 0.456140011548996 6688.86767578125 956.5598 6688.41162109375 956.49462890625 7 15 1.1.1.4582.15 1 70.7539 822.2469 70.8153 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 RHFWQQDEPPQSPWDRVKDLATVYVDVLK cleaved A-R@N-term; missed R-H@1; missed R-V@16; missed K-D@18 0.464210987091064 3552.25927734375 593.0505 3551.794921875 592.973083496094 6 20 1.1.1.4037.2 1 57.1128 1542.041 57.1337 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.6599986553192 RHFWQQDEPPQSPWDRVKDLATVYVDVLK cleaved A-R@N-term; missed R-H@1; missed R-V@16; missed K-D@18 0.258623003959656 3552.05322265625 1185.025 3551.794921875 1184.93896484375 3 12 1.1.1.4036.20 1 57.1024 1229.148 57.1083 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 RHFWQQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved A-R@N-term; missed R-H@1; missed R-V@16; missed K-D@18; missed K-D@29; missed R-D@33 0.491742998361588 5349.11962890625 892.5272 5348.6279296875 892.445251464844 6 25 1.1.1.4276.13 1 62.964 2907.593 63.1004 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 RHFWQQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved A-R@N-term; missed R-H@1; missed R-V@16; missed K-D@18; missed K-D@29; missed R-D@33 0.428097009658813 5349.0537109375 1070.818 5348.6279296875 1070.73291015625 5 20 1.1.1.4280.14 1 63.0652 929.2674 63.0752 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.3300008773804 RHFWQQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved A-R@N-term; missed R-H@1; missed R-V@16; missed K-D@18; missed K-D@29; missed R-D@33 -12.8794002532959 5335.74853515625 890.2987 5348.6279296875 892.445251464844 6 19 1.1.1.3884.5 1 53.3836 931.4024 53.3743 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 52.5499999523163 RHFWQQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved A-R@N-term; missed R-H@1; missed R-V@16; missed K-D@18; missed K-D@29; missed R-D@33 -0.498490989208221 5348.12939453125 892.3622 5348.6279296875 892.445251464844 6 12 1.1.1.4267.9 1 62.7322 1211.965 62.825 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 33.8800013065338 RQGLLPVLESFKVSFLSALEEYTKKLNTQ cleaved L-R@N-term; missed R-Q@1; missed K-V@12; missed K-K@24; missed K-L@25 -11.6923999786377 3326.13623046875 832.5413 3337.82861328125 835.464416503906 4 13 1.1.1.4695.8 1 73.7152 2096.29 73.8337 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 63.7399971485138 RQKVEPLRAELQEGAR Acetyl@N-term; HPNE addition +172(K)@3 cleaved Y-R@N-term; missed R-Q@1; missed K-V@3; missed R-A@8 0.204733997583389 2093.36401367188 698.7953 2093.1591796875 698.72705078125 3 13 1.1.1.3302.6 1 39.1019 0 -1 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 RVKDLATVYVDVLKDSGRDYVSQFEGSALGK Formyl@N-term; reduced acrolein addition +96(K)@3 cleaved D-R@N-term; missed R-V@1; missed K-D@3; missed K-D@14; missed R-D@18 0.37083101272583 3539.20166015625 708.8476 3538.83081054688 708.7734375 5 22 1.1.1.3872.3 1 53.0885 1001.349 53.0808 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 RVKDLATVYVDVLKDSGRDYVSQFEGSALGK Delta:H(2)C(2)@N-term; hexanoyl addition +98(K)@3 cleaved D-R@N-term; missed R-V@1; missed K-D@3; missed K-D@14; missed R-D@18 0.274156004190445 3539.14135742188 885.7926 3538.8671875 885.724060058594 4 21 1.1.1.3880.9 1 53.289 1180.135 53.3253 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.9000005722046 SALEEYTKKLNTQ cleaved L-S@N-term; missed K-K@8; missed K-L@9 0.170083001255989 1523.95324707031 762.9839 1523.78308105469 762.898864746094 2 12 1.1.1.4722.12 1 74.3859 476.6243 74.374 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 SEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Carbamidomethyl@N-term cleaved L-S@N-term; missed K-A@3; missed R-Q@12; missed K-V@23 0.324741989374161 3992.47583007813 999.1262 3992.15112304688 999.045043945313 4 20 1.1.1.4713.6 1 74.1738 1082.411 74.2031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2299983501434 SEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK reduced acrolein addition +58(K)@3 cleaved L-S@N-term; missed K-A@3; missed R-Q@12; missed K-V@23 0.377081990242004 3993.54858398438 799.717 3993.17138671875 799.641540527344 5 18 1.1.1.4712.7 1 74.1381 1061.874 74.2031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2700009346008 SEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK cleaved L-S@N-term; missed K-A@3; missed R-Q@12; missed K-V@23 -0.655991017818451 3934.4736328125 984.6257 3935.12963867188 984.789672851563 4 17 1.1.1.4714.10 1 74.1963 719.8892 74.1788 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.6099996566772 SEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK Acetyl@N-term cleaved L-S@N-term; missed K-A@3; missed R-Q@12; missed K-V@23 0.335640996694565 3977.47583007813 995.3762 3977.14013671875 995.292297363281 4 17 1.1.1.4704.8 1 73.9556 1250.92 74.0092 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.6099972724915 SEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK reduced acrolein addition +58(K)@3; Dehydrated(D)@10; Deamidated(Q)@13 cleaved L-S@N-term; missed K-A@3; missed R-Q@12; missed K-V@23 0.337969988584518 3976.48291015625 995.128 3976.14477539063 995.043518066406 4 16 1.1.1.4705.7 1 73.9799 1124.649 74.0092 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 45.6299990415573 SEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTK MDA adduct +54(K)@3; acrolein addition +76(K)@5 cleaved L-S@N-term; missed K-A@3; missed R-Q@12; missed K-V@23 0.283832997083664 4065.45483398438 1017.371 4065.17138671875 1017.30010986328 4 11 1.1.1.4775.17 1 75.6912 556.1565 75.6738 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 48.1599986553192 SEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKK reduced acrolein addition +58(K)@5 cleaved L-S@N-term; missed K-A@3; missed R-Q@12; missed K-V@23; missed K-K@35 0.364089012145996 4121.63037109375 825.3334 4121.2666015625 825.260559082031 5 12 1.1.1.4666.12 1 72.9674 618.6498 73.0072 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 45.6299990415573 SEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKK Acetyl@N-term cleaved L-S@N-term; missed K-A@3; missed R-Q@12; missed K-V@23; missed K-K@35 0.451588988304138 4105.6865234375 685.2884 4105.23486328125 685.213134765625 6 11 1.1.1.4680.4 1 73.3241 177.1147 73.3169 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.9199993610382 SEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKK reduced acrolein addition +96(K)@5; acrolein addition +94(K)@23; HPNE addition +172(K)@35; MDA adduct +54(K)@36 cleaved L-S@N-term; missed K-A@3; missed R-Q@12; missed K-V@23; missed K-K@35 0.237381994724274 4479.681640625 747.6209 4479.4443359375 747.581359863281 6 11 1.1.1.4283.8 1 63.1343 2065.651 63.1753 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.3500000238419 SEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKK hexanoyl addition +98(K)@3; hexanoyl addition +98(K)@5 cleaved L-S@N-term; missed K-A@3; missed R-Q@12; missed K-V@23; missed K-K@35 0.298272997140884 4259.6708984375 1065.925 4259.37109375 1065.84997558594 4 10 1.1.1.4674.19 1 73.1814 849.194 73.2135 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 46.2599992752075 SEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLN Methyl(E)@2; acrolein addition +56(K)@5; HPNE addition +172(K)@35; hexanoyl addition +98(K)@36 cleaved L-S@N-term; cleaved N-T@C-term; missed K-A@3; missed R-Q@12; missed K-V@23; missed K-K@35; missed K-L@36 0.339572012424469 4630.916015625 927.1905 4630.57666015625 927.12255859375 5 14 1.1.1.4768.19 1 75.5132 3697.682 75.5457 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.260000705719 SEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT Formyl@N-term; acrolein addition +56(K)@3 cleaved L-S@N-term; cleaved T-Q@C-term; missed K-A@3; missed R-Q@12; missed K-V@23; missed K-K@35; missed K-L@36 0.179270997643471 4475.599609375 896.1272 4475.42041015625 896.091369628906 5 15 1.1.1.4734.10 1 74.6758 3867.433 74.7376 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 16.9400006532669 SEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT Carbamidomethyl@N-term; MDA adduct +54(K)@3 cleaved L-S@N-term; cleaved T-Q@C-term; missed K-A@3; missed R-Q@12; missed K-V@23; missed K-K@35; missed K-L@36 0.389746010303497 4502.82080078125 901.5715 4502.43115234375 901.493530273438 5 12 1.1.1.4748.12 1 75.0211 949.9062 74.9077 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 SEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Formyl@N-term; acrolein addition +56(K)@3 cleaved L-S@N-term; missed K-A@3; missed R-Q@12; missed K-V@23; missed K-K@35; missed K-L@36 0.183743000030518 4603.66259765625 921.7398 4603.47900390625 921.703063964844 5 22 1.1.1.4727.9 1 74.5113 50923.7 74.6892 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 SEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Delta:H(2)C(2)@N-term; reduced acrolein addition +58(K)@5 cleaved L-S@N-term; missed K-A@3; missed R-Q@12; missed K-V@23; missed K-K@35; missed K-L@36 0.147357001900673 4603.66259765625 921.7398 4603.51513671875 921.710327148438 5 21 1.1.1.4734.12 1 74.6791 51266.2 74.6892 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 SEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Delta:H(2)C(2)@N-term; reduced acrolein addition +58(K)@3 cleaved L-S@N-term; missed K-A@3; missed R-Q@12; missed K-V@23; missed K-K@35; missed K-L@36 0.147357001900673 4603.66259765625 921.7398 4603.51513671875 921.710327148438 5 21 1.1.1.4741.11 1 74.8507 51266.2 74.6892 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.4300026893616 SEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Dehydrated(S)@1 cleaved L-S@N-term; missed K-A@3; missed R-Q@12; missed K-V@23; missed K-K@35; missed K-L@36 0.357832014560699 4501.80517578125 901.3683 4501.447265625 901.296691894531 5 18 1.1.1.4735.8 1 74.7035 1171.032 74.6648 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 41.839998960495 SEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Delta:H(2)C(2)(K)@3; reduced acrolein addition +58(K)@5 cleaved L-S@N-term; missed K-A@3; missed R-Q@12; missed K-V@23; missed K-K@35; missed K-L@36 0.0762033984065056 4603.5908203125 1151.905 4603.51513671875 1151.88610839844 4 18 1.1.1.4741.13 1 74.854 23503.19 74.7135 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.3500000238419 SEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Dehydrated(S)@1 cleaved L-S@N-term; missed K-A@3; missed R-Q@12; missed K-V@23; missed K-K@35; missed K-L@36 0.337994992733002 4501.78515625 901.3643 4501.447265625 901.296691894531 5 13 1.1.1.4726.16 1 74.4863 1578.742 74.471 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 36.8900001049042 SEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Dehydrated(S)@1 cleaved L-S@N-term; missed K-A@3; missed R-Q@12; missed K-V@23; missed K-K@35; missed K-L@36 0.37644699215889 4501.82373046875 901.372 4501.447265625 901.296691894531 5 13 1.1.1.4719.15 1 74.3178 1294.905 74.3245 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 51.9599974155426 SFKVSFLSALEEYTKKLNTQ cleaved E-S@N-term; missed K-V@3; missed K-K@15; missed K-L@16 2.86968994140625 2335.10107421875 779.3743 2332.2314453125 778.417785644531 3 12 1.1.1.4618.4 1 71.6962 236.2751 71.7079 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 SGRDYVSQFEGSALGK cleaved D-S@N-term; missed R-D@3 0.169128000736237 1699.98571777344 851.0001 1699.81652832031 850.915588378906 2 21 1.1.1.3280.10 1 38.5758 689.2811 38.557 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 SKLREQLGPVTQEFWDNLEKETEGLRQEMSK Acetyl@N-term; acrolein addition +56(K)@2 cleaved F-S@N-term; missed K-L@2; missed R-E@4; missed K-E@20; missed R-Q@26 0.227901995182037 3803.11157226563 761.6296 3802.88354492188 761.583984375 5 21 1.1.1.4065.5 1 57.8231 9063.92 57.716 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 SKLREQLGPVTQEFWDNLEKETEGLRQEMSK reduced acrolein addition +96(K)@2; Deamidated(Q)@6 cleaved F-S@N-term; missed K-L@2; missed R-E@4; missed K-E@20; missed R-Q@26 0.227363005280495 3802.11572265625 761.4304 3801.88842773438 761.384948730469 5 19 1.1.1.4062.2 1 57.7449 11373.28 57.7411 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.089998960495 SKLREQLGPVTQEFWDNLEKETEGLRQEMSK cleaved F-S@N-term; missed K-L@2; missed R-E@4; missed K-E@20; missed R-Q@26 -0.580227971076965 3704.2666015625 741.8606 3704.84692382813 741.976623535156 5 16 1.1.1.4058.7 1 57.6495 495.5273 57.6662 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.089998960495 SKLREQLGPVTQEFWDNLEKETEGLRQEMSK Formyl@N-term; acrolein addition +38(K)@2 cleaved F-S@N-term; missed K-L@2; missed R-E@4; missed K-E@20; missed R-Q@26 -0.663667976856232 3770.19360351563 755.046 3770.857421875 755.178771972656 5 18 1.1.1.4061.11 1 57.7277 1075.218 57.7411 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.8999998569489 SKLREQLGPVTQEFWDNLEKETEGLRQEMSK MDA adduct +54(K)@2; Oxidation(P)@9 cleaved F-S@N-term; missed K-L@2; missed R-E@4; missed K-E@20; missed R-Q@26 0.247728005051613 3775.10009765625 756.0273 3774.85229492188 755.977722167969 5 15 1.1.1.4063.8 1 57.7747 481.8731 57.7411 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.1599972248077 SKLREQLGPVTQEFWDNLEKETEGLRQEMSK Deamidated(Q)@6; Deamidated(Q)@12 cleaved F-S@N-term; missed K-L@2; missed R-E@4; missed K-E@20; missed R-Q@26 0.433613985776901 3707.24853515625 742.457 3706.81494140625 742.370239257813 5 15 1.1.1.4061.8 1 57.7252 2230.243 57.716 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.6900019645691 SPLGEEMRDR cleaved L-S@N-term; missed R-D@8 0.154336005449295 1188.71008300781 595.3623 1188.5556640625 595.28515625 2 13 1.1.1.2859.11 1 28.4601 1406.498 28.4446 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.1899983882904 SPLGEEMRDR cleaved L-S@N-term; missed R-D@8 0.154091998934746 1188.70983886719 595.3622 1188.5556640625 595.28515625 2 13 1.1.1.2845.9 1 28.1253 1323.029 28.1814 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1099998950958 SPLGEEMRDR cleaved L-S@N-term; missed R-D@8 0.154336005449295 1188.71008300781 595.3623 1188.5556640625 595.28515625 2 13 1.1.1.2867.8 1 28.6525 1245.11 28.5883 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.5900008678436 SPLGEEMRDR Oxidation(M)@7 cleaved L-S@N-term; missed R-D@8 0.151852995157242 1204.70251464844 603.3585 1204.55065917969 603.282592773438 2 12 1.1.1.2696.7 1 24.5687 2972.729 24.5284 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.0400009155273 SPWDRVKDLATVYVDVLK cleaved Q-S@N-term; missed R-V@5; missed K-D@7 0.8629230260849 2103.99926757813 1053.007 2103.13647460938 1052.57543945313 2 11 1.1.1.4173.5 1 60.4218 1237.955 60.4369 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 49.3699997663498 SPWDRVKDLATVYVDVLK cleaved Q-S@N-term; missed R-V@5; missed K-D@7 0.867805004119873 2104.00341796875 1053.009 2103.13647460938 1052.57543945313 2 11 1.1.1.4180.5 1 60.5932 922.0274 60.5841 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 SQARHFWQQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved G-S@N-term; missed R-H@4; missed R-V@19; missed K-D@21; missed K-D@32; missed R-D@36 -2.19018006324768 5632.5654296875 939.7682 5634.755859375 940.133239746094 6 26 1.1.1.4378.5 1 65.6019 3249.148 65.7444 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 SQARHFWQQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved G-S@N-term; missed R-H@4; missed R-V@19; missed K-D@21; missed K-D@32; missed R-D@36 -2.19018006324768 5632.5654296875 939.7682 5634.755859375 940.133239746094 6 24 1.1.1.4380.3 1 65.6515 3249.148 65.7444 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 SQARHFWQQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved G-S@N-term; missed R-H@4; missed R-V@19; missed K-D@21; missed K-D@32; missed R-D@36 -2.19018006324768 5632.5654296875 939.7682 5634.755859375 940.133239746094 6 23 1.1.1.4383.3 1 65.739 3249.148 65.7444 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 SQARHFWQQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGK cleaved G-S@N-term; missed R-H@4; missed R-V@19; missed K-D@21; missed K-D@32; missed R-D@36 -2.19018006324768 5632.5654296875 939.7682 5634.755859375 940.133239746094 6 22 1.1.1.4390.4 1 65.9032 3249.148 65.7444 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.5400009155273 STLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Methyl(E)@5; acrolein addition +38(K)@8; Deamidated(Q)@16 cleaved L-S@N-term; missed K-A@6; missed R-Q@15; missed K-V@26; missed K-K@38; missed K-L@39 0.0937917977571487 4873.73046875 1219.44 4873.63671875 1219.41650390625 4 19 1.1.1.4734.15 1 74.6842 3585.37 74.6892 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.9699983596802 STLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ Methyl(E)@5; acrolein addition +38(K)@8; Deamidated(Q)@16 cleaved L-S@N-term; missed K-A@6; missed R-Q@15; missed K-V@26; missed K-K@38; missed K-L@39 0.0937917977571487 4873.73046875 1219.44 4873.63671875 1219.41650390625 4 16 1.1.1.4733.13 1 74.6598 3585.37 74.6892 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 28.7099987268448 STLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +38(K)@8; Deamidated(Q)@16 cleaved L-S@N-term; missed K-A@6; missed R-Q@15; missed K-V@26; missed K-K@38; missed K-L@39 0.413506001234055 4860.03466796875 973.0142 4859.62109375 972.931518554688 5 12 1.1.1.4749.12 1 75.0414 2658.527 74.9077 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 TEHLSTLSEK cleaved A-T@N-term 0.149856999516487 1143.72705078125 572.8708 1143.5771484375 572.795837402344 2 17 1.1.1.2628.9 1 22.9388 21553.99 23.0422 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 TEHLSTLSEK cleaved A-T@N-term 0.149856999516487 1143.72705078125 572.8708 1143.5771484375 572.795837402344 2 17 1.1.1.2635.4 1 23.1048 21553.99 23.0422 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 TEHLSTLSEK cleaved A-T@N-term 0.149856999516487 1143.72705078125 572.8708 1143.5771484375 572.795837402344 2 17 1.1.1.2642.10 1 23.2731 21929.45 23.0182 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 TEHLSTLSEK cleaved A-T@N-term 0.149735003709793 1143.72692871094 572.8707 1143.5771484375 572.795837402344 2 17 1.1.1.2657.10 1 23.6287 3122.333 23.5195 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 TEHLSTLSEK cleaved A-T@N-term 0.150832995772362 1143.72802734375 572.8713 1143.5771484375 572.795837402344 2 15 1.1.1.2664.11 1 23.7931 1393.963 23.8306 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 TEHLSTLSEK Dehydrated(T)@1 cleaved A-T@N-term 0.148092001676559 1125.71472167969 563.8646 1125.56665039063 563.790588378906 2 16 1.1.1.2637.5 1 23.1502 1434.767 23.0661 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6000001430511 TEHLSTLSEK cleaved A-T@N-term 0.15132200717926 1143.728515625 572.8715 1143.5771484375 572.795837402344 2 12 1.1.1.2685.10 1 24.3077 341.1263 24.3128 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2700009346008 TEHLSTLSEK Dehydrated(T)@1 cleaved A-T@N-term 0.148092001676559 1125.71472167969 563.8646 1125.56665039063 563.790588378906 2 15 1.1.1.2630.3 1 22.9792 1434.767 23.0661 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.4100022315979 TEHLSTLSEK cleaved A-T@N-term 0.150832995772362 1143.72802734375 572.8713 1143.5771484375 572.795837402344 2 11 1.1.1.2671.17 1 23.9675 1393.963 23.8306 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 TEHLSTLSEK cleaved A-T@N-term 0.151077002286911 1143.72827148438 572.8714 1143.5771484375 572.795837402344 2 10 1.1.1.2678.7 1 24.1352 1101.581 23.8788 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 33.2899987697601 TEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ MDA adduct +54(K)@10; Oxidation(P)@24; acrolein addition +76(K)@30 cleaved A-T@N-term; missed K-A@10; missed R-Q@19; missed K-V@30; missed K-K@42; missed K-L@43 -0.447762995958328 5446.44384765625 779.0707 5446.8916015625 779.134643554688 7 13 1.1.1.4696.3 1 73.736 472.574 73.808 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 30.9700012207031 TEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ acrolein addition +38(K)@12; hexanoyl addition +98(K)@30 cleaved A-T@N-term; missed K-A@10; missed R-Q@19; missed K-V@30; missed K-K@42; missed K-L@43 0.435822010040283 5437.37939453125 907.2372 5436.94384765625 907.16455078125 6 12 1.1.1.4769.16 1 75.5365 431.0803 75.5457 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6400008201599 THLAPYSDELR 0.156660005450249 1300.7978515625 651.4062 1300.64111328125 651.327880859375 2 15 1.1.1.2828.10 1 27.7197 17384.24 27.8712 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.4100022315979 THLAPYSDELR 0.212280005216599 1300.85339355469 434.6251 1300.64111328125 434.554321289063 3 14 1.1.1.2836.4 1 27.9022 59787.86 27.8712 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.5100028514862 THLAPYSDELR Dehydrated(S)@7 0.212956994771957 1282.84350585938 428.6218 1282.63061523438 428.550811767578 3 12 1.1.1.2832.4 1 27.8083 2485.03 27.8712 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.0999989509583 THLAPYSDELR 0.212280005216599 1300.85339355469 434.6251 1300.64111328125 434.554321289063 3 13 1.1.1.2835.7 1 27.8783 59787.86 27.8712 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 39.4499987363815 THLAPYSDELR 0.212280005216599 1300.85339355469 434.6251 1300.64111328125 434.554321289063 3 12 1.1.1.2828.3 1 27.708 59787.86 27.8712 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.162010997533798 1584.962890625 793.4887 1584.80090332031 793.40771484375 2 20 1.1.1.2734.6 1 25.4778 45145.98 25.6966 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.16176700592041 1584.96264648438 793.4886 1584.80090332031 793.40771484375 2 22 1.1.1.2742.10 1 25.6677 66442.6 25.792 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.16176700592041 1584.96264648438 793.4886 1584.80090332031 793.40771484375 2 22 1.1.1.2749.6 1 25.8273 66442.6 25.792 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.16176700592041 1584.96264648438 793.4886 1584.80090332031 793.40771484375 2 22 1.1.1.2756.10 1 25.9994 61432.7 25.9118 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.221018001437187 1585.02185058594 529.3479 1584.80090332031 529.274230957031 3 18 1.1.1.2711.8 1 24.9235 3634.828 24.9353 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.221018001437187 1585.02185058594 529.3479 1584.80090332031 529.274230957031 3 17 1.1.1.2749.5 1 25.8248 260378.8 25.8159 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.221018001437187 1585.02185058594 529.3479 1584.80090332031 529.274230957031 3 17 1.1.1.2756.8 1 25.996 267821.6 25.9357 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.221018001437187 1585.02185058594 529.3479 1584.80090332031 529.274230957031 3 17 1.1.1.2763.8 1 26.1682 279252.5 26.0798 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.221018001437187 1585.02185058594 529.3479 1584.80090332031 529.274230957031 3 17 1.1.1.2770.4 1 26.3273 279989.3 26.0798 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.218272000551224 1585.01916503906 529.347 1584.80090332031 529.274230957031 3 17 1.1.1.2803.3 1 27.1272 1355.296 27.1561 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.22138500213623 1585.02221679688 529.348 1584.80090332031 529.274230957031 3 16 1.1.1.2734.4 1 25.4711 191452.4 25.6966 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.161644995212555 1584.96252441406 793.4885 1584.80090332031 793.40771484375 2 16 1.1.1.2770.7 1 26.3323 59553.03 26.0798 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.221018001437187 1585.02185058594 529.3479 1584.80090332031 529.274230957031 3 16 1.1.1.2742.5 1 25.6576 260378.8 25.8159 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.221018001437187 1585.02185058594 529.3479 1584.80090332031 529.274230957031 3 16 1.1.1.2751.2 1 25.8676 260378.8 25.8159 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.221018001437187 1585.02185058594 529.3479 1584.80090332031 529.274230957031 3 16 1.1.1.2758.6 1 26.0432 279252.5 26.0798 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.221018001437187 1585.02185058594 529.3479 1584.80090332031 529.274230957031 3 16 1.1.1.2784.9 1 26.6711 3071.776 26.5838 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR missed R-Q@11 0.223032996058464 1585.02392578125 529.3486 1584.80090332031 529.274230957031 3 16 1.1.1.2821.6 1 27.5489 1443.636 27.466 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQR Carbamidomethyl@N-term missed R-Q@11 0.272967010736465 1642.09533691406 411.5311 1641.822265625 411.462860107422 4 15 1.1.1.2763.4 1 26.159 11927.81 26.1518 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2699990272522 THLAPYSDELRQR Delta:H(2)C(2)(H)@2 missed R-Q@11 0.164305001497269 1610.98083496094 806.4977 1610.81652832031 806.41552734375 2 13 1.1.1.3003.15 1 31.927 498.1364 31.9562 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.6700007915497 THLAPYSDELRQR missed R-Q@11 0.223032996058464 1585.02392578125 529.3486 1584.80090332031 529.274230957031 3 15 1.1.1.2791.6 1 26.8329 2606.422 26.7272 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.0499992370605 THLAPYSDELRQR missed R-Q@11 0.223948001861572 1585.02478027344 529.3489 1584.80090332031 529.274230957031 3 15 1.1.1.2813.6 1 27.3581 1512.781 27.2992 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.7899978160858 THLAPYSDELRQR Delta:H(2)C(2)(H)@2 missed R-Q@11 0.225936993956566 1611.04248046875 538.0214 1610.81652832031 537.946105957031 3 14 1.1.1.3004.7 1 31.9395 7672.373 31.9562 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.5399980545044 THLAPYSDELRQR missed R-Q@11 0.217172995209694 1585.01806640625 529.3466 1584.80090332031 529.274230957031 3 15 1.1.1.2694.6 1 24.5183 1694.915 24.5523 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.4100022315979 THLAPYSDELRQR Oxidation(Y)@6 missed R-Q@11 0.219633996486664 1601.01538085938 534.6791 1600.79577636719 534.605895996094 3 14 1.1.1.2671.16 1 23.9667 4142.498 24.0003 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.4100022315979 THLAPYSDELRQR Carbamidomethyl@N-term missed R-Q@11 0.272967010736465 1642.09533691406 411.5311 1641.822265625 411.462860107422 4 12 1.1.1.2756.3 1 25.9877 11927.81 26.1518 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9199993610382 THLAPYSDELRQR Carbamidomethyl@N-term missed R-Q@11 0.220795005559921 1642.04309082031 548.355 1641.822265625 548.281372070313 3 13 1.1.1.2760.8 1 26.0904 7993.555 26.1518 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.3099994659424 THLAPYSDELRQR missed R-Q@11 0.221934005618095 1585.02282714844 529.3482 1584.80090332031 529.274230957031 3 14 1.1.1.2777.5 1 26.5071 2987.141 26.5121 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 THLAPYSDELRQR Cation:Na(D)@8 missed R-Q@11 0.227293998003006 1607.01013183594 536.6773 1606.78283691406 536.6015625 3 14 1.1.1.2739.3 1 25.5964 558.8051 25.7204 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.7300004959106 THLAPYSDELRQR Formyl@N-term missed R-Q@11 0.228422999382019 1613.02416992188 538.682 1612.79577636719 538.605895996094 3 13 1.1.1.2995.10 1 31.7241 3048.974 31.7626 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.4799973964691 THLAPYSDELRQR Delta:H(2)C(2)(H)@2 missed R-Q@11 0.227402001619339 1611.0439453125 538.0219 1610.81652832031 537.946105957031 3 12 1.1.1.2997.10 1 31.7725 1925.3 31.811 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.7800004482269 THLAPYSDELRQR missed R-Q@11 0.221018001437187 1585.02185058594 529.3479 1584.80090332031 529.274230957031 3 13 1.1.1.2718.8 1 25.0908 3634.828 24.9353 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.7599980831146 THLAPYSDELRQR Delta:H(2)C(2)(H)@2 missed R-Q@11 0.282442003488541 1611.09899902344 403.782 1610.81652832031 403.711395263672 4 12 1.1.1.3005.2 1 31.9595 5682.321 31.932 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 76.9200026988983 THLAPYSDELRQR Cation:Na(D)@8 missed R-Q@11 0.237730994820595 1607.0205078125 536.6808 1606.78283691406 536.6015625 3 13 1.1.1.2754.7 1 25.948 903.8405 25.9357 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 52.5099992752075 THLAPYSDELRQR Nitro(Y)@6 missed R-Q@11 0.228066995739937 1630.01403808594 544.3453 1629.78588867188 544.269226074219 3 12 1.1.1.2950.8 1 30.6476 1432.115 30.5872 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 32.8000009059906 THLAPYSDELRQR missed R-Q@11 0.220651999115944 1585.021484375 529.3478 1584.80090332031 529.274230957031 3 12 1.1.1.2704.4 1 24.7511 3633.753 24.9353 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQRLAARLEALKENGGAR missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.319965988397598 3134.98974609375 784.7547 3134.66967773438 784.674682617188 4 18 1.1.1.3609.19 1 46.5945 13944.79 46.5257 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQRLAARLEALKENGGAR missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.251314997673035 3134.92114257813 1045.981 3134.66967773438 1045.89721679688 3 13 1.1.1.3604.21 1 46.4701 2487.506 46.5003 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 THLAPYSDELRQRLAARLEALKENGGAR missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.387275010347366 3135.05688476563 628.0187 3134.66967773438 627.941223144531 5 17 1.1.1.3609.12 1 46.5887 51449.85 46.5257 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2900023460388 THLAPYSDELRQRLAARLEALKENGGAR missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.445549994707108 3135.115234375 523.5265 3134.66967773438 523.452209472656 6 16 1.1.1.3606.6 1 46.5081 62069.09 46.5257 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.1399981975555 THLAPYSDELRQRLAARLEALKENGGAR missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.445549994707108 3135.115234375 523.5265 3134.66967773438 523.452209472656 6 15 1.1.1.3607.4 1 46.5319 62069.09 46.5257 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.1399981975555 THLAPYSDELRQRLAARLEALKENGGAR missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.445549994707108 3135.115234375 523.5265 3134.66967773438 523.452209472656 6 15 1.1.1.3614.4 1 46.7078 62069.09 46.5257 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.0900018215179 THLAPYSDELRQRLAARLEALKENGGAR missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 1.31313002109528 3135.98291015625 785.003 3134.66967773438 784.674682617188 4 16 1.1.1.3601.17 1 46.391 10246.85 46.3483 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.4600005149841 THLAPYSDELRQRLAARLEALKENGGAR Deamidated(N)@24 missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.452134996652603 3136.10595703125 523.6916 3135.65380859375 523.6162109375 6 14 1.1.1.3635.11 1 47.2574 11691.89 47.1392 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.7000014781952 THLAPYSDELRQRLAARLEALKENGGAR missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.319965988397598 3134.98974609375 784.7547 3134.66967773438 784.674682617188 4 14 1.1.1.3616.18 1 46.7706 14704.01 46.5003 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.1100008487701 THLAPYSDELRQRLAARLEALKENGGAR Deamidated(N)@24 missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.393860012292862 3136.04760742188 628.2168 3135.65380859375 628.138000488281 5 13 1.1.1.3637.13 1 47.3111 10117.96 47.1392 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.1100008487701 THLAPYSDELRQRLAARLEALKENGGAR Dehydrated(E)@19 missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.387585997581482 3117.04663085938 624.4166 3116.6591796875 624.339111328125 5 14 1.1.1.3639.10 1 47.3608 3423.704 47.3751 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.9199991226196 THLAPYSDELRQRLAARLEALKENGGAR missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.50239098072052 3135.17211914063 448.889 3134.66967773438 448.817230224609 7 14 1.1.1.3612.7 1 46.6597 19167.67 46.5003 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.9199991226196 THLAPYSDELRQRLAARLEALKENGGAR missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.445549994707108 3135.115234375 523.5265 3134.66967773438 523.452209472656 6 14 1.1.1.3621.5 1 46.8871 46760.43 46.6261 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.8999996185303 THLAPYSDELRQRLAARLEALKENGGAR Trimethyl(K)@22 missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.349296987056732 3177.06591796875 636.4205 3176.716796875 636.3505859375 5 14 1.1.1.3744.11 1 49.8967 307.3584 49.9101 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.4900000095367 THLAPYSDELRQRLAARLEALKENGGAR Deamidated(R)@11 missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.394775003194809 3136.04858398438 628.217 3135.65380859375 628.138000488281 5 13 1.1.1.3602.14 1 46.4136 38715.63 46.3483 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.7699997425079 THLAPYSDELRQRLAARLEALKENGGAR Deamidated(N)@24 missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.452134996652603 3136.10595703125 523.6916 3135.65380859375 523.6162109375 6 12 1.1.1.3628.9 1 47.0714 11691.89 47.1392 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 77.2800028324127 THLAPYSDELRQRLAARLEALKENGGAR Deamidated(N)@24 missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.394775003194809 3136.04858398438 628.217 3135.65380859375 628.138000488281 5 12 1.1.1.3595.13 1 46.2353 38715.63 46.3483 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.1299986839294 THLAPYSDELRQRLAARLEALKENGGAR Carbamidomethyl(E)@9 missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.422987997531891 3192.1142578125 533.0263 3191.69116210938 532.955810546875 6 13 1.1.1.3634.9 1 47.2293 512.033 47.2708 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 24.9099999666214 THLAPYSDELRQRLAARLEALKENGGAR Trimethyl(R)@13 missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 -0.632453978061676 3176.08422851563 636.2241 3176.716796875 636.3505859375 5 13 1.1.1.3645.15 1 47.518 2013.653 47.477 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 17.0399993658066 THLAPYSDELRQRLAARLEALKENGGAR Arg->Orn(R)@17; acrolein addition +76(K)@22; Deamidated(N)@24 missed R-Q@11; missed R-L@13; missed R-L@17; missed K-E@22 0.194686993956566 3169.85913085938 1057.627 3169.66333007813 1057.56164550781 3 11 1.1.1.2741.8 1 25.6439 888.257 25.7442 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.6200001239777 TVYVDVLKDSGRDYVSQFEGSALGK cleaved A-T@N-term; missed K-D@8; missed R-D@12 -9.77713966369629 2722.58862304688 908.5368 2732.36572265625 911.795837402344 3 14 1.1.1.4468.5 1 67.8316 1596.406 68.0798 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 40.5900001525879 TVYVDVLKDSGRDYVSQFEGSALGK cleaved A-T@N-term; missed K-D@8; missed R-D@12 -0.767803013324738 2731.59790039063 911.5399 2732.36572265625 911.795837402344 3 16 1.1.1.4495.5 1 68.5273 486.6964 68.593 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.2400004863739 VDALRTHLAPYSDELRQR cleaved H-V@N-term; missed R-T@5; missed R-Q@16 -3.10756993293762 2136.01098632813 535.01 2139.11840820313 535.786926269531 4 12 1.1.1.2974.10 1 31.228 1616.008 31.2827 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 32.4400007724762 VDVLKDSGRDYVSQFEGSALGK Formyl@N-term; acrolein addition +38(K)@5 cleaved Y-V@N-term; missed K-D@5; missed R-D@9 0.131277993321419 2435.328125 812.7833 2435.19677734375 812.739562988281 3 12 1.1.1.3365.11 1 40.6101 589.1669 40.5733 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VEPLRAELQEGAR missed R-A@5 0.16236600279808 1466.94653320313 734.4805 1466.7841796875 734.399353027344 2 21 1.1.1.2908.13 1 29.6401 118832.6 29.6955 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VEPLRAELQEGAR missed R-A@5 0.16236600279808 1466.94653320313 734.4805 1466.7841796875 734.399353027344 2 21 1.1.1.2915.10 1 29.8094 118832.6 29.6955 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VEPLRAELQEGAR missed R-A@5 0.16236600279808 1466.94653320313 734.4805 1466.7841796875 734.399353027344 2 17 1.1.1.2770.6 1 26.3306 806.1416 26.3199 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VEPLRAELQEGAR Delta:H(2)C(2)@N-term missed R-A@5 0.164294004440308 1492.96411132813 747.4893 1492.7998046875 747.407165527344 2 16 1.1.1.3311.10 1 39.3121 920.7156 39.2982 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VEPLRAELQEGAR missed R-A@5 0.162732005119324 1466.94689941406 734.4807 1466.7841796875 734.399353027344 2 17 1.1.1.2936.14 1 30.3182 1392.535 30.0579 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VEPLRAELQEGAR missed R-A@5 0.162487998604774 1466.94665527344 734.4806 1466.7841796875 734.399353027344 2 16 1.1.1.2893.8 1 29.2808 60653.29 29.5024 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VEPLRAELQEGAR missed R-A@5 0.221037998795509 1467.00512695313 490.009 1466.7841796875 489.935333251953 3 16 1.1.1.2894.6 1 29.2965 192378 29.5264 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.989999294281 VEPLRAELQEGAR missed R-A@5 0.218658000230789 1467.00280761719 490.0082 1466.7841796875 489.935333251953 3 16 1.1.1.2915.5 1 29.8011 337397.9 29.7437 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.989999294281 VEPLRAELQEGAR missed R-A@5 0.16236600279808 1466.94653320313 734.4805 1466.7841796875 734.399353027344 2 16 1.1.1.2922.12 1 29.9801 118240.7 29.7196 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.9099979400635 VEPLRAELQEGAR missed R-A@5 0.16236600279808 1466.94653320313 734.4805 1466.7841796875 734.399353027344 2 15 1.1.1.2929.14 1 30.1493 44312.77 29.8885 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.1500029563904 VEPLRAELQEGAR missed R-A@5 0.218016996979713 1467.00219726563 490.008 1466.7841796875 489.935333251953 3 15 1.1.1.2929.9 1 30.141 148386.7 29.8885 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9000020027161 VEPLRAELQEGAR missed R-A@5 0.221037998795509 1467.00512695313 490.009 1466.7841796875 489.935333251953 3 14 1.1.1.2901.6 1 29.4657 306689 29.6955 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9000020027161 VEPLRAELQEGAR missed R-A@5 0.218658000230789 1467.00280761719 490.0082 1466.7841796875 489.935333251953 3 14 1.1.1.2908.7 1 29.6301 337397.9 29.7437 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9000020027161 VEPLRAELQEGAR missed R-A@5 0.218658000230789 1467.00280761719 490.0082 1466.7841796875 489.935333251953 3 14 1.1.1.2922.5 1 29.9684 338958 29.7196 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.9000020027161 VEPLRAELQEGAR missed R-A@5 0.218016996979713 1467.00219726563 490.008 1466.7841796875 489.935333251953 3 14 1.1.1.2945.3 1 30.5283 4094.778 30.3954 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.7800004482269 VEPLRAELQEGAR missed R-A@5 0.218016996979713 1467.00219726563 490.008 1466.7841796875 489.935333251953 3 13 1.1.1.2937.9 1 30.3323 4094.778 30.3954 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.410001039505 VEPLRAELQEGAR Cation:Na(E)@10 missed R-A@5 0.217426002025604 1488.98352050781 497.3351 1488.76611328125 497.262634277344 3 12 1.1.1.2902.6 1 29.4898 1191.293 29.6955 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 64.410001039505 VEPLRAELQEGAR Cation:Na(E)@10 missed R-A@5 0.220996007323265 1488.98706054688 497.3363 1488.76611328125 497.262634277344 3 12 1.1.1.2916.6 1 29.8277 1265.767 29.8162 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 35.3700011968613 VEPLRAELQEGAR missed R-A@5 0.217741996049881 1467.00183105469 490.0079 1466.7841796875 489.935333251953 3 12 1.1.1.2973.6 1 31.1974 2057.152 31.115 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK missed K-D@2 0.164602994918823 1462.00891113281 732.0117 1461.84423828125 731.929443359375 2 22 1.1.1.3581.12 1 45.8914 20049.28 46.0989 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK missed K-D@2 0.164602994918823 1462.00891113281 732.0117 1461.84423828125 731.929443359375 2 23 1.1.1.3588.16 1 46.0653 32308.27 46.1971 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK missed K-D@2 0.164602994918823 1462.00891113281 732.0117 1461.84423828125 731.929443359375 2 23 1.1.1.3595.17 1 46.2387 32308.27 46.1971 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK missed K-D@2 0.164969995617867 1462.00927734375 732.0119 1461.84423828125 731.929443359375 2 22 1.1.1.3600.18 1 46.3663 30708.48 46.3483 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK missed K-D@2 0.164969995617867 1462.00927734375 732.0119 1461.84423828125 731.929443359375 2 23 1.1.1.3602.18 1 46.4169 30708.48 46.3483 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK missed K-D@2 0.164602994918823 1462.00891113281 732.0117 1461.84423828125 731.929443359375 2 23 1.1.1.3609.18 1 46.5937 29704.6 46.5257 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK missed K-D@2 0.164602994918823 1462.00891113281 732.0117 1461.84423828125 731.929443359375 2 22 1.1.1.3615.17 1 46.7443 29704.6 46.5257 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK missed K-D@2 0.164602994918823 1462.00891113281 732.0117 1461.84423828125 731.929443359375 2 23 1.1.1.3616.16 1 46.7689 30655.63 46.5003 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK missed K-D@2 0.164725005626678 1462.00903320313 732.0118 1461.84423828125 731.929443359375 2 22 1.1.1.3622.11 1 46.9178 23279.66 46.6513 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK missed K-D@2 0.164725005626678 1462.00903320313 732.0118 1461.84423828125 731.929443359375 2 23 1.1.1.3623.19 1 46.9504 22160.18 46.6764 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK missed K-D@2 0.164602994918823 1462.00891113281 732.0117 1461.84423828125 731.929443359375 2 22 1.1.1.3637.19 1 47.3161 1438.074 47.2183 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK missed K-D@2 0.22528900206089 1462.06958007813 488.3638 1461.84423828125 488.288696289063 3 18 1.1.1.3588.5 1 46.0561 18392.89 46.1971 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK Trimethyl(K)@2 missed K-D@2 0.127418994903564 1504.01867675781 753.0166 1503.89123535156 752.952880859375 2 19 1.1.1.3830.6 1 52.0508 439.0211 52.0684 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK missed K-D@2 0.224373996257782 1462.06860351563 488.3635 1461.84423828125 488.288696289063 3 17 1.1.1.3616.5 1 46.7598 17513.74 46.5003 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK Formyl(K)@2 missed K-D@2 0.163219004869461 1490.00244140625 746.0085 1489.83923339844 745.926879882813 2 19 1.1.1.3821.10 1 51.8267 661.6199 51.7891 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK missed K-D@2 0.22528900206089 1462.06958007813 488.3638 1461.84423828125 488.288696289063 3 16 1.1.1.3595.6 1 46.2295 18392.89 46.1971 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK missed K-D@2 0.224648997187614 1462.06896972656 488.3636 1461.84423828125 488.288696289063 3 16 1.1.1.3609.5 1 46.5828 17980.28 46.4499 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLK missed K-D@2 0.225014999508858 1462.0693359375 488.3637 1461.84423828125 488.288696289063 3 16 1.1.1.3623.7 1 46.9404 13814.33 46.6764 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6800014972687 VKDLATVYVDVLK missed K-D@2 0.224648997187614 1462.06896972656 488.3636 1461.84423828125 488.288696289063 3 15 1.1.1.3581.5 1 45.8856 12428.37 46.0989 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1000015735626 VKDLATVYVDVLK missed K-D@2 0.163383007049561 1462.00769042969 732.0111 1461.84423828125 731.929443359375 2 14 1.1.1.3645.17 1 47.5197 389.9451 47.5024 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2400019168854 VKDLATVYVDVLK missed K-D@2 0.224648997187614 1462.06896972656 488.3636 1461.84423828125 488.288696289063 3 15 1.1.1.3602.7 1 46.4077 17980.28 46.4499 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2400019168854 VKDLATVYVDVLK missed K-D@2 0.163748994469643 1462.00805664063 732.0113 1461.84423828125 731.929443359375 2 14 1.1.1.3749.8 1 50.0221 397.5404 50.1123 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.0300028324127 VKDLATVYVDVLK Carbamidomethyl@N-term; Deoxy(D)@3 missed K-D@2 0.167473003268242 1503.03833007813 752.5264 1502.87084960938 752.442687988281 2 17 1.1.1.3644.13 1 47.4907 3170.532 47.477 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.4200029373169 VKDLATVYVDVLK Amidated@C-term missed K-D@2 0.165343001484871 1461.02563476563 731.5201 1460.86022949219 731.437438964844 2 14 1.1.1.3709.6 1 49.0118 643.6667 49.0012 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.7300026416779 VKDLATVYVDVLK missed K-D@2 0.226753994822502 1462.07104492188 488.3643 1461.84423828125 488.288696289063 3 13 1.1.1.3637.5 1 47.3044 1277.122 47.2969 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.2699978351593 VKDLATVYVDVLK Carbamidomethyl@N-term; Deoxy(D)@3 missed K-D@2 0.225260004401207 1503.09606933594 502.0393 1502.87084960938 501.964233398438 3 14 1.1.1.3648.5 1 47.5847 2157.11 47.4515 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.8699970245361 VKDLATVYVDVLK Carbamidomethyl(K)@2 missed K-D@2 0.170360997319221 1519.0361328125 760.5253 1518.86572265625 760.440124511719 2 13 1.1.1.3584.8 1 45.9668 284.0479 45.9525 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.4600005149841 VKDLATVYVDVLK Delta:H(2)C(2)(K)@2 missed K-D@2 0.22563099861145 1488.08557128906 497.0358 1487.85998535156 496.960601806641 3 14 1.1.1.3778.3 1 50.7555 1409.268 50.7255 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.1499977111816 VKDLATVYVDVLK Carbamidomethyl@N-term; Deoxy(D)@3 missed K-D@2 0.225260004401207 1503.09606933594 502.0393 1502.87084960938 501.964233398438 3 16 1.1.1.3641.4 1 47.4067 2157.11 47.4515 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.1100008487701 VKDLATVYVDVLK Carbamidomethyl@N-term; Deoxy(D)@3 missed K-D@2 0.225260004401207 1503.09606933594 502.0393 1502.87084960938 501.964233398438 3 13 1.1.1.3639.6 1 47.3575 2157.11 47.4515 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.2500019073486 VKDLATVYVDVLK Carboxyethyl(K)@2 missed K-D@2 0.170818001031876 1534.03625488281 768.0254 1533.86535644531 767.940002441406 2 12 1.1.1.3992.2 1 55.9915 420.5197 56.0126 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 76.5100002288818 VKDLATVYVDVLK missed K-D@2 -1.97381997108459 1459.87048339844 730.9425 1461.84423828125 731.929443359375 2 11 1.1.1.3660.17 0 47.9029 1729.159 47.6284 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 20.4699993133545 VKDLATVYVDVLK missed K-D@2 0.225564002990723 1462.06982421875 488.3639 1461.84423828125 488.288696289063 3 12 1.1.1.3644.4 1 47.4832 621.2745 47.4515 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGR missed K-D@2; missed K-D@13 0.173975005745888 1877.19982910156 939.6072 1877.02587890625 939.520202636719 2 17 1.1.1.3644.20 1 47.4965 2516.932 47.6031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGR missed K-D@2; missed K-D@13 0.237132996320724 1877.26293945313 626.7616 1877.02587890625 626.682556152344 3 24 1.1.1.3648.10 1 47.5889 8007.855 47.6284 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGR missed K-D@2; missed K-D@13 0.237132996320724 1877.26293945313 626.7616 1877.02587890625 626.682556152344 3 17 1.1.1.3657.9 1 47.8186 8007.855 47.6284 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGR missed K-D@2; missed K-D@13 0.296629011631012 1877.32250976563 470.3379 1877.02587890625 470.263732910156 4 16 1.1.1.3650.4 1 47.6346 7211.722 47.6538 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6800014972687 VKDLATVYVDVLKDSGR missed K-D@2; missed K-D@13 0.237132996320724 1877.26293945313 626.7616 1877.02587890625 626.682556152344 3 16 1.1.1.3656.10 1 47.7935 8007.855 47.6284 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.6000020503998 VKDLATVYVDVLKDSGR Carbamidomethyl@N-term; Deoxy(D)@3 missed K-D@2; missed K-D@13 0.248548001050949 1918.30090332031 640.4409 1918.05236816406 640.358093261719 3 17 1.1.1.3674.5 1 48.2436 663.5021 48.2072 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2400019168854 VKDLATVYVDVLKDSGR missed K-D@2; missed K-D@13 0.296629011631012 1877.32250976563 470.3379 1877.02587890625 470.263732910156 4 15 1.1.1.3658.5 1 47.8409 7211.722 47.6538 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.7300026416779 VKDLATVYVDVLKDSGR missed K-D@2; missed K-D@13 0.296263009309769 1877.32214355469 470.3378 1877.02587890625 470.263732910156 4 14 1.1.1.3643.5 1 47.4585 7200.72 47.6538 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.9600028991699 VKDLATVYVDVLKDSGR missed K-D@2; missed K-D@13 -6.87084007263184 1870.15502929688 624.3923 1877.02587890625 626.682556152344 3 14 1.1.1.4035.2 1 57.0621 4172.834 57.1083 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.324189007282257 3259.00146484375 815.7576 3258.67724609375 815.676574707031 4 32 1.1.1.3766.15 1 50.4586 3389.889 50.4686 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.391315013170242 3259.06860351563 652.821 3258.67724609375 652.742736816406 5 24 1.1.1.3767.4 1 50.4747 3262.123 50.4686 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.391315013170242 3259.06860351563 652.821 3258.67724609375 652.742736816406 5 22 1.1.1.3870.2 1 53.0351 103059.8 53.13 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.324189007282257 3259.00146484375 815.7576 3258.67724609375 815.676574707031 4 32 1.1.1.3870.11 1 53.0426 140101.5 53.179 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.252730011940002 3258.92919921875 1087.317 3258.67724609375 1087.23303222656 3 41 1.1.1.3870.18 1 53.0485 52852.22 53.179 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Carbamidomethyl(K)@13 missed K-D@2; missed K-D@13; missed R-D@17 0.255802989006042 3315.953125 1106.325 3315.69873046875 1106.24011230469 3 21 1.1.1.3870.20 1 53.0501 2595.908 53.031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(R)@17 missed K-D@2; missed K-D@13; missed R-D@17 0.355309993028641 3260.0166015625 816.0114 3259.6611328125 815.922607421875 4 24 1.1.1.3876.4 1 53.1866 77984.45 53.13 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term missed K-D@2; missed K-D@13; missed R-D@17 0.315420985221863 3316.01416015625 830.0108 3315.69873046875 829.931945800781 4 22 1.1.1.3876.7 1 53.1933 7551.084 53.031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.391315013170242 3259.06860351563 652.821 3258.67724609375 652.742736816406 5 23 1.1.1.3877.2 1 53.2071 103059.8 53.13 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.324189007282257 3259.00146484375 815.7576 3258.67724609375 815.676574707031 4 35 1.1.1.3877.6 1 53.2104 140101.5 53.179 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.252730011940002 3258.92919921875 1087.317 3258.67724609375 1087.23303222656 3 41 1.1.1.3877.18 1 53.2204 52852.22 53.179 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.391925007104874 3259.06909179688 652.8211 3258.67724609375 652.742736816406 5 22 1.1.1.3884.2 1 53.3786 102109.3 53.179 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.324189007282257 3259.00146484375 815.7576 3258.67724609375 815.676574707031 4 35 1.1.1.3884.4 1 53.3819 140101.5 53.179 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.253829002380371 3258.93212890625 1087.318 3258.67724609375 1087.23303222656 3 40 1.1.1.3884.11 1 53.3936 34865.31 53.3743 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.392535001039505 3259.06982421875 652.8212 3258.67724609375 652.742736816406 5 22 1.1.1.3891.3 1 53.5539 79465.85 53.3009 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.324189007282257 3259.00146484375 815.7576 3258.67724609375 815.676574707031 4 35 1.1.1.3891.7 1 53.5572 107641.6 53.3009 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@22 missed K-D@2; missed K-D@13; missed R-D@17 -0.6598259806633 3259.00146484375 815.7576 3259.6611328125 815.922607421875 4 23 1.1.1.3891.8 1 53.5581 107641.6 53.3009 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.253096014261246 3258.92919921875 1087.317 3258.67724609375 1087.23303222656 3 38 1.1.1.3891.19 1 53.5673 35944.83 53.3009 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term; Deoxy(D)@3 missed K-D@2; missed K-D@13; missed R-D@17 0.317903995513916 3300.02172851563 826.0127 3299.70385742188 825.933227539063 4 27 1.1.1.3894.7 1 53.6362 6324.323 53.6965 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term; Deoxy(D)@3 missed K-D@2; missed K-D@13; missed R-D@17 0.317903995513916 3300.02172851563 826.0127 3299.70385742188 825.933227539063 4 30 1.1.1.3896.3 1 53.6814 6324.323 53.6965 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.330049008131027 3259.00732421875 815.7591 3258.67724609375 815.676574707031 4 30 1.1.1.3898.8 1 53.7291 50902.57 53.4733 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term; Deoxy(D)@3 missed K-D@2; missed K-D@13; missed R-D@17 0.317903995513916 3300.02172851563 826.0127 3299.70385742188 825.933227539063 4 25 1.1.1.3898.9 1 53.7299 6324.323 53.6965 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Delta:H(2)C(2)(K)@2 missed K-D@2; missed K-D@13; missed R-D@17 0.32880300283432 3285.02172851563 822.2627 3284.69287109375 822.180480957031 4 25 1.1.1.4022.8 1 56.7362 4686.529 56.8287 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Delta:H(2)C(2)(K)@2 missed K-D@2; missed K-D@13; missed R-D@17 0.32880300283432 3285.02172851563 822.2627 3284.69287109375 822.180480957031 4 25 1.1.1.4029.8 1 56.9148 4686.529 56.8287 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Formyl@N-term missed K-D@2; missed K-D@13; missed R-D@17 0.327077001333237 3286.99926757813 822.7571 3286.67211914063 822.67529296875 4 27 1.1.1.4037.9 1 57.1187 1909.347 57.1337 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Delta:H(2)C(2)(K)@2 missed K-D@2; missed K-D@13; missed R-D@17 0.328070014715195 3285.02099609375 822.2625 3284.69287109375 822.180480957031 4 22 1.1.1.4045.6 1 57.3134 4247.448 57.3555 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Delta:H(4)C(2)(K)@13 missed K-D@2; missed K-D@13; missed R-D@17 -0.688799977302551 3286.01977539063 822.5122 3286.70849609375 822.684387207031 4 27 1.1.1.4050.8 1 57.4435 2848.501 57.3814 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Trimethyl(K)@13 missed K-D@2; missed K-D@13; missed R-D@17 0.294328987598419 3301.0185546875 826.2619 3300.72412109375 826.188293457031 4 23 1.1.1.4055.7 1 57.5737 1449.372 57.6163 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Carboxyethyl(K)@13 missed K-D@2; missed K-D@13; missed R-D@17 0.334553986787796 3331.03295898438 833.7655 3330.6982421875 833.681884765625 4 25 1.1.1.4270.10 1 62.8107 2672.027 62.825 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK reduced acrolein addition +58(K)@13; Dimethyl(R)@17 missed K-D@2; missed K-D@13; missed R-D@17 0.298875987529755 3345.04931640625 837.2696 3344.75048828125 837.194885253906 4 23 1.1.1.4323.9 1 64.1699 6306.291 64.2885 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK acrolein addition +94(K)@2; Dicarbamidomethyl(D)@3 missed K-D@2; missed K-D@13; missed R-D@17 -0.624616980552673 3466.13745117188 867.5416 3466.76196289063 867.69775390625 4 22 1.1.1.3874.6 1 53.141 1012.966 53.1052 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK acrolein addition +56(K)@13; Ser->LacticAcid(S)@15 missed K-D@2; missed K-D@13; missed R-D@17 0.270251005887985 3299.96313476563 1100.995 3299.69262695313 1100.90478515625 3 21 1.1.1.3906.4 1 53.9334 1476.55 53.89 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term; Deoxy(D)@3 missed K-D@2; missed K-D@13; missed R-D@17 0.389241009950638 3300.09301757813 661.0259 3299.70385742188 660.948059082031 5 22 1.1.1.3898.2 1 53.7241 6010.334 53.6965 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK reduced acrolein addition +58(K)@13; Dimethyl(R)@17 missed K-D@2; missed K-D@13; missed R-D@17 0.366122990846634 3345.11645507813 670.0306 3344.75048828125 669.957336425781 5 21 1.1.1.4328.3 1 64.2939 868.0189 64.314 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term; acrolein addition +112(K)@2; Cation:K(D)@3 missed K-D@2; missed K-D@13; missed R-D@17 -0.568623006343842 3465.13842773438 867.2919 3465.70703125 867.434020996094 4 22 1.1.1.3871.10 1 53.0666 1270.954 53.1052 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term; Formyl(K)@2 missed K-D@2; missed K-D@13; missed R-D@17 0.140818998217583 3343.83447265625 836.9659 3343.69360351563 836.9306640625 4 21 1.1.1.4039.15 1 57.1745 1699.197 57.2339 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Delta:H(2)C(2)(K)@2 missed K-D@2; missed K-D@13; missed R-D@17 0.38823801279068 3285.0810546875 658.0235 3284.69287109375 657.945861816406 5 20 1.1.1.4024.5 1 56.7845 2361.122 56.8287 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK acrolein addition +56(K)@13; Ser->LacticAcid(S)@15 missed K-D@2; missed K-D@13; missed R-D@17 0.329625010490417 3300.02221679688 826.0128 3299.69262695313 825.930419921875 4 20 1.1.1.3905.5 1 53.8991 5918.575 53.9142 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Trimethyl(K)@2 missed K-D@2; missed K-D@13; missed R-D@17 0.294328987598419 3301.0185546875 826.2619 3300.72412109375 826.188293457031 4 20 1.1.1.4045.7 1 57.3142 1531.537 57.3309 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term missed K-D@2; missed K-D@13; missed R-D@17 0.385841995477676 3316.08447265625 664.2242 3315.69873046875 664.147033691406 5 19 1.1.1.3870.4 1 53.0368 5386.196 53.031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Hex(K)@13 missed K-D@2; missed K-D@13; missed R-D@17 0.386525988578796 3421.11645507813 685.2306 3420.72998046875 685.153259277344 5 20 1.1.1.3870.5 1 53.0376 2225.509 53.031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK HPNE addition +172(K)@13; Chloro(Y)@19 missed K-D@2; missed K-D@13; missed R-D@17 0.449797987937927 3465.19799804688 694.0469 3464.74829101563 693.956909179688 5 20 1.1.1.3877.4 1 53.2087 6732.135 53.1052 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK acrolein addition +94(K)@2; Dicarbamidomethyl(D)@3 missed K-D@2; missed K-D@13; missed R-D@17 0.371964991092682 3467.13403320313 867.7908 3466.76196289063 867.69775390625 4 19 1.1.1.3881.6 1 53.3119 693.9108 53.3253 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.324189007282257 3259.00146484375 815.7576 3258.67724609375 815.676574707031 4 19 1.1.1.3871.6 1 53.0632 140101.5 53.179 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.258222997188568 3258.93505859375 1087.319 3258.67724609375 1087.23303222656 3 17 1.1.1.3898.16 1 53.7357 16916.64 53.4733 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK HPNE addition +172(K)@13; Iodo(Y)@19 missed K-D@2; missed K-D@13; missed R-D@17 0.475560992956162 3557.15942382813 890.2971 3556.68383789063 890.17822265625 4 18 1.1.1.3877.11 1 53.2146 947.4136 53.2034 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term; Formyl(K)@2 missed K-D@2; missed K-D@13; missed R-D@17 0.140818998217583 3343.83447265625 836.9659 3343.69360351563 836.9306640625 4 18 1.1.1.4046.12 1 57.343 1699.197 57.2339 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.7600028514862 VKDLATVYVDVLKDSGRDYVSQFEGSALGK HPNE addition +172(K)@13; Chloro(Y)@19 missed K-D@2; missed K-D@13; missed R-D@17 0.450408011674881 3465.19848632813 694.047 3464.74829101563 693.956909179688 5 18 1.1.1.3884.3 1 53.3803 5270.589 53.3009 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6199975013733 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Cation:Na(E)@24 missed K-D@2; missed K-D@13; missed R-D@17 0.382941991090775 3281.0419921875 657.2157 3280.6591796875 657.139099121094 5 17 1.1.1.3871.2 1 53.0599 952.4901 53.1052 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.089998960495 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term; acrolein addition +112(K)@2; Cation:K(D)@3 missed K-D@2; missed K-D@13; missed R-D@17 -0.509005010128021 3465.19799804688 694.0469 3465.70703125 694.148681640625 5 18 1.1.1.3870.6 1 53.0385 6732.135 53.1052 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.089998960495 VKDLATVYVDVLKDSGRDYVSQFEGSALGK MDA adduct +54(K)@13 missed K-D@2; missed K-D@13; missed R-D@17 -0.702075004577637 3311.98559570313 663.4044 3312.68774414063 663.544860839844 5 16 1.1.1.3872.2 1 53.086 1251.165 53.1052 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4199988842011 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.328583985567093 3259.005859375 815.7587 3258.67724609375 815.676574707031 4 16 1.1.1.4027.9 1 56.865 756.2078 56.8801 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.0999994277954 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Carbamidomethyl@N-term missed K-D@2; missed K-D@13; missed R-D@17 0.315420985221863 3316.01416015625 830.0108 3315.69873046875 829.931945800781 4 15 1.1.1.3879.2 1 53.2564 8410.952 53.031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.5200023651123 VKDLATVYVDVLKDSGRDYVSQFEGSALGK missed K-D@2; missed K-D@13; missed R-D@17 0.321258991956711 3258.99853515625 815.7569 3258.67724609375 815.676574707031 4 15 1.1.1.3999.4 1 56.167 805.5891 56.2596 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.710000038147 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Formyl@N-term; reduced acrolein addition +58(K)@2 missed K-D@2; missed K-D@13; missed R-D@17 0.328913986682892 3345.04296875 837.268 3344.71411132813 837.185791015625 4 15 1.1.1.4234.6 1 61.9086 1208.345 61.9515 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.710000038147 VKDLATVYVDVLKDSGRDYVSQFEGSALGK reduced acrolein addition +58(K)@13; Methyl(D)@14 missed K-D@2; missed K-D@13; missed R-D@17 0.230737999081612 3330.96508789063 1111.329 3330.73461914063 1111.25219726563 3 15 1.1.1.4270.20 1 62.8191 951.2945 62.825 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.2600028514862 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Hex(K)@13 missed K-D@2; missed K-D@13; missed R-D@17 0.258134007453918 3420.9892578125 1141.337 3420.72998046875 1141.25061035156 3 15 1.1.1.3870.21 1 53.051 975.9337 53.031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.809999704361 VKDLATVYVDVLKDSGRDYVSQFEGSALGK acrolein addition +56(K)@13; Ser->LacticAcid(S)@21 missed K-D@2; missed K-D@13; missed R-D@17 0.401695013046265 3300.09423828125 661.0261 3299.69262695313 660.94580078125 5 15 1.1.1.3887.2 1 53.4524 5606.635 53.6965 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.4099998474121 VKDLATVYVDVLKDSGRDYVSQFEGSALGK acrolein addition +56(K)@13; Ser->LacticAcid(S)@21 missed K-D@2; missed K-D@13; missed R-D@17 0.400474011898041 3300.09301757813 661.0259 3299.69262695313 660.94580078125 5 15 1.1.1.3907.2 1 53.9426 4874.646 53.8656 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.0100018978119 VKDLATVYVDVLKDSGRDYVSQFEGSALGK acrolein addition +56(K)@13; Ser->LacticAcid(S)@15 missed K-D@2; missed K-D@13; missed R-D@17 0.329625010490417 3300.02221679688 826.0128 3299.69262695313 825.930419921875 4 14 1.1.1.3912.3 1 54.0687 5918.575 53.9142 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.0100028514862 VKDLATVYVDVLKDSGRDYVSQFEGSALGK acrolein addition +112(K)@13; Deamidated(R)@17; Dicarbamidomethyl(D)@18 missed K-D@2; missed K-D@13; missed R-D@17 0.397893011569977 3486.15454101563 872.5459 3485.75659179688 872.446411132813 4 15 1.1.1.3883.11 1 53.3609 548.0686 53.3253 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 76.3999998569489 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@22 missed K-D@2; missed K-D@13; missed R-D@17 -0.6598259806633 3259.00146484375 815.7576 3259.6611328125 815.922607421875 4 13 1.1.1.3869.12 1 53.0184 140101.5 53.179 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.4199979305267 VKDLATVYVDVLKDSGRDYVSQFEGSALGK MDA adduct +54(K)@13 missed K-D@2; missed K-D@13; missed R-D@17 -0.695666015148163 3311.9921875 663.4057 3312.68774414063 663.544860839844 5 12 1.1.1.3880.5 1 53.2824 830.3759 53.3009 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 65.039998292923 VKDLATVYVDVLKDSGRDYVSQFEGSALGK Deamidated(Q)@22; Cation:Na(E)@24 missed K-D@2; missed K-D@13; missed R-D@17 0.396546006202698 3282.03979492188 657.4152 3281.64306640625 657.3359375 5 13 1.1.1.3880.4 1 53.2815 926.6625 53.2765 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 40.1699990034103 VKDLATVYVDVLKDSGRDYVSQFEGSALGK HPNE addition +172(K)@13; Octanoyl(S)@15 missed K-D@2; missed K-D@13; missed R-D@17 0.274085998535156 3557.16577148438 890.2987 3556.8916015625 890.230163574219 4 17 1.1.1.3884.5 1 53.3836 931.4024 53.3743 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 37.2299998998642 VKDLATVYVDVLKDSGRDYVSQFEGSALGK ONE addition +154(K)@13; Octanoyl(S)@15 missed K-D@2; missed K-D@13; missed R-D@17 0.320526003837585 3539.20166015625 708.8476 3538.88110351563 708.783508300781 5 20 1.1.1.3872.3 1 53.0885 1001.349 53.0808 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30 0.400925010442734 3855.44262695313 772.0958 3855.04174804688 772.015625 5 30 1.1.1.3980.5 1 55.7021 23771.68 55.7639 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK Carbamidomethyl(K)@30 missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30 0.403387010097504 3912.46655273438 783.5006 3912.06323242188 783.419921875 5 28 1.1.1.3980.6 1 55.7046 1623.369 55.7147 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30 0.455781996250153 3855.49755859375 643.5902 3855.04174804688 643.514221191406 6 21 1.1.1.3982.4 1 55.7447 8031.658 55.7639 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK reduced acrolein addition +58(K)@30; Ammonia-loss(N)@33 missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30 0.417104005813599 3896.47412109375 780.3021 3896.05712890625 780.218688964844 5 22 1.1.1.3984.5 1 55.7946 4520.308 55.8875 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30 0.400925010442734 3855.44262695313 772.0958 3855.04174804688 772.015625 5 30 1.1.1.3987.6 1 55.8699 23771.68 55.7639 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30 0.331174999475479 3855.373046875 964.8505 3855.04174804688 964.767761230469 4 31 1.1.1.3987.9 1 55.8724 8179.773 55.7639 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK reduced acrolein addition +58(K)@30; Ammonia-loss(N)@33 missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30 0.417104005813599 3896.47412109375 780.3021 3896.05712890625 780.218688964844 5 24 1.1.1.3991.5 1 55.9692 4520.308 55.8875 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK reduced acrolein addition +58(K)@30 missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30 0.356801986694336 3913.4404296875 783.6954 3913.08374023438 783.6240234375 5 23 1.1.1.4038.5 1 57.141 898.6338 57.1083 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK reduced acrolein addition +58(K)@30; Methyl(Q)@31 missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30 0.363368988037109 3927.46264648438 786.4998 3927.09936523438 786.427124023438 5 27 1.1.1.4049.6 1 57.4158 2989.545 57.4333 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK reduced acrolein addition +58(K)@30; Methyl(Q)@31 missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30 0.298319011926651 3927.39770507813 982.8567 3927.09936523438 982.782104492188 4 37 1.1.1.4049.13 1 57.4216 2187.054 57.4333 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK Trimethyl(K)@30 missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30 0.372712999582291 3897.46142578125 780.4996 3897.0888671875 780.425048828125 5 20 1.1.1.4024.6 1 56.7854 731.4176 56.7521 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK acrolein addition +56(K)@13; Hex(Y)@19 missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30 0.522740006446838 4073.6435546875 679.9479 4073.12084960938 679.860778808594 6 20 1.1.1.3982.5 1 55.7455 963.0725 55.7639 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK reduced acrolein addition +58(K)@30; Ammonia-loss(N)@33 missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30 0.471473008394241 3896.52856445313 650.4287 3896.05712890625 650.350158691406 6 18 1.1.1.3988.3 1 55.8924 1865.943 55.8875 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK Ammonia-loss(N)@33; reduced acrolein addition +58(K)@35 missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30 0.337343990802765 3896.39453125 975.1059 3896.05712890625 975.021545410156 4 18 1.1.1.3991.12 1 55.9751 1463.273 55.8875 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.2399997711182 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLK Ammonia-loss(N)@33; reduced acrolein addition +58(K)@35 missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30 0.471473008394241 3896.52856445313 650.4287 3896.05712890625 650.350158691406 6 13 1.1.1.3985.3 1 55.8176 1865.943 55.8875 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30; missed K-L@35 0.559436023235321 5449.36865234375 779.4885 5448.80908203125 779.408630371094 7 21 1.1.1.4300.7 1 63.5729 2517.183 63.6158 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK reduced acrolein addition +58(K)@30 missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30; missed K-L@35 0.478217005729675 5507.32958984375 918.8955 5506.85107421875 918.815795898438 6 21 1.1.1.4362.7 1 65.1896 523.7357 65.1801 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Deamidated(R)@17; Dioxidation(W)@40 missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30; missed K-L@35 -0.559157013893127 5481.22314453125 1097.252 5481.783203125 1097.36389160156 5 21 1.1.1.4229.6 1 61.7898 897.2936 61.827 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Deamidated(Q)@22; Dioxidation(W)@40 missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30; missed K-L@35 -0.475980013608933 5481.30712890625 914.5585 5481.783203125 914.637817382813 6 19 1.1.1.4226.4 1 61.7097 1485.771 61.827 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Deamidated(Q)@22; Deamidated(Q)@31; Deamidated(N)@33; acrolein addition +38(K)@35 missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30; missed K-L@35 0.554337978363037 5490.33154296875 916.0625 5489.77685546875 915.970092773438 6 19 1.1.1.4299.13 1 63.5516 1547.345 63.6418 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30; missed K-L@35 0.425552010536194 5449.2333984375 1090.854 5448.80908203125 1090.76916503906 5 18 1.1.1.4298.18 1 63.5295 2290.832 63.6158 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Ammonia-loss(N)@33; reduced acrolein addition +58(K)@35 missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30; missed K-L@35 0.506718993186951 5490.33154296875 916.0625 5489.82470703125 915.97802734375 6 18 1.1.1.4304.13 1 63.6824 1547.345 63.6418 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4199988842011 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30; missed K-L@35 0.493593007326126 5449.302734375 909.2244 5448.80908203125 909.142150878906 6 17 1.1.1.4307.11 1 63.7588 7280.105 63.6158 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4199988842011 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK reduced acrolein addition +58(K)@35 missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30; missed K-L@35 0.409200012683868 5507.25830078125 1102.459 5506.85107421875 1102.37756347656 5 17 1.1.1.4361.8 1 65.17 499.5299 65.1801 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.710000038147 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK Trimethyl(K)@35 missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30; missed K-L@35 0.383607000112534 5491.23876953125 1099.255 5490.8564453125 1099.17846679688 5 14 1.1.1.4342.15 1 64.6703 310.6263 64.6283 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.8099985122681 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30; missed K-L@35 0.425552010536194 5449.2333984375 1090.854 5448.80908203125 1090.76916503906 5 14 1.1.1.4305.18 1 63.7127 2290.832 63.6158 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 44.990000128746 VKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK HPNE addition +172(K)@2; acrolein addition +76(K)@13; Dioxidation(W)@40 missed K-D@2; missed K-D@13; missed R-D@17; missed K-Q@30; missed K-L@35 -0.619170010089874 5728.3212890625 955.7275 5728.9404296875 955.830688476563 6 13 1.1.1.4591.13 1 70.9873 417.0364 70.9974 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.0299985408783 VLESFKVSFLSALEEYTKKLNTQ cleaved P-V@N-term; missed K-V@6; missed K-K@18; missed K-L@19 -5.92962980270386 2667.49682617188 890.1729 2673.42651367188 892.149475097656 3 15 1.1.1.4761.12 1 75.3345 3413.34 75.2983 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 48.1599986553192 VLESFKVSFLSALEEYTKKLNTQ Acetyl@N-term cleaved P-V@N-term; missed K-V@6; missed K-K@18; missed K-L@19 -0.181780993938446 2715.25537109375 679.8211 2715.43701171875 679.866577148438 4 13 1.1.1.4668.7 1 73.0171 472.289 72.9799 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 44.4499999284744 VLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSK acrolein addition +76(K)@3; acrolein addition +56(K)@20; MDA adduct +62(K)@25; Deamidated(N)@29 cleaved D-V@N-term; missed K-D@3; missed R-D@7; missed K-Q@20; missed K-L@25 0.368831992149353 4540.64892578125 909.1371 4540.2802734375 909.063293457031 5 12 1.1.1.4257.9 1 62.4788 329.0474 62.594 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8100011348724 VQPYLDDFQK 0.15692800283432 1251.7705078125 626.8925 1251.61352539063 626.814025878906 2 16 1.1.1.3184.9 1 36.2733 125301.8 36.2809 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.8100011348724 VQPYLDDFQK 0.15692800283432 1251.7705078125 626.8925 1251.61352539063 626.814025878906 2 16 1.1.1.3191.6 1 36.4436 125301.8 36.2809 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.9499974250793 VQPYLDDFQK 0.156683996319771 1251.77026367188 626.8924 1251.61352539063 626.814025878906 2 14 1.1.1.3212.6 1 36.9439 21655.81 36.6883 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 85.7800006866455 VQPYLDDFQK 0.15692800283432 1251.7705078125 626.8925 1251.61352539063 626.814025878906 2 13 1.1.1.3226.3 1 37.2744 5336.072 37.0242 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 50.8499979972839 VQPYLDDFQK Cation:Na(D)@6 0.161190003156662 1273.75671386719 637.8856 1273.59545898438 637.805053710938 2 11 1.1.1.3184.10 1 36.2758 361.8769 36.3289 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 42.4699991941452 VQPYLDDFQK 0.157049998641014 1251.77062988281 626.8926 1251.61352539063 626.814025878906 2 12 1.1.1.3219.8 1 37.1126 11753.78 36.8562 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 31.1699986457825 VQPYLDDFQK 0.15692800283432 1251.7705078125 626.8925 1251.61352539063 626.814025878906 2 12 1.1.1.3205.8 1 36.7791 49995.54 36.5205 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 25.3800004720688 VQPYLDDFQK 0.15692800283432 1251.7705078125 626.8925 1251.61352539063 626.814025878906 2 12 1.1.1.3177.6 1 36.1049 124358.9 36.2809 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKK missed K-K@10 0.158522993326187 1379.86706542969 690.9408 1379.70849609375 690.861511230469 2 17 1.1.1.2983.11 1 31.4452 18177.41 31.57 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 37.6899987459183 VQPYLDDFQKK missed K-K@10 0.158522993326187 1379.86706542969 690.9408 1379.70849609375 690.861511230469 2 12 1.1.1.2997.19 1 31.78 18177.41 31.57 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 35.3700011968613 VQPYLDDFQKK missed K-K@10 0.217743992805481 1379.92626953125 460.9827 1379.70849609375 460.910125732422 3 12 1.1.1.2990.4 1 31.6012 93369.49 31.594 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12 missed K-K@10; missed K-W@11 0.241261005401611 2660.49926757813 887.8404 2660.25805664063 887.759948730469 3 21 1.1.1.3498.18 1 43.8817 1194.969 43.8867 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12 missed K-K@10; missed K-W@11 0.315100014209747 2660.5732421875 666.1506 2660.25805664063 666.07177734375 4 20 1.1.1.3593.12 1 46.1845 4202.805 46.3739 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Trp->Kynurenin(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.252876996994019 2664.505859375 889.1759 2664.2529296875 889.091613769531 3 21 1.1.1.3614.19 1 46.7203 7651.358 46.6012 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Oxidation(M)@16 missed K-K@10; missed K-W@11 0.246388003230095 2660.50439453125 887.8421 2660.25805664063 887.759948730469 3 23 1.1.1.3700.6 1 48.8 57576.93 48.8324 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Oxidation(M)@16 missed K-K@10; missed K-W@11 0.24693700671196 2660.50512695313 887.8423 2660.25805664063 887.759948730469 3 23 1.1.1.3707.6 1 48.9718 60662.96 49.0253 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Oxidation(M)@16 missed K-K@10; missed K-W@11 0.24693700671196 2660.50512695313 887.8423 2660.25805664063 887.759948730469 3 21 1.1.1.3714.15 1 49.1357 60662.96 49.0253 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Dioxidation(W)@12 missed K-K@10; missed K-W@11 0.252876996994019 2676.505859375 893.1759 2676.2529296875 893.091613769531 3 21 1.1.1.3729.13 1 49.5117 18447.2 49.4478 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR acrolein addition +76(K)@10; MDA adduct +62(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 0.208588004112244 2734.51538085938 912.5124 2734.306640625 912.44287109375 3 20 1.1.1.3746.18 1 49.9556 1087.185 49.9884 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Deamidated(Q)@2; Oxidation(M)@16 missed K-K@10; missed K-W@11 -0.668914973735809 2660.5732421875 666.1506 2661.2421875 666.317810058594 4 21 1.1.1.3781.4 1 50.8304 2361.46 50.9504 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR missed K-K@10; missed K-W@11 0.248870998620987 2644.51196289063 882.5113 2644.26318359375 882.428344726563 3 20 1.1.1.3784.13 1 50.9141 132070 51.1247 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR missed K-K@10; missed K-W@11 0.248870998620987 2644.51196289063 882.5113 2644.26318359375 882.428344726563 3 22 1.1.1.3791.9 1 51.0921 133859.8 51.1247 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Deamidated(Q)@2; Oxidation(W)@12 missed K-K@10; missed K-W@11 -0.667939007282257 2660.57421875 666.1508 2661.2421875 666.317810058594 4 21 1.1.1.3798.6 1 51.2575 1517.754 51.2701 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR missed K-K@10; missed K-W@11 0.24923700094223 2644.51245117188 882.5114 2644.26318359375 882.428344726563 3 22 1.1.1.3798.8 1 51.2626 122116.8 51.2701 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Trimethyl(K)@11 missed K-K@10; missed K-W@11 0.208330005407333 2686.5185546875 896.5134 2686.31005859375 896.443969726563 3 24 1.1.1.4015.4 1 56.5612 1720.572 56.6271 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR missed K-K@10; missed K-W@11 0.314164996147156 2644.57739257813 662.1516 2644.26318359375 662.073059082031 4 19 1.1.1.3784.5 1 50.9074 250115.8 51.1247 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR missed K-K@10; missed K-W@11 0.314164996147156 2644.57739257813 662.1516 2644.26318359375 662.073059082031 4 18 1.1.1.3798.5 1 51.255 247535.8 51.246 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR missed K-K@10; missed K-W@11 0.31367701292038 2644.57690429688 662.1515 2644.26318359375 662.073059082031 4 18 1.1.1.3819.4 1 51.7699 24944.48 51.5128 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR missed K-K@10; missed K-W@11 0.314164996147156 2644.57739257813 662.1516 2644.26318359375 662.073059082031 4 18 1.1.1.3805.4 1 51.4303 247535.8 51.246 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Delta:H(2)C(2)@N-term missed K-K@10; missed K-W@11 0.313163995742798 2670.59204101563 668.6553 2670.27880859375 668.576965332031 4 20 1.1.1.3941.4 1 54.7643 2497.65 54.7836 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR missed K-K@10; missed K-W@11 0.314898014068604 2644.578125 662.1518 2644.26318359375 662.073059082031 4 18 1.1.1.3744.14 1 49.8992 4153.788 49.9101 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Carbamidomethyl(E)@14; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.316098004579544 2717.595703125 680.4062 2717.27954101563 680.3271484375 4 20 1.1.1.3691.5 1 48.5759 2412.152 48.6392 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12 missed K-K@10; missed K-W@11 0.30875301361084 2660.56689453125 666.149 2660.25805664063 666.07177734375 4 19 1.1.1.3505.10 1 44.0463 5284.3 43.8867 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12 missed K-K@10; missed K-W@11 0.30875301361084 2660.56689453125 666.149 2660.25805664063 666.07177734375 4 19 1.1.1.3498.14 1 43.8759 5284.3 43.8867 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12 missed K-K@10; missed K-W@11 0.314368009567261 2660.57250976563 666.1504 2660.25805664063 666.07177734375 4 19 1.1.1.3600.15 1 46.3638 4285.562 46.3994 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR acrolein addition +56(K)@10; MDA adduct +62(K)@11; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.243646994233131 2778.54370117188 927.1885 2778.30004882813 927.107238769531 3 17 1.1.1.3941.11 1 54.7702 1235.783 54.7836 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Oxidation(M)@16 missed K-K@10; missed K-W@11 0.314855992794037 2660.57299804688 666.1505 2660.25805664063 666.07177734375 4 18 1.1.1.3707.3 1 48.9618 123754.1 49.0253 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR missed K-K@10; missed K-W@11 0.314164996147156 2644.57739257813 662.1516 2644.26318359375 662.073059082031 4 17 1.1.1.3791.2 1 51.0771 254176.5 51.1247 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR missed K-K@10; missed K-W@11 0.314410001039505 2644.57763671875 662.1517 2644.26318359375 662.073059082031 4 17 1.1.1.3812.6 1 51.594 175039.7 51.3429 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Delta:H(2)C(2)@N-term missed K-K@10; missed K-W@11 0.251042991876602 2670.52978515625 891.1839 2670.27880859375 891.100219726563 3 18 1.1.1.4035.11 1 57.0697 4042.56 57.1083 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Dioxidation(W)@12; Carbamidomethyl(E)@15; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.316258996725082 2749.58569335938 688.4037 2749.26928710938 688.324645996094 4 20 1.1.1.3543.6 1 44.9809 3116.397 45.0853 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR reduced acrolein addition +96(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 0.245129004120827 2692.5625 674.1479 2692.3173828125 674.086608886719 4 18 1.1.1.3556.6 1 45.2883 223582.1 45.3978 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR reduced acrolein addition +96(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 0.245129004120827 2692.5625 674.1479 2692.3173828125 674.086608886719 4 18 1.1.1.3570.4 1 45.6271 225345 45.3738 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR reduced acrolein addition +96(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 0.245129004120827 2692.5625 674.1479 2692.3173828125 674.086608886719 4 18 1.1.1.3577.5 1 45.7983 174002.3 45.5428 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Trp->Hydroxykynurenin(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.256437003612518 2680.50439453125 894.5087 2680.24780273438 894.423278808594 3 19 1.1.1.3584.10 1 45.9701 740.6424 45.9771 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12 missed K-K@10; missed K-W@11 0.316076993942261 2660.57421875 666.1508 2660.25805664063 666.07177734375 4 18 1.1.1.3586.2 1 46.0082 3077.148 46.2221 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Trp->Kynurenin(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.252876996994019 2664.505859375 889.1759 2664.2529296875 889.091613769531 3 18 1.1.1.3607.19 1 46.5444 7452.948 46.5512 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Dioxidation(W)@12; Dioxidation(M)@16 missed K-K@10; missed K-W@11 0.250292003154755 2708.4931640625 903.8383 2708.24291992188 903.7548828125 3 18 1.1.1.3613.21 1 46.6966 7713.785 46.8041 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Dioxidation(W)@12 missed K-K@10; missed K-W@11 0.319209009408951 2676.572265625 670.1503 2676.2529296875 670.070556640625 4 18 1.1.1.3729.6 1 49.5058 48522.25 49.4221 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.24720099568367 2676.50024414063 893.174 2676.2529296875 893.091613769531 3 18 1.1.1.3431.7 1 42.2289 463.3056 42.2098 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Trp->Kynurenin(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.315791010856628 2664.56884765625 667.1495 2664.2529296875 667.070556640625 4 18 1.1.1.3607.11 1 46.5378 32628.71 46.6261 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.306270003318787 2676.55932617188 670.1471 2676.2529296875 670.070556640625 4 18 1.1.1.3441.11 1 42.4703 2705.05 42.2098 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Oxidation(M)@16 missed K-K@10; missed K-W@11 0.314368009567261 2660.57250976563 666.1504 2660.25805664063 666.07177734375 4 17 1.1.1.3693.4 1 48.6241 115645.9 48.8084 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR Oxidation(M)@16 missed K-K@10; missed K-W@11 0.314855992794037 2660.57299804688 666.1505 2660.25805664063 666.07177734375 4 17 1.1.1.3714.4 1 49.1266 123754.1 49.0253 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYR missed K-K@10; missed K-W@11 0.249420002102852 2644.5126953125 882.5115 2644.26318359375 882.428344726563 3 16 1.1.1.3812.11 1 51.5982 88403.78 51.3429 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8499999046326 VQPYLDDFQKKWQEEMELYR Dioxidation(W)@12; Dioxidation(M)@16 missed K-K@10; missed K-W@11 0.317173004150391 2708.56005859375 678.1473 2708.24291992188 678.067993164063 4 18 1.1.1.3617.12 1 46.7915 31871.65 46.8296 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.7100005149841 VQPYLDDFQKKWQEEMELYR reduced acrolein addition +96(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 0.245129004120827 2692.5625 674.1479 2692.3173828125 674.086608886719 4 17 1.1.1.3549.8 1 45.1183 204621 45.3017 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6800014972687 VQPYLDDFQKKWQEEMELYR missed K-K@10; missed K-W@11 0.253082990646362 2644.51635742188 882.5127 2644.26318359375 882.428344726563 3 15 1.1.1.3743.20 1 49.8779 1477.499 49.9101 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.5499978065491 VQPYLDDFQKKWQEEMELYR reduced acrolein addition +96(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 0.245129004120827 2692.5625 674.1479 2692.3173828125 674.086608886719 4 17 1.1.1.3563.7 1 45.4599 223582.1 45.3978 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.3799993991852 VQPYLDDFQKKWQEEMELYR Dehydrated(D)@7 missed K-K@10; missed K-W@11 0.317405998706818 2626.57006835938 657.6498 2626.25268554688 657.570434570313 4 17 1.1.1.3778.5 1 50.7572 4442.587 50.8497 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.199999332428 VQPYLDDFQKKWQEEMELYR Oxidation(M)@16 missed K-K@10; missed K-W@11 0.314368009567261 2660.57250976563 666.1504 2660.25805664063 666.07177734375 4 16 1.1.1.3788.2 1 51.0033 2359.636 50.9995 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.7999985218048 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.314570993185043 2676.56762695313 670.1492 2676.2529296875 670.070556640625 4 15 1.1.1.3318.2 1 39.4764 1871.672 39.5138 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.7999985218048 VQPYLDDFQKKWQEEMELYR Oxidation(M)@16 missed K-K@10; missed K-W@11 0.314855992794037 2660.57299804688 666.1505 2660.25805664063 666.07177734375 4 16 1.1.1.3721.8 1 49.304 97998.08 49.0493 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.5899994373322 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.307002007961273 2676.56005859375 670.1473 2676.2529296875 670.070556640625 4 17 1.1.1.3434.11 1 42.295 2687.257 42.2098 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.5899994373322 VQPYLDDFQKKWQEEMELYR Oxidation(M)@16 missed K-K@10; missed K-W@11 0.314368009567261 2660.57250976563 666.1504 2660.25805664063 666.07177734375 4 16 1.1.1.3700.3 1 48.7917 116465.5 48.8324 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1199989318848 VQPYLDDFQKKWQEEMELYR Deamidated(Q)@9; hexanoyl addition +98(K)@10; acrolein addition +38(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 0.254960000514984 2733.58764648438 684.4042 2733.33251953125 684.340454101563 4 17 1.1.1.3546.10 1 45.0513 4077.557 45.0853 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.6000020503998 VQPYLDDFQKKWQEEMELYR Dioxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 -0.66789299249649 2691.580078125 673.9023 2692.24780273438 674.069274902344 4 17 1.1.1.3457.13 1 42.8578 9773.095 42.7711 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.6000020503998 VQPYLDDFQKKWQEEMELYR Deamidated(Q)@9; acrolein addition +56(K)@11; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.327331006526947 2717.595703125 680.4062 2717.26831054688 680.324340820313 4 16 1.1.1.3698.3 1 48.7467 2412.152 48.6392 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.6000020503998 VQPYLDDFQKKWQEEMELYR Dioxidation(W)@12 missed K-K@10; missed K-W@11 0.319209009408951 2676.572265625 670.1503 2676.2529296875 670.070556640625 4 16 1.1.1.3722.11 1 49.332 48522.25 49.4221 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.6000020503998 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12 missed K-K@10; missed K-W@11 0.252613991498947 2660.5107421875 887.8442 2660.25805664063 887.759948730469 3 15 1.1.1.3738.18 1 49.7467 1499.789 49.6769 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.6000020503998 VQPYLDDFQKKWQEEMELYR Delta:H(2)C(2)@N-term; Dioxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.254031002521515 2718.517578125 907.1798 2718.263671875 907.095153808594 3 17 1.1.1.3750.6 1 50.0574 2398.859 50.0873 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.6000020503998 VQPYLDDFQKKWQEEMELYR reduced acrolein addition +58(K)@10; Deamidated(Q)@13; Dehydrated(E)@14 missed K-K@10; missed K-W@11 0.327657997608185 2685.60620117188 672.4088 2685.27856445313 672.326904296875 4 17 1.1.1.3781.5 1 50.8313 10479.96 50.8748 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.6000020503998 VQPYLDDFQKKWQEEMELYR Deoxy(D)@7; acrolein addition +38(K)@10 missed K-K@10; missed K-W@11 0.286105990409851 2666.57006835938 667.6498 2666.28393554688 667.578247070313 4 17 1.1.1.3793.2 1 51.1289 800.5817 51.1489 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.3199973106384 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.309199005365372 2676.56225585938 670.1478 2676.2529296875 670.070556640625 4 16 1.1.1.3420.8 1 41.9601 2413.687 42.1601 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.3199973106384 VQPYLDDFQKKWQEEMELYR Trp->Kynurenin(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.315791010856628 2664.56884765625 667.1495 2664.2529296875 667.070556640625 4 16 1.1.1.3615.13 1 46.7409 32628.71 46.6261 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.0300028324127 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.307002007961273 2676.56005859375 670.1473 2676.2529296875 670.070556640625 4 16 1.1.1.3427.8 1 42.1282 2687.257 42.2098 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.0300028324127 VQPYLDDFQKKWQEEMELYR Deamidated(Q)@9; reduced acrolein addition +96(K)@10; acrolein addition +56(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 0.258091986179352 2749.58569335938 688.4037 2749.32763671875 688.339172363281 4 16 1.1.1.3550.3 1 45.144 3116.397 45.0853 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.0300028324127 VQPYLDDFQKKWQEEMELYR Deamidated(Q)@9; hexanoyl addition +98(K)@10; acrolein addition +38(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 0.258621990680695 2733.59130859375 684.4051 2733.33251953125 684.340454101563 4 16 1.1.1.3599.12 1 46.3357 9397.925 46.2471 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.0300028324127 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.321161985397339 2676.57421875 670.1508 2676.2529296875 670.070556640625 4 16 1.1.1.3625.15 1 46.9984 1060.076 46.9313 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.0300028324127 VQPYLDDFQKKWQEEMELYR Oxidation(M)@16 missed K-K@10; missed K-W@11 0.315100014209747 2660.5732421875 666.1506 2660.25805664063 666.07177734375 4 15 1.1.1.3780.7 1 50.8083 2361.46 50.9504 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.0300028324127 VQPYLDDFQKKWQEEMELYR Deamidated(Q)@9; acrolein addition +56(K)@10 missed K-K@10; missed K-W@11 0.263177007436752 2701.53662109375 901.5195 2701.2734375 901.431762695313 3 15 1.1.1.3783.19 1 50.8936 4593.408 50.9258 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12 missed K-K@10; missed K-W@11 0.251148998737335 2660.50927734375 887.8437 2660.25805664063 887.759948730469 3 15 1.1.1.3606.19 1 46.5189 815.5501 46.5003 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 VQPYLDDFQKKWQEEMELYR acrolein addition +76(K)@11; Trp->Kynurenin(W)@12; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 0.286439001560211 2676.57250976563 670.1504 2676.2861328125 670.078796386719 4 16 1.1.1.3611.17 1 46.6429 1212.088 46.7782 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.4200029373169 VQPYLDDFQKKWQEEMELYR Trp->Kynurenin(W)@12 missed K-K@10; missed K-W@11 0.316320985555649 2648.57446289063 663.1509 2648.25805664063 663.07177734375 4 15 1.1.1.3746.9 1 49.9481 5719.733 49.9101 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.0900018215179 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12 missed K-K@10; missed K-W@11 0.247669994831085 2660.505859375 887.8425 2660.25805664063 887.759948730469 3 13 1.1.1.3505.18 1 44.053 1039.227 44.0356 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.0900018215179 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12 missed K-K@10; missed K-W@11 0.316320985555649 2660.57446289063 666.1509 2660.25805664063 666.07177734375 4 15 1.1.1.3740.13 1 49.7942 3471.03 49.7026 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.7499990463257 VQPYLDDFQKKWQEEMELYR reduced acrolein addition +96(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 0.245129004120827 2692.5625 674.1479 2692.3173828125 674.086608886719 4 15 1.1.1.3584.6 1 45.9634 60336.73 45.7107 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.7499990463257 VQPYLDDFQKKWQEEMELYR reduced acrolein addition +96(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 0.247081995010376 2692.564453125 674.1484 2692.3173828125 674.086608886719 4 15 1.1.1.3592.12 1 46.1598 1546.2 46.1477 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.7499990463257 VQPYLDDFQKKWQEEMELYR Deamidated(Q)@9; reduced acrolein addition +58(K)@10; Dehydrated(E)@14 missed K-K@10; missed K-W@11 0.327657997608185 2685.60620117188 672.4088 2685.27856445313 672.326904296875 4 16 1.1.1.3821.7 1 51.8242 11157.68 51.7118 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.8699970245361 VQPYLDDFQKKWQEEMELYR MDA adduct +54(K)@11; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.273530006408691 2714.54223632813 679.6428 2714.2685546875 679.574462890625 4 14 1.1.1.3555.5 1 45.2609 889.4044 45.3738 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.8699970245361 VQPYLDDFQKKWQEEMELYR Carbamidomethyl(E)@15 missed K-K@10; missed K-W@11 0.315162986516953 2701.59985351563 676.4072 2701.28466796875 676.328430175781 4 15 1.1.1.3787.4 1 50.9802 8901.178 50.9258 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.4600005149841 VQPYLDDFQKKWQEEMELYR Deamidated(Q)@2; reduced acrolein addition +58(K)@11; Deamidated(Q)@13; Dehydrated(E)@14 missed K-K@10; missed K-W@11 -0.656356990337372 2685.60620117188 672.4088 2686.26245117188 672.572875976563 4 17 1.1.1.3814.5 1 51.6432 11157.68 51.7118 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.6000008583069 VQPYLDDFQKKWQEEMELYR Trp->Hydroxykynurenin(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.318924009799957 2680.56689453125 671.149 2680.24780273438 671.069274902344 4 15 1.1.1.3583.5 1 45.9407 2490.446 45.9525 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.1499977111816 VQPYLDDFQKKWQEEMELYR Deamidated(Q)@9; hexanoyl addition +98(K)@10; acrolein addition +38(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 0.258621990680695 2733.59130859375 684.4051 2733.33251953125 684.340454101563 4 15 1.1.1.3592.14 1 46.1614 9397.925 46.2471 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 91.1499977111816 VQPYLDDFQKKWQEEMELYR FormaldehydeAdduct(W)@12; Deamidated(Q)@13 missed K-K@10; missed K-W@11 0.260948985815048 2657.50805664063 886.8433 2657.2470703125 886.75634765625 3 15 1.1.1.3729.12 1 49.5108 757.0051 49.4985 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.2100026607513 VQPYLDDFQKKWQEEMELYR reduced acrolein addition +96(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 0.249279007315636 2692.56665039063 674.1489 2692.3173828125 674.086608886719 4 14 1.1.1.3608.12 1 46.5662 1289.526 46.3232 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.7000014781952 VQPYLDDFQKKWQEEMELYR missed K-K@10; missed K-W@11 0.255279988050461 2644.5185546875 882.5134 2644.26318359375 882.428344726563 3 14 1.1.1.3819.12 1 51.7765 1103.796 51.841 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.7199997901917 VQPYLDDFQKKWQEEMELYR reduced acrolein addition +96(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 0.260264992713928 2692.57763671875 674.1517 2692.3173828125 674.086608886719 4 14 1.1.1.3464.13 1 43.031 6999.353 42.7711 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.7199997901917 VQPYLDDFQKKWQEEMELYR Methyl(D)@6; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.276257008314133 2674.55004882813 669.6448 2674.27368164063 669.57568359375 4 15 1.1.1.3554.7 1 45.2385 2257.715 45.2776 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.7199997901917 VQPYLDDFQKKWQEEMELYR reduced acrolein addition +96(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 0.254893988370895 2692.572265625 674.1503 2692.3173828125 674.086608886719 4 14 1.1.1.3639.16 1 47.3659 925.3427 47.3751 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1900012493134 VQPYLDDFQKKWQEEMELYR Dioxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.259916007518768 2692.5078125 898.5099 2692.24780273438 898.423278808594 3 14 1.1.1.3458.13 1 42.8858 999.4675 42.7711 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1900012493134 VQPYLDDFQKKWQEEMELYR Dioxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.278225988149643 2692.52612304688 898.516 2692.24780273438 898.423278808594 3 14 1.1.1.3467.12 1 43.1089 2264.05 43.3414 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1900012493134 VQPYLDDFQKKWQEEMELYR Deamidated(Q)@9; hexanoyl addition +98(K)@10; acrolein addition +38(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 0.196684002876282 2733.529296875 912.1837 2733.33251953125 912.1181640625 3 13 1.1.1.3599.17 1 46.3399 2122.385 46.2724 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1900012493134 VQPYLDDFQKKWQEEMELYR Trp->Kynurenin(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.316280007362366 2664.5693359375 667.1496 2664.2529296875 667.070556640625 4 14 1.1.1.3600.16 1 46.3646 29197.93 46.5512 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1900012493134 VQPYLDDFQKKWQEEMELYR Dioxidation(W)@12; Dioxidation(M)@16 missed K-K@10; missed K-W@11 0.317173004150391 2708.56005859375 678.1473 2708.24291992188 678.067993164063 4 15 1.1.1.3624.15 1 46.9726 31871.65 46.8296 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.1100008487701 VQPYLDDFQKKWQEEMELYR Deamidated(Q)@9; reduced acrolein addition +96(K)@10; acrolein addition +56(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 0.197496995329857 2749.52514648438 917.5156 2749.32763671875 917.449768066406 3 14 1.1.1.3549.14 1 45.1283 908.0579 45.0613 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.1100008487701 VQPYLDDFQKKWQEEMELYR Delta:H(2)C(2)@N-term; reduced acrolein addition +96(K)@10; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 0.251940011978149 2718.5849609375 680.6535 2718.3330078125 680.590515136719 4 15 1.1.1.3751.11 1 50.0739 1894.619 50.0873 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 82.8999996185303 VQPYLDDFQKKWQEEMELYR Dehydrated(D)@7; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.312236994504929 2642.55981445313 661.6472 2642.24755859375 661.569152832031 4 14 1.1.1.3685.3 1 48.4465 1211.932 48.4409 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.580001115799 VQPYLDDFQKKWQEEMELYR MDA adduct +54(K)@10; Lys->Allysine(K)@11 missed K-K@10; missed K-W@11 0.251982986927032 2697.494140625 675.3808 2697.2421875 675.317810058594 4 14 1.1.1.3797.2 1 51.2275 889.7025 51.2701 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.5100014209747 VQPYLDDFQKKWQEEMELYR Formyl(K)@11 missed K-K@10; missed K-W@11 0.256642013788223 2672.5146484375 891.8455 2672.25805664063 891.759948730469 3 13 1.1.1.4003.7 1 56.2673 437.1466 56.2352 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.4900000095367 VQPYLDDFQKKWQEEMELYR Oxidation(M)@16 missed K-K@10; missed K-W@11 0.254810988903046 2660.51293945313 887.8449 2660.25805664063 887.759948730469 3 12 1.1.1.3779.8 1 50.7843 672.7611 50.7506 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 76.3999998569489 VQPYLDDFQKKWQEEMELYR Formyl(K)@10; reduced acrolein addition +58(K)@11 missed K-K@10; missed K-W@11 0.262690007686615 2730.56274414063 911.1948 2730.30004882813 911.107238769531 3 13 1.1.1.4247.3 1 62.2276 772.5783 62.2721 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.1299986839294 VQPYLDDFQKKWQEEMELYR acrolein addition +76(K)@11; Deamidated(Q)@13; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 0.29050201177597 2673.56567382813 669.3987 2673.27514648438 669.326049804688 4 13 1.1.1.3581.11 1 45.8906 3348.398 45.9282 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.1299986839294 VQPYLDDFQKKWQEEMELYR acrolein addition +56(K)@11; Deamidated(Q)@13 missed K-K@10; missed K-W@11 0.329813987016678 2701.60327148438 676.4081 2701.2734375 676.325622558594 4 12 1.1.1.3729.7 1 49.5067 3092.023 49.5742 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.9599981307983 VQPYLDDFQKKWQEEMELYR missed K-K@10; missed K-W@11 0.312456011772156 2644.57568359375 662.1512 2644.26318359375 662.073059082031 4 12 1.1.1.3993.3 1 56.0177 312.2791 56.0626 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 69.9599981307983 VQPYLDDFQKKWQEEMELYR missed K-K@10; missed K-W@11 0.253632009029388 2644.51684570313 882.5129 2644.26318359375 882.428344726563 3 14 1.1.1.4025.13 1 56.8169 348.2614 56.8287 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.1299993991852 VQPYLDDFQKKWQEEMELYR reduced acrolein addition +96(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 0.246838003396988 2692.56420898438 674.1483 2692.3173828125 674.086608886719 4 12 1.1.1.3599.11 1 46.3349 1544.47 46.2471 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 62.279999256134 VQPYLDDFQKKWQEEMELYR reduced acrolein addition +96(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 0.245617002248764 2692.56298828125 674.148 2692.3173828125 674.086608886719 4 12 1.1.1.3615.14 1 46.7418 1143.177 46.6513 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 62.279999256134 VQPYLDDFQKKWQEEMELYR MDA adduct +62(K)@10; acrolein addition +76(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 0.208405002951622 2734.51513671875 912.5123 2734.306640625 912.44287109375 3 12 1.1.1.3648.19 1 47.5964 984.7834 47.6284 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.2400004863739 VQPYLDDFQKKWQEEMELYR reduced acrolein addition +96(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 0.248790994286537 2692.56616210938 674.1488 2692.3173828125 674.086608886719 4 12 1.1.1.3623.17 1 46.9487 735.9274 46.9055 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.2400004863739 VQPYLDDFQKKWQEEMELYR MDA adduct +62(K)@10; MDA adduct +62(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 0.210993006825447 2720.50219726563 907.8413 2720.291015625 907.77099609375 3 12 1.1.1.3647.14 1 47.5727 313.6206 47.553 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.2400004863739 VQPYLDDFQKKWQEEMELYR Dioxidation(W)@12 missed K-K@10; missed K-W@11 0.319209009408951 2676.572265625 670.1503 2676.2529296875 670.070556640625 4 12 1.1.1.3728.10 1 49.4842 48522.25 49.4221 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.6600024700165 VQPYLDDFQKKWQEEMELYR MDA adduct +54(K)@11 missed K-K@10; missed K-W@11 0.226451992988586 2698.50024414063 675.6323 2698.27368164063 675.57568359375 4 13 1.1.1.3789.3 1 51.0284 821.1166 51.0728 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 52.700001001358 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.319453001022339 2676.57250976563 670.1504 2676.2529296875 670.070556640625 4 12 1.1.1.3618.18 1 46.8221 1212.088 46.7782 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 50.4400014877319 VQPYLDDFQKKWQEEMELYR Trp->Hydroxykynurenin(W)@12 missed K-K@10; missed K-W@11 0.315791010856628 2664.56884765625 667.1495 2664.2529296875 667.070556640625 4 12 1.1.1.3607.10 1 46.5369 32628.71 46.6261 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 48.1400012969971 VQPYLDDFQKKWQEEMELYR Oxidation(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.319453001022339 2676.57250976563 670.1504 2676.2529296875 670.070556640625 4 12 1.1.1.3641.10 1 47.4117 2221.035 47.4515 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 43.979999423027 VQPYLDDFQKKWQEEMELYR missed K-K@10; missed K-W@11 0.312945008277893 2644.576171875 662.1513 2644.26318359375 662.073059082031 4 13 1.1.1.3870.3 1 53.036 785.8285 52.9818 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 31.1500012874603 VQPYLDDFQKKWQEEMELYR Trp->Kynurenin(W)@12; Oxidation(M)@16; Dehydrated(E)@17 missed K-K@10; missed K-W@11 0.31292799115181 2646.55541992188 662.6461 2646.24243164063 662.56787109375 4 13 1.1.1.3512.8 1 44.2188 809.2921 44.1601 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 29.899999499321 VQPYLDDFQKKWQEEMELYR hexanoyl addition +98(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11 -0.771741986274719 2693.56127929688 674.3976 2694.3330078125 674.590515136719 4 13 1.1.1.3582.11 1 45.9148 51394 45.6628 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 26.1599987745285 VQPYLDDFQKKWQEEMELYR Dioxidation(W)@12; Dioxidation(M)@16 missed K-K@10; missed K-W@11 0.317173004150391 2708.56005859375 678.1473 2708.24291992188 678.067993164063 4 12 1.1.1.3610.9 1 46.6144 32747.08 46.8296 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 26.1599987745285 VQPYLDDFQKKWQEEMELYR Trp->Kynurenin(W)@12; Dioxidation(M)@16 missed K-K@10; missed K-W@11 0.256985992193222 2680.5048828125 894.5089 2680.24780273438 894.423278808594 3 10 1.1.1.3643.20 1 47.471 842.2256 47.4005 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 24.9099999666214 VQPYLDDFQKKWQEEMELYR Delta:H(2)C(2)@N-term; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.258996993303299 2686.53271484375 896.5182 2686.27368164063 896.431884765625 3 12 1.1.1.3785.10 1 50.9362 3737.063 50.8748 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 21.1799994111061 VQPYLDDFQKKWQEEMELYR Dioxidation(W)@12; Deamidated(Q)@13; Oxidation(M)@16 missed K-K@10; missed K-W@11 0.329780995845795 2693.56176757813 674.3977 2693.23193359375 674.315246582031 4 12 1.1.1.3589.7 1 46.0871 1135.366 46.1723 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 21.1799994111061 VQPYLDDFQKKWQEEMELYR Dioxidation(W)@12; Dioxidation(M)@16 missed K-K@10; missed K-W@11 0.250292003154755 2708.4931640625 903.8383 2708.24291992188 903.7548828125 3 10 1.1.1.3624.21 1 46.9776 7713.785 46.8041 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 20.4699993133545 VQPYLDDFQKKWQEEMELYR missed K-K@10; missed K-W@11 0.313432991504669 2644.57666015625 662.1514 2644.26318359375 662.073059082031 4 13 1.1.1.3828.5 1 52.0002 1085.469 52.0434 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 17.3199996352196 VQPYLDDFQKKWQEEMELYR missed K-K@10; missed K-W@11 0.321734011173248 2644.5849609375 662.1535 2644.26318359375 662.073059082031 4 12 1.1.1.4026.5 1 56.8358 482.8409 56.7777 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQK missed K-K@10; missed K-W@11; missed R-Q@20 0.323711007833481 2900.74047851563 726.1924 2900.41674804688 726.111450195313 4 20 1.1.1.3751.12 1 50.0747 82646.14 49.9884 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQK Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 0.32098400592804 2916.73266601563 730.1904 2916.41162109375 730.110168457031 4 19 1.1.1.3642.19 1 47.4448 20176.05 47.426 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQK Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 0.321227997541428 2916.73291015625 730.1905 2916.41162109375 730.110168457031 4 18 1.1.1.3651.17 1 47.6707 16759.29 47.6538 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQK reduced acrolein addition +96(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 0.310202986001968 2948.78100585938 590.7635 2948.47094726563 590.701477050781 5 18 1.1.1.3468.8 1 43.1264 41376.09 43.0925 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQK reduced acrolein addition +96(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 0.244909003376961 2948.7158203125 738.1862 2948.47094726563 738.125 4 18 1.1.1.3468.12 1 43.1297 31149.48 43.0677 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQK Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 0.253004014492035 2916.66455078125 973.2288 2916.41162109375 973.144470214844 3 17 1.1.1.3638.21 1 47.3443 3572.17 47.426 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.6800014972687 VQPYLDDFQKKWQEEMELYRQK missed K-K@10; missed K-W@11; missed R-Q@20 0.383390009403229 2900.80004882813 581.1673 2900.41674804688 581.090637207031 5 16 1.1.1.3751.5 1 50.0689 95686.75 49.9884 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.5499978065491 VQPYLDDFQKKWQEEMELYRQK Dioxidation(W)@12 missed K-K@10; missed K-W@11; missed R-Q@20 0.383612006902695 2932.7900390625 587.5653 2932.40649414063 587.488586425781 5 17 1.1.1.3650.7 1 47.6371 5882.266 47.6791 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.5899994373322 VQPYLDDFQKKWQEEMELYRQK Delta:H(2)C(2)(K)@10; acrolein addition +38(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 0.351859986782074 2916.79638671875 584.3666 2916.44458007813 584.296203613281 5 18 1.1.1.3652.9 1 47.6896 21923.1 47.6538 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.0300028324127 VQPYLDDFQKKWQEEMELYRQK Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 0.386094987392426 2916.79760742188 584.3668 2916.41162109375 584.289611816406 5 15 1.1.1.3637.8 1 47.3069 28785.21 47.4005 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 VQPYLDDFQKKWQEEMELYRQK reduced acrolein addition +96(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 0.173327997326851 2948.64428710938 983.8887 2948.47094726563 983.830871582031 3 15 1.1.1.3464.20 1 43.0369 2715.07 43.0677 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.7499990463257 VQPYLDDFQKKWQEEMELYRQK Dioxidation(W)@12 missed K-K@10; missed K-W@11; missed R-Q@20 0.324360013008118 2932.73095703125 734.19 2932.40649414063 734.10888671875 4 15 1.1.1.3648.15 1 47.5931 4906.502 47.6791 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.8699970245361 VQPYLDDFQKKWQEEMELYRQK Deamidated(Q)@2; Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 -0.597921013832092 2916.79760742188 584.3668 2917.39575195313 584.486389160156 5 15 1.1.1.3644.5 1 47.484 28785.21 47.4005 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.7199997901917 VQPYLDDFQKKWQEEMELYRQK Deamidated(Q)@2 missed K-K@10; missed K-W@11; missed R-Q@20 -0.600625991821289 2900.80004882813 581.1673 2901.40063476563 581.287414550781 5 14 1.1.1.3744.7 1 49.8934 95686.75 49.9884 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1900012493134 VQPYLDDFQKKWQEEMELYRQK reduced acrolein addition +96(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 0.310202986001968 2948.78100585938 590.7635 2948.47094726563 590.701477050781 5 14 1.1.1.3461.9 1 42.9533 41376.09 43.0925 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.1100008487701 VQPYLDDFQKKWQEEMELYRQK Dehydrated(D)@7 missed K-K@10; missed K-W@11; missed R-Q@20 0.327439993619919 2882.73364257813 721.6907 2882.40625 721.608825683594 4 14 1.1.1.3741.13 1 49.8202 665.7825 49.8578 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.5499973297119 VQPYLDDFQKKWQEEMELYRQK Deamidated(Q)@9; acrolein addition +56(K)@11 missed K-K@10; missed K-W@11; missed R-Q@20 0.400747001171112 2957.82763671875 592.5728 2957.42700195313 592.49267578125 5 13 1.1.1.3744.8 1 49.8942 1665.19 49.9101 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 79.4900000095367 VQPYLDDFQKKWQEEMELYRQK Trp->Kynurenin(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 0.325581014156342 2920.73217773438 731.1903 2920.40649414063 731.10888671875 4 13 1.1.1.3522.9 1 44.4623 611.9828 44.4757 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 68.0499970912933 VQPYLDDFQKKWQEEMELYRQK Deamidated(Q)@9; Dioxidation(W)@12 missed K-K@10; missed K-W@11; missed R-Q@20 0.276515007019043 2933.6669921875 978.8963 2933.390625 978.804138183594 3 12 1.1.1.3650.21 1 47.6488 480.2177 47.6791 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.2400004863739 VQPYLDDFQKKWQEEMELYRQK reduced acrolein addition +96(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 0.244909003376961 2948.7158203125 738.1862 2948.47094726563 738.125 4 12 1.1.1.3460.14 1 42.9327 31149.48 43.0677 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 60.2400004863739 VQPYLDDFQKKWQEEMELYRQK Oxidation(W)@12 missed K-K@10; missed K-W@11; missed R-Q@20 0.325378000736237 2916.73706054688 730.1915 2916.41162109375 730.110168457031 4 12 1.1.1.3745.14 1 49.926 668.8809 49.8838 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 33.6400002241135 VQPYLDDFQKKWQEEMELYRQK acrolein addition +56(K)@11; FormaldehydeAdduct(W)@12; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20 0.349559992551804 2920.7890625 585.1651 2920.439453125 585.09521484375 5 13 1.1.1.3536.2 1 44.7984 1034.435 44.767 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLR reduced acrolein addition +96(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.330458998680115 3543.15014648438 709.6373 3542.81982421875 709.571228027344 5 21 1.1.1.3621.14 1 46.8946 13943.35 46.8296 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLR Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.39597499370575 3511.15649414063 703.2386 3510.76049804688 703.159362792969 5 20 1.1.1.3731.14 1 49.5632 14149.86 49.6251 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLR missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.386860996484756 3495.15258789063 700.0378 3494.765625 699.960388183594 5 21 1.1.1.3796.2 1 51.2025 39746.04 51.4399 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLR missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.393575012683868 3495.1591796875 700.0391 3494.765625 699.960388183594 5 20 1.1.1.3803.2 1 51.372 73832.48 51.5128 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLR missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.32803601026535 3495.09375 874.7807 3494.765625 874.698669433594 4 22 1.1.1.3803.5 1 51.3796 25767.82 51.5128 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLR missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.453985989093781 3495.2197265625 583.5439 3494.765625 583.468200683594 6 20 1.1.1.3809.4 1 51.5182 69367.59 51.5128 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLR missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.393575012683868 3495.1591796875 700.0391 3494.765625 699.960388183594 5 21 1.1.1.3810.5 1 51.5437 73832.48 51.5128 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLR missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.32803601026535 3495.09375 874.7807 3494.765625 874.698669433594 4 23 1.1.1.3810.11 1 51.5487 25767.82 51.5128 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLR Methyl(Q)@21; reduced acrolein addition +58(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.364868998527527 3567.18798828125 714.4449 3566.8232421875 714.371887207031 5 21 1.1.1.4038.4 1 57.1402 2525.067 57.1594 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLR missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.452888011932373 3495.21850585938 583.5437 3494.765625 583.468200683594 6 18 1.1.1.3795.4 1 51.1782 33297.57 51.4154 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLR missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.453985989093781 3495.2197265625 583.5439 3494.765625 583.468200683594 6 18 1.1.1.3802.4 1 51.3487 69367.59 51.5128 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLR reduced acrolein addition +96(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.391418993473053 3543.21118164063 591.5425 3542.81982421875 591.477233886719 6 19 1.1.1.3620.11 1 46.8667 12604.65 46.8296 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLR Dioxidation(W)@12 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.393186986446381 3527.14868164063 706.437 3526.75537109375 706.3583984375 5 19 1.1.1.3745.13 1 49.9252 4623.231 49.8838 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLR Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.396584987640381 3511.1572265625 703.2387 3510.76049804688 703.159362792969 5 17 1.1.1.3721.10 1 49.3057 10657.26 49.3965 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLR Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.452235996723175 3511.212890625 586.2094 3510.76049804688 586.134033203125 6 17 1.1.1.3735.6 1 49.6594 12893.79 49.6251 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.5499978065491 VQPYLDDFQKKWQEEMELYRQKVEPLR Oxidation(W)@12 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.39597499370575 3511.15649414063 703.2386 3510.76049804688 703.159362792969 5 17 1.1.1.3738.9 1 49.7392 14149.86 49.6251 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.2900023460388 VQPYLDDFQKKWQEEMELYRQKVEPLR missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.453985989093781 3495.2197265625 583.5439 3494.765625 583.468200683594 6 16 1.1.1.3816.5 1 51.6934 69367.59 51.5128 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.3599970340729 VQPYLDDFQKKWQEEMELYRQKVEPLR HPNE addition +172(K)@10; HPNE addition +172(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.389324009418488 3791.37158203125 632.9025 3790.98217773438 632.837646484375 6 17 1.1.1.3732.9 1 49.5844 555.2653 49.6251 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.1399981975555 VQPYLDDFQKKWQEEMELYRQKVEPLR missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.255356997251511 3495.02026367188 1166.014 3494.765625 1165.92919921875 3 15 1.1.1.3803.7 1 51.3862 4349.893 51.5128 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.7200000286102 VQPYLDDFQKKWQEEMELYRQKVEPLR Dimethyl(R)@20; reduced acrolein addition +58(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.284168004989624 3581.123046875 896.288 3580.8388671875 896.216979980469 4 16 1.1.1.4055.9 1 57.5754 924.1009 57.5644 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.0400004386902 VQPYLDDFQKKWQEEMELYRQKVEPLR Dehydrated(D)@7; Deamidated(Q)@9; reduced acrolein addition +58(K)@10 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.408226996660233 3536.18920898438 708.2451 3535.78100585938 708.163452148438 5 16 1.1.1.3784.6 1 50.9083 1350.392 50.9258 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.8699970245361 VQPYLDDFQKKWQEEMELYRQKVEPLR Deamidated(Q)@2; Deamidated(Q)@9; MDA adduct +62(K)@10; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.474530011415482 3511.22045898438 586.2107 3510.74584960938 586.131591796875 6 16 1.1.1.3728.8 1 49.4825 9848.108 49.3965 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1900012493134 VQPYLDDFQKKWQEEMELYRQKVEPLR Dioxidation(W)@12; Dioxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.470421999692917 3559.2158203125 594.2099 3558.74536132813 594.131469726563 6 15 1.1.1.3639.9 1 47.36 1397.758 47.3494 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1900012493134 VQPYLDDFQKKWQEEMELYRQKVEPLR Amino(Y)@19; Delta:H(2)C(2)(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.39546799659729 3536.18774414063 708.2448 3535.79223632813 708.165710449219 5 16 1.1.1.3820.5 1 51.7968 3703.572 51.8152 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.6600027084351 VQPYLDDFQKKWQEEMELYRQKVEPLR Dioxidation(W)@12; Oxidation(M)@16; Methyl(Q)@21; reduced acrolein addition +58(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.35955598950386 3615.16748046875 724.0408 3614.80786132813 723.968872070313 5 16 1.1.1.3784.7 1 50.9091 1124.97 50.9003 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.710000038147 VQPYLDDFQKKWQEEMELYRQKVEPLR reduced acrolein addition +58(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 -0.642979979515076 3552.16455078125 711.4402 3552.8076171875 711.568786621094 5 14 1.1.1.4014.2 1 56.5328 489.6012 56.529 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 74.1299986839294 VQPYLDDFQKKWQEEMELYRQKVEPLR Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.459926009178162 3511.22045898438 586.2107 3510.76049804688 586.134033203125 6 12 1.1.1.3721.6 1 49.3023 9848.108 49.3965 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 51.5799999237061 VQPYLDDFQKKWQEEMELYRQKVEPLR reduced acrolein addition +96(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22 0.391418993473053 3543.21118164063 591.5425 3542.81982421875 591.477233886719 6 12 1.1.1.3613.10 1 46.6874 12604.65 46.8296 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR reduced acrolein addition +96(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.395134001970291 4397.6396484375 733.9472 4397.24462890625 733.88134765625 6 22 1.1.1.3708.3 1 48.9903 44214.5 48.9529 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Dethiomethyl(M)@16; acrolein addition +112(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.402173012495041 4413.6416015625 736.6142 4413.2392578125 736.547180175781 6 21 1.1.1.3721.11 1 49.3065 7290.405 49.2943 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Arg->Orn(R)@20; reduced acrolein addition +58(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.380701988935471 4365.5908203125 874.1255 4365.21044921875 874.049377441406 5 21 1.1.1.3760.13 1 50.3025 23342.95 50.3663 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Deamidated(Q)@2; Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 -0.449526011943817 4365.7197265625 624.6815 4366.16943359375 624.745727539063 7 21 1.1.1.3761.7 1 50.3236 20445 50.3918 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.479754000902176 4365.6650390625 728.6181 4365.18505859375 728.538146972656 6 21 1.1.1.3767.7 1 50.4772 34861.29 50.3918 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Deamidated(Q)@2; Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 -0.450381010770798 4365.71875 624.6814 4366.16943359375 624.745727539063 7 20 1.1.1.3775.6 1 50.6829 27767.37 50.597 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Deamidated(Q)@2 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 -0.517525017261505 4349.65673828125 725.9501 4350.17431640625 726.036315917969 6 22 1.1.1.3844.4 1 52.3991 94441.67 52.3677 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.333826005458832 4349.5224609375 1088.388 4349.1904296875 1088.30480957031 4 22 1.1.1.3845.17 1 52.4349 20799.64 52.3677 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.325524985790253 4349.5146484375 1088.386 4349.1904296875 1088.30480957031 4 26 1.1.1.3855.10 1 52.6815 16951.14 52.6639 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.465025007724762 4349.6552734375 725.9498 4349.1904296875 725.872314453125 6 21 1.1.1.3865.3 1 52.9149 86646.13 52.7127 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR reduced acrolein addition +58(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.370011985301971 4407.60205078125 882.5277 4407.23193359375 882.453735351563 5 22 1.1.1.4047.10 1 57.3672 7062.899 57.3814 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Methyl(Q)@21; reduced acrolein addition +58(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.440836012363434 4421.6884765625 737.9554 4421.248046875 737.881896972656 6 22 1.1.1.4056.5 1 57.5979 9872.688 57.716 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.40131801366806 4349.591796875 870.9256 4349.1904296875 870.845336914063 5 19 1.1.1.3864.4 1 52.8939 64728.11 52.7127 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR reduced acrolein addition +58(K)@22; Methyl(E)@24 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.367729008197784 4421.61572265625 885.3304 4421.248046875 885.2568359375 5 21 1.1.1.4056.13 1 57.6046 11101.14 57.716 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Arg->Orn(R)@20; Deamidated(Q)@21; hexanoyl addition +98(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.389860987663269 4406.61572265625 882.3304 4406.2255859375 882.25244140625 5 21 1.1.1.3835.11 1 52.179 6947.112 52.2178 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.40131801366806 4349.591796875 870.9256 4349.1904296875 870.845336914063 5 19 1.1.1.3857.6 1 52.7237 64728.11 52.7127 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Methyl(Q)@21; reduced acrolein addition +58(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.367729008197784 4421.61572265625 885.3304 4421.248046875 885.2568359375 5 21 1.1.1.4063.10 1 57.7763 11101.14 57.716 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.333826005458832 4349.5224609375 1088.388 4349.1904296875 1088.30480957031 4 18 1.1.1.3837.20 1 52.2371 20799.64 52.3677 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.404675006866455 4349.5947265625 870.9263 4349.1904296875 870.845336914063 5 18 1.1.1.3843.8 1 52.377 78039.19 52.3677 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.464293003082275 4349.65478515625 725.9497 4349.1904296875 725.872314453125 6 18 1.1.1.3851.4 1 52.5723 90633.79 52.5417 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.466490000486374 4349.65673828125 725.9501 4349.1904296875 725.872314453125 6 18 1.1.1.3837.5 1 52.2246 94441.67 52.3677 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Deamidated(Q)@13; reduced acrolein addition +58(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 -0.550478994846344 4407.66552734375 735.6182 4408.21630859375 735.7099609375 6 19 1.1.1.4048.4 1 57.3881 5821.295 57.3814 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Oxidation(M)@16; reduced acrolein addition +58(K)@22; Methyl(E)@24 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.362803995609283 4437.60546875 888.5284 4437.24267578125 888.455810546875 5 20 1.1.1.4009.5 1 56.4159 2986.877 56.4555 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR PyridoxalPhosphate(K)@10; HPNE addition +172(K)@11; hexanoyl addition +98(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.320704996585846 4390.68017578125 732.7873 4390.359375 732.733825683594 6 20 1.1.1.3874.2 1 53.1343 14065.6 53.031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR reduced acrolein addition +96(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.395134001970291 4397.6396484375 733.9472 4397.24462890625 733.88134765625 6 19 1.1.1.3701.3 1 48.8157 44214.5 48.9529 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Dethiomethyl(M)@16; reduced acrolein addition +96(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.260639011859894 4397.5068359375 1100.384 4397.24462890625 1100.318359375 4 19 1.1.1.3708.4 1 48.9961 5846.28 48.9286 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Arg->Orn(R)@20; reduced acrolein addition +58(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.448009997606277 4365.658203125 728.617 4365.21044921875 728.542358398438 6 20 1.1.1.3774.7 1 50.6581 47863.2 50.597 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Arg->Orn(R)@20; reduced acrolein addition +58(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.381312012672424 4365.591796875 874.1256 4365.21044921875 874.049377441406 5 20 1.1.1.3774.13 1 50.6631 32911.98 50.597 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR reduced acrolein addition +96(K)@11; Dethiomethyl(M)@16; Methyl(Q)@21; reduced acrolein addition +58(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.365085005760193 4469.6669921875 745.9518 4469.3017578125 745.890930175781 6 20 1.1.1.3902.5 1 53.8265 3149.945 53.7931 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Deamidated(Q)@2; Dethiomethyl(M)@16; acrolein addition +76(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 -0.611970007419586 4377.59033203125 876.5253 4378.2021484375 876.647705078125 5 19 1.1.1.4010.4 1 56.4387 1530.308 56.5046 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Arg->Orn(R)@20; Deamidated(Q)@21; hexanoyl addition +98(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.452347993850708 4406.67822265625 735.4536 4406.2255859375 735.378234863281 6 20 1.1.1.3834.5 1 52.1489 10908.72 52.2178 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.404675006866455 4349.5947265625 870.9263 4349.1904296875 870.845336914063 5 17 1.1.1.3836.9 1 52.2028 78039.19 52.3677 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.400402009487152 4349.5908203125 870.9254 4349.1904296875 870.845336914063 5 17 1.1.1.3850.7 1 52.5529 68301.48 52.5663 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Delta:H(4)C(2)(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.419930994510651 4377.6416015625 730.6142 4377.2216796875 730.544189453125 6 18 1.1.1.4012.6 1 56.4918 1141.519 56.5046 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR reduced acrolein addition +96(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.329046010971069 4397.5732421875 880.522 4397.24462890625 880.456176757813 5 18 1.1.1.3699.2 1 48.7707 26806.17 48.9286 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.405853986740112 4365.5908203125 874.1255 4365.18505859375 874.044311523438 5 17 1.1.1.3767.13 1 50.4822 23342.95 50.3663 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Trp->Kynurenin(W)@12; Dimethyl(R)@20 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.366984993219376 4381.58349609375 877.324 4381.21630859375 877.250549316406 5 19 1.1.1.3779.7 1 50.7835 7225.168 50.8497 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Deamidated(Q)@2; Dioxidation(W)@12 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 -0.450910001993179 4381.71337890625 626.9663 4382.1640625 627.030700683594 7 18 1.1.1.3780.6 1 50.8074 8131.105 50.8497 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Delta:H(2)C(2)@N-term missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.46280300617218 4375.6689453125 730.2854 4375.2060546875 730.208251953125 6 18 1.1.1.3977.6 1 55.6241 2310.065 55.6172 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR reduced acrolein addition +58(K)@22; Methyl(E)@24 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.440836012363434 4421.6884765625 737.9554 4421.248046875 737.881896972656 6 18 1.1.1.4063.6 1 57.773 9872.688 57.716 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.5899994373322 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Dethiomethyl(M)@16; acrolein addition +112(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.340296000242233 4413.57958984375 883.7232 4413.2392578125 883.655151367188 5 17 1.1.1.3720.17 1 49.2859 3693.247 49.2943 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1199989318848 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Oxidation(M)@16; Dimethyl(R)@20; reduced acrolein addition +58(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.42807400226593 4451.6865234375 742.955 4451.25830078125 742.883666992188 6 17 1.1.1.4048.5 1 57.3889 2397.44 57.3814 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.6000020503998 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Deamidated(Q)@2; Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 -0.449526011943817 4365.7197265625 624.6815 4366.16943359375 624.745727539063 7 16 1.1.1.3762.4 1 50.347 20445 50.3918 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.0300028324127 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Trimethyl(K)@10 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 -0.623598992824554 4390.61376953125 879.13 4391.2373046875 879.254699707031 5 17 1.1.1.3834.11 1 52.1539 2768.168 52.1924 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.8500027656555 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR PyridoxalPhosphate(K)@10; hexanoyl addition +98(K)@11; HPNE addition +172(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.323269009590149 4390.6826171875 732.7877 4390.359375 732.733825683594 6 17 1.1.1.3888.6 1 53.4806 4995.802 53.3743 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.338423013687134 4365.5224609375 1092.388 4365.18505859375 1092.30358886719 4 15 1.1.1.3774.20 1 50.669 6854.042 50.597 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.7300007343292 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Delta:H(4)C(2)(K)@11; Trp->Kynurenin(W)@12 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.431363999843597 4381.64794921875 731.2819 4381.21630859375 731.210021972656 6 17 1.1.1.3778.9 1 50.7606 13714.41 50.8497 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 94.4000005722046 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Deamidated(Q)@2; Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 -0.450381010770798 4365.71875 624.6814 4366.16943359375 624.745727539063 7 15 1.1.1.3770.7 1 50.5545 27767.37 50.597 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.0999994277954 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Dehydrated(D)@7; Deamidated(Q)@9; reduced acrolein addition +58(K)@11 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.348783999681473 4390.5546875 1098.646 4390.20556640625 1098.55871582031 4 16 1.1.1.3870.19 1 53.0493 1710.337 53.056 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.8699970245361 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Dethiomethyl(M)@16; reduced acrolein addition +96(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.329046010971069 4397.5732421875 880.522 4397.24462890625 880.456176757813 5 15 1.1.1.3713.3 1 49.1164 26806.17 48.9286 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 92.4600005149841 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR reduced acrolein addition +96(K)@11; Dethiomethyl(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.329046010971069 4397.5732421875 880.522 4397.24462890625 880.456176757813 5 15 1.1.1.3706.8 1 48.9453 26806.17 48.9286 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.1700019836426 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR HPNE addition +172(K)@10; hexanoyl addition +98(K)@11; PyridoxalPhosphate(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.260354995727539 4390.61962890625 879.1312 4390.359375 879.079162597656 5 16 1.1.1.3874.7 1 53.1427 7397.517 53.031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.7199997901917 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Deamidated(Q)@21; acrolein addition +56(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.340198010206223 4406.53857421875 1102.642 4406.20068359375 1102.55737304688 4 14 1.1.1.3836.18 1 52.2103 1904.219 52.2178 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 88.1900012493134 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Dioxidation(W)@12 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.467750012874603 4381.64794921875 731.2819 4381.18017578125 731.203979492188 6 14 1.1.1.3785.3 1 50.9304 13714.41 50.8497 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 87.1100008487701 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Oxidation(W)@12 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.463640987873077 4365.64892578125 728.6154 4365.18505859375 728.538146972656 6 14 1.1.1.3716.8 1 49.1786 1224.849 49.2691 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.710000038147 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR hexanoyl addition +98(K)@11; Cation:Na(E)@24 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.352311998605728 4469.59765625 894.9268 4469.24560546875 894.856384277344 5 15 1.1.1.3898.11 1 53.7316 3295.767 53.7931 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 81.580001115799 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Oxidation(W)@12; Deamidated(Q)@21 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 -0.643639028072357 4365.52685546875 1092.389 4366.16943359375 1092.54956054688 4 15 1.1.1.3760.17 1 50.3059 3746.196 50.3663 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.8099985122681 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR reduced acrolein addition +58(K)@11; acrolein addition +76(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.34579199552536 4483.609375 897.7291 4483.263671875 897.659973144531 5 15 1.1.1.3965.6 1 55.3594 1420.952 55.3453 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.510002374649 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Dethiomethyl(M)@16; hexanoyl addition +98(K)@22; Oxidation(R)@27 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.345519989728928 4415.6005859375 884.1274 4415.2548828125 884.058288574219 5 15 1.1.1.4038.8 1 57.1435 793.7845 57.1337 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.0100028514862 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Deamidated(Q)@13; Oxidation(M)@16; reduced acrolein addition +58(K)@22; Methyl(E)@24 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 -0.548592984676361 4437.67822265625 740.6203 4438.2265625 740.711730957031 6 15 1.1.1.4021.4 1 56.7073 2029.519 56.8287 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 80.0100028514862 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Trimethyl(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.431259006261826 4391.66845703125 732.952 4391.2373046875 732.880126953125 6 14 1.1.1.4023.8 1 56.7618 2622.911 56.6767 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.7699997425079 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Oxidation(M)@16; Deamidated(Q)@21; acrolein addition +56(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.484539002180099 4422.68017578125 738.1206 4422.1953125 738.039855957031 6 13 1.1.1.3768.11 1 50.5063 2561.613 50.4939 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 78.7699997425079 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Deamidated(Q)@21; Dehydrated(E)@24 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 -0.506228029727936 4331.65771484375 722.9502 4332.16357421875 723.034545898438 6 14 1.1.1.3836.4 1 52.1986 2868.664 52.1924 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 70.7400023937225 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Trp->Kynurenin(W)@12; Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.470678985118866 4369.65087890625 729.2824 4369.18017578125 729.203979492188 6 13 1.1.1.3724.9 1 49.3815 3484.044 49.3706 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.7799999713898 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR MDA adduct +62(K)@22; Cation:Na(E)@24 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.386267006397247 4433.57421875 887.7221 4433.18798828125 887.644836425781 5 13 1.1.1.4046.13 1 57.3438 1186.096 57.3555 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 67.7799999713898 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Met->Hcy(M)@16; hexanoyl addition +98(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.397623002529144 4433.6455078125 739.9482 4433.248046875 739.881896972656 6 13 1.1.1.4047.5 1 57.363 1270.16 57.3555 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 56.3099980354309 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Dethiomethyl(M)@16; hexanoyl addition +98(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.347393006086349 4399.607421875 880.9288 4399.26025390625 880.859313964844 5 12 1.1.1.4252.4 1 62.3503 940.035 62.3696 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 55.7699978351593 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Deamidated(Q)@21; reduced acrolein addition +58(K)@22; Dehydrated(E)@24 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.414139002561569 4390.61962890625 879.1312 4390.20556640625 879.048400878906 5 13 1.1.1.3875.8 1 53.1631 7397.517 53.031 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 29.899999499321 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Oxidation(W)@12 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.473895013332367 4365.6591796875 728.6171 4365.18505859375 728.538146972656 6 14 1.1.1.3782.5 1 50.8564 48785.84 50.597 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 24.0299999713898 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Oxidation(M)@16; Dimethyl(R)@20; reduced acrolein addition +58(K)@22 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.361741989850998 4451.6201171875 891.3313 4451.25830078125 891.258972167969 5 12 1.1.1.4048.12 1 57.3948 2687.412 57.3814 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 21.1799994111061 VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR Oxidation(M)@16 missed K-K@10; missed K-W@11; missed R-Q@20; missed K-V@22; missed R-A@27 0.479754000902176 4365.6650390625 728.6181 4365.18505859375 728.538146972656 6 15 1.1.1.3760.6 1 50.2967 34861.29 50.3918 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VSFLSALEEYTK 0.163220003247261 1385.87109375 693.9428 1385.70788574219 693.861206054688 2 21 1.1.1.3944.4 1 54.8399 27843.04 54.7591 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VSFLSALEEYTK 0.163220003247261 1385.87109375 693.9428 1385.70788574219 693.861206054688 2 21 1.1.1.3937.2 1 54.6666 27843.04 54.7591 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VSFLSALEEYTK 0.166759997606277 1385.87463378906 693.9446 1385.70788574219 693.861206054688 2 18 1.1.1.3963.2 1 55.3005 973.9047 55.1754 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 93.4199988842011 VSFLSALEEYTK 0.166759997606277 1385.87463378906 693.9446 1385.70788574219 693.861206054688 2 13 1.1.1.3953.4 1 55.0581 973.9047 55.1754 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 86.9199991226196 VSFLSALEEYTKK missed K-K@12 0.231268003582954 1514.03405761719 505.6853 1513.80285644531 505.608215332031 3 13 1.1.1.3817.2 1 51.7169 3333.791 51.7634 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 84.4099998474121 VSFLSALEEYTKKLNT acrolein addition +56(K)@12; acrolein addition +112(K)@13; Deamidated(N)@15 cleaved T-Q@C-term; missed K-K@12; missed K-L@13 0.262798994779587 2011.30297851563 671.4416 2011.04016113281 671.35400390625 3 13 1.1.1.4046.3 1 57.3355 1101.928 57.3814 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 VSFLSALEEYTKKLNTQ Deamidated(N)@15 missed K-K@12; missed K-L@13 0.240629002451897 1971.2607421875 658.0942 1971.02001953125 658.013977050781 3 18 1.1.1.3989.2 1 55.9165 2982.235 56.0126 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.7600028514862 VSFLSALEEYTKKLNTQ Formyl(K)@12; reduced acrolein addition +58(K)@13 missed K-K@12; missed K-L@13 0.252256989479065 2056.3251953125 686.449 2056.07275390625 686.364868164063 3 19 1.1.1.4482.2 1 68.1944 326.038 68.2908 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9499995708466 VSFLSALEEYTKKLNTQ missed K-K@12; missed K-L@13 0.240636005997658 1970.27673339844 657.7662 1970.03601074219 657.685974121094 3 17 1.1.1.4050.4 1 57.4402 46133.92 57.3555 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.1800029277802 VSFLSALEEYTKKLNTQ Formyl(K)@12; reduced acrolein addition +58(K)@13 missed K-K@12; missed K-L@13 0.252256989479065 2056.3251953125 686.449 2056.07275390625 686.364868164063 3 17 1.1.1.4489.3 1 68.3813 326.038 68.2908 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 59.960001707077 VSQFEGSALGKQLNLKLLDNWDSVTSTFSK Deamidated(Q)@3; Dioxidation(W)@21 cleaved Y-V@N-term; missed K-Q@11; missed K-L@16 0.304996013641357 3344.98266601563 837.2529 3344.677734375 837.176696777344 4 14 1.1.1.4588.6 1 70.902 164.7653 70.867 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 62.3700022697449 VYVDVLKDSGRDYVSQFEGSALGK Dehydrated(D)@4; reduced acrolein addition +96(K)@7 cleaved T-V@N-term; missed K-D@7; missed R-D@11 0.146193996071815 2709.51123046875 904.1777 2709.36499023438 904.128967285156 3 13 1.1.1.3373.8 1 40.8042 8345.681 40.7194 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 WQEEMELYR Oxidation(M)@5 0.15870800614357 1298.71887207031 650.3667 1298.56018066406 650.287353515625 2 15 1.1.1.2976.7 1 31.2777 18662.42 31.3067 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 98.8900005817413 WQEEMELYR Oxidation(M)@5 0.15870800614357 1298.71887207031 650.3667 1298.56018066406 650.287353515625 2 14 1.1.1.2969.7 1 31.1074 18709.55 31.2827 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.9300022125244 WQEEMELYR 0.158383995294571 1282.7236328125 642.3691 1282.56518554688 642.289916992188 2 15 1.1.1.3277.8 1 38.5015 13271.12 38.5809 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 97.4799990653992 WQEEMELYR 0.158383995294571 1282.7236328125 642.3691 1282.56518554688 642.289916992188 2 15 1.1.1.3284.4 1 38.6673 13271.12 38.5809 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 96.2700009346008 WQEEMELYR Oxidation(M)@5 0.158097997307777 1298.71826171875 650.3664 1298.56018066406 650.287353515625 2 13 1.1.1.2990.9 1 31.6095 13109.99 31.3546 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 95.6099987030029 WQEEMELYR 0.15777300298214 1282.72302246094 642.3688 1282.56518554688 642.289916992188 2 14 1.1.1.3293.7 1 38.8842 12095.56 38.6288 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 WQEEMELYR Oxidation(M)@5 0.158097997307777 1298.71826171875 650.3664 1298.56018066406 650.287353515625 2 11 1.1.1.2997.18 1 31.7792 3108.586 31.5221 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 WQEEMELYR Methyl+Deamidated(Q)@2; Oxidation(M)@5 0.123397998511791 1313.68322753906 657.8489 1313.55981445313 657.787170410156 2 14 1.1.1.3347.6 1 40.1745 3631.043 40.3077 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 WQEEMELYR Methyl+Deamidated(Q)@2; Oxidation(M)@5 0.123397998511791 1313.68322753906 657.8489 1313.55981445313 657.787170410156 2 14 1.1.1.3354.5 1 40.3408 3631.043 40.3077 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 90.719997882843 WQEEMELYR Methyl+Deamidated(Q)@2; Oxidation(M)@5 0.123397998511791 1313.68322753906 657.8489 1313.55981445313 657.787170410156 2 14 1.1.1.3361.10 1 40.5132 3631.043 40.3077 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 83.569997549057 WQEEMELYR 0.158016994595528 1282.72326660156 642.3689 1282.56518554688 642.289916992188 2 13 1.1.1.3291.4 1 38.8322 13169.66 38.5809 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 43.5799986124039 WQEEMELYR 0.15862800180912 1282.72387695313 642.3692 1282.56518554688 642.289916992188 2 12 1.1.1.3270.6 1 38.3316 12301.39 38.533 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 76.9800007343292 WQEEMELYRQK missed R-Q@9 0.223701998591423 1538.94250488281 513.9881 1538.71875 513.913513183594 3 13 1.1.1.3076.4 1 33.6771 1417.493 33.6649 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.7300004959106 YSDELRQR cleaved P-Y@N-term; missed R-Q@6 0.147743001580238 1065.66809082031 533.8413 1065.52026367188 533.767456054688 2 12 1.1.1.2751.5 1 25.8752 6704.581 25.9598 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 89.7300004959106 YSDELRQR cleaved P-Y@N-term; missed R-Q@6 0.147743001580238 1065.66809082031 533.8413 1065.52026367188 533.767456054688 2 12 1.1.1.2758.7 1 26.0457 6773.195 26.1038 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 YVSQFEGSALGK cleaved D-Y@N-term 0.158047005534172 1284.79309082031 643.4038 1284.63500976563 643.324768066406 2 15 1.1.1.3003.13 1 31.9236 7654.483 31.8594 1 284 284 100 98.5000014305115 98.1299996376038 sp|P02647|APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 0 99.0000009536743 YVSQFEGSALGK cleaved D-Y@N-term 0.158047005534172 1284.79309082031 643.4038 1284.63500976563 643.324768066406 2 15 1.1.1.3006.16 1 31.998 7654.483 31.8594 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 AATVGSLAGQPLQER 0.160589993000031 1496.95532226563 749.4849 1496.79467773438 749.404602050781 2 26 1.1.1.3066.12 1 33.444 7041.268 33.1853 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 AATVGSLAGQPLQERAQAWGER missed R-A@15 0.239407002925873 2295.41137695313 766.1444 2295.171875 766.064636230469 3 28 1.1.1.3349.8 1 40.2302 4144.122 40.2835 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 AKLEEQAQQIR missed K-L@2 0.152731001377106 1312.86267089844 657.4386 1312.7099609375 657.362243652344 2 19 1.1.1.2654.9 1 23.5621 8997.403 23.591 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 AKLEEQAQQIRLQAEAFQAR missed K-L@2; missed R-L@11 0.238940000534058 2327.4736328125 776.8318 2327.23461914063 776.752136230469 3 29 1.1.1.3403.12 1 41.5395 14199.25 41.672 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 AYKSELEEQLTPVAEETR missed K-S@3 0.171767994761467 2092.20336914063 1047.109 2092.03247070313 1047.0234375 2 24 1.1.1.3243.8 1 37.6875 1781.708 37.7431 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 AYKSELEEQLTPVAEETRAR missed K-S@3; missed R-A@18 0.305123001337051 2319.47583007813 580.8762 2319.17065429688 580.799926757813 4 23 1.1.1.3192.6 1 36.4593 2521.608 36.4727 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 DADDLQKRLAVYQAGAR missed K-R@7; missed R-L@8 0.231590002775192 1889.20715332031 630.743 1888.97546386719 630.665771484375 3 23 1.1.1.3204.3 1 36.7552 1781.322 36.8082 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 DRLDEVKEQVAEVR missed R-L@2; missed K-E@7 0.228147998452187 1685.1025390625 562.7081 1684.87438964844 562.632080078125 3 20 1.1.1.3112.4 1 34.5426 2388.428 34.5543 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 DRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQAR missed R-L@2; missed K-E@7; missed R-A@14; missed K-L@16; missed R-L@25 0.400090992450714 3994.49853515625 799.907 3994.09838867188 799.826965332031 5 26 1.1.1.4034.10 1 57.0432 1637.306 57.0575 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 GEVQAMLGQSTEELR 0.159103006124496 1646.95251464844 824.4835 1646.79333496094 824.403991699219 2 21 1.1.1.3434.13 1 42.2984 824.4036 42.2098 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 GEVQAMLGQSTEELRVR Oxidation(M)@6 missed R-V@15 0.231955006718636 1918.18981933594 640.4039 1917.95776367188 640.326538085938 3 19 1.1.1.3126.7 1 34.8847 2139.052 34.6268 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 KVEQAVETEPEPELR cleaved A-K@N-term; missed K-V@1 0.16551199555397 1753.05493164063 877.5347 1752.88940429688 877.451965332031 2 20 1.1.1.2822.7 1 27.5802 3562.054 27.466 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 KVEQAVETEPEPELRQQTEWQSGQR cleaved A-K@N-term; missed K-V@1; missed R-Q@15 0.247014999389648 2981.69482421875 994.9056 2981.44799804688 994.8232421875 3 20 1.1.1.3000.11 1 31.8544 579.7006 31.811 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 LEEQAQQIRLQAEAFQAR missed R-L@9 0.237960994243622 2128.34057617188 710.4541 2128.1025390625 710.374755859375 3 29 1.1.1.3349.7 1 40.2277 3439.598 40.3077 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 LGADMEDVCGR Oxidation(M)@5; Carbamidomethyl(C)@9 0.151333004236221 1237.65808105469 619.8363 1237.50671386719 619.760620117188 2 19 1.1.1.2657.11 1 23.6303 26231.6 23.5195 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 LKSWFEPLVEDMQR missed K-S@2 0.174362003803253 1777.06127929688 889.5379 1776.88684082031 889.450744628906 2 18 1.1.1.3801.8 1 51.3328 1517.268 51.2944 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 LKSWFEPLVEDMQRQWAGLVEK missed K-S@2; missed R-Q@14 0.321134001016617 2688.69458007813 673.1809 2688.37329101563 673.100646972656 4 20 1.1.1.4302.5 1 63.6234 1070.721 63.537 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 LKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH missed K-S@2; missed R-Q@14; missed K-V@22 0.329436004161835 4290.48291015625 1073.628 4290.1533203125 1073.54553222656 4 31 1.1.1.4684.16 1 73.4404 2770.423 73.3956 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 LLRDADDLQKR missed R-D@3; missed K-R@10 0.154379993677139 1341.89086914063 671.9527 1341.73645019531 671.87548828125 2 15 1.1.1.2664.16 1 23.8014 404.1429 23.7823 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 LVQYRGEVQAMLGQSTEELR missed R-G@5 0.243861004710197 2306.41284179688 769.8115 2306.1689453125 769.730224609375 3 24 1.1.1.3610.11 1 46.6177 1708.804 46.5003 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 LVQYRGEVQAMLGQSTEELRVR Oxidation(M)@11 missed R-G@5; missed R-V@20 0.311159014701843 2577.64453125 645.4184 2577.33325195313 645.340576171875 4 18 1.1.1.3311.6 1 39.3054 730.9641 39.2982 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 QWAGLVEKVQAAVGTSAAPVPSDNH missed K-V@8 0.249598994851112 2531.5263671875 844.8494 2531.27685546875 844.766235351563 3 32 1.1.1.3739.16 1 49.7707 3320.609 49.8319 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 RLAVYQAGAR missed R-L@1 0.147698000073433 1103.76770019531 552.8911 1103.61999511719 552.817260742188 2 16 1.1.1.2672.9 1 23.9852 5277.872 24.0003 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 SELEEQLTPVAEETR 0.163681998848915 1730.00073242188 866.0076 1729.83703613281 865.92578125 2 23 1.1.1.3242.9 1 37.6636 1428.466 37.6472 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 TRDRLDEVKEQVAEVR missed R-D@2; missed R-L@4; missed K-E@9 0.228834003210068 1942.25207519531 648.4246 1942.02319335938 648.348327636719 3 26 1.1.1.2950.10 1 30.6509 5092.322 30.7556 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 TRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQAR missed R-D@2; missed R-L@4; missed K-E@9; missed R-A@16; missed K-L@18; missed R-L@27 0.466803014278412 4251.7138671875 709.6263 4251.2470703125 709.548461914063 6 28 1.1.1.3963.3 1 55.303 2605.882 55.3453 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 VQAAVGTSAAPVPSDNH 0.161651998758316 1619.95202636719 810.9833 1619.79040527344 810.902465820313 2 28 1.1.1.2811.11 1 27.3179 12536.13 27.2277 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 2 99.0000009536743 VRAATVGSLAGQPLQER missed R-A@2 0.224877998232841 1752.18908691406 585.0703 1751.96423339844 584.995361328125 3 19 1.1.1.2996.6 1 31.7542 3216.891 31.7868 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 1.79588079452515 99.0000009536743 LGPLVEQGRVR missed R-V@9 0.153411000967026 1222.86804199219 612.4413 1222.71459960938 612.364562988281 2 16 1.1.1.2820.10 1 27.5292 4808.275 27.5376 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 1.74472737312317 99.0000009536743 LSKELQAAQAR missed K-E@3 0.207055002450943 1213.88488769531 405.6356 1213.67785644531 405.566558837891 3 17 1.1.1.2616.2 1 22.6404 108643.4 22.6835 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 1.49484992027283 99.0000009536743 LDEVKEQVAEVR missed K-E@5 0.215546995401382 1413.9619140625 472.3279 1413.74633789063 472.256072998047 3 16 1.1.1.2762.4 1 26.135 3022.188 26.1518 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 1.49484992027283 99.0000009536743 SKELQAAQAR cleaved L-S@N-term; missed K-E@2 0.146997004747391 1100.74084472656 551.3777 1100.59387207031 551.30419921875 2 17 1.1.1.2617.8 1 22.6784 1543.904 22.6835 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 1.33724212646484 98.6899971961975 LGPLVEQGR 0.146788001060486 967.69189453125 484.8532 967.545104980469 484.779815673828 2 15 1.1.1.2838.6 1 27.9567 49890.76 27.8951 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0.841637551784515 96.1000025272369 LEEQAQQIR 0.148211002349854 1113.72607421875 557.8703 1113.57788085938 557.796203613281 2 15 1.1.1.2631.6 1 23.0056 1632.595 23.0182 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0.809668362140656 95.4299986362457 LAVYQAGAR 0.146209001541138 947.665100097656 474.8398 947.518859863281 474.766723632813 2 14 1.1.1.2713.7 1 24.9664 99731.61 24.9831 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0.754487335681915 94.6300029754639 LQAEAFQAR 0.147835999727249 1032.68310546875 517.3488 1032.53527832031 517.27490234375 2 14 1.1.1.2772.6 1 26.3796 19570.74 26.2716 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0.730487108230591 94.1900014877319 ARLSKELQAAQAR missed R-L@2; missed K-E@5 0.215924993157387 1441.03198242188 481.3513 1440.81616210938 481.279327392578 3 14 1.1.1.2652.3 1 23.506 1023.453 23.4957 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0.411168247461319 88.3899986743927 AATVGSLAGQPLQERAQAWGERLR missed R-A@15; missed R-L@22 0.309040009975433 2564.66625976563 642.1738 2564.35717773438 642.096557617188 4 14 1.1.1.3488.6 1 43.6284 5341.828 43.5151 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0.320572108030319 80.4499983787537 AQAWGERLR missed R-L@7 0.148017004132271 1085.72106933594 543.8678 1085.57299804688 543.793762207031 2 13 1.1.1.2709.7 1 24.8758 6291.08 24.9114 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0.316052883863449 82.9699993133545 QQTEWQSGQR 0.156740993261337 1246.72583007813 624.3702 1246.56909179688 624.291809082031 2 13 1.1.1.2603.7 1 22.3387 671.3334 22.3685 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0.0574958920478821 35.0199997425079 RLLRDADDLQK missed R-L@1; missed R-D@4 0.212166994810104 1341.94860839844 448.3235 1341.73645019531 448.252777099609 3 12 1.1.1.2670.8 1 23.9357 1369.741 23.9272 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0.0467236638069153 96.399998664856 ALMDETMKELK Oxidation(M)@3; Oxidation(M)@7 missed K-E@8 0.157335996627808 1339.79370117188 670.9041 1339.63635253906 670.825439453125 2 11 1.1.1.2657.13 1 23.6337 407.5662 23.591 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0.033389013260603 99.0000009536743 SWFEPLVEDMQR Dioxidation(W)@2; Oxidation(M)@10 0.170646995306015 1583.86328125 792.9389 1583.69262695313 792.853576660156 2 17 1.1.1.3530.20 1 44.6632 726.2735 44.6447 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0.0291883870959282 95.550000667572 KLEEQAQQIR acrolein addition +112(K)@1 cleaved A-K@N-term; missed K-L@1 0.217724993824959 1353.94299316406 452.3216 1353.72521972656 452.2490234375 3 13 1.1.1.2667.7 1 23.8621 956.5883 23.8547 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0.0114410435780883 50.8499979972839 AKVEQAVETEPEPELR cleaved Q-A@N-term; missed K-V@2 0.025492500513792 1823.95202636719 912.9833 1823.92651367188 912.970520019531 2 10 1.1.1.3307.6 1 39.2181 750.0805 39.2026 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0.00744648277759552 94.5800006389618 VRAATVGSLAGQPLQERAQAWGER Carbamyl@N-term missed R-A@2; missed R-A@17 0.215068995952606 2593.5625 865.5281 2593.34741210938 865.456359863281 3 14 1.1.1.3352.7 1 40.3026 597.1301 40.2835 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0.00217691925354302 43.7299996614456 FQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH ONE addition +154(K)@6 cleaved A-F@N-term; missed R-L@4; missed K-S@6; missed R-Q@18; missed K-V@26 0.222883999347687 4946.74072265625 990.3554 4946.517578125 990.310852050781 5 12 1.1.1.4636.10 1 72.1718 362.3923 72.1058 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0.00174066168256104 65.0799989700317 KAYKSELEEQLTPVAEETR reduced acrolein addition +58(K)@1; acrolein addition +112(K)@4 cleaved L-K@N-term; missed K-A@1; missed K-S@4 0.196364998817444 2390.41796875 797.8133 2390.2216796875 797.747863769531 3 12 1.1.1.3244.12 1 37.7141 1662.236 37.7431 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0.00174066168256104 62.7799987792969 KLEEQAQQIRLQAEAFQAR acrolein addition +112(K)@1 cleaved A-K@N-term; missed K-L@1; missed R-L@10 0.252615988254547 2368.50244140625 790.5081 2368.25 790.423889160156 3 10 1.1.1.3423.18 1 42.0307 284.028 42.0383 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0.000434511806815863 54.3699979782104 AKLEEQAQQIRLQAEAFQARLK missed K-L@2; missed R-L@11; missed R-L@20 -0.715918004512787 2567.69775390625 642.9317 2568.41357421875 643.110656738281 4 12 1.1.1.3632.13 1 47.18 310.5618 47.1918 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AATVGSLAGQPLQER 0.161567002534866 1496.95629882813 749.4854 1496.79467773438 749.404602050781 2 22 1.1.1.3005.13 1 31.9737 544.0573 31.9804 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AATVGSLAGQPLQER 0.161567002534866 1496.95629882813 749.4854 1496.79467773438 749.404602050781 2 24 1.1.1.3035.5 1 32.6995 10576.74 32.873 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AATVGSLAGQPLQER 0.164130002260208 1496.95886230469 749.4867 1496.79467773438 749.404602050781 2 26 1.1.1.3043.7 1 32.887 13207.71 32.9692 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AATVGSLAGQPLQER 0.221276998519897 1497.01599121094 500.0126 1496.79467773438 499.938842773438 3 21 1.1.1.3052.6 1 33.1033 6206.587 32.9932 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AATVGSLAGQPLQER 0.163885995745659 1496.95861816406 749.4866 1496.79467773438 749.404602050781 2 26 1.1.1.3052.8 1 33.1083 13052.52 33.0413 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AATVGSLAGQPLQER 0.221001997590065 1497.01574707031 500.0125 1496.79467773438 499.938842773438 3 20 1.1.1.3059.8 1 33.2736 5974.449 33.0173 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AATVGSLAGQPLQER 0.16193300485611 1496.95666503906 749.4856 1496.79467773438 749.404602050781 2 26 1.1.1.3059.9 1 33.2761 13057.98 33.0413 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AATVGSLAGQPLQER 0.22393199801445 1497.01867675781 500.0135 1496.79467773438 499.938842773438 3 21 1.1.1.3066.11 1 33.4424 3854.224 33.1853 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AATVGSLAGQPLQER 0.164130002260208 1496.95886230469 749.4867 1496.79467773438 749.404602050781 2 26 1.1.1.3073.13 1 33.6118 2766.424 33.569 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AATVGSLAGQPLQER 0.164985001087189 1496.95971679688 749.4871 1496.79467773438 749.404602050781 2 26 1.1.1.3081.8 1 33.8036 2594.497 33.7367 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AATVGSLAGQPLQER 0.160956993699074 1496.95568847656 749.4851 1496.79467773438 749.404602050781 2 25 1.1.1.3088.8 1 33.9715 3060.595 33.9766 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AATVGSLAGQPLQER 0.221276998519897 1497.01599121094 500.0126 1496.79467773438 499.938842773438 3 20 1.1.1.3045.6 1 32.9326 6206.587 32.9932 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AATVGSLAGQPLQER 0.223656997084618 1497.01831054688 500.0134 1496.79467773438 499.938842773438 3 19 1.1.1.3038.9 1 32.7692 5716.62 32.9452 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AATVGSLAGQPLQER 0.228143006563187 1497.02282714844 500.0149 1496.79467773438 499.938842773438 3 17 1.1.1.3074.7 1 33.6333 1571.385 33.5449 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 63.0599975585938 AATVGSLAGQPLQER Hex(1)HexNAc(1)NeuAc(1)(T)@3 0.245404005050659 2153.26782226563 718.7632 2153.02221679688 718.681396484375 3 13 1.1.1.3087.10 1 33.9459 3872.016 34.0005 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 63.0599975585938 AATVGSLAGQPLQER Hex(1)HexNAc(1)NeuAc(1)(T)@3 0.173334002494812 2153.1953125 1077.605 2153.02221679688 1077.51843261719 2 11 1.1.1.3087.11 1 33.9475 651.6339 33.9766 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 58.0200016498566 AATVGSLAGQPLQERAQAWGERL Trp->Hydroxykynurenin(W)@19; Oxidation(R)@22 cleaved L-R@C-term; missed R-A@15; missed R-L@22 0.128912001848221 2444.36962890625 815.7972 2444.24072265625 815.754211425781 3 14 1.1.1.3175.7 1 36.0579 833.0068 36.0178 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 56.6600024700165 AATVGSLAGQPLQERAQAWGERLR missed R-A@15; missed R-L@22 0.242158994078636 2564.59936523438 855.8737 2564.35717773438 855.79296875 3 12 1.1.1.3482.16 1 43.4812 1104.032 43.5396 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 98.1500029563904 AKLEEQAQQIR missed K-L@2 0.211922004818916 1312.921875 438.6479 1312.7099609375 438.577239990234 3 15 1.1.1.2654.4 1 23.5504 45391.16 23.591 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 94.4100022315979 AKLEEQAQQIR missed K-L@2 0.211922004818916 1312.921875 438.6479 1312.7099609375 438.577239990234 3 14 1.1.1.2661.5 1 23.7193 45391.16 23.591 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AKLEEQAQQIRLQAEAFQAR missed K-L@2; missed R-L@11 0.306614995002747 2327.54125976563 582.8926 2327.23461914063 582.81591796875 4 28 1.1.1.3409.9 1 41.6829 9027.988 41.672 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AKLEEQAQQIRLQAEAFQAR missed K-L@2; missed R-L@11 0.238940000534058 2327.4736328125 776.8318 2327.23461914063 776.752136230469 3 18 1.1.1.3416.14 1 41.8586 14188.43 41.672 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 86.9199991226196 AKLEEQAQQIRLQAEAFQAR missed K-L@2; missed R-L@11 0.306614995002747 2327.54125976563 582.8926 2327.23461914063 582.81591796875 4 12 1.1.1.3416.8 1 41.8511 8956.557 41.672 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 92.9199993610382 ALMDETMKELK Oxidation(M)@3; Oxidation(M)@7 missed K-E@8 0.211429998278618 1339.84777832031 447.6232 1339.63635253906 447.552734375 3 13 1.1.1.2657.7 1 23.6237 2261.237 23.591 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 37.6899987459183 ALMDETMKELK missed K-E@8 0.216122001409531 1307.86267089844 436.9615 1307.646484375 436.889434814453 3 12 1.1.1.3200.5 1 36.6492 2105.598 36.6404 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 35.3700011968613 ALMDETMKELK missed K-E@8 0.215571999549866 1307.86206054688 436.9613 1307.646484375 436.889434814453 3 12 1.1.1.3192.4 1 36.4559 2277.351 36.5445 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AYKSELEEQLTPVAEETR missed K-S@3 0.235352993011475 2092.26782226563 698.4299 2092.03247070313 698.351440429688 3 23 1.1.1.3240.4 1 37.6182 14546.95 37.7431 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 AYKSELEEQLTPVAEETR missed K-S@3 0.235352993011475 2092.26782226563 698.4299 2092.03247070313 698.351440429688 3 21 1.1.1.3247.6 1 37.7828 14546.95 37.7431 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 98.8300025463104 AYKSELEEQLTPVAEETR missed K-S@3 0.235352993011475 2092.26782226563 698.4299 2092.03247070313 698.351440429688 3 16 1.1.1.3246.5 1 37.762 14546.95 37.7431 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 DADDLQKRLAVYQAGAR missed K-R@7; missed R-L@8 0.295419991016388 1889.27099609375 473.325 1888.97546386719 473.251159667969 4 18 1.1.1.3208.6 1 36.8478 2489.963 36.7842 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 DRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQAR missed R-L@2; missed K-E@7; missed R-A@14; missed K-L@16; missed R-L@25 0.461174011230469 3994.5595703125 666.7672 3994.09838867188 666.690368652344 6 22 1.1.1.4034.6 1 57.0399 1776.581 57.0575 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 83.950001001358 ERLGPLVEQGR missed R-L@2 -0.790233016014099 1251.89855957031 418.3068 1252.68884277344 418.570190429688 3 13 1.1.1.2819.5 1 27.4987 2599.268 27.5138 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 GEVQAMLGQSTEELR 0.159103006124496 1646.95251464844 824.4835 1646.79333496094 824.403991699219 2 24 1.1.1.3433.7 1 42.2724 824.4036 42.2098 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 GEVQAMLGQSTEELRVR Oxidation(M)@6 missed R-V@15 0.231955006718636 1918.18981933594 640.4039 1917.95776367188 640.326538085938 3 19 1.1.1.3116.8 1 34.6434 2011.785 34.6509 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 GEVQAMLGQSTEELRVR Oxidation(M)@6 missed R-V@15 0.235616996884346 1918.19348144531 640.4051 1917.95776367188 640.326538085938 3 21 1.1.1.3133.9 1 35.0554 1350.886 34.8923 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 GEVQAMLGQSTEELRVR missed R-V@15 0.237551003694534 1902.20043945313 635.0741 1901.962890625 634.994934082031 3 19 1.1.1.3484.6 1 43.5245 9252.846 43.4654 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 GEVQAMLGQSTEELRVR missed R-V@15 0.167678996920586 1902.13061523438 952.0726 1901.962890625 951.988708496094 2 18 1.1.1.3477.20 1 43.3611 4476.646 43.4654 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 GEVQAMLGQSTEELRVR missed R-V@15 0.167678996920586 1902.13061523438 952.0726 1901.962890625 951.988708496094 2 18 1.1.1.3484.12 1 43.5346 4476.646 43.4654 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 GEVQAMLGQSTEELRVR missed R-V@15 0.237551003694534 1902.20043945313 635.0741 1901.962890625 634.994934082031 3 16 1.1.1.3477.7 1 43.3494 9252.847 43.4654 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 KVEQAVETEPEPELR cleaved A-K@N-term; missed K-V@1 0.222565993666649 1753.11193847656 585.3779 1752.88940429688 585.3037109375 3 18 1.1.1.2814.6 1 27.3894 26353.77 27.466 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 KVEQAVETEPEPELR cleaved A-K@N-term; missed K-V@1 0.222565993666649 1753.11193847656 585.3779 1752.88940429688 585.3037109375 3 18 1.1.1.2821.8 1 27.5539 26353.77 27.466 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 KVEQAVETEPEPELR cleaved A-K@N-term; missed K-V@1 0.28389298915863 1753.17333984375 439.3006 1752.88940429688 439.229614257813 4 16 1.1.1.2816.3 1 27.4287 621.0029 27.4422 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 KVEQAVETEPEPELRQQTEWQSGQR Dioxidation(W)@20 cleaved A-K@N-term; missed K-V@1; missed R-Q@15 0.31393501162529 3013.75170898438 754.4452 3013.43774414063 754.36669921875 4 26 1.1.1.2960.7 1 30.8944 678.536 30.8755 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 KVEQAVETEPEPELRQQTEWQSGQR cleaved A-K@N-term; missed K-V@1; missed R-Q@15 0.31938898563385 2981.76733398438 746.4491 2981.44799804688 746.369262695313 4 26 1.1.1.2995.16 1 31.7316 4487.469 31.7868 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 KVEQAVETEPEPELRQQTEWQSGQR cleaved A-K@N-term; missed K-V@1; missed R-Q@15 0.31938898563385 2981.76733398438 746.4491 2981.44799804688 746.369262695313 4 26 1.1.1.3002.13 1 31.9011 4487.469 31.7868 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 90.719997882843 LAVYQAGAR Deamidated(Q)@5 0.165184006094933 948.668090820313 475.3413 948.502868652344 475.258728027344 2 12 1.1.1.2714.6 1 24.9895 28303.16 24.9831 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 82.370001077652 LAVYQAGAR 0.145964995026588 947.664855957031 474.8397 947.518859863281 474.766723632813 2 12 1.1.1.2728.6 1 25.3305 2830.305 25.2216 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 69.1600024700165 LAVYQAGAR 0.146209001541138 947.665100097656 474.8398 947.518859863281 474.766723632813 2 12 1.1.1.2720.5 1 25.1387 99731.61 24.9831 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LEEQAQQIRLQAEAFQAR missed R-L@9 0.237960994243622 2128.34057617188 710.4541 2128.1025390625 710.374755859375 3 30 1.1.1.3356.9 1 40.3966 3439.598 40.3077 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LGADMEDVCGR Oxidation(M)@5; Carbamidomethyl(C)@9 0.151333004236221 1237.65808105469 619.8363 1237.50671386719 619.760620117188 2 18 1.1.1.2649.12 1 23.4397 26231.6 23.5195 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LGADMEDVCGR Oxidation(M)@5; Carbamidomethyl(C)@9 0.151576995849609 1237.65832519531 619.8364 1237.50671386719 619.760620117188 2 16 1.1.1.2664.12 1 23.7947 21602.89 23.5433 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LGADMEDVCGR Carbamidomethyl(C)@9 0.155891001224518 1221.66772460938 611.8411 1221.51184082031 611.76318359375 2 19 1.1.1.2867.9 1 28.655 26514.17 28.8046 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LGADMEDVCGR Carbamidomethyl(C)@9 0.155891001224518 1221.66772460938 611.8411 1221.51184082031 611.76318359375 2 19 1.1.1.2874.5 1 28.8236 26514.17 28.8046 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LGADMEDVCGR Carbamidomethyl(C)@9 0.153694003820419 1221.66552734375 611.84 1221.51184082031 611.76318359375 2 18 1.1.1.2895.8 1 29.3289 3701.19 29.0694 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LGADMEDVCGR Carbamidomethyl(C)@9 0.155891001224518 1221.66772460938 611.8411 1221.51184082031 611.76318359375 2 18 1.1.1.2881.5 1 28.9922 26514.17 28.8046 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LGADMEDVCGR Carbamidomethyl(C)@9 0.156012997031212 1221.66784667969 611.8412 1221.51184082031 611.76318359375 2 18 1.1.1.2888.8 1 29.1555 13105.54 28.9009 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LGADMEDVCGR Carbamidomethyl(C)@9 0.155891001224518 1221.66772460938 611.8411 1221.51184082031 611.76318359375 2 17 1.1.1.2902.8 1 29.4948 922.1731 29.358 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LGADMEDVCGR Carbamidomethyl(C)@9 0.332038998603821 1221.84387207031 611.9292 1221.51184082031 611.76318359375 2 15 1.1.1.2913.7 1 29.7628 1769.148 29.8645 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 98.4399974346161 LGADMEDVCGR Dioxidation(M)@5; Carbamidomethyl(C)@9 0.160202994942665 1253.66186523438 627.8382 1253.50158691406 627.758117675781 2 11 1.1.1.2672.16 1 23.9911 127.3395 23.9759 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 94.4100022315979 LGADMEDVCGR Oxidation(M)@5; Carbamidomethyl(C)@9 0.151333004236221 1237.65808105469 619.8363 1237.50671386719 619.760620117188 2 10 1.1.1.2671.18 1 23.9683 977.317 23.7104 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 88.6699974536896 LGADMEDVCGR Carbamidomethyl(C)@9 0.333626002073288 1221.84545898438 611.93 1221.51184082031 611.76318359375 2 10 1.1.1.2937.12 1 30.3373 1143.059 30.2992 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 96.5399980545044 LGPLVEQGR 0.146788001060486 967.69189453125 484.8532 967.545104980469 484.779815673828 2 14 1.1.1.2831.4 1 27.7903 49890.76 27.8951 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 84.7000002861023 LGPLVEQGR 0.146788001060486 967.69189453125 484.8532 967.545104980469 484.779815673828 2 13 1.1.1.2834.7 1 27.8594 49890.76 27.8951 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 61.6699993610382 LGPLVEQGR -0.835816979408264 966.709289550781 484.3619 967.545104980469 484.779815673828 2 11 1.1.1.2855.5 1 28.3575 914.904 28.3487 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 98.989999294281 LGPLVEQGRVR missed R-V@9 0.15548600256443 1222.8701171875 612.4423 1222.71459960938 612.364562988281 2 15 1.1.1.2813.8 1 27.3631 4752.11 27.5376 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 98.1500029563904 LGPLVEQGRVR missed R-V@9 0.15548600256443 1222.8701171875 612.4423 1222.71459960938 612.364562988281 2 15 1.1.1.2827.7 1 27.6993 4808.275 27.5376 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 82.370001077652 LGPLVEQGRVR missed R-V@9 0.208786994218826 1222.92333984375 408.6484 1222.71459960938 408.578796386719 3 13 1.1.1.2813.2 1 27.3506 35248.77 27.5376 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 81.0999989509583 LGPLVEQGRVR missed R-V@9 0.208786994218826 1222.92333984375 408.6484 1222.71459960938 408.578796386719 3 13 1.1.1.2820.4 1 27.5192 35566.82 27.5376 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LKSWFEPLVEDMQR missed K-S@2 0.234589993953705 1777.12145996094 593.3811 1776.88684082031 593.302917480469 3 17 1.1.1.3798.4 1 51.2534 2621.099 51.2701 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 96.6000020503998 LKSWFEPLVEDMQR Oxidation(M)@12 missed K-S@2 0.237782999873161 1793.11962890625 598.7138 1792.8818359375 598.634521484375 3 15 1.1.1.3649.14 1 47.6176 2436.898 47.7047 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 91.9399976730347 LKSWFEPLVEDMQR missed K-S@2 0.174362003803253 1777.06127929688 889.5379 1776.88684082031 889.450744628906 2 13 1.1.1.3793.6 1 51.1356 1517.268 51.2944 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 88.1900012493134 LKSWFEPLVEDMQR Dioxidation(W)@4; Oxidation(M)@12 missed K-S@2 0.232999995350838 1825.10461425781 609.3755 1824.87158203125 609.2978515625 3 14 1.1.1.3515.7 1 44.2952 4521.113 44.2348 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 88.1900012493134 LKSWFEPLVEDMQR Dioxidation(W)@4 missed K-S@2 0.231637999415398 1809.1083984375 604.0434 1808.87670898438 603.966186523438 3 14 1.1.1.3734.13 1 49.6392 1049.111 49.6251 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 87.1100008487701 LKSWFEPLVEDMQR Dioxidation(W)@4 missed K-S@2 0.143272995948792 1809.02001953125 905.5173 1808.87670898438 905.445617675781 2 11 1.1.1.3733.19 1 49.6184 208.7436 49.6251 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 96.3100016117096 LKSWFEPLVEDMQRQWAGLVEK missed K-S@2; missed R-Q@14 0.321134001016617 2688.69458007813 673.1809 2688.37329101563 673.100646972656 4 17 1.1.1.4295.3 1 63.439 1070.721 63.537 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 96.3100016117096 LKSWFEPLVEDMQRQWAGLVEK missed K-S@2; missed R-Q@14 0.251872003078461 2688.62524414063 897.2157 2688.37329101563 897.131713867188 3 17 1.1.1.4299.12 1 63.5508 758.1095 63.5114 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 92.6699995994568 LKSWFEPLVEDMQRQWAGLVEK Dioxidation(K)@2; Oxidation(M)@12 missed K-S@2; missed R-Q@14 0.313928991556168 2736.67211914063 685.1753 2736.35815429688 685.096801757813 4 17 1.1.1.3776.6 1 50.7079 1773.35 50.7506 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 68.0499970912933 LKSWFEPLVEDMQRQWAGLVEK Dioxidation(W)@4; Trioxidation(W)@16 missed K-S@2; missed R-Q@14 0.320437997579575 2768.66845703125 693.1744 2768.34790039063 693.09423828125 4 14 1.1.1.3733.14 1 49.6142 716.5062 49.651 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH missed K-S@2; missed R-Q@14; missed K-V@22 0.399430006742477 4290.552734375 859.1178 4290.1533203125 859.037902832031 5 17 1.1.1.4677.8 1 73.2488 8814.813 73.3956 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH missed K-S@2; missed R-Q@14; missed K-V@22 0.464540988206863 4290.61767578125 716.1102 4290.1533203125 716.032775878906 6 14 1.1.1.4678.11 1 73.2779 1870.776 73.3956 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH HPNE addition +172(K)@2; hexanoyl addition +98(K)@22 missed K-S@2; missed R-Q@14; missed K-V@22 0.29525300860405 4560.630859375 1141.165 4560.33642578125 1141.09130859375 4 14 1.1.1.4679.15 1 73.3102 1112.932 73.3689 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH missed K-S@2; missed R-Q@14; missed K-V@22 0.399430006742477 4290.552734375 859.1178 4290.1533203125 859.037902832031 5 30 1.1.1.4684.9 1 73.432 8814.813 73.3956 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH missed K-S@2; missed R-Q@14; missed K-V@22 0.464540988206863 4290.61767578125 716.1102 4290.1533203125 716.032775878906 6 19 1.1.1.4685.8 1 73.4568 1870.776 73.3956 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH Oxidation(M)@12 missed K-S@2; missed R-Q@14; missed K-V@22 0.41007000207901 4306.55810546875 862.3189 4306.14794921875 862.236877441406 5 19 1.1.1.4265.13 1 62.6845 893.554 62.773 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH acrolein addition +76(K)@2; Trp->Kynurenin(W)@16 missed K-S@2; missed R-Q@14; missed K-V@22 0.340256005525589 4370.51953125 875.1112 4370.17919921875 875.043151855469 5 19 1.1.1.4027.13 1 56.8683 1044.971 56.8287 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH Oxidation(M)@12 missed K-S@2; missed R-Q@14; missed K-V@22 0.347705006599426 4306.49462890625 1077.631 4306.14794921875 1077.54431152344 4 18 1.1.1.4266.17 1 62.7134 427.6272 62.7991 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH Dioxidation(W)@4 missed K-S@2; missed R-Q@14; missed K-V@22 0.398126006126404 4322.541015625 865.5155 4322.14306640625 865.435852050781 5 23 1.1.1.4602.10 1 71.2737 1689.495 71.444 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH Dioxidation(W)@4 missed K-S@2; missed R-Q@14; missed K-V@22 0.330330014228821 4322.474609375 1081.626 4322.14306640625 1081.54296875 4 22 1.1.1.4604.14 1 71.3322 519.5615 71.4174 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH Delta:H(4)C(2)@N-term; Trp->Kynurenin(W)@4 missed K-S@2; missed R-Q@14; missed K-V@22 0.361741006374359 4322.541015625 865.5155 4322.17919921875 865.443176269531 5 31 1.1.1.4609.5 1 71.4576 1689.495 71.444 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 88.0299985408783 LKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH Dioxidation(W)@16 missed K-S@2; missed R-Q@14; missed K-V@22 0.426508009433746 4322.5693359375 865.5212 4322.14306640625 865.435852050781 5 15 1.1.1.4493.6 1 68.472 337.3699 68.5122 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 75.3799974918365 LKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH Dioxidation(W)@4 missed K-S@2; missed R-Q@14; missed K-V@22 0.459208995103836 4322.60205078125 721.441 4322.14306640625 721.364440917969 6 12 1.1.1.4612.7 1 71.5322 229.0385 71.4702 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 35.6799989938736 LKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH Dioxidation(W)@4 missed K-S@2; missed R-Q@14; missed K-V@22 0.477885991334915 4322.62109375 721.4441 4322.14306640625 721.364440917969 6 11 1.1.1.4604.9 1 71.3239 160.3509 71.3129 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LLRDADDLQKR missed R-D@3; missed K-R@10 0.209511995315552 1341.94592285156 448.3226 1341.73645019531 448.252777099609 3 18 1.1.1.2663.3 1 23.7639 8019.135 23.8064 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 58.7700009346008 LQAEAFQAR -0.873037993907928 1031.66223144531 516.8384 1032.53527832031 517.27490234375 2 11 1.1.1.2791.4 1 26.8296 9843.002 26.9893 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 47.2499996423721 LQAEAFQAR 0.1475919932127 1032.68286132813 517.3487 1032.53527832031 517.27490234375 2 12 1.1.1.2786.6 1 26.7138 3647.012 26.7749 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 43.5799986124039 LQAEAFQAR 0.15064300596714 1032.68591308594 517.3502 1032.53527832031 517.27490234375 2 12 1.1.1.2779.5 1 26.5474 2566.425 26.6317 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 37.6899987459183 LQAEAFQAR 0.147835999727249 1032.68310546875 517.3488 1032.53527832031 517.27490234375 2 12 1.1.1.2765.5 1 26.212 19570.74 26.2716 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 98.1500029563904 LSKELQAAQAR missed K-E@3 0.151801005005836 1213.82971191406 607.9221 1213.67785644531 607.84619140625 2 15 1.1.1.2615.17 1 22.6307 16398.72 22.6835 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 63.0599975585938 LSKELQAAQAR Deamidated(Q)@6; Deamidated(Q)@9 missed K-E@3 0.241831004619598 1215.8876953125 406.3032 1215.64587402344 406.222595214844 3 13 1.1.1.2618.3 1 22.6889 10009.7 22.6835 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LVQYRGEVQAMLGQSTEELR missed R-G@5 0.243861004710197 2306.41284179688 769.8115 2306.1689453125 769.730224609375 3 24 1.1.1.3603.18 1 46.4423 1708.804 46.5003 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LVQYRGEVQAMLGQSTEELRVR Oxidation(M)@11 missed R-G@5; missed R-V@20 0.323610007762909 2577.65698242188 645.4215 2577.33325195313 645.340576171875 4 18 1.1.1.3297.3 1 38.974 720.9683 38.9635 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LVQYRGEVQAMLGQSTEELRVR missed R-G@5; missed R-V@20 0.317791998386383 2561.65625 641.4213 2561.33837890625 641.341857910156 4 21 1.1.1.3636.12 1 47.2844 18803.12 47.2183 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 LVQYRGEVQAMLGQSTEELRVR missed R-G@5; missed R-V@20 0.251033008098602 2561.58935546875 854.8704 2561.33837890625 854.786743164063 3 26 1.1.1.3636.18 1 47.2894 10487.29 47.2183 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 94.4100022315979 LVQYRGEVQAMLGQSTEELRVR Oxidation(M)@11 missed R-G@5; missed R-V@20 0.245070993900299 2577.57836914063 860.2001 2577.33325195313 860.118408203125 3 13 1.1.1.3296.8 1 38.9559 1554.208 38.9395 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 32.2299987077713 QQTEWQSGQR Gln->pyro-Glu@N-term 0.143494993448257 1229.68603515625 615.8503 1229.54248046875 615.778503417969 2 12 1.1.1.2740.5 0 25.6168 579.4014 25.6015 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 37.2299998998642 QWAGLVEKVQAAVGTSAAPVPSD Gln->pyro-Glu@N-term; Trp->Kynurenin(W)@2; Oxidation(P)@21 cleaved D-N@C-term; missed K-V@8 0.190343007445335 2283.32861328125 762.1168 2283.13818359375 762.053344726563 3 11 1.1.1.4306.5 1 63.7279 229.5175 63.7722 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 QWAGLVEKVQAAVGTSAAPVPSDNH Dioxidation(W)@2 missed K-V@8 0.253239005804062 2563.52001953125 855.5139 2563.2666015625 855.429504394531 3 28 1.1.1.3662.20 1 47.9566 1597.332 48.0136 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 QWAGLVEKVQAAVGTSAAPVPSDNH missed K-V@8 0.334425002336502 2531.611328125 633.9101 2531.27685546875 633.826477050781 4 17 1.1.1.3740.10 1 49.7917 2167.919 49.8838 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 91.2800014019012 QWAGLVEKVQAAVGTSAAPVPSDNH Gln->pyro-Glu@N-term missed K-V@8 0.249902993440628 2514.50024414063 839.174 2514.25024414063 839.090698242188 3 15 1.1.1.4054.9 1 57.5493 406.3351 57.5384 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 SELEEQLTPVAEETR 0.167587995529175 1730.00463867188 866.0096 1729.83703613281 865.92578125 2 26 1.1.1.3235.6 1 37.495 1369.481 37.5753 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 89.7300004959106 SKELQAAQAR ONE addition +154(K)@2 cleaved L-S@N-term; missed K-E@2 0.22155499458313 1254.91479492188 419.3122 1254.69323730469 419.238342285156 3 12 1.1.1.2651.3 1 23.479 2693.448 23.5433 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 96.6000020503998 SWFEPLVEDMQR Dioxidation(W)@2 0.164707005023956 1567.86242675781 784.9385 1567.69775390625 784.856140136719 2 15 1.1.1.3755.15 1 50.1769 390.3648 50.2122 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 TRDRLDEVKEQVAEVR missed R-D@2; missed R-L@4; missed K-E@9 0.173427000641823 1942.19665527344 972.1056 1942.02319335938 972.018859863281 2 14 1.1.1.2954.13 1 30.7506 547.8068 30.7316 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 TRDRLDEVKEQVAEVR missed R-D@2; missed R-L@4; missed K-E@9 0.288513004779816 1942.31176757813 486.5852 1942.02319335938 486.513092041016 4 17 1.1.1.2954.7 1 30.7406 26708.56 30.7316 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 TRDRLDEVKEQVAEVR missed R-D@2; missed R-L@4; missed K-E@9 0.288513004779816 1942.31176757813 486.5852 1942.02319335938 486.513092041016 4 16 1.1.1.2947.7 1 30.5738 26708.56 30.7316 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 97.8500008583069 TRDRLDEVKEQVAEVR missed R-D@2; missed R-L@4; missed K-E@9 0.288513004779816 1942.31176757813 486.5852 1942.02319335938 486.513092041016 4 15 1.1.1.2961.6 1 30.9099 26708.56 30.7316 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 TRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQAR missed R-D@2; missed R-L@4; missed K-E@9; missed R-A@16; missed K-L@18; missed R-L@27 0.467534989118576 4251.71484375 709.6264 4251.2470703125 709.548461914063 6 18 1.1.1.3955.3 1 55.1062 2110.596 55.1997 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 88.5200023651123 TRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQAR missed R-D@2; missed R-L@4; missed K-E@9; missed R-A@16; missed K-L@18; missed R-L@27 0.393940001726151 4251.64111328125 851.3355 4251.2470703125 851.256713867188 5 15 1.1.1.3957.5 1 55.1603 908.1622 55.1997 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 VQAAVGTSAAPVPSDNH 0.218950003385544 1620.00927734375 541.0104 1619.79040527344 540.937377929688 3 20 1.1.1.2804.8 1 27.1443 8802.956 27.2515 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 VQAAVGTSAAPVPSDNH 0.161651998758316 1619.95202636719 810.9833 1619.79040527344 810.902465820313 2 27 1.1.1.2804.12 1 27.151 12536.13 27.2277 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 VQAAVGTSAAPVPSDNH 0.218950003385544 1620.00927734375 541.0104 1619.79040527344 540.937377929688 3 20 1.1.1.2811.6 1 27.3096 8802.956 27.2515 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 VQAAVGTSAAPVPSDNH 0.161896005272865 1619.95227050781 810.9834 1619.79040527344 810.902465820313 2 24 1.1.1.2818.11 1 27.4848 14001.66 27.2277 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 VQAAVGTSAAPVPSDNH Deamidated(N)@16 0.171287998557091 1620.94567871094 811.4801 1620.7744140625 811.394470214844 2 26 1.1.1.2826.6 1 27.6755 571.8351 27.7043 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 99.0000009536743 VQAAVGTSAAPVPSDNH 1.15530002117157 1620.94567871094 811.4801 1619.79040527344 810.902465820313 2 23 1.1.1.2834.10 1 27.8661 571.8351 27.7043 2 68.24 68.24 88.9599978923798 73.5000014305115 71.9200015068054 sp|P02649|APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 0 94.4100022315979 VQAAVGTSAAPVPSDNH Cation:Na(D)@15 0.229986995458603 1642.00231933594 548.3414 1641.77233886719 548.264709472656 3 15 1.1.1.2808.6 1 27.2415 690.4136 27.2277 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 2 99.0000009536743 GNTLDNDIMLIKLSSPATLNSR cleaved N-G@N-term; missed K-L@12 0.248841002583504 2372.48583984375 791.8359 2372.23706054688 791.7529296875 3 19 1.1.1.3806.7 1 51.449 545.6544 51.4154 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 2 99.0000009536743 IDVLEGNEQFINAAK cleaved N-I@N-term 0.169042006134987 1660.01586914063 831.0152 1659.84680175781 830.9306640625 2 27 1.1.1.3520.4 1 44.4158 1103.716 44.4275 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 2 99.0000009536743 IITHPNFNGNTLDNDIMLIK 0.170699000358582 2282.34326171875 1142.179 2282.1728515625 1142.09375 2 22 1.1.1.3744.21 1 49.9051 5289.594 49.9632 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 2 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATL Dethiomethyl(M)@17; MDA adduct +62(K)@20 cleaved L-N@C-term; missed K-L@20 0.25595098733902 2965.81079101563 989.6109 2965.55493164063 989.525573730469 3 23 1.1.1.4051.13 1 57.4743 1241.237 57.4595 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 2 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR missed K-L@20 0.325670003890991 3309.04443359375 828.2684 3308.71875 828.186950683594 4 29 1.1.1.3839.10 1 52.279 33469.37 52.3677 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 2 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAK missed R-L@4 0.250578999519348 2706.65942382813 903.2271 2706.40893554688 903.143615722656 3 34 1.1.1.3662.21 1 47.9574 13761.29 47.9113 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 2 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPN acrolein addition +112(K)@24; reduced HNE(H)@28; Deamidated(N)@30 cleaved N-F@C-term; missed R-L@4; missed K-I@24 0.294939994812012 3653.24145507813 914.3176 3652.94653320313 914.243896484375 4 27 1.1.1.3890.13 1 53.5371 1237.106 53.5489 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 2 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN reduced acrolein addition +96(K)@24; reduced HNE(H)@28; Dethiomethyl(M)@41; acrolein addition +94(K)@44 cleaved N-S@C-term; missed R-L@4; missed K-I@24; missed K-L@44 0.422477006912231 6054.63427734375 1010.113 6054.21044921875 1010.04235839844 6 25 1.1.1.4120.4 1 59.149 19018.39 59.3821 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 2 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR missed R-L@4; missed K-I@24; missed K-L@44 -0.531702995300293 5996.58447265625 1000.438 5997.1171875 1000.52679443359 6 25 1.1.1.4059.12 1 57.6794 479.9145 57.7411 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 2 99.0000009536743 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@7; Carbamidomethyl(C)@25; Carbamidomethyl(C)@41; Carbamidomethyl(Y)@42; hexanoyl addition +98(K)@43 0.420078992843628 4814.68798828125 963.9449 4814.26806640625 963.86083984375 5 26 1.1.1.3779.9 1 50.7852 22788.58 50.7506 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 2 99.0000009536743 LGEHNIDVLEGNEQ cleaved Q-F@C-term 0.159898996353149 1565.89208984375 783.9533 1565.73217773438 783.873352050781 2 18 1.1.1.3179.8 1 36.1535 6593.499 35.9223 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 2 99.0000009536743 LGEHNIDVLEGNEQF cleaved F-I@C-term 0.164482995867729 1712.96508789063 857.4898 1712.80053710938 857.407592773438 2 20 1.1.1.3512.19 1 44.228 2477.931 44.2588 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 2 99.0000009536743 LGEHNIDVLEGNEQFIN cleaved N-A@C-term 0.172622993588448 1940.10021972656 971.0574 1939.92761230469 970.971069335938 2 23 1.1.1.3585.12 1 45.9947 12419.7 46.1477 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 2 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.170181006193161 2210.26733398438 1106.141 2210.0966796875 1106.0556640625 2 29 1.1.1.3517.8 1 44.3502 75521.01 44.3553 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 2 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPN acrolein addition +112(K)@20; reduced HNE(H)@24; Deamidated(N)@26 cleaved N-F@C-term; missed K-I@20 0.287283003330231 3156.92163085938 790.2377 3156.63427734375 790.165832519531 4 22 1.1.1.3891.6 1 53.5564 8323.917 53.7931 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 2 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNF Deamidated(N)@17; ONE addition +154(K)@20; reduced HNE(H)@24; Deamidated(N)@26 cleaved F-N@C-term; missed K-I@20 0.251134991645813 3346.98486328125 837.7535 3346.73364257813 837.690673828125 4 22 1.1.1.3874.5 1 53.1393 5709.226 53.228 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 2 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGN Delta:H(4)C(2)(K)@20 cleaved N-T@C-term; missed K-I@20 0.320616990327835 3345.99487304688 837.506 3345.67431640625 837.425842285156 4 26 1.1.1.3866.6 1 52.9401 5344.87 52.6882 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 2 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIK Methyl(I)@22 missed K-I@20 0.329935014247894 4488.6025390625 1123.158 4488.27490234375 1123.07592773438 4 37 1.1.1.4050.17 1 57.451 5680.987 57.486 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 2 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN acrolein addition +94(K)@20; reduced HNE(H)@24; Dethiomethyl(M)@37; reduced acrolein addition +96(K)@40 cleaved N-S@C-term; missed K-I@20; missed K-L@40 0.371437013149261 5558.2685546875 1112.661 5557.8984375 1112.5869140625 5 22 1.1.1.4208.3 1 61.2804 117097 61.1947 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 2 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR missed K-I@20; missed K-L@40 0.49005800485611 5501.294921875 917.8898 5500.8046875 917.80810546875 6 32 1.1.1.4082.12 1 58.2069 1842.078 58.1949 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 2 99.0000009536743 LSSPATLNSR Deamidated(N)@8 0.150869995355606 1045.69128417969 523.8529 1045.54040527344 523.777465820313 2 16 1.1.1.2719.10 1 25.1181 15638.75 25.0787 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 2 99.0000009536743 NIDVLEGNEQFINAAK cleaved H-N@N-term 0.170670002698898 1774.06042480469 888.0375 1773.88977050781 887.9521484375 2 23 1.1.1.3588.18 1 46.067 1604.164 46.1723 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 2 99.0000009536743 NKPGVYTKVCNYVNWIQQTIAAN acrolein addition +76(K)@8; Carbamidomethyl(C)@10; Deamidated(N)@11 missed K-V@8 0.205636993050575 2757.56420898438 920.1953 2757.3583984375 920.126770019531 3 23 1.1.1.4048.13 1 57.3956 1696.456 57.3814 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 2 99.0000009536743 NYVNWIQQTIAAN cleaved C-N@N-term 0.166087999939919 1533.92370605469 767.9691 1533.75756835938 767.886047363281 2 21 1.1.1.3878.3 1 53.2339 780.092 53.2765 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 2 99.0000009536743 TLDNDIMLIKLSSPATLNSR Methyl(K)@10 cleaved N-T@N-term; missed K-L@10 0.240513995289803 2215.4287109375 739.4835 2215.18823242188 739.4033203125 3 25 1.1.1.3789.5 1 51.0301 2355.299 51.0485 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 2 99.0000009536743 VATVSLPR 0.146320000290871 841.648498535156 421.8315 841.502136230469 421.758361816406 2 7 1.1.1.4631.2 1 72.0323 428.4258 72.0264 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 2 99.0000009536743 VLEGNEQFINAAK cleaved D-V@N-term 0.157857000827789 1431.89367675781 716.9541 1431.73583984375 716.875183105469 2 23 1.1.1.3097.6 1 34.1841 1280.534 34.1925 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 1.58502626419067 99.0000009536743 LGEHNIDVLEGNEQFINA cleaved A-A@C-term 0.170788004994392 2011.13549804688 1006.575 2010.96472167969 1006.48962402344 2 19 1.1.1.3641.20 1 47.4201 1572.445 47.477 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.978810608386993 99.0000009536743 LGEHNIDVLEGNEQFINAA cleaved A-K@C-term 0.175543993711472 2082.17724609375 1042.096 2082.00170898438 1042.00817871094 2 19 1.1.1.3652.21 1 47.6996 1979.079 47.7562 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.962573409080505 99.0000009536743 LGEHNIDVLEGN cleaved N-E@C-term 0.15828600525856 1308.78930664063 655.4019 1308.63098144531 655.32275390625 2 16 1.1.1.3174.7 1 36.0315 2919.577 36.0655 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.793174088001251 99.0000009536743 YVNWIQQTIAAN cleaved N-Y@N-term 0.16482600569725 1419.87951660156 710.947 1419.71472167969 710.864624023438 2 19 1.1.1.3780.10 1 50.8108 13310.35 50.7255 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.703334808349609 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITH Deamidated(N)@17; MDA adduct +62(K)@20; reduced HNE(H)@24 cleaved H-P@C-term; missed K-I@20 0.310377985239029 2895.81225585938 724.9603 2895.50170898438 724.882751464844 4 20 1.1.1.3812.7 1 51.5949 8497.377 51.7891 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.493494987487793 99.0000009536743 IVGGYTCAANSIPYQVSLNSG Carbamidomethyl(C)@7 cleaved G-S@C-term 0.173344001173973 2170.20947265625 1086.112 2170.03637695313 1086.02551269531 2 17 1.1.1.3635.21 1 47.2657 453.355 47.2969 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.365522742271423 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATL acrolein addition +56(K)@40 cleaved L-N@C-term; missed K-I@20; missed K-L@40 0.458099991083145 5200.11376953125 1041.03 5199.6552734375 1040.93823242188 5 18 1.1.1.4303.18 1 63.6602 9011.841 63.7463 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.29670861363411 98.3699977397919 SSGSSYPSLLQCLK Deamidated(Q)@11; Carbamidomethyl(C)@12; acrolein addition +76(K)@14 0.116112999618053 1602.87609863281 802.4453 1602.76000976563 802.387268066406 2 15 1.1.1.3869.10 1 53.0168 1156.599 53.0061 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.26201269030571 98.0000019073486 IITHPNFNGN cleaved N-T@C-term 0.151885002851486 1125.70861816406 563.8616 1125.55676269531 563.78564453125 2 13 1.1.1.2826.5 1 27.6721 1387.054 27.6567 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.225483030080795 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKII MDA adduct +54(K)@24 cleaved I-T@C-term; missed R-L@4; missed K-I@24 0.276096999645233 2986.86376953125 747.7232 2986.58764648438 747.654174804688 4 17 1.1.1.3659.18 1 47.8782 1439.573 47.9113 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.168130233883858 99.0000009536743 SSGSSYPSLLQCLKAPVLSDSS Carbamidomethyl(C)@12; HPNE addition +172(K)@14 cleaved S-C@C-term; missed K-A@14 0.208820998668671 2454.4287109375 819.1502 2454.21997070313 819.080627441406 3 18 1.1.1.3804.3 1 51.4003 3563.13 51.4882 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.122628659009933 99.0000009536743 QKNKPGVYTKVCNYVNWIQQTIAAN HPNE addition +172(K)@4; HPNE addition +172(K)@10; Carbamidomethyl(C)@12 cleaved A-Q@N-term; missed K-N@2; missed K-V@10 0.226721003651619 3280.943359375 821.2431 3280.71655273438 821.186401367188 4 19 1.1.1.4307.8 1 63.7563 459.951 63.7722 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.110138282179832 94.9199974536896 TLDNDIMLIK cleaved N-T@N-term 0.157515004277229 1174.78430175781 588.3994 1174.62670898438 588.320678710938 2 13 1.1.1.3532.6 1 44.701 1003.396 44.7186 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.0649968460202217 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITH Deamidated(N)@21; MDA adduct +62(K)@24; reduced HNE(H)@28 cleaved H-P@C-term; missed R-L@4; missed K-I@24 0.378019988536835 3392.19189453125 679.4457 3391.81396484375 679.370056152344 5 19 1.1.1.3825.5 1 51.9245 787.0469 51.9175 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.0574958920478821 97.979998588562 IDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@35 cleaved N-I@N-term; missed K-I@15; missed K-L@35 0.45032799243927 5007.03369140625 1002.414 5006.5810546875 1002.32348632813 5 16 1.1.1.4240.7 1 62.0699 4227.047 62.002 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.0264103766530752 99.0000009536743 NIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@36 cleaved H-N@N-term; missed K-I@16; missed K-L@36 0.451590001583099 5121.07373046875 1025.222 5120.6240234375 1025.13208007813 5 18 1.1.1.4244.16 1 62.1659 17972.11 62.2721 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.021819481626153 95.8899974822998 QVRLGEHNIDVLEGNEQFINAAK cleaved I-Q@N-term; missed R-L@3 4.0472297668457 2597.3720703125 866.798 2593.32495117188 865.448913574219 3 16 1.1.1.3521.6 1 44.4466 1133.161 44.3312 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.021819481626153 88.9699995517731 RLGEHNIDVLEGNEQFINAAK reduced HNE(H)@5 cleaved V-R@N-term; missed R-L@1 0.169761002063751 2524.49829101563 842.5067 2524.32861328125 842.450134277344 3 13 1.1.1.3512.18 1 44.2272 755.2624 44.3553 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.0195421073585749 97.759997844696 QGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAAN Carbamidomethyl(C)@10; HPNE addition +172(K)@15; acrolein addition +94(K)@21; Carbamidomethyl(C)@23 cleaved L-Q@N-term; missed K-N@13; missed K-V@21 0.392888993024826 4381.55859375 1096.397 4381.16650390625 1096.298828125 4 16 1.1.1.4272.19 1 62.8694 5643.093 62.825 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.00921730790287256 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIK Deamidated(Q)@18; Deamidated(N)@21; Delta:H(2)C(2)(H)@28 missed R-L@4; missed K-I@24 0.516140997409821 4999.0712890625 834.1858 4998.55517578125 834.099792480469 6 20 1.1.1.4045.9 1 57.3159 1084.792 57.3555 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.00877392385154963 93.8499987125397 SIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@15; Deamidated(N)@21; Carbamidomethyl(C)@31; ONE addition +154(K)@33 cleaved N-S@N-term 0.35563400387764 3808.158203125 953.0468 3807.80249023438 952.957885742188 4 15 1.1.1.3720.19 1 49.2876 40925.75 49.3965 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.00833099242299795 87.3799979686737 VLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@13; reduced HNE(H)@17 cleaved D-V@N-term; missed K-I@13; missed K-L@33 0.1103900000453 4936.71142578125 823.7925 4936.60107421875 823.774108886719 6 14 1.1.1.3854.9 1 52.6488 705.5297 52.6395 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.00788851175457239 88.9400005340576 IQVRLGEHNID cleaved D-V@C-term; missed R-L@4 0.172598004341125 1292.85632324219 647.4354 1292.68371582031 647.34912109375 2 12 1.1.1.2978.8 1 31.3256 631.3102 31.3307 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.00392634514719248 96.6799974441528 LGEHNIDVLEGNEQFINAAKIITHPNFNGNT hexanoyl addition +98(K)@20; reduced HNE(H)@24; Deamidated(N)@30 cleaved T-L@C-term; missed K-I@20 0.268965989351273 3676.1474609375 920.0441 3675.87841796875 919.976867675781 4 16 1.1.1.3939.3 1 54.7199 4504.233 54.7591 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.00392634514719248 99.0000009536743 QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@23; Oxidation(P)@28; Delta:H(4)C(2)(K)@43 cleaved I-Q@N-term; missed R-L@3; missed K-I@23; missed K-L@43 -0.39818400144577 6039.71337890625 863.8235 6040.11181640625 863.88037109375 7 22 1.1.1.4143.3 1 59.692 2920.248 59.6847 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.00348832807503641 80.7600021362305 AAGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYPGQITGN Carbamidomethyl(C)@6; acrolein addition +56(K)@15; Carbamidomethyl(C)@27; reduced acrolein addition +58(K)@29; Carbamidomethyl(C)@38; acrolein addition +56(K)@39 cleaved A-A@N-term; cleaved N-M@C-term; missed K-S@15; missed K-A@29; missed K-S@39 0.369531989097595 5290.87841796875 1059.183 5290.5107421875 1059.10949707031 5 16 1.1.1.3955.11 1 55.1196 3821.403 55.102 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.00217691925354302 86.2600028514862 AAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@13; acrolein addition +56(K)@23 cleaved N-A@N-term; missed K-I@3; missed K-L@23 0.427486002445221 3636.32568359375 728.2724 3635.89819335938 728.186889648438 5 14 1.1.1.3827.2 1 51.9723 5278.265 52.0684 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.00174066168256104 78.7299990653992 EGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@31 cleaved L-E@N-term; missed K-I@11; missed K-L@31 0.363178998231888 4566.6787109375 1142.677 4566.31787109375 1142.58666992188 4 13 1.1.1.4040.19 1 57.2031 4900.211 57.2098 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.00174066168256104 58.2099974155426 RLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@41 cleaved V-R@N-term; missed R-L@1; missed K-I@21; missed K-L@41 0.508361995220184 5713.4404296875 953.2474 5712.93212890625 953.162658691406 6 12 1.1.1.4324.15 1 64.201 304.1552 64.211 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.00130484171677381 60.7599973678589 IQVRLGEHNIDVLEGNEQFINAAKI Deamidated(N)@21; reduced acrolein addition +96(K)@24 cleaved I-I@C-term; missed R-L@4; missed K-I@24 0.198336005210876 2916.73291015625 730.1905 2916.53442382813 730.140930175781 4 12 1.1.1.3660.16 1 47.902 17493.03 47.6538 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.000869458774104714 94.5299983024597 DNDIMLIKLSSPATLNSR cleaved L-D@N-term; missed K-L@8 5.12785005569458 1992.16870117188 997.0916 1987.04077148438 994.527709960938 2 14 1.1.1.4252.13 1 62.3578 851.4324 62.3451 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.000869458774104714 56.580001115799 EQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@8; acrolein addition +76(K)@28 cleaved N-E@N-term; missed K-I@8; missed K-L@28 0.243476003408432 4384.53076171875 1097.14 4384.2890625 1097.07946777344 4 12 1.1.1.4291.19 1 63.3489 421.4482 63.3556 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.000434511806815863 80.2600026130676 AQKNKPGVYTKVCNYVNWIQQTIAAN ONE addition +154(K)@3; ONE addition +154(K)@5; reduced acrolein addition +96(K)@11; Carbamidomethyl(C)@13; Deamidated(N)@17 cleaved C-A@N-term; missed K-N@3; missed K-V@11 0.189300000667572 3412.96411132813 1138.662 3412.77416992188 1138.5986328125 3 12 1.1.1.4021.13 1 56.7215 447.2724 56.7266 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.000434511806815863 81.7600011825562 FINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@20; acrolein addition +56(K)@26 cleaved Q-F@N-term; missed K-I@6; missed K-L@26 0.443201005458832 4010.53662109375 803.1146 4010.09350585938 803.026000976563 5 14 1.1.1.3993.7 1 56.021 2911.276 56.0378 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.000434511806815863 51.010000705719 FPTDDDDKIVGGYTCAANSIPYQVSLNSGSHF Carbamidomethyl(C)@15 cleaved F-C@C-term; missed K-I@8 -2.03182005882263 3472.53564453125 869.1412 3474.5673828125 869.649108886719 4 12 1.1.1.3759.16 1 50.2793 405.8068 50.2886 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.000434511806815863 96.3599979877472 GEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@19; reduced HNE(H)@23; Dethiomethyl(M)@36; acrolein addition +76(K)@39 cleaved L-G@N-term; missed K-I@19; missed K-L@39 -0.431753993034363 5611.46337890625 802.6449 5611.89501953125 802.706604003906 7 17 1.1.1.4348.7 1 64.8207 3033.045 64.7329 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.000434511806815863 91.6400015354156 IITHPNFNGNTLDNDIMLIKLSSPATLN Dethiomethyl(M)@17; acrolein addition +76(K)@20 cleaved N-S@C-term; missed K-L@20 0.254197001457214 3093.869140625 1032.297 3093.61352539063 1032.21179199219 3 15 1.1.1.3983.13 1 55.7816 1203.689 55.6661 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.000434511806815863 49.6300011873245 INAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@5; Oxidation(M)@22; acrolein addition +112(K)@25 cleaved F-I@N-term; missed K-I@5; missed K-L@25 0.267697006464005 3990.35620117188 998.5963 3990.08837890625 998.529418945313 4 11 1.1.1.4302.16 1 63.6326 124.8718 63.5896 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.000434511806815863 77.700001001358 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTL cleaved L-D@C-term; missed R-L@4; missed K-I@24 -1.01240003108978 4027.07495117188 1007.776 4028.0869140625 1008.02899169922 4 12 1.1.1.4130.3 1 59.3954 1387.236 59.3821 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.000434511806815863 65.8699989318848 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLI Deamidated(N)@34; Deamidated(N)@38 cleaved I-K@C-term; missed R-L@4; missed K-I@24 0.0504870004951954 4844.49462890625 1212.131 4844.4443359375 1212.11840820313 4 12 1.1.1.4097.4 1 58.5802 0 -1 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.000434511806815863 60.9300017356873 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTL hexanoyl addition +98(K)@20; reduced HNE(H)@24; Deamidated(N)@30 cleaved L-D@C-term; missed K-I@20 0.249110996723175 3789.21166992188 948.3102 3788.96240234375 948.247924804688 4 12 1.1.1.3887.9 1 53.4582 698.6039 53.4733 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.000434511806815863 86.2600028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPR reduced acrolein addition +96(K)@20; hexanoyl addition +98(K)@40; Deamidated(N)@48; Deamidated(R)@58 missed K-I@20; missed K-L@40; missed R-V@50 -0.0567965991795063 6520.33837890625 932.4842 6520.39501953125 932.492309570313 7 15 1.1.1.4093.8 1 58.4754 1640.176 58.3675 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.000434511806815863 45.1999992132187 PYQVSLNSGSHFCGGSLINSQWVVSAAHCYKSR Carbamidomethyl(C)@13; Deamidated(N)@19; Carbamidomethyl(C)@29; acrolein addition +112(K)@31 cleaved I-P@N-term; missed K-S@31 0.372352987527847 3809.14501953125 953.2935 3808.77270507813 953.200439453125 4 12 1.1.1.3746.20 1 49.9573 4347.265 49.8838 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0.000434511806815863 98.1899976730347 RIQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced HNE(H)@9; MDA adduct +54(K)@25; Deamidated(N)@33; Delta:H(4)C(2)(K)@45 cleaved S-R@N-term; missed R-I@1; missed R-L@5; missed K-I@25; missed K-L@45 0.317436993122101 6394.68994140625 1066.789 6394.37451171875 1066.73645019531 6 18 1.1.1.4219.4 1 61.5459 954.9744 61.5336 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 64.7700011730194 AAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@3; HPNE addition +172(K)@23 cleaved N-A@N-term; missed K-I@3; missed K-L@23 0.414319008588791 3863.46459960938 773.7002 3863.05029296875 773.617309570313 5 12 1.1.1.3886.4 1 53.4295 978.8815 53.4237 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 44.6099996566772 AAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@13; acrolein addition +56(K)@23 cleaved N-A@N-term; missed K-I@3; missed K-L@23 0.433894991874695 3636.33203125 728.2737 3635.89819335938 728.186889648438 5 12 1.1.1.3817.8 1 51.7219 2522.5 51.7891 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 42.6699995994568 AAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@3; Deamidated(N)@17 cleaved N-A@N-term; missed K-I@3; missed K-L@23 0.482425004243851 3656.38427734375 1219.802 3655.9033203125 1219.64172363281 3 12 1.1.1.4259.21 1 62.5381 491.3297 62.5432 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 40.6699985265732 AAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR ONE addition +154(K)@3; Deamidated(N)@9; Deamidated(N)@11; Oxidation(M)@20 cleaved N-A@N-term; missed K-I@3; missed K-L@23 -0.24422499537468 3750.7060546875 938.6838 3750.9501953125 938.744812011719 4 12 1.1.1.4087.5 1 58.3273 627.0558 58.3179 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 68.5100018978119 AKIITHPNFNGNTLDNDIMLIK Carbamyl@N-term; acrolein addition +38(K)@2 cleaved A-A@N-term; missed K-I@2 0.229241997003555 2562.5556640625 855.1925 2562.32641601563 855.116088867188 3 13 1.1.1.3747.18 1 49.9809 359.4566 49.9369 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 88.6900007724762 AKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@2; Methyl(K)@22 cleaved A-A@N-term; missed K-I@2; missed K-L@22 0.084844596683979 3694.06127929688 924.5226 3693.97631835938 924.501342773438 4 16 1.1.1.3891.13 1 53.5622 946.7617 53.5989 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 73.4000027179718 APVLSDSSCK Carbamidomethyl(S)@8; Carbamidomethyl(C)@9; MDA adduct +62(K)@10 0.0958214029669762 1181.63452148438 591.8245 1181.53869628906 591.776611328125 2 12 1.1.1.3273.3 1 38.3984 3614.657 38.5091 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 64.410001039505 APVLSDSSCK Carbamidomethyl(S)@8; Carbamidomethyl(C)@9; MDA adduct +62(K)@10 0.0958214029669762 1181.63452148438 591.8245 1181.53869628906 591.776611328125 2 12 1.1.1.3280.7 1 38.5692 3614.657 38.5091 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 55.7099997997284 APVLSDSSCK Carbamidomethyl(S)@8; Carbamidomethyl(C)@9; MDA adduct +62(K)@10 0.0947227030992508 1181.63342285156 591.824 1181.53869628906 591.776611328125 2 11 1.1.1.3266.5 1 38.2309 2433.318 38.4613 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 85.5799973011017 DDDKIVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Oxidation(Y)@9; Carbamidomethyl(C)@11; Carbamidomethyl(C)@29; Deamidated(N)@35; Carbamidomethyl(C)@45; ONE addition +154(K)@47 cleaved D-D@N-term; missed K-I@4 0.218429997563362 5303.6435546875 1061.736 5303.42724609375 1061.69274902344 5 16 1.1.1.3918.7 1 54.2242 4030.48 54.1326 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 56.3099980354309 DDDKIVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Oxidation(Y)@9; Carbamidomethyl(C)@11; Carbamidomethyl(C)@29; Deamidated(N)@35; Carbamidomethyl(C)@45; ONE addition +154(K)@47 cleaved D-D@N-term; missed K-I@4 0.235520005226135 5303.66357421875 1061.74 5303.42724609375 1061.69274902344 5 14 1.1.1.3904.12 1 53.8774 4823.693 53.89 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 56.3099980354309 DDDKIVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Oxidation(Y)@9; Carbamidomethyl(C)@11; Carbamidomethyl(C)@29; Deamidated(N)@35; Carbamidomethyl(C)@45; ONE addition +154(K)@47 cleaved D-D@N-term; missed K-I@4 0.236741006374359 5303.66357421875 1061.74 5303.42724609375 1061.69274902344 5 14 1.1.1.3911.17 1 54.0513 4972.123 54.0114 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 42.4199998378754 DKIVGGYTCAANSIPYQVSLNSG Carbamidomethyl(C)@9 cleaved D-D@N-term; cleaved G-S@C-term; missed K-I@2 -5.24617004394531 2407.91137695313 1204.963 2413.15844726563 1207.58642578125 2 11 1.1.1.3916.13 1 54.1727 5450.159 53.9385 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 67.7799999713898 DNDIMLIKLSSPATLNSR cleaved L-D@N-term; missed K-L@8 5.13627004623413 1992.17712402344 997.0958 1987.04077148438 994.527709960938 2 12 1.1.1.4269.18 1 62.7916 618.7531 62.7991 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 44.1900014877319 DNDIMLIKLSSPATLNSR cleaved L-D@N-term; missed K-L@8 5.12625980377197 1992.16711425781 997.0908 1987.04077148438 994.527709960938 2 12 1.1.1.4260.17 1 62.5601 734.336 62.5432 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 35.3100001811981 DNDIMLIKLSSPATLNSR cleaved L-D@N-term; missed K-L@8 -1.84981000423431 1985.19104003906 993.6028 1987.04077148438 994.527709960938 2 11 1.1.1.4226.9 1 61.7139 278.5775 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 70.5099999904633 EGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; HPNE addition +172(K)@31 cleaved L-E@N-term; missed K-I@11; missed K-L@31 0.403575003147125 4683.7890625 937.7651 4683.38525390625 937.684387207031 5 13 1.1.1.4266.11 1 62.7084 835.9156 62.7991 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 52.0099997520447 FINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR ONE addition +154(K)@6; reduced HNE(H)@10; Deamidated(N)@20 cleaved Q-F@N-term; missed K-I@6; missed K-L@26 0.353248000144959 4266.650390625 854.3374 4266.29736328125 854.266723632813 5 12 1.1.1.3987.8 1 55.8716 5960.934 55.9125 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 49.3699997663498 FINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@3; ONE addition +154(K)@6; reduced HNE(H)@10 cleaved Q-F@N-term; missed K-I@6; missed K-L@26 0.414452999830246 4266.7119140625 712.1259 4266.29736328125 712.056823730469 6 12 1.1.1.3988.4 1 55.8933 737.3643 55.9125 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 91.2299990653992 FNGNTLDNDIMLIKLSSPATLNSR Dethiomethyl(M)@11; acrolein addition +76(K)@14 cleaved N-F@N-term; missed K-L@14 0.252330988645554 2661.62866210938 888.2168 2661.37622070313 888.132690429688 3 15 1.1.1.3882.9 1 53.3345 5447.476 53.3497 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.489999294281 GEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIK hexanoyl addition +98(K)@19; Delta:H(2)C(2)(H)@23 cleaved L-G@N-term; missed K-I@19 0.399841994047165 4485.66357421875 898.14 4485.263671875 898.06005859375 5 15 1.1.1.4057.8 1 57.6252 993.4128 57.6163 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 91.430002450943 GEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@19; Dethiomethyl(M)@36; acrolein addition +76(K)@39 cleaved L-G@N-term; missed K-I@19; missed K-L@39 0.328469008207321 5478.09326171875 1096.626 5477.7646484375 1096.56018066406 5 16 1.1.1.4247.11 1 62.241 1555.753 62.2477 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 79.5000016689301 GEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@19; acrolein addition +76(K)@39 cleaved L-G@N-term; missed K-I@19; missed K-L@39 -0.459277987480164 5525.30859375 921.892 5525.767578125 921.968566894531 6 13 1.1.1.4230.3 1 61.8118 303.2971 61.827 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 67.7799999713898 GEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@16; acrolein addition +38(K)@19; ONE addition +154(K)@39 cleaved L-G@N-term; missed K-I@19; missed K-L@39 -0.535224974155426 5580.283203125 1117.064 5580.81982421875 1117.17126464844 5 13 1.1.1.4164.8 1 60.2116 1567.575 60.2673 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 44.6999996900558 GEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@16; reduced acrolein addition +96(K)@19; reduced acrolein addition +58(K)@39 cleaved L-G@N-term; missed K-I@19; missed K-L@39 0.535404980182648 5543.33984375 924.8972 5542.80419921875 924.807983398438 6 12 1.1.1.4335.10 1 64.4831 631.0909 64.4706 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 GGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK HexNAc(T)@4; Carbamidomethyl(C)@5; Carbamidomethyl(C)@23; Deamidated(N)@29; Carbamidomethyl(C)@39; ONE addition +154(K)@41 cleaved V-G@N-term 0.392735987901688 4805.57470703125 1202.401 4805.18359375 1202.30322265625 4 19 1.1.1.3837.21 1 52.238 6386.658 52.243 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 88.7199997901917 GGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK HexNAc(T)@4; Carbamidomethyl(C)@5; Carbamidomethyl(C)@23; Deamidated(N)@29; Carbamidomethyl(C)@39; ONE addition +154(K)@41 cleaved V-G@N-term 0.46511098742485 4805.64892578125 962.137 4805.18359375 962.044006347656 5 16 1.1.1.3837.15 1 52.233 3097.944 52.243 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 60.2400004863739 GGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@5; Hex(N)@17; Carbamidomethyl(C)@23; reduced HNE(H)@38; Carbamidomethyl(C)@39; acrolein addition +56(K)@41 cleaved V-G@N-term 0.371957004070282 4823.6025390625 965.7278 4823.23046875 965.653381347656 5 13 1.1.1.3786.10 1 50.9615 22322.2 50.9749 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 54.9199998378754 GGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@5; Hex(N)@17; Carbamidomethyl(C)@23; reduced HNE(H)@38; Carbamidomethyl(C)@39; acrolein addition +56(K)@41 cleaved V-G@N-term 0.303306013345718 4823.53466796875 1206.891 4823.23046875 1206.81494140625 4 13 1.1.1.3789.18 1 51.0418 48316.16 50.9749 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 43.9399987459183 GNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@10; Oxidation(M)@27; acrolein addition +76(K)@30 cleaved E-G@N-term; missed K-I@10; missed K-L@30 0.492787003517151 4567.8095703125 762.3089 4567.31689453125 762.226745605469 6 12 1.1.1.4053.8 1 57.5225 775.5898 57.5121 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 GNTLDNDIMLIKLSSPATLNSR Dethiomethyl(M)@9; MDA adduct +62(K)@12 cleaved N-G@N-term; missed K-L@12 0.25255298614502 2386.50170898438 796.5079 2386.24926757813 796.423706054688 3 21 1.1.1.3813.10 1 51.6223 3154.021 51.7118 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 GNTLDNDIMLIKLSSPATLNSR Dethiomethyl(M)@9; acrolein addition +76(K)@12 cleaved N-G@N-term; missed K-L@12 0.251428991556168 2400.51635742188 801.1794 2400.26489257813 801.095581054688 3 22 1.1.1.3817.12 1 51.7252 47744.08 51.841 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 GNTLDNDIMLIKLSSPATLNSR Dethiomethyl(M)@9; MDA adduct +62(K)@12 cleaved N-G@N-term; missed K-L@12 0.25255298614502 2386.50170898438 796.5079 2386.24926757813 796.423706054688 3 21 1.1.1.3820.8 1 51.7993 3154.021 51.7118 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 GNTLDNDIMLIKLSSPATLNSR Dethiomethyl(M)@9; acrolein addition +76(K)@12 cleaved N-G@N-term; missed K-L@12 0.251428991556168 2400.51635742188 801.1794 2400.26489257813 801.095581054688 3 24 1.1.1.3824.8 1 51.9016 47744.08 51.841 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 GNTLDNDIMLIKLSSPATLNSR Dethiomethyl(M)@9; acrolein addition +76(K)@12 cleaved N-G@N-term; missed K-L@12 0.183449000120163 2400.447265625 1201.231 2400.26489257813 1201.13977050781 2 20 1.1.1.3822.18 1 51.8589 21411.96 51.841 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 GNTLDNDIMLIKLSSPATLNSR Dethiomethyl(M)@9; acrolein addition +76(K)@12 cleaved N-G@N-term; missed K-L@12 0.314404010772705 2400.57934570313 601.1521 2400.26489257813 601.073486328125 4 18 1.1.1.3825.3 1 51.9228 6612.542 51.841 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 96.8699991703033 GNTLDNDIMLIKLSSPATLNSR Dethiomethyl(M)@9; hexanoyl addition +98(K)@12 cleaved N-G@N-term; missed K-L@12 0.255448997020721 2422.56225585938 606.6478 2422.306640625 606.583984375 4 17 1.1.1.3823.3 1 51.8719 567.5458 51.841 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.5499973297119 GNTLDNDIMLIKLSSPATLNSR Dethiomethyl(M)@9; acrolein addition +76(K)@12 cleaved N-G@N-term; missed K-L@12 0.183449000120163 2400.447265625 1201.231 2400.26489257813 1201.13977050781 2 14 1.1.1.3818.17 1 51.755 21411.96 51.841 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 83.5399985313416 GNTLDNDIMLIKLSSPATLNSR Dethiomethyl(M)@9; acrolein addition +76(K)@12 cleaved N-G@N-term; missed K-L@12 0.314404010772705 2400.57934570313 601.1521 2400.26489257813 601.073486328125 4 14 1.1.1.3818.3 1 51.7433 6612.542 51.841 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 69.4199979305267 GYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@4; reduced HNE(H)@20; Carbamidomethyl(C)@22; reduced HNE(H)@37; Carbamidomethyl(C)@38; Sulfo(Y)@39; ONE addition +154(K)@40 cleaved G-G@N-term 0.333314001560211 4940.650390625 989.1373 4940.31689453125 989.070678710938 5 14 1.1.1.3960.3 1 55.2375 5849.582 55.1997 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 82.2499990463257 GYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYKSR Carbamidomethyl(C)@4; reduced HNE(H)@20; Carbamidomethyl(C)@22; Carbamidomethyl(C)@38; Carbamidomethyl(Y)@39; acrolein addition +76(K)@40; Oxidation(R)@42 cleaved G-G@N-term; missed K-S@40 0.339370012283325 4940.650390625 989.1373 4940.31103515625 989.069458007813 5 16 1.1.1.3960.3 1 55.2375 5849.582 55.1997 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 91.0199999809265 IDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@15 cleaved N-I@N-term; missed K-I@15; missed K-L@35 0.52715802192688 5007.1083984375 835.5253 5006.5810546875 835.4375 6 15 1.1.1.4236.5 1 61.9583 656.6708 61.9767 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.0100028514862 IDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamidomethyl(K)@35 cleaved N-I@N-term; missed K-I@15; missed K-L@35 0.447205007076263 5008.0234375 1002.612 5007.576171875 1002.52258300781 5 14 1.1.1.4258.18 1 62.5102 1082.164 62.5685 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 47.7999985218048 IDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(Q)@9; acrolein addition +56(K)@35 cleaved N-I@N-term; missed K-I@15; missed K-L@35 0.459964990615845 5008.0234375 1002.612 5007.56494140625 1002.52032470703 5 12 1.1.1.4276.19 1 62.969 2707.824 62.9757 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Oxidation(M)@17 0.244680002331734 2298.41259765625 767.1448 2298.16772460938 767.063232421875 3 28 1.1.1.3674.6 1 48.2469 4259.094 48.2852 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Oxidation(M)@17; Methyl(K)@20 0.242640003561974 2312.42602539063 771.816 2312.18334960938 771.735107421875 3 25 1.1.1.3688.3 1 48.502 1175.265 48.4707 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Deamidated(N)@14 0.241479992866516 2283.3984375 762.1401 2283.15698242188 762.0595703125 3 26 1.1.1.3694.5 1 48.6483 2059.625 48.6634 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Deamidated(N)@8; Oxidation(M)@17 0.247052997350693 2299.39892578125 767.4736 2299.15185546875 767.391235351563 3 27 1.1.1.3715.7 1 49.16 1632.93 49.219 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK 0.243134006857872 2282.416015625 761.8126 2282.1728515625 761.731567382813 3 26 1.1.1.3743.14 1 49.8729 36385.31 49.9632 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK 0.243134006857872 2282.416015625 761.8126 2282.1728515625 761.731567382813 3 28 1.1.1.3750.4 1 50.0508 36385.31 49.9632 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Methyl(K)@20 0.176045000553131 2296.365234375 1149.19 2296.1884765625 1149.1015625 2 20 1.1.1.3755.20 1 50.1819 1865.12 50.2122 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Methyl(K)@20 0.244390994310379 2296.43286132813 766.4849 2296.1884765625 766.403442382813 3 29 1.1.1.3760.9 1 50.2992 15592.94 50.2122 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Deamidated(N)@8 0.173500001430511 2283.32934570313 1142.672 2283.15698242188 1142.58569335938 2 18 1.1.1.3762.20 1 50.3604 847.2317 50.3663 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Deamidated(N)@8 0.246423006057739 2283.4033203125 762.1417 2283.15698242188 762.0595703125 3 27 1.1.1.3764.10 1 50.4031 9121.454 50.3663 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Deamidated(N)@8 0.178382992744446 2283.33544921875 1142.675 2283.15698242188 1142.58569335938 2 22 1.1.1.3769.19 1 50.5386 3655.084 50.5453 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Deamidated(N)@8 0.246607005596161 2283.40356445313 762.1418 2283.15698242188 762.0595703125 3 28 1.1.1.3773.8 1 50.6329 26296.16 50.5453 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Deamidated(N)@8; Methyl(K)@20 0.244933992624283 2297.41748046875 766.8131 2297.17260742188 766.7314453125 3 27 1.1.1.3774.10 1 50.6606 6909.164 50.6749 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK 0.304827988147736 2282.47778320313 571.6267 2282.1728515625 571.550476074219 4 18 1.1.1.3744.6 1 49.8925 4734.093 49.9632 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Methyl(K)@20 0.310662001371384 2296.49926757813 575.1321 2296.1884765625 575.054443359375 4 18 1.1.1.3756.4 1 50.1929 3090.095 50.2375 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Methyl(K)@20 0.310662001371384 2296.49926757813 575.1321 2296.1884765625 575.054443359375 4 18 1.1.1.3757.5 1 50.2191 3090.095 50.2375 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIK Methyl(K)@20 0.310662001371384 2296.49926757813 575.1321 2296.1884765625 575.054443359375 4 18 1.1.1.3759.5 1 50.2701 3090.095 50.2375 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8499999046326 IITHPNFNGNTLDNDIMLIK Deamidated(N)@6; Deamidated(N)@10 0.249346002936363 2284.39038085938 762.4707 2284.14086914063 762.387573242188 3 22 1.1.1.3781.12 1 50.8371 845.1078 50.8497 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.5499978065491 IITHPNFNGNTLDNDIMLIK Methyl(L)@18 0.244390994310379 2296.43286132813 766.4849 2296.1884765625 766.403442382813 3 20 1.1.1.3753.9 1 50.1252 15592.94 50.2122 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.5499978065491 IITHPNFNGNTLDNDIMLIK Deamidated(N)@8; Methyl(K)@20 0.310288995504379 2297.48291015625 575.378 2297.17260742188 575.300415039063 4 18 1.1.1.3776.4 1 50.7063 1012.332 50.6749 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 96.8699991703033 IITHPNFNGNTLDNDIMLIK Methyl(K)@20 0.310662001371384 2296.49926757813 575.1321 2296.1884765625 575.054443359375 4 17 1.1.1.3755.7 1 50.1702 3090.095 50.2375 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 96.6000020503998 IITHPNFNGNTLDNDIMLIK Oxidation(M)@17 0.242116004228592 2298.40991210938 767.1439 2298.16772460938 767.063232421875 3 15 1.1.1.3736.13 1 49.6908 530.8389 49.806 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 96.0300028324127 IITHPNFNGNTLDNDIMLIK Deamidated(N)@8; Oxidation(M)@17; Methyl(K)@20 0.239703997969627 2313.4072265625 772.143 2313.16748046875 772.063110351563 3 17 1.1.1.3724.13 1 49.3848 456.4693 49.3965 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 96.0300028324127 IITHPNFNGNTLDNDIMLIK Deamidated(N)@6 0.30689600110054 2283.4638671875 571.8732 2283.15698242188 571.796508789063 4 15 1.1.1.3766.4 1 50.4494 2776.434 50.5453 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 95.4200029373169 IITHPNFNGNTLDNDIMLIK Methyl(K)@20 0.310662001371384 2296.49926757813 575.1321 2296.1884765625 575.054443359375 4 16 1.1.1.3758.3 1 50.2429 3090.095 50.2375 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 94.4000005722046 IITHPNFNGNTLDNDIMLIK Deamidated(N)@10 0.246423006057739 2283.4033203125 762.1417 2283.15698242188 762.0595703125 3 21 1.1.1.3757.14 1 50.2266 9121.454 50.3663 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 88.1900012493134 IITHPNFNGNTLDNDIMLIK Deamidated(N)@10; Dethiomethyl(M)@17; MDA adduct +62(K)@20 0.2483039945364 2297.41748046875 766.8131 2297.16918945313 766.730346679688 3 14 1.1.1.3767.9 1 50.4788 7472.106 50.7005 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 88.1900012493134 IITHPNFNGNTLDNDIMLIK Deamidated(N)@8; Dethiomethyl(M)@17; MDA adduct +62(K)@20 0.173672005534172 2297.34326171875 1149.679 2297.16918945313 1149.59191894531 2 14 1.1.1.3775.20 1 50.6946 663.277 50.7005 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.5499973297119 IITHPNFNGNTLDNDIMLIK Deamidated(N)@8; Deamidated(N)@14 0.245134994387627 2284.38598632813 762.4693 2284.14086914063 762.387573242188 3 13 1.1.1.3718.12 1 49.2312 561.7849 49.2943 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.580001115799 IITHPNFNGNTLDNDIMLIK Deamidated(N)@14; Oxidation(M)@17 0.257124006748199 2299.40893554688 767.4769 2299.15185546875 767.391235351563 3 12 1.1.1.3619.14 1 46.8441 122.1235 46.8041 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 79.449999332428 IITHPNFNGNTLDNDIMLIK 0.304827988147736 2282.47778320313 571.6267 2282.1728515625 571.550476074219 4 12 1.1.1.3751.4 1 50.0681 4734.093 49.9632 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.5100014209747 IITHPNFNGNTLDNDIMLIKLSSPATL Dethiomethyl(M)@17; MDA adduct +62(K)@20 cleaved L-N@C-term; missed K-L@20 0.326371997594833 2965.88134765625 742.4776 2965.55493164063 742.39599609375 4 14 1.1.1.4051.4 1 57.4668 510.6546 57.486 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.2600028514862 IITHPNFNGNTLDNDIMLIKLSSPATLN Formyl(K)@20 cleaved N-S@C-term; missed K-L@20 0.351101994514465 3093.931640625 774.4902 3093.58056640625 774.402404785156 4 15 1.1.1.3984.4 1 55.7938 713.8314 55.7393 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@17; Methyl(K)@20 missed K-L@20 0.318767994642258 3339.04809570313 835.7693 3338.72924804688 835.689575195313 4 28 1.1.1.3792.4 1 51.1126 4234.147 51.3429 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@14; Delta:H(4)C(2)(K)@20 missed K-L@20 0.348928987979889 3338.0830078125 835.528 3337.73413085938 835.440795898438 4 23 1.1.1.3795.12 1 51.1891 1853.29 51.1489 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@17; Delta:H(4)C(2)(K)@20 missed K-L@20 0.32557800412178 3353.07055664063 839.2749 3352.74487304688 839.193481445313 4 32 1.1.1.3800.7 1 51.3019 4437.53 51.3186 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@17; Methyl(K)@20 missed K-L@20 0.324382990598679 3339.0537109375 835.7707 3338.72924804688 835.689575195313 4 34 1.1.1.3802.10 1 51.3587 4205.007 51.3186 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@14; Methyl(K)@20 missed K-L@20 0.327713996171951 3324.04614257813 832.0188 3323.71826171875 831.936889648438 4 28 1.1.1.3803.4 1 51.3771 3320.374 51.4399 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@17; Delta:H(4)C(2)(K)@20 missed K-L@20 0.325089991092682 3353.07006835938 839.2748 3352.74487304688 839.193481445313 4 38 1.1.1.3807.4 1 51.473 3652.555 51.4882 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@14; Delta:H(4)C(2)(K)@20 missed K-L@20 0.323781996965408 3338.05786132813 835.5217 3337.73413085938 835.440795898438 4 30 1.1.1.3809.14 1 51.5266 4458.293 51.5128 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@14; Methyl(K)@20 missed K-L@20 0.327713996171951 3324.04614257813 832.0188 3323.71826171875 831.936889648438 4 25 1.1.1.3810.10 1 51.5479 3320.374 51.4399 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Deamidated(N)@14; Delta:H(4)C(2)(K)@20 missed K-L@20 0.32633900642395 3339.04443359375 835.7684 3338.71801757813 835.686767578125 4 23 1.1.1.3823.12 1 51.8794 2700.228 52.0434 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Oxidation(M)@17; Delta:H(4)C(2)(K)@20 missed K-L@20 0.329111993312836 3354.05810546875 839.5218 3353.72900390625 839.439514160156 4 28 1.1.1.3825.11 1 51.9295 1173.359 51.9175 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Deamidated(N)@14; Methyl(K)@20 missed K-L@20 0.324411004781723 3325.02685546875 832.264 3324.70239257813 832.182861328125 4 24 1.1.1.3826.13 1 51.9561 2858.531 51.9932 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Deamidated(N)@14; Methyl(K)@20 missed K-L@20 0.324411004781723 3325.02685546875 832.264 3324.70239257813 832.182861328125 4 25 1.1.1.3829.6 1 52.0259 2858.531 51.9932 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Deamidated(N)@14; Delta:H(4)C(2)(K)@20 missed K-L@20 0.32633900642395 3339.04443359375 835.7684 3338.71801757813 835.686767578125 4 25 1.1.1.3830.10 1 52.0541 2700.228 52.0434 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Oxidation(M)@17; Delta:H(4)C(2)(K)@20 missed K-L@20 0.32837900519371 3354.05737304688 839.5216 3353.72900390625 839.439514160156 4 29 1.1.1.3836.8 1 52.2019 2705.78 52.243 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Oxidation(M)@17; Methyl(K)@20 missed K-L@20 0.326694995164871 3340.0400390625 836.0173 3339.71337890625 835.935607910156 4 36 1.1.1.3839.11 1 52.2798 3384.807 52.2178 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR missed K-L@20 0.387057989835739 3309.10571289063 662.8284 3308.71875 662.751037597656 5 25 1.1.1.3841.3 1 52.3229 4871.022 52.3677 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Oxidation(M)@17; Delta:H(4)C(2)(K)@20 missed K-L@20 0.323251992464066 3354.05224609375 839.5203 3353.72900390625 839.439514160156 4 34 1.1.1.3843.7 1 52.3762 4008.51 52.3677 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(K)@20 missed K-L@20 0.382333010435104 3323.11669921875 665.6306 3322.734375 665.554138183594 5 29 1.1.1.3844.3 1 52.3982 33533.31 52.4682 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(K)@20 missed K-L@20 0.326866000890732 3323.06127929688 831.7726 3322.734375 831.690856933594 4 33 1.1.1.3844.12 1 52.4058 182075.2 52.4682 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(K)@20 missed K-L@20 0.255041003227234 3322.98828125 1108.67 3322.734375 1108.58544921875 3 33 1.1.1.3844.19 1 52.4116 35858.79 52.4682 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Deamidated(N)@28 missed K-L@20 -0.644313991069794 3310.04248046875 828.5179 3310.68676757813 828.678955078125 4 21 1.1.1.3845.8 1 52.4274 17628.57 52.3677 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@14; Delta:H(4)C(2)(K)@20 missed K-L@20 0.339650988578796 3338.07373046875 835.5257 3337.73413085938 835.440795898438 4 23 1.1.1.3846.11 1 52.4547 97378.69 52.5663 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20 missed K-L@20 0.384627997875214 3337.13452148438 668.4342 3336.75 668.357299804688 5 29 1.1.1.3847.2 1 52.4718 34053.12 52.5663 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(K)@20 missed K-L@20 0.326866000890732 3323.06127929688 831.7726 3322.734375 831.690856933594 4 21 1.1.1.3847.7 1 52.4777 182075.2 52.4682 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@28 missed K-L@20 0.339700996875763 3310.04248046875 828.5179 3309.70263671875 828.432983398438 4 32 1.1.1.3848.5 1 52.5046 17628.57 52.3677 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20 missed K-L@20 0.247691005468369 3336.998046875 1113.34 3336.75 1113.25732421875 3 37 1.1.1.3848.7 1 52.5096 32758.14 52.5663 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Dethiomethyl(M)@17; hexanoyl addition +98(K)@20 missed K-L@20 0.338016003370285 3359.12646484375 672.8326 3358.78857421875 672.764953613281 5 23 1.1.1.3850.2 1 52.5454 2584.889 52.5663 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20 missed K-L@20 0.321226000785828 3337.0712890625 835.2751 3336.75 835.194763183594 4 25 1.1.1.3850.4 1 52.5479 171396.5 52.5663 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(K)@20 missed K-L@20 0.382333010435104 3323.11669921875 665.6306 3322.734375 665.554138183594 5 27 1.1.1.3851.2 1 52.5698 33533.31 52.4682 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(K)@20 missed K-L@20 0.326866000890732 3323.06127929688 831.7726 3322.734375 831.690856933594 4 31 1.1.1.3851.5 1 52.574 182075.2 52.4682 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(K)@20 missed K-L@20 0.255041003227234 3322.98828125 1108.67 3322.734375 1108.58544921875 3 22 1.1.1.3851.10 1 52.5823 35858.79 52.4682 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20 missed K-L@20 0.384627997875214 3337.13452148438 668.4342 3336.75 668.357299804688 5 29 1.1.1.3854.2 1 52.643 34053.12 52.5663 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20 missed K-L@20 0.247691005468369 3336.998046875 1113.34 3336.75 1113.25732421875 3 36 1.1.1.3855.11 1 52.6831 32758.14 52.5663 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(K)@20; Deamidated(N)@28 missed K-L@20 0.321366012096405 3324.03979492188 832.0172 3323.71826171875 831.936889648438 4 21 1.1.1.3856.3 1 52.6942 12248.64 52.737 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(K)@20; Deamidated(N)@28 missed K-L@20 0.321366012096405 3324.03979492188 832.0172 3323.71826171875 831.936889648438 4 31 1.1.1.3858.5 1 52.743 12248.64 52.737 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20 missed K-L@20 0.384627997875214 3337.13452148438 668.4342 3336.75 668.357299804688 5 28 1.1.1.3861.2 1 52.8149 32828.57 52.5663 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20 missed K-L@20 0.321226000785828 3337.0712890625 835.2751 3336.75 835.194763183594 4 33 1.1.1.3861.5 1 52.8199 167544.9 52.5663 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@10; Methyl(K)@20 missed K-L@20 0.321366012096405 3324.03979492188 832.0172 3323.71826171875 831.936889648438 4 24 1.1.1.3865.4 1 52.9174 12248.64 52.737 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8 missed K-L@20 0.325296998023987 3310.02807617188 828.5143 3309.70263671875 828.432983398438 4 28 1.1.1.3868.3 1 52.9876 2506.414 53.13 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20; Deamidated(N)@28 missed K-L@20 0.329153001308441 3338.06323242188 835.5231 3337.73413085938 835.440795898438 4 28 1.1.1.3868.5 1 52.991 9649.554 53.031 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20; Deamidated(N)@28 missed K-L@20 0.393653988838196 3338.12768554688 668.6328 3337.73413085938 668.554077148438 5 26 1.1.1.3871.3 1 53.0607 2421.981 53.179 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@10 missed K-L@20 0.325296998023987 3310.02807617188 828.5143 3309.70263671875 828.432983398438 4 26 1.1.1.3874.3 1 53.136 2506.414 53.13 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@14; Methyl(K)@20 missed K-L@20 0.32820200920105 3324.04663085938 832.0189 3323.71826171875 831.936889648438 4 22 1.1.1.3874.4 1 53.1377 5274.492 53.1544 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20; Deamidated(N)@28 missed K-L@20 0.329153001308441 3338.06323242188 835.5231 3337.73413085938 835.440795898438 4 30 1.1.1.3875.7 1 53.1623 13902.7 53.179 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8 missed K-L@20 -0.6615189909935 3309.04125976563 828.2676 3309.70263671875 828.432983398438 4 27 1.1.1.3876.6 1 53.1908 2563.762 53.1544 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@10; Delta:H(4)C(2)(K)@20 missed K-L@20 0.388466000556946 3338.12255859375 668.6318 3337.73413085938 668.554077148438 5 27 1.1.1.3880.6 1 53.284 8472.847 53.4982 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@6 missed K-L@20 0.327006012201309 3310.02978515625 828.5147 3309.70263671875 828.432983398438 4 23 1.1.1.3883.8 1 53.3584 20246.7 53.4982 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20; Deamidated(N)@28 missed K-L@20 0.330130010843277 3338.06420898438 835.5233 3337.73413085938 835.440795898438 4 28 1.1.1.3883.9 1 53.3592 42268.72 53.4982 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8 missed K-L@20 0.390897005796433 3310.09350585938 663.026 3309.70263671875 662.947814941406 5 27 1.1.1.3887.3 1 53.4532 2875.875 53.4982 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@6; Methyl(K)@20 missed K-L@20 0.394717007875443 3324.11303710938 665.8299 3323.71826171875 665.7509765625 5 25 1.1.1.3887.4 1 53.4541 5321.807 53.3987 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Delta:H(4)C(2)(K)@20 missed K-L@20 0.388466000556946 3338.12255859375 668.6318 3337.73413085938 668.554077148438 5 30 1.1.1.3887.5 1 53.4549 7745.958 53.4982 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8 missed K-L@20 0.390897005796433 3310.09350585938 663.026 3309.70263671875 662.947814941406 5 30 1.1.1.3888.2 1 53.4773 2875.875 53.4982 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@6; Methyl(K)@20 missed K-L@20 0.325028002262115 3324.04345703125 832.0181 3323.71826171875 831.936889648438 4 31 1.1.1.3888.9 1 53.4831 90773.45 53.5989 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@6; Methyl(K)@20; Deamidated(N)@28 missed K-L@20 0.345651000738144 3325.04809570313 832.2693 3324.70239257813 832.182861328125 4 24 1.1.1.3888.10 1 53.4839 17705.46 53.3987 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@6 missed K-L@20 0.327006012201309 3310.02978515625 828.5147 3309.70263671875 828.432983398438 4 24 1.1.1.3890.9 1 53.5338 20246.7 53.4982 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Methyl(K)@20 missed K-L@20 0.325028002262115 3324.04345703125 832.0181 3323.71826171875 831.936889648438 4 27 1.1.1.3890.10 1 53.5346 90773.45 53.5989 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8 missed K-L@20 0.256157994270325 3309.95922851563 1104.327 3309.70263671875 1104.24157714844 3 21 1.1.1.3890.17 1 53.5405 3959.845 53.4982 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Delta:H(4)C(2)(K)@20 missed K-L@20 0.330130010843277 3338.06420898438 835.5233 3337.73413085938 835.440795898438 4 27 1.1.1.3891.9 1 53.5589 42268.72 53.4982 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Methyl(K)@20 missed K-L@20 0.393191009759903 3324.11157226563 665.8296 3323.71826171875 665.7509765625 5 30 1.1.1.3894.2 1 53.6279 15304.01 53.5989 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Methyl(K)@20 missed K-L@20 0.253569006919861 3323.97241210938 1108.998 3323.71826171875 1108.91345214844 3 32 1.1.1.3894.9 1 53.6396 18512.46 53.5989 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Delta:H(4)C(2)(K)@20 missed K-L@20 0.323781996965408 3338.05786132813 835.5217 3337.73413085938 835.440795898438 4 34 1.1.1.3898.10 1 53.7307 60229.4 53.9629 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Methyl(K)@20 missed K-L@20 0.325028002262115 3324.04345703125 832.0181 3323.71826171875 831.936889648438 4 35 1.1.1.3901.4 1 53.8055 90773.45 53.5989 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Methyl(K)@20 missed K-L@20 0.253569006919861 3323.97241210938 1108.998 3323.71826171875 1108.91345214844 3 32 1.1.1.3901.5 1 53.8089 18512.46 53.5989 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Delta:H(4)C(2)(K)@20 missed K-L@20 0.387551009654999 3338.12158203125 668.6316 3337.73413085938 668.554077148438 5 29 1.1.1.3902.2 1 53.8214 11808.72 53.9629 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Methyl(K)@20; Deamidated(N)@28 missed K-L@20 0.346139013767242 3325.04858398438 832.2694 3324.70239257813 832.182861328125 4 25 1.1.1.3904.8 1 53.874 37287.11 53.6235 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Delta:H(4)C(2)(K)@20 missed K-L@20 0.323294013738632 3338.05737304688 835.5216 3337.73413085938 835.440795898438 4 35 1.1.1.3905.6 1 53.9008 61444.14 53.9629 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Delta:H(4)C(2)(K)@20 missed K-L@20 0.252079010009766 3337.98510742188 1113.669 3337.73413085938 1113.58532714844 3 36 1.1.1.3905.8 1 53.9041 18336.81 53.9629 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Deamidated(N)@14; Methyl(K)@20 missed K-L@20 0.346872001886368 3325.04931640625 832.2696 3324.70239257813 832.182861328125 4 23 1.1.1.3908.2 1 53.9687 14013.51 53.7206 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Delta:H(4)C(2)(K)@20 missed K-L@20 0.387551009654999 3338.12158203125 668.6316 3337.73413085938 668.554077148438 5 31 1.1.1.3909.2 1 53.9912 11808.72 53.9629 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Methyl(K)@20; Deamidated(N)@28 missed K-L@20 0.332222998142242 3325.03466796875 832.2659 3324.70239257813 832.182861328125 4 25 1.1.1.3911.8 1 54.0438 12090.79 53.8172 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Delta:H(4)C(2)(K)@20 missed K-L@20 0.252079010009766 3337.98510742188 1113.669 3337.73413085938 1113.58532714844 3 35 1.1.1.3912.5 1 54.0754 18336.81 53.9629 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Methyl(K)@20 missed K-L@20 0.32820200920105 3324.04663085938 832.0189 3323.71826171875 831.936889648438 4 26 1.1.1.3915.4 1 54.1401 9258.328 53.89 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Delta:H(4)C(2)(K)@20 missed K-L@20 0.387551009654999 3338.12158203125 668.6316 3337.73413085938 668.554077148438 5 30 1.1.1.3916.2 1 54.1602 11808.72 53.9629 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Delta:H(4)C(2)(K)@20 missed K-L@20 0.323294013738632 3338.05737304688 835.5216 3337.73413085938 835.440795898438 4 37 1.1.1.3916.4 1 54.1619 61444.14 53.9629 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Delta:H(4)C(2)(K)@20 missed K-L@20 0.250981003046036 3337.98510742188 1113.669 3337.73413085938 1113.58532714844 3 26 1.1.1.3921.5 1 54.2929 15105.21 54.0354 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Methyl(K)@20; Deamidated(N)@28 missed K-L@20 0.340523988008499 3325.04296875 832.268 3324.70239257813 832.182861328125 4 28 1.1.1.3923.4 1 54.3346 1684.684 54.3981 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Delta:H(4)C(2)(K)@20 missed K-L@20 0.323294013738632 3338.05737304688 835.5216 3337.73413085938 835.440795898438 4 34 1.1.1.3923.5 1 54.3371 5520.054 54.35 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Delta:H(4)C(2)(K)@20 missed K-L@20 0.323294013738632 3338.05737304688 835.5216 3337.73413085938 835.440795898438 4 31 1.1.1.3930.6 1 54.51 5520.054 54.35 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Methyl(K)@20; Deamidated(N)@28 missed K-L@20 0.332955986261368 3325.03540039063 832.2661 3324.70239257813 832.182861328125 4 25 1.1.1.3931.3 1 54.5315 1532.475 54.5184 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Delta:H(4)C(2)(K)@20 missed K-L@20 0.32524698972702 3338.05932617188 835.5221 3337.73413085938 835.440795898438 4 29 1.1.1.3937.4 1 54.67 2073.334 54.735 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@6; Deamidated(N)@8; Methyl(K)@20 missed K-L@20 0.331734985113144 3325.0341796875 832.2658 3324.70239257813 832.182861328125 4 31 1.1.1.3940.5 1 54.7407 2671.052 54.7591 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Deamidated(N)@10; Delta:H(4)C(2)(K)@20 missed K-L@20 0.32804799079895 3339.04614257813 835.7688 3338.71801757813 835.686767578125 4 29 1.1.1.3944.6 1 54.8432 3753.835 54.7591 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@6; Deamidated(N)@10; Delta:H(4)C(2)(K)@20 missed K-L@20 0.327560007572174 3339.04565429688 835.7687 3338.71801757813 835.686767578125 4 24 1.1.1.3951.4 1 55.0092 2688.572 54.9058 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@10; Delta:H(4)C(2)(K)@20 missed K-L@20 0.336966007947922 3338.07104492188 835.525 3337.73413085938 835.440795898438 4 24 1.1.1.3977.13 1 55.6299 500.8634 55.5929 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20 missed K-L@20 0.312191992998123 3337.06225585938 835.2728 3336.75 835.194763183594 4 23 1.1.1.4020.9 1 56.6867 383.9415 56.7777 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@10; Deamidated(N)@14 missed K-L@20 -0.65700900554657 3310.02978515625 828.5147 3310.68676757813 828.678955078125 4 21 1.1.1.3885.10 1 53.4094 20246.7 53.4982 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@17; Delta:H(4)C(2)(K)@20; Deamidated(N)@28 missed K-L@20 0.337900996208191 3354.06689453125 839.524 3353.72900390625 839.439514160156 4 21 1.1.1.3818.11 1 51.75 628.6155 51.7891 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Deamidated(N)@14; Delta:H(4)C(2)(K)@20 missed K-L@20 0.350753009319305 3339.06884765625 835.7745 3338.71801757813 835.686767578125 4 21 1.1.1.3841.9 1 52.3279 37278.38 52.5663 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Dehydrated(S)@22 missed K-L@20 -0.662568986415863 3352.06127929688 839.0226 3352.72387695313 839.188232421875 4 21 1.1.1.3850.5 1 52.5495 637.7751 52.5172 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20; Deamidated(N)@28 missed K-L@20 0.252811998128891 3337.98828125 1113.67 3337.73413085938 1113.58532714844 3 21 1.1.1.3875.18 1 53.1714 3231.969 53.179 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@6; Methyl(K)@20 missed K-L@20 0.259429007768631 3323.97827148438 1109 3323.71826171875 1108.91345214844 3 21 1.1.1.3887.12 1 53.4607 7004.181 53.3987 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20; Deamidated(N)@28 missed K-L@20 0.25500899553299 3337.98828125 1113.67 3337.73413085938 1113.58532714844 3 20 1.1.1.3882.16 1 53.3412 8691.086 53.4982 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(K)@20 missed K-L@20 0.328087002038956 3323.0625 831.7729 3322.734375 831.690856933594 4 20 1.1.1.4031.6 1 56.964 340.5891 56.8801 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Methyl(K)@20 missed K-L@20 0.327329009771347 3349.07739257813 838.2766 3348.75 838.194763183594 4 21 1.1.1.4068.7 1 57.8981 988.8079 57.8648 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Delta:H(4)C(2)(K)@20 missed K-L@20 0.25500899553299 3337.98828125 1113.67 3337.73413085938 1113.58532714844 3 20 1.1.1.3890.19 1 53.5421 8691.086 53.4982 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@10; Delta:H(4)C(2)(K)@20 missed K-L@20 0.335256993770599 3338.0693359375 835.5246 3337.73413085938 835.440795898438 4 19 1.1.1.4008.6 1 56.389 354.7755 56.3816 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Delta:H(4)C(2)(K)@20 missed K-L@20 0.252811998128891 3337.98828125 1113.67 3337.73413085938 1113.58532714844 3 19 1.1.1.3897.14 1 53.7156 15766.38 53.9385 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Dehydrated(T)@11; MDA adduct +54(K)@20 missed K-L@20 0.381015986204147 3345.099609375 670.0272 3344.71875 669.950988769531 5 19 1.1.1.3846.3 1 52.4481 2751.038 52.4682 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@10; Deamidated(N)@28 missed K-L@20 0.347384989261627 3311.0341796875 828.7658 3310.68676757813 828.678955078125 4 18 1.1.1.3893.10 1 53.6093 11018.78 53.4982 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Delta:H(4)C(2)(K)@20 missed K-L@20 0.337698012590408 3338.07177734375 835.5252 3337.73413085938 835.440795898438 4 19 1.1.1.3984.10 1 55.7988 688.3121 55.7147 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@14; Dethiomethyl(M)@17; reduced acrolein addition +58(K)@20 missed K-L@20 0.308531999588013 3320.0498046875 831.0197 3319.7412109375 830.942565917969 4 19 1.1.1.3880.8 1 53.2874 7776.098 53.3987 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Methyl(K)@20 missed K-L@20 0.394717007875443 3324.11303710938 665.8299 3323.71826171875 665.7509765625 5 19 1.1.1.3886.3 1 53.4286 5321.807 53.3987 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@14; Dethiomethyl(M)@17; reduced acrolein addition +58(K)@20 missed K-L@20 0.308531999588013 3320.0498046875 831.0197 3319.7412109375 830.942565917969 4 19 1.1.1.3887.8 1 53.4574 7776.098 53.3987 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Dethiomethyl(M)@17; hexanoyl addition +98(K)@20 missed K-L@20 0.328121989965439 3360.1005859375 673.0274 3359.7724609375 672.961791992188 5 18 1.1.1.3888.3 1 53.4781 755.1931 53.4982 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20 missed K-L@20 0.357611000537872 3337.0712890625 835.2751 3336.71362304688 835.185668945313 4 19 1.1.1.3851.6 1 52.5756 171396.5 52.5663 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Deamidated(N)@14; MDA adduct +54(K)@20; Dehydrated(S)@22 missed K-L@20 -0.591531991958618 3346.09521484375 670.2263 3346.68676757813 670.344604492188 5 19 1.1.1.3892.4 1 53.5796 903.1776 53.574 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR ONE addition +154(K)@20; Phospho(S)@22 missed K-L@20 0.495848000049591 3543.2802734375 709.6633 3542.78442382813 709.564147949219 5 19 1.1.1.3854.3 1 52.6438 1732.098 52.5417 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20 missed K-L@20 0.284076988697052 3336.998046875 1113.34 3336.71362304688 1113.2451171875 3 18 1.1.1.3846.16 1 52.4589 32758.14 52.5663 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@17 missed K-L@20 -0.655084013938904 3324.05859375 832.0219 3324.71362304688 832.185668945313 4 18 1.1.1.3849.5 1 52.5266 104692.9 52.4682 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Dehydrated(S)@22 missed K-L@20 -0.686984002590179 3352.03686523438 839.0165 3352.72387695313 839.188232421875 4 19 1.1.1.3793.5 1 51.1339 1171.971 51.1489 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(K)@20 missed K-L@20 0.352501004934311 3323.0869140625 831.779 3322.734375 831.690856933594 4 18 1.1.1.3982.12 1 55.7513 483.0522 55.7147 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Delta:H(4)C(2)(K)@20 missed K-L@20 0.330861985683441 3338.06494140625 835.5235 3337.73413085938 835.440795898438 4 18 1.1.1.4033.11 1 57.0189 451.9231 56.8801 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Methyl(K)@20 missed K-L@20 0.259429007768631 3323.97827148438 1109 3323.71826171875 1108.91345214844 3 17 1.1.1.3880.11 1 53.2924 7004.181 53.3987 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 96.6000020503998 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Dehydrated(T)@11; MDA adduct +62(K)@20 missed K-L@20 0.421761006116867 3354.12963867188 671.8332 3353.70776367188 671.748840332031 5 17 1.1.1.3843.3 1 52.3728 751.0635 52.3677 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 96.6000020503998 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(K)@20; Deamidated(N)@28 missed K-L@20 0.25246998667717 3323.97241210938 1108.998 3323.71826171875 1108.91345214844 3 17 1.1.1.3858.12 1 52.7531 2155.601 52.6882 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 96.5200006961823 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Dethiomethyl(M)@17; acrolein addition +76(K)@20; Deamidated(N)@28 missed K-L@20 0.268267005681992 3338 1113.674 3337.73071289063 1113.58410644531 3 16 1.1.1.3868.10 1 52.9993 5132.146 52.737 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 95.4900026321411 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; CHDH(D)@15 missed K-L@20 0.303077012300491 3604.18896484375 902.0545 3603.8857421875 901.978759765625 4 17 1.1.1.3892.13 1 53.5871 537.2385 53.574 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 95.1099991798401 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20 missed K-L@20 0.330502986907959 3337.08056640625 835.2774 3336.75 835.194763183594 4 16 1.1.1.3988.6 1 55.8949 373.0399 55.8875 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 90.6899988651276 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@17 missed K-L@20 -0.674371004104614 3324.03930664063 832.0171 3324.71362304688 832.185668945313 4 15 1.1.1.3819.10 1 51.7749 621.0428 51.7118 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 90.2100026607513 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamidomethyl(D)@15; Dethiomethyl(M)@17; reduced acrolein addition +58(K)@20 missed K-L@20 0.281446009874344 3376.06005859375 676.2193 3375.77856445313 676.163024902344 5 16 1.1.1.3847.3 1 52.4727 684.9085 52.4929 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 88.1900012493134 IITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced HNE(H)@4; Delta:H(4)C(2)(K)@20 missed K-L@20 -0.625995993614197 3494.25463867188 699.8582 3494.88061523438 699.9833984375 5 15 1.1.1.3824.4 1 51.8983 959.6961 51.9175 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.2600028514862 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Methyl(K)@20 missed K-L@20 0.247710004448891 3323.96606445313 1108.996 3323.71826171875 1108.91345214844 3 15 1.1.1.3908.5 1 53.9787 3286.887 53.8656 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.580001115799 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Oxidation(K)@20 missed K-L@20 0.335754007101059 3326.03344726563 832.5156 3325.69775390625 832.431701660156 4 15 1.1.1.3829.7 1 52.0267 1904.562 51.9932 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.0100018978119 IITHPNFNGNTLDNDIMLIKLSSPATLNSR missed K-L@20 -2.99002003669739 3305.72875976563 662.153 3308.71875 662.751037597656 5 13 1.1.1.3875.2 1 53.1581 701.1249 53.13 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.0100018978119 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Dethiomethyl(M)@17; reduced acrolein addition +58(K)@20 missed K-L@20 -0.662177979946136 3318.09497070313 664.6263 3318.75732421875 664.758728027344 5 14 1.1.1.3889.4 1 53.5042 444.3659 53.3497 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.0100018978119 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Oxidation(K)@20 missed K-L@20 0.346740007400513 3326.04443359375 832.5184 3325.69775390625 832.431701660156 4 15 1.1.1.3890.11 1 53.5355 22427.85 53.5989 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.8899998664856 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Ammonia-loss(N)@14; MDA adduct +62(K)@20 missed K-L@20 0.344381988048553 3354.05224609375 839.5203 3353.70776367188 839.434204101563 4 14 1.1.1.3758.15 1 50.2529 285.9243 50.263 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.0100028514862 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Formyl(K)@20 missed K-L@20 0.374816000461578 3338.07250976563 835.5254 3337.69775390625 835.431701660156 4 14 1.1.1.4024.8 1 56.787 477.4527 56.8542 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.0100028514862 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Methyl(K)@20 missed K-L@20 0.321610003709793 3324.0400390625 832.0173 3323.71826171875 831.936889648438 4 14 1.1.1.4028.10 1 56.8913 422.7485 56.8287 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 73.2100009918213 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Dethiomethyl(M)@17; reduced acrolein addition +58(K)@20 missed K-L@20 0.369493007659912 3320.11059570313 665.0294 3319.7412109375 664.955505371094 5 13 1.1.1.3881.2 1 53.3053 1365.105 53.3743 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 69.4199979305267 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Dethiomethyl(M)@17; acrolein addition +76(K)@20 missed K-L@20 0.358646988868713 3338.08935546875 835.5296 3337.73071289063 835.43994140625 4 13 1.1.1.3992.5 1 55.9941 373.0737 56.0378 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 69.4199979305267 IITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20 missed K-L@20 -0.662400007247925 3480.16625976563 697.0405 3480.82861328125 697.173034667969 5 12 1.1.1.4063.4 1 57.7713 2117.844 57.7411 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 23.6699998378754 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; Deamidated(N)@14; Dethiomethyl(M)@17; reduced acrolein addition +96(K)@20 missed K-L@20 0.312772005796433 3359.0537109375 840.7707 3358.74096679688 840.692504882813 4 12 1.1.1.3852.5 1 52.5999 1559.951 52.5663 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 16.4100006222725 IITHPNFNGNTLDNDIMLIKLSSPATLNSR missed K-L@20 0.325670003890991 3309.04443359375 828.2684 3308.71875 828.186950683594 4 13 1.1.1.3846.9 1 52.4531 33469.37 52.3677 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 15.0299996137619 IITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@10; Deamidated(N)@14; Dethiomethyl(M)@17; reduced acrolein addition +58(K)@20 missed K-L@20 0.330375999212265 3321.0556640625 831.2712 3320.72534179688 831.188598632813 4 12 1.1.1.3837.10 1 52.2288 689.3329 52.2178 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 41.6700005531311 INAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@5; reduced HNE(H)@9; Oxidation(P)@10; acrolein addition +112(K)@25 cleaved F-I@N-term; missed K-I@5; missed K-L@25 0.317196995019913 4204.5625 701.7677 4204.2451171875 701.71484375 6 12 1.1.1.4311.6 1 63.8584 11677.56 64.0312 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 18.0899992585182 INAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@25 cleaved F-I@N-term; missed K-I@5; missed K-L@25 0.423121005296707 3862.46411132813 773.5001 3862.041015625 773.41552734375 5 13 1.1.1.3838.6 1 52.2508 1325.498 52.2684 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAK Deamidated(N)@21 missed R-L@4 0.335031986236572 2707.72802734375 677.9393 2707.39282226563 677.855529785156 4 23 1.1.1.3655.13 1 47.77 13017.99 47.9113 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAK missed R-L@4 0.380557000637054 2706.78955078125 542.3652 2706.40893554688 542.2890625 5 22 1.1.1.3660.7 1 47.8945 1066.587 47.9113 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAK missed R-L@4 0.318314999341965 2706.72729492188 677.6891 2706.40893554688 677.609497070313 4 23 1.1.1.3667.6 1 48.0738 27664.47 47.9113 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAK Delta:H(2)C(2)@N-term missed R-L@4 0.308035999536514 2732.73266601563 684.1904 2732.42456054688 684.113403320313 4 21 1.1.1.3762.11 1 50.3529 310.3737 50.3403 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 68.0499970912933 IQVRLGEHNIDVLEGNEQFINAAK missed R-L@4 1.04727005958557 2707.45629882813 903.4927 2706.40893554688 903.143615722656 3 11 1.1.1.3655.20 1 47.7759 798.0874 47.6538 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 66.9600009918213 IQVRLGEHNIDVLEGNEQFINAAK NeuGc(N)@21 missed R-L@4 -0.113081000745296 3013.38623046875 754.3538 3013.49926757813 754.382080078125 4 13 1.1.1.4066.5 1 57.8464 1194.16 57.8398 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 46.2399989366531 IQVRLGEHNIDVLEGNEQFINAAK Oxidation(F)@19; Hex(N)@21; ONE addition +154(K)@24 missed R-L@4 -0.172796994447708 3038.38330078125 760.6031 3038.55615234375 760.646301269531 4 13 1.1.1.4069.2 1 57.9194 1475.493 57.9883 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 24.0299999713898 IQVRLGEHNIDVLEGNEQFINAAK Deamidated(N)@16; Methyl(N)@21; acrolein addition +38(K)@24 missed R-L@4 0.162815004587173 2759.58715820313 920.8696 2759.42431640625 920.815368652344 3 11 1.1.1.4072.2 1 57.996 795.6187 58.0129 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 44.6099996566772 IQVRLGEHNIDVLEGNEQFINAAKI Deamidated(N)@16; Deamidated(N)@21; hexanoyl addition +98(K)@24 cleaved I-I@C-term; missed R-L@4; missed K-I@24 0.206726998090744 2919.74096679688 730.9425 2919.5341796875 730.890808105469 4 12 1.1.1.3660.17 0 47.9029 1729.159 47.6284 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.5199997425079 IQVRLGEHNIDVLEGNEQFINAAKII Deamidated(N)@21; acrolein addition +94(K)@24 cleaved I-T@C-term; missed R-L@4; missed K-I@24 -0.207237005233765 3027.39575195313 757.8562 3027.60302734375 757.908020019531 4 15 1.1.1.4082.7 1 58.2027 13246.6 57.9883 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 89.7499978542328 IQVRLGEHNIDVLEGNEQFINAAKII Deamidated(N)@21; acrolein addition +94(K)@24 cleaved I-T@C-term; missed R-L@4; missed K-I@24 -0.208456993103027 3027.39453125 757.8559 3027.60302734375 757.908020019531 4 14 1.1.1.4073.3 1 58.0205 13152.6 57.9883 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 88.0400002002716 IQVRLGEHNIDVLEGNEQFINAAKII Deamidated(N)@21; acrolein addition +94(K)@24 cleaved I-T@C-term; missed R-L@4; missed K-I@24 -0.208456993103027 3027.39453125 757.8559 3027.60302734375 757.908020019531 4 14 1.1.1.4066.6 1 57.8472 13152.6 57.9883 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 IQVRLGEHNIDVLEGNEQFINAAKII Deamidated(N)@21; acrolein addition +94(K)@24 cleaved I-T@C-term; missed R-L@4; missed K-I@24 0.289101004600525 3027.89208984375 757.9803 3027.60302734375 757.908020019531 4 14 1.1.1.4135.2 1 59.5087 4217.548 59.6847 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.5100014209747 IQVRLGEHNIDVLEGNEQFINAAKII Deamidated(N)@21; acrolein addition +94(K)@24 cleaved I-T@C-term; missed R-L@4; missed K-I@24 0.288368999958038 3027.89135742188 757.9801 3027.60302734375 757.908020019531 4 13 1.1.1.4143.2 1 59.6895 4425.134 59.7089 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.5100014209747 IQVRLGEHNIDVLEGNEQFINAAKII Deamidated(N)@21; acrolein addition +94(K)@24 cleaved I-T@C-term; missed R-L@4; missed K-I@24 0.28031200170517 3027.88330078125 757.9781 3027.60302734375 757.908020019531 4 13 1.1.1.4157.2 1 60.0288 5784.521 59.782 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 76.3999998569489 IQVRLGEHNIDVLEGNEQFINAAKII Deamidated(N)@21; acrolein addition +94(K)@24 cleaved I-T@C-term; missed R-L@4; missed K-I@24 -0.258736997842789 3027.34423828125 1010.122 3027.60302734375 1010.20825195313 3 11 1.1.1.4193.4 1 60.9245 1106.403 60.9297 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 72.1300005912781 IQVRLGEHNIDVLEGNEQFINAAKII Deamidated(N)@21; acrolein addition +94(K)@24 cleaved I-T@C-term; missed R-L@4; missed K-I@24 0.280800014734268 3027.8837890625 757.9782 3027.60302734375 757.908020019531 4 12 1.1.1.4150.2 1 59.8614 5476.037 59.8062 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 54.1499972343445 IQVRLGEHNIDVLEGNEQFINAAKII Deamidated(N)@21; acrolein addition +94(K)@24 cleaved I-T@C-term; missed R-L@4; missed K-I@24 0.217336997389793 3027.8212890625 1010.281 3027.60302734375 1010.20825195313 3 10 1.1.1.4201.2 1 61.105 1235.804 61.026 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPN acrolein addition +112(K)@24; reduced HNE(H)@28; Deamidated(N)@30 cleaved N-F@C-term; missed R-L@4; missed K-I@24 0.363103002309799 3653.3095703125 731.6692 3652.94653320313 731.596557617188 5 21 1.1.1.3889.7 1 53.5067 1447.687 53.5234 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 94.7200000286102 IQVRLGEHNIDVLEGNEQFINAAKIITHPN acrolein addition +56(K)@24; Deamidated(N)@30 cleaved N-F@C-term; missed R-L@4; missed K-I@24 -0.130196005105972 3438.65942382813 860.6721 3438.78955078125 860.704650878906 4 14 1.1.1.4081.2 1 58.1755 1814.245 58.1949 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 56.3099980354309 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTL cleaved L-D@C-term; missed R-L@4; missed K-I@24 -1.01190996170044 4027.07495117188 1007.776 4028.0869140625 1008.02899169922 4 12 1.1.1.4116.9 1 59.0529 929.6245 59.0617 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 66.1400020122528 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIK Formyl(K)@24; Dehydrated(T)@35 missed R-L@4; missed K-I@24 0.108075998723507 4980.66357421875 997.14 4980.5556640625 997.118408203125 5 14 1.1.1.4046.17 1 57.3471 1270.116 57.3555 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 48.0599999427795 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATL Deamidated(N)@16; acrolein addition +76(K)@24; acrolein addition +76(K)@44 cleaved L-N@C-term; missed R-L@4; missed K-I@24; missed K-L@44 -0.461578011512756 5792.52587890625 966.4283 5792.98779296875 966.505187988281 6 12 1.1.1.4245.5 1 62.1826 1248.719 62.1993 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN acrolein addition +94(K)@24; reduced HNE(H)@28; Dethiomethyl(M)@41; reduced acrolein addition +96(K)@44 cleaved N-S@C-term; missed R-L@4; missed K-I@24; missed K-L@44 0.44701299071312 6054.658203125 1010.117 6054.21044921875 1010.04235839844 6 23 1.1.1.4218.3 1 61.5225 2639.29 61.3637 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN acrolein addition +94(K)@24; reduced HNE(H)@28; Dethiomethyl(M)@41; reduced acrolein addition +96(K)@44 cleaved N-S@C-term; missed R-L@4; missed K-I@24; missed K-L@44 0.449577003717422 6054.658203125 1010.117 6054.21044921875 1010.04235839844 6 21 1.1.1.4177.3 1 60.5241 2853.256 60.5599 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 78.9900004863739 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN reduced acrolein addition +96(K)@24; reduced HNE(H)@28; MDA adduct +62(K)@44 cleaved N-S@C-term; missed R-L@4; missed K-I@24; missed K-L@44 0.395346999168396 6070.58349609375 1215.124 6070.18798828125 1215.04479980469 5 13 1.1.1.4063.20 1 57.7855 1139.936 57.7906 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 61.2100005149841 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN MDA adduct +62(K)@24; reduced HNE(H)@28; reduced acrolein addition +96(K)@44 cleaved N-S@C-term; missed R-L@4; missed K-I@24; missed K-L@44 -0.533805012702942 6069.65234375 1012.616 6070.18798828125 1012.70526123047 6 18 1.1.1.4049.15 1 57.4233 14912.69 57.486 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@21; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.585066974163055 6054.71240234375 865.9662 6054.12744140625 865.882629394531 7 22 1.1.1.4050.9 1 57.4444 16996.64 57.5384 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.482675999403 6011.6142578125 1002.943 6011.1328125 1002.86273193359 6 29 1.1.1.4062.9 1 57.7507 9869.167 57.8154 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@21; Formyl(K)@24 missed R-L@4; missed K-I@24; missed K-L@44 -0.466809988021851 6025.63037109375 1005.279 6026.09619140625 1005.35662841797 6 23 1.1.1.4062.10 1 57.7516 18185.37 57.8398 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@28 missed R-L@4; missed K-I@24; missed K-L@44 0.553987979888916 6025.7021484375 861.8219 6025.1484375 861.742736816406 7 32 1.1.1.4065.7 1 57.8264 16309.03 57.8398 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Dimethyl(N)@38 missed R-L@4; missed K-I@24; missed K-L@44 0.408506989479065 6025.55859375 1206.119 6025.1484375 1206.03698730469 5 35 1.1.1.4065.12 1 57.8347 5888.997 57.8398 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.549984991550446 6011.6826171875 859.8191 6011.1328125 859.740539550781 7 30 1.1.1.4066.7 1 57.848 8291.415 57.8154 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@28; Dethiomethyl(M)@41; acrolein addition +76(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.450356990098953 6038.71044921875 863.6802 6039.16064453125 863.744506835938 7 24 1.1.1.4066.8 1 57.8489 16316.97 57.8899 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@41; Carbamidomethyl(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.582275986671448 6070.7158203125 868.2524 6070.13330078125 868.169189453125 7 24 1.1.1.4066.10 1 57.8505 4354.74 57.8154 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@16; Deamidated(N)@21; Delta:H(2)C(2)(K)@24; Oxidation(M)@41 missed R-L@4; missed K-I@24; missed K-L@44 -0.524751007556915 6040.568359375 1209.121 6041.095703125 1209.22644042969 5 24 1.1.1.4066.17 1 57.8564 5481.596 57.8648 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(P)@29; Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.573110997676849 6041.71630859375 864.1096 6041.14306640625 864.027770996094 7 26 1.1.1.4067.9 1 57.8748 9094.713 57.8899 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.480820000171661 6025.63037109375 1005.279 6025.1484375 1005.19866943359 6 22 1.1.1.4067.16 1 57.8807 18185.37 57.8398 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@24; Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.423330008983612 6083.6142578125 1014.943 6083.1904296875 1014.87231445313 6 24 1.1.1.4067.19 1 57.8832 709.7063 58.0129 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@21; reduced acrolein addition +58(K)@24; Deamidated(N)@30; Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.503150999546051 6085.66015625 1015.284 6085.158203125 1015.20031738281 6 26 1.1.1.4069.8 1 57.9319 932.6004 58.0129 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.480820000171661 6025.63037109375 1005.279 6025.1484375 1005.19866943359 6 33 1.1.1.4070.5 1 57.9489 18185.37 57.8398 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@24 missed R-L@4; missed K-I@24; missed K-L@44 -0.415042012929916 6034.7177734375 863.1098 6035.1328125 863.169067382813 7 21 1.1.1.4074.2 1 58.0427 5807.601 58.0129 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@24; Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.410026013851166 6062.75390625 867.115 6063.1640625 867.173583984375 7 25 1.1.1.4074.4 1 58.0477 1429.526 57.9883 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.463973999023438 6025.6123046875 1005.276 6025.1484375 1005.19866943359 6 29 1.1.1.4077.4 1 58.1203 3147.137 58.1949 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(Q)@18; Deamidated(N)@38; Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.496610999107361 6026.6201171875 1005.444 6027.1162109375 1005.52667236328 6 31 1.1.1.4077.5 1 58.1228 3694.719 58.1702 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +38(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.588064014911652 6036.70458984375 863.3937 6036.11669921875 863.309692382813 7 22 1.1.1.4082.10 1 58.2052 20200.52 58.1949 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@41 missed R-L@4; missed K-I@24; missed K-L@44 -0.505988001823425 6012.60400390625 1003.108 6013.11181640625 1003.19262695313 6 23 1.1.1.4082.17 1 58.211 1748.187 58.1949 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamidomethyl(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.560416996479034 6053.57861328125 1211.723 6054.138671875 1211.8349609375 5 30 1.1.1.4082.21 1 58.2144 82878.48 57.9883 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.576789021492004 6054.58349609375 1211.924 6055.1591796875 1212.0390625 5 25 1.1.1.4089.5 1 58.3866 40899.01 58.1702 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.520078003406525 6054.646484375 1010.115 6054.12744140625 1010.02850341797 6 25 1.1.1.4092.6 1 58.4594 92750.85 58.1949 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamidomethyl(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.493829995393753 6054.63427734375 1010.113 6054.138671875 1010.03039550781 6 23 1.1.1.4106.6 1 58.7988 8422.118 58.8283 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamidomethyl(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.57041597366333 6054.708984375 865.9657 6054.138671875 865.884216308594 7 22 1.1.1.4124.2 1 59.2358 24784.95 59.4797 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.598151981830597 6054.55810546875 1211.919 6055.1591796875 1212.0390625 5 28 1.1.1.4127.6 1 59.3288 11362.08 59.5522 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@32; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.435313999652863 6054.56396484375 1211.92 6054.12744140625 1211.83276367188 5 27 1.1.1.4134.6 1 59.4987 24369.56 59.7089 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.585922002792358 6054.71337890625 865.9663 6054.12744140625 865.882629394531 7 21 1.1.1.4139.4 1 59.6153 86843.91 59.8062 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamidomethyl(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.50738000869751 6054.646484375 1010.115 6054.138671875 1010.03039550781 6 26 1.1.1.4149.5 1 59.8428 89002.39 59.8062 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@32; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.437144994735718 6054.56396484375 1211.92 6054.12744140625 1211.83276367188 5 29 1.1.1.4149.7 1 59.8495 29238.02 59.8062 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.594489991664886 6054.56396484375 1211.92 6055.1591796875 1212.0390625 5 23 1.1.1.4156.6 1 60.0197 29238.02 59.8062 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(P)@29; Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.508234977722168 6040.63671875 1007.78 6041.14306640625 1007.86450195313 6 25 1.1.1.4157.6 1 60.0388 3512.829 59.782 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.584114015102386 6054.57373046875 1211.922 6055.1591796875 1212.0390625 5 21 1.1.1.4163.8 1 60.1899 12093.58 59.9283 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)@N-term; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.516398012638092 6079.67236328125 1014.286 6079.1591796875 1014.20043945313 6 22 1.1.1.4246.4 1 62.2093 4678.309 62.1751 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; Oxidation(M)@41; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.39385598897934 6069.728515625 868.1113 6070.1220703125 868.167602539063 7 21 1.1.1.4052.12 1 57.4996 13317.97 57.486 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.437144994735718 6054.56396484375 1211.92 6054.12744140625 1211.83276367188 5 27 1.1.1.4142.5 1 59.6794 29238.02 59.8062 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@16; Deamidated(Q)@18; Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.482695013284683 6026.63232421875 1005.446 6027.1162109375 1005.52667236328 6 22 1.1.1.4067.17 1 57.8815 11524.06 57.8398 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamidomethyl(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.504817008972168 6054.646484375 1010.115 6054.138671875 1010.03039550781 6 28 1.1.1.4134.5 1 59.4954 71211.55 59.7089 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamidomethyl(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.508844971656799 6054.646484375 1010.115 6054.138671875 1010.03039550781 6 23 1.1.1.4163.6 1 60.1849 36063.81 59.9283 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@24; Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.469516009092331 6078.689453125 869.3915 6079.1591796875 869.458557128906 7 21 1.1.1.4068.9 1 57.8997 1215.679 57.8899 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.476765990257263 6054.68212890625 1010.121 6055.1591796875 1010.20043945313 6 14 1.1.1.4533.8 1 69.5007 268.3807 69.5082 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@24 missed R-L@4; missed K-I@24; missed K-L@44 -0.526570975780487 6054.63427734375 1010.113 6055.1591796875 1010.20043945313 6 14 1.1.1.4630.10 1 72.0179 193.5623 72.0532 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@41; Carbamidomethyl(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.405088990926743 6069.728515625 868.1113 6070.13330078125 868.169189453125 7 21 1.1.1.4049.8 1 57.4174 13317.97 57.486 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@28; Dethiomethyl(M)@41; acrolein addition +76(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.48343300819397 6039.646484375 1007.615 6039.16064453125 1007.53405761719 6 31 1.1.1.4066.15 1 57.8547 25937.23 57.8648 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamidomethyl(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.50408399105072 6054.640625 1010.114 6054.138671875 1010.03039550781 6 24 1.1.1.4099.8 1 58.6286 6938.378 58.6095 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@28; Dethiomethyl(M)@41; acrolein addition +76(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.459262996912003 6039.62255859375 1007.611 6039.16064453125 1007.53405761719 6 23 1.1.1.4136.8 1 59.5446 3593.732 59.6847 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamyl(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.409417003393173 6039.71337890625 863.8235 6040.123046875 863.881958007813 7 21 1.1.1.4067.8 1 57.874 25230.25 57.8648 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Trimethyl(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.51969301700592 6038.64453125 1007.448 6039.1640625 1007.53460693359 6 30 1.1.1.4069.6 1 57.9269 16750.9 57.8899 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@24; Delta:H(2)C(2)(H)@28; Dethiomethyl(M)@41; acrolein addition +76(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.547006011009216 6106.6396484375 873.3844 6107.18701171875 873.462524414063 7 21 1.1.1.4075.5 1 58.0711 1895.451 58.0377 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamidomethyl(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.519831001758575 6054.658203125 1010.117 6054.138671875 1010.03039550781 6 20 1.1.1.4233.14 1 61.8904 3575.938 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@41; reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.421889007091522 6070.73193359375 868.2547 6071.15380859375 868.31494140625 7 19 1.1.1.4075.3 1 58.0678 1840.211 57.964 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.506895005702972 6054.63427734375 1010.113 6054.12744140625 1010.02850341797 6 23 1.1.1.4127.5 1 59.3255 37955.31 59.5522 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@44; Deamidated(N)@52 missed R-L@4; missed K-I@24; missed K-L@44 0.51861298084259 6054.646484375 1010.115 6054.12744140625 1010.02850341797 6 22 1.1.1.4156.5 1 60.0163 89002.39 59.8062 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@16; Deamidated(N)@38; acrolein addition +76(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.408488988876343 6074.7080078125 868.8227 6075.1162109375 868.881042480469 7 19 1.1.1.4076.5 1 58.092 3015.602 58.0129 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamidomethyl(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.50738000869751 6054.646484375 1010.115 6054.138671875 1010.03039550781 6 27 1.1.1.4142.4 1 59.6752 89002.39 59.8062 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@24; Deamidated(N)@30; Oxidation(M)@41 missed R-L@4; missed K-I@24; missed K-L@44 0.59350997209549 6070.7158203125 868.2524 6070.1220703125 868.167602539063 7 19 1.1.1.4068.8 1 57.8989 4354.74 57.8154 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)@N-term; Deamidated(N)@21; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.467617988586426 6079.67236328125 1014.286 6080.14306640625 1014.36444091797 6 20 1.1.1.4239.14 1 62.0424 4678.309 62.1751 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@24; Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.5591139793396 6080.61376953125 1217.13 6081.1748046875 1217.2421875 5 20 1.1.1.4245.12 1 62.1943 654.9893 62.1751 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@8; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.596035003662109 6079.7548828125 869.5437 6079.1591796875 869.458557128906 7 19 1.1.1.4262.10 1 62.6053 2186.921 62.5432 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@28; Deamidated(N)@38; reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.487801998853683 6070.6484375 1012.782 6070.15869140625 1012.70037841797 6 20 1.1.1.4063.16 1 57.7813 4607.35 57.7906 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.505796015262604 6054.63427734375 1010.113 6054.12744140625 1010.02850341797 6 24 1.1.1.4113.7 1 58.9833 6384.323 58.94 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deoxy(D)@39; reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.465047985315323 6039.62841796875 1007.612 6039.1640625 1007.53460693359 6 20 1.1.1.4144.6 1 59.723 3613.587 59.6847 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamidomethyl(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.519098997116089 6054.658203125 1010.117 6054.138671875 1010.03039550781 6 19 1.1.1.4209.5 1 61.3071 2639.29 61.3637 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(Q)@18; Dioxidation(P)@29; acrolein addition +38(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.378863990306854 6067.72607421875 1012.295 6068.1064453125 1012.3583984375 6 20 1.1.1.4365.7 1 65.2759 829.4661 65.286 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@21; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.517880976200104 6054.646484375 1010.115 6054.12744140625 1010.02850341797 6 22 1.1.1.4048.20 1 57.4014 16116.27 57.5384 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +96(K)@24; HPNE addition +172(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.608318984508514 6265.89306640625 896.1348 6265.28466796875 896.047912597656 7 18 1.1.1.4067.11 1 57.8765 1394.249 57.9883 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@24; Formyl(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.566295027732849 6081.70458984375 869.8222 6081.13818359375 869.741333007813 7 19 1.1.1.4075.4 1 58.0695 923.1378 58.0377 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.513752996921539 6054.646484375 1010.115 6055.1591796875 1010.20043945313 6 22 1.1.1.4055.16 1 57.5812 16116.27 57.5384 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.434832006692886 6053.57861328125 1211.723 6053.14306640625 1211.63598632813 5 30 1.1.1.4073.7 1 58.0321 81267.34 58.0129 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.444431006908417 6054.71435546875 865.9665 6055.1591796875 866.029968261719 7 20 1.1.1.4091.2 1 58.4194 100546.2 58.1702 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@41; reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.507447004318237 6070.6484375 1012.782 6071.15380859375 1012.86627197266 6 18 1.1.1.4070.7 1 57.9523 4607.35 57.7906 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@24; Deamidated(N)@34; Oxidation(M)@41 missed R-L@4; missed K-I@24; missed K-L@44 0.527849018573761 6070.6484375 1012.782 6070.1220703125 1012.6943359375 6 18 1.1.1.4056.18 1 57.6087 10806.72 57.486 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@16; Deamidated(Q)@18; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.454050004482269 6054.658203125 1010.117 6055.111328125 1010.19250488281 6 18 1.1.1.4059.14 1 57.6827 4026.035 57.6911 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.446566998958588 6054.71240234375 865.9662 6055.1591796875 866.029968261719 7 18 1.1.1.4057.6 1 57.6236 16996.64 57.5384 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.582144021987915 6053.7255859375 865.8252 6053.14306640625 865.742004394531 7 20 1.1.1.4073.4 1 58.023 219855.6 58.0129 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.448702991008759 6054.71044921875 865.9659 6055.1591796875 866.029968261719 7 19 1.1.1.4132.3 1 59.4388 54096.36 59.6602 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.445713013410568 6054.71337890625 865.9663 6055.1591796875 866.029968261719 7 19 1.1.1.4147.6 1 59.7886 86120.85 59.8062 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.445713013410568 6054.71337890625 865.9663 6055.1591796875 866.029968261719 7 18 1.1.1.4154.6 1 59.9598 86120.85 59.8062 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +38(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.439287006855011 6036.5537109375 1208.318 6036.11669921875 1208.23059082031 5 28 1.1.1.4081.7 1 58.1897 5710.335 58.1949 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.595709979534149 6054.56396484375 1211.92 6055.1591796875 1212.0390625 5 17 1.1.1.4049.20 1 57.4274 5284.436 57.5384 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@41; reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.431715995073318 6070.72216796875 868.2533 6071.15380859375 868.31494140625 7 17 1.1.1.4056.12 1 57.6037 10088.14 57.486 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@21; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.531064987182617 6054.658203125 1010.117 6054.12744140625 1010.02850341797 6 22 1.1.1.4085.18 1 58.2858 123800.1 58.1461 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.544247984886169 6054.67041015625 1010.119 6054.12744140625 1010.02850341797 6 17 1.1.1.4273.10 1 62.8877 1234.733 62.7991 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.530332028865814 6054.658203125 1010.117 6054.12744140625 1010.02850341797 6 17 1.1.1.4287.17 1 63.2437 1214.33 63.1502 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@41; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.439673006534576 6069.57861328125 1214.923 6069.13818359375 1214.8349609375 5 17 1.1.1.4051.20 1 57.4801 5004.183 57.486 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@24; reduced HNE(H)@28; Carbamidomethyl(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.386929988861084 6265.89306640625 896.1348 6266.27978515625 896.190124511719 7 17 1.1.1.4068.13 1 57.9031 1394.249 57.9883 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@24; Dethiomethyl(M)@41; reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.541902005672455 6068.62646484375 1012.445 6069.17138671875 1012.53582763672 6 17 1.1.1.4077.6 1 58.1261 1404.347 58.0129 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamidomethyl(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.516901016235352 6054.658203125 1010.117 6054.138671875 1010.03039550781 6 17 1.1.1.4244.14 1 62.1642 1487.409 62.1751 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@16; reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.39664700627327 6055.74609375 866.1139 6056.14306640625 866.170532226563 7 16 1.1.1.4261.9 1 62.5789 659.4943 62.3204 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.450381010770798 6053.67431640625 1009.953 6054.12744140625 1010.02850341797 6 16 1.1.1.4302.17 1 63.6335 944.5463 63.6678 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Dioxidation(M)@41; acrolein addition +38(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.57805198431015 6067.70263671875 1012.291 6067.12255859375 1012.19439697266 6 17 1.1.1.4328.12 1 64.3089 1589.174 64.185 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.9499995708466 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.501668989658356 6054.658203125 1010.117 6055.1591796875 1010.20043945313 6 18 1.1.1.4062.11 1 57.7524 3893.84 57.716 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.9499995708466 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.596243977546692 6053.73974609375 865.8272 6053.14306640625 865.742004394531 7 18 1.1.1.4310.4 1 63.8309 523.5869 63.9019 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(Q)@18; acrolein addition +38(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.502444982528687 6036.6162109375 1007.11 6036.11669921875 1007.02673339844 6 16 1.1.1.4060.12 1 57.7042 5240.593 57.9395 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +38(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.493283003568649 6035.62646484375 1006.945 6036.11669921875 1007.02673339844 6 19 1.1.1.4076.10 1 58.1003 5721.01 58.0377 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +38(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.515627980232239 6036.63427734375 1007.113 6036.11669921875 1007.02673339844 6 16 1.1.1.4085.17 1 58.285 19239.07 58.1949 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)@N-term; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.527750015258789 6079.6845703125 1014.288 6079.1591796875 1014.20043945313 6 17 1.1.1.4263.18 1 62.6376 3414.824 62.5432 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.533994019031525 6054.658203125 1010.117 6054.12744140625 1010.02850341797 6 16 1.1.1.4336.12 1 64.513 632.242 64.4448 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(Q)@18; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.45294401049614 6053.67431640625 1009.953 6054.12744140625 1010.02850341797 6 16 1.1.1.4407.10 1 66.2907 432.7319 66.2796 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 96.3100016117096 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.582144021987915 6053.7255859375 865.8252 6053.14306640625 865.742004394531 7 19 1.1.1.4066.9 1 57.8497 219855.6 58.0129 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 95.4900026321411 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@16; Dehydrated(E)@17; MDA adduct +54(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.435283005237579 6034.53857421875 1207.915 6034.10107421875 1207.82751464844 5 17 1.1.1.4070.10 1 57.9589 1708.69 57.9883 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 95.4900026321411 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@28; MDA adduct +54(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.554922997951508 6077.6982421875 869.2499 6077.14306640625 869.170593261719 7 16 1.1.1.4076.6 1 58.0936 2652.428 58.0377 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 95.4900026321411 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@41; MDA adduct +54(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.546923995018005 6067.67236328125 1012.286 6067.12255859375 1012.19439697266 6 14 1.1.1.4343.19 1 64.7 463.1349 64.6543 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 95.1099991798401 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@8; reduced acrolein addition +58(K)@24 missed R-L@4; missed K-I@24; missed K-L@44 -0.48997500538826 6080.6865234375 1014.455 6081.1748046875 1014.53637695313 6 16 1.1.1.4271.19 1 62.8437 2858.434 62.8761 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 94.3300008773804 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(H)@28; Deamidated(N)@38; Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.526669979095459 6042.65234375 1008.116 6042.12744140625 1008.02850341797 6 18 1.1.1.4076.11 1 58.102 5964.686 57.8899 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.434832006692886 6053.57861328125 1211.723 6053.14306640625 1211.63598632813 5 27 1.1.1.4066.18 1 57.8572 81267.34 58.0129 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.582144021987915 6053.7255859375 865.8252 6053.14306640625 865.742004394531 7 18 1.1.1.4074.3 1 58.0452 219855.6 58.0129 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.509464979171753 6053.650390625 1009.949 6053.14306640625 1009.86450195313 6 21 1.1.1.4076.12 1 58.1037 217150.1 58.0129 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.442295014858246 6054.716796875 865.9668 6055.1591796875 866.029968261719 7 17 1.1.1.4082.11 1 58.206 153506 57.9883 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.501353025436401 6035.63232421875 1006.946 6035.1328125 1006.86273193359 6 18 1.1.1.4151.7 1 59.8933 1964.643 59.8062 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.482706010341644 6055.642578125 1010.281 6055.1591796875 1010.20043945313 6 21 1.1.1.4170.4 1 60.3546 8429.46 60.2916 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.498373001813889 6054.658203125 1010.117 6055.1591796875 1010.20043945313 6 18 1.1.1.4185.5 1 60.7209 2944.569 60.5356 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.500569999217987 6054.658203125 1010.117 6055.1591796875 1010.20043945313 6 17 1.1.1.4225.11 1 61.6925 3575.938 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@24 missed R-L@4; missed K-I@24; missed K-L@44 0.546086013317108 6053.6923828125 1009.956 6053.14306640625 1009.86450195313 6 16 1.1.1.4433.11 1 66.9663 387.1695 66.8468 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.0999994277954 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.461367011070251 6053.66845703125 1009.952 6054.12744140625 1010.02850341797 6 15 1.1.1.4259.13 1 62.5315 969.2631 62.4922 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 91.0199999809265 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)@N-term; reduced acrolein addition +58(K)@24 missed R-L@4; missed K-I@24; missed K-L@44 -0.48997500538826 6080.6865234375 1014.455 6081.1748046875 1014.53637695313 6 16 1.1.1.4279.16 1 63.0412 2858.434 62.8761 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 90.6000018119812 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)@N-term; reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.501326978206635 6080.67431640625 1014.453 6081.1748046875 1014.53637695313 6 16 1.1.1.4286.15 1 63.2161 1444.668 63.3298 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 90.1700019836426 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced HNE(H)@8; MDA adduct +54(K)@24; reduced HNE(H)@28; Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.265047997236252 6395.68603515625 1066.955 6395.42041015625 1066.91064453125 6 16 1.1.1.4226.14 1 61.7181 1487.786 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 89.3299996852875 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@16; reduced acrolein addition +58(K)@24; Deamidated(N)@32 missed R-L@4; missed K-I@24; missed K-L@44 0.608168005943298 6057.7353515625 866.398 6057.126953125 866.311157226563 7 15 1.1.1.4067.10 1 57.8757 15650.87 57.964 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(N)@21; reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.479386001825333 6069.65234375 1012.616 6069.1748046875 1012.53637695313 6 17 1.1.1.4051.17 1 57.4776 14912.69 57.486 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@24; Deamidated(N)@38 missed R-L@4; missed K-I@24; missed K-L@44 0.507912993431091 6074.638671875 1013.447 6074.13232421875 1013.36267089844 6 14 1.1.1.4068.15 1 57.9048 2284.499 58.0129 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@24; Delta:H(2)C(2)(H)@28; Dethiomethyl(M)@41; acrolein addition +76(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.626155018806458 6106.55859375 1018.767 6107.18701171875 1018.87176513672 6 16 1.1.1.4068.17 1 57.9064 1456.42 57.9395 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@24; Deamidated(N)@32; Deamidated(N)@34; Deamidated(N)@38 missed R-L@4; missed K-I@24; missed K-L@44 0.549305975437164 6038.63232421875 1007.446 6038.0849609375 1007.35473632813 6 15 1.1.1.4154.11 1 59.9682 2489.889 59.7579 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.574958026409149 6054.58349609375 1211.924 6055.1591796875 1212.0390625 5 14 1.1.1.4173.9 1 60.4318 2179.629 60.2673 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)@N-term; acrolein addition +56(K)@24; Deamidated(N)@38 missed R-L@4; missed K-I@24; missed K-L@44 0.530306994915009 6080.67431640625 1014.453 6080.14306640625 1014.36444091797 6 16 1.1.1.4293.19 1 63.4005 1444.668 63.3298 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.466127991676331 6053.662109375 1009.951 6054.12744140625 1010.02850341797 6 14 1.1.1.4323.16 1 64.1757 689.65 64.1073 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.2600028514862 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@24; Deamidated(N)@38 missed R-L@4; missed K-I@24; missed K-L@44 0.53582501411438 6054.6640625 1010.118 6054.12744140625 1010.02850341797 6 14 1.1.1.4280.13 1 63.0635 1059.445 63.0504 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.2600028514862 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@24; Oxidation(M)@41 missed R-L@4; missed K-I@24; missed K-L@44 0.57805198431015 6067.70263671875 1012.291 6067.12255859375 1012.19439697266 6 14 1.1.1.4321.16 1 64.1237 1589.174 64.185 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 85.809999704361 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@24; Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.521499991416931 6081.6943359375 1014.623 6081.1748046875 1014.53637695313 6 15 1.1.1.4307.19 1 63.7655 438.3121 63.7722 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 84.8800003528595 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@24; Deamidated(N)@38; Oxidation(M)@41 missed R-L@4; missed K-I@24; missed K-L@44 0.501793026924133 6076.6123046875 1013.776 6076.11181640625 1013.69256591797 6 14 1.1.1.4076.13 1 58.1053 2501.417 58.0129 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 84.4099998474121 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@9; Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.448220014572144 6026.57861328125 1005.437 6026.13232421875 1005.36267089844 6 15 1.1.1.4321.15 1 64.1229 262.1938 64.1073 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 83.9399993419647 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@24; Deamidated(N)@32; Deamidated(N)@34 missed R-L@4; missed K-I@24; missed K-L@44 0.595965981483459 6075.71240234375 868.9662 6075.1162109375 868.881042480469 7 14 1.1.1.4066.11 1 57.8514 3103.034 57.964 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 82.4899971485138 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)@N-term; Deamidated(N)@38; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.45626500248909 6079.6845703125 1014.288 6080.14306640625 1014.36444091797 6 15 1.1.1.4256.13 1 62.4557 3414.824 62.5432 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.5100014209747 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@24; Deamidated(N)@38 missed R-L@4; missed K-I@24; missed K-L@44 0.456676006317139 6054.58349609375 1211.924 6054.12744140625 1211.83276367188 5 13 1.1.1.4225.15 1 61.6992 842.571 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.8099985122681 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.566433012485504 6055.7255859375 866.1109 6055.1591796875 866.029968261719 7 15 1.1.1.4076.4 1 58.0911 74040.13 58.0129 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.510002374649 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.442690014839172 6053.6865234375 1009.955 6054.12744140625 1010.02850341797 6 13 1.1.1.4252.14 1 62.3587 1264.35 62.2477 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.0100028514862 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@16; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.615401983261108 6054.74267578125 865.9705 6054.12744140625 865.882629394531 7 13 1.1.1.4298.7 1 63.5203 399.8844 63.4847 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.0100028514862 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@16; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.546811997890472 6054.67626953125 1010.12 6054.12744140625 1010.02850341797 6 13 1.1.1.4354.10 1 64.9837 553.5698 64.9689 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 78.9900004863739 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; Trimethyl(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.434569001197815 6039.71337890625 863.8235 6040.14794921875 863.885559082031 7 21 1.1.1.4143.3 1 59.692 2920.248 59.6847 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 69.9599981307983 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.410759001970291 6055.568359375 1212.121 6055.1591796875 1212.0390625 5 15 1.1.1.4059.15 1 57.6844 3802.218 57.5384 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 69.9599981307983 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.509464979171753 6053.650390625 1009.949 6053.14306640625 1009.86450195313 6 15 1.1.1.4067.18 1 57.8823 217150.1 58.0129 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 69.9599981307983 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@24; acrolein addition +38(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.476467996835709 6091.63525390625 871.2409 6091.1591796875 871.1728515625 7 15 1.1.1.4068.10 1 57.9006 1199.339 58.0129 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 69.9599981307983 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.509464979171753 6053.650390625 1009.949 6053.14306640625 1009.86450195313 6 15 1.1.1.4074.6 1 58.0535 217150.1 58.0129 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 69.9599981307983 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.521915972232819 6053.662109375 1009.951 6053.14306640625 1009.86450195313 6 15 1.1.1.4294.17 1 63.4248 795.2656 63.3556 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 69.9599981307983 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.547185003757477 6053.6923828125 1009.956 6053.14306640625 1009.86450195313 6 15 1.1.1.4425.8 1 66.7606 406.4889 66.8206 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 68.8700020313263 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@44; Amidated@C-term missed R-L@4; missed K-I@24; missed K-L@44 0.485276997089386 6054.658203125 1010.117 6054.1748046875 1010.03643798828 6 20 1.1.1.4177.3 1 60.5241 2853.256 60.5599 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 68.3300018310547 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@24; Dethiomethyl(M)@41; reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.501904010772705 6060.6640625 1011.118 6061.166015625 1011.20166015625 6 13 1.1.1.4075.7 1 58.0761 2786.867 58.0129 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 67.7799999713898 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.463930994272232 6053.662109375 1009.951 6054.12744140625 1010.02850341797 6 12 1.1.1.4343.18 1 64.6992 665.3066 64.7067 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 65.5900001525879 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.544981002807617 6054.67041015625 1010.119 6054.12744140625 1010.02850341797 6 12 1.1.1.4364.6 1 65.2459 641.9694 65.1269 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 63.400000333786 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@24; Formyl(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.457251012325287 6080.68017578125 1014.454 6081.13818359375 1014.53033447266 6 13 1.1.1.4300.19 1 63.5829 1526.72 63.3038 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 56.9400012493134 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.518620014190674 6053.662109375 1009.951 6053.14306640625 1009.86450195313 6 14 1.1.1.4316.16 1 63.9961 876.8293 63.9795 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 56.9400012493134 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@24 missed R-L@4; missed K-I@24; missed K-L@44 0.596670985221863 6053.73974609375 865.8273 6053.14306640625 865.742004394531 7 14 1.1.1.4432.4 1 66.9325 219.6152 66.8995 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 55.7699978351593 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)@N-term; reduced acrolein addition +58(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.48997500538826 6080.6865234375 1014.455 6081.1748046875 1014.53637695313 6 13 1.1.1.4278.18 1 63.0179 2858.434 62.8761 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 47.2799986600876 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Dioxidation(M)@41; acrolein addition +38(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 -0.395336985588074 6066.72412109375 1012.128 6067.12255859375 1012.19439697266 6 11 1.1.1.4370.13 1 65.4064 535.2668 65.286 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 46.2399989366531 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamidomethyl(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.494563013315201 6054.63427734375 1010.113 6054.138671875 1010.03039550781 6 23 1.1.1.4120.4 1 59.149 19018.39 59.3821 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 43.979999423027 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.509464979171753 6053.650390625 1009.949 6053.14306640625 1009.86450195313 6 23 1.1.1.4069.7 1 57.9294 217150.1 58.0129 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 37.2299998998642 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced HNE(H)@28; acrolein addition +38(K)@44; PhosphoribosyldephosphoCoA(S)@46 missed R-L@4; missed K-I@24; missed K-L@44 0.626406013965607 7075.0380859375 1011.727 7074.41015625 1011.63732910156 7 13 1.1.1.4070.6 1 57.9506 1244.479 58.0129 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 34.3600004911423 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.530332028865814 6054.658203125 1010.117 6054.12744140625 1010.02850341797 6 20 1.1.1.4218.3 1 61.5225 2639.29 61.3637 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 23.6000001430511 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@38; acrolein addition +56(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.531064987182617 6054.658203125 1010.117 6054.12744140625 1010.02850341797 6 16 1.1.1.4225.10 1 61.6908 3575.938 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 19.0599992871284 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamidomethyl@N-term; ONE addition +154(K)@24; reduced HNE(H)@28; Delta:H(4)C(2)(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.292284995317459 6394.68994140625 1066.789 6394.39990234375 1066.74060058594 6 16 1.1.1.4219.4 1 61.5459 954.9744 61.5336 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 15.2600005269051 IQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@24; acrolein addition +38(K)@44 missed R-L@4; missed K-I@24; missed K-L@44 0.471354007720947 6091.63037109375 1016.279 6091.1591796875 1016.20043945313 6 13 1.1.1.4068.16 1 57.9056 1066.729 58.0377 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 90.6899988651276 IVGGYTCAANSIPYQVSLNSG Carbamidomethyl(C)@7 cleaved G-S@C-term 0.250357002019882 2170.28686523438 724.4362 2170.03637695313 724.352783203125 3 14 1.1.1.3636.15 1 47.2869 688.0573 47.2969 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@7; Carbamidomethyl(C)@25; Deamidated(N)@31; Carbamidomethyl(C)@41; ONE addition +154(K)@43 0.499291986227036 4814.755859375 803.4666 4814.2568359375 803.383422851563 6 20 1.1.1.3779.6 1 50.7827 3289.911 50.7506 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@7; Deamidated(N)@10; Carbamidomethyl(C)@25; Deamidated(N)@31; Carbamidomethyl(C)@41; ONE addition +154(K)@43 0.44522100687027 4815.68603515625 964.1445 4815.24072265625 964.055419921875 5 19 1.1.1.3772.15 1 50.6128 15548.78 50.7506 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@7; Carbamidomethyl(C)@25; Deamidated(N)@31; Carbamidomethyl(C)@41; ONE addition +154(K)@43 -0.645700991153717 4813.61083984375 1204.41 4814.2568359375 1204.57141113281 4 19 1.1.1.3779.17 1 50.7935 3199.563 50.7255 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 96.3199973106384 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@7; Dehydrated(S)@17; Carbamidomethyl(C)@25; Deamidated(N)@31; Carbamidomethyl(C)@41; ONE addition +154(K)@43 0.430402010679245 4796.6767578125 960.3426 4796.24609375 960.256530761719 5 17 1.1.1.3776.15 1 50.7154 29102.44 50.6749 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 96.0200011730194 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Dehydrated(T)@6; Carbamidomethyl(C)@7; Carbamidomethyl(C)@25; Deamidated(N)@31; Carbamidomethyl(C)@41; ONE addition +154(K)@43 -0.573625981807709 4795.67236328125 960.1418 4796.24609375 960.256530761719 5 17 1.1.1.4042.4 1 57.249 10701.06 57.1846 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 88.1900012493134 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Dehydrated(T)@6; Carbamidomethyl(C)@7; Carbamidomethyl(C)@25; Deamidated(N)@31; Carbamidomethyl(C)@41; ONE addition +154(K)@43 0.498869985342026 4796.7451171875 800.4648 4796.24609375 800.381652832031 6 15 1.1.1.3774.12 1 50.6623 5188.191 50.6749 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 88.1900012493134 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@7; Carbamidomethyl(C)@25; Deamidated(N)@31; Carbamidomethyl(C)@41; ONE addition +154(K)@43 -0.5033940076828 4813.75341796875 803.2995 4814.2568359375 803.383422851563 6 14 1.1.1.3787.7 1 50.9827 2504.128 50.9258 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 87.1100008487701 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@7; Deamidated(N)@19; Carbamidomethyl(C)@25; reduced HNE(H)@40; Carbamidomethyl(C)@41; Dehydrated(Y)@42 0.393243014812469 4800.6708984375 961.1414 4800.27734375 961.062744140625 5 15 1.1.1.3754.20 1 50.1563 14563.27 50.2122 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.5499973297119 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Bromo(Y)@5; Carbamidomethyl(C)@7; Carbamidomethyl(C)@25; Deamidated(N)@31; Carbamidomethyl(C)@41; ONE addition +154(K)@43 -0.451626002788544 4891.7158203125 816.2932 4892.16748046875 816.368469238281 6 16 1.1.1.3827.6 1 51.9756 35646.18 52.0434 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 82.9800009727478 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@7; Dehydrated(S)@17; Carbamidomethyl(C)@25; Deamidated(N)@31; Carbamidomethyl(C)@41; ONE addition +154(K)@43 -0.565081000328064 4795.68115234375 960.1435 4796.24609375 960.256530761719 5 15 1.1.1.4035.13 1 57.0713 7575.478 57.0323 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.580001115799 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@7; Carbamidomethyl(C)@25; Delta:H(2)C(2)(H)@40; Carbamidomethyl(C)@41; acrolein addition +38(K)@43 0.395164012908936 4723.5986328125 1181.907 4723.20458984375 1181.80847167969 4 14 1.1.1.3785.20 0 50.9445 51750.13 50.9258 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.580001115799 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Bromo(Y)@5; Carbamidomethyl(C)@7; Carbamidomethyl(C)@25; Deamidated(N)@31; Carbamidomethyl(C)@41; ONE addition +154(K)@43 -0.512037992477417 4891.6552734375 979.3383 4892.16748046875 979.440734863281 5 16 1.1.1.3833.10 1 52.1283 127587.5 52.0434 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 67.7799999713898 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Dehydrated(T)@6; Carbamidomethyl(C)@7; Deamidated(N)@19; Carbamidomethyl(C)@25; Deamidated(N)@31; Carbamidomethyl(C)@41; ONE addition +154(K)@43 -0.563073992729187 4796.6669921875 960.3407 4797.22998046875 960.453308105469 5 14 1.1.1.4053.15 1 57.5283 3669.45 57.5121 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 48.1400012969971 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@7; Dioxidation(P)@13; Carbamidomethyl(C)@25; Deamidated(N)@31; Carbamidomethyl(C)@41; ONE addition +154(K)@43 -0.592330992221832 4845.654296875 970.1381 4846.24658203125 970.256591796875 5 14 1.1.1.3789.9 1 51.0334 2774.191 50.9749 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 31.5699994564056 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@7; Carbamidomethyl(C)@25; Bromo(W)@34; reduced HNE(H)@40; Carbamidomethyl(C)@41; acrolein addition +38(K)@43 0.352530986070633 4933.58251953125 1234.403 4933.22998046875 1234.31481933594 4 12 1.1.1.3914.8 1 54.1271 97088.17 54.0597 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 24.9099999666214 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@7; Carbamidomethyl(C)@25; FormaldehydeAdduct(W)@34; reduced HNE(H)@40; Carbamidomethyl(C)@41; MDA adduct +62(K)@43 0.247418999671936 4891.56689453125 1223.899 4891.31982421875 1223.83715820313 4 12 1.1.1.3825.21 1 51.9379 63028.8 52.0434 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 16.2499994039536 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(T)@6; Carbamidomethyl(C)@7; Deamidated(N)@10; Carbamidomethyl(C)@25; Deamidated(N)@31; Carbamidomethyl(C)@41; ONE addition +154(K)@43 0.415030002593994 4872.67724609375 975.5427 4872.26220703125 975.459716796875 5 13 1.1.1.3784.16 1 50.9166 1675.223 50.9258 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 76.6600012779236 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYKSR Carbamidomethyl(C)@7; Oxidation(P)@13; Carbamidomethyl(C)@25; Carbamidomethyl(C)@41; Carbamidomethyl(Y)@42; reduced acrolein addition +58(K)@43; Oxidation(R)@45 missed K-S@43 0.341533005237579 5049.70361328125 1010.948 5049.35986328125 1010.87921142578 5 16 1.1.1.4028.14 1 56.8946 2276.809 56.8801 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 52.0099997520447 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYKSR Carbamidomethyl(C)@7; Carbamidomethyl(C)@25; Oxidation(H)@40; Carbamidomethyl(C)@41; Deamidated(R)@45 missed K-S@43 0.27972599864006 4919.56689453125 1230.899 4919.28564453125 1230.82861328125 4 13 1.1.1.3873.21 1 53.1249 44725.68 53.056 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 40.6699985265732 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYKSR Carbamidomethyl(C)@7; Carbamidomethyl(C)@25; Oxidation(H)@40; Carbamidomethyl(C)@41; Oxidation(R)@45 missed K-S@43 0.281033992767334 4934.57861328125 1234.652 4934.29638671875 1234.58129882813 4 13 1.1.1.3935.6 1 54.6337 41183.79 54.8325 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 36.7300003767014 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYKSR Carbamidomethyl(C)@7; Carbamidomethyl(C)@25; Oxidation(H)@40; Carbamidomethyl(C)@41; Deamidated(R)@45 missed K-S@43 0.279237985610962 4919.5625 1230.898 4919.28564453125 1230.82861328125 4 13 1.1.1.3859.7 1 52.7808 64813.52 52.6639 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 35.3100001811981 IVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYKSR Carbamidomethyl(C)@7; Dioxidation(Y)@14; Carbamidomethyl(C)@25; Carbamidomethyl(C)@41 missed K-S@43 0.279569000005722 4934.57470703125 1234.651 4934.29638671875 1234.58129882813 4 12 1.1.1.3942.10 1 54.8028 49072.29 54.8812 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 59.2999994754791 LDNDIMLIKLSSPATLNSR cleaved T-L@N-term; missed K-L@9 -5.94236993789673 2094.1826171875 699.0681 2100.125 701.048889160156 3 12 1.1.1.4273.4 1 62.8818 562.1862 62.8761 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 45.9899991750717 LEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced HNE(H)@16; acrolein addition +38(K)@32 cleaved V-L@N-term; missed K-I@12; missed K-L@32 0.529653012752533 4820.05126953125 965.0176 4819.52197265625 964.91162109375 5 12 1.1.1.4340.12 1 64.618 148.4537 64.6543 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 96.2700009346008 LGEHNIDVLEGN cleaved N-E@C-term 0.164877995848656 1308.7958984375 655.4052 1308.63098144531 655.32275390625 2 13 1.1.1.3186.8 1 36.3188 522.6384 36.3289 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 94.4100022315979 LGEHNIDVLEGN cleaved N-E@C-term 0.158041998744011 1308.7890625 655.4018 1308.63098144531 655.32275390625 2 13 1.1.1.3167.10 1 35.8694 2876.209 36.0655 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQ cleaved Q-F@C-term 0.160143002867699 1565.89233398438 783.9534 1565.73217773438 783.873352050781 2 21 1.1.1.3165.7 1 35.8217 6248.386 35.9223 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQ cleaved Q-F@C-term 0.160143002867699 1565.89233398438 783.9534 1565.73217773438 783.873352050781 2 22 1.1.1.3172.7 1 35.9888 6248.386 35.9223 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFIN cleaved N-A@C-term 0.239993005990982 1940.16760253906 647.7298 1939.92761230469 647.649780273438 3 20 1.1.1.3588.14 1 46.0637 6767.793 46.1477 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFIN cleaved N-A@C-term 0.172622993588448 1940.10021972656 971.0574 1939.92761230469 970.971069335938 2 22 1.1.1.3592.21 1 46.1673 12419.7 46.1477 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFIN cleaved N-A@C-term 0.172622993588448 1940.10021972656 971.0574 1939.92761230469 970.971069335938 2 21 1.1.1.3599.19 1 46.3432 12419.7 46.1477 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFIN Deamidated(N)@17 cleaved N-A@C-term 0.238520994782448 1941.15014648438 648.0573 1940.91162109375 647.977783203125 3 18 1.1.1.3627.14 1 47.0497 966.2526 47.0865 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFIN cleaved N-A@C-term 0.239993005990982 1940.16760253906 647.7298 1939.92761230469 647.649780273438 3 17 1.1.1.3595.15 1 46.237 6767.793 46.1477 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 96.0300028324127 LGEHNIDVLEGNEQFIN Deamidated(Q)@14 cleaved N-A@C-term 0.178476005792618 1941.09008789063 971.5523 1940.91162109375 971.463073730469 2 12 1.1.1.3606.21 1 46.5206 439.4323 46.5257 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 95.0900018215179 LGEHNIDVLEGNEQFIN Deamidated(N)@17 cleaved N-A@C-term 0.174692004919052 1941.08630371094 971.5504 1940.91162109375 971.463073730469 2 15 1.1.1.3625.20 1 47.0026 1856.742 47.0865 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 94.4000005722046 LGEHNIDVLEGNEQFIN Deamidated(N)@12 cleaved N-A@C-term 0.1788419932127 1941.09045410156 971.5525 1940.91162109375 971.463073730469 2 10 1.1.1.3639.20 1 47.3692 387.2311 47.3228 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 94.0400004386902 LGEHNIDVLEGNEQFIN cleaved N-A@C-term 0.172867000102997 1940.10046386719 971.0575 1939.92761230469 970.971069335938 2 14 1.1.1.3607.20 1 46.5453 2983.732 46.2724 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 92.059999704361 LGEHNIDVLEGNEQFIN cleaved N-A@C-term 2.90822005271912 1942.83581542969 972.4252 1939.92761230469 970.971069335938 2 12 1.1.1.4099.5 1 58.6211 664.5731 58.6095 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 87.6600027084351 LGEHNIDVLEGNEQFIN cleaved N-A@C-term 0.17823800444603 1940.10583496094 971.0602 1939.92761230469 970.971069335938 2 9 1.1.1.3622.16 1 46.922 307.9538 46.9827 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.5499973297119 LGEHNIDVLEGNEQFIN Dehydrated(E)@13 cleaved N-A@C-term 0.129233002662659 1922.04626464844 962.0304 1921.9169921875 961.965759277344 2 16 1.1.1.3646.7 1 47.5454 3957.282 47.6284 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 85.3500008583069 LGEHNIDVLEGNEQFIN cleaved N-A@C-term -8.10776996612549 1931.81982421875 966.9172 1939.92761230469 970.971069335938 2 12 1.1.1.4108.8 1 58.8367 842.3264 58.8283 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 82.9800009727478 LGEHNIDVLEGNEQFIN cleaved N-A@C-term 1.90443003177643 1941.83203125 971.9233 1939.92761230469 970.971069335938 2 11 1.1.1.4087.8 1 58.3323 737.473 58.3179 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.510002374649 LGEHNIDVLEGNEQFIN Oxidation(F)@15; Deamidated(N)@17 cleaved N-A@C-term -0.0714436993002892 1956.83508300781 979.4248 1956.90649414063 979.460510253906 2 11 1.1.1.4118.7 1 59.1023 629.7452 59.0858 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 78.9900004863739 LGEHNIDVLEGNEQFIN Oxidation(F)@15; Deamidated(N)@17 cleaved N-A@C-term -0.0660727024078369 1956.84045410156 979.4275 1956.90649414063 979.460510253906 2 10 1.1.1.4104.6 1 58.7471 556.2891 58.7071 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 62.279999256134 LGEHNIDVLEGNEQFIN Dehydrated(E)@13 cleaved N-A@C-term 0.16805100440979 1922.08508300781 962.0498 1921.9169921875 961.965759277344 2 14 1.1.1.3639.19 1 47.3684 710.4823 47.477 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 88.7199997901917 LGEHNIDVLEGNEQFINA cleaved A-A@C-term 0.239926993846893 2011.20458984375 671.4088 2010.96472167969 671.328857421875 3 13 1.1.1.3647.10 1 47.566 834.3067 47.477 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 83.7000012397766 LGEHNIDVLEGNEQFINA cleaved A-A@C-term -1.07885003089905 2009.88549804688 1005.95 2010.96472167969 1006.48962402344 2 11 1.1.1.4173.4 1 60.4202 450.1164 60.4126 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.580001115799 LGEHNIDVLEGNEQFINA cleaved A-A@C-term 0.170788004994392 2011.13549804688 1006.575 2010.96472167969 1006.48962402344 2 10 1.1.1.3648.21 1 47.5981 1572.445 47.477 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAA cleaved A-K@C-term 0.242790997028351 2082.24462890625 695.0888 2082.00170898438 695.007873535156 3 18 1.1.1.3653.17 1 47.7218 1179.636 47.7562 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 88.7199997901917 LGEHNIDVLEGNEQFINAA cleaved A-K@C-term 0.175543993711472 2082.17724609375 1042.096 2082.00170898438 1042.00817871094 2 11 1.1.1.3659.21 1 47.8807 1979.079 47.7562 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Deamidated(N)@17 0.170783996582031 2211.25146484375 1106.633 2211.08081054688 1106.54760742188 2 21 1.1.1.3486.12 1 43.5839 752.1401 43.6385 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Deamidated(N)@17 0.238519996404648 2211.3193359375 738.1137 2211.08081054688 738.0341796875 3 26 1.1.1.3489.14 1 43.6526 7117.337 43.6635 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Deamidated(N)@17 0.170783996582031 2211.25146484375 1106.633 2211.08081054688 1106.54760742188 2 20 1.1.1.3493.10 1 43.7576 684.613 43.7626 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Deamidated(N)@17 0.238519996404648 2211.3193359375 738.1137 2211.08081054688 738.0341796875 3 27 1.1.1.3496.9 1 43.8239 7117.337 43.6635 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Deamidated(N)@17; Methyl(K)@20 0.238312005996704 2225.33471679688 742.7855 2225.09643554688 742.706115722656 3 24 1.1.1.3498.17 1 43.88 2064.302 43.9366 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Deamidated(N)@17; Methyl(K)@20 0.150739997625351 2225.24731445313 1113.631 2225.09643554688 1113.55554199219 2 22 1.1.1.3500.14 1 43.9315 0 -1 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Deamidated(N)@17; Methyl(K)@20 0.238312005996704 2225.33471679688 742.7855 2225.09643554688 742.706115722656 3 20 1.1.1.3505.13 1 44.0488 2064.302 43.9366 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Deamidated(N)@17; Delta:H(4)C(2)(K)@20 0.243413999676704 2239.35546875 747.4591 2239.11206054688 747.377990722656 3 23 1.1.1.3507.18 1 44.1028 314.3586 44.0853 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.170181006193161 2210.26733398438 1106.141 2210.0966796875 1106.0556640625 2 27 1.1.1.3510.14 1 44.1798 75434.25 44.3553 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Cation:Na(E)@10 0.244252994656563 2232.32299804688 745.1149 2232.07861328125 745.033508300781 3 24 1.1.1.3511.14 1 44.1988 2574.719 44.3312 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.242372006177902 2210.33911132813 737.787 2210.0966796875 737.706176757813 3 26 1.1.1.3514.3 1 44.2677 162697.9 44.3553 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.304553002119064 2210.4013671875 553.6076 2210.0966796875 553.531494140625 4 20 1.1.1.3515.5 1 44.2919 19440.9 44.3553 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Deamidated(N)@12 0.259211003780365 2211.34008789063 738.1206 2211.08081054688 738.0341796875 3 21 1.1.1.3516.3 1 44.3201 107842 44.3553 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.242372006177902 2210.33911132813 737.787 2210.0966796875 737.706176757813 3 21 1.1.1.3517.4 1 44.3401 162697.9 44.3553 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Cation:Na(E)@10 0.244252994656563 2232.32299804688 745.1149 2232.07861328125 745.033508300781 3 33 1.1.1.3518.7 1 44.3676 2574.719 44.3312 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.242372006177902 2210.33911132813 737.787 2210.0966796875 737.706176757813 3 27 1.1.1.3522.10 1 44.464 162697.9 44.3553 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Methyl(H)@4 0.241613999009132 2224.35400390625 742.4586 2224.1123046875 742.378051757813 3 20 1.1.1.3523.5 1 44.4915 1462.761 44.4999 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.170181006193161 2210.26733398438 1106.141 2210.0966796875 1106.0556640625 2 31 1.1.1.3524.10 1 44.5189 75521.01 44.3553 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Cation:Na(E)@13 0.240591004490852 2232.3193359375 745.1137 2232.07861328125 745.033508300781 3 28 1.1.1.3525.4 1 44.5338 1104.776 44.5481 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.242189005017281 2210.3388671875 737.7869 2210.0966796875 737.706176757813 3 27 1.1.1.3529.12 1 44.6346 151928.4 44.3794 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Methyl(K)@20 0.240333005785942 2224.35278320313 742.4582 2224.1123046875 742.378051757813 3 21 1.1.1.3531.13 1 44.6822 28638.92 44.9115 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.170181006193161 2210.26733398438 1106.141 2210.0966796875 1106.0556640625 2 19 1.1.1.3532.19 1 44.7118 42125.13 44.4516 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.241456001996994 2210.33813476563 737.7867 2210.0966796875 737.706176757813 3 29 1.1.1.3536.4 1 44.8101 78202.18 44.5481 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Methyl(K)@20 0.24015000462532 2224.3525390625 742.4581 2224.1123046875 742.378051757813 3 28 1.1.1.3538.7 1 44.8467 41683.52 44.9651 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Methyl(K)@20 0.167226001620293 2224.279296875 1113.147 2224.1123046875 1113.0634765625 2 25 1.1.1.3538.15 1 44.8583 10048.8 44.9651 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Methyl(K)@20 0.305748999118805 2224.41821289063 557.1118 2224.1123046875 557.035400390625 4 22 1.1.1.3539.5 1 44.8691 4675.235 44.9651 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.242189005017281 2210.3388671875 737.7869 2210.0966796875 737.706176757813 3 29 1.1.1.3543.7 1 44.9842 4463.742 44.9651 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Methyl(K)@20 0.24015000462532 2224.3525390625 742.4581 2224.1123046875 742.378051757813 3 27 1.1.1.3545.6 1 45.0248 41683.52 44.9651 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Methyl(K)@20 0.167226001620293 2224.279296875 1113.147 2224.1123046875 1113.0634765625 2 25 1.1.1.3545.9 1 45.0323 10048.8 44.9651 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Methyl(K)@20 0.305748999118805 2224.41821289063 557.1118 2224.1123046875 557.035400390625 4 21 1.1.1.3546.4 1 45.0421 4675.235 44.9651 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.242372006177902 2210.33911132813 737.787 2210.0966796875 737.706176757813 3 27 1.1.1.3550.4 1 45.1481 3742.524 45.2536 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Methyl(K)@20 0.169910997152328 2224.28125 1113.148 2224.1123046875 1113.0634765625 2 26 1.1.1.3552.5 1 45.2004 10462.42 44.9651 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Methyl(K)@20 0.24015000462532 2224.3525390625 742.4581 2224.1123046875 742.378051757813 3 26 1.1.1.3553.10 1 45.2195 43404.04 44.9651 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Delta:H(4)C(2)(K)@20 0.237744003534317 2238.36572265625 747.1292 2238.12817382813 747.049987792969 3 26 1.1.1.3553.11 1 45.2211 12497.03 45.3978 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.242372006177902 2210.33911132813 737.787 2210.0966796875 737.706176757813 3 24 1.1.1.3557.3 1 45.3123 3742.524 45.2536 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Deamidated(N)@12 0.244195997714996 2211.32495117188 738.1156 2211.08081054688 738.0341796875 3 23 1.1.1.3558.4 1 45.3355 5632.449 45.3738 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Dimethyl(N)@5 0.237744003534317 2238.36572265625 747.1292 2238.12817382813 747.049987792969 3 28 1.1.1.3560.7 1 45.3878 12582.92 45.3978 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Deamidated(N)@17 0.176643997430801 2211.25732421875 1106.636 2211.08081054688 1106.54760742188 2 20 1.1.1.3561.10 1 45.4168 1541.681 45.3978 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Methyl(K)@20 0.239417001605034 2224.35180664063 742.4579 2224.1123046875 742.378051757813 3 25 1.1.1.3562.7 1 45.4325 10756.26 45.1814 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.243286997079849 2210.34008789063 737.7873 2210.0966796875 737.706176757813 3 27 1.1.1.3564.5 1 45.483 4115.497 45.3738 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Delta:H(4)C(2)@N-term 0.237744003534317 2238.36572265625 747.1292 2238.12817382813 747.049987792969 3 30 1.1.1.3567.6 1 45.5542 12582.92 45.3978 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.244203001260757 2210.34106445313 737.7876 2210.0966796875 737.706176757813 3 25 1.1.1.3571.6 1 45.6501 1854.189 45.6388 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.248963996767998 2210.345703125 737.7892 2210.0966796875 737.706176757813 3 26 1.1.1.3578.7 1 45.8196 1471.023 45.8073 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Deamidated(N)@17; Methyl(K)@20 0.245819002389908 2225.34228515625 742.788 2225.09643554688 742.706115722656 3 24 1.1.1.3578.8 1 45.8213 1216.267 45.8073 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.248780995607376 2210.34545898438 737.7891 2210.0966796875 737.706176757813 3 24 1.1.1.3585.8 1 45.988 1558.231 45.9525 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Methyl(K)@20 0.241247996687889 2224.35375976563 742.4585 2224.1123046875 742.378051757813 3 23 1.1.1.3585.9 1 45.9897 773.9265 45.904 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.243836998939514 2210.34057617188 737.7875 2210.0966796875 737.706176757813 3 23 1.1.1.3592.15 1 46.1623 1303.021 46.1723 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.242189005017281 2210.3388671875 737.7869 2210.0966796875 737.706176757813 3 23 1.1.1.3599.13 1 46.3365 1126.591 46.3994 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Deamidated(N)@5 0.18079400062561 2211.26123046875 1106.638 2211.08081054688 1106.54760742188 2 16 1.1.1.3605.20 1 46.4944 325.6125 46.5003 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Deamidated(N)@5 0.247492000460625 2211.32836914063 738.1167 2211.08081054688 738.0341796875 3 23 1.1.1.3607.14 1 46.5403 2787.029 46.5003 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Delta:H(2)C(2)(H)@4; Deamidated(N)@17 0.245086997747421 2237.34155273438 746.7878 2237.09643554688 746.706115722656 3 20 1.1.1.3613.18 1 46.6941 368.0515 46.7527 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Deamidated(N)@12 0.24694299697876 2211.32763671875 738.1165 2211.08081054688 738.0341796875 3 24 1.1.1.3614.14 1 46.7161 8304.838 46.8041 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Deamidated(N)@12 0.176155000925064 2211.25732421875 1106.636 2211.08081054688 1106.54760742188 2 20 1.1.1.3615.21 1 46.7476 1607.866 46.7782 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Deamidated(N)@12 0.24694299697876 2211.32763671875 738.1165 2211.08081054688 738.0341796875 3 23 1.1.1.3622.12 1 46.9187 8304.838 46.8041 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.243653997778893 2210.34033203125 737.7874 2210.0966796875 737.706176757813 3 24 1.1.1.3629.15 1 47.1027 847.485 47.0865 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Delta:H(2)C(2)(H)@4 0.247473999857903 2236.35986328125 746.4606 2236.1123046875 746.378051757813 3 25 1.1.1.3643.13 1 47.4652 19459.52 47.6791 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Delta:H(2)C(2)(H)@4 0.175527006387711 2236.28735351563 1119.151 2236.1123046875 1119.0634765625 2 25 1.1.1.3644.21 1 47.4974 7919.999 47.6791 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.244203001260757 2210.34106445313 737.7876 2210.0966796875 737.706176757813 3 25 1.1.1.3646.6 1 47.5429 866.7573 47.426 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Delta:H(2)C(2)(H)@4 0.247290998697281 2236.35961914063 746.4605 2236.1123046875 746.378051757813 3 28 1.1.1.3650.15 1 47.6437 19899.71 47.7047 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Delta:H(2)C(2)(H)@4 0.175527006387711 2236.28735351563 1119.151 2236.1123046875 1119.0634765625 2 25 1.1.1.3651.20 1 47.6732 7911.312 47.6791 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Deamidated(N)@5 0.248774006962776 2211.32958984375 738.1171 2211.08081054688 738.0341796875 3 20 1.1.1.3654.17 1 47.7478 1138.207 47.7047 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Delta:H(2)C(2)(H)@4 0.247290998697281 2236.35961914063 746.4605 2236.1123046875 746.378051757813 3 25 1.1.1.3657.18 1 47.8261 19899.71 47.7047 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.242920994758606 2210.33959960938 737.7872 2210.0966796875 737.706176757813 3 20 1.1.1.3663.18 1 47.9804 442.2621 47.9625 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Delta:H(2)C(2)(H)@4; Methyl(K)@20 0.246350005269051 2250.37451171875 751.1321 2250.12817382813 751.049987792969 3 30 1.1.1.3665.2 1 48.0242 4851.76 47.9879 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Methyl(E)@3; Delta:H(2)C(2)(H)@4 0.242504999041557 2250.37060546875 751.1308 2250.12817382813 751.049987792969 3 22 1.1.1.3722.17 1 49.337 585.5826 49.3199 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.244569003582001 2210.34130859375 737.7877 2210.0966796875 737.706176757813 3 21 1.1.1.3742.15 1 49.8477 646.5123 49.806 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Formyl@N-term 0.177462995052338 2238.26928710938 1120.142 2238.091796875 1120.05310058594 2 27 1.1.1.3748.9 1 50.0081 711.0122 50.038 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Delta:H(4)C(2)@N-term 0.212842002511024 2238.3408203125 747.1209 2238.12817382813 747.049987792969 3 23 1.1.1.3751.13 1 50.0756 940.5657 50.0132 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Delta:H(2)C(2)@N-term; Delta:H(2)C(2)(H)@4 0.244884997606277 2262.373046875 755.1316 2262.12817382813 755.049987792969 3 27 1.1.1.3771.10 1 50.5828 6687.363 50.6488 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.169691994786263 2210.26733398438 1106.141 2210.0966796875 1106.0556640625 2 19 1.1.1.3540.9 1 44.9039 8963.287 44.6447 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.249696001410484 2210.34643554688 737.7894 2210.0966796875 737.706176757813 3 19 1.1.1.3636.16 1 47.2877 873.9824 47.3228 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.304553002119064 2210.4013671875 553.6076 2210.0966796875 553.531494140625 4 18 1.1.1.3522.6 1 44.4581 19440.9 44.3553 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Delta:H(2)C(2)@N-term; Delta:H(2)C(2)(H)@4 0.244335994124413 2262.37231445313 755.1314 2262.12817382813 755.049987792969 3 20 1.1.1.3784.11 1 50.9124 1516.603 50.9504 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Cation:Na(E)@13 0.305031001567841 2232.3837890625 559.1032 2232.07861328125 559.026977539063 4 19 1.1.1.3518.3 1 44.361 1650.449 44.3553 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Deamidated(N)@5; Deamidated(N)@12; Deamidated(Q)@14; Deamidated(N)@17 0.309177994728088 2214.34204101563 739.1213 2214.03271484375 739.018188476563 3 20 1.1.1.3516.4 1 44.3259 5420.348 44.3553 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Delta:H(2)C(2)(H)@4; Methyl(K)@20 0.169397994875908 2250.29736328125 1126.156 2250.12817382813 1126.0712890625 2 19 1.1.1.3661.17 1 47.9315 1506.856 47.9879 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Ammonia-loss(N)@12 0.256042987108231 2193.326171875 732.116 2193.0703125 732.030700683594 3 18 1.1.1.3512.11 1 44.2213 405.6303 44.2348 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Formyl(K)@20 0.201876997947693 2238.29345703125 1120.154 2238.091796875 1120.05310058594 2 21 1.1.1.3562.11 1 45.4392 2384.037 45.3978 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Deamidated(N)@17; Delta:H(2)C(2)(K)@20 0.288300007581711 2237.384765625 746.8022 2237.09643554688 746.706115722656 3 18 1.1.1.3593.15 1 46.187 261.6258 46.1971 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.242189005017281 2210.3388671875 737.7869 2210.0966796875 737.706176757813 3 16 1.1.1.3610.10 1 46.616 1126.591 46.3994 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Formyl(K)@20 0.204806998372078 2238.29736328125 1120.156 2238.091796875 1120.05310058594 2 17 1.1.1.3555.11 1 45.2709 1051.208 45.2776 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Delta:H(2)C(2)(H)@4; Methyl(K)@20 0.246350005269051 2250.37451171875 751.1321 2250.12817382813 751.049987792969 3 19 1.1.1.3658.13 1 47.8475 4851.76 47.9879 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK Dimethyl(N)@17; reduced acrolein addition +58(K)@20 0.13900800049305 2296.30932617188 1149.162 2296.169921875 1149.09228515625 2 18 1.1.1.3854.15 1 52.6555 684.9228 52.6639 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAK 0.247133001685143 2210.34399414063 737.7886 2210.0966796875 737.706176757813 3 16 1.1.1.3735.17 1 49.6685 505.9206 49.651 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8499999046326 LGEHNIDVLEGNEQFINAAK Deamidated(N)@17 0.238153994083405 2211.31884765625 738.1136 2211.08081054688 738.0341796875 3 16 1.1.1.3500.11 1 43.9265 7361.035 43.6635 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8499999046326 LGEHNIDVLEGNEQFINAAK Delta:H(2)C(2)(H)@4 0.308923006057739 2236.42138671875 560.1126 2236.1123046875 560.035400390625 4 17 1.1.1.3652.7 1 47.6879 1523.961 47.6791 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.6800014972687 LGEHNIDVLEGNEQFINAAK 0.169448003172874 2210.26538085938 1106.14 2210.0966796875 1106.0556640625 2 16 1.1.1.3554.13 1 45.2485 1107.843 45.2536 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.5899994373322 LGEHNIDVLEGNEQFINAAK Cation:Na(E)@13 0.305031001567841 2232.3837890625 559.1032 2232.07861328125 559.026977539063 4 17 1.1.1.3525.2 1 44.5288 1650.449 44.3553 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.3599970340729 LGEHNIDVLEGNEQFINAAK Delta:H(4)C(2)@N-term 0.236278995871544 2238.3642578125 747.1287 2238.12817382813 747.049987792969 3 17 1.1.1.3643.14 1 47.466 3594.138 47.6538 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.3599970340729 LGEHNIDVLEGNEQFINAAK -0.757749974727631 2209.33911132813 737.4536 2210.0966796875 737.706176757813 3 17 1.1.1.3749.9 1 50.023 531.5166 49.806 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.1000015735626 LGEHNIDVLEGNEQFINAAK 0.242920994758606 2210.33959960938 737.7872 2210.0966796875 737.706176757813 3 15 1.1.1.3725.14 1 49.4112 677.6296 49.4221 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 96.8699991703033 LGEHNIDVLEGNEQFINAAK Cation:K(E)@13 0.244985997676849 2248.29760742188 750.4398 2248.052734375 750.358154296875 3 14 1.1.1.3512.14 1 44.2238 617.5175 44.4035 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 96.8699991703033 LGEHNIDVLEGNEQFINAAK Deamidated(Q)@14 0.176155000925064 2211.25732421875 1106.636 2211.08081054688 1106.54760742188 2 13 1.1.1.3622.19 1 46.9262 1607.866 46.7782 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 96.6000020503998 LGEHNIDVLEGNEQFINAAK Methyl(K)@20 0.170156002044678 2224.28344726563 1113.149 2224.1123046875 1113.0634765625 2 14 1.1.1.3531.20 1 44.688 6119.414 44.8875 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 95.7300007343292 LGEHNIDVLEGNEQFINAAK Methyl(K)@20 0.235571995377541 2224.34790039063 742.4566 2224.1123046875 742.378051757813 3 13 1.1.1.3619.13 1 46.8433 390.9234 46.7782 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 95.7300007343292 LGEHNIDVLEGNEQFINAAK -0.757201015949249 2209.33959960938 737.4538 2210.0966796875 737.706176757813 3 16 1.1.1.3728.13 1 49.4867 760.0093 49.2691 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 95.0900018215179 LGEHNIDVLEGNEQFINAAK Delta:H(2)C(2)(H)@4 0.308923006057739 2236.42138671875 560.1126 2236.1123046875 560.035400390625 4 15 1.1.1.3645.10 1 47.5138 1523.961 47.6791 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 94.0400004386902 LGEHNIDVLEGNEQFINAAK Deamidated(N)@17 0.165901005268097 2211.24731445313 1106.631 2211.08081054688 1106.54760742188 2 14 1.1.1.3570.6 1 45.6337 646.815 45.5668 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.7300026416779 LGEHNIDVLEGNEQFINAAK 0.168715998530388 2210.26538085938 1106.14 2210.0966796875 1106.0556640625 2 16 1.1.1.3544.8 1 45.0082 974.4805 44.9651 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 92.8699970245361 LGEHNIDVLEGNEQFINAAK -3.02239990234375 2207.07446289063 736.6987 2210.0966796875 737.706176757813 3 14 1.1.1.3765.9 1 50.4279 1732.106 50.3663 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 92.4600005149841 LGEHNIDVLEGNEQFINAAK Cation:Na(E)@13 0.305031001567841 2232.3837890625 559.1032 2232.07861328125 559.026977539063 4 15 1.1.1.3511.9 1 44.1946 1650.449 44.3553 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 90.6899988651276 LGEHNIDVLEGNEQFINAAK Deamidated(N)@12; Methyl(K)@20 0.249115005135536 2225.34545898438 742.7891 2225.09643554688 742.706115722656 3 14 1.1.1.3631.18 1 47.1581 1291.44 47.2708 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 88.7199997901917 LGEHNIDVLEGNEQFINAAK NeuAc(N)@17; reduced acrolein addition +96(K)@20 0.122400000691414 2597.3720703125 866.798 2597.24975585938 866.757202148438 3 16 1.1.1.3512.20 1 44.2289 1133.161 44.3312 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 88.1900012493134 LGEHNIDVLEGNEQFINAAK Formyl(K)@20 0.340889006853104 2238.4326171875 560.6154 2238.091796875 560.530212402344 4 12 1.1.1.3554.3 1 45.2335 1783.858 45.3978 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 88.1900012493134 LGEHNIDVLEGNEQFINAAK Deamidated(N)@12 0.306865990161896 2211.3876953125 553.8542 2211.08081054688 553.777465820313 4 13 1.1.1.3617.6 1 46.7865 616.2901 46.8041 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.5499973297119 LGEHNIDVLEGNEQFINAAK HexNAc(N)@17; reduced acrolein addition +96(K)@20 0.23701499402523 2509.470703125 837.4975 2509.23364257813 837.418518066406 3 13 1.1.1.3490.19 1 43.6816 503.0876 43.6635 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 83.5399985313416 LGEHNIDVLEGNEQFINAAK -0.829575002193451 2209.26733398438 1105.641 2210.0966796875 1106.0556640625 2 15 1.1.1.3825.16 1 51.9337 2055.303 51.9175 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 82.2399973869324 LGEHNIDVLEGNEQFINAAK Delta:H(2)C(2)(H)@4 0.226783007383347 2236.33911132813 746.4537 2236.1123046875 746.378051757813 3 13 1.1.1.3756.16 1 50.2029 458.7968 50.2886 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 74.1299986839294 LGEHNIDVLEGNEQFINAAK Formyl@N-term; Delta:H(2)C(2)(H)@4 0.285273998975754 2264.392578125 755.8048 2264.107421875 755.709716796875 3 21 1.1.1.3779.5 1 50.7818 1534.564 50.7506 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 57.0900022983551 LGEHNIDVLEGNEQFINAAK Delta:H(2)C(2)(H)@4 0.242164000868797 2236.3544921875 746.4588 2236.1123046875 746.378051757813 3 11 1.1.1.3768.13 1 50.508 268.4391 50.4939 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 44.6099996566772 LGEHNIDVLEGNEQFINAAK Delta:H(2)C(2)(H)@4; Deamidated(N)@12; Deamidated(N)@17 0.272179007530212 2238.3525390625 747.1248 2238.08032226563 747.034118652344 3 12 1.1.1.3723.14 1 49.3597 426.6132 49.3199 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 87.9299998283386 LGEHNIDVLEGNEQFINAAKII Oxidation(N)@17; acrolein addition +56(K)@20 cleaved I-T@C-term; missed K-I@20 0.198256000876427 2508.484375 837.1687 2508.2861328125 837.102600097656 3 15 1.1.1.3525.6 1 44.5397 12938.92 44.3794 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 74.1299986839294 LGEHNIDVLEGNEQFINAAKII Oxidation(N)@17; acrolein addition +56(K)@20 cleaved I-T@C-term; missed K-I@20 0.198256000876427 2508.484375 837.1687 2508.2861328125 837.102600097656 3 14 1.1.1.3518.9 1 44.3718 12938.92 44.3794 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 33.6400002241135 LGEHNIDVLEGNEQFINAAKII Oxidation(N)@17; acrolein addition +56(K)@20 cleaved I-T@C-term; missed K-I@20 0.198256000876427 2508.484375 837.1687 2508.2861328125 837.102600097656 3 13 1.1.1.3511.19 1 44.203 12808.34 44.3794 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITH Deamidated(N)@17; MDA adduct +62(K)@20; reduced HNE(H)@24 cleaved H-P@C-term; missed K-I@20 0.310377985239029 2895.81225585938 724.9603 2895.50170898438 724.882751464844 4 18 1.1.1.3819.6 1 51.7715 8444.207 51.7891 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 94.1299974918365 LGEHNIDVLEGNEQFINAAKIITH reduced acrolein addition +58(K)@20; reduced HNE(H)@24 cleaved H-P@C-term; missed K-I@20 -0.307002991437912 2890.23706054688 964.4196 2890.5439453125 964.52197265625 3 13 1.1.1.4133.4 1 59.4655 818.1922 59.4797 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 88.4700000286102 LGEHNIDVLEGNEQFINAAKIITH reduced acrolein addition +96(K)@20; reduced HNE(H)@24 cleaved H-P@C-term; missed K-I@20 -0.316365987062454 2928.24340820313 977.0884 2928.5595703125 977.19384765625 3 12 1.1.1.4109.5 1 58.8684 1329.595 58.8526 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITH reduced acrolein addition +58(K)@20; reduced HNE(H)@24 cleaved H-P@C-term; missed K-I@20 -0.312678992748261 2890.2314453125 964.4177 2890.5439453125 964.52197265625 3 12 1.1.1.4105.7 1 58.7697 970.0948 58.7314 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.0100018978119 LGEHNIDVLEGNEQFINAAKIITH Deamidated(N)@17; acrolein addition +56(K)@20; reduced HNE(H)@24 cleaved H-P@C-term; missed K-I@20 -0.2776879966259 2889.23461914063 964.0855 2889.51245117188 964.178100585938 3 11 1.1.1.4112.5 1 58.9517 1352.199 58.9018 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.0100018978119 LGEHNIDVLEGNEQFINAAKIITH acrolein addition +94(K)@20; reduced HNE(H)@24 cleaved H-P@C-term; missed K-I@20 0.211003005504608 2926.75512695313 976.5923 2926.5439453125 976.52197265625 3 11 1.1.1.4123.4 1 59.2167 845.0366 59.256 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 73.2100009918213 LGEHNIDVLEGNEQFINAAKIITH Oxidation(N)@17; reduced acrolein addition +58(K)@20; reduced HNE(H)@24 cleaved H-P@C-term; missed K-I@20 -0.275061994791031 2906.26391601563 969.7619 2906.53881835938 969.853576660156 3 12 1.1.1.4094.5 1 58.5013 869.9749 58.4647 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 71.5900003910065 LGEHNIDVLEGNEQFINAAKIITH acrolein addition +94(K)@20; reduced HNE(H)@24 cleaved H-P@C-term; missed K-I@20 0.211917996406555 2926.755859375 976.5926 2926.5439453125 976.52197265625 3 10 1.1.1.4137.4 1 59.5645 853.9825 59.528 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 68.3300018310547 LGEHNIDVLEGNEQFINAAKIITH reduced acrolein addition +96(K)@20; reduced HNE(H)@24 cleaved H-P@C-term; missed K-I@20 -0.313069999217987 2928.24658203125 977.0895 2928.5595703125 977.19384765625 3 11 1.1.1.4200.4 1 61.0868 1056.497 61.0745 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 67.2399997711182 LGEHNIDVLEGNEQFINAAKIITH reduced acrolein addition +96(K)@20; reduced HNE(H)@24 cleaved H-P@C-term; missed K-I@20 -0.303182989358902 2928.25659179688 977.0928 2928.5595703125 977.19384765625 3 10 1.1.1.4159.4 1 60.0884 777.8937 60.0736 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 63.9500021934509 LGEHNIDVLEGNEQFINAAKIITH acrolein addition +94(K)@20; reduced HNE(H)@24 cleaved H-P@C-term; missed K-I@20 0.20660799741745 2926.75073242188 976.5908 2926.5439453125 976.52197265625 3 11 1.1.1.4108.12 1 58.84 1113.131 58.9018 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 61.2100005149841 LGEHNIDVLEGNEQFINAAKIITH MDA adduct +62(K)@20; reduced HNE(H)@24 cleaved H-P@C-term; missed K-I@20 -0.268397986888886 2894.24951171875 965.7571 2894.51782226563 965.846557617188 3 10 1.1.1.4094.4 1 58.4988 833.0242 58.4647 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 61.2100005149841 LGEHNIDVLEGNEQFINAAKIITH Oxidation(N)@17; acrolein addition +56(K)@20; reduced HNE(H)@24 cleaved H-P@C-term; missed K-I@20 0.229418992996216 2904.75268554688 969.2582 2904.52319335938 969.181701660156 3 12 1.1.1.4151.4 1 59.8867 689.168 59.9283 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 66.4099991321564 LGEHNIDVLEGNEQFINAAKIITHP Delta:H(2)C(2)(K)@20 cleaved P-N@C-term; missed K-I@20 0.21204499900341 2797.65185546875 933.5579 2797.43994140625 933.487243652344 3 12 1.1.1.4114.4 1 59.0034 1389.648 58.9885 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPN acrolein addition +112(K)@20; reduced HNE(H)@24; Deamidated(N)@26 cleaved N-F@C-term; missed K-I@20 0.288258999586105 3156.92260742188 790.2379 3156.63427734375 790.165832519531 4 23 1.1.1.3898.7 1 53.7282 12185.04 53.8415 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPN acrolein addition +112(K)@20; reduced HNE(H)@24; Deamidated(N)@26 cleaved N-F@C-term; missed K-I@20 0.288258999586105 3156.92260742188 790.2379 3156.63427734375 790.165832519531 4 25 1.1.1.3905.4 1 53.8975 12185.04 53.8415 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPN HPNE addition +172(K)@20; reduced HNE(H)@24; Oxidation(P)@25; Deamidated(N)@26 cleaved N-F@C-term; missed K-I@20 0.24974599480629 3232.9365234375 809.2414 3232.68676757813 809.178955078125 4 21 1.1.1.3888.7 1 53.4814 897.6064 53.4487 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPN Oxidation(K)@20; reduced HNE(H)@24; Deamidated(N)@26 cleaved N-F@C-term; missed K-I@20 0.324045985937119 3060.90087890625 766.2325 3060.57666015625 766.151489257813 4 22 1.1.1.3945.4 1 54.862 593.6949 54.8812 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPN acrolein addition +112(K)@20; reduced HNE(H)@24; Deamidated(N)@26 cleaved N-F@C-term; missed K-I@20 0.2187529951334 3156.85424804688 1053.292 3156.63427734375 1053.21875 3 19 1.1.1.3898.15 1 53.7349 4431.92 53.8656 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPN HPNE addition +172(K)@20; reduced HNE(H)@24; Oxidation(P)@25 cleaved N-F@C-term; missed K-I@20 0.258174985647202 3231.9609375 808.9975 3231.70263671875 808.932983398438 4 18 1.1.1.3877.5 1 53.2096 1708.559 53.2523 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.5100014209747 LGEHNIDVLEGNEQFINAAKIITHPN Deamidated(N)@17; acrolein addition +56(K)@20 cleaved N-F@C-term; missed K-I@20 0.260719001293182 2942.73803710938 981.92 2942.47729492188 981.833068847656 3 11 1.1.1.4107.6 1 58.8231 1063.147 58.8283 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 74.2799997329712 LGEHNIDVLEGNEQFINAAKIITHPN cleaved N-F@C-term; missed K-I@20 -0.223435997962952 2885.24365234375 962.7552 2885.46728515625 962.829650878906 3 10 1.1.1.4143.6 1 59.7004 908.7048 59.6847 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 72.6700007915497 LGEHNIDVLEGNEQFINAAKIITHPN Deamidated(N)@17; acrolein addition +56(K)@20 cleaved N-F@C-term; missed K-I@20 -0.221580997109413 2942.255859375 981.7592 2942.47729492188 981.833068847656 3 11 1.1.1.4101.10 1 58.6753 868.7592 58.5853 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 62.3000025749207 LGEHNIDVLEGNEQFINAAKIITHPN acrolein addition +94(K)@20 cleaved N-F@C-term; missed K-I@20 0.243488997220993 2979.75244140625 994.2581 2979.50903320313 994.176940917969 3 10 1.1.1.4118.8 1 59.1048 933.0426 59.1342 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 49.3699997663498 LGEHNIDVLEGNEQFINAAKIITHPN Oxidation(P)@25 cleaved N-F@C-term; missed K-I@20 -0.207974001765251 2901.25415039063 968.092 2901.46215820313 968.161315917969 3 10 1.1.1.4154.10 1 59.9665 695.6342 59.9766 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNF Deamidated(N)@17; ONE addition +154(K)@20; reduced HNE(H)@24; Deamidated(N)@26 cleaved F-N@C-term; missed K-I@20 0.251134991645813 3346.98486328125 837.7535 3346.73364257813 837.690673828125 4 23 1.1.1.3881.5 1 53.3103 5709.226 53.228 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 78.9900004863739 LGEHNIDVLEGNEQFINAAKIITHPNF Deamidated(N)@17; ONE addition +154(K)@20; reduced HNE(H)@24; Deamidated(N)@26 cleaved F-N@C-term; missed K-I@20 0.180287003517151 3346.91333007813 1116.645 3346.73364257813 1116.58520507813 3 13 1.1.1.3877.20 1 53.2221 1616.846 53.228 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 48.7199991941452 LGEHNIDVLEGNEQFINAAKIITHPNF ONE addition +154(K)@20; reduced HNE(H)@24; Deamidated(N)@26 cleaved F-N@C-term; missed K-I@20 0.246380999684334 3345.99609375 837.5063 3345.74975585938 837.444702148438 4 12 1.1.1.3846.12 1 52.4556 5724.627 52.6395 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGN Delta:H(4)C(2)(K)@20 cleaved N-T@C-term; missed K-I@20 0.321105003356934 3345.99536132813 837.5061 3345.67431640625 837.425842285156 4 36 1.1.1.3852.4 1 52.5982 5768.258 52.6639 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGN Delta:H(4)C(2)(K)@20 cleaved N-T@C-term; missed K-I@20 0.321105003356934 3345.99536132813 837.5061 3345.67431640625 837.425842285156 4 37 1.1.1.3859.3 1 52.7691 5768.258 52.6639 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8499999046326 LGEHNIDVLEGNEQFINAAKIITHPNFNGN Formyl(K)@20 cleaved N-T@C-term; missed K-I@20 0.297262012958527 3345.93505859375 1116.319 3345.6376953125 1116.21984863281 3 18 1.1.1.3849.8 1 52.5316 1295.393 52.6395 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 91.8500006198883 LGEHNIDVLEGNEQFINAAKIITHPNFNGNT hexanoyl addition +98(K)@20; reduced HNE(H)@24 cleaved T-L@C-term; missed K-I@20 0.26274698972702 3675.1572265625 919.7966 3674.89453125 919.730895996094 4 15 1.1.1.3928.2 1 54.4511 1411.383 54.4463 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 54.6899974346161 LGEHNIDVLEGNEQFINAAKIITHPNFNGNT MDA adduct +62(K)@20 cleaved T-L@C-term; missed K-I@20 -0.539977014064789 3480.16625976563 697.0405 3480.70629882813 697.148498535156 5 12 1.1.1.4063.4 1 57.7713 2117.844 57.7411 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 33.6600005626678 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDND cleaved D-I@C-term; missed K-I@20 -0.85979300737381 3875.01171875 969.7602 3875.87133789063 969.975158691406 4 11 1.1.1.4109.4 1 58.8651 800.8727 58.8526 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 26.6200006008148 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDND cleaved D-I@C-term; missed K-I@20 -0.852957010269165 3875.0185546875 969.7619 3875.87133789063 969.975158691406 4 11 1.1.1.4094.5 1 58.5013 869.9749 58.4647 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIK Methyl(H)@24 missed K-I@20 0.404383987188339 4488.67919921875 898.7431 4488.27490234375 898.662231445313 5 37 1.1.1.4050.11 1 57.446 17303.14 57.486 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIK Delta:H(4)C(2)(K)@20 missed K-I@20 0.40820500254631 4502.69873046875 901.547 4502.29052734375 901.46533203125 5 35 1.1.1.4050.13 1 57.4477 27877.83 57.486 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIK Delta:H(4)C(2)(K)@20 missed K-I@20 0.326979994773865 4502.61865234375 1126.662 4502.29052734375 1126.57983398438 4 34 1.1.1.4050.18 1 57.4519 9916.111 57.486 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIK Delta:H(4)C(2)(H)@24; Deamidated(N)@28 missed K-I@20 0.409601986408234 4503.68408203125 901.7441 4503.2744140625 901.662170410156 5 34 1.1.1.4057.9 1 57.6261 6083.699 57.6911 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIK Methyl(H)@24; Deamidated(N)@28 missed K-I@20 0.330294013023376 4489.5908203125 1123.405 4489.2587890625 1123.32202148438 4 23 1.1.1.4057.18 1 57.6336 1442.333 57.6163 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIK Delta:H(4)C(2)(H)@24 missed K-I@20 0.479175001382828 4502.76953125 751.4689 4502.29052734375 751.389038085938 6 21 1.1.1.4051.5 1 57.4676 3825.329 57.486 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIK Delta:H(4)C(2)(H)@24; Deamidated(N)@28 missed K-I@20 0.334663987159729 4503.61083984375 1126.91 4503.2744140625 1126.82592773438 4 20 1.1.1.4057.19 1 57.6344 1999.233 57.6662 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIK Trimethyl(K)@40 missed K-I@20 0.330861002206802 4516.638671875 1130.167 4516.30615234375 1130.08374023438 4 19 1.1.1.4053.19 1 57.5317 2708.503 57.5384 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIK Methyl(H)@24; Deamidated(N)@30 missed K-I@20 -0.514702975749969 4488.744140625 749.1313 4489.2587890625 749.217041015625 6 18 1.1.1.4050.6 1 57.4419 2209.881 57.486 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.2600028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIK Methyl(H)@24; Deamidated(N)@30 missed K-I@20 0.445867985486984 4489.70458984375 749.2914 4489.2587890625 749.217041015625 6 15 1.1.1.4057.5 0 57.6227 448.8871 57.6911 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.0100018978119 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIK ONE addition +154(K)@20; Delta:H(2)C(2)(H)@24; Deamidated(N)@28; MDA adduct +54(K)@40 missed K-I@20 0.299804002046585 4709.66845703125 942.941 4709.36865234375 942.881042480469 5 14 1.1.1.3898.12 1 53.7324 744.1451 53.6235 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 71.5900003910065 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIK Delta:H(2)C(2)(H)@24; Oxidation(M)@37 missed K-I@20 0.442000985145569 4516.71142578125 904.3496 4516.26953125 904.26123046875 5 13 1.1.1.4051.12 1 57.4735 8951.285 57.5384 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 69.4199979305267 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIK ONE addition +154(K)@20; Deamidated(N)@34; reduced acrolein addition +96(K)@40 missed K-I@20 0.281076997518539 4725.68115234375 946.1435 4725.39990234375 946.087280273438 5 12 1.1.1.4061.16 1 57.7319 539.7442 57.7411 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 69.4199979305267 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIK Carbamyl(K)@40 missed K-I@20 0.432774990797043 4517.69775390625 904.5468 4517.26513671875 904.460266113281 5 13 1.1.1.4064.7 0 57.802 1842.306 57.8154 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.2399983406067 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKL reduced acrolein addition +58(K)@20; reduced HNE(H)@24; Oxidation(P)@25; Dioxidation(M)@37 cleaved L-S@C-term; missed K-I@20; missed K-L@40 0.124544002115726 4851.625 971.3323 4851.50048828125 971.307373046875 5 15 1.1.1.3789.10 1 51.0343 2594.651 50.9995 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 22.1300005912781 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKL hexanoyl addition +98(K)@20; reduced HNE(H)@24; acrolein addition +76(K)@40 cleaved L-S@C-term; missed K-I@20; missed K-L@40 0.0548050999641418 4919.63330078125 984.9339 4919.578125 984.922912597656 5 10 1.1.1.4129.8 0 59.3771 2247.084 59.256 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 44.6999996900558 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSS cleaved S-P@C-term; missed K-I@20; missed K-L@40 0.996753990650177 4762.40380859375 794.7413 4761.4072265625 794.575134277344 6 12 1.1.1.3880.7 1 53.2857 13861.84 53.3987 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 40.4199987649918 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSS HPNE addition +172(K)@20; reduced acrolein addition +58(K)@40 cleaved S-P@C-term; missed K-I@20; missed K-L@40 0.125476002693176 4991.6845703125 999.3442 4991.55908203125 999.319091796875 5 11 1.1.1.4054.15 1 57.5543 601.8866 57.3814 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 41.4200007915497 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSP cleaved P-A@C-term; missed K-I@20; missed K-L@40 -3.85190010070801 4854.60791015625 971.9289 4858.4599609375 972.699279785156 5 12 1.1.1.4204.4 1 61.1854 1076.244 61.1947 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 23.1800004839897 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSP cleaved P-A@C-term; missed K-I@20; missed K-L@40 -3.87997007369995 4854.580078125 971.9233 4858.4599609375 972.699279785156 5 12 1.1.1.4087.8 1 58.3323 737.473 58.3179 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 84.6499979496002 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPA hexanoyl addition +98(K)@20; reduced HNE(H)@24; Oxidation(D)@35; acrolein addition +94(K)@40 cleaved A-T@C-term; missed K-I@20; missed K-L@40 0.406926989555359 5296.1435546875 1060.236 5295.73779296875 1060.15478515625 5 16 1.1.1.4288.14 1 63.2672 9990.104 63.2521 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 73.2100009918213 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPA reduced acrolein addition +96(K)@20; reduced HNE(H)@24; acrolein addition +112(K)@40 cleaved A-T@C-term; missed K-I@20; missed K-L@40 0.482780009508133 5296.220703125 883.7107 5295.73779296875 883.630249023438 6 13 1.1.1.4290.11 1 63.3164 2358.767 63.2781 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 41.1700010299683 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPA reduced acrolein addition +96(K)@20; reduced HNE(H)@24; Deamidated(N)@30; acrolein addition +112(K)@40 cleaved A-T@C-term; missed K-I@20; missed K-L@40 0.480942994356155 5297.20263671875 883.8744 5296.7216796875 883.794250488281 6 12 1.1.1.4313.8 1 63.9123 1405.183 63.9535 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATL acrolein addition +56(K)@40 cleaved L-N@C-term; missed K-I@20; missed K-L@40 0.458099991083145 5200.11376953125 1041.03 5199.6552734375 1040.93823242188 5 16 1.1.1.4310.14 1 63.8392 9011.841 63.7463 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATL Deamidated(N)@17; acrolein addition +56(K)@20 cleaved L-N@C-term; missed K-I@20; missed K-L@40 0.465294986963272 5201.103515625 1041.228 5200.63916015625 1041.13513183594 5 16 1.1.1.4322.17 1 64.1511 547.4108 64.133 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 90.6000018119812 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATL acrolein addition +56(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 cleaved L-N@C-term; missed K-I@20; missed K-L@40 0.462397009134293 5228.1435546875 1046.636 5227.68310546875 1046.54382324219 5 16 1.1.1.4306.18 1 63.7387 12901.25 63.8501 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 90.6000018119812 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATL acrolein addition +56(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 cleaved L-N@C-term; missed K-I@20; missed K-L@40 0.462397009134293 5228.1435546875 1046.636 5227.68310546875 1046.54382324219 5 16 1.1.1.4313.16 1 63.919 12901.25 63.8501 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.9999992847443 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATL Deamidated(N)@12; acrolein addition +56(K)@40 cleaved L-N@C-term; missed K-I@20; missed K-L@40 0.463463991880417 5201.103515625 1041.228 5200.63916015625 1041.13513183594 5 14 1.1.1.4329.13 1 64.3287 2114.124 64.3924 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.0100028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATL acrolein addition +56(K)@40 cleaved L-N@C-term; missed K-I@20; missed K-L@40 0.525164008140564 5200.18017578125 867.704 5199.6552734375 867.616455078125 6 13 1.1.1.4304.10 1 63.6799 1779.385 63.6941 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 61.2100005149841 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATL ONE addition +154(K)@20; reduced HNE(H)@24; acrolein addition +112(K)@40 cleaved L-N@C-term; missed K-I@20; missed K-L@40 0.361005008220673 5568.2734375 1114.662 5567.9111328125 1114.58959960938 5 15 1.1.1.4312.19 1 63.8951 819.7446 63.6941 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN acrolein addition +94(K)@20; reduced HNE(H)@24; Dethiomethyl(M)@37; reduced acrolein addition +96(K)@40 cleaved N-S@C-term; missed K-I@20; missed K-L@40 0.372657001018524 5558.2685546875 1112.661 5557.8984375 1112.5869140625 5 24 1.1.1.4180.6 1 60.5957 168863.8 60.5841 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN Oxidation(M)@37; Delta:H(2)C(2)(K)@40 cleaved N-S@C-term; missed K-I@20; missed K-L@40 0.461340010166168 5300.1435546875 1061.036 5299.68212890625 1060.94372558594 5 20 1.1.1.4254.16 1 62.4091 1501.634 62.3451 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN acrolein addition +56(K)@40 cleaved N-S@C-term; missed K-I@20; missed K-L@40 0.453258007764816 5314.15380859375 1063.838 5313.69775390625 1063.74682617188 5 18 1.1.1.4252.16 1 62.3603 30345 62.4675 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN Deamidated(N)@17; acrolein addition +56(K)@40 cleaved N-S@C-term; missed K-I@20; missed K-L@40 0.457401990890503 5315.138671875 1064.035 5314.68212890625 1063.94372558594 5 18 1.1.1.4281.13 1 63.0903 7770.444 63.2521 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN reduced acrolein addition +58(K)@40 cleaved N-S@C-term; missed K-I@20; missed K-L@40 0.415147006511688 5316.12890625 1064.233 5315.7138671875 1064.15002441406 5 17 1.1.1.4300.21 1 63.5846 1465.634 63.6418 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8900005817413 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN acrolein addition +56(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 cleaved N-S@C-term; missed K-I@20; missed K-L@40 0.46976301074028 5342.19384765625 1069.446 5341.72607421875 1069.35241699219 5 18 1.1.1.4259.15 1 62.5331 2468.949 62.5685 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8900005817413 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN reduced acrolein addition +58(K)@40 cleaved N-S@C-term; missed K-I@20; missed K-L@40 -0.564467012882233 5315.1484375 1064.037 5315.7138671875 1064.15002441406 5 17 1.1.1.4274.15 1 62.9158 2728.705 62.7991 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8900005817413 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN reduced acrolein addition +58(K)@40 cleaved N-S@C-term; missed K-I@20; missed K-L@40 -0.574232995510101 5315.138671875 1064.035 5315.7138671875 1064.15002441406 5 17 1.1.1.4288.15 1 63.2681 7770.444 63.2521 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN acrolein addition +56(K)@40 cleaved N-S@C-term; missed K-I@20; missed K-L@40 0.453258007764816 5314.15380859375 1063.838 5313.69775390625 1063.74682617188 5 16 1.1.1.4259.14 1 62.5323 30345 62.4675 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN acrolein addition +56(K)@40 cleaved N-S@C-term; missed K-I@20; missed K-L@40 0.450816988945007 5314.14892578125 1063.837 5313.69775390625 1063.74682617188 5 16 1.1.1.4267.15 1 62.7372 1842.137 62.7991 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN reduced acrolein addition +58(K)@40 cleaved N-S@C-term; missed K-I@20; missed K-L@40 -0.505459010601044 5315.2080078125 886.8753 5315.7138671875 886.959533691406 6 16 1.1.1.4284.7 1 63.1586 2344.348 63.2521 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.0999994277954 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN acrolein addition +56(K)@40 cleaved N-S@C-term; missed K-I@20; missed K-L@40 0.526914000511169 5314.22509765625 886.7114 5313.69775390625 886.623596191406 6 15 1.1.1.4254.6 1 62.4007 9376.123 62.4922 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 91.8500006198883 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN acrolein addition +56(K)@40 cleaved N-S@C-term; missed K-I@20; missed K-L@40 0.526914000511169 5314.22509765625 886.7114 5313.69775390625 886.623596191406 6 15 1.1.1.4261.10 1 62.5797 9376.123 62.4922 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 91.8500006198883 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN reduced acrolein addition +58(K)@40 cleaved N-S@C-term; missed K-I@20; missed K-L@40 -0.505459010601044 5315.2080078125 886.8753 5315.7138671875 886.959533691406 6 15 1.1.1.4291.7 1 63.3389 2344.348 63.2521 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN reduced acrolein addition +58(K)@20 cleaved N-S@C-term; missed K-I@20; missed K-L@40 -0.436930000782013 5315.27685546875 760.3325 5315.7138671875 760.394958496094 7 14 1.1.1.4286.4 1 63.207 401.9127 63.2781 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.2600028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN reduced acrolein addition +58(K)@40 cleaved N-S@C-term; missed K-I@20; missed K-L@40 -0.505459010601044 5315.2080078125 886.8753 5315.7138671875 886.959533691406 6 14 1.1.1.4292.8 1 63.3657 2344.348 63.2521 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 84.4099998474121 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN Deamidated(N)@34; acrolein addition +38(K)@40 cleaved N-S@C-term; missed K-I@20; missed K-L@40 0.461984992027283 5297.13330078125 1060.434 5296.67138671875 1060.34155273438 5 14 1.1.1.4263.19 1 62.6385 1013.029 62.6708 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 83.459997177124 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN Deamidated(N)@34; acrolein addition +56(K)@40 cleaved N-S@C-term; missed K-I@20; missed K-L@40 0.526175022125244 5315.2080078125 886.8753 5314.68212890625 886.78759765625 6 14 1.1.1.4282.4 1 63.1084 2344.348 63.2521 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 82.9800009727478 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN Deamidated(N)@12; acrolein addition +56(K)@40 cleaved N-S@C-term; missed K-I@20; missed K-L@40 0.536428987979889 5315.21826171875 886.877 5314.68212890625 886.78759765625 6 14 1.1.1.4270.12 1 62.8124 752.697 62.7991 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.5100014209747 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN acrolein addition +76(K)@20; Deamidated(N)@30; Deamidated(N)@34 cleaved N-S@C-term; missed K-I@20; missed K-L@40 0.455850005149841 5336.12890625 1068.233 5335.6708984375 1068.14147949219 5 14 1.1.1.4257.11 1 62.4822 667.8831 62.4675 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.0100028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@40 cleaved N-S@C-term; missed K-I@20; missed K-L@40 0.453233003616333 5340.16845703125 1069.041 5339.7138671875 1068.94995117188 5 14 1.1.1.4323.18 1 64.1774 2247.046 64.0312 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 76.3999998569489 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN acrolein addition +56(K)@40; Dehydrated(T)@46 cleaved N-S@C-term; missed K-I@20; missed K-L@40 0.457230985164642 5296.1435546875 1060.236 5295.6875 1060.14477539063 5 14 1.1.1.4281.12 1 63.0886 9990.104 63.2521 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 67.7799999713898 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN acrolein addition +94(K)@20; HPNE addition +172(K)@40 cleaved N-S@C-term; missed K-I@20; missed K-L@40 0.464993000030518 5524.28857421875 1105.865 5523.82373046875 1105.77197265625 5 11 1.1.1.4357.10 1 65.06 929.5033 64.8374 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 63.9500021934509 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN reduced acrolein addition +58(K)@20 cleaved N-S@C-term; missed K-I@20; missed K-L@40 -0.510951995849609 5315.20263671875 886.8744 5315.7138671875 886.959533691406 6 12 1.1.1.4300.13 1 63.5779 376.0273 63.6418 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 61.2100005149841 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN hexanoyl addition +98(K)@20; Oxidation(M)@37; HPNE addition +172(K)@40 cleaved N-S@C-term; missed K-I@20; missed K-L@40 0.40276700258255 5544.25390625 1109.858 5543.849609375 1109.77722167969 5 20 1.1.1.4181.4 1 60.623 51252.85 60.4126 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 54.6899974346161 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN acrolein addition +38(K)@20; Deamidated(N)@48 cleaved N-S@C-term; missed K-I@20; missed K-L@40 -0.450931012630463 5296.220703125 883.7107 5296.67138671875 883.785827636719 6 12 1.1.1.4283.14 1 63.1393 2358.767 63.2781 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 49.3699997663498 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN Formyl@N-term; acrolein addition +56(K)@40 cleaved N-S@C-term; missed K-I@20; missed K-L@40 0.565081000328064 5342.2578125 891.3836 5341.69287109375 891.289428710938 6 13 1.1.1.4260.11 1 62.5551 1561.709 62.5685 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 27.9500007629395 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN reduced acrolein addition +96(K)@20; Oxidation(M)@37; HPNE addition +172(K)@40 cleaved N-S@C-term; missed K-I@20; missed K-L@40 0.408529996871948 5542.24365234375 1109.456 5541.833984375 1109.37414550781 5 19 1.1.1.4103.8 1 58.7262 7393.235 58.7555 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 24.0299999713898 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLN Delta:H(2)C(2)(H)@4; reduced acrolein addition +58(K)@40 cleaved N-S@C-term; missed K-I@20; missed K-L@40 -0.568153977394104 5341.16357421875 1069.24 5341.7294921875 1069.35314941406 5 12 1.1.1.4337.15 1 64.544 724.9081 64.6283 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.513463973999023 5540.31787109375 924.3936 5539.8046875 924.308044433594 6 22 1.1.1.4034.13 1 57.0457 4500.134 57.1337 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.511443018913269 5574.330078125 930.0623 5574.841796875 930.147583007813 6 21 1.1.1.4047.13 1 57.3697 3625.592 57.2339 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.517804980278015 5528.318359375 922.3937 5528.83642578125 922.47998046875 6 22 1.1.1.4050.14 1 57.4485 1422.796 57.4333 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.520843029022217 5558.3359375 927.3966 5557.81494140625 927.309814453125 6 22 1.1.1.4050.15 1 57.4494 30243.31 57.486 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.446961998939514 5558.39990234375 795.0644 5558.8466796875 795.128234863281 7 21 1.1.1.4051.8 1 57.4701 7518.713 57.486 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.443769007921219 5558.2587890625 1112.659 5557.81494140625 1112.5703125 5 24 1.1.1.4051.19 1 57.4793 12897 57.486 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.525862991809845 5587.33642578125 932.23 5587.8623046875 932.317626953125 6 23 1.1.1.4053.13 1 57.5267 1520.639 57.5644 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(D)@33; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.506371021270752 5544.32470703125 925.0614 5544.8310546875 925.145812988281 6 25 1.1.1.4055.10 1 57.5762 5962.879 57.5644 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.517230987548828 5530.30126953125 922.7241 5529.78369140625 922.637939453125 6 26 1.1.1.4057.10 1 57.6269 2123.004 57.716 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(D)@35; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.407471001148224 5573.2685546875 1115.661 5572.8623046875 1115.57971191406 5 24 1.1.1.4060.14 1 57.7076 40376.28 57.5905 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.471381008625031 5543.31982421875 924.8939 5542.8486328125 924.815368652344 6 23 1.1.1.4063.12 1 57.778 4338.862 57.7411 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamidomethyl(K)@40 missed K-I@20; missed K-L@40 0.432536005973816 5558.2587890625 1112.659 5557.826171875 1112.57250976563 5 29 1.1.1.4065.11 1 57.8331 29627.35 57.7906 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.518962025642395 5586.365234375 932.0682 5585.8466796875 931.981689453125 6 24 1.1.1.4067.13 1 57.8782 1689.191 57.8398 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl+Deamidated(Q)@14; reduced acrolein addition +58(K)@20 missed K-I@20; missed K-L@40 0.498088002204895 5574.3447265625 930.0647 5573.8466796875 929.981689453125 6 23 1.1.1.4068.14 1 57.9039 61141.33 57.6411 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.435223996639252 5558.24853515625 1112.657 5557.81494140625 1112.5703125 5 24 1.1.1.4072.4 1 58.0077 5565.791 58.0129 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@24 missed K-I@20; missed K-L@40 0.476848989725113 5515.29736328125 920.2235 5514.8203125 920.14404296875 6 37 1.1.1.4081.3 1 58.178 22450.98 58.2195 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24 missed K-I@20; missed K-L@40 0.475358992815018 5529.3115234375 922.5592 5528.83642578125 922.47998046875 6 40 1.1.1.4081.4 1 58.1805 64419.63 58.2686 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.437184005975723 5557.26904296875 1112.461 5556.8310546875 1112.37353515625 5 24 1.1.1.4081.5 1 58.183 156258.7 58.4159 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.482347995042801 5585.3447265625 931.8981 5584.8623046875 931.817687988281 6 24 1.1.1.4082.13 1 58.2077 3020.852 58.2686 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20 missed K-I@20; missed K-L@40 0.400483012199402 5529.23828125 1106.855 5528.83642578125 1106.77453613281 5 47 1.1.1.4082.19 1 58.2127 26353.76 58.2686 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Dethiomethyl(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 -0.582352995872498 5540.24853515625 1109.057 5540.8330078125 1109.173828125 5 29 1.1.1.4082.20 1 58.2135 4143.722 58.1949 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(N)@30 missed K-I@20; missed K-L@40 0.404291987419128 5515.2236328125 1104.052 5514.8203125 1103.97143554688 5 46 1.1.1.4083.4 1 58.2385 9090.485 58.2195 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(K)@40 missed K-I@20; missed K-L@40 0.476848989725113 5515.29736328125 920.2235 5514.8203125 920.14404296875 6 33 1.1.1.4084.5 1 58.2502 22450.98 58.2195 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.475358992815018 5529.3115234375 922.5592 5528.83642578125 922.47998046875 6 24 1.1.1.4084.6 1 58.251 64419.63 58.2686 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(N)@17; MDA adduct +54(K)@20; Oxidation(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.459096014499664 5615.2958984375 936.8899 5614.83642578125 936.813354492188 6 25 1.1.1.4084.11 1 58.2552 1880.114 58.3179 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Methyl(K)@40 missed K-I@20; missed K-L@40 -0.510931015014648 5770.513671875 962.7595 5771.0244140625 962.844665527344 6 24 1.1.1.4084.14 1 58.2577 6308.026 58.4159 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.558197021484375 5784.48193359375 965.0876 5785.0400390625 965.180603027344 6 25 1.1.1.4084.16 1 58.2594 1296.167 58.3423 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR ONE addition +154(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.60247802734375 5840.4638671875 974.4179 5841.06640625 974.518310546875 6 23 1.1.1.4084.18 1 58.261 1128.234 58.3179 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(N)@17; MDA adduct +54(K)@20; reduced HNE(H)@24; Methyl(K)@40 missed K-I@20; missed K-L@40 -0.468636006116867 5742.48828125 958.0886 5742.95654296875 958.166748046875 6 28 1.1.1.4085.10 1 58.2791 1418.973 58.2686 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; Dethiomethyl(M)@37; Methyl(K)@40 missed K-I@20; missed K-L@40 0.406758010387421 5543.25341796875 1109.658 5542.8486328125 1109.57702636719 5 31 1.1.1.4085.19 1 58.2866 52747.75 58.2934 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Trimethyl(K)@40 missed K-I@20; missed K-L@40 0.477531999349594 5543.32958984375 924.8955 5542.85205078125 924.81591796875 6 23 1.1.1.4086.6 1 58.3003 118480 58.2934 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.624292016029358 5610.25048828125 936.049 5610.87451171875 936.153076171875 6 26 1.1.1.4086.8 1 58.302 3939.77 58.4159 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; reduced HNE(H)@24; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.541953027248383 5796.4619140625 967.0842 5797.00390625 967.174560546875 6 26 1.1.1.4086.9 1 58.3028 2169.883 58.4647 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.544230997562408 5780.46435546875 964.418 5781.0087890625 964.508728027344 6 28 1.1.1.4087.6 1 58.3289 1497.854 58.4647 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.475358992815018 5529.3115234375 922.5592 5528.83642578125 922.47998046875 6 34 1.1.1.4088.2 1 58.3474 64419.63 58.2686 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.437184005975723 5557.26904296875 1112.461 5556.8310546875 1112.37353515625 5 27 1.1.1.4088.7 1 58.3616 159495.3 58.4159 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.497949004173279 5544.3330078125 925.0628 5544.8310546875 925.145812988281 6 24 1.1.1.4089.2 1 58.3741 85137.47 58.2934 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; Dehydrated(T)@23; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.434655994176865 5542.25341796875 1109.458 5541.8203125 1109.37133789063 5 25 1.1.1.4089.4 1 58.3824 27965.18 58.2934 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.583532989025116 5529.23828125 1106.855 5529.8203125 1106.97131347656 5 33 1.1.1.4090.4 1 58.4108 26353.76 58.2686 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Oxidation(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.470342993736267 5601.32763671875 934.5619 5600.857421875 934.483520507813 6 23 1.1.1.4091.4 1 58.4219 1556.676 58.4159 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Delta:H(2)C(2)(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.631274998188019 5612.25927734375 936.3838 5612.89013671875 936.489013671875 6 23 1.1.1.4091.5 1 58.4235 2931.967 58.4159 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR ONE addition +154(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.604309022426605 5840.4619140625 974.4176 5841.06640625 974.518310546875 6 28 1.1.1.4091.8 1 58.4285 1140.782 58.4647 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.475358992815018 5529.3115234375 922.5592 5528.83642578125 922.47998046875 6 26 1.1.1.4093.3 1 58.4687 64419.63 58.2686 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.511043012142181 5573.3369140625 929.8968 5572.826171875 929.811645507813 6 21 1.1.1.4093.6 1 58.4721 13354.77 58.3179 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.624292016029358 5610.25048828125 936.049 5610.87451171875 936.153076171875 6 24 1.1.1.4093.9 1 58.4771 3939.77 58.4159 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(K)@40 missed K-I@20; missed K-L@40 -0.516681015491486 5514.3037109375 920.0579 5514.8203125 920.14404296875 6 28 1.1.1.4094.2 1 58.4938 8665.33 58.244 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.437184005975723 5557.26904296875 1112.461 5556.8310546875 1112.37353515625 5 27 1.1.1.4095.4 1 58.528 159495.3 58.4159 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.473527997732162 5529.3095703125 922.5589 5528.83642578125 922.47998046875 6 33 1.1.1.4096.2 1 58.5444 38815.13 58.2934 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Trimethyl(K)@40 missed K-I@20; missed K-L@40 0.401555985212326 5543.25341796875 1109.658 5542.85205078125 1109.57763671875 5 27 1.1.1.4096.3 1 58.5503 49945.89 58.2934 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.384986013174057 5611.259765625 936.2172 5610.87451171875 936.153076171875 6 24 1.1.1.4100.6 1 58.6494 3890.125 58.6338 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.50893497467041 5544.322265625 925.061 5544.8310546875 925.145812988281 6 25 1.1.1.4101.3 1 58.6636 15207.97 58.6095 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamidomethyl(K)@20; Formyl(K)@40 missed K-I@20; missed K-L@40 -0.45490899682045 5585.3662109375 931.9017 5585.8212890625 931.977478027344 6 28 1.1.1.4101.5 1 58.6669 5422.208 58.8526 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.384986013174057 5611.259765625 936.2172 5610.87451171875 936.153076171875 6 23 1.1.1.4101.6 1 58.6686 3890.125 58.6338 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Dethiomethyl(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 -0.426328986883163 5542.3857421875 792.7767 5542.81201171875 792.837585449219 7 26 1.1.1.4102.2 1 58.6892 4388.343 58.7555 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.436574012041092 5557.26904296875 1112.461 5556.8310546875 1112.37353515625 5 26 1.1.1.4102.4 1 58.7009 153326.5 58.7314 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(H)@24; Formyl(K)@40 missed K-I@20; missed K-L@40 -0.513104021549225 5610.32861328125 802.4828 5610.841796875 802.556091308594 7 25 1.1.1.4103.4 1 58.7162 2997.072 58.8283 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.462175995111465 5529.29833984375 922.557 5528.83642578125 922.47998046875 6 29 1.1.1.4103.5 1 58.7187 4821.893 58.7314 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR PyridoxalPhosphate(K)@20; reduced HNE(H)@24; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 0.268664002418518 5542.24365234375 1109.456 5541.97412109375 1109.40209960938 5 22 1.1.1.4103.8 1 58.7262 7393.235 58.7555 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; Dethiomethyl(M)@37; Formyl(K)@40 missed K-I@20; missed K-L@40 0.477768003940582 5575.31591796875 930.2266 5574.83837890625 930.14697265625 6 23 1.1.1.4105.4 1 58.763 7891.453 58.7314 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.621361970901489 5610.25341796875 936.0495 5610.87451171875 936.153076171875 6 29 1.1.1.4107.4 1 58.8165 4211.84 58.8526 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.516624987125397 5544.314453125 925.0597 5544.8310546875 925.145812988281 6 29 1.1.1.4108.5 1 58.8342 17986.41 58.8283 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Dethiomethyl(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 -0.428891986608505 5542.38330078125 792.7763 5542.81201171875 792.837585449219 7 25 1.1.1.4109.2 1 58.8584 4854.806 58.8526 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.436574012041092 5557.26904296875 1112.461 5556.8310546875 1112.37353515625 5 26 1.1.1.4109.6 1 58.8717 162650 58.8283 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.473527997732162 5529.3095703125 922.5589 5528.83642578125 922.47998046875 6 30 1.1.1.4110.2 1 58.8825 5246.91 58.8283 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Methyl(K)@40 missed K-I@20; missed K-L@40 0.473527997732162 5541.3095703125 924.5589 5540.83642578125 924.47998046875 6 25 1.1.1.4112.2 1 58.9442 19439.94 59.1342 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +96(K)@20; Dethiomethyl(M)@37; Formyl(K)@40 missed K-I@20; missed K-L@40 0.471516996622086 5577.32568359375 930.5615 5576.85400390625 930.48291015625 6 23 1.1.1.4112.3 1 58.9467 6298.477 58.94 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Formyl(K)@40 missed K-I@20; missed K-L@40 -0.478484004735947 5586.36328125 932.0678 5586.841796875 932.147583007813 6 22 1.1.1.4113.3 1 58.9716 4713.53 58.9018 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; MDA adduct +54(K)@20; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.44328698515892 5610.25341796875 936.0495 5609.81005859375 935.975646972656 6 25 1.1.1.4115.2 1 59.0317 4211.84 58.8526 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Methyl(K)@40 missed K-I@20; missed K-L@40 0.548955023288727 5541.38525390625 792.6337 5540.83642578125 792.555297851563 7 26 1.1.1.4116.2 1 59.0412 4952.69 59.1342 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.436574012041092 5557.26904296875 1112.461 5556.8310546875 1112.37353515625 5 23 1.1.1.4116.10 1 59.0546 133934.6 59.1342 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.547442018985748 5557.26904296875 1112.461 5557.81494140625 1112.5703125 5 21 1.1.1.4116.11 1 59.0562 133934.6 59.1342 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Dehydrated(T)@31; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.415863990783691 5541.25390625 1109.258 5540.83642578125 1109.17456054688 5 23 1.1.1.4117.6 1 59.0806 7680.975 59.1342 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +56(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.478229999542236 5585.3681640625 931.902 5585.8466796875 931.981689453125 6 25 1.1.1.4118.4 1 59.0948 6321.227 59.1342 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.537580013275146 5528.298828125 922.3904 5528.83642578125 922.47998046875 6 28 1.1.1.4119.2 1 59.114 3205.756 59.1342 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Methyl(K)@40 missed K-I@20; missed K-L@40 0.472795993089676 5541.30908203125 924.5588 5540.83642578125 924.47998046875 6 23 1.1.1.4119.3 1 59.1157 19788.62 59.1342 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; Dethiomethyl(M)@37; Formyl(K)@40 missed K-I@20; missed K-L@40 -0.443266004323959 5574.39501953125 797.3494 5574.83837890625 797.412719726563 7 24 1.1.1.4122.2 1 59.1897 2576.807 59.1099 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Dethiomethyl(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.467408001422882 5573.32666015625 929.895 5572.85888671875 929.817138671875 6 22 1.1.1.4122.4 1 59.2014 7040.485 59.1582 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Methyl(K)@40 missed K-I@20; missed K-L@40 0.548955023288727 5541.38525390625 792.6337 5540.83642578125 792.555297851563 7 24 1.1.1.4123.2 1 59.2117 4761.2 59.256 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.437184005975723 5557.26904296875 1112.461 5556.8310546875 1112.37353515625 5 24 1.1.1.4123.7 1 59.2259 134847.1 59.2317 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.428820997476578 5540.2333984375 1109.054 5539.8046875 1108.96813964844 5 23 1.1.1.4124.10 1 59.2509 6906.036 59.2317 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Deamidated(N)@30 missed K-I@20; missed K-L@40 -0.500208020210266 5527.30419921875 922.2247 5527.8046875 922.308044433594 6 25 1.1.1.4126.4 1 59.2948 2363.524 59.1342 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Deamidated(N)@30; Dethiomethyl(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.486443996429443 5574.32958984375 930.0622 5573.84326171875 929.981140136719 6 22 1.1.1.4127.3 1 59.3188 6653.877 59.256 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20 missed K-I@20; missed K-L@40 0.437184005975723 5557.26904296875 1112.461 5556.8310546875 1112.37353515625 5 21 1.1.1.4130.4 1 59.4012 129719 59.3581 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@30; Deamidated(N)@34 missed K-I@20; missed K-L@40 -0.406599998474121 5540.3818359375 792.4904 5540.78857421875 792.548522949219 7 21 1.1.1.4131.2 1 59.4113 4654.821 59.4797 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.4391970038414 5540.24365234375 1109.056 5539.8046875 1108.96813964844 5 26 1.1.1.4131.8 1 59.4263 7809.565 59.4556 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.518455982208252 5544.3125 925.0594 5544.8310546875 925.145812988281 6 28 1.1.1.4132.4 1 59.4413 11791.49 59.3581 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.631982028484344 5610.24267578125 936.0477 5610.87451171875 936.153076171875 6 26 1.1.1.4132.6 1 59.4472 2922.34 59.3821 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.482677012681961 5530.302734375 922.7244 5529.8203125 922.643981933594 6 26 1.1.1.4134.2 1 59.4854 3239.89 59.6004 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Dethiomethyl(M)@37; Formyl(K)@40 missed K-I@20; missed K-L@40 0.522503972053528 5579.39208984375 798.0633 5578.86962890625 797.988647460938 7 24 1.1.1.4136.3 1 59.5338 3976.54 59.5522 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.611108005046844 5610.263671875 936.0512 5610.87451171875 936.153076171875 6 30 1.1.1.4137.2 1 59.5579 2486.699 59.5522 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.437184005975723 5557.26904296875 1112.461 5556.8310546875 1112.37353515625 5 24 1.1.1.4137.5 1 59.5679 129719 59.3581 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.441639006137848 5540.24853515625 1109.057 5539.8046875 1108.96813964844 5 24 1.1.1.4138.7 1 59.5929 8685.181 59.5763 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.474260985851288 5529.310546875 922.559 5528.83642578125 922.47998046875 6 28 1.1.1.4142.2 1 59.6668 3362.773 59.7089 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.494408011436462 5587.37255859375 932.236 5586.8779296875 932.153625488281 6 25 1.1.1.4144.4 1 59.718 4011.354 59.6602 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.50578498840332 5585.3681640625 931.902 5584.8623046875 931.817687988281 6 23 1.1.1.4145.3 1 59.7461 8478.691 59.8303 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.437795013189316 5557.26904296875 1112.461 5556.8310546875 1112.37353515625 5 23 1.1.1.4145.4 1 59.752 86273.34 59.6602 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Oxidation(D)@33; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.509245991706848 5598.33251953125 934.0627 5598.841796875 934.147583007813 6 23 1.1.1.4146.3 1 59.7644 2516.975 59.8549 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.373558014631271 5611.25146484375 936.2159 5610.8779296875 936.153625488281 6 27 1.1.1.4146.4 1 59.7669 2594.719 59.9525 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.444079995155334 5540.24853515625 1109.057 5539.8046875 1108.96813964844 5 27 1.1.1.4146.7 1 59.7744 10418.05 59.8303 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Oxidation(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.509245991706848 5598.33251953125 934.0627 5598.841796875 934.147583007813 6 26 1.1.1.4147.9 1 59.7911 2516.975 59.8549 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.500271022319794 5626.4091796875 938.7421 5626.9091796875 938.825500488281 6 24 1.1.1.4147.11 1 59.7944 1820.273 59.9766 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.473527997732162 5529.3095703125 922.5589 5528.83642578125 922.47998046875 6 26 1.1.1.4149.3 1 59.8378 3735.269 59.8303 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.423546999692917 5530.24365234375 1107.056 5529.8203125 1106.97131347656 5 27 1.1.1.4149.6 1 59.8462 2607.063 60.0736 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.510487020015717 5529.3095703125 922.5589 5529.8203125 922.643981933594 6 29 1.1.1.4150.3 1 59.8656 3735.269 59.8303 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@26; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.517521977424622 5584.34814453125 931.732 5583.83056640625 931.645751953125 6 24 1.1.1.4152.4 1 59.9183 6647.032 59.8792 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.374291002750397 5611.25244140625 936.216 5610.8779296875 936.153625488281 6 27 1.1.1.4153.4 1 59.9357 2705.792 59.9766 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.444079995155334 5540.24853515625 1109.057 5539.8046875 1108.96813964844 5 28 1.1.1.4153.8 1 59.9449 10418.05 59.8303 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Oxidation(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.504426002502441 5599.34619140625 934.2316 5598.841796875 934.147583007813 6 27 1.1.1.4154.9 1 59.9648 3832.068 59.9766 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.498751997947693 5627.408203125 938.9086 5626.9091796875 938.825500488281 6 24 1.1.1.4155.5 1 59.9955 2785.218 60.1226 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@28; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.500240027904511 5530.30419921875 922.7246 5530.80419921875 922.807983398438 6 28 1.1.1.4157.3 1 60.0313 12345.69 60.1226 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Deamidated(N)@26 missed K-I@20; missed K-L@40 -0.595130026340485 5529.2236328125 1106.852 5529.8203125 1106.97131347656 5 31 1.1.1.4157.7 1 60.0413 2986.553 60.1468 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@24; Deamidated(N)@28 missed K-I@20; missed K-L@40 0.4845330119133 5516.2890625 920.3888 5515.8046875 920.308044433594 6 35 1.1.1.4158.2 1 60.0679 6309.971 60.1468 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(K)@20; Deamidated(N)@28 missed K-I@20; missed K-L@40 0.415760010480881 5516.21826171875 1104.251 5515.8046875 1104.16821289063 5 35 1.1.1.4160.5 1 60.1141 3064.737 60.1468 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 -0.524065971374512 5540.263671875 1109.06 5540.78857421875 1109.1650390625 5 22 1.1.1.4160.6 1 60.1174 5490.723 60.1468 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Methyl(K)@40 missed K-I@20; missed K-L@40 0.569890022277832 5541.40625 792.6367 5540.83642578125 792.555297851563 7 25 1.1.1.4161.4 1 60.13 4141.589 60.1468 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Oxidation(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.494230985641479 5598.34765625 934.0652 5598.841796875 934.147583007813 6 26 1.1.1.4161.6 1 60.1333 4095.417 60.1226 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(N)@17; hexanoyl addition +98(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.487415999174118 5801.5224609375 967.9277 5801.03515625 967.846435546875 6 29 1.1.1.4161.7 1 60.135 29721.02 60.2916 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.499172985553741 5626.41015625 938.7423 5626.9091796875 938.825500488281 6 25 1.1.1.4162.7 1 60.1592 2559.024 60.1226 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24; Deamidated(N)@28 missed K-I@20; missed K-L@40 0.48377600312233 5530.30419921875 922.7246 5529.8203125 922.643981933594 6 39 1.1.1.4164.3 1 60.2008 12345.69 60.1226 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.545014023780823 5784.4951171875 965.0898 5785.0400390625 965.180603027344 6 25 1.1.1.4164.4 1 60.2024 2032.111 60.2916 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@20; Deamidated(N)@28 missed K-I@20; missed K-L@40 0.413170993328094 5530.2333984375 1107.054 5529.8203125 1106.97131347656 5 33 1.1.1.4164.7 1 60.2091 6104.558 60.1468 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.505070984363556 5584.3359375 931.7299 5583.83056640625 931.645751953125 6 22 1.1.1.4165.2 1 60.2299 4185.466 60.1226 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Methyl(K)@40 missed K-I@20; missed K-L@40 0.483801007270813 5516.28857421875 920.3887 5515.8046875 920.308044433594 6 34 1.1.1.4166.2 1 60.2498 4437.452 60.2673 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamidomethyl(K)@40 missed K-I@20; missed K-L@40 0.442301005125046 5558.2685546875 1112.661 5557.826171875 1112.57250976563 5 26 1.1.1.4166.4 1 60.2581 135734 60.2916 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +96(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.453669011592865 5783.47802734375 964.9203 5783.0244140625 964.844665527344 6 27 1.1.1.4167.9 1 60.2782 1605.669 60.2673 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@28; Methyl(K)@40 missed K-I@20; missed K-L@40 0.412708014249802 5516.21826171875 1104.251 5515.8046875 1104.16821289063 5 34 1.1.1.4167.11 1 60.2815 2783.475 60.2916 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Dehydrated(T)@23; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.589385986328125 5540.24853515625 1109.057 5540.83642578125 1109.17456054688 5 23 1.1.1.4167.12 1 60.2832 5230.093 60.2433 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.404926985502243 5543.25341796875 1109.658 5542.8486328125 1109.57702636719 5 25 1.1.1.4167.13 1 60.2849 25262.79 60.3883 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(N)@17; hexanoyl addition +98(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.487415999174118 5801.5224609375 967.9277 5801.03515625 967.846435546875 6 25 1.1.1.4168.5 1 60.304 29721.02 60.2916 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.488498002290726 5627.39794921875 938.9069 5626.9091796875 938.825500488281 6 32 1.1.1.4169.5 1 60.3272 2341.881 60.3157 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; reduced HNE(H)@24; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.492226004600525 5773.49609375 963.2566 5773.00390625 963.174560546875 6 21 1.1.1.4169.6 1 60.3297 5782.542 60.3883 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Oxidation(P)@25; Methyl(K)@40 missed K-I@20; missed K-L@40 0.416225999593735 5787.43359375 1158.494 5787.01953125 1158.4111328125 5 25 1.1.1.4169.8 1 60.3347 11003.36 60.4126 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(N)@17; hexanoyl addition +98(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.417299002408981 5801.45361328125 1161.298 5801.03515625 1161.21423339844 5 26 1.1.1.4170.5 1 60.3588 52051.9 60.5841 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.48377600312233 5530.30419921875 922.7246 5529.8203125 922.643981933594 6 30 1.1.1.4171.2 1 60.3681 16289.25 60.3883 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.507103979587555 5544.32421875 925.0613 5544.8310546875 925.145812988281 6 23 1.1.1.4171.3 1 60.3698 45977.25 60.3883 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(N)@17; hexanoyl addition +98(K)@20; reduced HNE(H)@24; Methyl(K)@40 missed K-I@20; missed K-L@40 0.487807005643845 5787.50732421875 965.5918 5787.01953125 965.510498046875 6 27 1.1.1.4171.6 1 60.3757 14336.46 60.4126 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(N)@17; acrolein addition +112(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.525606989860535 5815.5400390625 970.2639 5815.01416015625 970.176330566406 6 25 1.1.1.4171.7 1 60.3782 1604.815 60.5108 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@28; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.41500198841095 5530.2333984375 1107.054 5529.8203125 1106.97131347656 5 33 1.1.1.4171.8 1 60.3807 15906.13 60.3883 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.517863988876343 5586.3642578125 932.068 5585.8466796875 931.981689453125 6 24 1.1.1.4172.4 1 60.3942 4615.803 60.3883 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamidomethyl(K)@40 missed K-I@20; missed K-L@40 0.444743007421494 5558.2685546875 1112.661 5557.826171875 1112.57250976563 5 22 1.1.1.4173.6 1 60.4243 168863.8 60.5841 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.42179998755455 5627.33349609375 1126.474 5626.9091796875 1126.38916015625 5 28 1.1.1.4173.7 1 60.4268 2394.722 60.4126 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.381980985403061 5611.26025390625 936.2173 5610.8779296875 936.153625488281 6 27 1.1.1.4174.3 1 60.4476 1889.207 60.5356 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Trimethyl(K)@40 missed K-I@20; missed K-L@40 0.416685998439789 5544.25390625 1109.858 5543.8359375 1109.7744140625 5 29 1.1.1.4174.5 1 60.456 51252.85 60.4126 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.48377600312233 5530.30419921875 922.7246 5529.8203125 922.643981933594 6 29 1.1.1.4175.5 1 60.4677 16289.25 60.3883 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.487049013376236 5801.52197265625 967.9276 5801.03515625 967.846435546875 6 25 1.1.1.4175.10 1 60.4718 64286.81 60.5841 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(N)@17; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.440284013748169 5544.390625 793.0631 5544.8310546875 793.126037597656 7 29 1.1.1.4176.3 1 60.492 8868.978 60.3883 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Trimethyl(K)@40 missed K-I@20; missed K-L@40 0.467278003692627 5543.3193359375 924.8938 5542.85205078125 924.81591796875 6 22 1.1.1.4178.2 1 60.5406 22556.69 60.3883 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.470849007368088 5786.4951171875 965.4231 5786.02392578125 965.344604492188 6 24 1.1.1.4178.4 1 60.5456 7749.487 60.4126 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@28; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.41500198841095 5530.2333984375 1107.054 5529.8203125 1106.97131347656 5 32 1.1.1.4178.5 1 60.5481 15906.13 60.3883 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(N)@17; hexanoyl addition +98(K)@20; reduced HNE(H)@24; Methyl(K)@40 missed K-I@20; missed K-L@40 0.487807005643845 5787.50732421875 965.5918 5787.01953125 965.510498046875 6 25 1.1.1.4179.4 1 60.5699 14336.46 60.4126 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.525606989860535 5815.5400390625 970.2639 5815.01416015625 970.176330566406 6 23 1.1.1.4180.3 1 60.5899 1604.815 60.5108 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.507103979587555 5544.32421875 925.0613 5544.8310546875 925.145812988281 6 25 1.1.1.4181.2 1 60.6147 48270.32 60.3883 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Deamidated(N)@28; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.402563989162445 5786.42822265625 1158.293 5786.02392578125 1158.21203613281 5 28 1.1.1.4181.5 1 60.6272 6030.051 60.4126 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.487049013376236 5801.52197265625 967.9276 5801.03515625 967.846435546875 6 24 1.1.1.4182.3 1 60.6412 64286.81 60.5841 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.384543985128403 5611.2626953125 936.2177 5610.8779296875 936.153625488281 6 28 1.1.1.4183.5 1 60.672 1844.737 60.7788 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.623925983905792 5610.2509765625 936.0491 5610.87451171875 936.153076171875 6 26 1.1.1.4184.2 1 60.6911 1125.078 60.6805 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Methyl(K)@40 missed K-I@20; missed K-L@40 0.0476250983774662 5540.8837890625 924.4879 5540.83642578125 924.47998046875 6 25 1.1.1.4185.2 1 60.7109 3519.718 60.7788 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.571388006210327 5785.45263671875 965.2494 5786.02392578125 965.344604492188 6 27 1.1.1.4185.3 1 60.7143 1882.829 60.6805 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.506371021270752 5544.32470703125 925.0614 5544.8310546875 925.145812988281 6 27 1.1.1.4188.2 1 60.7821 9385.649 60.7788 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@28; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.403405994176865 5530.2236328125 1107.052 5529.8203125 1106.97131347656 5 25 1.1.1.4188.12 1 60.7929 1652.072 60.7788 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.487415999174118 5801.5224609375 967.9277 5801.03515625 967.846435546875 6 25 1.1.1.4189.4 1 60.8219 54783.14 60.7788 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Trimethyl(K)@20; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.409972012042999 5544.2431640625 1109.856 5543.8359375 1109.7744140625 5 22 1.1.1.4190.8 1 60.8517 9973.299 60.7293 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Methyl(K)@40 missed K-I@20; missed K-L@40 0.0241876002401114 5540.8603515625 924.484 5540.83642578125 924.47998046875 6 25 1.1.1.4192.4 1 60.8904 4518.214 61.002 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.471947014331818 5786.49609375 965.4233 5786.02392578125 965.344604492188 6 27 1.1.1.4192.6 1 60.8954 3028.787 60.803 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.397437006235123 5611.27197265625 936.2193 5610.87451171875 936.153076171875 6 26 1.1.1.4193.3 1 60.9186 2425.318 60.978 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.51589298248291 5544.3154296875 925.0598 5544.8310546875 925.145812988281 6 26 1.1.1.4196.3 1 60.9836 10481.63 60.9539 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(N)@17; hexanoyl addition +98(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.487415999174118 5801.5224609375 967.9277 5801.03515625 967.846435546875 6 25 1.1.1.4196.6 1 60.9894 59168.82 60.9297 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.52079302072525 5586.3671875 932.0685 5585.8466796875 931.981689453125 6 23 1.1.1.4198.3 1 61.0366 3594.156 60.9539 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.47341200709343 5786.49755859375 965.4235 5786.02392578125 965.344604492188 6 30 1.1.1.4199.2 1 61.061 2567.547 61.0745 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Methyl(K)@40 missed K-I@20; missed K-L@40 0.0512872003018856 5540.8876953125 924.4885 5540.83642578125 924.47998046875 6 23 1.1.1.4200.2 1 61.0801 4034.886 61.0986 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Delta:H(2)C(2)(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.621752977371216 5612.2685546875 936.3854 5612.89013671875 936.489013671875 6 26 1.1.1.4200.3 1 61.0835 2182.564 61.002 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.50893497467041 5544.322265625 925.061 5544.8310546875 925.145812988281 6 25 1.1.1.4203.4 1 61.1539 8427.98 61.0745 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(N)@17; hexanoyl addition +98(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.487049013376236 5801.52197265625 967.9276 5801.03515625 967.846435546875 6 28 1.1.1.4203.7 1 61.1606 50492.51 61.0745 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Deamidated(N)@28; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.559302985668182 5785.46484375 965.2514 5786.02392578125 965.344604492188 6 30 1.1.1.4206.4 1 61.2241 1915.991 60.978 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(N)@17; hexanoyl addition +98(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.487049013376236 5801.52197265625 967.9276 5801.03515625 967.846435546875 6 27 1.1.1.4210.6 1 61.3312 34878 61.3396 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR ONE addition +154(K)@20; reduced HNE(H)@24; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.562480986118317 5856.49853515625 977.0904 5857.06103515625 977.184143066406 6 27 1.1.1.4211.6 1 61.3512 1206.791 61.3637 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.409364998340607 5801.44384765625 1161.296 5801.03515625 1161.21423339844 5 24 1.1.1.4212.5 1 61.3827 19698.08 61.3156 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +96(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.405694991350174 5783.43017578125 964.9123 5783.0244140625 964.844665527344 6 25 1.1.1.4213.4 1 61.3938 973.2172 61.3156 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Methyl(K)@40 missed K-I@20; missed K-L@40 0.0487237982451916 5540.884765625 924.4881 5540.83642578125 924.47998046875 6 25 1.1.1.4214.2 1 61.4312 3446.783 61.3637 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(H)@24; Formyl(K)@40 missed K-I@20; missed K-L@40 0.442903012037277 5611.28466796875 936.2214 5610.841796875 936.147583007813 6 23 1.1.1.4215.3 1 61.4476 1542.913 61.4612 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamidomethyl(K)@40 missed K-I@20; missed K-L@40 0.442912012338638 5558.2685546875 1112.661 5557.826171875 1112.57250976563 5 24 1.1.1.4215.4 1 61.4518 122341.7 61.3637 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.452910989522934 5785.4931640625 965.2561 5785.0400390625 965.180603027344 6 27 1.1.1.4216.5 1 61.4737 1317.092 61.3637 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(N)@17; hexanoyl addition +98(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.487049013376236 5801.52197265625 967.9276 5801.03515625 967.846435546875 6 28 1.1.1.4217.7 1 61.4994 34878 61.3396 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Trimethyl(K)@40 missed K-I@20; missed K-L@40 0.405218005180359 5543.2587890625 1109.659 5542.85205078125 1109.57763671875 5 22 1.1.1.4218.4 1 61.5284 3543.181 61.437 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.409364998340607 5801.44384765625 1161.296 5801.03515625 1161.21423339844 5 26 1.1.1.4219.5 1 61.5493 20456.92 61.2914 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Methyl(K)@40 missed K-I@20; missed K-L@40 0.0487237982451916 5540.884765625 924.4881 5540.83642578125 924.47998046875 6 24 1.1.1.4221.2 1 61.6007 3441.564 61.3637 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)@N-term; acrolein addition +56(K)@20; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.518962025642395 5586.365234375 932.0682 5585.8466796875 931.981689453125 6 22 1.1.1.4222.5 1 61.614 5140.467 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.454755991697311 5558.2685546875 1112.661 5557.81494140625 1112.5703125 5 24 1.1.1.4222.10 1 61.6223 120634.3 61.3637 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.489246994256973 5801.5244140625 967.928 5801.03515625 967.846435546875 6 29 1.1.1.4224.8 1 61.6639 26900.73 61.4122 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.439727991819382 5785.47998046875 965.2539 5785.0400390625 965.180603027344 6 25 1.1.1.4225.4 1 61.685 600.6605 61.6797 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Deamidated(N)@30; Deamidated(N)@34 missed K-I@20; missed K-L@40 -0.395924985408783 5558.4033203125 795.0649 5558.79931640625 795.121459960938 7 21 1.1.1.4226.2 1 61.708 14779.73 61.6797 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.497348010540009 5627.39599609375 938.9066 5627.8935546875 938.989501953125 6 23 1.1.1.4226.6 1 61.7114 1938.818 61.8518 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Methyl(K)@40 missed K-I@20; missed K-L@40 0.485612988471985 5541.32177734375 924.5609 5540.83642578125 924.47998046875 6 26 1.1.1.4228.3 1 61.7644 2398.843 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.509301006793976 5544.32177734375 925.0609 5544.8310546875 925.145812988281 6 26 1.1.1.4228.4 1 61.7686 4618.908 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.390112996101379 5611.2646484375 936.2181 5610.87451171875 936.153076171875 6 23 1.1.1.4229.4 1 61.7857 959.0062 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +56(K)@20 missed K-I@20; missed K-L@40 0.454755991697311 5558.2685546875 1112.661 5557.81494140625 1112.5703125 5 21 1.1.1.4229.7 1 61.7923 53383.95 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Oxidation(M)@37; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.504791975021362 5599.3466796875 934.2317 5598.841796875 934.147583007813 6 25 1.1.1.4230.4 1 61.8152 2025.436 61.8518 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(N)@17; hexanoyl addition +98(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.488880008459091 5801.52392578125 967.9279 5801.03515625 967.846435546875 6 28 1.1.1.4231.14 1 61.8409 10799.33 61.5817 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; hexanoyl addition +98(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.497348010540009 5627.39599609375 938.9066 5627.8935546875 938.989501953125 6 25 1.1.1.4233.5 1 61.8829 1938.818 61.8518 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.522289991378784 5583.369140625 931.5688 5582.8466796875 931.481750488281 6 22 1.1.1.4235.5 1 61.9331 132059.6 62.1751 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.450587004423141 5583.29833984375 1117.667 5582.8466796875 1117.57666015625 5 23 1.1.1.4236.17 1 61.9684 103975 62.1751 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Oxidation(P)@25; Dethiomethyl(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.515797972679138 5557.34375 927.2312 5556.82763671875 927.145263671875 6 25 1.1.1.4237.5 1 61.9836 18784.29 61.9767 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Methyl(K)@40 missed K-I@20; missed K-L@40 0.52744197845459 5569.3583984375 929.2337 5568.8310546875 929.145812988281 6 23 1.1.1.4237.6 1 61.9844 16116.17 62.0274 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@20; Formyl(K)@40 missed K-I@20; missed K-L@40 0.475495010614395 5611.3173828125 936.2268 5610.841796875 936.147583007813 6 25 1.1.1.4237.7 1 61.9852 773.5345 62.0533 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.462262004613876 5639.33544921875 940.8965 5638.873046875 940.819458007813 6 24 1.1.1.4238.6 1 62.0098 605.168 62.0274 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(N)@17; hexanoyl addition +98(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.497669011354446 5801.53271484375 967.9294 5801.03515625 967.846435546875 6 27 1.1.1.4238.10 1 62.0131 6273.923 61.7534 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.450587004423141 5583.29833984375 1117.667 5582.8466796875 1117.57666015625 5 26 1.1.1.4238.18 1 62.0198 104008.7 62.1751 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.490689009428024 5628.38427734375 939.0713 5627.8935546875 938.989501953125 6 34 1.1.1.4240.4 1 62.0624 2859.279 61.9767 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(N)@17; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.422015011310577 5560.40380859375 795.3507 5560.826171875 795.411010742188 7 24 1.1.1.4241.2 1 62.0966 4185.961 61.9262 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.584532022476196 5583.43115234375 798.6403 5582.8466796875 798.556823730469 7 23 1.1.1.4244.4 1 62.1559 29792.21 62.1751 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.522289991378784 5583.369140625 931.5688 5582.8466796875 931.481750488281 6 25 1.1.1.4244.8 1 62.1592 134003.4 62.1751 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(N)@17; acrolein addition +112(K)@20; Oxidation(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.510371029376984 5673.388671875 946.5721 5672.87841796875 946.486999511719 6 27 1.1.1.4244.12 1 62.1625 3425.598 62.3204 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.450587004423141 5583.29833984375 1117.667 5582.8466796875 1117.57666015625 5 26 1.1.1.4245.10 1 62.191 104008.7 62.1751 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; hexanoyl addition +98(K)@20; Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.506510019302368 5628.37109375 939.0691 5628.87744140625 939.153503417969 6 29 1.1.1.4247.8 1 62.236 1453.657 62.2235 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Methyl(K)@40 missed K-I@20; missed K-L@40 0.49769800901413 5541.333984375 924.5629 5540.83642578125 924.47998046875 6 24 1.1.1.4249.4 1 62.2812 2984.141 62.3696 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.454755991697311 5558.2685546875 1112.661 5557.81494140625 1112.5703125 5 21 1.1.1.4250.5 1 62.312 8741.451 62.3204 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; Oxidation(H)@24; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.453682988882065 5673.33349609375 1135.674 5672.87841796875 1135.5830078125 5 28 1.1.1.4250.6 1 62.3154 1350.482 62.3204 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(F)@15; Oxidation(N)@17; acrolein addition +112(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.510371029376984 5673.388671875 946.5721 5672.87841796875 946.486999511719 6 31 1.1.1.4251.5 1 62.3363 3425.598 62.3204 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.522289991378784 5583.369140625 931.5688 5582.8466796875 931.481750488281 6 24 1.1.1.4252.5 1 62.3512 134003.4 62.1751 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.450587004423141 5583.29833984375 1117.667 5582.8466796875 1117.57666015625 5 27 1.1.1.4252.18 1 62.362 104008.7 62.1751 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(N)@17; hexanoyl addition +98(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.495837986469269 5801.53076171875 967.9291 5801.03515625 967.846435546875 6 25 1.1.1.4256.12 1 62.4549 650.006 62.4183 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.499884992837906 5566.35205078125 928.7326 5566.85205078125 928.81591796875 6 24 1.1.1.4261.16 1 62.5847 7831.806 62.5178 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.539129018783569 5584.3701171875 931.7356 5583.83056640625 931.645751953125 6 24 1.1.1.4263.14 1 62.6343 25504.25 62.6708 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@28; Methyl(K)@40 missed K-I@20; missed K-L@40 -0.465728998184204 5569.349609375 929.2322 5569.81494140625 929.309814453125 6 23 1.1.1.4268.15 1 62.7629 4772.754 62.7991 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.538396000862122 5584.369140625 931.7355 5583.83056640625 931.645751953125 6 24 1.1.1.4270.15 1 62.8149 55641.3 63.0006 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.538396000862122 5584.369140625 931.7355 5583.83056640625 931.645751953125 6 25 1.1.1.4284.9 1 63.1603 55983.54 63.0255 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.502026975154877 5584.3603515625 931.734 5584.8623046875 931.817687988281 6 22 1.1.1.4298.11 1 63.5236 5172.814 63.5114 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Methyl(K)@40 missed K-I@20; missed K-L@40 0.486712008714676 5541.32275390625 924.5611 5540.83642578125 924.47998046875 6 24 1.1.1.4302.12 1 63.6293 2096.881 63.3556 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.518262028694153 5583.365234375 931.5681 5582.8466796875 931.481750488281 6 25 1.1.1.4304.15 1 63.684 2913.24 63.6941 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.518262028694153 5583.365234375 931.5681 5582.8466796875 931.481750488281 6 23 1.1.1.4306.12 1 63.7337 2913.24 63.6941 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; MDA adduct +54(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.46552899479866 5609.3232421875 1122.872 5608.85888671875 1122.77905273438 5 25 1.1.1.4315.21 1 63.9744 34681.03 64.0053 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; MDA adduct +54(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.464309006929398 5609.3232421875 1122.872 5608.85888671875 1122.77905273438 5 25 1.1.1.4329.18 1 64.3328 15988.25 64.3404 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@28; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.465754002332687 5583.365234375 931.5681 5583.83056640625 931.645751953125 6 23 1.1.1.4331.15 1 64.3823 1550.286 64.3924 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; MDA adduct +54(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.467548012733459 5584.29833984375 1117.867 5583.83056640625 1117.7734375 5 28 1.1.1.4338.12 1 64.5671 1650.036 64.5755 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(H)@4; Ammonia-loss(N)@5; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.468452990055084 5556.2685546875 1112.261 5555.79931640625 1112.16711425781 5 23 1.1.1.4340.15 1 64.623 20194.23 64.6016 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +96(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.531369984149933 5625.42529296875 938.5781 5624.8935546875 938.489562988281 6 22 1.1.1.4343.11 1 64.6933 1260.482 64.7329 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Deamidated(N)@34 missed K-I@20; missed K-L@40 -0.46865901350975 5557.3466796875 927.2317 5557.81494140625 927.309814453125 6 21 1.1.1.4345.10 1 64.7447 8324.946 64.6016 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.461751013994217 5585.384765625 931.9047 5585.8466796875 931.981689453125 6 23 1.1.1.4347.8 1 64.7954 1565.288 64.7067 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamyl@N-term; acrolein addition +38(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.537100970745087 5610.3916015625 936.0725 5609.8544921875 935.982971191406 6 24 1.1.1.4349.6 1 64.8504 14800.56 64.7067 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; reduced HNE(H)@24; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.562905013561249 5797.56640625 967.2684 5797.00390625 967.174560546875 6 23 1.1.1.4353.8 1 64.9588 250.7487 64.9689 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +96(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.531369984149933 5625.42529296875 938.5781 5624.8935546875 938.489562988281 6 23 1.1.1.4359.7 1 65.1168 1055.268 65.1269 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.476000994443893 5582.37060546875 931.4024 5582.8466796875 931.481750488281 6 29 1.1.1.4364.5 1 65.2443 622.5838 65.1536 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +96(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.518185973167419 5625.412109375 938.5759 5624.8935546875 938.489562988281 6 27 1.1.1.4366.4 1 65.3009 862.423 65.3929 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Dethiomethyl(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.490112990140915 5573.34912109375 929.8988 5572.85888671875 929.817138671875 6 21 1.1.1.4061.15 1 57.731 90687.17 57.5905 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(N)@17; Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.514252007007599 5546.32958984375 925.3955 5545.81494140625 925.309814453125 6 23 1.1.1.4064.9 1 57.8053 3186.685 57.7658 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.506120026111603 5588.3681640625 932.402 5587.8623046875 932.317626953125 6 22 1.1.1.4106.3 1 58.7887 2736.688 58.8526 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Deamidated(N)@26; Dethiomethyl(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.425819009542465 5542.24365234375 1109.456 5541.81689453125 1109.37060546875 5 22 1.1.1.4110.7 1 58.8966 8650.315 58.9643 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +56(K)@20; reduced HNE(H)@24; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.492522001266479 5773.4951171875 963.2565 5773.98779296875 963.338562011719 6 21 1.1.1.4162.8 1 60.1609 5163.068 60.3883 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Dehydrated(T)@31; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 -0.423696011304855 5558.40185546875 795.0647 5558.82568359375 795.125244140625 7 21 1.1.1.4170.2 1 60.3463 53829.7 60.2433 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.492399990558624 5598.34912109375 934.0655 5598.841796875 934.147583007813 6 22 1.1.1.4171.5 1 60.3732 4343.687 60.1226 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(N)@17; acrolein addition +112(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.525606989860535 5815.5400390625 970.2639 5815.01416015625 970.176330566406 6 23 1.1.1.4173.3 1 60.4185 1604.815 60.5108 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Trimethyl(K)@40 missed K-I@20; missed K-L@40 0.416685998439789 5544.25390625 1109.858 5543.8359375 1109.7744140625 5 22 1.1.1.4181.4 1 60.623 51252.85 60.4126 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(N)@17; hexanoyl addition +98(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.418520003557205 5801.45361328125 1161.298 5801.03515625 1161.21423339844 5 23 1.1.1.4184.3 1 60.6995 47350.52 60.6805 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(N)@17; hexanoyl addition +98(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.409364998340607 5801.44384765625 1161.296 5801.03515625 1161.21423339844 5 23 1.1.1.4198.5 1 61.045 36452.24 60.9297 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Oxidation(P)@25 missed K-I@20; missed K-L@40 -0.497161000967026 5574.3447265625 930.0647 5574.841796875 930.147583007813 6 21 1.1.1.4202.4 1 61.1349 2493.449 60.9539 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(N)@17; hexanoyl addition +98(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.418520003557205 5801.45361328125 1161.298 5801.03515625 1161.21423339844 5 23 1.1.1.4205.4 1 61.2136 21407.33 61.1947 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Methyl(K)@40 missed K-I@20; missed K-L@40 0.455006986856461 5569.28857421875 1114.865 5568.8310546875 1114.77355957031 5 22 1.1.1.4238.17 1 62.019 13675.59 62.0274 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; Deamidated(N)@17; acrolein addition +38(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.538675010204315 5569.3583984375 929.2337 5568.81982421875 929.143920898438 6 22 1.1.1.4244.7 1 62.1584 16116.17 62.0274 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.522616982460022 5627.37060546875 938.9024 5627.8935546875 938.989501953125 6 22 1.1.1.4252.7 1 62.3528 1823.597 62.1507 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.598564028739929 5584.42919921875 798.7829 5583.83056640625 798.697387695313 7 22 1.1.1.4265.9 1 62.6812 5218.878 62.6708 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Carbamidomethyl(K)@40 missed K-I@20; missed K-L@40 0.447769999504089 5584.28857421875 1117.865 5583.841796875 1117.77563476563 5 22 1.1.1.4266.19 1 62.7151 19582.73 62.6708 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.486653000116348 5585.35986328125 931.9006 5585.8466796875 931.981689453125 6 22 1.1.1.4275.9 1 62.9406 40995.98 62.9757 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@28; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.466327011585236 5584.29833984375 1117.867 5583.83056640625 1117.7734375 5 22 1.1.1.4280.16 1 63.0685 40996.72 62.9757 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.45372799038887 5799.5498046875 967.5989 5800.00341796875 967.674499511719 6 22 1.1.1.4283.19 1 63.1435 223.8191 63.1251 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@26; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.457782000303268 5584.28857421875 1117.865 5583.83056640625 1117.7734375 5 22 1.1.1.4294.20 1 63.4273 17889.89 63.1502 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; MDA adduct +54(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.46552899479866 5609.3232421875 1122.872 5608.85888671875 1122.77905273438 5 22 1.1.1.4322.20 1 64.1536 34681.03 64.0053 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Deamidated(N)@30 missed K-I@20; missed K-L@40 -0.50313800573349 5527.30126953125 922.2242 5527.8046875 922.308044433594 6 21 1.1.1.4069.3 1 57.9211 790.2477 58.0377 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.542595982551575 5543.39111328125 792.9203 5542.8486328125 792.8427734375 7 22 1.1.1.4086.5 1 58.2995 29208.74 58.2934 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Delta:H(2)C(2)(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.621020972728729 5612.26953125 936.3855 5612.89013671875 936.489013671875 6 22 1.1.1.4105.5 1 58.7647 3305.297 58.8283 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.513463973999023 5540.31787109375 924.3936 5539.8046875 924.308044433594 6 20 1.1.1.4142.3 1 59.671 22118.26 59.6847 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40; Deamidated(N)@48 missed K-I@20; missed K-L@40 0.454145014286041 5558.2685546875 1112.661 5557.81494140625 1112.5703125 5 20 1.1.1.4159.5 1 60.0926 94371.43 59.9283 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR ONE addition +154(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.653428971767426 5840.41357421875 1169.09 5841.06640625 1169.22058105469 5 22 1.1.1.4213.11 1 61.4055 2848.486 61.3396 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.508693993091583 5674.40087890625 946.7407 5674.9091796875 946.825500488281 6 20 1.1.1.4280.8 1 63.0594 1306.513 63.1251 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.0498120002448559 5566.80224609375 928.8076 5566.85205078125 928.81591796875 6 21 1.1.1.4282.6 1 63.1117 1295.247 62.9506 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; Delta:H(2)C(2)(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.435438007116318 5556.2685546875 1112.261 5555.83251953125 1112.173828125 5 22 1.1.1.4333.17 1 64.4364 20194.23 64.6016 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamyl@N-term; acrolein addition +38(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.538199007511139 5610.392578125 936.0727 5609.8544921875 935.982971191406 6 22 1.1.1.4335.12 1 64.4848 14893.44 64.211 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(Q)@14; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.456573992967606 5557.3583984375 927.2337 5557.81494140625 927.309814453125 6 20 1.1.1.4352.6 1 64.932 3243.966 64.9955 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamyl@N-term; acrolein addition +38(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.526113986968994 5610.38037109375 936.0707 5609.8544921875 935.982971191406 6 22 1.1.1.4356.9 1 65.0345 3311.419 65.0214 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Deamidated(N)@30 missed K-I@20; missed K-L@40 -0.433869004249573 5557.38134765625 927.2375 5557.81494140625 927.309814453125 6 20 1.1.1.4419.6 1 66.5987 1453.336 66.5856 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 0.436852991580963 5851.4873046875 976.2552 5851.05078125 976.182373046875 6 20 1.1.1.4087.9 1 58.3339 1160.828 58.3675 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.511940002441406 5586.3662109375 932.0683 5586.8779296875 932.153625488281 6 21 1.1.1.4129.6 1 59.3721 6034.539 59.3821 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Deamidated(N)@30; Methyl(L)@38 missed K-I@20; missed K-L@40 -0.512403011322021 5771.49609375 962.9233 5772.00830078125 963.008666992188 6 22 1.1.1.4167.8 1 60.2765 1295.536 60.2673 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.524872004985809 5558.33984375 927.3973 5557.81494140625 927.309814453125 6 20 1.1.1.4196.4 1 60.9853 188872.3 60.9539 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Dethiomethyl(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 -0.0464638993144035 5540.78857421875 1109.165 5540.8330078125 1109.173828125 5 21 1.1.1.4197.8 1 61.021 3151.691 61.0745 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.522289991378784 5583.369140625 931.5688 5582.8466796875 931.481750488281 6 21 1.1.1.4242.3 1 62.1086 134003.4 62.1751 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; hexanoyl addition +98(K)@20; Dethiomethyl(M)@37; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 -0.500880002975464 5645.39990234375 941.9072 5645.900390625 941.99072265625 6 21 1.1.1.4242.5 1 62.1136 1048.766 61.9767 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.522289991378784 5583.369140625 931.5688 5582.8466796875 931.481750488281 6 21 1.1.1.4249.5 1 62.2837 134003.4 62.1751 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.584532022476196 5583.43115234375 798.6403 5582.8466796875 798.556823730469 7 21 1.1.1.4251.3 1 62.3297 29792.21 62.1751 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@40; Deamidated(N)@48 missed K-I@20; missed K-L@40 0.467548012733459 5584.29833984375 1117.867 5583.83056640625 1117.7734375 5 21 1.1.1.4259.17 1 62.5348 46720.08 62.2721 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.582984983921051 5557.41064453125 794.9231 5556.82763671875 794.839782714844 7 22 1.1.1.4335.4 1 64.4781 1884.589 64.6016 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Methyl(K)@40 missed K-I@20; missed K-L@40 0.49440199136734 5541.33056640625 924.5624 5540.83642578125 924.47998046875 6 22 1.1.1.4338.9 1 64.5621 548.3441 64.4706 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.508989989757538 5557.30859375 1112.469 5557.81494140625 1112.5703125 5 20 1.1.1.4421.3 1 66.658 914.9844 66.5595 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.44385701417923 5573.2685546875 1115.661 5572.826171875 1115.57250976563 5 20 1.1.1.4053.18 1 57.5308 40376.28 57.5905 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Oxidation(M)@37 missed K-I@20; missed K-L@40 -0.481339007616043 5544.3134765625 925.0595 5544.794921875 925.139709472656 6 21 1.1.1.4062.6 1 57.7482 6570.584 57.7411 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.57694798707962 5573.40283203125 797.2077 5572.826171875 797.125305175781 7 20 1.1.1.4084.3 1 58.2485 4078.665 58.3179 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Methyl(H)@24; Deamidated(N)@34 missed K-I@20; missed K-L@40 -0.522541999816895 5573.32373046875 929.8946 5573.8466796875 929.981689453125 6 21 1.1.1.4107.3 1 58.8131 9676.226 58.8283 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.505639016628265 5544.32568359375 925.0615 5544.8310546875 925.145812988281 6 22 1.1.1.4119.4 1 59.1174 11876.8 59.1342 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; Dethiomethyl(M)@37; Methyl(K)@40 missed K-I@20; missed K-L@40 0.479070991277695 5543.32763671875 924.8952 5542.8486328125 924.815368652344 6 22 1.1.1.4156.3 1 60.0097 25074.55 59.9283 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.417910009622574 5801.45361328125 1161.298 5801.03515625 1161.21423339844 5 22 1.1.1.4163.7 1 60.1874 20418.23 60.3157 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Dethiomethyl(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 -0.0342569015920162 5540.79833984375 1109.167 5540.8330078125 1109.173828125 5 21 1.1.1.4204.5 1 61.1896 3514.961 60.9297 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 -0.559529006481171 5597.287109375 933.8884 5597.8466796875 933.981689453125 6 20 1.1.1.4217.6 1 61.4969 945.6077 61.4612 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.420962005853653 5801.45361328125 1161.298 5801.03515625 1161.21423339844 5 22 1.1.1.4226.16 1 61.7206 6228.716 61.6797 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.522610008716583 5626.38671875 938.7384 5626.9091796875 938.825500488281 6 21 1.1.1.4259.10 1 62.529 1741.938 62.6708 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.466327011585236 5584.29833984375 1117.867 5583.83056640625 1117.7734375 5 21 1.1.1.4273.12 1 62.891 40996.72 62.9757 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.535234987735748 5557.27880859375 1112.463 5557.81494140625 1112.5703125 5 20 1.1.1.4376.4 1 65.5604 1715.82 65.5895 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.506762981414795 5558.33984375 927.3973 5558.8466796875 927.481750488281 6 17 1.1.1.4440.6 1 67.1415 1510.03 67.1338 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.514990985393524 5557.34619140625 927.2316 5556.8310546875 927.145812988281 6 19 1.1.1.4447.10 1 67.3137 2284.244 67.3034 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.497608006000519 5558.34912109375 927.3988 5558.8466796875 927.481750488281 6 17 1.1.1.4461.6 1 67.6561 1630.45 67.6483 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.451222002506256 5557.28369140625 1112.464 5556.8310546875 1112.37353515625 5 14 1.1.1.4463.7 1 67.7147 1280.965 67.8467 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.417481988668442 5558.42919921875 795.0686 5558.8466796875 795.128234863281 7 16 1.1.1.4478.2 1 68.0864 332.0434 68.0798 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.406800985336304 5558.43994140625 795.0701 5558.8466796875 795.128234863281 7 16 1.1.1.4486.3 1 68.2992 336.3221 68.2908 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.535865008831024 5557.3671875 927.2351 5556.8310546875 927.145812988281 6 18 1.1.1.4496.5 1 68.5536 1060.162 68.593 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.462208986282349 5557.29345703125 1112.466 5556.8310546875 1112.37353515625 5 17 1.1.1.4499.5 1 68.6379 567.8131 68.5392 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.536962985992432 5557.3681640625 927.2353 5556.8310546875 927.145812988281 6 19 1.1.1.4510.18 1 68.9321 930.6064 68.9128 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.534766018390656 5557.36572265625 927.2349 5556.8310546875 927.145812988281 6 17 1.1.1.4532.5 1 69.4693 1037.509 69.5082 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.534766018390656 5557.36572265625 927.2349 5556.8310546875 927.145812988281 6 16 1.1.1.4540.4 1 69.6823 1037.509 69.5082 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.450612008571625 5557.28369140625 1112.464 5556.8310546875 1112.37353515625 5 15 1.1.1.4547.12 1 69.8693 649.149 69.8497 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20 missed K-I@20; missed K-L@40 -0.498340010643005 5558.3486328125 927.3987 5558.8466796875 927.481750488281 6 18 1.1.1.4554.6 1 70.0482 919.4679 70.0352 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.508960008621216 5558.337890625 927.3969 5558.8466796875 927.481750488281 6 17 1.1.1.4565.3 1 70.3285 1000.179 70.2851 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.413991004228592 5557.24365234375 1112.456 5556.8310546875 1112.37353515625 5 17 1.1.1.4567.9 1 70.3751 355.1199 70.358 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.513526022434235 5557.3447265625 927.2314 5556.8310546875 927.145812988281 6 17 1.1.1.4572.11 1 70.5007 647.6765 70.4581 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.508764982223511 5557.33984375 927.2306 5556.8310546875 927.145812988281 6 17 1.1.1.4581.13 1 70.7265 827.9576 70.764 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20 missed K-I@20; missed K-L@40 0.462208986282349 5557.29345703125 1112.466 5556.8310546875 1112.37353515625 5 15 1.1.1.4586.15 1 70.8603 495.2525 70.8412 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.510595977306366 5557.341796875 927.2309 5556.8310546875 927.145812988281 6 18 1.1.1.4588.8 1 70.9053 794.4863 70.867 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.511328995227814 5557.34228515625 927.231 5556.8310546875 927.145812988281 6 19 1.1.1.4595.11 1 71.0925 784.5572 71.1025 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.522144019603729 5558.32470703125 927.3947 5558.8466796875 927.481750488281 6 17 1.1.1.4609.6 1 71.4601 851.2537 71.4963 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20 missed K-I@20; missed K-L@40 0.440236002206802 5557.27392578125 1112.462 5556.8310546875 1112.37353515625 5 16 1.1.1.4619.9 1 71.7265 461.653 71.7079 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.512426972389221 5557.34375 927.2312 5556.8310546875 927.145812988281 6 15 1.1.1.4623.20 1 71.8349 764.3342 71.8938 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.526709973812103 5557.35791015625 927.2336 5556.8310546875 927.145812988281 6 14 1.1.1.4660.12 1 72.8077 546.912 72.7674 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +96(K)@20; reduced HNE(H)@24; Oxidation(M)@37; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 0.436648011207581 5883.47705078125 981.5868 5883.04052734375 981.514038085938 6 20 1.1.1.4086.11 1 58.3045 1441.9 58.3179 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; reduced HNE(H)@24; Oxidation(M)@37; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 0.485323995351791 5827.49951171875 972.2572 5827.01416015625 972.176330566406 6 20 1.1.1.4091.7 1 58.4269 1241.406 58.3675 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; reduced HNE(H)@24; Oxidation(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.477108985185623 5770.5107421875 962.7591 5770.98779296875 962.838623046875 6 20 1.1.1.4105.6 1 58.7672 4299.103 58.7314 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; MDA adduct +54(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.515559017658234 5583.3154296875 931.5598 5583.83056640625 931.645751953125 6 21 1.1.1.4116.5 1 59.0462 4549.518 59.0372 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; reduced HNE(H)@24; Deamidated(N)@30; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.544272005558014 5770.50048828125 962.7574 5769.95654296875 962.666687011719 6 20 1.1.1.4127.4 1 59.3221 3256.104 59.0617 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.496959000825882 5530.3173828125 922.7268 5529.8203125 922.643981933594 6 21 1.1.1.4234.8 1 61.9103 695.9626 61.8765 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.538396000862122 5584.369140625 931.7355 5583.83056640625 931.645751953125 6 21 1.1.1.4277.7 1 62.9838 55983.54 63.0255 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@30; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.533599019050598 5541.322265625 924.561 5540.78857421875 924.472045898438 6 20 1.1.1.4295.10 1 63.4448 2053.793 63.3556 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.456232011318207 5583.37451171875 931.5697 5583.83056640625 931.645751953125 6 21 1.1.1.4347.7 1 64.7945 1389.818 64.8113 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; MDA adduct +54(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.450738996267319 5583.3798828125 931.5706 5583.83056640625 931.645751953125 6 21 1.1.1.4425.3 1 66.7497 623.5137 66.8468 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Deamidated(N)@30; Formyl(K)@40 missed K-I@20; missed K-L@40 0.528841018676758 5786.5166015625 965.4267 5785.98779296875 965.338562011719 6 21 1.1.1.4058.15 1 57.6561 1256.005 57.6163 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; Dethiomethyl(M)@37; Formyl(K)@40 missed K-I@20; missed K-L@40 -0.431730985641479 5574.40673828125 797.3511 5574.83837890625 797.412719726563 7 21 1.1.1.4065.6 1 57.8247 18210.07 57.5644 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Oxidation(H)@24; Methyl(K)@40 missed K-I@20; missed K-L@40 -0.512566983699799 5588.3447265625 932.3981 5588.857421875 932.483520507813 6 22 1.1.1.4086.7 1 58.3011 2296.001 58.2934 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +38(K)@20; Deamidated(N)@26; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.463798999786377 5569.28369140625 1114.864 5568.81982421875 1114.77124023438 5 21 1.1.1.4087.10 1 58.3356 1426.572 58.3179 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Dehydrated(T)@31 missed K-I@20; missed K-L@40 0.481218993663788 5541.3173828125 924.5602 5540.83642578125 924.47998046875 6 20 1.1.1.4127.2 1 59.3155 22643.23 59.256 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.481218993663788 5577.3173828125 930.5602 5576.83642578125 930.47998046875 6 19 1.1.1.4144.3 1 59.7154 3577.825 59.4797 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.507103979587555 5544.32421875 925.0613 5544.8310546875 925.145812988281 6 21 1.1.1.4173.2 1 60.4168 45977.25 60.3883 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Deamidated(N)@26; Formyl(K)@40 missed K-I@20; missed K-L@40 0.43894898891449 5786.42822265625 1158.293 5785.98779296875 1158.20483398438 5 21 1.1.1.4175.18 1 60.4785 6030.051 60.4126 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(N)@17; hexanoyl addition +98(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.417299002408981 5801.45361328125 1161.298 5801.03515625 1161.21423339844 5 22 1.1.1.4177.4 1 60.53 52349.27 60.5841 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Dethiomethyl(M)@37; Formyl(K)@40 missed K-I@20; missed K-L@40 0.451350003480911 5579.32080078125 930.8941 5578.86962890625 930.818908691406 6 21 1.1.1.4183.4 1 60.6686 2317.884 60.7788 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; Dethiomethyl(M)@37; Formyl(K)@40 missed K-I@20; missed K-L@40 -0.482804000377655 5574.35546875 930.0665 5574.83837890625 930.14697265625 6 21 1.1.1.4210.4 1 61.3253 2110.245 61.3396 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(H)@24; Formyl(K)@40 missed K-I@20; missed K-L@40 0.423126995563507 5611.2646484375 936.2181 5610.841796875 936.147583007813 6 21 1.1.1.4222.6 1 61.6156 959.0062 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; MDA adduct +62(K)@20; Formyl(K)@40 missed K-I@20; missed K-L@40 0.483130007982254 5617.314453125 937.2263 5616.8310546875 937.145812988281 6 21 1.1.1.4244.11 1 62.1617 660.6484 62.1751 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; hexanoyl addition +98(K)@20; Dehydrated(T)@31 missed K-I@20; missed K-L@40 -0.459176987409592 5606.423828125 801.925 5606.88330078125 801.990600585938 7 21 1.1.1.4249.3 1 62.2787 1794.437 62.1993 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Deamidated(N)@28; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.506794989109039 5629.38427734375 939.238 5628.87744140625 939.153503417969 6 21 1.1.1.4255.10 1 62.4344 1064.334 62.2963 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(4)C(2)(K)@40; Deamidated(N)@48 missed K-I@20; missed K-L@40 0.604972004890442 5584.435546875 798.7838 5583.83056640625 798.697387695313 7 21 1.1.1.4258.8 1 62.5018 17492.16 62.2477 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; hexanoyl addition +98(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.505393981933594 5653.42724609375 943.2451 5652.921875 943.160888671875 6 21 1.1.1.4263.15 1 62.6351 470.1508 62.6452 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; hexanoyl addition +98(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.501731991767883 5653.42333984375 943.2445 5652.921875 943.160888671875 6 21 1.1.1.4272.12 1 62.8635 577.9391 62.825 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.430175989866257 5585.2939453125 1118.066 5584.8623046875 1117.97973632813 5 20 1.1.1.4273.13 1 62.8927 29940.41 62.9757 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; reduced HNE(H)@24; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.567945003509521 5782.560546875 964.7674 5781.99267578125 964.672729492188 6 21 1.1.1.4328.11 1 64.3073 220.8035 64.263 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Dethiomethyl(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.633984982967377 5571.4775390625 796.9326 5570.84326171875 796.842041015625 7 20 1.1.1.4361.6 1 65.1666 1103.356 65.1536 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Dioxidation(P)@25; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 -0.383226007223129 5571.4111328125 929.5758 5571.79443359375 929.6396484375 6 21 1.1.1.4421.2 1 66.6497 1964.057 66.8206 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; MDA adduct +62(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.568705022335052 5593.388671875 933.2387 5592.81982421875 933.143920898438 6 21 1.1.1.4426.8 1 66.7841 278.1435 66.7942 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(N)@17; hexanoyl addition +98(K)@20; reduced HNE(H)@24; Methyl(K)@40 missed K-I@20; missed K-L@40 0.487073987722397 5787.50634765625 965.5917 5787.01953125 965.510498046875 6 22 1.1.1.4186.4 1 60.744 3460.372 60.7788 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Deamidated(N)@26; Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.53030800819397 5587.36083984375 932.2341 5586.83056640625 932.145690917969 6 21 1.1.1.4060.10 1 57.7017 1290.789 57.716 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.463611006736755 5540.2685546875 1109.061 5539.8046875 1108.96813964844 5 19 1.1.1.4073.6 1 58.0288 1657.988 58.0377 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.516393005847931 5540.32080078125 924.3941 5539.8046875 924.308044433594 6 19 1.1.1.4077.3 1 58.1178 12871.64 58.1949 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Oxidation(M)@37 missed K-I@20; missed K-L@40 0.511043012142181 5573.3369140625 929.8968 5572.826171875 929.811645507813 6 19 1.1.1.4084.9 1 58.2535 13354.77 58.3179 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +96(K)@20; reduced HNE(H)@24; Deamidated(N)@30; Methyl(K)@40 missed K-I@20; missed K-L@40 0.520703971385956 5770.513671875 962.7595 5769.99267578125 962.672729492188 6 21 1.1.1.4084.15 1 58.2585 6308.026 58.4159 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.512175023555756 5574.32958984375 930.0622 5574.841796875 930.147583007813 6 19 1.1.1.4119.5 1 59.119 7423.908 59.1342 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.511999011039734 5540.31640625 924.3934 5539.8046875 924.308044433594 6 19 1.1.1.4134.3 1 59.4887 20960.88 59.5763 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; Carbamidomethyl(K)@40 missed K-I@20; missed K-L@40 -0.487136006355286 5573.333984375 929.8963 5573.8212890625 929.977478027344 6 20 1.1.1.4143.5 1 59.697 4308.765 59.6847 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.517126023769379 5540.32177734375 924.3942 5539.8046875 924.308044433594 6 19 1.1.1.4149.4 1 59.8403 28944.02 59.9034 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Dehydrated(T)@31; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 -0.465777993202209 5574.35498046875 930.0664 5574.8203125 930.14404296875 6 20 1.1.1.4167.4 1 60.2723 3391.982 60.2673 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; reduced HNE(H)@24; Dioxidation(M)@37; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 0.524639010429382 5839.50244140625 974.2577 5838.97802734375 974.170227050781 6 20 1.1.1.4213.5 1 61.3955 908.2911 61.3396 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.523041009902954 5558.33837890625 927.397 5557.81494140625 927.309814453125 6 19 1.1.1.4224.4 1 61.6605 74741.82 61.6797 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.454145014286041 5558.2685546875 1112.661 5557.81494140625 1112.5703125 5 19 1.1.1.4243.3 1 62.1452 9419.884 62.1751 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.458703011274338 5566.2783203125 1114.263 5565.8203125 1114.17126464844 5 20 1.1.1.4259.16 1 62.534 5946.474 62.5178 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Deamidated(N)@30 missed K-I@20; missed K-L@40 0.532927989959717 5558.34814453125 927.3986 5557.81494140625 927.309814453125 6 19 1.1.1.4261.15 1 62.5839 15575.91 62.5178 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@17; acrolein addition +56(K)@20 missed K-I@20; missed K-L@40 0.599846005439758 5584.4306640625 798.7831 5583.83056640625 798.697387695313 7 20 1.1.1.4274.6 1 62.9083 13279.54 62.9011 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.420033991336823 5610.4580078125 802.5013 5610.8779296875 802.561279296875 7 21 1.1.1.4333.8 1 64.4289 2233.931 64.3404 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Deamidated(N)@34 missed K-I@20; missed K-L@40 -0.391157001256943 5557.423828125 794.925 5557.81494140625 794.980895996094 7 19 1.1.1.4361.5 1 65.165 1183.245 65.2064 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(N)@17; acrolein addition +56(K)@20 missed K-I@20; missed K-L@40 0.523127973079681 5573.34912109375 929.8988 5572.826171875 929.811645507813 6 20 1.1.1.4052.14 1 57.5012 90687.17 57.5905 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 -0.574621021747589 5850.47607421875 976.0866 5851.05078125 976.182373046875 6 19 1.1.1.4094.7 1 58.508 1156.785 58.4888 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.514844000339508 5584.34765625 931.7319 5584.8623046875 931.817687988281 6 20 1.1.1.4108.6 1 58.835 5719.539 58.8283 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@30; Deamidated(N)@34 missed K-I@20; missed K-L@40 -0.40446400642395 5540.38427734375 792.4907 5540.78857421875 792.548522949219 7 19 1.1.1.4139.3 1 59.6111 4669.992 59.5039 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40; Deamidated(N)@48 missed K-I@20; missed K-L@40 -0.545611023902893 5557.26904296875 1112.461 5557.81494140625 1112.5703125 5 19 1.1.1.4152.5 1 59.9225 71876.83 59.782 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.468201994895935 5582.37841796875 798.4899 5582.8466796875 798.556823730469 7 20 1.1.1.4233.3 1 61.8812 718.8984 61.8024 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.546769022941589 5598.29345703125 1120.666 5598.841796875 1120.77563476563 5 20 1.1.1.4245.11 1 62.1926 917.3926 62.1751 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.544166028499603 5622.333984375 938.0629 5622.8779296875 938.153625488281 6 20 1.1.1.4247.7 1 62.2343 992.6186 62.2477 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.426656007766724 5566.42529296875 796.2109 5566.85205078125 796.271850585938 7 20 1.1.1.4259.5 1 62.5248 1702.373 62.5178 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Methyl(K)@40 missed K-I@20; missed K-L@40 0.496966004371643 5541.3330078125 924.5628 5540.83642578125 924.47998046875 6 21 1.1.1.4263.13 1 62.6335 3060.313 62.3696 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.498796999454498 5529.3349609375 922.5631 5528.83642578125 922.47998046875 6 20 1.1.1.4294.12 1 63.4206 249.775 63.4332 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.528515994548798 5583.37548828125 931.5698 5582.8466796875 931.481750488281 6 20 1.1.1.4402.3 1 66.1681 610.2065 66.1591 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Deamidated(N)@34; Oxidation(M)@37 missed K-I@20; missed K-L@40 -0.481085002422333 5543.318359375 924.8937 5543.79931640625 924.973876953125 6 20 1.1.1.4048.15 1 57.3973 4324.426 57.486 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.440066009759903 5574.2490234375 1115.857 5573.81005859375 1115.76928710938 5 19 1.1.1.4075.9 1 58.0811 9638.892 58.1702 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; reduced HNE(H)@24; Hex(N)@26; reduced acrolein addition +96(K)@40 missed K-I@20; missed K-L@40 0.403097987174988 5975.49072265625 996.9224 5975.087890625 996.855224609375 6 20 1.1.1.4146.5 1 59.7694 7180.673 59.528 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@30; Deamidated(N)@34 missed K-I@20; missed K-L@40 -0.393355995416641 5540.39501953125 792.4923 5540.78857421875 792.548522949219 7 19 1.1.1.4154.5 1 59.9581 5640.818 59.9283 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.532397985458374 5582.314453125 931.393 5582.8466796875 931.481750488281 6 20 1.1.1.4188.4 1 60.7837 2388.903 60.7788 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.49550598859787 5587.37353515625 932.2362 5586.8779296875 932.153625488281 6 20 1.1.1.4188.5 1 60.7846 1721.167 60.803 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; Delta:H(2)C(2)(H)@24; Deamidated(N)@30 missed K-I@20; missed K-L@40 0.524809002876282 5529.3134765625 922.5595 5528.78857421875 922.472045898438 6 20 1.1.1.4226.5 1 61.7105 518.3859 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Oxidation(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.435286998748779 5599.27880859375 1120.863 5598.841796875 1120.77563476563 5 21 1.1.1.4227.4 1 61.7416 1649.457 61.8518 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@20; Deamidated(N)@34; Oxidation(M)@37 missed K-I@20; missed K-L@40 0.528222978115082 5600.35400390625 934.3996 5599.82568359375 934.311584472656 6 20 1.1.1.4231.12 1 61.8392 2728.379 61.8518 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.510109007358551 5586.3681640625 932.0686 5586.8779296875 932.153625488281 6 20 1.1.1.4242.4 1 62.1111 25205.11 62.1507 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(2)C(2)(H)@24; Methyl(K)@40 missed K-I@20; missed K-L@40 0.524852991104126 5595.37158203125 933.5692 5594.8466796875 933.481750488281 6 21 1.1.1.4312.9 1 63.8868 3062.364 63.876 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Trimethyl(K)@40 missed K-I@20; missed K-L@40 -0.506483972072601 5543.32958984375 924.8955 5543.8359375 924.979919433594 6 20 1.1.1.4093.4 1 58.4696 118480 58.2934 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; reduced HNE(H)@24; Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.492186009883881 5777.46923828125 963.9188 5777.96142578125 964.000854492188 6 19 1.1.1.4094.3 1 58.4963 1671.044 58.4647 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HexNAc(N)@17; acrolein addition +38(K)@20; reduced HNE(H)@24; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.562232971191406 5975.49951171875 996.9239 5976.06201171875 997.017578125 6 20 1.1.1.4103.7 1 58.7237 14803.98 58.9643 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR PyridoxalPhosphate(K)@20; reduced HNE(H)@24; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 0.34866800904274 5542.32275390625 924.7277 5541.97412109375 924.669616699219 6 20 1.1.1.4105.3 1 58.7613 23926.58 58.8283 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@28; Deamidated(N)@34; Oxidation(M)@37 missed K-I@20; missed K-L@40 -0.449151009321213 5572.3291015625 929.7288 5572.7783203125 929.803649902344 6 19 1.1.1.4129.5 1 59.3696 4676.327 59.2317 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Dethiomethyl(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.488252013921738 5541.3212890625 924.5608 5540.8330078125 924.479431152344 6 20 1.1.1.4163.2 1 60.1749 17279.59 60.1468 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Oxidation(M)@37; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.5157790184021 5599.357421875 934.2335 5598.841796875 934.147583007813 6 20 1.1.1.4163.4 1 60.1799 6129.26 60.1226 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Methyl(K)@40 missed K-I@20; missed K-L@40 -0.504199028015137 5570.3427734375 929.3977 5570.8466796875 929.481750488281 6 20 1.1.1.4171.4 1 60.3715 1450.038 60.2916 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Methyl(K)@40 missed K-I@20; missed K-L@40 -0.0480036996304989 5540.78857421875 1109.165 5540.83642578125 1109.17456054688 5 20 1.1.1.4182.5 1 60.6479 4333.538 60.5841 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamidomethyl(K)@40 missed K-I@20; missed K-L@40 0.444133013486862 5558.2685546875 1112.661 5557.826171875 1112.57250976563 5 19 1.1.1.4194.6 1 60.9454 165827.5 60.9297 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Oxidation(M)@37; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.498932987451553 5599.3408203125 934.2307 5598.841796875 934.147583007813 6 20 1.1.1.4224.7 1 61.663 1628.161 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.471947014331818 5786.49609375 965.4233 5786.02392578125 965.344604492188 6 20 1.1.1.4232.7 1 61.8598 681.0222 61.827 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.544281005859375 5784.49560546875 965.0899 5785.0400390625 965.180603027344 6 20 1.1.1.4235.6 1 61.9339 934.5106 61.9515 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; Deamidated(N)@26; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.507974028587341 5605.34375 935.2312 5605.8515625 935.315856933594 6 20 1.1.1.4244.10 1 62.1609 3908.356 62.1751 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.497640997171402 5606.34912109375 935.3988 5605.8515625 935.315856933594 6 20 1.1.1.4245.4 1 62.181 3193.145 62.1751 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.494475990533829 5784.54541015625 965.0982 5785.0400390625 965.180603027344 6 20 1.1.1.4371.13 1 65.4313 365.914 65.4677 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamidomethyl(K)@40 missed K-I@20; missed K-L@40 -0.453891009092331 5557.37255859375 927.236 5557.826171875 927.311645507813 6 19 1.1.1.4433.8 1 66.9621 2113.499 66.9518 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Dehydrated(T)@23; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 0.47138699889183 5595.318359375 933.5603 5594.8466796875 933.481750488281 6 19 1.1.1.4059.7 1 57.6744 1869.963 57.5905 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.512175023555756 5574.32958984375 930.0622 5574.841796875 930.147583007813 6 18 1.1.1.4075.6 1 58.0736 26627.75 58.1702 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Dioxidation(P)@25; Deamidated(N)@28; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.540773987770081 5562.34765625 928.0652 5561.806640625 927.975036621094 6 21 1.1.1.4129.4 1 59.3671 11146.83 59.3821 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.517126023769379 5540.32177734375 924.3942 5539.8046875 924.308044433594 6 18 1.1.1.4156.2 1 60.0063 28944.02 59.9034 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Delta:H(2)C(2)(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.619189977645874 5612.27099609375 936.3858 5612.89013671875 936.489013671875 6 20 1.1.1.4167.6 1 60.274 2373.351 60.171 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(N)@17; hexanoyl addition +98(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.409974992275238 5801.44384765625 1161.296 5801.03515625 1161.21423339844 5 21 1.1.1.4191.3 1 60.8756 45814.49 60.7788 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Dehydrated(T)@31 missed K-I@20; missed K-L@40 0.486712008714676 5541.32275390625 924.5611 5540.83642578125 924.47998046875 6 19 1.1.1.4235.4 1 61.9323 5874.542 61.9515 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Delta:H(2)C(2)(H)@24; Oxidation(M)@37 missed K-I@20; missed K-L@40 0.455006986856461 5569.28857421875 1114.865 5568.8310546875 1114.77355957031 5 20 1.1.1.4245.9 1 62.1893 13675.59 62.0274 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; MDA adduct +54(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.523072004318237 5609.38232421875 935.9043 5608.85888671875 935.817138671875 6 20 1.1.1.4300.15 1 63.5796 1599.308 63.5634 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamyl@N-term; acrolein addition +38(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.540030002593994 5610.39453125 936.073 5609.8544921875 935.982971191406 6 20 1.1.1.4307.13 1 63.7605 25212.23 64.0053 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; Delta:H(2)C(2)(H)@24; Dethiomethyl(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 -0.467931985855103 5541.34912109375 924.5654 5541.81689453125 924.643432617188 6 20 1.1.1.4316.10 1 63.9911 551.8896 63.9795 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamidomethyl(K)@40 missed K-I@20; missed K-L@40 -0.544026970863342 5557.28369140625 1112.464 5557.826171875 1112.57250976563 5 19 1.1.1.4411.8 1 66.3957 1484.902 66.2555 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Dethiomethyl(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.492897987365723 5571.3388671875 1115.275 5570.84326171875 1115.17590332031 5 19 1.1.1.4430.14 1 66.891 6599.267 66.8206 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.441058993339539 5560.2734375 1113.062 5559.83056640625 1112.97338867188 5 18 1.1.1.4180.7 1 60.5982 76294.17 60.5841 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.523773014545441 5558.3388671875 927.3971 5557.81494140625 927.309814453125 6 18 1.1.1.4168.4 1 60.3015 205564.9 60.2673 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.523041009902954 5558.33837890625 927.397 5557.81494140625 927.309814453125 6 18 1.1.1.4189.3 1 60.8161 148893.1 60.803 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.524505019187927 5558.33984375 927.3972 5557.81494140625 927.309814453125 6 18 1.1.1.4217.3 1 61.4911 157308.6 61.3396 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; Oxidation(H)@24; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.441466003656387 5654.42626953125 943.4117 5654.86767578125 943.485229492188 6 21 1.1.1.4256.11 1 62.4541 948.8622 62.4922 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.393292993307114 5557.421875 794.9247 5557.81494140625 794.980895996094 7 18 1.1.1.4270.7 1 62.8082 2210.276 62.7991 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.466327011585236 5584.29833984375 1117.867 5583.83056640625 1117.7734375 5 19 1.1.1.4287.21 1 63.247 41005.79 62.9757 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.534026980400085 5558.34912109375 927.3988 5557.81494140625 927.309814453125 6 18 1.1.1.4296.9 1 63.4696 8472.887 63.2521 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(E)@3; Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.484082996845245 5596.37841796875 933.737 5596.8623046875 933.817687988281 6 20 1.1.1.4309.12 1 63.8117 3786.221 63.9019 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Dethiomethyl(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 -0.473313003778458 5542.3388671875 924.7304 5542.81201171875 924.809265136719 6 20 1.1.1.4330.9 1 64.3513 868.2054 64.2367 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.532927989959717 5558.34814453125 927.3986 5557.81494140625 927.309814453125 6 18 1.1.1.4397.3 1 66.0452 3210.117 66.135 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Deamidated(N)@30 missed K-I@20; missed K-L@40 -0.458404988050461 5557.35693359375 927.2334 5557.81494140625 927.309814453125 6 21 1.1.1.4468.6 1 67.8341 2321.124 67.8216 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Deamidated(N)@34 missed K-I@20; missed K-L@40 -0.461333990097046 5557.35400390625 927.2329 5557.81494140625 927.309814453125 6 21 1.1.1.4525.3 1 69.302 984.5297 69.3316 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.532927989959717 5558.34814453125 927.3986 5557.81494140625 927.309814453125 6 21 1.1.1.4547.10 1 69.866 1208.482 69.8497 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.501882016658783 5557.32958984375 927.2289 5556.82763671875 927.145263671875 6 31 1.1.1.4616.4 1 71.6456 814.2017 71.549 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.501515984535217 5557.3291015625 927.2288 5556.82763671875 927.145263671875 6 25 1.1.1.4653.17 1 72.6272 627.41 72.6621 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.511443018913269 5574.330078125 930.0623 5574.841796875 930.147583007813 6 18 1.1.1.4040.8 1 57.1939 3625.592 57.2339 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; reduced acrolein addition +96(K)@40 missed K-I@20; missed K-L@40 -0.578674972057343 5852.48779296875 976.4219 5853.06640625 976.518310546875 6 18 1.1.1.4092.4 1 58.4527 1354.128 58.4403 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Deamidated(N)@34; Dethiomethyl(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.508916974067688 5573.333984375 929.8963 5573.84326171875 929.981140136719 6 19 1.1.1.4100.5 1 58.6461 7937.551 58.5853 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Trimethyl(K)@40 missed K-I@20; missed K-L@40 -0.539070010185242 5542.31298828125 924.7261 5542.85205078125 924.81591796875 6 19 1.1.1.4116.4 1 59.0446 20798.81 59.0126 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.404926985502243 5543.25341796875 1109.658 5542.8486328125 1109.57702636719 5 20 1.1.1.4175.15 1 60.476 25262.79 60.3883 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; reduced HNE(H)@24; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.51335597038269 5773.49609375 963.2566 5772.982421875 963.171020507813 6 18 1.1.1.4176.7 1 60.5003 5782.542 60.3883 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.455365985631943 5558.2685546875 1112.661 5557.81494140625 1112.5703125 5 18 1.1.1.4201.3 1 61.1092 165827.5 60.9297 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.524505019187927 5558.33984375 927.3972 5557.81494140625 927.309814453125 6 18 1.1.1.4210.3 1 61.3228 157308.6 61.3396 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR ONE addition +154(K)@20; reduced HNE(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.581896007061005 5840.48095703125 974.4208 5841.06298828125 974.517761230469 6 19 1.1.1.4224.11 1 61.6664 617.6907 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.504687011241913 5585.3671875 931.9018 5584.8623046875 931.817687988281 6 19 1.1.1.4231.11 1 61.8384 3734.368 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.59663599729538 5558.41162109375 795.0661 5557.81494140625 794.980895996094 7 18 1.1.1.4252.3 1 62.3495 3625.2 62.1751 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.534026980400085 5558.34912109375 927.3988 5557.81494140625 927.309814453125 6 18 1.1.1.4289.12 1 63.2912 8472.887 63.2521 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.47893100976944 5582.36767578125 931.4019 5582.8466796875 931.481750488281 6 19 1.1.1.4311.14 1 63.865 2053.694 63.7985 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(H)@24 missed K-I@20; missed K-L@40 0.487444013357162 5529.32373046875 922.5612 5528.83642578125 922.47998046875 6 19 1.1.1.4335.9 1 64.4822 288.3792 64.4706 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.40012601017952 5626.50927734375 804.7943 5626.9091796875 804.851501464844 7 19 1.1.1.4345.7 1 64.7422 402.0412 64.7067 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Deamidated(N)@34 missed K-I@20; missed K-L@40 -0.471587985754013 5557.34375 927.2312 5557.81494140625 927.309814453125 6 18 1.1.1.4371.10 1 65.4288 2796.889 65.443 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.448242992162704 5558.3984375 795.0642 5558.8466796875 795.128234863281 7 20 1.1.1.4061.12 1 57.7285 18961.01 57.7906 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.546831011772156 5557.26904296875 1112.461 5557.81494140625 1112.5703125 5 18 1.1.1.4091.10 1 58.4319 159495.3 58.4159 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0655876994132996 5539.8701171875 924.319 5539.8046875 924.308044433594 6 20 1.1.1.4100.4 1 58.6436 9562.726 58.7314 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.528541028499603 5557.35986328125 927.2339 5556.8310546875 927.145812988281 6 20 1.1.1.4310.7 1 63.8334 6403.372 63.7722 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.496508985757828 5558.35009765625 927.399 5558.8466796875 927.481750488281 6 20 1.1.1.4412.4 1 66.4136 2922.822 66.2796 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +76(K)@20; reduced HNE(H)@24; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.508197009563446 5812.490234375 969.7557 5811.982421875 969.670959472656 6 18 1.1.1.4087.7 1 58.3306 1213.369 58.3423 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +96(K)@20; reduced HNE(H)@24; Oxidation(M)@37 missed K-I@20; missed K-L@40 -0.474545001983643 5770.513671875 962.7595 5770.98779296875 962.838623046875 6 18 1.1.1.4091.6 1 58.4252 6308.026 58.4159 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +96(K)@20; reduced HNE(H)@24; Oxidation(M)@37; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 0.462648987770081 5883.5029296875 981.5911 5883.04052734375 981.514038085938 6 18 1.1.1.4093.12 1 58.4821 1578.755 58.4403 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +96(K)@20; reduced HNE(H)@24; Deamidated(N)@28; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 0.457013010978699 5850.47607421875 976.0866 5850.01904296875 976.010437011719 6 18 1.1.1.4094.6 1 58.5046 1156.785 58.4888 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Methyl(H)@24; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.399408012628555 5574.2431640625 1115.856 5573.8466796875 1115.77661132813 5 19 1.1.1.4105.8 1 58.7722 3576.56 58.7314 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Trimethyl(K)@40 missed K-I@20; missed K-L@40 -0.530646979808807 5542.3212890625 924.7275 5542.85205078125 924.81591796875 6 19 1.1.1.4124.3 1 59.2375 24772.02 59.1342 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@30; Deamidated(N)@34 missed K-I@20; missed K-L@40 -0.474945992231369 5540.3134765625 924.3929 5540.78857421875 924.472045898438 6 18 1.1.1.4125.3 1 59.2667 17610.56 59.256 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.592790007591248 5574.2490234375 1115.857 5574.841796875 1115.9755859375 5 18 1.1.1.4128.4 1 59.3488 2716.03 59.2317 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.485424011945724 5573.32470703125 929.8947 5573.81005859375 929.975646972656 6 18 1.1.1.4135.5 1 59.5162 5248.836 59.256 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@30; Deamidated(N)@34 missed K-I@20; missed K-L@40 -0.393355995416641 5540.39501953125 792.4923 5540.78857421875 792.548522949219 7 18 1.1.1.4147.5 1 59.7877 5640.818 59.9283 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; MDA adduct +54(K)@20; Oxidation(P)@25; Formyl(K)@40 missed K-I@20; missed K-L@40 -0.4983049929142 5599.28857421875 1120.865 5599.78955078125 1120.96508789063 5 20 1.1.1.4165.3 1 60.2382 2867.477 60.1468 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(Q)@14; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.523773014545441 5558.3388671875 927.3971 5557.81494140625 927.309814453125 6 18 1.1.1.4203.5 1 61.1556 173468.5 61.0986 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.529322028160095 5600.35498046875 934.3998 5599.82568359375 934.311584472656 6 19 1.1.1.4238.5 1 62.009 2726.461 61.9013 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.546221017837524 5557.26904296875 1112.461 5557.81494140625 1112.5703125 5 18 1.1.1.4347.14 1 64.8029 14499.49 64.6016 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(Q)@14; Deamidated(N)@17; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.608658015727997 5565.3974609375 796.064 5564.78857421875 795.97705078125 7 18 1.1.1.4087.2 1 58.3223 2439.208 58.2934 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; reduced HNE(H)@24; Oxidation(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.484432995319366 5770.50341796875 962.7579 5770.98779296875 962.838623046875 6 18 1.1.1.4098.4 1 58.6002 4262.115 58.6095 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; reduced HNE(H)@24; Oxidation(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.486629992723465 5770.50146484375 962.7575 5770.98779296875 962.838623046875 6 18 1.1.1.4112.4 1 58.9492 3535.168 59.0126 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; reduced HNE(H)@24; Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.5450040102005 5770.50146484375 962.7575 5769.95654296875 962.666687011719 6 18 1.1.1.4119.6 1 59.1207 3535.168 59.0126 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Dethiomethyl(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.490083009004593 5541.32275390625 924.5611 5540.8330078125 924.479431152344 6 19 1.1.1.4146.2 1 59.7619 24501.18 59.8062 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; HPNE addition +172(K)@20; reduced HNE(H)@24; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.528820991516113 5870.57421875 979.4363 5870.04541015625 979.34814453125 6 18 1.1.1.4172.7 1 60.3992 1136.322 60.4126 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Hex(N)@17; hexanoyl addition +98(K)@20; reduced HNE(H)@24; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.587894022464752 5976.515625 997.0932 5977.103515625 997.191162109375 6 19 1.1.1.4209.4 1 61.3038 11726.43 61.388 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; reduced HNE(H)@24; Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.522360980510712 5787.50537109375 965.5915 5786.98291015625 965.504455566406 6 18 1.1.1.4227.2 1 61.735 683.8429 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Dethiomethyl(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.490083009004593 5541.32275390625 924.5611 5540.8330078125 924.479431152344 6 19 1.1.1.4242.2 1 62.1061 5874.542 61.9515 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.461726009845734 5583.369140625 931.5688 5583.83056640625 931.645751953125 6 19 1.1.1.4244.9 1 62.16 134003.4 62.1751 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +56(K)@20; Oxidation(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.466064989566803 5601.37548828125 934.5698 5601.84130859375 934.647521972656 6 20 1.1.1.4249.6 1 62.2862 1704.2 62.2235 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; MDA adduct +54(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.541692018508911 5584.37255859375 931.736 5583.83056640625 931.645751953125 6 19 1.1.1.4261.17 1 62.5856 57856.86 62.3204 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.431789010763168 5584.4306640625 798.7831 5584.8623046875 798.844787597656 7 18 1.1.1.4282.2 1 63.105 13279.54 62.9011 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.533599019050598 5541.322265625 924.561 5540.78857421875 924.472045898438 6 18 1.1.1.4287.11 1 63.2387 2053.793 63.3556 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.531098008155823 5784.5087890625 965.0921 5785.0400390625 965.180603027344 6 19 1.1.1.4326.16 1 64.2538 295.6661 64.2367 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.523127973079681 5573.34912109375 929.8988 5572.826171875 929.811645507813 6 18 1.1.1.4054.11 1 57.551 90687.17 57.5905 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Dethiomethyl(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 -0.528685986995697 5572.33056640625 929.729 5572.85888671875 929.817138671875 6 18 1.1.1.4145.2 1 59.7403 3082.214 59.5039 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Dethiomethyl(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.514769971370697 5572.34423828125 929.7313 5572.85888671875 929.817138671875 6 18 1.1.1.4152.3 1 59.9141 3940.453 59.9283 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.0157580003142357 5565.8359375 928.6466 5565.8203125 928.643981933594 6 18 1.1.1.4245.2 1 62.1784 2979.06 62.1507 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.431789010763168 5584.4306640625 798.7831 5584.8623046875 798.844787597656 7 18 1.1.1.4278.10 1 63.0113 13279.54 62.9011 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.538396000862122 5584.369140625 931.7355 5583.83056640625 931.645751953125 6 19 1.1.1.4291.12 1 63.343 44589.71 63.0752 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; hexanoyl addition +98(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.497348010540009 5627.39599609375 938.9066 5627.8935546875 938.989501953125 6 19 1.1.1.4326.12 1 64.2504 451.6822 64.2367 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Dethiomethyl(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.567775011062622 5571.4111328125 929.5758 5570.84326171875 929.481201171875 6 18 1.1.1.4428.4 1 66.8301 1964.057 66.8206 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; reduced HNE(H)@24; HexNAc(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.580797970294952 5975.50244140625 996.9243 5976.0830078125 997.021118164063 6 19 1.1.1.4138.5 1 59.5878 10547.44 59.3339 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; reduced acrolein addition +96(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.48735299706459 5784.49560546875 965.0899 5784.00830078125 965.008666992188 6 19 1.1.1.4239.10 1 62.039 934.5106 61.9515 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Delta:H(2)C(2)(H)@24 missed K-I@20; missed K-L@40 -0.492902010679245 5588.34326171875 932.3978 5588.83642578125 932.47998046875 6 18 1.1.1.4058.10 1 57.652 1351.169 57.5905 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamidomethyl(K)@40 missed K-I@20; missed K-L@40 0.444133013486862 5558.2685546875 1112.661 5557.826171875 1112.57250976563 5 18 1.1.1.4187.5 1 60.7728 158776.3 60.7788 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24 missed K-I@20; missed K-L@40 -0.558721005916595 5526.263671875 1106.26 5526.8203125 1106.37133789063 5 18 1.1.1.4340.14 1 64.6214 717.7893 64.6283 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamidomethyl(K)@40 missed K-I@20; missed K-L@40 0.526821970939636 5558.35302734375 927.3995 5557.826171875 927.311645507813 6 21 1.1.1.4503.9 1 68.7429 1453.199 68.7259 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.42619800567627 5557.25830078125 1112.459 5556.8310546875 1112.37353515625 5 18 1.1.1.4058.20 1 57.6603 16881.75 57.7658 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.511524021625519 5558.33544921875 927.3965 5558.8466796875 927.481750488281 6 19 1.1.1.4060.9 1 57.7009 71803.02 57.7906 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.577476978302002 5557.40869140625 794.9228 5556.8310546875 794.840270996094 7 19 1.1.1.4085.4 1 58.2741 112041.1 58.4159 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.5051029920578 5557.33642578125 927.23 5556.8310546875 927.145812988281 6 18 1.1.1.4097.2 1 58.5685 268429.1 58.6095 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.568933010101318 5557.39990234375 794.9216 5556.8310546875 794.840270996094 7 18 1.1.1.4108.4 1 58.8333 112533.1 58.8283 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.568933010101318 5557.39990234375 794.9216 5556.8310546875 794.840270996094 7 19 1.1.1.4116.3 1 59.0429 112533.1 58.8283 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.570641994476318 5557.40185546875 794.9218 5556.8310546875 794.840270996094 7 18 1.1.1.4135.3 1 59.5112 80747.63 59.3581 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.507861018180847 5558.3388671875 927.3971 5558.8466796875 927.481750488281 6 18 1.1.1.4182.2 1 60.6379 159215.8 60.5841 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.443544000387192 5558.4033203125 795.0649 5558.8466796875 795.128234863281 7 19 1.1.1.4194.4 1 60.9396 49779.56 60.9539 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.443544000387192 5558.4033203125 795.0649 5558.8466796875 795.128234863281 7 19 1.1.1.4233.2 1 61.8804 14779.73 61.6797 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.443971008062363 5558.40283203125 795.0648 5558.8466796875 795.128234863281 7 18 1.1.1.4259.4 1 62.524 3073.594 62.5178 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.495409995317459 5558.3515625 927.3992 5558.8466796875 927.481750488281 6 19 1.1.1.4275.6 1 62.9356 8530.53 63.1251 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.418763011693954 5558.42822265625 795.0684 5558.8466796875 795.128234863281 7 19 1.1.1.4301.6 1 63.5983 1143.654 63.5634 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.486986994743347 5558.35986328125 927.4006 5558.8466796875 927.481750488281 6 18 1.1.1.4324.13 1 64.1993 5784.012 64.263 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20 missed K-I@20; missed K-L@40 0.526342988014221 5557.357421875 927.2335 5556.8310546875 927.145812988281 6 19 1.1.1.4330.10 1 64.3521 5460.489 64.263 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20 missed K-I@20; missed K-L@40 0.51535701751709 5557.3466796875 927.2317 5556.8310546875 927.145812988281 6 18 1.1.1.4338.10 1 64.5638 8324.946 64.6016 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.509498000144959 5557.3408203125 927.2307 5556.8310546875 927.145812988281 6 19 1.1.1.4378.4 1 65.5994 2115.705 65.5895 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.439626008272171 5557.26904296875 1112.461 5556.8310546875 1112.37353515625 5 19 1.1.1.4397.6 1 66.0527 1627.329 66.0146 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.520843029022217 5558.3359375 927.3966 5557.81494140625 927.309814453125 6 20 1.1.1.4602.12 1 71.277 771.3287 71.2854 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40; Deamidated(N)@48 missed K-I@20; missed K-L@40 0.585955023765564 5558.40087890625 795.0646 5557.81494140625 794.980895996094 7 17 1.1.1.4153.2 1 59.9324 55938.57 59.9525 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR ONE addition +154(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.653428971767426 5840.41357421875 1169.09 5841.06640625 1169.22058105469 5 19 1.1.1.4206.15 1 61.2366 2848.486 61.3396 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@28; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.539774000644684 5569.35986328125 929.2339 5568.81982421875 929.143920898438 6 19 1.1.1.4251.4 1 62.333 7680.935 62.0775 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@28; Deamidated(N)@30; Deamidated(N)@34 missed K-I@20; missed K-L@40 -0.437233000993729 5541.33544921875 924.5632 5541.7724609375 924.636047363281 6 18 1.1.1.4345.9 1 64.7439 723.3413 64.8374 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(Q)@14; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.547210991382599 5558.3623046875 927.401 5557.81494140625 927.309814453125 6 20 1.1.1.4489.4 1 68.3847 1280.565 68.3965 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; MDA adduct +54(K)@20; Oxidation(M)@37; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.470800012350082 5599.35498046875 934.2331 5599.82568359375 934.311584472656 6 19 1.1.1.4055.11 1 57.577 1586.408 57.6662 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.454847991466522 5811.47412109375 969.5863 5811.01953125 969.510498046875 6 17 1.1.1.4058.16 1 57.657 716.4773 57.6163 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced HNE(H)@24; reduced acrolein addition +96(K)@40 missed K-I@20; missed K-L@40 0.484113991260529 5755.47705078125 960.2535 5754.9931640625 960.172790527344 6 17 1.1.1.4084.13 1 58.2569 1969.447 58.2934 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 -0.578181028366089 5595.25244140625 933.5494 5595.83056640625 933.645751953125 6 17 1.1.1.4092.3 1 58.4494 2560.933 58.3423 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 -0.557439982891083 5794.466796875 966.7518 5795.0244140625 966.844665527344 6 17 1.1.1.4093.10 1 58.4787 2183.565 58.4888 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Trimethyl(K)@40 missed K-I@20; missed K-L@40 0.47460201382637 5543.32666015625 924.895 5542.85205078125 924.81591796875 6 18 1.1.1.4098.2 1 58.5919 22715.7 58.6095 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Trimethyl(K)@40 missed K-I@20; missed K-L@40 -0.528083980083466 5542.32373046875 924.7279 5542.85205078125 924.81591796875 6 18 1.1.1.4131.3 1 59.4138 23506.29 59.3581 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(H)@24; Formyl(K)@40 missed K-I@20; missed K-L@40 0.420929998159409 5611.2626953125 936.2177 5610.841796875 936.147583007813 6 19 1.1.1.4132.7 1 59.4505 2887.361 59.3339 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Trimethyl(K)@40 missed K-I@20; missed K-L@40 -0.527351021766663 5542.32470703125 924.728 5542.85205078125 924.81591796875 6 18 1.1.1.4138.2 1 59.5803 20435.52 59.5522 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Hex(N)@17; ONE addition +154(K)@20; reduced HNE(H)@24 missed K-I@20; missed K-L@40 0.355565011501312 5975.443359375 1196.096 5975.087890625 1196.02478027344 5 18 1.1.1.4141.3 1 59.655 2792.309 59.6602 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Deamidated(N)@34; Dethiomethyl(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.49500098824501 5573.34814453125 929.8986 5573.84326171875 929.981140136719 6 18 1.1.1.4157.4 1 60.0338 4966.296 59.9525 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; reduced HNE(H)@24; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 -0.49702000617981 5772.4853515625 963.0882 5772.982421875 963.171020507813 6 17 1.1.1.4175.9 1 60.471 3749.88 60.4126 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.523773014545441 5558.3388671875 927.3971 5557.81494140625 927.309814453125 6 17 1.1.1.4176.5 1 60.4953 159215.8 60.5841 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Trimethyl(K)@40 missed K-I@20; missed K-L@40 0.477531999349594 5543.32958984375 924.8955 5542.85205078125 924.81591796875 6 18 1.1.1.4207.2 1 61.2505 5219.376 61.219 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; reduced HNE(H)@24; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.467642992734909 5788.509765625 965.7589 5788.9775390625 965.836853027344 6 17 1.1.1.4212.3 1 61.3744 1577.57 61.3637 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.434675991535187 5599.27880859375 1120.863 5598.841796875 1120.77563476563 5 19 1.1.1.4213.10 1 61.4038 805.6785 61.4122 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.489190995693207 5559.341796875 927.5642 5559.83056640625 927.645751953125 6 17 1.1.1.4236.8 1 61.9608 56093.61 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.454755991697311 5558.2685546875 1112.661 5557.81494140625 1112.5703125 5 17 1.1.1.4236.16 1 61.9675 51278.38 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Oxidation(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.393866986036301 5600.46337890625 801.0735 5600.857421875 801.129760742188 7 18 1.1.1.4244.5 1 62.1567 488.7928 62.1507 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced HNE(H)@24; Deamidated(N)@34; Carboxy(D)@35; hexanoyl addition +98(K)@40 missed K-I@20; missed K-L@40 0.531118988990784 5802.513671875 968.0929 5801.982421875 968.00439453125 6 19 1.1.1.4252.11 1 62.3562 987.3347 62.2477 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.523773014545441 5558.3388671875 927.3971 5557.81494140625 927.309814453125 6 17 1.1.1.4254.11 1 62.4049 15712.59 62.3204 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +38(K)@20; Deamidated(N)@30 missed K-I@20; missed K-L@40 -0.465442985296249 5565.35498046875 928.5664 5565.8203125 928.643981933594 6 18 1.1.1.4254.12 1 62.4058 5651.699 62.5178 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.52639901638031 5599.3681640625 934.2353 5598.841796875 934.147583007813 6 19 1.1.1.4259.9 1 62.5281 1245.098 62.4922 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.538396000862122 5584.369140625 931.7355 5583.83056640625 931.645751953125 6 18 1.1.1.4272.9 1 62.861 55983.54 63.0255 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@20; Oxidation(M)@37; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.435187011957169 5637.29248046875 940.556 5636.857421875 940.483520507813 6 18 1.1.1.4272.11 1 62.8627 938.9079 62.9757 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; acrolein addition +56(K)@20 missed K-I@20; missed K-L@40 -0.38816699385643 5557.4267578125 794.9254 5557.81494140625 794.980895996094 7 17 1.1.1.4278.8 1 63.0096 1547.725 63.1004 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@12; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.538396000862122 5584.369140625 931.7355 5583.83056640625 931.645751953125 6 18 1.1.1.4280.6 1 63.0577 55983.54 63.0255 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.536224007606506 5558.3515625 927.3992 5557.81494140625 927.309814453125 6 17 1.1.1.4282.5 1 63.11 8607.944 63.1251 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.504621028900146 5528.33154296875 922.3959 5528.83642578125 922.47998046875 6 18 1.1.1.4284.8 1 63.1594 293.4626 63.2007 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.554637014865875 5610.31884765625 1123.071 5610.87451171875 1123.18225097656 5 19 1.1.1.4308.19 1 63.7917 24809.22 64.0053 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.533294975757599 5558.3486328125 927.3987 5557.81494140625 927.309814453125 6 17 1.1.1.4317.11 1 64.0177 6206.387 63.9795 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.507561028003693 5567.359375 928.9005 5566.85205078125 928.81591796875 6 18 1.1.1.4319.14 1 64.0711 335.468 63.9282 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.415553987026215 5584.44677734375 798.7854 5584.8623046875 798.844787597656 7 18 1.1.1.4341.7 1 64.6376 443.7781 64.6543 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Oxidation(M)@37; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 -0.385057002305985 5571.4091796875 929.5755 5571.79443359375 929.6396484375 6 17 1.1.1.4363.5 1 65.2178 2815.164 65.1536 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.445165991783142 5587.32373046875 1118.472 5586.8779296875 1118.38293457031 5 18 1.1.1.4364.9 1 65.2518 1903.552 65.2064 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Deamidated(N)@28; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.567605972290039 5593.3876953125 933.2385 5592.81982421875 933.143920898438 6 19 1.1.1.4365.5 1 65.2709 469.2272 65.1536 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(Q)@14; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.451472014188766 5583.37939453125 931.5705 5583.83056640625 931.645751953125 6 18 1.1.1.4409.7 1 66.3364 594.7543 66.2312 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.525913000106812 5571.3388671875 1115.275 5570.810546875 1115.16931152344 5 17 1.1.1.4423.8 1 66.706 6599.267 66.8206 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.491360992193222 5814.52294921875 970.0944 5815.01416015625 970.176330566406 6 19 1.1.1.4236.10 1 61.9625 485.8302 61.9515 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.48666700720787 5627.39599609375 938.9066 5626.9091796875 938.825500488281 6 18 1.1.1.4276.17 1 62.9673 1324.646 62.773 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8900005817413 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.537263989448547 5604.330078125 935.0623 5604.86767578125 935.15185546875 6 18 1.1.1.4085.8 1 58.2775 1234.042 58.3423 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8900005817413 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Oxidation(M)@37; reduced acrolein addition +96(K)@40 missed K-I@20; missed K-L@40 0.439471989870071 5869.50048828125 979.2574 5869.06103515625 979.184143066406 6 17 1.1.1.4093.11 1 58.4804 1245.618 58.4647 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8900005817413 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Met->Hcy(M)@37; ONE addition +154(K)@40 missed K-I@20; missed K-L@40 0.429901003837585 5897.5224609375 983.9277 5897.09228515625 983.856018066406 6 18 1.1.1.4095.3 1 58.5238 2017.562 58.4888 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8900005817413 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.591569006443024 5574.2490234375 1115.857 5574.841796875 1115.9755859375 5 17 1.1.1.4108.17 1 58.8475 3626.668 58.8041 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8900005817413 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Hex(N)@17; reduced acrolein addition +96(K)@20; reduced HNE(H)@24; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.414451003074646 5975.50244140625 996.9243 5975.087890625 996.855224609375 6 18 1.1.1.4131.6 1 59.4213 10261.86 59.3581 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8900005817413 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Oxidation(M)@37; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.535230994224548 5572.32958984375 929.7289 5571.79443359375 929.6396484375 6 17 1.1.1.4136.4 1 59.5355 3051.805 59.528 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8900005817413 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Deamidated(N)@30; Methyl(D)@35 missed K-I@20; missed K-L@40 -0.495442003011703 5573.35107421875 929.8991 5573.8466796875 929.981689453125 6 18 1.1.1.4174.2 1 60.4435 3272.227 60.5356 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8900005817413 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Deamidated(N)@30; reduced acrolein addition +96(K)@40 missed K-I@20; missed K-L@40 0.399468004703522 5854.44970703125 976.7489 5854.05029296875 976.682312011719 6 17 1.1.1.4174.4 1 60.4518 1247.991 60.5841 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8900005817413 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; Oxidation(M)@37; hexanoyl addition +98(K)@40 missed K-I@20; missed K-L@40 0.455053001642227 5787.4384765625 1158.495 5786.98291015625 1158.40380859375 5 17 1.1.1.4196.9 1 60.9969 1742.675 60.9297 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8900005817413 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HexNAc(N)@17; acrolein addition +56(K)@20; reduced HNE(H)@24; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.422986000776291 5976.505859375 997.0916 5976.0830078125 997.021118164063 6 18 1.1.1.4202.6 1 61.1416 10366.82 61.3396 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8900005817413 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; reduced HNE(H)@24; Oxidation(M)@37; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 0.52529102563858 5823.50830078125 971.592 5822.98291015625 971.504455566406 6 17 1.1.1.4211.4 1 61.347 1045.213 61.3156 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8900005817413 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.577854990959167 5582.26904296875 1117.461 5582.8466796875 1117.57666015625 5 18 1.1.1.4217.9 1 61.5044 1272.707 61.4854 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8900005817413 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Deamidated(N)@34 missed K-I@20; missed K-L@40 -0.532792985439301 5557.28369140625 1112.464 5557.81494140625 1112.5703125 5 17 1.1.1.4264.20 1 62.665 4877.777 62.6196 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8900005817413 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.481947988271713 5567.35400390625 928.8996 5567.8359375 928.979919433594 6 18 1.1.1.4305.11 1 63.7069 897.3141 63.6678 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8900005817413 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(H)@24; Methyl(K)@40 missed K-I@20; missed K-L@40 -0.484082996845245 5596.37841796875 933.737 5596.8623046875 933.817687988281 6 19 1.1.1.4316.11 1 63.9919 3786.221 63.9019 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8900005817413 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(Q)@14; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.457807004451752 5558.2734375 1112.662 5557.81494140625 1112.5703125 5 17 1.1.1.4322.18 1 64.1519 2616.122 64.2367 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8900005817413 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced HNE(H)@24; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 -0.498800992965698 5696.45263671875 950.416 5696.951171875 950.499145507813 6 16 1.1.1.4336.9 1 64.508 504.7242 64.6016 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8900005817413 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.508208990097046 5785.54833984375 965.2653 5785.0400390625 965.180603027344 6 18 1.1.1.4358.5 1 65.0919 240.2339 65.2064 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8900005817413 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(H)@4; Ammonia-loss(N)@5; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.555987000465393 5557.25830078125 1112.459 5557.81494140625 1112.5703125 5 19 1.1.1.4361.9 1 65.1716 8491.79 65.2329 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8900005817413 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 -0.317871004343033 5571.4765625 796.9325 5571.79443359375 796.977905273438 7 17 1.1.1.4429.6 1 66.8555 575.137 66.8206 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8699972629547 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.50859397649765 5558.33837890625 927.397 5558.8466796875 927.481750488281 6 18 1.1.1.4231.9 1 61.8367 74741.82 61.6797 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8699972629547 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20 missed K-I@20; missed K-L@40 -0.494677990674973 5558.35205078125 927.3993 5558.8466796875 927.481750488281 6 18 1.1.1.4331.13 1 64.3807 4992.545 64.4184 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.7600028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR ONE addition +154(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.59002697467804 5840.47607421875 974.42 5841.06640625 974.518310546875 6 18 1.1.1.4061.18 1 57.7335 334.3242 57.7411 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.7600028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Hex(N)@17; acrolein addition +94(K)@20; reduced HNE(H)@24; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 -0.536970973014832 5976.5087890625 997.0921 5977.0458984375 997.181579589844 6 18 1.1.1.4162.10 1 60.1659 2124.346 60.1226 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.7600028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HexNAc(N)@17; acrolein addition +38(K)@20; reduced HNE(H)@24; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.445214003324509 5976.50732421875 997.0918 5976.06201171875 997.017578125 6 18 1.1.1.4240.6 1 62.0674 5526.189 61.827 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.7600028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.486288994550705 5606.337890625 935.3969 5605.8515625 935.315856933594 6 18 1.1.1.4272.10 1 62.8619 1702.752 63.0255 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.7600028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(Q)@14; MDA adduct +54(K)@20; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.487854987382889 5557.27392578125 1112.462 5556.78369140625 1112.36401367188 5 17 1.1.1.4304.19 1 63.6874 3610.523 63.6678 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.7600028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.441217988729477 5583.3896484375 931.5722 5583.83056640625 931.645751953125 6 18 1.1.1.4417.5 1 66.5428 351.6934 66.4537 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.7299978733063 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.454400986433029 5583.37646484375 931.57 5583.83056640625 931.645751953125 6 20 1.1.1.4485.6 1 68.2782 339.2556 68.2642 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.6199975013733 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; reduced HNE(H)@24; HexNAc(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.5815309882164 5975.50146484375 996.9242 5976.0830078125 997.021118164063 6 18 1.1.1.4124.8 1 59.2458 17557.36 59.1099 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.6199975013733 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.433807998895645 5565.2685546875 1114.061 5564.83642578125 1113.97448730469 5 17 1.1.1.4252.17 1 62.3612 4185.154 62.5178 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.6199975013733 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(2)C(2)(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.46186700463295 5609.318359375 1122.871 5608.85888671875 1122.77905273438 5 18 1.1.1.4296.20 1 63.4796 1514.061 63.5114 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.6199975013733 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Dethiomethyl(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.502533972263336 5541.33544921875 924.5632 5540.8330078125 924.479431152344 6 18 1.1.1.4353.6 1 64.9555 723.3413 64.8374 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.4799981117249 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.450002014636993 5557.28369140625 1112.464 5556.8310546875 1112.37353515625 5 18 1.1.1.4278.19 1 63.0188 3881.627 63.1251 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.470002412796 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.445953994989395 5557.369140625 927.2355 5557.81494140625 927.309814453125 6 18 1.1.1.4482.4 1 68.2061 1430.222 68.2642 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.3900010585785 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.463164985179901 5557.35205078125 927.2326 5557.81494140625 927.309814453125 6 18 1.1.1.4518.3 1 69.1239 1183.007 69.0645 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.2299983501434 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.531463980674744 5558.3466796875 927.3984 5557.81494140625 927.309814453125 6 18 1.1.1.4454.8 1 67.4846 1832.913 67.451 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.2299983501434 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.532706022262573 5572.29345703125 1115.466 5572.826171875 1115.57250976563 5 18 1.1.1.4467.17 1 67.8148 2001.652 67.7966 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.2299983501434 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.474518001079559 5557.3408203125 927.2307 5557.81494140625 927.309814453125 6 18 1.1.1.4632.6 1 72.0743 632.235 72.0532 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.1500029563904 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.524248003959656 5557.28857421875 1112.465 5557.81494140625 1112.5703125 5 18 1.1.1.4448.6 1 67.3472 1181.802 67.3034 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Dethiomethyl(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.478027999401093 5573.3369140625 929.8968 5572.85888671875 929.817138671875 6 17 1.1.1.4084.8 1 58.2527 13354.77 58.3179 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +96(K)@20 missed K-I@20; missed K-L@40 -0.601635992527008 5596.2607421875 933.7174 5596.8623046875 933.817687988281 6 16 1.1.1.4084.10 1 58.2544 2564.478 58.3179 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; reduced HNE(H)@24; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 0.469862014055252 5811.4892578125 969.5888 5811.01953125 969.510498046875 6 16 1.1.1.4085.11 1 58.28 1153.671 58.3675 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; reduced acrolein addition +96(K)@40 missed K-I@20; missed K-L@40 0.419250011444092 5853.4853515625 976.5882 5853.06640625 976.518310546875 6 16 1.1.1.4085.13 1 58.2816 1312.099 58.3917 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.511443018913269 5574.330078125 930.0623 5574.841796875 930.147583007813 6 16 1.1.1.4088.4 1 58.3524 12447.56 58.3179 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Formyl(K)@20; Dethiomethyl(M)@37; hexanoyl addition +98(K)@40 missed K-I@20; missed K-L@40 0.438899010419846 5579.30859375 930.892 5578.86962890625 930.818908691406 6 18 1.1.1.4102.3 1 58.6951 6997.853 58.7314 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.497859001159668 5573.32373046875 929.8946 5572.826171875 929.811645507813 6 16 1.1.1.4113.2 1 58.9691 9676.226 58.8283 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.497859001159668 5573.32373046875 929.8946 5572.826171875 929.811645507813 6 16 1.1.1.4114.3 1 58.9992 9676.226 58.8283 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40; Deamidated(N)@48 missed K-I@20; missed K-L@40 0.524505019187927 5558.33984375 927.3972 5557.81494140625 927.309814453125 6 16 1.1.1.4154.7 1 59.9615 199392.7 59.9525 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(2)C(2)(K)@40 missed K-I@20; missed K-L@40 0.480201005935669 5581.3115234375 931.2258 5580.8310546875 931.145812988281 6 17 1.1.1.4162.6 1 60.1575 3700.579 60.171 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +96(K)@20; Dethiomethyl(M)@37; reduced acrolein addition +96(K)@40 missed K-I@20; missed K-L@40 0.488261997699738 5645.40478515625 941.9081 5644.91650390625 941.826721191406 6 17 1.1.1.4167.7 1 60.2748 1164.857 60.2916 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.524959027767181 5573.35107421875 929.8991 5572.826171875 929.811645507813 6 16 1.1.1.4181.3 1 60.6189 3272.227 60.5356 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@28; Deamidated(N)@30; Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.516833007335663 5581.30029296875 931.224 5580.78369140625 931.137878417969 6 17 1.1.1.4190.5 1 60.8442 3741.545 60.9297 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.523127973079681 5573.34912109375 929.8988 5572.826171875 929.811645507813 6 16 1.1.1.4217.4 1 61.4927 2275.199 61.3396 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; reduced HNE(H)@24; Dioxidation(M)@37; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 0.528953015804291 5823.51171875 971.5926 5822.98291015625 971.504455566406 6 17 1.1.1.4224.9 1 61.6647 524.5443 61.6797 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; reduced HNE(H)@24; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.504621982574463 5791.49755859375 966.2569 5790.9931640625 966.172790527344 6 16 1.1.1.4226.7 1 61.7122 550.571 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Deamidated(N)@28; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.586018979549408 5627.30859375 1126.469 5627.8935546875 1126.5859375 5 17 1.1.1.4234.17 1 61.9178 1069.154 61.9767 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Dehydrated(T)@23; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 -0.471717000007629 5570.35400390625 929.3996 5570.82568359375 929.478210449219 6 18 1.1.1.4248.7 1 62.2669 12942.92 62.002 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.51589298248291 5610.35888671875 936.0671 5610.87451171875 936.153076171875 6 18 1.1.1.4261.18 1 62.5864 906.8347 62.6452 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.494116008281708 5611.36865234375 936.2354 5610.87451171875 936.153076171875 6 18 1.1.1.4270.16 1 62.8157 1101.937 62.7991 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; MDA adduct +62(K)@20; Delta:H(2)C(2)(K)@40 missed K-I@20; missed K-L@40 0.547111988067627 5615.39892578125 936.9071 5614.85205078125 936.81591796875 6 18 1.1.1.4280.7 1 63.0585 398.1079 63.0504 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@28; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.537943005561829 5569.35791015625 929.2336 5568.81982421875 929.143920898438 6 18 1.1.1.4298.10 1 63.5228 508.0877 63.4847 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 -0.484026998281479 5674.38916015625 946.7388 5674.873046875 946.819458007813 6 16 1.1.1.4304.16 1 63.6849 2043.93 63.6678 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 -0.475306004285812 5539.3291015625 924.2288 5539.8046875 924.308044433594 6 16 1.1.1.4309.10 1 63.81 320.0641 63.8242 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@30; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.439832001924515 5568.2734375 1114.662 5567.83251953125 1114.57373046875 5 17 1.1.1.4312.19 1 63.8951 819.7446 63.6941 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(2)C(2)(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.536256015300751 5609.3955078125 935.9065 5608.85888671875 935.817138671875 6 18 1.1.1.4314.12 1 63.941 32745.42 63.9795 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamyl@N-term; acrolein addition +38(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.613137006759644 5610.46728515625 802.5026 5609.8544921875 802.4150390625 7 18 1.1.1.4319.7 1 64.0653 6081.234 64.0053 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(2)C(2)(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.536256015300751 5609.3955078125 935.9065 5608.85888671875 935.817138671875 6 18 1.1.1.4321.7 1 64.1162 32745.42 63.9795 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(2)C(2)(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.535522997379303 5609.39453125 935.9064 5608.85888671875 935.817138671875 6 18 1.1.1.4328.9 1 64.3039 27119.74 64.0312 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Delta:H(2)C(2)(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.499188005924225 5593.36328125 933.2345 5592.8642578125 933.151306152344 6 18 1.1.1.4330.11 1 64.353 1741.08 64.263 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.464877992868423 5571.2734375 1115.262 5570.810546875 1115.16931152344 5 15 1.1.1.4335.20 1 64.4914 1030.459 64.3404 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamyl@N-term; acrolein addition +38(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.537100970745087 5610.3916015625 936.0725 5609.8544921875 935.982971191406 6 18 1.1.1.4342.11 1 64.6669 14800.56 64.7067 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.456232011318207 5583.37451171875 931.5697 5583.83056640625 931.645751953125 6 17 1.1.1.4357.4 1 65.055 1442.714 64.7851 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.532737970352173 5786.556640625 965.4334 5786.02392578125 965.344604492188 6 18 1.1.1.4363.6 1 65.2194 223.9055 65.2064 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.43724200129509 5798.58203125 967.4376 5799.01953125 967.510498046875 6 17 1.1.1.4427.9 1 66.8072 152.7772 66.8206 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.9499995708466 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.577476978302002 5557.40869140625 794.9228 5556.8310546875 794.840270996094 7 18 1.1.1.4085.5 1 58.275 112041.1 58.4159 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.9499995708466 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.517804980278015 5576.318359375 930.3937 5576.83642578125 930.47998046875 6 18 1.1.1.4095.2 1 58.5196 6148.715 58.4888 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.9499995708466 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.513159990310669 5557.34423828125 927.2313 5556.8310546875 927.145812988281 6 18 1.1.1.4192.5 1 60.8929 94950.38 60.978 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.445300996303558 5540.24853515625 1109.057 5539.8046875 1108.96813964844 5 16 1.1.1.4037.21 1 57.1287 1892.434 57.1337 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR ONE addition +154(K)@20; reduced HNE(H)@24; Deamidated(N)@34; hexanoyl addition +98(K)@40 missed K-I@20; missed K-L@40 0.405699014663696 5912.498046875 986.4236 5912.09228515625 986.35595703125 6 16 1.1.1.4057.13 1 57.6294 586.8105 57.5905 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +96(K)@20; reduced HNE(H)@24; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.377588987350464 5794.36865234375 1159.881 5793.99267578125 1159.80578613281 5 16 1.1.1.4093.13 1 58.4838 5574.098 58.4888 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; Carbamidomethyl(K)@40 missed K-I@20; missed K-L@40 -0.564209997653961 5573.2587890625 1115.659 5573.8212890625 1115.771484375 5 17 1.1.1.4095.5 1 58.5322 4591.58 58.3179 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; reduced acrolein addition +96(K)@20; Dehydrated(T)@23 missed K-I@20; missed K-L@40 0.477524995803833 5580.3134765625 931.0595 5579.8359375 930.979919433594 6 17 1.1.1.4109.3 1 58.8617 6465.191 58.8526 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Hex(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.410055994987488 5975.498046875 996.9236 5975.087890625 996.855224609375 6 17 1.1.1.4110.6 1 58.8933 18039.54 59.0126 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Deamidated(N)@34; Dethiomethyl(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.50635302066803 5573.3369140625 929.8967 5573.84326171875 929.981140136719 6 17 1.1.1.4150.4 1 59.8697 4204.853 59.8303 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Oxidation(M)@37; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.51467102766037 5787.49755859375 965.5902 5786.98291015625 965.504455566406 6 16 1.1.1.4208.2 1 61.2745 1898.16 61.1947 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced HNE(H)@24; Oxidation(M)@37; ONE addition +154(K)@40 missed K-I@20; missed K-L@40 -0.497610986232758 5828.5322265625 972.4293 5829.02978515625 972.512268066406 6 16 1.1.1.4211.5 1 61.3487 1659.686 61.3396 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; reduced HNE(H)@24; Oxidation(M)@37; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 -0.488406002521515 5824.51025390625 971.759 5824.99853515625 971.840393066406 6 16 1.1.1.4212.4 1 61.3785 1148.162 61.3156 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR GlnThrGlyGly(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.413006991147995 5871.56884765625 979.6021 5871.98193359375 979.670959472656 6 18 1.1.1.4229.5 1 61.7873 493.3915 61.7779 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.4617800116539 5540.2685546875 1109.061 5539.8046875 1108.96813964844 5 16 1.1.1.4232.14 1 61.8656 2705.234 61.9262 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Delta:H(2)C(2)(H)@24; Formyl(K)@40 missed K-I@20; missed K-L@40 0.481330007314682 5613.3388671875 936.5637 5612.857421875 936.483520507813 6 18 1.1.1.4239.7 1 62.0365 953.6078 61.9515 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@30; Deamidated(N)@34 missed K-I@20; missed K-L@40 -0.456270009279251 5540.33251953125 924.396 5540.78857421875 924.472045898438 6 16 1.1.1.4256.8 1 62.4516 2625.848 62.3696 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.527496993541718 5599.369140625 934.2355 5598.841796875 934.147583007813 6 18 1.1.1.4266.9 1 62.7067 998.7646 62.6708 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.433925002813339 5584.4287109375 798.7828 5584.8623046875 798.844787597656 7 17 1.1.1.4293.6 1 63.3897 6407.241 63.1251 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Dehydrated(D)@7; hexanoyl addition +98(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.486687004566193 5609.38232421875 935.9043 5608.8955078125 935.823181152344 6 18 1.1.1.4299.14 1 63.5525 1599.308 63.5634 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Cation:Na(E)@3; acrolein addition +56(K)@20 missed K-I@20; missed K-L@40 0.592297971248627 5579.4052734375 798.0652 5578.81298828125 797.980590820313 7 17 1.1.1.4324.8 1 64.1951 433.0128 64.185 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.50278502702713 5586.37548828125 932.0698 5586.8779296875 932.153625488281 6 17 1.1.1.4331.16 1 64.3832 672.6718 64.3664 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.487765997648239 5627.39697265625 938.9068 5626.9091796875 938.825500488281 6 17 1.1.1.4336.7 1 64.5063 462.747 64.2367 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.48471000790596 5574.35693359375 930.0668 5574.841796875 930.147583007813 6 16 1.1.1.4346.7 1 64.7684 412.2274 64.6804 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.532792985439301 5557.28369140625 1112.464 5557.81494140625 1112.5703125 5 16 1.1.1.4389.6 1 65.8834 1668.743 65.6136 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.869998216629 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.531810998916626 5583.37841796875 931.5704 5582.8466796875 931.481750488281 6 18 1.1.1.4478.4 1 68.0898 429.0078 68.1065 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.869998216629 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@20 missed K-I@20; missed K-L@40 -0.489917010068893 5582.35693359375 931.4001 5582.8466796875 931.481750488281 6 18 1.1.1.4551.7 1 69.9707 273.3431 69.8761 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.6599991321564 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.458404988050461 5557.35693359375 927.2334 5557.81494140625 927.309814453125 6 17 1.1.1.4475.6 1 68.0152 2321.124 67.8216 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.6400017738342 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.528469979763031 5626.380859375 938.7374 5626.9091796875 938.825500488281 6 17 1.1.1.4312.10 1 63.8876 629.546 63.876 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.5499987602234 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.55341100692749 5584.38427734375 931.738 5583.83056640625 931.645751953125 6 18 1.1.1.4503.10 1 68.7446 451.3774 68.753 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.4300026893616 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; reduced HNE(H)@24; Deamidated(N)@34; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.481193989515305 5775.52197265625 963.5943 5776.00341796875 963.674499511719 6 17 1.1.1.4609.7 1 71.4626 476.8228 71.4963 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.1199989318848 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Met->Hcy(M)@37; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 -0.518823027610779 5580.3125 931.0593 5580.8310546875 931.145812988281 6 17 1.1.1.4093.7 1 58.4737 6080.788 58.4888 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.1199989318848 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@17; Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.454079002141953 5600.2783203125 1121.063 5599.82568359375 1120.97241210938 5 17 1.1.1.4242.6 1 62.1161 2630.274 61.8518 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.1199989318848 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; HPNE addition +172(K)@20; Oxidation(M)@37; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 -0.498724013566971 5826.478515625 1166.303 5826.97802734375 1166.40283203125 5 17 1.1.1.4246.5 1 62.2118 12688.3 62.1507 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.1199989318848 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@26; Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.456883996725082 5599.36865234375 934.2354 5599.82568359375 934.311584472656 6 17 1.1.1.4252.6 1 62.352 1506.906 62.3938 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.1199989318848 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(Q)@14; acrolein addition +94(K)@20; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.532486975193024 5672.39453125 946.4064 5671.8623046875 946.317626953125 6 16 1.1.1.4290.15 1 63.3197 663.2216 63.3038 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 96.5200006961823 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; acrolein addition +56(K)@40; Deamidated(N)@48 missed K-I@20; missed K-L@40 0.542442977428436 5559.341796875 927.5642 5558.79931640625 927.473815917969 6 16 1.1.1.4154.8 1 59.9632 140980.8 59.9525 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 96.5200006961823 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced HNE(H)@24; HexNAc(N)@34; hexanoyl addition +98(K)@40 missed K-I@20; missed K-L@40 0.445244014263153 5960.533203125 994.4295 5960.087890625 994.355285644531 6 17 1.1.1.4231.17 1 61.8434 744.7262 61.827 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 96.5200006961823 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.608964025974274 5541.3974609375 792.6355 5540.78857421875 792.548522949219 7 16 1.1.1.4234.5 1 61.9078 1141.512 61.9262 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 96.5200006961823 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +76(K)@20; Deamidated(N)@28; Deamidated(N)@30 missed K-I@20; missed K-L@40 0.53135097026825 5605.35107421875 935.2325 5604.81982421875 935.143920898438 6 17 1.1.1.4254.13 1 62.4066 2247.401 62.3204 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 96.5200006961823 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.433506995439529 5606.28369140625 1122.264 5605.8515625 1122.17761230469 5 17 1.1.1.4255.12 1 62.4377 1173.596 62.1993 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 96.1899995803833 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(4)C(2)(K)@40; Deamidated(N)@48 missed K-I@20; missed K-L@40 0.540960013866425 5584.37158203125 931.7359 5583.83056640625 931.645751953125 6 17 1.1.1.4256.9 1 62.4524 85337.13 62.2235 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 95.8500027656555 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; MDA adduct +62(K)@20; Deamidated(N)@34; Oxidation(M)@37 missed K-I@20; missed K-L@40 0.594316005706787 5606.40966796875 801.9229 5605.81494140625 801.838012695313 7 17 1.1.1.4277.3 1 62.9805 1104.907 63.0006 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 95.5099999904633 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(Q)@14; acrolein addition +56(K)@20 missed K-I@20; missed K-L@40 -0.537675976753235 5557.27880859375 1112.463 5557.81494140625 1112.5703125 5 16 1.1.1.4527.15 1 69.3461 506.9227 69.3561 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 95.4900026321411 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; reduced acrolein addition +58(K)@20; reduced HNE(H)@24; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.573746025562286 5773.4130859375 1155.69 5773.98779296875 1155.80480957031 5 16 1.1.1.4172.12 1 60.4075 3191.836 60.4126 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 95.4900026321411 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Deamidated(N)@30; Oxidation(M)@37 missed K-I@20; missed K-L@40 -0.553246021270752 5575.2734375 1116.062 5575.82568359375 1116.17236328125 5 16 1.1.1.4178.6 1 60.5515 2411.07 60.5599 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 95.4900026321411 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; reduced HNE(H)@24; Hex(N)@28; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 -0.531477987766266 5976.5146484375 997.093 5977.0458984375 997.181579589844 6 17 1.1.1.4216.6 1 61.477 12062.09 61.4612 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 95.4900026321411 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Dicarbamidomethyl(D)@35; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.554144024848938 5960.50830078125 994.4253 5961.06201171875 994.517639160156 6 17 1.1.1.4224.13 1 61.668 838.7464 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 95.4900026321411 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HexNAc(N)@17; acrolein addition +56(K)@20; reduced HNE(H)@24; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.422986000776291 5976.505859375 997.0916 5976.0830078125 997.021118164063 6 17 1.1.1.4230.5 1 61.8185 9648.393 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 95.4900026321411 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Dioxidation(M)@37 missed K-I@20; missed K-L@40 0.550984978675842 5571.361328125 929.5675 5570.810546875 929.475646972656 6 16 1.1.1.4231.10 1 61.8375 7274.972 62.0274 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 95.4900026321411 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +96(K)@20; HexNAc(N)@26; ONE addition +154(K)@40 missed K-I@20; missed K-L@40 0.517463028430939 5954.55859375 993.4337 5954.041015625 993.347473144531 6 17 1.1.1.4233.10 1 61.8871 363.458 61.8518 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 95.4900026321411 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; MDA adduct +62(K)@20; Oxidation(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.428119003772736 5608.2587890625 1122.659 5607.83056640625 1122.57348632813 5 18 1.1.1.4238.19 1 62.0206 722.5318 62.0775 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 95.4900026321411 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; MDA adduct +62(K)@20; Dethiomethyl(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.424244999885559 5599.29833984375 1120.867 5598.87451171875 1120.7822265625 5 17 1.1.1.4252.19 1 62.3628 1041.046 62.4183 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 95.4900026321411 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; MDA adduct +54(K)@20; Dethiomethyl(M)@37; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 -0.491306990385056 5570.35205078125 929.3993 5570.84326171875 929.481201171875 6 17 1.1.1.4275.8 1 62.9389 9330.61 62.7991 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 95.4900026321411 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.430934011936188 5584.431640625 798.7832 5584.8623046875 798.844787597656 7 16 1.1.1.4289.6 1 63.2862 11866.53 63.0255 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 95.4900026321411 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@28; Deamidated(N)@30; Deamidated(N)@34 missed K-I@20; missed K-L@40 -0.450417011976242 5541.322265625 924.561 5541.7724609375 924.636047363281 6 16 1.1.1.4294.13 1 63.4214 2053.793 63.3556 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 95.4900026321411 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24 missed K-I@20; missed K-L@40 0.439814001321793 5527.25830078125 1106.459 5526.8203125 1106.37133789063 5 16 1.1.1.4359.9 1 65.1218 451.2353 64.8374 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 94.8499977588654 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; reduced HNE(H)@24; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.516737997531891 5775.5361328125 963.5966 5775.01953125 963.510498046875 6 16 1.1.1.4494.5 1 68.4996 608.481 68.5662 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 94.7200000286102 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@20; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 -0.566399991512299 5636.291015625 940.3891 5636.857421875 940.483520507813 6 16 1.1.1.4246.2 1 62.2042 1895.6 62.1751 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 94.6099996566772 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.532927989959717 5558.34814453125 927.3986 5557.81494140625 927.309814453125 6 16 1.1.1.4646.10 1 72.4379 508.8597 72.4496 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 94.6099996566772 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.479279011487961 5557.3359375 927.2299 5557.81494140625 927.309814453125 6 16 1.1.1.4798.20 1 76.2981 480.5511 76.3306 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 94.3300008773804 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamyl(K)@40 missed K-I@20; missed K-L@40 -0.481332004070282 5543.32958984375 924.8955 5543.810546875 924.975708007813 6 16 1.1.1.4091.3 1 58.4202 118480 58.2934 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 94.3300008773804 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; HexNAc(N)@34; hexanoyl addition +98(K)@40; Deamidated(N)@48 missed K-I@20; missed K-L@40 0.404157012701035 5975.45361328125 1196.098 5975.05126953125 1196.017578125 5 17 1.1.1.4153.9 1 59.9474 1576.965 59.9283 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 94.3300008773804 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Dioxidation(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.493649989366531 5645.33837890625 1130.075 5644.84716796875 1129.97668457031 5 16 1.1.1.4173.8 1 60.4293 1844.498 60.4126 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 94.3300008773804 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.448430001735687 5572.37744140625 929.7369 5572.826171875 929.811645507813 6 15 1.1.1.4224.5 1 61.6613 1470.125 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 94.3300008773804 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(H)@24; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.537280023097992 5645.39990234375 941.9072 5644.8623046875 941.817687988281 6 16 1.1.1.4233.6 1 61.8837 1048.766 61.9767 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 94.3300008773804 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; Deamidated(N)@34; Oxidation(M)@37; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 -0.490283012390137 5801.45361328125 1161.298 5801.9462890625 1161.396484375 5 16 1.1.1.4233.20 1 61.8954 6228.716 61.6797 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 94.3300008773804 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Dethiomethyl(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 -0.491306990385056 5570.35205078125 929.3993 5570.84326171875 929.481201171875 6 16 1.1.1.4291.10 1 63.3414 695.9839 63.3298 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 94.3300008773804 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.532006025314331 5786.55615234375 965.4333 5786.02392578125 965.344604492188 6 17 1.1.1.4427.8 1 66.8055 174.9649 66.8206 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.9300000667572 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@20; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 -0.566399991512299 5636.291015625 940.3891 5636.857421875 940.483520507813 6 16 1.1.1.4239.9 1 62.0382 1895.6 62.1751 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.8199996948242 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Deamidated(N)@34 missed K-I@20; missed K-L@40 -0.523638010025024 5557.29345703125 1112.466 5557.81494140625 1112.5703125 5 16 1.1.1.4478.8 1 68.0989 728.0747 68.1065 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.5199975967407 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.000225593001232482 5540.78857421875 1109.165 5540.78857421875 1109.1650390625 5 15 1.1.1.4211.8 1 61.3562 2450.072 61.388 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.5199975967407 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; reduced HNE(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.506101012229919 5712.47314453125 953.0861 5712.97900390625 953.170471191406 6 17 1.1.1.4310.10 1 63.8359 433.0434 63.8501 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20 missed K-I@20; missed K-L@40 -0.511524021625519 5558.33544921875 927.3965 5558.8466796875 927.481750488281 6 17 1.1.1.4063.13 1 57.7788 71803.02 57.7906 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.52701997756958 5539.34765625 924.2319 5538.8203125 924.14404296875 6 16 1.1.1.4070.4 1 57.9473 3614.962 58.0619 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.520850002765656 5557.35205078125 927.2326 5556.8310546875 927.145812988281 6 16 1.1.1.4083.3 1 58.2327 308294.9 58.4159 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.405243009328842 5577.24365234375 1116.456 5576.83642578125 1116.37451171875 5 16 1.1.1.4086.16 1 58.3111 2774.895 58.3423 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.520850002765656 5557.35205078125 927.2326 5556.8310546875 927.145812988281 6 17 1.1.1.4090.2 1 58.3991 315996.5 58.4403 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.520850002765656 5557.35205078125 927.2326 5556.8310546875 927.145812988281 6 16 1.1.1.4093.5 1 58.4704 315996.5 58.4403 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.521583020687103 5557.3525390625 927.2327 5556.8310546875 927.145812988281 6 17 1.1.1.4111.2 1 58.9125 321512.3 58.8526 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.504737019538879 5557.3359375 927.2299 5556.8310546875 927.145812988281 6 16 1.1.1.4118.3 1 59.0923 283046.4 59.1342 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20 missed K-I@20; missed K-L@40 0.520850002765656 5557.35205078125 927.2326 5556.8310546875 927.145812988281 6 17 1.1.1.4125.5 1 59.2751 278749.8 59.2317 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.520117998123169 5557.35107421875 927.2325 5556.8310546875 927.145812988281 6 17 1.1.1.4132.5 1 59.4438 272742.9 59.3581 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.520850002765656 5557.35205078125 927.2326 5556.8310546875 927.145812988281 6 17 1.1.1.4139.5 1 59.6194 224111.2 59.5522 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20 missed K-I@20; missed K-L@40 0.513526022434235 5557.3447265625 927.2314 5556.8310546875 927.145812988281 6 16 1.1.1.4143.4 1 59.6945 185832.2 59.6602 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.520117998123169 5557.35107421875 927.2325 5556.8310546875 927.145812988281 6 17 1.1.1.4147.8 1 59.7903 173192.7 59.8062 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20 missed K-I@20; missed K-L@40 0.520117998123169 5557.35107421875 927.2325 5556.8310546875 927.145812988281 6 17 1.1.1.4152.2 1 59.91 173192.7 59.8062 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.507861018180847 5558.3388671875 927.3971 5558.8466796875 927.481750488281 6 17 1.1.1.4161.5 1 60.1317 205564.9 60.2673 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20 missed K-I@20; missed K-L@40 0.50144100189209 5557.33251953125 927.2294 5556.8310546875 927.145812988281 6 17 1.1.1.4167.3 1 60.2715 109828.3 60.2673 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.507861018180847 5558.3388671875 927.3971 5558.8466796875 927.481750488281 6 17 1.1.1.4168.3 1 60.299 205564.9 60.2673 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.507861018180847 5558.3388671875 927.3971 5558.8466796875 927.481750488281 6 16 1.1.1.4175.6 1 60.4685 159215.8 60.5841 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.580467998981476 5557.41162109375 794.9232 5556.8310546875 794.840270996094 7 16 1.1.1.4206.2 1 61.2224 13378.43 61.219 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.504004001617432 5557.3349609375 927.2298 5556.8310546875 927.145812988281 6 16 1.1.1.4211.3 1 61.3453 74640.23 61.3156 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.507129013538361 5558.33984375 927.3972 5558.8466796875 927.481750488281 6 17 1.1.1.4215.2 1 61.4435 157308.6 61.3396 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.50859397649765 5558.33837890625 927.397 5558.8466796875 927.481750488281 6 16 1.1.1.4247.5 1 62.231 17290.91 62.1751 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.470142990350723 5557.3037109375 1112.468 5556.8310546875 1112.37353515625 5 17 1.1.1.4257.12 1 62.4838 7393.54 62.4922 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20 missed K-I@20; missed K-L@40 -0.533827006816864 5672.380859375 946.4041 5672.9150390625 946.493103027344 6 17 1.1.1.4258.15 1 62.5077 1920.749 62.6452 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20 missed K-I@20; missed K-L@40 0.588159024715424 5557.41943359375 794.9243 5556.8310546875 794.840270996094 7 17 1.1.1.4261.8 1 62.5781 1797.546 62.594 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.523779988288879 5557.35498046875 927.2331 5556.8310546875 927.145812988281 6 16 1.1.1.4268.14 1 62.7621 10908.64 62.7991 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.450612008571625 5557.28369140625 1112.464 5556.8310546875 1112.37353515625 5 17 1.1.1.4271.20 1 62.8445 6227.608 62.7991 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.52744197845459 5557.3583984375 927.2337 5556.8310546875 927.145812988281 6 17 1.1.1.4276.16 1 62.9665 5403.721 62.9757 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.450002014636993 5557.28369140625 1112.464 5556.8310546875 1112.37353515625 5 16 1.1.1.4286.19 1 63.2195 4213.852 63.2521 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.495775997638702 5558.35107421875 927.3991 5558.8466796875 927.481750488281 6 16 1.1.1.4303.11 1 63.6544 6459.188 63.6418 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.594995021820068 5557.42626953125 794.9253 5556.8310546875 794.840270996094 7 17 1.1.1.4313.5 1 63.9098 1138.311 64.0053 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.523779988288879 5557.35498046875 927.2331 5556.8310546875 927.145812988281 6 17 1.1.1.4319.13 1 64.0703 5295.907 64.0053 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.431580990552902 5558.4150390625 795.0666 5558.8466796875 795.128234863281 7 17 1.1.1.4322.7 1 64.1427 1080.98 64.314 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.601830005645752 5557.43310546875 794.9263 5556.8310546875 794.840270996094 7 17 1.1.1.4354.5 1 64.977 738.8053 64.9689 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.534034013748169 5557.365234375 927.2348 5556.8310546875 927.145812988281 6 16 1.1.1.4364.4 1 65.2426 4451.603 65.1801 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.520117998123169 5557.35107421875 927.2325 5556.8310546875 927.145812988281 6 17 1.1.1.4389.4 1 65.8767 1591.053 65.8644 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.514990985393524 5557.34619140625 927.2316 5556.8310546875 927.145812988281 6 17 1.1.1.4404.3 1 66.2161 2482.487 66.2555 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.451222002506256 5557.28369140625 1112.464 5556.8310546875 1112.37353515625 5 17 1.1.1.4404.6 1 66.2261 1484.902 66.2555 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.4199988842011 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.539892971515656 5557.37109375 927.2358 5556.8310546875 927.145812988281 6 16 1.1.1.4426.7 1 66.7824 2275.171 66.7419 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.0999994277954 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; Trimethyl(K)@20 missed K-I@20; missed K-L@40 -0.581848978996277 5543.25341796875 1109.658 5543.8359375 1109.7744140625 5 17 1.1.1.4055.19 1 57.5837 1814.081 57.5384 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.0999994277954 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.57109397649765 5579.38671875 798.0625 5578.8154296875 797.980895996094 7 15 1.1.1.4151.3 1 59.885 2896.111 59.8792 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.0999994277954 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamyl(K)@40 missed K-I@20; missed K-L@40 -0.49048700928688 5543.3203125 924.894 5543.810546875 924.975708007813 6 16 1.1.1.4166.3 1 60.2539 25771.53 60.1226 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.0999994277954 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.430770009756088 5575.2734375 1116.062 5574.841796875 1115.9755859375 5 15 1.1.1.4188.13 1 60.7946 2448.008 60.5599 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.0999994277954 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.520197987556458 5573.34619140625 929.8983 5572.826171875 929.811645507813 6 15 1.1.1.4195.3 1 60.9644 2654.726 60.9539 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.0999994277954 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; reduced HNE(H)@24; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.477946996688843 5828.53076171875 972.4291 5829.0087890625 972.508728027344 6 15 1.1.1.4219.3 1 61.5426 1677.67 61.388 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.0999994277954 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; CHDH(D)@35; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.529962003231049 6043.66015625 1008.284 6043.12939453125 1008.19549560547 6 17 1.1.1.4225.9 1 61.6891 396.3506 61.6797 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.0999994277954 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Oxidation(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.397285014390945 5600.4599609375 801.073 5600.857421875 801.129760742188 7 16 1.1.1.4267.6 1 62.7297 498.6582 62.8504 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.0999994277954 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.567138016223907 5584.29345703125 1117.866 5584.8623046875 1117.97973632813 5 16 1.1.1.4301.20 1 63.61 5438.581 63.3298 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.0999994277954 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Deamidated(N)@28; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.495442986488342 5629.373046875 939.2361 5628.87744140625 939.153503417969 6 17 1.1.1.4325.12 1 64.2242 602.0679 64.211 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 92.6900029182434 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.458703011274338 5566.2783203125 1114.263 5565.8203125 1114.17126464844 5 16 1.1.1.4266.18 1 62.7142 5946.474 62.5178 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 92.6900029182434 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Carbamyl(K)@40 missed K-I@20; missed K-L@40 0.458903014659882 5570.283203125 1115.064 5569.826171875 1114.97253417969 5 17 1.1.1.4273.11 1 62.8893 6913.713 62.7991 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 92.6900029182434 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.486515998840332 5572.33935546875 929.7305 5572.826171875 929.811645507813 6 15 1.1.1.4294.14 1 63.4223 706.999 63.3816 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 92.6900029182434 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Deamidated(N)@26; Deamidated(N)@28; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.567605972290039 5593.3876953125 933.2385 5592.81982421875 933.143920898438 6 17 1.1.1.4358.4 1 65.0886 469.2272 65.1536 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 92.6900029182434 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Oxidation(M)@37 missed K-I@20; missed K-L@40 0.54101699590683 5543.3564453125 924.9 5542.8154296875 924.809875488281 6 16 1.1.1.4426.6 1 66.7808 250.7135 66.7681 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 92.2800004482269 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.498145014047623 5557.3291015625 927.2288 5556.8310546875 927.145812988281 6 13 1.1.1.4782.19 1 75.8758 638.3513 75.8826 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 91.9099986553192 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.462092012166977 5583.36865234375 931.5687 5583.83056640625 931.645751953125 6 17 1.1.1.4460.12 1 67.6357 390.1121 67.6483 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 91.8500006198883 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.525358974933624 5574.31640625 930.06 5574.841796875 930.147583007813 6 15 1.1.1.4025.15 1 56.8186 753.0408 56.803 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 91.8500006198883 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@26; Dethiomethyl(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 -0.45576599240303 5569.35595703125 929.2333 5569.8115234375 929.309265136719 6 16 1.1.1.4264.13 1 62.6591 4736.551 62.5178 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 91.8500006198883 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.501811027526855 5674.40087890625 946.7407 5673.89892578125 946.657104492188 6 15 1.1.1.4287.14 1 63.2412 1306.513 63.1251 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 91.8500006198883 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.561936020851135 5584.29833984375 1117.867 5584.85888671875 1117.97912597656 5 16 1.1.1.4302.21 1 63.6368 5415.671 63.3556 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 91.8500006198883 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(E)@3; Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.412075012922287 5596.4501953125 800.5002 5596.8623046875 800.559020996094 7 17 1.1.1.4308.7 1 63.7817 814.7615 63.7985 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 91.8500006198883 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced acrolein addition +96(K)@40 missed K-I@20; missed K-L@40 0.536868989467621 5695.47265625 950.2527 5694.935546875 950.163208007813 6 14 1.1.1.4343.12 1 64.6942 602.9299 64.6016 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 91.430002450943 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +96(K)@20; reduced HNE(H)@24; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.377588987350464 5794.36865234375 1159.881 5793.99267578125 1159.80578613281 5 15 1.1.1.4101.11 1 58.677 5574.098 58.4888 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 91.430002450943 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; reduced HNE(H)@24; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.486036986112595 5875.5576171875 980.2669 5875.07177734375 980.185913085938 6 17 1.1.1.4235.8 1 61.9356 434.0875 61.9515 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 91.430002450943 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; acrolein addition +76(K)@20; hexanoyl addition +98(K)@40 missed K-I@20; missed K-L@40 -0.488925993442535 5675.404296875 946.908 5675.8935546875 946.989501953125 6 15 1.1.1.4237.9 1 61.9869 422.284 62.002 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 91.430002450943 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; MDA adduct +54(K)@20; Oxidation(M)@37; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.47732600569725 5635.31884765625 940.2271 5634.841796875 940.147583007813 6 16 1.1.1.4256.10 1 62.4532 1304.958 62.1993 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 91.430002450943 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(Q)@14; HPNE addition +172(K)@20; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 -0.429794013500214 5811.537109375 969.5968 5811.966796875 969.66845703125 6 16 1.1.1.4278.17 1 63.0171 160.1509 63.0255 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 91.430002450943 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +96(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.479734003543854 5625.37353515625 938.5695 5624.8935546875 938.489562988281 6 16 1.1.1.4297.12 1 63.4988 596.3589 63.6678 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 90.6000018119812 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Deamidated(N)@34; Oxidation(M)@37 missed K-I@20; missed K-L@40 -0.402794986963272 5573.4072265625 797.2083 5573.81005859375 797.265869140625 7 15 1.1.1.4052.7 1 57.4954 27538.38 57.5905 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 90.6000018119812 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.534375011920929 5583.38134765625 931.5708 5582.8466796875 931.481750488281 6 16 1.1.1.4433.9 1 66.9629 567.8868 66.9518 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 90.1700019836426 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.570206999778748 5574.27392578125 1115.862 5574.841796875 1115.9755859375 5 15 1.1.1.4068.18 1 57.9073 25631.02 57.6411 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 90.1700019836426 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Oxidation(M)@37; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 0.482870995998383 5899.51806640625 984.2603 5899.03515625 984.179809570313 6 15 1.1.1.4090.3 1 58.405 1742.417 58.3675 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 90.1700019836426 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.513909995555878 5580.3134765625 931.0595 5579.79931640625 930.973876953125 6 15 1.1.1.4176.6 1 60.4978 2939.725 60.5108 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 90.1700019836426 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@30; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.46958601474762 5541.2587890625 1109.259 5540.78857421875 1109.1650390625 5 15 1.1.1.4225.12 1 61.6941 3477.541 61.9262 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 90.1700019836426 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Hex(N)@34; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.331492006778717 5977.43359375 1196.494 5977.103515625 1196.42797851563 5 16 1.1.1.4234.19 1 61.9195 7104.028 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 90.1700019836426 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; HPNE addition +172(K)@20; Oxidation(M)@37; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 0.499200999736786 5827.47900390625 1166.503 5826.97802734375 1166.40283203125 5 16 1.1.1.4274.17 1 62.9191 2283.891 63.0006 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 90.1700019836426 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Cation:Na(E)@3; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.540732026100159 5578.2734375 1116.662 5578.81298828125 1116.76989746094 5 16 1.1.1.4320.10 1 64.0989 2965.791 64.211 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 89.92999792099 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Dethiomethyl(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 -0.491331994533539 5572.36767578125 929.7352 5572.85888671875 929.817138671875 6 16 1.1.1.4461.7 1 67.6578 615.6866 67.7966 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 89.92999792099 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.456586986780167 5558.2734375 1112.662 5557.81494140625 1112.5703125 5 15 1.1.1.4471.13 1 67.9169 1212.578 67.8467 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 89.7499978542328 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; Deamidated(N)@26; Formyl(K)@40 missed K-I@20; missed K-L@40 -0.442290991544724 5605.373046875 935.2361 5605.81494140625 935.309814453125 6 16 1.1.1.4053.14 1 57.5275 589.7717 57.5905 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 89.3299996852875 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; Met->Hcy(M)@37; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 -0.455505013465881 5525.33349609375 921.8962 5525.7890625 921.972106933594 6 16 1.1.1.4048.14 1 57.3964 1847.542 57.4073 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 89.3299996852875 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Deamidated(N)@34; Deamidated(N)@48 missed K-I@20; missed K-L@40 0.561145007610321 5557.3447265625 927.2314 5556.78369140625 927.137878417969 6 15 1.1.1.4159.3 1 60.0843 169788.5 59.8303 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 89.3299996852875 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; Deamidated(N)@26; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.467144995927811 5541.25390625 1109.258 5540.78857421875 1109.1650390625 5 15 1.1.1.4233.18 1 61.8938 4034.028 61.9515 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 88.8999998569489 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@30; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.458086013793945 5579.263671875 1116.86 5578.80419921875 1116.76806640625 5 15 1.1.1.4188.14 1 60.7963 1710.668 60.978 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 88.5299980640411 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Deamidated(N)@34 missed K-I@20; missed K-L@40 -0.544390022754669 5557.26904296875 1112.461 5557.81494140625 1112.5703125 5 15 1.1.1.4455.6 1 67.5199 981.822 67.4759 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 88.5299980640411 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; Iodo(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.226079002022743 5766.5556640625 962.0999 5766.78173828125 962.137573242188 6 17 1.1.1.4494.4 1 68.4971 1996.857 68.5662 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 88.5299980640411 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.520093023777008 5583.36669921875 931.5684 5582.8466796875 931.481750488281 6 16 1.1.1.4585.16 1 70.8328 232.6454 70.8412 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 88.4700000286102 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; reduced HNE(H)@24; Hex(N)@28; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 -0.531477987766266 5976.5146484375 997.093 5977.0458984375 997.181579589844 6 16 1.1.1.4223.3 1 61.6496 12062.09 61.4612 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 88.4700000286102 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; reduced HNE(H)@24; HexNAc(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.35274800658226 5976.43310546875 1196.294 5976.0830078125 1196.22387695313 5 16 1.1.1.4229.9 1 61.7973 8204.75 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 88.4700000286102 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.486288994550705 5606.337890625 935.3969 5605.8515625 935.315856933594 6 16 1.1.1.4279.9 1 63.0353 1702.752 63.0255 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 88.0400002002716 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.526709973812103 5581.35791015625 931.2336 5580.8310546875 931.145812988281 6 15 1.1.1.4320.5 1 64.0906 2209.72 64.211 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 87.1599972248077 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; Delta:H(2)C(2)(H)@24; GlnGlnGlnThrGlyGly(K)@40 missed K-I@20; missed K-L@40 -0.437067002058029 6219.69482421875 1037.623 6220.12890625 1037.69543457031 6 17 1.1.1.4234.13 1 61.9145 1836.395 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 0.433380991220474 5611.27490234375 936.2198 5610.841796875 936.147583007813 6 14 1.1.1.4058.11 1 57.6528 906.7808 57.5905 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@28; Deamidated(N)@30; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.551169991493225 5542.32373046875 924.7279 5541.7724609375 924.636047363281 6 15 1.1.1.4084.7 1 58.2519 81356.9 58.2934 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.565540015697479 5579.380859375 798.0617 5578.8154296875 797.980895996094 7 14 1.1.1.4085.6 1 58.2758 6280.108 58.4159 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 -0.454629987478256 5570.35595703125 929.3999 5570.810546875 929.475646972656 6 14 1.1.1.4092.2 1 58.446 6754.968 58.3179 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(2)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.518455982208252 5580.3125 931.0594 5580.8310546875 931.145812988281 6 15 1.1.1.4123.3 1 59.2142 5063.632 59.256 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; Deamidated(N)@30 missed K-I@20; missed K-L@40 0.502819001674652 5578.3232421875 930.7278 5577.8203125 930.643981933594 6 14 1.1.1.4126.5 1 59.2973 4952.198 59.3581 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.505493998527527 5579.32080078125 930.8941 5578.8154296875 930.809875488281 6 14 1.1.1.4156.4 1 60.013 3586.595 59.9766 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.483220010995865 5572.3427734375 929.7311 5572.826171875 929.811645507813 6 14 1.1.1.4163.3 0 60.1774 3233.351 60.2192 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(2)C(2)(K)@40 missed K-I@20; missed K-L@40 0.479467988014221 5581.310546875 931.2257 5580.8310546875 931.145812988281 6 15 1.1.1.4169.4 1 60.3247 3665.572 60.2192 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +96(K)@20; CHDH(D)@35; ONE addition +154(K)@40 missed K-I@20; missed K-L@40 -0.432099014520645 6044.71044921875 1008.459 6045.14501953125 1008.53143310547 6 16 1.1.1.4172.9 1 60.4025 2900.316 60.5841 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(H)@4; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.512767970561981 5571.359375 929.5672 5570.8466796875 929.481750488281 6 15 1.1.1.4178.3 1 60.5431 2094.43 60.5108 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Oxidation(M)@37 missed K-I@20; missed K-L@40 0.445077002048492 5573.2685546875 1115.661 5572.826171875 1115.57250976563 5 14 1.1.1.4194.7 1 60.9488 1942.729 60.9297 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(2)C(2)(K)@40 missed K-I@20; missed K-L@40 0.480567008256912 5581.3115234375 931.2259 5580.8310546875 931.145812988281 6 15 1.1.1.4207.3 1 61.2563 2754.864 61.1947 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Phospho(T)@31; Deamidated(N)@48 missed K-I@20; missed K-L@40 0.460942000150681 5838.4189453125 1168.691 5837.958984375 1168.59912109375 5 16 1.1.1.4225.13 1 61.6958 1746.697 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@12; acrolein addition +94(K)@20 missed K-I@20; missed K-L@40 -0.500935018062592 5621.345703125 937.8982 5621.8466796875 937.981689453125 6 15 1.1.1.4239.8 1 62.0374 828.5871 62.0775 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; HPNE addition +172(K)@20; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 -0.459084004163742 5810.52392578125 969.4279 5810.98291015625 969.504455566406 6 15 1.1.1.4245.6 1 62.1843 526.9648 62.2721 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.533788025379181 5594.3134765625 1119.87 5594.8466796875 1119.97668457031 5 14 1.1.1.4257.13 1 62.4855 439.0171 62.4922 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +38(K)@20; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 -0.455574005842209 5626.396484375 938.74 5626.85205078125 938.81591796875 6 15 1.1.1.4271.13 1 62.8387 1281.492 62.7991 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 -0.469013005495071 5674.40380859375 946.7413 5674.873046875 946.819458007813 6 14 1.1.1.4272.13 1 62.8644 3004.066 62.6452 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; Deamidated(N)@26; Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.452908992767334 5607.28857421875 1122.465 5606.83544921875 1122.37438964844 5 16 1.1.1.4272.20 1 62.8702 769.2855 62.825 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; Deamidated(N)@34; Oxidation(M)@37; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 0.576659023761749 5802.52294921875 968.0944 5801.9462890625 967.998291015625 6 15 1.1.1.4279.13 1 63.0387 353.0891 63.0504 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Delta:H(2)C(2)(H)@24; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.556456029415131 5607.4033203125 802.0649 5606.8466796875 801.985412597656 7 16 1.1.1.4285.9 1 63.1857 977.3707 62.9258 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Dioxidation(M)@37; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 -0.469989985227585 5802.5078125 968.0919 5802.97802734375 968.170227050781 6 15 1.1.1.4290.17 1 63.3214 368.2854 63.2521 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; MDA adduct +54(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.523072004318237 5609.38232421875 935.9043 5608.85888671875 935.817138671875 6 16 1.1.1.4292.13 1 63.3699 1590.493 63.5634 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; hexanoyl addition +98(K)@40 missed K-I@20; missed K-L@40 -0.491035014390945 5654.4130859375 943.4095 5654.904296875 943.491333007813 6 14 1.1.1.4294.15 1 63.4231 313.5522 63.3556 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@28; Deamidated(N)@30; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.55300098657608 5542.32568359375 924.7282 5541.7724609375 924.636047363281 6 15 1.1.1.4309.11 1 63.8108 607.9865 63.7985 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; MDA adduct +54(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.46552899479866 5609.3232421875 1122.872 5608.85888671875 1122.77905273438 5 16 1.1.1.4324.18 1 64.2035 34681.03 64.0053 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(2)C(2)(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.600939989089966 5609.4599609375 802.3587 5608.85888671875 802.272827148438 7 16 1.1.1.4326.7 1 64.2463 6765.777 63.9795 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@20 missed K-I@20; missed K-L@40 0.592222988605499 5583.43896484375 798.6414 5582.8466796875 798.556823730469 7 15 1.1.1.4331.8 1 64.3765 422.6944 64.2885 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@17; MDA adduct +54(K)@20 missed K-I@20; missed K-L@40 -0.459136992692947 5581.35595703125 931.2333 5581.81494140625 931.309814453125 6 15 1.1.1.4335.11 1 64.4839 1201.813 64.6016 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; MDA adduct +54(K)@20; Dethiomethyl(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.515040993690491 5595.3583984375 933.567 5594.84326171875 933.481201171875 6 16 1.1.1.4342.10 1 64.6661 1465.677 64.5755 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Oxidation(K)@40 missed K-I@20; missed K-L@40 -0.48471000790596 5574.35693359375 930.0668 5574.841796875 930.147583007813 6 16 1.1.1.4353.7 1 64.9572 256.9001 64.9955 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.517978012561798 5571.328125 1115.273 5570.810546875 1115.16931152344 5 14 1.1.1.4363.9 1 65.2244 7368.94 65.1536 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.2600028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(P)@25; Formyl(K)@40 missed K-I@20; missed K-L@40 -0.540956974029541 5544.25390625 1109.858 5544.794921875 1109.96618652344 5 16 1.1.1.4062.13 1 57.7541 2634.944 57.7411 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.2600028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.523773014545441 5558.3388671875 927.3971 5557.81494140625 927.309814453125 6 14 1.1.1.4141.2 1 59.6467 165702.7 59.4556 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.2600028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.449324995279312 5599.28857421875 1120.865 5598.841796875 1120.77563476563 5 15 1.1.1.4157.8 1 60.0439 2867.477 60.1468 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.2600028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.556509971618652 5572.26904296875 1115.461 5572.826171875 1115.57250976563 5 14 1.1.1.4166.5 1 60.2623 1500.913 60.2673 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.2600028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.524872004985809 5558.33984375 927.3973 5557.81494140625 927.309814453125 6 14 1.1.1.4195.2 1 60.9603 188872.3 60.9539 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.2600028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@26; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.4617800116539 5540.2685546875 1109.061 5539.8046875 1108.96813964844 5 14 1.1.1.4240.8 1 62.0724 2705.234 61.9262 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.2600028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +38(K)@20; Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.455633997917175 5636.40185546875 806.2075 5636.857421875 806.272583007813 7 15 1.1.1.4254.5 1 62.3999 284.9613 62.3451 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.2600028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Oxidation(M)@37; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 -0.444768011569977 5596.38134765625 933.7375 5596.826171875 933.811645507813 6 15 1.1.1.4277.8 1 62.9846 1896.01 62.8761 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.2600028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@12; acrolein addition +56(K)@20; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.44938200712204 5622.2958984375 938.0566 5621.8466796875 937.981689453125 6 15 1.1.1.4279.10 1 63.0362 648.5507 63.0504 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.2600028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.510034024715424 5544.3212890625 925.0608 5544.8310546875 925.145812988281 6 16 1.1.1.4317.10 1 64.0169 681.4902 64.0053 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.2600028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; Formyl(K)@40 missed K-I@20; missed K-L@40 -0.492711007595062 5640.359375 941.0672 5640.85205078125 941.149291992188 6 15 1.1.1.4321.8 1 64.1171 300.0119 64.0053 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.2600028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.563069999217987 5571.37353515625 929.5695 5570.810546875 929.475646972656 6 14 1.1.1.4342.9 1 64.6653 351.0842 64.6804 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.2600028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamyl@N-term; acrolein addition +38(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.462101995944977 5610.31884765625 1123.071 5609.8544921875 1122.97814941406 5 16 1.1.1.4343.21 1 64.7017 16306.31 64.7067 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.2600028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 0.467059999704361 5596.29833984375 1120.267 5595.83056640625 1120.17346191406 5 14 1.1.1.4344.11 1 64.7245 2333.505 64.5755 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.2600028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.483666002750397 5544.34765625 925.0652 5544.8310546875 925.145812988281 6 16 1.1.1.4352.5 1 64.9295 404.1593 64.9421 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.2600028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Cation:Na(E)@3; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.447158008813858 5581.2734375 1117.262 5580.82861328125 1117.17297363281 5 15 1.1.1.4356.12 1 65.0395 2957.338 64.8638 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.2600028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.55222100019455 5582.29345703125 1117.466 5582.8466796875 1117.57666015625 5 15 1.1.1.4363.10 1 65.2261 687.3638 65.1536 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 85.8299970626831 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.530713021755219 5583.37744140625 931.5702 5582.8466796875 931.481750488281 6 15 1.1.1.4467.12 1 67.809 572.9863 67.8978 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 85.809999704361 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Dehydrated(D)@35; hexanoyl addition +98(K)@40 missed K-I@20; missed K-L@40 0.365337014198303 5837.4365234375 973.9134 5837.0712890625 973.852478027344 6 15 1.1.1.4085.12 1 58.2808 1176.943 58.3917 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 85.809999704361 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced HNE(H)@24; Oxidation(M)@37; ONE addition +154(K)@40 missed K-I@20; missed K-L@40 0.508004009723663 5829.5380859375 972.5969 5829.02978515625 972.512268066406 6 14 1.1.1.4224.10 1 61.6655 1305.365 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 85.809999704361 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Trimethyl(K)@40 missed K-I@20; missed K-L@40 0.480461001396179 5543.33251953125 924.896 5542.85205078125 924.81591796875 6 15 1.1.1.4271.12 1 62.8378 1121.786 62.7991 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 85.809999704361 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; acrolein addition +38(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.439832001924515 5568.2734375 1114.662 5567.83251953125 1114.57373046875 5 15 1.1.1.4303.20 1 63.6619 819.7446 63.6941 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 85.809999704361 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +96(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.502439022064209 5625.39599609375 938.5733 5624.8935546875 938.489562988281 6 15 1.1.1.4319.15 1 64.072 649.541 63.9795 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 85.809999704361 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Met->Hcy(M)@37 missed K-I@20; missed K-L@40 -0.43792000412941 5524.3671875 921.7351 5524.8046875 921.80810546875 6 15 1.1.1.4334.6 1 64.4572 464.257 64.4184 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 84.8800003528595 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; reduced acrolein addition +58(K)@20; reduced HNE(H)@24; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 -0.464293003082275 5829.5498046875 972.5989 5830.013671875 972.67626953125 6 14 1.1.1.4235.7 1 61.9348 560.887 61.827 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 84.8800003528595 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; Oxidation(M)@37; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 -0.432298004627228 5571.3623046875 929.5676 5571.79443359375 929.6396484375 6 14 1.1.1.4314.10 1 63.9393 552.2643 63.7985 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 84.8800003528595 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.515968024730682 5586.3623046875 932.0676 5586.8779296875 932.153625488281 6 15 1.1.1.4321.6 1 64.1154 1286.066 64.1594 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 84.8800003528595 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +96(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.531736016273499 5625.42529296875 938.5782 5624.8935546875 938.489562988281 6 15 1.1.1.4335.13 1 64.4856 1196.147 64.7329 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 84.4099998474121 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Deamidated(N)@30; Oxidation(M)@37 missed K-I@20; missed K-L@40 0.526362001895905 5580.32568359375 931.0616 5579.79931640625 930.973876953125 6 14 1.1.1.4217.5 1 61.4944 2808.68 61.388 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 84.4099998474121 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Hex(N)@34; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.401973992586136 5977.50537109375 997.2582 5977.103515625 997.191162109375 6 15 1.1.1.4233.12 1 61.8887 8314.245 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 84.4099998474121 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; Oxidation(M)@37; Carbamidomethyl(K)@40 missed K-I@20; missed K-L@40 -0.448689997196198 5574.3564453125 930.0667 5574.80517578125 930.141479492188 6 15 1.1.1.4291.11 1 63.3422 672.4148 63.2781 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 84.4099998474121 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +94(K)@20; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.457033008337021 5696.4365234375 950.4134 5696.8935546875 950.489562988281 6 14 1.1.1.4310.9 1 63.835 273.4897 63.7985 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 84.4099998474121 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; reduced HNE(H)@24; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 0.533267021179199 5807.521484375 968.9275 5806.98779296875 968.838623046875 6 13 1.1.1.4362.8 1 65.1904 132.1274 65.1801 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 83.9699983596802 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.458317011594772 5572.36767578125 929.7352 5572.826171875 929.811645507813 6 14 1.1.1.4468.7 1 67.8366 615.6866 67.7966 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 83.9399993419647 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@34; reduced acrolein addition +58(K)@40; Dehydrated(S)@42 missed K-I@20; missed K-L@40 0.476426005363464 5580.3125 931.0593 5579.8359375 930.979919433594 6 15 1.1.1.4131.4 1 59.4163 4116.774 59.3821 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 83.9399993419647 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Deamidated(N)@34; Oxidation(M)@37 missed K-I@20; missed K-L@40 0.46137198805809 5580.25830078125 1117.059 5579.79931640625 1116.96716308594 5 14 1.1.1.4213.9 1 61.4021 1412.857 61.3637 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 82.6099991798401 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@12; MDA adduct +54(K)@20 missed K-I@20; missed K-L@40 0.519011974334717 5582.333984375 931.3963 5581.81494140625 931.309814453125 6 15 1.1.1.4577.20 1 70.6305 190.8469 70.6112 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 82.6099991798401 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(Q)@14; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.476007997989655 5583.35498046875 931.5664 5583.83056640625 931.645751953125 6 15 1.1.1.4610.10 1 71.4879 258.0023 71.4174 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 82.6099991798401 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamidomethyl@N-term; reduced acrolein addition +96(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.442607998847961 5681.47265625 947.9194 5681.9150390625 947.9931640625 6 16 1.1.1.4644.4 1 72.3826 1042.602 72.4496 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 82.4899971485138 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; HPNE addition +172(K)@20; Iodo(H)@24; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 -0.319557994604111 5862.5234375 978.0945 5862.8427734375 978.147766113281 6 16 1.1.1.4238.12 1 62.0148 308.0894 62.0775 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 82.4899971485138 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Cation:Na(E)@3; Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.532428979873657 5580.32958984375 931.0622 5579.796875 930.973449707031 6 15 1.1.1.4348.13 1 64.8257 1110.127 64.8374 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.9999992847443 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; reduced HNE(H)@24; HexNAc(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.37533101439476 5976.45849609375 1196.299 5976.0830078125 1196.22387695313 5 15 1.1.1.4182.6 1 60.6513 1704.712 60.5841 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.9999992847443 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Hex(N)@34; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.560321986675262 5990.5224609375 999.4277 5991.08251953125 999.521057128906 6 15 1.1.1.4226.10 1 61.7147 530.4063 61.6797 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.9999992847443 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 -0.514111995697021 5620.34814453125 937.732 5620.8623046875 937.817687988281 6 14 1.1.1.4255.9 1 62.4327 391.6269 62.4427 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.9999992847443 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.498739987611771 5606.35009765625 935.399 5605.8515625 935.315856933594 6 15 1.1.1.4265.17 1 62.6879 1363.304 62.8761 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.9999992847443 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 0.420879989862442 5639.2939453125 940.8896 5638.873046875 940.819458007813 6 14 1.1.1.4281.8 1 63.0845 783.4518 62.9757 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.9999992847443 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Cation:Na(E)@3; Deamidated(N)@34; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.469271004199982 5580.2685546875 1117.061 5579.796875 1116.96667480469 5 15 1.1.1.4321.19 1 64.1262 6338.121 64.211 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.5100014209747 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(2)C(2)(H)@24 missed K-I@20; missed K-L@40 -0.518455982208252 5580.3125 931.0594 5580.8310546875 931.145812988281 6 14 1.1.1.4085.7 1 58.2766 6115.597 58.3917 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.5100014209747 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; Delta:H(2)C(2)(H)@24; GlnGlnGlnThrGlyGly(K)@40 missed K-I@20; missed K-L@40 -0.436334013938904 6219.69482421875 1037.623 6220.12890625 1037.69543457031 6 17 1.1.1.4220.3 1 61.5708 2829.28 61.388 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.5100014209747 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; FMN(T)@31; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 -0.29135400056839 6172.732421875 1029.796 6173.0244140625 1029.8447265625 6 15 1.1.1.4224.15 1 61.6697 788.5327 61.6797 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.5100014209747 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; reduced acrolein addition +96(K)@40 missed K-I@20; missed K-L@40 0.429504007101059 5853.49560546875 976.5899 5853.06640625 976.518310546875 6 13 1.1.1.4225.6 1 61.6866 500.8064 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.5100014209747 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.554527997970581 5581.3857421875 798.3481 5580.8310546875 798.268859863281 7 14 1.1.1.4226.3 1 61.7089 930.7109 61.6797 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.5100014209747 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; Delta:H(2)C(2)(H)@24; GlnGlnGlnThrGlyGly(K)@40 missed K-I@20; missed K-L@40 -0.437067002058029 6219.69482421875 1037.623 6220.12890625 1037.69543457031 6 17 1.1.1.4227.3 1 61.7383 1836.395 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.5100014209747 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; Oxidation(P)@25; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.549103975296021 5647.390625 942.2391 5646.841796875 942.147583007813 6 14 1.1.1.4234.9 1 61.9111 1000.267 61.9767 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.5100014209747 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Oxidation(D)@33; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.458709001541138 5598.3828125 934.0711 5598.841796875 934.147583007813 6 16 1.1.1.4290.14 1 63.3189 2613.161 63.1251 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.5100014209747 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 0.506236970424652 5671.4052734375 946.2415 5670.8994140625 946.157165527344 6 13 1.1.1.4297.13 1 63.4996 423.0152 63.5634 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.5100014209747 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; acrolein addition +94(K)@20; reduced HNE(H)@24; Oxidation(M)@37 missed K-I@20; missed K-L@40 0.54134202003479 5770.49755859375 962.7569 5769.95654296875 962.666687011719 6 14 1.1.1.4300.17 1 63.5812 268.6933 63.6158 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.5100014209747 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Dethiomethyl(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.515407025814056 5571.35888671875 929.5671 5570.84326171875 929.481201171875 6 14 1.1.1.4333.13 1 64.4331 698.5654 64.314 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.5100014209747 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.419227004051209 5610.45556640625 802.5009 5610.87451171875 802.560791015625 7 15 1.1.1.4340.6 1 64.6105 3047.845 64.7067 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.5100014209747 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; reduced HNE(H)@24; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.468472987413406 5828.53857421875 1166.715 5829.0087890625 1166.80908203125 5 13 1.1.1.4430.15 1 66.8927 211.015 66.8206 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.0100018978119 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.459049999713898 5572.3671875 929.7351 5572.826171875 929.811645507813 6 13 1.1.1.4197.4 1 61.011 2333.297 60.9539 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.0100018978119 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +96(K)@20; Hex(N)@34; Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.574599027633667 5837.50048828125 973.924 5836.92578125 973.828247070313 6 15 1.1.1.4225.5 1 61.6858 507.7805 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.0100018978119 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.112726002931595 5566.73828125 1114.355 5566.85205078125 1114.37768554688 5 14 1.1.1.4277.13 1 62.9922 826.4335 62.9506 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.8099985122681 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.511328995227814 5557.34228515625 927.231 5556.8310546875 927.145812988281 6 15 1.1.1.4056.14 1 57.6054 28072.45 57.6662 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.8099985122681 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.511524021625519 5558.33544921875 927.3965 5558.8466796875 927.481750488281 6 15 1.1.1.4067.12 1 57.8773 71803.02 57.7906 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.8099985122681 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.522876024246216 5558.32373046875 927.3946 5558.8466796875 927.481750488281 6 15 1.1.1.4074.5 1 58.0502 14655.55 57.9883 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.8099985122681 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.512426972389221 5557.34375 927.2312 5556.8310546875 927.145812988281 6 15 1.1.1.4104.2 1 58.7363 304383.7 58.7314 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.8099985122681 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.520117998123169 5557.35107421875 927.2325 5556.8310546875 927.145812988281 6 15 1.1.1.4155.4 1 59.9914 173192.7 59.8062 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.8099985122681 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 -0.474932998418808 5562.345703125 928.0649 5562.8203125 928.14404296875 6 15 1.1.1.4175.7 1 60.4693 13497.17 60.5841 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.8099985122681 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.507861018180847 5558.3388671875 927.3971 5558.8466796875 927.481750488281 6 15 1.1.1.4223.2 1 61.6413 138724.4 61.388 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.8099985122681 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.507861018180847 5558.3388671875 927.3971 5558.8466796875 927.481750488281 6 15 1.1.1.4240.3 1 62.0599 51369.32 61.8024 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.8099985122681 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.421570003032684 5673.3388671875 1135.675 5672.9150390625 1135.59020996094 5 15 1.1.1.4263.21 1 62.6401 1280.826 62.594 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.8099985122681 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.42985999584198 5557.25830078125 1112.459 5556.8310546875 1112.37353515625 5 15 1.1.1.4354.11 1 64.9854 3721.988 64.9689 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.8099985122681 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.536597013473511 5557.36767578125 927.2352 5556.8310546875 927.145812988281 6 15 1.1.1.4359.6 1 65.1143 4386.356 65.1536 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.510002374649 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; reduced HNE(H)@24; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 0.499103993177414 5829.5078125 972.5919 5829.0087890625 972.508728027344 6 13 1.1.1.4055.14 1 57.5795 480.1634 57.5905 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.510002374649 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.487360000610352 5559.34326171875 927.5645 5559.83056640625 927.645751953125 6 13 1.1.1.4098.3 1 58.596 142115.5 58.8283 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.510002374649 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; reduced HNE(H)@24; HexNAc(N)@30; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.585192978382111 5975.498046875 996.9236 5976.0830078125 997.021118164063 6 18 1.1.1.4117.4 1 59.074 18039.54 59.0126 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.510002374649 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.524872004985809 5558.33984375 927.3973 5557.81494140625 927.309814453125 6 13 1.1.1.4133.3 1 59.463 190550 59.3581 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.510002374649 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; Deamidated(N)@26; Deamidated(N)@34; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.496410012245178 5580.283203125 1117.064 5579.7880859375 1116.96496582031 5 14 1.1.1.4172.11 1 60.4058 1567.575 60.2673 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.510002374649 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; MDA adduct +54(K)@20; reduced HNE(H)@24; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 -0.479696989059448 5832.52392578125 973.0946 5833.00390625 973.174560546875 6 14 1.1.1.4280.10 1 63.061 493.5574 63.0504 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.510002374649 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Oxidation(M)@37 missed K-I@20; missed K-L@40 -0.459024995565414 5570.3515625 929.3992 5570.810546875 929.475646972656 6 13 1.1.1.4312.8 1 63.886 654.2821 63.7722 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.510002374649 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Delta:H(2)C(2)(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.480370998382568 5610.39453125 936.073 5610.87451171875 936.153076171875 6 15 1.1.1.4314.13 1 63.9418 25655.09 64.0053 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.510002374649 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; reduced HNE(H)@24; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.533658027648926 5769.505859375 962.5916 5768.97216796875 962.502685546875 6 13 1.1.1.4337.11 1 64.5373 295.9733 64.5755 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.0100028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.466708987951279 5571.2783203125 1115.263 5570.810546875 1115.16931152344 5 13 1.1.1.4180.8 1 60.6007 2209.781 60.5108 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.0100028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Deamidated(N)@30 missed K-I@20; missed K-L@40 0.548254013061523 5564.35302734375 928.3994 5563.8046875 928.308044433594 6 13 1.1.1.4213.3 1 61.3921 4009.502 61.388 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.0100028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +38(K)@20; Deamidated(N)@34; Formyl(K)@40 missed K-I@20; missed K-L@40 0.502624988555908 5569.28857421875 1114.865 5568.78369140625 1114.76391601563 5 15 1.1.1.4232.15 1 61.8665 13675.59 62.0274 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.0100028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; Deamidated(N)@34; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.57540100812912 5606.42333984375 801.9249 5605.84814453125 801.842712402344 7 14 1.1.1.4238.3 1 62.0073 1747.053 62.1993 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.0100028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Oxidation(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.52639901638031 5599.3681640625 934.2353 5598.841796875 934.147583007813 6 14 1.1.1.4245.3 1 62.1793 1653.578 62.1993 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.0100028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(Q)@14; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.441639006137848 5540.24853515625 1109.057 5539.8046875 1108.96813964844 5 13 1.1.1.4247.12 1 62.2427 1648.565 62.2477 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.0100028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +112(K)@20; reduced HNE(H)@24; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 -0.499864012002945 5834.51953125 973.4272 5835.01953125 973.510498046875 6 14 1.1.1.4273.7 1 62.8843 453.7507 62.8761 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.0100028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.441431999206543 5583.28857421875 1117.665 5582.8466796875 1117.57666015625 5 13 1.1.1.4276.21 1 62.9706 18846.16 63.0006 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.0100028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +94(K)@20; Oxidation(M)@37 missed K-I@20; missed K-L@40 0.435187011957169 5637.29248046875 940.556 5636.857421875 940.483520507813 6 14 1.1.1.4279.11 1 63.037 938.9079 62.9757 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.0100028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; Oxidation(P)@25; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 -0.50485098361969 5646.3369140625 942.0634 5646.841796875 942.147583007813 6 13 1.1.1.4287.12 1 63.2395 282.3221 63.0255 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.0100028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.48497399687767 5540.2880859375 1109.065 5539.8046875 1108.96813964844 5 13 1.1.1.4288.17 1 63.2697 1011.007 63.2521 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.0100028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.544592022895813 5564.34912109375 928.3988 5563.8046875 928.308044433594 6 13 1.1.1.4296.10 1 63.4704 555.8339 63.6418 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.0100028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced HNE(H)@24; Oxidation(M)@37; reduced acrolein addition +96(K)@40 missed K-I@20; missed K-L@40 0.498477011919022 5771.486328125 962.9217 5770.98779296875 962.838623046875 6 13 1.1.1.4303.12 1 63.6552 285.5215 63.6158 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.0100028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Oxidation(M)@37 missed K-I@20; missed K-L@40 0.541463971138 5571.35205078125 929.5659 5570.810546875 929.475646972656 6 13 1.1.1.4305.12 1 63.7077 900.4518 63.6158 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.0100028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; Deamidated(N)@30 missed K-I@20; missed K-L@40 0.542002975940704 5578.3623046875 930.7343 5577.8203125 930.643981933594 6 13 1.1.1.4314.11 1 63.9401 483.6427 63.9535 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.0100028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.5484219789505 5571.35888671875 929.5671 5570.810546875 929.475646972656 6 13 1.1.1.4326.11 1 64.2496 698.5654 64.314 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.0100028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.528478026390076 5540.3330078125 924.3961 5539.8046875 924.308044433594 6 13 1.1.1.4330.8 1 64.3504 1094.118 64.211 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.0100028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.517181992530823 5784.52294921875 965.0944 5785.0400390625 965.180603027344 6 14 1.1.1.4347.10 1 64.797 204.2581 64.8113 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.0100028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Oxidation(M)@37 missed K-I@20; missed K-L@40 0.598959028720856 5571.4091796875 929.5755 5570.810546875 929.475646972656 6 13 1.1.1.4356.7 1 65.0311 2815.164 65.1536 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.0100028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Oxidation(P)@25; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.44997900724411 5814.564453125 970.1013 5815.01416015625 970.176330566406 6 15 1.1.1.4357.9 1 65.0591 202.7267 64.9689 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.0100028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamyl@N-term; acrolein addition +38(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.453557014465332 5610.30859375 1123.069 5609.8544921875 1122.97814941406 5 15 1.1.1.4357.11 1 65.0608 5190.666 65.0214 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.0100028514862 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +96(K)@20; Deamidated(N)@30; Formyl(K)@40 missed K-I@20; missed K-L@40 -0.488940000534058 5625.353515625 1126.078 5625.84130859375 1126.17553710938 5 14 1.1.1.4371.17 1 65.4346 735.4156 65.3929 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 78.9900004863739 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.536891996860504 5626.37255859375 938.736 5626.9091796875 938.825500488281 6 14 1.1.1.4305.14 1 63.7094 973.9439 63.6418 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 78.9900004863739 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.518633008003235 5641.4072265625 941.2418 5640.888671875 941.155395507813 6 14 1.1.1.4340.9 1 64.613 209.8761 64.6283 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 77.9600024223328 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Hex(N)@34; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 -0.379359006881714 6044.71630859375 1008.46 6045.09326171875 1008.52282714844 6 14 1.1.1.4180.4 1 60.5915 2980.353 60.5841 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 77.9600024223328 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR ONE addition +154(K)@20; reduced HNE(H)@24; Oxidation(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.528734028339386 5886.54296875 982.0978 5887.07177734375 982.185913085938 6 13 1.1.1.4231.16 1 61.8425 413.0015 61.8518 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 77.4399995803833 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; HPNE addition +172(K)@20; Oxidation(M)@37; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 0.499200999736786 5827.47900390625 1166.503 5826.97802734375 1166.40283203125 5 14 1.1.1.4281.16 1 63.0953 2283.891 63.0006 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 76.9200026988983 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; reduced HNE(H)@24; HexNAc(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.44411501288414 5976.505859375 997.0916 5976.06201171875 997.017578125 6 17 1.1.1.4233.11 1 61.8879 9648.393 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 76.3999998569489 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; Deamidated(N)@34; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.478985011577606 5565.2685546875 1114.061 5564.78857421875 1113.96496582031 5 13 1.1.1.4175.16 1 60.4769 2805.571 60.5599 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 76.3999998569489 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Hex(N)@17; reduced HNE(H)@24; Deamidated(N)@26; ONE addition +154(K)@40 missed K-I@20; missed K-L@40 0.353605002164841 5976.42333984375 1196.292 5976.07177734375 1196.2216796875 5 16 1.1.1.4200.6 1 61.0935 8891.97 61.3156 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 76.3999998569489 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; HPNE addition +172(K)@20; Oxidation(M)@37; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 -0.498724013566971 5826.478515625 1166.303 5826.97802734375 1166.40283203125 5 14 1.1.1.4253.4 1 62.382 12913.99 62.1507 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 76.3999998569489 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; reduced HNE(H)@24; Hex(N)@34; hexanoyl addition +98(K)@40 missed K-I@20; missed K-L@40 -0.572147011756897 5976.53125 997.0958 5977.103515625 997.191162109375 6 17 1.1.1.4268.18 1 62.7654 618.7531 62.7991 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 76.2799978256226 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.495189994573593 5583.341796875 931.5643 5582.8466796875 931.481750488281 6 14 1.1.1.4595.12 1 71.0941 236.3493 70.9707 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 76.2799978256226 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.501416027545929 5583.34814453125 931.5653 5582.8466796875 931.481750488281 6 14 1.1.1.4620.14 1 71.7501 250.4312 71.761 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 75.3400027751923 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.44353199005127 5581.2734375 1117.262 5580.8310546875 1117.17346191406 5 13 1.1.1.4231.20 1 61.8459 759.3515 61.8765 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 74.8099982738495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; Oxidation(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.594316005706787 5606.40966796875 801.9229 5605.81494140625 801.838012695313 7 14 1.1.1.4274.7 1 62.9091 1104.907 63.0006 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 74.2799997329712 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Hex(N)@34; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 -0.389613002538681 6044.70458984375 1008.458 6045.09326171875 1008.52282714844 6 15 1.1.1.4187.3 1 60.7645 2629.932 60.7788 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 73.2100009918213 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; Deamidated(N)@30; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.55671101808548 5713.455078125 953.2498 5712.8984375 953.157043457031 6 13 1.1.1.4301.13 1 63.6041 502.4797 63.6941 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 73.2100009918213 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Cation:Na(E)@3; acrolein addition +56(K)@20; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.466219007968903 5580.263671875 1117.06 5579.796875 1116.96667480469 5 14 1.1.1.4346.13 1 64.7751 3332.307 64.8638 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 72.1300005912781 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; reduced acrolein addition +58(K)@20 missed K-I@20; missed K-L@40 0.572667002677917 5585.43505859375 798.9266 5584.8623046875 798.844787597656 7 13 1.1.1.4322.8 1 64.1435 386.854 64.1594 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 71.5900003910065 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; ONE addition +154(K)@40 missed K-I@20; missed K-L@40 0.489351987838745 5827.50341796875 972.2579 5827.01416015625 972.176330566406 6 12 1.1.1.4233.7 1 61.8846 576.9656 61.8518 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 71.5900003910065 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.45269700884819 5604.28857421875 1121.865 5603.8359375 1121.7744140625 5 13 1.1.1.4244.18 1 62.1675 1219.268 62.1751 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 71.5900003910065 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.509527981281281 5613.36669921875 936.5684 5612.857421875 936.483520507813 6 12 1.1.1.4258.14 1 62.5069 570.2805 62.5178 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 71.5900003910065 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.50161600112915 5528.3310546875 922.3958 5528.8330078125 922.479431152344 6 13 1.1.1.4348.10 1 64.8232 186.8432 64.8113 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 71.0500001907349 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR ONE addition +154(K)@20; reduced HNE(H)@24; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.393274009227753 5851.44384765625 976.2479 5851.05078125 976.182373046875 6 12 1.1.1.4058.17 1 57.6578 628.4682 57.6911 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 70.5600023269653 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.533294975757599 5558.3486328125 927.3987 5557.81494140625 927.309814453125 6 13 1.1.1.4677.12 1 73.2522 557.9954 73.3956 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 69.9599981307983 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 0.55425900220871 5595.40087890625 800.3503 5594.8466796875 800.271118164063 7 14 1.1.1.4056.9 1 57.6012 1730.779 57.5905 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 69.9599981307983 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.494287014007568 5556.3369140625 927.0634 5556.8310546875 927.145812988281 6 15 1.1.1.4087.3 1 58.3239 192270.8 58.3917 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 69.9599981307983 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 -0.474932998418808 5562.345703125 928.0649 5562.8203125 928.14404296875 6 14 1.1.1.4088.3 1 58.3499 16167.77 58.3675 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 69.9599981307983 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20 missed K-I@20; missed K-L@40 0.512426972389221 5557.34375 927.2312 5556.8310546875 927.145812988281 6 15 1.1.1.4101.4 1 58.6653 304383.7 58.7314 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 69.9599981307983 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.523724019527435 5563.34423828125 928.2313 5562.8203125 928.14404296875 6 15 1.1.1.4106.2 1 58.7854 8384.483 58.7555 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 69.9599981307983 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.495018988847733 5556.3359375 927.0633 5556.8310546875 927.145812988281 6 15 1.1.1.4110.3 1 58.885 202400.2 58.8283 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 69.9599981307983 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.507129013538361 5558.33984375 927.3972 5558.8466796875 927.481750488281 6 15 1.1.1.4111.3 1 58.9209 239866.1 58.8283 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 69.9599981307983 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.504737019538879 5557.3359375 927.2299 5556.8310546875 927.145812988281 6 14 1.1.1.4117.2 1 59.0673 283046.4 59.1342 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 69.9599981307983 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.513159990310669 5557.34423828125 927.2313 5556.8310546875 927.145812988281 6 15 1.1.1.4202.2 1 61.1282 94950.38 60.978 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 69.9599981307983 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.495591998100281 5673.41064453125 946.5757 5672.9150390625 946.493103027344 6 15 1.1.1.4265.19 1 62.6895 3716.141 62.6452 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 69.9599981307983 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.450002014636993 5557.28369140625 1112.464 5556.8310546875 1112.37353515625 5 15 1.1.1.4293.20 1 63.4014 4213.852 63.2521 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 68.8700020313263 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR ONE addition +154(K)@20; reduced HNE(H)@24; Oxidation(M)@37; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 0.454598009586334 5941.537109375 991.2634 5941.08251953125 991.187683105469 6 12 1.1.1.4233.9 1 61.8862 218.4622 62.0533 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 68.8700020313263 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Dioxidation(M)@37 missed K-I@20; missed K-L@40 -0.445454001426697 5802.5322265625 968.096 5802.97802734375 968.170227050781 6 13 1.1.1.4269.16 1 62.7899 544.4833 62.773 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 68.8700020313263 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(P)@25; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.482127010822296 5544.345703125 925.0649 5544.82763671875 925.145263671875 6 14 1.1.1.4277.6 0 62.983 631.8109 63.1004 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 68.8700020313263 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@28; Deamidated(N)@30; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.554099977016449 5542.32666015625 924.7284 5541.7724609375 924.636047363281 6 13 1.1.1.4280.5 1 63.0569 1662.183 63.3038 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 68.3300018310547 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; hexanoyl addition +98(K)@20; reduced HNE(H)@24; hexanoyl addition +98(K)@40 missed K-I@20; missed K-L@40 0.439341992139816 5881.537109375 981.2634 5881.09765625 981.190185546875 6 13 1.1.1.4238.13 1 62.0156 402.4476 62.102 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 68.3300018310547 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@26; Deamidated(N)@28; Deamidated(N)@30 missed K-I@20; missed K-L@40 0.491430014371872 5542.26318359375 1109.46 5541.7724609375 1109.36181640625 5 13 1.1.1.4288.18 1 63.2706 1086.934 63.2781 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 67.7799999713898 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@34; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.439860999584198 5598.2861328125 934.055 5597.8466796875 933.981689453125 6 12 1.1.1.4082.14 1 58.2085 2029.767 58.3179 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 67.7799999713898 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.428939014673233 5575.2685546875 1116.061 5574.841796875 1115.9755859375 5 12 1.1.1.4168.7 1 60.3106 1523.728 60.2673 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 67.7799999713898 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; reduced HNE(H)@24; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.535350978374481 5888.55224609375 982.4326 5889.08740234375 982.521850585938 6 12 1.1.1.4235.9 1 61.9364 443.0944 61.9262 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 67.7799999713898 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@34; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.382676005363464 5616.21875 937.0437 5615.8359375 936.979919433594 6 12 1.1.1.4237.8 1 61.9861 513.7359 62.102 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 67.7799999713898 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; reduced acrolein addition +58(K)@20; reduced HNE(H)@24; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.419131010770798 5801.45361328125 1161.298 5801.03515625 1161.21423339844 5 13 1.1.1.4259.18 1 62.5356 442.7651 62.5178 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 67.7799999713898 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +38(K)@20; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.472737014293671 5597.37353515625 933.9029 5597.8466796875 933.981689453125 6 12 1.1.1.4295.11 1 63.4457 765.0165 63.4847 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 67.7799999713898 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(2)C(2)(H)@24; Dethiomethyl(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.462013989686966 5595.3037109375 1120.068 5594.84326171875 1119.97595214844 5 14 1.1.1.4310.18 1 63.8425 3442.339 63.9019 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 67.7799999713898 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Dethiomethyl(M)@37; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 0.542164981365204 5569.3701171875 929.2356 5568.82763671875 929.145263671875 6 13 1.1.1.4331.14 0 64.3815 481.961 64.3404 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 67.7799999713898 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.466708987951279 5571.2783203125 1115.263 5570.810546875 1115.16931152344 5 12 1.1.1.4349.10 1 64.857 516.2582 64.8113 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 67.7799999713898 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.517978012561798 5571.328125 1115.273 5570.810546875 1115.16931152344 5 12 1.1.1.4356.11 1 65.0378 7368.94 65.1536 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 67.7799999713898 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.490512013435364 5571.29833984375 1115.267 5570.810546875 1115.16931152344 5 12 1.1.1.4371.16 1 65.4338 840.5831 65.3929 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 65.039998292923 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.48497399687767 5540.2880859375 1109.065 5539.8046875 1108.96813964844 5 12 1.1.1.4281.14 1 63.092 1011.007 63.2521 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 63.9500021934509 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 0.630627989768982 5629.48291015625 805.2191 5628.85205078125 805.129028320313 7 12 1.1.1.4343.4 1 64.6875 241.175 64.7329 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 62.9100024700165 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; Oxidation(M)@37; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 -0.49533399939537 5571.29833984375 1115.267 5571.79443359375 1115.3662109375 5 13 1.1.1.4460.17 1 67.6399 1305.238 67.8216 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 62.8499984741211 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Oxidation(M)@37; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.450246006250381 5581.28369140625 1117.264 5580.8310546875 1117.17346191406 5 13 1.1.1.4312.20 1 63.896 1584.629 63.7722 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 62.3000025749207 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; HPNE addition +172(K)@20; Dioxidation(M)@37; reduced acrolein addition +96(K)@40 missed K-I@20; missed K-L@40 -0.498724013566971 5826.478515625 1166.303 5826.97802734375 1166.40283203125 5 14 1.1.1.4239.16 1 62.044 12688.3 62.1507 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 61.760002374649 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +96(K)@20; reduced HNE(H)@24; Deamidated(N)@34; hexanoyl addition +98(K)@40 missed K-I@20; missed K-L@40 0.328619003295898 5854.37890625 1171.883 5854.05029296875 1171.8173828125 5 12 1.1.1.4179.7 1 60.5791 999.6418 60.6083 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 61.2100005149841 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Dioxidation(M)@37; acrolein addition +94(K)@40 missed K-I@20; missed K-L@40 -0.514295995235443 5896.50537109375 983.7582 5897.01953125 983.843872070313 6 15 1.1.1.4088.6 1 58.3582 1426.189 58.3675 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 61.2100005149841 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; reduced HNE(H)@24; Oxidation(M)@37; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 0.337906002998352 5959.42822265625 1192.893 5959.0927734375 1192.82580566406 5 12 1.1.1.4232.16 1 61.8681 689.2778 61.9262 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 60.6599986553192 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; Delta:H(2)C(2)(H)@24; GlnGlnGlnThrGlyGly(K)@40 missed K-I@20; missed K-L@40 -0.436334013938904 6219.69482421875 1037.623 6220.12890625 1037.69543457031 6 16 1.1.1.4213.8 1 61.4005 2829.28 61.388 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 60.6599986553192 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; reduced HNE(H)@24; Oxidation(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.447421014308929 5804.52490234375 968.4281 5804.97216796875 968.502685546875 6 12 1.1.1.4292.16 1 63.3724 287.7351 63.2521 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 60.6599986553192 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.458092987537384 5566.2783203125 1114.263 5565.8203125 1114.17126464844 5 12 1.1.1.4306.20 1 63.7404 738.0827 63.6678 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 60.6599986553192 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Cation:Na(E)@3; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.460243999958038 5579.27392578125 1116.862 5578.81298828125 1116.76989746094 5 13 1.1.1.4329.17 1 64.332 7013.583 64.211 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 60.6599986553192 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(H)@4; Ammonia-loss(N)@5; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.540458977222443 5555.25830078125 1112.059 5555.79931640625 1112.16711425781 5 14 1.1.1.4339.13 1 64.5899 8358.785 64.5755 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 60.6599986553192 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.486721009016037 5626.4228515625 938.7444 5626.9091796875 938.825500488281 6 13 1.1.1.4357.6 1 65.0566 946.1776 65.1269 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 59.0200006961823 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; Delta:H(2)C(2)(H)@24; GlnGlnGlnThrGlyGly(K)@40 missed K-I@20; missed K-L@40 -0.436334013938904 6219.69482421875 1037.623 6220.12890625 1037.69543457031 6 17 1.1.1.4206.13 1 61.2332 2829.28 61.388 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 58.4800004959106 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Formyl(K)@40 missed K-I@20; missed K-L@40 -0.487980008125305 5584.337890625 931.7303 5584.826171875 931.811645507813 6 13 1.1.1.4059.6 0 57.6735 949.0243 57.6662 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 58.4800004959106 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Formyl(K)@40 missed K-I@20; missed K-L@40 -0.518276989459991 5582.29345703125 1117.466 5582.810546875 1117.5693359375 5 13 1.1.1.4304.20 1 63.6882 2251.778 63.7722 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 56.9400012493134 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.520850002765656 5557.35205078125 927.2326 5556.8310546875 927.145812988281 6 14 1.1.1.4135.4 1 59.5137 224111.2 59.5522 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 56.9400012493134 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.435963988304138 5557.26904296875 1112.461 5556.8310546875 1112.37353515625 5 14 1.1.1.4186.5 1 60.7482 94663.9 60.6805 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 56.9400012493134 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 -0.533827006816864 5672.380859375 946.4041 5672.9150390625 946.493103027344 6 14 1.1.1.4273.6 1 62.8835 1978.048 62.6196 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 56.9400012493134 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.437795013189316 5557.26904296875 1112.461 5556.8310546875 1112.37353515625 5 14 1.1.1.4342.16 1 64.6711 14499.49 64.6016 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 56.9400012493134 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +96(K)@20; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 -0.456941992044449 5768.515625 962.4265 5768.97216796875 962.502685546875 6 14 1.1.1.4351.5 1 64.9075 206.5298 65.0479 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 56.9400012493134 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.464040011167526 5557.29345703125 1112.466 5556.8310546875 1112.37353515625 5 14 1.1.1.4429.17 1 66.868 1312.087 66.7681 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 56.3099980354309 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@12; Delta:H(2)C(2)(H)@24; Oxidation(M)@37 missed K-I@20; missed K-L@40 0.52123498916626 5544.32080078125 925.0607 5543.79931640625 924.973876953125 6 13 1.1.1.4261.14 1 62.5831 1436.307 62.5178 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 55.7699978351593 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; Dethiomethyl(M)@37; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.398689985275269 5567.26904296875 1114.461 5566.86962890625 1114.38122558594 5 12 1.1.1.4327.15 1 64.2784 548.9385 64.185 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 55.6999981403351 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; Iodo(H)@24; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.247685998678207 5766.5341796875 962.0963 5766.78173828125 962.137573242188 6 15 1.1.1.4463.6 1 67.7122 1048.747 67.6483 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 54.6899974346161 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +112(K)@20; Oxidation(M)@37; HPNE addition +172(K)@40 missed K-I@20; missed K-L@40 0.50408399105072 5827.48388671875 1166.504 5826.97802734375 1166.40283203125 5 13 1.1.1.4260.21 1 62.5634 4525.843 62.3204 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 53.6199986934662 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +54(K)@20; Delta:H(2)C(2)(H)@24 missed K-I@20; missed K-L@40 0.491919010877609 5581.3232421875 931.2278 5580.8310546875 931.145812988281 6 12 1.1.1.4224.6 1 61.6622 1596.461 61.6797 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 53.6199986934662 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(Q)@14; acrolein addition +56(K)@20; Oxidation(M)@37 missed K-I@20; missed K-L@40 0.454688996076584 5600.2783203125 1121.063 5599.82568359375 1120.97241210938 5 13 1.1.1.4234.16 1 61.917 2617.245 61.8765 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 53.6199986934662 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; Deamidated(N)@30; Deamidated(N)@34; Dethiomethyl(M)@37 missed K-I@20; missed K-L@40 0.530351996421814 5531.3310546875 922.8958 5530.80078125 922.807434082031 6 13 1.1.1.4236.7 1 61.96 505.9418 61.9262 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 53.6199986934662 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; reduced HNE(H)@24; MDA adduct +54(K)@40; HexNAc(S)@42 missed K-I@20; missed K-L@40 -0.436150014400482 5977.60498046875 997.2748 5978.041015625 997.347473144531 6 13 1.1.1.4285.20 1 63.1948 335.2008 63.1753 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 53.0799984931946 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@34; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.516001999378204 5530.33642578125 922.73 5529.8203125 922.643981933594 6 13 1.1.1.4301.11 1 63.6024 288.7242 63.6941 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 52.5499999523163 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; reduced HNE(H)@24; HexNAc(N)@34; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.37533101439476 5976.45849609375 1196.299 5976.0830078125 1196.22387695313 5 13 1.1.1.4175.19 1 60.4794 1704.712 60.5841 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 51.9599974155426 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@12; Deamidated(N)@28; MDA adduct +54(K)@40 missed K-I@20; missed K-L@40 0.499426990747452 5583.29833984375 1117.667 5582.79931640625 1117.56713867188 5 14 1.1.1.4469.18 1 67.8646 435.7473 67.8978 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 49.3699997663498 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Deamidated(N)@28; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.490323007106781 5628.3837890625 939.0712 5627.8935546875 938.989501953125 6 13 1.1.1.4291.13 1 63.3439 680.4852 63.2781 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 45.6299990415573 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 -0.587255001068115 5558.2587890625 1112.659 5558.8466796875 1112.77661132813 5 12 1.1.1.4441.6 1 67.1775 992.4037 67.1338 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 45.6299990415573 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@20; reduced HNE(H)@24; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.516737997531891 5775.5361328125 963.5966 5775.01953125 963.510498046875 6 12 1.1.1.4499.3 1 68.6312 608.481 68.5662 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 45.6299990415573 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.500171005725861 5582.3466796875 931.3984 5582.8466796875 931.481750488281 6 12 1.1.1.4629.12 1 71.9873 208.9446 71.9998 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 45.210000872612 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Deamidated(N)@26; Deamidated(N)@28; Oxidation(M)@37 missed K-I@20; missed K-L@40 0.538439989089966 5581.32177734375 931.2276 5580.78369140625 931.137878417969 6 12 1.1.1.4198.2 1 61.0325 3555.213 61.0504 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 45.210000872612 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@20; Dethiomethyl(M)@37; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.506537020206451 5567.35498046875 928.8998 5566.8486328125 928.815368652344 6 12 1.1.1.4348.12 1 64.8249 466.3025 64.7851 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 44.6999996900558 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Oxidation(P)@25; Delta:H(2)C(2)(K)@40 missed K-I@20; missed K-L@40 0.439747989177704 5569.2685546875 1114.861 5568.8310546875 1114.77355957031 5 14 1.1.1.4280.15 1 63.0669 4309.84 62.7991 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 44.1900014877319 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +94(K)@20; reduced HNE(H)@24; Hex(N)@34; MDA adduct +62(K)@40 missed K-I@20; missed K-L@40 -0.611359000205994 5976.43310546875 1196.294 5977.0458984375 1196.41650390625 5 17 1.1.1.4208.4 1 61.2862 11801.21 61.437 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 44.1900014877319 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@28; Deamidated(N)@30; Deamidated(N)@34; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.492040008306503 5542.26318359375 1109.46 5541.7724609375 1109.36181640625 5 12 1.1.1.4264.19 1 62.6641 1283.081 62.5685 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 44.1900014877319 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; MDA adduct +54(K)@20; Dethiomethyl(M)@37; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.565198004245758 5571.40869140625 796.9228 5570.84326171875 796.842041015625 7 13 1.1.1.4279.7 1 63.0337 1599.608 62.825 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 43.1800007820129 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; acrolein addition +38(K)@20 missed K-I@20; missed K-L@40 0.433196991682053 5565.2685546875 1114.061 5564.83642578125 1113.97448730469 5 10 1.1.1.4284.15 1 63.1653 348.0144 63.1502 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 42.6699995994568 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.511936008930206 5627.42138671875 938.9108 5626.9091796875 938.825500488281 6 12 1.1.1.4350.10 1 64.8753 1025.145 64.7329 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 41.839998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamidomethyl@N-term; reduced acrolein addition +96(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.442607998847961 5681.47265625 947.9194 5681.9150390625 947.9931640625 6 14 1.1.1.4651.15 1 72.5728 1042.602 72.4496 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 41.839998960495 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Oxidation(M)@37; acrolein addition +38(K)@40 missed K-I@20; missed K-L@40 0.617555022239685 5555.43310546875 926.9128 5554.8154296875 926.809875488281 6 12 1.1.1.4697.17 1 73.7739 395.3487 73.808 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 41.6700005531311 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@24; Oxidation(M)@37 missed K-I@20; missed K-L@40 0.524170994758606 5543.33984375 924.8972 5542.8154296875 924.809875488281 6 12 1.1.1.4335.10 1 64.4831 631.0909 64.4706 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 40.5900001525879 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +112(K)@20; reduced HNE(H)@24; Deamidated(N)@34 missed K-I@20; missed K-L@40 0.52776700258255 5772.5 963.0906 5771.97216796875 963.002624511719 6 12 1.1.1.4536.5 1 69.5749 164.8976 69.5349 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 40.1699990034103 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; HPNE addition +172(K)@20; reduced HNE(H)@24; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 -0.532420992851257 5912.55517578125 986.4331 5913.08740234375 986.521850585938 6 12 1.1.1.4279.15 1 63.0404 342.7967 63.0006 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 40.1699990034103 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; MDA adduct +62(K)@20; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.158996999263763 5591.6787109375 1119.343 5591.8359375 1119.37451171875 5 12 1.1.1.4318.18 1 64.049 621.2894 64.0053 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 40.1699990034103 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@20; Deamidated(N)@34; Dethiomethyl(M)@37 missed K-I@20; missed K-L@40 0.415524005889893 5510.228515625 1103.053 5509.8115234375 1102.96960449219 5 12 1.1.1.4407.12 1 66.294 470.9224 66.3041 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 39.1799986362457 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@20; Deamidated(N)@30; Deamidated(N)@34; Formyl(K)@40 missed K-I@20; missed K-L@40 0.588244020938873 5569.37158203125 929.2359 5568.78369140625 929.137878417969 6 13 1.1.1.4341.10 1 64.6401 390.5712 64.7067 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 39.1799986362457 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamyl@N-term; acrolein addition +38(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 0.462101995944977 5610.31884765625 1123.071 5609.8544921875 1122.97814941406 5 13 1.1.1.4350.17 1 64.8828 16306.31 64.7067 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 38.6900007724762 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@17; acrolein addition +112(K)@20; Deamidated(N)@26; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 -0.459529995918274 5642.39697265625 941.4068 5642.8564453125 941.4833984375 6 13 1.1.1.4313.11 1 63.9148 310.5742 63.9282 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 37.2299998998642 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(N)@12; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.458393007516861 5584.28857421875 1117.865 5583.83056640625 1117.7734375 5 12 1.1.1.4309.19 1 63.8175 4300.566 63.537 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 36.269998550415 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Delta:H(2)C(2)(H)@4; Deamidated(Q)@14; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.439812988042831 5586.28857421875 1118.265 5585.8466796875 1118.17651367188 5 12 1.1.1.4278.20 1 63.0196 16907.51 63.0006 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 28.8399994373322 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Methyl(E)@3; Delta:H(2)C(2)(H)@4; acrolein addition +56(K)@40 missed K-I@20; missed K-L@40 0.52812397480011 5597.390625 933.9057 5596.8623046875 933.817687988281 6 13 1.1.1.4274.13 1 62.9141 2921.254 62.8504 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 28.8399994373322 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; reduced HNE(H)@24; Dioxidation(M)@37; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 0.413717985153198 5975.50146484375 996.9242 5975.087890625 996.855224609375 6 15 1.1.1.4284.12 1 63.1628 446.7695 63.1502 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 24.8799994587898 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR hexanoyl addition +98(K)@20; reduced HNE(H)@24; Carbamidomethyl(D)@35; reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40 0.498153001070023 5872.5703125 979.769 5872.072265625 979.685974121094 6 12 1.1.1.4236.12 1 61.9642 567.9435 61.9515 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 23.6000001430511 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR HPNE addition +172(K)@20; reduced HNE(H)@24; Dioxidation(M)@37; acrolein addition +112(K)@40 missed K-I@20; missed K-L@40 0.425071001052856 5975.5126953125 996.9261 5975.087890625 996.855224609375 6 17 1.1.1.4153.6 1 59.9399 2992.002 59.9034 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 21.4499995112419 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Carbamidomethyl@N-term; reduced acrolein addition +96(K)@20; Dethiomethyl(M)@37; acrolein addition +76(K)@40 missed K-I@20; missed K-L@40 -0.427518993616104 5681.484375 947.9213 5681.91162109375 947.992553710938 6 13 1.1.1.4606.9 1 71.3827 288.6986 71.3651 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 15.5100002884865 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@20; Deamidated(N)@30; Delta:H(4)C(2)(K)@40 missed K-I@20; missed K-L@40 0.456847012042999 5592.29345703125 1119.466 5591.8359375 1119.37451171875 5 12 1.1.1.4326.19 1 64.2563 1579.432 64.263 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.9300007820129 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVAT reduced HNE(H)@24; hexanoyl addition +98(K)@40; Oxidation(P)@44 cleaved T-V@C-term; missed K-I@20; missed K-L@40; missed R-V@50 0.546783983707428 6044.70458984375 1008.458 6044.15673828125 1008.36676025391 6 16 1.1.1.4187.3 1 60.7645 2629.932 60.7788 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 39.4300013780594 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATV HPNE addition +172(K)@20; Deamidated(N)@34 cleaved V-S@C-term; missed K-I@20; missed K-L@40; missed R-V@50 0.51537299156189 6044.63330078125 1209.934 6044.12060546875 1209.83142089844 5 12 1.1.1.4180.9 1 60.6032 1140.943 60.5841 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 21.9200000166893 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATV HPNE addition +172(K)@20 cleaved V-S@C-term; missed K-I@20; missed K-L@40; missed R-V@50 0.522750973701477 6043.66015625 1008.284 6043.13623046875 1008.19671630859 6 13 1.1.1.4225.9 1 61.6891 396.3506 61.6797 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 75.7499992847443 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPR reduced acrolein addition +58(K)@40 missed K-I@20; missed K-L@40; missed R-V@50 -0.417003989219666 6381.92138671875 912.7103 6382.33837890625 912.769897460938 7 15 1.1.1.4231.8 1 61.8359 856.8892 61.8024 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 44.1900014877319 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPR acrolein addition +56(K)@40; Oxidation(P)@57 missed K-I@20; missed K-L@40; missed R-V@50 -0.63594001531601 6395.68017578125 1066.954 6396.3173828125 1067.06018066406 6 12 1.1.1.4233.16 1 61.8921 1229.425 61.8024 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 25.7499992847443 LGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPR ONE addition +154(K)@20; reduced HNE(H)@24; reduced acrolein addition +96(K)@40; HexNAc(S)@55 missed K-I@20; missed K-L@40; missed R-V@50 0.155204996466637 6935.81884765625 1156.977 6935.66357421875 1156.951171875 6 12 1.1.1.4047.20 1 57.3755 1555.403 57.3814 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LSSPATLNSR 0.149045005440712 1044.70544433594 523.36 1044.55639648438 523.285461425781 2 17 1.1.1.2710.7 1 24.9013 401127 24.8875 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LSSPATLNSR 0.149045005440712 1044.70544433594 523.36 1044.55639648438 523.285461425781 2 16 1.1.1.2712.5 1 24.9441 401127 24.8875 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 LSSPATLNSR Deamidated(N)@8 0.151235997676849 1045.69165039063 523.8531 1045.54040527344 523.777465820313 2 14 1.1.1.2735.4 1 25.4973 4049.819 25.4829 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.1500029563904 LSSPATLNSR 0.149045005440712 1044.70544433594 523.36 1044.55639648438 523.285461425781 2 15 1.1.1.2705.7 1 24.7817 401127 24.8875 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 95.389997959137 LSSPATLNSR Deamidated(N)@8 0.150625005364418 1045.69104003906 523.8528 1045.54040527344 523.777465820313 2 13 1.1.1.2727.5 1 25.3043 16364.92 25.0787 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.2999975681305 LSSPATLNSR Dehydrated(T)@6 0.145694002509117 1026.69152832031 514.353 1026.54577636719 514.280151367188 2 11 1.1.1.2709.4 1 24.8708 745.8375 24.8875 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 70.6300020217896 LSSPATLNSR Delta:H(2)C(2)@N-term 0.151216998696327 1070.72326660156 536.3689 1070.57202148438 536.293273925781 2 12 1.1.1.2825.5 1 27.6441 1697.591 27.5853 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 64.410001039505 LSSPATLNSR Methyl(L)@1 0.150850996375084 1058.72290039063 530.3687 1058.57202148438 530.293273925781 2 12 1.1.1.2716.5 1 25.0464 1173.873 25.0787 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 37.6899987459183 LSSPATLNSR 0.146847993135452 1044.70324707031 523.3589 1044.55639648438 523.285461425781 2 11 1.1.1.2698.13 1 24.6125 1340.284 24.6243 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 NIDVLEGNEQFINAAK cleaved H-N@N-term 0.170670002698898 1774.06042480469 888.0375 1773.88977050781 887.9521484375 2 18 1.1.1.3596.19 1 46.2656 1604.164 46.1723 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 NIDVLEGNEQFINAAK cleaved H-N@N-term 0.23285199701786 1774.12255859375 592.3815 1773.88977050781 592.303833007813 3 18 1.1.1.3589.5 1 46.0838 682.1733 46.1723 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.6199975013733 NIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@36 cleaved H-N@N-term; missed K-I@16; missed K-L@36 0.451590001583099 5121.07373046875 1025.222 5120.6240234375 1025.13208007813 5 17 1.1.1.4251.6 1 62.3397 17972.11 62.2721 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.2600028514862 NIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@16 cleaved H-N@N-term; missed K-I@16; missed K-L@36 0.522315979003906 5121.146484375 854.5317 5120.6240234375 854.444641113281 6 16 1.1.1.4250.4 1 62.3087 2821.831 62.2963 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.5100014209747 NIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@36 cleaved H-N@N-term; missed K-I@16; missed K-L@36 0.450369000434875 5121.07373046875 1025.222 5120.6240234375 1025.13208007813 5 14 1.1.1.4237.17 1 61.9936 10482.4 62.2235 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.5100014209747 NIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced acrolein addition +58(K)@36 cleaved H-N@N-term; missed K-I@16; missed K-L@36 -0.503099024295807 5122.13671875 854.6967 5122.6396484375 854.780578613281 6 14 1.1.1.4283.13 1 63.1385 1131.125 63.1251 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 NKPGVYTKVCNYVNWIQQTIAAN hexanoyl addition +98(K)@2; acrolein addition +76(K)@8; Carbamidomethyl(C)@10; Deamidated(N)@11 missed K-V@8 0.210536003112793 2855.64208984375 952.888 2855.431640625 952.817810058594 3 21 1.1.1.4264.16 1 62.6616 5024.573 62.5178 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 NKPGVYTKVCNYVNWIQQTIAAN hexanoyl addition +98(K)@2; acrolein addition +76(K)@8; Carbamidomethyl(C)@10; Deamidated(N)@11 missed K-V@8 0.210902005434036 2855.642578125 952.8881 2855.431640625 952.817810058594 3 22 1.1.1.4271.15 1 62.8403 3403.906 62.773 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 NKPGVYTKVCNYVNWIQQTIAAN Deamidated(N)@1; acrolein addition +112(K)@2; MDA adduct +62(K)@8; Carbamidomethyl(C)@10 missed K-V@8 0.246371999382973 2855.6416015625 952.8878 2855.39526367188 952.8056640625 3 24 1.1.1.4288.12 1 63.2656 8680.866 63.3556 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 NKPGVYTKVCNYVNWIQQTIAAN acrolein addition +76(K)@8; No Carbamidomethyl(C)@10 missed K-V@8 0.226191997528076 2699.5791015625 900.867 2699.35302734375 900.791625976563 3 21 1.1.1.4050.12 1 57.4469 3789.693 57.4595 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 NKPGVYTKVCNYVNWIQQTIAAN acrolein addition +56(K)@2; MDA adduct +62(K)@8; No Carbamidomethyl(C)@10 missed K-V@8 0.237782999873161 2741.60131835938 914.8744 2741.36352539063 914.795104980469 3 21 1.1.1.4233.4 1 61.8821 4450.552 61.9262 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 NKPGVYTKVCNYVNWIQQTIAAN Tyr->Dha(Y)@6; ONE addition +154(K)@8; Carbamidomethyl(C)@10; Deamidated(N)@11 missed K-V@8 0.211893007159233 2741.5966796875 914.8728 2741.384765625 914.802185058594 3 21 1.1.1.4269.14 1 62.7882 2421.606 62.7991 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 NKPGVYTKVCNYVNWIQQTIAAN acrolein addition +56(K)@2; MDA adduct +62(K)@8; Carbamidomethyl(C)@10; Amino(Y)@12 missed K-V@8 0.225927993655205 2813.62182617188 938.8812 2813.39599609375 938.805908203125 3 20 1.1.1.4063.14 1 57.7797 2411.421 57.6911 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 NKPGVYTKVCNYVNWIQQTIAAN Lys->Allysine(K)@2; MDA adduct +62(K)@8; Carbamidomethyl(C)@10 missed K-V@8 0.269773989915848 2741.59692382813 914.8729 2741.3271484375 914.783020019531 3 20 1.1.1.4261.13 1 62.5822 3036.798 62.6196 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 NKPGVYTKVCNYVNWIQQTIAAN Deamidated(N)@1; Oxidation(P)@3; Dehydrated(T)@7; MDA adduct +62(K)@8; Carbamidomethyl(C)@10 missed K-V@8 0.273618996143341 2741.60083007813 914.8742 2741.3271484375 914.783020019531 3 21 1.1.1.4276.15 1 62.9656 1915.941 62.9506 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 NKPGVYTKVCNYVNWIQQTIAAN hexanoyl addition +98(K)@2; acrolein addition +76(K)@8; Carbamidomethyl(C)@10; Deamidated(N)@11 missed K-V@8 0.276562005281448 2855.70825195313 714.9343 2855.431640625 714.865173339844 4 20 1.1.1.4291.3 1 63.3355 2434.752 63.3556 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 NKPGVYTKVCNYVNWIQQTIAAN hexanoyl addition +98(K)@2; acrolein addition +76(K)@8; Carbamidomethyl(C)@10; Deamidated(N)@11 missed K-V@8 0.276562005281448 2855.70825195313 714.9343 2855.431640625 714.865173339844 4 18 1.1.1.4257.3 1 62.4722 995.5248 62.5685 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 NKPGVYTKVCNYVNWIQQTIAAN Carbamidomethyl@N-term; acrolein addition +76(K)@2; Carbamidomethyl(C)@10 missed K-V@8 0.29372501373291 2813.68969726563 704.4297 2813.39599609375 704.356262207031 4 18 1.1.1.4065.2 1 57.8189 1124.414 57.8154 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 NKPGVYTKVCNYVNWIQQTIAAN acrolein addition +56(K)@2; MDA adduct +62(K)@8; No Carbamidomethyl(C)@10 missed K-V@8 0.237782999873161 2741.60131835938 914.8744 2741.36352539063 914.795104980469 3 19 1.1.1.4240.2 1 62.0574 4450.552 61.9262 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 NKPGVYTKVCNYVNWIQQTIAAN hexanoyl addition +98(K)@2; acrolein addition +76(K)@8; Carbamidomethyl(C)@10; Deamidated(N)@11 missed K-V@8 0.276562005281448 2855.70825195313 714.9343 2855.431640625 714.865173339844 4 17 1.1.1.4264.4 1 62.6516 995.5248 62.5685 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8900005817413 NKPGVYTKVCNYVNWIQQTIAAN hexanoyl addition +98(K)@2; MDA adduct +62(K)@8; Carbamidomethyl(C)@10; Deamidated(N)@14 missed K-V@8 0.212026000022888 2841.6279296875 948.2166 2841.416015625 948.145935058594 3 16 1.1.1.4285.16 1 63.1915 646.6022 63.2262 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8900005817413 NKPGVYTKVCNYVNWIQQTIAAN hexanoyl addition +98(K)@2; acrolein addition +76(K)@8; Carbamidomethyl(C)@10; Deamidated(N)@11; Deamidated(Q)@17 missed K-V@8 0.214374005794525 2856.63012695313 953.2173 2856.41577148438 953.145812988281 3 16 1.1.1.4369.5 1 65.3845 325.4857 65.3929 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.6199975013733 NKPGVYTKVCNYVNWIQQTIAAN Deamidated(N)@1; acrolein addition +56(K)@2; acrolein addition +76(K)@8; Carbamidomethyl(C)@10 missed K-V@8 0.304957985877991 2813.68969726563 704.4297 2813.384765625 704.353454589844 4 16 1.1.1.4058.5 1 57.6478 1124.414 57.8154 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 NKPGVYTKVCNYVNWIQQTIAAN acrolein addition +38(K)@8; Carbamidomethyl(C)@10; Methyl(N)@11 missed K-V@8 0.284745007753372 2732.6591796875 911.8937 2732.37451171875 911.798767089844 3 17 1.1.1.4021.9 1 56.7148 1584.531 56.7777 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 NKPGVYTKVCNYVNWIQQTIAAN hexanoyl addition +98(K)@2; acrolein addition +76(K)@8; Carbamidomethyl(C)@10; Deamidated(N)@11; Deamidated(Q)@18 missed K-V@8 0.224994003772736 2856.640625 953.2208 2856.41577148438 953.145812988281 3 16 1.1.1.4280.9 1 63.0602 4181.357 63.3038 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 NKPGVYTKVCNYVNWIQQTIAAN hexanoyl addition +98(K)@2; Oxidation(P)@3; MDA adduct +62(K)@8; Carbamidomethyl(C)@10 missed K-V@8 -0.713559985160828 2855.71337890625 714.9356 2856.42700195313 715.114013671875 4 17 1.1.1.4271.4 1 62.8312 739.8055 62.773 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 96.5200006961823 NKPGVYTKVCNYVNWIQQTIAAN hexanoyl addition +98(K)@2; Oxidation(P)@3; PyridoxalPhosphate(K)@8; Carbamidomethyl(C)@10 missed K-V@8 0.18775600194931 2565.5849609375 856.2023 2565.39721679688 856.139709472656 3 17 1.1.1.4014.6 1 56.5361 553.9941 56.578 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 96.5200006961823 NKPGVYTKVCNYVNWIQQTIAAN hexanoyl addition +98(K)@2; acrolein addition +76(K)@8; Carbamidomethyl(C)@10; Deamidated(N)@11 missed K-V@8 0.210536003112793 2855.64208984375 952.888 2855.431640625 952.817810058594 3 15 1.1.1.4252.9 1 62.3545 5024.573 62.5178 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 95.4900026321411 NKPGVYTKVCNYVNWIQQTIAAN hexanoyl addition +98(K)@2; acrolein addition +76(K)@8; Carbamidomethyl(C)@10; Deamidated(N)@11 missed K-V@8 0.276562005281448 2855.70825195313 714.9343 2855.431640625 714.865173339844 4 15 1.1.1.4284.2 1 63.1544 2420.251 63.3556 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 82.9800009727478 NKPGVYTKVCNYVNWIQQTIAAN Deamidated(N)@1; Tyr->Dha(Y)@6; ONE addition +154(K)@8; Carbamidomethyl(C)@10 missed K-V@8 0.27981099486351 2741.66455078125 686.4234 2741.384765625 686.353454589844 4 15 1.1.1.4268.6 1 62.7554 501.7517 62.7991 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 77.9600024223328 NKPGVYTKVCNYVNWIQQTIAAN hexanoyl addition +98(K)@2; acrolein addition +76(K)@8; Carbamidomethyl(C)@10; Deamidated(N)@11 missed K-V@8 0.210536003112793 2855.64208984375 952.888 2855.431640625 952.817810058594 3 12 1.1.1.4278.15 1 63.0154 3507.959 62.7473 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 76.3999998569489 NKPGVYTKVCNYVNWIQQTIAAN Tyr->Dha(Y)@6; ONE addition +154(K)@8; Carbamidomethyl(C)@10; Deamidated(N)@11 missed K-V@8 0.27810201048851 2741.66284179688 686.423 2741.384765625 686.353454589844 4 14 1.1.1.4261.5 1 62.5756 587.7051 62.594 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 76.3999998569489 NKPGVYTKVCNYVNWIQQTIAAN Deamidated(N)@1; ONE addition +154(K)@2; Carbamidomethyl(C)@10; Tyr->Dha(Y)@12 missed K-V@8 0.216104000806808 2741.60083007813 914.8742 2741.384765625 914.802185058594 3 14 1.1.1.4283.17 1 63.1418 1915.941 62.9506 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 68.8700020313263 NKPGVYTKVCNYVNWIQQTIAAN hexanoyl addition +98(K)@2; MDA adduct +62(K)@8; Carbamidomethyl(C)@10; Deamidated(N)@11; Deamidated(Q)@18 missed K-V@8 0.226117998361588 2842.62622070313 948.5493 2842.39990234375 948.473937988281 3 11 1.1.1.4292.14 1 63.3707 473.7887 63.2262 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 68.3300018310547 NKPGVYTKVCNYVNWIQQTIAAN Lys->Allysine(K)@2; MDA adduct +62(K)@8; Carbamidomethyl(C)@10 missed K-V@8 0.357834011316299 2741.68505859375 686.4285 2741.3271484375 686.339050292969 4 13 1.1.1.4276.5 1 62.9573 331.1828 62.9506 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 44.1900014877319 NKPGVYTKVCNYVNWIQQTIAAN GlnGlnGlnThrGlyGly(K)@8; Carbamidomethyl(C)@10; Deamidated(N)@14 missed K-V@8 0.343448996543884 3280.93701171875 821.2415 3280.59350585938 821.155639648438 4 12 1.1.1.4316.8 1 63.9894 601.3842 64.1594 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 NYVNWIQQTIAAN Dioxidation(W)@5 cleaved C-N@N-term 0.169179007411003 1565.91662597656 783.9656 1565.74743652344 783.880981445313 2 18 1.1.1.3685.6 1 48.4524 0 -1 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8499999046326 NYVNWIQQTIAAN Dioxidation(W)@5 cleaved C-N@N-term 0.16966700553894 1565.91711425781 783.9658 1565.74743652344 783.880981445313 2 17 1.1.1.3719.15 1 49.259 715.5768 49.2943 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 54.9600005149841 PNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@6; Deamidated(N)@10; HPNE addition +172(K)@16 cleaved H-P@N-term; missed K-L@16 -0.131151005625725 3018.39086914063 755.605 3018.52197265625 755.637756347656 4 12 1.1.1.4076.2 1 58.0895 1169.343 58.1345 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 59.0200006961823 QGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAAN Carbamidomethyl(C)@10; HPNE addition +172(K)@15; acrolein addition +94(K)@21; Carbamidomethyl(C)@23 cleaved L-Q@N-term; missed K-N@13; missed K-V@21 0.393377006053925 4381.55859375 1096.397 4381.16650390625 1096.298828125 4 12 1.1.1.4279.19 1 63.0437 5663.801 63.0255 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 91.8500006198883 QKNKPGVYTKVCNYVNWIQQTIAAN HPNE addition +172(K)@2; reduced acrolein addition +96(K)@4; MDA adduct +62(K)@10; Carbamidomethyl(C)@12 cleaved A-Q@N-term; missed K-N@2; missed K-V@10 0.238598003983498 3266.91845703125 817.7369 3266.6796875 817.67724609375 4 15 1.1.1.4314.4 1 63.9343 380.8901 63.9535 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 61.2100005149841 QKNKPGVYTKVCNYVNWIQQTIAAN ONE addition +154(K)@2; acrolein addition +94(K)@4; reduced acrolein addition +96(K)@10; Carbamidomethyl(C)@12; Deamidated(Q)@19 cleaved A-Q@N-term; missed K-N@2; missed K-V@10 0.19140000641346 3281.8701171875 1094.964 3281.67944335938 1094.900390625 3 11 1.1.1.4321.18 1 64.1254 395.747 64.1073 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 45.7899987697601 QVRLGEHNIDVLEGNEQFINAAK cleaved I-Q@N-term; missed R-L@3 4.0472297668457 2597.3720703125 866.798 2593.32495117188 865.448913574219 3 13 1.1.1.3512.20 1 44.2289 1133.161 44.3312 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@20; MDA adduct +62(K)@23; Delta:H(4)C(2)(K)@43 cleaved I-Q@N-term; missed R-L@3; missed K-I@23; missed K-L@43 0.369614005088806 5975.43359375 1196.094 5975.06396484375 1196.02001953125 5 21 1.1.1.4105.9 1 58.7747 8077.447 59.0126 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@20; MDA adduct +62(K)@23; Delta:H(4)C(2)(K)@43 cleaved I-Q@N-term; missed R-L@3; missed K-I@23; missed K-L@43 0.367783010005951 5975.43359375 1196.094 5975.06396484375 1196.02001953125 5 20 1.1.1.4126.8 1 59.3048 7591.786 59.2317 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Gln->pyro-Glu@N-term; Deamidated(N)@8; reduced HNE(H)@27; Delta:H(4)C(2)(K)@43 cleaved I-Q@N-term; missed R-L@3; missed K-I@23; missed K-L@43 0.505912005901337 6054.658203125 1010.117 6054.15234375 1010.03271484375 6 20 1.1.1.4225.10 1 61.6908 3575.938 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@15; MDA adduct +62(K)@23; Delta:H(4)C(2)(K)@43 cleaved I-Q@N-term; missed R-L@3; missed K-I@23; missed K-L@43 0.371445000171661 5975.43359375 1196.094 5975.06396484375 1196.02001953125 5 20 1.1.1.4133.7 1 59.4747 4178.542 59.4797 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.089998960495 QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@20; MDA adduct +62(K)@23; Deamidated(N)@31; Delta:H(4)C(2)(K)@43 cleaved I-Q@N-term; missed R-L@3; missed K-I@23; missed K-L@43 0.386575013399124 5976.43310546875 1196.294 5976.0478515625 1196.21691894531 5 19 1.1.1.4215.5 1 61.456 11801.21 61.437 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@15; MDA adduct +62(K)@23; Delta:H(4)C(2)(K)@43 cleaved I-Q@N-term; missed R-L@3; missed K-I@23; missed K-L@43 0.368393003940582 5975.43359375 1196.094 5975.06396484375 1196.02001953125 5 18 1.1.1.4112.6 1 58.9542 9140.884 59.0372 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@20; MDA adduct +62(K)@23; Delta:H(4)C(2)(K)@43 cleaved I-Q@N-term; missed R-L@3; missed K-I@23; missed K-L@43 0.359847992658615 5975.423828125 1196.092 5975.06396484375 1196.02001953125 5 18 1.1.1.4119.10 1 59.1274 9205.205 59.1099 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.8799998760223 QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@20; MDA adduct +62(K)@23; Deamidated(N)@31; Delta:H(4)C(2)(K)@43 cleaved I-Q@N-term; missed R-L@3; missed K-I@23; missed K-L@43 0.387185007333755 5976.43310546875 1196.294 5976.0478515625 1196.21691894531 5 19 1.1.1.4222.12 1 61.6257 11592.14 61.4612 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 97.1199989318848 QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@23; Delta:H(4)C(2)(K)@43; Deamidated(N)@51 cleaved I-Q@N-term; missed R-L@3; missed K-I@23; missed K-L@43 0.44888499379158 5975.5126953125 996.9261 5975.06396484375 996.851257324219 6 20 1.1.1.4153.6 1 59.9399 2992.002 59.9034 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 95.4900026321411 QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; MDA adduct +62(K)@23; Delta:H(4)C(2)(K)@43 cleaved I-Q@N-term; missed R-L@3; missed K-I@23; missed K-L@43 0.437532991170883 5975.50146484375 996.9242 5975.06396484375 996.851257324219 6 18 1.1.1.4284.12 1 63.1628 446.7695 63.1502 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 93.5199975967407 QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@20; MDA adduct +62(K)@23; Deamidated(N)@31; Delta:H(4)C(2)(K)@43 cleaved I-Q@N-term; missed R-L@3; missed K-I@23; missed K-L@43 0.386575013399124 5976.43310546875 1196.294 5976.0478515625 1196.21691894531 5 19 1.1.1.4208.4 1 61.2862 11801.21 61.437 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 91.430002450943 QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@23; Delta:H(2)C(2)(H)@27; Dethiomethyl(M)@40; acrolein addition +76(K)@43 cleaved I-Q@N-term; missed R-L@3; missed K-I@23; missed K-L@43 0.409025013446808 5976.50146484375 997.0908 5976.09228515625 997.022644042969 6 17 1.1.1.4260.17 1 62.5601 734.336 62.5432 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Gln->pyro-Glu@N-term; Deamidated(N)@20; Delta:H(4)C(2)(K)@43 cleaved I-Q@N-term; missed R-L@3; missed K-I@23; missed K-L@43 0.483637988567352 5896.50537109375 983.7582 5896.02197265625 983.677551269531 6 17 1.1.1.4088.6 1 58.3582 1426.189 58.3675 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 85.3500008583069 QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@20; MDA adduct +62(K)@23; Deamidated(N)@31; Delta:H(4)C(2)(K)@43 cleaved I-Q@N-term; missed R-L@3; missed K-I@23; missed K-L@43 0.377420008182526 5976.42333984375 1196.292 5976.0478515625 1196.21691894531 5 17 1.1.1.4200.6 1 61.0935 8891.97 61.3156 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 84.8800003528595 QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(Q)@1; MDA adduct +62(K)@23; Deamidated(N)@33; Formyl(K)@43 cleaved I-Q@N-term; missed R-L@3; missed K-I@23; missed K-L@43 0.494419008493423 5976.505859375 997.0916 5976.01171875 997.009216308594 6 18 1.1.1.4233.11 1 61.8879 9648.393 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 84.8800003528595 QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@15; Deamidated(N)@20; MDA adduct +62(K)@23; Delta:H(4)C(2)(K)@43 cleaved I-Q@N-term; missed R-L@3; missed K-I@23; missed K-L@43 0.483301997184753 5976.53125 997.0958 5976.0478515625 997.015258789063 6 18 1.1.1.4268.18 1 62.7654 618.7531 62.7991 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 83.9399993419647 QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +76(K)@23; Delta:H(4)C(2)(K)@43 cleaved I-Q@N-term; missed R-L@3; missed K-I@23; missed K-L@43 -0.55162101984024 5987.5439453125 998.9313 5988.095703125 999.023193359375 6 15 1.1.1.4239.12 1 62.0407 731.5208 62.0274 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.5100014209747 QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Deamidated(N)@8; MDA adduct +62(K)@23; Delta:H(4)C(2)(K)@43 cleaved I-Q@N-term; missed R-L@3; missed K-I@23; missed K-L@43 0.433871001005173 5975.498046875 996.9236 5975.06396484375 996.851257324219 6 18 1.1.1.4117.4 1 59.074 18039.54 59.0126 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 61.760002374649 QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR Dioxidation(R)@3; reduced acrolein addition +58(K)@23; Dethiomethyl(M)@40; acrolein addition +76(K)@43 cleaved I-Q@N-term; missed R-L@3; missed K-I@23; missed K-L@43 -0.550963997840881 6001.5400390625 1001.264 6002.0927734375 1001.35601806641 6 15 1.1.1.4246.3 1 62.2067 2959.468 62.1751 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 54.6899974346161 QVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@23; Oxidation(P)@28; Delta:H(4)C(2)(K)@43 cleaved I-Q@N-term; missed R-L@3; missed K-I@23; missed K-L@43 -0.523627996444702 5983.56201171875 998.2676 5984.08544921875 998.354858398438 6 14 1.1.1.4266.15 1 62.7117 513.9759 62.5178 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 88.8999998569489 RIQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@25; Deamidated(N)@35; Delta:H(4)C(2)(K)@45 cleaved S-R@N-term; missed R-I@1; missed R-L@5; missed K-I@25; missed K-L@45 -0.556724011898041 6219.69482421875 1037.623 6220.2490234375 1037.71545410156 6 18 1.1.1.4206.13 1 61.2332 2829.28 61.388 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 88.0400002002716 RIQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@25; Deamidated(N)@33; Delta:H(4)C(2)(K)@45 cleaved S-R@N-term; missed R-I@1; missed R-L@5; missed K-I@25; missed K-L@45 -0.556724011898041 6219.69482421875 1037.623 6220.2490234375 1037.71545410156 6 17 1.1.1.4213.8 1 61.4005 2829.28 61.388 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 82.9800009727478 RIQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR reduced HNE(H)@9; HPNE addition +172(K)@25; Oxidation(H)@29; Delta:H(4)C(2)(K)@45 cleaved S-R@N-term; missed R-I@1; missed R-L@5; missed K-I@25; missed K-L@45 -0.307686001062393 6527.17724609375 933.4612 6527.48486328125 933.505126953125 7 16 1.1.1.4247.6 1 62.2326 860.9507 62.1993 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.0100028514862 RIQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@25; Delta:H(4)C(2)(K)@45 cleaved S-R@N-term; missed R-I@1; missed R-L@5; missed K-I@25; missed K-L@45 0.427291005849838 6219.69482421875 1037.623 6219.26513671875 1037.55151367188 6 16 1.1.1.4220.3 1 61.5708 2829.28 61.388 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 80.0100028514862 RIQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@25; Delta:H(4)C(2)(K)@45 cleaved S-R@N-term; missed R-I@1; missed R-L@5; missed K-I@25; missed K-L@45 0.426559001207352 6219.69482421875 1037.623 6219.26513671875 1037.55151367188 6 16 1.1.1.4227.3 1 61.7383 1836.395 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 59.0200006961823 RIQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +38(K)@25; Deamidated(N)@35; Dethiomethyl(M)@42; acrolein addition +76(K)@45 cleaved S-R@N-term; missed R-I@1; missed R-L@5; missed K-I@25; missed K-L@45 -0.554086029529572 6219.69482421875 1037.623 6220.24560546875 1037.71496582031 6 15 1.1.1.4234.13 1 61.9145 1836.395 61.7042 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 91.1499977111816 SIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@15; Deamidated(N)@21; Deamidated(Q)@23; Carbamidomethyl(C)@31; ONE addition +154(K)@33 cleaved N-S@N-term 0.347447991371155 3809.13403320313 953.2908 3808.78662109375 953.203918457031 4 15 1.1.1.3710.8 1 49.0418 1610.352 49.0253 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 88.1900012493134 SIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@15; Deamidated(N)@21; Carbamidomethyl(C)@31; ONE addition +154(K)@33 cleaved N-S@N-term 0.4237360060215 3808.22631835938 762.6525 3807.80249023438 762.567810058594 5 14 1.1.1.3725.16 1 49.4129 30869.12 49.3706 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 85.3799998760223 SIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Deamidated(N)@9; Carbamidomethyl(C)@15; Deamidated(N)@21; Carbamidomethyl(C)@31; ONE addition +154(K)@33 cleaved N-S@N-term 0.356725990772247 3809.14331054688 953.2931 3808.78662109375 953.203918457031 4 14 1.1.1.3754.18 1 50.1547 3931.972 50.2122 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 69.4100022315979 SRIQVRLGEHNIDVLEGNEQFINAAK Carbamidomethyl@N-term; Arg->Orn(R)@6 missed R-I@2; missed R-L@6 0.170861005783081 2964.71264648438 742.1854 2964.54174804688 742.142700195313 4 14 1.1.1.3518.6 1 44.366 1580.282 44.4757 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 89.9699985980988 SSGSSYPSLLQCLK Deamidated(Q)@11; Carbamidomethyl(C)@12; acrolein addition +76(K)@14 0.111717998981476 1602.87170410156 802.4431 1602.76000976563 802.387268066406 2 13 1.1.1.3855.4 1 52.6715 1506.994 52.5907 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 68.3300018310547 SSGSSYPSLLQCLK Carbamidomethyl(S)@8; Carbamidomethyl(C)@12; MDA adduct +62(K)@14 0.108231000602245 1644.89001464844 823.4523 1644.78173828125 823.398132324219 2 12 1.1.1.4039.14 1 57.1737 4377.167 57.2098 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 95.7300007343292 SSGSSYPSLLQCLKAPVLSDSS Carbamidomethyl(C)@12; HPNE addition +172(K)@14 cleaved S-C@C-term; missed K-A@14 0.208820998668671 2454.4287109375 819.1502 2454.21997070313 819.080627441406 3 15 1.1.1.3811.8 1 51.571 3563.13 51.4882 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 70.2400028705597 SSYPGQITGNMICVGFLEGGK Carbamidomethyl(C)@13; Carbamidomethyl(E)@18; MDA adduct +62(K)@21 0.105313003063202 2333.18725585938 1167.601 2333.08203125 1167.54833984375 2 12 1.1.1.4136.9 1 59.5471 1082.772 59.6004 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 87.8199994564056 TKVCNYVNWIQQTIAAN Carbamyl@N-term; MDA adduct +62(K)@2; Carbamidomethyl(C)@4 cleaved Y-T@N-term; missed K-V@2 0.214491993188858 2127.2353515625 710.0857 2127.02075195313 710.014221191406 3 15 1.1.1.4031.3 1 56.9615 493.6857 56.9564 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 76.3999998569489 TKVCNYVNWIQQTIAAN Carbamyl@N-term; MDA adduct +62(K)@2; Carbamidomethyl(C)@4 cleaved Y-T@N-term; missed K-V@2 0.149258002638817 2127.16943359375 1064.592 2127.02075195313 1064.51770019531 2 13 1.1.1.4031.17 1 56.9732 525.0788 56.9816 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 TLDNDIMLIKLSSPATLNSR Formyl(K)@10 cleaved N-T@N-term; missed K-L@10 0.278156012296677 2229.44555664063 744.1558 2229.16748046875 744.063110351563 3 26 1.1.1.3791.5 1 51.0821 40800.09 51.0975 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 TLDNDIMLIKLSSPATLNSR Dethiomethyl(M)@7; acrolein addition +76(K)@10 cleaved N-T@N-term; missed K-L@10 0.177039995789528 2229.37744140625 1115.696 2229.20043945313 1115.60754394531 2 18 1.1.1.3789.17 1 51.0401 13669.04 51.0975 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 TLDNDIMLIKLSSPATLNSR Dethiomethyl(M)@7; acrolein addition +76(K)@10; Deamidated(N)@18 cleaved N-T@N-term; missed K-L@10 0.244402006268501 2230.42895507813 744.4836 2230.1845703125 744.402099609375 3 18 1.1.1.3799.4 1 51.2777 4255.089 51.2944 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 98.8499999046326 TLDNDIMLIKLSSPATLNSR MDA adduct +62(K)@10; Dehydrated(S)@12 cleaved N-T@N-term; missed K-L@10 0.266092985868454 2245.44384765625 749.4885 2245.177734375 749.399841308594 3 18 1.1.1.3725.15 1 49.412 1143 49.3706 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 96.8699991703033 TLDNDIMLIKLSSPATLNSR Dehydrated(D)@5; MDA adduct +62(K)@10 cleaved N-T@N-term; missed K-L@10 0.266092985868454 2245.44384765625 749.4885 2245.177734375 749.399841308594 3 17 1.1.1.3718.9 1 49.2287 1143 49.3706 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 94.7499990463257 TLDNDIMLIKLSSPATLNSR Dethiomethyl(M)@7; acrolein addition +76(K)@10 cleaved N-T@N-term; missed K-L@10 0.177039995789528 2229.37744140625 1115.696 2229.20043945313 1115.60754394531 2 15 1.1.1.3796.5 1 51.21 13669.04 51.0975 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 91.6000008583069 TLDNDIMLIKLSSPATLNSR Formyl(K)@10 cleaved N-T@N-term; missed K-L@10 0.263141989707947 2229.4306640625 744.1508 2229.16748046875 744.063110351563 3 15 1.1.1.3808.9 1 51.4977 786.6332 51.4882 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 88.7199997901917 TLDNDIMLIKLSSPATLNSR Delta:H(4)C(2)(K)@10 cleaved N-T@N-term; missed K-L@10 0.300229012966156 2229.50415039063 558.3833 2229.20385742188 558.308227539063 4 15 1.1.1.3795.3 1 51.1774 2731.296 51.0975 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 60.2400004863739 TLDNDIMLIKLSSPATLNSR Methyl(K)@10 cleaved N-T@N-term; missed K-L@10 0.171251997351646 2215.359375 1108.687 2215.18823242188 1108.60144042969 2 13 1.1.1.3789.15 1 51.0384 594.3815 51.0485 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 VATVSLPR 0.147724002599716 841.64990234375 421.8322 841.502136230469 421.758361816406 2 8 1.1.1.4502.2 1 68.7058 161.5074 68.6463 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 VATVSLPR 0.146686002612114 841.648864746094 421.8317 841.502136230469 421.758361816406 2 7 1.1.1.4557.2 1 70.1199 503.251 70.1887 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 VATVSLPR 0.146503001451492 841.648681640625 421.8316 841.502136230469 421.758361816406 2 8 1.1.1.4655.2 1 72.6673 385.4433 72.6882 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 VATVSLPR 0.146869003772736 841.649047851563 421.8318 841.502136230469 421.758361816406 2 8 1.1.1.4672.3 1 73.1162 525.1701 73.1363 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 VATVSLPR 0.147112995386124 841.649291992188 421.8319 841.502136230469 421.758361816406 2 8 1.1.1.4686.2 1 73.4771 445.5039 73.4727 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 VATVSLPR 0.147295996546745 841.649475097656 421.832 841.502136230469 421.758361816406 2 8 1.1.1.4528.2 1 69.3612 542.0193 69.2827 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 VATVSLPR 0.147295996546745 841.649475097656 421.832 841.502136230469 421.758361816406 2 8 1.1.1.4537.2 1 69.5935 203.9345 69.5875 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 VATVSLPR 0.144306004047394 841.646484375 421.8305 841.502136230469 421.758361816406 2 8 1.1.1.4638.2 1 72.2179 386.7931 72.2908 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 90.719997882843 VATVSLPR Formyl@N-term 0.183570995926857 869.6806640625 435.8476 869.4970703125 435.755798339844 2 13 1.1.1.2964.5 1 30.9786 577498.9 31.1628 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 83.5900008678436 VATVSLPR Dehydrated(T)@3 0.143639996647835 823.63525390625 412.8249 823.491577148438 412.753082275391 2 12 1.1.1.2887.3 1 29.1231 116418.8 29.1897 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 83.5900008678436 VATVSLPR Dehydrated(T)@3 0.143456995487213 823.635070800781 412.8248 823.491577148438 412.753082275391 2 12 1.1.1.2915.2 1 29.7961 98851.28 29.5504 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 82.8599989414215 VATVSLPR Dehydrated(T)@3 0.143639996647835 823.63525390625 412.8249 823.491577148438 412.753082275391 2 12 1.1.1.2873.2 1 28.7912 110437.5 28.8046 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 82.8599989414215 VATVSLPR Dehydrated(T)@3 0.143639996647835 823.63525390625 412.8249 823.491577148438 412.753082275391 2 12 1.1.1.2894.2 1 29.2898 117699.6 29.3099 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 81.580001115799 VATVSLPR Delta:H(2)C(2)@N-term 0.150628000497818 867.66845703125 434.8415 867.517822265625 434.766174316406 2 11 1.1.1.3435.2 1 42.3109 1652.501 42.2825 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 76.9200026988983 VATVSLPR Formyl@N-term 0.183570995926857 869.6806640625 435.8476 869.4970703125 435.755798339844 2 12 1.1.1.2978.3 1 31.3131 620396.9 31.2348 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 76.9200026988983 VATVSLPR Formyl@N-term 0.183570995926857 869.6806640625 435.8476 869.4970703125 435.755798339844 2 12 1.1.1.2985.4 1 31.4814 623884.7 31.2348 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 74.9599993228912 VATVSLPR Formyl@N-term 0.183387994766235 869.680480957031 435.8475 869.4970703125 435.755798339844 2 12 1.1.1.2957.5 1 30.8125 368208 31.0432 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 74.9599993228912 VATVSLPR Formyl@N-term 0.183570995926857 869.6806640625 435.8476 869.4970703125 435.755798339844 2 12 1.1.1.2968.4 1 31.0742 620396.9 31.2348 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 74.9599993228912 VATVSLPR Formyl@N-term 0.183570995926857 869.6806640625 435.8476 869.4970703125 435.755798339844 2 12 1.1.1.2971.3 1 31.1494 620396.9 31.2348 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 74.9599993228912 VATVSLPR Formyl@N-term 0.183570995926857 869.6806640625 435.8476 869.4970703125 435.755798339844 2 12 1.1.1.2975.5 1 31.2403 620396.9 31.2348 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 70.6300020217896 VATVSLPR Delta:H(2)C(2)@N-term 0.146051004528999 867.663879394531 434.8392 867.517822265625 434.766174316406 2 12 1.1.1.3164.2 1 35.7835 74103.66 35.8506 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 70.6300020217896 VATVSLPR Delta:H(2)C(2)@N-term 0.146051004528999 867.663879394531 434.8392 867.517822265625 434.766174316406 2 12 1.1.1.3171.3 1 35.9591 74103.66 35.8506 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 70.6300020217896 VATVSLPR Delta:H(2)C(2)@N-term 0.146051004528999 867.663879394531 434.8392 867.517822265625 434.766174316406 2 12 1.1.1.3178.3 1 36.1238 71028.59 35.8745 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 70.6300020217896 VATVSLPR Delta:H(2)C(2)@N-term 0.147637993097305 867.665466308594 434.84 867.517822265625 434.766174316406 2 12 1.1.1.3206.4 1 36.7931 47506.36 36.8804 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 70.6300020217896 VATVSLPR Delta:H(2)C(2)@N-term 0.147637993097305 867.665466308594 434.84 867.517822265625 434.766174316406 2 12 1.1.1.3213.5 1 36.9638 47506.36 36.8804 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 70.6300020217896 VATVSLPR Delta:H(2)C(2)@N-term 0.147637993097305 867.665466308594 434.84 867.517822265625 434.766174316406 2 12 1.1.1.3220.4 1 37.1323 47257.73 36.8804 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 60.2400004863739 VATVSLPR 0.0351881012320518 841.537353515625 842.5446 841.502136230469 842.509399414063 1 9 1.1.1.2887.9 1 29.1365 0 -1 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 59.9500000476837 VATVSLPR 0.146686002612114 841.648864746094 421.8317 841.502136230469 421.758361816406 2 9 1.1.1.3494.4 1 43.7683 2460.03 43.8373 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 22.7400004863739 VATVSLPR 0.150287002325058 841.652465820313 421.8335 841.502136230469 421.758361816406 2 7 1.1.1.4234.2 1 61.9053 480.1286 61.8518 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 91.3800001144409 VATVSLPRSCAAAGTECLISGWGNTK Dioxidation(R)@8; Carbamidomethyl(C)@10; Carbamidomethyl(C)@17; MDA adduct +54(K)@26 missed R-S@8 0.284191995859146 2791.61108398438 931.5443 2791.32690429688 931.449584960938 3 16 1.1.1.3691.8 1 48.5834 5057.32 48.6151 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 33.6400002241135 VATVSLPRSCAAAGTECLISGWGNTK Carbamidomethyl(C)@10; Carboxy(E)@16; Carbamidomethyl(C)@17; Deamidated(N)@24; hexanoyl addition +98(K)@26 missed R-S@8 0.262477993965149 2848.63598632813 950.5526 2848.37353515625 950.465148925781 3 13 1.1.1.3685.9 1 48.4599 1560.146 48.4707 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 90.3900027275085 VCNYVNWIQQTIAAN Carbamidomethyl@N-term; Carbamidomethyl(C)@2; Trp->Hydroxykynurenin(W)@7 0.12567900121212 1869.99365234375 936.0041 1869.86791992188 935.941223144531 2 15 1.1.1.4167.5 1 60.2732 2428.876 60.0984 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 86.710000038147 VCNYVNWIQQTIAAN Carbamidomethyl@N-term; Carbamidomethyl(C)@2; Trp->Hydroxykynurenin(W)@7 0.12567900121212 1869.99365234375 936.0041 1869.86791992188 935.941223144531 2 14 1.1.1.4160.2 1 60.1041 2428.876 60.0984 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 52.0099997520447 VCNYVNWIQQTIAAN Carbamidomethyl@N-term; Carbamidomethyl(C)@2; Trp->Hydroxykynurenin(W)@7 0.130073994398117 1869.998046875 936.0063 1869.86791992188 935.941223144531 2 12 1.1.1.4147.10 1 59.7928 1699.109 59.8792 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 84.1799974441528 VGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@6; Phospho(S)@10; Carbamidomethyl(C)@24; Deamidated(N)@30; Carbamidomethyl(C)@40; ONE addition +154(K)@42 cleaved I-V@N-term 0.518649995326996 4781.65771484375 957.3388 4781.13916015625 957.235046386719 5 15 1.1.1.3967.5 1 55.401 5055.516 55.4904 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 76.3999998569489 VGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@6; Phospho(S)@10; Carbamidomethyl(C)@24; Deamidated(N)@30; Carbamidomethyl(C)@40; ONE addition +154(K)@42 cleaved I-V@N-term 0.518649995326996 4781.65771484375 957.3388 4781.13916015625 957.235046386719 5 14 1.1.1.3975.4 1 55.5812 5067.097 55.4904 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 42.8099989891052 VGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK HexNAc(T)@5; Carbamidomethyl(C)@6; Oxidation(N)@9; Carbamidomethyl(C)@24; Deamidated(N)@30; Carbamidomethyl(C)@40; ONE addition +154(K)@42 cleaved I-V@N-term 0.4619500041008 4920.708984375 821.1254 4920.2470703125 821.048461914063 6 15 1.1.1.3847.6 1 52.476 26966 52.6639 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 33.6400002241135 VGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYK Carbamidomethyl(C)@6; Bromo(Y)@13; Carbamidomethyl(C)@24; reduced HNE(H)@39; Carbamidomethyl(C)@40; acrolein addition +56(K)@42 cleaved I-V@N-term -0.527046978473663 4837.62939453125 968.5332 4838.15673828125 968.638610839844 5 14 1.1.1.3820.16 1 51.8059 33421.21 51.8665 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 92.9000020027161 VGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYKSR Dehydrated(T)@5; Carbamidomethyl(C)@6; Carbamidomethyl(C)@24; Carbamidomethyl(C)@40; acrolein addition +76(K)@42; Carbamidomethyl(S)@43 cleaved I-V@N-term; missed K-S@42 -0.0859057009220123 4904.1787109375 981.843 4904.2646484375 981.860168457031 5 17 1.1.1.3923.6 1 54.3396 4881.514 54.4222 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 77.4399995803833 VGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYKSR Carbamidomethyl(C)@6; Carbamidomethyl(C)@24; Dehydrated(S)@27; Carbamidomethyl(C)@40; acrolein addition +76(K)@42; Carbamidomethyl(S)@43 cleaved I-V@N-term; missed K-S@42 0.37185800075531 4904.63623046875 981.9346 4904.2646484375 981.860168457031 5 15 1.1.1.3909.4 1 53.9962 2368.349 54.0597 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 41.1700010299683 VLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@13 cleaved D-V@N-term; missed K-I@13; missed K-L@33 0.437860995531082 4778.908203125 956.7889 4778.47021484375 956.701293945313 5 14 1.1.1.4056.16 1 57.6071 5841.604 57.6662 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 33.8899999856949 VLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSR acrolein addition +56(K)@13; Deamidated(N)@27 cleaved D-V@N-term; missed K-I@13; missed K-L@33 0.43681600689888 4779.89111328125 956.9855 4779.4541015625 956.898132324219 5 12 1.1.1.4084.12 1 58.256 2160.507 58.2686 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 99.0000009536743 YVNWIQQTIAAN cleaved N-Y@N-term 0.16482600569725 1419.87951660156 710.947 1419.71472167969 710.864624023438 2 17 1.1.1.3773.5 1 50.6304 13310.35 50.7255 3 61.34 61.34 100 92.6400005817413 70.9999978542328 cont|000141 spt|P00761| Trypsin precursor (EC 3.4.21.4) [Sus scrofa (contaminant)] 0 96.6000020503998 YVNWIQQTIAAN Deamidated(Q)@6 cleaved N-Y@N-term 0.167015999555588 1420.86572265625 711.4401 1420.69873046875 711.356628417969 2 15 1.1.1.3823.5 1 51.8736 500.9883 51.892 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 AGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term 0.173124000430107 2256.30541992188 1129.16 2256.13134765625 1129.07299804688 2 17 1.1.1.4790.21 1 76.0882 234.8933 76.0667 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 AGTELVNFLSYFVELGTQPATQ 0.172407999634743 2384.361328125 1193.188 2384.18994140625 1193.10229492188 2 24 1.1.1.4743.10 1 74.9009 23264.02 74.6407 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 CVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@1 cleaved P-C@N-term; missed K-D@18 0.262585997581482 2739.53979492188 914.1872 2739.27709960938 914.099670410156 3 21 1.1.1.4305.10 1 63.706 1272.367 63.7722 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 CVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@1 cleaved P-C@N-term; missed K-D@18; missed K-V@23 0.334059000015259 2966.77465820313 742.7009 2966.4404296875 742.617431640625 4 24 1.1.1.4365.2 1 65.2659 324.0008 65.2593 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 CVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@1 cleaved P-C@N-term; missed K-D@18; missed K-V@23; missed K-S@25 0.405640989542007 3920.32788085938 785.0729 3919.92236328125 784.991760253906 5 22 1.1.1.4337.4 1 64.5298 431.5342 64.5491 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 EPCVESLVSQYFQTVTDYGK Carbamidomethyl(C)@3 0.183463007211685 2349.26733398438 1175.641 2349.08349609375 1175.54907226563 2 21 1.1.1.4219.6 1 61.5526 805.0668 61.5095 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3 missed K-D@20 0.251762986183167 2965.62426757813 989.5487 2965.37255859375 989.464782714844 3 26 1.1.1.4431.7 1 66.9118 98988.43 67.1582 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25 0.339776009321213 3192.87573242188 799.2262 3192.53588867188 799.141235351563 4 20 1.1.1.4348.6 1 64.8199 724.7324 64.8374 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25; missed K-S@27 0.411011010408401 4162.423828125 833.492 4162.0126953125 833.409790039063 5 26 1.1.1.4264.8 1 62.6549 3592.441 62.6196 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAKSYFEK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25; missed K-S@27; missed K-S@36 0.488741010427475 4800.8076171875 801.1419 4800.31884765625 801.060424804688 6 14 1.1.1.4462.4 1 67.6784 1983.759 67.8978 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAKSYFEKSKEQLTPLIK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25; missed K-S@27; missed K-S@36; missed K-S@41; missed K-E@43 0.5728560090065 5938.56787109375 849.3741 5937.99462890625 849.292236328125 7 20 1.1.1.4483.4 1 68.2281 711.772 68.1065 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 0.175573006272316 2384.4013671875 1193.208 2384.22631835938 1193.12048339844 2 17 1.1.1.4612.14 1 71.5439 204.1183 71.549 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.240639999508858 2512.52563476563 838.5158 2512.28491210938 838.435607910156 3 13 1.1.1.4682.14 1 73.3847 232.0954 73.4727 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 KEPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@4 cleaved A-K@N-term; missed K-E@1; missed K-D@21 0.330309003591537 3093.7978515625 774.4567 3093.46752929688 774.374145507813 4 25 1.1.1.4300.6 1 63.5721 1362.516 63.7722 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 KEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@4 cleaved A-K@N-term; missed K-E@1; missed K-D@21; missed K-V@26; missed K-S@28 0.416981011629105 4274.52978515625 855.9132 4274.11279296875 855.829833984375 5 23 1.1.1.4340.7 1 64.6114 752.3362 64.6543 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23 0.273081988096237 3275.81005859375 1092.944 3275.53662109375 1092.85278320313 3 24 1.1.1.4430.13 1 66.8894 4405.977 67.0044 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28 0.414673000574112 3520.14111328125 705.0355 3519.7265625 704.952575683594 5 22 1.1.1.4363.2 1 65.2128 755.3332 65.2593 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 -0.572631001472473 4472.6357421875 895.5344 4473.20849609375 895.64892578125 5 22 1.1.1.4343.9 1 64.6917 652.7817 64.7067 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 SKEQLTPLIKK Carbamidomethyl(K)@10 missed K-E@2; missed K-K@10 0.154863998293877 1340.95764160156 671.4861 1340.802734375 671.408630371094 2 18 1.1.1.2705.8 1 24.7842 609.5378 24.7679 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 SPELQAEAKSYFEK missed K-S@9 0.170993000268936 1625.96472167969 813.9896 1625.79370117188 813.904113769531 2 23 1.1.1.3183.5 1 36.2518 711.4146 36.2809 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 SYFEKSKEQLTPLIK missed K-S@5; missed K-E@7 0.171013996005058 1810.15869140625 906.0866 1809.98767089844 906.001098632813 2 25 1.1.1.3210.6 1 36.896 1415.497 36.9524 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 2 99.0000009536743 SYFEKSKEQLTPLIKK missed K-S@5; missed K-E@7; missed K-K@15 0.174195006489754 1938.2568359375 970.1357 1938.08264160156 970.048583984375 2 19 1.1.1.3007.20 1 32.0239 478.064 32.0047 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 1.92081785202026 99.0000009536743 AGTELVNFLSYFVELGTQPA cleaved A-T@C-term 0.175637006759644 2155.25927734375 1078.637 2155.08374023438 1078.54919433594 2 27 1.1.1.4760.8 1 75.315 4580.49 75.4204 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 1.85387206077576 99.0000009536743 KAGTELVNFLSYFVELGTQPA cleaved A-T@C-term; missed K-A@1 0.181259006261826 2283.359375 1142.687 2283.1787109375 1142.5966796875 2 18 1.1.1.4596.10 1 71.1216 2649.308 71.3129 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 1.69897043704987 99.0000009536743 VKSPELQAEAKSYFEK missed K-S@2; missed K-S@11 0.2308080047369 1853.18786621094 618.7366 1852.95703125 618.659606933594 3 19 1.1.1.3083.4 1 33.8474 1390.015 33.8566 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 1.60206043720245 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAKSYFEK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30; missed K-S@39 0.479665011167526 5110.962890625 852.8344 5110.48291015625 852.754455566406 6 16 1.1.1.4462.9 1 67.6826 911.0645 67.6977 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 1.14266729354858 99.0000009536743 SKEQLTPLIK missed K-E@2 0.15446999669075 1155.8408203125 578.9277 1155.68627929688 578.850463867188 2 17 1.1.1.2908.10 1 29.6351 1801.147 29.671 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 1.08618605136871 99.0000009536743 SPELQAEAK 0.145659998059273 971.638061523438 486.8263 971.492370605469 486.753479003906 2 15 1.1.1.2675.4 1 24.0568 1631.221 23.8547 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 1.05061006546021 99.0000009536743 AGTELVNFLSYF cleaved F-V@C-term 0.16313399374485 1359.83422851563 680.9244 1359.67102050781 680.842834472656 2 19 1.1.1.4405.4 1 66.2404 835.9866 66.3041 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.692503929138184 99.0000009536743 KSPELQAEAK cleaved V-K@N-term; missed K-S@1 0.148718997836113 1099.73608398438 550.8753 1099.58728027344 550.800964355469 2 17 1.1.1.2626.13 1 22.8901 1938.385 22.8985 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.261219441890717 94.4800019264221 SPELQAEAKSYFEKSKEQLTPLIK missed K-S@9; missed K-S@14; missed K-E@16 0.322966009378433 2763.79248046875 691.9554 2763.46948242188 691.874633789063 4 15 1.1.1.3657.12 1 47.8211 970.6525 47.8593 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.223298817873001 98.9600002765656 FVELGTQPATQ cleaved Y-F@N-term 0.156099006533623 1189.75402832031 595.8843 1189.59790039063 595.806213378906 2 14 1.1.1.3127.2 1 34.8995 435.9138 34.8923 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.152427345514297 88.2099986076355 EQLTPLIKK missed K-K@8 0.153782993555069 1068.80810546875 535.4113 1068.654296875 535.334411621094 2 12 1.1.1.2822.4 1 27.571 1264.953 27.6805 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.109020404517651 99.0000009536743 KEPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@4 cleaved A-K@N-term; missed K-E@1; missed K-D@21; missed K-V@26 0.406664997339249 3321.03759765625 665.2148 3320.630859375 665.133422851563 5 23 1.1.1.4362.3 1 65.1863 454.2166 65.1536 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.0550240911543369 97.3699986934662 DLMEKVKSPELQAEAKSYFEKSKEQLTPLIKKAGTELVNFLSYFVELGTQPATQ reduced acrolein addition +96(K)@7; reduced acrolein addition +96(K)@16; HPNE addition +172(K)@31; acrolein addition +94(K)@32 missed K-V@5; missed K-S@7; missed K-S@16; missed K-S@21; missed K-E@23; missed K-K@31; missed K-A@32 0.482482999563217 6559.94873046875 1094.332 6559.462890625 1094.25109863281 6 17 1.1.1.4726.20 1 74.4896 7337.119 74.6407 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.0190880633890629 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQ Carbamidomethyl(C)@3; hexanoyl addition +98(K)@20; Oxidation(M)@23; ONE addition +154(K)@25; HPNE addition +172(K)@27 cleaved Q-A@C-term; missed K-D@20; missed K-V@25; missed K-S@27 0.31334200501442 4187.39453125 1047.856 4187.08349609375 1047.77807617188 4 26 1.1.1.4493.8 1 68.4754 831.3903 68.5122 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.00833099242299795 99.0000009536743 AKEPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl@N-term; reduced acrolein addition +96(K)@2; Carbamidomethyl(C)@5 cleaved Q-A@N-term; missed K-E@2; missed K-D@22 0.219539999961853 3317.80419921875 1106.942 3317.58349609375 1106.86853027344 3 23 1.1.1.4629.17 1 71.9915 1147.949 72.0532 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.00788851175457239 99.0000009536743 AKEPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl@N-term; reduced acrolein addition +96(K)@2; Carbamidomethyl(C)@5 cleaved Q-A@N-term; missed K-E@2; missed K-D@22; missed K-V@27 0.294737011194229 3545.04174804688 887.2677 3544.7470703125 887.194030761719 4 22 1.1.1.4670.10 1 73.0704 928.2189 73.1103 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.00788851175457239 84.2899978160858 DLMEKVKSPELQAEAKSYFEKSKEQLTPLIKKAGTELVNFLSYFVELGTQPAT acrolein addition +38(K)@5; acrolein addition +94(K)@7; ONE addition +154(K)@23; HPNE addition +172(K)@31 cleaved T-Q@C-term; missed K-V@5; missed K-S@7; missed K-S@16; missed K-S@21; missed K-E@23; missed K-K@31; missed K-A@32 0.490278989076614 6431.896484375 1072.99 6431.404296875 1072.90808105469 6 17 1.1.1.4743.8 0 74.8976 1952.428 74.9077 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.00568284746259451 96.17999792099 GKDLMEKVKSPELQAEAKSYFEKSKEQLTPLIKKAGTELVNFLSYFVELGTQPATQ acrolein addition +112(K)@2; acrolein addition +38(K)@9; MDA adduct +62(K)@25; MDA adduct +62(K)@33 cleaved Y-G@N-term; missed K-D@2; missed K-V@7; missed K-S@9; missed K-S@18; missed K-S@23; missed K-E@25; missed K-K@33; missed K-A@34 -0.432792991399765 6559.978515625 1094.337 6560.412109375 1094.40930175781 6 17 1.1.1.4750.18 1 75.0711 3547.842 74.8107 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.00305075151845813 98.4300017356873 AEAKSYFEKSKEQLTPLIKKAGTELVNFLSYFVELGTQPATQ HPNE addition +172(K)@11; MDA adduct +54(K)@19; acrolein addition +94(K)@20; Deamidated(N)@27 cleaved Q-A@N-term; missed K-S@4; missed K-S@9; missed K-E@11; missed K-K@19; missed K-A@20 0.36354398727417 5024.98388671875 1006.004 5024.6201171875 1005.93133544922 5 19 1.1.1.4564.4 1 70.3002 1478.753 70.2851 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.00305075151845813 90.1400029659271 KKAGTELVNFLSYFVELGTQPATQ MDA adduct +62(K)@1; reduced acrolein addition +96(K)@2 cleaved I-K@N-term; missed K-K@1; missed K-A@2 0.189638003706932 2798.64282226563 933.8882 2798.453125 933.824951171875 3 15 1.1.1.4741.12 1 74.8523 1120.141 74.8833 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.00261361571028829 99.0000009536743 VKSPELQAEAK Carboxyethyl(K)@2 missed K-S@2 0.156954005360603 1270.83386230469 636.4242 1270.67687988281 636.345703125 2 18 1.1.1.2975.13 1 31.2536 2260.269 31.3067 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.00130484171677381 86.0300004482269 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQA Carbamidomethyl(C)@3; acrolein addition +94(K)@20; ONE addition +154(K)@25; reduced acrolein addition +96(K)@27 cleaved A-E@C-term; missed K-D@20; missed K-V@25; missed K-S@27 0.383361995220184 4162.42529296875 833.4923 4162.0419921875 833.415649414063 5 14 1.1.1.4278.12 1 63.0129 2334.57 62.773 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.000869458774104714 76.7199993133545 AEAKSYFEKSKEQLTPLIKKAGTELVNFLSYFVELGTQPAT HPNE addition +172(K)@9; MDA adduct +54(K)@19; reduced acrolein addition +96(K)@20 cleaved Q-A@N-term; cleaved T-Q@C-term; missed K-S@4; missed K-S@9; missed K-E@11; missed K-K@19; missed K-A@20 0.267271012067795 4897.85888671875 1225.472 4897.59326171875 1225.40563964844 4 11 1.1.1.4577.21 1 70.6314 212.6094 70.5865 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.000869458774104714 99.0000009536743 GALVRRQAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@12 cleaved E-G@N-term; missed R-R@5; missed R-Q@6; missed K-E@9; missed K-D@29; missed K-V@34; missed K-S@36 -5.8869800567627 5119.73486328125 854.2964 5125.62158203125 855.277526855469 6 21 1.1.1.4446.5 1 67.2883 1580.988 67.3279 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.000869458774104714 26.7800003290176 MEKVKSPELQAEAKSYFEKSKEQLTPLIKKAGTELVNFLSYF HPNE addition +172(K)@5 cleaved L-M@N-term; cleaved F-V@C-term; missed K-V@3; missed K-S@5; missed K-S@14; missed K-S@19; missed K-E@21; missed K-K@29; missed K-A@30 0.239646002650261 5020.916015625 837.8266 5020.67626953125 837.786682128906 6 11 1.1.1.3730.18 1 49.5412 560.7083 49.4985 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.000869458774104714 97.7100014686584 SLVSQYFQTVTDYGKDLMEKVK cleaved E-S@N-term; missed K-D@15; missed K-V@20 0.970661997795105 2579.26953125 860.7638 2578.298828125 860.440246582031 3 17 1.1.1.4513.2 1 68.9981 377.9792 69.0401 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.000434511806815863 84.9200010299683 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAKSY Carbamidomethyl(C)@3; reduced acrolein addition +58(K)@20; MDA adduct +54(K)@25; MDA adduct +54(K)@27; Deamidated(Q)@32 cleaved Y-F@C-term; missed K-D@20; missed K-V@25; missed K-S@27; missed K-S@36 0.464426010847092 4563.62451171875 913.7322 4563.16015625 913.639282226563 5 15 1.1.1.4465.6 1 67.7584 266.2126 67.7468 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.000434511806815863 94.2300021648407 GKDLMEKVKSPELQAEAKSYFEKSKEQLTPLIKKAGTELVNFLSYFVELGTQPAT acrolein addition +112(K)@2; hexanoyl addition +98(K)@9; Deamidated(Q)@27; MDA adduct +62(K)@34 cleaved Y-G@N-term; cleaved T-Q@C-term; missed K-D@2; missed K-V@7; missed K-S@9; missed K-S@18; missed K-S@23; missed K-E@25; missed K-K@33; missed K-A@34 0.522755980491638 6431.90234375 1072.991 6431.37939453125 1072.90380859375 6 17 1.1.1.4751.20 1 75.0975 2314.276 75.0787 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.000434511806815863 98.1899976730347 LLLTICSLEGALVRRQAKEPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@6; Carbamidomethyl(C)@21 cleaved V-L@N-term; missed R-R@14; missed R-Q@15; missed K-E@18; missed K-D@38; missed K-V@43 0.862622976303101 5215.57568359375 870.2699 5214.712890625 870.126098632813 6 19 1.1.1.4515.7 1 69.0511 279.705 69.0401 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.000434511806815863 35.5500012636185 MEKVKSPELQAEAKSYFEKSK ONE addition +154(K)@5; acrolein addition +38(K)@14; MDA adduct +62(K)@21 cleaved L-M@N-term; missed K-V@3; missed K-S@5; missed K-S@14; missed K-S@19 0.136099994182587 2710.52880859375 904.5169 2710.39282226563 904.471557617188 3 10 1.1.1.3873.9 1 53.1149 497.2332 53.1052 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.000434511806815863 27.0599991083145 SKEQLTPLIKKAG MDA adduct +54(K)@2; MDA adduct +54(K)@11 cleaved G-T@C-term; missed K-E@2; missed K-K@10; missed K-A@11 -0.0121435998007655 1519.84887695313 760.9317 1519.86096191406 760.937744140625 2 9 1.1.1.4056.6 1 57.5987 2578.014 57.6911 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0.000434511806815863 96.7400014400482 VKSPELQAEAKSYFEKSKEQLTPLIKK Delta:H(4)C(2)(K)@11; reduced acrolein addition +58(K)@16 missed K-S@2; missed K-S@11; missed K-S@16; missed K-E@18; missed K-K@26 0.353691011667252 3205.15454101563 642.0382 3204.80102539063 641.967468261719 5 17 1.1.1.3768.9 1 50.5046 641.9014 50.4939 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 95.0800001621246 AEAKSYFEKSKEQLTPLIKKAGTELVNFLSYFVELGTQPATQ HPNE addition +172(K)@11; MDA adduct +54(K)@19; acrolein addition +94(K)@20; Deamidated(N)@27 cleaved Q-A@N-term; missed K-S@4; missed K-S@9; missed K-E@11; missed K-K@19; missed K-A@20 0.362933993339539 5024.98388671875 1006.004 5024.6201171875 1005.93133544922 5 18 1.1.1.4557.11 1 70.1341 2512.741 70.1646 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 91.8500006198883 AGTELVNFLSYF cleaved F-V@C-term 0.16313399374485 1359.83422851563 680.9244 1359.67102050781 680.842834472656 2 13 1.1.1.4410.3 1 66.3597 835.9866 66.3041 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPA cleaved A-T@C-term 0.2411749958992 2155.32495117188 719.4489 2155.08374023438 719.368530273438 3 23 1.1.1.4762.2 1 75.3531 12944.62 75.4204 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPA cleaved A-T@C-term 0.175637006759644 2155.25927734375 1078.637 2155.08374023438 1078.54919433594 2 28 1.1.1.4767.14 1 75.4894 4580.49 75.4204 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPA cleaved A-T@C-term 0.2411749958992 2155.32495117188 719.4489 2155.08374023438 719.368530273438 3 22 1.1.1.4769.8 1 75.5298 12944.62 75.4204 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPA cleaved A-T@C-term 0.185402005910873 2155.26928710938 1078.642 2155.08374023438 1078.54919433594 2 19 1.1.1.4778.19 1 75.7709 311.6552 75.7515 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPA Cation:Na(E)@14 cleaved A-T@C-term 0.175136998295784 2177.24145507813 1089.628 2177.06567382813 1089.54016113281 2 20 1.1.1.4763.14 1 75.3908 895.8461 75.4204 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 96.8999981880188 AGTELVNFLSYFVELGTQPA Cation:Na(E)@14 cleaved A-T@C-term 0.245069995522499 2177.31079101563 726.7775 2177.06567382813 726.695861816406 3 17 1.1.1.4763.5 1 75.3775 1170.264 75.4204 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 93.5400009155273 AGTELVNFLSYFVELGTQPA cleaved A-T@C-term -0.273900985717773 2154.80981445313 719.2772 2155.08374023438 719.368530273438 3 16 1.1.1.4776.7 1 75.7086 4076.797 75.4697 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 20.4999998211861 AGTELVNFLSYFVELGTQPA Cation:K(E)@14; Oxidation(P)@19 cleaved A-T@C-term 0.202488005161285 2209.23706054688 737.4196 2209.03442382813 737.352111816406 3 12 1.1.1.4765.3 1 75.4266 330.7965 75.4204 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term 0.240066006779671 2256.37158203125 753.1311 2256.13134765625 753.051086425781 3 25 1.1.1.4739.4 1 74.7956 29697.88 75.0295 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term 0.173857003450394 2256.30541992188 1129.16 2256.13134765625 1129.07299804688 2 25 1.1.1.4744.15 1 74.927 18386.61 75.0787 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term 0.244277998805046 2256.37573242188 753.1325 2256.13134765625 753.051086425781 3 25 1.1.1.4746.4 1 74.9668 50508.39 75.1034 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term 0.173857003450394 2256.30541992188 1129.16 2256.13134765625 1129.07299804688 2 25 1.1.1.4751.21 1 75.0983 18386.61 75.0787 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term 0.244277998805046 2256.37573242188 753.1325 2256.13134765625 753.051086425781 3 26 1.1.1.4753.4 1 75.1356 50508.39 75.1034 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term 0.173857003450394 2256.30541992188 1129.16 2256.13134765625 1129.07299804688 2 24 1.1.1.4758.10 1 75.2689 18386.61 75.0787 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term 0.244277998805046 2256.37573242188 753.1325 2256.13134765625 753.051086425781 3 23 1.1.1.4760.3 1 75.3042 50508.39 75.1034 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term 0.173368006944656 2256.30541992188 1129.16 2256.13134765625 1129.07299804688 2 23 1.1.1.4766.14 1 75.4647 8049.931 75.2012 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term 0.239700004458427 2256.37109375 753.131 2256.13134765625 753.051086425781 3 25 1.1.1.4767.6 1 75.4769 24685.44 75.2256 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term 0.244644001126289 2256.3759765625 753.1326 2256.13134765625 753.051086425781 3 23 1.1.1.4774.6 1 75.6562 10444.63 75.3959 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term 0.174588993191719 2256.30541992188 1129.16 2256.13134765625 1129.07299804688 2 19 1.1.1.4774.20 1 75.6679 2714.178 75.3959 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term 0.244644001126289 2256.3759765625 753.1326 2256.13134765625 753.051086425781 3 23 1.1.1.4781.6 1 75.8388 2550.408 75.7515 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term 0.177518993616104 2256.30932617188 1129.162 2256.13134765625 1129.07299804688 2 17 1.1.1.4781.21 1 75.8513 1042.562 75.5711 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term 0.174832999706268 2256.30541992188 1129.16 2256.13134765625 1129.07299804688 2 19 1.1.1.4782.21 1 75.8775 917.0001 75.5966 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term 0.174345001578331 2256.30541992188 1129.16 2256.13134765625 1129.07299804688 2 13 1.1.1.4788.21 1 76.0354 517.4119 75.9349 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term 0.245376005768776 2256.37670898438 753.1329 2256.13134765625 753.051086425781 3 23 1.1.1.4789.10 1 76.0524 2463.887 75.7776 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term 0.244827002286911 2256.37622070313 753.1327 2256.13134765625 753.051086425781 3 19 1.1.1.4796.12 1 76.2391 1681.9 75.961 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term 0.183134004473686 2256.3154296875 1129.165 2256.13134765625 1129.07299804688 2 12 1.1.1.4797.17 1 76.2727 192.1291 76.1989 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term 0.246108993887901 2256.37744140625 753.1331 2256.13134765625 753.051086425781 3 14 1.1.1.4799.15 1 76.3205 1408.935 76.0405 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT Cation:Na(E)@14 cleaved T-Q@C-term 0.240849003195763 2278.35424804688 760.4587 2278.11328125 760.37841796875 3 23 1.1.1.4746.5 1 74.9693 4601.098 75.1034 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT Cation:Na(E)@14 cleaved T-Q@C-term 0.175065994262695 2278.28735351563 1140.151 2278.11328125 1140.06396484375 2 26 1.1.1.4750.20 1 75.0728 2576.477 75.1034 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT Cation:Na(E)@14 cleaved T-Q@C-term 0.240849003195763 2278.35424804688 760.4587 2278.11328125 760.37841796875 3 24 1.1.1.4753.5 1 75.1373 4601.098 75.1034 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT Cation:Na@C-term cleaved T-Q@C-term 0.240849003195763 2278.35424804688 760.4587 2278.11328125 760.37841796875 3 23 1.1.1.4760.5 1 75.3075 4601.098 75.1034 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT Delta:H(2)C(2)@N-term cleaved T-Q@C-term 0.244984999299049 2282.39208984375 761.8046 2282.14697265625 761.722961425781 3 26 1.1.1.4780.14 1 75.8192 3127.438 75.9088 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT Cation:Na(E)@14 cleaved T-Q@C-term 0.175065994262695 2278.28735351563 1140.151 2278.11328125 1140.06396484375 2 21 1.1.1.4757.6 1 75.2414 2576.477 75.1034 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT Delta:H(2)C(2)@N-term cleaved T-Q@C-term 0.195803999900818 2282.34326171875 1142.179 2282.14697265625 1142.08081054688 2 20 1.1.1.4780.21 1 75.825 464.0872 75.8826 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPAT Cation:Na(E)@14 cleaved T-Q@C-term 0.241215005517006 2278.3544921875 760.4588 2278.11328125 760.37841796875 3 20 1.1.1.4744.4 1 74.9128 4581.063 75.1034 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.1500029563904 AGTELVNFLSYFVELGTQPAT Cation:Na(E)@14 cleaved T-Q@C-term 0.175310000777245 2278.28930664063 1140.152 2278.11328125 1140.06396484375 2 18 1.1.1.4743.9 1 74.8993 2619.989 75.1279 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.1500029563904 AGTELVNFLSYFVELGTQPAT Cation:Na(E)@14 cleaved T-Q@C-term 0.242496997117996 2278.35595703125 760.4592 2278.11328125 760.37841796875 3 18 1.1.1.4767.8 1 75.4794 2191.835 75.2256 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 93.8199996948242 AGTELVNFLSYFVELGTQPAT Deamidated(Q)@18; Oxidation(P)@19 cleaved T-Q@C-term 0.223003000020981 2273.33325195313 1137.674 2273.1103515625 1137.5625 2 16 1.1.1.4748.14 1 75.0244 1513.969 75.1034 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 93.5400009155273 AGTELVNFLSYFVELGTQPAT Cation:Na(E)@14 cleaved T-Q@C-term 0.243595004081726 2278.35693359375 760.4596 2278.11328125 760.37841796875 3 16 1.1.1.4774.8 1 75.6578 936.3854 75.3959 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 89.0100002288818 AGTELVNFLSYFVELGTQPAT Deamidated(Q)@18; Oxidation(P)@19 cleaved T-Q@C-term 0.287564009428024 2273.39794921875 758.8066 2273.1103515625 758.710754394531 3 15 1.1.1.4751.6 1 75.0858 2025.902 75.1034 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 77.9999971389771 AGTELVNFLSYFVELGTQPAT Deamidated(N)@7; Oxidation(F)@8 cleaved T-Q@C-term 0.223003000020981 2273.33325195313 1137.674 2273.1103515625 1137.5625 2 14 1.1.1.4759.6 1 75.2932 1513.969 75.1034 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 62.9100024700165 AGTELVNFLSYFVELGTQPAT Oxidation(Y)@11; Cation:K(E)@14 cleaved T-Q@C-term 0.21602800488472 2310.29833984375 771.1067 2310.08227539063 771.03466796875 3 14 1.1.1.4759.2 1 75.2799 614.808 75.274 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ 0.256805986166 2384.44677734375 795.8229 2384.18994140625 795.737243652344 3 20 1.1.1.4653.8 1 72.6197 1108.49 72.6356 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ 0.191695004701614 2384.38134765625 1193.198 2384.18994140625 1193.10229492188 2 15 1.1.1.4655.20 1 72.6823 188.2483 72.6356 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ 0.244537994265556 2384.4345703125 795.8188 2384.18994140625 795.737243652344 3 25 1.1.1.4722.14 1 74.3876 57331.13 74.568 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ 0.244537994265556 2384.4345703125 795.8188 2384.18994140625 795.737243652344 3 27 1.1.1.4729.2 1 74.5495 81701.65 74.6648 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ 0.172652006149292 2384.36328125 1193.189 2384.18994140625 1193.10229492188 2 29 1.1.1.4729.6 1 74.5629 22512.15 74.6648 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ 0.244537994265556 2384.4345703125 795.8188 2384.18994140625 795.737243652344 3 27 1.1.1.4736.2 1 74.7192 81701.65 74.6648 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ 0.172652006149292 2384.36328125 1193.189 2384.18994140625 1193.10229492188 2 29 1.1.1.4736.6 1 74.7325 22512.15 74.6648 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ 0.244537994265556 2384.4345703125 795.8188 2384.18994140625 795.737243652344 3 27 1.1.1.4743.5 1 74.8926 84913.05 74.6648 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ 0.245087996125221 2384.43505859375 795.819 2384.18994140625 795.737243652344 3 27 1.1.1.4750.12 1 75.0661 15467.57 75.1034 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ 0.175825998187065 2384.365234375 1193.19 2384.18994140625 1193.10229492188 2 23 1.1.1.4750.21 1 75.0736 11473.89 74.8107 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ 0.175582006573677 2384.365234375 1193.19 2384.18994140625 1193.10229492188 2 27 1.1.1.4757.7 1 75.2447 3818.472 75.0052 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ 0.245087996125221 2384.43505859375 795.819 2384.18994140625 795.737243652344 3 28 1.1.1.4758.4 1 75.2572 15467.57 75.1034 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ 0.180952996015549 2384.37133789063 1193.193 2384.18994140625 1193.10229492188 2 23 1.1.1.4764.8 1 75.4153 1347.753 75.3226 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ 0.245453998446465 2384.435546875 795.8191 2384.18994140625 795.737243652344 3 26 1.1.1.4765.4 1 75.4283 11057.24 75.1768 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ 0.179976001381874 2384.36938476563 1193.192 2384.18994140625 1193.10229492188 2 23 1.1.1.4771.20 1 75.5915 665.4283 75.5199 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ 0.245453998446465 2384.435546875 795.8191 2384.18994140625 795.737243652344 3 24 1.1.1.4772.12 1 75.6098 7376.805 75.3471 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ 0.245087996125221 2384.43505859375 795.819 2384.18994140625 795.737243652344 3 25 1.1.1.4779.15 1 75.7938 3515.856 75.8038 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ 0.185836002230644 2384.37524414063 1193.195 2384.18994140625 1193.10229492188 2 22 1.1.1.4779.21 1 75.7988 550.3636 75.8038 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ 0.185836002230644 2384.37524414063 1193.195 2384.18994140625 1193.10229492188 2 16 1.1.1.4783.21 1 75.9038 550.3636 75.8038 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ 0.245087996125221 2384.43505859375 795.819 2384.18994140625 795.737243652344 3 23 1.1.1.4786.18 1 75.9799 3515.856 75.8038 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ 0.245087996125221 2384.43505859375 795.819 2384.18994140625 795.737243652344 3 21 1.1.1.4793.15 1 76.1622 2880.349 75.8826 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ 0.250580996274948 2384.44067382813 795.8208 2384.18994140625 795.737243652344 3 21 1.1.1.4801.18 1 76.3758 1710.118 76.0932 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ 0.256256997585297 2384.4462890625 795.8227 2384.18994140625 795.737243652344 3 18 1.1.1.4897.16 1 78.6299 171.8967 78.6349 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ Cation:Na(E)@14 0.24312299489975 2406.4150390625 803.1456 2406.171875 803.064575195313 3 24 1.1.1.4726.7 1 74.4788 4110.232 74.568 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ Cation:Na(E)@14 0.173372998833656 2406.34545898438 1204.18 2406.171875 1204.09326171875 2 22 1.1.1.4726.21 1 74.4905 1509.854 74.568 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ Cation:K@C-term 0.248616993427277 2422.39453125 808.4721 2422.14599609375 808.389221191406 3 29 1.1.1.4730.10 1 74.5789 1071.985 74.568 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ Cation:Na(E)@14 0.243305996060371 2406.41528320313 803.1457 2406.171875 803.064575195313 3 23 1.1.1.4733.3 1 74.6447 5954.795 74.6892 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ Cation:Na(E)@14 0.178011998534203 2406.34936523438 1204.182 2406.171875 1204.09326171875 2 22 1.1.1.4733.12 1 74.6581 2147.4 74.6892 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ Cation:Na(E)@14 0.243305996060371 2406.41528320313 803.1457 2406.171875 803.064575195313 3 22 1.1.1.4740.3 1 74.8148 5954.795 74.6892 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ Cation:Na(E)@14 0.241475000977516 2406.41333007813 803.1451 2406.171875 803.064575195313 3 22 1.1.1.4751.8 1 75.0875 993.0323 75.1034 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ Delta:H(2)C(2)@N-term 0.244330003857613 2410.44995117188 804.4906 2410.20556640625 804.4091796875 3 27 1.1.1.4772.14 1 75.6115 5398.651 75.7515 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ Delta:H(2)C(2)@N-term 0.179707005620003 2410.38525390625 1206.2 2410.20556640625 1206.11010742188 2 21 1.1.1.4776.20 1 75.7195 690.9027 75.7515 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ Delta:H(2)C(2)@N-term 0.244330003857613 2410.44995117188 804.4906 2410.20556640625 804.4091796875 3 27 1.1.1.4779.17 1 75.7954 5398.651 75.7515 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ Deamidated(N)@7 0.252954006195068 2385.42700195313 796.1496 2385.17407226563 796.065307617188 3 20 1.1.1.4503.5 1 68.7363 326.0713 68.8067 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AGTELVNFLSYFVELGTQPATQ Deamidated(N)@7 0.263390988111496 2385.4375 796.1531 2385.17407226563 796.065307617188 3 19 1.1.1.4730.8 1 74.5764 36375.61 74.6648 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.7299978733063 AGTELVNFLSYFVELGTQPATQ Cation:Na@C-term 0.247152000665665 2406.41918945313 803.147 2406.171875 803.064575195313 3 20 1.1.1.4768.9 1 75.5048 486.9262 75.5199 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.5499987602234 AGTELVNFLSYFVELGTQPATQ Deamidated(N)@7 0.264306992292404 2385.43823242188 796.1534 2385.17407226563 796.065307617188 3 16 1.1.1.4779.16 1 75.7946 1504.793 75.7254 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 93.2399988174438 AGTELVNFLSYFVELGTQPATQ Deamidated(Q)@18; Oxidation(P)@19 0.29569798707962 2401.46459960938 801.4955 2401.1689453125 801.396911621094 3 16 1.1.1.4730.9 1 74.5773 887.9733 74.568 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 86.9700014591217 AGTELVNFLSYFVELGTQPATQ Deamidated(N)@7; Oxidation(F)@8 0.229610994458199 2401.3994140625 1201.707 2401.1689453125 1201.591796875 2 15 1.1.1.4730.15 1 74.5873 443.5904 74.568 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 81.1699986457825 AGTELVNFLSYFVELGTQPATQ Delta:H(2)C(2)@N-term 0.247991994023323 2410.45361328125 804.4918 2410.20556640625 804.4091796875 3 14 1.1.1.4788.10 1 76.0262 5640.092 75.7515 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 20.4999998211861 AGTELVNFLSYFVELGTQPATQ -0.760344982147217 2383.4296875 795.4838 2384.18994140625 795.737243652344 3 12 1.1.1.4449.5 1 67.3586 297.6122 67.3523 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AKEPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl@N-term; reduced acrolein addition +96(K)@2; Carbamidomethyl(C)@5 cleaved Q-A@N-term; missed K-E@2; missed K-D@22 0.278425991535187 3317.86206054688 830.4728 3317.58349609375 830.403198242188 4 24 1.1.1.4633.10 1 72.0924 452.9729 72.0794 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AKEPCVESLVSQYFQTVTDYGKDLMEK Carbamyl@N-term; ONE addition +154(K)@2; Carbamidomethyl(C)@5 cleaved Q-A@N-term; missed K-E@2; missed K-D@22 0.221036002039909 3361.83227539063 1121.618 3361.60986328125 1121.54382324219 3 25 1.1.1.4752.9 1 75.1228 915.3123 75.1523 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.7600028514862 AKEPCVESLVSQYFQTVTDYGKDLMEK reduced acrolein addition +58(K)@2; Carbamidomethyl(C)@5 cleaved Q-A@N-term; missed K-E@2; missed K-D@22 0.278382986783981 3222.82421875 1075.282 3222.54638671875 1075.189453125 3 17 1.1.1.4440.10 1 67.1482 719.4745 67.1825 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 89.92999792099 AKEPCVESLVSQYFQTVTDYGKDLMEK reduced acrolein addition +58(K)@2; Carbamidomethyl(C)@5 cleaved Q-A@N-term; missed K-E@2; missed K-D@22 0.291931986808777 3222.83911132813 1075.287 3222.54638671875 1075.189453125 3 15 1.1.1.4447.14 1 67.3179 212.8544 67.3034 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AKEPCVESLVSQYFQTVTDYGKDLMEKVK Carbamyl@N-term; ONE addition +154(K)@2; Carbamidomethyl(C)@5 cleaved Q-A@N-term; missed K-E@2; missed K-D@22; missed K-V@27 0.218302994966507 3588.9921875 1197.338 3588.77319335938 1197.26501464844 3 25 1.1.1.4765.10 1 75.44 1098.224 75.4451 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 95.3000009059906 AKEPCVESLVSQYFQTVTDYGKDLMEKVK hexanoyl addition +98(K)@2; Carbamidomethyl(C)@5 cleaved Q-A@N-term; missed K-E@2; missed K-D@22; missed K-V@27 0.301770985126495 3490.04296875 873.518 3489.7412109375 873.442565917969 4 15 1.1.1.4512.9 1 68.9763 281.5954 69.0645 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 68.4700012207031 AKEPCVESLVSQYFQTVTDYGKDLMEKVK acrolein addition +56(K)@2; Carbamidomethyl(C)@5 cleaved Q-A@N-term; missed K-E@2; missed K-D@22; missed K-V@27 0.350185990333557 3448.04443359375 863.0184 3447.69409179688 862.930847167969 4 13 1.1.1.4511.6 1 68.9572 359.5414 69.0645 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 34.4799995422363 AKEPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl@N-term; reduced acrolein addition +96(K)@2; Carbamidomethyl(C)@5 cleaved Q-A@N-term; missed K-E@2; missed K-D@22; missed K-V@27 0.294737011194229 3545.04174804688 887.2677 3544.7470703125 887.194030761719 4 12 1.1.1.4677.10 1 73.2505 928.2189 73.1103 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 AKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK MDA adduct +54(K)@2; Dioxidation(P)@4; Carbamidomethyl(C)@5 cleaved Q-A@N-term; missed K-E@2; missed K-D@22; missed K-V@27; missed K-S@29 0.402483999729156 4431.552734375 887.3178 4431.150390625 887.2373046875 5 24 1.1.1.4628.16 1 71.9671 938.2821 71.9998 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 89.92999792099 AKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl@N-term; reduced acrolein addition +96(K)@2; Carbamidomethyl(C)@5 cleaved Q-A@N-term; missed K-E@2; missed K-D@22; missed K-V@27; missed K-S@29 0.368272006511688 4498.59716796875 900.7267 4498.22900390625 900.653015136719 5 16 1.1.1.4620.13 1 71.7492 715.3926 71.734 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 82.6099991798401 AKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl@N-term; acrolein addition +94(K)@2; Carbamidomethyl(C)@5 cleaved Q-A@N-term; missed K-E@2; missed K-D@22; missed K-V@27; missed K-S@29 0.33687698841095 4496.55078125 1125.145 4496.212890625 1125.060546875 4 15 1.1.1.4461.11 1 67.6645 616.3519 67.6235 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 74.4599997997284 AKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl@N-term; reduced acrolein addition +96(K)@2; Carbamidomethyl(C)@5 cleaved Q-A@N-term; missed K-E@2; missed K-D@22; missed K-V@27; missed K-S@29 0.292905986309052 4498.5224609375 1125.638 4498.22900390625 1125.564453125 4 14 1.1.1.4615.12 1 71.6234 974.3194 71.7079 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 CVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@1 cleaved P-C@N-term; missed K-D@18 0.330444008111954 2739.60766601563 685.9092 2739.27709960938 685.826599121094 4 18 1.1.1.4307.5 1 63.7538 178.3077 63.7463 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 89.92999792099 DLMEKVKSPELQAEAKSYFEKSKEQLTPLIKKAGTELVNFLSYFVELGTQPATQ HPNE addition +172(K)@16; GlnGlnGlnThrGlyGly(K)@23; MDA adduct +54(K)@31; MDA adduct +62(K)@32 missed K-V@5; missed K-S@7; missed K-S@16; missed K-S@21; missed K-E@23; missed K-K@31; missed K-A@32 -0.660256028175354 6987.93994140625 1165.664 6988.5986328125 1165.77368164063 6 17 1.1.1.4736.5 1 74.7292 2358.785 74.7376 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 84.6099972724915 DLMEKVKSPELQAEAKSYFEKSKEQLTPLIKKAGTELVNFLSYFVELGTQPATQ reduced acrolein addition +96(K)@7; MDA adduct +54(K)@21; ONE addition +154(K)@31; ONE addition +154(K)@32 missed K-V@5; missed K-S@7; missed K-S@16; missed K-S@21; missed K-E@23; missed K-K@31; missed K-A@32 0.563036024570465 6560.0263671875 938.1539 6559.462890625 938.073425292969 7 18 1.1.1.4729.4 0 74.5562 7977.587 74.6407 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 66.2999987602234 DLMEKVKSPELQAEAKSYFEKSKEQLTPLIKKAGTELVNFLSYFVELGTQPATQ reduced acrolein addition +96(K)@7; MDA adduct +54(K)@21; ONE addition +154(K)@31; ONE addition +154(K)@32 missed K-V@5; missed K-S@7; missed K-S@16; missed K-S@21; missed K-E@23; missed K-K@31; missed K-A@32 0.563036024570465 6560.0263671875 938.1539 6559.462890625 938.073425292969 7 17 1.1.1.4737.5 0 74.7501 7977.587 74.6407 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 91.3600027561188 EGALVRRQAKEPCVESLVSQYFQTVTDYGKDLMEK Deamidated(Q)@8; acrolein addition +112(K)@10; Oxidation(P)@12; Carbamidomethyl(C)@13 cleaved L-E@N-term; missed R-R@6; missed R-Q@7; missed K-E@10; missed K-D@30 0.324292004108429 4203.37451171875 1051.851 4203.05029296875 1051.76989746094 4 17 1.1.1.4447.13 1 67.3162 402.304 67.3279 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGK Carbamidomethyl(C)@3 0.253762006759644 2349.33715820313 784.1197 2349.08349609375 784.035095214844 3 21 1.1.1.4225.3 1 61.6841 784.0414 61.7042 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGK Carbamidomethyl(C)@3 0.183463007211685 2349.26733398438 1175.641 2349.08349609375 1175.54907226563 2 19 1.1.1.4211.9 1 61.3587 805.0668 61.5095 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGK Carbamidomethyl(C)@3 0.186881005764008 2349.26928710938 1175.642 2349.08349609375 1175.54907226563 2 17 1.1.1.4226.17 1 61.7222 731.8267 61.7042 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGK Carbamidomethyl(C)@3 0.186881005764008 2349.26928710938 1175.642 2349.08349609375 1175.54907226563 2 17 1.1.1.4227.5 1 61.745 731.8267 61.7042 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 86.2600028514862 EPCVESLVSQYFQTVTDYGK Carbamidomethyl(C)@3 0.0746849998831749 2349.158203125 784.06 2349.08349609375 784.035095214844 3 14 1.1.1.4232.3 1 61.8565 442.6728 61.8518 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 0.260266005992889 2981.62768554688 994.8832 2981.36743164063 994.796447753906 3 23 1.1.1.4289.16 1 63.2945 17134.68 63.537 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 0.260998010635376 2981.62841796875 994.8834 2981.36743164063 994.796447753906 3 29 1.1.1.4296.12 1 63.4721 26435.11 63.6158 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 0.326353996992111 2981.69384765625 746.4307 2981.36743164063 746.34912109375 4 25 1.1.1.4299.3 1 63.5433 6961.406 63.6158 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 0.260998010635376 2981.62841796875 994.8834 2981.36743164063 994.796447753906 3 33 1.1.1.4303.15 1 63.6577 26435.11 63.6158 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 0.326353996992111 2981.69384765625 746.4307 2981.36743164063 746.34912109375 4 24 1.1.1.4306.4 1 63.7271 6961.406 63.6158 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 0.260998010635376 2981.62841796875 994.8834 2981.36743164063 994.796447753906 3 29 1.1.1.4310.12 1 63.8375 26435.11 63.6158 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Acetyl(S)@6 missed K-D@20 0.262255012989044 3007.64624023438 1003.556 3007.38305664063 1003.46832275391 3 24 1.1.1.4406.3 1 66.2687 706.3924 66.3531 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Acetyl(S)@6 missed K-D@20 0.262255012989044 3007.64624023438 1003.556 3007.38305664063 1003.46832275391 3 22 1.1.1.4413.4 1 66.4445 706.3924 66.3531 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3 missed K-D@20 0.317606002092361 2965.69018554688 742.4298 2965.37255859375 742.350402832031 4 21 1.1.1.4433.2 1 66.9571 33593.33 67.1582 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3 missed K-D@20 0.25212898850441 2965.62475585938 989.5488 2965.37255859375 989.464782714844 3 28 1.1.1.4439.2 1 67.1273 101512.4 67.1582 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3 missed K-D@20 0.317851006984711 2965.6904296875 742.4299 2965.37255859375 742.350402832031 4 25 1.1.1.4440.3 1 67.1382 33798.09 67.1582 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3 missed K-D@20 0.317851006984711 2965.6904296875 742.4299 2965.37255859375 742.350402832031 4 25 1.1.1.4447.4 1 67.3087 33798.09 67.1582 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3 missed K-D@20 0.25212898850441 2965.62475585938 989.5488 2965.37255859375 989.464782714844 3 28 1.1.1.4447.12 1 67.3154 101512.4 67.1582 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3 missed K-D@20 0.322488993406296 2965.69506835938 742.431 2965.37255859375 742.350402832031 4 25 1.1.1.4454.4 1 67.4813 21408.55 67.2551 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3 missed K-D@20 0.256157010793686 2965.62866210938 989.5502 2965.37255859375 989.464782714844 3 28 1.1.1.4454.10 1 67.4871 65103.14 67.2309 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3 missed K-D@20 0.262199997901917 2965.634765625 989.5522 2965.37255859375 989.464782714844 3 24 1.1.1.4461.9 1 67.6612 26189.29 67.4013 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3 missed K-D@20 0.324685990810394 2965.697265625 742.4316 2965.37255859375 742.350402832031 4 19 1.1.1.4466.2 1 67.7765 1542.724 67.525 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3 missed K-D@20 0.252312004566193 2965.62475585938 989.5489 2965.37255859375 989.464782714844 3 23 1.1.1.4473.9 1 67.9624 1309.409 67.6977 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3 missed K-D@20 0.262932002544403 2965.63549804688 989.5524 2965.37255859375 989.464782714844 3 24 1.1.1.4480.12 1 68.1497 400.5829 68.0798 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3 missed K-D@20 0.264396995306015 2965.63696289063 989.5529 2965.37255859375 989.464782714844 3 16 1.1.1.4492.5 1 68.4436 333.8397 68.4587 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3 missed K-D@20 0.262199997901917 2965.634765625 989.5522 2965.37255859375 989.464782714844 3 19 1.1.1.4507.7 1 68.8523 487.6339 68.7259 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3 missed K-D@20 0.274284988641739 2965.64672851563 989.5562 2965.37255859375 989.464782714844 3 18 1.1.1.4542.7 1 69.7306 388.5507 69.4559 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3 missed K-D@20 0.258720993995667 2965.63134765625 989.551 2965.37255859375 989.464782714844 3 13 1.1.1.4571.15 1 70.4768 177.0671 70.5865 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 0.326353996992111 2981.69384765625 746.4307 2981.36743164063 746.34912109375 4 19 1.1.1.4301.4 1 63.5966 6961.406 63.6158 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; acrolein addition +112(K)@20; HPNE addition +172(K)@25 missed K-D@20 0.362751990556717 3249.89770507813 813.4817 3249.53491210938 813.390991210938 4 22 1.1.1.4503.6 1 68.7379 623.6776 68.7801 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; reduced acrolein addition +58(K)@20; Myristoyl(K)@25 missed K-D@20 0.27683898806572 3233.8896484375 809.4797 3233.61279296875 809.410461425781 4 27 1.1.1.4519.3 1 69.1431 1542.571 69.1615 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; reduced acrolein addition +96(K)@20; HPNE addition +172(K)@25 missed K-D@20 0.34961000084877 3233.8896484375 809.4797 3233.5400390625 809.392272949219 4 21 1.1.1.4526.3 1 69.3138 1542.571 69.1615 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Myristoyl(K)@20; reduced acrolein addition +58(K)@25 missed K-D@20 0.279769003391266 3233.892578125 809.4804 3233.61279296875 809.410461425781 4 28 1.1.1.4556.3 1 70.0957 1970.458 70.0886 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Myristoyl(K)@20; reduced acrolein addition +58(K)@25 missed K-D@20 0.278548002243042 3233.89135742188 809.4801 3233.61279296875 809.410461425781 4 25 1.1.1.4563.3 1 70.2717 1911.376 70.1646 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3 missed K-D@20 0.248227998614311 2947.61010742188 983.544 2947.36206054688 983.461242675781 3 24 1.1.1.4667.18 1 72.9997 1341.126 72.9799 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 0.260998010635376 2981.62841796875 994.8834 2981.36743164063 994.796447753906 3 20 1.1.1.4437.6 1 67.0686 571.6237 67.1081 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3 missed K-D@20 0.248227998614311 2947.61010742188 983.544 2947.36206054688 983.461242675781 3 20 1.1.1.4660.14 1 72.8094 1341.126 72.9799 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Deamidated(Q)@13; Dehydrated(T)@16; reduced acrolein addition +58(K)@20 missed K-D@20 0.275510013103485 3006.66235351563 1003.228 3006.38793945313 1003.13653564453 3 21 1.1.1.4455.5 1 67.5166 987.4083 67.4261 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Acetyl(S)@6 missed K-D@20 0.270494997501373 3007.65209960938 1003.558 3007.38305664063 1003.46832275391 3 18 1.1.1.4423.5 1 66.701 630.7441 66.4803 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.8499999046326 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Carbamidomethyl(K)@25 missed K-D@20 0.257948011159897 3022.65209960938 1008.558 3022.39404296875 1008.47192382813 3 19 1.1.1.4438.12 1 67.0956 307.7332 67.1081 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.8499999046326 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Deamidated(Q)@10; Dehydrated(T)@16; reduced acrolein addition +58(K)@20 missed K-D@20 0.275510013103485 3006.66235351563 1003.228 3006.38793945313 1003.13653564453 3 20 1.1.1.4448.5 1 67.3439 987.4083 67.4261 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.089998960495 EPCVESLVSQYFQTVTDYGKDLMEK Oxidation(P)@2; Carbamidomethyl(C)@3 missed K-D@20 0.265210002660751 2981.63256835938 994.8848 2981.36743164063 994.796447753906 3 16 1.1.1.4402.4 1 66.1715 813.7384 66.2312 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.869998216629 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3 missed K-D@20 -3.37280988693237 2961.99975585938 988.3405 2965.37255859375 989.464782714844 3 18 1.1.1.4535.5 1 69.5562 711.7051 69.4819 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.7699995040894 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Cation:Na(E)@5 missed K-D@20 0.318327993154526 2987.6728515625 747.9255 2987.3544921875 747.845886230469 4 18 1.1.1.4443.4 1 67.2216 2799.346 67.1582 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.5499987602234 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; acrolein addition +38(K)@20; Deoxy(D)@21 missed K-D@20 0.279536992311478 2987.6728515625 747.9255 2987.39331054688 747.855590820313 4 18 1.1.1.4436.3 1 67.0389 2799.346 67.1582 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 96.7499971389771 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Cation:Na(E)@5 missed K-D@20 0.320037007331848 2987.67456054688 747.9259 2987.3544921875 747.845886230469 4 17 1.1.1.4450.2 1 67.3836 1990.735 67.2791 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 93.5400009155273 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Deamidated(Q)@10; Deamidated(Q)@13 missed K-D@20 0.282876998186111 2967.62353515625 990.2151 2967.34057617188 990.120788574219 3 16 1.1.1.4440.8 1 67.1448 29780.04 67.1582 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 93.4199988842011 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3 missed K-D@20 0.339578986167908 2965.71215820313 742.4353 2965.37255859375 742.350402832031 4 16 1.1.1.4291.4 1 63.3364 170.0211 63.3298 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 90.1700019836426 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20 0.260998010635376 2981.62841796875 994.8834 2981.36743164063 994.796447753906 3 14 1.1.1.4305.15 1 63.7102 26435.11 63.6158 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 89.92999792099 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; hexanoyl addition +98(K)@20; Oxidation(M)@23; ONE addition +154(K)@25 missed K-D@20 0.352539986371994 3233.892578125 809.4804 3233.5400390625 809.392272949219 4 13 1.1.1.4549.6 1 69.9118 1970.458 70.0886 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 86.710000038147 EPCVESLVSQYFQTVTDYGKDLMEK Oxidation(P)@2; Carbamidomethyl(C)@3 missed K-D@20 0.254040002822876 2981.62158203125 994.8811 2981.36743164063 994.796447753906 3 13 1.1.1.4409.10 1 66.3389 757.1129 66.3283 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 84.6099972724915 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; ONE addition +154(K)@20; Oxidation(M)@23; hexanoyl addition +98(K)@25 missed K-D@20 0.34961000084877 3233.8896484375 809.4797 3233.5400390625 809.392272949219 4 14 1.1.1.4517.6 1 69.103 1542.571 69.1615 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 77.1499991416931 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Didehydro(Y)@11 missed K-D@20 -0.476801991462708 2962.88012695313 741.7273 2963.35693359375 741.846496582031 4 15 1.1.1.4506.2 1 68.814 227.8244 68.8067 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 76.3999998569489 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Phospho(S)@9 missed K-D@20 0.261139988899231 3045.59912109375 1016.207 3045.3388671875 1016.12023925781 3 13 1.1.1.4424.5 1 66.7268 421.7243 66.7681 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 68.4700012207031 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Deamidated(Q)@13 missed K-D@20 -0.659328997135162 2965.697265625 742.4316 2966.3564453125 742.596435546875 4 12 1.1.1.4458.2 1 67.5784 15231.92 67.3279 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 67.7799999713898 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; Cation:Na(E)@5; Oxidation(M)@23 missed K-D@20 0.331470012664795 3003.68090820313 751.9275 3003.34936523438 751.844604492188 4 13 1.1.1.4300.4 1 63.5704 461.2097 63.6158 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 48.1599986553192 EPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@3; HPNE addition +172(K)@20; reduced acrolein addition +96(K)@25 missed K-D@20 -0.509521007537842 3233.03051757813 809.2649 3233.5400390625 809.392272949219 4 12 1.1.1.4570.6 1 70.4405 323.6042 70.4328 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 45.6299990415573 EPCVESLVSQYFQTVTDYGKDLMEK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3; Dehydrated(T)@16; reduced acrolein addition +58(K)@20 missed K-D@20 0.211373999714851 2987.60473632813 996.8755 2987.39331054688 996.805053710938 3 13 1.1.1.4441.5 1 67.1741 1063.722 67.1582 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25 0.331678003072739 3208.86254882813 803.2229 3208.53076171875 803.139953613281 4 23 1.1.1.4296.4 1 63.4654 10574.38 63.5634 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25 0.331678003072739 3208.86254882813 803.2229 3208.53076171875 803.139953613281 4 24 1.1.1.4303.4 1 63.6485 10574.38 63.5634 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25 0.332899004220963 3208.86376953125 803.2232 3208.53076171875 803.139953613281 4 21 1.1.1.4311.10 1 63.8617 10861.56 63.876 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25 0.265224009752274 3208.79614257813 1070.606 3208.53076171875 1070.517578125 3 20 1.1.1.4298.17 1 63.5286 1847.315 63.5634 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25 0.32464000582695 3192.86059570313 799.2224 3192.53588867188 799.141235351563 4 18 1.1.1.4505.5 1 68.7883 74546.7 69.0401 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25 0.257818996906281 3192.79418945313 1065.272 3192.53588867188 1065.18591308594 3 12 1.1.1.4508.12 1 68.8765 17114.8 69.0645 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25 0.383341997861862 3192.91918945313 639.5911 3192.53588867188 639.514465332031 5 23 1.1.1.4510.7 1 68.923 13513.11 69.0888 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25 0.257818996906281 3192.79418945313 1065.272 3192.53588867188 1065.18591308594 3 27 1.1.1.4515.10 1 69.0561 17274.88 69.0645 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25 0.383341997861862 3192.91918945313 639.5911 3192.53588867188 639.514465332031 5 22 1.1.1.4517.2 1 69.093 13513.11 69.0888 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25 0.32464000582695 3192.86059570313 799.2224 3192.53588867188 799.141235351563 4 26 1.1.1.4517.4 1 69.098 116636.4 69.113 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25 0.383341997861862 3192.91918945313 639.5911 3192.53588867188 639.514465332031 5 22 1.1.1.4524.6 1 69.2702 13513.11 69.0888 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25 0.32464000582695 3192.86059570313 799.2224 3192.53588867188 799.141235351563 4 24 1.1.1.4524.7 1 69.2727 116636.4 69.113 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25 0.257818996906281 3192.79418945313 1065.272 3192.53588867188 1065.18591308594 3 27 1.1.1.4524.8 1 69.2752 17274.88 69.0645 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25 0.32464000582695 3192.86059570313 799.2224 3192.53588867188 799.141235351563 4 30 1.1.1.4531.6 1 69.4475 78471.71 69.1857 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25 0.258552014827728 3192.79418945313 1065.272 3192.53588867188 1065.18591308594 3 19 1.1.1.4531.7 1 69.4508 8439.577 69.1857 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25 0.325372010469437 3192.861328125 799.2226 3192.53588867188 799.141235351563 4 26 1.1.1.4538.6 1 69.631 9661.782 69.3561 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25 0.332208007574081 3192.8681640625 799.2243 3192.53588867188 799.141235351563 4 24 1.1.1.4545.5 1 69.8114 529.7681 69.8232 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25 0.332208007574081 3192.8681640625 799.2243 3192.53588867188 799.141235351563 4 15 1.1.1.4552.7 1 69.9926 512.0448 69.9294 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25 0.331474989652634 3192.86743164063 799.2241 3192.53588867188 799.141235351563 4 22 1.1.1.4576.3 1 70.5977 848.4389 70.7383 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25 0.331474989652634 3192.86743164063 799.2241 3192.53588867188 799.141235351563 4 18 1.1.1.4583.5 1 70.7715 848.4389 70.7383 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25 0.325372010469437 3192.861328125 799.2226 3192.53588867188 799.141235351563 4 18 1.1.1.4592.11 1 71.0099 583.1321 70.9707 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25 0.316094994544983 3192.85205078125 799.2203 3192.53588867188 799.141235351563 4 22 1.1.1.4599.10 1 71.1943 436.0499 71.1805 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25 0.323419004678726 3192.859375 799.2221 3192.53588867188 799.141235351563 4 22 1.1.1.4606.8 1 71.381 295.9013 71.3129 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25 0.318291991949081 3192.85424804688 799.2208 3192.53588867188 799.141235351563 4 13 1.1.1.4613.18 1 71.5687 317.4381 71.5226 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25 0.317315012216568 3192.85327148438 799.2206 3192.53588867188 799.141235351563 4 14 1.1.1.4627.9 1 71.9362 271.7556 71.9998 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25 0.391844987869263 3208.92260742188 642.7918 3208.53076171875 642.713439941406 5 19 1.1.1.4311.3 1 63.8559 1172.53 63.876 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; reduced acrolein addition +58(K)@25; Amidated@C-term missed K-D@20; missed K-V@25 0.303900003433228 3249.89770507813 813.4817 3249.59375 813.405700683594 4 20 1.1.1.4334.3 1 64.4522 282.7458 64.5231 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25 0.265224009752274 3208.79614257813 1070.606 3208.53076171875 1070.517578125 3 18 1.1.1.4310.15 1 63.84 1858.265 63.876 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25 0.398254007101059 3208.92895507813 642.7931 3208.53076171875 642.713439941406 5 18 1.1.1.4296.2 1 63.4638 1035.434 63.5896 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Oxidation(P)@2; Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25 0.338514000177383 3208.86938476563 803.2246 3208.53076171875 803.139953613281 4 21 1.1.1.4488.3 1 68.3552 1111.335 68.4587 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Acetyl(S)@6 missed K-D@20; missed K-V@25 0.339221000671387 3234.8857421875 809.7287 3234.54638671875 809.643920898438 4 26 1.1.1.4493.3 1 68.467 1469.896 68.5122 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Oxidation(P)@2; Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25 0.338514000177383 3208.86938476563 803.2246 3208.53076171875 803.139953613281 4 23 1.1.1.4495.3 1 68.5223 1108.67 68.4587 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Acetyl(S)@6 missed K-D@20; missed K-V@25 0.339221000671387 3234.8857421875 809.7287 3234.54638671875 809.643920898438 4 22 1.1.1.4500.8 1 68.6607 1469.896 68.5122 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25 0.253369003534317 3174.77905273438 1059.267 3174.525390625 1059.18237304688 3 29 1.1.1.4688.18 1 73.5443 907.6205 73.5752 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25 0.323484987020493 3174.84887695313 794.7195 3174.525390625 794.638610839844 4 24 1.1.1.4689.8 1 73.5593 460.8761 73.5752 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.6199975013733 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25 0.398254007101059 3208.92895507813 642.7931 3208.53076171875 642.713439941406 5 16 1.1.1.4304.3 1 63.674 1035.434 63.5896 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 95.8500027656555 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25 0.331678003072739 3208.86254882813 803.2229 3208.53076171875 803.139953613281 4 15 1.1.1.4289.7 1 63.287 8757.381 63.537 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 92.2699987888336 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Cation:Na(E)@5 missed K-D@20; missed K-V@25 0.32633700966835 3214.84423828125 804.7183 3214.51782226563 804.63671875 4 16 1.1.1.4514.2 1 69.0266 1068.412 69.113 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 89.92999792099 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Deamidated(Q)@10 missed K-D@20; missed K-V@25 -0.65937602519989 3192.86059570313 799.2224 3193.52001953125 799.387268066406 4 14 1.1.1.4569.5 1 70.4177 472.5923 70.4328 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 88.4700000286102 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Carbamidomethyl(D)@21 missed K-D@20; missed K-V@25 0.341993987560272 3249.8994140625 813.4821 3249.55737304688 813.396606445313 4 15 1.1.1.4326.8 1 64.2471 347.1103 64.263 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 82.6099991798401 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Acetyl(S)@6 missed K-D@20; missed K-V@25 0.339221000671387 3234.8857421875 809.7287 3234.54638671875 809.643920898438 4 15 1.1.1.4486.4 1 68.3009 1446.743 68.5122 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 82.6099991798401 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Deamidated(Q)@13; acrolein addition +56(K)@20 missed K-D@20; missed K-V@25 0.351274013519287 3249.8974609375 813.4816 3249.54614257813 813.393798828125 4 12 1.1.1.4510.9 1 68.9246 339.6392 68.8866 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 78.8299977779388 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Cation:Na(E)@5 missed K-D@20; missed K-V@25 0.32633700966835 3214.84423828125 804.7183 3214.51782226563 804.63671875 4 14 1.1.1.4515.5 1 69.0477 1068.412 69.113 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 76.2799978256226 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Diiodo(Y)@11 missed K-D@20; missed K-V@25 -0.278216987848282 3444.05102539063 862.02 3444.3291015625 862.089599609375 4 15 1.1.1.4512.7 1 68.9747 402.1629 69.0401 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 50.6900012493134 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; MDA adduct +54(K)@20 missed K-D@20; missed K-V@25 -0.686854004859924 3245.85961914063 650.1792 3246.54638671875 650.316589355469 5 12 1.1.1.4517.3 1 69.0955 489.4597 69.113 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 36.8900001049042 EPCVESLVSQYFQTVTDYGKDLMEKVK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3; Amino(Y)@11; acrolein addition +56(K)@20 missed K-D@20; missed K-V@25 0.214838996529579 3245.77734375 812.4516 3245.5625 812.397888183594 4 13 1.1.1.4517.7 1 69.1055 413.7524 69.113 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 28.7099987268448 EPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@3; Cation:Na(E)@5 missed K-D@20; missed K-V@25 0.32633700966835 3214.84423828125 804.7183 3214.51782226563 804.63671875 4 12 1.1.1.4522.4 1 69.2198 1068.412 69.113 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 15.2999997138977 EPCVESLVSQYFQTVTDYGKDLMEKVK Oxidation(P)@2; Carbamidomethyl(C)@3; HexNAc(S)@6 missed K-D@20; missed K-V@25 0.407579004764557 3412.01782226563 854.0117 3411.61010742188 853.909851074219 4 13 1.1.1.4624.6 1 71.8532 351.9983 71.9197 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQ Carbamidomethyl(C)@3; HPNE addition +172(K)@20; HPNE addition +172(K)@25; reduced acrolein addition +96(K)@27 cleaved Q-A@C-term; missed K-D@20; missed K-V@25; missed K-S@27 0.378758013248444 4187.4619140625 838.4997 4187.08349609375 838.423950195313 5 26 1.1.1.4486.6 1 68.3051 4504.431 68.4855 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQ Carbamidomethyl(C)@3; HPNE addition +172(K)@20; HPNE addition +172(K)@25; reduced acrolein addition +96(K)@27 cleaved Q-A@C-term; missed K-D@20; missed K-V@25; missed K-S@27 0.378758013248444 4187.4619140625 838.4997 4187.08349609375 838.423950195313 5 27 1.1.1.4500.10 1 68.664 4654.337 68.5122 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 36.8900001049042 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQ Carbamidomethyl(C)@3; HPNE addition +172(K)@20; HPNE addition +172(K)@25; reduced acrolein addition +96(K)@27 cleaved Q-A@C-term; missed K-D@20; missed K-V@25; missed K-S@27 0.378758013248444 4187.4619140625 838.4997 4187.08349609375 838.423950195313 5 31 1.1.1.4493.5 1 68.4704 4654.337 68.5122 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25; missed K-S@27 0.41192701458931 4162.42431640625 833.4922 4162.0126953125 833.409790039063 5 24 1.1.1.4250.3 1 62.3054 3074.477 62.3451 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25; missed K-S@27 0.41192701458931 4162.42431640625 833.4922 4162.0126953125 833.409790039063 5 28 1.1.1.4257.6 1 62.4747 3403.075 62.5178 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Acetyl(S)@6 missed K-D@20; missed K-V@25; missed K-S@27 0.423193007707596 4188.45166015625 838.6976 4188.0283203125 838.612915039063 5 29 1.1.1.4431.5 1 66.9084 987.4763 66.978 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25; missed K-S@27 0.346450001001358 4162.35888671875 1041.597 4162.0126953125 1041.51037597656 4 20 1.1.1.4261.19 1 62.5872 1219.305 62.6196 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25; missed K-S@27 0.404949992895126 4146.4228515625 830.2918 4146.017578125 830.210815429688 5 23 1.1.1.4445.3 1 67.2623 48260.98 67.451 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25; missed K-S@27 0.465970993041992 4146.48388671875 692.0879 4146.017578125 692.01025390625 6 26 1.1.1.4449.3 1 67.3569 5140.954 67.5497 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25; missed K-S@27 0.404949992895126 4146.4228515625 830.2918 4146.017578125 830.210815429688 5 30 1.1.1.4452.4 1 67.4317 49068.65 67.451 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25; missed K-S@27 0.335992991924286 4146.3544921875 1037.596 4146.017578125 1037.51171875 4 35 1.1.1.4452.10 1 67.4367 12631.37 67.451 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25; missed K-S@27 0.465970993041992 4146.48388671875 692.0879 4146.017578125 692.01025390625 6 29 1.1.1.4456.3 1 67.5329 5276.134 67.5497 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25; missed K-S@27 0.405254989862442 4146.4228515625 830.2919 4146.017578125 830.210815429688 5 29 1.1.1.4459.2 1 67.6034 53543.38 67.5497 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25; missed K-S@27 0.336970001459122 4146.3544921875 1037.596 4146.017578125 1037.51171875 4 35 1.1.1.4459.6 1 67.6109 14686.13 67.5497 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25; missed K-S@27 0.405254989862442 4146.4228515625 830.2919 4146.017578125 830.210815429688 5 17 1.1.1.4460.4 1 67.629 53543.38 67.5497 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; acrolein addition +38(K)@20 missed K-D@20; missed K-V@25; missed K-S@27 0.352250993251801 4184.3857421875 837.8844 4184.033203125 837.81396484375 5 14 1.1.1.4460.6 1 67.6307 168.2109 67.6235 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25; missed K-S@27 0.465970993041992 4146.48388671875 692.0879 4146.017578125 692.01025390625 6 29 1.1.1.4463.3 1 67.7047 5276.134 67.5497 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25; missed K-S@27 0.405254989862442 4146.4228515625 830.2919 4146.017578125 830.210815429688 5 30 1.1.1.4466.3 1 67.7781 55796.28 67.525 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25; missed K-S@27 0.336970001459122 4146.3544921875 1037.596 4146.017578125 1037.51171875 4 35 1.1.1.4466.8 1 67.7865 15060.66 67.5497 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25; missed K-S@27 0.404949992895126 4146.4228515625 830.2918 4146.017578125 830.210815429688 5 21 1.1.1.4467.5 1 67.8031 54722.05 67.5497 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25; missed K-S@27 0.46670401096344 4146.484375 692.088 4146.017578125 692.01025390625 6 18 1.1.1.4470.4 1 67.8785 5004.849 67.6235 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25; missed K-S@27 0.411053001880646 4146.4287109375 830.293 4146.017578125 830.210815429688 5 34 1.1.1.4473.6 1 67.9583 39723.02 67.6977 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25; missed K-S@27 0.33550500869751 4146.3544921875 1037.596 4146.017578125 1037.51171875 4 18 1.1.1.4473.11 1 67.9658 9514.954 67.6977 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25; missed K-S@27 0.414409995079041 4146.43212890625 830.2937 4146.017578125 830.210815429688 5 19 1.1.1.4480.8 1 68.1439 12339.02 67.8721 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25; missed K-S@27 0.413800001144409 4146.431640625 830.2936 4146.017578125 830.210815429688 5 21 1.1.1.4502.8 1 68.7158 412.0682 68.7801 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Carbamidomethyl(K)@27 missed K-D@20; missed K-V@25; missed K-S@27 0.404054999351501 4203.443359375 841.6959 4203.0390625 841.615112304688 5 31 1.1.1.4446.4 1 67.2867 1736.016 67.3279 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; HPNE addition +172(K)@20; PyridoxalPhosphate(K)@25; hexanoyl addition +98(K)@27 missed K-D@20; missed K-V@25; missed K-S@27 0.275278002023697 4187.4619140625 838.4997 4187.18701171875 838.444641113281 5 33 1.1.1.4493.5 1 68.4704 4654.337 68.5122 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Formyl(K)@25 missed K-D@20; missed K-V@25; missed K-S@27 0.333265990018845 4174.3466796875 1044.594 4174.0126953125 1044.51037597656 4 30 1.1.1.4614.4 1 71.5971 438.4887 71.6022 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Trimethyl(K)@25 missed K-D@20; missed K-V@25; missed K-S@27 0.290995985269547 4188.3544921875 1048.096 4188.064453125 1048.0234375 4 23 1.1.1.4624.9 1 71.8582 453.8742 71.8666 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Carboxyethyl(K)@27 missed K-D@20; missed K-V@25; missed K-S@27 0.332929998636246 4218.37060546875 1055.6 4218.0390625 1055.51696777344 4 28 1.1.1.4762.5 1 75.3631 2793.729 75.2983 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Delta:H(4)C(2)(K)@25; reduced acrolein addition +58(K)@27 missed K-D@20; missed K-V@25; missed K-S@27 0.286754012107849 4232.37890625 1059.102 4232.0908203125 1059.03002929688 4 32 1.1.1.4774.19 1 75.667 3369.365 75.6996 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Delta:H(4)C(2)(K)@25; reduced acrolein addition +58(K)@27 missed K-D@20; missed K-V@25; missed K-S@27 0.355343997478485 4232.4462890625 847.4965 4232.0908203125 847.425476074219 5 24 1.1.1.4775.10 1 75.6854 1103.432 75.6996 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Oxidation(P)@2; Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25; missed K-S@27 0.422607988119125 4162.43505859375 833.4943 4162.0126953125 833.409790039063 5 18 1.1.1.4429.8 1 66.8571 575.3359 66.9518 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3; Deamidated(Q)@13; reduced acrolein addition +58(K)@20 missed K-D@20; missed K-V@25; missed K-S@27 0.408616006374359 4187.44140625 838.4956 4187.033203125 838.413879394531 5 21 1.1.1.4455.2 1 67.5066 1056.507 67.4261 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Deamidated(Q)@10; Dioxidation(M)@23; MDA adduct +54(K)@25 missed K-D@20; missed K-V@25; missed K-S@27 -0.618143022060394 4232.3828125 1059.103 4233.001953125 1059.2578125 4 22 1.1.1.4761.20 1 75.3412 1355.761 75.3471 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25; missed K-S@27 0.413493990898132 4146.43115234375 830.2935 4146.017578125 830.210815429688 5 18 1.1.1.4325.7 1 64.22 482.6034 64.211 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25; missed K-S@27 0.334351003170013 4128.3427734375 1033.093 4128.00732421875 1033.00903320313 4 19 1.1.1.4641.16 1 72.3084 840.1192 72.238 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Trimethyl(K)@27 missed K-D@20; missed K-V@25; missed K-S@27 0.296366989612579 4188.36279296875 1048.098 4188.064453125 1048.0234375 4 21 1.1.1.4641.17 1 72.3092 643.8422 72.344 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(Y)@18 missed K-D@20; missed K-V@25; missed K-S@27 0.412537008523941 4162.42529296875 833.4923 4162.0126953125 833.409790039063 5 18 1.1.1.4271.10 1 62.8362 2332.727 62.773 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Carbamidomethyl(K)@25 missed K-D@20; missed K-V@25; missed K-S@27 0.404969990253448 4203.4443359375 841.6961 4203.0390625 841.615112304688 5 20 1.1.1.4438.8 1 67.0923 1011.628 67.1338 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.8699972629547 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25; missed K-S@27 -8.70160007476807 4137.31494140625 1035.336 4146.017578125 1037.51171875 4 20 1.1.1.4677.17 1 73.2564 2211.179 73.1363 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.2299983501434 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Amino(Y)@11 missed K-D@20; missed K-V@25; missed K-S@27 0.398627996444702 4161.42724609375 833.2927 4161.02880859375 833.213012695313 5 19 1.1.1.4452.5 1 67.4326 271.2891 67.451 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.1500029563904 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25; missed K-S@27 -8.70160007476807 4137.31494140625 1035.336 4146.017578125 1037.51171875 4 19 1.1.1.4670.17 1 73.0762 2211.179 73.1363 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.869998216629 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Deamidated(Q)@13; Delta:H(2)C(2)(K)@25; acrolein addition +76(K)@27 missed K-D@20; missed K-V@25; missed K-S@27 -0.684719026088715 4248.36279296875 1063.098 4249.048828125 1063.26940917969 4 18 1.1.1.4615.11 1 71.6217 251.2425 71.549 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.7699995040894 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3; Deamidated(Q)@10; Deamidated(Q)@13; reduced acrolein addition +58(K)@20 missed K-D@20; missed K-V@25; missed K-S@27 0.428934007883072 4188.44580078125 838.6965 4188.01708984375 838.610656738281 5 18 1.1.1.4438.7 1 67.0914 987.346 66.978 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 91.430002450943 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25; missed K-S@27 0.346450001001358 4162.35888671875 1041.597 4162.0126953125 1041.51037597656 4 14 1.1.1.4268.20 1 62.7671 826.4651 62.773 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 89.92999792099 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3; reduced acrolein addition +58(K)@20 missed K-D@20; missed K-V@25; missed K-S@27 0.359611004590988 4186.40869140625 838.289 4186.048828125 838.217102050781 5 15 1.1.1.4447.7 1 67.3112 438.1901 67.3279 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 88.0299985408783 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3; Deamidated(Q)@13; reduced acrolein addition +58(K)@25 missed K-D@20; missed K-V@25; missed K-S@27 0.410142004489899 4187.443359375 838.4959 4187.033203125 838.413879394531 5 16 1.1.1.4462.7 1 67.6809 912.7739 67.5497 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 87.5100016593933 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Deamidated(Q)@13; reduced acrolein addition +58(K)@20; Methyl(D)@21 missed K-D@20; missed K-V@25; missed K-S@27 0.32082998752594 4219.37890625 1055.852 4219.05908203125 1055.77209472656 4 16 1.1.1.4677.18 1 73.2572 256.7303 73.2648 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 82.6099991798401 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Oxidation(P)@2; Carbamidomethyl(C)@3; Deamidated(Q)@10 missed K-D@20; missed K-V@25; missed K-S@27 -0.562627971172333 4162.43408203125 833.4941 4162.99658203125 833.606628417969 5 15 1.1.1.4505.8 1 68.7908 303.0575 68.8067 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 76.2799978256226 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Delta:H(4)C(2)(K)@27 missed K-D@20; missed K-V@25; missed K-S@27 0.278326004743576 4174.32666015625 1044.589 4174.048828125 1044.51953125 4 14 1.1.1.4636.12 1 72.1752 322.8458 72.1319 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 73.5199987888336 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25; missed K-S@27 0.419604003429413 4128.4267578125 826.6926 4128.00732421875 826.608703613281 5 13 1.1.1.4460.3 1 67.6282 194.5652 67.6483 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 69.5200026035309 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3; ONE addition +154(K)@20; Oxidation(M)@23; acrolein addition +94(K)@25 missed K-D@20; missed K-V@25; missed K-S@27 0.457944005727768 4392.60107421875 879.5275 4392.14306640625 879.435913085938 5 12 1.1.1.4458.6 1 67.5817 260.559 67.5497 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 62.9100024700165 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Oxidation(P)@2; Carbamidomethyl(C)@3; HexNAc(S)@6 missed K-D@20; missed K-V@25; missed K-S@27 0.505466997623444 4365.59765625 874.1268 4365.091796875 874.025695800781 5 15 1.1.1.4552.8 1 69.9934 284.4956 70.0352 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 54.6899974346161 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23; Deamidated(Q)@32 missed K-D@20; missed K-V@25; missed K-S@27 -0.572089016437531 4162.42431640625 833.4922 4162.99658203125 833.606628417969 5 12 1.1.1.4259.7 1 62.5265 3403.075 62.5178 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 45.6299990415573 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3; hexanoyl addition +98(K)@20; Dethiomethyl(M)@23; MDA adduct +54(K)@27 missed K-D@20; missed K-V@25; missed K-S@27 0.290125012397766 4232.37890625 1059.102 4232.08740234375 1059.02917480469 4 13 1.1.1.4773.21 1 75.643 3369.365 75.6996 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 43.1800007820129 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23; Deamidated(Q)@32 missed K-D@20; missed K-V@25; missed K-S@27 -0.637565970420837 4162.35888671875 1041.597 4162.99658203125 1041.75646972656 4 12 1.1.1.4254.15 1 62.4083 1032.733 62.3696 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 41.839998960495 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@3; Oxidation(M)@23 missed K-D@20; missed K-V@25; missed K-S@27 -0.604614019393921 4161.408203125 833.2889 4162.0126953125 833.409790039063 5 12 1.1.1.4469.11 1 67.8587 133.1644 67.8216 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 30.9700012207031 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Glu->pyro-Glu@N-term; Carbamidomethyl(C)@3; Deamidated(Q)@13; reduced acrolein addition +58(K)@27 missed K-D@20; missed K-V@25; missed K-S@27 0.429062992334366 4187.4619140625 838.4997 4187.033203125 838.413879394531 5 12 1.1.1.4493.4 1 68.4687 4654.337 68.5122 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 82.6099991798401 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAKSY Carbamidomethyl(C)@3; MDA adduct +54(K)@20; hexanoyl addition +98(K)@27 cleaved Y-F@C-term; missed K-D@20; missed K-V@25; missed K-S@27; missed K-S@36 0.399325013160706 4548.59619140625 910.7265 4548.19677734375 910.646606445313 5 14 1.1.1.4466.7 1 67.7848 1335.82 67.6729 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAKSYFEK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25; missed K-S@27; missed K-S@36 0.489472985267639 4800.80859375 801.142 4800.31884765625 801.060424804688 6 19 1.1.1.4469.9 1 67.8571 2002.498 67.8978 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAKSYFEK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25; missed K-S@27; missed K-S@36 0.489472985267639 4800.80859375 801.142 4800.31884765625 801.060424804688 6 24 1.1.1.4476.4 1 68.0391 2002.498 67.8978 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.9300012588501 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAKSYFEKSK Carbamidomethyl(C)@3; Deamidated(Q)@32; PyridoxalPhosphate(K)@36; MDA adduct +54(K)@43 missed K-D@20; missed K-V@25; missed K-S@27; missed K-S@36; missed K-S@41 0.420607000589371 4841.84716796875 807.9818 4841.4267578125 807.911682128906 6 21 1.1.1.4484.5 1 68.2491 613.774 68.1331 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAKSYFEKSKEQLTPLIK Carbamidomethyl(C)@3 missed K-D@20; missed K-V@25; missed K-S@27; missed K-S@36; missed K-S@41; missed K-E@43 0.5728560090065 5938.56787109375 849.3741 5937.99462890625 849.292236328125 7 20 1.1.1.4475.4 1 68.011 609.9546 67.9758 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 89.92999792099 EPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAKSYFEKSKEQLTPLIK Carbamidomethyl(C)@3; Deamidated(Q)@32 missed K-D@20; missed K-V@25; missed K-S@27; missed K-S@36; missed K-S@41; missed K-E@43 -0.483655989170074 5938.4951171875 990.7565 5938.97900390625 990.837097167969 6 15 1.1.1.4478.7 1 68.0964 414.9801 68.0798 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 85.7800006866455 EQLTPLIKK missed K-K@8 0.153782993555069 1068.80810546875 535.4113 1068.654296875 535.334411621094 2 12 1.1.1.2829.7 1 27.7402 1264.953 27.6805 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 81.9100022315979 EQLTPLIKK Carboxyethyl(K)@8 missed K-K@8 0.155237004160881 1140.83068847656 571.4226 1140.67541503906 571.344970703125 2 10 1.1.1.3502.14 1 43.9752 541.4149 43.8867 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 53.82000207901 EQLTPLIKK Carboxyethyl(K)@8 missed K-K@8 0.155237004160881 1140.83068847656 571.4226 1140.67541503906 571.344970703125 2 12 1.1.1.3495.10 1 43.8057 541.4149 43.8867 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 32.6999992132187 FEKSKEQLTPLIKKAGTELVNFLSYFVELGTQPATQ reduced acrolein addition +96(K)@14; Phospho(S)@24 cleaved Y-F@N-term; missed K-S@3; missed K-E@5; missed K-K@13; missed K-A@14 0.47316101193428 4230.66357421875 847.14 4230.1904296875 847.04541015625 5 13 1.1.1.4758.6 1 75.2606 1206.757 75.2256 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 96.5200006961823 GALVRRQAKEPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@12 cleaved E-G@N-term; missed R-R@5; missed R-Q@6; missed K-E@9; missed K-D@29 -2.85713005065918 3942.11938476563 986.5371 3944.9765625 987.251403808594 4 18 1.1.1.4691.18 1 73.6198 2062.445 73.5494 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 GALVRRQAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@12 cleaved E-G@N-term; missed R-R@5; missed R-Q@6; missed K-E@9; missed K-D@29; missed K-V@34; missed K-S@36 -5.86355018615723 5119.75830078125 854.3003 5125.62158203125 855.277526855469 6 18 1.1.1.4416.3 1 66.5181 649.6396 66.5595 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.1500029563904 GALVRRQAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@12 cleaved E-G@N-term; missed R-R@5; missed R-Q@6; missed K-E@9; missed K-D@29; missed K-V@34; missed K-S@36 -5.8869800567627 5119.73486328125 854.2964 5125.62158203125 855.277526855469 6 19 1.1.1.4453.5 1 67.4608 1580.988 67.3279 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 60.6599986553192 GALVRRQAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@12 cleaved E-G@N-term; missed R-R@5; missed R-Q@6; missed K-E@9; missed K-D@29; missed K-V@34; missed K-S@36 -5.87416982650757 5119.74755859375 854.2985 5125.62158203125 855.277526855469 6 13 1.1.1.4423.3 1 66.6977 646.8248 66.7161 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 62.9100024700165 GKDLMEKVKSPELQAEAKSYFEKSKEQLTPLIKKAGTELVNFLSYFVELGTQPATQ reduced acrolein addition +58(K)@2; ONE addition +154(K)@7; MDA adduct +62(K)@34 cleaved Y-G@N-term; missed K-D@2; missed K-V@7; missed K-S@9; missed K-S@18; missed K-S@23; missed K-E@25; missed K-K@33; missed K-A@34 -0.523998975753784 6559.94873046875 1094.332 6560.4697265625 1094.41882324219 6 18 1.1.1.4740.11 0 74.8265 7337.119 74.6407 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPA cleaved A-T@C-term; missed K-A@1 0.243136003613472 2283.421875 762.1479 2283.1787109375 762.066833496094 3 23 1.1.1.4597.3 1 71.1411 6931.787 71.3389 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPA cleaved A-T@C-term; missed K-A@1 0.305377990007401 2283.48413085938 571.8783 2283.1787109375 571.801940917969 4 13 1.1.1.4602.8 1 71.2703 518.904 71.3129 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPA cleaved A-T@C-term; missed K-A@1 0.243136003613472 2283.421875 762.1479 2283.1787109375 762.066833496094 3 25 1.1.1.4604.10 1 71.3255 6969.501 71.3389 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPA cleaved A-T@C-term; missed K-A@1 0.181259006261826 2283.359375 1142.687 2283.1787109375 1142.5966796875 2 24 1.1.1.4604.15 1 71.3339 2669.089 71.3129 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPA cleaved A-T@C-term; missed K-A@1 0.305377990007401 2283.48413085938 571.8783 2283.1787109375 571.801940917969 4 13 1.1.1.4609.4 1 71.4551 518.904 71.3129 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPA cleaved A-T@C-term; missed K-A@1 0.181259006261826 2283.359375 1142.687 2283.1787109375 1142.5966796875 2 17 1.1.1.4611.9 1 71.5176 2669.089 71.3129 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPA cleaved A-T@C-term; missed K-A@1 0.243136003613472 2283.421875 762.1479 2283.1787109375 762.066833496094 3 22 1.1.1.4612.8 1 71.5339 6969.501 71.3389 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPA cleaved A-T@C-term; missed K-A@1 0.242587000131607 2283.42138671875 762.1477 2283.1787109375 762.066833496094 3 20 1.1.1.4619.5 1 71.7189 4077.459 71.444 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPA cleaved A-T@C-term; missed K-A@1 0.237460002303123 2283.41625976563 762.146 2283.1787109375 762.066833496094 3 17 1.1.1.4626.8 1 71.9046 299.4171 71.9463 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPA cleaved A-T@C-term; missed K-A@1 0.237460002303123 2283.41625976563 762.146 2283.1787109375 762.066833496094 3 10 1.1.1.4633.9 1 72.0907 299.4171 71.9463 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPA Cation:Na(E)@15 cleaved A-T@C-term; missed K-A@1 0.247031003236771 2305.40771484375 769.4765 2305.16064453125 769.394165039063 3 22 1.1.1.4607.6 1 71.404 720.7429 71.3651 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.0399975776672 KAGTELVNFLSYFVELGTQPA Cation:Na(E)@15 cleaved A-T@C-term; missed K-A@1 0.247031003236771 2305.40771484375 769.4765 2305.16064453125 769.394165039063 3 17 1.1.1.4614.2 1 71.5855 720.7429 71.3651 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 96.8999981880188 KAGTELVNFLSYFVELGTQPA Cation:Na(E)@15 cleaved A-T@C-term; missed K-A@1 0.245565995573997 2305.40625 769.476 2305.16064453125 769.394165039063 3 17 1.1.1.4600.9 1 71.2234 513.3405 71.2334 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 92.5999999046326 KAGTELVNFLSYFVELGTQPA reduced acrolein addition +58(K)@1; Dehydrated(T)@4; Deamidated(N)@8 cleaved A-T@C-term; missed K-A@1 0.262122005224228 2324.4560546875 775.826 2324.19409179688 775.738586425781 3 15 1.1.1.4620.11 1 71.7476 395.802 71.7869 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 0.179723992943764 2384.4052734375 1193.21 2384.22631835938 1193.12048339844 2 21 1.1.1.4567.10 1 70.3776 18023.65 70.6112 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 0.248985007405281 2384.47534179688 795.8324 2384.22631835938 795.749389648438 3 28 1.1.1.4569.4 1 70.4161 31644.21 70.6617 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 0.306039988994598 2384.53247070313 597.1404 2384.22631835938 597.063842773438 4 13 1.1.1.4570.2 1 70.4371 4185.721 70.6364 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 0.179479002952576 2384.4052734375 1193.21 2384.22631835938 1193.12048339844 2 28 1.1.1.4574.9 1 70.5552 19049.11 70.6112 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 0.248985007405281 2384.47534179688 795.8324 2384.22631835938 795.749389648438 3 28 1.1.1.4576.2 1 70.5936 30751 70.6364 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 0.306039988994598 2384.53247070313 597.1404 2384.22631835938 597.063842773438 4 16 1.1.1.4577.8 1 70.6205 4237.777 70.6364 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 0.248985007405281 2384.47534179688 795.8324 2384.22631835938 795.749389648438 3 21 1.1.1.4577.13 1 70.6247 30751 70.6364 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 0.179479002952576 2384.4052734375 1193.21 2384.22631835938 1193.12048339844 2 26 1.1.1.4581.21 1 70.7332 19049.11 70.6112 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 0.306039988994598 2384.53247070313 597.1404 2384.22631835938 597.063842773438 4 16 1.1.1.4584.3 1 70.7952 4237.777 70.6364 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 0.248985007405281 2384.47534179688 795.8324 2384.22631835938 795.749389648438 3 22 1.1.1.4584.7 1 70.8002 30751 70.6364 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 0.248985007405281 2384.47534179688 795.8324 2384.22631835938 795.749389648438 3 28 1.1.1.4584.8 1 70.8019 30751 70.6364 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 0.179234996438026 2384.4052734375 1193.21 2384.22631835938 1193.12048339844 2 22 1.1.1.4588.13 1 70.9136 18551.55 70.6364 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 0.249534994363785 2384.47583007813 795.8326 2384.22631835938 795.749389648438 3 29 1.1.1.4591.10 1 70.9831 25534.41 70.7127 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 0.179723992943764 2384.4052734375 1193.21 2384.22631835938 1193.12048339844 2 17 1.1.1.4596.11 1 71.1233 5568.583 70.8412 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 0.331674993038177 2384.55810546875 597.1468 2384.22631835938 597.063842773438 4 13 1.1.1.4598.5 1 71.1654 134.6324 71.1284 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 0.250266999006271 2384.4765625 795.8328 2384.22631835938 795.749389648438 3 26 1.1.1.4598.6 1 71.1671 8987.44 70.8929 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 0.250266999006271 2384.4765625 795.8328 2384.22631835938 795.749389648438 3 18 1.1.1.4605.11 1 71.3516 3019.249 71.0758 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 0.179479002952576 2384.4052734375 1193.21 2384.22631835938 1193.12048339844 2 12 1.1.1.4605.18 1 71.3583 477.5732 71.2854 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 0.245323002338409 2384.4716796875 795.8312 2384.22631835938 795.749389648438 3 18 1.1.1.4613.17 1 71.5678 1262.212 71.2854 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 0.178014993667603 2384.4033203125 1193.209 2384.22631835938 1193.12048339844 2 9 1.1.1.4620.20 1 71.7551 273.1906 71.6548 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 0.2466049939394 2384.47290039063 795.8316 2384.22631835938 795.749389648438 3 21 1.1.1.4621.9 1 71.7793 811.7689 71.6817 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 0.250449985265732 2384.47680664063 795.8329 2384.22631835938 795.749389648438 3 20 1.1.1.4628.13 1 71.9621 808.1771 71.6817 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 0.179234996438026 2384.4052734375 1193.21 2384.22631835938 1193.12048339844 2 12 1.1.1.4628.17 1 71.9687 273.121 71.8408 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 0.245140001177788 2384.47143554688 795.8311 2384.22631835938 795.749389648438 3 15 1.1.1.4635.14 1 72.1485 457.3743 72.1319 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT cleaved T-Q@C-term; missed K-A@1 0.22078700363636 2384.447265625 795.823 2384.22631835938 795.749389648438 3 15 1.1.1.4646.6 1 72.432 1092.324 72.6356 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT Cation:Na@C-term cleaved T-Q@C-term; missed K-A@1 0.247204005718231 2406.45556640625 803.1591 2406.20825195313 803.076721191406 3 25 1.1.1.4574.7 1 70.5502 4602.422 70.6617 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT Cation:K@C-term cleaved T-Q@C-term; missed K-A@1 0.247571006417274 2422.42993164063 808.4839 2422.18237304688 808.4013671875 3 28 1.1.1.4578.10 1 70.6474 1331.952 70.6617 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT Cation:Na@C-term cleaved T-Q@C-term; missed K-A@1 0.247204005718231 2406.45556640625 803.1591 2406.20825195313 803.076721191406 3 25 1.1.1.4581.9 1 70.7232 4602.422 70.6617 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT Cation:K@C-term cleaved T-Q@C-term; missed K-A@1 0.247571006417274 2422.42993164063 808.4839 2422.18237304688 808.4013671875 3 23 1.1.1.4585.10 1 70.827 1331.952 70.6617 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT Cation:Na(E)@15 cleaved T-Q@C-term; missed K-A@1 0.247204005718231 2406.45556640625 803.1591 2406.20825195313 803.076721191406 3 23 1.1.1.4589.3 1 70.9272 4708.892 70.6617 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT reduced acrolein addition +58(K)@1; Dehydrated(T)@4; Deamidated(N)@8 cleaved T-Q@C-term; missed K-A@1 0.259914994239807 2425.50170898438 809.5078 2425.24169921875 809.421203613281 3 25 1.1.1.4601.8 1 71.2444 4039.315 71.1544 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT Delta:H(2)C(2)(K)@1 cleaved T-Q@C-term; missed K-A@1 0.248227998614311 2410.490234375 804.504 2410.24194335938 804.421264648438 3 22 1.1.1.4764.5 1 75.4078 600.3548 75.4204 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT reduced acrolein addition +58(K)@1; Dimethyl(N)@8 cleaved T-Q@C-term; missed K-A@1 0.207742005586624 2470.50732421875 824.5097 2470.29956054688 824.4404296875 3 26 1.1.1.4807.3 1 76.5299 758.0457 76.535 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPAT reduced acrolein addition +58(K)@1; Dimethyl(N)@8 cleaved T-Q@C-term; missed K-A@1 0.14342400431633 2470.443359375 1236.229 2470.29956054688 1236.15710449219 2 20 1.1.1.4808.6 1 76.5546 161.8548 76.5597 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.8499999046326 KAGTELVNFLSYFVELGTQPAT Carbamidomethyl@N-term cleaved T-Q@C-term; missed K-A@1 0.185114994645119 2441.43334960938 1221.724 2441.24780273438 1221.63122558594 2 18 1.1.1.4569.10 1 70.4277 276.1769 70.4328 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.8499999046326 KAGTELVNFLSYFVELGTQPAT Delta:H(2)C(2)(K)@1 cleaved T-Q@C-term; missed K-A@1 0.243284001946449 2410.4853515625 804.5024 2410.24194335938 804.421264648438 3 19 1.1.1.4720.9 1 74.3339 692.8751 74.3003 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.470002412796 KAGTELVNFLSYFVELGTQPAT reduced acrolein addition +58(K)@1; Ammonia-loss(N)@8 cleaved T-Q@C-term; missed K-A@1 0.259548008441925 2425.50122070313 809.5077 2425.24169921875 809.421203613281 3 19 1.1.1.4608.8 1 71.4339 4030.495 71.1544 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.3900010585785 KAGTELVNFLSYFVELGTQPAT Carbamidomethyl@N-term cleaved T-Q@C-term; missed K-A@1 0.185114994645119 2441.43334960938 1221.724 2441.24780273438 1221.63122558594 2 17 1.1.1.4576.5 1 70.6061 276.1769 70.4328 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.869998216629 KAGTELVNFLSYFVELGTQPAT reduced acrolein addition +58(K)@1; Dehydrated(T)@4; Deamidated(N)@8 cleaved T-Q@C-term; missed K-A@1 0.191263005137444 2425.43334960938 1213.724 2425.24169921875 1213.62817382813 2 18 1.1.1.4598.11 1 71.1754 1080.532 71.1544 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.1800029277802 KAGTELVNFLSYFVELGTQPAT reduced acrolein addition +58(K)@1; Ammonia-loss(N)@8 cleaved T-Q@C-term; missed K-A@1 0.26009801030159 2425.50170898438 809.5079 2425.24169921875 809.421203613281 3 17 1.1.1.4589.4 1 70.9297 3915.456 71.1284 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 93.5400009155273 KAGTELVNFLSYFVELGTQPAT Cation:Na(E)@15 cleaved T-Q@C-term; missed K-A@1 0.180445000529289 2406.38940429688 1204.202 2406.20825195313 1204.11145019531 2 15 1.1.1.4579.17 1 70.6805 772.6986 70.6617 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 91.1700010299683 KAGTELVNFLSYFVELGTQPAT Cation:Na(E)@15 cleaved T-Q@C-term; missed K-A@1 0.251049011945724 2406.45947265625 803.1604 2406.20825195313 803.076721191406 3 13 1.1.1.4605.12 1 71.3525 156.4833 71.3129 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 89.92999792099 KAGTELVNFLSYFVELGTQPAT Cation:Na(E)@15 cleaved T-Q@C-term; missed K-A@1 0.312620013952255 2406.52099609375 602.6375 2406.20825195313 602.559387207031 4 15 1.1.1.4578.4 1 70.6424 352.9543 70.6364 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 88.5299980640411 KAGTELVNFLSYFVELGTQPAT Deamidated(Q)@19; Oxidation(P)@20 cleaved T-Q@C-term; missed K-A@1 0.29483500123024 2401.50024414063 801.5073 2401.20532226563 801.409057617188 3 15 1.1.1.4574.6 1 70.5477 1684.418 70.6617 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 82.6099991798401 KAGTELVNFLSYFVELGTQPAT Deamidated(N)@8; Oxidation(P)@20 cleaved T-Q@C-term; missed K-A@1 0.29483500123024 2401.50024414063 801.5073 2401.20532226563 801.409057617188 3 14 1.1.1.4580.8 1 70.6993 1684.418 70.6617 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 81.9000005722046 KAGTELVNFLSYFVELGTQPAT Deamidated(Q)@19; Oxidation(P)@20 cleaved T-Q@C-term; missed K-A@1 0.29483500123024 2401.50024414063 801.5073 2401.20532226563 801.409057617188 3 14 1.1.1.4587.5 1 70.8811 1684.418 70.6617 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 74.4599997997284 KAGTELVNFLSYFVELGTQPAT reduced acrolein addition +58(K)@1; Dehydrated(T)@4; Deamidated(N)@8 cleaved T-Q@C-term; missed K-A@1 0.260464012622833 2425.50219726563 809.508 2425.24169921875 809.421203613281 3 14 1.1.1.4627.10 1 71.9378 111.8531 71.9197 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 56.92999958992 KAGTELVNFLSYFVELGTQPAT Cation:Na(E)@15 cleaved T-Q@C-term; missed K-A@1 0.247204005718231 2406.45556640625 803.1591 2406.20825195313 803.076721191406 3 13 1.1.1.4596.4 1 71.1116 1983.004 70.8412 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 51.9599974155426 KAGTELVNFLSYFVELGTQPAT Cation:K(E)@15 cleaved T-Q@C-term; missed K-A@1 0.295469999313354 2422.47778320313 606.6267 2422.18237304688 606.552856445313 4 10 1.1.1.4584.4 1 70.7961 220.9535 70.8153 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 44.3599998950958 KAGTELVNFLSYFVELGTQPAT Deamidated(N)@8; Oxidation(Y)@12 cleaved T-Q@C-term; missed K-A@1 0.29483500123024 2401.50024414063 801.5073 2401.20532226563 801.409057617188 3 13 1.1.1.4585.9 1 70.8262 1684.418 70.6617 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 30.9700012207031 KAGTELVNFLSYFVELGTQPAT Cation:K(E)@15 cleaved T-Q@C-term; missed K-A@1 0.249035999178886 2422.43139648438 808.4844 2422.18237304688 808.4013671875 3 10 1.1.1.4592.12 1 71.0108 914.7953 70.7383 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 22.4199995398521 KAGTELVNFLSYFVELGTQPAT Cation:Na(E)@15 cleaved T-Q@C-term; missed K-A@1 0.180445000529289 2406.38940429688 1204.202 2406.20825195313 1204.11145019531 2 10 1.1.1.4572.12 1 70.5024 772.6986 70.6617 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.253823012113571 2512.53881835938 838.5202 2512.28491210938 838.435607910156 3 21 1.1.1.4471.6 1 67.906 438.0038 67.8216 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.247231006622314 2512.5322265625 838.518 2512.28491210938 838.435607910156 3 15 1.1.1.4549.7 1 69.9127 52160.53 70.1646 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.311426997184753 2512.59643554688 629.1564 2512.28491210938 629.078491210938 4 14 1.1.1.4552.3 1 69.9893 13687.04 70.1887 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.251626014709473 2512.53662109375 838.5195 2512.28491210938 838.435607910156 3 28 1.1.1.4556.5 1 70.099 64474.82 70.2367 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.307033002376556 2512.59204101563 629.1553 2512.28491210938 629.078491210938 4 19 1.1.1.4559.2 1 70.1703 14004.4 70.2125 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.307033002376556 2512.59204101563 629.1553 2512.28491210938 629.078491210938 4 19 1.1.1.4566.3 1 70.3396 14004.4 70.2125 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.251626014709473 2512.53662109375 838.5195 2512.28491210938 838.435607910156 3 29 1.1.1.4566.5 1 70.3429 64474.82 70.2367 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.307033002376556 2512.59204101563 629.1553 2512.28491210938 629.078491210938 4 19 1.1.1.4573.8 1 70.519 12303.63 70.2609 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.251626014709473 2512.53662109375 838.5195 2512.28491210938 838.435607910156 3 29 1.1.1.4573.14 1 70.524 57464.04 70.2609 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.251626014709473 2512.53662109375 838.5195 2512.28491210938 838.435607910156 3 29 1.1.1.4580.10 1 70.7026 17137.74 70.4328 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.319972008466721 2512.60498046875 629.1585 2512.28491210938 629.078491210938 4 13 1.1.1.4585.6 1 70.8236 385.9875 70.8153 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.247598007321358 2512.53247070313 838.5181 2512.28491210938 838.435607910156 3 29 1.1.1.4587.6 1 70.8844 3948.207 70.6112 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.251626014709473 2512.53662109375 838.5195 2512.28491210938 838.435607910156 3 28 1.1.1.4594.14 1 71.0657 1630.181 70.9974 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.318751007318497 2512.60375976563 629.1582 2512.28491210938 629.078491210938 4 12 1.1.1.4595.5 1 71.0841 237.8003 70.9974 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.251626014709473 2512.53662109375 838.5195 2512.28491210938 838.435607910156 3 26 1.1.1.4601.9 1 71.2461 1670.215 70.9707 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.252357989549637 2512.53735351563 838.5197 2512.28491210938 838.435607910156 3 28 1.1.1.4608.9 1 71.4356 900.4434 71.4702 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.252357989549637 2512.53735351563 838.5197 2512.28491210938 838.435607910156 3 25 1.1.1.4615.7 1 71.6151 887.6703 71.5762 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.306055992841721 2512.59106445313 629.155 2512.28491210938 629.078491210938 4 13 1.1.1.4621.7 1 71.7751 80.8913 71.761 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.251626014709473 2512.53662109375 838.5195 2512.28491210938 838.435607910156 3 26 1.1.1.4622.5 1 71.8009 799.8635 71.734 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.246865004301071 2512.53173828125 838.5179 2512.28491210938 838.435607910156 3 23 1.1.1.4629.8 1 71.9839 692.7034 71.9738 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.243019998073578 2512.52807617188 838.5166 2512.28491210938 838.435607910156 3 25 1.1.1.4636.8 1 72.1693 670.2222 72.0794 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.246865004301071 2512.53173828125 838.5179 2512.28491210938 838.435607910156 3 13 1.1.1.4643.13 1 72.3588 666.9706 72.0794 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.24668200314045 2512.53173828125 838.5178 2512.28491210938 838.435607910156 3 15 1.1.1.4650.15 1 72.5465 345.2683 72.4768 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.253457009792328 2512.53833007813 838.5201 2512.28491210938 838.435607910156 3 21 1.1.1.4657.13 1 72.729 376.6444 72.7674 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.25858399271965 2512.54345703125 838.5218 2512.28491210938 838.435607910156 3 16 1.1.1.4665.11 1 72.9403 269.3792 72.9001 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.252357989549637 2512.53735351563 838.5197 2512.28491210938 838.435607910156 3 18 1.1.1.4690.9 1 73.5858 276.5544 73.6273 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ reduced acrolein addition +58(K)@1 missed K-A@1 0.21848900616169 2570.54541015625 857.8557 2570.32690429688 857.782897949219 3 20 1.1.1.4781.13 1 75.8446 277.9376 75.8564 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ Deamidated(N)@8 missed K-A@1 0.249605000019073 2513.5185546875 838.8468 2513.26904296875 838.763610839844 3 19 1.1.1.4361.7 1 65.1683 232.3781 65.1269 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ acrolein addition +56(K)@1 missed K-A@1 0.223823994398117 2568.53491210938 857.1856 2568.31127929688 857.111022949219 3 12 1.1.1.4556.6 1 70.1015 1763.285 70.0616 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ Cation:K@C-term missed K-A@1 0.246184006333351 2550.48706054688 851.1696 2550.24072265625 851.087585449219 3 30 1.1.1.4555.9 1 70.0752 1651.522 70.2367 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ Cation:K(E)@15 missed K-A@1 0.246184006333351 2550.48706054688 851.1696 2550.24072265625 851.087585449219 3 31 1.1.1.4563.5 1 70.2801 1651.522 70.2367 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ reduced acrolein addition +58(K)@1; Dehydrated(T)@4; Deamidated(N)@8 missed K-A@1 0.262006014585495 2553.56225585938 852.1947 2553.30029296875 852.107360839844 3 29 1.1.1.4577.15 1 70.6264 4406.89 70.6617 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ reduced acrolein addition +58(K)@1; Dehydrated(T)@4; Deamidated(N)@8 missed K-A@1 0.262006014585495 2553.56225585938 852.1947 2553.30029296875 852.107360839844 3 31 1.1.1.4584.9 1 70.8036 4406.89 70.6617 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ reduced acrolein addition +58(K)@1; Dimethyl(N)@8 missed K-A@1 0.21679100394249 2598.57495117188 867.1989 2598.35815429688 867.126647949219 3 27 1.1.1.4804.7 1 76.45 1474.432 76.4602 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ reduced acrolein addition +58(K)@1; Ammonia-loss(N)@8 missed K-A@1 0.262555003166199 2553.56274414063 852.1949 2553.30029296875 852.107360839844 3 21 1.1.1.4591.11 1 70.9839 4448.285 70.7127 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ Carboxy(E)@15 missed K-A@1 0.231095999479294 2556.505859375 853.1759 2556.27490234375 853.098876953125 3 20 1.1.1.4555.10 1 70.0769 520.497 70.1141 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ Cation:K(E)@15 missed K-A@1 0.305741012096405 2550.54663085938 638.6439 2550.24072265625 638.567504882813 4 20 1.1.1.4557.5 1 70.1241 476.4482 70.1408 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KAGTELVNFLSYFVELGTQPATQ reduced acrolein addition +58(K)@1; Dehydrated(T)@4; Deamidated(N)@8 missed K-A@1 0.26383700966835 2553.56420898438 852.1953 2553.30029296875 852.107360839844 3 20 1.1.1.4599.11 1 71.196 1382.495 70.9187 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.8499999046326 KAGTELVNFLSYFVELGTQPATQ Deamidated(Q)@19; Oxidation(P)@20 missed K-A@1 0.296927005052567 2529.56079101563 844.1942 2529.26391601563 844.09521484375 3 19 1.1.1.4570.9 1 70.443 1972.09 70.2367 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.6999988555908 KAGTELVNFLSYFVELGTQPATQ Carboxy(E)@15 missed K-A@1 0.22120800614357 2556.49609375 853.1726 2556.27490234375 853.098876953125 3 19 1.1.1.4562.4 1 70.2558 847.2742 70.2367 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.3900010585785 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 -1.2260400056839 2511.05883789063 838.0269 2512.28491210938 838.435607910156 3 18 1.1.1.4751.11 1 75.09 1132.054 75.1768 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.869998216629 KAGTELVNFLSYFVELGTQPATQ reduced acrolein addition +58(K)@1; Dehydrated(T)@4; Deamidated(N)@8 missed K-A@1 0.322234004735947 2553.62255859375 639.4129 2553.30029296875 639.332336425781 4 18 1.1.1.4577.9 1 70.6213 1302.184 70.6872 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 96.8999981880188 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 -0.623618006706238 2511.66137695313 838.2277 2512.28491210938 838.435607910156 3 17 1.1.1.4727.6 1 74.5063 933.0922 74.5197 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 92.5999999046326 KAGTELVNFLSYFVELGTQPATQ Deamidated(Q)@19; Oxidation(P)@20 missed K-A@1 0.296927005052567 2529.56079101563 844.1942 2529.26391601563 844.09521484375 3 16 1.1.1.4555.8 1 70.0735 1972.09 70.2367 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 92.5999999046326 KAGTELVNFLSYFVELGTQPATQ Deamidated(Q)@19; Oxidation(P)@20 missed K-A@1 0.296927005052567 2529.56079101563 844.1942 2529.26391601563 844.09521484375 3 16 1.1.1.4562.3 1 70.25 1972.09 70.2367 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 91.5499985218048 KAGTELVNFLSYFVELGTQPATQ Carboxyethyl(K)@1 missed K-A@1 0.253385007381439 2584.5595703125 862.5271 2584.30615234375 862.442626953125 3 22 1.1.1.4791.19 1 76.113 1797.405 76.1723 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 91.1700010299683 KAGTELVNFLSYFVELGTQPATQ reduced acrolein addition +58(K)@1; Dehydrated(T)@4; Deamidated(N)@8 missed K-A@1 0.262006014585495 2553.56225585938 852.1947 2553.30029296875 852.107360839844 3 16 1.1.1.4573.15 1 70.5248 4406.89 70.6617 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 89.92999792099 KAGTELVNFLSYFVELGTQPATQ reduced acrolein addition +58(K)@1; Dehydrated(T)@4; Deamidated(N)@8 missed K-A@1 0.322234004735947 2553.62255859375 639.4129 2553.30029296875 639.332336425781 4 16 1.1.1.4584.5 1 70.7969 1302.184 70.6872 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 88.5299980640411 KAGTELVNFLSYFVELGTQPATQ Cation:K(E)@15 missed K-A@1 0.246184006333351 2550.48706054688 851.1696 2550.24072265625 851.087585449219 3 15 1.1.1.4570.11 1 70.4447 1651.522 70.2367 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 87.5100016593933 KAGTELVNFLSYFVELGTQPATQ reduced acrolein addition +58(K)@1; Dehydrated(T)@4; Deamidated(N)@8 missed K-A@1 0.327116996049881 2553.62744140625 639.4141 2553.30029296875 639.332336425781 4 14 1.1.1.4592.7 1 71.0066 1261.986 70.7383 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 84.6099972724915 KAGTELVNFLSYFVELGTQPATQ reduced acrolein addition +58(K)@1; Ammonia-loss(N)@8 missed K-A@1 0.262006014585495 2553.56225585938 852.1947 2553.30029296875 852.107360839844 3 15 1.1.1.4594.15 1 71.0674 3938.825 70.7899 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 81.9000005722046 KAGTELVNFLSYFVELGTQPATQ Cation:Na@C-term missed K-A@1 0.302870988845825 2534.56982421875 634.6497 2534.26684570313 634.573974609375 4 18 1.1.1.4569.2 1 70.4127 923.8417 70.2367 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 81.9000005722046 KAGTELVNFLSYFVELGTQPATQ Cation:Na(E)@15 missed K-A@1 0.238858997821808 2534.505859375 845.8425 2534.26684570313 845.762939453125 3 21 1.1.1.4578.13 1 70.6499 274.0752 70.6364 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 56.92999958992 KAGTELVNFLSYFVELGTQPATQ Cation:Na(E)@15 missed K-A@1 0.302870988845825 2534.56982421875 634.6497 2534.26684570313 634.573974609375 4 21 1.1.1.4562.2 1 70.2442 923.8417 70.2367 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 51.9599974155426 KAGTELVNFLSYFVELGTQPATQ Cation:Na(E)@15 missed K-A@1 0.249295994639397 2534.51611328125 845.846 2534.26684570313 845.762939453125 3 24 1.1.1.4554.5 1 70.0465 6160.309 70.2367 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 51.9599974155426 KAGTELVNFLSYFVELGTQPATQ Cation:Na(E)@15 missed K-A@1 0.24966199696064 2534.5166015625 845.8461 2534.26684570313 845.762939453125 3 27 1.1.1.4569.7 1 70.4211 6175.117 70.2367 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 50.6900012493134 KAGTELVNFLSYFVELGTQPATQ Cation:Na(E)@15 missed K-A@1 0.24966199696064 2534.5166015625 845.8461 2534.26684570313 845.762939453125 3 28 1.1.1.4561.5 1 70.225 6175.117 70.2367 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 45.6299990415573 KAGTELVNFLSYFVELGTQPATQ Deamidated(N)@8; Cation:Na(E)@15 missed K-A@1 0.327645003795624 2535.57861328125 634.9019 2535.2509765625 634.820007324219 4 13 1.1.1.4555.4 1 70.0694 898.9826 70.1408 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 45.6299990415573 KAGTELVNFLSYFVELGTQPATQ Deamidated(N)@8; Cation:Na(E)@15 missed K-A@1 0.258260995149612 2535.50927734375 846.177 2535.2509765625 846.090942382813 3 13 1.1.1.4570.10 1 70.4438 3747.936 70.2367 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 41.839998960495 KAGTELVNFLSYFVELGTQPATQ Cation:K(E)@15; Oxidation(P)@20 missed K-A@1 0.284458994865417 2566.52026367188 642.6373 2566.23583984375 642.566223144531 4 13 1.1.1.4554.2 1 70.0415 1073.818 70.1408 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 30.9700012207031 KAGTELVNFLSYFVELGTQPATQ missed K-A@1 0.180947005748749 2512.4658203125 838.4959 2512.28491210938 838.435607910156 3 14 1.1.1.4462.7 1 67.6809 912.7739 67.5497 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 20.4999998211861 KAGTELVNFLSYFVELGTQPATQ reduced acrolein addition +58(K)@1; Dehydrated(T)@4; Deamidated(N)@8 missed K-A@1 0.261640012264252 2553.56201171875 852.1946 2553.30029296875 852.107360839844 3 11 1.1.1.4570.12 1 70.4455 4258.998 70.6617 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 79.2400002479553 KDLMEKVKSPELQAEAKSYFEKSKEQLTPLIKKAGTELVNFLSYFVELGTQPATQ acrolein addition +38(K)@1; hexanoyl addition +98(K)@8; hexanoyl addition +98(K)@32; reduced acrolein addition +96(K)@33 cleaved G-K@N-term; missed K-D@1; missed K-V@6; missed K-S@8; missed K-S@17; missed K-S@22; missed K-E@24; missed K-K@32; missed K-A@33 0.434864014387131 6559.94873046875 1094.332 6559.5107421875 1094.25903320313 6 18 1.1.1.4733.10 0 74.6548 7337.119 74.6407 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KEPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@4 cleaved A-K@N-term; missed K-E@1; missed K-D@21 0.330309003591537 3093.7978515625 774.4567 3093.46752929688 774.374145507813 4 26 1.1.1.4307.7 1 63.7555 1375.545 63.7722 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KEPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@4 cleaved A-K@N-term; missed K-E@1; missed K-D@21 -7.80548000335693 3085.66137695313 1029.561 3093.46752929688 1032.1630859375 3 19 1.1.1.4387.4 1 65.8354 1177.609 65.913 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KEPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@4 cleaved A-K@N-term; missed K-E@1; missed K-D@21 -7.80768013000488 3085.66137695313 1029.561 3093.46752929688 1032.1630859375 3 18 1.1.1.4395.3 1 66.0096 966.8312 66.0146 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KEPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@4 cleaved A-K@N-term; missed K-E@1; missed K-D@21 -7.81243991851807 3085.65502929688 1029.559 3093.46752929688 1032.1630859375 3 18 1.1.1.4402.5 1 66.1748 873.8372 66.1109 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.9200005531311 KEPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@4 cleaved A-K@N-term; missed K-E@1; missed K-D@21 -7.80108976364136 3085.66723632813 1029.563 3093.46752929688 1032.1630859375 3 19 1.1.1.4437.8 1 67.072 2256.189 66.978 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 96.8299984931946 KEPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@4 cleaved A-K@N-term; missed K-E@1; missed K-D@21 -7.80108976364136 3085.66723632813 1029.563 3093.46752929688 1032.1630859375 3 17 1.1.1.4430.12 1 66.8877 2255.409 66.978 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 81.9999992847443 KEPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@4 cleaved A-K@N-term; missed K-E@1; missed K-D@21 -7.72950983047485 3085.73803710938 772.4418 3093.46752929688 774.374145507813 4 15 1.1.1.4433.3 1 66.9579 575.5794 66.978 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 28.7099987268448 KEPCVESLVSQYFQTVTDYGKDLMEK hexanoyl addition +98(K)@1; Carbamidomethyl(C)@4; Deamidated(Q)@11 cleaved A-K@N-term; missed K-E@1; missed K-D@21 0.290293008089066 3192.8154296875 1065.279 3192.52465820313 1065.18212890625 3 12 1.1.1.4437.9 1 67.0745 820.6586 67.1825 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.089998960495 KEPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@4 cleaved A-K@N-term; missed K-E@1; missed K-D@21; missed K-V@26 0.340516000986099 3320.97143554688 831.2501 3320.630859375 831.164978027344 4 20 1.1.1.4359.4 1 65.1101 588.9901 65.1801 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 94.9699997901917 KEPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@4 cleaved A-K@N-term; missed K-E@1; missed K-D@21; missed K-V@26 -7.73198986053467 3312.89892578125 829.232 3320.630859375 831.164978027344 4 18 1.1.1.4483.3 1 68.224 1745.164 68.1065 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 92.2699987888336 KEPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@4 cleaved A-K@N-term; missed K-E@1; missed K-D@21; missed K-V@26 -7.73198986053467 3312.89892578125 829.232 3320.630859375 831.164978027344 4 17 1.1.1.4476.5 1 68.0416 1745.164 68.1065 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 91.5499985218048 KEPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@4 cleaved A-K@N-term; missed K-E@1; missed K-D@21; missed K-V@26 -7.73516988754272 3312.89575195313 829.2312 3320.630859375 831.164978027344 4 17 1.1.1.4511.4 1 68.9514 2351.438 68.8866 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 78.8299977779388 KEPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@4 cleaved A-K@N-term; missed K-E@1; missed K-D@21; missed K-V@26 -7.73516988754272 3312.89575195313 829.2312 3320.630859375 831.164978027344 4 15 1.1.1.4504.8 1 68.7701 2351.438 68.8866 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@4 cleaved A-K@N-term; missed K-E@1; missed K-D@21; missed K-V@26; missed K-S@28 0.482946991920471 4274.595703125 713.4399 4274.11279296875 713.359375 6 20 1.1.1.4345.5 1 64.7405 617.7161 64.6283 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 KEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@4 cleaved A-K@N-term; missed K-E@1; missed K-D@21; missed K-V@26; missed K-S@28 0.482946991920471 4274.595703125 713.4399 4274.11279296875 713.359375 6 17 1.1.1.4338.3 1 64.5554 617.7161 64.6283 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 96.6799974441528 KEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK HPNE addition +172(K)@1; Carbamidomethyl(C)@4; Deamidated(Q)@11 cleaved A-K@N-term; missed K-E@1; missed K-D@21; missed K-V@26; missed K-S@28 0.277440994977951 4447.48291015625 1112.878 4447.20654296875 1112.80895996094 4 17 1.1.1.4658.18 1 72.7624 1002.26 72.794 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 70.5600023269653 KEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK hexanoyl addition +98(K)@1; Carbamidomethyl(C)@4; Deamidated(Q)@14 cleaved A-K@N-term; missed K-E@1; missed K-D@21; missed K-V@26; missed K-S@28 0.385998010635376 4373.5546875 1094.396 4373.169921875 1094.29968261719 4 14 1.1.1.4461.10 1 67.6628 534.6797 67.6483 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 55.6999981403351 KKAGTELVNFLSYFVELGTQPATQ reduced acrolein addition +58(K)@1; acrolein addition +94(K)@2 cleaved I-K@N-term; missed K-K@1; missed K-A@2 0.208003997802734 2792.67163085938 931.8978 2792.46362304688 931.828491210938 3 12 1.1.1.4566.6 1 70.3454 1028.683 70.2851 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 20.4999998211861 LAATVLLLTICSLEGALVRRQAKEPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@11; Carbamidomethyl(C)@26 cleaved L-L@N-term; missed R-R@19; missed R-Q@20; missed K-E@23; missed K-D@43 -13.8227996826172 5429.00146484375 905.8408 5442.82421875 908.144653320313 6 14 1.1.1.4550.9 1 69.9461 409.0396 69.9561 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 50.0599980354309 PCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@2; Deamidated(Q)@12; ONE addition +154(K)@19; HPNE addition +172(K)@24; ONE addition +154(K)@26 cleaved E-P@N-term; missed K-D@19; missed K-V@24; missed K-S@26 0.260672003030777 4498.52685546875 1125.639 4498.26806640625 1125.57421875 4 13 1.1.1.4624.10 1 71.8599 968.0157 71.734 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23 0.337785989046097 3291.86938476563 823.9746 3291.53149414063 823.89013671875 4 23 1.1.1.4297.10 1 63.4971 337.3952 63.5114 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23 0.336425006389618 3292.89965820313 824.2322 3292.56323242188 824.148071289063 4 24 1.1.1.4313.6 1 63.9106 1831.204 63.9019 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23 0.341978013515472 3275.87866210938 819.9769 3275.53662109375 819.891418457031 4 18 1.1.1.4430.3 1 66.8794 1591.356 67.0044 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Gln->pyro-Glu@N-term; Carbamidomethyl(E)@4; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23 0.341998010873795 3332.90014648438 834.2323 3332.55810546875 834.146789550781 4 25 1.1.1.4434.4 1 66.9877 411.6469 66.978 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23 0.341978013515472 3275.87866210938 819.9769 3275.53662109375 819.891418457031 4 29 1.1.1.4437.3 1 67.0636 1600.975 67.0044 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23 0.273081988096237 3275.81005859375 1092.944 3275.53662109375 1092.85278320313 3 35 1.1.1.4437.10 1 67.077 4405.977 67.0044 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23 0.259227991104126 3316.8232421875 1106.615 3316.56323242188 1106.5283203125 3 25 1.1.1.4438.15 1 67.0981 4987.134 67.2067 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23 0.322508990764618 3316.8857421875 830.2287 3316.56323242188 830.148071289063 4 24 1.1.1.4444.2 1 67.2383 4820.29 67.3279 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23 0.260327011346817 3316.8232421875 1106.615 3316.56323242188 1106.5283203125 3 30 1.1.1.4445.7 1 67.274 6116.314 67.3279 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23 0.260327011346817 3316.8232421875 1106.615 3316.56323242188 1106.5283203125 3 24 1.1.1.4452.12 1 67.4384 6116.314 67.3279 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Methyl+Deamidated(Q)@1; MDA adduct +54(K)@3; Carbamidomethyl(C)@6; Oxidation(K)@28 missed K-E@3; missed K-D@23 0.252007991075516 3377.8193359375 1126.947 3377.568359375 1126.86340332031 3 23 1.1.1.4629.20 1 71.9948 468.9104 72.1058 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Gln->pyro-Glu@N-term; acrolein addition +76(K)@3; Oxidation(P)@5; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23 0.233196005225182 3367.79614257813 1123.606 3367.56274414063 1123.52819824219 3 20 1.1.1.4440.12 1 67.1515 2676.266 67.2067 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEK Deamidated(Q)@1; reduced acrolein addition +58(K)@3; Oxidation(P)@5; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23 0.219024002552032 3367.80224609375 1123.608 3367.583984375 1123.53527832031 3 20 1.1.1.4447.16 1 67.3212 1204.544 67.3034 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.1500029563904 QAKEPCVESLVSQYFQTVTDYGKDLMEK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23 0.26069301366806 3316.8232421875 1106.615 3316.56323242188 1106.5283203125 3 19 1.1.1.4459.7 1 67.6134 5726.143 67.377 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.869998216629 QAKEPCVESLVSQYFQTVTDYGKDLMEK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23 0.32055601477623 3316.8837890625 830.2282 3316.56323242188 830.148071289063 4 19 1.1.1.4437.4 1 67.0653 4423.313 67.3034 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 96.8999981880188 QAKEPCVESLVSQYFQTVTDYGKDLMEK Gln->pyro-Glu@N-term; Carbamidomethyl(K)@3; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23 0.272125989198685 3332.83129882813 1111.951 3332.55810546875 1111.85998535156 3 17 1.1.1.4436.7 1 67.0489 949.0412 66.978 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 95.3000009059906 QAKEPCVESLVSQYFQTVTDYGKDLMEK Gln->pyro-Glu@N-term; Formyl(K)@3; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23 0.277924001216888 3303.80908203125 1102.277 3303.53149414063 1102.18444824219 3 17 1.1.1.4626.14 1 71.9146 203.6215 71.9197 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 86.710000038147 QAKEPCVESLVSQYFQTVTDYGKDLMEK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23 0.263274997472763 3291.79418945313 1098.272 3291.53149414063 1098.18444824219 3 14 1.1.1.4303.19 1 63.661 1138.237 63.6158 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 81.5100014209747 QAKEPCVESLVSQYFQTVTDYGKDLMEK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23 0.338030010461807 3291.86962890625 823.9747 3291.53149414063 823.89013671875 4 13 1.1.1.4304.8 1 63.6782 294.3747 63.6678 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 73.5199987888336 QAKEPCVESLVSQYFQTVTDYGKDLMEK Gln->pyro-Glu@N-term; Trimethyl(K)@3; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23 0.278425991535187 3317.86206054688 830.4728 3317.58349609375 830.403198242188 4 24 1.1.1.4633.10 1 72.0924 452.9729 72.0794 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 45.6299990415573 QAKEPCVESLVSQYFQTVTDYGKDLMEK Gln->pyro-Glu@N-term; Trimethyl(K)@3; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23 0.219539999961853 3317.80419921875 1106.942 3317.58349609375 1106.86853027344 3 13 1.1.1.4636.13 1 72.1768 1147.949 72.0532 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK acrolein addition +76(K)@3; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28 0.290672987699509 3596.04858398438 900.0194 3595.7578125 899.946716308594 4 16 1.1.1.4518.2 1 69.1197 1005.955 69.0645 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Gln->pyro-Glu@N-term; Carbamidomethyl(K)@3; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28 0.342684000730515 3560.06420898438 891.0233 3559.72143554688 890.937622070313 4 29 1.1.1.4502.9 1 68.7175 1111.463 68.8333 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28 0.340954005718231 3503.041015625 876.7675 3502.69995117188 876.682250976563 4 28 1.1.1.4503.7 1 68.7396 6738.132 68.8599 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Gln->pyro-Glu@N-term; Carbamidomethyl(K)@3; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28 0.342684000730515 3560.06420898438 891.0233 3559.72143554688 890.937622070313 4 28 1.1.1.4509.10 1 68.8994 1111.463 68.8333 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28 0.340954005718231 3503.041015625 876.7675 3502.69995117188 876.682250976563 4 30 1.1.1.4510.14 1 68.9288 6738.132 68.8599 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28 0.395080000162125 3544.12158203125 709.8316 3543.7265625 709.752563476563 5 26 1.1.1.4512.3 1 68.9713 2230.931 69.113 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28 -0.644397020339966 3502.0556640625 876.5212 3502.69995117188 876.682250976563 4 26 1.1.1.4517.8 1 69.108 549.6277 69.0645 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28 0.325635999441147 3544.05224609375 887.0203 3543.7265625 886.938903808594 4 28 1.1.1.4519.4 1 69.1447 9218.911 69.0888 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28 0.395080000162125 3544.12158203125 709.8316 3543.7265625 709.752563476563 5 25 1.1.1.4520.2 1 69.1722 2230.931 69.113 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28 0.325635999441147 3544.05224609375 887.0203 3543.7265625 886.938903808594 4 29 1.1.1.4527.9 1 69.3411 9557.744 69.0888 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28 0.325635999441147 3544.05224609375 887.0203 3543.7265625 886.938903808594 4 22 1.1.1.4510.15 1 68.9296 9218.911 69.0888 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28 0.334809005260468 3519.02978515625 880.7647 3518.69482421875 880.681030273438 4 17 1.1.1.4296.6 1 63.4671 550.5202 63.537 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(M)@26 missed K-E@3; missed K-D@23; missed K-V@28 0.336273998022079 3519.03125 880.7651 3518.69482421875 880.681030273438 4 17 1.1.1.4305.4 1 63.701 695.0646 63.7985 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Gln->pyro-Glu@N-term; Oxidation(P)@5; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28 0.320405006408691 3519.01538085938 880.7611 3518.69482421875 880.681030273438 4 20 1.1.1.4689.10 1 73.561 154.4734 73.5238 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.8499999046326 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Gln->pyro-Glu@N-term; acrolein addition +76(K)@3; Oxidation(P)@5; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28 0.314251005649567 3595.04052734375 899.7674 3594.72631835938 899.688842773438 4 19 1.1.1.4512.12 1 68.9788 1259.481 69.0401 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 93.8199996948242 QAKEPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28 -4.70195007324219 3515.02465820313 879.7634 3519.7265625 880.938903808594 4 17 1.1.1.4515.8 1 69.0527 285.4929 69.0401 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 38.730001449585 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQ Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; HPNE addition +172(K)@23; HPNE addition +172(K)@28; reduced acrolein addition +96(K)@30 cleaved Q-A@C-term; missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.377617001533508 4497.625 900.5323 4497.24755859375 900.456787109375 5 12 1.1.1.4487.12 1 68.3319 492.4759 68.2642 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.402893006801605 4456.58447265625 892.3242 4456.181640625 892.24365234375 5 20 1.1.1.4438.9 1 67.0931 12762.08 67.3279 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.403198003768921 4456.5849609375 892.3243 4456.181640625 892.24365234375 5 37 1.1.1.4445.4 1 67.2648 13181.31 67.3279 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.403198003768921 4456.5849609375 892.3243 4456.181640625 892.24365234375 5 39 1.1.1.4452.8 1 67.4351 13181.31 67.3279 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.477768987417221 4456.65966796875 743.7839 4456.181640625 743.704223632813 6 25 1.1.1.4453.3 1 67.4575 1684.4 67.3034 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.347669005393982 4456.53076171875 1115.14 4456.181640625 1115.052734375 4 29 1.1.1.4444.4 1 67.25 1652.217 67.3279 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.413331001996994 4497.62158203125 900.5316 4497.20849609375 900.448974609375 5 28 1.1.1.4450.3 1 67.3878 5404.238 67.5747 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.48735299706459 4497.69580078125 750.6232 4497.20849609375 750.5419921875 6 24 1.1.1.4458.3 1 67.5792 1281.461 67.5747 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.411742985248566 4456.59375 892.326 4456.181640625 892.24365234375 5 30 1.1.1.4459.3 1 67.605 10854.81 67.3523 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.481128007173538 4497.689453125 750.6222 4497.20849609375 750.5419921875 6 24 1.1.1.4465.3 1 67.7534 1344.142 67.6729 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.415771991014481 4497.6240234375 900.5321 4497.20849609375 900.448974609375 5 31 1.1.1.4469.13 1 67.8604 6389.761 67.6729 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; Oxidation(Y)@21 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 -0.582256019115448 4471.59423828125 895.3262 4472.1767578125 895.442626953125 5 19 1.1.1.4257.8 1 62.4772 1211.683 62.6196 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.497240990400314 4473.70556640625 746.6249 4473.20849609375 746.5419921875 6 19 1.1.1.4346.4 1 64.7659 1290.973 64.7329 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK acrolein addition +76(K)@3; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 -0.643543004989624 4548.59619140625 910.7265 4549.23974609375 910.855224609375 5 20 1.1.1.4459.5 1 67.6084 1612.048 67.5497 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.470002412796 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.347669005393982 4456.53076171875 1115.14 4456.181640625 1115.052734375 4 18 1.1.1.4452.13 1 67.4392 1652.217 67.3279 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.5499987602234 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Methyl+Deamidated(Q)@1; MDA adduct +54(K)@3; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.332861989736557 4542.55078125 1136.645 4542.21875 1136.56188964844 4 18 1.1.1.4694.20 1 73.6998 1285.008 73.7561 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.0399975776672 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.347669005393982 4456.53076171875 1115.14 4456.181640625 1115.052734375 4 16 1.1.1.4442.5 1 67.1982 1652.217 67.3279 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 94.6099996566772 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK acrolein addition +76(K)@3; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 -0.645678997039795 4548.59375 910.7261 4549.23974609375 910.855224609375 5 16 1.1.1.4449.12 1 67.3653 1505.118 67.451 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 94.6099996566772 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@3; Carbamidomethyl(C)@6; Dehydrated(S)@9 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.396616995334625 4496.60986328125 900.3292 4496.212890625 900.249877929688 5 17 1.1.1.4461.5 1 67.6545 3999.083 67.6729 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 86.9700014591217 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; HPNE addition +172(K)@23; HPNE addition +172(K)@28; reduced acrolein addition +58(K)@30 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.327113002538681 4858.7705078125 972.7614 4858.443359375 972.695983886719 5 13 1.1.1.4451.7 1 67.4094 346.192 67.3279 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 82.6099991798401 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Gln->pyro-Glu@N-term; reduced acrolein addition +58(K)@3; Carbamidomethyl(C)@6; Dehydrated(S)@9 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 -0.66312301158905 4495.55078125 1124.895 4496.212890625 1125.060546875 4 16 1.1.1.4466.9 1 67.7881 580.0811 67.5497 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 51.9599974155426 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Methyl+Deamidated(Q)@1; MDA adduct +54(K)@3; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.40004900097847 4542.61865234375 909.531 4542.21875 909.450988769531 5 14 1.1.1.4695.12 1 73.7185 698.0496 73.7823 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 30.9700012207031 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK acrolein addition +76(K)@3; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 -0.709204018115997 4548.53076171875 1138.14 4549.23974609375 1138.31713867188 4 11 1.1.1.4462.15 1 67.6893 550.9946 67.6483 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 20.4999998211861 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6; acrolein addition +56(K)@23; Dethiomethyl(M)@26 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30 0.407086998224258 4464.61181640625 893.9296 4464.20458984375 893.848205566406 5 12 1.1.1.4473.7 1 67.9591 591.236 67.9497 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAKSYFEK Gln->pyro-Glu@N-term; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30; missed K-S@39 0.479665011167526 5110.962890625 852.8344 5110.48291015625 852.754455566406 6 18 1.1.1.4458.5 1 67.5809 911.0645 67.6977 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 39.3500000238419 QAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAKSYFEK Acetyl@N-term; Dehydrated(E)@4; Carbamidomethyl(C)@6 missed K-E@3; missed K-D@23; missed K-V@28; missed K-S@30; missed K-S@39 0.494376003742218 5152.00390625 859.6746 5151.509765625 859.592224121094 6 14 1.1.1.4472.6 1 67.9362 335.3473 67.9758 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SKEQLTPLIK missed K-E@2 0.152150005102158 1155.83850097656 578.9265 1155.68627929688 578.850463867188 2 17 1.1.1.2922.8 1 29.9734 2389.063 30.0337 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SKEQLTPLIK missed K-E@2 0.154714003205299 1155.84106445313 578.9278 1155.68627929688 578.850463867188 2 17 1.1.1.2894.10 1 29.3049 1787.461 29.4302 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SKEQLTPLIK missed K-E@2 0.153981000185013 1155.84033203125 578.9274 1155.68627929688 578.850463867188 2 16 1.1.1.2851.6 1 28.2684 27137.27 28.4925 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SKEQLTPLIK missed K-E@2 0.152150005102158 1155.83850097656 578.9265 1155.68627929688 578.850463867188 2 16 1.1.1.2880.9 1 28.9681 1324.597 28.9732 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SKEQLTPLIK missed K-E@2 0.152760997414589 1155.83911132813 578.9268 1155.68627929688 578.850463867188 2 16 1.1.1.2915.6 1 29.8027 1460.825 29.8403 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SKEQLTPLIK missed K-E@2 0.155080005526543 1155.84143066406 578.928 1155.68627929688 578.850463867188 2 16 1.1.1.2929.11 1 30.1443 2177.211 30.251 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.989999294281 SKEQLTPLIK missed K-E@2 0.154102995991707 1155.84045410156 578.9275 1155.68627929688 578.850463867188 2 16 1.1.1.2865.4 1 28.603 27770.99 28.4925 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.9099979400635 SKEQLTPLIK missed K-E@2 0.154102995991707 1155.84045410156 578.9275 1155.68627929688 578.850463867188 2 16 1.1.1.2858.6 1 28.4361 27770.99 28.4925 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.8300025463104 SKEQLTPLIK missed K-E@2 0.154348000884056 1155.84069824219 578.9276 1155.68627929688 578.850463867188 2 16 1.1.1.2872.9 1 28.773 19264.78 28.6601 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.2900023460388 SKEQLTPLIK missed K-E@2 0.154714003205299 1155.84106445313 578.9278 1155.68627929688 578.850463867188 2 15 1.1.1.2901.7 1 29.4682 1787.461 29.4302 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.1500029563904 SKEQLTPLIK missed K-E@2 0.154957994818687 1155.84130859375 578.9279 1155.68627929688 578.850463867188 2 15 1.1.1.2887.8 1 29.134 1473.757 29.1416 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 96.2599992752075 SKEQLTPLIK missed K-E@2 0.155080005526543 1155.84143066406 578.928 1155.68627929688 578.850463867188 2 14 1.1.1.2936.11 1 30.3132 2177.211 30.251 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 94.2200005054474 SKEQLTPLIK Formyl@N-term; reduced acrolein addition +58(K)@2 missed K-E@2 0.160171002149582 1241.88330078125 621.9489 1241.72314453125 621.868835449219 2 15 1.1.1.3712.2 1 49.084 2418.909 48.9772 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 94.0400004386902 SKEQLTPLIK Formyl@N-term; reduced acrolein addition +58(K)@2 missed K-E@2 0.160171002149582 1241.88330078125 621.9489 1241.72314453125 621.868835449219 2 15 1.1.1.3705.3 1 48.9152 2418.909 48.9772 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 92.8699970245361 SKEQLTPLIK Methyl(S)@1; reduced acrolein addition +58(K)@2 missed K-E@2 0.118560999631882 1227.86242675781 614.9385 1227.74389648438 614.879211425781 2 15 1.1.1.3548.6 1 45.0959 1280.985 45.1574 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 57.0900022983551 SKEQLTPLIK reduced acrolein addition +58(K)@2; Deamidated(Q)@4 missed K-E@2 0.0582767985761166 1214.7705078125 608.3925 1214.71215820313 608.363403320313 2 10 1.1.1.3437.5 1 42.367 340.4715 42.3796 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SKEQLTPLIKK Trimethyl(K)@10 missed K-E@2; missed K-K@10 0.122175998985767 1325.95043945313 663.9825 1325.82824707031 663.92138671875 2 16 1.1.1.2953.12 1 30.7265 551.9985 30.7075 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SKEQLTPLIKK missed K-E@2; missed K-K@10 0.151914000511169 1283.93322753906 642.9739 1283.78125 642.89794921875 2 19 1.1.1.2703.8 1 24.7389 17713.5 24.8157 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SKEQLTPLIKK missed K-E@2; missed K-K@10 0.151914000511169 1283.93322753906 642.9739 1283.78125 642.89794921875 2 17 1.1.1.2714.13 1 25.0004 17713.5 24.8157 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SKEQLTPLIKK missed K-E@2; missed K-K@10 0.211897999048233 1283.9931640625 429.005 1283.78125 428.934387207031 3 16 1.1.1.2707.2 1 24.8203 112022.7 24.8157 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 95.2400028705597 SKEQLTPLIKK missed K-E@2; missed K-K@10 0.211897999048233 1283.9931640625 429.005 1283.78125 428.934387207031 3 14 1.1.1.2714.4 1 24.9879 112022.7 24.8157 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 94.5800006389618 SKEQLTPLIKK Formyl(K)@10; reduced acrolein addition +58(K)@11 missed K-E@2; missed K-K@10 0.15956799685955 1369.97766113281 685.9961 1369.81811523438 685.916320800781 2 14 1.1.1.3443.12 1 42.5174 2434.592 42.5015 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 92.8699970245361 SKEQLTPLIKK Formyl(K)@10; reduced acrolein addition +58(K)@11 missed K-E@2; missed K-K@10 0.15956799685955 1369.97766113281 685.9961 1369.81811523438 685.916320800781 2 14 1.1.1.3437.7 1 42.372 2683.503 42.4283 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 81.0999989509583 SKEQLTPLIKK missed K-E@2; missed K-K@10 0.212172999978065 1283.99340820313 429.0051 1283.78125 428.934387207031 3 13 1.1.1.2721.2 1 25.1549 1655.513 25.1504 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 72.8600025177002 SKEQLTPLIKK Ser->LacticAcid(S)@1; acrolein addition +56(K)@2 missed K-E@2; missed K-K@10 0.167603999376297 1324.96423339844 663.4894 1324.79663085938 663.405578613281 2 13 1.1.1.2719.12 1 25.1214 1258.736 25.1265 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 68.0499970912933 SKEQLTPLIKK Formyl@N-term; reduced acrolein addition +58(K)@2 missed K-E@2; missed K-K@10 0.223793998360634 1370.04187011719 457.6879 1369.81811523438 457.613311767578 3 12 1.1.1.3454.4 1 42.7765 3653.738 42.8203 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 60.2400004863739 SKEQLTPLIKK Methyl(K)@10; reduced acrolein addition +58(K)@11 missed K-E@2; missed K-K@10 0.181024998426437 1356.01977539063 453.0139 1355.83874511719 452.953552246094 3 12 1.1.1.3245.5 1 37.7314 16855.18 37.7672 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 94.0999984741211 SLVSQYFQTVTDYGKDLMEKVK cleaved E-S@N-term; missed K-D@15; missed K-V@20 3.97725009918213 2582.27612304688 861.766 2578.298828125 860.440246582031 3 16 1.1.1.4511.5 1 68.9539 391.9914 69.0401 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.1500029563904 SPELQAEAK 0.146087005734444 971.638488769531 486.8265 971.492370605469 486.753479003906 2 15 1.1.1.2654.5 1 23.5521 1916.083 23.5433 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.8500008583069 SPELQAEAK 0.145842999219894 971.638244628906 486.8264 971.492370605469 486.753479003906 2 15 1.1.1.2612.7 1 22.5511 112205.6 22.6358 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.4799990653992 SPELQAEAK 0.145476996898651 971.637878417969 486.8262 971.492370605469 486.753479003906 2 15 1.1.1.2639.5 1 23.1972 2026.172 23.2337 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.0499992370605 SPELQAEAK 0.145049005746841 971.637451171875 486.826 971.492370605469 486.753479003906 2 15 1.1.1.2632.3 1 23.0312 6671.291 22.8985 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.0499992370605 SPELQAEAK 0.148101001977921 971.640502929688 486.8275 971.492370605469 486.753479003906 2 13 1.1.1.2704.3 1 24.7495 479.6258 24.744 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 96.8100011348724 SPELQAEAK 0.145842999219894 971.638244628906 486.8264 971.492370605469 486.753479003906 2 15 1.1.1.2618.10 1 22.7023 112205.6 22.6358 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 96.5399980545044 SPELQAEAK 0.145292997360229 971.6376953125 486.8261 971.492370605469 486.753479003906 2 15 1.1.1.2646.7 1 23.3651 1679.461 23.3531 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 96.5399980545044 SPELQAEAK 0.145292997360229 971.6376953125 486.8261 971.492370605469 486.753479003906 2 15 1.1.1.2661.7 1 23.7243 1702.649 23.7104 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 95.6099987030029 SPELQAEAK 0.145049005746841 971.637451171875 486.826 971.492370605469 486.753479003906 2 15 1.1.1.2625.9 1 22.866 6671.291 22.8985 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 92.3099994659424 SPELQAEAK 0.145659998059273 971.638061523438 486.8263 971.492370605469 486.753479003906 2 13 1.1.1.2668.6 1 23.8854 1631.221 23.8547 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 92.3099994659424 SPELQAEAK 0.145842999219894 971.638244628906 486.8264 971.492370605469 486.753479003906 2 13 1.1.1.2682.4 1 24.2242 712.1364 24.217 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 91.0000026226044 SPELQAEAK 0.152495995163918 971.644897460938 486.8297 971.492370605469 486.753479003906 2 13 1.1.1.2689.6 1 24.3933 1817.144 24.5045 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 73.9700019359589 SPELQAEAK 0.152495995163918 971.644897460938 486.8297 971.492370605469 486.753479003906 2 14 1.1.1.2696.6 1 24.5662 1817.144 24.5045 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 72.8600025177002 SPELQAEAK Cation:Na(E)@7 0.144549995660782 993.618896484375 497.8167 993.474304199219 497.744445800781 2 10 1.1.1.2615.12 1 22.6232 438.0854 22.6358 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SPELQAEAKSYFEK missed K-S@9 0.170993000268936 1625.96472167969 813.9896 1625.79370117188 813.904113769531 2 24 1.1.1.3185.9 1 36.2973 711.4146 36.2809 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SPELQAEAKSYFEK Carboxyethyl(K)@9 missed K-S@9 0.168418005108833 1697.98327636719 849.9989 1697.81481933594 849.914672851563 2 25 1.1.1.3688.5 1 48.507 1623.469 48.5187 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SPELQAEAKSYFEK missed K-S@9 0.227314993739128 1626.02099609375 543.0143 1625.79370117188 542.938537597656 3 20 1.1.1.3178.5 1 36.1322 4889.706 36.2569 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SPELQAEAKSYFEK missed K-S@9 0.227314993739128 1626.02099609375 543.0143 1625.79370117188 542.938537597656 3 19 1.1.1.3185.5 1 36.2898 4889.706 36.2569 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SPELQAEAKSYFEK missed K-S@9 -0.792581975460052 1625.00109863281 542.6743 1625.79370117188 542.938537597656 3 16 1.1.1.2999.11 1 31.8235 1629.278 31.642 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 96.8699991703033 SPELQAEAKSYFEK Formyl(K)@9 missed K-S@9 0.161063998937607 1653.94970703125 827.9821 1653.78857421875 827.901611328125 2 14 1.1.1.3489.16 1 43.6543 255.4347 43.6385 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 95.7300007343292 SPELQAEAKSYFEK Trimethyl(K)@9 missed K-S@9 0.127339005470276 1667.96801757813 834.9913 1667.84069824219 834.927612304688 2 14 1.1.1.3502.21 1 43.981 393.888 43.986 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 83.5300028324127 SPELQAEAKSYFEK reduced acrolein addition +58(K)@9 missed K-S@9 0.138894006609917 1683.97448730469 842.9945 1683.83557128906 842.925048828125 2 11 1.1.1.3624.20 1 46.9768 205.9772 46.9571 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 81.580001115799 SPELQAEAKSYFEK Formyl(K)@9; reduced acrolein addition +58(K)@14 missed K-S@9 0.170956999063492 1712.00146484375 857.008 1711.83044433594 856.922546386719 2 14 1.1.1.3766.17 1 50.4602 1470.888 50.5197 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 43.860000371933 SPELQAEAKSYFEK Delta:H(2)C(2)(K)@9; Amino(Y)@11 missed K-S@9 0.226095005869865 1667.04638671875 556.6894 1666.82019042969 556.614013671875 3 13 1.1.1.3228.4 1 37.3307 3475.814 37.1201 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 18.0899992585182 SPELQAEAKSYFEK Deamidated(Q)@5; Dehydrated(E)@7; reduced acrolein addition +58(K)@9 missed K-S@9 0.237329006195068 1667.04638671875 556.6894 1666.80895996094 556.610290527344 3 12 1.1.1.3218.4 1 37.0811 3475.814 37.1201 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 54.4200003147125 SPELQAEAKSYFEKSKEQLTPLIK Formyl(K)@14; reduced acrolein addition +58(K)@16 missed K-S@9; missed K-S@14; missed K-E@16 0.315483003854752 2849.82177734375 713.4627 2849.50634765625 713.383850097656 4 12 1.1.1.4026.7 1 56.8374 378.346 56.8287 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SYFEKSKEQLTPLIK missed K-S@5; missed K-E@7 0.229228004813194 1810.21691894531 604.4129 1809.98767089844 604.336486816406 3 23 1.1.1.3209.3 1 36.875 27493.03 36.9524 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SYFEKSKEQLTPLIK missed K-S@5; missed K-E@7 0.229228004813194 1810.21691894531 604.4129 1809.98767089844 604.336486816406 3 23 1.1.1.3216.5 1 37.0431 27493.03 36.9524 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SYFEKSKEQLTPLIK Carboxyethyl(K)@5 missed K-S@5; missed K-E@7 0.168926998972893 1882.177734375 942.0961 1882.0087890625 942.011657714844 2 20 1.1.1.3685.8 1 48.4574 899.8596 48.4169 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SYFEKSKEQLTPLIK Trimethyl(K)@5 missed K-S@5; missed K-E@7 0.19692599773407 1852.23156738281 618.4178 1852.03454589844 618.352172851563 3 19 1.1.1.3501.12 1 43.9494 907.5812 43.986 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SYFEKSKEQLTPLIK Deamidated(Q)@9 missed K-S@5; missed K-E@7 0.20872700214386 1811.18041992188 906.5975 1810.9716796875 906.493103027344 2 15 1.1.1.3213.8 1 36.9713 1798.486 37.0242 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SYFEKSKEQLTPLIK Carboxyethyl(K)@7 missed K-S@5; missed K-E@7 0.172101005911827 1882.18090820313 942.0977 1882.0087890625 942.011657714844 2 18 1.1.1.3737.19 1 49.7216 1165.726 49.78 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.3599970340729 SYFEKSKEQLTPLIK Carboxyethyl(K)@5 missed K-S@5; missed K-E@7 0.235381007194519 1882.244140625 628.422 1882.0087890625 628.343566894531 3 17 1.1.1.3683.2 1 48.4001 2784.436 48.4169 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 94.7499990463257 SYFEKSKEQLTPLIK Formyl(K)@5; reduced acrolein addition +58(K)@7 missed K-S@5; missed K-E@7 0.174395993351936 1896.19885253906 949.1067 1896.0244140625 949.019470214844 2 14 1.1.1.3789.7 1 51.0318 3720.559 50.9995 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 88.7199997901917 SYFEKSKEQLTPLIK Formyl(K)@7 missed K-S@5; missed K-E@7 0.23480199277401 1838.21740722656 613.7464 1837.98254394531 613.668151855469 3 14 1.1.1.3511.10 1 44.1954 353.8297 44.2097 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 53.82000207901 SYFEKSKEQLTPLIK Delta:H(4)C(2)(K)@5; reduced acrolein addition +58(K)@7 missed K-S@5; missed K-E@7 0.200252994894981 1896.26110839844 633.0943 1896.06079101563 633.027526855469 3 12 1.1.1.3761.8 1 50.3244 2116.354 50.263 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 30.6800007820129 SYFEKSKEQLTPLIK missed K-S@5; missed K-E@7 0.287198007106781 1810.27490234375 453.576 1809.98767089844 453.504180908203 4 12 1.1.1.3210.3 1 36.8876 26819.05 36.9524 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 30.6800007820129 SYFEKSKEQLTPLIK missed K-S@5; missed K-E@7 0.287198007106781 1810.27490234375 453.576 1809.98767089844 453.504180908203 4 12 1.1.1.3217.2 1 37.0589 26819.05 36.9524 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SYFEKSKEQLTPLIKK missed K-S@5; missed K-E@7; missed K-K@15 0.23301999270916 1938.31567382813 647.1125 1938.08264160156 647.034790039063 3 23 1.1.1.3003.14 1 31.9253 5991.922 32.029 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SYFEKSKEQLTPLIKK missed K-S@5; missed K-E@7; missed K-K@15 0.23301999270916 1938.31567382813 647.1125 1938.08264160156 647.034790039063 3 25 1.1.1.3010.10 1 32.0968 5991.922 32.029 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SYFEKSKEQLTPLIKK Carboxyethyl(K)@5 missed K-S@5; missed K-E@7; missed K-K@15 0.234412997961044 2010.33813476563 671.12 2010.10375976563 671.041870117188 3 21 1.1.1.3500.8 1 43.9215 2126.734 43.9612 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 SYFEKSKEQLTPLIKK Carboxyethyl(K)@15 missed K-S@5; missed K-E@7; missed K-K@15 0.235328003764153 2010.33911132813 671.1203 2010.10375976563 671.041870117188 3 19 1.1.1.3447.14 1 42.613 3591.64 42.673 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.3599970340729 SYFEKSKEQLTPLIKK reduced acrolein addition +58(K)@5; Delta:H(4)C(2)(K)@7 missed K-S@5; missed K-E@7; missed K-K@15 0.265065997838974 2024.4208984375 507.1125 2024.15576171875 507.046234130859 4 17 1.1.1.3692.3 1 48.5975 4076.612 48.591 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.3599970340729 SYFEKSKEQLTPLIKK Formyl(K)@5; reduced acrolein addition +58(K)@7 missed K-S@5; missed K-E@7; missed K-K@15 0.171839997172356 2024.29150390625 1013.153 2024.11938476563 1013.06695556641 2 16 1.1.1.3692.8 1 48.61 376.2433 48.591 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.1199989318848 SYFEKSKEQLTPLIKK Methyl(K)@5; reduced acrolein addition +58(K)@7 missed K-S@5; missed K-E@7; missed K-K@15 0.26240599155426 2010.40258789063 503.6079 2010.14013671875 503.542297363281 4 17 1.1.1.3501.8 1 43.9453 2877.965 43.9612 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 95.7300007343292 SYFEKSKEQLTPLIKK Methyl(K)@5; reduced acrolein addition +58(K)@7 missed K-S@5; missed K-E@7; missed K-K@15 0.264358997344971 2010.40454101563 503.6084 2010.14013671875 503.542297363281 4 16 1.1.1.3618.7 1 46.8129 2769.991 46.727 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 94.4000005722046 SYFEKSKEQLTPLIKK Methyl(K)@15; reduced acrolein addition +58(K)@16 missed K-S@5; missed K-E@7; missed K-K@15 0.198943004012108 2010.33911132813 671.1203 2010.14013671875 671.054016113281 3 14 1.1.1.3454.13 1 42.784 3591.64 42.673 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 88.7199997901917 SYFEKSKEQLTPLIKK reduced acrolein addition +58(K)@7; Methyl(E)@8 missed K-S@5; missed K-E@7; missed K-K@15 0.206816002726555 2010.34692382813 671.1229 2010.14013671875 671.054016113281 3 14 1.1.1.3611.18 1 46.6437 2395.785 46.727 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 78.7699997425079 SYFEKSKEQLTPLIKK Formyl(K)@5; reduced acrolein addition +58(K)@7 missed K-S@5; missed K-E@7; missed K-K@15 0.244458004832268 2024.36389160156 675.7952 2024.11938476563 675.713745117188 3 12 1.1.1.3606.13 1 46.5139 924.3489 46.5762 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 78.7699997425079 SYFEKSKEQLTPLIKK reduced acrolein addition +58(K)@5; Formyl(K)@7 missed K-S@5; missed K-E@7; missed K-K@15 0.299865007400513 2024.41931152344 507.1121 2024.11938476563 507.037139892578 4 13 1.1.1.3611.8 1 46.6353 1742.366 46.5762 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 70.8000004291534 SYFEKSKEQLTPLIKK missed K-S@5; missed K-E@7; missed K-K@15 0.292333006858826 1938.375 485.601 1938.08264160156 485.527923583984 4 13 1.1.1.3008.5 1 32.0382 26801.39 32.0047 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 64.2599999904633 SYFEKSKEQLTPLIKK Methyl(S)@6; reduced acrolein addition +58(K)@7 missed K-S@5; missed K-E@7; missed K-K@15 0.264358997344971 2010.40454101563 503.6084 2010.14013671875 503.542297363281 4 13 1.1.1.3611.6 1 46.6337 2769.991 46.727 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 60.2400004863739 SYFEKSKEQLTPLIKK Carboxyethyl(K)@15 missed K-S@5; missed K-E@7; missed K-K@15 0.299524009227753 2010.4033203125 503.6081 2010.10375976563 503.533203125 4 13 1.1.1.3448.7 1 42.6317 2366.783 42.673 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 42.2100007534027 SYFEKSKEQLTPLIKK Formyl(K)@5; reduced acrolein addition +58(K)@7 missed K-S@5; missed K-E@7; missed K-K@15 0.239513993263245 2024.35888671875 675.7936 2024.11938476563 675.713745117188 3 11 1.1.1.3689.6 1 48.5345 7296.718 48.591 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 TVLLLTICSLEGALVRRQAKEPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@8; Carbamidomethyl(C)@23 cleaved A-T@N-term; missed R-R@16; missed R-Q@17; missed K-E@20; missed K-D@40; missed K-V@45 1.70917999744415 5416.53857421875 903.7637 5414.8291015625 903.478820800781 6 21 1.1.1.4512.13 1 68.9797 1336.256 69.0401 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.869998216629 TVLLLTICSLEGALVRRQAKEPCVESLVSQYFQTVTDYGKDLMEKVK Carbamidomethyl(C)@8; Carbamidomethyl(C)@23 cleaved A-T@N-term; missed R-R@16; missed R-Q@17; missed K-E@20; missed K-D@40; missed K-V@45 0.221261993050575 5415.05029296875 903.5157 5414.8291015625 903.478820800781 6 19 1.1.1.4519.5 1 69.1464 844.0021 69.0401 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 VKSPELQAEAK Formyl(K)@2 missed K-S@2 0.160341992974281 1226.81103515625 614.4128 1226.65063476563 614.332580566406 2 16 1.1.1.2717.8 1 25.0736 541.0981 25.0787 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.5899984836578 VKSPELQAEAK missed K-S@2 0.206391006708145 1198.86218261719 400.628 1198.65576171875 400.559204101563 3 16 1.1.1.2627.2 1 22.9023 398827.1 22.8985 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 98.0099976062775 VKSPELQAEAK missed K-S@2 0.187255993485451 1198.84301757813 400.6216 1198.65576171875 400.559204101563 3 15 1.1.1.2661.2 1 23.7143 27886.57 23.5433 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 97.0499992370605 VKSPELQAEAK missed K-S@2 0.14988499879837 1198.8056640625 600.4101 1198.65576171875 600.335144042969 2 18 1.1.1.2624.6 1 22.8421 90048.27 22.8985 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 96.8100011348724 VKSPELQAEAK missed K-S@2 0.206391006708145 1198.86218261719 400.628 1198.65576171875 400.559204101563 3 15 1.1.1.2623.2 1 22.8082 398827.1 22.8985 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 96.8100011348724 VKSPELQAEAK missed K-S@2 0.14988499879837 1198.8056640625 600.4101 1198.65576171875 600.335144042969 2 16 1.1.1.2631.7 1 23.0081 90048.27 22.8985 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 95.6099987030029 VKSPELQAEAK missed K-S@2 0.130109995603561 1198.78588867188 600.4002 1198.65576171875 600.335144042969 2 14 1.1.1.2646.9 1 23.3685 3400.553 23.5433 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 94.4100022315979 VKSPELQAEAK missed K-S@2 -0.837584972381592 1197.81811523438 400.28 1198.65576171875 400.559204101563 3 14 1.1.1.2634.2 1 23.07 9377.597 22.9943 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 94.4100022315979 VKSPELQAEAK Formyl@N-term; reduced acrolein addition +58(K)@2 missed K-S@2 0.154366001486778 1284.84692382813 643.4307 1284.69250488281 643.353515625 2 14 1.1.1.3119.10 1 34.7183 1054.952 34.7233 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 92.9199993610382 VKSPELQAEAK missed K-S@2 -0.235442996025085 1198.42028808594 400.4807 1198.65576171875 400.559204101563 3 12 1.1.1.2754.2 1 25.9397 1039.127 25.9357 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 92.9199993610382 VKSPELQAEAK Formyl@N-term; reduced acrolein addition +58(K)@2 missed K-S@2 0.154366001486778 1284.84692382813 643.4307 1284.69250488281 643.353515625 2 14 1.1.1.3126.8 1 34.8872 1054.952 34.7233 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 91.6800022125244 VKSPELQAEAK missed K-S@2 0.153059005737305 1198.80883789063 600.4117 1198.65576171875 600.335144042969 2 14 1.1.1.2638.7 1 23.1783 1467.064 23.138 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 91.1899983882904 VKSPELQAEAK Carbamidomethyl(K)@2 missed K-S@2 0.202687993645668 1255.8798828125 419.6339 1255.67724609375 419.566345214844 3 13 1.1.1.2625.5 1 22.8593 4441.704 22.8985 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 91.0000026226044 VKSPELQAEAK missed K-S@2 0.187255993485451 1198.84301757813 400.6216 1198.65576171875 400.559204101563 3 14 1.1.1.2648.2 1 23.4077 27886.57 23.5433 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 90.719997882843 VKSPELQAEAK Delta:H(2)C(2)(K)@2 missed K-S@2 0.208837002515793 1224.88024902344 409.3007 1224.67138671875 409.231079101563 3 13 1.1.1.2718.4 1 25.0841 1315.594 25.0787 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 86.7999970912933 VKSPELQAEAK missed K-S@2 0.130109995603561 1198.78588867188 600.4002 1198.65576171875 600.335144042969 2 13 1.1.1.2661.9 1 23.7293 3411.474 23.5433 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 86.7999970912933 VKSPELQAEAK missed K-S@2 0.201354995369911 1198.85705566406 400.6263 1198.65576171875 400.559204101563 3 13 1.1.1.2668.2 1 23.8821 4236.279 23.903 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 84.7000002861023 VKSPELQAEAK missed K-S@2 0.146955996751785 1198.802734375 600.4086 1198.65576171875 600.335144042969 2 13 1.1.1.2668.11 1 23.8929 540.3312 23.903 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 64.410001039505 VKSPELQAEAK missed K-S@2 -0.837311029434204 1197.81848144531 400.2801 1198.65576171875 400.559204101563 3 12 1.1.1.2641.2 1 23.2383 9322.741 22.9943 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 64.410001039505 VKSPELQAEAK Carboxyethyl(K)@2 missed K-S@2 0.156954005360603 1270.83386230469 636.4242 1270.67687988281 636.345703125 2 12 1.1.1.2982.14 1 31.4213 2260.269 31.3067 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 34.6799999475479 VKSPELQAEAK missed K-S@2 0.187255993485451 1198.84301757813 400.6216 1198.65576171875 400.559204101563 3 12 1.1.1.2649.2 1 23.4272 27886.57 23.5433 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 99.0000009536743 VKSPELQAEAKSYFEK missed K-S@2; missed K-S@11 0.288228988647461 1853.24536132813 464.3186 1852.95703125 464.246551513672 4 17 1.1.1.3081.5 1 33.7961 3156.238 33.8566 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 95.2600002288818 VKSPELQAEAKSYFEK Carboxyethyl(K)@11 missed K-S@2; missed K-S@11 0.235863000154495 1925.21411132813 642.7453 1924.97814941406 642.666687011719 3 16 1.1.1.3595.14 1 46.2362 1579.557 46.1971 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 78.7699997425079 VKSPELQAEAKSYFEK Formyl(K)@11; reduced acrolein addition +58(K)@16 missed K-S@2; missed K-S@11 0.238950997591019 1939.23278808594 647.4182 1938.99389648438 647.338562011719 3 12 1.1.1.3679.2 1 48.322 2535.546 48.3629 4 55.91 55.91 100 93.9999997615814 93.9999997615814 sp|P02652|APOA2_HUMAN Apolipoprotein A-II OS=Homo sapiens GN=APOA2 PE=1 SV=1 0 85.5300009250641 VSQYFQTVTDYGKDLMEKVK cleaved L-V@N-term; missed K-D@13; missed K-V@18 -2.31376004219055 2375.869140625 792.9636 2378.18286132813 793.73486328125 3 15 1.1.1.4689.7 1 73.5584 3909.591 73.5238 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 AEAESLYQSKYEELQITAGR missed K-Y@10 0.240437000989914 2285.35791015625 762.7933 2285.11767578125 762.713134765625 3 33 1.1.1.3386.9 1 41.1232 1194.223 41.1806 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 FLEQQNQVLQTK 0.162044003605843 1474.94006347656 738.4773 1474.77795410156 738.396301269531 2 21 1.1.1.3004.15 0 31.9495 565.6183 31.9562 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 FLEQQNQVLQTKWELLQQVDTSTR missed K-W@12 0.251545011997223 2931.76049804688 978.2608 2931.50903320313 978.176940917969 3 35 1.1.1.3774.18 1 50.6673 2965.339 50.6488 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 GGGGGGYGSGGSSYGSGGGSYGSGGGGGGGR 0.159041002392769 2383.10327148438 1192.559 2382.94458007813 1192.47961425781 2 33 1.1.1.2635.5 1 23.109 1367.659 23.138 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 GSYGSGGSSYGSGGGSYGSGGGGGGHGSYGSGSSSGGYR 0.231279999017715 3311.53100585938 1104.851 3311.30078125 1104.77416992188 3 36 1.1.1.2683.10 1 24.2599 1162.291 24.3128 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 LALDLEIATYR 0.159332007169724 1276.86206054688 639.4383 1276.70275878906 639.358642578125 2 19 1.1.1.3745.9 1 49.9219 1943.887 49.8838 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 MSGECAPNVSVSVSTSHTTISGGGSR Oxidation(M)@1; Carbamidomethyl(C)@5 0.249828994274139 2580.404296875 861.142 2580.15454101563 861.058776855469 3 29 1.1.1.2981.7 1 31.3974 1072.5 31.4263 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 NKLNDLEDALQQAKEDLAR missed K-L@2; missed K-E@14 0.309944987297058 2183.42822265625 546.8643 2183.1181640625 546.786804199219 4 21 1.1.1.3783.4 1 50.8811 3431.359 50.9003 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 QISNLQQSISDAEQR 0.162237003445625 1716.00610351563 859.0103 1715.84387207031 858.92919921875 2 27 1.1.1.3192.10 1 36.4676 2010.257 36.4966 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 QISNLQQSISDAEQRGENALK missed R-G@15 0.245348006486893 2328.41235351563 777.1447 2328.1669921875 777.062927246094 3 19 1.1.1.3604.16 1 46.4659 5221.962 46.5257 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 QISNLQQSISDAEQRGENALKDAK missed R-G@15; missed K-D@21 0.317027986049652 2642.64306640625 661.668 2642.32592773438 661.588745117188 4 21 1.1.1.3659.13 1 47.874 3544.229 47.7818 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 SKAEAESLYQSKYEELQITAGR missed K-A@2; missed K-Y@12 0.244975998997688 2500.48950195313 834.5038 2500.24462890625 834.422119140625 3 31 1.1.1.3280.9 1 38.5733 1288.019 38.557 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 SLDLDSIIAEVK 0.161145001649857 1301.86901855469 651.9418 1301.70788574219 651.861206054688 2 21 1.1.1.3900.3 1 53.7747 6458.178 53.8415 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 SLDLDSIIAEVKAQYEDIAQK missed K-A@12 0.253437995910645 2348.46459960938 783.8288 2348.21118164063 783.744323730469 3 22 1.1.1.4361.4 1 65.1633 3557.252 65.0214 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 SLNNQFASFIDKVR missed K-V@12 0.167438000440598 1638.02001953125 820.0173 1637.8525390625 819.933532714844 2 18 1.1.1.3739.15 1 49.7699 1668.995 49.78 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 SLNNQFASFIDKVRFLEQQNQVLQTKWELLQQVDTSTR missed K-V@12; missed R-F@14; missed K-W@26 0.415571004152298 4551.7666015625 911.3606 4551.35107421875 911.277465820313 5 32 1.1.1.4261.12 1 62.5814 2888.996 62.5178 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 2 99.0000009536743 THNLEPYFESFINNLR 0.242376998066902 1993.21179199219 665.4112 1992.96936035156 665.330383300781 3 21 1.1.1.3948.7 1 54.9386 1780.467 54.9058 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 1.95860815048218 99.0000009536743 NKLNDLEDALQQAK missed K-L@2 0.15904800593853 1598.98547363281 800.5 1598.82641601563 800.420471191406 2 19 1.1.1.3440.7 1 42.4451 849.7164 42.4039 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 1.13076829910278 99.0000009536743 TNAENEFVTIKK missed K-K@11 0.21357299387455 1392.9384765625 465.3201 1392.72485351563 465.248901367188 3 18 1.1.1.2821.5 1 27.5463 14861.83 27.6329 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0.99999988079071 99.0000009536743 LDSELKNMQDMVEDYRNKYEDEINKR Oxidation(M)@11 missed K-N@6; missed R-N@16; missed K-Y@18; missed K-R@25 0.394358992576599 3290.91259765625 659.1898 3290.51831054688 659.110961914063 5 19 1.1.1.3592.10 1 46.1581 1103.491 46.1971 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0.698970019817352 99.0000009536743 TNAENEFVTIK 0.156541004776955 1264.78649902344 633.4005 1264.6298828125 633.322265625 2 17 1.1.1.3065.6 1 33.4168 857.9211 33.569 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0.612610161304474 99.0000009536743 THNLEPYFESFINNLRR missed R-R@16 0.239409998059273 2149.30981445313 717.4439 2149.07055664063 717.364135742188 3 16 1.1.1.3851.3 1 52.5706 1923.38 52.5172 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0.596879422664642 99.0000009536743 AEAESLYQSK 0.151283994317055 1124.68627929688 563.3504 1124.53491210938 563.274780273438 2 16 1.1.1.2667.12 1 23.8704 1089.234 23.8788 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0.551293671131134 99.0000009536743 LLRDYQELMNTK missed R-D@3 0.222411006689072 1523.00378417969 508.6752 1522.78137207031 508.60107421875 3 16 1.1.1.3223.4 1 37.2109 2027.632 37.2399 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0.41680121421814 98.3500003814697 AQYEDIAQK 0.148243993520737 1064.662109375 533.3383 1064.51379394531 533.264221191406 2 15 1.1.1.2663.8 1 23.7722 7359.553 23.7583 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0.283162266016006 99.0000009536743 SLDLDSIIAEVKAQYEDIAQKSKAEAESLYQSKYEELQITAGR Deamidated(Q)@31 missed K-A@12; missed K-S@21; missed K-A@23; missed K-Y@33 -0.496459990739822 4830.9326171875 806.1627 4831.42919921875 806.245483398438 6 18 1.1.1.4368.5 1 65.3494 522.6481 65.443 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0.254144787788391 96.399998664856 TLLEGEESR 0.147835999727249 1032.65661621094 517.3356 1032.5087890625 517.261657714844 2 15 1.1.1.2699.12 1 24.6364 19795.63 24.6723 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0.204119980335236 92.6100015640259 DVDGAYMTK 0.147159993648529 998.585083007813 500.2998 998.437927246094 500.226226806641 2 13 1.1.1.2691.7 1 24.4447 2918.222 24.3845 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0.118045032024384 92.8900003433228 IEISELNRVIQR missed R-V@8 0.226100996136665 1469.06225585938 490.6947 1468.83618164063 490.619323730469 3 14 1.1.1.3455.2 0 42.8002 4472.458 42.6974 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0.0624821111559868 87.279999256134 YEELQITAGR 0.156454995274544 1178.74963378906 590.3821 1178.59313964844 590.303833007813 2 13 1.1.1.3004.9 1 31.9411 2418.414 31.9804 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0.0357403717935085 76.2399971485138 IEISELNR 0.148632004857063 972.672668457031 487.3436 972.523986816406 487.269287109375 2 11 1.1.1.2988.5 0 31.555 4402.409 31.7142 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0.0141246430575848 53.6300003528595 SLVNLGGSK 0.145077005028725 873.637084960938 437.8258 873.492004394531 437.753265380859 2 11 1.1.1.2861.6 1 28.5038 915.7376 28.4685 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0.0127807697281241 55.1699995994568 SDQSRLDSELK missed R-L@5 0.15250700712204 1276.77844238281 639.3965 1276.62585449219 639.320251464844 2 10 1.1.1.2675.10 1 24.0668 157.448 24.0735 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0.0118871601298451 96.1300015449524 NVEIDPEIQK cleaved L-N@N-term 0.15481099486351 1183.76330566406 592.8889 1183.60852050781 592.8115234375 2 14 1.1.1.2978.7 1 31.3231 1123.999 31.3785 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0.00966114550828934 41.9400006532669 LRSEIDNVKK missed R-S@2; missed K-K@9 0.206302002072334 1200.88891601563 401.3036 1200.6826171875 401.234832763672 3 12 1.1.1.2571.2 1 21.5825 1929.971 21.626 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0.00305075151845813 29.0100008249283 SLDLDSIIAEVKAQYEDIAQKSK missed K-A@12; missed K-S@21 0.328337997198105 2563.66650390625 641.9239 2563.33813476563 641.841796875 4 11 1.1.1.4316.2 1 63.9844 235.905 63.9019 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 84.7000002861023 DVDGAYMTK Oxidation(M)@7 0.145835995674133 1014.57867431641 508.2966 1014.43280029297 508.223693847656 2 12 1.1.1.2581.5 1 21.7871 581.8803 21.8444 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 98.6800014972687 FLEQQNQVLQTKWELLQQVDTSTR missed K-W@12 0.319036990404129 2931.828125 733.9643 2931.50903320313 733.884521484375 4 16 1.1.1.3773.6 1 50.6312 1383.025 50.6488 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 99.0000009536743 GGGGGGYGSGGSSYGSGGGSYGSGGGGGGGR 0.234222993254662 2383.1787109375 795.4002 2382.94458007813 795.322143554688 3 39 1.1.1.2636.16 1 23.1329 2967.759 23.138 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 99.0000009536743 GGGGGGYGSGGSSYGSGGGSYGSGGGGGGGR 0.234222993254662 2383.1787109375 795.4002 2382.94458007813 795.322143554688 3 37 1.1.1.2637.7 1 23.1569 2967.759 23.138 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 99.0000009536743 GSYGSGGSSYGSGGGSYGSGGGGGGHGSYGSGSSSGGYR 0.302372992038727 3311.60327148438 828.9081 3311.30078125 828.832458496094 4 41 1.1.1.2684.7 1 24.2813 1265.627 24.3367 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 99.0000009536743 GSYGSGGSSYGSGGGSYGSGGGGGGHGSYGSGSSSGGYR 0.231279999017715 3311.53100585938 1104.851 3311.30078125 1104.77416992188 3 14 1.1.1.2692.16 1 24.4755 1162.291 24.3128 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 26.3900011777878 IDPEIQKVKSR acrolein addition +112(K)@7; acrolein addition +38(K)@9 cleaved E-I@N-term; missed K-V@7; missed K-S@9 0.0553559996187687 1461.87451171875 731.9445 1461.81909179688 731.916870117188 2 10 1.1.1.2633.10 1 23.061 20679.74 23.114 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 74.6800005435944 IEISELNRVIQR missed R-V@8 0.226100996136665 1469.06225585938 490.6947 1468.83618164063 490.619323730469 3 13 1.1.1.3448.5 0 42.6301 4472.458 42.6974 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 30.6499987840652 KQISNLQQSISDAEQRGENALKDAKNKLNDLEDALQQAKE MDA adduct +62(K)@1; reduced acrolein addition +96(K)@27; HPNE addition +172(K)@39 cleaved E-D@C-term; missed K-Q@1; missed R-G@16; missed K-D@22; missed K-N@25; missed K-L@27; missed K-E@39 0.236606001853943 4810.69921875 963.1471 4810.46240234375 963.099792480469 5 11 1.1.1.4059.8 1 57.6752 8356.397 57.8154 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 52.700001001358 LALDLEIATYR -0.861419975757599 1275.84130859375 638.9279 1276.70275878906 639.358642578125 2 11 1.1.1.3749.6 1 50.0205 1386.504 50.1123 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 99.0000009536743 LDSELKNMQDMVEDYRNKYEDEINKR missed K-N@6; missed R-N@16; missed K-Y@18; missed K-R@25 0.388296991586685 3274.91162109375 655.9896 3274.5234375 655.911987304688 5 18 1.1.1.3719.12 1 49.2565 1663.721 49.2691 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 99.0000009536743 NKLNDLEDALQQAK missed K-L@2 0.15904800593853 1598.98547363281 800.5 1598.82641601563 800.420471191406 2 17 1.1.1.3438.8 1 42.3938 849.7164 42.4039 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 34.8800003528595 NKLNDLEDALQQAKEDLAR Methyl(D)@8 missed K-L@2; missed K-E@14 0.311141014099121 2197.44506835938 550.3685 2197.1337890625 550.290771484375 4 18 1.1.1.3821.2 0 51.82 284.9873 51.8665 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 34.8800003528595 NKLNDLEDALQQAKEDLAR Methyl(D)@8 missed K-L@2; missed K-E@14 0.242672994732857 2197.37646484375 733.4661 2197.1337890625 733.38525390625 3 21 1.1.1.3821.8 0 51.825 1016.328 51.8665 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 36.5099996328354 PLNVEIDPEIQKVKSREREQIKSLNNQFASFIDKVR ONE addition +154(K)@22; reduced acrolein addition +96(K)@34 cleaved Q-P@N-term; missed K-V@12; missed K-S@14; missed R-E@16; missed R-E@18; missed K-S@22; missed K-V@34 0.233088999986649 4517.69775390625 904.5468 4517.46435546875 904.500183105469 5 11 1.1.1.4064.7 0 57.802 1842.306 57.8154 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 99.0000009536743 QISNLQQSISDAEQR 0.228812992572784 1716.07263183594 573.0315 1715.84387207031 572.955200195313 3 18 1.1.1.3193.7 1 36.4865 2496.989 36.4966 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 96.6000020503998 QISNLQQSISDAEQRGENALK Gln->pyro-Glu@N-term missed R-G@15 0.257005006074905 2311.3974609375 771.4731 2311.14038085938 771.387390136719 3 15 1.1.1.3771.11 1 50.5836 653.5159 50.5453 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 99.0000009536743 QISNLQQSISDAEQRGENALKDAK missed R-G@15; missed K-D@21 0.317027986049652 2642.64306640625 661.668 2642.32592773438 661.588745117188 4 19 1.1.1.3652.13 1 47.6929 3544.229 47.7818 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 99.0000009536743 QISNLQQSISDAEQRGENALKDAK missed R-G@15; missed K-D@21 0.254114001989365 2642.580078125 881.8673 2642.32592773438 881.782592773438 3 17 1.1.1.3655.19 1 47.775 858.4947 47.7818 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 32.8000009059906 SDQSRLDSELK missed R-L@5 0.213437005877495 1276.83935546875 426.6204 1276.62585449219 426.549255371094 3 12 1.1.1.2677.3 1 24.1062 715.2695 24.0735 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 99.0000009536743 SLDLDSIIAEVKAQYEDIAQK missed K-A@12 0.253437995910645 2348.46459960938 783.8288 2348.21118164063 783.744323730469 3 29 1.1.1.4351.3 1 64.9008 3557.252 65.0214 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 99.0000009536743 SLDLDSIIAEVKAQYEDIAQK missed K-A@12 0.321296006441116 2348.53247070313 588.1404 2348.21118164063 588.06005859375 4 18 1.1.1.4354.3 1 64.9754 496.5832 65.0214 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 93.4199988842011 SLDLDSIIAEVKAQYEDIAQK missed K-A@12 0.183504998683929 2348.39526367188 1175.205 2348.21118164063 1175.11279296875 2 15 1.1.1.4357.15 1 65.0641 818.6449 65.0214 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 46.3800013065338 SLDLDSIIAEVKAQYEDIAQKSKAEAESLYQSKYEELQI MDA adduct +54(K)@12; MDA adduct +54(K)@21; acrolein addition +94(K)@23; acrolein addition +76(K)@33 cleaved I-T@C-term; missed K-A@12; missed K-S@21; missed K-A@23; missed K-Y@33 0.351678997278214 4723.68359375 945.744 4723.33203125 945.673706054688 5 12 1.1.1.3834.14 1 52.1564 117977.7 52.2178 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 93.4199988842011 SLDLDSIIAEVKAQYEDIAQKSKAEAESLYQSKYEELQITAGR missed K-A@12; missed K-S@21; missed K-A@23; missed K-Y@33 0.401387006044388 4830.8466796875 967.1766 4830.4453125 967.096313476563 5 16 1.1.1.4371.14 1 65.4321 805.3937 65.4181 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 91.9399976730347 SLNNQFASFIDKVR missed K-V@12 0.23309899866581 1638.08569335938 547.0358 1637.8525390625 546.958129882813 3 14 1.1.1.3741.7 1 49.8152 5609.271 49.78 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 93.4199988842011 SLNNQFASFIDKVRFLEQQNQVLQTKWELLQQVDTSTR missed K-V@12; missed R-F@14; missed K-W@26 0.415571004152298 4551.7666015625 911.3606 4551.35107421875 911.277465820313 5 17 1.1.1.4254.9 1 62.4033 2888.996 62.5178 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 93.4199988842011 SLNNQFASFIDKVRFLEQQNQVLQTKWELLQQVDTSTR missed K-V@12; missed R-F@14; missed K-W@26 0.343502014875412 4551.69482421875 1138.931 4551.35107421875 1138.84509277344 4 16 1.1.1.4256.16 1 62.4582 1710.352 62.5178 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 43.5799986124039 SLVNLGGSK 0.141293004155159 873.63330078125 437.8239 873.492004394531 437.753265380859 2 12 1.1.1.2847.3 1 28.1705 2699.859 28.086 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 25.0800013542175 SLVNLGGSK 0.141293004155159 873.63330078125 437.8239 873.492004394531 437.753265380859 2 10 1.1.1.2840.4 1 27.9995 2699.859 28.086 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 99.0000009536743 THNLEPYFESFINNLR 0.242376998066902 1993.21179199219 665.4112 1992.96936035156 665.330383300781 3 21 1.1.1.3941.3 1 54.7635 1780.467 54.9058 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 99.0000009536743 THNLEPYFESFINNLRR missed R-R@16 0.300309985876083 2149.37084960938 538.35 2149.07055664063 538.27490234375 4 16 1.1.1.3844.2 1 52.3974 1574.66 52.4184 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 89.7000014781952 THNLEPYFESFINNLRR missed R-R@16 0.238495007157326 2149.30908203125 717.4436 2149.07055664063 717.364135742188 3 14 1.1.1.3843.4 1 52.3737 2197.056 52.4184 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 49.9199986457825 THNLEPYFESFINNLRR missed R-R@16 0.247100993990898 2149.31762695313 717.4465 2149.07055664063 717.364135742188 3 13 1.1.1.3867.8 1 52.9659 673.4454 52.957 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 95.9399998188019 TLLEGEESR 0.147835999727249 1032.65661621094 517.3356 1032.5087890625 517.261657714844 2 14 1.1.1.2706.4 1 24.8064 19795.63 24.6723 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 79.7800004482269 TLLEGEESR 0.147103995084763 1032.65588378906 517.3352 1032.5087890625 517.261657714844 2 12 1.1.1.2713.11 1 24.9714 14203.9 24.7202 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 52.8699994087219 TLLEGEESR 0.1545500010252 1032.66333007813 517.3389 1032.5087890625 517.261657714844 2 12 1.1.1.2720.6 1 25.142 902.0288 25.1026 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 99.0000009536743 TNAENEFVTIK 0.156541004776955 1264.78649902344 633.4005 1264.6298828125 633.322265625 2 16 1.1.1.3073.12 1 33.6101 857.9211 33.569 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 99.0000009536743 TNAENEFVTIKK missed K-K@11 0.21357299387455 1392.9384765625 465.3201 1392.72485351563 465.248901367188 3 18 1.1.1.2828.6 1 27.713 14861.83 27.6329 5 41.98 41.98 77.1700024604797 54.6599984169006 49.219998717308 sp|P04264|K2C1_HUMAN; cont|000135 Keratin, type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6; cra|hCP1609934.2| keratin 1 (epidermolytic hyperkeratosis) [Homo sapiens (contaminant)] 0 64.1700029373169 YEELQITAGR 0.156454995274544 1178.74963378906 590.3821 1178.59313964844 590.303833007813 2 12 1.1.1.3011.13 1 32.1146 2418.414 31.9804 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 2 99.0000009536743 ALEESNYELEGKIKEWYEKHGNSHQGEPR missed K-I@12; missed K-E@14; missed K-H@19 0.396807998418808 3457.0302734375 692.4133 3456.63354492188 692.333984375 5 22 1.1.1.3435.7 1 42.3235 394.4998 42.3554 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 2 99.0000009536743 ELTTEIDNNIEQISSYKSEITELRR missed K-S@17; missed R-R@24 0.314254999160767 2980.81323242188 746.2106 2980.4990234375 746.132019042969 4 22 1.1.1.3745.17 1 49.9285 1432.437 49.9369 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 2 99.0000009536743 GGGSFGGGYGGGSSGGGSSGGGHG cleaved G-G@C-term 0.219678997993469 1812.92443847656 605.3154 1812.70483398438 605.2421875 3 19 1.1.1.2553.3 1 21.2225 180.9484 21.2008 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 2 99.0000009536743 GSLGGGFSSGGFSGGSFSR 0.16516500711441 1706.93005371094 854.4723 1706.76489257813 854.389709472656 2 29 1.1.1.3368.14 1 40.6849 4303.41 40.7918 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 2 99.0000009536743 LAADDFRLKYENEVALR missed R-L@7; missed K-Y@9 0.237109005451202 2022.29052734375 675.1041 2022.05346679688 675.025085449219 3 19 1.1.1.3426.6 1 42.0989 643.5788 42.1115 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 2 99.0000009536743 NVQALEIELQSQLALK 0.173344001173973 1796.177734375 899.0961 1796.00439453125 899.009460449219 2 25 1.1.1.3885.12 1 53.4111 1102.975 53.4237 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 2 99.0000009536743 NVSTGDVNVEMNAAPGVDLTQLLNNMR 0.245451003313065 2871.630859375 958.2176 2871.38549804688 958.135803222656 3 30 1.1.1.4076.7 1 58.0953 1115.072 58.0862 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 2 99.0000009536743 SKELTTEIDNNIEQISSYK missed K-E@2 0.175292998552322 2211.26538085938 1106.64 2211.09057617188 1106.55261230469 2 20 1.1.1.3579.8 1 45.8505 459.7139 45.8314 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 2 99.0000009536743 SLLEGEGSSGGGGR 0.154623001813889 1261.74450683594 631.8795 1261.58984375 631.802185058594 2 24 1.1.1.2697.10 1 24.5953 9196.045 24.6004 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 2 99.0000009536743 SQYEQLAEQNRKDAEAWFNEK missed R-K@11; missed K-D@12 0.239320993423462 2583.43823242188 862.1534 2583.19897460938 862.073608398438 3 23 1.1.1.3426.9 1 42.1064 1161.849 42.1844 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 2 99.0000009536743 TIDDLKNQILNLTTDNANILLQIDNAR missed K-N@6 0.255712002515793 3051.87524414063 1018.299 3051.6201171875 1018.21392822266 3 34 1.1.1.4244.15 1 62.165 2579.295 62.1507 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 2 99.0000009536743 VTMQNLNDRLASYLDKVR missed R-L@9; missed K-V@16 0.2411720007658 2135.35693359375 712.7929 2135.11572265625 712.712524414063 3 19 1.1.1.3722.13 1 49.3337 4076.29 49.2691 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 1.61978900432587 99.0000009536743 ELTTEIDNNIEQISSYK 0.242761000990868 1996.20642089844 666.4094 1995.96362304688 666.328491210938 3 18 1.1.1.3650.13 1 47.6421 801.8234 47.6284 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 1.50863802433014 99.0000009536743 YCVQLSQIQAQISALEEQLQQIR Carbamidomethyl(C)@2 0.260176986455917 2745.67211914063 916.2313 2745.41186523438 916.144592285156 3 21 1.1.1.4447.9 1 67.3129 308.8648 67.3034 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 0.966576337814331 99.0000009536743 SQYEQLAEQNR 0.157956004142761 1364.7900390625 683.4023 1364.63208007813 683.323303222656 2 18 1.1.1.2706.5 1 24.8106 777.1068 24.8396 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 0.872895181179047 99.0000009536743 ALEESNYELEGK 0.162916004657745 1380.80383300781 691.4092 1380.64086914063 691.327697753906 2 18 1.1.1.2869.13 1 28.7031 1404.801 28.7324 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 0.721246421337128 99.0000009536743 SKELTTEIDNNIEQISSYKSEITELRR missed K-E@2; missed K-S@19; missed R-R@26 0.331795006990433 3195.95776367188 799.9967 3195.6259765625 799.913757324219 4 17 1.1.1.3716.13 1 49.1828 662.4802 49.1945 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 0.472370088100433 99.0000009536743 SQYEQLAEQNRK missed R-K@11 0.216147005558014 1492.94311523438 498.655 1492.72705078125 498.582946777344 3 16 1.1.1.2651.5 1 23.484 9676.398 23.5433 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 0.0525662787258625 84.1400027275085 NHEEEMKDLR missed K-D@7 0.21000200510025 1299.79772949219 434.2732 1299.58776855469 434.203186035156 3 13 1.1.1.2585.3 1 21.8833 665.7173 21.9229 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 0.0433514192700386 99.0000009536743 NVSTGDVNVEMNAAPGVDLTQLLNNMRSQYEQLAEQNRKDAEAWFNEK Deamidated(Q)@21 missed R-S@27; missed R-K@38; missed K-D@39 -0.562457978725433 5436.99365234375 1088.406 5437.55810546875 1088.51892089844 5 18 1.1.1.4352.8 1 64.937 429.7476 64.9689 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 0.0145735256373882 71.6000020503998 DAEAWFNEK 0.153542995452881 1108.63610839844 555.3253 1108.48254394531 555.24853515625 2 12 1.1.1.3211.4 1 36.9116 815.7367 36.9524 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 0.013228265568614 60.0099980831146 DYSKYYK missed K-Y@4 0.145800992846489 965.595275878906 483.8049 965.449462890625 483.731994628906 2 11 1.1.1.2656.8 1 23.6015 1330.941 23.6149 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 0.00744648277759552 45.3500002622604 VTMQNLNDR 0.149132996797562 1089.6728515625 545.8437 1089.52368164063 545.769104003906 2 10 1.1.1.2704.5 1 24.7528 3116.253 24.6243 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 0 99.0000009536743 ELTTEIDNNIEQISSYK 0.643593013286591 1996.60729980469 999.3109 1995.96362304688 998.989135742188 2 21 1.1.1.3646.8 1 47.5479 1343.774 47.477 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 0 99.0000009536743 GSLGGGFSSGGFSGGSFSR 0.16516500711441 1706.93005371094 854.4723 1706.76489257813 854.389709472656 2 32 1.1.1.3375.8 1 40.8541 4303.41 40.7918 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 0 99.0000009536743 GSLGGGFSSGGFSGGSFSR 0.167606994509697 1706.93249511719 854.4735 1706.76489257813 854.389709472656 2 17 1.1.1.3383.14 1 41.0484 323.0455 41.0341 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 0 27.0700007677078 QNLNDRLASYLDKVRALEESNYELEGKIKEWYEKHGN Protein Terminal Acetyl@N-term; HPNE addition +172(K)@13; HPNE addition +172(K)@29; acrolein addition +112(K)@34 cleaved M-Q@N-term; cleaved N-S@C-term; missed R-L@6; missed K-V@13; missed R-A@15; missed K-I@27; missed K-E@29; missed K-H@34 0.270783990621567 4949.7666015625 1238.449 4949.49755859375 1238.38159179688 4 12 1.1.1.4497.6 1 68.5879 883.3275 68.753 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 0 61.1500024795532 QSLEASLAETEGRYCVQLSQIQAQISALEEQLQQIR Carbamidomethyl(C)@15 missed R-Y@13 -1.16805994510651 4115.90673828125 1029.984 4117.0751953125 1030.27600097656 4 13 1.1.1.4551.10 1 69.9758 186.7988 69.9561 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 0 99.0000009536743 SQYEQLAEQNRKDAEAWFNEK missed R-K@11; missed K-D@12 0.308766007423401 2583.5078125 646.8842 2583.19897460938 646.807006835938 4 18 1.1.1.3433.5 1 42.2674 2861.333 42.1844 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 0 98.6800014972687 SQYEQLAEQNRKDAEAWFNEK missed R-K@11; missed K-D@12 0.239320993423462 2583.43823242188 862.1534 2583.19897460938 862.073608398438 3 16 1.1.1.3433.8 1 42.2749 1161.849 42.1844 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 0 99.0000009536743 TIDDLKNQILNLTTDNANILLQIDNAR missed K-N@6 0.255712002515793 3051.87524414063 1018.299 3051.6201171875 1018.21392822266 3 24 1.1.1.4237.16 1 61.9927 2579.295 62.1507 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 0 99.0000009536743 TIDDLKNQILNLTTDNANILLQIDNAR missed K-N@6 0.328146994113922 3051.9482421875 763.9943 3051.6201171875 763.912292480469 4 29 1.1.1.4244.3 1 62.155 1834.487 62.1507 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 0 93.4199988842011 TIDDLKNQILNLTTDNANILLQIDNAR missed K-N@6 0.328146994113922 3051.9482421875 763.9943 3051.6201171875 763.912292480469 4 17 1.1.1.4237.2 1 61.981 1834.487 62.1507 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 0 63.0599975585938 VLDELTLTK Didehydro(T)@6 0.166418001055717 1028.74182128906 515.3782 1028.57531738281 515.294982910156 2 11 1.1.1.3296.3 1 38.9451 2440.531 39.083 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 0 63.0599975585938 VLDELTLTK Didehydro@C-term 0.166418001055717 1028.74182128906 515.3782 1028.57531738281 515.294982910156 2 12 1.1.1.3303.3 1 39.1158 2440.531 39.083 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 0 99.0000009536743 VTMQNLNDRLASYLDKVR missed R-L@9; missed K-V@16 0.2411720007658 2135.35693359375 712.7929 2135.11572265625 712.712524414063 3 22 1.1.1.3715.5 1 49.155 4076.29 49.2691 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 0 95.1399981975555 VTMQNLNDRLASYLDKVR missed R-L@9; missed K-V@16 0.303903013467789 2135.41967773438 534.8622 2135.11572265625 534.786193847656 4 15 1.1.1.3715.3 1 49.1516 7186.56 49.2691 6 30.29 30.29 72.4300026893616 51.5399992465973 44.8599994182587 sp|P13645|K1C10_HUMAN Keratin, type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 0 56.6600024700165 VTMQNLNDRLASYLDKVR missed R-L@9; missed K-V@16 0.303903013467789 2135.41967773438 534.8622 2135.11572265625 534.786193847656 4 13 1.1.1.3722.4 1 49.3262 7186.56 49.2691 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 2 99.0000009536743 AAFTECCQAADK Carbamidomethyl(C)@6; Carbamidomethyl(C)@7 0.153744995594025 1370.71325683594 686.3639 1370.55944824219 686.287048339844 2 21 1.1.1.2659.6 1 23.6814 1883.141 23.7344 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 2 99.0000009536743 AAFTECCQAADKAACLLPK Carbamidomethyl(C)@6; Carbamidomethyl(C)@7; Carbamidomethyl(C)@15 missed K-A@12 0.235624998807907 2124.2158203125 709.0792 2123.98022460938 709.000671386719 3 21 1.1.1.3425.6 1 42.0721 1041.082 42.0627 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 2 99.0000009536743 ADDKETCFAEEGKK Carbamidomethyl(C)@7 missed K-E@4; missed K-K@13 0.220655992627144 1626.94018554688 543.3207 1626.71960449219 543.247131347656 3 21 1.1.1.2580.6 1 21.7604 547.5898 21.7922 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 2 99.0000009536743 AEFAEVSKLVTDLTK missed K-L@8 0.231010004878044 1650.11865234375 551.0468 1649.88757324219 550.969787597656 3 19 1.1.1.3839.2 1 52.2723 1499.495 52.2684 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 2 99.0000009536743 AVMDDFAAFVEK 0.163988992571831 1341.79150390625 671.903 1341.62744140625 671.821044921875 2 20 1.1.1.3773.3 1 50.6287 4334.992 50.6228 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 2 99.0000009536743 KVPQVSTPTLVEVSR missed K-V@1 0.227815002202988 1639.15832519531 547.3934 1638.93041992188 547.317443847656 3 21 1.1.1.3225.5 1 37.2488 6678.32 37.0723 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 2 99.0000009536743 RHPDYSVVLLLR missed R-H@1 0.16431300342083 1467.00012207031 734.5073 1466.83581542969 734.425170898438 2 19 1.1.1.3521.4 1 44.4399 1032.476 44.4757 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 2 99.0000009536743 RMPCAEDYLSVVLNQLCVLHEKTPVSDRVTK Carbamidomethyl(C)@4; Carbamidomethyl(C)@17 missed R-M@1; missed K-T@22; missed R-V@28 0.399556010961533 3657.24731445313 732.4567 3656.84765625 732.376831054688 5 22 1.1.1.4054.5 1 57.546 934.5936 57.5384 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 2 99.0000009536743 TCVADESAENCDK Carbamidomethyl(C)@2; Carbamidomethyl(C)@11 0.157316997647285 1497.728515625 749.8715 1497.57116699219 749.792846679688 2 23 1.1.1.2545.4 1 21.0278 296.8251 21.0593 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 2 99.0000009536743 VFDEFKPLVEEPQNLIK 0.241211995482445 2044.32934570313 682.4504 2044.08813476563 682.369995117188 3 22 1.1.1.3778.8 1 50.7597 1928.568 50.8002 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 2 99.0000009536743 VFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVR Carbamidomethyl(C)@20 missed K-Q@17; missed K-F@30 0.425132989883423 4624.79248046875 925.9658 4624.36767578125 925.880798339844 5 28 1.1.1.4275.5 1 62.9339 870.1547 62.8504 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 2 99.0000009536743 YICENQDSISSK Carbamidomethyl(C)@3 0.155864000320435 1442.79064941406 722.4026 1442.634765625 722.324645996094 2 20 1.1.1.2668.14 1 23.8979 3619.531 23.9272 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 1.24412524700165 99.0000009536743 CCAAADPHECYAK Carbamidomethyl(C)@1; Carbamidomethyl(C)@2; Carbamidomethyl(C)@10 0.218086004257202 1551.80859375 518.2768 1551.59045410156 518.2041015625 3 19 1.1.1.2579.3 1 21.728 2292.009 21.7655 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0.782516002655029 99.0000009536743 ETYGEMADCCAK Oxidation(M)@6; Carbamidomethyl(C)@9; Carbamidomethyl(C)@10 0.154826000332832 1449.67590332031 725.8452 1449.52099609375 725.767822265625 2 18 1.1.1.2583.4 1 21.8393 116.1932 21.8184 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0.625251650810242 99.0000009536743 TCVADESAENCDKSLHTLFGDKLCTVATLR Carbamidomethyl(C)@2; Carbamidomethyl(C)@11; Carbamidomethyl(C)@24 missed K-S@13; missed K-L@22 0.398533999919891 3410.98901367188 683.2051 3410.59057617188 683.125366210938 5 17 1.1.1.3646.4 1 47.5379 542.5269 47.5778 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0.453457325696945 99.0000009536743 MPCAEDYLSVVLNQLCVLHEK Carbamidomethyl(C)@3; Carbamidomethyl(C)@16 0.269813001155853 2517.47631835938 840.1661 2517.20654296875 840.076110839844 3 17 1.1.1.4342.6 1 64.6628 212.187 64.6804 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0.161780774593353 93.1800007820129 VPQVSTPTLVEVSR 0.168494001030922 1511.00402832031 756.5093 1510.83544921875 756.425048828125 2 11 1.1.1.3366.12 1 40.6337 376.2428 40.5733 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0.145693957805634 97.2500026226044 QNCELFEQLGEYKFQNALLVR Carbamidomethyl(C)@3 missed K-F@13 0.252077996730804 2598.54223632813 867.188 2598.2900390625 867.103942871094 3 16 1.1.1.3879.3 1 53.2589 1116.138 53.2765 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0.031050318852067 79.1000008583069 LDELRDEGKASSAK missed R-D@5; missed K-A@9 0.214107006788254 1517.98266601563 507.0015 1517.7685546875 506.930114746094 3 13 1.1.1.2579.2 1 21.7222 108.0665 21.7389 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0.0254883076995611 74.7399985790253 LDELRDEGK missed R-D@5 0.143748000264168 1073.67907714844 537.8468 1073.53527832031 537.77490234375 2 12 1.1.1.2597.5 1 22.1792 131.9991 22.1877 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0.0109953843057156 56.7499995231628 TYETTLEK 0.145480006933212 983.626647949219 492.8206 983.481140136719 492.747833251953 2 12 1.1.1.2666.5 1 23.8396 8154.545 23.8788 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0.00436480529606342 36.4800006151199 CCTESLVNR Carbamidomethyl(C)@1; Carbamidomethyl(C)@2 0.150530993938446 1137.64123535156 569.8279 1137.49072265625 569.752624511719 2 11 1.1.1.2668.9 1 23.8896 3918.365 23.9516 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0.00130484171677381 53.82000207901 QIKKQTALVELVKHKPK Gln->pyro-Glu@N-term; acrolein addition +112(K)@3; acrolein addition +112(K)@13; reduced acrolein addition +58(K)@15 missed K-K@3; missed K-Q@4; missed K-H@13 0.034850899130106 2252.3857421875 751.8025 2252.35083007813 751.790893554688 3 11 1.1.1.3578.9 1 45.8238 4592.04 45.8796 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0.000869458774104714 48.8000005483627 FKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAK Deamidated(N)@8; Carbamidomethyl(C)@24 missed K-D@2; missed K-A@10; missed K-L@31 0.504495978355408 4828.95068359375 805.8324 4828.4462890625 805.748291015625 6 12 1.1.1.4517.5 1 69.1005 437.1658 69.113 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0.000434511806815863 29.7399997711182 FQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCK MDA adduct +54(K)@12; reduced acrolein addition +58(K)@30; reduced acrolein addition +96(K)@34; Carbamidomethyl(C)@35; Carbamidomethyl(C)@36; ONE addition +154(K)@37 missed R-Y@8; missed K-K@11; missed K-V@12; missed R-N@26; missed K-V@30; missed K-C@34 0.246476992964745 4566.75341796875 914.358 4566.5068359375 914.308654785156 5 10 1.1.1.4038.12 1 57.1468 10979.85 57.2098 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0.000434511806815863 71.17999792099 KPKATKEQLKAVMDDFAAFVEK reduced acrolein addition +96(K)@3; reduced acrolein addition +96(K)@10 cleaved H-K@N-term; missed K-A@3; missed K-E@6; missed K-A@10 0.234473004937172 2685.6796875 672.4272 2685.44506835938 672.368591308594 4 12 1.1.1.3773.4 1 50.6296 5865.33 50.5713 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0 97.2699999809265 ADDKETCFAEEGKK Carbamidomethyl(C)@7 missed K-E@4; missed K-K@13 0.272949993610382 1626.99255371094 407.7554 1626.71960449219 407.687164306641 4 15 1.1.1.2580.2 1 21.7471 1442.345 21.7922 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0 79.7500014305115 AEFAEVSKLVTDLTK Trimethyl(A)@4 missed K-L@8 0.234962999820709 1692.16955566406 565.0638 1691.9345703125 564.985473632813 3 14 1.1.1.3889.3 1 53.5033 989.2482 53.5234 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0 90.9600019454956 ALLVRYTKKVPQVSTPTLVEVSR cleaved N-A@N-term; missed R-Y@5; missed K-K@8; missed K-V@9 -1.9355800151825 2581.57568359375 646.4012 2583.51123046875 646.885070800781 4 14 1.1.1.3214.8 1 36.9927 398.1452 36.9764 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0 99.0000009536743 AVMDDFAAFVEK Oxidation(M)@3 0.163702994585037 1357.7861328125 679.9003 1357.62243652344 679.818481445313 2 20 1.1.1.3530.19 1 44.6624 814.3347 44.6691 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0 81.0999989509583 CCAAADPHECYAK Carbamidomethyl(C)@1; Carbamidomethyl(C)@2; Carbamidomethyl(C)@10 0.218086004257202 1551.80859375 518.2768 1551.59045410156 518.2041015625 3 13 1.1.1.2582.3 1 21.8075 2292.009 21.7655 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0 24.9099999666214 ERQIKKQTALVELVKHK acrolein addition +56(K)@5; acrolein addition +94(K)@6; Deamidated(Q)@7; MDA adduct +54(K)@15 cleaved K-P@C-term; missed R-Q@2; missed K-K@5; missed K-Q@6; missed K-H@15 0.0235868003219366 2252.31323242188 1127.164 2252.28930664063 1127.15185546875 2 8 1.1.1.3581.18 1 45.8989 319.5641 45.8796 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0 54.6899974346161 ERQIKKQTALVELVKHKPK Hex(R)@2; acrolein addition +38(K)@5; hexanoyl addition +98(K)@6; hexanoyl addition +98(K)@19 missed R-Q@2; missed K-K@5; missed K-Q@6; missed K-H@15 0.12347000092268 2668.71264648438 668.1854 2668.58911132813 668.154541015625 4 13 1.1.1.4359.2 1 65.1068 1888.832 64.9689 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0 28.1699985265732 FQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCK MDA adduct +54(K)@12; reduced acrolein addition +58(K)@30; reduced acrolein addition +96(K)@34; Carbamidomethyl(C)@35; Carbamidomethyl(C)@36; ONE addition +154(K)@37 missed R-Y@8; missed K-K@11; missed K-V@12; missed R-N@26; missed K-V@30; missed K-C@34 0.246476992964745 4566.75341796875 914.358 4566.5068359375 914.308654785156 5 10 1.1.1.4045.12 1 57.3184 10979.85 57.2098 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0 99.0000009536743 KVPQVSTPTLVEVSR missed K-V@1 0.227815002202988 1639.15832519531 547.3934 1638.93041992188 547.317443847656 3 21 1.1.1.3218.3 1 37.0786 6678.32 37.0723 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0 99.0000009536743 KVPQVSTPTLVEVSR missed K-V@1 0.165938004851341 1639.09643554688 820.5555 1638.93041992188 820.472534179688 2 18 1.1.1.3218.6 1 37.0861 1437.134 37.0723 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0 99.0000009536743 KVPQVSTPTLVEVSR missed K-V@1 0.165938004851341 1639.09643554688 820.5555 1638.93041992188 820.472534179688 2 15 1.1.1.3225.9 1 37.2555 1437.134 37.0723 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0 36.1000001430511 KVPQVSTPTLVEVSR missed K-V@1 0.227815002202988 1639.15832519531 547.3934 1638.93041992188 547.317443847656 3 12 1.1.1.3211.3 1 36.9099 6678.32 37.0723 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0 70.3000009059906 LVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLR acrolein addition +112(K)@10; Carbamidomethyl(C)@12; Methyl(D)@15; Carbamidomethyl(C)@21; acrolein addition +56(K)@32; Carbamidomethyl(C)@34 missed K-T@10; missed K-S@23; missed K-L@32 0.317856997251511 4723.5986328125 1181.907 4723.28173828125 1181.82775878906 4 14 1.1.1.3785.20 0 50.9445 51750.13 50.9258 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0 62.0299994945526 PKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPK MDA adduct +62(K)@2; acrolein addition +76(K)@20; Carbamidomethyl(C)@21; Oxidation(P)@45; ONE addition +154(K)@46 cleaved L-P@N-term; missed K-L@2; missed R-D@7; missed K-A@11; missed K-Q@16; missed R-L@18; missed K-C@20; missed K-F@26; missed R-A@30; missed K-A@33; missed R-L@39; missed R-F@43 0.298426002264023 5610.31884765625 1123.071 5610.02001953125 1123.01123046875 5 13 1.1.1.4336.14 1 64.5163 14136.41 64.2367 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0 94.7200000286102 QNCELFEQLGEYKFQNALLVR Carbamidomethyl(C)@3 missed K-F@13 0.778737008571625 2599.06884765625 650.7745 2598.2900390625 650.579772949219 4 14 1.1.1.3880.3 1 53.2807 2161.448 53.179 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0 99.0000009536743 RHPDYSVVLLLR missed R-H@1 0.225152000784874 1467.06091308594 490.0276 1466.83581542969 489.952545166016 3 18 1.1.1.3522.4 1 44.4565 3674.397 44.4757 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0 53.8800001144409 TLSEKERQIKKQTALVELVKHK ONE addition +154(K)@10; acrolein addition +112(K)@11; MDA adduct +62(K)@20 cleaved C-T@N-term; cleaved K-P@C-term; missed K-E@5; missed R-Q@7; missed K-K@10; missed K-Q@11; missed K-H@20 0.240100994706154 2933.935546875 587.7944 2933.6953125 587.746337890625 5 11 1.1.1.4269.2 1 62.7782 30631.27 62.5178 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0 21.9400003552437 TLSEKERQIKKQTALVELVKHK reduced acrolein addition +96(K)@5; acrolein addition +112(K)@11; acrolein addition +94(K)@20; hexanoyl addition +98(K)@22 cleaved C-T@N-term; cleaved K-P@C-term; missed K-E@5; missed R-Q@7; missed K-K@10; missed K-Q@11; missed K-H@20 0.135235995054245 3005.88818359375 752.4793 3005.7529296875 752.445495605469 4 11 1.1.1.4599.8 1 71.1918 519.6165 71.2077 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0 21.5100005269051 TLSEKERQIKKQTALVELVKHK hexanoyl addition +98(K)@10; acrolein addition +38(K)@11; acrolein addition +94(K)@20; hexanoyl addition +98(K)@22 cleaved C-T@N-term; cleaved K-P@C-term; missed K-E@5; missed R-Q@7; missed K-K@10; missed K-Q@11; missed K-H@20 0.205241993069649 2933.93701171875 587.7947 2933.73168945313 587.753601074219 5 10 1.1.1.4248.2 1 62.2528 39022.7 62.4922 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0 98.089998960495 VFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVR Carbamidomethyl(C)@20 missed K-Q@17; missed K-F@30 -4.08536005020142 4620.2822265625 925.0637 4624.36767578125 925.880798339844 5 16 1.1.1.4268.13 1 62.7613 652.3835 62.7473 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0 78.9900004863739 VFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVR Carbamidomethyl(C)@20 missed K-Q@17; missed K-F@30 -4.07956981658936 4620.2880859375 925.0649 4624.36767578125 925.880798339844 5 13 1.1.1.4277.6 0 62.983 631.8109 63.1004 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0 98.6000001430511 YICENQDSISSK Carbamidomethyl(C)@3 0.341306000947952 1442.97607421875 481.9993 1442.634765625 481.885528564453 3 14 1.1.1.2669.14 1 23.9163 1089.544 23.9272 7 27.49 27.49 100 52.3800015449524 36.6200000047684 sp|P02768|ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 0 92.3099994659424 YICENQDSISSK Carbamidomethyl(C)@3 0.156230002641678 1442.791015625 722.4028 1442.634765625 722.324645996094 2 14 1.1.1.2676.9 1 24.0899 1768.345 24.0974 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 2 99.0000009536743 DIENQYETQITQIEHEVSSSGQEVQSSAK 0.256251007318497 3263.76220703125 1088.928 3263.50659179688 1088.8427734375 3 42 1.1.1.3793.9 1 51.1406 2085.802 51.1732 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 2 99.0000009536743 EIETYHNLLEGGQEDFESSGAGK 0.239054992794991 2509.36352539063 837.4618 2509.12451171875 837.382080078125 3 27 1.1.1.3442.19 1 42.4948 1500.285 42.4039 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 2 99.0000009536743 FSSSSGYGGGSSR 0.152968004345894 1234.67443847656 618.3445 1234.521484375 618.268005371094 2 21 1.1.1.2579.4 1 21.7338 4459.181 21.7922 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 2 99.0000009536743 GGGGSFGYSYGGGSGGGFSASSLGGGFGGGSR 0.251825988292694 2704.40576171875 902.4758 2704.15380859375 902.391906738281 3 32 1.1.1.3599.16 1 46.339 3145.869 46.2221 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 2 99.0000009536743 GGSGGSHGGGSGFGGESGGSYGGGEEASGSGGGYGGGSGK 0.233049005270004 3222.50634765625 1075.176 3222.2744140625 1075.09875488281 3 32 1.1.1.2675.11 1 24.0684 381.3669 24.1213 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 2 99.0000009536743 GGSGGSYGGGGSGGGYGGGSGSR 0.16125699877739 1790.88171386719 896.4481 1790.72045898438 896.367492675781 2 38 1.1.1.2551.4 1 21.1689 799.2676 21.2008 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 2 99.0000009536743 HGVQELEIELQSQLSK 0.170860007405281 1837.12902832031 919.5718 1836.95812988281 919.486328125 2 25 1.1.1.3685.7 1 48.4549 2827.518 48.4707 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 2 99.0000009536743 HGVQELEIELQSQLSKK missed K-K@16 0.239823997020721 1965.29296875 656.1049 1965.05310058594 656.024963378906 3 20 1.1.1.3625.13 1 46.9968 1934.174 46.9571 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 2 99.0000009536743 NYSPYYNTIDDLKDQIVDLTVGNNK missed K-D@13 0.258653998374939 2901.66186523438 968.2279 2901.4033203125 968.141662597656 3 27 1.1.1.4040.11 1 57.1964 1822.122 57.1846 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 2 99.0000009536743 SGGGGGGGLGSGGSIR 0.148460999131203 1231.73901367188 616.8768 1231.59057617188 616.802551269531 2 26 1.1.1.2647.8 1 23.3956 2882.334 23.4007 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0.863279342651367 99.0000009536743 TLNDMRQEYEQLIAK missed R-Q@6 0.237966001033783 1851.15759277344 618.0598 1850.91967773438 617.98046875 3 17 1.1.1.3599.9 1 46.3332 5189.931 46.2724 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0.58838027715683 99.0000009536743 SRSGGGGGGGLGSGGSIR cleaved L-S@N-term; missed R-S@2 0.21620500087738 1474.93981933594 492.6539 1474.7236328125 492.581817626953 3 15 1.1.1.2598.5 1 22.2078 186.1447 22.2129 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0.391473948955536 99.0000009536743 STMQELNSR Oxidation(M)@3 0.145935997366905 1080.63293457031 541.3237 1080.48693847656 541.250732421875 2 15 1.1.1.2502.2 1 20.3668 243.8181 20.2358 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0.0245681907981634 77.700001001358 IGLGGRGGSGGSYGR missed R-G@6 0.210819005966187 1349.89086914063 450.9709 1349.68005371094 450.900604248047 3 13 1.1.1.2666.3 1 23.8363 860.1335 23.8306 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0.0136762224137783 77.1499991416931 MTLDDFRIKFEMEQNLR missed R-I@7; missed K-F@9 0.256718993186951 2185.32275390625 729.4482 2185.06591796875 729.362609863281 3 13 1.1.1.3755.11 1 50.1735 658.0331 50.1123 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0.000869458774104714 97.3800003528595 QGVDADINGLR 0.121767997741699 1156.70544433594 579.36 1156.58361816406 579.299072265625 2 13 1.1.1.2988.8 1 31.56 797.9886 31.4982 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 99.0000009536743 EIETYHNLLEGGQEDFESSGAGK 0.239054992794991 2509.36352539063 837.4618 2509.12451171875 837.382080078125 3 28 1.1.1.3435.8 1 42.326 1500.285 42.4039 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 99.0000009536743 FSSSSGYGGGSSR 0.152968004345894 1234.67443847656 618.3445 1234.521484375 618.268005371094 2 17 1.1.1.2587.8 1 21.9442 4459.181 21.7922 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 99.0000009536743 FSSSSGYGGGSSR 0.151259005069733 1234.67272949219 618.3436 1234.521484375 618.268005371094 2 14 1.1.1.2595.8 1 22.1326 202.9496 22.0881 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 88.1099998950958 FSSSSGYGGGSSR Deamidated(R)@13 0.173225000500679 1235.6787109375 618.8466 1235.50549316406 618.760009765625 2 12 1.1.1.2585.5 1 21.8916 1535.909 21.7922 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 99.0000009536743 GGGGSFGYSYGGGSGGGFSASSLGGGFGGGSR 0.251825988292694 2704.40576171875 902.4758 2704.15380859375 902.391906738281 3 39 1.1.1.3592.19 1 46.1656 3145.869 46.2221 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 99.0000009536743 GGSGGSYGGGGSGGGYGGGSGSR 0.220202997326851 1790.94067382813 597.9875 1790.72045898438 597.9140625 3 31 1.1.1.2551.3 1 21.163 1356.324 21.2008 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 99.0000009536743 GGSGGSYGGGGSGGGYGGGSGSR 0.220202997326851 1790.94067382813 597.9875 1790.72045898438 597.9140625 3 26 1.1.1.2558.4 1 21.3381 1356.324 21.2008 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 99.0000009536743 HGVQELEIELQSQLSK 0.236764997243881 1837.19494628906 613.4056 1836.95812988281 613.32666015625 3 22 1.1.1.3685.2 1 48.4449 3561.997 48.4945 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 99.0000009536743 HGVQELEIELQSQLSKK missed K-K@16 0.239823997020721 1965.29296875 656.1049 1965.05310058594 656.024963378906 3 22 1.1.1.3618.17 1 46.8212 1934.174 46.9571 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 99.0000009536743 HGVQELEIELQSQLSKK missed K-K@16 0.303043007850647 1965.35620117188 492.3463 1965.05310058594 492.270538330078 4 18 1.1.1.3624.6 1 46.9651 958.1978 46.9571 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 56.5500020980835 HNLLEGGQEDFESSGAGK cleaved Y-H@N-term -2.16603994369507 1871.67822265625 936.8464 1873.84423828125 937.929382324219 2 12 1.1.1.3439.17 1 42.4233 462.4054 42.4039 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 43.979999423027 NYSPYYNTIDDLKDQIVDLTVGNNK missed K-D@13 0.322055995464325 2901.72534179688 726.4386 2901.4033203125 726.358093261719 4 13 1.1.1.4037.6 1 57.1162 753.3033 57.1594 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 23.6599996685982 QGVDADINGLR 0.157411992549896 1156.74108886719 579.3778 1156.58361816406 579.299072265625 2 12 1.1.1.2995.14 1 31.7283 1170.788 31.642 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 99.0000009536743 SGGGGGGGLGSGGSIR 0.148460999131203 1231.73901367188 616.8768 1231.59057617188 616.802551269531 2 28 1.1.1.2640.7 1 23.2287 2865.125 23.4007 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 99.0000009536743 SGGGGGGGLGSGGSIR 0.148460999131203 1231.73901367188 616.8768 1231.59057617188 616.802551269531 2 18 1.1.1.2656.13 1 23.6098 2882.334 23.4007 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 99.0000009536743 SGGGGGGGLGSGGSIR 0.148460999131203 1231.73901367188 616.8768 1231.59057617188 616.802551269531 2 18 1.1.1.2649.11 1 23.4381 2882.334 23.4007 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 99.0000009536743 SGGGGGGGLGSGGSIR 0.16457399725914 1231.75512695313 616.8848 1231.59057617188 616.802551269531 2 14 1.1.1.2665.8 1 23.823 225.9199 23.8064 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 96.7899978160858 SGGGGGGGLGSGGSIR Delta:H(2)C(2)@N-term 0.0718977004289627 1257.67810058594 629.8463 1257.60620117188 629.810363769531 2 13 1.1.1.2675.9 1 24.0651 1158.749 23.8064 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 95.9399998188019 STMQELNSR 0.14792999625206 1064.64001464844 533.3273 1064.49206542969 533.253295898438 2 14 1.1.1.2648.3 1 23.4135 5417.193 23.4719 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 94.4100022315979 STMQELNSR Oxidation(M)@3 0.145935997366905 1080.63293457031 541.3237 1080.48693847656 541.250732421875 2 12 1.1.1.2492.2 1 20.1864 243.8181 20.2358 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 30.6800007820129 STMQELNSR 0.14792999625206 1064.64001464844 533.3273 1064.49206542969 533.253295898438 2 10 1.1.1.2656.10 1 23.6048 5417.193 23.4719 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 98.360002040863 TLNDMRQEYEQLIAK Oxidation(M)@5 missed R-Q@6 0.232187002897263 1867.14672851563 623.3895 1866.91455078125 623.312133789063 3 14 1.1.1.3225.8 1 37.2538 617.3378 37.2399 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 98.2699990272522 TLNDMRQEYEQLIAK Oxidation(M)@5 missed R-Q@6 0.237497001886368 1867.15209960938 623.3913 1866.91455078125 623.312133789063 3 14 1.1.1.3233.5 1 37.4438 921.2269 37.5514 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 96.2400019168854 TLNDMRQEYEQLIAK missed R-Q@6 0.170658007264137 1851.09033203125 926.5524 1850.91967773438 926.467102050781 2 15 1.1.1.3599.18 1 46.3415 1946.305 46.2976 8 21.88 21.88 74.1599977016449 47.5100010633469 40.9299999475479 sp|P35527|K1C9_HUMAN Keratin, type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 0 60.2400004863739 TVGNNKTLLDIDNTR MDA adduct +62(K)@6; Carbamidomethyl(D)@12 cleaved L-T@N-term; missed K-T@6 0.0514600984752178 1791.96301269531 896.9888 1791.91149902344 896.963012695313 2 13 1.1.1.3716.18 1 49.187 7484.017 49.2943 9 19.7 23.99 85.4499995708466 43.0400013923645 39.750000834465 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 2 99.0000009536743 FGGFGGPGGVGGLGGPGGFGPGGYPGGIHEVSVNQSLLQPLNVK 0.345488011837006 4091.41088867188 1023.86 4091.0654296875 1023.77362060547 4 25 1.1.1.3999.9 1 56.1729 431.3008 56.1369 9 19.7 23.99 85.4499995708466 43.0400013923645 39.750000834465 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 2 99.0000009536743 GFSSGSAVVSGGSR 0.15140999853611 1253.75146484375 627.883 1253.59997558594 627.807312011719 2 20 1.1.1.2704.9 1 24.7628 1573.679 24.8157 9 19.7 23.99 85.4499995708466 43.0400013923645 39.750000834465 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 2 99.0000009536743 GGGFGGGSSFGGGSGFSGGGFGGGGFGGGR 0.245663002133369 2398.2568359375 800.4262 2398.01123046875 800.344299316406 3 25 1.1.1.3600.20 1 46.368 637.8762 46.4245 9 19.7 23.99 85.4499995708466 43.0400013923645 39.750000834465 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 2 99.0000009536743 GGSGGGGSISGGGYGSGGGSGGR 0.223394006490707 1740.96459960938 581.3288 1740.7412109375 581.254333496094 3 26 1.1.1.2589.6 1 21.9971 470.8041 22.0103 9 19.7 23.99 85.4499995708466 43.0400013923645 39.750000834465 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 2 99.0000009536743 GSSSGGGYSSGSSSYGSGGR 0.160196006298065 1739.85852050781 870.9365 1739.6982421875 870.8564453125 2 26 1.1.1.2560.6 1 21.3914 215.6306 21.3964 9 19.7 23.99 85.4499995708466 43.0400013923645 39.750000834465 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 2 99.0000009536743 NLDLDSIIAEVK 0.159156993031502 1328.8779296875 665.4462 1328.71875 665.366638183594 2 20 1.1.1.3901.2 1 53.7988 1971.032 53.8172 9 19.7 23.99 85.4499995708466 43.0400013923645 39.750000834465 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 2 99.0000009536743 NLDLDSIIAEVKAQYEEIAQR missed K-A@12 0.260657995939255 2417.50439453125 806.8421 2417.24389648438 806.755187988281 3 28 1.1.1.4417.2 1 66.5386 783.8287 66.5856 9 19.7 23.99 85.4499995708466 43.0400013923645 39.750000834465 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 2 99.0000009536743 QSGSRGGSGGGGSISGGGYGSGGGSGGR Deamidated(Q)@1 missed R-G@5 0.229642003774643 2257.19995117188 753.4073 2256.97045898438 753.330749511719 3 30 1.1.1.2599.3 1 22.2335 140.1804 22.2129 9 19.7 23.99 85.4499995708466 43.0400013923645 39.750000834465 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 2 99.0000009536743 TSQNSELNNMQDLVEDYKK missed K-K@18 0.240750998258591 2255.2783203125 752.7667 2255.03759765625 752.686462402344 3 27 1.1.1.3491.19 1 43.7066 1146.931 43.7379 9 19.7 23.99 85.4499995708466 43.0400013923645 39.750000834465 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 1.13667702674866 99.0000009536743 GGSISGGGYGSGGGK 0.150910004973412 1196.69311523438 599.3538 1196.54223632813 599.278381347656 2 20 1.1.1.2560.5 1 21.388 253.516 21.4046 9 19.7 23.99 85.4499995708466 43.0400013923645 39.750000834465 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 0.245651677250862 98.2200026512146 NVQDAIADAEQR 0.141598001122475 1328.77368164063 665.3941 1328.63208007813 665.323303222656 2 14 1.1.1.3005.12 1 31.972 267.0225 31.9078 9 19.7 23.99 85.4499995708466 43.0400013923645 39.750000834465 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 0.161150917410851 98.0400025844574 LALDVEIATYR 0.162042006850243 1262.84912109375 632.4318 1262.68701171875 632.350830078125 2 15 1.1.1.3625.11 1 46.9951 461.2596 47.0606 9 19.7 23.99 85.4499995708466 43.0400013923645 39.750000834465 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 0.129596084356308 96.6799974441528 AQYEEIAQR 0.148784995079041 1106.68444824219 554.3495 1106.53564453125 554.275085449219 2 14 1.1.1.2681.4 1 24.2053 1663.366 24.241 9 19.7 23.99 85.4499995708466 43.0400013923645 39.750000834465 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 0.00788851175457239 95.2400028705597 SCQISCK Protein Terminal Acetyl@N-term; Carbamidomethyl(C)@2; Carbamidomethyl(C)@6 cleaved M-S@N-term 0.145182996988297 923.529296875 462.7719 923.384094238281 462.699310302734 2 8 1.1.1.2602.10 1 22.3077 89.7916 22.2913 9 19.7 23.99 85.4499995708466 43.0400013923645 39.750000834465 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 0.00744648277759552 99.0000009536743 NKLNDLEEALQQAKEDLAR missed K-L@2; missed K-E@14 0.242672994732857 2197.37646484375 733.4661 2197.1337890625 733.38525390625 3 21 1.1.1.3821.8 0 51.825 1016.328 51.8665 9 19.7 23.99 85.4499995708466 43.0400013923645 39.750000834465 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 0.00568284746259451 50.6699979305267 YLDGLTAER 0.150361001491547 1036.66931152344 519.3419 1036.51892089844 519.266723632813 2 12 1.1.1.2982.11 1 31.4163 3885.592 31.4263 9 19.7 23.99 85.4499995708466 43.0400013923645 39.750000834465 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 0.00305075151845813 43.0200010538101 TAAENDFVTLK 0.157374992966652 1207.76586914063 604.8902 1207.60852050781 604.8115234375 2 12 1.1.1.3102.7 1 34.3081 756.1575 34.2891 9 19.7 23.99 85.4499995708466 43.0400013923645 39.750000834465 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 0 24.779999256134 AQYEEIAQR 0.148784995079041 1106.68444824219 554.3495 1106.53564453125 554.275085449219 2 11 1.1.1.2689.7 1 24.395 1663.366 24.241 9 19.7 23.99 85.4499995708466 43.0400013923645 39.750000834465 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 0 99.0000009536743 FLEQQNQVLQTK 0.162044003605843 1474.94006347656 738.4773 1474.77795410156 738.396301269531 2 21 1.1.1.3004.15 0 31.9495 565.6183 31.9562 9 19.7 23.99 85.4499995708466 43.0400013923645 39.750000834465 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 0 93.4700012207031 GGGSGFSGGGFGGGGFGGGR cleaved F-G@N-term -8.84360027313232 1578.837890625 790.4262 1587.68151855469 794.848022460938 2 14 1.1.1.3617.16 1 46.7948 222.2039 46.7527 9 19.7 23.99 85.4499995708466 43.0400013923645 39.750000834465 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 0 99.0000009536743 GSSSGGGYSSGSSSYGSGGR 0.221094995737076 1739.91943359375 580.9804 1739.6982421875 580.90673828125 3 19 1.1.1.2560.4 1 21.3847 191.2848 21.3964 9 19.7 23.99 85.4499995708466 43.0400013923645 39.750000834465 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 0 76.2399971485138 IEISELNR 0.148632004857063 972.672668457031 487.3436 972.523986816406 487.269287109375 2 11 1.1.1.2988.5 0 31.555 4402.409 31.7142 9 19.7 23.99 85.4499995708466 43.0400013923645 39.750000834465 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 0 92.8900003433228 IEISELNRVIQR missed R-V@8 0.226100996136665 1469.06225585938 490.6947 1468.83618164063 490.619323730469 3 14 1.1.1.3455.2 0 42.8002 4472.458 42.6974 9 19.7 23.99 85.4499995708466 43.0400013923645 39.750000834465 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 0 74.6800005435944 IEISELNRVIQR missed R-V@8 0.226100996136665 1469.06225585938 490.6947 1468.83618164063 490.619323730469 3 13 1.1.1.3448.5 0 42.6301 4472.458 42.6974 9 19.7 23.99 85.4499995708466 43.0400013923645 39.750000834465 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 0 57.6200008392334 NKLNDLEEALQQAK missed K-L@2 -0.774950981140137 1612.06713867188 538.363 1612.84204101563 538.621276855469 3 12 1.1.1.3502.9 1 43.971 164.8198 43.9118 9 19.7 23.99 85.4499995708466 43.0400013923645 39.750000834465 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 0 99.0000009536743 NKLNDLEEALQQAKEDLAR missed K-L@2; missed K-E@14 0.311141014099121 2197.44506835938 550.3685 2197.1337890625 550.290771484375 4 18 1.1.1.3821.2 0 51.82 284.9873 51.8665 9 19.7 23.99 85.4499995708466 43.0400013923645 39.750000834465 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 0 69.9599981307983 NLDLDSIIAEVKAQYEEIAQR missed K-A@12 0.186940997838974 2417.43139648438 1209.723 2417.24389648438 1209.62915039063 2 13 1.1.1.4419.10 1 66.6054 188.2218 66.5595 9 19.7 23.99 85.4499995708466 43.0400013923645 39.750000834465 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 0 98.5400021076202 NLDLDSIIAEVKAQYEEIAQRSK PyridoxalPhosphate(K)@23 missed K-A@12; missed R-S@21 0.138824999332428 2403.49560546875 802.1725 2403.35668945313 802.126220703125 3 17 1.1.1.4431.4 1 66.9068 245.3194 66.9518 9 19.7 23.99 85.4499995708466 43.0400013923645 39.750000834465 sp|P35908|K22E_HUMAN Keratin, type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 0 49.8699992895126 NSELNNMQDLVEDYKKKYEDEINKR MDA adduct +62(K)@15; reduced acrolein addition +58(K)@16; acrolein addition +56(K)@17 cleaved Q-N@N-term; missed K-K@15; missed K-K@16; missed K-Y@17; missed K-R@24 0.395565986633301 3290.97216796875 549.5026 3290.57641601563 549.436706542969 6 12 1.1.1.3595.10 1 46.2328 825.0256 46.1971 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 2 99.0000009536743 GNYDAAQRGPGGVWAAK missed R-G@8 0.16541500389576 1716.99865722656 859.5066 1716.83325195313 859.423889160156 2 28 1.1.1.2889.11 1 29.1846 3009.775 29.1416 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 2 99.0000009536743 LIDCYLFGNSSTVLEDSKSNEKAEEWGR Carbamidomethyl(C)@4 cleaved G-L@N-term; missed K-S@18; missed K-A@22 -3.81670999526978 3242.697265625 811.6816 3246.51391601563 812.6357421875 4 22 1.1.1.4050.7 1 57.4427 3373.999 57.4595 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 2 99.0000009536743 SFFKEALQGVGDMGR Oxidation(M)@13 missed K-E@4 0.163037002086639 1656.9560546875 829.4853 1656.79296875 829.403747558594 2 23 1.1.1.3365.13 1 40.6134 2507.169 40.695 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 2 99.0000009536743 SFFKEALQGVGDMGRAYWDIMISNHQNSNRYLYAR missed K-E@4; missed R-A@15; missed R-Y@30 0.405310988426209 4137.37890625 828.4831 4136.9736328125 828.402038574219 5 21 1.1.1.4037.11 1 57.1203 511.4267 57.1083 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0.982966780662537 99.0000009536743 AYWDIMISNHQNSNR 0.2291119992733 1848.06640625 617.0294 1847.83728027344 616.953063964844 3 17 1.1.1.3471.10 1 43.2028 1586.589 43.0925 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0.723538160324097 99.0000009536743 GNYDAAQRGPGGVWAAKLISR reduced acrolein addition +58(K)@17 missed R-G@8; missed K-L@17 0.205935999751091 2244.38232421875 749.1347 2244.17626953125 749.066040039063 3 17 1.1.1.3757.13 1 50.2258 294.1236 50.263 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0.657577276229858 99.0000009536743 AYWDIMISNHQNSNRYLYAR missed R-Y@15 0.310999989509583 2514.49731445313 629.6316 2514.18627929688 629.553833007813 4 17 1.1.1.3598.15 1 46.3132 3769.732 46.2471 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0.392545014619827 98.7800002098084 GPGGVWAAK 0.142005994915962 841.586669921875 421.8006 841.444641113281 421.729583740234 2 15 1.1.1.2727.3 1 25.2993 1969.034 25.2216 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0.185752391815186 99.0000009536743 ESWRSFFKEALQGVGDMGR cleaved S-E@N-term; missed R-S@4; missed K-E@8 0.249329000711441 2199.30249023438 734.1081 2199.05322265625 734.024963378906 3 20 1.1.1.3885.5 1 53.4052 1149.698 53.4237 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0.180456072092056 99.0000009536743 EALQGVGDMGR Oxidation(M)@9 0.14682699739933 1147.67602539063 574.8453 1147.52917480469 574.771850585938 2 16 1.1.1.2668.10 1 23.8912 4648.773 23.9272 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0.0920514762401581 95.0500011444092 SNEKAEEWGR missed K-A@4 0.205381006002426 1204.75268554688 402.5915 1204.54724121094 402.523040771484 3 14 1.1.1.2594.2 1 22.0963 1542.067 22.1377 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0.0190880633890629 90.64000248909 SGKDPDRFRPDGLPK missed K-D@3; missed R-F@7 0.170745000243187 1684.0400390625 843.0273 1683.86926269531 842.94189453125 2 14 1.1.1.2710.9 1 24.9063 503.4163 24.9114 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 AYWDIMISNHQNSNR 0.167297005653381 1848.00463867188 925.0096 1847.83728027344 924.925964355469 2 15 1.1.1.3464.19 1 43.036 762.4069 43.0925 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 98.2900023460388 AYWDIMISNHQNSNR 0.167297005653381 1848.00463867188 925.0096 1847.83728027344 924.925964355469 2 13 1.1.1.3471.21 1 43.212 762.4069 43.0925 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 89.7000014781952 AYWDIMISNHQNSNR 0.2291119992733 1848.06640625 617.0294 1847.83728027344 616.953063964844 3 14 1.1.1.3464.10 1 43.0285 1586.589 43.0925 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 AYWDIMISNHQNSNRYLYAR missed R-Y@15 0.247841998934746 2514.43408203125 839.152 2514.18627929688 839.0693359375 3 16 1.1.1.3592.17 1 46.1639 1740.006 46.2221 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 AYWDIMISNHQNSNRYLYAR Dioxidation(W)@3; Oxidation(M)@6 missed R-Y@15 0.241309002041817 2562.41235351563 855.1447 2562.1708984375 855.064270019531 3 16 1.1.1.3352.6 1 40.2993 564.2767 40.3077 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 98.989999294281 AYWDIMISNHQNSNRYLYAR missed R-Y@15 0.310999989509583 2514.49731445313 629.6316 2514.18627929688 629.553833007813 4 16 1.1.1.3591.4 1 46.1356 3769.732 46.2471 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 96.6000020503998 AYWDIMISNHQNSNRYLYAR Oxidation(M)@6 missed R-Y@15 0.241147994995117 2530.42236328125 844.4814 2530.18115234375 844.401000976563 3 15 1.1.1.3432.10 1 42.2515 1267.998 42.3068 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 95.7300007343292 AYWDIMISNHQNSNRYLYAR Dioxidation(W)@3; Oxidation(M)@6; Deamidated(N)@9 missed R-Y@15 0.310990989208221 2563.46606445313 641.8738 2563.15502929688 641.796020507813 4 16 1.1.1.3432.7 1 42.2465 607.3633 42.2583 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 92.8699970245361 AYWDIMISNHQNSNRYLYAR Deamidated(N)@9 missed R-Y@15 0.318195998668671 2515.48852539063 629.8794 2515.17016601563 629.799865722656 4 14 1.1.1.3639.12 1 47.3625 935.4377 47.3751 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 82.2399973869324 AYWDIMISNHQNSNRYLYAR Oxidation(M)@6; Deamidated(N)@9 missed R-Y@15 -0.671836018562317 2530.49340820313 633.6306 2531.16528320313 633.798583984375 4 14 1.1.1.3436.11 1 42.3469 2475.933 42.3068 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 96.8100011348724 EALQGVGDMGR 0.159807994961739 1131.69409179688 566.8543 1131.53430175781 566.7744140625 2 16 1.1.1.2864.5 1 28.5832 700.3121 28.5883 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 ESWRSFFKEALQGVGDMGR cleaved S-E@N-term; missed R-S@4; missed K-E@8 0.249878004193306 2199.30297851563 734.1083 2199.05322265625 734.024963378906 3 19 1.1.1.3893.5 1 53.6051 1302.686 53.5234 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 97.9099988937378 ESWRSFFKEALQGVGDMGR Oxidation(M)@17 cleaved S-E@N-term; missed R-S@4; missed K-E@8 0.304937988519669 2215.35302734375 554.8455 2215.04809570313 554.769287109375 4 17 1.1.1.3782.3 1 50.8548 2680.781 50.8497 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 68.8700020313263 ESWRSFFKEALQGVGDMGR cleaved S-E@N-term; missed R-S@4; missed K-E@8 0.306932985782623 2199.36010742188 550.8473 2199.05322265625 550.770568847656 4 12 1.1.1.3886.2 1 53.4278 1310.13 53.4487 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 GNYDAAQRGPGGVWAAK missed R-G@8 0.16541500389576 1716.99865722656 859.5066 1716.83325195313 859.423889160156 2 22 1.1.1.2882.11 1 29.0162 3009.775 29.1416 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 GNYDAAQRGPGGVWAAK Dioxidation(W)@14 missed R-G@8 0.224704995751381 1749.04772949219 584.0232 1748.82299804688 583.948303222656 3 17 1.1.1.2817.9 1 27.4576 2086.475 27.5138 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 GNYDAAQRGPGGVWAAK missed R-G@8 0.224911004304886 1717.05810546875 573.36 1716.83325195313 573.285034179688 3 19 1.1.1.2882.9 1 29.0129 9572.274 29.1656 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 GNYDAAQRGPGGVWAAK missed R-G@8 0.224911004304886 1717.05810546875 573.36 1716.83325195313 573.285034179688 3 18 1.1.1.2889.10 1 29.183 9572.274 29.1656 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 GNYDAAQRGPGGVWAAK missed R-G@8 0.224911004304886 1717.05810546875 573.36 1716.83325195313 573.285034179688 3 18 1.1.1.2896.7 1 29.353 9572.274 29.1656 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 98.4200000762939 GPGGVWAAK 0.142005994915962 841.586669921875 421.8006 841.444641113281 421.729583740234 2 15 1.1.1.2719.5 1 25.1097 1969.034 25.2216 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 93.6900019645691 GPGGVWAAK Dioxidation(W)@6 0.142960995435715 873.577453613281 437.796 873.434448242188 437.724517822266 2 13 1.1.1.2697.3 1 24.582 2861.82 24.5765 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 81.0999989509583 GPGGVWAAK 0.201210007071495 841.645874023438 421.8302 841.444641113281 421.729583740234 2 13 1.1.1.2735.3 1 25.4931 2049.724 25.4592 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 15.7399997115135 GPGGVWAAK 0.141212999820709 841.585876464844 421.8002 841.444641113281 421.729583740234 2 11 1.1.1.2764.2 1 26.1814 518.5731 26.1758 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 SFFKEALQGVGDMGR Oxidation(M)@13 missed K-E@4 0.163037002086639 1656.9560546875 829.4853 1656.79296875 829.403747558594 2 20 1.1.1.3373.7 1 40.8025 2507.169 40.695 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 SFFKEALQGVGDMGR missed K-E@4 0.231729999184608 1641.02978515625 548.0172 1640.79809570313 547.93994140625 3 22 1.1.1.3607.8 1 46.5353 6221.24 46.5257 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 SFFKEALQGVGDMGR missed K-E@4 0.166619002819061 1640.96472167969 821.4896 1640.79809570313 821.406311035156 2 23 1.1.1.3607.18 1 46.5436 3332.998 46.5257 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 SFFKEALQGVGDMGR missed K-E@4 0.166619002819061 1640.96472167969 821.4896 1640.79809570313 821.406311035156 2 18 1.1.1.3614.15 1 46.717 3332.998 46.5257 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 SFFKEALQGVGDMGR Oxidation(M)@13 missed K-E@4 0.227964997291565 1657.02099609375 553.3476 1656.79296875 553.271606445313 3 16 1.1.1.3366.5 1 40.6279 1819.707 40.695 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 SFFKEALQGVGDMGR missed K-E@4 0.231729999184608 1641.02978515625 548.0172 1640.79809570313 547.93994140625 3 17 1.1.1.3614.6 1 46.7095 6221.24 46.5257 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 97.7699995040894 SFFKEALQGVGDMGR missed K-E@4 0.231729999184608 1641.02978515625 548.0172 1640.79809570313 547.93994140625 3 12 1.1.1.3600.10 1 46.3596 6221.24 46.5257 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 98.8300025463104 SRVYLQGLIDCYLFGNSSTVLEDSK Carbamidomethyl(C)@11 missed R-V@2 3.3649799823761 2866.77124023438 717.7001 2863.40625 716.858825683594 4 18 1.1.1.4263.4 1 62.6259 474.7661 62.6708 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 40.6699985265732 SRVYLQGLIDCYLFGNSSTVLEDSK Deamidated(R)@2; Deamidated(Q)@6; Carbamidomethyl(C)@11; Deamidated(N)@16 missed R-V@2 0.342754006385803 2866.70092773438 956.5743 2866.35815429688 956.460021972656 3 12 1.1.1.4255.11 1 62.436 1618.272 62.6196 10 11.23 11.23 84.6199989318848 84.6199989318848 73.0799973011017 sp|P35542|SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 0 99.0000009536743 SRVYLQGLIDCYLFGNSSTVLEDSKSNEK Carbamidomethyl(C)@11 missed R-V@2; missed K-S@25 3.3670699596405 3324.98583984375 832.2537 3321.61865234375 831.411987304688 4 19 1.1.1.4062.3 1 57.7457 1075.724 57.7658 11 3.04 3.04 89.3899977207184 51.7700016498566 41.159999370575 sp|P06727|APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 2 99.0000009536743 SELTQQLNALFQDKLGEVNTYAGDLQK missed K-L@14 0.324079006910324 3022.84887695313 756.7195 3022.52465820313 756.638488769531 4 23 1.1.1.4035.6 1 57.0655 793.1036 57.0575 11 3.04 3.04 89.3899977207184 51.7700016498566 41.159999370575 sp|P06727|APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 0.284832656383514 99.0000009536743 KLVPFATELHER missed K-L@1 0.223984003067017 1439.01721191406 480.6797 1438.79321289063 480.605010986328 3 15 1.1.1.3037.13 1 32.741 807.3719 32.7287 11 3.04 3.04 89.3899977207184 51.7700016498566 41.159999370575 sp|P06727|APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 0.180456072092056 97.759997844696 LLPHANEVSQK 0.15183499455452 1234.81884765625 618.4167 1234.6669921875 618.340759277344 2 15 1.1.1.2666.9 1 23.8471 1310.435 23.8788 11 3.04 3.04 89.3899977207184 51.7700016498566 41.159999370575 sp|P06727|APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 0.173925206065178 98.8699972629547 VLRENADSLQASLRPHADELK missed R-E@3 0.301624000072479 2361.54174804688 591.3927 2361.23999023438 591.317321777344 4 16 1.1.1.3085.6 1 33.892 553.664 33.8806 11 3.04 3.04 89.3899977207184 51.7700016498566 41.159999370575 sp|P06727|APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 0.161150917410851 98.8499999046326 IGDNLRELQQRLEPYADQLR missed R-E@6; missed R-L@11 0.30901101231575 2426.57568359375 607.6512 2426.2666015625 607.573913574219 4 16 1.1.1.3719.8 1 49.2532 995.7745 49.2691 11 3.04 3.04 89.3899977207184 51.7700016498566 41.159999370575 sp|P06727|APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 0.0570004098117352 96.7000007629395 RVEPYGENFNKALVQQMEQLRQK missed R-V@1; missed K-A@11; missed R-Q@21 0.317357003688812 2804.75659179688 702.1964 2804.43920898438 702.117065429688 4 13 1.1.1.3612.18 1 46.6689 291.158 46.6513 11 3.04 3.04 89.3899977207184 51.7700016498566 41.159999370575 sp|P06727|APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 0.0540392957627773 95.7300007343292 SLAELGGHLDQQVEEFRR missed R-R@17 0.298543006181717 2083.34326171875 521.8431 2083.04467773438 521.768432617188 4 15 1.1.1.3486.5 1 43.5722 2256.3 43.5643 11 3.04 3.04 89.3899977207184 51.7700016498566 41.159999370575 sp|P06727|APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 0.0423927158117294 99.0000009536743 EVSADQVATVMWDYFSQLSNNAKEAVEHLQK cleaved A-E@N-term; missed K-E@23 0.319806009531021 3537.00805664063 885.2593 3536.68823242188 885.179321289063 4 23 1.1.1.4694.10 1 73.6915 808.9608 73.6797 11 3.04 3.04 89.3899977207184 51.7700016498566 41.159999370575 sp|P06727|APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 0.0338582694530487 99.0000009536743 EVSADQVATVMWDYFSQLSNNAK cleaved A-E@N-term 0.264019012451172 2602.46508789063 868.4956 2602.20092773438 868.407592773438 3 28 1.1.1.4550.8 1 69.9444 287.3623 69.9825 11 3.04 3.04 89.3899977207184 51.7700016498566 41.159999370575 sp|P06727|APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 0.021819481626153 89.0699982643127 VLRENADSLQASLRPHADELKAK missed R-E@3; missed K-A@21 0.363564997911453 2560.73559570313 513.1544 2560.3720703125 513.081726074219 5 14 1.1.1.2998.6 1 31.7976 2313.055 31.7868 11 3.04 3.04 89.3899977207184 51.7700016498566 41.159999370575 sp|P06727|APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 0.00877392385154963 73.1899976730347 QLTPYAQR 0.14708299934864 975.660888671875 488.8377 975.513793945313 488.76416015625 2 11 1.1.1.2684.3 1 24.2713 5215.755 24.3606 11 3.04 3.04 89.3899977207184 51.7700016498566 41.159999370575 sp|P06727|APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 0.00788851175457239 97.1499979496002 PHANEVSQK cleaved L-P@N-term 0.146378993988037 1008.64526367188 505.3299 1008.49884033203 505.256713867188 2 12 1.1.1.2667.10 1 23.8671 758.8103 23.8788 11 3.04 3.04 89.3899977207184 51.7700016498566 41.159999370575 sp|P06727|APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 0.00700490176677704 81.580001115799 DSEKLKEEIGKELEELRAR missed K-L@4; missed K-E@6; missed K-E@11; missed R-A@17 0.309753000736237 2271.51684570313 568.8865 2271.20703125 568.809020996094 4 13 1.1.1.3664.7 1 47.9968 701.8436 48.0136 11 3.04 3.04 89.3899977207184 51.7700016498566 41.159999370575 sp|P06727|APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 0.00305075151845813 46.5999990701675 IDQNVEELKGR missed K-G@9 0.208553001284599 1299.88684082031 434.3029 1299.67822265625 434.233367919922 3 12 1.1.1.2692.5 1 24.4622 4936.187 24.4084 11 3.04 3.04 89.3899977207184 51.7700016498566 41.159999370575 sp|P06727|APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 0.00261361571028829 49.2599993944168 ISASAEELRQR missed R-Q@9 0.152318000793457 1258.81530761719 630.4149 1258.66296386719 630.338745117188 2 13 1.1.1.2669.21 1 23.9222 1015.128 23.9272 11 3.04 3.04 89.3899977207184 51.7700016498566 41.159999370575 sp|P06727|APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 0 91.4200007915497 DKVNSFFSTFKEK reduced acrolein addition +58(K)@2; Deamidated(N)@4; Dehydrated(S)@8; hexanoyl addition +98(K)@11 missed K-V@2; missed K-E@11 0.198248997330666 1715.080078125 572.7006 1714.8818359375 572.634521484375 3 14 1.1.1.3343.3 1 40.0721 7000.427 40.0423 11 3.04 3.04 89.3899977207184 51.7700016498566 41.159999370575 sp|P06727|APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 0 90.719997882843 DKVNSFFSTFKEK reduced acrolein addition +58(K)@2; Deamidated(N)@4; Dehydrated(S)@8; hexanoyl addition +98(K)@13 missed K-V@2; missed K-E@11 0.198248997330666 1715.080078125 572.7006 1714.8818359375 572.634521484375 3 14 1.1.1.3336.3 1 39.9088 7000.427 40.0423 11 3.04 3.04 89.3899977207184 51.7700016498566 41.159999370575 sp|P06727|APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 0 19.6400001645088 IDQNVEELKGR missed K-G@9 0.153604000806808 1299.83190917969 650.9232 1299.67822265625 650.846435546875 2 13 1.1.1.2689.12 1 24.4033 510.0034 24.3845 11 3.04 3.04 89.3899977207184 51.7700016498566 41.159999370575 sp|P06727|APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 0 37.9599988460541 KLVPFATELHERLAKDSEKLK hexanoyl addition +98(K)@1; hexanoyl addition +98(K)@15; Carbamidomethyl(E)@18; reduced acrolein addition +58(K)@19 missed K-L@1; missed R-L@12; missed K-D@15; missed K-L@19 0.197824999690056 2762.79248046875 691.7054 2762.59448242188 691.655944824219 4 12 1.1.1.3771.8 1 50.5811 2188.555 50.597 11 3.04 3.04 89.3899977207184 51.7700016498566 41.159999370575 sp|P06727|APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 0 99.0000009536743 SELTQQLNALFQDKLGEVNTYAGDLQK missed K-L@14 0.0676836967468262 3022.59228515625 1008.538 3022.52465820313 1008.51550292969 3 24 1.1.1.4033.17 1 57.0239 948.541 57.0323 11 3.04 3.04 89.3899977207184 51.7700016498566 41.159999370575 sp|P06727|APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 0 96.3100016117096 SELTQQLNALFQDKLGEVNTYAGDLQK missed K-L@14 0.25500100851059 3022.78125 1008.601 3022.52465820313 1008.51550292969 3 17 1.1.1.4035.16 1 57.0738 1591.72 57.0575 11 3.04 3.04 89.3899977207184 51.7700016498566 41.159999370575 sp|P06727|APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 0 25.220000743866 SLAELGGHLDQQVEEFRR missed R-R@17 0.237032994627953 2083.28173828125 695.4345 2083.04467773438 695.35546875 3 14 1.1.1.3482.10 1 43.4761 1840.731 43.5396 11 3.04 3.04 89.3899977207184 51.7700016498566 41.159999370575 sp|P06727|APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 0 38.280001282692 VNSFFSTFKEK HexNAc(S)@3 missed K-E@9 0.0823284983634949 1535.83312988281 768.9238 1535.75073242188 768.882690429688 2 11 1.1.1.3029.8 1 32.5551 4723.252 32.4399 12 2.42 2.42 69.3099975585938 48.5100001096725 48.5100001096725 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 2 99.0000009536743 STAAMSTYTGIFTDQVLSVLKGEE missed K-G@21 0.25968399643898 2547.50122070313 850.1743 2547.24145507813 850.087768554688 3 32 1.1.1.4344.5 1 64.7145 1992.927 64.6804 12 2.42 2.42 69.3099975585938 48.5100001096725 48.5100001096725 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0.267606258392334 98.9499986171722 TAAQNLYEK 0.146943002939224 1036.66589355469 519.3402 1036.51892089844 519.266723632813 2 13 1.1.1.2649.7 1 23.4314 2867.477 23.4957 12 2.42 2.42 69.3099975585938 48.5100001096725 48.5100001096725 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0.151195302605629 99.0000009536743 TYLPAVDEKLRDLYSK missed K-L@9; missed R-D@11 0.238510996103287 1910.25341796875 637.7584 1910.01489257813 637.678894042969 3 16 1.1.1.3510.8 1 44.1698 683.371 44.1849 12 2.42 2.42 69.3099975585938 48.5100001096725 48.5100001096725 sp|P02655|APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 0 99.0000009536743 STAAMSTYTGIFTDQVLSVLKGEE missed K-G@21 0.25968399643898 2547.50122070313 850.1743 2547.24145507813 850.087768554688 3 18 1.1.1.4337.6 1 64.5315 1992.927 64.6804 13 1.39 1.39 62.6699984073639 11.3300003111362 5.83299994468689 sp|Q9NSB2|KRT84_HUMAN Keratin, type II cuticular Hb4 OS=Homo sapiens GN=KRT84 PE=1 SV=1 1.17392539978027 99.0000009536743 SLLTPLNLEIDPNAQR 0.0403277985751629 1793.00866699219 897.5116 1792.96826171875 897.491455078125 2 18 1.1.1.3827.12 1 51.9806 550.1041 52.0434 13 1.39 1.39 62.6699984073639 11.3300003111362 5.83299994468689 sp|Q9NSB2|KRT84_HUMAN Keratin, type II cuticular Hb4 OS=Homo sapiens GN=KRT84 PE=1 SV=1 0.198596298694611 99.0000009536743 VGGVGVPAAPSITAVTVNK 0.168838992714882 1736.15209960938 869.0833 1735.98327636719 868.998901367188 2 15 1.1.1.3494.20 1 43.7817 412.018 43.8867 13 1.39 1.39 62.6699984073639 11.3300003111362 5.83299994468689 sp|Q9NSB2|KRT84_HUMAN Keratin, type II cuticular Hb4 OS=Homo sapiens GN=KRT84 PE=1 SV=1 0.013228265568614 90.8900022506714 AKLEAAVAEAEQQGEATLSDAK missed K-L@2 0.247291997075081 2229.35986328125 744.1272 2229.11254882813 744.044738769531 3 13 1.1.1.3596.17 1 46.264 214.6152 46.1971 13 1.39 1.39 62.6699984073639 11.3300003111362 5.83299994468689 sp|Q9NSB2|KRT84_HUMAN Keratin, type II cuticular Hb4 OS=Homo sapiens GN=KRT84 PE=1 SV=1 0.00744648277759552 66.6800022125244 SVITFGSYSPR 0.157937005162239 1212.77185058594 607.3932 1212.61389160156 607.314208984375 2 12 1.1.1.3316.8 1 39.4343 563.1135 39.3939 13 1.39 1.39 62.6699984073639 11.3300003111362 5.83299994468689 sp|Q9NSB2|KRT84_HUMAN Keratin, type II cuticular Hb4 OS=Homo sapiens GN=KRT84 PE=1 SV=1 0 32.3900014162064 DEKEQIKTLNNK acrolein addition +76(K)@3; reduced acrolein addition +58(K)@7; Ammonia-loss(N)@11; hexanoyl addition +98(K)@12 missed K-E@3; missed K-T@7 0.0620778016746044 1673.94970703125 837.9821 1673.88757324219 837.951049804688 2 11 1.1.1.3747.17 1 49.9801 4526.414 50.0873 13 1.39 1.39 62.6699984073639 11.3300003111362 5.83299994468689 sp|Q9NSB2|KRT84_HUMAN Keratin, type II cuticular Hb4 OS=Homo sapiens GN=KRT84 PE=1 SV=1 0 79.4900000095367 SLLTPLNLEIDPNAQR -1.63265001773834 1791.33569335938 896.6751 1792.96826171875 897.491455078125 2 12 1.1.1.3826.14 1 51.957 660.199 51.9679 14 1.31 1.31 25.5800008773804 0.87660001590848 0.87660001590848 sp|P04114|APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=1 1.30980372428894 99.0000009536743 IADFELPTIIVPEQTIEIPSIKFSVPAGIVIPSFQALTAR missed K-F@22 0.326207995414734 4320.7265625 1081.189 4320.40234375 1081.10791015625 4 22 1.1.1.4661.21 1 72.8421 219.9633 72.8472 14 1.31 1.31 25.5800008773804 0.87660001590848 0.87660001590848 sp|P04114|APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=1 0 99.0000009536743 IADFELPTIIVPEQTIEIPSIKFSVPAGIVIPSFQALTAR missed K-F@22 0.326696991920471 4320.73046875 1081.19 4320.40234375 1081.10791015625 4 28 1.1.1.4639.11 1 72.2594 675.6349 72.2644 14 1.31 1.31 25.5800008773804 0.87660001590848 0.87660001590848 sp|P04114|APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=1 0 99.0000009536743 IADFELPTIIVPEQTIEIPSIKFSVPAGIVIPSFQALTAR missed K-F@22 0.326696991920471 4320.73046875 1081.19 4320.40234375 1081.10791015625 4 19 1.1.1.4642.11 1 72.3373 675.6349 72.2644 14 1.31 1.31 25.5800008773804 0.87660001590848 0.87660001590848 sp|P04114|APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=1 0 99.0000009536743 IADFELPTIIVPEQTIEIPSIKFSVPAGIVIPSFQALTAR missed K-F@22 0.326696991920471 4320.73046875 1081.19 4320.40234375 1081.10791015625 4 32 1.1.1.4646.13 1 72.4429 675.6349 72.2644